Citrus Sinensis ID: 002897

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------87
Protein Sequence
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDGLR
Secondary Structure (PSIPRED)
cEEEccccccccccHHHHHccccccEEEccccccEEcccccccccccccccccccccccccccHHHcccccccEEEcccccccccccccccccccccccccccccccccccccHHcccccccEEEccccccEEcccHHHHHHccccEEccccccccccccccccccccccEEEccccccccccccccccHHcccccccccEEEcccccccccccHHHHcccccccEEEEcccEEEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHHcccccccccccccEEcccccccccccccccEEEcccccccccccHHHHcccccccHHccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHcccccccccEEEEcccccccccEEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccHHHHHccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHcccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccccccccccccccHHccccccEEEEEccccccccccHHHHccccccEEEEcccccccccccHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHccccHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHccHHHHHHHHEEEccccccccccEEEEEEEcccccHHHHHccccccccccEccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHEEccccccccccccccEEEEEccccEcccHHccccEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHcccccHHHccHHHccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcHcccccccccc
Coil and Loop (DISEMBL)
mfdaqnnklvgdipVEIGCYLFKLenlslaenhltgqlpvsignlsaLQVIDIrgnrlggkipdtLGQLRKLIYLNigrnqfsgfippsiynissFEFIFLQsnrfhgslpfdmvanlPNLRKFVAAKnnltgflpislsnasnlellelRDNQFIGKMSINFNSLKNLSVLILGnnhlgnraandlDFVTVLANcsklenlglydnqfggllphslanlsntmttidiggnyfsgtippglgnlvhLNSIAmegnqligtvppeigwlknlqslylnsnflhgyipsslgnlTMLTLLALEINNlqgkipsslgncTSLIMLTLSknkldgvlppqilSVTTLSLFLNLsdnllsgslpseignlkNLVQldisgnrfsgdipgtlsactSLEYVKmqdnsfsgsippslnflksikvldlssnklsgqipkyleNLSFLEYLNLSYnhfegevpkkgvfsnktrfslsgngklcggldefhlpscpskrSRKLIATILKVVIPTIVSCLILSACFIVIYgrrrstdrsferttmveqqfpMISYAKLSkatsefsssnmvgqgsfgTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICssidfngvdFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLhhhckppvvhgdlkpsnvlldhdmvahvgdfglakflparpldtvvetpssssgikgtvgyiapeygtgseasmtgdvYSFGILLLEMfsrrrptdsmfhegltlhefskmvlpekvmeivdpsLLLEVRAnnsmsrggervkIEECLVAVIRIGVvcsmesptdrmQMRDVVVKLCAAREAFVSMQDGLR
Flexible Loop (DISEMBL)
mfdaqnnklvgdipVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGrrrstdrsferttmveqqfpmISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVvetpssssgikgtvGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRAnnsmsrggervkieeCLVAVIRIGVvcsmesptdrmQMRDVVVKLCAAREAFvsmqdglr
Low Complexity Region (SEG)
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIslsnasnlellelRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSlgnltmltllalEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTlslflnlsdnllsgslpsEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDGLR
Disordered region (IsUnstruct)
********LVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRR****************************************SFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE*******IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANN****GGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV*******
Disordered Region (DISOPRED)
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGL*********************KVVIPTIVSCLILSACFIVIY*********************MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA*************SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVR**********RVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA*********
Disordered Region (DISEMBL)
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT*********GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDGLR
Disordered Region (DISPRO)
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRST********MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVR*********ERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR***********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDGLR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	869	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.966	0.831	0.443	0.0
C0LGT6	1031	LRR receptor-like serine/	no	no	0.962	0.810	0.435	0.0
Q9SD62	1025	Putative receptor-like pr	no	no	0.964	0.817	0.455	0.0
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.958	0.85	0.369	1e-136
Q9FL28	1173	LRR receptor-like serine/	no	no	0.943	0.699	0.328	1e-117
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.904	0.627	0.334	1e-112
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.942	0.655	0.341	1e-111
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.924	0.673	0.328	1e-111
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.937	0.804	0.309	1e-110
O49545	1003	Leucine-rich repeat recep	no	no	0.919	0.796	0.321	1e-108

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/873 (44%), Positives = 552/873 (63%), Gaps = 33/873 (3%)

Query: 5    QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
             +N+L G +P E+G  L  L  L+L  N++ G+LP S+GNL+ L+ + +  N L G+IP 
Sbjct: 146  DSNRLGGSVPSELGS-LTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPS 204

Query: 65   TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF 124
             + QL ++  L +  N FSG  PP++YN+SS + + +  N F G L  D+   LPNL  F
Sbjct: 205  DVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSF 264

Query: 125  VAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAA 184
                N  TG +P +LSN S LE L + +N   G +   F ++ NL +L L  N LG+ ++
Sbjct: 265  NMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSS 323

Query: 185  NDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN 244
             DL+F+T L NC++LE LG+  N+ GG LP S+ANLS  + T+D+GG   SG+IP  +GN
Sbjct: 324  RDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGN 383

Query: 245  LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEIN 304
            L++L  + ++ N L G +P  +G L NL+ L L SN L G IP+ +GN+TML  L L  N
Sbjct: 384  LINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNN 443

Query: 305  NLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIG 364
              +G +P+SLGNC+ L+ L +  NKL+G +P +I+ +  L L L++S N L GSLP +IG
Sbjct: 444  GFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSLPQDIG 502

Query: 365  NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
             L+NL  L +  N+ SG +P TL  C ++E + ++ N F G I P L  L  +K +DLS+
Sbjct: 503  ALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI-PDLKGLVGVKEVDLSN 561

Query: 425  NKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHL 484
            N LSG IP+Y  + S LEYLNLS+N+ EG+VP KG+F N T  S+ GN  LCGG+  F L
Sbjct: 562  NDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQL 621

Query: 485  -------PSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTT-- 535
                   PS   K S +L   ++ V +   +  L+  A   +I+ R+R  ++     T  
Sbjct: 622  KPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPS 681

Query: 536  MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
             +E     ISY  L  AT+ FSSSNMVG GSFGTV+K ++     +VAVKVLN+ ++GA+
Sbjct: 682  TLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAM 741

Query: 596  KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
            KSF+ ECE+L+ IRHRNL+K++T CSSIDF G +F+A++Y+FM NGSL+ WLH   +++E
Sbjct: 742  KSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP--EEVE 799

Query: 656  VCN-----LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
              +     L+L++ LNIAIDVAS ++YLH HC  P+ H DLKPSNVLLD D+ AHV DFG
Sbjct: 800  EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859

Query: 711  LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
            LA+ L     ++      SS+G++GT+GY APEYG G + S+ GDVYSFGILLLEMF+ +
Sbjct: 860  LARLLLKFDEESFFNQ-LSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGK 918

Query: 771  RPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV--KIEECLVA 828
            RPT+ +F    TL+ ++K  LPE++++IVD S+L            G RV   + ECL  
Sbjct: 919  RPTNELFGGNFTLNSYTKSALPERILDIVDESIL----------HIGLRVGFPVVECLTM 968

Query: 829  VIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
            V  +G+ C  ESP +R+    VV +L + RE F
Sbjct: 969  VFEVGLRCCEESPMNRLATSIVVKELISIRERF 1001

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  662 bits (1709), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/877 (43%), Positives = 547/877 (62%), Gaps = 41/877 (4%)

Query: 3    DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
            D  +N L   +P E+G  L KL  L L++N+LTG  P S+GNL++LQ +D   N++ G+I
Sbjct: 151  DLSSNHLGHGVPSELGS-LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEI 209

Query: 63   PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
            PD + +L ++++  I  N FSG  PP++YNISS E + L  N F G+L  D    LPNLR
Sbjct: 210  PDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLR 269

Query: 123  KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
            + +   N  TG +P +L+N S+LE  ++  N   G + ++F  L+NL  L + NN LGN 
Sbjct: 270  RLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNN 329

Query: 183  AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
            +++ L+F+  +ANC++LE L +  N+ GG LP S+ANLS T+T++ +G N  SGTIP  +
Sbjct: 330  SSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDI 389

Query: 243  GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
            GNLV L  +++E N L G +P   G L NLQ + L SN + G IPS  GN+T L  L L 
Sbjct: 390  GNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLN 449

Query: 303  INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE 362
             N+  G+IP SLG C  L+ L +  N+L+G +P +IL + +L+ +++LS+N L+G  P E
Sbjct: 450  SNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEE 508

Query: 363  IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
            +G L+ LV L  S N+ SG +P  +  C S+E++ MQ NSF G+I P ++ L S+K +D 
Sbjct: 509  VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAI-PDISRLVSLKNVDF 567

Query: 423  SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
            S+N LSG+IP+YL +L  L  LNLS N FEG VP  GVF N T  S+ GN  +CGG+ E 
Sbjct: 568  SNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREM 627

Query: 483  HLPSC-----PSKRS-----RKLIATILKVVIPTIVSCLILSACFIVIYGRR-RSTDRSF 531
             L  C     P KR      +K+++ I   +   ++  ++ S C+ +   ++  ++D + 
Sbjct: 628  QLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNP 687

Query: 532  ERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ 591
              +T +      +SY +L  ATS FSS+N++G G+FG VFKG++G    LVAVKVLNL++
Sbjct: 688  SDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLK 747

Query: 592  KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN 651
             GA KSF+ ECE  + IRHRNL+K+IT+CSS+D  G DF+A+VY+FM  GSL+ WL    
Sbjct: 748  HGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQL-- 805

Query: 652  DKLEVCN-----LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV 706
            + LE  N     L+  + LNIAIDVASA+EYLH HC  PV H D+KPSN+LLD D+ AHV
Sbjct: 806  EDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHV 865

Query: 707  GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             DFGLA+ L     ++ +    SS+G++GT+GY APEYG G + S+ GDVYSFGILLLEM
Sbjct: 866  SDFGLAQLLYKYDRESFLNQ-FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEM 924

Query: 767  FSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECL 826
            FS ++PTD  F     LH ++K +L                  +   S GG    I+E L
Sbjct: 925  FSGKKPTDESFAGDYNLHSYTKSIL------------------SGCTSSGGSNA-IDEGL 965

Query: 827  VAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS 863
              V+++G+ CS E P DRM+  + V +L + R  F S
Sbjct: 966  RLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFS 1002

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  659 bits (1699), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/874 (45%), Positives = 556/874 (63%), Gaps = 36/874 (4%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N L   +P+E G    KL  LSL  N+LTG+ P S+GNL++LQ++D   N++ G+IP  +
Sbjct: 163  NHLEQGVPLEFGSLS-KLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDI 221

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
             +L+++I+  I  N+F+G  PP IYN+SS  F+ +  N F G+L  D  + LPNL+    
Sbjct: 222  ARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYM 281

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
              N+ TG +P +LSN S+L  L++  N   GK+ ++F  L+NL +L L NN LGN ++ D
Sbjct: 282  GINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGD 341

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            LDF+  L NCS+L+ L +  N+ GG LP  +ANLS  +T + +GGN  SG+IP G+GNLV
Sbjct: 342  LDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLV 401

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
             L ++ +  N L G +PP +G L  L+ + L SN L G IPSSLGN++ LT L L  N+ 
Sbjct: 402  SLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSF 461

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
            +G IPSSLG+C+ L+ L L  NKL+G +P +++ + +L + LN+S NLL G L  +IG L
Sbjct: 462  EGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKL 520

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
            K L+ LD+S N+ SG IP TL+ C SLE++ +Q NSF G I P +  L  ++ LDLS N 
Sbjct: 521  KFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPI-PDIRGLTGLRFLDLSKNN 579

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSG IP+Y+ N S L+ LNLS N+F+G VP +GVF N +  S+ GN  LCGG+    L  
Sbjct: 580  LSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQP 639

Query: 487  C----PSKRS--RKLIATILKVVIPTIVSCLILSACFIVIYGRRRST-------DRSFER 533
            C    P + S  RK+I   +  V+  ++   +          R +S        DRSF  
Sbjct: 640  CSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSF-- 697

Query: 534  TTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG 593
             + V+  +  ISY +L K T  FSSSN++G G+FG VFKG +G     VA+KVLNL ++G
Sbjct: 698  -SPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRG 756

Query: 594  ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK 653
            A KSF+ ECEAL  IRHRNL+K++TICSS DF G DF+A+VY+FM NG+L+ WLH   D+
Sbjct: 757  AAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DE 814

Query: 654  LEVC-----NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
            +E        L L   LNIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ AHV D
Sbjct: 815  IEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSD 874

Query: 709  FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            FGLA+ L     DT      SS+G++GT+GY APEYG G   S+ GDVYSFGI+LLE+F+
Sbjct: 875  FGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFT 933

Query: 769  RRRPTDSMFHEGLTLHEFSKMVLPEK-VMEIVDPSLLLEVRANNSMSRGGERVKIEECLV 827
             +RPT+ +F +GLTLH F+K  L ++  ++I D ++L    A        +   + ECL 
Sbjct: 934  GKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYA--------QHFNMVECLT 985

Query: 828  AVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
             V R+GV CS ESP +R+ M + + KL + RE+F
Sbjct: 986  LVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  486 bits (1251), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 337/913 (36%), Positives = 486/913 (53%), Gaps = 80/913 (8%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNL-SALQVIDIRGNRLGG 60
            D     L G+I   I   L  L  L L+ N   G++P  IG+L   L+ + +  N L G
Sbjct: 71  LDISGRDLGGEISPSIA-NLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHG 129

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIY---NISSFEFIFLQSNRFHGSLPFDMVAN 117
            IP  LG L +L+YL++G N+ +G IP  ++   + SS ++I L +N   G +P +   +
Sbjct: 130 NIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCH 189

Query: 118 LPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM-SINFNSLKNLSVLILGN 176
           L  LR  +   N LTG +P SLSN++NL+ ++L  N   G++ S   + +  L  L L  
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249

Query: 177 NHL--GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF 234
           NH    N   N   F   LAN S L+ L L  N  GG +  S+ +LS  +  I +  N  
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRI 309

Query: 235 SGTIPPG------------------------LGNLVHLNSIAMEGNQLIGTVPPEIGWLK 270
            G+IPP                         L  L  L  + +  N L G +P E+G + 
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
            L  L ++ N L G IP S GNL+ L  L L  N+L G +P SLG C +L +L LS N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429

Query: 331 DGVLPPQILS-VTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSA 389
            G +P +++S +  L L+LNLS N LSG +P E+  +  ++ +D+S N  SG IP  L +
Sbjct: 430 TGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGS 489

Query: 390 CTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
           C +LE++ +  N FS ++P SL  L  +K LD+S N+L+G IP   +  S L++LN S+N
Sbjct: 490 CIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFN 549

Query: 450 HFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSK-RSRKLIATILKVVIPTIV 508
              G V  KG FS  T  S  G+  LCG +      +C  K +   ++  +L  +I T V
Sbjct: 550 LLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPV 607

Query: 509 SC-----LILSACF---IVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSN 560
            C     L+  + F   + +Y +    D   E+    + ++P ISY +L  AT  F++S+
Sbjct: 608 LCVFGYPLVQRSRFGKNLTVYAKEEVEDE--EKQNQNDPKYPRISYQQLIAATGGFNASS 665

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKII 617
           ++G G FG V+KG++  N   VAVKVL+   K AL+   SF  EC+ L+  RHRNLI+II
Sbjct: 666 LIGSGRFGHVYKGVL-RNNTKVAVKVLD--PKTALEFSGSFKRECQILKRTRHRNLIRII 722

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
           T CS   FN     A+V   M NGSLE  L+    +    NL LIQ +NI  DVA  I Y
Sbjct: 723 TTCSKPGFN-----ALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVNICSDVAEGIAY 775

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP----LDTVVETPSSSSGI 733
           LHH+    VVH DLKPSN+LLD +M A V DFG+++ +         D  V   S+   +
Sbjct: 776 LHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLL 835

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
            G+VGYIAPEYG G  AS  GDVYSFG+LLLE+ S RRPTD + +EG +LHEF K   P+
Sbjct: 836 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPD 895

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEEC-------LVAVIRIGVVCSMESPTDRMQ 846
            +  I++ +L          SR   + K E+C       ++ +I +G+VC+  +P+ R  
Sbjct: 896 SLEGIIEQAL----------SRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPD 945

Query: 847 MRDVVVKLCAARE 859
           M DV  ++   +E
Sbjct: 946 MLDVAHEMGRLKE 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  424 bits (1090), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 309/940 (32%), Positives = 472/940 (50%), Gaps = 120/940 (12%)

Query: 7    NKLVGDIPVEIG-CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
            N L GDIP EIG C    L  L L +N LTG++P  +GNL  LQ + I  N+L   IP +
Sbjct: 250  NLLEGDIPAEIGNCS--SLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSS 307

Query: 66   LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLP-------------- 111
            L +L +L +L +  N   G I   I  + S E + L SN F G  P              
Sbjct: 308  LFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTV 367

Query: 112  -FDMVAN--------LPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN 162
             F+ ++         L NLR   A  N LTG +P S+SN + L+LL+L  NQ  G++   
Sbjct: 368  GFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG 427

Query: 163  FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN 222
            F  + NL+ + +G NH      +D+       NCS LE L + DN   G L   +  L  
Sbjct: 428  FGRM-NLTFISIGRNHFTGEIPDDI------FNCSNLETLSVADNNLTGTLKPLIGKLQK 480

Query: 223  TMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFL 282
             +  + +  N  +G IP  +GNL  LN + +  N   G +P E+  L  LQ L + SN L
Sbjct: 481  -LRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDL 539

Query: 283  HGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVT 342
             G IP  + ++ +L++L L  N   G+IP+      SL  L+L  NK +G +P  + S++
Sbjct: 540  EGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLS 599

Query: 343  TLS-------------------------LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGN 377
             L+                         L+LN S+NLL+G++P E+G L+ + ++D+S N
Sbjct: 600  LLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNN 659

Query: 378  RFSGDIPGTLSACT---SLEY----------------------VKMQDNSFSGSIPPSLN 412
             FSG IP +L AC    +L++                      + +  NSFSG IP S  
Sbjct: 660  LFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFG 719

Query: 413  FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
             +  +  LDLSSN L+G+IP+ L NLS L++L L+ N+ +G VP+ GVF N     L GN
Sbjct: 720  NMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGN 779

Query: 473  GKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVS----------CLILSACFIVIYG 522
              LCG   +  L  C  K+     +   +V++  + S           LIL+ C      
Sbjct: 780  TDLCGS--KKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKK 837

Query: 523  RRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
               S++ S         +       +L +AT  F+S+N++G  S  TV+KG + E+G ++
Sbjct: 838  IENSSESSLPDLDSA-LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVI 895

Query: 583  AVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQN 640
            AVKVLNL +  A   K F TE + L  ++HRNL+KI+       +     KA+V  FM+N
Sbjct: 896  AVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMEN 951

Query: 641  GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH 700
            G+LE+ +H +   +     SL++ +++ + +AS I+YLH     P+VH DLKP+N+LLD 
Sbjct: 952  GNLEDTIHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDS 1007

Query: 701  DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFG 760
            D VAHV DFG A+ L  R   +   T +S+S  +GT+GY+APE+    + +   DV+SFG
Sbjct: 1008 DRVAHVSDFGTARILGFREDGS---TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFG 1064

Query: 761  ILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV 820
            I+++E+ +++RPT       L   +   M L + V + +       VR  + M  G   V
Sbjct: 1065 IIMMELMTKQRPT------SLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLD-MELGDSIV 1117

Query: 821  --KIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR 858
              K EE +   +++ + C+   P DR  M +++  L   R
Sbjct: 1118 SLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  407 bits (1047), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 294/878 (33%), Positives = 446/878 (50%), Gaps = 92/878 (10%)

Query: 2    FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
            F   +N L G +P EIG +L KLE + L EN  +G++PV IGN + LQ ID  GNRL G+
Sbjct: 414  FTLYHNNLEGKVPKEIG-FLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGE 472

Query: 62   IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
            IP ++G+L+ L  L++  N+  G IP S+ N      I L  N+  GS+P      L  L
Sbjct: 473  IPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSF-GFLTAL 531

Query: 122  RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
              F+   N+L G LP SL N  NL  +    N+F G +S                     
Sbjct: 532  ELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSIS--------------------- 570

Query: 182  RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
                       L   S   +  + +N F G +P  L   +N +  + +G N F+G IP  
Sbjct: 571  ----------PLCGSSSYLSFDVTENGFEGDIPLELGKSTN-LDRLRLGKNQFTGRIPRT 619

Query: 242  LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
             G +  L+ + +  N L G +P E+G  K L  + LN+N+L G IP+ LG L +L  L L
Sbjct: 620  FGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKL 679

Query: 302  EINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS 361
              N   G +P+ + + T+++ L L  N L+G +P +I ++  L+  LNL +N LSG LPS
Sbjct: 680  SSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNA-LNLEENQLSGPLPS 738

Query: 362  EIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE-YVKMQDNSFSGSIPPSLNFLKSIKVL 420
             IG L  L +L +S N  +G+IP  +     L+  + +  N+F+G IP +++ L  ++ L
Sbjct: 739  TIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESL 798

Query: 421  DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLD 480
            DLS N+L G++P  + ++  L YLNLSYN+ EG++ K+  FS     +  GN  LCG   
Sbjct: 799  DLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS-P 855

Query: 481  EFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERT------ 534
              H     SK  R L    + V+I  I S   ++   +VI    +     F++       
Sbjct: 856  LSHCNRAGSKNQRSLSPKTV-VIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSA 914

Query: 535  ---TMVEQQFPM---------ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
                    Q P+         I +  + +AT   +   M+G G  G V+K  + +NG  +
Sbjct: 915  FSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAEL-KNGETI 973

Query: 583  AVKVLNLMQKGAL---KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQ 639
            AVK   ++ K  L   KSF  E + L +IRHR+L+K++  CSS   +G++   ++Y++M 
Sbjct: 974  AVK--KILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS-KADGLNL--LIYEYMA 1028

Query: 640  NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD 699
            NGS+ +WLH N +  +   L     L IA+ +A  +EYLH+ C PP+VH D+K SNVLLD
Sbjct: 1029 NGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLD 1088

Query: 700  HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSF 759
             ++ AH+GDFGLAK L     DT  E   S++   G+ GYIAPEY    +A+   DVYS 
Sbjct: 1089 SNIEAHLGDFGLAKILTGN-YDTNTE---SNTMFAGSYGYIAPEYAYSLKATEKSDVYSM 1144

Query: 760  GILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL-----PEKVMEIVDPSL--LLEVRANNS 812
            GI+L+E+ + + PT++MF E   +  + + VL      E   +++D  L  LL       
Sbjct: 1145 GIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCE---- 1200

Query: 813  MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDV 850
                      EE    V+ I + C+   P +R   R  
Sbjct: 1201 ----------EEAAYQVLEIALQCTKSYPQERPSSRQA 1228

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  404 bits (1038), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 309/905 (34%), Positives = 457/905 (50%), Gaps = 86/905 (9%)

Query: 2    FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
             D  NN L G IP E    L +L +L L  N L G L  SI NL+ LQ + +  N L GK
Sbjct: 365  LDLSNNSLAGSIP-EALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423

Query: 62   IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
            +P  +  LRKL  L +  N+FSG IP  I N +S + I +  N F G +P   +  L  L
Sbjct: 424  LPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIP-PSIGRLKEL 482

Query: 122  RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG- 180
                  +N L G LP SL N   L +L+L DNQ  G +  +F  LK L  L+L NN L  
Sbjct: 483  NLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG 542

Query: 181  ---------------NRAANDLD-FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
                           N + N L+  +  L   S   +  + +N F   +P  L N S  +
Sbjct: 543  NLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGN-SQNL 601

Query: 225  TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
              + +G N  +G IP  LG +  L+ + M  N L GT+P ++   K L  + LN+NFL G
Sbjct: 602  DRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSG 661

Query: 285  YIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
             IP  LG L+ L  L L  N     +P+ L NCT L++L+L  N L+G +P +I ++  L
Sbjct: 662  PIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGAL 721

Query: 345  SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE-YVKMQDNSF 403
            ++ LNL  N  SGSLP  +G L  L +L +S N  +G+IP  +     L+  + +  N+F
Sbjct: 722  NV-LNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNF 780

Query: 404  SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
            +G IP ++  L  ++ LDLS N+L+G++P  + ++  L YLN+S+N+  G++ K+  FS 
Sbjct: 781  TGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSR 838

Query: 464  KTRFSLSGNGKLCGGLDEFHLPSCPSKRS--RKLIATILKVVIPTIVSCLI---LSACFI 518
                S  GN  LCG      L  C   RS  ++   +   VVI + +S L    L    I
Sbjct: 839  WPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVI 894

Query: 519  VIYGRRR----------STDRSFERTTMVEQQFPM---------ISYAKLSKATSEFSSS 559
             ++ ++R          ST  +   ++      P+         I +  + +AT   S  
Sbjct: 895  ALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEE 954

Query: 560  NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL---KSFLTECEALRSIRHRNLIKI 616
             M+G G  G V+K  + ENG  VAVK   ++ K  L   KSF  E + L  IRHR+L+K+
Sbjct: 955  FMIGSGGSGKVYKAEL-ENGETVAVK--KILWKDDLMSNKSFSREVKTLGRIRHRHLVKL 1011

Query: 617  ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIAIDVASA 674
            +  CSS    G++   ++Y++M+NGS+ +WLH++   LE     L     L IA+ +A  
Sbjct: 1012 MGYCSS-KSEGLNL--LIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQG 1068

Query: 675  IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
            +EYLHH C PP+VH D+K SNVLLD +M AH+GDFGLAK L     DT  +   S++   
Sbjct: 1069 VEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL-TENCDTNTD---SNTWFA 1124

Query: 735  GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM---VL 791
             + GYIAPEY    +A+   DVYS GI+L+E+ + + PTDS+F   + +  + +    V 
Sbjct: 1125 CSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA 1184

Query: 792  PEKVMEIVDPSL--LLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD 849
                 +++DP L  LL                 E+    V+ I + C+  SP +R   R 
Sbjct: 1185 GSARDKLIDPKLKPLLPFE--------------EDAACQVLEIALQCTKTSPQERPSSRQ 1230

Query: 850  VVVKL 854
                L
Sbjct: 1231 ACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  403 bits (1036), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 295/898 (32%), Positives = 446/898 (49%), Gaps = 95/898 (10%)

Query: 6    NNKLVGDIPVEI-GCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
            NN+  G+IP EI  C + K  +LSLA N L+G +P  +    +L+ ID+ GN L G I +
Sbjct: 338  NNRFSGEIPHEIEDCPMLK--HLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEE 395

Query: 65   TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF 124
                   L  L +  NQ +G IP  ++ +     + L SN F G +P  +  +  NL +F
Sbjct: 396  VFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKST-NLMEF 453

Query: 125  VAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAA 184
             A+ N L G+LP  + NA++L+ L L DNQ  G++      L +LSVL L  N    +  
Sbjct: 454  TASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIP 513

Query: 185  NDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP----- 239
             +L       +C+ L  L L  N   G +P  +  L+     + +  N  SG+IP     
Sbjct: 514  VEL------GDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLV-LSYNNLSGSIPSKPSA 566

Query: 240  -------PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGN 292
                   P L  L H     +  N+L G +P E+G    L  + L++N L G IP+SL  
Sbjct: 567  YFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSR 626

Query: 293  LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD 352
            LT LT+L L  N L G IP  +GN   L  L L+ N+L+G +P     + +L + LNL+ 
Sbjct: 627  LTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSL-VKLNLTK 685

Query: 353  NLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLN 412
            N L G +P+ +GNLK L  +D+S N  SG++   LS    L  + ++ N F+G IP  L 
Sbjct: 686  NKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELG 745

Query: 413  FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
             L  ++ LD+S N LSG+IP  +  L  LE+LNL+ N+  GEVP  GV  + ++  LSGN
Sbjct: 746  NLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGN 805

Query: 473  GKLCGGL--DEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRS 530
             +LCG +   +  +     + +  +   +L   I   V    L    +    ++R     
Sbjct: 806  KELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPER 865

Query: 531  FERT--------------------------TMVEQQFPMISYAKLSKATSEFSSSNMVGQ 564
             E +                           M EQ    +    + +AT  FS  N++G 
Sbjct: 866  MEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGD 925

Query: 565  GSFGTVFKGII-GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSI 623
            G FGTV+K  + GE    VAVK L+  +    + F+ E E L  ++H NL+ ++  CS  
Sbjct: 926  GGFGTVYKACLPGEK--TVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS-- 981

Query: 624  DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCK 683
             F+  + K +VY++M NGSL+ WL      LEV + S  + L IA+  A  + +LHH   
Sbjct: 982  -FS--EEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWS--KRLKIAVGAARGLAFLHHGFI 1036

Query: 684  PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPE 743
            P ++H D+K SN+LLD D    V DFGLA+ + A   ++ V     S+ I GT GYI PE
Sbjct: 1037 PHIIHRDIKASNILLDGDFEPKVADFGLARLISA--CESHV-----STVIAGTFGYIPPE 1089

Query: 744  YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE-------GLTLHEFSKMVLPEKVM 796
            YG  + A+  GDVYSFG++LLE+ + + PT   F E       G  + + ++     K +
Sbjct: 1090 YGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQ----GKAV 1145

Query: 797  EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
            +++DP LL+ V   NS  R             +++I ++C  E+P  R  M DV+  L
Sbjct: 1146 DVIDP-LLVSVALKNSQLR-------------LLQIAMLCLAETPAKRPNMLDVLKAL 1189

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  401 bits (1031), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 272/878 (30%), Positives = 457/878 (52%), Gaps = 63/878 (7%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
            +A  N L G++  ++G  L  LE L L  N   G LP S  NL  L+ + + GN L G+
Sbjct: 145 LNASGNNLSGNLTEDLG-NLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGE 203

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           +P  LGQL  L    +G N+F G IPP   NI+S +++ L   +  G +P ++   L +L
Sbjct: 204 LPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSEL-GKLKSL 262

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
              +  +NN TG +P  + + + L++L+  DN   G++ +    LKNL +L L  N L  
Sbjct: 263 ETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSG 322

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
                      +++ ++L+ L L++N   G LP  L   ++ +  +D+  N FSG IP  
Sbjct: 323 ------SIPPAISSLAQLQVLELWNNTLSGELPSDLGK-NSPLQWLDVSSNSFSGEIPST 375

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
           L N  +L  + +  N   G +P  +   ++L  + + +N L+G IP   G L  L  L L
Sbjct: 376 LCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLEL 435

Query: 302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS 361
             N L G IP  + +  SL  +  S+N++   LP  ILS+  L  FL ++DN +SG +P 
Sbjct: 436 AGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFL-VADNFISGEVPD 494

Query: 362 EIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLD 421
           +  +  +L  LD+S N  +G IP ++++C  L  + +++N+ +G IP  +  + ++ VLD
Sbjct: 495 QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLD 554

Query: 422 LSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDE 481
           LS+N L+G +P+ +     LE LN+SYN   G VP  G         L GN  LCGG+  
Sbjct: 555 LSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV-- 612

Query: 482 FHLPSC----------PSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSF 531
             LP C           S   ++++A  L + I ++++  IL+     +Y +  S     
Sbjct: 613 --LPPCSKFQRATSSHSSLHGKRIVAGWL-IGIASVLALGILTIVTRTLYKKWYSNGFCG 669

Query: 532 ERT-TMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKV 586
           + T +  E  + ++++ +L    S+       SNM+G G+ G V+K  +  +  ++AVK 
Sbjct: 670 DETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKK 729

Query: 587 LNL----MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGS 642
           L      ++ G    F+ E   L  +RHRN+++++       +N  +   IVY+FM NG+
Sbjct: 730 LWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFL----YNDKNM-MIVYEFMLNGN 784

Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L + +H  N    +  +  +   NIA+ VA  + YLHH C PPV+H D+K +N+LLD ++
Sbjct: 785 LGDAIHGKNAAGRLL-VDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANL 843

Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
            A + DFGLA+ + AR  +TV       S + G+ GYIAPEYG   +     D+YS+G++
Sbjct: 844 DARIADFGLARMM-ARKKETV-------SMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVV 895

Query: 763 LLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM--EIVDPSLLLEVRANNSMSRGGERV 820
           LLE+ + RRP +  F E + + E+ +  + + +   E +DP++             G   
Sbjct: 896 LLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV-------------GNCR 942

Query: 821 KIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR 858
            ++E ++ V++I ++C+ + P DR  MRDV+  L  A+
Sbjct: 943 YVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAK 980

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  394 bits (1013), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 284/884 (32%), Positives = 434/884 (49%), Gaps = 85/884 (9%)

Query: 6   NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
           NN   G  P EI   L  L  L +  N+LTG LPVS+ NL+ L+ + + GN   GKIP +
Sbjct: 126 NNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPS 185

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL-QSNRFHGSLPFDMVANLPNLRKF 124
            G    + YL +  N+  G IPP I N+++   +++   N F   LP + + NL  L +F
Sbjct: 186 YGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE-IGNLSELVRF 244

Query: 125 VAAKNNLTGFLP------------------------ISLSNASNLELLELRDNQFIGKMS 160
             A   LTG +P                          L   S+L+ ++L +N F G++ 
Sbjct: 245 DGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIP 304

Query: 161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANL 220
            +F  LKNL++L L  N L        +    + +  +LE L L++N F G +P  L   
Sbjct: 305 ASFAELKNLTLLNLFRNKLHG------EIPEFIGDLPELEVLQLWENNFTGSIPQKLGE- 357

Query: 221 SNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSN 280
           +  +  +D+  N  +GT+PP + +   L ++   GN L G++P  +G  ++L  + +  N
Sbjct: 358 NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGEN 417

Query: 281 FLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILS 340
           FL+G IP  L  L  LT + L+ N L G++P + G   +L  ++LS N+L G LPP I +
Sbjct: 418 FLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGN 477

Query: 341 VTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD 400
            T +   L L  N   G +PSE+G L+ L ++D S N FSG I   +S C  L +V +  
Sbjct: 478 FTGVQKLL-LDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSR 536

Query: 401 NSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGV 460
           N  SG IP  +  +K +  L+LS N L G IP  + ++  L  L+ SYN+  G VP  G 
Sbjct: 537 NELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQ 596

Query: 461 FSNKTRFSLSGNGKLCGGL-----DEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSA 515
           FS     S  GN  LCG       D        S     L A++  +++  ++ C I  A
Sbjct: 597 FSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFA 656

Query: 516 CFIVIYGR---RRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFK 572
              +I  R   + S  R++  T      F                  N++G+G  G V+K
Sbjct: 657 VVAIIKARSLKKASESRAWRLTAFQRLDF------TCDDVLDSLKEDNIIGKGGAGIVYK 710

Query: 573 GIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITICSSIDFNGVDF 630
           G++  NG LVAVK L  M +G+     F  E + L  IRHR++++++  CS+ + N    
Sbjct: 711 GVM-PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN---- 765

Query: 631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGD 690
             +VY++M NGSL E LH         +L       IA++ A  + YLHH C P +VH D
Sbjct: 766 -LLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRD 820

Query: 691 LKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA 750
           +K +N+LLD +  AHV DFGLAKFL          T    S I G+ GYIAPEY    + 
Sbjct: 821 VKSNNILLDSNFEAHVADFGLAKFLQDS------GTSECMSAIAGSYGYIAPEYAYTLKV 874

Query: 751 SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL---PEKVMEIVDPSLLLEV 807
               DVYSFG++LLE+ + R+P    F +G+ + ++ + +     + V++++DP L    
Sbjct: 875 DEKSDVYSFGVVLLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLKVLDPRL---- 929

Query: 808 RANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV 851
                       + I E +  V  + ++C  E   +R  MR+VV
Sbjct: 930 ----------SSIPIHE-VTHVFYVAMLCVEEQAVERPTMREVV 962

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	869
224081190	1011	predicted protein [Populus trichocarpa]	0.976	0.839	0.492	0.0
359482058	1040	PREDICTED: probable LRR receptor-like se	0.968	0.809	0.486	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.968	0.442	0.485	0.0
224113117	1006	predicted protein [Populus trichocarpa]	0.982	0.848	0.478	0.0
224141953	1026	predicted protein [Populus trichocarpa]	0.967	0.819	0.473	0.0
255581223	1015	receptor-kinase, putative [Ricinus commu	0.978	0.837	0.486	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.986	0.838	0.464	0.0
444737622	1032	Putative LRR receptor-like serine/threon	0.988	0.832	0.468	0.0
359486510	965	PREDICTED: probable LRR receptor-like se	0.973	0.876	0.483	0.0
357505893	1003	Receptor kinase-like protein [Medicago t	0.973	0.843	0.474	0.0

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2040), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/869 (49%), Positives = 580/869 (66%), Gaps = 20/869 (2%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N L G IP ++G  L KL    L  N+L G +P S GNLS++Q      N L G IP++L
Sbjct: 156  NNLTGKIPAQLGS-LSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESL 214

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            G L++L Y  +  N  SG IP SI NISS  ++ L  N+ HGSLP D+  NLPNL   V 
Sbjct: 215  GNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVI 274

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
              N+L G +P +LSNAS + L++L  N   GK+  +  SL +L  L++ +N LGN   +D
Sbjct: 275  NFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDD 333

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            L F+  LAN + LE+LG+ DN FGG+LP  ++N S  +  I  G N   G+IP  +GNL+
Sbjct: 334  LSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLI 393

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
             L+++++E NQL G +P  IG L+NL +LYLN N + G IPSSLGN+T L  ++   NNL
Sbjct: 394  SLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSFAQNNL 453

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
            QG IP+SLGN   L++L LS+N L G +P ++L +++LS+ L L DN L+GSLPSE+G L
Sbjct: 454  QGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQL 513

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
             NL  L +S NR SG+IP +L +C SLE + +  N F G + P L+ L+++++L LS N 
Sbjct: 514  VNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPV-PDLSSLRALQMLLLSYNN 572

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSGQIP++L++   LE L+LSYN FEGEVP++GVF N +R S+ GN KLCGG+ +  LP 
Sbjct: 573  LSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPK 632

Query: 487  CPSK---RSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPM 543
            C S    R +     IL + IP     ++L   F++ Y R+   + +   +   E  F  
Sbjct: 633  CTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTKDEPASGPSW--ESSFQR 690

Query: 544  ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
            ++Y  L +AT  FSSSN+VG G+FG+V++G +  +G +VAVKVLNL++KGA KSF+ EC 
Sbjct: 691  LTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECA 750

Query: 604  ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ---NNDKLEVCNLS 660
            AL +IRHRNL+K+IT CSS DF G DFKA+VY+FM NGSLEEWLH    ++   E  NL 
Sbjct: 751  ALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLD 810

Query: 661  LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL 720
            L+Q LNIAIDVASA++YLH+HC+ PVVH DLKPSNVLL  DM A VGDFGLA+FLP    
Sbjct: 811  LVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEAS- 869

Query: 721  DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
            + +    SSS G+KGT+GY APEYG GSE S  GDVYS+GILLLEMF+ RRPTD MF +G
Sbjct: 870  NQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDG 929

Query: 781  LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES 840
              LH ++KMVLP+ V+E VDP+L    R +  M+   +  K+ EC+V++I++G+ CS E 
Sbjct: 930  HNLHNYAKMVLPDNVLEFVDPTL----REHEEMNHNDDSHKVMECMVSIIKVGLACSAEL 985

Query: 841  PTDRMQMRDVVVKLCAAREAFVSMQDGLR 869
            P +RM + +VVV+L   RE    M DG +
Sbjct: 986  PGERMGIANVVVELHRIRE----MLDGRK 1010

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  787 bits (2032), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/875 (48%), Positives = 585/875 (66%), Gaps = 33/875 (3%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N L+G IP  +G Y  K+  + L  N+LTG +P S+GNL++++ +    N L G IP  L
Sbjct: 163  NNLIGRIPSWLGSYP-KVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQAL 221

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            GQL+ L ++ +G N FSG IP S+YN+SS E   L  N+ +GSLP+D+   LPNL+    
Sbjct: 222  GQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNI 281

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
              N+ TG LP SLSNASNL   ++  + F GK+SI+F  + NL  L L +N LG   A+D
Sbjct: 282  GNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADD 341

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            L F+  L  C  L+ L L  +QFGG+LP+S+ANLS  +  + +  N  SGTIPPG+GNLV
Sbjct: 342  LSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLV 401

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            +L  + +  N   G++P  IG L+ L  + L+ N L G+IPSSLGN+T L  L L+ N+L
Sbjct: 402  NLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHL 461

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
             GKIPSS GN   L  L LS N L+G +P +++ + +L++ LNL+ N L+G LPSE+  L
Sbjct: 462  SGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKL 521

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
            KNL  LD+S N+ SG+IP  L +C +LE++ M+ N F GSIPPS   L+ +  LDLS N 
Sbjct: 522  KNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNN 581

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSGQIP++L+ LS L  LNLS+N+FEG++P KGVF+N T  S++GN KLCGG+ E HLP+
Sbjct: 582  LSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPA 640

Query: 487  CP--------SKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVE 538
            CP        SKR  KL+  +L   +  +   LI+S   +++  R R   R   +T+   
Sbjct: 641  CPVTKPKTGESKRGLKLMIGLLTGFLGLV---LIMS---LLVINRLRRVKREPSQTSASS 694

Query: 539  QQFPM-ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
            +   + +SY  L KAT  FSS+N++G G FG+V+KGI+G++  +VAVKV+ L Q+GA+KS
Sbjct: 695  KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKS 754

Query: 598  FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH------QNN 651
            F  ECEALR+IRHRNL+K++T CSS+D+ G DFKA+VY+FM NGSLE WLH      + N
Sbjct: 755  FKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIN 814

Query: 652  DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
            D L +  LSL Q LNIAIDVASA++YLHHHC  P+VH DLKPSN+LLD+DM AHVGDFGL
Sbjct: 815  DVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGL 872

Query: 712  AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            A+F+P         + SSS G+KGT+GY APEYG G++ S  GD YS+GILLLEMF+ +R
Sbjct: 873  ARFIP-EAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKR 931

Query: 772  PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLE-------VRANNSMSRGGERVKIEE 824
            PT+SMF + L LH F KM LPE++ +I+DP  L           A++S     +R K+ E
Sbjct: 932  PTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHE 991

Query: 825  CLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE 859
            CL++++RIGV CS+ESP +RM + + + +L   R+
Sbjct: 992  CLISILRIGVSCSLESPRERMAITEAIKELQLIRK 1026

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  785 bits (2026), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/875 (48%), Positives = 584/875 (66%), Gaps = 33/875 (3%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N L+G IP  +G Y  K+  + L  N+LTG +P S+GNL++++ +    N L G IP  L
Sbjct: 194  NNLIGRIPSWLGSYP-KVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQAL 252

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            GQL+ L ++ +G N FSG IP S+YN+SS E   L  N+ +GSLP+D+   LPNL+    
Sbjct: 253  GQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNI 312

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
              N+ TG LP SLSNASNL   ++  + F GK+SI+F  + NL  L L +N LG   A+D
Sbjct: 313  GNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADD 372

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            L F+  L  C  L+ L L  +QFGG+LP+S+ANLS  +  + +  N  SGTIPPG+GNLV
Sbjct: 373  LSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLV 432

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            +L  + +  N   G++P  IG L+ L  + L+ N L G+IPSSLGN+T L  L L+ N+L
Sbjct: 433  NLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHL 492

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
             GKIPSS GN   L  L LS N L+G +P +++ + +L++ LNL+ N L+G LPSE+  L
Sbjct: 493  SGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKL 552

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
            KNL  LD+S N+ SG+IP  L +C +LE++ M+ N F GSIPPS   L+ +  LDLS N 
Sbjct: 553  KNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNN 612

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSGQIP++L+ LS L  LNLS+N+FEG++P KGVF+N T  S++GN KLCGG+ E HLP+
Sbjct: 613  LSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPA 671

Query: 487  CP--------SKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVE 538
            CP        SKR  KL+  +L   +  +   LI+S   +++  R R   R   +T+   
Sbjct: 672  CPVTKPKTGESKRGLKLMIGLLTGFLGLV---LIMS---LLVINRLRRVKREPSQTSASS 725

Query: 539  QQFPM-ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
            +   + +SY  L KAT  FSS+N++G G FG+V+KG +G++  +VAVKV+ L Q+GA+KS
Sbjct: 726  KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKS 785

Query: 598  FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH------QNN 651
            F  ECEALR+IRHRNL+K++T CSS+D+ G DFKA+VY+FM NGSLE WLH      + N
Sbjct: 786  FKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIN 845

Query: 652  DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
            D L +  LSL Q LNIAIDVASA++YLHHHC  P+VH DLKPSN+LLD+DM AHVGDFGL
Sbjct: 846  DVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGL 903

Query: 712  AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            A+F+P         + SSS G+KGT+GY APEYG G++ S  GD YS+GILLLEMF+ +R
Sbjct: 904  ARFIP-EAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKR 962

Query: 772  PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLE-------VRANNSMSRGGERVKIEE 824
            PT+SMF + L LH F KM LPE++ +I+DP  L           A++S     +R K+ E
Sbjct: 963  PTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHE 1022

Query: 825  CLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE 859
            CL++++RIGV CS+ESP +RM + + + +L   R+
Sbjct: 1023 CLISILRIGVSCSLESPRERMAITEAIKELQLIRK 1057

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/868 (47%), Positives = 580/868 (66%), Gaps = 14/868 (1%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
           + D + N L+G IP E+G  L  L+   L  NHL G++P+S  NLS++++I +  N L G
Sbjct: 133 LIDLKGNNLIGKIPAELGS-LLNLQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHLQG 191

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
            IP  +G+L++L  L++  N  SG IPPSIYN+SS     +  N+FHGSLP D+   LP+
Sbjct: 192 SIPYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKLPS 251

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG 180
           L   V   N   G +P+++SNAS L +++  +N F GK+   F +L NL  L + +N LG
Sbjct: 252 LEVLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVP-PFANLPNLQYLGIDSNELG 310

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP 240
           N    DL F+  LAN + LE LG+ DN  GG+ P  ++N S+  TT+ +G N   G+IP 
Sbjct: 311 NGEEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSIPV 370

Query: 241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLA 300
            +GNL+ L+++ +E NQL G +P  IG LKNL  L L  N + G IPSSLGN+T L  L 
Sbjct: 371 DIGNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVELY 430

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP 360
           L  NNLQG IPSSL NC +L+ L L++N L G L  Q++ + +LS+ L+LS N L G LP
Sbjct: 431 LSANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGPLP 490

Query: 361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL 420
           SE+G L NL  LD+S NR SG+IPG+L +C  LEY+ ++ N   GSIP  L+ L++++ L
Sbjct: 491 SEVGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQYL 550

Query: 421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLD 480
           +LS N L+GQIP++L +   L+ L+LS+NH EGE+P + VF N +  S+ GN KLCGG+ 
Sbjct: 551 NLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGGIS 610

Query: 481 EFHLPSCPSKRSRK-LIATILKVV--IPTIVSCLILSACFIVIYGRRRSTDRSFERTTMV 537
           + +L  C S   RK   +T LK+V  IP      +L    ++I+  R++ +      +  
Sbjct: 611 QLNLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLLISSLLIHSWRKTKNEPASGASW- 669

Query: 538 EQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           E  F  ++Y +L +AT  FSSSN +G GSFG+V+K I+  +GM+VAVKV NL++KGA KS
Sbjct: 670 EVSFRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKS 729

Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL---HQNNDKL 654
           ++ EC AL +IRHRNL+KI+T CSS+DF G DFKA+VY+FM NGSLEEWL   H ++++ 
Sbjct: 730 YMAECAALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEER 789

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
           E  NL+LIQ LN+AIDVASA++YLH+HC+  VVH DLKPSNVLLD DM AHVGDFGLA+F
Sbjct: 790 EQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARF 849

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
            P   +  +    +SS G+KGTVGY APEYG G+E S  GDVYS+GILLLE+ + + PTD
Sbjct: 850 RPEASVQ-LSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTD 908

Query: 775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNS-MSRGGERV---KIEECLVAVI 830
             F EGL LH++ KM LP++V+E+VDP LL E+   ++  S G +R+   K+ ECLV+++
Sbjct: 909 GSFKEGLNLHKYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIM 968

Query: 831 RIGVVCSMESPTDRMQMRDVVVKLCAAR 858
            +GV CS++ P +R  + +VV +L   R
Sbjct: 969 EVGVSCSVDLPRERTNISNVVAELHRIR 996

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa]

 Score =  771 bits (1992), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/865 (47%), Positives = 583/865 (67%), Gaps = 24/865 (2%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            NKL G+IP E+G +L KL  LS  +N+L G++P SIGNL++L+ + ++ N L G IPD+L
Sbjct: 156  NKLGGEIPTELG-FLSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGTIPDSL 214

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            G+L++L  L +G N+ SGFIPPS+YN+S     +L  N F GSLP ++  + P+L+    
Sbjct: 215  GRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHLQWLAL 274

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
             +N  +G +P SL+NAS L+++    N   GK+   F  L +LS L  G+N+LG    ++
Sbjct: 275  WQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGTGGDDE 334

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            + F+  L NCS L+ + + +N+  G LP ++ NLS  M    + GN+  G IP G+GNLV
Sbjct: 335  MAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSGIGNLV 394

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            +L  + M+ N   G +P   G L+ L+   L SN L G IPSSLGNL++L++L L+ N L
Sbjct: 395  NLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYLDDNKL 454

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
            +  IP+SLG C +L+ L LS+  L+G +P Q+   +++   LNLS N  +GSLPS IG+L
Sbjct: 455  KDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPSTIGSL 514

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
            K L +LD+S N  SG+IP +   CTSLE + M+DN F GSIP S + L+ I+ LDLS N 
Sbjct: 515  KGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDLSCNN 574

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSGQ+P +L  + F+  LNLSYN+FEGEVP+KGVF+N++  S+ GN KLCGG+ E HLP 
Sbjct: 575  LSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGILELHLPE 633

Query: 487  CPSKRSRKLIATILKVVIPTIVSCLILSA----CFIVIYGRRRSTDRSFERTTMVEQQFP 542
            CP+K  +K   + L+ ++   + C ++ A     F+  + +++  + S +  T++++ FP
Sbjct: 634  CPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKRKEHSSD--TLLKESFP 691

Query: 543  MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTEC 602
             ISY +L KAT  FS++N++G GSF +V+KG I E+G LVA+KVLNL ++GA KSF  EC
Sbjct: 692  QISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFKDEC 751

Query: 603  EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH---QNNDKLEVCNL 659
            EALR+IRHRNL+KIIT CSSIDF G +FKA+VY++M  GSLE+WLH   + +D  ++  +
Sbjct: 752  EALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQQINQV 811

Query: 660  ---SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP 716
               +L++ +NIAIDVA+A++YLHHHC  P++H D+KPSN+LLD DM+ H+GDFGLA+   
Sbjct: 812  QRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGLARIFQ 871

Query: 717  ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
                 ++    SSS+GIKGT GY APEYG G E S+ GDVYS+GILLLEM + +RP D  
Sbjct: 872  EFSEPSL---ESSSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEMMTGKRPIDDT 928

Query: 777  FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVC 836
            F +GL LH F+KM LP+ V+EI DP LL E    N+ S       +EECL ++++IGV C
Sbjct: 929  FEKGLNLHMFAKMALPDHVIEITDPVLLSERHLENAAS-------MEECLTSLVKIGVAC 981

Query: 837  SMESPTDRMQMRDVVVKLCAAREAF 861
            SM+SP DRM M  VV +L   R+ F
Sbjct: 982  SMDSPRDRMDMSRVVRELLMVRDTF 1006

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  771 bits (1991), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/866 (48%), Positives = 577/866 (66%), Gaps = 16/866 (1%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N+L G+IP E+   L KL+ +S+ +N+ +G +P SIGNLS+LQV+    N L G IPD +
Sbjct: 157  NQLEGEIPEELS-LLAKLQVISIQKNYFSGSIPPSIGNLSSLQVLSAPENYLSGNIPDAI 215

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            GQL  LI++++  N  SG IPPSIYN+SS   + +  N+  G LP ++   LPNL+ F  
Sbjct: 216  GQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIVYNQIQGRLPSNLGITLPNLQVFAI 275

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
            A+N+  G +P S SNASNL  L + +N+  G++  +   L NL +L LG N+LG   AND
Sbjct: 276  ARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVP-SLEQLHNLQILGLGYNYLG-LEAND 333

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            LDFV+ L NC+ L  L +++N+F G+LP S++N S T + + I  N  +G IP  + NLV
Sbjct: 334  LDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTTFSQLVIAENNIAGRIPSSISNLV 393

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            +L  + M  NQL G +P   G L  L+ L+L  N L G IPSSLGNLTML  L+   NNL
Sbjct: 394  NLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLSGTIPSSLGNLTMLLTLSFYDNNL 453

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
            QG+IPSSL  C +L++L L+KN L G +P Q+  +++LS+ L+LS N  +G +P E+GNL
Sbjct: 454  QGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSSLSIALDLSANHFTGVIPMEVGNL 513

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
            K+L QL IS N  SG IP +L +C  LE + +Q N F G +P SL+ L+ ++VLD SSN 
Sbjct: 514  KDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFFDGLVPSSLSSLRGLRVLDFSSNN 573

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSG+IP++L++   LE LNLSYN+FEG VP +G+F N +   + GN KLCGG+ EFHL  
Sbjct: 574  LSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNASTTLVMGNDKLCGGIPEFHLAK 633

Query: 487  CPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFPM--I 544
            C +K  +KL   +LK+VI TI S L LS  FI+I+       +  E  T       +  +
Sbjct: 634  CNAKSPKKL-TLLLKIVISTICSLLGLS--FILIFALTFWLRKKKEEPTSDPYGHLLLNV 690

Query: 545  SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA 604
            S+  L +AT  FSS+N++G+GSFG V+KG + E  + +AVKVLNL+  GA  SF+ ECEA
Sbjct: 691  SFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTSFIAECEA 750

Query: 605  LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV---CNLSL 661
            LR+IRHRNL+K++T CS ID+ G DFKA+VY++M NGSLEEWLH      EV    +L+L
Sbjct: 751  LRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEVEPPRSLNL 810

Query: 662  IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
            +Q LNIAIDVASA++YLH+ C  P+VH DLKPSNVLLD +M  HV DFGLAK L +   +
Sbjct: 811  LQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAKIL-SESTN 869

Query: 722  TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
            +   + SSS G++GTVG+  PEYG GS  S  GDVYS+GILLLE+F+ +RPTD MF E L
Sbjct: 870  SFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTDDMFKEDL 929

Query: 782  TLHEFSKMVLPEKVMEIVDPSLLLE--VRANNSMSRGGERVKIEECLVAVIRIGVVCSME 839
             LH F+++   +++ E+ DP LL E  VR     SR  +R  +EECL +++RIGV CS E
Sbjct: 930  NLHNFAEIAFRDQLAEVADPILLQETAVRETRLNSRKCQR--LEECLFSMLRIGVACSTE 987

Query: 840  SPTDRMQMRDVVVKLCAAREAFVSMQ 865
             P +RM++ DVV  L A R+  V ++
Sbjct: 988  MPQERMKINDVVTGLHAIRDKLVRIR 1013

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  765 bits (1975), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/876 (46%), Positives = 575/876 (65%), Gaps = 19/876 (2%)

Query: 1    MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
            + D     L G +P E+G  L KL+ L++  N+  G++P S GNLSA+  I    N L G
Sbjct: 152  ILDFSRGNLTGKLPAELGL-LSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEG 210

Query: 61   KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
             IP+  GQL++L  L++G N  SG IPPSI+N+SS   +    N+ +GSLP  +   LPN
Sbjct: 211  SIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPN 270

Query: 121  LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG 180
            L+ F    N   G +P + SNASNL   ++  N F GK+    +S  +L VL +G+N+LG
Sbjct: 271  LQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP-PLSSSHDLQVLGVGDNNLG 329

Query: 181  NRAANDLDFVTVLAN-CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
                NDL+FV  LAN  + LE L   DN FGG+LP  ++N S  +  +    N   G+IP
Sbjct: 330  KGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIP 389

Query: 240  PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
              +GNL++L ++ +E NQL G +P  +G L+ L  L+LN N + G IPSS+GN+T L  +
Sbjct: 390  TQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRV 449

Query: 300  ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL 359
             + +NNL+G IP SLGN   L+ L LS+N L G +P +++S+ +LS++L LS+N L+GSL
Sbjct: 450  NMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSL 509

Query: 360  PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV 419
            P E+  L NL  LD+S NRFSG+IP +L +C SLE + +++N   G IP +L+ L++I+ 
Sbjct: 510  PIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQE 569

Query: 420  LDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGL 479
            L+LS N L+GQIP++LE+   LE LNLS+N FEGEVP +G F N +  S+ GN KLCGG+
Sbjct: 570  LNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGI 629

Query: 480  DEFHLPSCPSKR-SRKLIATILKVVIPTIVSCL--ILSACFIVIYGRRRSTDRSFERTTM 536
             + +L  CPS   +     T L  +I ++   L  IL   F++ Y  R+  D+       
Sbjct: 630  PQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPAASQPS 689

Query: 537  VEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK 596
            +E  FP ++Y  L  AT  FSS+N++G+GSFG+VFKGI+G + ++VAVKVLNL++KGA K
Sbjct: 690  LETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASK 749

Query: 597  SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH--QNNDKL 654
            SF+ ECEAL+SIRHRNL+K++T CSSIDF G DFKA+VY+FM NG+LEEWLH  Q +D+ 
Sbjct: 750  SFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSDEA 809

Query: 655  EVCN-LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
                 L L+  LNIAI +ASA+ YLHH C+ P++H DLKPSN+LLD +M AHVGDFGLA+
Sbjct: 810  NGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLAR 869

Query: 714  FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT 773
            F       +     +SS G+KGT+GY APEYG G + S  GDVYS+GILLLEMF+ +RP 
Sbjct: 870  F------HSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPV 923

Query: 774  DSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGER----VKIEECLVAV 829
            D MF +GL LH ++KM LP++++E+VDP L+ E+R+ NS    G       +I  CL+ +
Sbjct: 924  DGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTI 983

Query: 830  IRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ 865
            I++GV CS+E P +RM + DVV +L   ++  +  +
Sbjct: 984  IKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTR 1019

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|444737622|emb|CCM07279.1| Putative LRR receptor-like serine/threonine-protein kinase FLS2 [Musa balbisiana]

 Score =  762 bits (1968), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/870 (46%), Positives = 581/870 (66%), Gaps = 11/870 (1%)

Query: 5    QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
            ++N L G+IP ++G  L K+   +LA+N+LTG +P S+GN+++L  + ++ N L G IP+
Sbjct: 157  RSNLLTGEIPRDVG-LLSKMLVFNLAQNNLTGSIPSSLGNMTSLFALFLQSNTLEGSIPE 215

Query: 65   TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF 124
            ++G L+ L  L I  N+ SG IP S+YN+SS     + SN   G+LP +M   LP+L   
Sbjct: 216  SIGNLKSLQLLQIAYNRLSGAIPSSLYNLSSMSIFSVGSNLLEGTLPANMFDTLPSLEML 275

Query: 125  VAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAA 184
            +   N+  G +P SLSNAS +  +EL  N F G +  +  +L+ L  + L +N L    +
Sbjct: 276  LMNNNHFQGHIPASLSNASYMGDIELSVNYFTGTVPSHLENLRRLYFINLSDNQLEATDS 335

Query: 185  NDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN 244
            +D +F+  L NCS L  L L  N FGG+LP SLAN S+++ T+ +  N+ SGTIP G+GN
Sbjct: 336  SDWEFLASLTNCSLLHVLVLGTNNFGGMLPTSLANFSSSLNTMTLESNHISGTIPTGIGN 395

Query: 245  LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEIN 304
            L +L ++++  N L G +PP IG L+NL  L L+ N L G IP S+GNLT L L+ L+ N
Sbjct: 396  LFNLTTLSLSDNHLTGLIPPTIGGLRNLHGLGLSGNRLTGQIPDSIGNLTELNLIYLQDN 455

Query: 305  NLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIG 364
            +L G+IP S+GNC  +  + LS NKL G +P Q+ S+++LS +LNLS+NLL+G+LP ++G
Sbjct: 456  DLGGRIPESIGNCRRVEEMDLSHNKLSGQIPMQLYSISSLSTYLNLSNNLLNGTLPLQVG 515

Query: 365  NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
            NL+NL  L ++ N+ SGDIP TL  C SLEY+ + DNSF GSIP SL+ L+ +  LDLS+
Sbjct: 516  NLRNLGALVLAHNKLSGDIPTTLGQCQSLEYLYLHDNSFQGSIPQSLSNLRGLSELDLSN 575

Query: 425  NKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHL 484
            N +SG IP++L +L  L++LNLSYN  EG VP  GVF N T FS+ GN KLCGG    HL
Sbjct: 576  NNISGNIPEFLADLLALQHLNLSYNDLEGNVPNDGVFRNITAFSVIGNNKLCGGNQGLHL 635

Query: 485  PSCPSKRSRKLIATILKVVIPTI--VSCLILSACFIVIYGRRRSTDRSFERTTMVEQQFP 542
            P C     RK  +  L+VVIP I  V C ++    + +  R ++  +    T  +E+QF 
Sbjct: 636  PPCHIHSGRKHKSLALEVVIPVISVVLCAVILLIALAVLHRTKNLKKKKSFTNYIEEQFK 695

Query: 543  MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTEC 602
             ISY +L +AT EFS+SN++G GSFG+V+KG +  +G  VAVKVLNL + GA +SF++EC
Sbjct: 696  RISYNELLRATDEFSASNLIGMGSFGSVYKGAMDADGTTVAVKVLNLERHGASQSFISEC 755

Query: 603  EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV-CNLSL 661
            EALR+IRHRNL+KI+TIC S+D  G DFKA+V ++M NGSLE WLH    +      L+L
Sbjct: 756  EALRNIRHRNLVKILTICLSVDNRGNDFKALVLNYMSNGSLENWLHPKESEASTRRKLTL 815

Query: 662  IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             Q L+IAIDV+SA++YLHHH   P+VH DLKPSNVLLD +M AHVGDFGLA+FL    LD
Sbjct: 816  PQRLSIAIDVSSALDYLHHHGPMPIVHCDLKPSNVLLDQEMCAHVGDFGLARFLQGTMLD 875

Query: 722  TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
            T     + S+GIKGT+GY+APEY  G + S  GD+YS+GILLLEM + +RPT+ MF +GL
Sbjct: 876  T-DRNRTISTGIKGTIGYVAPEYAMGGKVSTNGDIYSYGILLLEMLTGKRPTEDMFKDGL 934

Query: 782  TLHEFSKMVLPEKVMEIVDPSLLLEVRAN------NSMSRGGERVKIEECLVAVIRIGVV 835
            +LH++ +M   E +  ++DP L L +  N      N + R  +R+++++C V+ + +G+ 
Sbjct: 935  SLHKYVEMTPIEDLFMVLDPGLGLLLVENGQQGEQNVVYRDVDRLEVQKCFVSAVNVGLA 994

Query: 836  CSMESPTDRMQMRDVVVKLCAAREAFVSMQ 865
            CS E+P +RMQM DV+ +L   R+  +++ 
Sbjct: 995  CSKENPRERMQMGDVIKELSETRDKLLNVH 1024

Source: Musa balbisiana

Species: Musa balbisiana

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/870 (48%), Positives = 568/870 (65%), Gaps = 24/870 (2%)

Query: 7   NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
           N+LVG IP E+G  L KL+ L +  N L+G +P S GNLS+L+ +    N + G IP +L
Sbjct: 91  NRLVGKIPAELGS-LSKLQYLFIHANSLSGGIPRSFGNLSSLERLSATQNNIVGTIPASL 149

Query: 67  GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            QL  L ++ +  N  SG IPPS+ N+SS  F  +  N  HG+LP ++   LPNL+    
Sbjct: 150 FQLITLTHVALNANGLSGTIPPSLSNLSSLIFFAVSFNHLHGNLPSNLGITLPNLQDLSL 209

Query: 127 AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
           + N  TG +P+SLSNASNLE      N   GK+  +   L+ L    + +N+LGN    D
Sbjct: 210 SGNRFTGSIPVSLSNASNLEYFSCNGNNLTGKVP-SLEKLQRLHFFSVTSNNLGNGEIED 268

Query: 187 LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
           L F++ L N S LE L L  N FGG+LP S+ N S  + T+ + GN   G+IP G+GNLV
Sbjct: 269 LGFLSSLTNVSNLEVLALNVNNFGGVLPESIGNWSTKLATLLLDGNKIGGSIPAGIGNLV 328

Query: 247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            L  + M  NQL G++P +IG L+NL+ L L  N L G +PSSLGNL  L  L L  N  
Sbjct: 329 SLERLEMWENQLSGSIPVDIGKLQNLRVLMLIKNKLSGILPSSLGNLENLIQLVLGRNYF 388

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
           QGKIPSSLG C +L+ L LS N L G +PPQ++S+++LS+ L++SDN L+G+LP E+GNL
Sbjct: 389 QGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQVVSLSSLSISLDISDNRLTGALPIEVGNL 448

Query: 367 KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
           KNL  LD+S N  SG IP ++ +CTSLEY+ M+ N F GSIP S + L+ I++LDLS N 
Sbjct: 449 KNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSMKGNFFQGSIPSSFSSLRGIRILDLSHNN 508

Query: 427 LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
           LSG+IP++L+++ F + +NLSYN FEG +P +GVF N +  S+ GN KLCGG+ EF LP 
Sbjct: 509 LSGKIPEFLQDIHF-QLVNLSYNDFEGILPTEGVFKNVSATSIMGNSKLCGGIPEFQLPK 567

Query: 487 C----PSKRSRKLIATILKVVIPTIVSCLILSAC---FIVIYGRRRSTDRSFERTTMVEQ 539
           C    P KR   L    LK++I T+   L ++      I ++ R++  + +   +     
Sbjct: 568 CNLQEPKKRGLSL---ALKIIIATVSGLLAITCVLSFLIFLWLRKKKGEPASSSSEKSLL 624

Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFL 599
               +SY  L +AT  FSSSN++G GSFG+V+KGI+  +G  +AVKVLNL++KGA KSF+
Sbjct: 625 ---KVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFI 681

Query: 600 TECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC-- 657
            ECEALR+IRHRNL+K++T CS +D+ G DFKA+VY+FM NGSLE+WLH      E    
Sbjct: 682 AECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAP 741

Query: 658 --NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
              L+ +Q LNIAIDVA A++YLHH C+ P+VH DLKPSNVLLD +M  HVGDFG+AKFL
Sbjct: 742 PRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFL 801

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           P      V E  SSS GI+GT+GY APEYG GSE S +GDVYSFGILLLEMF+ +RPT+ 
Sbjct: 802 P-EAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTED 860

Query: 776 MFHEGLTLHEFSKMVLPEKVMEIVDPSLLLE-VRANNSMS--RGGERVKIEECLVAVIRI 832
           MF + L +H F K  +PE+V EI DP LL E V  +N+ S  R       +ECL+++  I
Sbjct: 861 MFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQRRMASSHDAQECLISIFGI 920

Query: 833 GVVCSMESPTDRMQMRDVVVKLCAAREAFV 862
           G+ CS E P +R  + D   +L + R+ F+
Sbjct: 921 GLACSAELPRERKNITDAAAELNSVRDIFL 950

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/870 (47%), Positives = 560/870 (64%), Gaps = 24/870 (2%)

Query: 7    NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
            N   G IP  +     +L  LS   N+ TG +P  IGN S+L ++++  N L G IP+ +
Sbjct: 142  NSFSGSIPSNLS-QCIELSILSSGHNNFTGTIPTWIGNFSSLSLLNLAVNNLHGTIPNEV 200

Query: 67   GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
            G+L +L    +  N   G IP S++NISS  F+    N  HG+LP+D+   LPNL  F  
Sbjct: 201  GKLSRLTLFALNGNHLYGTIPLSVFNISSLSFLTFSQNNLHGNLPYDVGFTLPNLETFAG 260

Query: 127  AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
              N+ TG +P SLSNAS LE+L+  +N  IG +  N   L  L  L    N LGN    +
Sbjct: 261  GVNDFTGTIPESLSNASRLEILDFAENNLIGTLPKNIGRLTLLKRLNFDTNRLGNGEDGE 320

Query: 187  LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
            L+F+T L NC+ LE LGL +NQFGG LP S+ NLS  +  +D+G N   G+IP G+ NLV
Sbjct: 321  LNFLTSLINCTALEVLGLAENQFGGKLPSSIGNLSINLNALDLGENAIYGSIPIGISNLV 380

Query: 247  HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
            +L S+ ME N L G VP  IG L+ L  L L SN   G IPSS+GNLT LT L +  NN 
Sbjct: 381  NLTSLGMEKNNLSGFVPDTIGMLQKLVDLELYSNKFSGVIPSSIGNLTRLTKLLIADNNF 440

Query: 307  QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
            +G IP+SL NC  L+ML LS N L+G +P Q+ ++++LS++L+LS N L+GSLP EIG L
Sbjct: 441  EGSIPTSLENCQRLLMLNLSHNMLNGSIPRQVFALSSLSIYLDLSHNSLTGSLPFEIGKL 500

Query: 367  KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
             NL  LD+S N+ SG IP ++ +C SLE++ MQ N F G+IP ++  L+ I+ +DLS N 
Sbjct: 501  VNLANLDLSKNKLSGMIPSSIGSCVSLEWLHMQGNFFEGNIPSTIQNLRGIQHIDLSCNN 560

Query: 427  LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
            LSG+IP++L  +  L +LNLSYN+ +GE+P  G+F N T FS++GN KLCGG+ E +LP+
Sbjct: 561  LSGKIPEFLGEIKGLMHLNLSYNNLDGELPMNGIFKNATSFSINGNIKLCGGVPELNLPA 620

Query: 487  CPSKRSRKLIATILKVVIPTIVSCLI---LSACFIVIYGRRRSTDRSFERTTMVEQQFPM 543
            C  K+ +      LKV+IP I S LI     + F++I   +RS  ++   TT +E     
Sbjct: 621  CTIKKEK---FHSLKVIIP-IASALIFLLFLSGFLIIIVIKRSRKKTSRETTTIEDLELN 676

Query: 544  ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
            ISY+++ K T  FS+ N++G GSFG+V+KG +  +G  +A+KVLNL Q+GA KSF+ EC 
Sbjct: 677  ISYSEIVKCTGGFSNDNLIGSGSFGSVYKGTLSSDGTTIAIKVLNLEQRGASKSFIDECN 736

Query: 604  ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            AL+ IRHRNL+KIIT  SSID  G DFKA+VY+FM NGSLE+WLH  N K     L+ +Q
Sbjct: 737  ALKVIRHRNLLKIITAISSIDHQGKDFKALVYEFMSNGSLEDWLHPINQKK---TLTFVQ 793

Query: 664  TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
             LNIAIDVA A+EYLHH C+ P+VH D+KPSNVLLD+DMVA VGDFGLA FL     D+ 
Sbjct: 794  RLNIAIDVACALEYLHHFCETPIVHCDIKPSNVLLDNDMVARVGDFGLATFLFEESCDSP 853

Query: 724  VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
              +  S+S +KG+VGYI PEYG G   S  GDVYS+GILLLE+F+ +RPT+ MF  G+ +
Sbjct: 854  KHSTMSAS-LKGSVGYIPPEYGMGGHPSALGDVYSYGILLLEIFTGKRPTNEMFEGGMGI 912

Query: 784  HEFSKMVLPEKVMEIVDPSLLL------------EVRANNSMSRGGERVKIEECLVAVIR 831
             +F+ + LP   ++I+DPSLL             E +A       G+   +E CL++V++
Sbjct: 913  QQFTALALPNHAIDIIDPSLLYDQEFDGKDHDYSEEKALRREKEPGDFSTMENCLISVLQ 972

Query: 832  IGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
            IGV CS  SP +R+ M  VV KL A   +F
Sbjct: 973  IGVSCSSTSPNERIPMTLVVNKLHAINNSF 1002

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	869
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.968	0.821	0.429	1.8e-181
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.970	0.834	0.417	9.9e-174
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.978	0.829	0.420	3e-172
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.964	0.812	0.419	1.7e-171
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.973	0.838	0.409	8.2e-170
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.974	0.837	0.401	2.2e-169
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.756	0.808	0.401	1.9e-122
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.959	0.851	0.351	6e-119
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.887	0.768	0.316	1.7e-107
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.858	0.677	0.324	1.4e-103

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1761 (625.0 bits), Expect = 1.8e-181, P = 1.8e-181
 Identities = 377/878 (42%), Positives = 531/878 (60%)

Query:     3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
             D  +N L   +P+E G  L KL  LSL  N+LTG+ P S+GNL++LQ++D   N++ G+I
Sbjct:   159 DLSSNHLEQGVPLEFGS-LSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEI 217

Query:    63 PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             P  + +L+++I+  I  N+F+G  PP IYN+SS  F+ +  N F G+L  D  + LPNL+
Sbjct:   218 PGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQ 277

Query:   123 KFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
                   N+ TG +P                N   GK+ ++F  L+NL +L L NN LGN 
Sbjct:   278 ILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNY 337

Query:   183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
             ++ DLDF+  L NCS+L+ L +  N+ GG LP  +ANLS  +T + +GGN  SG+IP G+
Sbjct:   338 SSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGI 397

Query:   243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXE 302
             GNLV L ++ +  N L G +PP +G L  L+ + L SN L G IPSS             
Sbjct:   398 GNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLL 457

Query:   303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXE 362
              N+ +G IPSSLG+C+ L+ L L  NKL+G +P +++ + +                  +
Sbjct:   458 NNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ-D 516

Query:   363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             IG LK L+ LD+S N+ SG IP TL+ C SLE++ +Q NSF G IP  +  L  ++ LDL
Sbjct:   517 IGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDL 575

Query:   423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
             S N LSG IP+Y+ N S L+ LNLS N+F+G VP +GVF N +  S+ GN  LCGG+   
Sbjct:   576 SKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSL 635

Query:   483 HLPSCPSKRSRK--LIATILKVVIPTIVSCLILSACFIVIY------------GRRRSTD 528
              L  C  +  R+   +  I+ + +  +++ L+L  C  V+Y                  D
Sbjct:   636 QLQPCSVELPRRHSSVRKIITICVSAVMAALLL-LCLCVVYLCWYKLRVKSVRANNNEND 694

Query:   529 RSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
             RSF   + V+  +  ISY +L K T  FSSSN++G G+FG VFKG +G     VA+KVLN
Sbjct:   695 RSF---SPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLN 751

Query:   589 LMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH 648
             L ++GA KSF+ ECEAL  IRHRNL+K++TICSS DF G DF+A+VY+FM NG+L+ WLH
Sbjct:   752 LCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

Query:   649 QNNDKLEVCN----LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA 704
              +  + E  N    L L   LNIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ A
Sbjct:   812 PDEIE-ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTA 870

Query:   705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL 764
             HV DFGLA+ L     DT      SS+G++GT+GY APEYG G   S+ GDVYSFGI+LL
Sbjct:   871 HVSDFGLAQLLLKFDRDTF-HIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLL 929

Query:   765 EMFSRRRPTDSMFHEGLTLHEFSKMVLPEK-VMEIVDPSLLLEVRANNSMSRGGERVKIE 823
             E+F+ +RPT+ +F +GLTLH F+K  L ++  ++I D ++L    A        +   + 
Sbjct:   930 EIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYA--------QHFNMV 981

Query:   824 ECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
             ECL  V R+GV CS ESP +R+ M + + KL + RE+F
Sbjct:   982 ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1688 (599.3 bits), Expect = 9.9e-174, P = 9.9e-174
 Identities = 362/868 (41%), Positives = 522/868 (60%)

Query:     6 NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
             +N+L G +P E+G  L  L  L+L  N++ G+LP S+GNL+ L+ + +  N L G+IP  
Sbjct:   147 SNRLGGSVPSELGS-LTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSD 205

Query:    66 LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
             + QL ++  L +  N FSG  PP++YN+SS + + +  N F G L  D+   LPNL  F 
Sbjct:   206 VAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFN 265

Query:   126 AAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
                N  TG +P               +N   G +   F ++ NL +L L  N LG+ ++ 
Sbjct:   266 MGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR 324

Query:   186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
             DL+F+T L NC++LE LG+  N+ GG LP S+ANLS  + T+D+GG   SG+IP  +GNL
Sbjct:   325 DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNL 384

Query:   246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXEINN 305
             ++L  + ++ N L G +P  +G L NL+ L L SN L G IP+               N 
Sbjct:   385 INLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNG 444

Query:   306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXEIGN 365
              +G +P+SLGNC+ L+ L +  NKL+G +P +I+ +                    +IG 
Sbjct:   445 FEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ-DIGA 503

Query:   366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN 425
             L+NL  L +  N+ SG +P TL  C ++E + ++ N F G IP  L  L  +K +DLS+N
Sbjct:   504 LQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNN 562

Query:   426 KLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLP 485
              LSG IP+Y  + S LEYLNLS+N+ EG+VP KG+F N T  S+ GN  LCGG+  F L 
Sbjct:   563 DLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLK 622

Query:   486 SC----PS---KRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTT--M 536
              C    PS   K S +L   ++ V +   +  L+  A   +I+ R+R  ++     T   
Sbjct:   623 PCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPST 682

Query:   537 VEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK 596
             +E     ISY  L  AT+ FSSSNMVG GSFGTV+K ++     +VAVKVLN+ ++GA+K
Sbjct:   683 LEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK 742

Query:   597 SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-DKLE 655
             SF+ ECE+L+ IRHRNL+K++T CSSIDF G +F+A++Y+FM NGSL+ WLH    +++ 
Sbjct:   743 SFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIH 802

Query:   656 VCN--LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
               +  L+L++ LNIAIDVAS ++YLH HC  P+ H DLKPSNVLLD D+ AHV DFGLA+
Sbjct:   803 RPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLAR 862

Query:   714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT 773
              L     ++      SS+G++GT+GY APEYG G + S+ GDVYSFGILLLEMF+ +RPT
Sbjct:   863 LLLKFDEESFFNQ-LSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPT 921

Query:   774 DSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIG 833
             + +F    TL+ ++K  LPE++++IVD S+L      +   R G    + ECL  V  +G
Sbjct:   922 NELFGGNFTLNSYTKSALPERILDIVDESIL------HIGLRVG--FPVVECLTMVFEVG 973

Query:   834 VVCSMESPTDRMQMRDVVVKLCAAREAF 861
             + C  ESP +R+    VV +L + RE F
Sbjct:   974 LRCCEESPMNRLATSIVVKELISIRERF 1001

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
 Identities = 362/860 (42%), Positives = 515/860 (59%)

Query:     3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
             D  +N+L G IP EIG  L  L NL L +N L+G++P ++GNL++LQ  D+  NRL G I
Sbjct:   157 DLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAI 216

Query:    63 PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             P +LGQL  L+ +N+G+N  SG IP SI+N+SS     ++ N+  G +P +    L  L 
Sbjct:   217 PSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLE 276

Query:   123 KFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
                   N   G +P                N F G ++  F  L+NL+ L L  N    R
Sbjct:   277 VIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTR 336

Query:   183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
               +D  F++ L NCSKL+ L L +N  GG+LP+S +NLS +++ + +  N  +G+IP  +
Sbjct:   337 EQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDI 396

Query:   243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXE 302
             GNL+ L  + +  N   G++P  +G LKNL  L    N L G IP +             
Sbjct:   397 GNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLG 456

Query:   303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXE 362
              N   G IP +L N T+L+ L LS N L G +P ++ ++ T                  E
Sbjct:   457 TNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQE 516

Query:   363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             IG+LKNLV+     NR SG IP TL  C  L Y+ +Q+N  SGSIP +L  LK ++ LDL
Sbjct:   517 IGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDL 576

Query:   423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
             SSN LSGQIP  L +++ L  LNLS+N F GEVP  G F+  +  S+ GN KLCGG+ + 
Sbjct:   577 SSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDL 636

Query:   483 HLPSC-PSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTTMVEQQF 541
             HLP C P   +RK    +L + +    +  ILS+ +++I   +R+   +  RT+M  +  
Sbjct:   637 HLPRCCPLLENRKHFP-VLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSM--KGH 693

Query:   542 PMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTE 601
             P++SY++L KAT  F+ +N++G GSFG+V+KG +      VAVKVL L    ALKSF  E
Sbjct:   694 PLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLKLENPKALKSFTAE 752

Query:   602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QNNDKLEVCNLS 660
             CEALR++RHRNL+KI+TICSSID  G DFKAIVYDFM NGSLE+W+H + ND+ +  +L+
Sbjct:   753 CEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLN 812

Query:   661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL 720
             L + + I +DVA A++YLH H   PVVH D+K SNVLLD DMVAHVGDFGLA+ L     
Sbjct:   813 LHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT- 871

Query:   721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
              ++++  +SS G  GT+GY APEYG G  AS  GD+YS+GIL+LE+ + +RPTDS F   
Sbjct:   872 -SLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPD 930

Query:   781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRA-NNSMSRGGERVKIEECLVAVIRIGVVCSME 839
             L L ++ ++ L  +V ++VD  L+L+     NS +    R +I EC+V ++R+G+ CS E
Sbjct:   931 LGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCR-RITECIVWLLRLGLSCSQE 989

Query:   840 SPTDRMQMRDVVVKLCAARE 859
              P+ R    D++ +L A ++
Sbjct:   990 LPSSRTPTGDIIDELNAIKQ 1009

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1667 (591.9 bits), Expect = 1.7e-171, P = 1.7e-171
 Identities = 367/875 (41%), Positives = 520/875 (59%)

Query:     3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
             D  +N L   +P E+G  L KL  L L++N+LTG  P S+GNL++LQ +D   N++ G+I
Sbjct:   151 DLSSNHLGHGVPSELGS-LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEI 209

Query:    63 PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             PD + +L ++++  I  N FSG  PP++YNISS E + L  N F G+L  D    LPNLR
Sbjct:   210 PDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLR 269

Query:   123 KFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
             + +   N  TG +P                N   G + ++F  L+NL  L + NN LGN 
Sbjct:   270 RLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNN 329

Query:   183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
             +++ L+F+  +ANC++LE L +  N+ GG LP S+ANLS T+T++ +G N  SGTIP  +
Sbjct:   330 SSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDI 389

Query:   243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXE 302
             GNLV L  +++E N L G +P   G L NLQ + L SN + G IPS              
Sbjct:   390 GNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLN 449

Query:   303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXE 362
              N+  G+IP SLG C  L+ L +  N+L+G +P +IL + +                  E
Sbjct:   450 SNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPE-E 508

Query:   363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             +G L+ LV L  S N+ SG +P  +  C S+E++ MQ NSF G+IP  ++ L S+K +D 
Sbjct:   509 VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDF 567

Query:   423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
             S+N LSG+IP+YL +L  L  LNLS N FEG VP  GVF N T  S+ GN  +CGG+ E 
Sbjct:   568 SNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREM 627

Query:   483 HLPSC---PSKRSRKLIATILKVV------IPTIVSCLIL-SAC-FIVIYGRRRSTDRSF 531
              L  C    S R RK ++   KVV      I +++  +I+ S C F+    +  ++D + 
Sbjct:   628 QLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNP 687

Query:   532 ERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ 591
               +T +      +SY +L  ATS FSS+N++G G+FG VFKG++G    LVAVKVLNL++
Sbjct:   688 SDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLK 747

Query:   592 KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QN 650
              GA KSF+ ECE  + IRHRNL+K+IT+CSS+D  G DF+A+VY+FM  GSL+ WL  ++
Sbjct:   748 HGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLED 807

Query:   651 NDKLEVCNLSLI--QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
              +++   + SL   + LNIAIDVASA+EYLH HC  PV H D+KPSN+LLD D+ AHV D
Sbjct:   808 LERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSD 867

Query:   709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             FGLA+ L     ++ +    SS+G++GT+GY APEYG G + S+ GDVYSFGILLLEMFS
Sbjct:   868 FGLAQLLYKYDRESFLNQ-FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFS 926

Query:   769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVA 828
              ++PTD  F     LH ++K +L                  +   S GG    I+E L  
Sbjct:   927 GKKPTDESFAGDYNLHSYTKSIL------------------SGCTSSGGSNA-IDEGLRL 967

Query:   829 VIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS 863
             V+++G+ CS E P DRM+  + V +L + R  F S
Sbjct:   968 VLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFS 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1651 (586.2 bits), Expect = 8.2e-170, P = 8.2e-170
 Identities = 356/870 (40%), Positives = 511/870 (58%)

Query:     3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
             D  +N L   +P E+G  L KL  L L  N L G+ PV I NL++L V+++  N L G+I
Sbjct:   144 DLFSNNLGDGVPSELGS-LRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEI 202

Query:    63 PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             PD +  L +++ L +  N FSG  PP+ YN+SS E ++L  N F G+L  D    LPN+ 
Sbjct:   203 PDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIH 262

Query:   123 KFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
             +     N LTG +P                N+  G +S NF  L+NL  L L NN LG+ 
Sbjct:   263 ELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSY 322

Query:   183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
             +  DL F+  L NCS L  L +  N+ GG LP S+ N+S  +T +++ GN   G+IP  +
Sbjct:   323 SFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDI 382

Query:   243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXE 302
             GNL+ L S+ +  N L G +P  +G L  L  L L SN   G IPS              
Sbjct:   383 GNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLS 442

Query:   303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXE 362
              N+ +G +P SLG+C+ ++ L +  NKL+G +P +I+ + T                  +
Sbjct:   443 NNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPN-D 501

Query:   363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             IG L+NLV+L +  N  SG +P TL  C S+E + +Q+N F G+IP  +  L  +K +DL
Sbjct:   502 IGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIP-DIKGLMGVKNVDL 560

Query:   423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
             S+N LSG I +Y EN S LEYLNLS N+FEG VP +G+F N T  S+ GN  LCG + E 
Sbjct:   561 SNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKEL 620

Query:   483 HLPSC----PSKRSRKLIATILKVVIPTIVSCLILSACFIVIYG--RRRSTDRSFERTT- 535
              L  C    P   +R   + + KV I   V   +L   FIV     ++R  ++    +  
Sbjct:   621 KLKPCIAQAPPVETRHP-SLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAP 679

Query:   536 -MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
               +E     +SY  L  AT  FSSSN+VG GSFGTVFK ++     +VAVKVLN+ ++GA
Sbjct:   680 FTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGA 739

Query:   595 LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-DK 653
             +KSF+ ECE+L+ IRHRNL+K++T C+SIDF G +F+A++Y+FM NGSL++WLH    ++
Sbjct:   740 MKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEE 799

Query:   654 LEVCN--LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
             +   +  L+L++ LNIAIDVAS ++YLH HC  P+ H DLKPSN+LLD D+ AHV DFGL
Sbjct:   800 IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGL 859

Query:   712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
             A+ L     ++      SS+G++GT+GY APEYG G + S+ GDVYSFG+L+LEMF+ +R
Sbjct:   860 ARLLLKFDQESFFNQ-LSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKR 918

Query:   772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIR 831
             PT+ +F    TL+ ++K  LPE+V++I D S+L      +S  R G    + ECL  ++ 
Sbjct:   919 PTNELFGGNFTLNSYTKAALPERVLDIADKSIL------HSGLRVG--FPVLECLKGILD 970

Query:   832 IGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
             +G+ C  ESP +R+   +   +L + RE F
Sbjct:   971 VGLRCCEESPLNRLATSEAAKELISIRERF 1000

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1647 (584.8 bits), Expect = 2.2e-169, P = 2.2e-169
 Identities = 350/871 (40%), Positives = 517/871 (59%)

Query:     3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
             D  +N L   +P E+G  L KL  L L  N+L G+LP S+GNL++L+ +    N + G++
Sbjct:   144 DLYSNPLRQGVPSELGS-LTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEV 202

Query:    63 PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             PD L +L +++ L +  N+F G  PP+IYN+S+ E +FL  + F GSL  D    LPN+R
Sbjct:   203 PDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIR 262

Query:   123 KFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
             +    +N+L G +P                N   G +  NF  + +L  L L  N LG+ 
Sbjct:   263 ELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSY 322

Query:   183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
                DL+F+  L NC+ L+ L +   + GG LP S+AN+S  + ++++ GN+F G+IP  +
Sbjct:   323 TFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDI 382

Query:   243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXE 302
             GNL+ L  + +  N L G +P  +G L  L  L L SN + G IPS              
Sbjct:   383 GNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLS 442

Query:   303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXE 362
              N+ +G +P SLG C+ ++ L +  NKL+G +P +I+ + T                  +
Sbjct:   443 NNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPN-D 501

Query:   363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             IG+L+NLV+L +  N+FSG +P TL  C ++E + +Q NSF G+IP ++  L  ++ +DL
Sbjct:   502 IGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDL 560

Query:   423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
             S+N LSG IP+Y  N S LEYLNLS N+F G+VP KG F N T   + GN  LCGG+ + 
Sbjct:   561 SNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDL 620

Query:   483 HLPSC-----P--SKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERT- 534
              L  C     P  +K S  L    + V I   +  L++ A  ++ + R+R  ++      
Sbjct:   621 KLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLV 680

Query:   535 -TMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG 593
              + +E     ISY  L  AT+ FSSSNMVG GSFGTVFK ++     +VAVKVLN+ ++G
Sbjct:   681 PSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRG 740

Query:   594 ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-D 652
             A+KSF+ ECE+L+  RHRNL+K++T C+S DF G +F+A++Y+++ NGS++ WLH    +
Sbjct:   741 AMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVE 800

Query:   653 KLE--VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
             ++      L+L++ LNI IDVAS ++YLH HC  P+ H DLKPSNVLL+ D+ AHV DFG
Sbjct:   801 EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFG 860

Query:   711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
             LA+ L     ++ +    SS+G++GT+GY APEYG G + S+ GDVYSFG+LLLEMF+ +
Sbjct:   861 LARLLLKFDKESFLNQ-LSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGK 919

Query:   771 RPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVI 830
             RPTD +F   LTLH ++K+ LPEKV EI D ++L      +   R G R    ECL  V+
Sbjct:   920 RPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL------HIGLRVGFRTA--ECLTLVL 971

Query:   831 RIGVVCSMESPTDRMQMRDVVVKLCAAREAF 861
              +G+ C  E PT+R+   +V  +L + RE F
Sbjct:   972 EVGLRCCEEYPTNRLATSEVAKELISIRERF 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 268/667 (40%), Positives = 378/667 (56%)

Query:     7 NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
             N L G+IP  +G  L  L  L L  N L+G +P S+G L+ L  + +  N L G IP + 
Sbjct:   136 NSLSGEIPAALG-NLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSF 194

Query:    67 GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
             GQLR+L +L++  N  SG IP  I+NISS     + SN+  G+LP +  +NLP+L++   
Sbjct:   195 GQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYM 254

Query:   127 AKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAND 186
               N   G +P                N F G +      ++NL  L L          ND
Sbjct:   255 YYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETND 314

Query:   187 LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV 246
               F+T L NCS L+ + L   +FGG+LP S++NLS+++ ++ I  N  SG++P  +GNLV
Sbjct:   315 WKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLV 374

Query:   247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXEINNL 306
             +L  +++  N L G++P     LKNL+ L +++N L G +P +            + N  
Sbjct:   375 NLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAF 434

Query:   307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXEIGNL 366
              G IPS+LGN T L  + L  N   G +P +I S+                    EIG L
Sbjct:   435 GGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKL 494

Query:   367 KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
             KN+V+     N+ SG+ P T+  C  L+++ +Q+N  +GSIP +L  LK +  LDLS N 
Sbjct:   495 KNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNN 554

Query:   427 LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPS 486
             LSGQIP  L ++  L  LNLS+N F GEVP  GVF+N +   + GN  +CGG+ E HLP+
Sbjct:   555 LSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPT 614

Query:   487 CPSK-RSRKLIATILKVVIPTIVSCL-ILSACFIVIYGRRRSTDRSFERTTMVEQQFPMI 544
             C  K R +K    +L VV+  +VS L + S  ++++   +R        T+M  Q  PMI
Sbjct:   615 CSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSM--QGHPMI 672

Query:   545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQKGALKSFLT 600
             +Y +L KAT  FSSS+++G GSFG+V+KG      GE   LVAV+VL L    ALKSF  
Sbjct:   673 TYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTA 732

Query:   601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QNNDKLEVCNL 659
             ECE LR+ RHRNL+KI+TICSSID  G DFKAIVYDFM NGSLE+WLH + ND+ E  +L
Sbjct:   733 ECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHL 792

Query:   660 SLIQTLN 666
             +L Q ++
Sbjct:   793 TLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1171 (417.3 bits), Expect = 6.0e-119, P = 6.0e-119
 Identities = 313/890 (35%), Positives = 459/890 (51%)

Query:     1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
             + D   N  VG IP EIG     L+ LSL+EN L G +P  +G L+ L  +D+  NRL G
Sbjct:    94 VLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNG 153

Query:    61 KIPDTL---GQLRKLIYLNIGRNQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVA 116
              IP  L   G    L Y+++  N  +G IP + + ++    F+ L SN+  G++P  + +
Sbjct:   154 SIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSL-S 212

Query:   117 NLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRD-NQFIG-KMSIN----FNSLKN-- 168
             N  NL+      N L+G LP                 N F+    + N    F SL N  
Sbjct:   213 NSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSS 272

Query:   169 -LSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
              L  L L  N LG    + +  ++V      L  + L  N+  G +P  ++NL N +T +
Sbjct:   273 DLQELELAGNSLGGEITSSVRHLSV-----NLVQIHLDQNRIHGSIPPEISNLLN-LTLL 326

Query:   228 DIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIP 287
             ++  N  SG IP  L  L  L  + +  N L G +P E+G +  L  L ++ N L G IP
Sbjct:   327 NLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIP 386

Query:   288 SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILS-VTTXXX 346
              S              N+L G +P SLG C +L +L LS N L G +P +++S +     
Sbjct:   387 DSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKL 446

Query:   347 XXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
                            E+  +  ++ +D+S N  SG IP  L +C +LE++ +  N FS +
Sbjct:   447 YLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSST 506

Query:   407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR 466
             +P SL  L  +K LD+S N+L+G IP   +  S L++LN S+N   G V  KG FS  T 
Sbjct:   507 LPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTI 566

Query:   467 FSLSGNGKLCGGLDEFHLPSCPSKRSR-KLIATILKVVIPTIVSC-----LILSACF--- 517
              S  G+  LCG +    + +C  K     ++  +L  +I T V C     L+  + F   
Sbjct:   567 ESFLGDSLLCGSIKG--MQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKN 624

Query:   518 IVIYGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGE 577
             + +Y +    D   E+    + ++P ISY +L  AT  F++S+++G G FG V+KG++  
Sbjct:   625 LTVYAKEEVEDE--EKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-R 681

Query:   578 NGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV 634
             N   VAVKVL+   K AL+   SF  EC+ L+  RHRNLI+IIT CS   FN     A+V
Sbjct:   682 NNTKVAVKVLD--PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN-----ALV 734

Query:   635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPS 694
                M NGSLE  L+      +  NL LIQ +NI  DVA  I YLHH+    VVH DLKPS
Sbjct:   735 LPLMPNGSLERHLYPGEYSSK--NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPS 792

Query:   695 NVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG-----IKGTVGYIAPEYGTGSE 749
             N+LLD +M A V DFG+++ +     +TV    S S G     + G+VGYIAPEYG G  
Sbjct:   793 NILLDDEMTALVTDFGISRLVQGVE-ETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKR 851

Query:   750 ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRA 809
             AS  GDVYSFG+LLLE+ S RRPTD + +EG +LHEF K   P+ +  I++ +L    + 
Sbjct:   852 ASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALS-RWKP 910

Query:   810 NNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE 859
                  +  E++   E ++ +I +G+VC+  +P+ R  M DV  ++   +E
Sbjct:   911 QGKPEKC-EKLW-REVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 947 (338.4 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
 Identities = 263/831 (31%), Positives = 405/831 (48%)

Query:     6 NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
             NN   G  P EI   L  L  L +  N+LTG LPVS+ NL+ L+ + + GN   GKIP +
Sbjct:   126 NNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPS 185

Query:    66 LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL-QSNRFHGSLPFDMVANLPNLRKF 124
              G    + YL +  N+  G IPP I N+++   +++   N F   LP + + NL  L +F
Sbjct:   186 YGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE-IGNLSELVRF 244

Query:   125 VAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHL-GNRA 183
               A   LTG +P              + N F G ++    +L +L  + L NN   G   
Sbjct:   245 DGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIP 304

Query:   184 AN--DLDFVTVL---------------ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTT 226
             A+  +L  +T+L                +  +LE L L++N F G +P  L   +  +  
Sbjct:   305 ASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGE-NGKLNL 363

Query:   227 IDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYI 286
             +D+  N  +GT+PP + +   L ++   GN L G++P  +G  ++L  + +  NFL+G I
Sbjct:   364 VDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSI 423

Query:   287 PSSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXX 346
             P              + N L G++P + G   +L  ++LS N+L G LPP I + T    
Sbjct:   424 PKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFT-GVQ 482

Query:   347 XXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
                            E+G L+ L ++D S N FSG I   +S C  L +V +  N  SG 
Sbjct:   483 KLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGE 542

Query:   407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR 466
             IP  +  +K +  L+LS N L G IP  + ++  L  L+ SYN+  G VP  G FS    
Sbjct:   543 IPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNY 602

Query:   467 FSLSGNGKLCGGLDEFHLPSCPS--------KRSRKLIATILKVVIPTIVSCLILSACFI 518
              S  GN  LCG     +L  C            S+  ++  +K+++  ++  L+ S  F 
Sbjct:   603 TSFLGNPDLCGP----YLGPCKDGVAKGGHQSHSKGPLSASMKLLL--VLGLLVCSIAFA 656

Query:   519 VI-YGRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGE 577
             V+   + RS  ++ E        F  + +             N++G+G  G V+KG++  
Sbjct:   657 VVAIIKARSLKKASESRAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVM-P 714

Query:   578 NGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY 635
             NG LVAVK L  M +G+     F  E + L  IRHR++++++  CS+ + N      +VY
Sbjct:   715 NGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN-----LLVY 769

Query:   636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN 695
             ++M NGSL E LH         +L       IA++ A  + YLHH C P +VH D+K +N
Sbjct:   770 EYMPNGSLGEVLHGKKGG----HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNN 825

Query:   696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGD 755
             +LLD +  AHV DFGLAKFL     D+   T    S I G+ GYIAPEY    +     D
Sbjct:   826 ILLDSNFEAHVADFGLAKFLQ----DS--GTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 879

Query:   756 VYSFGILLLEMFSRRRPTDSMFHEGLTLHEF-SKMVLPEK--VMEIVDPSL 803
             VYSFG++LLE+ + R+P    F +G+ + ++  KM    K  V++++DP L
Sbjct:   880 VYSFGVVLLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLKVLDPRL 929

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 1.4e-103, Sum P(2) = 1.4e-103
 Identities = 257/793 (32%), Positives = 384/793 (48%)

Query:     7 NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
             N+L G+IP  +G  + +LE L+L EN+ TG +P  IG L+ ++ + +  N+L G+IP  +
Sbjct:   245 NRLSGEIPPSVG-NISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREI 303

Query:    67 GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
             G L     ++   NQ +GFIP    +I + + + L  N   G +P ++   L  L K   
Sbjct:   304 GNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPREL-GELTLLEKLDL 362

Query:   127 AKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKNLSVLILGNNHL-GNRAAN 185
             + N L G +P               DNQ  GK+        N SVL +  N L G   A+
Sbjct:   363 SINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH 422

Query:   186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
                F T++     L +LG   N+  G +P  L    + +T + +G N  +G++P  L NL
Sbjct:   423 FCRFQTLI-----LLSLG--SNKLSGNIPRDLKTCKS-LTKLMLGDNQLTGSLPIELFNL 474

Query:   246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXEINN 305
              +L ++ +  N L G +  ++G LKNL+ L L +N   G IP                N 
Sbjct:   475 QNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQ 534

Query:   306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXEIGN 365
             L G IP  LG+C ++  L LS NK  G +  Q L                        G+
Sbjct:   535 LTGHIPKELGSCVTIQRLDLSGNKFSGYIA-QELGQLVYLEILRLSDNRLTGEIPHSFGD 593

Query:   366 LKNLVQLDISGNRFSGDIPGTLSACTSLEY-VKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
             L  L++L + GN  S +IP  L   TSL+  + +  N+ SG+IP SL  L+ +++L L+ 
Sbjct:   594 LTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLND 653

Query:   425 NKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHL 484
             NKLSG+IP  + NL  L   N+S N+  G VP   VF      + +GN  LC        
Sbjct:   654 NKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQ 713

Query:   485 PSCPSKRSRK--LIATILKVVIPTIVSCLILSACFIVIY-G------RRRSTDRSFERTT 535
             P  P   S+   LI    +  I TI +C+++ + F++ + G      RR     + E  T
Sbjct:   714 PLVPHSDSKLNWLINGSQRQKILTI-TCIVIGSVFLITFLGLCWTIKRREPAFVALEDQT 772

Query:   536 ----MVEQQFPM--ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL 589
                 M    FP    +Y  L  AT  FS   ++G+G+ GTV+K  +   G ++AVK LN 
Sbjct:   773 KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMS-GGEVIAVKKLNS 831

Query:   590 MQKGALK--SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL 647
               +GA    SF  E   L  IRHRN++K+   C   + N      ++Y++M  GSL E L
Sbjct:   832 RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSN-----LLLYEYMSKGSLGEQL 886

Query:   648 HQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG 707
              Q  +K   C L       IA+  A  + YLHH C+P +VH D+K +N+LLD    AHVG
Sbjct:   887 -QRGEKN--CLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVG 943

Query:   708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             DFGLAK +        +    S S + G+ GYIAPEY    + +   D+YSFG++LLE+ 
Sbjct:   944 DFGLAKLID-------LSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 996

Query:   768 SRRRPTDSMFHEG 780
             + + P   +   G
Sbjct:   997 TGKPPVQPLEQGG 1009

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.4432	0.9666	0.8316	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00050192 hypothetical protein (1011 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	869
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-104
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-60
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-53
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
COG3173	321	COG3173, COG3173, Predicted aminoglycoside phospho	0.002
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.004
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  344 bits (885), Expect = e-104
 Identities = 261/872 (29%), Positives = 435/872 (49%), Gaps = 59/872 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D  NN L G+IP +IG +   L+ L L  N L G++P S+ NL++L+ + +  N+L G+I
Sbjct: 146 DLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           P  LGQ++ L ++ +G N  SG IP  I  ++S   + L  N   G +P  +  NL NL+
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL-GNLKNLQ 263

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
                +N L+G +P S+ +   L  L+L DN   G++      L+NL +L L +N+   +
Sbjct: 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
                     L +  +L+ L L+ N+F G +P +L    N +T +D+  N  +G IP GL
Sbjct: 324 IP------VALTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGL 376

Query: 243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
            +  +L  + +  N L G +P  +G  ++L+ + L  N   G +PS    L ++  L + 
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436

Query: 303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE 362
            NNLQG+I S   +  SL ML+L++NK  G LP    S    +L  +LS N  SG++P +
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL--DLSRNQFSGAVPRK 494

Query: 363 IGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
           +G+L  L+QL +S N+ SG+IP  LS+C  L  + +  N  SG IP S + +  +  LDL
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554

Query: 423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEF 482
           S N+LSG+IPK L N+  L  +N+S+NH  G +P  G F      +++GN  LCGG    
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS 614

Query: 483 HLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTDRSFERTT-MVEQQF 541
            LP C   R        +   +   +   +++  F+ I GR     +  E      E QF
Sbjct: 615 GLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF 674

Query: 542 PMISYAK---LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF 598
                +K   ++   S     N++ +G  G  +KG   +NGM   VK +N +      S 
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-SE 733

Query: 599 LTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
           + +   +  ++H N++K+I +C S       +  +++++++  +L E L          N
Sbjct: 734 IAD---MGKLQHPNIVKLIGLCRS---EKGAY--LIHEYIEGKNLSEVLR---------N 776

Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           LS  +   IAI +A A+ +LH  C P VV G+L P  +++D     H     L   LP  
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPG- 830

Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
            L T  +   SS+       Y+APE     + +   D+Y FG++L+E+ + + P D+ F 
Sbjct: 831 LLCTDTKCFISSA-------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883

Query: 779 EGLTLHEFSKMVLPEKVMEI-VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCS 837
              ++ E+++    +  +++ +DPS+  +V  N            +  +V V+ + + C+
Sbjct: 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN------------QNEIVEVMNLALHCT 931

Query: 838 MESPTDRMQMRDVVVKLCAAREAFVSMQDGLR 869
              PT R    DV+  L +A  +  S   GL+
Sbjct: 932 ATDPTARPCANDVLKTLESASRSSSSCVTGLK 963

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  220 bits (561), Expect = 9e-60
 Identities = 143/451 (31%), Positives = 228/451 (50%), Gaps = 36/451 (7%)

Query: 23  KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQL-RKLIYLNIGRNQ 81
           ++ ++ L+  +++G++  +I  L  +Q I++  N+L G IPD +      L YLN+  N 
Sbjct: 70  RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 82  FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN 141
           F+G IP    +I + E + L +N   G +P D+  +  +L+      N L G +P SL+N
Sbjct: 130 FTGSIPRG--SIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLVGKIPNSLTN 186

Query: 142 ASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
            ++LE L L  NQ +G++      +K+L  + LG N+L                      
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL---------------------- 224

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT 261
                    G +P+ +  L+ ++  +D+  N  +G IP  LGNL +L  + +  N+L G 
Sbjct: 225 --------SGEIPYEIGGLT-SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP 275

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           +PP I  L+ L SL L+ N L G IP  +  L  L +L L  NN  GKIP +L +   L 
Sbjct: 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335

Query: 322 MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG 381
           +L L  NK  G +P  +     L++ L+LS N L+G +P  + +  NL +L +  N   G
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTV-LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394

Query: 382 DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFL 441
           +IP +L AC SL  V++QDNSFSG +P     L  +  LD+S+N L G+I     ++  L
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454

Query: 442 EYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           + L+L+ N F G +P            LS N
Sbjct: 455 QMLSLARNKFFGGLPDSFGSKRLENLDLSRN 485

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  200 bits (509), Expect = 4e-53
 Identities = 138/412 (33%), Positives = 201/412 (48%), Gaps = 34/412 (8%)

Query: 44  NLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS 103
           N S +  ID+ G  + GKI   + +L  +  +N+  NQ SG IP  I+  SS       S
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS-------S 119

Query: 104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF 163
            R+          NL N        NN TG   I   +  NLE L+L +N   G++  + 
Sbjct: 120 LRY---------LNLSN--------NNFTG--SIPRGSIPNLETLDLSNNMLSGEIPNDI 160

Query: 164 NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNT 223
            S  +L VL LG N L  +  N       L N + LE L L  NQ  G +P  L  + + 
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNS------LTNLTSLEFLTLASNQLVGQIPRELGQMKS- 213

Query: 224 MTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH 283
           +  I +G N  SG IP  +G L  LN + +  N L G +P  +G LKNLQ L+L  N L 
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273

Query: 284 GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT 343
           G IP S+ +L  L  L L  N+L G+IP  +    +L +L L  N   G +P  + S+  
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333

Query: 344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           L + L L  N  SG +P  +G   NL  LD+S N  +G+IP  L +  +L  + +  NS 
Sbjct: 334 LQV-LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392

Query: 404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEV 455
            G IP SL   +S++ + L  N  SG++P     L  + +L++S N+ +G +
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  181 bits (460), Expect = 5e-47
 Identities = 128/375 (34%), Positives = 188/375 (50%), Gaps = 21/375 (5%)

Query: 91  YNISSFEFIFLQSNRFHGS-----LPFDMVANLPNLRKFVAAKNNLTGF---LPISLSNA 142
           Y I    F+FL  +  H       L F    N P   K+++  N+         I+ +N+
Sbjct: 11  YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDP--LKYLSNWNSSADVCLWQGITCNNS 68

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           S +  ++L      GK+S     L  +  + L NN L     +D     +    S L  L
Sbjct: 69  SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD-----IFTTSSSLRYL 123

Query: 203 GLYDNQFGGLLPH-SLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT 261
            L +N F G +P  S+ NL     T+D+  N  SG IP  +G+   L  + + GN L+G 
Sbjct: 124 NLSNNNFTGSIPRGSIPNLE----TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           +P  +  L +L+ L L SN L G IP  LG +  L  + L  NNL G+IP  +G  TSL 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 322 MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG 381
            L L  N L G +P  + ++  L  +L L  N LSG +P  I +L+ L+ LD+S N  SG
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQ-YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298

Query: 382 DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFL 441
           +IP  +    +LE + +  N+F+G IP +L  L  ++VL L SNK SG+IPK L   + L
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358

Query: 442 EYLNLSYNHFEGEVP 456
             L+LS N+  GE+P
Sbjct: 359 TVLDLSTNNLTGEIP 373

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (394), Expect = 4e-43
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-SFLTECEALRSIRHRNLIKIITIC 620
           +G+G FGTV+     + G  VA+K++      +L    L E E L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                   +   +V ++ + GSL++ L +N  K     LS  + L I + +   +EYLH 
Sbjct: 61  EDE-----NHLYLVMEYCEGGSLKDLLKENEGK-----LSEDEILRILLQILEGLEYLHS 110

Query: 681 HCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
           +    ++H DLKP N+LLD D     + DFGL+K L            S    I GT  Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--------SDKSLLKTIVGTPAY 159

Query: 740 IAPEYGTG-SEASMTGDVYSFGILLLEM 766
           +APE   G    S   D++S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  147 bits (373), Expect = 1e-39
 Identities = 72/241 (29%), Positives = 110/241 (45%), Gaps = 42/241 (17%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           +G+GSFG V+     + G LVA+KV+     K   +  L E + L+ ++H N++++  + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
               F   D   +V ++ + G L + L +         LS  +       + SA+EYLH 
Sbjct: 66  ----FEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTVGY 739
                +VH DLKP N+LLD D    + DFGLA+ L P   L T V          GT  Y
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV----------GTPEY 162

Query: 740 IAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           +APE      YG         D++S G++L E+ + + P    F     L E  K +   
Sbjct: 163 MAPEVLLGKGYGKAV------DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKP 212

Query: 794 K 794
           K
Sbjct: 213 K 213

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (366), Expect = 9e-39
 Identities = 63/238 (26%), Positives = 115/238 (48%), Gaps = 38/238 (15%)

Query: 563 GQGSFGTVFKGII----GENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G+FG V+KG +          VAVK L     +   + FL E   ++ + H N+++++
Sbjct: 8   GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C+  +        IV ++M  G L ++L ++ +KL     +L   L +A+ +A  +EY
Sbjct: 68  GVCTQGEPL-----YIVTEYMPGGDLLDFLRKHGEKL-----TLKDLLQMALQIAKGMEY 117

Query: 678 LH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           L   +     VH DL   N L+  ++V  + DFGL++ +                G K  
Sbjct: 118 LESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK------RGGGKLP 167

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           + ++APE    G  +  S   DV+SFG+LL E+F+   +P     + G++  E  +++
Sbjct: 168 IKWMAPESLKDGKFTSKS---DVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLELL 217

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  142 bits (359), Expect = 7e-38
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+K      G +VAVK+L     +    ++   E   LR + H N++++I  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               D        +V ++ + G L ++L +         LS  +   IA+ +   +EYLH
Sbjct: 67  FEDKDHL-----YLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIKGTV 737
            +    ++H DLKP N+LLD + V  + DFGLAK L   +  L T V          GT 
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----------GTP 162

Query: 738 GYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            Y+APE    G+      DV+S G++L E+ + + P
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (358), Expect = 1e-37
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)

Query: 563 GQGSFGTVFKGI----IGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKII 617
           G+G+FG V+KG          + VAVK L        ++ FL E   +R + H N++K++
Sbjct: 8   GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C+       +   IV ++M  G L ++L +N  K     LSL   L+ A+ +A  +EY
Sbjct: 68  GVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEY 118

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        +H DL   N L+  ++V  + DFGL++ L       V        G K  +
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV-------KGGKLPI 168

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR 769
            ++APE    G  +  S   DV+SFG+LL E+F+ 
Sbjct: 169 RWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  140 bits (356), Expect = 2e-37
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 563 GQGSFGTVFKGI----IGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKII 617
           G+G+FG V+KG      G+  + VAVK L     +  ++ FL E   +R + H N++K++
Sbjct: 8   GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C+       +   IV ++M+ G L  +L +N  KL     SL   L+ A+ +A  +EY
Sbjct: 68  GVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPKL-----SLSDLLSFALQIARGMEY 117

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        +H DL   N L+  ++V  + DFGL++ L                G K  +
Sbjct: 118 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK-------RGGKLPI 167

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR 769
            ++APE    G  +  S   DV+SFG+LL E+F+ 
Sbjct: 168 RWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  136 bits (345), Expect = 6e-36
 Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 37/244 (15%)

Query: 560 NMVGQGSFGTVFKGI---IGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG V+KG           VAVK L     +   K FL E   ++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 616 IITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC---NLSLIQTLNIAID 670
           ++ +C+  +  +       +V ++M+ G L ++L ++           LSL   L+ AI 
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +A  +EYL        VH DL   N L+  D+V  + DFGL++ +     D   +     
Sbjct: 114 IAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--DDDYYRKKTGGK 168

Query: 731 SGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEF 786
             I+    ++APE    G  +  S   DV+SFG+LL E+F+    P     + GL+  E 
Sbjct: 169 LPIR----WMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATP-----YPGLSNEEV 216

Query: 787 SKMV 790
            + +
Sbjct: 217 LEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (324), Expect = 4e-33
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 20/220 (9%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRN 612
           E++   ++G+GSFG+V+  +  + G L+AVK + L    +  L++   E   L S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           +++        + N ++   I  +++  GSL   L     KL      +I+       + 
Sbjct: 61  IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLK-KFGKL---PEPVIRKY--TRQIL 111

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             + YLH +    +VH D+K +N+L+D D V  + DFG AK L        +ET   +  
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGTGS 162

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           ++GT  ++APE   G E     D++S G  ++EM + + P
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  121 bits (306), Expect = 2e-30
 Identities = 78/301 (25%), Positives = 134/301 (44%), Gaps = 34/301 (11%)

Query: 559 SNMVGQGSFGTVFKG---IIGEN-GMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNL 613
              +G+G FG V       +G+N G  VAVK LN   +   +S F  E E LR++ H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K   +C       +    ++ +++ +GSL ++L ++ D      ++L + L  +  +  
Sbjct: 69  VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICK 120

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            ++YL        +H DL   N+L++ + +  + DFGLAK LP       V+ P  S   
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP-- 175

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
              + + APE    S+ S   DV+SFG+ L E+F+   P+ S         EF +M+   
Sbjct: 176 ---IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS------PPAEFLRMIGIA 226

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
           +   IV        R    +  G    +   C   V  +  +C    P DR    D+++ 
Sbjct: 227 QGQMIV-------TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279

Query: 854 L 854
           +
Sbjct: 280 V 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 24/219 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
            F     +G+G FG V+K      G  VA+KV+ L  K   +  + E + L+  +H N++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           K      S      D   IV +F   GSL++ L   N  L     S I    +  ++   
Sbjct: 61  KYYG---SYLKK--DELWIVMEFCSGGSLKDLLKSTNQTL---TESQIAY--VCKELLKG 110

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGI 733
           +EYLH +    ++H D+K +N+LL  D    + DFGL+  L   +  +T+V         
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--------- 158

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT  ++APE   G       D++S GI  +E+   + P
Sbjct: 159 -GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (294), Expect = 4e-29
 Identities = 73/235 (31%), Positives = 114/235 (48%), Gaps = 31/235 (13%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            EF+    +G G FG V++G+  +N + VA+K+L        + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           I +  +CS       +   I+ + M+ GSL  +L     +     L +   +++A  VA 
Sbjct: 65  ISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAE 115

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + YL        +H DL   N+L+  D+V  V DFGLA+ +         E    SS  
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK--------EDVYLSSDK 164

Query: 734 KGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           K    + APE   +GT S  S   DV+SFGILL EMF+       + + G+  HE
Sbjct: 165 KIPYKWTAPEAASHGTFSTKS---DVWSFGILLYEMFTY----GQVPYPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V  G     G  VAVK L      A ++FL E   + ++RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV- 69

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            +  N +    IV ++M  GSL ++L      +    ++L Q L  A+DV   +EYL   
Sbjct: 70  -LQGNPL---YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLEEK 121

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
                VH DL   NVL+  D+VA V DFGLAK           E        K  V + A
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------EASQGQDSGKLPVKWTA 167

Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE     + S   DV+SFGILL E++S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 2e-25
 Identities = 78/240 (32%), Positives = 115/240 (47%), Gaps = 42/240 (17%)

Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT---ECEALRSIRHRNLIK 615
            N +G G+FG V+  +  + G L+AVK + + Q    K+      E + L  ++H NL+K
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 616 IITICSSIDFNGVDF-KAIVYDFM---QNGSLEEWL-HQNNDKLEVCNLSLIQTLNIAID 670
                    + GV+  +  VY FM     G+LEE L H       V  +  +Q L     
Sbjct: 64  ---------YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL----- 109

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
               + YLH H    +VH D+KP+N+ LDH+ V  +GDFG A  L      T+ E     
Sbjct: 110 --EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGE---EV 160

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG---DVYSFGILLLEMFSRRRP---TDS----MFHEG 780
             + GT  Y+APE  TG +    G   D++S G ++LEM + +RP    D+    MFH G
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 1e-24
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRHRNLIKII 617
           +G+GSF TV      E     A+K+L+   L+++  +K    E E L R   H  +IK+ 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              +  D   + F   V ++  NG L +++ +        +L    T   A ++  A+EY
Sbjct: 69  --YTFQDEENLYF---VLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEY 117

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL---DTVVETPSSSSGIK 734
           LH      ++H DLKP N+LLD DM   + DFG AK L        +    T   S   K
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 735 ---------GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                    GT  Y++PE      A  + D+++ G ++ +M + + P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-24
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 26/238 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+GSFG V      + G L A+KVL    ++++  ++  LTE   L  I H  ++K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
             +      +     V ++   G L  + H +    E    S  +    A ++  A+EYL
Sbjct: 59  HYAFQTEEKLYL---VLEYAPGGEL--FSHLSK---EGR-FSEERARFYAAEIVLALEYL 109

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +++ DLKP N+LLD D    + DFGLAK         +    S ++   GT  
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAK--------ELSSEGSRTNTFCGTPE 158

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKMVLPEKV 795
           Y+APE   G       D +S G+LL EM + + P       E         +  PE +
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 32/220 (14%)

Query: 563 GQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIITI 619
           G G FG V+ G    NG   VAVK L   + G +   +FL E + ++ +RH  L+++  +
Sbjct: 15  GAGQFGEVWMGTW--NGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           CS       +   IV ++M  GSL ++L     K     L L Q +++A  +A  + YL 
Sbjct: 70  CS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLE 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP--SSSSGIKGTV 737
                  +H DL   N+L+  ++V  + DFGLA+         ++E    ++  G K  +
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLAR---------LIEDDEYTAREGAKFPI 168

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR-PTDSM 776
            + APE       ++  DV+SFGILL E+ +  R P   M
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (271), Expect = 5e-24
 Identities = 60/167 (35%), Positives = 99/167 (59%), Gaps = 2/167 (1%)

Query: 292 NLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS 351
           N + +  + L   N+ GKI S++     +  + LS N+L G +P  I + ++   +LNLS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 352 DNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL 411
           +N  +GS+P   G++ NL  LD+S N  SG+IP  + + +SL+ + +  N   G IP SL
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 412 NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK 458
             L S++ L L+SN+L GQIP+ L  +  L+++ L YN+  GE+P +
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231

Length = 968

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 7e-24
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 37/220 (16%)

Query: 560 NMVGQGSFGTVFKGIIGENG---MLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK 615
            ++G G FG V +G +   G   + VA+K L           FLTE   +    H N+I+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 616 IITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           +          GV  K+    I+ ++M+NGSL+++L +N+ K      ++ Q + +   +
Sbjct: 70  LE---------GVVTKSRPVMIITEYMENGSLDKFLRENDGKF-----TVGQLVGMLRGI 115

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           AS ++YL        VH DL   N+L++ ++V  V DFGL++ L     +    T     
Sbjct: 116 ASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTTKGGKI 170

Query: 732 GIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
            I+ T    APE   Y   + AS   DV+SFGI++ E+ S
Sbjct: 171 PIRWT----APEAIAYRKFTSAS---DVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (253), Expect = 9e-24
 Identities = 58/214 (27%), Positives = 114/214 (53%), Gaps = 22/214 (10%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           ++ +  + +G G +G V++G+  +  + VAVK L       ++ FL E   ++ I+H NL
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 64

Query: 614 IKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++++ +C+    F       I+ +FM  G+L ++L + N +     ++ +  L +A  ++
Sbjct: 65  VQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQE----VNAVVLLYMATQIS 114

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           SA+EYL    K   +H DL   N L+  + +  V DFGL++ +         +T ++ +G
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAG 164

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  103 bits (257), Expect = 1e-23
 Identities = 73/222 (32%), Positives = 110/222 (49%), Gaps = 24/222 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRH-RNLIKII 617
           +G+GSFG V+      +  LVA+KVL      +   ++ FL E + L S+ H  N++K+ 
Sbjct: 8   LGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                          +V +++  GSLE+ L +   K     LS  + L I   + SA+EY
Sbjct: 65  DFFQDEGSL-----YLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEY 116

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           LH      ++H D+KP N+LLD D  V  + DFGLAK LP     + +    S+    GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGT 171

Query: 737 VGYIAPEYGTGSE---ASMTGDVYSFGILLLEMFSRRRPTDS 775
            GY+APE   G     AS + D++S GI L E+ +   P + 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 73/231 (31%), Positives = 115/231 (49%), Gaps = 29/231 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V++G+   N   VAVK L   + G +  K FL E + ++ +RH  LI++  +
Sbjct: 14  LGAGQFGEVWEGL-WNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+       +   IV + M+ GSL E+L     +     L L Q +++A  VAS + YL 
Sbjct: 70  CTL-----EEPIYIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLE 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   NVL+  + +  V DFGLA+ +     + + E   +  G K  + +
Sbjct: 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYE---AREGAKFPIKW 170

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
            APE    +  S+  DV+SFGILL E+ +  R    M + G+T  E  + V
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGR----MPYPGMTNAEVLQQV 217

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (249), Expect = 2e-23
 Identities = 75/230 (32%), Positives = 111/230 (48%), Gaps = 34/230 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V +G     G  VAVK  N+      ++FL E   +  + H+NL++++ +  
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            I  NG+    IV + M  G+L  +L      L    +S+IQ L  ++DVA  +EYL   
Sbjct: 68  -ILHNGL---YIVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE-- 117

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
               +VH DL   N+L+  D VA V DFGLA+      +D            K  V + A
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS-MGVDNS----------KLPVKWTA 165

Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           PE     + S   DV+S+G+LL E+FS  R P   M     +L E  + V
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-----SLKEVKECV 210

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 34/217 (15%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           GQGS G V+K      G + A+K +++   +   K  L E + LRS     ++K      
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK------ 63

Query: 622 SIDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                G  +K    +IV ++M  GSL + L +   K+    L+ I     A  +   ++Y
Sbjct: 64  ---CYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYI-----ARQILKGLDY 114

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR--PLDTVVETPSSSSGIKG 735
           LH      ++H D+KPSN+L++      + DFG++K L       +T V          G
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----------G 162

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           TV Y++PE   G   S   D++S G+ LLE    + P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 44/227 (19%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKII 617
             +G+GSFG V+      +G L  +K ++L  M +   +  L E + L+ + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F       IV ++   G L + + +   K E       Q L+  + +  A++Y
Sbjct: 66  E-----SFEEKGKLCIVMEYADGGDLSQKIKK--QKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 678 LH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP-----ARPLDTVVETPSSSS 731
           LH       ++H D+KP N+ L  + +  +GDFG++K L      A+   TVV TP    
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK---TVVGTPY--- 168

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                  Y++PE      Y   S      D++S G +L E+ + + P
Sbjct: 169 -------YLSPELCQNKPYNYKS------DIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 40/228 (17%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTECEALRSIRHRN 612
            +   +++G+G+FG V+KG+  E G  VA+K   L  +++ ALKS + E + L++++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 613 LIKIIT-ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI-----QTLN 666
           ++K I  I +S      D   I+ ++ +NGSL + + +          SL+     Q L 
Sbjct: 61  IVKYIGSIETS------DSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQ 110

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA--RPLDTVV 724
                   + YLH   +  V+H D+K +N+L   D V  + DFG+A  L    +   +VV
Sbjct: 111 -------GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                     GT  ++APE    S AS   D++S G  ++E+ +   P
Sbjct: 161 ----------GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G      + VA+K   ++++GA+    F+ E + +  + H 
Sbjct: 4   SELTFLKELGSGQFGVVHLGK-WRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHP 59

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           NL+++  +C+        F  IV ++M NG L  +L +   KL    L     L++  DV
Sbjct: 60  NLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDV 109

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+EYL  +     +H DL   N L+  D V  V DFGLA+++    LD   +  +SS 
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV----LD---DQYTSSQ 159

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           G K  V +  PE    S  S   DV+SFG+L+ E+FS
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 33/214 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-SFLTECEALRSIRHRNLIKIITIC 620
           +G+G+FG V+KG++ +    VAVK         LK  FL E E L+   H N++K+I +C
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 621 SSIDFNGVDFKA--IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
                  V  +   IV + +  GSL  +L +  ++L V  L     L +++D A+ +EYL
Sbjct: 62  -------VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYL 109

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT-V 737
                   +H DL   N L+  + V  + DFG++     R  +  + T   S G+K   +
Sbjct: 110 ESKN---CIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYT--VSDGLKQIPI 159

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
            + APE   YG  +  S   DV+S+GILL E FS
Sbjct: 160 KWTAPEALNYGRYTSES---DVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 20/212 (9%)

Query: 561 MVGQGSFGTVFK---GIIGEN-GMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
            +G+G+FG+V       + +N G +VAVK L       L+ F  E E L+S++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +C S     +    +V +++  GSL ++L ++ ++L+       + L  A  +   +E
Sbjct: 71  KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDH-----RKLLLYASQICKGME 122

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YL        VH DL   N+L++ +    +GDFGL K LP       V  P  S      
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP----- 174

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           + + APE  T S+ S+  DV+SFG++L E+F+
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 93.7 bits (233), Expect = 5e-21
 Identities = 83/317 (26%), Positives = 138/317 (43%), Gaps = 75/317 (23%)

Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIK 615
           +G+G+FG VF G         +  LVAVK L       A K F  E E L + +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN--------NDKLEVCNLSLIQTLNI 667
              +C+       D   +V+++M++G L ++L  +        +    +  L+L Q L I
Sbjct: 73  FYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 668 AIDVASAIEYL--HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           A+ +AS + YL   H      VH DL   N L+ +D+V  +GDFG+++         V  
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYT 174

Query: 726 TPSSSSGIKGT----VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMF 777
           T      + G     + ++ PE   Y   +  S   DV+SFG++L E+F+  ++P     
Sbjct: 175 TDYYR--VGGHTMLPIRWMPPESIMYRKFTTES---DVWSFGVVLWEIFTYGKQP----- 224

Query: 778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCS 837
             GL+  E         V+E +    LL+              +   C   V  I + C 
Sbjct: 225 WYGLSNEE---------VIECITQGRLLQ--------------RPRTCPSEVYDIMLGCW 261

Query: 838 MESPTDRMQMRDVVVKL 854
              P  R+ ++D+  +L
Sbjct: 262 KRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 6e-21
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)

Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 14  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 69  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 118

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 168

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 32/223 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V+ G        VA+K +   ++GA+  + F+ E + +  + H 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59

Query: 612 NLIKIITIC---SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            L+++  +C   S I         +V++FM++G L ++L     K     L     L + 
Sbjct: 60  KLVQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMC 106

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           +DV   + YL       V+H DL   N L+  + V  V DFG+ +F+    LD   +  +
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LD---DQYT 156

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           SS+G K  V + +PE  + S+ S   DV+SFG+L+ E+FS  +
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           + +   +G+G+ G V+K      G  VA+K + L ++   +  + E   ++  +H N++ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
                 S       +  +V ++M  GSL + + QN  ++   N   I    +  +V   +
Sbjct: 80  YY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRM---NEPQIAY--VCREVLQGL 129

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVETPSSSSGI 733
           EYLH      V+H D+K  N+LL  D    + DFG A  L       ++VV TP      
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY----- 181

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                ++APE     +     D++S GI+ +EM
Sbjct: 182 -----WMAPEVIKRKDYGPKVDIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 32/275 (11%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRN 612
           F    ++G+G+FG V      +   + A+K +N    ++KG++++ L E   L+ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           L+ +     S  F   +   +V D +  G L   L Q     E       Q      ++ 
Sbjct: 62  LVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKFWICEIV 110

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            A+EYLH      ++H D+KP N+LLD     H+ DF +A  +    L T          
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT---------S 158

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP---TDSMFHEGLTLHEFSKM 789
             GT GY+APE       S+  D +S G+   E    +RP         + +   + +  
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218

Query: 790 VL--PEKVMEIVDP-SLLLEVRANNSMSRGGERVK 821
           VL       E +D  + LLE      +    + +K
Sbjct: 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 31/243 (12%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI---IGENGML-VAVKVL-NLMQKGALKSFLTECEALRSI 608
           +E     ++G G+FGTV+KG+    GE   + VA+KVL       A K  L E   + S+
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H ++++++ IC S          ++   M  G L +++  + D +    L     LN  
Sbjct: 67  DHPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWC 115

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L         E   
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD------EKEY 166

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS 787
            + G K  + ++A E       +   DV+S+G+ + E+ +   +P     +EG+   E  
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP-----YEGIPAVEIP 221

Query: 788 KMV 790
            ++
Sbjct: 222 DLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 562 VGQGSFGTVFKGIIGE-NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           +G+G FG V   ++G+  G  VAVK +        ++FL E   +  +RH NL++++ + 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
             ++  G  +  IV ++M  GSL ++L      +    L     L  ++DV  A+EYL  
Sbjct: 69  --VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEA 120

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
           +     VH DL   NVL+  D VA V DFGL K           E  S+    K  V + 
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 166

Query: 741 APEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           APE     + S   DV+SFGILL E++S  R
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 36/219 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G++G V+K    + G LVA+K + +   ++G   + + E + L+ +RH N++++  I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL-SLIQTLNIAIDVASAIEYL 678
            +S     +    +V+++M +  L   L     K     +   ++ L         ++YL
Sbjct: 67  VTSKGKGSI---YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYL 116

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H +    ++H D+K SN+L+++D V  + DFGL     ARP         ++  I  T+ 
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGL-----ARPYTKRNSADYTNRVI--TLW 166

Query: 739 YIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
           Y  PE       YG         D++S G +L E+F  +
Sbjct: 167 YRPPELLLGATRYGPEV------DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 1e-19
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 41/220 (18%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G++G V+K    + G +VA+K + L  +  G   + L E   L+ ++H N++K++ +
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                 +      +V+++     L+++L +    L   + +LI++  I   +   + Y H
Sbjct: 67  I-----HTERKLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKS--IMYQLLRGLAYCH 115

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSSGIKGTV 737
            H    ++H DLKP N+L++ D V  + DFGLA+   +P R     V T           
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL---------- 162

Query: 738 GYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
            Y APE       Y T        D++S G +  EM + +
Sbjct: 163 WYRAPEILLGSKHYSTAV------DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 28/216 (12%)

Query: 561 MVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKI 616
           ++G G FG V +G   + G+  + VA+K L     +   + FL+E   +    H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 617 ITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                     GV  K+    I+ +FM+NG+L+ +L QN+ +  V     IQ + +   +A
Sbjct: 71  ---------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-----IQLVGMLRGIA 116

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + ++YL    +   VH DL   N+L++ ++V  V DFGL++FL     D    T +SS G
Sbjct: 117 AGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP---TYTSSLG 170

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            K  + + APE     + +   DV+S+GI++ E+ S
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 28/213 (13%)

Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+ +  
Sbjct: 14  LGQGCFGEVWMGTW--NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV +FM  GSL ++L + + K     L L Q +++A  +A  + Y+
Sbjct: 69  VVSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYI 118

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   +H DL+ +N+L+  ++V  + DFGLA+ +            ++  G K  + 
Sbjct: 119 E---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIK 168

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+ G    N   VAVK L   + G +  +SFL E + ++ +RH  L+++  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            S           IV ++M  GSL ++L     +     L L   +++A  VA+ + Y+ 
Sbjct: 70  VSEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
              +   +H DL+ +N+L+   +V  + DFGLA+ +            ++  G K  + +
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKW 169

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL E+ ++ R
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 7e-19
 Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 44/302 (14%)

Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L         S +  E   L+++ H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              CS     G+    ++ +++  GSL ++L ++        L+L Q L  A  +   + 
Sbjct: 72  KGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMA 121

Query: 677 YLH--HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           YLH  H+     +H DL   NVLLD+D +  +GDFGLAK +P       V     S    
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--- 173

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
             V + A E    ++ S   DV+SFG+ L E+ +      S                P+K
Sbjct: 174 --VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP---------------PKK 216

Query: 795 VMEIVDPS--LLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV 852
             E++ P    +  VR    + RG      + C   V  +   C       R   R ++ 
Sbjct: 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Query: 853 KL 854
            L
Sbjct: 277 IL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 26/221 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTECEALRSIR 609
           S  +   ++G G FG VF+GI+   G   + VA+K L     +   + FL+E   +    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 610 HRNLIKIITICSSIDFNGVDFK--AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           H N+I++  + +        FK   I+ ++M+NG+L+++L  ++ +      S  Q + +
Sbjct: 65  HHNIIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHDGEF-----SSYQLVGM 112

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
              +A+ ++YL        VH DL   N+L++ ++   V DFGL++ L   P     E  
Sbjct: 113 LRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-----EGT 164

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            ++SG K  + + APE     + +   DV+SFGI++ E+ S
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.2 bits (217), Expect = 1e-18
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 38/220 (17%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----SFLTECEALRSIRHRNLIKI 616
           +G+G++  V+K    E G +VA+K + L ++   K     + L E + L+ ++H N+I +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS--LIQTLNIAIDVASA 674
           + +     F       +V++FM+   LE+ +   +  L   ++   ++ TL         
Sbjct: 68  LDV-----FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR-------G 114

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDT-VVETPSSSS 731
           +EYLH +    ++H DLKP+N+L+  D V  + DFGLA+    P R +   VV       
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV------- 164

Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
               T  Y APE   G+     G D++S G +  E+  R 
Sbjct: 165 ----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 2e-18
 Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNLIKIIT 618
           +G GSFG V       +G   A+K+L+  +   LK     L E   L+SIRH  L+ +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
                 F       +V +++  G L   L ++                 A  V  A+EYL
Sbjct: 69  -----SFQDDSNLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYL 117

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
            H     +V+ DLKP N+LLD D    + DFG AK +  R           +  + GT  
Sbjct: 118 -HSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----------TYTLCGTPE 163

Query: 739 YIAPEY----GTGSEASMTGDVYSFGILLLEM 766
           Y+APE     G G       D ++ GIL+ EM
Sbjct: 164 YLAPEIILSKGYGKAV----DWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 71/229 (31%), Positives = 115/229 (50%), Gaps = 34/229 (14%)

Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT-ECEALRSIR 609
           K+ SE    N +G G+ GTV+K I    G L A+KV+    +  ++  +  E E LR + 
Sbjct: 71  KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN 130

Query: 610 HRNLIKIITICSSI-DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           H N++K    C  + D NG     ++ +FM  GSLE       D+  + ++        A
Sbjct: 131 HPNVVK----CHDMFDHNGE--IQVLLEFMDGGSLEG--THIADEQFLADV--------A 174

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             + S I YLH   +  +VH D+KPSN+L++      + DFG+++ L A+ +D     P 
Sbjct: 175 RQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL-AQTMD-----PC 225

Query: 729 SSSGIKGTVGYIAPE-----YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +SS   GT+ Y++PE        G+     GD++S G+ +LE +  R P
Sbjct: 226 NSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 34/215 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKIITIC 620
           +G+G+FG VF G +  +   VAVK         LK+ FL E   L+   H N++++I +C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 621 SSIDFNGVDFKA---IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
           +         K    IV + +Q G    +L     +L+V  L     + +  + A+ +EY
Sbjct: 63  TQ--------KQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEY 109

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT- 736
           L        +H DL   N L+    V  + DFG+++       D V    +S+ G+K   
Sbjct: 110 LESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVY---ASTGGMKQIP 159

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE   YG  S  S   DV+SFGILL E FS
Sbjct: 160 VKWTAPEALNYGRYSSES---DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 25/216 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVA---VKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+G F  V+K I   +G +VA   V++  +M   A +  L E + L+ + H N+IK + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLH--QNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             S I+ N ++   IV +    G L   +   +   +L    +         + + SA+E
Sbjct: 70  --SFIENNELN---IVLELADAGDLSRMIKHFKKQKRL----IPERTIWKYFVQLCSALE 120

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           ++H      ++H D+KP+NV +    V  +GD GL +F  +       +T ++ S + GT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLV-GT 169

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             Y++PE    +  +   D++S G LL EM + + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 28/220 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +VG+G+FG V       +  LV +K + +  M K    +   EC+ L+ + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 619 ICSSIDFNGVDFKA--IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                  N ++ KA  IV ++   G+L E++ +  + L    L     L+  + +  A+ 
Sbjct: 67  -------NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL----LDEDTILHFFVQILLALH 115

Query: 677 YLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           ++H      ++H DLK  N+LLD H MV  +GDFG++K L          + S +  + G
Sbjct: 116 HVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------SSKSKAYTVVG 163

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           T  YI+PE   G   +   D+++ G +L E+ S +R  ++
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 34/295 (11%)

Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G  VAVK L     G  +     E E LR++ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             IC+    NG+    ++ +F+ +GSL+E+L +N +K+     +L Q L  A+ +   ++
Sbjct: 72  KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKGMD 123

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YL        VH DL   NVL++ +    +GDFGL K      ++T  E  +    +   
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSP 175

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
           V + APE    S+  +  DV+SFG+ L E+ +     DS   E   +  F KM+ P    
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLTY---CDS---ESSPMTLFLKMIGPTHGQ 229

Query: 797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV 851
             V        R    +  G    +   C   V ++   C    P+ R   ++++
Sbjct: 230 MTV-------TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 83.3 bits (207), Expect = 3e-17
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 44/225 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G++G V   +    G  VA+K ++ +    +  K  L E + LR +RH N+I ++ I
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 620 C---SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNIAIDVASAI 675
               S  DFN V    IV + M+   L + +        +     L Q L         +
Sbjct: 68  LRPPSPEDFNDV---YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL-------RGL 116

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +YLH      V+H DLKPSN+L++ +    + DFGLA+         V         +  
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR--------GVDPDEDEKGFLTE 165

Query: 736 TVG---YIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
            V    Y APE       Y          D++S G +  E+ +R+
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 34/215 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           ++G+G+FG VFKG + ++   VAVK    +L Q+  +K FL+E   L+   H N++K+I 
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C+           IV + +  G    +L +  D+L+       Q +  A+D A+ + YL
Sbjct: 60  VCTQ-----RQPIYIVMELVPGGDFLSFLRKKKDELK-----TKQLVKFALDAAAGMAYL 109

Query: 679 H-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT- 736
              +C    +H DL   N L+  + V  + DFG++     R  D  +    SSSG+K   
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMS-----RQEDDGI---YSSSGLKQIP 157

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
           + + APE   YG  S  S   DV+S+GILL E FS
Sbjct: 158 IKWTAPEALNYGRYSSES---DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 30/216 (13%)

Query: 561 MVGQGSFGTVFKG---IIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIK 615
           ++G G FG V  G   + G+  + VA+K L     +K   + FL+E   +    H N+I 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIH 69

Query: 616 ---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
              ++T    +         IV ++M+NGSL+ +L +++ +  V     IQ + +   +A
Sbjct: 70  LEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRGIA 116

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           S ++YL        VH DL   N+L++ ++V  V DFGL++ L   P     E   ++ G
Sbjct: 117 SGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EAAYTTRG 168

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            K  + + APE     + +   DV+S+GI++ E+ S
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 562 VGQGSFGTVFKGIIGENG---MLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKII 617
           +G G+FG+V KG+        + VAVK L      A K  FL E   +  + H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C            +V +    G L ++L +   ++ V +L       +A  VA  + Y
Sbjct: 63  GVCKGEPL------MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGMAY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH DL   NVLL +   A + DFG+++ L A       +   +++  +  +
Sbjct: 111 LES-KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-----DYYRATTAGRWPL 162

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR 769
            + APE   YG  S  S   DV+S+G+ L E FS 
Sbjct: 163 KWYAPECINYGKFSSKS---DVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.2 bits (200), Expect = 8e-17
 Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 32/223 (14%)

Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF       +  ++ MLVAVK L    + A + F  E E L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN---------LSLIQTLNI 667
             +C+           +V+++M++G L  +L  +    ++           L+L Q L I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  +AS + YL        VH DL   N L+   +V  +GDFG+++         +  T 
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTD 176

Query: 728 SSSSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
               G +    + ++ PE     + +   D++SFG++L E+F+
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 17/210 (8%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           + +G++G VF       G + A+KV+    +++K  +   LTE + L   +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
             S   F G     +V +++  G L   L        V +L          ++  A+EYL
Sbjct: 60  -YS---FQGKKNLYLVMEYLPGGDLASLLEN------VGSLDEDVARIYIAEIVLALEYL 109

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H +    ++H DLKP N+L+D +    + DFGL+K    R    + +       I GT  
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           YIAPE   G   S T D +S G +L E   
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G      + VA+K +N   +GA+  + F+ E + +  + H 
Sbjct: 4   SELTFMKELGSGQFGVVHLGK-WRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHP 59

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C+           IV +FM+NG L  +L Q   KL     S    L++  DV
Sbjct: 60  KLVQLYGVCTQ-----QKPLYIVTEFMENGCLLNYLRQRQGKL-----SKDMLLSMCQDV 109

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              +EYL    +   +H DL   N L+    V  V DFG+ +++    LD   +  +SSS
Sbjct: 110 CEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LD---DEYTSSS 159

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           G K  V +  PE    S+ S   DV+SFG+L+ E+F+
Sbjct: 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 37/218 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS+G+V+K I  E G +VA+KV+ +  +  L+  + E   L+      ++K      
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62

Query: 622 SIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI---DVASA 674
              + G  FK     IV ++   GS+       +D +++ N +L +   IA         
Sbjct: 63  ---YYGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEEE-IAAILYQTLKG 111

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +EYLH + K   +H D+K  N+LL+ +  A + DFG++  L         +T +  + + 
Sbjct: 112 LEYLHSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTMAKRNTVI 160

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           GT  ++APE       +   D++S GI  +EM   + P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+ G VFK    E G  VA+K + L +   G     L E +AL++ +H  ++K++ +
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 620 CSSIDFN-GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
                F  G  F  +V ++M    L E L       E   L   Q  +    +   + Y+
Sbjct: 68  -----FPHGSGF-VLVMEYMP-SDLSEVLRD-----EERPLPEAQVKSYMRMLLKGVAYM 115

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      ++H DLKP+N+L+  D V  + DFGL     AR      E P   S    T  
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGL-----ARLFSE--EEPRLYSHQVATRW 165

Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEM 766
           Y APE   G+     G D+++ G +  E+
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 34/217 (15%)

Query: 562 VGQGSFGTVFKGI-IGENGML--VAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKI- 616
           +G GSFG V +G      G +  VAVK L   +    +  FL E   + S+ H NLI++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 617 -ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            + +   +         +V +    GSL + L +  D L    +S +   + A+ +A+ +
Sbjct: 63  GVVLTHPL--------MMVTELAPLGSLLDRLRK--DALGHFLISTL--CDYAVQIANGM 110

Query: 676 EYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
            YL         +H DL   N+LL  D    +GDFGL      R L    +       +K
Sbjct: 111 RYLESKRF----IHRDLAARNILLASDDKVKIGDFGL-----MRALPQNEDHYVMEEHLK 161

Query: 735 GTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
               + APE     T S AS   DV+ FG+ L EMF+
Sbjct: 162 VPFAWCAPESLRTRTFSHAS---DVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 25/211 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRNLIKIITIC 620
           +G G+   V+  I   N   VA+K ++L +    +     E +A+    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
           S   F   D   +V  ++  GSL + +  +       + ++I T  +  +V   +EYLH 
Sbjct: 67  S---FVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIAT--VLKEVLKGLEYLHS 120

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
           + +   +H D+K  N+LL  D    + DFG++  L     D    T        GT  ++
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVRKTFVGTPCWM 173

Query: 741 APE-----YGTGSEASMTGDVYSFGILLLEM 766
           APE     +G   +A    D++SFGI  +E+
Sbjct: 174 APEVMEQVHGYDFKA----DIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 34/213 (15%)

Query: 562 VGQGSFGTVFKGII-GENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIIT 618
           +G G FG V  G   G+    VA+K   ++++G++    F+ E + +  + H  L+++  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD--VAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 619 ICSS---IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +C+    I         IV ++M NG L  +L ++  + +       Q L +  DV   +
Sbjct: 67  VCTKQRPI--------YIVTEYMSNGCLLNYLREHGKRFQ-----PSQLLEMCKDVCEGM 113

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N L+D      V DFGL++++    LD   +  +SS G K 
Sbjct: 114 AYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LD---DEYTSSVGSKF 163

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            V +  PE    S+ S   DV++FG+L+ E++S
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 31/253 (12%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNL 613
           +    + +G+G+ G+V K  +   GM+ A+K +       L K  L E E  +S +   +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 614 IKIITIC-----SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +K          SSI         I  ++ + GSL+    +   +       ++    IA
Sbjct: 62  VKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL--GKIA 111

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             V   + YLH      ++H D+KPSN+LL       + DFG++            E  +
Sbjct: 112 ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG-----------ELVN 157

Query: 729 SSSG-IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
           S +G   GT  Y+APE   G   S+T DV+S G+ LLE+   R P        L   E  
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217

Query: 788 KMVLPEKVMEIVD 800
             ++     E+ D
Sbjct: 218 SYIVNMPNPELKD 230

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G++G V+K      G +VA+K + L    +G  K+ L E + L+ + H N+IK++ +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL---EVCNLSLIQTLNIAIDVASAIE 676
                F       +V++FM    L + +      L    + +  L Q L         + 
Sbjct: 67  -----FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSY-LYQLL-------QGLA 112

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPL-DTVVETPSSSSGI 733
           + H H    ++H DLKP N+L++ + V  + DFGLA+    P RP    VV         
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--------- 160

Query: 734 KGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
             T  Y APE   G +   T  D++S G +  E+ SRR
Sbjct: 161 --TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 68/288 (23%), Positives = 131/288 (45%), Gaps = 59/288 (20%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+ G        VA+K L   ++G++  ++FL E   ++ ++H  L+++  +
Sbjct: 14  LGAGQFGEVWMGYY-NGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +           I+ ++M+NGSL ++L           L++ + +++A  +A  + ++ 
Sbjct: 70  VTQEPI------YIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE 119

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
              +   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKW 169

Query: 740 IAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
            APE   YGT +  S   DV+SFGILL E+ +  R    + + G+T              
Sbjct: 170 TAPEAINYGTFTIKS---DVWSFGILLTEIVTYGR----IPYPGMT-------------- 208

Query: 797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
              +P    EV  N  + RG    + + C   +  +  +C  E P +R
Sbjct: 209 ---NP----EVIQN--LERGYRMPRPDNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 61/250 (24%), Positives = 111/250 (44%), Gaps = 58/250 (23%)

Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKG-IIGENGML----VAVKVLNLMQKGALKS-FLTE 601
           ++  +   F     +G+G+FG V+KG + G N  L    VA+K L    +  ++  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL--HQNNDKLEVCN- 658
            E +  ++H N++ ++ +C+           ++++++ +G L E+L  +  +  +   + 
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 659 -------LSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
                  L     L+IAI +A+ +EYL  HH     VH DL   N L+   +   + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 711 LA---------KFLPARPLDTVVETPSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYS 758
           L+         +      L                V ++ PE   YG  +  S   D++S
Sbjct: 170 LSRDIYSADYYRVQSKSLL---------------PVRWMPPEAILYGKFTTES---DIWS 211

Query: 759 FGILLLEMFS 768
           FG++L E+FS
Sbjct: 212 FGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 25/237 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+G FG V    +   G + A K L+   L ++   +  L E + L  +  R       
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  +  F   D   +V   M  G L+  ++   +          + +  A  +   +E+L
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHL 111

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +V+ DLKP NVLLD      + D GLA  L                G  GT G
Sbjct: 112 HQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---------KKIKGRAGTPG 159

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           Y+APE   G     + D ++ G  L EM + R P      E +   E  +  L   V
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+GSFGTV K     +G ++  K ++   M +   +  ++E   LR ++H N   I+  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN---IVRY 64

Query: 620 CSSIDFNGVDFKA----IVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVA 672
              I    +D       IV ++ + G L + +    +    +E      I    I   + 
Sbjct: 65  YDRI----IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE---EFI--WRILTQLL 115

Query: 673 SAIEYLHH--HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
            A+   H+       V+H DLKP+N+ LD +    +GDFGLAK L              S
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-----------GHDS 164

Query: 731 SGIKGTVG---YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           S  K  VG   Y++PE           D++S G L+ E+ +   P
Sbjct: 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 47/233 (20%)

Query: 561 MVGQGSFGTVFKG-IIG----ENGMLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRN 612
            +G+G+FG V K   +G         VAVK+L  +  +K  L   ++E E ++ I +H+N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKN 77

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL----IQTL--- 665
           +I ++ +C+     G  +  +V ++  +G+L ++L       E  +        +TL   
Sbjct: 78  IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 666 ---NIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
              + A  VA  +E+L    C    +H DL   NVL+  D V  + DFGLA+ +    +D
Sbjct: 133 DLVSFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDI--HHID 186

Query: 722 TVVETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFS 768
              +T +    +K    ++APE      Y   S      DV+SFG+LL E+F+
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRVYTHQS------DVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 38/262 (14%)

Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNL 613
           +GQGSFG V++G+      GE    VA+K +N    M++     FL E   ++     ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNEASVMKEFNCHHV 71

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL----SLIQTLNIAI 669
           ++++ + S+          +V + M  G L+ +L     + E        +L + + +A 
Sbjct: 72  VRLLGVVST-----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL        VH DL   N ++  D+   +GDFG+ +         + ET   
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYY 175

Query: 730 SSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
             G KG   V ++APE       +   DV+SFG++L EM +         ++GL+  E  
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT----LAEQPYQGLSNEEVL 231

Query: 788 KMVLPEKVMEIVD--PSLLLEV 807
           K V+    +++ +  P  LLE+
Sbjct: 232 KFVIDGGHLDLPENCPDKLLEL 253

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.6 bits (199), Expect = 1e-15
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 32/185 (17%)

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
           L L +  L G +P++I  L++L  +++SGN   G+IP +L + TSLE + +  NSF+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 408 PPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRF 467
           P SL  L S+++L+L+ N LSG++P  L                 G             F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHR-----ASF 520

Query: 468 SLSGNGKLCG--GLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRR 525
           + + N  LCG  G     L +C    S   +   + +     V+ L L  C +  + RR+
Sbjct: 521 NFTDNAGLCGIPG-----LRACGPHLS---VGAKIGIAFGVSVAFLFLVICAMCWWKRRQ 572

Query: 526 STDRS 530
           +  R+
Sbjct: 573 NILRA 577

Length = 623

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNLIKIITICS 621
           G G+ G V K +    G ++AVK + L    A+ K  L E + L       ++       
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF- 68

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              +N  D  +I  ++M  GSL++ L +   ++    L       IA+ V   + YLH  
Sbjct: 69  ---YNNGDI-SICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
            K  ++H D+KPSN+L++      + DFG++  L      T V          GT  Y+A
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----------GTSSYMA 167

Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           PE   G++ S+  D++S G+ L+E+ + R P
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 25/221 (11%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---------LKSFLTECEALRSIRHR 611
           ++G GSFG+V+ G+   +G L+AVK + L    A         L +   E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N+++ +   SS+D + ++   I  +++  GS+   L+      E    +L++  N    +
Sbjct: 67  NIVQYLG--SSLDADHLN---IFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YLH+     ++H D+K +N+L+D+     + DFG++K L A  L T       S 
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            ++G+V ++APE    +  +   D++S G L++EM + + P
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 25/220 (11%)

Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIR---HRNL 613
              +G+G++GTV+K      G  VA+K +   L ++G   S L E   L+ +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           ++++ +C     +      +V++ +     ++ L     K     L      ++   +  
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR-PLDTVVETPSSSSG 732
            +++LH H    +VH DLKP N+L+  D    + DFGLA+       L +VV        
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV------- 168

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              T+ Y APE    S  +   D++S G +  E+F RRRP
Sbjct: 169 ---TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 85/315 (26%), Positives = 132/315 (41%), Gaps = 71/315 (22%)

Query: 560 NMVGQGSFGTVFKG-IIGENG----MLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNL 613
             +G G+FG V++G   G +G    + VAVK L        +S FL E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 614 IKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLE-VCNLSLIQTLNIA 668
           +++I         GV F+     I+ + M  G L+ +L +N  + E   +L++   L  A
Sbjct: 72  VRLI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGLAKFLPARPLDTVVE 725
            DVA   +YL  +     +H D+   N LL       VA + DFG+A+           +
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----------D 168

Query: 726 TPSSSSGIKG-----TVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE 779
              +S   KG      + ++ PE +  G   S T DV+SFG+LL E+FS       M + 
Sbjct: 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKT-DVWSFGVLLWEIFSLGY----MPYP 223

Query: 780 GLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSME 839
           G T  E         VME V              + GG     + C   V RI   C   
Sbjct: 224 GRTNQE---------VMEFV--------------TGGGRLDPPKGCPGPVYRIMTDCWQH 260

Query: 840 SPTDRMQMRDVVVKL 854
           +P DR     ++ ++
Sbjct: 261 TPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 29/223 (13%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGI-IGENGML---VAVKVLNLMQKGALKSFLTECE---AL 605
            +E     ++G G FGTV KGI I E   +   VA+K +    +   ++F    +   A+
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAM 63

Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
            S+ H  +++++ IC            +V      GSL + + Q+ D     +L   + L
Sbjct: 64  GSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRD-----SLDPQRLL 112

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           N  + +A  + YL  H    +VH +L   N+LL  D +  + DFG+A  L   P D    
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKY- 166

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                S  K  + ++A E       +   DV+S+G+ + EM S
Sbjct: 167 ---FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 46/307 (14%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENG---MLVAVKVLNL--MQKGALKSFLTECEALRSIRH 610
                ++G+G FG+V +G + ++    + VAVK + L       ++ FL+E   ++   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 611 RNLIKIITIC-SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
            N++K+I +C  +     +    ++  FM++G L  +L  +        L L   L   +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           D+A  +EYL +      +H DL   N +L  DM   V DFGL+K + +   D   +   +
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIA 175

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSK 788
               K  V +IA E       +   DV++FG+ + E+ +R + P     + G+  HE   
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP-----YPGVENHEIYD 226

Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI-EECLVAVIRIGVVCSMESPTDRMQM 847
            +                        R G R+K  E+CL  +  +   C    P DR   
Sbjct: 227 YL------------------------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF 262

Query: 848 RDVVVKL 854
             +   L
Sbjct: 263 TKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 30/221 (13%)

Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRH 610
           A + + +   +G+GS+ TV+KGI   NG LVA+KV+++  ++G   + + E   L+ ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 611 RNLI---KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
            N++    II    ++ F        V+++M    L +++ Q+   L   N+ L      
Sbjct: 63  ANIVLLHDIIHTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVRLFM---- 109

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
              +   + Y+H      ++H DLKP N+L     ++++G+  LA F  AR      +T 
Sbjct: 110 -FQLLRGLAYIHGQ---HILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPSQTY 160

Query: 728 SSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMF 767
           SS      T+ Y  P+   G+ + S   D++  G + +EM 
Sbjct: 161 SSEV---VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 58/228 (25%), Positives = 110/228 (48%), Gaps = 40/228 (17%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL----------MQKGALKSFLTECEALRSIRH 610
           ++G+G++G V+  +    G ++AVK + L           QK  +K+  +E E L+ + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE--VCNLSLIQTLNIA 668
            N+++ +           ++ +I  +++  GS+   L +   + E  +      Q L   
Sbjct: 68  LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL--- 118

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
                 + YLH      ++H DLK  N+L+D D +  + DFG++K    +  D  +    
Sbjct: 119 ----EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK----KSDD--IYDND 165

Query: 729 SSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +  ++G+V ++APE    Y  G  A +  D++S G ++LEMF+ RRP
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 20/217 (9%)

Query: 560 NMVGQGSFGTVFKG-IIGENG--MLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLIK 615
            ++G+G FG V+ G +I  +G  +  AVK LN +     ++ FL E   ++   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           ++ IC  +   G     +V  +M++G L  ++        V +L     +   + VA  +
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K 
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI----YDKEYYSVHNHTGAKL 164

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 25/220 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLN-LMQKGALKSFLTECEALRSI 608
           +E     ++G G+FGTV+KGI    G    + VA+K+LN      A   F+ E   + S+
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H +L++++ +C S          +V   M +G L +++H++ D     N+     LN  
Sbjct: 67  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWC 115

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L         E   
Sbjct: 116 VQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEY 166

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           ++ G K  + ++A E     + +   DV+S+G+ + E+ +
Sbjct: 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 38/81 (46%), Positives = 52/81 (64%), Gaps = 1/81 (1%)

Query: 256 NQ-LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL 314
           NQ L G +P +I  L++LQS+ L+ N + G IP SLG++T L +L L  N+  G IP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 315 GNCTSLIMLTLSKNKLDGVLP 335
           G  TSL +L L+ N L G +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+GS+G+V+K     +    A+K ++L  M +   +  + E   L S+ H N+I      
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE-- 66

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
           + +D N +    IV ++   G L + + +   K ++     I    I I +   ++ LH 
Sbjct: 67  AFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEI--WRIFIQLLRGLQALHE 121

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
                ++H DLK +N+LL  + +  +GD G++K L      T + TP           Y+
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH----------YM 168

Query: 741 APEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           APE   G   S   D++S G LL EM +   P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)

Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF          ++ MLVAVK L      A K F  E E L +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC----------NLSLIQTLN 666
             +C     +G D   +V+++M++G L ++L  +     +            L L Q L+
Sbjct: 73  YGVCG----DG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           IA  +AS + YL        VH DL   N L+  +++  +GDFG+++ + +     V   
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV--- 181

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     + ++ PE     + +   DV+SFG++L E+F+
Sbjct: 182 ---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 67/291 (23%), Positives = 126/291 (43%), Gaps = 64/291 (21%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+ G    N   VAVK L   + G +  ++FL E   +++++H  L+++  +
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +       +   I+ ++M  GSL ++L  +    E   + L + ++ +  +A  + Y+ 
Sbjct: 70  VTK-----EEPIYIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP--SSSSGIKGTV 737
              +   +H DL+ +NVL+   ++  + DFGLA+         V+E    ++  G K  +
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLAR---------VIEDNEYTAREGAKFPI 168

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP----E 793
            + APE       ++  DV+SFGILL E+ +                 + K+  P     
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVT-----------------YGKIPYPGMSNS 211

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            VM              +++ RG    ++E C   +  I   C  E   +R
Sbjct: 212 DVM--------------SALQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 3e-14
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 23/164 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF-----LTECEALRSI-RHRNLIK 615
           +G G+FG+V+     E G LVA+K +    K    S+     L E ++LR +  H N++K
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +    + + + F   V+++M  G+L + +     K      S     +I   +   +
Sbjct: 63  LKEVF--RENDELYF---VFEYM-EGNLYQLMKDRKGKP----FSESVIRSIIYQILQGL 112

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
            ++H H      H DLKP N+L+    V  + DFGLA+ + +RP
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 20/220 (9%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGE----NGMLVAVK-VLNLMQKGALKSFLTECEALRSIRH 610
            + S+++ +G+FG +F GI+ +        V VK V +   +  +   L E   L  + H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN--DKLEVCNLSLIQTLNIA 668
           +N++ I+ +C        +   ++Y +M  G+L+ +L Q    +      LS  Q +++A
Sbjct: 68  QNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           I +A  + YLH      V+H D+   N ++D ++   + D  L++ L   P+D      +
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL--FPMDYHCLGDN 178

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +  +K    ++A E     E S   DV+SFG+LL E+ +
Sbjct: 179 ENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 49/239 (20%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIK 615
           ++G GSFG+V++G+  ++G   AVK ++L       + A+K    E   L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 616 II-TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAIDVA 672
            + T     +        I  + +  GSL + L +        V  L   Q L       
Sbjct: 67  YLGTEREEDNLY------IFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQIL------- 112

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             +EYLH       VH D+K +N+L+D + V  + DFG+AK          V   S +  
Sbjct: 113 LGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKS 160

Query: 733 IKGTVGYIAPEY-----GTGSEASMTGDVYSFGILLLEM------FSRRRPTDSMFHEG 780
            KG+  ++APE      G G  A    D++S G  +LEM      +S+     ++F  G
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 26/225 (11%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRN 612
           +F   N +G+GSFG VFK +   +  + A+K ++L  M +   +  + E   L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           +I+     S +D   ++   IV ++ +NG L + L     +     L   Q     I + 
Sbjct: 61  IIRYYE--SFLDKGKLN---IVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQIL 111

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVETPSSS 730
             + +LH      ++H D+K  N+ LD      +GD G+AK L       +T+V TP   
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY-- 166

Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                   Y++PE       +   DV++ G++L E  + + P D+
Sbjct: 167 --------YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 48/220 (21%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G++G V+K      G LVA+KV+ L      +    E   L+  RH N++       
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA------ 64

Query: 622 SIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLE------VCNLSLIQTLNIAIDV 671
              + G   +     IV ++   GSL++        L       VC  +L + L      
Sbjct: 65  ---YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-KGLA----- 115

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
                YLH   K   +H D+K +N+LL  D    + DFG++  L A        T +   
Sbjct: 116 -----YLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRK 159

Query: 732 GIKGTVGYIAPEYGTGSEASMTG-----DVYSFGILLLEM 766
              GT  ++APE    +     G     D+++ GI  +E+
Sbjct: 160 SFIGTPYWMAPE--VAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 26/241 (10%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK---VLNLMQKGALKSFLTECEALRSIRH 610
           + F     +G+G F  V++     +G+ VA+K   + +LM   A    + E + L+ + H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL-HQNNDKLEVCNLSLIQTLNIAI 669
            N+IK     S I+ N ++   IV +    G L   + H    K  +   ++ +     +
Sbjct: 62  PNVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF---V 113

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            + SA+E++H      V+H D+KP+NV +    V  +GD GL +F  ++         ++
Sbjct: 114 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTA 162

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM 789
           +  + GT  Y++PE    +  +   D++S G LL EM + + P    + + + L+   K 
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 219

Query: 790 V 790
           +
Sbjct: 220 I 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 75/309 (24%), Positives = 132/309 (42%), Gaps = 58/309 (18%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII---GENGML-VAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    GE   + VA+K L       A K  L E   + S+
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 609 RHRNLIKIITIC--SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
            + ++ +++ IC  S++         ++   M  G L +++ ++ D   + +  L   LN
Sbjct: 67  DNPHVCRLLGICLTSTVQ--------LITQLMPFGCLLDYVREHKDN--IGSQYL---LN 113

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
             + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E 
Sbjct: 114 WCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EK 164

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHE 785
              + G K  + ++A E       +   DV+S+G+ + E+ +   +P D     G+   E
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASE 219

Query: 786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM 845
            S ++  EK   +  P +                     C + V  I V C M     R 
Sbjct: 220 ISSIL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRP 256

Query: 846 QMRDVVVKL 854
           + R+++++ 
Sbjct: 257 KFRELIIEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 15/220 (6%)

Query: 556 FSSSNMVGQGSFGTVFKGIIG-ENGML--VAVKVL--NLMQKGALKSFLTECEALRSIRH 610
           F+   M+G+G FG+V +  +  E+G    VAVK+L  ++     ++ FL E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 611 RNLIKIITICSSIDFNG-VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
            N+IK+I +       G +    ++  FM++G L  +L  +    E   L L   +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           D+AS +EYL        +H DL   N +L+ +M   V DFGL+K + +       +    
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG------DYYRQ 171

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
               K  V ++A E    +  +   DV++FG+ + E+ +R
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 56/229 (24%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA------LKSFLTECEALRSIRHRNLI 614
           +VG+G++G V K      G +VA+K      K +       K+ L E + LR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF----KESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAIDVA 672
            +          G  +  +V+++++   LE  L  +   L  +     + Q L       
Sbjct: 64  NLKEAFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ------ 111

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP----LDTVVETPS 728
            AI Y H H    ++H D+KP N+L+    V  + DFG A+ L ARP     D V     
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA---- 163

Query: 729 SSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
                  T  Y APE       YG         DV++ G ++ E+    
Sbjct: 164 -------TRWYRAPELLVGDTNYGKPV------DVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 53/212 (25%), Positives = 105/212 (49%), Gaps = 26/212 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+     ++   VAVK    M+ G++  ++FL E   +++++H  L+K+  +
Sbjct: 14  LGAGQFGEVWMATYNKHTK-VAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +       +   I+ +FM  GSL ++L  +    E     L + ++ +  +A  + ++ 
Sbjct: 70  VTK------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
              +   +H DL+ +N+L+   +V  + DFGLA+ +            ++  G K  + +
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKW 169

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL+E+ +  R
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 45/245 (18%)

Query: 562 VGQGSFGTVFK----GII-GENGMLVAVKVLN-----LMQKGALKSFLTECEALRSIRHR 611
           +GQG+FG VF+    G++  E   +VAVK+L       MQ      F  E   +    H 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------------LE 655
           N++K++ +C+     G     +++++M  G L E+L   + +                L 
Sbjct: 69  NIVKLLGVCAV----GKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
              LS  + L IA  VA+ + YL        VH DL   N L+  +MV  + DFGL++ +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 180

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTD 774
            +   D    + + +  I+    ++ PE    +  +   DV+++G++L E+FS   +P  
Sbjct: 181 YSA--DYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Query: 775 SMFHE 779
            M HE
Sbjct: 235 GMAHE 239

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 561 MVGQGSFGTVFKGI----IGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIK 615
            +G+G FG V++G+      E  + VAVK        +++  FL E   +R   H +++K
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEK-IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +I + +       +   IV +    G L  +L  N   L++ +L L      +  +++A+
Sbjct: 72  LIGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTAL 120

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        VH D+   NVL+       +GDFGL+++L         E+   +S  K 
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-------ESYYKASKGKL 170

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
            + ++APE       +   DV+ FG+ + E+   
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 35/80 (43%), Positives = 51/80 (63%)

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
           G IP  +  L HL SI + GN + G +PP +G + +L+ L L+ N  +G IP SLG LT 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 296 LTLLALEINNLQGKIPSSLG 315
           L +L L  N+L G++P++LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECE 603
           ++ +L K          +G+G++ TV+KG     G +VA+K ++L  ++G   + + E  
Sbjct: 1   NFKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS 50

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            ++ ++H N++++  +      +  +   +V+++M    L++++  +  +     L    
Sbjct: 51  LMKELKHENIVRLHDV-----IHTENKLMLVFEYMDK-DLKKYMDTHGVR---GALDPNT 101

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
             +    +   I + H +    V+H DLKP N+L++      + DFGL     AR     
Sbjct: 102 VKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL-----ARAFGIP 153

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
           V T S+      T+ Y AP+   GS    T  D++S G ++ EM + R
Sbjct: 154 VNTFSNEV---VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 42/229 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVK-VLNLMQK-GALKSFLTECEALRSIRHRNLIKIITIC 620
           G+G+FG V+K    + G +VA+K +L   +K G   + L E + L+ ++H N++ +I + 
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMA 76

Query: 621 SSIDFNGVDFKAIVYDFM--QNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIE 676
                     +  VY      +  L   L   + KL    +     Q L         I 
Sbjct: 77  VERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE-------GIN 129

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG- 735
           YLH   +  ++H D+K +N+L+D+  +  + DFGL     ARP D     P    G    
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGL-----ARPYDGPPPNPKGGGGGGTR 181

Query: 736 -------TVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
                  T  Y  PE       Y T        D++  G +  EMF+RR
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAV------DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 41/229 (17%)

Query: 560 NMVGQGSFGTVFKGI------IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSIR 609
           N +G G+FG V++G        G   + VAVK L   +KGA     K FL E   + +  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-DKLEVCNLSLIQTLNIA 668
           H N++K++ +C        + + I+ + M+ G L  +L     ++     L+L + L+I 
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLPARPLDTV 723
           +DVA    YL    +   +H DL   N L+     D D V  +GDFGLA+ +        
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-------- 161

Query: 724 VETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
               S     +G     V ++APE     + +   DV+SFG+L+ E+ +
Sbjct: 162 --YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 47/247 (19%)

Query: 540 QFPMI----SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGA 594
           +FP       Y KL+K          +GQG+FG VFK    +   +VA+K VL   +K  
Sbjct: 4   EFPFCDEVSKYEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG 53

Query: 595 LK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA---IVYDFMQNGSLEEWLHQN 650
              + L E + L+ ++H N++ +I IC +       +K    +V++F ++  L   L   
Sbjct: 54  FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK 112

Query: 651 NDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
           N K     LS I+   +   + + + Y+H +    ++H D+K +N+L+  D +  + DFG
Sbjct: 113 NVKF---TLSEIKK--VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164

Query: 711 LAKFLPARPLDTVVET-PSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGIL 762
           L     AR       + P+  +    T+ Y  PE       YG         D++  G +
Sbjct: 165 L-----ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI------DMWGAGCI 213

Query: 763 LLEMFSR 769
           + EM++R
Sbjct: 214 MAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 46/226 (20%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
             F+    +G+GSFG V+K I      +VA+KV++L      +    E E        ++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL------EEAEDEIE--------DI 46

Query: 614 IKIITICSSIDFNGV---------DFK-AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            + I   S      +           K  I+ ++   GS         D L+   L    
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-------DLLKPGKLDETY 99

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--D 721
              I  +V   +EYLH   K   +H D+K +N+LL  +    + DFG++  L +     +
Sbjct: 100 IAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           T V TP           ++APE    S      D++S GI  +E+ 
Sbjct: 157 TFVGTPF----------WMAPEVIKQSGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKV--LNLMQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K   L+   +G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 614 IKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           +K++ +  +      + K  +V++F+ +  L++++    D   +  + L    +    + 
Sbjct: 62  VKLLDVIHT------ENKLYLVFEFL-HQDLKKFM----DASPLSGIPLPLIKSYLFQLL 110

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSS 730
             + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V      
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----- 162

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 163 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---------MQKGALKSFLTECEA 604
           S +    ++G+G++G V++G     G +VA+K++NL         +Q+        E   
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR--------EVAL 52

Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           L  +R      I     S    G     I+ ++ + GS+   +       +  ++ + + 
Sbjct: 53  LSQLRQSQPPNITKYYGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREV 110

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L        A++Y+H   K  V+H D+K +N+L+ +     + DFG+A  L         
Sbjct: 111 L-------VALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--------N 152

Query: 725 ETPSSSSGIKGTVGYIAPEYGT-GSEASMTGDVYSFGILLLEM 766
           +  S  S   GT  ++APE  T G       D++S GI + EM
Sbjct: 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 80/309 (25%), Positives = 132/309 (42%), Gaps = 58/309 (18%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII---GENGML-VAVKVL--NLMQKGALKSFLTECEALRS 607
           +E     ++G G+FGTV+KGI    GEN  + VA+KVL  N   K A K  L E   +  
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 65

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           +    + +++ IC +          +V   M  G L +++ +N D++   +L     LN 
Sbjct: 66  VGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
            + +A  + YL    +  +VH DL   NVL+       + DFGLA+ L       + ET 
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETE 165

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF 786
             + G K  + ++A E       +   DV+S+G+ + E+ +   +P D            
Sbjct: 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------I 215

Query: 787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDRM 845
               +P+          LLE          GER+ +   C + V  I V C M     R 
Sbjct: 216 PAREIPD----------LLE---------KGERLPQPPICTIDVYMIMVKCWMIDSECRP 256

Query: 846 QMRDVVVKL 854
           + R++V + 
Sbjct: 257 RFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.5 bits (178), Expect = 5e-13
 Identities = 32/85 (37%), Positives = 54/85 (63%), Gaps = 1/85 (1%)

Query: 6   NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
           N  L G IP +I   L  L++++L+ N + G +P S+G++++L+V+D+  N   G IP++
Sbjct: 427 NQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSI 90
           LGQL  L  LN+  N  SG +P ++
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 26/224 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRHR 611
           S +     +G G++G V   I   +G  VA+K + +      L K  L E + LR  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 612 NLIKIITICSSIDFNGVDFKAI--VYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNIA 668
           N+I I  I       G DFK +  V D M++  L   +H +     E     L Q L   
Sbjct: 65  NIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR-- 118

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD-TVVETP 727
                 ++Y+H      V+H DLKPSN+L++ D    +GDFG+A+ L + P +     T 
Sbjct: 119 -----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 728 SSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             +     T  Y APE   +  E +   D++S G +  EM  RR
Sbjct: 171 YVA-----TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 21/214 (9%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+G FG V    +   G L A K LN   L ++   +  + E   L  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +  F       +V   M  G L    H  N   E       +       + S +E+L
Sbjct: 59  ---AYAFQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +++ DLKP NVLLD+D    + D GLA  L         +  S + G  GT G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--------KDGQSKTKGYAGTPG 162

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           ++APE   G E   + D ++ G+ L EM + R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)

Query: 562 VGQGSFGTVFKGIIGENGML--VAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG+V +G + ++  +  VAVK + +    +  ++ FL+E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 618 TIC-SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL-IQTL-NIAIDVASA 674
            +C  +++  G     ++  FM++G L  +L  +  +L  C   L  Q L     D+AS 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS--RLGDCPQYLPTQMLVKFMTDIASG 124

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG-- 732
           +EYL        +H DL   N +L+ +M   V DFGL+K         +        G  
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK--------KIYNGDYYRQGRI 173

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
            K  V +IA E       +   DV+SFG+ + E+ +R
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F+    +G GSFG V+         +VA+K ++   K + + +   + E   L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI--- 669
                    +I++ G   +    +      +E  L   +D LEV    L Q + IA    
Sbjct: 77  ---------TIEYKGCYLR----EHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICH 122

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
                + YLH H +   +H D+K  N+LL       + DFG A      P ++ V TP  
Sbjct: 123 GALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL--VSPANSFVGTPY- 176

Query: 730 SSGIKGTVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
                    ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 177 ---------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.8 bits (173), Expect = 8e-13
 Identities = 83/313 (26%), Positives = 134/313 (42%), Gaps = 22/313 (7%)

Query: 139 LSNASNLELLELRDNQFIGKMSI--NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
            S+ S L  L+L     I  +    N  +L  L  L L  N L     +++     L   
Sbjct: 63  PSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRL----RSNISE---LLEL 115

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
           + L +L L +N    + P  +  L + +  +D+  N    ++P  L NL +L ++ +  N
Sbjct: 116 TNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
            L   +P  +  L NL +L L+ N +   +P  +  L+ L  L L  NN   ++ SSL N
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLS-NNSIIELLSSLSN 230

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG 376
             +L  L LS NKL     P+ +   +    L+LS+N +S    S +G+L NL +LD+SG
Sbjct: 231 LKNLSGLELSNNKL--EDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSG 286

Query: 377 NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE 436
           N  S  +P        LE   + +   +      L     +   ++ SN      P+ L 
Sbjct: 287 NSLSNALPLIALLLLLLE--LLLNLLLT-LKALELKLNSILLNNNILSNGE-TSSPEALS 342

Query: 437 NLSFLEYLNLSYN 449
            L  L  L    N
Sbjct: 343 ILESLNNLWTLDN 355

Length = 394

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF          ++ +LVAVK L      A K F  E E L +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV-------CNLSLIQTLNIAI 669
             +C        D   +V+++M++G L ++L  +     +         L+  Q L+IA 
Sbjct: 73  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +A+ + YL        VH DL   N L+  +++  +GDFG+++         V  T   
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--------DVYSTDYY 176

Query: 730 SSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G      + ++ PE     + +   DV+S G++L E+F+
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 25/217 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIR---HRNLIKI 616
           +G G++GTV+K     +G  VA+K + +   + G   S + E   L+ +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           + +C++   +      +V++ +    L  +L    DK+    L      ++       ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR-PLDTVVETPSSSSGIKG 735
           +LH +C   +VH DLKP N+L+       + DFGLA+    +  L  VV           
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---------- 169

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 23/228 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL------KSFLTECEALRSI 608
           E++   ++G+G++GTV+ G+  + G L+AVK + L     L      +    E + L+S+
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +H N+++ +  C  +D N +    I  +F+  GS+   L++     E       +     
Sbjct: 60  KHVNIVQYLGTC--LDDNTIS---IFMEFVPGGSISSILNRFGPLPEPVFCKYTK----- 109

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +   + YLH++C   VVH D+K +NV+L  + +  + DFG A+ L    L       +
Sbjct: 110 -QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH--GTHSN 163

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
               + GT  ++APE    S      D++S G  + EM + + P  SM
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT--- 618
           +GQG+ GTV+  I    G  VA+K +NL Q+   +  + E   +R  +H N++  +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +   +         +V +++  GSL        D +    +   Q   +  +   A+E+L
Sbjct: 87  VGDEL--------WVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFL 131

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSGIKGTV 737
           H +    V+H D+K  N+LL  D    + DFG  A+  P +         S  S + GT 
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRSTMVGTP 179

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            ++APE  T        D++S GI+ +EM     P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 560 NMVGQGSFGTVFKGIIGENG--MLVAVKVLN-LMQKGALKSFLTECEALRSI-RHRNLIK 615
           +++G+G+FG V + +I ++G  M  A+K+L     +   + F  E E L  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 616 IITICSSIDFNGVDFKAIVY-------DFMQNGS-LEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++  C +    G  + AI Y       DF++    LE       +      L+  Q L  
Sbjct: 68  LLGACEN---RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A DVA+ ++YL    +   +H DL   NVL+  ++ + + DFGL++        T+   P
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                    V ++A E    S  +   DV+SFG+LL E+ S
Sbjct: 182 ---------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 2e-12
 Identities = 36/90 (40%), Positives = 57/90 (63%), Gaps = 1/90 (1%)

Query: 275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVL 334
           L L++  L G+IP+ +  L  L  + L  N+++G IP SLG+ TSL +L LS N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 335 PPQILSVTTLSLFLNLSDNLLSGSLPSEIG 364
           P  +  +T+L + LNL+ N LSG +P+ +G
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.3 bits (175), Expect = 2e-12
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKS-FLTECEALRSIRHRNLIKII 617
           ++G+G  G V+          VA+K +  +L +   LK  FL E +    + H  ++ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 618 TICSSID--------FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           +ICS  D          G   K+++    Q  SL + L +          S+   L+I  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT--------SVGAFLSIFH 120

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP---LDTVVET 726
            + + IEY+H      V+H DLKP N+LL       + D+G A F        LD  V+ 
Sbjct: 121 KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 727 PSSSSG-------IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +           I GT  Y+APE   G  AS + D+Y+ G++L +M +   P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 23/223 (10%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK---VLNLMQKGALKSFLTECEALRSIRH 610
           + F     +G+G F  V++     +   VA+K   +  +M   A +  + E + L+ + H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL-HQNNDKLEVCNLSLIQTLNIAI 669
            N+IK +   S I+ N ++   IV +    G L + + +    K  +   ++ +     +
Sbjct: 62  PNVIKYLD--SFIEDNELN---IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF---V 113

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            + SA+E++H      V+H D+KP+NV +    V  +GD GL +F  ++         ++
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTA 162

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +  + GT  Y++PE    +  +   D++S G LL EM + + P
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 52/250 (20%)

Query: 561 MVGQGSFGTVF--KGIIGEN-GMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK-- 615
           ++GQGSFG VF  + I G + G L A+KVL   +K  LK      + +R+   R+++   
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVR----DRVRTKMERDILAEV 55

Query: 616 ----IITICSSIDFNGVDFKAIVYDFMQNGSL-----EEWLHQNND-KLEVCNLSLIQTL 665
               I+ +  +    G  +  ++ DF++ G L     +E +    D K  +  L+L    
Sbjct: 56  NHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL---- 109

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
                   A+++LH      +++ DLKP N+LLD +    + DFGL+K      +D   +
Sbjct: 110 --------ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK 154

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
             S      GTV Y+APE       + + D +SFG+L+ EM      T S+  +G    E
Sbjct: 155 AYS----FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML-----TGSLPFQGKDRKE 205

Query: 786 FSKMVLPEKV 795
              M+L  K+
Sbjct: 206 TMTMILKAKL 215

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 30/223 (13%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRH 610
            +      VG G+FG V       +    A+KV+ + +   LK       E   L+ + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             +I++    +  D     F  ++ +++  G L  +L  +         S    L  A +
Sbjct: 61  PFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASE 109

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +  A+EYLH      +V+ DLKP N+LLD +    + DFG AK L  R   T+  TP   
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-TLCGTPE-- 163

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRP 772
                   Y+APE    S+      D ++ GIL+ EM     P
Sbjct: 164 --------YLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+FG        E+  LV  K +NL  + +   +  L E   L  ++H N   II  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +    +      I  ++   G+L + + +   +L          L     + SA+ Y+H
Sbjct: 65  YNHFMDDNTLL--IEMEYANGGTLYDKIVRQKGQL----FEEEMVLWYLFQIVSAVSYIH 118

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVETPSSSSGIKGTV 737
              K  ++H D+K  N+ L    +  +GDFG++K L +     +TVV TP          
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY--------- 166

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            Y++PE   G + +   D+++ G +L E+ + +R
Sbjct: 167 -YMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 51/220 (23%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIK 615
           ++GQG+FG V+     + G  +AVK +         K  + +   E + L++++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 616 ---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
               +    ++        +I  ++M  GS+++ L           L+   T      + 
Sbjct: 69  YYGCLRDDETL--------SIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             +EYLH +    +VH D+K +N+L D      +GDFG +K      L T+  + +    
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICSSGTGMKS 166

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  +++PE  +G       DV+S G  ++EM + + P
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 42/240 (17%)

Query: 555 EFSSSNMV-----GQGSFGTVFK----GIIGEN---GMLVAVKVL--NLMQKGALKSFLT 600
           EF    +V     G+G FG V +    GI        + VAVK+L  N   K  L   ++
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLIS 66

Query: 601 ECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ---------- 649
           E E ++ I +H+N+I ++ +C+     G  +  ++ ++   G+L E+L            
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 650 NNDKLEVCNLSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
           +  K+    LS    ++ A  VA  +EYL    C    +H DL   NVL+  D V  + D
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIAD 177

Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           FGL     AR +  +     +S+G +  V ++APE       +   DV+SFGIL+ E+F+
Sbjct: 178 FGL-----ARGVHDIDYYKKTSNG-RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 44/232 (18%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHR 611
             + + + +G+G++G V        G+ VA+K ++  +      ++ L E + LR  +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-----QN--NDKLEVCNLSLIQT 664
           N+I I+ I     F   +   IV + M     E  L+     Q+  ND        L Q 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDH---IQYFLYQI 115

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L         ++Y+H      V+H DLKPSN+LL+ +    + DFGLA+          +
Sbjct: 116 LR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----------I 155

Query: 725 ETPSSSSGIK-----GTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             P             T  Y APE        +   D++S G +L EM S R
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 37/230 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L +           + +  I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 616 IITICSS---IDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D LE   L   Q   I 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-------DLLEPGPLDETQIATIL 107

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--------TDTQI 156

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ ++  P  S  H
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPHSELH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHR 611
           +EF   N +G+G++G V++     +G +VA+K + +  +  G   S L E   L ++RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++  +      + +        F+     E+ L    D +     S  Q   + + +
Sbjct: 67  NIVELKEVVVGKHLDSI--------FLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQL 117

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLD-TVVETPS 728
              ++YLH +    ++H DLK SN+LL       + DFGLA+   LPA+P+   VV    
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV---- 170

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMF 767
                  T+ Y APE   G     T  D+++ G +L E+ 
Sbjct: 171 -------TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)

Query: 562 VGQGSFGTVFKG-IIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G FG V     IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ----------NNDKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L            N  ++    LS  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +    +D 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 195

Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 196 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 41/246 (16%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT-- 618
           ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIMLSLVSTG 54

Query: 619 -----ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
                +C +  F+  D    + D M  G L   L Q+         S  +    A ++  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIIL 108

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSG 732
            +E++H+     VV+ DLKP+N+LLD      + D GLA  F   +P  +V         
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------- 156

Query: 733 IKGTVGYIAPEY---GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM 789
             GT GY+APE    GT  ++S   D +S G +L ++     P     H+    HE  +M
Sbjct: 157 --GTHGYMAPEVLQKGTAYDSS--ADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRM 210

Query: 790 VLPEKV 795
            L   V
Sbjct: 211 TLTVNV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 8e-12
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRHRNLIKII 617
           +G+GSFG V       +G   AVKVL    +++K   K  + E   L ++++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   D    V D++  G L   L +     E       +    A ++ASA+ Y
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGY 111

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH      +++ DLKP N+LLD      + DFGL K          +E   ++S   GT 
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCGTP 160

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            Y+APE         T D +  G +L EM  
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.9 bits (163), Expect = 8e-12
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 31/229 (13%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG--MLVAVKVL-NLMQKGALKSFLTECEAL-RSIR 609
           ++    +++G+G+FG V K  I ++G  M  A+K +     K   + F  E E L +   
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN-----NDKLEVCN-----L 659
           H N+I ++  C   +  G  + AI  ++  +G+L ++L ++     +    + N     L
Sbjct: 67  HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           S  Q L+ A DVA  ++YL    +   +H DL   N+L+  + VA + DFGL++      
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             T+   P         V ++A E    S  +   DV+S+G+LL E+ S
Sbjct: 179 KKTMGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 36/224 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSS 622
           G G+FG V+K    E G+  A K++ +  +  L+ F+ E + L   +H N++ +      
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY----E 69

Query: 623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE-VCNLSLIQTLNIAIDVASAIEYLHHH 681
             F       I+ +F   G+L+  +     +LE       I+   +   +  A+ +LH H
Sbjct: 70  AYFYENKL-WILIEFCDGGALDSIM----LELERGLTEPQIRY--VCRQMLEALNFLHSH 122

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSSGIKGTV 737
               V+H DLK  N+LL  D    + DFG        L  R  DT + TP          
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPY--------- 168

Query: 738 GYIAPEY---GTGSEASMT--GDVYSFGILLLEMFSRRRPTDSM 776
            ++APE     T  +       D++S GI L+E+     P   +
Sbjct: 169 -WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)

Query: 555 EFSSSNMV-----GQGSFGTVFK----GIIGENG-MLVAVKVL----NLMQKGALKSFLT 600
           EF  +N+      G G+FG V +    G+   +  M VAVK+L    +  ++ AL S L 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
               L +  H N++ ++  C+     G     ++ ++   G L  +L +  +      L+
Sbjct: 91  IMSHLGN--HENIVNLLGACTI---GGPIL--VITEYCCYGDLLNFLRRKRESF----LT 139

Query: 661 LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           L   L+ +  VA  + +L   +C    +H DL   NVLL H  +  + DFGLA+      
Sbjct: 140 LEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR------ 189

Query: 720 LDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            D + +   S+  +KG     V ++APE       +   DV+S+GILL E+FS
Sbjct: 190 -DIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 35/219 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           S   +   +G+GS G V        G  VAVK ++L ++   +    E   +R  +H N 
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN- 77

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             I+ + SS      D   +V +F++ G+L + +           ++  Q   + + V  
Sbjct: 78  --IVEMYSSYLVG--DELWVVMEFLEGGALTDIVTHTR-------MNEEQIATVCLAVLK 126

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A+ +LH      V+H D+K  ++LL  D    + DFG              E P   S +
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA-------QVSKEVPRRKS-L 175

Query: 734 KGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEM 766
            GT  ++APE      YGT  E     D++S GI+++EM
Sbjct: 176 VGTPYWMAPEVISRLPYGT--EV----DIWSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)

Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++GI       E    VA+K +N  +  +++    FL E  
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL---- 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E   +    
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 167

Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 221

Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++G++  +  + V+   +++  D  P +L E+
Sbjct: 222 -YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFEL 253

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G       GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH------QNNDKLEVCNLSLIQTLNI 667
           ++++ + S           +V + M +G L+ +L       +NN       L   + + +
Sbjct: 72  VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQM 124

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET 
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETD 173

Query: 728 SSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
               G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 29/226 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V       +G   A+K+L    ++ K  +   LTE   L++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   D    V +++  G L  + H + +++     S  +T     ++ SA++Y
Sbjct: 61  ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGAEIVSALDY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK--FLPARPLDTVVETPSSSSGIKG 735
           LH      +V+ DLK  N++LD D    + DFGL K     A  + T   TP        
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE------- 160

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
              Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 161 ---YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG+  + ++   VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L +N    E     L+        V+  ++Y
Sbjct: 63  GICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVH------QVSMGMKY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH DL   NVLL     A + DFGL+K L A           + +  K  V
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-----NYYKAKTHGKWPV 162

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 65/237 (27%), Positives = 112/237 (47%), Gaps = 40/237 (16%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRS 607
            +   +F     +G+G++G V+K    + G LVA+K + L   ++G   + + E + LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 608 IRHRNLIKIITICSSIDFNGVDFKA------IVYDFMQN---GSLEEWL-HQNNDKLEVC 657
           + HRN++ +  I +    + +DFK       +V+++M +   G LE  L H + D ++  
Sbjct: 63  LNHRNIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
              L++ LN          Y H   K   +H D+K SN+LL++     + DFGLA+   +
Sbjct: 122 MKQLLEGLN----------YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 718 ---RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
              RP    V           T+ Y  PE   G E      DV+S G +L E+F+++
Sbjct: 169 EESRPYTNKVI----------TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +VG+GS+G V K    E G +VA+K    +   K   K  + E   L+ +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 619 ICSSIDFNGVDFKA---IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +           K    +V++F+ +  L++     N       L   +       +   I
Sbjct: 68  VFRR--------KKRLYLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGI 113

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           E+ H H    ++H D+KP N+L+    V  + DFG A+ L A P +   +  +       
Sbjct: 114 EFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVA------- 162

Query: 736 TVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFS 768
           T  Y APE   G ++     D+++ G L+ EM +
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 24/217 (11%)

Query: 562 VGQGSFGTVFKGIIGENG-MLVAVKVLNLM--QKGALKSFLTECEALR---SIRHRNLIK 615
           +G+G++G VFK    +NG   VA+K + +   ++G   S + E   LR   +  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +C+    +      +V++ +    L  +L    DK+    +      ++   +   +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTETIKDMMFQLLRGL 123

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           ++LH H    VVH DLKP N+L+       + DFGLA+    +   T V           
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--------- 171

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 33/245 (13%)

Query: 556 FSSSNM-----VGQGSFGTVF----KGIIGENG-MLVAVKVLNLM-QKGALKSFLTECEA 604
           F  SN+     +G+G FG VF    KGI  E G  LV VK L     +     F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC---NLSL 661
            R + H+N+++++ +C   + +      ++ ++   G L+++L     K E      LS 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
            Q + +   +A  +++L +      VH DL   N L+       V    L+K       D
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK-------D 166

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
                          + ++APE     + S   DV+SFG+L+ E+F+       +   GL
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----QGELPFYGL 222

Query: 782 TLHEF 786
           +  E 
Sbjct: 223 SDEEV 227

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 28/238 (11%)

Query: 536 MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
           ++E+   ++S     K  + F     +GQG+ GTV+  +    G  VA++ +NL Q+   
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 596 KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           +  + E   +R  ++ N++  +       +   D   +V +++  GSL + +       E
Sbjct: 62  ELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TE 110

Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKF 714
            C +   Q   +  +   A+E+LH +    V+H D+K  N+LL  D    + DFG  A+ 
Sbjct: 111 TC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            P +         S  S + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 167 TPEQ---------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 66/250 (26%), Positives = 111/250 (44%), Gaps = 42/250 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E G+L A KV++   +  L+ ++ E + L S  H N++K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLH 679
              F   +   I+ +F   G+++  + +    L    + ++  QTL        A+ YLH
Sbjct: 71  ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-------ALNYLH 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
            +    ++H DLK  N+L   D    + DFG++    A+   T+    S      GT  +
Sbjct: 121 EN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDS----FIGTPYW 169

Query: 740 IAPEYGTGSEAS------MTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           +APE     E S         DV+S GI L+EM     P           HE + M +  
Sbjct: 170 MAPEV-VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH----------HELNPMRVLL 218

Query: 794 KVMEIVDPSL 803
           K+ +   P+L
Sbjct: 219 KIAKSEPPTL 228

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)

Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+FG V KG+  + +  + VA+KVL N  +K      + E E +  + +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C +          +V +    G L ++L    D++ V N+  +        V+  ++YL
Sbjct: 63  VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-----QVSMGMKYL 111

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   VH DL   NVLL +   A + DFGL+K L A   D+  +   + S  K  + 
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD--DSYYK---ARSAGKWPLK 163

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           + APE     + S   DV+S+GI + E FS
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 5e-11
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 28/238 (11%)

Query: 536 MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
           ++E+   ++S     K  + F     +GQG+ GTV+  I    G  VA+K +NL Q+   
Sbjct: 4   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 596 KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           +  + E   +R  ++ N++  +       +   D   +V +++  GSL + +       E
Sbjct: 61  ELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TE 109

Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKF 714
            C +   Q   +  +   A+++LH +    V+H D+K  N+LL  D    + DFG  A+ 
Sbjct: 110 TC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            P +         S  S + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 166 TPEQ---------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GSFG V    + E+G L AVKVL    ++Q   ++  +TE   L   R+   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN--DKLEVCNLSLIQTLNIAIDVASAI 675
             C    F   D    V +F+  G L   + ++   D+              A ++ SA+
Sbjct: 62  YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--------AAEITSAL 109

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            +LH      +++ DLK  NVLLDH+    + DFG+ K          +    ++S   G
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGIFNGKTTSTFCG 158

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  YIAPE         + D ++ G+LL EM     P
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 82

Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +N     D   +V +F++ G+L + +       E       Q   + + V  A+  L
Sbjct: 83  ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVL 132

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      V+H D+K  ++LL HD    + DFG    +         E P   S + GT  
Sbjct: 133 HAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-------EVPRRKS-LVGTPY 181

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           ++APE  +        D++S GI+++EM     P
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 37/230 (16%)

Query: 561 MVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK- 615
           ++G G FG + +G +    +  + VA+  L         + FL E   L    H N+++ 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 616 --IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             +IT  +++         IV ++M NG+L+ +L ++  +L        Q + +   +AS
Sbjct: 72  EGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQL-----VAGQLMGMLPGLAS 118

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            ++YL    +   VH  L    VL++ D+V  +  F        R  +   E   ++   
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSG 168

Query: 734 KGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHE 779
           K  V + APE   Y   S AS   DV+SFGI++ E+ S   RP   M  +
Sbjct: 169 KSPVLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMSYGERPYWDMSGQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 28/219 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GSFG V    +     L AVKVL    ++Q   ++  +TE   L        +  +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
             C    F   D    V +++  G L   + ++            +    A ++   +++
Sbjct: 62  HSC----FQTKDRLFFVMEYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQF 111

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK--FLPARPLDTVVETPSSSSGIKG 735
           LH      +++ DLK  NVLLD +    + DFG+ K   L      T   TP        
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD------- 161

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
              YIAPE  +        D ++ G+LL EM + + P +
Sbjct: 162 ---YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 32/218 (14%)

Query: 562 VGQGSFGTVFKGIIGENGM-LVAVKVLNL----MQKGA------LKSFLTECEALR-SIR 609
           +G G+FG V+K     NG  L+A+K +N+      K        +   ++E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N+++         F   D   IV D ++   L E  H N+ K +    +  +  NI +
Sbjct: 68  HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-PARPLDTVVETPS 728
            +  A+ YLH   +  +VH DL P+N++L  D    + DFGLAK   P   L +VV    
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---- 174

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                 GT+ Y  PE           DV++FG +L +M
Sbjct: 175 ------GTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 37/244 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT-- 618
           ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIMLSLVSTG 54

Query: 619 -----ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
                +C S  F+  D  + + D M  G L   L Q+         S  +    A ++  
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIIL 108

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSG 732
            +E++H+     VV+ DLKP+N+LLD      + D GLA  F   +P  +V         
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------- 156

Query: 733 IKGTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
             GT GY+APE    G     + D +S G +L ++     P     H+    HE  +M L
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTL 212

Query: 792 PEKV 795
              V
Sbjct: 213 TMAV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.6 bits (154), Expect = 7e-11
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 560 NMVGQGSFGTVFKGIIGENG--MLVAVKVLN-LMQKGALKSFLTECEALRSI-RHRNLIK 615
           +++G+G+FG V K  I ++G  M  A+K +     K   + F  E E L  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 616 IITICSSIDFNGVDFKAIVY-------DFMQNGS-LEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++  C      G  + AI Y       DF++    LE              LS  Q L+ 
Sbjct: 61  LLGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A DVA  ++YL    +   +H DL   N+L+  + VA + DFGL++        T+   P
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                    V ++A E    S  +   DV+S+G+LL E+ S
Sbjct: 175 ---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 63.6 bits (154), Expect = 9e-11
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +++    +GQG+ GTVF  I    G  VA+K +NL ++   +  + E   ++ +++ N++
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
             +       F   D   +V +++  GSL + +       E C +   Q   +  +   A
Sbjct: 80  NFLD-----SFLVGDELFVVMEYLAGGSLTDVV------TETC-MDEAQIAAVCRECLQA 127

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSGI 733
           +E+LH +    V+H D+K  NVLL  D    + DFG  A+  P +         S  S +
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ---------SKRSTM 175

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 40/228 (17%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRN 612
           F    ++G+G FG V    +   G + A K L    + ++      L E + L  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 613 LIKIITICSSID--------FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           ++ +     + D         NG D K  +Y+    G  EE                 + 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-----------------RA 104

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L  A ++   +E LH   +   V+ DLKP N+LLD      + D GLA  +P        
Sbjct: 105 LFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-------- 153

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               S  G  GTVGY+APE       +++ D +  G L+ EM   + P
Sbjct: 154 -EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 37/249 (14%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L +           + +  I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 616 IITICSS---IDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D L        Q   + 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL-------DLLRAGPFDEFQIATML 107

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 108 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--------TDTQI 156

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
             +   GT  ++APE    S      D++S GI  +E+ ++  P +S  H    L    K
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL-AKGEPPNSDMHPMRVLFLIPK 215

Query: 789 MVLPEKVME 797
              P    E
Sbjct: 216 NNPPTLTGE 224

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 72/310 (23%), Positives = 132/310 (42%), Gaps = 59/310 (19%)

Query: 562 VGQGSFGTVFKGIIGENGM----LVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+ +FG ++KG +   GM    LVA+K L ++        F  E   +  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWL-----------HQNNDKLEVCNLSLIQTL 665
           + + +           ++++++  G L E+L             + D     +L     L
Sbjct: 73  LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           +IAI +A+ +EYL  H     VH DL   N+L+   +   + D GL++ + +   D    
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA--DYYRV 182

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT-LH 784
            P S   I+    ++ PE     + S   D++SFG++L E+FS           GL   +
Sbjct: 183 QPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF----------GLQPYY 228

Query: 785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            FS     ++V+E+V    LL                 E+C   +  +   C  E P+ R
Sbjct: 229 GFSN----QEVIEMVRKRQLLPCS--------------EDCPPRMYSLMTECWQEGPSRR 270

Query: 845 MQMRDVVVKL 854
            + +D+  +L
Sbjct: 271 PRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 63/248 (25%)

Query: 555 EFSSSN---MVGQGSFGTVFKGIIGENGMLVAVK---------VLNLMQKGALKSFLTEC 602
           E+  +    ++G+G++G V+        + +A+K         V  L ++ AL S+L   
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL--- 62

Query: 603 EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN----NDKLEVCN 658
                 +HRN+++ +   S   F    FK I  + +  GSL   L        D  +   
Sbjct: 63  ------KHRNIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTII 111

Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPA 717
               Q L         ++YLH +    +VH D+K  NVL++ +  V  + DFG +K L  
Sbjct: 112 FYTKQIL-------EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEY------GTGSEASMTGDVYSFGILLLEMFSRRR 771
             ++   ET        GT+ Y+APE       G G+ A    D++S G  ++EM + + 
Sbjct: 162 --INPCTET------FTGTLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKP 209

Query: 772 PTDSMFHE 779
           P    F E
Sbjct: 210 P----FIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 21/164 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC- 620
           +G GS G VF  +  +    VAVK + L    ++K  L E + +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 621 -SSIDFNG-------VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            S  D          ++   IV ++M+   L   L Q     E   L + Q L       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFL 715
             ++Y+H      V+H DLKP+NV ++  D+V  +GDFGLA+ +
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 59/245 (24%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITIC 620
           +G+G++G V+K    + G LVA+K+++++ +   +    E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNI------- 65

Query: 621 SSIDFNGVDFKA----------IVYDFMQNGS---LEEWLHQNNDKLEVCNLSLI--QTL 665
               F G   K           +V +    GS   L + L +   +L+   ++ I  +TL
Sbjct: 66  --ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLAKFLPARPLDTV 723
                    + YLH +    V+H D+K  N+LL  +  A V   DFG+     +  LD+ 
Sbjct: 124 R-------GLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGV-----SAQLDST 166

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEA-----SMTGDVYSFGILLLEM------FSRRRP 772
           +   ++     GT  ++APE     E          DV+S GI  +E+           P
Sbjct: 167 LGRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223

Query: 773 TDSMF 777
             ++F
Sbjct: 224 MRALF 228

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 58/232 (25%), Positives = 111/232 (47%), Gaps = 49/232 (21%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG---ALKSFLTECEALRSIRHR 611
           E+   N + +G++G V++    + G +VA+K L + ++     + S L E   L  ++H 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKLQHP 64

Query: 612 NLIKI--ITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNI 667
           N++ +  + + S      +D   +V +++++   SL E + Q   + EV  L ++Q L  
Sbjct: 65  NIVTVKEVVVGS-----NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQLL-- 116

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVE 725
                S + +LH +    ++H DLK SN+LL++  +  + DFGLA+    P +P   +V 
Sbjct: 117 -----SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168

Query: 726 TPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
                     T+ Y APE       Y T        D++S G +  E+ +++
Sbjct: 169 ----------TLWYRAPELLLGAKEYSTAI------DMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 35/239 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   D    V ++   G L  + H + +++     +  +      ++ SA+EY
Sbjct: 61  ----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSALEY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK--- 734
           LH      VV+ D+K  N++LD D    + DFGL K           E  S  + +K   
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFC 156

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L    F  +++ E
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEE 211

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 40/250 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E G L A KV+    +  L+ ++ E E L +  H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLH 679
           +  ++G  +  I+ +F   G+++  + + +  L    + +I  Q L        A++YLH
Sbjct: 77  AFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-------EALQYLH 127

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                 ++H DLK  NVLL  D    + DFG++    A+ + T+    S      GT  +
Sbjct: 128 ---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDS----FIGTPYW 176

Query: 740 IAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
           +APE         +      D++S GI L+EM     P           HE + M +  K
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNPMRVLLK 226

Query: 795 VMEIVDPSLL 804
           + +   P+L 
Sbjct: 227 IAKSEPPTLS 236

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 40/228 (17%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRN 612
           F    ++G+G FG V    +   G + A K L    + ++      L E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 613 LIKIITICSSID--------FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           ++ +     + D         NG D K  +Y   + G  E                  + 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----------------RA 104

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           +  A ++   +E LH   +  +V+ DLKP N+LLD      + D GLA  +P        
Sbjct: 105 VFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-------- 153

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               +  G  GTVGY+APE       + + D ++ G LL EM + + P
Sbjct: 154 -EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 38/238 (15%)

Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGE---NGMLVAVKVL-NLMQKGALKSFLTE 601
           E S + +     +G+G FG V      GI  +     + VAVK+L +      L   ++E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 602 CEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN-----NDKLE 655
            E ++ I +H+N+I ++  C+    +G  +  ++ ++   G+L E+L        +   +
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQ---DGPLY--VLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 656 VC-----NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
            C      L+    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           LA+      +D   +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 180 LAR--DVHNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 25/224 (11%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   D    V ++   G L  + H + +++     S  +      ++ SA+ Y
Sbjct: 61  ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSALGY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH  C   VV+ DLK  N++LD D    + DFGL K          +   ++     GT 
Sbjct: 111 LHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTP 159

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
            Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           ++G+GSFG V       +G   AVKVL    +++K      + E   L ++++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                   F   +    V D++  G L  + H   ++   C L   +    A +VASAI 
Sbjct: 62  -----HYSFQTAEKLYFVLDYVNGGEL--FFHLQRER---CFLE-PRARFYAAEVASAIG 110

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH      +++ DLKP N+LLD      + DFGL K          VE   ++S   GT
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             Y+APE         T D +  G +L EM 
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 3/94 (3%)

Query: 199 LENLGLYDNQ-FGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQ 257
           ++ LGL DNQ   G +P+ ++ L + + +I++ GN   G IPP LG++  L  + +  N 
Sbjct: 420 IDGLGL-DNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477

Query: 258 LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLG 291
             G++P  +G L +L+ L LN N L G +P++LG
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 70/236 (29%), Positives = 100/236 (42%), Gaps = 40/236 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+G  G VF   +   G L A+KVL+   ++++  +K  LTE E L ++ H     + T+
Sbjct: 10  GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPTL 66

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +S       +  +V D+   G L   L +   K     LS       A +V  A+EYLH
Sbjct: 67  YASFQTE--TYLCLVMDYCPGGELFRLLQRQPGKC----LSEEVARFYAAEVLLALEYLH 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARP------------------ 719
                 +V+ DLKP N+LL      H+   DF L+K     P                  
Sbjct: 121 --LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 720 --LDTVVETPSS-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              +T  E PS  S+   GT  YIAPE  +G       D ++ GILL EM     P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 562 VGQGSFGTVFKGII--GENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKII 617
           +G G FG V  G +  G     V VK L  +     +   FL E +  RS++H NL++ +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             C+      V    +V +F   G L+ +L      +L   + + +Q +  A ++A  + 
Sbjct: 62  GQCTE-----VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLL 114

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
           +LH +     +H DL   N LL  D+   +GD+GL+
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 38/226 (16%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECE 603
           SY KL K          +G+GS+ TV+KG    NG LVA+KV+ L  ++G   + + E  
Sbjct: 6   SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEE-WLHQNNDKLEVCNLSLI 662
            L+ ++H N++ +  I  + +   + F+ +  D  Q        LH  N K     L L 
Sbjct: 56  LLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-----LFLF 110

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           Q L         + Y+H      ++H DLKP N+L+       + DFGLA+         
Sbjct: 111 QLLR-------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--------- 151

Query: 723 VVETPSSS-SGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEM 766
               PS + S    T+ Y  P+   GS E S   D++  G + +EM
Sbjct: 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 29/199 (14%)

Query: 581 LVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQ 639
           LVAVK+L   + K A   FL E + +  +++ N+I+++ +C S      D   ++ ++M+
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYME 100

Query: 640 NGSLEEWLHQNN--DKLEVCN----LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP 693
           NG L ++L Q          N    +S+   L +A+ +AS ++YL        VH DL  
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157

Query: 694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG----TVGYIAPEYGTGSE 749
            N L+ +     + DFG+++ L +               I+G     + ++A E     +
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYS----------GDYYRIQGRAVLPIRWMAWESILLGK 207

Query: 750 ASMTGDVYSFGILLLEMFS 768
            +   DV++FG+ L EMF+
Sbjct: 208 FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 15/113 (13%)

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           IA+ +  A+EYLH      V+H D+KPSNVL++ +    + DFG++ +L    +D+V +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKT 161

Query: 727 PSSSSGIKGTVGYIAPEY----GTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             +     G   Y+APE            +  DV+S GI ++E+ + R P DS
Sbjct: 162 IDA-----GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 24/224 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   D    V ++   G L  + H + +++     S  +      ++ SA++Y
Sbjct: 61  ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSALDY 110

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++     GT 
Sbjct: 111 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTFCGTP 160

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
            Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK----SFLTECEALRSIRHRNLIKII 617
           +G G FG V  G     GM  A  V+  ++  A       FL E +  R + H N+++ +
Sbjct: 3   IGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 618 TIC-SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             C  SI +       +V +F   G L+ +L  N   +       +    +A +VAS + 
Sbjct: 62  GQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-QRMACEVASGLL 114

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           +LH   +   +H DL   N  L  D+   +GD+GLA  L   P D  +     +  ++  
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR-- 167

Query: 737 VGYIAPEYGTG-------SEASMTGDVYSFGILLLEMFS 768
             ++APE            + +   +++S G+ + E+F+
Sbjct: 168 --WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 30/208 (14%)

Query: 581 LVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQ 639
           LVAVKVL       A + FL E + L  +   N+ +++ +C+           ++ ++M+
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYME 102

Query: 640 NGSLEEWL--HQNNDKLEVCNLSLI--QTL-NIAIDVASAIEYLHHHCKPPVVHGDLKPS 694
           NG L ++L  H        CN   +   TL  +A  +AS + YL        VH DL   
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159

Query: 695 NVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEA 750
           N L+  +    + DFG+++ L +          S    ++G     + ++A E     + 
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYS----------SDYYRVQGRAPLPIRWMAWESVLLGKF 209

Query: 751 SMTGDVYSFGILLLEMFS--RRRPTDSM 776
           +   DV++FG+ L E+ +  R +P + +
Sbjct: 210 TTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 43/221 (19%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNLIKIIT 618
            ++G G+ GTV+K        ++AVKV+ L     L K  ++E E            I+ 
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE------------ILY 54

Query: 619 ICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            C S   I F G  F     +I  +FM  GSL+ +       L            IA+ V
Sbjct: 55  KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAV 104

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL       ++H D+KPSN+L++      + DFG++  L      T V       
Sbjct: 105 VKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------- 154

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              GT  Y+APE  +G +  +  DV+S GI  +E+   R P
Sbjct: 155 ---GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.6 bits (149), Expect = 6e-10
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           ++G+GSFG V            AVKVL    +++K   K  ++E   L ++++H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                   F   D    V D++  G L   L +    LE       +    A ++ASA+ 
Sbjct: 62  -----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALG 110

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH      +V+ DLKP N+LLD      + DFGL K          +E   ++S   GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNGTTSTFCGT 159

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             Y+APE         T D +  G +L EM 
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 37/230 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG V+KGI      +VA+K+++L +           + +  I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 616 IITICSS---IDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D L+   L       I 
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL-------DLLKPGPLEETYIATIL 107

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 108 REILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--------TDTQI 156

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ ++  P +S  H
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL-AKGEPPNSDLH 205

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKIITI 619
           VG+GS+G V       +G    +K LNL      +    E EA  L  ++H N   I+  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64

Query: 620 CSSIDFNGVD-FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
             S  + G D    IV  F + G L   L +   KL    L   Q +   + +A A++YL
Sbjct: 65  RES--WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H   +  ++H DLK  NV L    +  VGD G+A+ L  +           +S + GT  
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--------CDMASTLIGTPY 167

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEM 766
           Y++PE  +    +   DV++ G  + EM
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 50/238 (21%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTE 601
           + +Y KL K          +G+GS+ TV+KG     G LVA+K + L   +GA  + + E
Sbjct: 4   LETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE 53

Query: 602 CEALRSIRHRNLI---KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
              L+ ++H N++    II    ++          V++++    L++++      L + N
Sbjct: 54  ASLLKDLKHANIVTLHDIIHTKKTLTL--------VFEYLDT-DLKQYMDDCGGGLSMHN 104

Query: 659 --LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL--AKF 714
             L L Q L         + Y H      V+H DLKP N+L+       + DFGL  AK 
Sbjct: 105 VRLFLFQLLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154

Query: 715 LPARPL-DTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
           +P++   + VV           T+ Y  P+   GS E S + D++  G +  EM + R
Sbjct: 155 VPSKTYSNEVV-----------TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 38/224 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRNLIKIIT 618
           +G GSFG V+         +VAVK ++   K      +  + E + L+ ++H N      
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE-- 676
              +I++ G   K    +      +E  L   +D LEV    L Q + IA     A++  
Sbjct: 83  ---TIEYKGCYLK----EHTAWLVMEYCLGSASDLLEVHKKPL-QEVEIAAITHGALQGL 134

Query: 677 -YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YLH H     +H D+K  N+LL       + DFG A    + P ++ V TP        
Sbjct: 135 AYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK--SSPANSFVGTPY------- 182

Query: 736 TVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
              ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 183 ---WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 57/253 (22%), Positives = 111/253 (43%), Gaps = 32/253 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V    I  +  +  V V  L    + K    FL + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 619 IC-SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            C  +I +       +V+++ + G L+ +L Q         L L+Q +  A ++A+ + +
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           +H H     +H DL   N  L  D+   VGD+G+    P+R  +  +ET          +
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKC---VPL 165

Query: 738 GYIAPEYGT-------GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
            ++APE           +E +   +V++ G+ L E+F       S   +   L+     V
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH----V 221

Query: 791 LPEKVMEIVDPSL 803
           + ++ +++  P L
Sbjct: 222 IKDQQVKLFKPQL 234

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 45/236 (19%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTEC 602
            Y KL K          +G+G++GTVFK    E   +VA+K + L    +G   S L E 
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 603 EALRSIRHRNLIKIITICSSIDFNGVDFK-AIVYDFMQNGSLEEWLHQNNDKLE--VCNL 659
             L+ ++H+N++++  +  S      D K  +V+++     L+++    N  ++  +   
Sbjct: 51  CLLKELKHKNIVRLYDVLHS------DKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKS 103

Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPA 717
            + Q L         + + H H    V+H DLKP N+L++ +    + DFGLA+   +P 
Sbjct: 104 FMFQLLK-------GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRP 772
           R            S    T+ Y  P+   G++   T  D++S G +  E+ +  RP
Sbjct: 154 R----------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.8 bits (148), Expect = 9e-10
 Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 51/227 (22%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+G++G V      E    VA+K +      +  A ++ L E + LR + H N+I I  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71

Query: 619 ICSSID---FNGVDFKAIVYDFMQNGSLEEWLHQ---NNDKL--EVCNLSLIQTLNIAID 670
           I        FN V    IVY+ M        LHQ   ++  L  + C   L Q L     
Sbjct: 72  IMPPPHREAFNDV---YIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR---- 119

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
               ++Y+H      V+H DLKPSN+LL+ +    + DFGLA+        T  E     
Sbjct: 120 ---GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFM 165

Query: 731 SGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
           +    T  Y APE       Y T        DV+S G +  E+  R+
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAI------DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 30/223 (13%)

Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRS-IRHRNLIK 615
           +G+  FG V+KG +     GE    VA+K L    +G L+        +RS ++H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWL----------HQNNDKLEVCNLSLIQTL 665
           ++ + +          ++++ +  +  L E+L            ++DK     L     +
Sbjct: 73  LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           +I   +A+ +E+L  H    VVH DL   NVL+   +   + D GL  F      D    
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADYYKL 182

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +S   I+    +++PE     + S+  D++S+G++L E+FS
Sbjct: 183 MGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 40/239 (16%)

Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGEN---GMLVAVKVL--NLMQKGALKSFLT 600
           EFS   +     +G+G FG V      GI  +     + VAVK+L  +  +K  L   ++
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVS 69

Query: 601 ECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-------- 651
           E E ++ I +H+N+I ++  C+    +G  +  ++ ++   G+L E+L            
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 652 --DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF 709
              ++    ++    ++    VA  +EYL        +H DL   NVL+  + V  + DF
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 181

Query: 710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           GL     AR ++ +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 182 GL-----ARDVNNIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 43/246 (17%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLT 600
           M  Y K+ K           G+G++G V+K         +A+K + L Q+  G   + + 
Sbjct: 1   MDQYEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR 50

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNL 659
           E   L+ ++H N++++  +  S      + +  +V++++    L+   H ++      N 
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHS------EKRLYLVFEYL---DLDLKKHMDSSPDFAKNP 101

Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA-HVGDFGLAKF--LP 716
            LI+T    I     I Y H H    V+H DLKP N+L+D    A  + DFGLA+   +P
Sbjct: 102 RLIKTYLYQI--LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156

Query: 717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PT 773
            R     V           T+ Y APE   GS    T  D++S G +  EM +++   P 
Sbjct: 157 VRTFTHEVV----------TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206

Query: 774 DSMFHE 779
           DS   E
Sbjct: 207 DSEIDE 212

Length = 294

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 28/218 (12%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F     VGQG +G VF     + G +VA+K +    L +   ++  LTE + L + + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K++       F   ++  +  +++  G     L+          LS         +
Sbjct: 61  EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAE 109

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +  A++ LH   +   +H DLKP N L+D      + DFGL+K              + +
Sbjct: 110 MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----------GIVTYA 155

Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           + + G+  Y+APE   G     T D +S G +L E   
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 2e-09
 Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 42/240 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F    ++G+G+FG V+     + G + A+KVL    ++++  +     E + L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             ++K+    S   F   +   +V ++M  G L   L     + +V      +   IA +
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFY-IA-E 109

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAK--------------- 713
           +  A++ +H   K   +H D+KP N+L+D D   H+   DFGL K               
Sbjct: 110 LVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 714 -FLPARPLDTVVETPSS-----SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             L  R    V           ++   GT  YIAPE   G+   +  D +S G++L EM 
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++        + IR    +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--------QIIRE---L 54

Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 107

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 108 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 155

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 46/182 (25%)

Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL------NLMQKGALKSFL 599
           Y KLSK          +G+GS+G VFK    E G +VA+K         +++K AL+   
Sbjct: 3   YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR--- 49

Query: 600 TECEALRSIRHRNLIKIITICSSIDFNGVDFKA-----IVYDFMQNGSLEEWLHQNNDKL 654
            E   L+ ++H NL+ +I +          F+      +V+++  +  L E L +N   +
Sbjct: 50  -EIRMLKQLKHPNLVNLIEV----------FRRKRKLHLVFEYCDHTVLNE-LEKNPRGV 97

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
                       I      A+ + H H+C    +H D+KP N+L+       + DFG A+
Sbjct: 98  PE-----HLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFAR 148

Query: 714 FL 715
            L
Sbjct: 149 IL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 3e-09
 Identities = 30/88 (34%), Positives = 46/88 (52%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
           ++ L L    L G +P  I  L  LQ I++ GN + G IP +LG +  L  L++  N F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLP 111
           G IP S+  ++S   + L  N   G +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 38/230 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRN 612
           FS    +G GSFG V+      N  +VA+K ++   K +    +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                    +I + G   +      +    +E  L   +D LEV    L Q + IA    
Sbjct: 77  ---------TIQYRGCYLREHTAWLV----MEYCLGSASDLLEVHKKPL-QEVEIAAVTH 122

Query: 673 SAIE---YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            A++   YLH H    ++H D+K  N+LL    +  +GDFG A  +   P +  V TP  
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--PANXFVGTPY- 176

Query: 730 SSGIKGTVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
                    ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 177 ---------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 47/223 (21%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V       +G  VAVK+++L ++   +    E   +R  +H+N++++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM----- 83

Query: 622 SIDFNGVDFKA--------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
                   +K+        ++ +F+Q G+L + + Q         L+  Q   +   V  
Sbjct: 84  --------YKSYLVGEELWVLMEFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQ 128

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSS 729
           A+ YLH      V+H D+K  ++LL  D    + DFG    ++K +P R           
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR----------- 174

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              + GT  ++APE  + +      D++S GI+++EM     P
Sbjct: 175 -KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---FLTECEA--LRSIRHRNLIK 615
           ++GQG+FG V+     + G  +A K +    +    S      ECE   L++++H    +
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           I+     +         I  ++M  GS+++ L       E        T      +   +
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV------TRKYTRQILEGM 119

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YLH +    +VH D+K +N+L D      +GDFG +K      L T+  + +    + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVTG 171

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  +++PE  +G       DV+S G  ++EM + + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 23/211 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V        G  VAVK ++L ++   +    E   +R   H N++ +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              +   D   +V +F++ G+L + +       E       Q   + + V  A+ YLH+ 
Sbjct: 87  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
               V+H D+K  ++LL  D    + DFG    +         E P   S + GT  ++A
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-------EVPKRKS-LVGTPYWMA 186

Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           PE  +        D++S GI+++EM     P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 47/237 (19%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRN 612
           +++    +G+G++G V+KG   + G +VA+K + L   ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 613 LIKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           ++ +  +           +F  +D K  +    +   ++          E+    L Q L
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD---------AELVKSYLYQIL 111

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLD-T 722
                    I + H      V+H DLKP N+L+D+  V  + DFGLA+   +P R     
Sbjct: 112 Q-------GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE 161

Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFH 778
           VV           T+ Y APE   GS   S   D++S G +  EM +++     +FH
Sbjct: 162 VV-----------TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK----PLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 44/239 (18%)

Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECE 603
           Y K+ K          +G+G++G V+K      G +VA+K + L    +G   + + E  
Sbjct: 1   YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS 50

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
            L+ + H N+++++ +  S      + K  +V++F+    L+   + ++  L   +  LI
Sbjct: 51  LLKELNHPNIVRLLDVVHS------ENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLI 101

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-F-LPARPL 720
           ++    +     I Y H H    V+H DLKP N+L+D +    + DFGLA+ F +P R  
Sbjct: 102 KSYLYQL--LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156

Query: 721 D-TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
              VV           T+ Y APE   GS    T  D++S G +  EM +RR   P DS
Sbjct: 157 THEVV-----------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 16/116 (13%)

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A ++   +++LH   K  +++ DLK  NVLLD D    + DFG+ K       +   E  
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGK 152

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFH 778
           +S+    GT  YIAPE   G + + + D +SFG+LL EM   + P      D +F 
Sbjct: 153 AST--FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 11/107 (10%)

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A ++  A+ +LH      +++ DLK  NVLLD D    + D+G+ K     P DT     
Sbjct: 102 AAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDT----- 152

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G E   + D ++ G+L+ EM + R P D
Sbjct: 153 --TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 11/107 (10%)

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +++ A+ +LH      +++ DLK  NVLLD +    + D+G+ K    RP DT     
Sbjct: 102 SAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDT----- 152

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 57.2 bits (139), Expect = 7e-09
 Identities = 55/215 (25%), Positives = 81/215 (37%), Gaps = 42/215 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G FG V    +       A+K +    +++ G  +   +E E L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 619 ICSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
             +  D      K  +Y   ++   G L   L                       V  A 
Sbjct: 60  -RTFKD------KKYIYMLMEYCLGGELWTILRDRG------LFDEYTARFYIACVVLAF 106

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK- 734
           EYLH+     +++ DLKP N+LLD +    + DFG AK L               SG K 
Sbjct: 107 EYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--------------KSGQKT 149

Query: 735 ----GTVGYIAPEYGTGSEASMTGDVYSFGILLLE 765
               GT  Y+APE         + D +S GILL E
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYE 184

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 33/214 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G+FG V++    +   + A+KVL      + K  + + E   +I  RN++    +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 622 SIDFNGVDFK-------AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           S    G+ F         +V D+M  G L  W  Q   +             IA ++  A
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDRAKFY----IA-ELVLA 108

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +E+LH +    +V+ DLKP N+LLD      + DFGL+K       +    T        
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNT------FC 157

Query: 735 GTVGYIAPEYGTGSEASMTG--DVYSFGILLLEM 766
           GT  Y+APE     E   T   D +S G+L+ EM
Sbjct: 158 GTTEYLAPEV-LLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 32/223 (14%)

Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECE 603
           Y K+ K          +G+GSFG        E+G    +K +N+  M     +    E  
Sbjct: 2   YVKVKK----------IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA 51

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            L +++H N   I+    S + NG  +  IV D+ + G L + ++     L        Q
Sbjct: 52  VLSNMKHPN---IVQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVL----FPEDQ 102

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L+  + +  A++++H      ++H D+K  N+ L  D    +GDFG+     AR L++ 
Sbjct: 103 ILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI-----ARVLNST 154

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           VE   +     GT  Y++PE       +   D+++ G +L EM
Sbjct: 155 VELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 57/257 (22%), Positives = 93/257 (36%), Gaps = 55/257 (21%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           + +G+FG+V+       G   A+KVL   +++ K  + +   E    R+I          
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL---------NIAI 669
                 F   D+  +V +++  G                  SLI+TL             
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           +V   +E LH   +  ++H D+KP N+L+D      + DFGL++                
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR---------NGLENKK 152

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM 789
                GT  Y+APE   G       D +S G ++ E      P    FH       F  +
Sbjct: 153 ---FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP----FHAETPDAVFDNI 205

Query: 790 V-----LPEKVMEIVDP 801
           +      PE+V E   P
Sbjct: 206 LSRRINWPEEVKEFCSP 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 52/238 (21%)

Query: 562 VGQGSFGTVFKG----IIGENGML-VAVKVLNLMQKGA----LKSFLTECEALRSIRHRN 612
           +G+G FG V K     + G  G   VAVK+L   ++ A    L+  L+E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN--------------------ND 652
           +IK+   CS    +G     ++ ++ + GSL  +L ++                    N 
Sbjct: 65  VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 653 KLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
                 +  +  ++ A  ++  ++YL    +  +VH DL   NVL+       + DFGL+
Sbjct: 120 DERALTMGDL--ISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 713 KFLPARPLDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +         V E  S     KG   V ++A E       +   DV+SFG+LL E+ +
Sbjct: 175 R--------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 60/227 (26%), Positives = 88/227 (38%), Gaps = 38/227 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F    ++G+G FG V    +   G + A K L   +K  +K    E  AL   R    + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58

Query: 616 IITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
              + S +  +   D   +V   M  G L         K  + N+      N   D   A
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDL---------KFHIYNMG-----NPGFDEQRA 104

Query: 675 IEYLHHHC-------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           I Y    C       +  +V+ DLKP N+LLD      + D GLA           V+ P
Sbjct: 105 IFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA-----------VQIP 153

Query: 728 SSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              +  G  GTVGY+APE     + + + D +  G L+ EM   + P
Sbjct: 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 9e-09
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           +HH     ++H D+K +N+LL  + +  +GDFG +K   A   D V  T        GT 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
            Y+APE       S   D++S G+LL E+ + +RP D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 63/189 (33%), Positives = 85/189 (44%), Gaps = 7/189 (3%)

Query: 286 IPSSLGNLTMLTLLA--LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT 343
                 NL  L  L       N      S L   T+L  L L  N +  + P   L  + 
Sbjct: 82  SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN 141

Query: 344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           L   L+LSDN +  SLPS + NL NL  LD+S N  S D+P  LS  ++L  + +  N  
Sbjct: 142 LKE-LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
           S  +PP +  L +++ LDLS+N +  ++   L NL  L  L LS N  E      G  SN
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256

Query: 464 KTRFSLSGN 472
                LS N
Sbjct: 257 LETLDLSNN 265

Length = 394

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALR-SIRHRNLIKI 616
           M+G+GSFG VF   +       A+K L    ++    ++  + E   L  +  H  L  +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN-LSLIQTLNIAIDVASAI 675
              C+   F   +    V +++  G L    H     ++ C+   L +    A ++   +
Sbjct: 62  Y--CT---FQTKENLFFVMEYLNGGDL--MFH-----IQSCHKFDLPRATFYAAEIICGL 109

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           ++LH      +V+ DLK  N+LLD D    + DFG+ K          +   + +    G
Sbjct: 110 QFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--------ENMLGDAKTCTFCG 158

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
           T  YIAPE   G + + + D +SFG+LL EM   + P    FH
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP----FH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 50/233 (21%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS------FLTECEALRSIR 609
           F    ++G+G FG V    +   G + A K L   +K  +K        L E + L  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVN 58

Query: 610 HRNLIKIITICSSID--------FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
            R ++ +     + D         NG D K  +Y+    G  EE                
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---------------- 102

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
            + +  A ++   +E LH   +  +V+ DLKP N+LLD      + D GLA         
Sbjct: 103 -RAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA--------- 149

Query: 722 TVVETPSSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             VE P   +  G  GTVGY+APE       + + D +  G L+ EM   + P
Sbjct: 150 --VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 36/220 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           S+F     +G GSFG V        G   A+K L    +++   ++    E   L  + H
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN----NDKLEVCNLSLIQTLN 666
             ++ ++  CS  D N V F   + +F+  G L   L +     ND  +  +  L+    
Sbjct: 78  PFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--- 129

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
                  A EYLH      +++ DLKP N+LLD+     V DFG AK +P R   T+  T
Sbjct: 130 -------AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-TLCGT 178

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           P           Y+APE           D ++ G+LL E 
Sbjct: 179 PE----------YLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 34/230 (14%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTE 601
           + +Y KL K          +G+G++ TVFKG       LVA+K + L  ++GA  + + E
Sbjct: 4   LETYVKLDK----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE 53

Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              L++++H N++ +  I  +          +V++++ +  L+++L    + + + N+ +
Sbjct: 54  VSLLKNLKHANIVTLHDIIHT-----ERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI 107

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
                    +   + Y H      ++H DLKP N+L++      + DFGLA+        
Sbjct: 108 FM-----FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR-------A 152

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
             V T + S+ +  T+ Y  P+   GS E S   D++  G +L EM + R
Sbjct: 153 KSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 28/221 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GSFG V    +   G   AVK L    ++    ++  + E   L ++   N     
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL-ALAWENPFLTH 60

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
             C+   F   +    V +F+  G L   +    DK       L +    A ++   +++
Sbjct: 61  LYCT---FQTKEHLFFVMEFLNGGDL---MFHIQDK---GRFDLYRATFYAAEIVCGLQF 111

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH      +++ DLK  NV+LD D    + DFG+ K          V   + +S   GT 
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK--------ENVFGDNRASTFCGTP 160

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
            YIAPE   G + + + D +SFG+LL EM   + P    FH
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F+    +G GSFG V+         +VA+K ++   K + + +   + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                    SI++ G   +      +    +E  L   +D LEV    L Q + IA    
Sbjct: 87  ---------SIEYKGCYLREHTAWLV----MEYCLGSASDLLEVHKKPL-QEVEIAAITH 132

Query: 673 SAIE---YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            A++   YLH H    ++H D+K  N+LL       + DFG A    A P ++ V TP  
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI--ASPANSFVGTPY- 186

Query: 730 SSGIKGTVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
                    ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 187 ---------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 24/223 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F+   ++G+GSFG V          L A+K+L    ++Q   ++  + E   L      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
             +  +  C    F  VD    V +++  G L   + Q      V      Q +  A ++
Sbjct: 61  PFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEI 110

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           +  + +LH   +  +++ DLK  NV+LD +    + DFG+ K       + +V+  ++ +
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRT 160

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
              GT  YIAPE         + D +++G+LL EM + + P D
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 11/105 (10%)

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           +++ A+ YLH      +++ DLK  NVLLD +    + D+G+ K    RP DT       
Sbjct: 104 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT------- 152

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           ++G+GSFG V       +G   AVKVL    ++ +   K  + E   L ++++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                   F   +    V DF+  G L  + H   ++    +    +    A ++ASA+ 
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGEL--FFHLQRER----SFPEPRARFYAAEIASALG 110

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH      +V+ DLKP N+LLD      + DFGL K          +    +++   GT
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGT 159

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             Y+APE         T D +  G +L EM 
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 562 VGQGSFGTVFKGIIGENG-------MLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +GQG+F  +FKGI  E G         V +KVL+   +   +SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
               +C   D +      +V ++++ GSL+ +L +N +      +++   L +A  +A A
Sbjct: 63  LNYGVCVCGDES-----IMVQEYVKFGSLDTYLKKNKNL-----INISWKLEVAKQLAWA 112

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF------LPARPLDTVVETPS 728
           + +L       + HG++   NVLL  +     G+    K       +   P + ++E   
Sbjct: 113 LHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE--- 166

Query: 729 SSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFS 768
                   + ++ PE     +  S+  D +SFG  L E+FS
Sbjct: 167 -------RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.8 bits (138), Expect = 2e-08
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 55/267 (20%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR----------HR 611
           +G+G++G V+K I      +VA+K      K    +F    +A R+ R          H 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK------K-IFDAFRNATDAQRTFREIMFLQELGDHP 67

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN---IA 668
           N++K++ +  +   N  D   +V+++M     E  LH       V   ++++ ++   I 
Sbjct: 68  NIVKLLNVIKAE--NDKDI-YLVFEYM-----ETDLHA------VIRANILEDVHKRYIM 113

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +  A++Y+H      V+H DLKPSN+LL+ D    + DFGL     AR L  + E P 
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL-----ARSLSELEENPE 165

Query: 729 SS--SGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           +   +    T  Y APE   GS     G D++S G +L EM   +     +F    TL++
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PLFPGTSTLNQ 221

Query: 786 FSKMVLPEKVMEIVDPSLLLEVRANNS 812
                  EK++E++ P    ++ +  S
Sbjct: 222 L------EKIIEVIGPPSAEDIESIKS 242

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 54/248 (21%), Positives = 100/248 (40%), Gaps = 40/248 (16%)

Query: 570 VFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRNLIKI----ITICSS 622
           ++KGI   N   V ++      KG    +     E + LR I   N++KI    I I   
Sbjct: 36  IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-- 91

Query: 623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC 682
              + +   +++ ++   G L E L +  D      LS    L++AID    +  L+ + 
Sbjct: 92  ---DDLPRLSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYT 142

Query: 683 KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAP 742
             P  + +L   + L+  +    +   GL K L + P   V             + Y + 
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV-----------NFMVYFSY 189

Query: 743 EYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVD 800
           +      SE ++  D+YS G++L E+F+ + P      E LT  E   +++ +     + 
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP-----FENLTTKEIYDLIINKNNSLKLP 244

Query: 801 PSLLLEVR 808
               LE++
Sbjct: 245 LDCPLEIK 252

Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 32/186 (17%)

Query: 586 VLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV---DFKAIVYDFMQNGS 642
           VL + QKG     L E   L+++ H ++I++     S     +    + + +Y ++   S
Sbjct: 95  VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS 151

Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
                           L + Q L I   +   + YLH      ++H D+K  N+ ++   
Sbjct: 152 RP--------------LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194

Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
              +GD G A+F    P            G+ GTV   APE     + +   D++S GI+
Sbjct: 195 QVCIGDLGAAQFPVVAPAFL---------GLAGTVETNAPEVLARDKYNSKADIWSAGIV 245

Query: 763 LLEMFS 768
           L EM +
Sbjct: 246 LFEMLA 251

Length = 357

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 14/219 (6%)

Query: 237 TIPPGLGNLVHLNSIAM---EGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNL 293
           +   G  NL++L  +       N+L      E+  L NL SL L++N +   IP  +G L
Sbjct: 81  SSLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNI-TDIPPLIGLL 138

Query: 294 TM-LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD 352
              L  L L  N ++  +PS L N  +L  L LS N L   LP  +LS  +    L+LS 
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPK-LLSNLSNLNNLDLSG 195

Query: 353 NLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLN 412
           N +S  LP EI  L  L +LD+S N    ++  +LS   +L  +++ +N     +P S+ 
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIG 252

Query: 413 FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
            L +++ LDLS+N++S  I   L +L+ L  L+LS N  
Sbjct: 253 NLSNLETLDLSNNQIS-SIS-SLGSLTNLRELDLSGNSL 289

Length = 394

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEA--LRSIRHRNLIK 615
           ++G+G+FG V+     + G  +AVK +      Q+ + +    ECE   L+++RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
                   +   +   +I  ++M  GS+++ L       E  N++   T  I       +
Sbjct: 69  YYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTE--NVTRRYTRQIL----QGV 119

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YLH +    +VH D+K +N+L D      +GDFG +K      + T+  + +    + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVTG 171

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  +++PE  +G       DV+S    ++EM + + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 9/214 (4%)

Query: 261 TVPPEIGWLKNLQSLYLN-SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
             P        +  L LN S+     +PSSL  L  L LL+    +       +L N   
Sbjct: 36  NFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISS-LDGSENLLNLLP 94

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK-NLVQLDISGNR 378
           L  L L+ N+L   +   +L +T L+  L+L +N ++  +P  IG LK NL +LD+S N+
Sbjct: 95  LPSLDLNLNRLRSNISE-LLELTNLTS-LDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL 438
               +P  L    +L+ + +  N  S  +P  L+ L ++  LDLS NK+S  +P  +E L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208

Query: 439 SFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           S LE L+LS N     +       N +   LS N
Sbjct: 209 SALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242

Length = 394

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 31/234 (13%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTEC 602
           +Y KL K          +G+G++G V+K      G LVA+K   L + ++G   + L E 
Sbjct: 2   AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51

Query: 603 EALRSIRHRNLI-KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLS 660
             L+ +     I +++ +    + NG     +V++++ +  L++++  N           
Sbjct: 52  SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAK 110

Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARP 719
            I+  +    +   + + H H    V+H DLKP N+L+D    +  + D GL +      
Sbjct: 111 TIK--SFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---- 161

Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
               +   S +  I  T+ Y APE   GS   S   D++S G +  EM SR++P
Sbjct: 162 ---SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM-SRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 49/228 (21%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA------LKSFLTECEALRSI 608
           E+     +G G+F + ++    + G L+AVK +  ++  +      +++   E   +  +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 609 RHRNLIKII-TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
            H ++I+++   C    FN      +  ++M  GS+   L +     E   + +  T  +
Sbjct: 61  NHPHIIRMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQL 112

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVV 724
              ++    YLH +    ++H D+K +N+L+D     +   + DFG A  L A       
Sbjct: 113 LRGLS----YLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAA----KGT 159

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                   + GT+ ++APE   G +   + DV+S G +++EM + + P
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 59/261 (22%), Positives = 111/261 (42%), Gaps = 34/261 (13%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGML---VAVKVLNLMQKGALKSFLTECEALRSIRHR 611
           E+    ++G G FG V++     +  +      K+ NL  +    + + E     +I   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68

Query: 612 NLIKIITICSSIDFNGV-------DFK--AIVYDFMQNGSLEEWLHQNNDKL----EVCN 658
           + I +     +ID  G+        FK   + Y F+    L E L +N  ++    +  N
Sbjct: 69  DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKN 124

Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
             LI+  NI  D+ + +EY+H H    + HGD+KP N+++D +   ++ D+G+A      
Sbjct: 125 KKLIK--NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179

Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
               +  +       +GT+ Y   +   G+  +  GD+ S G  +L+    + P     H
Sbjct: 180 G-KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238

Query: 779 EGLTLH----EFSKMVLPEKV 795
            G  +H    +F K +   K+
Sbjct: 239 NGNLIHAAKCDFIKRLHEGKI 259

Length = 294

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 29/239 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+G FG V    +   G + A K L+   L +K   K  L E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  +  F       +V   M  G L+  ++   ++     L + + ++ +  +   I +L
Sbjct: 58  LAYA--FESKTHLCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHL 111

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK--GT 736
           H      +V+ D+KP NVLLD      + D GLA           VE     +  +  GT
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA-----------VELKDGKTITQRAGT 157

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            GY+APE       S   D ++ G  + EM + R P      E +   E  +  L ++V
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 52/230 (22%), Positives = 100/230 (43%), Gaps = 36/230 (15%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSF------------LTECEAL 605
             +G+G++G V K      G +VA+K + +++      K              L E + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
             I+H N++ ++ +     +   DF  +V D M    L++ +   + K+    L+  Q  
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVV---DRKIR---LTESQVK 122

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK---FLPARPLDT 722
            I + + + +  LH   K   +H DL P+N+ ++   +  + DFGLA+   + P     +
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 723 VVETPSSSSGIKG---TVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFS 768
             ET      +     T+ Y APE   G+E      D++S G +  E+ +
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 34/230 (14%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTE 601
           M +Y KL K          +G+G++ TVFKG       LVA+K + L  ++GA  + + E
Sbjct: 5   METYIKLEK----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE 54

Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              L+ ++H N++ +  I  +          +V++++ +  L++++    + + + N+ +
Sbjct: 55  VSLLKDLKHANIVTLHDIVHTDKS-----LTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI 108

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
                    +   + Y H   +  V+H DLKP N+L++      + DFGLA+        
Sbjct: 109 F-----LYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-------A 153

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRR 770
             V T + S+ +  T+ Y  P+   G SE S   D++  G +  EM S R
Sbjct: 154 KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 28/228 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKIITI 619
           +G+GSFG ++      +     +K ++L +    +   ++ E   L  ++H N   I+T 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN---IVTF 64

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +S   NG  F  IV ++   G L + +++    L     S  Q L+  + ++  ++++H
Sbjct: 65  FASFQENGRLF--IVMEYCDGGDLMKRINRQRGVL----FSEDQILSWFVQISLGLKHIH 118

Query: 680 HHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                 ++H D+K  N+ L  + MVA +GDFG+     AR L+  +E   +     GT  
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGI-----ARQLNDSMELAYTCV---GTPY 167

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF 786
           Y++PE       +   D++S G +L E+ + + P      EG  LH+ 
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNLHQL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 38/220 (17%)

Query: 580 MLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           +LVAVK+L     K A   FL E + L  ++  N+I+++ +C        D   ++ ++M
Sbjct: 47  LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYM 101

Query: 639 QNGSLEEWL--HQNNDKLEVCN-----------LSLIQTLNIAIDVASAIEYLHHHCKPP 685
           +NG L ++L  H  +DK E  N           +S    L++A+ +AS ++YL       
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158

Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG----TVGYIA 741
            VH DL   N L+  ++   + DFG+++ L A               I+G     + ++A
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYA----------GDYYRIQGRAVLPIRWMA 208

Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS--RRRPTDSMFHE 779
            E     + +   DV++FG+ L E+    + +P   +  E
Sbjct: 209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 59/243 (24%), Positives = 110/243 (45%), Gaps = 34/243 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNLIKIITIC 620
           +G G+ G+V K      G ++A KV+++  K ++ K  L E   L+ +       I++  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE---LQIMHECRSPYIVSFY 69

Query: 621 SS-IDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNIAIDVASAIEYL 678
            + ++ N +    +  +FM  GSL+    +     +E+          IA+ V   + YL
Sbjct: 70  GAFLNENNI---CMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGLTYL 119

Query: 679 H--HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           +  H     ++H D+KPSN+L++      + DFG++  L     DT V          GT
Sbjct: 120 YNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----------GT 165

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
             Y++PE   G + ++  DV+S GI ++E+   + P    F       +   M + + + 
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDLLQ 223

Query: 797 EIV 799
           +IV
Sbjct: 224 QIV 226

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 34/230 (14%)

Query: 556 FSSSNM-----VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIR 609
           F++ ++     +G+G+FGTV K +   +G ++AVK +         K  L + + +  +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 610 HRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
             +   I+       F G  F+     I  + M + SL+++     + L+      I   
Sbjct: 59  SSDCPYIVK------FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG- 110

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
            IA+    A+ YL    K  ++H D+KPSN+LLD +    + DFG++  L    +D++ +
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAK 164

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEAS---MTGDVYSFGILLLEMFSRRRP 772
           T  +     G   Y+APE    S      +  DV+S GI L E+ + + P
Sbjct: 165 TRDA-----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL------NLMQKGALKSFLTECEALRSIRHRNLIK 615
           VG G++GTV   +    G  VA+K L       L  K A +    E   L+ ++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 616 IITICSSIDFNGVDFKA--IVYDFMQN--GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           ++ + +  D +   F    +V  FM    G L +    + D+++     +++ L      
Sbjct: 79  LLDVFTP-DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL------ 131

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
               +Y+H      ++H DLKP N+ ++ D    + DFGLA+           +T S  +
Sbjct: 132 ----KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEMT 173

Query: 732 GIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRR 770
           G   T  Y APE        + T D++S G ++ EM + +
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---FLTECEA--LRSIRHRNLIK 615
           ++GQG+FG V+     + G  +AVK +    +    S      ECE   L+++ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
                       +   +I  + M  GS+++ L       E        T      +   +
Sbjct: 69  YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENV------TRKYTRQILEGV 119

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YLH +    +VH D+K +N+L D      +GDFG      ++ L T+  + +    + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMKSVTG 171

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  +++PE  +G       D++S G  ++EM + + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 52/237 (21%)

Query: 562 VGQGSFGTV----------FK------GIIGENGMLVAVKVLNL-MQKGALKSFLTECEA 604
           +G+G FG V          F        + G   +LVAVK+L     K A   FL E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL--HQNNDKLEVCNLSLI 662
           +  ++  N+I+++ +C +      D   ++ ++M+NG L ++L  H+  +  E  ++  I
Sbjct: 73  MSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 663 Q---TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
                + +A  +AS ++YL        VH DL   N L+  +    + DFG+++ L    
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---- 180

Query: 720 LDTVVETPSSSSG----IKG----TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                      SG    I+G     + +++ E     + +   DV++FG+ L E+ +
Sbjct: 181 ----------YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 36/225 (16%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G V K     +G+++A K+++L  K A+++        + IR    +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--------QIIRE---L 54

Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E     ++  ++I
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSI 110

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  V   + YL    K  ++H D+KPSN+L++      + DFG++  L            
Sbjct: 111 A--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------ID 156

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           S ++   GT  Y++PE   G+  S+  D++S G+ L+E+   R P
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 28/163 (17%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIIT 618
           ++G+GS+G V   I    G  VA+K +N + +    +   L E + LR +RH ++++I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 619 IC---SSIDFNGVDFKAIVYDFMQNGSLEEWLHQ---NNDKL--EVCNLSLIQTLNIAID 670
           I    S  +F  +    +V++ M     E  LHQ    ND L  E     L Q L     
Sbjct: 67  IMLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR---- 114

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
              A++Y+H      V H DLKP N+L + D    + DFGLA+
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL-----NLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+FG V+      +G  VA+K +     NL+   + K    E + L   +H N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV---SCKRVFRELKMLCFFKHDNVLSA 64

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ---NNDKL--EVCNLSLIQTLNIAIDV 671
           + I      +  +   +V + MQ+      LH+   +   L  +   + L Q L      
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQILR----- 114

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              ++YLH      ++H D+KP N+L++ + V  + DFGLA+          VE P  S 
Sbjct: 115 --GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR----------VEEPDESK 159

Query: 732 GIKGTV---GYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
            +   V    Y APE   GS    +  D++S G +  E+  RR
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALR-SIRHRNLIKI 616
           ++G+GSFG V    +     + A+KVL    ++Q   +   +TE   L  + +H  L   
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT-- 59

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +     F   D    V +++  G L   + Q + K +            A +V  A+ 
Sbjct: 60  -ALHCC--FQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFY-----AAEVTLALM 110

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK--FLPARPLDTVVETPSSSSGIK 734
           +LH H    V++ DLK  N+LLD +    + DFG+ K   L      T   TP       
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD------ 161

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               YIAPE     E   + D ++ G+L+ EM + + P
Sbjct: 162 ----YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 31/227 (13%)

Query: 556 FSSSNMVGQGSFGTVF--KGIIG-ENGMLVAVKVL---NLMQKGALKSFL-TECEALRSI 608
           F    ++G G++G VF  + + G ++G L A+KVL    ++QK        TE + L  I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           R    +  +      D        ++ D++  G L   L Q     E       Q + I 
Sbjct: 62  RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIY 110

Query: 669 I-DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
             ++  A+E+LH   K  +++ D+K  N+LLD +    + DFGL+K       +   +  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------EFHEDEV 160

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTG--DVYSFGILLLEMFSRRRP 772
             +    GT+ Y+AP+   G +       D +S G+L+ E+ +   P
Sbjct: 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 27/140 (19%)

Query: 665 LNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFGLA+ +        
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI-------- 264

Query: 724 VETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS------RRRPT 773
                S+  +KG     V ++APE       +   DV+S+GILL E+FS         P 
Sbjct: 265 --RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322

Query: 774 DSMFHEGLTLHEFSKMVLPE 793
           DS F++   + E  +M+ PE
Sbjct: 323 DSKFYK--MIKEGYRMLSPE 340

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 31/244 (12%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK--SFLTECEALRSIRHRN 612
           +F   ++VG+G FG V        G + A+KV+      A +  SF  E   + SI +  
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  +       F   D   +V ++   G L   L++  D+ +     + Q       +A
Sbjct: 62  WIPQLQYA----FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQFY-----LA 109

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             +  +H   +   VH D+KP NVL+D      + DFG A  L      T  +  +S   
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL------TANKMVNSKLP 163

Query: 733 IKGTVGYIAPEYGT---GSEASMTG---DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF 786
           + GT  YIAPE  T   G      G   D +S G++  EM   R P    FHEG +   +
Sbjct: 164 V-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKTY 218

Query: 787 SKMV 790
           + ++
Sbjct: 219 NNIM 222

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 29/133 (21%)

Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L L Q   +A  + SAI+Y+H   +  ++H D+K  NVL++      +GDFG A F    
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARG- 312

Query: 719 PLDTVVETPSSSS----GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLE-------MF 767
                    S S+    GI GTV   APE   G   + + D++S G+++ E       +F
Sbjct: 313 ---------SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363

Query: 768 S-----RRRPTDS 775
           S      RRP D+
Sbjct: 364 SASRGDERRPYDA 376

Length = 461

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 27/174 (15%)

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGV---DFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           E  AL  + H N++KI  I  S     +    +   +Y FM + + + W  +        
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-WKDRP------- 264

Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
              L QT  I   +  A+EY+H      ++H D+K  N+ L+ D    +GDFG A     
Sbjct: 265 --LLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA----- 314

Query: 718 RPLDTVVETPSSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
                  E    +   G  GTV   +PE   G       D++S G++LL+M S 
Sbjct: 315 ----MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 58/236 (24%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA---------L 605
            + + + VG G++G V      + G  VA+K L+       + F +   A         L
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLL 68

Query: 606 RSIRHRNLIKIITI----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
           + + H N+I ++ +     S  DF  V    +V   M    L   +     K +  +   
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDV---YLVTHLMG-ADLNNIV-----KCQKLSDDH 119

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           IQ L   I     ++Y+H      ++H DLKPSN+ ++ D    + DFGL     AR  D
Sbjct: 120 IQFLVYQI--LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL-----ARHTD 169

Query: 722 TVVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
                    +G   T  Y APE       Y      + T D++S G ++ E+ + +
Sbjct: 170 ------DEMTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRH 610
           T+ +     VG G+FG V        G  VA+K ++       L K    E + L+ +RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 611 RNLIKIITICSS--------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
            N+I +  I  S         +  G D   +    + +  LE+   Q           L 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQ---------YFLY 115

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           Q L         ++Y+H      VVH DLKPSN+L++ +    + DFGL     AR  D 
Sbjct: 116 QILR-------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL-----ARIQD- 159

Query: 723 VVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
                   +G   T  Y APE   T  +  +  D++S G +  EM 
Sbjct: 160 -----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 13/120 (10%)

Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           N+++   L I   V  AI+YLH +    ++H D+K  N+ ++H     +GDFG A F   
Sbjct: 178 NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF--- 231

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF 777
            P+D      +   G  GT+   APE           D++S GI+L EM +     DS+F
Sbjct: 232 -PVDI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLF 284

Length = 391

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 39/223 (17%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN------LMQKGALKSFLTECEALRSIR 609
           ++S   VG G++G+V   I    G  VA+K L+      +  K A +    E   L+ ++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQ 72

Query: 610 HRNLIKIITI-CSSIDFNGVDFKAIVYDFMQNGSLEE--WLHQNNDKLEVCNLSLIQTLN 666
           H N+I ++ +  S++  +      +V  +MQ   L++      + DK++     + Q L 
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYL---VYQML- 127

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
                   ++Y+H      ++H DLKP N+ ++ D    + DFGLA+   A     VV  
Sbjct: 128 ------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 176

Query: 727 PSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFS 768
                    T  Y APE        + T D++S G ++ EM +
Sbjct: 177 ---------TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 4e-07
 Identities = 23/62 (37%), Positives = 39/62 (62%), Gaps = 1/62 (1%)

Query: 6   NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
            N + G+IP  +G  +  LE L L+ N   G +P S+G L++L+++++ GN L G++P  
Sbjct: 451 GNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Query: 66  LG 67
           LG
Sbjct: 510 LG 511

Length = 623

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 34/228 (14%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECE 603
           +Y KL K          +G+G++ TV+KG       LVA+K + L  ++GA  + + E  
Sbjct: 7   TYIKLDK----------LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS 56

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            L+ ++H N++ +  I  +          +V++++ +  L+++L    + + + N+ L  
Sbjct: 57  LLKDLKHANIVTLHDIIHT-----EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF- 109

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
                  +   + Y H   +  V+H DLKP N+L++      + DFGLA+   A+ + T 
Sbjct: 110 ----LFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPT- 158

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
                + S    T+ Y  P+   GS + S   D++  G +  EM + R
Sbjct: 159 ----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 33/247 (13%)

Query: 555 EFSSSNMVGQGSFGTVF--KGIIG-ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR 611
            F    ++G G++G VF  + + G + G L A+KVL   QK AL       E  R+   R
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL---QKAALVQKAKTVEHTRT--ER 55

Query: 612 NLIKIIT-----ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           N+++ +      +     F       ++ D++  G +   L+Q +      N S  +   
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRF 109

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            + ++  A+E+LH   K  +V+ D+K  N+LLD +    + DFGL+K       + + E 
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK-------EFLSEE 159

Query: 727 PSSSSGIKGTVGYIAPEY--GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH 784
              +    GT+ Y+APE   G G       D +S GIL+ E+ +   P  ++  E  T  
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASPF-TLEGERNTQS 217

Query: 785 EFSKMVL 791
           E S+ +L
Sbjct: 218 EVSRRIL 224

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 6e-07
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 27/175 (15%)

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           + N IK+    +++  +      ++ D++++G L + L +   KL        +   I  
Sbjct: 68  NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLL-KKEGKLSE-----AEVKKIIR 116

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV-AHVGDFGLAKFLPARPLDTVVETPS 728
            +  A+  LH H    ++H D+K  NVL D      ++ D+GL K         ++ TPS
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPS 164

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
                 GT+ Y +PE   G    ++ D ++ G+L  E+ + + P      E L L
Sbjct: 165 CYD---GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 42/201 (20%)

Query: 562 VGQGSFGTVFK--GIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G++G V+K     G++G   A+K          G  +S   E   LR ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 617 ITICSS---------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI-QTLN 666
           + +             D+   D   I+    Q   +   +  +  K      SL+ Q LN
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS--IPPSMVK------SLLWQILN 119

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLPARPLDT 722
                   + YLH +    V+H DLKP+N+L+        V  +GD GLA+   A PL  
Sbjct: 120 -------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-PL-- 166

Query: 723 VVETPSSSSGIKGTVGYIAPE 743
             +  +    +  T+ Y APE
Sbjct: 167 --KPLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 35/213 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTE---CEALRSIRHRNLIKI 616
           G+G FG V      + G L A+K L   +++ +  ++S + E    E   S RH  L+ +
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C    F   D    V ++   G L   +H +         S  + +  A  V   ++
Sbjct: 68  FA-C----FQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVVLGLQ 115

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET---PSSSSGI 733
           YLH +    +V+ DLK  N+LLD +    + DFGL K           E       +S  
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----------EGMGFGDRTSTF 161

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            GT  ++APE  T +  +   D +  G+L+ EM
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 15/110 (13%)

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           + + +  A+ YL    K  V+H D+KPSN+LLD      + DFG++  L    +D+  +T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKT 172

Query: 727 PSSSSGIKGTVGYIAPEY----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S      G   Y+APE         +  +  DV+S GI L+E+ + + P
Sbjct: 173 RS-----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F+   ++G+GSFG V          L A+K+L    ++Q   ++  + E   L      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
             +  +  C    F  +D    V +++  G L   + Q      V        +  A ++
Sbjct: 61  PFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEI 110

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  + +LH      +++ DLK  NV+LD +    + DFG+ K       + +     ++ 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-------ENIFG-GKTTR 159

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
              GT  YIAPE         + D ++FG+LL EM + + P D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 52/226 (23%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G+ VAVK L+   +  + +  T  E   L+ ++H N+I ++ +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA----------- 668
                            F    SLEE+    ND   V +L      NI            
Sbjct: 85  -----------------FTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123

Query: 669 ---IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
                +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+            
Sbjct: 124 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------H 169

Query: 726 TPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRR 770
           T    +G   T  Y APE        + T D++S G ++ E+ + R
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 36/217 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSS 622
           G G+ G V K +   +G+++A K+++L  K A+++ +           R L K++  C+S
Sbjct: 10  GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQII----------REL-KVLHECNS 58

Query: 623 ---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              + F G  +     +I  + M  GSL++ L       +   +       I+I V   +
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------KAGRIPENILGKISIAVLRGL 112

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL    K  ++H D+KPSN+L++      + DFG++  L    +D      S ++   G
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID------SMANSFVG 160

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  Y++PE   G+  ++  D++S G+ L+EM   R P
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSI-RHRN 612
           F    +VG G++G V+KG   + G L A+KV+++   ++  +K    E   L+    HRN
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64

Query: 613 LIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           +          +  G+D +  +V +F   GS+ + +   N K        I    I  ++
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREI 120

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + +LH H    V+H D+K  NVLL  +    + DFG++  L          T    +
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--------RTVGRRN 169

Query: 732 GIKGTVGYIAPEYGTGSEA-----SMTGDVYSFGILLLEM 766
              GT  ++APE     E          D++S GI  +EM
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.8 bits (124), Expect = 2e-06
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 20/195 (10%)

Query: 577 ENGMLVAVKVL-NLMQKGA--LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI 633
             G  VA+K+L     +       F  E      + H N++ ++    +           
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP----GLLFA 56

Query: 634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP 693
           V++++   +L E L  +        L   +T  + + V  A+   H+     +VH DLKP
Sbjct: 57  VFEYVPGRTLREVLAADG------ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKP 107

Query: 694 SNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA 750
            N+++        A V DFG+   LP    D  V T + ++ + GT  Y APE   G   
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 751 SMTGDVYSFGILLLE 765
           +   D+Y++G++ LE
Sbjct: 167 TPNSDLYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 24/138 (17%)

Query: 659 LSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           L L   L  +  VA  +++L   +C    +H D+   NVLL    VA + DFGLA+ +  
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-- 262

Query: 718 RPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRP 772
                      S+  +KG     V ++APE       ++  DV+S+GILL E+FS  + P
Sbjct: 263 --------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Query: 773 TDSMFHEGLTLHEFSKMV 790
              +    L   +F KMV
Sbjct: 315 YPGI----LVNSKFYKMV 328

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 46/226 (20%)

Query: 563 GQGSFGTVFKGIIGENGML----------VAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
           GQG+F  ++KG++     L          V +KVL    + +L +F      +  + H++
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKH 62

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           L+K+  +C        D   +V ++++ G L+ +LH+  +     N+SL   L++A  +A
Sbjct: 63  LVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLA 111

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHD-------MVAHVGDFGLAKFLPARPLDTVVE 725
           SA+ YL       +VHG++   N+L+              + D G+        + +  E
Sbjct: 112 SALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-----ITVLSREE 163

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMT--GDVYSFGILLLEMFSR 769
                        +IAPE     +AS+T   D +SFG  LLE+ S 
Sbjct: 164 RVERIP-------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHR 611
           ++F    +VG+G++G V K    E   +VA+K     ++     ++ L E + LR+++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----DKLEVCNLSLIQTLNI 667
           N++++        F       +V+++++   LE      N    +K+      LI+    
Sbjct: 61  NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK---- 111

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
                 AI + H   K  +VH D+KP N+L+ H+ V  + DFG A+ L          + 
Sbjct: 112 ------AIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-------GSN 155

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           ++ +    T  Y +PE   G+      D++S G +L E+
Sbjct: 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F    ++G+G+FG V    +     + A+K+LN  +   LK   T C      R    +
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETAC-----FREERNV 54

Query: 615 KIITICSSID-----FNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIA 668
            +   C  I      F   ++  +V D+   G L   L +  D+L E      I  + +A
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           I    +I  LH+      VH D+KP NVLLD +    + DFG         L    +   
Sbjct: 115 IH---SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSC-------LKMNQDGTV 158

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTG-----DVYSFGILLLEMFSRRRP 772
            SS   GT  YI+PE     E  M       D +S G+ + EM     P
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 13/112 (11%)

Query: 659 LSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           L+ +  L+    VA  +E+L   +C    VH DL   NVLL    +  + DFGLA+    
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLAR---- 285

Query: 718 RPLDTVVETPSSSSGIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
              D + ++   S G     V ++APE    +  +   DV+S+GILL E+FS
Sbjct: 286 ---DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 25/221 (11%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F     +G G++G V+K      G L A+KV+ L           E   ++  +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
                     +   D   I  +F   GSL++  H          LS  Q   ++ +    
Sbjct: 70  AYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTGP------LSESQIAYVSRETLQG 118

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           + YLH   K   +H D+K +N+LL  +    + DFG++  + A        T +      
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--------TIAKRKSFI 167

Query: 735 GTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
           GT  ++APE          +   D+++ GI  +E+   + P
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 25/215 (11%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +VG+GSFG         +    A+K + L     A++    E   L  ++H N   I+  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAF 63

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S + +G  +  IV ++   G L + +     KL          L   + +   ++++H
Sbjct: 64  KESFEADGHLY--IVMEYCDGGDLMQKIKLQRGKL----FPEDTILQWFVQMCLGVQHIH 117

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIKGTV 737
              +  V+H D+K  N+ L  +    +GDFG A+ L  P     T V TP          
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY--------- 165

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            Y+ PE       +   D++S G +L E+ + + P
Sbjct: 166 -YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 24/223 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F+   ++G+GSFG V          L A+K+L    ++Q   ++  + E   L      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
             +  +  C    F  +D    V +++  G L   + Q      V        +  A ++
Sbjct: 61  PFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYAAEI 110

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  + +LH      +++ DLK  NV+LD +    + DFG+ K       D V     ++ 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGV-----TTK 159

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
              GT  YIAPE         + D ++FG+LL EM + + P +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 42/217 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G G+ G V        G+ VAVK L+     +   K    E   L+ + H+N+I ++ +
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID--------- 670
                            F    SLEE+       +E+ + +L Q +++ +D         
Sbjct: 89  -----------------FTPQKSLEEF-QDVYLVMELMDANLCQVIHMELDHERMSYLLY 130

Query: 671 -VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +   I++LH      ++H DLKPSN+++  D    + DFGLA+          + TP  
Sbjct: 131 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYV 183

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                 T  Y APE   G       D++S G ++ E+
Sbjct: 184 V-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 32/236 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           VG G++G V+K      G L AVK++ L           E   ++  +H N++       
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG--- 73

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              +   +   I  ++   GSL++  H          LS +Q   +  +    + YLH  
Sbjct: 74  --SYLSREKLWICMEYCGGGSLQDIYHVTGP------LSELQIAYVCRETLQGLAYLHSK 125

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
            K   +H D+K +N+LL  +    + DFG+A  + A        T +      GT  ++A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITA--------TIAKRKSFIGTPYWMA 174

Query: 742 PEYGTGSEA---SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
           PE     +    +   D+++ GI  +E+   + P   MF     LH    + L  K
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP---MF----DLHPMRALFLMSK 223

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 11/99 (11%)

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A+E+LH      +++ DLKP N+LLD      + DFGL K          +   + +   
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--------ESIHEGTVTHTF 160

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT+ Y+APE    S      D +S G L+ +M +   P
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 66/249 (26%), Positives = 114/249 (45%), Gaps = 42/249 (16%)

Query: 563 GQGSFGTVF--KGIIGEN-GMLVAVKVLN---LMQKG-ALKSFLTECEALRSIRHRNLIK 615
           G G++G VF  + + G + G L A+KVL    ++QK    +   TE + L ++R    + 
Sbjct: 9   GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL- 67

Query: 616 IITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQ--NNDKLEVCNLSLIQTLNIAIDVA 672
            +T+  +      D K  ++ D++  G L   L+Q  +  + EV        + IA ++ 
Sbjct: 68  -VTLHYAFQ---TDTKLHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA-EIV 115

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLPARPLDTVVETPSSSS 731
            A+++LH   +  +++ D+K  N+LLD +    + DFGL+K FL         E    + 
Sbjct: 116 LALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA--------EEEERAY 164

Query: 732 GIKGTVGYIAPEYGTGSEA--SMTGDVYSFGILLLEMFSRRRP--TDSMFHEGLTLHEFS 787
              GT+ Y+APE   G         D +S G+L  E+ +   P   D    E  +  E S
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG---EQNSQSEIS 221

Query: 788 KMVLPEKVM 796
           + +L  K  
Sbjct: 222 RRILKSKPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 9e-06
 Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 25/102 (24%)

Query: 58  LGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN 117
           L G IP+ + +LR L  +N+  N   G IPPS+ +I+S E + L  N F+GS        
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS-------- 481

Query: 118 LPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM 159
                            +P SL   ++L +L L  N   G++
Sbjct: 482 -----------------IPESLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 23/230 (10%)

Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
           I  + L      F    +VG G++G V+KG   + G L A+KV+++ +    +    E  
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64

Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
            L+    HRN+             G D +  +V +F   GS+ + +   N K        
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDW 122

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           I    I  ++   + +LH H    V+H D+K  NVLL  +    + DFG++  L      
Sbjct: 123 IAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----- 172

Query: 722 TVVETPSSSSGIKGTVGYIAPEY-----GTGSEASMTGDVYSFGILLLEM 766
               T    +   GT  ++APE         +      D++S GI  +EM
Sbjct: 173 ---RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLPARPLDTVVETPSSSSG 732
           A++ +H      ++H DLK +N+ L    +  +GDFG +K +  +  LD        +S 
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV-------ASS 230

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT  Y+APE       S   D++S G++L E+ +  RP
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 49/229 (21%)

Query: 562 VGQGSFGTV----FKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIR-HRNLI 614
           +GQG++G V          E    VA+K + N+  K  L K  L E + LR  R H+N+ 
Sbjct: 8   LGQGAYGIVCSARNAETSEEET--VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 615 KII--TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI----QTLNIA 668
            +    I    +FN +      Y + +              L   +L  I    Q L  A
Sbjct: 66  CLYDMDIVFPGNFNEL------YLYEE--------------LMEADLHQIIRSGQPLTDA 105

Query: 669 ------IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
                   +   ++Y+H      V+H DLKP N+L++ D    + DFGLA+     P   
Sbjct: 106 HFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP--- 159

Query: 723 VVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             E     +    T  Y APE   +    +   DV+S G +L E+  R+
Sbjct: 160 -GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 67/252 (26%), Positives = 109/252 (43%), Gaps = 64/252 (25%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTEC 602
           M+    L   T  +     +G+G++G V+K    ++G L AVK+L+      +     E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEI 65

Query: 603 EA----LRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           EA    L+S+  H N++K         F G+ +KA   D +  G L  WL      LE+C
Sbjct: 66  EAEYNILQSLPNHPNVVK---------FYGMFYKA---DKLVGGQL--WL-----VLELC 106

Query: 658 N----LSLIQTL----------NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV 703
           N      L++ L           I+  +  A+  L H     ++H D+K +N+LL  +  
Sbjct: 107 NGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166

Query: 704 AHVGDFGLAKFLPARPL--DTVVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTG 754
             + DFG++  L +  L  +T V TP           ++APE       Y    +A    
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVGTPF----------WMAPEVIACEQQYDYSYDARC-- 214

Query: 755 DVYSFGILLLEM 766
           DV+S GI  +E+
Sbjct: 215 DVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 19/179 (10%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           EF     + +G+FG V+ G    N  L AVKV+   +++ K  +     E +AL   +  
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            ++ +     S   N V    +V +++  G ++  LH      E   +  I       +V
Sbjct: 65  FIVHLYYSLQSA--NNV---YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS------EV 113

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT--VVETPS 728
           A A++YLH H    ++H DLKP N+L+ ++    + DFGL+K    R L+   ++ TPS
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPS 169

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 44/220 (20%)

Query: 562 VGQGSFGTVF-----KGIIGENGMLVAVKVLNLMQKGALKSFLT-----ECEALRSIRHR 611
           +G+GSFGTV+     K +  E      +KVL  +  G L    T     E + L  + H 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN-----LSLIQTLN 666
            ++K         F   D   I+ ++ +   L+        KLE        LS  Q   
Sbjct: 63  AIVKFHA-----SFLERDAFCIITEYCEGRDLD-------CKLEELKHTGKTLSENQVCE 110

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
             I +   + Y+H      ++H DLK  N+ L ++++  +GDFG+++ L        + +
Sbjct: 111 WFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLL--------MGS 158

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              ++   GT  Y++PE           D++S G +L EM
Sbjct: 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 11/99 (11%)

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A+E LH   K  V++ DLKP N+LLD+     + DFGL K L  +  D        ++  
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDK-------TNTF 153

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT  Y+APE   G   +   D ++ G+LL EM +   P
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 21/173 (12%)

Query: 600 TECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
            E + L++I HR +I +I        +   +K+ V   M     +  L    D+     L
Sbjct: 135 REIDILKTISHRAIINLI--------HAYRWKSTVCMVMPKYKCD--LFTYVDRSG--PL 182

Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
            L Q + I   +  A+ YLH      ++H D+K  N+ LD    A +GDFG A  L A P
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                +TP    G  GT+   +PE           D++S G++L EM  +   
Sbjct: 240 -----DTP-QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)

Query: 659 LSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           L+L   ++ +  VA  +E+L    C    +H DL   N+LL  + V  + DFGLA+ +  
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            P    V    +   +K    ++APE       +   DV+SFG+LL E+FS
Sbjct: 226 DP--DYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 11/121 (9%)

Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVG 707
           Q  D L    L++   +  +  VA  +E+L    C    +H DL   N+LL  + V  + 
Sbjct: 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKIC 216

Query: 708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           DFGLA+ +   P    V   S+   +K    ++APE       +   DV+SFG+LL E+F
Sbjct: 217 DFGLARDIYKDP--DYVRKGSARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Query: 768 S 768
           S
Sbjct: 271 S 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 29/82 (35%), Positives = 41/82 (50%), Gaps = 11/82 (13%)

Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           +V+ DLKP N+LLD D    + DFG AK         VV+T + +  + GT  YIAPE  
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYT--LCGTPEYIAPEIL 200

Query: 746 TGSEASMTGDVYSFGILLLEMF 767
                    D ++ GI + E+ 
Sbjct: 201 LNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 13/135 (9%)

Query: 637 FMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKP 693
           F++  SL +   +  ++ ++    L+L   +  +  VA  +E+L    C    +H DL  
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207

Query: 694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT 753
            N+LL  + V  + DFGLA+ +   P D V +  +     +  + ++APE       ++ 
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDP-DYVRKGDA-----RLPLKWMAPETIFDRVYTIQ 261

Query: 754 GDVYSFGILLLEMFS 768
            DV+SFG+LL E+FS
Sbjct: 262 SDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 32/228 (14%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F    ++G+G+FG V    +     + A+K+LN   ++++     F  E + L +  ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAI 669
            +  +        F   +   +V D+   G L   L +  D+L  ++    L + + IAI
Sbjct: 62  WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           D   ++  LH+      VH D+KP N+L+D +    + DFG         L  + +    
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSC-------LKLMEDGTVQ 159

Query: 730 SSGIKGTVGYIAPEYGTGSEASM-----TGDVYSFGILLLEMFSRRRP 772
           SS   GT  YI+PE     E          D +S G+ + EM     P
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 35/222 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           +G+G++G+V+K +    G+ +A+K + L + +      + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 621 SSIDFNGVDF-KAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +DF G  F +  VY   ++M  GSL++          +    L +     +     ++
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
             H+     ++H D+KP+NVL++ +    + DFG++  L A    T +          G 
Sbjct: 120 EEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----------GC 164

Query: 737 VGYIAPEY---GTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
             Y+APE    G  ++    ++  DV+S G+ +LEM   R P
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 32/213 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRN---LIKI 616
           VG G++G+V           VAVK L+   +  + +  T  E   L+ ++H N   L+ +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 617 ITICSSI-DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            T  +SI +FN V    +V + M    L       N+ ++   LS      +   +   +
Sbjct: 83  FTPATSIENFNEV---YLVTNLM-GADL-------NNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +Y+H      ++H DLKPSNV ++ D    + DFGLA+           +     +G   
Sbjct: 132 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QADDEMTGYVA 177

Query: 736 TVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
           T  Y APE        + T D++S G ++ E+ 
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 36/137 (26%), Positives = 56/137 (40%), Gaps = 20/137 (14%)

Query: 578 NGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY 635
              LVAVK +NL    K  LK    E    R ++H N++  +T  S I  + +    +V 
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT--SFIVDSEL---YVVS 78

Query: 636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTL--NIAIDVASAIEYLHH-HCKPPVVHGDLK 692
             M  GS E+ L             L +     I  DV +A++Y+H        +H  +K
Sbjct: 79  PLMAYGSCEDLLK------THFPEGLPELAIAFILKDVLNALDYIHSKGF----IHRSVK 128

Query: 693 PSNVLLDHDMVAHVGDF 709
            S++LL  D    +   
Sbjct: 129 ASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 9e-05
 Identities = 18/60 (30%), Positives = 28/60 (46%)

Query: 23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF 82
           L++L L+ N LT     +   L  L+V+D+ GN L    P+    L  L  L++  N  
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 9e-05
 Identities = 22/60 (36%), Positives = 28/60 (46%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
           NL+SL L++N L      +   L  L +L L  NNL    P +     SL  L LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 38/226 (16%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F    ++G+G+FG V    +   G + A+K+LN   ++++     F  E + L +   R
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAI 669
            +  +        F   +   +V D+   G L   L +  D+L  ++    L + + +AI
Sbjct: 62  WITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LAI 115

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETP 727
           D    + Y         VH D+KP NVLL  D   H+   DFG    L      TV    
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLL--DKNGHIRLADFG--SCLRLLADGTV---- 158

Query: 728 SSSSGIKGTVGYIAPEY------GTGSEASMTGDVYSFGILLLEMF 767
             S+   GT  YI+PE       G G       D +S G+ + EM 
Sbjct: 159 -QSNVAVGTPDYISPEILQAMEDGKGRYGPEC-DWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 57/276 (20%), Positives = 96/276 (34%), Gaps = 60/276 (21%)

Query: 46  SALQVIDIRGNRLGGK------IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNI---SSF 96
            +L+ + +  N  G        +   L +   L  L++  N         + ++   SS 
Sbjct: 51  PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110

Query: 97  EFIFLQSNRFHGSLPFDMVA-----NLPNLRKFVAAKNNLTGFLPISLSNA--------- 142
           + + L +N   G     ++A       P L K V  +N L G    +L+ A         
Sbjct: 111 QELKLNNNGL-GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE 169

Query: 143 -----------------------SNLELLELRDNQF----IGKMSINFNSLKNLSVLILG 175
                                   NLE+L+L +N         ++    SLK+L VL LG
Sbjct: 170 LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLG 229

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANL---SNTMTTIDIGGN 232
           +N+L +  A  L    +  N S L  L L  N         LA +     ++  +D+ GN
Sbjct: 230 DNNLTDAGAAALASALLSPNIS-LLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGN 288

Query: 233 YFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGW 268
            F        G  +   S+   GN+L      +  +
Sbjct: 289 KFGEE-----GAQLLAESLLEPGNELESLWVKDDSF 319

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 2e-04
 Identities = 13/59 (22%), Positives = 22/59 (37%)

Query: 48  LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRF 106
           L+ +D+  NRL          L  L  L++  N  +   P +   + S   + L  N  
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 33/123 (26%), Positives = 47/123 (38%), Gaps = 33/123 (26%)

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP-------------ARPL 720
           AI+ +H       +H D+KP N+LLD      + DFGL   L              A P 
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 721 DTVVE--TPSSSSG---------------IKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           + +     P SS                   GT  YIAPE    +  +   D +S G+++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229

Query: 764 LEM 766
            EM
Sbjct: 230 YEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 48/220 (21%)

Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE+       +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHERMSY 130

Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 183

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           P        T  Y APE   G       D++S G ++ EM
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 3e-04
 Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 66/229 (28%)

Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+ G V   +  + G+N   VA+K L+        A +++  E   ++ + H+N+I 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIG 79

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND---KLEVCNLSLIQTLNIAID-- 670
           ++ +                 F    SLEE+     D    +E+ + +L Q + + +D  
Sbjct: 80  LLNV-----------------FTPQKSLEEF----QDVYLVMELMDANLCQVIQMDLDHE 118

Query: 671 --------VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-----FLPA 717
                   +   I++LH      ++H DLKPSN+++  D    + DFGLA+     F+  
Sbjct: 119 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                VV           T  Y APE   G       D++S G ++ EM
Sbjct: 176 ---PYVV-----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 48/224 (21%)

Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE+       +E+ + +L Q + + +D      
Sbjct: 82  LNV-----------------FTPQKSLEEF-QDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 124 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 176

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 177 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 52/262 (19%), Positives = 96/262 (36%), Gaps = 12/262 (4%)

Query: 23  KLENLSLAENHLTGQLPVSIGNLSA-LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ 81
            L +L L  N++T  +P  IG L + L+ +D+  N++   +P  L  L  L  L++  N 
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174

Query: 82  FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN 141
            S  +P  + N+S+   + L  N+            L +  + +   NN    L  SLSN
Sbjct: 175 LSD-LPKLLSNLSNLNNLDLSGNKIS---DLPPEIELLSALEELDLSNNSIIELLSSLSN 230

Query: 142 ASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR--AANDLDFVTVLANCSKL 199
             NL  LEL +N+   +         +    +  +N+  +   +   L  +  L      
Sbjct: 231 LKNLSGLELSNNKL--EDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNS 288

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN-YFSGTIPPGLGNLVHLNSIAMEGNQL 258
            +  L       LL   L NL  T+  +++  N           G      ++++  +  
Sbjct: 289 LSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLN 348

Query: 259 IGTVPPEIGWLKNLQSLYLNSN 280
                       NL    + + 
Sbjct: 349 NLWTLDNALDESNLNRYIVKNP 370

Length = 394

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 13/112 (11%)

Query: 659 LSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           LS +  +  +  VA+ +E+L   +C    VH DL   NVL+    +  + DFGLA+    
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLAR---- 287

Query: 718 RPLDTVVETPSSSSGIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
              D + ++   S G     + ++APE    +  +   DV+SFGILL E+F+
Sbjct: 288 ---DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 392 SLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
           +L+ + + +N  +  IP  +   L ++KVLDLS N L+   P+    L  L  L+LS N+
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 451 F 451
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 48/245 (19%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN-- 612
           +F S  ++G+G+FG V      + G + A+K+L        K+ + E E +  IR     
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDI 54

Query: 613 LIKIITICSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           L++  ++     F     K  +Y   +F+  G +   L + +   E      I    +AI
Sbjct: 55  LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI 114

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP------------- 716
           D    + ++H          D+KP N+LLD      + DFGL   L              
Sbjct: 115 DSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165

Query: 717 ARPLDTVVETPSSSSGIK--------------GTVGYIAPEYGTGSEASMTGDVYSFGIL 762
           + P D   +  +S    +              GT  YIAPE    +  +   D +S G++
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 763 LLEMF 767
           + EM 
Sbjct: 226 MYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 76/323 (23%), Positives = 137/323 (42%), Gaps = 64/323 (19%)

Query: 562 VGQGSFGTVFKG--IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           VG+G++G V+K     G++    A+K   +   G   S   E   LR ++H N+I +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIAL--- 63

Query: 620 CSSIDFNGVDFKA-IVYDFMQNGSLEEW----LH---QNNDKLEVCNLSLIQTLNIAIDV 671
              +  +  D K  +++D+ ++   + W     H   + N K      S++++L     +
Sbjct: 64  -QKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSL--LYQI 117

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFL--PARP---LDT 722
              I YLH +    V+H DLKP+N+L+           + D G A+    P +P   LD 
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR---------P 772
           VV           T  Y APE   G+       D+++ G +  E+ +             
Sbjct: 175 VVV----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224

Query: 773 TDSMFHEGLTLHEFSKMVLP-----EKVMEIVD-PSLLLEVR----ANNSMSRGGERVKI 822
           T + FH       FS M  P     E + ++ + P+L  + R    AN+S+ +  E+ K+
Sbjct: 225 TSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV 284

Query: 823 EECLVAVIRIGVVCSMESPTDRM 845
           +      + +  + +M+ PT R+
Sbjct: 285 KPDSKVFLLLQKLLTMD-PTKRI 306

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 32/138 (23%), Positives = 49/138 (35%), Gaps = 38/138 (27%)

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA----------------- 712
           ++  AIE +H   K   +H D+KP N+L+D D    + DFGL                  
Sbjct: 109 ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165

Query: 713 ----KFLPARPLDTVVETPSSS--------------SGIKGTVGYIAPEYGTGSEASMTG 754
                  P+     +                       + GT  YIAPE    +  +   
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 755 DVYSFGILLLEMFSRRRP 772
           D +S G++L EM   + P
Sbjct: 226 DWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 40.7 bits (96), Expect = 0.002
 Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 69/231 (29%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN-----LMQKGALKSFLTECEALRSIR-HRNLIKI 616
           G+G+F  V K    + G   A+K +      L Q   L+    E +ALR +  H N++++
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR----EIQALRRLSPHPNILRL 63

Query: 617 IT------------ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           I             +   +D N       +Y+ ++         +   +  V +  + Q 
Sbjct: 64  IEVLFDRKTGRLALVFELMDMN-------LYELIKG------RKRPLPEKRVKSY-MYQL 109

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L        +++++H +    + H D+KP N+L+  D++  + DFG  +         + 
Sbjct: 110 L-------KSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR--------GIY 150

Query: 725 ETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFS 768
             P  +  I  T  Y APE       YG      M  D+++ G +  E+ S
Sbjct: 151 SKPPYTEYI-STRWYRAPECLLTDGYYG----PKM--DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only]

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 27/131 (20%), Positives = 43/131 (32%), Gaps = 17/131 (12%)

Query: 591 QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQ 649
           +   + S L      R      L   +    SID     D      +  +   L  W  +
Sbjct: 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKP--NAYRGRQLARWDDE 165

Query: 650 NNDKLEVCNLSLIQTLNIAIDVASA-IEYLHHHC-----KPPVVHGDLKPSNVLLDHDMV 703
                      L       I +A   I++L  +       P +VHGD +P N+++D    
Sbjct: 166 ----YRRAKKELGGR----IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP 217

Query: 704 AHVGDFGLAKF 714
             V D+ LA  
Sbjct: 218 TGVLDWELATL 228

Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 31/113 (27%)

Query: 131 LTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFV 190
           L GF+P  +S   +L+ + L  N   G +  +  S+ +L VL             DL + 
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL-------------DLSY- 475

Query: 191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLG 243
                           N F G +P SL  L+ ++  +++ GN  SG +P  LG
Sbjct: 476 ----------------NSFNGSIPESLGQLT-SLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 27/137 (19%), Positives = 56/137 (40%), Gaps = 22/137 (16%)

Query: 582 VAVKVLNLMQKGALKSFLTECEALRSIRHRNLI--KIITICSSIDFNGVDFKAIVYDFMQ 639
             +K+    +KGA      E   L+ +  + L   K++    S  ++ +     + ++++
Sbjct: 24  YVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLASGESDGWSYL-----LMEWIE 76

Query: 640 NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD 699
             +L+E   +  +              IA  +A  +  LH      + HGDL P N+L+D
Sbjct: 77  GETLDEVSEEEKED-------------IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123

Query: 700 HDMVAHVGDFGLAKFLP 716
              +  + D+  A + P
Sbjct: 124 DGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 44/243 (18%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F S  ++G+G+FG V      + G + A+K+L   ++++K  +     E + L      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            ++K+        F       ++ +F+  G +   L + +   E      I    +AID 
Sbjct: 62  WVVKMF-----YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR------------- 718
              + ++H          D+KP N+LLD      + DFGL   L                
Sbjct: 117 IHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 719 PLDTVVETPSSSSGIK--------------GTVGYIAPEYGTGSEASMTGDVYSFGILLL 764
           P D   +  +S    +              GT  YIAPE    +  +   D +S G+++ 
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 765 EMF 767
           EM 
Sbjct: 228 EML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI--- 616
           N++G GSFG V++ I  +    VA+K   ++Q    K+   E   ++++ H N+I +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDY 127

Query: 617 -ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH--QNNDKLEVCNLSLIQTLNIAIDVAS 673
             T C   +   + F  +V +F+     +   H  +NN  L +  + L      +  +  
Sbjct: 128 YYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-----YSYQLCR 181

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           A+ Y+H      + H DLKP N+L+D +     + DFG AK L A           S S 
Sbjct: 182 ALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA--------GQRSVSY 230

Query: 733 IKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEM 766
           I     Y APE   G+    T  D++S G ++ EM
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-----RHRNLIKI 616
           +G+G++G VFK +  +NG   AVK+L+      +     E EA  +I      H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH---QNNDKLEVCNLSLIQTLNIAIDVAS 673
             +    D    D   +V +    GS+ + +    +  +++E           IA  +  
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME--------EPIIAYILHE 132

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVETPSSSS 731
           A+  L H      +H D+K +N+LL  +    + DFG++  L +  L  +T V TP   +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                   IA E    S      DV+S GI  +E+
Sbjct: 193 P-----EVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF----LPARPLDTVVETPS- 728
           A+EYLH++    +VH DLKP N+L+       + DFGL+K     L     +  +E  + 
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 729 --SSSGIKGTVGYIAPEY----GTGSEASMTGDVYSFGILLLE 765
                 + GT  YIAPE     G G       D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	869
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
smart00090	237	RIO RIO-like kinase.	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
PLN03150	623	hypothetical protein; Provisional	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.31
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.27
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.27
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.26
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.23
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
PLN03150	623	hypothetical protein; Provisional	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	99.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.01
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.98
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
PRK09902	216	hypothetical protein; Provisional	98.71
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.67
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.65
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.63
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.61
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.6

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.7e-100  Score=938.15  Aligned_cols=810  Identities=31%  Similarity=0.508  Sum_probs=558.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      |||++|.+++.+|..+. .+++|++|+|++|.+++.+|.+|+++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus       145 L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  223 (968)
T PLN00113        145 LDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN  223 (968)
T ss_pred             EECcCCcccccCChHHh-cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence            34444444444444443 44555555555555544445555555555555555555544445555555555555555555


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      +.+.+|..|.++++|++|+|++|.+.+.+| ..+.++++|+.|++++|.+++..|..+.++++|++|+|++|.+.+..|.
T Consensus       224 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~  302 (968)
T PLN00113        224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIP-SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE  302 (968)
T ss_pred             cCCcCChhHhcCCCCCEEECcCceeccccC-hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh
Confidence            554455555555555555555555544444 2344555555555555555544555555555555555555555555555


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCcc
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG  241 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  241 (869)
                      .|..+++|+.|++++|.+....+      ..+..+++|+.|++++|.+.+.+|..+..+.+ |+.|++++|.+++.+|..
T Consensus       303 ~~~~l~~L~~L~l~~n~~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~-L~~L~Ls~n~l~~~~p~~  375 (968)
T PLN00113        303 LVIQLQNLEILHLFSNNFTGKIP------VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN-LTVLDLSTNNLTGEIPEG  375 (968)
T ss_pred             hHcCCCCCcEEECCCCccCCcCC------hhHhcCCCCCEEECcCCCCcCcCChHHhCCCC-CcEEECCCCeeEeeCChh
Confidence            55555555555555555543221      24555666666666666666666666666554 666666666666666666


Q ss_pred             ccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccc
Q 002897          242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI  321 (869)
Q Consensus       242 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  321 (869)
                      +..+++|+.|++++|++.+..|..++.+++|+.|++++|++++..|..|.++++|+.|++++|++++.++..+..+++|+
T Consensus       376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  455 (968)
T PLN00113        376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ  455 (968)
T ss_pred             HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence            66666666666666666666677777777777777777777777777777777777888888877777777777788888


Q ss_pred             eeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCc
Q 002897          322 MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN  401 (869)
Q Consensus       322 ~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  401 (869)
                      .|++++|++.+.+|..+.  ...++.|++++|++++..|..+.++++|+.|+|++|.+++.+|..+.++++|++|++++|
T Consensus       456 ~L~L~~n~~~~~~p~~~~--~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  533 (968)
T PLN00113        456 MLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN  533 (968)
T ss_pred             EEECcCceeeeecCcccc--cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCC
Confidence            888888888776666442  256788999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCCCCC
Q 002897          402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDE  481 (869)
Q Consensus       402 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~  481 (869)
                      ++++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.+++++|+++|.+|..+.+..+....+.||+.+|+....
T Consensus       534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~  613 (968)
T PLN00113        534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT  613 (968)
T ss_pred             cccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccc
Confidence            99999999999999999999999999999999999999999999999999999999888888888899999999997655


Q ss_pred             CCCCCCCCCCcchhhhhhhhhhHHHHHHHHHHHHHHhheeeecccCC--Ccccch-hhhccCC---CcccHHHHHHHhcC
Q 002897          482 FHLPSCPSKRSRKLIATILKVVIPTIVSCLILSACFIVIYGRRRSTD--RSFERT-TMVEQQF---PMISYAKLSKATSE  555 (869)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~i~~~~~~~~~~~~r~~~--~~~~~~-~~~~~~~---~~~~~~~~~~~~~~  555 (869)
                      ...+.|...+....+  +..+++.+++.+++++++++++++++|+..  ++.+.. ...+...   ..............
T Consensus       614 ~~~~~c~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  691 (968)
T PLN00113        614 SGLPPCKRVRKTPSW--WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSS  691 (968)
T ss_pred             cCCCCCcccccccee--eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhh
Confidence            555677543222111  111111111111111122222222222211  111110 0000000   00001122333456


Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      |...++||+|+||.||+|++..+|..||||+++....    ....|++++++++|||||+++++|.+.     ...++||
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~  762 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIH  762 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEE
Confidence            8888999999999999999988999999999864332    223568899999999999999998654     5689999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.++++.         ++|.++.+++.|+|+|++|||..+.++|+|||+||+||+++.++.+++. ||.+...
T Consensus       763 Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        763 EYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             eCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999953         7899999999999999999996666699999999999999999888875 6554322


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc-c
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE-K  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-~  794 (869)
                      ..            .....|+..|+|||++.+..++.++|||||||++|||+||+.||+..........+|.+..... .
T Consensus       833 ~~------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        833 CT------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH  900 (968)
T ss_pred             cc------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc
Confidence            11            1123578999999999999999999999999999999999999976555445555555543322 2


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcccCC
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDG  867 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  867 (869)
                      .....|+.+...            .....+...++.+++.+||+.||++||||+||++.|+++.+.......+
T Consensus       901 ~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~  961 (968)
T PLN00113        901 LDMWIDPSIRGD------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG  961 (968)
T ss_pred             hhheeCccccCC------------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccccC
Confidence            333444433211            1112345567889999999999999999999999999998766554443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5e-56  Score=549.02  Aligned_cols=471  Identities=33%  Similarity=0.535  Sum_probs=318.3

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +|||++|+++|.+|.+++..+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..|+.+++|++|+|++|
T Consensus        97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n  174 (968)
T PLN00113         97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN  174 (968)
T ss_pred             EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccC
Confidence            3677888887778887776677777777777777655543  33555556666666555555555666666666666666


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      .+.+.+|..|.++++|++|+|++|.+.+.+| ..+.++++|+.|++++|++++.+|..++++++|++|++++|.+.+..|
T Consensus       175 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p  253 (968)
T PLN00113        175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIP-RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP  253 (968)
T ss_pred             cccccCChhhhhCcCCCeeeccCCCCcCcCC-hHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence            6655556666666666666666666554444 335555555555555555555555555555555555555555555555


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCc------------------chhhhccCCCCCcEEEccCCCCCCCCChhhhhccc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDL------------------DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN  222 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  222 (869)
                      ..|..+++|++|++++|.+....+..+                  ..+..+.++++|++|++++|.+++..|..+..+++
T Consensus       254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~  333 (968)
T PLN00113        254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR  333 (968)
T ss_pred             hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence            555555555555555555543211100                  01123445555555555555555555555555544


Q ss_pred             cceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecc
Q 002897          223 TMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE  302 (869)
Q Consensus       223 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  302 (869)
                       |+.|++++|.+.+.+|..++.+++|+.|++++|++.+..|..+..+++|+.|++++|.+.+..|..+..+++|+.|+++
T Consensus       334 -L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~  412 (968)
T PLN00113        334 -LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ  412 (968)
T ss_pred             -CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECc
Confidence             5555555555555555555555555555555555555555555555566666666666665666666666677777777


Q ss_pred             cccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccccccccc
Q 002897          303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGD  382 (869)
Q Consensus       303 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  382 (869)
                      +|++++..|..|..+++|+.|++++|++++.+|..+.. .+.++.|++++|++.+.+|..+ ..++|+.|++++|++++.
T Consensus       413 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~  490 (968)
T PLN00113        413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD-MPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGA  490 (968)
T ss_pred             CCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc-CCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCc
Confidence            77777666777777777777777777777665554443 3445678888888887777655 457889999999999999


Q ss_pred             CCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCC-Ccc
Q 002897          383 IPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVF  461 (869)
Q Consensus       383 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~  461 (869)
                      +|..+.++++|+.|++++|++++.+|..++.+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|.. ..+
T Consensus       491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  570 (968)
T PLN00113        491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV  570 (968)
T ss_pred             cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988864 567


Q ss_pred             CCCccccccCCcccCC
Q 002897          462 SNKTRFSLSGNGKLCG  477 (869)
Q Consensus       462 ~~~~~~~~~~n~~~c~  477 (869)
                      ..++.+.+++|+..+.
T Consensus       571 ~~L~~l~ls~N~l~~~  586 (968)
T PLN00113        571 ESLVQVNISHNHLHGS  586 (968)
T ss_pred             cccCEEeccCCcceee
Confidence            7889999999987653

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-48  Score=414.86  Aligned_cols=289  Identities=40%  Similarity=0.673  Sum_probs=244.1

Q ss_pred             CCCcccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEE
Q 002897          540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI  619 (869)
Q Consensus       540 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  619 (869)
                      ....+++.++..+|++|...++||+|+||.||+|... +|+.||||++........++|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4567999999999999999999999999999999996 669999998865443314569999999999999999999999


Q ss_pred             eeccccCCCc-eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          620 CSSIDFNGVD-FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       620 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      |.+.     + ..++|||||++|+|.++++.....    +++|..+++||.++|+||+|||+.+.|+||||||||+|||+
T Consensus       140 C~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  140 CLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             EecC-----CceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            9875     3 689999999999999999987642    58999999999999999999999998899999999999999


Q ss_pred             cCCCcEEEccccccccCCC-CCCCCccccCCCCCCc-cCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          699 DHDMVAHVGDFGLAKFLPA-RPLDTVVETPSSSSGI-KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      |+++++||+|||+|+..+. ..         ..... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+..
T Consensus       211 D~~~~aKlsDFGLa~~~~~~~~---------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEGDT---------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CCCCCEEccCccCcccCCcccc---------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            9999999999999965543 21         11111 6999999999999999999999999999999999999998764


Q ss_pred             c-cCCchHHHhhhhhccc-ccccccCccchh-hhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          777 F-HEGLTLHEFSKMVLPE-KVMEIVDPSLLL-EVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       777 ~-~~~~~~~~~~~~~~~~-~~~~~~d~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      . .....+..|....... .+.+++|+.+.. ..             ...+....+..++.+|++.+|++||+|.||+++
T Consensus       282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~-------------~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEY-------------PDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             CCcccccHHHHHHHHHHCcchhheeCCCccCCCC-------------ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            3 3344467776555444 688999988752 21             111566779999999999999999999999999


Q ss_pred             HHHHHHh
Q 002897          854 LCAAREA  860 (869)
Q Consensus       854 L~~~~~~  860 (869)
                      |+.+...
T Consensus       349 L~~~~~~  355 (361)
T KOG1187|consen  349 LEGILSL  355 (361)
T ss_pred             HHhhccc
Confidence            9666543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=380.09  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=210.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc-eEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD-FKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~  632 (869)
                      +.+..+.||+|..|+||+|+++.+++.+|+|++... +....+++.+|++++++.+||+||.++|.|...     . ...
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is  154 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS  154 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence            455678999999999999999999999999999533 445568899999999999999999999998754     4 699


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      |+||||++|+|.++++..+      .+++....+|+.+|++||.|||+ +   +||||||||+|||++..|++||||||.
T Consensus       155 I~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             eehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence            9999999999999998764      38999999999999999999996 6   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +..+...          .....+||..|||||.+.+..|+.++||||||++++|+++|+.||...........+....+.
T Consensus       226 S~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  226 SGILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV  295 (364)
T ss_pred             cHHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence            9876543          334578999999999999999999999999999999999999999765222223323222222


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIE-ECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .+..                       +..++ .+++++..++..|+++||.+|||+.|+++.
T Consensus       296 ~~pp-----------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  296 DEPP-----------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             cCCC-----------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1110                       01111 367789999999999999999999999873

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-46  Score=374.17  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-------chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-------KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..       .......++|+++|++++|||||++.+++...  
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--  248 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--  248 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence            456888999999999999999999999999999996321       11233467999999999999999999996554  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---C
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---M  702 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~  702 (869)
                         +..|+||||++||+|.+.+-....      +.+.....+++|++.|+.|||+.   ||+||||||+|||+..+   .
T Consensus       249 ---ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  249 ---DSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             ---CceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence               778999999999999999988764      77788899999999999999999   99999999999999766   6


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC---CCccccchhhhHHHHHHHcCCCCCCcCccC
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE---ASMTGDVYSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~el~tg~~pf~~~~~~  779 (869)
                      .+||+|||+|+..+..         ......+||+.|.|||++.+..   +..++|+||+||++|-+++|.+||.+....
T Consensus       317 llKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             EEEecccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            8999999999987643         4556788999999999988764   334789999999999999999999865443


Q ss_pred             CchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          780 GLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....++..+..+.                        ..++...+..++..++|.+||..||++|||+.|+++.
T Consensus       388 ~sl~eQI~~G~y~------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  388 PSLKEQILKGRYA------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ccHHHHHhcCccc------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            2222222221110                        1223445677888999999999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-46  Score=373.27  Aligned_cols=202  Identities=27%  Similarity=0.532  Sum_probs=183.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|...+.||+|+||+||+|+++.++..||||.+...  .+...+.+..|+.+|+.++|||||++++++.+.     +.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence            46899999999999999999999999999999999755  455667789999999999999999999997654     79


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC------CcE
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD------MVA  704 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~  704 (869)
                      .|+|||||.||+|.+|++..+.      +++..++.++.|+|.||++||++   +||||||||+|||++..      -.+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L  154 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL  154 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence            9999999999999999998863      89999999999999999999999   99999999999999765      468


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      ||+|||+|+.+.+..         .....+|++.|||||++...+|+.|+|+||+|+|+|++++|+.||+...
T Consensus       155 KIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  155 KIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             EecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            999999999887543         3455789999999999999999999999999999999999999998643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=388.85  Aligned_cols=260  Identities=30%  Similarity=0.449  Sum_probs=211.1

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeE-EEEEEeecccch--hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGML-VAVKVLNLMQKG--ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ....+.+|+|+||+||+|.+  .|+. ||||++......  ..+.|.+|+.++.+++|||||+++|+|....    ...+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence            34456699999999999999  5666 999999754322  2568999999999999999999999997641    2689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceeecCCC-cEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP-VVHGDLKPSNVLLDHDM-VAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg  710 (869)
                      +||||+++|+|.++++...    ...+++..+..++.|||+||.|||+.   + ||||||||+|||++.++ ++||+|||
T Consensus       117 iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            9999999999999998841    12499999999999999999999999   7 99999999999999998 99999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC--CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT--GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      +++......        ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||...... ........
T Consensus       190 lsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~~  260 (362)
T KOG0192|consen  190 LSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVVV  260 (362)
T ss_pred             cceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh
Confidence            998765431        1222367999999999999  568999999999999999999999999865431 11111110


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                      ..                          .++..+..++..+..++.+||+.||++||++.|++..|+.+......
T Consensus       261 ~~--------------------------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  261 GG--------------------------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             cC--------------------------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            00                          01111223677889999999999999999999999999999886654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-47  Score=359.87  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=213.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..+|++.++||+|+||+||+|+...+|..||.|.++.  .+..+......|+.+|++++|||||++++...   .++...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence            4568889999999999999999999999999999863  34556678899999999999999999988422   122344


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEEcc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      .+||||||.+|+|.++++..+..  ...+++..+|+++.|++.||.++|++ .++  |+||||||.||+++.+|.+||+|
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence            89999999999999999876543  34599999999999999999999994 235  89999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+++.+....        ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.     .+.+..+
T Consensus       172 fGL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~  238 (375)
T KOG0591|consen  172 FGLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK  238 (375)
T ss_pred             chhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH
Confidence            99999887653        3345578999999999999999999999999999999999999999753     3333333


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      .+...+..                      +...+.++..+..++..|+..||+.||+.-.++..+.
T Consensus       239 KI~qgd~~----------------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  239 KIEQGDYP----------------------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHcCCCC----------------------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            33221111                      1122467788999999999999999998655554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-45  Score=385.46  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=211.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .+|...+.||+|||+.||++++..+|..||+|++.+.   .....+...+|++|.+.++|||||+++++|     ++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999889999999999652   345567889999999999999999999995     45599


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      +|||.|+|+.++|..++++..      ++++.+++.+.+||+.||.|||+.   +|+|||||..|+|++++.++||+|||
T Consensus        93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            999999999999999999654      499999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|..+..+.        ......+|||.|+|||++.....+..+||||+|||+|.|+.|++||+..     .+.+....+
T Consensus       164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~I  230 (592)
T KOG0575|consen  164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKI  230 (592)
T ss_pred             eeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHH
Confidence            999876543        4456688999999999999989999999999999999999999999752     122222221


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...   +.                     ..+.....+..+||.++|+.||.+|||+++|+..
T Consensus       231 k~~---~Y---------------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  231 KLN---EY---------------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             Hhc---Cc---------------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            100   00                     0111334556799999999999999999999863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=351.14  Aligned_cols=275  Identities=19%  Similarity=0.286  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +.|+...++|+|+||+||+++++.+|+.||||++-...  +...+-..+|+++|++++|+|+|.++++|..     ....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----ccee
Confidence            35778889999999999999999999999999995332  3344667999999999999999999999654     4889


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+|||+. ++.+-+.....     .++...+.++++|++.|+.|+|++   +++||||||+||||+.+|.+||||||+
T Consensus        77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence            999999987 66566666554     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH--HHhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL--HEFSK  788 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~  788 (869)
                      |+.+....        ...+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+-+..+  .....
T Consensus       148 AR~L~~pg--------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  148 ARTLSAPG--------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             hHhhcCCc--------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            99876422        33455678999999999887 679999999999999999999999987643221111  01111


Q ss_pred             hhcccccccccCc--cchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDP--SLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...+. ...++..  .+.+..-........ .....+.....+++++..|++.||++|++.+|++.
T Consensus       220 ~L~pr-hq~iF~~N~~F~Gv~lP~~~~~ep-Le~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPR-HQSIFSSNPFFHGVRLPEPEHPEP-LERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHH-HHHHhccCCceeeeecCCCCCccc-hhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111 1111111  000000000000000 01112234457889999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-43  Score=335.56  Aligned_cols=277  Identities=21%  Similarity=0.286  Sum_probs=213.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+|...+++|+|.||.||+|++..+|+.||||.++...  ++......+|+..|+.++|+||+.+++++..     .+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCce
Confidence            46888899999999999999999999999999997543  2334678999999999999999999999655     4788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      .+|+|||+. +|+..++....     .++..++..++.++++|++|+|++   .|+|||+||.|+|++.+|.+||+|||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence            999999977 99999998765     499999999999999999999999   899999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+.+....        ......+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+- ..+....+..
T Consensus       148 Ar~f~~p~--------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~L  218 (318)
T KOG0659|consen  148 ARFFGSPN--------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRAL  218 (318)
T ss_pred             hhccCCCC--------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHc
Confidence            99887654        222333679999999988775 5999999999999999999998887653221 1111112221


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      -.....++.+-....++..-..............+.....+++.+|+.+||.+|+|+.|+++.
T Consensus       219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111122222222222222111111111222334556677999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=374.97  Aligned_cols=258  Identities=30%  Similarity=0.472  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +.+...+.||+|.||.||.|.+. ....||+|.++... ...+.|.+|+++|++++|++||+++++|...     +..+|
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyI  278 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYI  278 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEE
Confidence            34556789999999999999994 44589999997542 2347788999999999999999999999764     46899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |||||+.|+|.+|++....    ..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+
T Consensus       279 VtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            9999999999999998332    2488999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ...++..       .......-...|.|||.+..+.++.|||||||||+|||++| |+.||..+.     ..+..+.+  
T Consensus       352 ~~~d~~Y-------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~~l--  417 (468)
T KOG0197|consen  352 LIGDDEY-------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLELL--  417 (468)
T ss_pred             ccCCCce-------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHHHH--
Confidence            5554431       11222334678999999999999999999999999999999 899987543     22322222  


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                                           .++.+.+.++.||..+.++|..||+.+|++|||++.+...++.+...
T Consensus       418 ---------------------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  418 ---------------------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ---------------------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                                 12344556667999999999999999999999999999888887654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=367.92  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=214.5

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec---ccchhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .+...+|.+.+.||+|+|++|++|+...+++.||||++.+   ..+...+....|-++|.+| .||.|++++..|     
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence            3456789999999999999999999999999999999953   2344457788999999999 899999999884     


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      ++....|+|+||+++|+|.++|++.+.      +++...+.++.+|+.|++|||++   |||||||||+|||+|++|++|
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            455899999999999999999999864      89999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCc-----cccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          706 VGDFGLAKFLPARPLDTV-----VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      |+|||.|+.+.+......     .........++||..|.+||++..+..++.+|+||||||+|+|+.|++||.... +.
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-ey  293 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EY  293 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HH
Confidence            999999999876543311     111112256899999999999999999999999999999999999999997532 22


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..+.+.....+                            ..++..++.+.+|+.+.|..||.+|+|++||.+
T Consensus       294 liFqkI~~l~y----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  294 LIFQKIQALDY----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHHHhcc----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            23333222111                            011123355779999999999999999988865

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=374.50  Aligned_cols=408  Identities=22%  Similarity=0.241  Sum_probs=314.9

Q ss_pred             cCChhhhhccCCcCEEeccCCcCccccCcccccC--cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcc
Q 002897           12 DIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNL--SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPS   89 (869)
Q Consensus        12 ~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~   89 (869)
                      +.|+...|   +-..||++++.|..+....+.++  ..-+.||+++|+|..+.+..|.++++|+.++|..|.++ .+|..
T Consensus        45 ~cpa~c~c---~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f  120 (873)
T KOG4194|consen   45 ECPATCPC---NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRF  120 (873)
T ss_pred             cCCCcCCC---CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccc
Confidence            45655543   45667777777764433334333  23345777777777777777777777777777777777 55655


Q ss_pred             cccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCC
Q 002897           90 IYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNL  169 (869)
Q Consensus        90 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  169 (869)
                      .....+|+.|+|.+|.|+ ++....++.++.|+.|+|+.|.|+.+.-.+|..-.++++|+|++|.|+.+..+.|.++.+|
T Consensus       121 ~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL  199 (873)
T KOG4194|consen  121 GHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSL  199 (873)
T ss_pred             cccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchh
Confidence            555556777777777776 6666666777777777777777776655666666677777777777776666666666666


Q ss_pred             CEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCC
Q 002897          170 SVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLN  249 (869)
Q Consensus       170 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  249 (869)
                      ..|.|++|+|+.++..      .|+++++|+.|+|..|+|.                         -..--.|..+++|+
T Consensus       200 ~tlkLsrNrittLp~r------~Fk~L~~L~~LdLnrN~ir-------------------------ive~ltFqgL~Sl~  248 (873)
T KOG4194|consen  200 LTLKLSRNRITTLPQR------SFKRLPKLESLDLNRNRIR-------------------------IVEGLTFQGLPSLQ  248 (873)
T ss_pred             eeeecccCcccccCHH------Hhhhcchhhhhhcccccee-------------------------eehhhhhcCchhhh
Confidence            6666666666666543      4555666666666555554                         23344577888888


Q ss_pred             eeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcc
Q 002897          250 SIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNK  329 (869)
Q Consensus       250 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  329 (869)
                      .|.|..|.+.......|..+.++++|+|+.|++...-..++.+++.|+.|++++|.|..+.++++.-+++|++|+|++|+
T Consensus       249 nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~  328 (873)
T KOG4194|consen  249 NLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR  328 (873)
T ss_pred             hhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccc
Confidence            88899999888888889999999999999999998888899999999999999999998889999999999999999999


Q ss_pred             cCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCC---ccccCCCCCcEEEeeCccccCC
Q 002897          330 LDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP---GTLSACTSLEYVKMQDNSFSGS  406 (869)
Q Consensus       330 l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~  406 (869)
                      |+ .++++.+..+..++.|+|++|.++..-..+|..+++|+.|||++|.+++.+.   ..|.++++|+.|++.+|+|...
T Consensus       329 i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I  407 (873)
T KOG4194|consen  329 IT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI  407 (873)
T ss_pred             cc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence            98 7788888888888899999999987777889999999999999999987654   3588899999999999999955


Q ss_pred             CCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCC
Q 002897          407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       407 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  457 (869)
                      ...+|.+++.|++|||.+|.|..+-|++|..+ .|++|-+..-.|-+.+.-
T Consensus       408 ~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  408 PKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL  457 (873)
T ss_pred             chhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccH
Confidence            55799999999999999999999999999999 899998877666655543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=366.33  Aligned_cols=278  Identities=20%  Similarity=0.261  Sum_probs=210.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhh-HHHHHHHHHHHhCC-CCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|.+.++||.|.||.||+|+...+|..||||.++..-.... ..-.+|+..|++++ |||||++.+++.+.    ...
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cce
Confidence            4578999999999999999999999999999999964432222 23379999999998 99999999997654    238


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|||||+. +|++.++.++.     .+++.+++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence            9999999966 99999998854     499999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCccc-CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+.+...         ...+..+.|.+|+|||++ +.+-|+.+.||||+|||++|+.+-++.|.+..+-+ .+-.....
T Consensus       156 LARev~Sk---------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~V  225 (538)
T KOG0661|consen  156 LAREVRSK---------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEV  225 (538)
T ss_pred             cccccccC---------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHH
Confidence            99977554         345567889999999975 45678999999999999999999999987643321 12222221


Q ss_pred             hcccccccccC-ccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVD-PSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .-.....++.. ..+.....-. ..............+..+..+++.+|++|||.+||||.|.++.
T Consensus       226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111111110 0000000000 0111111112223367888999999999999999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.2e-47  Score=375.46  Aligned_cols=447  Identities=26%  Similarity=0.400  Sum_probs=334.5

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++|.++ .+-.++- .+..+.+|++++|+++ ..|.+++.+.+++.|+.++|+++ .+|..++.+.+|+.|+.++|.
T Consensus        50 lils~N~l~-~l~~dl~-nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~  125 (565)
T KOG0472|consen   50 LILSHNDLE-VLREDLK-NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNE  125 (565)
T ss_pred             hhhccCchh-hccHhhh-cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccc
Confidence            456667776 5555554 5677777777777777 66777777777777777777777 667777777777777777777


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      +. .+|+.++.+..|+.|+..+|++. ++|.+ +..+.+|..|++.+|++....|..+. ++.|++||.-.|.++ ..|.
T Consensus       126 ~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~-~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~  200 (565)
T KOG0472|consen  126 LK-ELPDSIGRLLDLEDLDATNNQIS-SLPED-MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPP  200 (565)
T ss_pred             ee-ecCchHHHHhhhhhhhccccccc-cCchH-HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCCh
Confidence            77 56667777777777777777776 66644 45666777777777777755444444 777777777777654 3455


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhh-hccccceEEEecCCcccccCCc
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLA-NLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                      .+++|.+|..|+|.+|+|..+|        .|.+|+.|++|+++.|+|. .+|.... ++. ++..|||.+|+++ ..|+
T Consensus       201 ~lg~l~~L~~LyL~~Nki~~lP--------ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~-~l~vLDLRdNklk-e~Pd  269 (565)
T KOG0472|consen  201 ELGGLESLELLYLRRNKIRFLP--------EFPGCSLLKELHVGENQIE-MLPAEHLKHLN-SLLVLDLRDNKLK-EVPD  269 (565)
T ss_pred             hhcchhhhHHHHhhhcccccCC--------CCCccHHHHHHHhcccHHH-hhHHHHhcccc-cceeeeccccccc-cCch
Confidence            6777777777777777776665        2667777777777777776 5555555 444 3777777777777 6677


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccC------------------------------------
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG------------------------------------  284 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------------------  284 (869)
                      .+.-+++|++|++++|.|+ ..|..++++ .|+.|.+.+|.+..                                    
T Consensus       270 e~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~  347 (565)
T KOG0472|consen  270 EICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETA  347 (565)
T ss_pred             HHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccccc
Confidence            7777777777777777776 566667777 67777777776541                                    


Q ss_pred             -c-CCCC---CCCCccccceecccccccccCCcCccCccc---cceeeccCcccCCCCCccccccccccceecccCCccc
Q 002897          285 -Y-IPSS---LGNLTMLTLLALEINNLQGKIPSSLGNCTS---LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLS  356 (869)
Q Consensus       285 -~-~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~  356 (869)
                       . .+..   ...+.+.+.|+++.-+++ .+|+....-..   .+..+++.|++. .+|............+.+++|.++
T Consensus       348 ~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is  425 (565)
T KOG0472|consen  348 MTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS  425 (565)
T ss_pred             CCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc
Confidence             0 1111   123456788888888888 56665554444   788999999998 788888888888888889999887


Q ss_pred             CCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccc
Q 002897          357 GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE  436 (869)
Q Consensus       357 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  436 (869)
                       .+|..++.+++|..|+|++|.+. .+|..++.+..|+.|++|.|+|. .+|..+..+..|+.+-.++|++....|..+.
T Consensus       426 -fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~  502 (565)
T KOG0472|consen  426 -FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK  502 (565)
T ss_pred             -cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence             88899999999999999999998 78999999999999999999998 8899988888888888888999877677799


Q ss_pred             cccccCeeccccccCcccCCCCCccCCCccccccCCccc
Q 002897          437 NLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKL  475 (869)
Q Consensus       437 ~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~  475 (869)
                      +|.+|..|||.+|.+...+|..|.+.+++++.+.|||+.
T Consensus       503 nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  503 NMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            999999999999999988888899999999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.2e-47  Score=377.92  Aligned_cols=432  Identities=32%  Similarity=0.464  Sum_probs=379.8

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      |+++++|+++ ++|..++ .+.+++.|+.++|+++ .+|+.+..+.+|+.|+.++|++. .+|+.++.+..|..|+..+|
T Consensus        72 vl~~~~n~l~-~lp~aig-~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N  147 (565)
T KOG0472|consen   72 VLNVHDNKLS-QLPAAIG-ELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN  147 (565)
T ss_pred             EEEeccchhh-hCCHHHH-HHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc
Confidence            6789999999 9999998 7999999999999999 89999999999999999999999 88999999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +|+ ..|+.+.++.+|..|++.+|++. .+|++.+. +++|++|+...|-++ .+|..++.+.+|+.|+|..|+|...+ 
T Consensus       148 ~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-  222 (565)
T KOG0472|consen  148 QIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-  222 (565)
T ss_pred             ccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-
Confidence            999 67999999999999999999998 88888777 999999999999998 57889999999999999999997544 


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                       .|.++..|++|+++.|+|+.++++      ..+.+++|..|||++|+++ ..|+.++-+.+ |..||+|+|.|+ ..|.
T Consensus       223 -ef~gcs~L~Elh~g~N~i~~lpae------~~~~L~~l~vLDLRdNklk-e~Pde~clLrs-L~rLDlSNN~is-~Lp~  292 (565)
T KOG0472|consen  223 -EFPGCSLLKELHVGENQIEMLPAE------HLKHLNSLLVLDLRDNKLK-EVPDEICLLRS-LERLDLSNNDIS-SLPY  292 (565)
T ss_pred             -CCCccHHHHHHHhcccHHHhhHHH------Hhcccccceeeeccccccc-cCchHHHHhhh-hhhhcccCCccc-cCCc
Confidence             899999999999999999999875      6789999999999999999 89999998876 999999999999 7899


Q ss_pred             cccCCCCCCeeecccCcceec-------------------------------------CCc----cccCCCCCCEEEccC
Q 002897          241 GLGNLVHLNSIAMEGNQLIGT-------------------------------------VPP----EIGWLKNLQSLYLNS  279 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~-------------------------------------~~~----~~~~l~~L~~L~L~~  279 (869)
                      .++++ +|+.|.+.||.+..+                                     .|.    ....+.+.+.|+++.
T Consensus       293 sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~  371 (565)
T KOG0472|consen  293 SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSD  371 (565)
T ss_pred             ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccc
Confidence            99999 999999999998321                                     011    122345688999999


Q ss_pred             ccccCcCCCCCCCCc--cccceecccccccccCCcCccCccccc-eeeccCcccCCCCCccccccccccceecccCCccc
Q 002897          280 NFLHGYIPSSLGNLT--MLTLLALEINNLQGKIPSSLGNCTSLI-MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLS  356 (869)
Q Consensus       280 N~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~  356 (869)
                      -+++.++.+.|....  -++..+++.|++. ++|..+..+..+. .+.+++|.+. .+ +.+....+.+..|+|++|-+.
T Consensus       372 ~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv-~~~l~~l~kLt~L~L~NN~Ln  448 (565)
T KOG0472|consen  372 KQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FV-PLELSQLQKLTFLDLSNNLLN  448 (565)
T ss_pred             cccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cc-hHHHHhhhcceeeecccchhh
Confidence            999844444443322  2899999999999 8999999988874 5666666665 44 444555566779999999998


Q ss_pred             CCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccc
Q 002897          357 GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE  436 (869)
Q Consensus       357 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  436 (869)
                       .+|.+++.+..|+.|++|.|+|. .+|..+..+..|+.+-.++|++....|..+.++.+|++|||.+|.+. ++|..++
T Consensus       449 -~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lg  525 (565)
T KOG0472|consen  449 -DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILG  525 (565)
T ss_pred             -hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhc
Confidence             89999999999999999999999 89999999999999999999999666666999999999999999998 8999999


Q ss_pred             cccccCeeccccccCcccCCCCC
Q 002897          437 NLSFLEYLNLSYNHFEGEVPKKG  459 (869)
Q Consensus       437 ~l~~L~~l~l~~N~l~~~~~~~~  459 (869)
                      +|++|++|+++||+|. .++...
T Consensus       526 nmtnL~hLeL~gNpfr-~Pr~~i  547 (565)
T KOG0472|consen  526 NMTNLRHLELDGNPFR-QPRHQI  547 (565)
T ss_pred             cccceeEEEecCCccC-CCHHHH
Confidence            9999999999999998 555543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=378.44  Aligned_cols=387  Identities=21%  Similarity=0.234  Sum_probs=347.1

Q ss_pred             cccCCCcccccC-----ChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEe
Q 002897            2 FDAQNNKLVGDI-----PVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLN   76 (869)
Q Consensus         2 l~l~~~~~~~~i-----p~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~   76 (869)
                      ||++++.+. .+     +..++   ...+.|||++|+|..+.+..|.++++|+++++..|.++ .+|...+...+|+.|+
T Consensus        57 ldcs~~~le-a~~~~~l~g~lp---~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~  131 (873)
T KOG4194|consen   57 LDCSDRELE-AIDKSRLKGFLP---SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD  131 (873)
T ss_pred             eecCccccc-cccccccCCcCc---cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence            788899888 65     44443   56788999999999999999999999999999999999 8898777788899999


Q ss_pred             CcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc
Q 002897           77 IGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI  156 (869)
Q Consensus        77 L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~  156 (869)
                      |.+|.|+++-...+..++.|+.||||.|.|+ .+|...|..-.++++|+|++|.|+......|..+.+|..|.|++|+|+
T Consensus       132 L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit  210 (873)
T KOG4194|consen  132 LRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT  210 (873)
T ss_pred             eeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc
Confidence            9999999988899999999999999999998 899888988899999999999999999999999999999999999999


Q ss_pred             cccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccc
Q 002897          157 GKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSG  236 (869)
Q Consensus       157 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~  236 (869)
                      .+.+..|++|++|+.|+|.+|+|.-+..      ..|.++++|+.|.|..|.+....-..|..+.. +++|+|+.|++..
T Consensus       211 tLp~r~Fk~L~~L~~LdLnrN~irive~------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~k-me~l~L~~N~l~~  283 (873)
T KOG4194|consen  211 TLPQRSFKRLPKLESLDLNRNRIRIVEG------LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEK-MEHLNLETNRLQA  283 (873)
T ss_pred             ccCHHHhhhcchhhhhhccccceeeehh------hhhcCchhhhhhhhhhcCcccccCcceeeecc-cceeecccchhhh
Confidence            9999999999999999999999987642      36999999999999999999888888888886 9999999999998


Q ss_pred             cCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccC
Q 002897          237 TIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN  316 (869)
Q Consensus       237 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  316 (869)
                      .-..++.+++.|+.|+|++|.|..+.++.....++|++|+|++|+|+...+++|..+..|+.|+|++|+|+-....+|..
T Consensus       284 vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~  363 (873)
T KOG4194|consen  284 VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG  363 (873)
T ss_pred             hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence            88889999999999999999999999999999999999999999999999999999999999999999999777788999


Q ss_pred             ccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEE
Q 002897          317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYV  396 (869)
Q Consensus       317 l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  396 (869)
                      +.+|++|||++|.|...+.+                      -...|.+++.|+.|+|.+|++....-.+|.++.+|+.|
T Consensus       364 lssL~~LdLr~N~ls~~IED----------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L  421 (873)
T KOG4194|consen  364 LSSLHKLDLRSNELSWCIED----------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL  421 (873)
T ss_pred             hhhhhhhcCcCCeEEEEEec----------------------chhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence            99999999999998854332                      22457778888999999999986666688889999999


Q ss_pred             EeeCccccCCCCccccccccccEEEccC
Q 002897          397 KMQDNSFSGSIPPSLNFLKSIKVLDLSS  424 (869)
Q Consensus       397 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~  424 (869)
                      +|.+|.|...-|.+|..+ .|+.|.+..
T Consensus       422 dL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  422 DLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             cCCCCcceeecccccccc-hhhhhhhcc
Confidence            999999888888888888 788776544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=347.73  Aligned_cols=243  Identities=26%  Similarity=0.364  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.++||+|+||.||.++.+.+++.+|+|++++.   .....+....|..++.+++||.||++...     |++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            56899999999999999999999999999999999643   33456778999999999999999999887     55669


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+|+||+.||.|...+.+.+.      +++..++-++.+|+.||.|||++   ||||||+||+|||+|.+|+++|+||
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            99999999999999999997663      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+..-...        ..+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...     ....+.+.
T Consensus       170 gL~k~~~~~~--------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~  236 (357)
T KOG0598|consen  170 GLCKEDLKDG--------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDK  236 (357)
T ss_pred             ccchhcccCC--------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHH
Confidence            9998543322        3445678999999999999999999999999999999999999999753     22333333


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM  845 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  845 (869)
                      +.......                       .+.-...+..+++.+.+..||++|.
T Consensus       237 I~~~k~~~-----------------------~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ILKGKLPL-----------------------PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCcCCC-----------------------CCccCCHHHHHHHHHHhccCHHHhc
Confidence            32222000                       0011234567899999999999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=357.07  Aligned_cols=278  Identities=22%  Similarity=0.308  Sum_probs=213.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +.|+.+++||+|.||.||+|++..+|+.||+|.++...  ++......+|+.||++++||||+++.+...+.   .....
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence            45777789999999999999999999999999997554  55567778999999999999999999987654   24689


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      |+|+|||+. ||..++....-     .+++.++..++.|++.||+|+|++   ||+|||||.+|||||.+|.+||+|||+
T Consensus       194 YlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence            999999988 99999887654     399999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+++.....       ...+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+- ..+..+.+..
T Consensus       265 Ar~y~~~~~-------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklc  336 (560)
T KOG0600|consen  265 ARFYTPSGS-------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLC  336 (560)
T ss_pred             eeeccCCCC-------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHh
Confidence            998766432       335567789999999998876 5999999999999999999999999764322 1222222111


Q ss_pred             c--ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 L--PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      -  .+..+...+-.....+......+ ...++.....+....+|+..+|..||.+|.||.++++
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~y~-r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQPYK-RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCChhccccccCCcccccCCCCccc-chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  11111111100000111100000 0112234455677889999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=352.32  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|...+.||+|+||+||++.+..+|+..|||.+...+....+.+.+|+.+|++++|||||+++|.....+  + ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence            345778899999999999999999889999999997654444677899999999999999999999744321  1 3689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~  711 (869)
                      +.|||+++|+|.+++...+.     .+++..++.+++||++||+|||++   |||||||||+|||++. ++.+||+|||.
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999998764     299999999999999999999999   9999999999999999 79999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......     ..........||+.|||||++..+ ....++||||+||++.||+||++||... .+  .........
T Consensus       165 a~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~--~~~~~~~ig  236 (313)
T KOG0198|consen  165 AKKLESKG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE--EAEALLLIG  236 (313)
T ss_pred             cccccccc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc--hHHHHHHHh
Confidence            98766411     111233457799999999999854 3446999999999999999999998753 00  011111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .....                       +..++..+....+++..|+..||++||||+|+++.-..
T Consensus       237 ~~~~~-----------------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  237 REDSL-----------------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             ccCCC-----------------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            00000                       01112345567799999999999999999999986544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=344.75  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=213.5

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..++|+....||.|..++||+|+....++.||||++.... ....+.+++|+..++.++||||++++..|...     ..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ce
Confidence            3468999999999999999999999999999999997543 23368899999999999999999999987654     88


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+||+||.+|++.+.++.....    .+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|||
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            99999999999999999887643    499999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      .+..+........    ......+||+.|||||++..  ..|+.|+||||||++..|+.+|..||.........+...-.
T Consensus       172 vsa~l~~~G~R~~----~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn  247 (516)
T KOG0582|consen  172 VSASLFDSGDRQV----TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN  247 (516)
T ss_pred             eeeeecccCceee----EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            9877665432111    11166789999999999543  35999999999999999999999999865443222222111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .. +.......|                  .+........+.+++..|++.||++||||+++++
T Consensus       248 ~p-p~~~t~~~~------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DP-PTLLTSGLD------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CC-CCcccccCC------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11 111111111                  1112234457889999999999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=360.75  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=212.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ..|....+||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++.|...     +..|.
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence            4577788999999999999999999999999999887777778889999999999999999999986543     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |||||+||+|.+.+....       +++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++.
T Consensus       348 VMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence            999999999999998765       89999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .+....        ......+||+.|||||+.....|++|.||||||++++||+-|++||-..    ..+.........+
T Consensus       418 qi~~~~--------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyLIa~ng  485 (550)
T KOG0578|consen  418 QISEEQ--------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLIATNG  485 (550)
T ss_pred             cccccc--------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHHHhhcC
Confidence            776543        3556788999999999999999999999999999999999999998531    1111111111000


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       .                     .....++..+..+.+++.+||..||++||+|.|+++
T Consensus       486 -~---------------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 -T---------------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -C---------------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             0                     011123345677899999999999999999999987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-42  Score=376.88  Aligned_cols=268  Identities=28%  Similarity=0.450  Sum_probs=221.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ..+....+.||+|+||.||+|+..     .+...||||.++..... ...+|++|++.+..++|||||+++|+|...   
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~---  561 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG---  561 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence            345667789999999999999874     34567999999866555 778999999999999999999999999875   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCccc--------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLE--------VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                        +..++|+|||..|||.+|+....+...        ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||
T Consensus       562 --~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  562 --DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV  636 (774)
T ss_pred             --CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence              789999999999999999987654432        23489999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCc
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMF  777 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~  777 (869)
                      .++..|||+|||+++.+-..+..      .......-..+|||||.+..++++++||||||||++||+++ |+.||.+..
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYY------k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYY------KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             ccceEEEecccccchhhhhhhhh------cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            99999999999999866443321      11223344789999999999999999999999999999999 999987543


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .     .+.++.+..+.+                       -+.++.||.++++||..||+..|++||+++||-..|++.
T Consensus       711 n-----~EVIe~i~~g~l-----------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  711 N-----QEVIECIRAGQL-----------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             h-----HHHHHHHHcCCc-----------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            3     233333322221                       223457899999999999999999999999999999987


Q ss_pred             HHhhh
Q 002897          858 REAFV  862 (869)
Q Consensus       858 ~~~~~  862 (869)
                      .++-.
T Consensus       763 ~~~s~  767 (774)
T KOG1026|consen  763 AQASP  767 (774)
T ss_pred             HhcCc
Confidence            76543

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=324.96  Aligned_cols=278  Identities=20%  Similarity=0.247  Sum_probs=222.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|||+.||+++...+++.||+|++.....+..+..++|++..++++|||++++++++....-++....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35689999999999999999999999999999999988777788999999999999999999999998876655667789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      |++++|+..|+|.+.+......  ...+++.++++|+.++++||++||+. .|+++||||||.||++.+++.++|.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999999876543  33599999999999999999999998 45699999999999999999999999999


Q ss_pred             cccCCCCCCCCcc-ccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          712 AKFLPARPLDTVV-ETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       712 a~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ++..+-....... ..-........|..|+|||.+.   +...++++|||||||++|+|+.|..||+.....+.++.-.+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            9765432111000 0001122334789999999864   44579999999999999999999999987665544332211


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ..   ..+.-                      +....+++.+.+++..|++.||.+||++.|++..+..+
T Consensus       256 ~n---~q~s~----------------------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  256 QN---AQISI----------------------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ec---ccccc----------------------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            11   00000                      00012567788999999999999999999999988764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=360.33  Aligned_cols=268  Identities=27%  Similarity=0.418  Sum_probs=213.8

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID  624 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  624 (869)
                      .++....+++.+..+||+|+||+||+|.|.   ..||||++...  .++..+.|++|+.++++-+|.||+-+.|||..+ 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence            444555667778899999999999999984   46999999644  345678999999999999999999999998764 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                           ...||+.+|+|-+|+.+++..+.+     +...+.+.||+|||+||.|||.+   +|||||+|..|||+.++++|
T Consensus       461 -----~~AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  461 -----PLAIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             -----ceeeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence                 349999999999999999987654     88999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC---CCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS---EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      ||+|||++.........      .......|...|||||+++..   +|++.+||||||+|+|||+||..||.....+ .
T Consensus       528 kIgDFGLatvk~~w~g~------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q  600 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGE------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q  600 (678)
T ss_pred             EEecccceeeeeeeccc------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h
Confidence            99999999765443211      222334578899999987643   6899999999999999999999999732221 1


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      .+-..-+...        -+..               ......++.++.+|+..||.++|++||.+.+|+..|+.+....
T Consensus       601 IifmVGrG~l--------~pd~---------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  601 IIFMVGRGYL--------MPDL---------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             eEEEeccccc--------Cccc---------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            1111111110        0100               0111257788999999999999999999999999998887643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=337.61  Aligned_cols=284  Identities=21%  Similarity=0.282  Sum_probs=217.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEee--cccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ....|...+.||+|+||.|+.|.++.+|+.||||.+.  ....-..++..+|+.+++.++|+||+.+.+++.....+.-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4456777899999999999999999999999999986  44555678899999999999999999999998875556668


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+|+|+|+ .+|.+.++....      ++...+..+.+|+++||+|+|+.   +|+|||+||+|++++.+..+||+||
T Consensus       100 DvYiV~elMe-tDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            8999999994 499999998764      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+......      .....+..+.|.+|+|||++.. ..|+.+.||||.|||+.||++|++-|.+...- ..+.....
T Consensus       170 GLAR~~~~~~------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~  242 (359)
T KOG0660|consen  170 GLARYLDKFF------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILE  242 (359)
T ss_pred             cceeeccccC------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHH
Confidence            9999876531      1134456778999999998654 57999999999999999999999998753211 11111111


Q ss_pred             hh--cccc-cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MV--LPEK-VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~--~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  .++. +..+-......-...-....+..-....+...+..++|+.+|+..||.+|+|++|.++
T Consensus       243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11  1111 1111111122211111111111111222344567889999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=351.61  Aligned_cols=247  Identities=28%  Similarity=0.441  Sum_probs=211.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..  +.+.+.+.+|++|+++++||||+.++++|     +...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            47888999999999999999999999999999997544  34567899999999999999999999985     455899


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+||+.| +|..++.....      ++++.+..++.+++.||.|||+.   +|.|||+||.||+++..|.+|+||||+
T Consensus        77 ~vVte~a~g-~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence            999999977 99999998764      99999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      |+.+....        .......||+.|||||+..+.+|+..+|.||+|||+||+++|++||..     ..+.+..+.+.
T Consensus       147 Ar~m~~~t--------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~  213 (808)
T KOG0597|consen  147 ARAMSTNT--------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSIL  213 (808)
T ss_pred             hhhcccCc--------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHh
Confidence            99876543        344567899999999999999999999999999999999999999963     23334444332


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+...                        .+......+..++...+..||.+|.|..+++.
T Consensus       214 ~d~v~------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  214 KDPVK------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cCCCC------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            22111                        11145567889999999999999999999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-41  Score=327.65  Aligned_cols=278  Identities=20%  Similarity=0.288  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|+..++|++|.||.||+|+++.+++.||+|+++...  .+..-...+|+.++.+.+|||||.+-.+.....   .+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence            457888999999999999999999999999999997443  233345689999999999999999999876543   366


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+|||||+. +|...+...+.     ++...++.-+..|+++|++|||..   .|+|||+||+|+|++..|.+||+|||
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence            9999999988 99999998774     489999999999999999999999   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+.++...        ...+..+-|.+|+|||.+.+. .|+++.|+||+|||+.|++++++.|.+..+-+. +....+.
T Consensus       223 LAR~ygsp~--------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~l  293 (419)
T KOG0663|consen  223 LAREYGSPL--------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKL  293 (419)
T ss_pred             hhhhhcCCc--------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHH
Confidence            999887653        345566789999999998776 589999999999999999999999986543322 2222211


Q ss_pred             h-ccc-cc-ccccCccchhhhhhcccccCCCccchHHH--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 V-LPE-KV-MEIVDPSLLLEVRANNSMSRGGERVKIEE--CLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~-~~~-~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      . .|. .+ .................... ..+..+..  ..+.-++++...+.+||.+|.||+|.++
T Consensus       294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  294 LGTPSEAIWPGYSELPAVKKMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hCCCccccCCCccccchhhccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1 111 11 11111111100000000000 00011111  2356679999999999999999999875

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-41  Score=337.76  Aligned_cols=278  Identities=21%  Similarity=0.298  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      -.|...+++|+|+||.||+|...++++.||||.+-...    +.-.+|+++|++++|||||++.-++....-.+.....+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35777899999999999999999999999999884322    33468999999999999999998887653233446679


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEcccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLA  712 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  712 (869)
                      |||||+. +|.++++.....  ...++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|
T Consensus       100 VleymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999987 999999863211  12388889999999999999999998   99999999999999977 89999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.+..+.         .......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.... ..+....+..-
T Consensus       174 K~L~~~e---------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG  243 (364)
T KOG0658|consen  174 KVLVKGE---------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLG  243 (364)
T ss_pred             eeeccCC---------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhC
Confidence            9886653         22345679999999998876 5999999999999999999999999863222 22222222221


Q ss_pred             cc--ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PE--KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  +......+... +...................+.+..+++.++++++|.+|.++.|++.
T Consensus       244 ~Pt~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCCHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11  00000111100 00000000011111122345567889999999999999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-41  Score=352.94  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=211.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .+-|..++.||.|+.|.|-+|++..+|+.+|||++...   .......+.+|+.||+.+.||||++++++|..     ..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-----~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-----KQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-----Cc
Confidence            35688899999999999999999999999999999644   22234678899999999999999999999654     48


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      +.|+|.||+++|-|++++...+.      +++.+..+++.||+.|+.|+|+.   +|+|||+||+|+|+|..+.+||+||
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence            99999999999999999988764      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|..-.++         ......+|++.|.|||++.|.+| +.++||||+|||+|.|+||+.||++     ..+.....
T Consensus       157 GMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLl  222 (786)
T KOG0588|consen  157 GMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLL  222 (786)
T ss_pred             ceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHH
Confidence            999865544         33455689999999999999998 6789999999999999999999983     23333332


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .+..+                        ..+.+...+.+..+|+.+|+..||++|.|++||++.-
T Consensus       223 KV~~G------------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  223 KVQRG------------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHcC------------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            22211                        1112234567788999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=352.54  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=206.1

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc----cc-hhhHHHHHHHHHHHhCC-CCccceEEEEeeccc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM----QK-GALKSFLTECEALRSIR-HRNLIKIITICSSID  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  624 (869)
                      ...++|.+.+.||+|+||.|+.|.+..+|+.||+|+++..    .. ...+.+.+|+.+++.++ ||||+++++++... 
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence            4467899999999999999999999999999999977543    11 23456778999999998 99999999997654 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cc
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MV  703 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  703 (869)
                          ...++||||+.+|+|.+++....      ++.+.++..+++|++.|++|+|++   ||+||||||+||+++.+ ++
T Consensus        93 ----~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   93 ----TKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             ----CeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence                66999999999999999999843      388999999999999999999999   99999999999999999 99


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CC-ccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-AS-MTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      +||+|||++......        .......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+..     
T Consensus       160 ~Kl~DFG~s~~~~~~--------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----  226 (370)
T KOG0583|consen  160 LKLSDFGLSAISPGE--------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----  226 (370)
T ss_pred             EEEeccccccccCCC--------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----
Confidence            999999999876411        13455678999999999999977 75 7899999999999999999999862     


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEEC-LVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..............                        ..+... ..++..++.+|+..||.+|+|+.|+++
T Consensus       227 ~~~~l~~ki~~~~~------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  227 NVPNLYRKIRKGEF------------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             cHHHHHHHHhcCCc------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11111111111100                        000111 456789999999999999999999983

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4e-40  Score=358.05  Aligned_cols=268  Identities=24%  Similarity=0.361  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.++||+|+||.||+|.+.     .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            468999999999999999999752     346789999986432 23456789999999999 899999999987543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc---------------------------------------------------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL---------------------------------------------------  654 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  654 (869)
                        ....++||||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              356899999999999999997643110                                                   


Q ss_pred             -----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCC
Q 002897          655 -----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS  729 (869)
Q Consensus       655 -----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  729 (869)
                           ...++++.++..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++........      ..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------~~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VR  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch------hc
Confidence                 013478899999999999999999999   9999999999999999999999999999865432210      11


Q ss_pred             CCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhh
Q 002897          730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVR  808 (869)
Q Consensus       730 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  808 (869)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||.......    .+.........             
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~-------------  295 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTR-------------  295 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCC-------------
Confidence            223346788999999998899999999999999999997 999987532211    11111100000             


Q ss_pred             hcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          809 ANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                                ...+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       296 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         296 ----------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                      000112345688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=367.14  Aligned_cols=273  Identities=21%  Similarity=0.266  Sum_probs=217.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccc-cCC-Cc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSID-FNG-VD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~-~~  629 (869)
                      ..++++.++|.+|||+.||.|++...|..||+|++-..++...+...+|+++|++|+ |+|||.+++...... -.+ ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            346778899999999999999998777999999997778888899999999999996 999999999432221 222 36


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ++++.||||++|.|-+++..+-..    .+++.++++|+.|+++|+++||.. .|+|||||||-+|||++.+|+.|||||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence            788999999999999999876543    499999999999999999999996 788999999999999999999999999


Q ss_pred             cccccCCCCC-CCCccccCCCCCCccCcccccCCccc---CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          710 GLAKFLPARP-LDTVVETPSSSSGIKGTVGYIAPEYG---TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       710 g~a~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |.|...-... ....+......-....|+.|+|||++   .+...++|+|||||||+||-|+....||+....-.     
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----  265 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----  265 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence            9997543332 11111111112234579999999974   56679999999999999999999999997532111     


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                                  +++-              ....+..+.++..+.+||+.||+.||.+||++.||+..+.+++..-
T Consensus       266 ------------Ilng--------------~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  266 ------------ILNG--------------NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------------EEec--------------cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                        0010              0111222357778999999999999999999999999999887654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=345.45  Aligned_cols=242  Identities=27%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      .+-||.|+.|.||+|+.  .++.||||.++.       .-..+++-|++++||||+.+.|+|...     ..+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeecc
Confidence            46799999999999999  689999998742       223568889999999999999999875     6789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      +.|-|.++++..+.      ++......|..+||.||.|||.+   .|||||||.-||||+.+..|||+|||.++...+.
T Consensus       195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            99999999998764      88899999999999999999999   9999999999999999999999999999866543


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                               .....+.||..|||||++...+.++|+||||||||||||+||..||.......     ++..+-       
T Consensus       266 ---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGVG-------  324 (904)
T KOG4721|consen  266 ---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGVG-------  324 (904)
T ss_pred             ---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEecc-------
Confidence                     23345789999999999999999999999999999999999999997532211     010000       


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                       ...              ...+.+..|++.+.-|++.||+..|..||++.+++..|.-+..
T Consensus       325 -sNs--------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  325 -SNS--------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             -CCc--------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence             000              1123445788899999999999999999999999998875543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=340.39  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=209.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..|+..+.||+|+||.||+|.+..+++.||+|++... .+...+.+++|+.++..++++||.++++.+...     ...+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence            4577789999999999999999999999999999754 345578899999999999999999999987654     7889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++||||.||++.+.++....      +.+..+.-+.+++..|+.|+|.+   +.+|||||+.||++..+|.+|++|||.+
T Consensus        88 iiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence            99999999999999987653      47888889999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ..+....        .....++||+.|||||++.+..|+.|+||||||++.+||++|.+|+........      -..++
T Consensus       159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------lflIp  224 (467)
T KOG0201|consen  159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------LFLIP  224 (467)
T ss_pred             eeeechh--------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------EEecc
Confidence            8765543        334678999999999999988999999999999999999999999876443210      01111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...    .|.+.                  ..+.+.+.+++..|++.||+.||||.++++
T Consensus       225 k~~----PP~L~------------------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  225 KSA----PPRLD------------------GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCC----CCccc------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111    11111                  144567889999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.8e-40  Score=340.50  Aligned_cols=258  Identities=20%  Similarity=0.297  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..++|+..++||+|+||.||+|+-+.+|..+|+|++++..   .+..+.++.|-.+|...++|.||+++..     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            5678999999999999999999999999999999997643   4556778999999999999999999987     4556


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ++.|+||||++||++..++.....      +++..++.++.+++-|+..+|+.   |+|||||||+|+|||..|++||+|
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence            999999999999999999988763      99999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCC----------------ccccC-----------------------CCCCCccCcccccCCcccCCCC
Q 002897          709 FGLAKFLPARPLDT----------------VVETP-----------------------SSSSGIKGTVGYIAPEYGTGSE  749 (869)
Q Consensus       709 fg~a~~~~~~~~~~----------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~  749 (869)
                      ||++..+.......                ..+.+                       ......+|||.|||||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            99996543211000                00000                       0112356999999999999999


Q ss_pred             CCccccchhhhHHHHHHHcCCCCCCcCccCC--chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHH
Q 002897          750 ASMTGDVYSFGILLLEMFSRRRPTDSMFHEG--LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLV  827 (869)
Q Consensus       750 ~~~~sDvwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  827 (869)
                      |+..+|.||+|||+|||+.|.+||.+.....  ..+..|.....                           .+...++..
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------------------------fP~~~~~s~  417 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------------------------FPEEVDLSD  417 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------------------------CCCcCcccH
Confidence            9999999999999999999999997643321  11112211110                           001112335


Q ss_pred             HHHHHHhhccCCCCCCCCC---HHHHH
Q 002897          828 AVIRIGVVCSMESPTDRMQ---MRDVV  851 (869)
Q Consensus       828 ~l~~li~~cl~~dP~~RPs---~~evl  851 (869)
                      +..+||.+|+. ||++|.-   ++||.
T Consensus       418 eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  418 EAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            67799999999 9999975   55553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=314.86  Aligned_cols=199  Identities=27%  Similarity=0.400  Sum_probs=180.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|+..+.||.|+||.|.+++.+.+|..+|+|++++..-   ...+...+|..+|+.+.||.++++++.+.+.     .
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----S  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----C
Confidence            4578899999999999999999999999999999975432   3345678999999999999999999986554     8


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||++||.|..++++.+.      +++..++.+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            89999999999999999998764      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      |+|+.+...           +...+||+.|+|||.+....++.++|-|||||++|||+.|.+||...
T Consensus       189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            999976542           45578999999999999999999999999999999999999999753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=332.20  Aligned_cols=273  Identities=26%  Similarity=0.361  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--CCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS--IRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ...+..+.+|+|+||.||+|..  +++.||||++..   +..+.+..|-+|++.  ++|+||++++++-...+.. ...+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            3455678999999999999999  679999999964   344778888888775  4899999999986554322 4578


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceeecCCCcEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC------KPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      ++|++|.+.|+|.+|++.+.       ++|....+++..+++||+|||+..      +|+|+|||||.+||||..|+++.
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            99999999999999999875       899999999999999999999863      68999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-C-----CccccchhhhHHHHHHHcCCCCCC-----
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-A-----SMTGDVYSFGILLLEMFSRRRPTD-----  774 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwslG~il~el~tg~~pf~-----  774 (869)
                      |+|||+|..+.....      .......+||.+|||||++.+.. +     -.+.||||+|.|+|||+++..-++     
T Consensus       357 IaDFGLAl~~~p~~~------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  357 IADFGLALRLEPGKP------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             eeccceeEEecCCCC------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            999999998875531      23344588999999999987753 1     236799999999999998765442     


Q ss_pred             -------cCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          775 -------SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       775 -------~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                             ........++++...+..++....+.    ..+             .....+..+.+.+..||+.||+.|.||
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p----~~W-------------~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP----DAW-------------RKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCCh----hhh-------------hcCccHHHHHHHHHHHcCCchhhhhhh
Confidence                   11112223333333332222211111    111             111345678899999999999999999


Q ss_pred             HHHHHHHHHHHHhhh
Q 002897          848 RDVVVKLCAAREAFV  862 (869)
Q Consensus       848 ~evl~~L~~~~~~~~  862 (869)
                      .=|.+++..+.....
T Consensus       494 ~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  494 GCVEERMAELMMLWE  508 (534)
T ss_pred             HHHHHHHHHHhccCC
Confidence            999999998876664

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=331.19  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=205.8

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------------chhhHHHHHHHHHHHhCCCCccce
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------------KGALKSFLTECEALRSIRHRNLIK  615 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~  615 (869)
                      .+..++|++.+.||+|.||.|-+|++..+++.||||++.+..              ....+..++|+.||++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345688999999999999999999999999999999996322              112368899999999999999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN  695 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  695 (869)
                      ++++..++   ..+..|+|+|||..|.+...=...      ..+++.++++++++++.||+|||.+   |||||||||+|
T Consensus       173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN  240 (576)
T KOG0585|consen  173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN  240 (576)
T ss_pred             EEEeecCc---ccCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence            99997765   347899999999887764332111      1289999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC----CCccccchhhhHHHHHHHcCCC
Q 002897          696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE----ASMTGDVYSFGILLLEMFSRRR  771 (869)
Q Consensus       696 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~el~tg~~  771 (869)
                      +|++++|++||+|||.+.........   .........+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~---~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDE---GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCcc---ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            99999999999999999876443211   1112334478999999999877643    3678899999999999999999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||.+.+.     .+....+....+.                      .+..++..+.+.+||.++|++||++|.+..+|.
T Consensus       318 PF~~~~~-----~~l~~KIvn~pL~----------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik  370 (576)
T KOG0585|consen  318 PFFDDFE-----LELFDKIVNDPLE----------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIK  370 (576)
T ss_pred             CcccchH-----HHHHHHHhcCccc----------------------CCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence            9965321     1111112111111                      111124456788999999999999999999997


Q ss_pred             HHHHH
Q 002897          852 VKLCA  856 (869)
Q Consensus       852 ~~L~~  856 (869)
                      ...+.
T Consensus       371 ~Hpwv  375 (576)
T KOG0585|consen  371 LHPWV  375 (576)
T ss_pred             eccee
Confidence            65543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=322.39  Aligned_cols=284  Identities=21%  Similarity=0.319  Sum_probs=210.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCc-cceEEEEeeccc-cCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN-LIKIITICSSID-FNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~  629 (869)
                      ..|...++||+|.||+||+|+.+.+|+.||+|.++...+  +......+|+.+++.++|+| |+++.+++.... +....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            346667789999999999999999999999999975533  45577899999999999999 999999987643 23344


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||++. +|..++.......  ..++...+..+++||+.||+|||++   +|+||||||+||+|+++|.+||+||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence            78899999965 9999998876321  2377789999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+...-..        ......++|.+|+|||++.+. .|+...||||+|||++||+++++-|.+..+.+... ...+
T Consensus       165 GlAra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~-~If~  235 (323)
T KOG0594|consen  165 GLARAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF-RIFR  235 (323)
T ss_pred             chHHHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH-HHHH
Confidence            9998655322        234556789999999998887 68999999999999999999999998755422111 1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECL---VAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..-......+.......+++. ......+........+   ....+++.+|++++|.+|.||+.++..
T Consensus       236 ~lGtP~e~~Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  236 LLGTPNEKDWPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HcCCCCccCCCCccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111111111111111111 1111111111111112   367899999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=353.46  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=217.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ...+.++||.|-||.||+|+.+..|   ..||||.++... +....+|..|+.||.+++||||+++.|+....     ..
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ce
Confidence            3456789999999999999998665   579999998654 44567899999999999999999999996653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+||+|||++|+|+.|++.+.+.     +++.+...+.++||.||.||-+.   ++|||||.++||||+.+..+|++|||
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence            89999999999999999998764     89999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +++.+.++....     ..+.+-.-..+|.|||.+...+++.+|||||||+++||.++ |..||.++...     +.++.
T Consensus       777 LSRvledd~~~~-----ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----dVIka  846 (996)
T KOG0196|consen  777 LSRVLEDDPEAA-----YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVIKA  846 (996)
T ss_pred             ceeecccCCCcc-----ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----HHHHH
Confidence            999887665111     11222223578999999999999999999999999999988 99998765433     22222


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      +                       +.+.+.+.+.+||..+.+|+..||++|-.+||.+.||+..|.++.+.
T Consensus       847 I-----------------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  847 I-----------------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             H-----------------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            1                       11233445568999999999999999999999999999999987654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-40  Score=324.41  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .+|++.+.||+|.||.|-+|.....|+.||||.+++.   +++..-.+++|++||..++||||+.++.+     |++.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence            4788899999999999999999889999999999643   45556678999999999999999999998     556689


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      ..|||||..+|.|++|+.+.+.      +++.+.+.+++||.+|+.|+|.+   +++|||+|.+|||+|.++++||+|||
T Consensus       128 IvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            9999999999999999998774      99999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ++-.+...         .....++|++-|.+||+..|.+| ++.+|-||+||++|.++.|..||++.     ....+++.
T Consensus       199 LSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQ  264 (668)
T KOG0611|consen  199 LSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQ  264 (668)
T ss_pred             hhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHH
Confidence            99877554         34556789999999999999988 68899999999999999999999863     22333333


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      +-.+...+..                         .+....-||++|+..+|++|.|+.||....+
T Consensus       265 Is~GaYrEP~-------------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  265 ISRGAYREPE-------------------------TPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             hhcccccCCC-------------------------CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            3222222211                         1223457899999999999999999987654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.3e-39  Score=337.88  Aligned_cols=252  Identities=20%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchh---hHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ...+|+|+++.||+|.+  +|+.||||+++......   .+.+.+|+.++++++||||+++++++.+. .++....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence            36899999999999999  79999999997543322   56788999999999999999999998652 22345789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++.....++.|++.|++|||+..  +++||||||+||++++++.+||+|||+++..
T Consensus       102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            9999999999998754      3889999999999999999999842  7889999999999999999999999999765


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ....           ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .+........
T Consensus       174 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~  237 (283)
T PHA02988        174 SSPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINK  237 (283)
T ss_pred             cccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhc
Confidence            3321           12357899999999876  6789999999999999999999999975321     1111111100


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      ...                      ...+..++..+.+++.+||+.||++|||++|+++.|+....
T Consensus       238 ~~~----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 NNS----------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCC----------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            000                      00011345678899999999999999999999999987653

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=340.87  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|...+++|+|+||.++.++++.+++.||+|.+....  ....+...+|+.+++++.|||||.+.+.|...    ....
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----CceE
Confidence            57889999999999999999999999999999996433  33345789999999999999999999986543    3449


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      +|||+||+||++.+.+.+.++.    .++++.+..|+.|++.|+.|||+.   +|+|||||+.|||++.++.|||+|||+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~----~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGV----LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence            9999999999999999987732    489999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      |+.+....        ......+||+.||.||.+.+.+|+.|+||||+||++|||++-+++|.....     ...+....
T Consensus       153 aK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~~Li~ki~  219 (426)
T KOG0589|consen  153 AKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----SELILKIN  219 (426)
T ss_pred             hhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----HHHHHHHh
Confidence            99887653        245567899999999999999999999999999999999999999975322     22222222


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      +...                       .+.+..+..++..++..|++.+|+.||++.|++.+
T Consensus       220 ~~~~-----------------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLY-----------------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccC-----------------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1110                       11222456678899999999999999999999987

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=370.57  Aligned_cols=268  Identities=28%  Similarity=0.440  Sum_probs=216.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCC-----eEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENG-----MLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..+..+.||+|+||.||.|......     ..||||.++.. +.+....|.+|+.+|++++|||||+++|+|.+.     
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-----  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-----  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-----
Confidence            4456789999999999999986332     34899988654 456678999999999999999999999998763     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ...+|++|||++|+|..|+++.+... ....++..+.+.++.|||+|+.||+++   ++|||||.++|+|+++...|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            67899999999999999999874432 234589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+|+.+.......      ......-...|||||.+..+.++.|+|||||||++||++| |..||......     +.
T Consensus       845 DFGlArDiy~~~yyr------~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v  913 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYR------KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EV  913 (1025)
T ss_pred             ccchhHhhhhchhee------ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HH
Confidence            999999544332111      1111123568999999999999999999999999999999 89998753222     11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ...+.                       .+++.+.+..|+..++++|..||+.+|++||++..+++++..+..+....
T Consensus       914 ~~~~~-----------------------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  914 LLDVL-----------------------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             HHHHH-----------------------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence            11111                       12344455678999999999999999999999999999999887765443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.4e-39  Score=349.71  Aligned_cols=282  Identities=20%  Similarity=0.259  Sum_probs=203.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.++||+|+||.||+|++..+|+.||||++...  .......+.+|++++++++||||+++++++......+....+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588899999999999999999999999999998642  223345688999999999999999999988655444445689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ ++|.+++....      .+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 69999987654      389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........     ........|++.|+|||++.+  ..++.++|||||||++|||++|+.||......  .........
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~  223 (338)
T cd07859         151 RVAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDL  223 (338)
T ss_pred             cccccccCc-----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHH
Confidence            765332210     012234568999999999865  57899999999999999999999999653211  100111000


Q ss_pred             cccc----cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEK----VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....    ...+...........................+..+.+++.+||+.||++|||++|+++.
T Consensus       224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000    00000000000000000000000000111234567899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-38  Score=336.07  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      |+..+.||+|+||.||+|.+..+|+.||+|.+....   ......+.+|+.++++++|++|+++++++.+     .+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeEE
Confidence            677899999999999999998899999999986432   2233467889999999999999999998654     36799


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999988865432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......         ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......... 
T Consensus       150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~-  218 (285)
T cd05631         150 VQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVK-  218 (285)
T ss_pred             EEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhh-
Confidence            7654321         1223468999999999999999999999999999999999999997532211 1111111110 


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      ...                       .......+..+.+++.+||+.||++||+     ++|+++
T Consensus       219 ~~~-----------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 EDQ-----------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccc-----------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            000                       0011123456789999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=303.76  Aligned_cols=252  Identities=22%  Similarity=0.343  Sum_probs=212.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +.++|++.+.||+|.||.||.|+.++++..||+|++.+..   .+...++.+|++|-..++||||+++++++.+     .
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-----~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-----S   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----c
Confidence            4578999999999999999999999999999999996432   3345788999999999999999999999655     4


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...|+++||..+|++...+...+..    .+++.....++.|+|.|+.|+|.+   +|+||||||+|+|++.++..||+|
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence            8899999999999999999965532    488888999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+...+.          ......+||..|.|||...+..++..+|+|++|+..||++.|.+||.... .+..+.+..+
T Consensus       168 fGwsV~~p~----------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k  236 (281)
T KOG0580|consen  168 FGWSVHAPS----------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK  236 (281)
T ss_pred             CCceeecCC----------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence            999975432          34456789999999999999999999999999999999999999998654 3333333322


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ..       ..+|                     ...+....++|.+|+..+|.+|.+..||++.-
T Consensus       237 ~~-------~~~p---------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  237 VD-------LKFP---------------------STISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             cc-------ccCC---------------------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            21       1111                     13345677999999999999999999998753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.9e-39  Score=344.37  Aligned_cols=242  Identities=24%  Similarity=0.319  Sum_probs=196.1

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|++..+|+.||+|+++...   ......+.+|++++++++||||+++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence            47999999999999999999999999997432   3344667899999999999999999998654     378999999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999998654      389999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      ...        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ............ 
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~-  212 (323)
T cd05571         147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEI-  212 (323)
T ss_pred             cCC--------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCC-
Confidence            211        222345699999999999999999999999999999999999999964211     111111111000 


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                                             ..+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       213 -----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 -----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                                   00112345678999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.7e-38  Score=340.76  Aligned_cols=200  Identities=24%  Similarity=0.377  Sum_probs=176.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+|..||+|++.... ......+.+|++++++++||||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            468999999999999999999999999999999997543 33456789999999999999999999997653     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            99999999999999998754      3889999999999999999999862  699999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      +......          ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       151 ~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccccccc----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            8755332          12234689999999999998999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=339.91  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCe---E-EEEEEeec---ccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGM---L-VAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .++....++||+|+||.||+|+.+..+.   . ||||..+.   .......++.+|+++|+.++|||||+++|++...  
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--
Confidence            3455566999999999999999874322   3 89999874   3466778999999999999999999999998764  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                         ...++|||+|.||+|.+|+++....     ++..++..++.++|.||+|||++   +++||||.++|+|++.++.+|
T Consensus       234 ---~Pl~ivmEl~~gGsL~~~L~k~~~~-----v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  234 ---EPLMLVMELCNGGSLDDYLKKNKKS-----LPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             ---CccEEEEEecCCCcHHHHHHhCCCC-----CCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence               7799999999999999999998753     89999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLH  784 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~  784 (869)
                      |+|||+++.-....        .......-...|+|||.+..+.|++++|||||||++||+++ |..||.+....     
T Consensus       303 ISDFGLs~~~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----  369 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----  369 (474)
T ss_pred             eCccccccCCccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----
Confidence            99999987543111        01111134689999999999999999999999999999999 88898753222     


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                      +....+....                      .....+...+..+..++.+||..+|++||||.++.+.++.+......
T Consensus       370 ~v~~kI~~~~----------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  370 EVKAKIVKNG----------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHhcC----------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            2222221111                      01111124566788899999999999999999999999998877654

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4e-38  Score=336.73  Aligned_cols=274  Identities=20%  Similarity=0.298  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence            4689999999999999999999998999999999864332 233567889999999999999999998654     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999995 688888876543     388999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.......        .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.................
T Consensus       150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (303)
T cd07869         150 ARAKSVPS--------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL  221 (303)
T ss_pred             ceeccCCC--------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence            87543221        12233468999999998765 4578899999999999999999999975432211111111110


Q ss_pred             cccc---ccc-----ccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEK---VME-----IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~---~~~-----~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....   ...     ..++........    ............+..+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         222 GTPNEDTWPGVHSLPHFKPERFTLYSP----KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CCCChhhccchhhccccccccccccCC----ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000   000     000000000000    000000000012345779999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=340.24  Aligned_cols=246  Identities=24%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|++++++++||||+++++++.+     ...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence            47899999999999999999999899999999986432   2234568899999999999999999987543     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            999999999999999998754      388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......           .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....     .......
T Consensus       147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i  210 (291)
T cd05612         147 FAKKLRDR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKI  210 (291)
T ss_pred             cchhccCC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            99765322           1234689999999999988899999999999999999999999965321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  853 (869)
                      .....                        ..+......+.+++.+||+.||.+||+     ++|+++.
T Consensus       211 ~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         211 LAGKL------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HhCCc------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            11000                        000112345779999999999999995     8888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.4e-38  Score=337.60  Aligned_cols=268  Identities=22%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC----------------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE----------------NGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIK  615 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  615 (869)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998632                34579999986543 334567899999999999999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcC
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-------------EVCNLSLIQTLNIAIDVASAIEYLHHHC  682 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~  682 (869)
                      +++++.+.     +..++||||+++|+|.+++.......             ....+++..+.+++.||+.||+|||+. 
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99997653     66899999999999999986543110             112478899999999999999999999 


Q ss_pred             CCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHH
Q 002897          683 KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL  762 (869)
Q Consensus       683 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i  762 (869)
                        +|+||||||+||+++.++.+||+|||.++........      .......++..|+|||++.++.++.++|||||||+
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  229 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT  229 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence              9999999999999999999999999999765433210      11223446788999999988899999999999999


Q ss_pred             HHHHHc--CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCC
Q 002897          763 LLEMFS--RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES  840 (869)
Q Consensus       763 l~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  840 (869)
                      +|||++  +..||......  ..................                   ...+..++..+.+++.+||+.|
T Consensus       230 l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~  288 (304)
T cd05096         230 LWEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVY-------------------LFRPPPCPQGLYELMLQCWSRD  288 (304)
T ss_pred             HHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhcccccc-------------------ccCCCCCCHHHHHHHHHHccCC
Confidence            999987  55677643211  111111111000000000                   0001134567889999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 002897          841 PTDRMQMRDVVVKLC  855 (869)
Q Consensus       841 P~~RPs~~evl~~L~  855 (869)
                      |++|||+.||.+.|+
T Consensus       289 p~~RPs~~~i~~~l~  303 (304)
T cd05096         289 CRERPSFSDIHAFLT  303 (304)
T ss_pred             chhCcCHHHHHHHHh
Confidence            999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=342.53  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++..     .+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence            46899999999999999999999899999999997432   2344678899999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            999999999999999997654      388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++.....           ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus       147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~  214 (333)
T cd05600         147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYWK  214 (333)
T ss_pred             CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhcc
Confidence            9975432           1234568999999999999899999999999999999999999997532211 011110000


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                        ....   .+..               .......+.++.+++.+|++.+|++||+++|+++.
T Consensus       215 --~~~~---~~~~---------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 --ETLQ---RPVY---------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --cccc---CCCC---------------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              0000   0000               00001335567899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-38  Score=347.08  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.++||+|+||.||+|++     ..++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            45799999999999999999974     3456789999986432 33446788999999999 899999999997553  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc---------------------------------------------------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL---------------------------------------------------  654 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  654 (869)
                         ...++||||+++|+|.++++......                                                   
T Consensus       112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence               67899999999999999997643110                                                   


Q ss_pred             ------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          655 ------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       655 ------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                                        +...+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                              112478999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      .....      .......++..|+|||++.+..++.++|||||||++|||++ |..||........ .........    
T Consensus       266 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~----  334 (375)
T cd05104         266 NDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGY----  334 (375)
T ss_pred             Ccccc------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCc----
Confidence            33210      11122335678999999999999999999999999999998 8889865322211 111111000    


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .                      ...+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus       335 ~----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 R----------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             c----------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0                      000011235688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-38  Score=335.31  Aligned_cols=275  Identities=20%  Similarity=0.294  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++..     ....+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEE
Confidence            57999999999999999999999899999999986433 2234567899999999999999999998654     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++ +|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999975 99999876543     378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh-
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV-  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-  790 (869)
                      +......        .......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ......+.. 
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~  221 (288)
T cd07871         151 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLG  221 (288)
T ss_pred             eeccCCC--------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            7543221        12233467999999998865 468999999999999999999999997532211 111111110 


Q ss_pred             --cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 --LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 --~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        .+..+....+..-............ ...........+..+++.+|+++||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              0000111111000000000000000 000000122356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.5e-38  Score=333.28  Aligned_cols=275  Identities=21%  Similarity=0.344  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECC-CCeEEEEEEeeccc--chhhHHHHHHHHHHHhC---CCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGE-NGMLVAVKVLNLMQ--KGALKSFLTECEALRSI---RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~  627 (869)
                      .+|++.+.||+|+||.||+|++.. +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            379999999999999999999853 57889999986432  22334566788777766   6999999999986544445


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence            567899999996 599999876542    2489999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.++.....         .......|+..|+|||++.+..++.++|||||||++|||++|++||......+ ......
T Consensus       153 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~  222 (290)
T cd07862         153 DFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL  222 (290)
T ss_pred             cccceEeccCC---------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH
Confidence            99999765432         12234568999999999988889999999999999999999999997532211 111111


Q ss_pred             hhhc---ccccccccCccchhhhhhcccccCCCc--cchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVL---PEKVMEIVDPSLLLEVRANNSMSRGGE--RVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~---~~~~~~~~d~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....   +.......  .....    ........  .....+.+..+.+++.+|++.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         223 DVIGLPGEEDWPRDV--ALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHhCCCChhhchhhh--cccch----hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1110   00000000  00000    00000000  0001124456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.8e-38  Score=335.55  Aligned_cols=278  Identities=20%  Similarity=0.254  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...  ....+.+.+|+++++.++||||+++++++..     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence            47899999999999999999999899999999986432  2334677899999999999999999988654     3788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++++.+..+.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999999877765543322      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch--HHHhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT--LHEFSKM  789 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~  789 (869)
                      +........       .......|++.|+|||++.+..++.++||||+||++|||++|+.||.........  .......
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         147 ARNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             ccccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            987643221       1223356899999999999888999999999999999999999999753221110  0000000


Q ss_pred             hcccccccc-cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEI-VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......... .++........................+..+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000 000000000000000000000111124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-38  Score=346.45  Aligned_cols=265  Identities=22%  Similarity=0.359  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||.||+|++..     ++..||+|+++... ......+.+|+++++.+ +|+||++++++|...  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            3579999999999999999998643     34579999996432 33456788999999999 899999999987653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCc----------------------------------------------------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDK----------------------------------------------------  653 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  653 (869)
                         ...++||||+++|+|.+++......                                                    
T Consensus       115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence               6789999999999999998653210                                                    


Q ss_pred             ------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCC
Q 002897          654 ------------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD  721 (869)
Q Consensus       654 ------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  721 (869)
                                  ....++++.++++++.||++||+|||++   +|+||||||+||++++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                        0112478899999999999999999999   9999999999999999999999999999765432210


Q ss_pred             CccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccccccC
Q 002897          722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVD  800 (869)
Q Consensus       722 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  800 (869)
                            .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..........     ....
T Consensus       269 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~-----~~~~  336 (374)
T cd05106         269 ------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY-----QMSR  336 (374)
T ss_pred             ------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc-----CccC
Confidence                  11122335678999999988899999999999999999997 999997532221 1111111000     0000


Q ss_pred             ccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          801 PSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                                           +...+.++.+++.+||+.||++|||+.||++.|+++.
T Consensus       337 ---------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 ---------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                                 0012456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=309.04  Aligned_cols=254  Identities=20%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++.|++.+.||+|.|+.||++.+..+|+.+|+|++..  -.....+.+.+|+.|.+.++||||+++.+.+.     ...
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccc
Confidence            35678888999999999999999999999999999852  23345688899999999999999999998754     347


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl  706 (869)
                      ..|+|+|+|+|++|..-+-.+.      -.++..+-..++||++||.|+|.+   +|||||+||+|+++...   --+||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence            8999999999999976554432      278889999999999999999999   99999999999999543   36999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|..+...         ....+++|||+|||||++...+|+..+|||+.|||+|-++.|.+||.+.... ..++..
T Consensus       155 ~~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I  224 (355)
T KOG0033|consen  155 ADFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQI  224 (355)
T ss_pred             cccceEEEeCCc---------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence            999999987632         3455678999999999999999999999999999999999999999753221 122222


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....+     ++ ++                  +......++..+|+++|+..||++|.|+.|.+..
T Consensus       225 ~~g~y-----d~-~~------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  225 KAGAY-----DY-PS------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             hcccc-----CC-CC------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            21111     11 11                  1112334556799999999999999999998763

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=313.87  Aligned_cols=274  Identities=25%  Similarity=0.400  Sum_probs=224.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC--CCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ...+.+..+.||+|.||.||+|.+  .|+.||||++...++   +...+|.+|++.+  +|+||+.+++.-... -..-.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~T  282 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWT  282 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc--cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceE
Confidence            445677889999999999999999  799999999965433   6678899998865  999999999874332 12234


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeecCCCcE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH-----CKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                      ..++|++|.+.|||+||+.+..       ++.+..++++..+|.||+|||-.     ++|.|+|||||..||||..++.+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            6799999999999999999854       89999999999999999999975     58999999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC------CCccccchhhhHHHHHHHcC---------
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE------ASMTGDVYSFGILLLEMFSR---------  769 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~el~tg---------  769 (869)
                      -|+|+|+|.........    ........+||.+|||||++...-      .-..+||||||.|+||++.+         
T Consensus       356 ~IADLGLAv~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             EEeeceeeEEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            99999999887665321    123456678999999999986542      23458999999999999763         


Q ss_pred             -CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          770 -RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       770 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                       +.||.+....+.+++++.+.+.-++....++.                 ++...++...+.++++.||..+|..|-||-
T Consensus       432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn-----------------rW~s~~~l~~m~klMkeCW~~Np~aRltAL  494 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN-----------------RWKSDPALRVMAKLMKECWYANPAARLTAL  494 (513)
T ss_pred             hcCCcccCCCCCCCHHHHhcceeecccCCCCCc-----------------ccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence             47888877778888887777665555444443                 344557888999999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 002897          849 DVVVKLCAARE  859 (869)
Q Consensus       849 evl~~L~~~~~  859 (869)
                      .+-+.|.++.+
T Consensus       495 riKKtl~~l~~  505 (513)
T KOG2052|consen  495 RIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHhc
Confidence            99999888765

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-38  Score=342.81  Aligned_cols=246  Identities=23%  Similarity=0.284  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++..     .+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence            357899999999999999999999899999999996432   2334678899999999999999999998654     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence            8999999999999999998754      378999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |++.......           ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....     ......
T Consensus       163 g~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~  226 (329)
T PTZ00263        163 GFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEK  226 (329)
T ss_pred             cCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHH
Confidence            9998654321           234689999999999998999999999999999999999999964211     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      .......                        .+......+.+++.+||+.||++||+     ++|++.
T Consensus       227 i~~~~~~------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        227 ILAGRLK------------------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HhcCCcC------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1111000                        00012345779999999999999997     677764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-38  Score=339.32  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|++..+|+.||+|+++..   .......+.+|+++++.++||||+++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence            4799999999999999989999999999743   23344567889999999999999999998654     378999999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|..++....      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999987654      389999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      ...        .......|++.|+|||++.+..++.++|||||||++|||++|+.||......     ........... 
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~-  212 (323)
T cd05595         147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI-  212 (323)
T ss_pred             CCC--------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC-
Confidence            211        1123356899999999999989999999999999999999999999643211     11111110000 


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                           .                  .+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       213 -----~------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 -----R------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----C------------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                 0                  0012345678999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.3e-38  Score=337.54  Aligned_cols=201  Identities=25%  Similarity=0.394  Sum_probs=175.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.++||+|+||.||+|.+..++..+|+|+++.. .......+.+|+++++.++||||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence            46899999999999999999999989999999998754 233456789999999999999999999997653     689


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999997654      3789999999999999999999742  799999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +.......          .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            87553321          12346899999999999888999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-39  Score=303.02  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=207.4

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhC-CCCccceEEEEe
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSI-RHRNLIKIITIC  620 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  620 (869)
                      ......|...+.+|+|..++|-++.++.+|..+|+|++....        ....+.-..|+.||+++ .||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888999999999999999999999999999996322        12235568899999999 699999999996


Q ss_pred             eccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 002897          621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH  700 (869)
Q Consensus       621 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  700 (869)
                      ..     +...++|+|.|+.|.|.+|+...-      .++++..++|++|+.+|++|||.+   .|||||+||+|||+++
T Consensus        93 es-----~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   93 ES-----DAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             cC-----cchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            54     478999999999999999998765      499999999999999999999999   9999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC------CCCCCccccchhhhHHHHHHHcCCCCCC
Q 002897          701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT------GSEASMTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~el~tg~~pf~  774 (869)
                      +.++||+|||+|+.+.++         ......+||++|.|||.+.      ...|+..+|+||+|||+|.++.|.+||.
T Consensus       159 n~~i~isDFGFa~~l~~G---------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPG---------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             ccceEEeccceeeccCCc---------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            999999999999987665         3345578999999999764      2358889999999999999999999985


Q ss_pred             cCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .  +.....   .+.+..+ ..+.                   ..+...+......+||.+|++.||.+|.|++|+++.
T Consensus       230 H--RkQmlM---LR~ImeG-kyqF-------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  230 H--RKQMLM---LRMIMEG-KYQF-------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             H--HHHHHH---HHHHHhc-cccc-------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            3  111111   1111111 1111                   122334566778899999999999999999999873

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-38  Score=338.93  Aligned_cols=243  Identities=24%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.++||||+++.+++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence            4799999999999999999999999999643   23345678899999999999999999988654     378999999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999987654      389999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      ...        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ............ 
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~-  212 (328)
T cd05593         147 TDA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI-  212 (328)
T ss_pred             Ccc--------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc-
Confidence            211        122335689999999999988999999999999999999999999964221     111111111000 


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVK  853 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  853 (869)
                           .                  .+...+..+.+++.+||+.||++||     ++.|+++.
T Consensus       213 -----~------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 -----K------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----c------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                 0                  0012345677999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-37  Score=326.82  Aligned_cols=257  Identities=23%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.++... ......+.+|+.++++++||||+++++++..     .
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence            356889999999999999999874   356789999987543 2334678899999999999999999998754     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence            678999999999999999986543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+........       .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......     ...
T Consensus       151 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~  218 (266)
T cd05064         151 FRRLQEDKSEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVI  218 (266)
T ss_pred             Ccccccccccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH
Confidence            998764322110       11112335678999999999999999999999999999775 99998653211     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ...... .                      ..+.+..++..+.+++.+||+.+|++|||++|+.+.|.++
T Consensus       219 ~~~~~~-~----------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 KAVEDG-F----------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHCC-C----------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111000 0                      0011123556788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=338.46  Aligned_cols=240  Identities=23%  Similarity=0.323  Sum_probs=193.4

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|+.++++++||||+++++++..     .+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence            69999999999999989999999998643   23345677899999999999999999998654     37889999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            9999999997654      389999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .        .......||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+..........   
T Consensus       147 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~---  210 (312)
T cd05585         147 D--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPL---  210 (312)
T ss_pred             C--------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCC---
Confidence            1        12234568999999999999899999999999999999999999996421     1122111111100   


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ---MRDVVV  852 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  852 (869)
                                           ..+...+..+.+++.+||+.||++||+   +.|++.
T Consensus       211 ---------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 ---------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                                 001123456789999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=342.52  Aligned_cols=271  Identities=22%  Similarity=0.235  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++++++||||+++++++...     ...++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEE
Confidence            57999999999999999999999999999999753      24567899999999999999999987543     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |+|++. ++|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus       161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            999995 68999887654      388999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccC------CchHHHhh
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE------GLTLHEFS  787 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~------~~~~~~~~  787 (869)
                      .......       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......      ...+....
T Consensus       231 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~  303 (391)
T PHA03212        231 FPVDINA-------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII  303 (391)
T ss_pred             ccccccc-------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence            5332110       1223457999999999999989999999999999999999999886432111      01111111


Q ss_pred             hhhc--ccccccccCccchhhh--hhcccccCCCccc---hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVL--PEKVMEIVDPSLLLEV--RANNSMSRGGERV---KIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~--~~~~~~~~d~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...-  +..........+...+  ...........++   ...+.+.++.+++.+||+.||++||||+|+++
T Consensus       304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1110  0000000000000000  0000000111111   12245668899999999999999999999986

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-37  Score=327.55  Aligned_cols=269  Identities=24%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|.+.+.||+|+||.||+|...     .++..+|+|.+........+.+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            56889999999999999999852     35677999998766555667899999999999999999999997643     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCc-------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDK-------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                      +..++||||+++++|.+++......       .....+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            6789999999999999999754321       1122489999999999999999999999   99999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~  780 (869)
                      +.++|+|||.+........      ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       157 ~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-  229 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-  229 (288)
T ss_pred             CcEEeccCCccccccCCce------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999976543211      011223345788999999998889999999999999999998 89998643221 


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                          .............                       ....++..+.+++.+||+.||.+|||+.||.+.|+++.+.
T Consensus       230 ----~~~~~i~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 ----EVIECITQGRVLQ-----------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ----HHHHHHHcCCcCC-----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                1111111110000                       0012334688999999999999999999999999999877


Q ss_pred             hhcc
Q 002897          861 FVSM  864 (869)
Q Consensus       861 ~~~~  864 (869)
                      ....
T Consensus       283 ~~~~  286 (288)
T cd05093         283 SPVY  286 (288)
T ss_pred             cccc
Confidence            5443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=335.20  Aligned_cols=245  Identities=23%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             eeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccC
Q 002897          561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQN  640 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  640 (869)
                      +||+|.||+||.|++..+...+|||.+...+.....-+..|+...+.++|.|||+++|.+...     ++.-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCCC
Confidence            799999999999999999999999999877766777889999999999999999999986543     688899999999


Q ss_pred             CCHHHHHhhCCCcccccCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEccccccccCCC
Q 002897          641 GSLEEWLHQNNDKLEVCNL--SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       641 gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  717 (869)
                      |+|.+.++..-+.     +  .+.++-.+.+||++||.|||+.   .|||||||-+||||+ -.|.+||+|||.++.+..
T Consensus       657 GSLSsLLrskWGP-----lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGP-----LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             CcHHHHHHhccCC-----CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9999999876543     5  7788889999999999999999   999999999999995 578999999999987654


Q ss_pred             CCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       718 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      -.        ..+..+.||..|||||++..++  |+.++|||||||++.||.||++||-.........   .+.-    +
T Consensus       729 in--------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVG----m  793 (1226)
T KOG4279|consen  729 IN--------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVG----M  793 (1226)
T ss_pred             CC--------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhc----c
Confidence            32        4556778999999999998775  8999999999999999999999996543321111   0000    0


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..                   .-++.+++...+...+|.+|+.+||.+||+|.++++
T Consensus       794 yK-------------------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 YK-------------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ee-------------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            00                   112344567788889999999999999999999986

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-37  Score=324.64  Aligned_cols=262  Identities=21%  Similarity=0.336  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...   .......+.+|+++++.++||||+++++++...     +.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            5799999999999999999999989999999987532   233446788999999999999999999987643     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|+||+++|+|.+++......  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            89999999999999988643221  12478999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.......        .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||......   ...+....
T Consensus       152 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~  220 (267)
T cd08228         152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKI  220 (267)
T ss_pred             cceeccchh--------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHH
Confidence            988664332        1112345888999999998888999999999999999999999998643221   11111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      ....     .                 ........+..+.+++.+||+.+|++||+++||++.+++++
T Consensus       221 ~~~~-----~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 EQCD-----Y-----------------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hcCC-----C-----------------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0000     0                 00111234567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=339.97  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=193.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|+..++||+|+||.||+|++..+|+.||||++.... ....+.+.+|+++++.++|+||+++++++..     ....+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEE
Confidence            45777899999999999999999899999999986443 2334678999999999999999999998654     37789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+..          ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999986432          256778889999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      +......        .......||..|+|||++..     ...+.++|||||||++|||++|+.||......  ......
T Consensus       216 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~  285 (353)
T PLN00034        216 RILAQTM--------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLM  285 (353)
T ss_pred             eeccccc--------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHH
Confidence            8654321        11233568999999998743     23456899999999999999999999732211  111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......                       .......++.++.+++.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        286 CAICMSQ-----------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHhccC-----------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110000                       000111344568899999999999999999999874

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-38  Score=339.17  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC-eEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++...   .....+.+.+|+++++.++||||+++++++.+.     
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-----  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence            457999999999999999999876444 78999998643   233456788999999999999999999997553     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence            78999999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||++......           .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ....
T Consensus       175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~  238 (340)
T PTZ00426        175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQ  238 (340)
T ss_pred             CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHH
Confidence            9999765322           12346899999999999888999999999999999999999999753211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  853 (869)
                      .......  ..                      +...+..+.+++.+|++.||++|+     +++|+++.
T Consensus       239 ~i~~~~~--~~----------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        239 KILEGII--YF----------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHhcCCC--CC----------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1111000  00                      011234567999999999999995     88888763

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=328.76  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=215.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCC----CeEEEEEEeec-ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGEN----GMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +..+..++||.|-||.||+|....-    .-.||||..+. ...+..+.|..|+.+|+.++||||++++|+|.+      
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------  462 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------  462 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------
Confidence            3445567999999999999998522    23588998875 344557889999999999999999999999976      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...|||||.++.|.|..|++.+...     ++......++.||+.||+|||+.   ++|||||..+||||.....+||+|
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             cceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence            5689999999999999999988764     89999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+++.+.+...       ...+...-...|||||.+.-..++.++|||.|||++||++. |..||.+....+..     
T Consensus       535 FGLSR~~ed~~y-------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----  602 (974)
T KOG4257|consen  535 FGLSRYLEDDAY-------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----  602 (974)
T ss_pred             cchhhhccccch-------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----
Confidence            999998876542       22223334678999999999999999999999999999987 99999864333111     


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                                       +      ..+.+.+.+.++.||+.++.++.+||.+||.+||++.|+...|..+.+
T Consensus       603 -----------------~------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 -----------------G------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -----------------E------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                             0      011233445567899999999999999999999999999999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=337.56  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ...++|...++||+|+||.|++|..+.+++.+|||++++.   ..++.+....|.+|+... +||.+++++..     |+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQ  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQ  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cc
Confidence            3457899999999999999999999999999999999754   456778889999998887 59999999998     45


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      ..++.++||||+.||++..+.+..       .+++..++-++..|+.||.|||++   |||+||||.+|||+|.+|++||
T Consensus       440 T~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             cCCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence            569999999999999955544433       289999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+++.--.        ....+++.+||+.|||||++.+..|+.++|-|||||++|||+.|+.||.+..+++ .++.+
T Consensus       510 ADFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI  580 (694)
T KOG0694|consen  510 ADFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSI  580 (694)
T ss_pred             cccccccccCC--------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH
Confidence            99999974321        2245677899999999999999999999999999999999999999998643321 11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .    .+                        +..++..++.+...++++++..+|++|.-+
T Consensus       581 ~----~d------------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 V----ND------------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             h----cC------------------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1    00                        111222455677899999999999999865

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-37  Score=328.67  Aligned_cols=276  Identities=27%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEE----CCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .+|++.+.||+|+||.||+|..    ..+++.||+|.+........+.+.+|+++++.++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4788999999999999999984    357889999999766666667889999999999999999999987542   335


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            68999999999999999976543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |++..........     .......++..|+|||+..+..++.++|||||||++|||++|..|+......      +...
T Consensus       153 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~  221 (284)
T cd05081         153 GLTKVLPQDKEYY-----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRM  221 (284)
T ss_pred             cccccccCCCcce-----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhh
Confidence            9998765432110     0111123455699999998888999999999999999999998776432111      1110


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .............+......      ....+....++..+.+++.+||+.+|++||||.||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         222 MGNDKQGQMIVYHLIELLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccccccchHHHHHHHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000000011111110000      011111223456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.9e-37  Score=333.52  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|+..+.||+|+||.||+|++..++.    .||+|+++... ....+++.+|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            579999999999999999999865555    48999986433 3445678899999999999999999999764      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++|+||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence            346799999999999999987643     388999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.++........      .......++..|+|||++.+..++.++|||||||++|||++ |+.||+.....  ......
T Consensus       153 fG~a~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~  224 (316)
T cd05108         153 FGLAKLLGADEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL  224 (316)
T ss_pred             ccccccccCCCcc------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            9999876543211      11122234678999999999899999999999999999998 99998653211  111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...    ..                      .+.+..++..+.+++.+||+.+|++|||+.|++..+.++.+..
T Consensus       225 ~~~----~~----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         225 EKG----ER----------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             hCC----CC----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            100    00                      0001123346789999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-37  Score=326.86  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCC-----eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENG-----MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ++|++.+.||+|+||.||+|.....+     ..||+|.+.... ......+.+|+++++.++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE----   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence            47889999999999999999986444     689999986433 23446789999999999999999999987543    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCccc----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLE----------VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                       ...+++|||+++|+|.+++.......+          ...+++.++..++.|++.||+|||+.   +++||||||+||+
T Consensus        81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence             678999999999999999986532111          13488999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      +++++.++|+|||++........      ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADY------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEECCCcceeecccccc------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999976533221      012233456789999999988899999999999999999998 99998753


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ...     +..........                       ...+..++.++.+++.+||+.||++||++.||++.|++
T Consensus       231 ~~~-----~~~~~i~~~~~-----------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         231 SNQ-----EVIEMIRSRQL-----------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CHH-----HHHHHHHcCCc-----------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            221     11111111000                       01122456788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-37  Score=336.58  Aligned_cols=267  Identities=24%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||.||+|...     .+++.||+|+++... ....+.+.+|+++++++ +|+||++++++|...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            457999999999999999999753     245789999986432 23346678899999999 899999999987543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc---------------------------------------------------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL---------------------------------------------------  654 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  654 (869)
                        ....+++|||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              357889999999999999986532110                                                   


Q ss_pred             ----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCC
Q 002897          655 ----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS  730 (869)
Q Consensus       655 ----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  730 (869)
                          ...++++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++..+......      ...
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------~~~  232 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VRK  232 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------hhc
Confidence                012589999999999999999999999   9999999999999999999999999999876433210      112


Q ss_pred             CCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhh
Q 002897          731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRA  809 (869)
Q Consensus       731 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  809 (869)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......+ .......    .....            
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~~~~------------  295 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EGTRM------------  295 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----ccCCC------------
Confidence            23446778999999999999999999999999999998 999986432111 1111100    00000            


Q ss_pred             cccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          810 NNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                                ..+......+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       296 ----------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         296 ----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                      0011234568899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=340.74  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....   ......+.+|+++++.++||||+++++++.+     .+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence            47899999999999999999999999999999997532   3344667899999999999999999998664     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            999999999999999998654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcccc------------------------------CCCCCCccCcccccCCcccCCCCCCccccchhhh
Q 002897          711 LAKFLPARPLDTVVET------------------------------PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFG  760 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG  760 (869)
                      ++..+...........                              .......+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            9876533211000000                              0011134699999999999988999999999999


Q ss_pred             HHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCC
Q 002897          761 ILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES  840 (869)
Q Consensus       761 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  840 (869)
                      |++|||++|..||......     ................                    .....++.+.+++.+|+. +
T Consensus       227 ~il~el~~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~--------------------~~~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQ-----ETYRKIINWKETLQFP--------------------DEVPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHH-----HHHHHHHcCCCccCCC--------------------CCCCCCHHHHHHHHHHcc-C
Confidence            9999999999999753211     1111110000000000                    000123456788999996 9


Q ss_pred             CCCCCC---HHHHHH
Q 002897          841 PTDRMQ---MRDVVV  852 (869)
Q Consensus       841 P~~RPs---~~evl~  852 (869)
                      |.+|++   ++|+++
T Consensus       281 p~~R~~~~~~~~ll~  295 (364)
T cd05599         281 AERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCHHHHhc
Confidence            999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-37  Score=340.88  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhCC-CCccceEEEEeeccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQ-KGALKSFLTECEALRSIR-HRNLIKIITICSSID  624 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  624 (869)
                      ..++|++.++||+|+||.||+|++..     .+..||||+++... ....+.+.+|+++++++. ||||+++++++... 
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence            35689999999999999999998742     24579999996433 333467899999999996 99999999997543 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcc--------------------------------------------------
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--------------------------------------------------  654 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------  654 (869)
                          ...++||||+++|+|.+++.......                                                  
T Consensus       114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence                67899999999999999987642100                                                  


Q ss_pred             ----------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002897          655 ----------------------------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPS  694 (869)
Q Consensus       655 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  694 (869)
                                                              ....+++..+..++.|+++||+|||+.   +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence                                                    012478889999999999999999999   9999999999


Q ss_pred             ceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCC
Q 002897          695 NVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPT  773 (869)
Q Consensus       695 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf  773 (869)
                      ||+++.++.+||+|||+++........      .......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999865432210      11223456788999999998899999999999999999997 99998


Q ss_pred             CcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          774 DSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       774 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .................                           ....+..++..+.+++.+||+.||++|||+.+|.+.
T Consensus       341 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         341 PGMIVDSTFYNKIKSGY---------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             cccchhHHHHHHHhcCC---------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            75322211111100000                           000112345678899999999999999999999999


Q ss_pred             HHHHHH
Q 002897          854 LCAARE  859 (869)
Q Consensus       854 L~~~~~  859 (869)
                      |+++.+
T Consensus       394 l~~l~~  399 (400)
T cd05105         394 VESLLP  399 (400)
T ss_pred             HHHHcC
Confidence            987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.9e-38  Score=337.50  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=194.9

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|.+..+|+.||+|+++..   .......+..|+++++.++||||+++.+++..     .+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence            4799999999999999989999999999743   22344667889999999999999999988654     378999999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      |+++|+|.+++....      .+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999987654      38999999999999999999997 6   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ............
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~~  213 (325)
T cd05594         147 IKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEI  213 (325)
T ss_pred             CCCC--------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCCC
Confidence            2211        122335689999999999998999999999999999999999999964221     111111110000


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVK  853 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  853 (869)
                                              ..+...+..+.+++.+||+.||++|+     ++.|+++.
T Consensus       214 ------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 ------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                                    00012334677999999999999997     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-37  Score=335.20  Aligned_cols=245  Identities=26%  Similarity=0.344  Sum_probs=193.5

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHH---HhCCCCccceEEEEeeccccCCCc
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEAL---RSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      |++.+.||+|+||.||+|.+..+|+.||||+++...   ....+.+.+|++++   +.++||||+++++++..     ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence            677899999999999999999899999999997432   23345666776665   45689999999998654     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|..++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            899999999999999888653       289999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+++......        .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......     .....
T Consensus       146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~  212 (324)
T cd05589         146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDS  212 (324)
T ss_pred             cCCccCCCCC--------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            9986432211        2223456899999999999989999999999999999999999999753211     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      ......                        ..+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       213 i~~~~~------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         213 IVNDEV------------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHhCCC------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            110000                        00112345677999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.4e-37  Score=321.74  Aligned_cols=256  Identities=25%  Similarity=0.454  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++||||+++++++...     ...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEE
Confidence            45888899999999999999998889999999986433 3356788999999999999999999987543     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++.....    ..+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||.+.
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999976432    2489999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++..|+|||...+..++.++|||||||++|||++ |..||.....     .+.......
T Consensus       153 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~  220 (263)
T cd05052         153 LMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEK  220 (263)
T ss_pred             cccccee-------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHC
Confidence            6644321       11112234668999999998899999999999999999998 9999864211     111111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      . .                      ....++.++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       221 ~-~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         221 G-Y----------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             C-C----------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            0 0                      0001113456788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=349.52  Aligned_cols=254  Identities=20%  Similarity=0.250  Sum_probs=203.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCC-CeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGEN-GMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .|.+.+.||+|++|.||+|....+ ++.||+|.+..........+..|+.+++.++||||+++++++...     +..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence            488999999999999999998877 788999987655555556788999999999999999999997653     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....  ...++++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            9999999999998865321  123488999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .......      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..........
T Consensus       218 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~  286 (478)
T PTZ00267        218 QYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYG  286 (478)
T ss_pred             ecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC
Confidence            7643221      1123345699999999999998999999999999999999999999964221     1111111110


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..    +                   +.+..++..+.+++.+||+.||++||+++|++.
T Consensus       287 ~~----~-------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 KY----D-------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CC----C-------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            00    0                   001123456889999999999999999999975

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-37  Score=341.20  Aligned_cols=260  Identities=20%  Similarity=0.245  Sum_probs=198.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .|+..+.||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.+     .+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence            5888999999999999999999999999999996532   3345678999999999999999999999764     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++++||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999997654      388999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCcc---------------------------------------ccCCCCCCccCcccccCCcccCCCCCCc
Q 002897          712 AKFLPARPLDTVV---------------------------------------ETPSSSSGIKGTVGYIAPEYGTGSEASM  752 (869)
Q Consensus       712 a~~~~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~  752 (869)
                      +............                                       ..........||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            8643211100000                                       0000112357999999999999888999


Q ss_pred             cccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHH
Q 002897          753 TGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRI  832 (869)
Q Consensus       753 ~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  832 (869)
                      ++|||||||++|||++|+.||........ .......  .... .                     .+.......++.++
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~i~~~--~~~~-~---------------------~~~~~~~s~~~~dl  282 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTET-QLKVINW--ENTL-H---------------------IPPQVKLSPEAVDL  282 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHH-HHHHHcc--cccc-C---------------------CCCCCCCCHHHHHH
Confidence            99999999999999999999975322111 0000000  0000 0                     00000123456677


Q ss_pred             Hhh--ccCCCCCCCCCHHHHHHH
Q 002897          833 GVV--CSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       833 i~~--cl~~dP~~RPs~~evl~~  853 (869)
                      +.+  |+..+|..||+++|+++.
T Consensus       283 i~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         283 ITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHccCcccccCCCCHHHHhcC
Confidence            777  556677779999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-37  Score=349.82  Aligned_cols=265  Identities=22%  Similarity=0.284  Sum_probs=208.2

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC-
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN-  626 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-  626 (869)
                      ....++|++.+.||+|+||+||+|++..+|+.||||+++..  .......+.+|+..+..++|+|++++.+.+...+.. 
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34557999999999999999999999989999999998643  334456788999999999999999988766543211 


Q ss_pred             --CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          627 --GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       627 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                        .....++||||+++|+|.++++.....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence              112468999999999999999764321  23589999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      ||+|||+++.+......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..
T Consensus       183 kL~DFGls~~~~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~  251 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSD------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----ME  251 (496)
T ss_pred             EEEecccCeeccccccc------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HH
Confidence            99999999866432211      12234569999999999999999999999999999999999999996421     11


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ............                       +.+..++..+.+++.+||+.||++||++.|+++.
T Consensus       252 ~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 EVMHKTLAGRYD-----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHhcCCCC-----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            221111111000                       0111344568899999999999999999999863

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=311.64  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=210.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      |.+..+||+|+||.||+|.++++|+.+|||.+...  ....++.+|+.++++++.|++|+++|.|..     ....||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEeeh
Confidence            56778999999999999999999999999998653  346889999999999999999999997643     36789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      |||..|+..+.++.++.     ++++.++..+.+..++||+|||..   .-+|||||+.|||++.+|.+||+|||.|..+
T Consensus       108 EYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             hhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999988765     499999999999999999999999   8999999999999999999999999999765


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      .+..        .....+.||+.|||||++..-.|+.++||||+|++..||..|++||.+...-...+      .++.  
T Consensus       180 TDTM--------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT--  243 (502)
T KOG0574|consen  180 TDTM--------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPT--  243 (502)
T ss_pred             hhhH--------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccC--
Confidence            5432        44566889999999999998889999999999999999999999997643321100      0000  


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                                        +.+.....+++.+.++.++++.|+-..|++|-||.++++.
T Consensus       244 ------------------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 ------------------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ------------------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                              1111223456778889999999999999999999998863

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-37  Score=326.17  Aligned_cols=273  Identities=25%  Similarity=0.344  Sum_probs=205.1

Q ss_pred             CC-CCCCeeeeecceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EF-SSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +| ++.+.||+|+||+||++..    ..+++.||+|+++... ....+.+.+|++++++++||||+++++++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            44 8889999999999987653    3578899999986543 23456788999999999999999999987542   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....       +++.+++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  150 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGD  150 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEee
Confidence            56899999999999999997643       89999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+..........     .......++..|+|||...+..++.++||||||+++|||++|..||......   ......
T Consensus       151 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~  222 (283)
T cd05080         151 FGLAKAVPEGHEYY-----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIG  222 (283)
T ss_pred             cccccccCCcchhh-----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhc
Confidence            99998765432110     1112234567799999998888999999999999999999999998643221   111110


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      ....    ......+.......      .....+..++..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus       223 ~~~~----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         223 PKQG----QMTVVRLIELLERG------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccc----ccchhhhhhhhhcC------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000    00000000000000      000111235567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5e-37  Score=326.21  Aligned_cols=278  Identities=20%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhC---CCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSI---RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|++.+.||+|+||+||+|++..+|+.||+|.++...  ......+.+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999999999999999986432  22234566777777665   799999999988765444456


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++ +|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            78999999975 89998876542    2389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |++.......         ......|+..|+|||++.+..++.++||||+||++|+|++|++||....... ........
T Consensus       153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~  222 (288)
T cd07863         153 GLARIYSCQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDL  222 (288)
T ss_pred             CccccccCcc---------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHH
Confidence            9997654321         1223467899999999998899999999999999999999999986532211 11111111


Q ss_pred             hcccccccc-cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEI-VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......... .+.........  ...........++....+.+++.+|++.||++|||+.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFS--PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCCCChhhCcccccccccccC--CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000000 00000000000  00000000111234566789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.4e-37  Score=323.62  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++...     ...+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence            35799999999999999999999889999999999765555556788999999999999999999987643     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.++++...      ++++..+..++.|++.|++|||+.   +|+|||++|+||+++.++.++|+|||.+
T Consensus        83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999987643      389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .......        .......|+..|+|||.+.   ...++.++||||+||++|||++|+.||......... ..+.. 
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~-  223 (267)
T cd06646         154 AKITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSK-  223 (267)
T ss_pred             eeecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeec-
Confidence            8654321        1122345889999999874   345788999999999999999999998543211000 00000 


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                         ..   ...+..                ......+..+.+++.+||+.+|++|||++++++.+
T Consensus       224 ---~~---~~~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 ---SN---FQPPKL----------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---CC---CCCCCC----------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               00   000000                00112345688999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-37  Score=331.72  Aligned_cols=242  Identities=21%  Similarity=0.324  Sum_probs=190.5

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|++..+++.||+|+++..   .....+.+..|+.++.++ +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            4799999999999999999999999999753   233445678899988877 89999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|..++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999999887654      389999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc---hHHHh-hhhhc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL---TLHEF-SKMVL  791 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~---~~~~~-~~~~~  791 (869)
                      ....        .......||..|+|||++.+..++.++|||||||++|||++|+.||........   ....+ .....
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~  218 (329)
T cd05618         147 LRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  218 (329)
T ss_pred             cCCC--------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh
Confidence            2211        122345689999999999999999999999999999999999999963221110   00111 11110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      ....                        ..+......+.+++.+||+.||++||++
T Consensus       219 ~~~~------------------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 EKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             cCCC------------------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            0000                        0011234557799999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-37  Score=331.96  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=193.9

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|++..+++.||+|+++..   .....+.+..|..+++.+ +||||+++++++...     ...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence            4799999999999999999999999999753   223345678999999988 799999999986543     7889999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999987654      389999999999999999999999   9999999999999999999999999998642


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC---chHHHhh-hhhc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG---LTLHEFS-KMVL  791 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~---~~~~~~~-~~~~  791 (869)
                      ....        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+......   .....+. +...
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  218 (329)
T cd05588         147 IRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL  218 (329)
T ss_pred             ccCC--------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH
Confidence            2111        12234568999999999999999999999999999999999999996422111   0011111 1110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ------MRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  852 (869)
                      ....                        ..+...+..+.+++.+|++.||++||+      ++|+++
T Consensus       219 ~~~~------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 EKQI------------------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCCC------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            0000                        001123446789999999999999998      567654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.3e-37  Score=338.85  Aligned_cols=255  Identities=18%  Similarity=0.243  Sum_probs=200.6

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..++|++.++||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+     .
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----D  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            4568999999999999999999999999999999996432   2334557889999999999999999988654     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....       +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence            78999999999999999987643       78889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      ||.+........       .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......     
T Consensus       186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----  253 (370)
T cd05596         186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----  253 (370)
T ss_pred             ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----
Confidence            999976543211       112345699999999987653    4789999999999999999999999753211     


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVVK  853 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  853 (869)
                      ........... ...                   .+.....+..+.+++.+|++.+|++  |||++|+++.
T Consensus       254 ~~~~~i~~~~~-~~~-------------------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         254 GTYSKIMDHKN-SLT-------------------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHHcCCC-cCC-------------------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11111110000 000                   0000123456789999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.9e-37  Score=322.98  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|++.+.||+|+||+||+|.+..+++    .|++|.+.... .....++..|+.++++++||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            578889999999999999999976666    47777775332 2334677888889999999999999998642      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++++||+++|+|.+++.....     .+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence            346789999999999999986543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.++.......      ........++..|+|||+..++.++.++|||||||++||+++ |+.||......  ...+..
T Consensus       153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~  224 (279)
T cd05111         153 FGVADLLYPDDK------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLL  224 (279)
T ss_pred             CccceeccCCCc------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            999986543321      012233457788999999998899999999999999999998 99998653211  111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...   .  ....                     +..++..+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus       225 ~~~---~--~~~~---------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         225 EKG---E--RLAQ---------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HCC---C--cCCC---------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            100   0  0000                     011234567899999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=334.00  Aligned_cols=247  Identities=23%  Similarity=0.450  Sum_probs=208.8

Q ss_pred             CCCeeeeecceEEEEEEECCCCeEEEEEEeec----ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL----MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       558 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ...+||+|+|-+||+|.+..+|..||--.++.    ..+...++|..|+.+|+.|+||||++++++|.+..   ....-+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~  120 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF  120 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence            45689999999999999999999998544431    23445689999999999999999999999988752   356789


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEcccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLA  712 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  712 (869)
                      |+|.+..|+|..|.++.+.      ++.+.+..|++||++||.|||++ .|+|+|||||.+||||+.+ |.|||+|+|+|
T Consensus       121 iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            9999999999999998875      88999999999999999999998 8999999999999999764 79999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......          ....++|||.|||||++. ..|++.+||||||+++.||+|+..||.........+.+......|
T Consensus       194 tl~r~s----------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  194 TLLRKS----------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP  262 (632)
T ss_pred             HHhhcc----------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence            876543          233478999999999987 689999999999999999999999998765555555555555555


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..+..+-||                          ++.++|.+|+.. .++|||+.|+++
T Consensus       263 ~sl~kV~dP--------------------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSKVKDP--------------------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhccCCH--------------------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            555555554                          366899999999 999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.3e-37  Score=319.26  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||.||+|.++ ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...     ...++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEE
Confidence            46888999999999999999986 56789999886432 2346788999999999999999999987543     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999999999976543     388999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++..|+|||...+..++.++||||||+++|||++ |+.||......     ........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----~~~~~i~~  216 (256)
T cd05114         149 YVLDDEY-------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----EVVEMISR  216 (256)
T ss_pred             ccCCCce-------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHC
Confidence            6543211       11122345678999999988889999999999999999999 89998643211     11111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ..  ....                     +...+..+.+++.+||+.+|++|||++|+++.|
T Consensus       217 ~~--~~~~---------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         217 GF--RLYR---------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CC--CCCC---------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            00  0000                     011234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=332.63  Aligned_cols=198  Identities=27%  Similarity=0.384  Sum_probs=173.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-C-----CccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-H-----RNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~  627 (869)
                      .+|.+.++||+|.||.|.+|.+..+++.||||+++... ....+...|+.+|..++ |     -|+|++++++..     
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----
Confidence            38899999999999999999999999999999996543 34567789999999996 4     389999999655     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC--cEE
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM--VAH  705 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~k  705 (869)
                      .++.|||+|.++. +|+++++.+.-    .+++...++.++.||+.||.+||+.   +|||+||||+|||+.+.+  .+|
T Consensus       260 r~HlciVfELL~~-NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  260 RNHLCIVFELLST-NLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             ccceeeeehhhhh-hHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence            4899999999955 99999998864    3699999999999999999999999   999999999999996544  799


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      |+|||.|+......           ...+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.
T Consensus       332 VIDFGSSc~~~q~v-----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  332 VIDFGSSCFESQRV-----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             EEecccccccCCcc-----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            99999998765432           1456789999999999999999999999999999999998888654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.6e-37  Score=335.90  Aligned_cols=208  Identities=24%  Similarity=0.328  Sum_probs=176.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++...   ......+..|+.++.+++||+|+++++.+.+     ...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence            47899999999999999999999899999999996432   2334567889999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            999999999999999998654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc---------------------------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHH
Q 002897          711 LAKFLPARPLDTVV---------------------------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL  763 (869)
Q Consensus       711 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il  763 (869)
                      +++...........                           ..........||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            99765432110000                           000011245799999999999998999999999999999


Q ss_pred             HHHHcCCCCCCc
Q 002897          764 LEMFSRRRPTDS  775 (869)
Q Consensus       764 ~el~tg~~pf~~  775 (869)
                      |||++|+.||..
T Consensus       227 ~ell~G~~Pf~~  238 (363)
T cd05628         227 YEMLIGYPPFCS  238 (363)
T ss_pred             HHHHhCCCCCCC
Confidence            999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.4e-37  Score=324.56  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||+|.++..... ..+.+.+|+++++.++||||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            356888999999999999999874     24678999998755443 457889999999999999999999997653   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCC--------cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNND--------KLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                        ...++||||+++++|.+++.....        ......+++..+..++.|++.|++|||+.   +++||||||+||++
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence              678999999999999999986542        11223478999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCc
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMF  777 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~  777 (869)
                      +.++.+||+|||.+.........      .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             cCCCeEEECCcccceecccCcce------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999765332110      11223345788999999999999999999999999999998 999986432


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ..     ...........                       ...+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       230 ~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         230 NE-----EVIECITQGRL-----------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH-----HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            21     11111100000                       0001134456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.4e-37  Score=330.72  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=190.2

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++... +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            47999999999999999899999999997432   23345566677777654 89999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999997654      389999999999999999999999   9999999999999999999999999999754


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+......... 
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~-  212 (316)
T cd05592         147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDR-  212 (316)
T ss_pred             CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC-
Confidence            3221        222345689999999999998999999999999999999999999975321     11111111000 


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR-DVV  851 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  851 (869)
                           +                  ..+..++..+.+++.+||+.||++||++. +++
T Consensus       213 -----~------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 -----P------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -----C------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                 0                  00012334567999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=347.04  Aligned_cols=279  Identities=20%  Similarity=0.267  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc---CCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF---NGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~  629 (869)
                      ..+|++.++||+|+||.||+|.+..+++.||||++....    ....+|+.+++.++||||+++++++....+   ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999998899999999885322    234579999999999999999988654322   1223


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEcc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGD  708 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  708 (869)
                      ..++||||+++ ++.+++......  ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++ .+||+|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            57799999975 787777542211  22489999999999999999999999   999999999999998665 799999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+|+.+....         ......||+.|+|||++.+. .++.++||||+||++|||++|.+||....... .+....
T Consensus       215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~  284 (440)
T PTZ00036        215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII  284 (440)
T ss_pred             cccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence            99998654321         12234689999999987664 68999999999999999999999997532211 111111


Q ss_pred             hhhcccc--cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEK--VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......  ......+.... ...............+...+.++.+++.+||++||++|||+.|+++
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYAD-IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhc-ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1110000  00000000000 0000000000000011123467889999999999999999999985

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.1e-37  Score=326.67  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++...     ...++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEE
Confidence            5799999999999999999999889999999999765555567889999999999999999999987643     68899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++....       +++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+.
T Consensus        95 v~e~~~~~~L~~~~~~~~-------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             eecccCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            999999999999986542       78999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......    .+.... ..
T Consensus       165 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~-~~  231 (296)
T cd06654         165 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA-TN  231 (296)
T ss_pred             hccccc--------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh-cC
Confidence            654321        11223468899999999988889999999999999999999999996432211    111000 00


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....                     ...++..+..+.+++.+||..+|++|||+.|+++.
T Consensus       232 ~~~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         232 GTPE---------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCC---------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000                     00112344567899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.4e-37  Score=329.80  Aligned_cols=237  Identities=27%  Similarity=0.358  Sum_probs=190.8

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|++..+++.||+|+++..   .....+.+..|..++... +||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence            4799999999999999989999999998643   233456677888888877 79999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999987654      389999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     ............
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~  213 (320)
T cd05590         147 IFNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEV  213 (320)
T ss_pred             CcCC--------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCC
Confidence            2211        122345689999999999988999999999999999999999999975321     111111111100


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                         .                     .+...+..+.+++.+|++.||++||++
T Consensus       214 ---~---------------------~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 ---V---------------------YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---C---------------------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence               0                     001133457799999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=320.14  Aligned_cols=265  Identities=25%  Similarity=0.396  Sum_probs=204.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCC---CeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCCc
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGVD  629 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  629 (869)
                      |.+.+.||+|+||.||+|....+   +..||+|+++...  ......+.+|++.++.++||||+++++++..... .+..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999998643   4789999986432  3345678999999999999999999998765432 3344


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++...........+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            5799999999999999986643222223589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++........      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......     +...
T Consensus       158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~  226 (273)
T cd05035         158 GLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYD  226 (273)
T ss_pred             cceeeccccccc------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            999866443211      11112234678999999988889999999999999999999 88888642211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .......                       ...+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       227 ~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 YLRHGNR-----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHcCCC-----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110000                       001113455788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.5e-37  Score=324.19  Aligned_cols=267  Identities=27%  Similarity=0.445  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+........+.+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence            46888899999999999999863     34567999998766555567889999999999999999999997543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      ...++||||+++++|.+++......          .....+++..++.++.||+.|++|||++   +|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            6789999999999999999764321          0112389999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCc
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMF  777 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~  777 (869)
                      +.++.++|+|||.+........      ........++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             ccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999976543221      011233456789999999998899999999999999999999 999986432


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ..     .............                       ....++..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus       231 ~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         231 NT-----EVIECITQGRVLE-----------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HH-----HHHHHHhCCCCCC-----------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            21     1111111100000                       0112345688999999999999999999999999999


Q ss_pred             HHhhh
Q 002897          858 REAFV  862 (869)
Q Consensus       858 ~~~~~  862 (869)
                      .+..+
T Consensus       283 ~~~~~  287 (291)
T cd05094         283 GKATP  287 (291)
T ss_pred             HhhcC
Confidence            77644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.8e-37  Score=332.61  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=194.1

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|++..+++.||+|+++..   .....+.+..|.+++..+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence            4699999999999999989999999999643   233445677899998876 79999999998754     37789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|..++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654      388999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......|++.|+|||++.+..++.++||||+||++|||++|+.||......     ...........
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~~  213 (321)
T cd05591         147 ILNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDV  213 (321)
T ss_pred             ccCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCC
Confidence            3221        1223456899999999999889999999999999999999999999753211     11111111100


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-------QMRDVVVK  853 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  853 (869)
                         .                     .+...+.++.+++.+|++.||++||       +++++++.
T Consensus       214 ---~---------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 ---L---------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ---C---------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence               0                     0011234677999999999999999       77777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.9e-37  Score=333.00  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCC-ccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHR-NLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  630 (869)
                      +|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+..|+++++.++|+ +|+++.+++..     .+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence            588899999999999999999989999999999643   233456778899999999765 57778877544     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            999999999999999997654      378999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++.......        .......||+.|+|||++.+..++.++||||+||++|+|+||+.||......     ......
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i  213 (324)
T cd05587         147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSI  213 (324)
T ss_pred             cceecCCCC--------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            986432211        1223456899999999999989999999999999999999999999753211     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .....                        ..+...+..+.+++.+||..||++||++
T Consensus       214 ~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         214 MEHNV------------------------SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HcCCC------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            10000                        0001233457799999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-36  Score=320.01  Aligned_cols=265  Identities=24%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCe--EEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCce
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGM--LVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDF  630 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  630 (869)
                      |.+.++||+|+||.||+|++..++.  .||+|.++..  .....+.+.+|+++++.++||||+++++++.... ......
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999876665  6999988643  3444677899999999999999999999875431 122345


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++|||+++|+|.+++...........+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            789999999999999885433221223489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .++........      .......+++.|+|||...+..++.++|||||||++|||++ |+.||.....     ......
T Consensus       158 ~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~  226 (272)
T cd05075         158 LSKKIYNGDYY------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDY  226 (272)
T ss_pred             cccccCcccce------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence            99876443210      11122345778999999998899999999999999999999 8889864221     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .......                       .....++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       227 ~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGNRL-----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCCCC-----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1100000                       00112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.2e-37  Score=322.84  Aligned_cols=262  Identities=23%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++.... ......+.+|+.+++.++||||+++++++..   
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            4678999999999999999999864     245789999985432 2334568899999999999999999998654   


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                        ....++||||+++|+|.+++.......+    ...+++..+..++.|++.|++|||+.   +++||||||+||+++++
T Consensus        81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence              3678999999999999999976432211    12367889999999999999999999   99999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~  780 (869)
                      +.++|+|||++.........      .......++..|+|||++.+..++.++|||||||++|||++ |..||.....  
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--  227 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--  227 (277)
T ss_pred             CCEEECCCCCccccCCccee------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            99999999998765432210      11112345788999999998889999999999999999999 7888864321  


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                         ..............                       .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       228 ---~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         228 ---EQVLRFVMEGGLLD-----------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---HHHHHHHHcCCcCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence               11111111110000                       01123456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-37  Score=330.83  Aligned_cols=243  Identities=21%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             CCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          559 SNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++||+|+||.||+|+..   .+++.||+|+++...    ......+..|+++++.++||||+++++++..     .+..
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence            368999999999999873   478899999996432    2233567889999999999999999998654     3678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            99999999999999997654      378889999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ++......        .......|++.|+|||++.+..++.++|||||||++|||++|+.||......     .......
T Consensus       147 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~  213 (323)
T cd05584         147 CKESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKIL  213 (323)
T ss_pred             CeecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHH
Confidence            87532221        1223356899999999999888999999999999999999999999753211     1111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      ....                        ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       214 ~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         214 KGKL------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cCCC------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1100                        00012234678999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=324.87  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=200.5

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .|++.++||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++..     .+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence            4788899999999999999998899999999986432   2223456789999999999999999998654     3689


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999998865432    2489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......         ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~  218 (285)
T cd05605         149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVK  218 (285)
T ss_pred             ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhh
Confidence            97654321         112346899999999999888999999999999999999999999753211 11111111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  853 (869)
                      ..                        ....+...+..+.+++.+||+.||++||     +++++++.
T Consensus       219 ~~------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 ED------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hc------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00                        0001123455678999999999999999     88888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.5e-37  Score=335.27  Aligned_cols=257  Identities=17%  Similarity=0.240  Sum_probs=199.3

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..    
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----  114 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----  114 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence            34457899999999999999999999989999999998642   22234567899999999999999999998654    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                       ....++||||+++|+|.+++....       +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         115 -DKYLYMVMEYMPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence             478999999999999999997543       78899999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----CCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      +|||+|........       .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||......   
T Consensus       184 ~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---  253 (370)
T cd05621         184 ADFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---  253 (370)
T ss_pred             EecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---
Confidence            99999986643211       122345699999999998654    3788999999999999999999999743211   


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVVK  853 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  853 (869)
                        ........... ..                   ..+.....+..+.+++..|+..+|.+  |||+.|+++.
T Consensus       254 --~~~~~i~~~~~-~~-------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         254 --GTYSKIMDHKN-SL-------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --HHHHHHHhCCc-cc-------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              11111110000 00                   00000123455678888999865543  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-37  Score=323.23  Aligned_cols=257  Identities=29%  Similarity=0.466  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ...+|++.++||.|+||.||+|.+.. ++.+|+|++..........+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence            44679999999999999999999985 899999999766655567889999999999999999999987543     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++.....    ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            999999999999999986542    2489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.......        .......++..|+|||...+..++.++||||||+++|+|++ |+.||...... ........ .
T Consensus       151 ~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~-~  220 (261)
T cd05148         151 ARLIKEDV--------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQITA-G  220 (261)
T ss_pred             hhhcCCcc--------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHHh-C
Confidence            97664322        11113345778999999988889999999999999999998 89998643211 11111100 0


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .                          ..+.+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       221 ~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         221 Y--------------------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             C--------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            0                          0001113445688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=337.31  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||+|+++...   ......+..|+++++.++||||+++++++.+     .+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence            47899999999999999999999899999999997432   2445678899999999999999999988654     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            999999999999999998763      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCc---------------------cccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC
Q 002897          711 LAKFLPARPLDTV---------------------VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR  769 (869)
Q Consensus       711 ~a~~~~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg  769 (869)
                      ++...........                     ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            9986654320000                     0000122345689999999999999999999999999999999999


Q ss_pred             CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-HH
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-MR  848 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~  848 (869)
                      +.||......     ......... ....                   ..+....++..+.+++.+|++ ||++||+ ++
T Consensus       227 ~~Pf~~~~~~-----~~~~~i~~~-~~~~-------------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         227 FPPFYSDTLQ-----ETYNKIINW-KESL-------------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             CCCCCCCCHH-----HHHHHHhcc-CCcc-------------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            9999753211     111111000 0000                   000000134567899999998 9999999 99


Q ss_pred             HHHHH
Q 002897          849 DVVVK  853 (869)
Q Consensus       849 evl~~  853 (869)
                      |+++.
T Consensus       281 ~ll~h  285 (350)
T cd05573         281 EIKSH  285 (350)
T ss_pred             HHhcC
Confidence            99874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.7e-37  Score=323.08  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=194.4

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||+||+|.+..+|+.||+|.+....   ....+.+..|+++++.++||||+++.+++..     ....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence            699999999999999999999999986432   2233567889999999999999999988654     36789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++|+|.+++......  ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||.+......
T Consensus        76 ~~g~L~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            999999887543211  22489999999999999999999999   9999999999999999999999999999765443


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .        .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .............    
T Consensus       151 ~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~----  217 (280)
T cd05608         151 Q--------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS----  217 (280)
T ss_pred             C--------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC----
Confidence            2        11233568999999999999999999999999999999999999997532211 1111111111000    


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                                          ...++..+..+.+++.+||+.||++||     +++|+++
T Consensus       218 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 --------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                                001123455678999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.5e-37  Score=352.38  Aligned_cols=274  Identities=23%  Similarity=0.310  Sum_probs=208.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.++||+|+||.||+|++..+|+.||+|+++...   ....+++.+|++++++++||||+++++++.+.     +.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence            57999999999999999999999899999999986432   23346789999999999999999999987653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKL-----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      .++||||+++|+|.+++.......     .....++..++.++.||++||+|||+.   ||+||||||+||+++.++.++
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            899999999999999987532110     112367788899999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCc----------cccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          706 VGDFGLAKFLPARPLDTV----------VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      |+|||+++..........          ...........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999987622110000          0000112335799999999999999999999999999999999999999965


Q ss_pred             CccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHH
Q 002897          776 MFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-QMRDVVVKL  854 (869)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L  854 (869)
                      .........   ..        ..++.               ......+.+..+.+++.+|++.||++|| +++++++.|
T Consensus       234 ~~~~ki~~~---~~--------i~~P~---------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        234 KKGRKISYR---DV--------ILSPI---------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             cchhhhhhh---hh--------ccChh---------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            221110000   00        00000               0001123456688999999999999996 677778888


Q ss_pred             HHHHHhh
Q 002897          855 CAAREAF  861 (869)
Q Consensus       855 ~~~~~~~  861 (869)
                      +...+..
T Consensus       288 e~~lq~~  294 (932)
T PRK13184        288 EPHLQGS  294 (932)
T ss_pred             HHHHhcC
Confidence            7776543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.3e-37  Score=321.86  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=193.7

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||.||+|+...+|+.||+|.+....   ......+..|++++++++||||+++.+++..     ....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence            699999999999999899999999986322   1223455679999999999999999988654     37899999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999998865432    2488999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .         ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ................  
T Consensus       149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--  216 (277)
T cd05607         149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDEVK--  216 (277)
T ss_pred             c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccccc--
Confidence            1         112345899999999999888999999999999999999999998643221 1111111111110000  


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                                           ......+.++.+++.+||+.||++||+++|+++..
T Consensus       217 ---------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 ---------------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ---------------------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence                                 00012345678999999999999999998776444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.2e-37  Score=318.58  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=196.7

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      +.||+|+||.||+|++..+++.||+|.+... ..+....+.+|++++++++||||+++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence            4699999999999999889999999987543 233456789999999999999999999997543     6789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++.....     .+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.+......
T Consensus        76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999976442     388999999999999999999999   9999999999999999999999999998754432


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVME  797 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  797 (869)
                      ...      .......++..|+|||.+.++.++.++|||||||++|||++ |..||......     ........ ..  
T Consensus       148 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~~~~~~~-~~--  213 (252)
T cd05084         148 VYA------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QTREAIEQ-GV--  213 (252)
T ss_pred             ccc------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HHHHHHHc-CC--
Confidence            110      01111223567999999998889999999999999999998 88888643211     11110000 00  


Q ss_pred             ccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       798 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                                          ....+..++..+.+++.+|++.+|++|||+.||.+.|+
T Consensus       214 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 --------------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             --------------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                                00111133557889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=337.33  Aligned_cols=260  Identities=20%  Similarity=0.245  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.++||+|+||.||+|.+..+++.||||++...   .....+.+.+|+++++.++||||+++++++.+     ...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence            4789999999999999999999999999999998643   23345678899999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999997654      388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCC---------cccc------------------------------CCCCCCccCcccccCCcccCCCCCC
Q 002897          711 LAKFLPARPLDT---------VVET------------------------------PSSSSGIKGTVGYIAPEYGTGSEAS  751 (869)
Q Consensus       711 ~a~~~~~~~~~~---------~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  751 (869)
                      +|+.........         ....                              ........||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            996432211000         0000                              0000124699999999999988999


Q ss_pred             ccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHH
Q 002897          752 MTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIR  831 (869)
Q Consensus       752 ~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  831 (869)
                      .++|||||||++|||++|+.||......    ..+.............+                     .......+.+
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~---------------------~~~~s~~~~d  281 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSH----ETYRKIINWRETLYFPD---------------------DIHLSVEAED  281 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHH----HHHHHHHccCCccCCCC---------------------CCCCCHHHHH
Confidence            9999999999999999999999643211    11111000000000000                     0012345778


Q ss_pred             HHhhccCCCCCCC---CCHHHHHHH
Q 002897          832 IGVVCSMESPTDR---MQMRDVVVK  853 (869)
Q Consensus       832 li~~cl~~dP~~R---Ps~~evl~~  853 (869)
                      ++.+|+. +|.+|   +|+.|++..
T Consensus       282 li~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         282 LIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             HHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            9999997 67765   599998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=325.33  Aligned_cols=265  Identities=25%  Similarity=0.452  Sum_probs=219.8

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ++++....+....++||-|.||.||.|.|+.-.-.||||.++. +....++|.+|+.+|+.++|||+|+++|+|...   
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E---  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE---  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence            3444444567778999999999999999998899999999854 344578999999999999999999999999864   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                        ...|||+|||..|+|.+|+++....    .++.-..+.++.||+.||+||..+   ++||||+.++|+||.++..+|+
T Consensus       336 --pPFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  336 --PPFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             --CCeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence              6689999999999999999986542    367778889999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~  785 (869)
                      +|||+++.+..+......       +..-...|.|||-+....++.|+|||+|||++||+.| |-.||.+.     ...+
T Consensus       407 ADFGLsRlMtgDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq  474 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ  474 (1157)
T ss_pred             eccchhhhhcCCceeccc-------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH
Confidence            999999998765432221       1223578999999999999999999999999999999 88888653     2222


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      .+...                       +.+.+...++.|++.+++|++.||+|+|++||+++|+-+.++.+..
T Consensus       475 VY~LL-----------------------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  475 VYGLL-----------------------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHH-----------------------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            22211                       1123344556899999999999999999999999999999887643

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-37  Score=333.96  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++..     ...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence            36889999999999999999999999999999997532   2345678899999999999999999988654     377


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            9999999999999999987633     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC------CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT------GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      ++........       .......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----  215 (330)
T cd05601         148 SAARLTANKM-------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----  215 (330)
T ss_pred             CCeECCCCCc-------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----
Confidence            9986643321       1122346899999999876      456789999999999999999999999643211     


Q ss_pred             Hhhhhhccc-ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          785 EFSKMVLPE-KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......... .....                     +.....+..+.+++..|++ +|++|||++++++
T Consensus       216 ~~~~~i~~~~~~~~~---------------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         216 KTYNNIMNFQRFLKF---------------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcCCCccCC---------------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111111100 00000                     0001234557789999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-37  Score=323.17  Aligned_cols=251  Identities=29%  Similarity=0.509  Sum_probs=192.7

Q ss_pred             CCCeeeeecceEEEEEEEC----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          558 SSNMVGQGSFGTVFKGIIG----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       558 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +.+.||.|.||.||+|.+.    ..+..|+||+++... ....+.+.+|++.+++++||||++++|++...     ...+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence            3468999999999999997    346889999996533 33468899999999999999999999998743     5589


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..+..|+.||++||+|||++   +++|+||+++||+++.++.+||+|||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            99999999999999998721    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .........      .......+...|+|||.+.+..++.++||||||+++||+++ |+.||....     ...+.....
T Consensus       151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~~~  219 (259)
T PF07714_consen  151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEKLK  219 (259)
T ss_dssp             EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHHHH
T ss_pred             ccccccccc------ccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc
Confidence            876322110      12233446789999999988889999999999999999999 778876431     112111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .....                       ..+..++..+.+++..||+.||++|||+.|+++.|
T Consensus       220 ~~~~~-----------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 QGQRL-----------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTEET-----------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccc-----------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11000                       01112455688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.8e-37  Score=331.64  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             CCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++....    ....+.+..|+.+++.+ +||+|+++++++..    
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT----   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence            4888999999999999999874   478999999996432    22345678899999999 59999999988543    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                       ....++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        77 -~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          77 -EAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence             377899999999999999997654      389999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      +|||+++.......       .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus       147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~  218 (332)
T cd05614         147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSE  218 (332)
T ss_pred             eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHH
Confidence            99999976533221       112235689999999998765 47889999999999999999999996432211 1111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      +.......      ++.                  .+...+..+.+++.+||+.||++||     +++|+++
T Consensus       219 ~~~~~~~~------~~~------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         219 VSRRILKC------DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHhcC------CCC------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111100      000                  0112345678999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=316.99  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.++... ......+.+|+.++++++||||+++++++..     .
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence            35789999999999999999998643   4689999986443 3345678899999999999999999998654     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++++|.+++.....     .+++..++.++.|++.|++|||+.   +|+||||||+||++++++.++|+|
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d  149 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD  149 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence            678999999999999999977543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+.........      .......++..|+|||...+..++.++||||||+++|++++ |..||......     ...
T Consensus       150 fg~~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~  218 (266)
T cd05033         150 FGLSRRLEDSEAT------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVI  218 (266)
T ss_pred             cchhhcccccccc------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHH
Confidence            9999877522110      11112335678999999998899999999999999999998 99998642211     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .......                       ..+.+..++..+.+++.+||+.+|++||+++||++.|.++
T Consensus       219 ~~~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         219 KAVEDGY-----------------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1110000                       0000113445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-36  Score=319.62  Aligned_cols=262  Identities=22%  Similarity=0.351  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|++|.||+|++..+++.||||.+...   .......+.+|+.+++.++||||+++++++...     +.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence            4688899999999999999999889999999988643   223446788999999999999999999987643     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++|||+++++|.+++......  ...+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            89999999999999998753211  12489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.......        .......|+..|+|||+..+..++.++||||||+++|+|++|..||.....+   ........
T Consensus       152 ~~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~  220 (267)
T cd08229         152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI  220 (267)
T ss_pred             hhhccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh
Confidence            987654332        1122345889999999998888999999999999999999999998643221   11111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      .     ....+                 .......+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       221 ~-----~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 E-----QCDYP-----------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             h-----cCCCC-----------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0     00000                 0011234567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-37  Score=308.60  Aligned_cols=260  Identities=25%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|+..+.||+|.-|+||+|+...++..+|+|++.+..   .....+.+.|-+||+.++||.++.+++.+.     ....
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----ccce
Confidence            45667789999999999999999889999999997543   445678899999999999999999999854     4589


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+|||||+||+|....++....    .+++..++.++.+++-||+|||-.   |||.|||||+||||.++|++.|+||.
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence            99999999999999999887654    599999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCC------------------------------c------------------cccCCCCCCccCcccccCC
Q 002897          711 LAKFLPARPLDT------------------------------V------------------VETPSSSSGIKGTVGYIAP  742 (869)
Q Consensus       711 ~a~~~~~~~~~~------------------------------~------------------~~~~~~~~~~~gt~~y~aP  742 (869)
                      ++......+...                              .                  ......+..++||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            886542211000                              0                  0111234557899999999


Q ss_pred             cccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchH
Q 002897          743 EYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI  822 (869)
Q Consensus       743 E~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~  822 (869)
                      |++.|...+.++|-|+||+++|||+.|+.||.+...+. ++.....    +...-                      +..
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~----~~l~F----------------------p~~  357 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVG----QPLKF----------------------PEE  357 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhc----CCCcC----------------------CCC
Confidence            99999999999999999999999999999998754432 2222111    11000                      001


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002897          823 EECLVAVIRIGVVCSMESPTDRMQ----MRDVVV  852 (869)
Q Consensus       823 ~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  852 (869)
                      .+.+..+.+||++.|.+||++|..    |+||-+
T Consensus       358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            134566889999999999999997    777643

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.5e-37  Score=330.61  Aligned_cols=242  Identities=22%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ......+..|..++..+ +|++|+++++++..     .+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence            5888999999999999999999899999999987432   22334567788888877 58899999888654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            899999999999999987654      388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +++......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~~i  213 (323)
T cd05616         147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSI  213 (323)
T ss_pred             CceecCCCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            987543221        1223456899999999999999999999999999999999999999753211     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .....                        ..+...+.++.+++.+|++.||++|+++
T Consensus       214 ~~~~~------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         214 MEHNV------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HhCCC------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11000                        0001234467799999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-36  Score=318.18  Aligned_cols=255  Identities=24%  Similarity=0.427  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++..     .+..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcE
Confidence            357899999999999999999975 67789999886433 235678999999999999999999998654     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+++|+|.++++....    ..+++..++.++.|+++|++|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999976432    2478999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||+..+..++.++|||||||++|+|++ |+.||......  ..........
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~  221 (261)
T cd05072         151 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGY  221 (261)
T ss_pred             eecCCCce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC
Confidence            87643221       11122345778999999988889999999999999999998 99998643211  1111110000


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                              .                  .+....++.++.+++.+|++.+|++||+++++.+.|++
T Consensus       222 --------~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 --------R------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --------C------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    0                  00011234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.6e-37  Score=328.26  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=191.4

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|++..+++.||+|+++...   .........|..++... +||||+++++++.+.     +..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            47999999999999999899999999997532   23345667788888765 899999999987543     6799999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999997653      388999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||..|+|||++.+..++.++||||+||++|||++|+.||.....     ..........  
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~--  211 (316)
T cd05619         147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIRMD--  211 (316)
T ss_pred             CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC--
Confidence            2211        122345689999999999988999999999999999999999999974321     1111111000  


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR-DVVV  852 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  852 (869)
                          .+.                  .+......+.+++.+||+.||++||++. ++.+
T Consensus       212 ----~~~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 ----NPC------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ----CCC------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                000                  0011234577999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.4e-37  Score=329.70  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=194.4

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|.+..+++.||+|+++...   ......+..|.++++.+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            47999999999999999899999999997532   33456678899999888 79999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999987654      389999999999999999999999   9999999999999999999999999998643


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.....     ............
T Consensus       147 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~~  213 (318)
T cd05570         147 ILGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDEV  213 (318)
T ss_pred             CcCC--------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            2211        122334689999999999999999999999999999999999999964321     111111111000


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM-----RDVVV  852 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  852 (869)
                                              ..+...+..+.+++.+||+.||++|||+     .++++
T Consensus       214 ------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 ------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                                    0001234567899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.8e-37  Score=327.74  Aligned_cols=275  Identities=21%  Similarity=0.288  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++||||+++++++...     +..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence            57999999999999999999999899999999986443 22335678899999999999999999997543     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999975 89888876543     378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .......        .......++..|+|||++.+ ..++.++||||+||++|+|+||+.||......+ ......+...
T Consensus       152 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~  222 (309)
T cd07872         152 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLG  222 (309)
T ss_pred             eecCCCc--------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence            7543321        11223457899999998765 458899999999999999999999997532211 1111111110


Q ss_pred             c--c-ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 P--E-KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~--~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .  . .+....+............. ...........+.++.+++.+|++.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         223 TPTEETWPGISSNDEFKNYNFPKYK-PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCHHHHhhhcchhhhhhhhcCccC-CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0  0 00000000000000000000 00000011124456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.9e-37  Score=337.91  Aligned_cols=260  Identities=20%  Similarity=0.217  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+|++++++++||||+++++++.+     .+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence            47999999999999999999999999999999986432   2234667899999999999999999998654     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999997754      378899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCc-----------------------------------cccCCCCCCccCcccccCCcccCCCCCCcccc
Q 002897          711 LAKFLPARPLDTV-----------------------------------VETPSSSSGIKGTVGYIAPEYGTGSEASMTGD  755 (869)
Q Consensus       711 ~a~~~~~~~~~~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  755 (869)
                      +|..+........                                   ...........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            9854321100000                                   00000112357999999999999989999999


Q ss_pred             chhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhh
Q 002897          756 VYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVV  835 (869)
Q Consensus       756 vwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  835 (869)
                      ||||||++|||++|+.||.......     ......... .....                   +.....+..+.+++.+
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~~-~~~~~-------------------~~~~~~s~~~~~li~~  281 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAE-----TQLKVINWE-TTLHI-------------------PSQAKLSREASDLILR  281 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHH-----HHHHHhccC-ccccC-------------------CCCCCCCHHHHHHHHH
Confidence            9999999999999999997532211     100000000 00000                   0001123456677777


Q ss_pred             ccCCCCCCCC---CHHHHHHH
Q 002897          836 CSMESPTDRM---QMRDVVVK  853 (869)
Q Consensus       836 cl~~dP~~RP---s~~evl~~  853 (869)
                      |+ .+|++|+   |+.|+++.
T Consensus       282 l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         282 LC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             Hh-cCHhhcCCCCCHHHHhCC
Confidence            66 4999999   88998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-36  Score=321.39  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ..+|++.++||+|+||+||+|++..+|+    .||+|+++.. .......+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            4578899999999999999999876665    4899998643 33345678899999999999999999998753     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++++||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence             346799999999999999986543     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+++........      .......++..|+|||...+..++.++|||||||++|||++ |..||+.....  ....+
T Consensus       152 dfG~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~  223 (279)
T cd05109         152 DFGLARLLDIDETE------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL  223 (279)
T ss_pred             CCCceeecccccce------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence            99999876533211      11112235678999999988889999999999999999998 89998643211  11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ......                          .+.+..++..+.+++.+||+.||++||++.|+++.|..+.....
T Consensus       224 ~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         224 LEKGER--------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             HHCCCc--------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            111000                          00011234567899999999999999999999999988876553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-36  Score=315.22  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=203.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...  .....+.+.+|+++++.++|||++++++++...     ...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence            477889999999999999999999999999998643  344567789999999999999999999986543     7889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999987532    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......|+..|+|||+..+..++.++|||||||++|+|++|+.||.....     .........
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~  215 (256)
T cd08529         149 KLLSDNT--------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIR  215 (256)
T ss_pred             eeccCcc--------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc
Confidence            8665432        112234578899999999998899999999999999999999999975321     111111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...                       ......++..+.+++.+||+.+|++||++.|+++.
T Consensus       216 ~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 GVF-----------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCC-----------------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            000                       00111344568899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.7e-37  Score=320.11  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++...     +..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence            35788889999999999999999989999999999766555556788999999999999999999986543     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++....      .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence            9999999999999987654      389999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .......        .......|+..|+|||++.   ...++.++||||+||++|+|++|+.||......... ......
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~  224 (267)
T cd06645         154 AQITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKS  224 (267)
T ss_pred             eEccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhhcc
Confidence            7654321        1223456899999999874   456889999999999999999999998543211110 000000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .    .   ..+...                ....++..+.+++.+|++.+|++|||++++++
T Consensus       225 ~----~---~~~~~~----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         225 N----F---QPPKLK----------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             C----C---CCCccc----------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0    0   000000                00012345779999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.2e-37  Score=337.77  Aligned_cols=207  Identities=22%  Similarity=0.296  Sum_probs=174.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +|++.++||+|+||+||+|++..+++.||+|++....   ......+.+|++++++++||||+++++++.+     .+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence            6889999999999999999999999999999996432   2345678899999999999999999999764     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999997654      378999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCc---------------------------------------cccCCCCCCccCcccccCCcccCCCCCCc
Q 002897          712 AKFLPARPLDTV---------------------------------------VETPSSSSGIKGTVGYIAPEYGTGSEASM  752 (869)
Q Consensus       712 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  752 (869)
                      |...........                                       ...........||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            864321100000                                       00000112357999999999999989999


Q ss_pred             cccchhhhHHHHHHHcCCCCCCc
Q 002897          753 TGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       753 ~sDvwslG~il~el~tg~~pf~~  775 (869)
                      ++||||+||++|||++|+.||..
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCC
Confidence            99999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.7e-37  Score=327.97  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=190.9

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|++..+|+.||+|+++...   .........|..++... +||+|+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence            47999999999999999999999999997532   23345667788888765 89999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999987654      388999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ....+.....  
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~--  211 (316)
T cd05620         147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVD--  211 (316)
T ss_pred             ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC--
Confidence            2211        122345689999999999999999999999999999999999999964321     1111111000  


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR-DVV  851 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  851 (869)
                          .+.                  .+.....++.+++.+||+.||++||++. ++.
T Consensus       212 ----~~~------------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 ----TPH------------------YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCC------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                000                  0001234577999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.7e-36  Score=315.84  Aligned_cols=262  Identities=22%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|++|.||+|....+|+.||+|.++..   .....+.+.+|++++++++|++++++++++...     +.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            5799999999999999999999989999999988632   233356789999999999999999999987543     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++......  ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            89999999999999998753221  22489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.......        .......++..|+|||.+.+..++.++|||||||++|+|++|+.||....   ....+.....
T Consensus       152 ~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~  220 (267)
T cd08224         152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI  220 (267)
T ss_pred             eeeeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh
Confidence            987654322        11123457889999999988889999999999999999999999986422   1111111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      .....                      .....+..+..+.+++.+||+.+|++|||+.+|++.++.+.
T Consensus       221 ~~~~~----------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         221 EKCDY----------------------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hcCCC----------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00000                      00011134557889999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-36  Score=327.67  Aligned_cols=238  Identities=27%  Similarity=0.328  Sum_probs=188.0

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECE-ALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence            47999999999999999999999999996432   222344555554 4678899999999998654     37889999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999997654      388999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+..........
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~  213 (323)
T cd05575         147 IEHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPL  213 (323)
T ss_pred             ccCC--------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC
Confidence            2211        22234568999999999999899999999999999999999999996421     1111111111100


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      .                        .....+..+.+++.+|++.||++||++.
T Consensus       214 ~------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 R------------------------LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C------------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0                        0011245678999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=321.59  Aligned_cols=264  Identities=22%  Similarity=0.374  Sum_probs=211.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +...+.++||+|-||.|.++... .+..||||.++.... .....|.+|+++|.+++||||++++|+|...     +..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            45678899999999999999985 569999999986554 3458899999999999999999999999865     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +++|||++|+|.+|+......    ....+...+|+.|||.||+||.+.   ++||||+.+.|+|++.++++||+|||++
T Consensus       612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence            999999999999999987542    135566778999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc--CCCCCCcCccCCchHHHhhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS--RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t--g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +-+-..+.      .......+-..+|||||.+.-++++.++|||+||+++||+++  ...||.....++  ..+-....
T Consensus       685 R~lysg~y------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~  756 (807)
T KOG1094|consen  685 RNLYSGDY------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEF  756 (807)
T ss_pred             cccccCCc------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhh
Confidence            86544321      123334556789999999999999999999999999999876  788987654331  11111112


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .+..-...+                   ...+.-|+..+++++.+||+.|.++|||++++...|.+.
T Consensus       757 ~~~~~~~~~-------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  757 FRDQGRQVV-------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCCccee-------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111111111                   112335778899999999999999999999999888754

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-36  Score=323.48  Aligned_cols=268  Identities=25%  Similarity=0.382  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeE--EEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGML--VAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+..++..  +|+|.++.. .......+.+|++++.++ +||||+++++++...     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence            35788999999999999999998777754  577776532 233456788999999999 899999999997543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      +..++||||+++|+|.++++......          ....+++.+++.++.|++.|++|||+.   |++||||||+||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili  157 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  157 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence            67899999999999999997653211          112488999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCc
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMF  777 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~  777 (869)
                      +.++.+||+|||++......         .......++..|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             cCCCcEEeCccccCcccchh---------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            99999999999998632211         01111234678999999988889999999999999999998 999986432


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ..     +...... ...    .                  ...+...+..+.+++.+||+.+|++||+++++++.++++
T Consensus       229 ~~-----~~~~~~~-~~~----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         229 CA-----ELYEKLP-QGY----R------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             hH-----HHHHHHh-cCC----c------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11     1111110 000    0                  000012344678999999999999999999999999998


Q ss_pred             HHhhhccc
Q 002897          858 REAFVSMQ  865 (869)
Q Consensus       858 ~~~~~~~~  865 (869)
                      .+...+..
T Consensus       281 ~~~~~~~~  288 (303)
T cd05088         281 LEERKTYV  288 (303)
T ss_pred             HHhhhhhh
Confidence            77766544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-36  Score=319.48  Aligned_cols=274  Identities=25%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             CCCCCCeeeeecceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      -|++.+.||+|+||.||.|..    ..++..||+|.++... ....+.+.+|+++++.++|||++++.+++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            468899999999999999984    3568899999986443 33456789999999999999999999987642   235


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.||+|||++   |++||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence            68999999999999999976532     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.++.........     .......++..|+|||+..+..++.++|||||||++|||++++.|+......   .......
T Consensus       154 g~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~  225 (284)
T cd05079         154 GLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGP  225 (284)
T ss_pred             ccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhccc
Confidence            9998765432110     1122345677899999998888999999999999999999988775432110   0000000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ...+   ...+ .........      ...+.+..++..+.+++.+||+.+|++|||++|+++.++++
T Consensus       226 ~~~~---~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         226 THGQ---MTVT-RLVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccc---ccHH-HHHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000   0000 000000000      00011123456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-36  Score=321.00  Aligned_cols=265  Identities=25%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM--LVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++...     .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence            578999999999999999999876664  4788888642 333456789999999999 799999999986543     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      ..++||||+++|+|.+++.......          ....+++..++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            7899999999999999997643210          112488999999999999999999999   999999999999999


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCcc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFH  778 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~  778 (869)
                      +++.+||+|||++.......         .......+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~  224 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC  224 (297)
T ss_pred             CCCeEEECCcCCCcccccee---------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999986432110         0111123567999999988889999999999999999997 9999864322


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      .     ......... ..                      ...+..++..+.+++.+||+.+|.+|||++++++.|+.+.
T Consensus       225 ~-----~~~~~~~~~-~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         225 A-----ELYEKLPQG-YR----------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             H-----HHHHHHhcC-CC----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1     111111100 00                      0001123456889999999999999999999999999988


Q ss_pred             Hhhhc
Q 002897          859 EAFVS  863 (869)
Q Consensus       859 ~~~~~  863 (869)
                      .....
T Consensus       277 ~~~~~  281 (297)
T cd05089         277 EARKA  281 (297)
T ss_pred             Hhhcc
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=332.77  Aligned_cols=204  Identities=23%  Similarity=0.300  Sum_probs=172.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999989999999998643  2334567889999999999999999999876432 2233


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++ ++.+.+..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence            467999999965 67666643        278889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      ||+++.....         .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       167 fg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         167 FGLARTACTN---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCCccccccC---------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999754322         1223356899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.7e-37  Score=321.14  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCC-C
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNG-V  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~  628 (869)
                      .+++.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++++ +||||+++++++...+..+ .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            456789999999999999999999998999999999865432 346788999999998 7999999999987543222 3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++|+|
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            568999999999999999986432    2488999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      ||++.......        .......|+..|+|||++.     +..++.++||||+||++|||++|+.||......    
T Consensus       155 fg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----  222 (272)
T cd06637         155 FGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----  222 (272)
T ss_pred             CCCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----
Confidence            99997653321        1223456899999999875     335788999999999999999999998643211    


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..... ......                      .......++..+.+++.+||..+|.+|||+.|+++
T Consensus       223 ~~~~~-~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         223 RALFL-IPRNPA----------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHH-HhcCCC----------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11000 000000                      00001123456789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-36  Score=322.09  Aligned_cols=266  Identities=25%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      ...++|++.+.||+|+||.||+|....     ....+|+|.+.... ......+.+|+++++++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345679999999999999999999863     33789999986432 33446788999999999 899999999987543


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           ...+++|||+++|+|.++++.....          .....+++..++.++.|++.|++|||+.   +|+||||||
T Consensus        89 -----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp  160 (293)
T cd05053          89 -----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA  160 (293)
T ss_pred             -----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence                 6789999999999999999764311          1123589999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||.++.+......      .......++..|+|||+..+..++.++|||||||++||+++ |..|
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYY------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccce------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence            9999999999999999999866543210      11122235678999999988889999999999999999998 9999


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |.....     .+..........                       ...+..++..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~-----~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~  286 (293)
T cd05053         235 YPGIPV-----EELFKLLKEGYR-----------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE  286 (293)
T ss_pred             CCCCCH-----HHHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            864221     111111100000                       0001123456889999999999999999999999


Q ss_pred             HHHHHH
Q 002897          853 KLCAAR  858 (869)
Q Consensus       853 ~L~~~~  858 (869)
                      .|+++.
T Consensus       287 ~l~~~~  292 (293)
T cd05053         287 DLDRML  292 (293)
T ss_pred             HHHHhh
Confidence            998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-36  Score=315.58  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=198.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||+||.|.+. .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++...     ...++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence            46888999999999999999885 456799998864332 346789999999999999999999997543     56799


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....     .+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            9999999999999976543     389999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++..|+|||+..+..++.++|||||||++|+|++ |+.||......     ........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~  216 (256)
T cd05113         149 YVLDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQ  216 (256)
T ss_pred             ecCCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhc
Confidence            6543221       11122345678999999988889999999999999999999 99998643211     11111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ....                       ..+...+..+.+++.+||+.+|++|||+.++++.+
T Consensus       217 ~~~~-----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         217 GLRL-----------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCC-----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            0000                       00001245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-36  Score=314.63  Aligned_cols=251  Identities=18%  Similarity=0.264  Sum_probs=202.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +|++.++||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++||||+++.+++.+     ....++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            578899999999999999999999999999998643 23345678899999999999999999998654     378999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....    ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++++|||.+.
T Consensus        76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999999875432    2478999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....     ..........
T Consensus       149 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~  215 (255)
T cd08219         149 LLTSPG--------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQG  215 (255)
T ss_pred             eecccc--------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcC
Confidence            654321        112235688999999999988899999999999999999999999974211     1111111110


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...                       ..+...+..+.+++.+||+.||++|||+.|++.+
T Consensus       216 ~~~-----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 SYK-----------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCC-----------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            000                       0011234457899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-36  Score=332.68  Aligned_cols=261  Identities=17%  Similarity=0.241  Sum_probs=201.7

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeec
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSS  622 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  622 (869)
                      ..++....++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3444556689999999999999999999999999999999986422   2334567889999999999999999998654


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                           ....++||||+++|+|.+++....       +++..+..++.||+.||+|||++   +|+||||||+||+++.++
T Consensus       115 -----~~~~~lv~Ey~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~  179 (371)
T cd05622         115 -----DRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence                 378999999999999999997543       78889999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----CCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----EASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      .+||+|||++........       .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....
T Consensus       180 ~ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  252 (371)
T cd05622         180 HLKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  252 (371)
T ss_pred             CEEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence            999999999986643211       122345699999999998653    378999999999999999999999974221


Q ss_pred             CCchHHHhhhhhccc-ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPE-KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVVKL  854 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  854 (869)
                           .......... .....                     +.....+..+.+++..|+..+|.+  ||+++|+++..
T Consensus       253 -----~~~~~~i~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         253 -----VGTYSKIMNHKNSLTF---------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -----HHHHHHHHcCCCcccC---------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                 1111111100 00000                     001123456778999999844433  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-36  Score=334.22  Aligned_cols=281  Identities=19%  Similarity=0.248  Sum_probs=201.5

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.++||+|+||.||+|.+..+|+.||+|++...  .....+++.+|+++++.++||||+++++++...+.......+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999889999999998543  223456788999999999999999999998765333334789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+. ++|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 58888886543      389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......       .......++..|+|||++.+. .++.++||||+||++|||++|+.||...... ..........-
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g  222 (372)
T cd07853         151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLG  222 (372)
T ss_pred             eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcC
Confidence            76543221       112234578999999998774 4789999999999999999999999753221 11111111000


Q ss_pred             ccccccccC--ccchhhhhhcccccCC--CccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVD--PSLLLEVRANNSMSRG--GERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....+...  ................  .......+..+++.+++.+|++.||++|||+.|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000  0000000000000000  0000011234567899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-36  Score=322.88  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++...     ...+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence            36899999999999999999999889999999999765555557788999999999999999999987543     6889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++....       +++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        93 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          93 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             EeecccCCCCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999987543       78999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......+++.|+|||...+..++.++|||||||++|++++|+.||............. .    
T Consensus       163 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~----  229 (297)
T cd06656         163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----  229 (297)
T ss_pred             eEccCCc--------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c----
Confidence            7654332        11223458889999999998889999999999999999999999996432111000000 0    


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....                     ....+...+..+.+++.+||+.+|++||+++|+++
T Consensus       230 ~~~~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         230 NGTP---------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCC---------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000                     00011233455778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.4e-36  Score=316.18  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCe---EEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGM---LVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|+..+.||+|+||.||+|+...++.   .+|+|.++.. .....+.+..|++++++++|||++++.+++...     
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence            3578889999999999999999875554   7999998644 233456788999999999999999999997543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++++|.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence            678999999999999999976543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+..........     ........+..|+|||++.+..++.++|||||||++||+++ |+.||.....     ..+.
T Consensus       151 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~  220 (268)
T cd05063         151 FGLSRVLEDDPEGT-----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVM  220 (268)
T ss_pred             Cccceecccccccc-----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHH
Confidence            99997664332110     11111223567999999988889999999999999999997 9999864321     1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .......                       ..+...+++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       221 ~~i~~~~-----------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         221 KAINDGF-----------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHhcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111000                       0001113456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.4e-37  Score=329.53  Aligned_cols=243  Identities=26%  Similarity=0.313  Sum_probs=189.3

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECE-ALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence            47999999999999999899999999996432   122234444444 5678899999999998654     37789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999997654      378889999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     ............
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~  213 (325)
T cd05602         147 IEHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPL  213 (325)
T ss_pred             ccCC--------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCc
Confidence            2211        223345699999999999998999999999999999999999999964221     111111111000


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .  .                      ....+..+.+++.+|++.||.+||++.+.+..
T Consensus       214 ~--~----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         214 Q--L----------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             C--C----------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            0  0                      01234457799999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-36  Score=312.74  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=195.4

Q ss_pred             eeeeecceEEEEEEEC--CCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeec
Q 002897          561 MVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .||+|+||.||+|.+.  ..+..||+|++..... ...+.+.+|+.++++++||||+++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999774  4566799999865432 334678999999999999999999998642      457999999


Q ss_pred             ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCC
Q 002897          638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       638 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  717 (869)
                      +++|+|.+++.....     .+++..++.++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+.....
T Consensus        76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999976443     389999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       718 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      .....     .......++..|+|||++.+..++.++|||||||++||+++ |..||......     .+........  
T Consensus       148 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~--  215 (257)
T cd05115         148 DDSYY-----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMSFIEQGK--  215 (257)
T ss_pred             Cccce-----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHCCC--
Confidence            32110     11111223578999999988889999999999999999996 99998753221     1111110000  


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                                           ....+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       216 ---------------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 ---------------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                                 0001113456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=316.12  Aligned_cols=254  Identities=21%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +.|.+.+.||+|++|.||.|.+..+++.||+|.+....     ....+.+.+|++++++++||||+++++++..     .
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence            46899999999999999999998899999999986432     1234578899999999999999999999654     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++|+||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            68999999999999999998654      378999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.++........     ........|+..|+|||+..+..++.++||||+|+++||+++|+.||.....    ......
T Consensus       148 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~  218 (263)
T cd06625         148 FGASKRLQTICSS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFK  218 (263)
T ss_pred             cccceeccccccc-----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHH
Confidence            9999765432110     0111234578899999999998899999999999999999999999864211    111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..... .                      ....+..+...+.+++.+||+.+|++|||+.|+++.
T Consensus       219 ~~~~~-~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 IATQP-T----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HhccC-C----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            00000 0                      000111344567899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=323.90  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=211.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIR-HRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  627 (869)
                      ....|++.+.||+|.||.||+|+.+.+|+.+|+|++.+...   .....+.+|+.+|+++. |||||.+.+++.+.    
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~----  108 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP----  108 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC----
Confidence            44678999999999999999999999999999999965432   23468899999999998 99999999996654    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----Cc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD----MV  703 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~  703 (869)
                       ...++|||+++||.|.+.+...       .+++.++..++.|++.|++|||+.   ||+|||+||+|+|+...    +.
T Consensus       109 -~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  109 -DSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             -CeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence             7899999999999999999876       189999999999999999999999   99999999999999643    47


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      +|++|||+|......         ......+||+.|+|||++....|+.++||||+||++|.|++|.+||..........
T Consensus       178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~  248 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL  248 (382)
T ss_pred             EEEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence            999999999877652         34556789999999999999999999999999999999999999998644332221


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                       ......+     +                   ...+..+.....+.+++..|+..||.+|+|+.++++.
T Consensus       249 -~i~~~~~-----~-------------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 -AILRGDF-----D-------------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -HHHcCCC-----C-------------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence             1111111     0                   1122333556678899999999999999999999984

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=358.58  Aligned_cols=437  Identities=29%  Similarity=0.399  Sum_probs=330.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      ||+++|++. +.|..+ +.+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.+|++. .+|..+..+++|++|++|.|+
T Consensus        50 l~lsnn~~~-~fp~~i-t~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~  125 (1081)
T KOG0618|consen   50 LDLSNNQIS-SFPIQI-TLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH  125 (1081)
T ss_pred             eeccccccc-cCCchh-hhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhc
Confidence            566666666 677666 35666777777777766 56666666677777777777666 666667777777777777777


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      +. .+|..+..++.++++..++|.....++     ... ++.+++..|.+.+.++..+..++.  .|+|++|.++   .-
T Consensus       126 f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg-----~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~  193 (1081)
T KOG0618|consen  126 FG-PIPLVIEVLTAEEELAASNNEKIQRLG-----QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VL  193 (1081)
T ss_pred             cC-CCchhHHhhhHHHHHhhhcchhhhhhc-----ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hh
Confidence            66 566666666666777777662211222     122 677777777777777767766666  6889888876   23


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCcc
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG  241 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  241 (869)
                      .+..+.+|+.|....|++..+..          ..++|+.|+.++|.++...+.   ..+..|+.+|+++|.++ .+|++
T Consensus       194 dls~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~-~lp~w  259 (1081)
T KOG0618|consen  194 DLSNLANLEVLHCERNQLSELEI----------SGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHNNLS-NLPEW  259 (1081)
T ss_pred             hhhhccchhhhhhhhcccceEEe----------cCcchheeeeccCcceeeccc---cccccceeeecchhhhh-cchHH
Confidence            56677888888888888877654          346888899999988844432   23345899999999998 56789


Q ss_pred             ccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCc-cCccc-
Q 002897          242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTS-  319 (869)
Q Consensus       242 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~-  319 (869)
                      ++.+.+|+.|...+|++. .+|..+..+++|+.|.+.+|.+. .+|....+++.|++|+|..|+|. .+|+.+ .-+.. 
T Consensus       260 i~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~  336 (1081)
T KOG0618|consen  260 IGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNAS  336 (1081)
T ss_pred             HHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHH
Confidence            999999999999999995 78888888899999999999998 77888888999999999999998 555533 33333 


Q ss_pred             cceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEee
Q 002897          320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQ  399 (869)
Q Consensus       320 L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  399 (869)
                      |+.|+.+.|++. ..|..-......++.|.+.+|.++...-..+.+..+|+.|+|++|+|.......+.++..|++|+||
T Consensus       337 l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LS  415 (1081)
T KOG0618|consen  337 LNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLS  415 (1081)
T ss_pred             HHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcc
Confidence            788888888887 5554334455667789999999988766778888999999999999984444567889999999999


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCccc-CCCCCccCCCccccccCCccc
Q 002897          400 DNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE-VPKKGVFSNKTRFSLSGNGKL  475 (869)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~~~~~~~~~~~~n~~~  475 (869)
                      +|+|+ .+|..+..++.|++|...+|+|. ..| .+.+++.|+.+|+|.|+|+.. +|.....++++.++++||.|.
T Consensus       416 GNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  416 GNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             cchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99998 88899999999999999999998 677 888999999999999998754 344444578899999999874

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-36  Score=319.04  Aligned_cols=261  Identities=23%  Similarity=0.416  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|++.+.||+|+||.||+|...    ..+..||+|.+.... ......+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence            46888899999999999999852    456889999986433 33446788999999999999999999986543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDK-----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      ...++||||+++++|.+++......           .....+++.++..++.|++.||+|||++   +++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            6789999999999999998643211           0112478999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      +++++.+||+|||+++........      .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYY------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEeccccccccccCCcce------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999866433210      11223345778999999988889999999999999999998 99998642


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ..     .............                       ..++.++..+.+++.+||+.||++||++.+|.+.|++
T Consensus       231 ~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         231 SN-----QEVIEMVRKRQLL-----------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CH-----HHHHHHHHcCCcC-----------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            21     1111111110000                       0011234567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-36  Score=313.80  Aligned_cols=255  Identities=31%  Similarity=0.455  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++.... ..+.+.+|++++++++||||+++++++...     +..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence            457899999999999999999985 667899999865432 346788999999999999999999986543     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            99999999999999976541    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       ........+..|+|||+..+..++.++||||||+++|||++ |+.||......     .......
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~  218 (261)
T cd05068         151 RVIKEDIY-------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQVD  218 (261)
T ss_pred             EEccCCcc-------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH
Confidence            87653211       11112223468999999998899999999999999999999 99998653211     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .. ..                      ...+..++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ~~-~~----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 QG-YR----------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cC-CC----------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            00 00                      00011234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-36  Score=326.81  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +|+..+.||+|+||+||+|.+..+|+.||+|++...   .....+.+..|..+++.+. |++|+++.+++..     .+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence            477889999999999999999999999999999743   2334456788999998885 5677788887544     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            999999999999999997654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +++......        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......     ......
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i  213 (323)
T cd05615         147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSI  213 (323)
T ss_pred             cccccCCCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            987543221        1223356899999999999889999999999999999999999999753211     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .....                        ..+...+..+.+++.+|++.+|++|+++
T Consensus       214 ~~~~~------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         214 MEHNV------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HhCCC------------------------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11000                        0011233457799999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-36  Score=328.27  Aligned_cols=268  Identities=23%  Similarity=0.353  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||+++... ......+.+|+.++.++ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            46899999999999999999985     2467899999996533 23446788999999999 689999999987543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc---------------------------------------------------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL---------------------------------------------------  654 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  654 (869)
                        ....++||||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              256789999999999999987542100                                                   


Q ss_pred             ----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCcc
Q 002897          655 ----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV  724 (869)
Q Consensus       655 ----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  724 (869)
                                ....+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++.........   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---  235 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---  235 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence                      012368889999999999999999999   9999999999999999999999999999765332210   


Q ss_pred             ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccccccCccc
Q 002897          725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSL  803 (869)
Q Consensus       725 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  803 (869)
                         .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......    ...........        
T Consensus       236 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~--------  300 (343)
T cd05103         236 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTR--------  300 (343)
T ss_pred             ---hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCC--------
Confidence               11122345678999999988889999999999999999997 999986432111    11111100000        


Q ss_pred             hhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          804 LLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                                     ...+......+.+++..||+.||++|||+.||++.|+.+.++
T Consensus       301 ---------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         301 ---------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                           000001234578999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-36  Score=320.09  Aligned_cols=270  Identities=20%  Similarity=0.279  Sum_probs=208.3

Q ss_pred             ccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeec
Q 002897          544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSS  622 (869)
Q Consensus       544 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  622 (869)
                      +.++.+..+.++|++.+.||+|+||.||+|.+..+++.+|+|+++... .....+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556667889999999999999999999999899999999886432 2235678899999999 79999999998865


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .+..+....++||||+++++|.+++......  ...+++..+..++.|+++|+.|||+.   +++||||||+||+++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            4445557899999999999999988643211  12488999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      .++|+|||.+.......        .......|+..|+|||++..     ..++.++||||+||++|||++|+.||....
T Consensus       162 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             CEEEccCCceeecccCC--------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99999999997654321        11223458999999998753     447889999999999999999999986432


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..    ....... ........++                     ..+...+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~----~~~~~~~-~~~~~~~~~~---------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         234 PM----RALFKIP-RNPPPTLHQP---------------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hh----HHHhhcc-ccCCCcccCC---------------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11    1111000 0000000000                     1123457899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-36  Score=312.92  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=195.3

Q ss_pred             eeeeecceEEEEEEE--CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          561 MVGQGSFGTVFKGII--GENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      .||+|+||.||+|.+  ..++..+|+|+++...  ....+.+.+|+.+++.++||||+++++++..      +..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            689999999999965  4568899999986433  2345678999999999999999999998642      45689999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++....      .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999997654      389999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ......     .......++..|+|||.+....++.++|||||||++|||++ |+.||......     .+.........
T Consensus       147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~i~~~~~  216 (257)
T cd05116         147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVTQMIESGER  216 (257)
T ss_pred             CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHCCCC
Confidence            432110     11122234678999999988889999999999999999998 99998753221     11111110000


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                                             ...+..++..+.+++.+||+.||++||++.+|.+.|+.
T Consensus       217 -----------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 -----------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                                   00111244568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-36  Score=325.14  Aligned_cols=243  Identities=22%  Similarity=0.333  Sum_probs=191.2

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|.+..+++.||+|+++..   .....+.+.+|+.++.++ +||+|+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence            4799999999999999999999999999753   233456688999999888 69999999998654     37799999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|..++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999887654      389999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC-chHHHhh-hhhccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG-LTLHEFS-KMVLPE  793 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~-~~~~~~~-~~~~~~  793 (869)
                      ....        .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ......
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  218 (327)
T cd05617         147 LGPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK  218 (327)
T ss_pred             cCCC--------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC
Confidence            2211        12234568999999999999999999999999999999999999996432211 1111111 111000


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      ..                        ..+...+..+.+++.+||+.||++||++.
T Consensus       219 ~~------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 PI------------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CC------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            00                        00112334567999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-36  Score=314.63  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|++++++++||||+++++++..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence            35799999999999999999998644 5699999864332 23578899999999999999999987532      4578


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..+..++.|+++||+|+|+.   +++||||||+||++++++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence            99999999999999976432    2378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||+..+..++.++|||||||++|+|+| |..||......     .......
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~~~  217 (262)
T cd05071         150 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVE  217 (262)
T ss_pred             eecccccc-------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHHh
Confidence            76644321       11123346778999999988889999999999999999999 88888643211     1111100


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      .. .                      ......+++..+.+++.+|++.+|++||+++++++.|+..
T Consensus       218 ~~-~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 RG-Y----------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cC-C----------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            00 0                      0001123556788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-36  Score=331.53  Aligned_cols=204  Identities=22%  Similarity=0.283  Sum_probs=173.1

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNG  627 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~  627 (869)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++.... ...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999999889999999998643  2334567789999999999999999999876432 233


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||+++ ++.+++..        .+++..+..++.|+++||+|||++   ||+||||||+||+++.++.+||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            3567999999965 67777653        278899999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      |||+++.....         .......||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       162 Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         162 DFGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             eCcccccCCCc---------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999765332         112335689999999999998999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.1e-36  Score=318.84  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      |++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++...     ...++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEE
Confidence            67788999999999999999989999999999765555667889999999999999999999987643     6789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++++|..++.....     ++++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        82 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          82 EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999998875432     489999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ....        .......|+..|+|||++.     +..++.++|||||||++|||++|+.||....... .........
T Consensus       154 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~  224 (282)
T cd06643         154 TRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE  224 (282)
T ss_pred             cccc--------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC
Confidence            3321        1223346889999999874     3457889999999999999999999986532111 111110000


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                          ....                     ..+..++..+.+++.+||+.||++||+++++++.
T Consensus       225 ----~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         225 ----PPTL---------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----CCCC---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000                     0011234567899999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-36  Score=317.29  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||.||+|.+..+++.||+|++... .......+.+|++++++++||||+++++++...     +..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence            3688899999999999999999889999999998644 233446788999999999999999999997654     6788


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|..+.          .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++
T Consensus        76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            999999999997652          267889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch--HHHhhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT--LHEFSKMV  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~  790 (869)
                      ......          ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  ........
T Consensus       143 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (279)
T cd06619         143 TQLVNS----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI  212 (279)
T ss_pred             eecccc----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence            765332          122346899999999999888999999999999999999999999753222111  00111100


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....     .+.                 ......+.++.+++.+|++.+|++||+++|+++.
T Consensus       213 ~~~~-----~~~-----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDED-----PPV-----------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccC-----CCC-----------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000     000                 0001233467899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-36  Score=321.71  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|.+........+.+.+|+.+++.++|||++++++++..     ....++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence            468899999999999999999988999999999976555556788999999999999999999998754     378999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |+||+++++|.+++....       +++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.
T Consensus        94 v~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTETC-------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            999999999999987542       89999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......|+..|+|||.+.+..++.++|||||||++|++++|+.||......    ....... ..
T Consensus       164 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~~~~-~~  230 (296)
T cd06655         164 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYLIA-TN  230 (296)
T ss_pred             hccccc--------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hc
Confidence            654322        1122345889999999999888999999999999999999999999653221    1110000 00


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....                     ...+..++..+.+++.+||..||++|||+.+++.
T Consensus       231 ~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 GTPE---------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcc---------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0000                     0011133456789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-36  Score=317.44  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|++|.||+|.+..     .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4679999999999999999999976     67889999886433 33346789999999999999999999986543   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  702 (869)
                        ...++||||+++++|.+++....... ....+++..+..++.||+.|++|||+.   +++||||||+||+++.++   
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence              56789999999999999998764321 123489999999999999999999999   999999999999998765   


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~  781 (869)
                      .+||+|||.++........      ........+..|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--  228 (277)
T cd05036         157 VAKIADFGMARDIYRASYY------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--  228 (277)
T ss_pred             ceEeccCccccccCCccce------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            6999999999866332110      11112234568999999998899999999999999999997 99998753221  


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                         ...........                       ...+..++..+.+++.+|++.+|++|||+.||++.|.
T Consensus       229 ---~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 ---EVMEFVTGGGR-----------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence               11111110000                       0001123456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-36  Score=321.34  Aligned_cols=260  Identities=23%  Similarity=0.384  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|.+.+.||+|+||.||+|.+     ..++..||+|+++... ....+.+.+|+++++++ +||||+++++++...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            45799999999999999999985     2356689999986543 33446789999999999 799999999987543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                         +..++||||+++|+|.++++....    ..+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.++
T Consensus       112 ---~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         112 ---GPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             ---CceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence               678999999999999999976442    1379999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLH  784 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~  784 (869)
                      ++|||.++........      .......++..|+|||.+.+..++.++||||+||++|||++ |..||....... ...
T Consensus       182 l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~  254 (302)
T cd05055         182 ICDFGLARDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFY  254 (302)
T ss_pred             ECCCcccccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHH
Confidence            9999999765433210      11122346788999999998899999999999999999998 999986532211 111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ....   .. ..                      ...+...+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       255 ~~~~---~~-~~----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIK---EG-YR----------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHH---cC-Cc----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1100   00 00                      000011234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-36  Score=312.70  Aligned_cols=250  Identities=30%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||+|+||.||+|..  .|..||+|.++...  ..+.+.+|+.++++++|+|++++++++..    .....++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEE
Confidence            4788999999999999999987  58889999985432  34678899999999999999999997543    2356899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.++++....    ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             EEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            9999999999999986543    2378999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......           ....++..|+|||+..+..++.++|||||||++|+|++ |+.||....     ..........
T Consensus       151 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~  214 (256)
T cd05082         151 EASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEK  214 (256)
T ss_pred             eccccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhc
Confidence            543221           12234568999999988889999999999999999997 999986421     1111111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ....                       .....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       215 ~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 GYKM-----------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCC-----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0000                       00113456788999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-36  Score=312.14  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=198.0

Q ss_pred             CeeeeecceEEEEEEECCCC---eEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|.+...+   ..||+|.+..... ...+.+.+|+.+++.++||||+++++++..      +..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            47999999999999875444   7899999864433 345678999999999999999999998642      4579999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999998765      389999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .......     .......++..|+|||...+..++.++|||||||++|++++ |..||.....  ..........   .
T Consensus       146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~---~  215 (257)
T cd05060         146 GAGSDYY-----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESG---E  215 (257)
T ss_pred             ecCCccc-----ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcC---C
Confidence            4432110     11112224568999999998899999999999999999998 9999865321  1111111110   0


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      .                       .+.+..++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       216 ~-----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 R-----------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             c-----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            0                       0011134456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-36  Score=326.71  Aligned_cols=242  Identities=26%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECE-ALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence            46999999999999999999999999996432   223345555555 4677899999999988654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|..++....      .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999999987654      389999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..........
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~~  213 (325)
T cd05604         147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKPL  213 (325)
T ss_pred             CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCCc
Confidence            2211        122345689999999999999999999999999999999999999964211     111111111100


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ...                      ...+..+.+++.+|++.+|.+||++.+.++
T Consensus       214 --~~~----------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         214 --VLR----------------------PGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             --cCC----------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence              000                      012345678999999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.1e-37  Score=329.19  Aligned_cols=239  Identities=26%  Similarity=0.324  Sum_probs=190.6

Q ss_pred             CeeeeecceEEEEEEE---CCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          560 NMVGQGSFGTVFKGII---GENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      +.||+|+||.||++++   ..+|+.||+|+++....  .....+..|++++++++||||+++++++..     ....++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence            6799999999999886   35789999999975332  233556789999999999999999998654     3788999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      |||+++|+|.+++....      .+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            99999999999997654      389999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .....        .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........
T Consensus       148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~  214 (318)
T cd05582         148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAK  214 (318)
T ss_pred             cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCC
Confidence            43321        122335689999999999988899999999999999999999999974321     11111111100


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                      .                        ..+...+..+.+++.+||+.||++||++.+
T Consensus       215 ~------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 L------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0                        000123456779999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.3e-36  Score=317.21  Aligned_cols=260  Identities=26%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|+..++||+|+||.||+|...     .++..+|+|.+..........+.+|+++++.++|+||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence            56888999999999999999742     35678999998766666667899999999999999999999987653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKL---------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      ...++||||+++|+|.+++.......         ....+++..++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            66899999999999999998654210         112488999999999999999999999   999999999999999


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCcc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFH  778 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~  778 (869)
                      +++.+||+|||++.........      .......+++.|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            9999999999999765432110      11223345788999999998899999999999999999998 8999864322


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      .     ..........                       ....+..++..+.+++.+||+.||++||+++||++.|+
T Consensus       231 ~-----~~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         231 T-----EAIECITQGR-----------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-----HHHHHHHcCc-----------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1     1111110000                       00001134456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.4e-36  Score=314.79  Aligned_cols=260  Identities=27%  Similarity=0.440  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe---EEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM---LVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.+.||+|+||.||+|.+..+++   .||||.+... .......+..|+.+++.++||||+++++++..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence            457889999999999999999876654   6999998654 34445789999999999999999999998654     36


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....     .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            78999999999999999986543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+............   ........+..|+|||++.+..++.++|||||||++||+++ |..||......  .......
T Consensus       151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~  225 (269)
T cd05065         151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIE  225 (269)
T ss_pred             ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHH
Confidence            998766443211100   00011112457999999998899999999999999999887 99998643211  1111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ...                          ..+.+.+++..+.+++.+||+.+|++||++++|+..|+++
T Consensus       226 ~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDY--------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCC--------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000                          0001123456688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.4e-36  Score=320.75  Aligned_cols=276  Identities=20%  Similarity=0.283  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||.||+|.+..++..+|+|.++... .....++.+|++++++++||||+++++++...     +..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence            36899999999999999999999899999999986542 33446688999999999999999999997643     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.++++...      .+++..+..++.|+++||+|||+..  +++||||||+||+++.++.+||+|||.+
T Consensus        76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence            9999999999999998653      3889999999999999999999732  8999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......          ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......  ....+......
T Consensus       148 ~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~  215 (308)
T cd06615         148 GQLIDS----------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVS  215 (308)
T ss_pred             cccccc----------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccc
Confidence            754322          122346889999999998888999999999999999999999998643211  11111111000


Q ss_pred             cccccc-----------cCccchhhhhhccc-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          793 EKVMEI-----------VDPSLLLEVRANNS-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       793 ~~~~~~-----------~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                       .....           .++........... .............+.++.+++.+||+.+|++|||++||++.-.
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         216 -EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             -cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence             00000           00000000000000 0000000001124556889999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.9e-39  Score=338.29  Aligned_cols=380  Identities=24%  Similarity=0.369  Sum_probs=252.6

Q ss_pred             cccCCCccc-ccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLV-GDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~-~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      .|+++|.+. +-.|.++- .++.+++|.|...++. .+|+.++.|.+|++|.+++|++. .+-+.++.|+.|+.+++.+|
T Consensus        12 vDfsgNDFsg~~FP~~v~-qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N   88 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVE-QMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDN   88 (1255)
T ss_pred             ccccCCcCCCCcCchhHH-HhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcc
Confidence            367777777 56777774 6777888888777777 77777888888888888888777 55566777777777777777


Q ss_pred             ccCc-cCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccccc
Q 002897           81 QFSG-FIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        81 ~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      ++.. -+|..+.++..|..||||+|++. .+|.. +..-+++-.|+|++|+|..++...|-+++.|-.||||+|++.. .
T Consensus        89 ~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~-LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-L  165 (1255)
T KOG0444|consen   89 NLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTN-LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-L  165 (1255)
T ss_pred             ccccCCCCchhcccccceeeecchhhhh-hcchh-hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-c
Confidence            7763 35666777777777777777776 55532 3344444444444444444333344444444444444444432 2


Q ss_pred             CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc-ccC
Q 002897          160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS-GTI  238 (869)
Q Consensus       160 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~-~~~  238 (869)
                      |..+..+.+|++|.|++|.+.....      ..+..+++                         |+.|.+++.+-+ ..+
T Consensus       166 PPQ~RRL~~LqtL~Ls~NPL~hfQL------rQLPsmts-------------------------L~vLhms~TqRTl~N~  214 (1255)
T KOG0444|consen  166 PPQIRRLSMLQTLKLSNNPLNHFQL------RQLPSMTS-------------------------LSVLHMSNTQRTLDNI  214 (1255)
T ss_pred             CHHHHHHhhhhhhhcCCChhhHHHH------hcCccchh-------------------------hhhhhcccccchhhcC
Confidence            2234444444444444444432211      11223333                         334444433211 245


Q ss_pred             CccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcc
Q 002897          239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT  318 (869)
Q Consensus       239 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  318 (869)
                      |..+..+.+|..++++.|.+. .+|..+-.+++|+.|+|++|+|+ .+.-..+...+|++|+||.|+++ .+|++++.++
T Consensus       215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~  291 (1255)
T KOG0444|consen  215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLT  291 (1255)
T ss_pred             CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhH
Confidence            666777777777777777776 77777777888888888888887 45555666777888888888887 7888888888


Q ss_pred             ccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEe
Q 002897          319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKM  398 (869)
Q Consensus       319 ~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  398 (869)
                      +|+.|++.+|+++-                       . -+|+.++.+.+|+.+..++|.+. .+|+.++.|..|+.|.|
T Consensus       292 kL~kLy~n~NkL~F-----------------------e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L  346 (1255)
T KOG0444|consen  292 KLTKLYANNNKLTF-----------------------E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL  346 (1255)
T ss_pred             HHHHHHhccCcccc-----------------------c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence            88888888888761                       1 46788888888999999999888 88888999999999999


Q ss_pred             eCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccc
Q 002897          399 QDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS  447 (869)
Q Consensus       399 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  447 (869)
                      +.|++. .+|+++.-|+.|..|||..|.----.|.--..-++|+.-++.
T Consensus       347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  347 DHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             ccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence            999887 788888888888888888886442444333333455554443

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.2e-36  Score=313.19  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+.+++.++|+||+++++++...     +
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----G   78 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----C
Confidence            44556666778999999999999999889999999998766555667899999999999999999999987643     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNL--SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl  706 (869)
                      ..++|+||+++++|.+++.....     ++  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEE
Confidence            78999999999999999986532     24  7888999999999999999999   9999999999999976 679999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      +|||.+.......        .......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||........  .
T Consensus       151 ~dfg~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~  220 (268)
T cd06624         151 SDFGTSKRLAGIN--------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--A  220 (268)
T ss_pred             ecchhheecccCC--------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--h
Confidence            9999987654321        1122335789999999986644  78899999999999999999999864221110  0


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+......  .    .                  ...+......+.+++.+||+.+|++|||+.|+++
T Consensus       221 ~~~~~~~~--~----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         221 MFKVGMFK--I----H------------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             Hhhhhhhc--c----C------------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00000000  0    0                  0011134456789999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=313.65  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+++++.++||||+++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCceEE
Confidence            46889999999999999999986 677899999864322 23567889999999999999999998654     367899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++.....     .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            9999999999999976543     389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++..|+|||...+..++.++||||||+++|++++ |+.||......     ........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~  216 (256)
T cd05059         149 YVLDDQY-------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVESVSA  216 (256)
T ss_pred             ecccccc-------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHHHHc
Confidence            6543211       11112234568999999998899999999999999999999 89998643211     11111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .     ...                  ..+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       217 ~-----~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 G-----YRL------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             C-----CcC------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0     000                  00012455788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-36  Score=331.33  Aligned_cols=280  Identities=18%  Similarity=0.198  Sum_probs=203.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++.... +...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999989999999998643  2334567889999999999999999999875432 2334


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++ ++.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence            568999999965 78777753        278889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+++.....         .......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus       170 fG~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~  239 (364)
T cd07875         170 FGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE  239 (364)
T ss_pred             CCCccccCCC---------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            9999765332         1123346899999999999999999999999999999999999999753221 11111111


Q ss_pred             hhcc--cccccccCccchhhhhhcccc---------c---CCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLP--EKVMEIVDPSLLLEVRANNSM---------S---RGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~--~~~~~~~d~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....  ......+.+............         .   ..............+.+++.+|++.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000  000000110000000000000         0   000000111123567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.6e-36  Score=317.65  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             CCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...     
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence            47888999999999999998742     33678999886433 23456788999999999999999999987543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKL------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGD  690 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  690 (869)
                      +..++||||+.+|+|.+++.......                  ...++++..++.++.|++.|++|||+.   +++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            66899999999999999987543210                  113488999999999999999999999   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-C
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-R  769 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g  769 (869)
                      |||+||++++++.+||+|||+++........      .......++..|+|||+..+..++.++||||||+++|||++ |
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            9999999999999999999999765332210      11122345678999999988889999999999999999998 9


Q ss_pred             CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                      ..||......  ..........                          ....+..++..+.+++.+||+.+|++||+++|
T Consensus       227 ~~p~~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         227 GNPYPGIAPE--RLFNLLKTGY--------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             CCCCCCCCHH--HHHHHHhCCC--------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            9998643211  1111111000                          00011123456889999999999999999999


Q ss_pred             HHHHHHHHHH
Q 002897          850 VVVKLCAARE  859 (869)
Q Consensus       850 vl~~L~~~~~  859 (869)
                      +++.|+++..
T Consensus       279 i~~~l~~~~~  288 (290)
T cd05045         279 ISKELEKMMV  288 (290)
T ss_pred             HHHHHHHHHh
Confidence            9999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-36  Score=317.55  Aligned_cols=275  Identities=26%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECC----CCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGE----NGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|++.+.||+|+||.||+|++..    ++..||||+++..... ..+.+.+|+++++.++||||+++++++...   +.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            467888999999999999999643    4789999999755443 467899999999999999999999987542   34


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            678999999999999999987653     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+..........     .......++..|+|||...+..++.++||||||+++|||++|+.|+.........   +..
T Consensus       153 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~  224 (284)
T cd05038         153 FGLAKVLPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG  224 (284)
T ss_pred             cccccccccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence            99998765332110     1111233566799999998888999999999999999999999998653222111   000


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ......    ....+......      ......+..++.++.+++.+||+.+|++||||.||+++|+++
T Consensus       225 ~~~~~~----~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         225 IAQGQM----IVTRLLELLKE------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccc----cHHHHHHHHHc------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000000    00000000000      001111223456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-36  Score=324.19  Aligned_cols=281  Identities=17%  Similarity=0.155  Sum_probs=198.4

Q ss_pred             CCCeeeee--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          558 SSNMVGQG--SFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       558 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +.++||+|  +|++||++.++.+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++...     +..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            45789999  67899999999999999999996432  33446678899999999999999999997654     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence            9999999999999976432    1389999999999999999999999   99999999999999999999999998765


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .......... ..........++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~  227 (327)
T cd08227         150 SMINHGQRLR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTV  227 (327)
T ss_pred             cccccccccc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCc
Confidence            4322111000 00011223456788999999876  35899999999999999999999999753322111111 11000


Q ss_pred             ccccc---------------cccCccchhhhhhc---ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVM---------------EIVDPSLLLEVRAN---NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~---------------~~~d~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +....               ...+..........   .........+........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000               00000000000000   000000001112234567899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-36  Score=330.79  Aligned_cols=266  Identities=23%  Similarity=0.332  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCC-CCccceEEEEeeccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIR-HRNLIKIITICSSID  624 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  624 (869)
                      ..++|.+.++||+|+||.||+|++.     ..++.||+|+++... ....+.+.+|++++.++. ||||+++++++... 
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            3457888999999999999999964     345789999997543 233457889999999997 99999999997653 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCc---------------------------------------------------
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDK---------------------------------------------------  653 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  653 (869)
                          ...++||||+++|+|.++++.....                                                   
T Consensus       114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence                6789999999999999999764321                                                   


Q ss_pred             -----------------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          654 -----------------------------------------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       654 -----------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                                                               .....+++..++.++.|++.||+|||+.   +++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                     0112467888999999999999999999   99999999


Q ss_pred             CCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCC
Q 002897          693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRR  771 (869)
Q Consensus       693 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~  771 (869)
                      |+||++++++.+||+|||+++........      .......++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~  340 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT  340 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999865332210      11122356788999999988889999999999999999998 889


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||........    .........     .                  ...+..++..+.+++.+||..+|++||+++||+
T Consensus       341 P~~~~~~~~~----~~~~~~~~~-----~------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell  393 (401)
T cd05107         341 PYPELPMNEQ----FYNAIKRGY-----R------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV  393 (401)
T ss_pred             CCCCCCchHH----HHHHHHcCC-----C------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9864321111    111110000     0                  000112345688999999999999999999999


Q ss_pred             HHHHHHH
Q 002897          852 VKLCAAR  858 (869)
Q Consensus       852 ~~L~~~~  858 (869)
                      +.|+++.
T Consensus       394 ~~L~~~~  400 (401)
T cd05107         394 HLVGDLL  400 (401)
T ss_pred             HHHHHHh
Confidence            9998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=341.37  Aligned_cols=204  Identities=22%  Similarity=0.343  Sum_probs=168.0

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCC------CccceEEEEe
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH------RNLIKIITIC  620 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~  620 (869)
                      .++....++|++.++||+|+||+||+|.+..+++.||||+++... ........|+++++.++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344455788999999999999999999999899999999996432 223455677777777754      4588888886


Q ss_pred             eccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeec
Q 002897          621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       621 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~  699 (869)
                      ...    ..+.++|||++ +++|.+++....      .+++..+..++.||+.||+|||+ .   +||||||||+|||++
T Consensus       201 ~~~----~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~  266 (467)
T PTZ00284        201 QNE----TGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME  266 (467)
T ss_pred             EcC----CceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence            532    35789999988 778999887654      38999999999999999999997 5   899999999999998


Q ss_pred             CCC----------------cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHH
Q 002897          700 HDM----------------VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL  763 (869)
Q Consensus       700 ~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il  763 (869)
                      .++                .+||+|||.+....           .......||+.|+|||++.+..++.++|||||||++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  335 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII  335 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCc-----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence            765                49999999875322           122345789999999999999999999999999999


Q ss_pred             HHHHcCCCCCCcC
Q 002897          764 LEMFSRRRPTDSM  776 (869)
Q Consensus       764 ~el~tg~~pf~~~  776 (869)
                      |||++|+.||+..
T Consensus       336 ~elltG~~pf~~~  348 (467)
T PTZ00284        336 YELYTGKLLYDTH  348 (467)
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999999753

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-36  Score=319.65  Aligned_cols=261  Identities=22%  Similarity=0.362  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      .+|.+.+.||+|+||.||+|.+..     .+..||+|+++..... ..+.+.+|+.+++.++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~----   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE----   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence            357778899999999999998753     3578999999754332 346688999999999999999999997543    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                       ...++++||+++++|.+++......          .....+++..+..++.|++.||+|+|++   +|+||||||+||+
T Consensus        81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence             6689999999999999998643211          0123478899999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      +++++.+||+|||+++........      .......+++.|+|||++.++.++.++|||||||++|||++ |..||...
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             ecCCCceEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999998765432210      11223346789999999988889999999999999999998 88887642


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ..     ..+..........                       ..+.+++..+.+++.+||+.+|++||+++||++.|+.
T Consensus       231 ~~-----~~~~~~i~~~~~~-----------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         231 SN-----QDVIEMIRNRQVL-----------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CH-----HHHHHHHHcCCcC-----------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            21     1111111111100                       0112355668899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=313.20  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++..     ....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            578899999999999999999988899999999986665567889999999999999999999998654     367899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      +|||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999887532     389999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC---CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS---EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ......        .......++..|+|||...+.   .++.++|||||||++|+|++|+.||........ ........
T Consensus       150 ~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~  220 (262)
T cd06613         150 QLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSN  220 (262)
T ss_pred             hhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcc
Confidence            654321        112234578899999998776   789999999999999999999999865321110 00000000


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                             ...+.                .......+.++.+++.+||+.+|.+|||+.||+.
T Consensus       221 -------~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 -------FPPPK----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -------CCCcc----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   00000                0111234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.3e-36  Score=312.04  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|++++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            357899999999999999999886 677899999865333 23678999999999999999999988632      4578


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence            99999999999999976432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||+..+..++.++||||||+++|+|++ |..||......     +......
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~  217 (260)
T cd05070         150 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVE  217 (260)
T ss_pred             eeccCccc-------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH
Confidence            86544321       11112235678999999988889999999999999999999 88998643211     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ...                       ..+.+...+..+.+++.+|++.+|++|||++++.+.|+.
T Consensus       218 ~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 RGY-----------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCC-----------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            000                       000112344568899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.6e-36  Score=318.63  Aligned_cols=267  Identities=23%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-------CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeec
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-------ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSS  622 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  622 (869)
                      ...+|.+.+.||+|+||.||+|+..       .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567899999999999999999752       245689999986432 33456789999999999 89999999998765


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                      .     ...++||||+++|+|.+++.......          ....+++.++..++.||++||+|||++   |++|||||
T Consensus        93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk  164 (304)
T cd05101          93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA  164 (304)
T ss_pred             C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence            3     67899999999999999998753211          122478899999999999999999999   99999999


Q ss_pred             CCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCC
Q 002897          693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRR  771 (869)
Q Consensus       693 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~  771 (869)
                      |+||+++.++.+||+|||.++........      .......++..|+|||++.+..++.++||||||+++|++++ |..
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  238 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  238 (304)
T ss_pred             cceEEEcCCCcEEECCCccceeccccccc------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999876443211      11222345678999999988889999999999999999998 788


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||....     ..++.........                       ...+..++..+.+++.+||+.+|++|||+.|++
T Consensus       239 p~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l  290 (304)
T cd05101         239 PYPGIP-----VEELFKLLKEGHR-----------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV  290 (304)
T ss_pred             CcccCC-----HHHHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence            875421     1222211110000                       001113456788999999999999999999999


Q ss_pred             HHHHHHHHh
Q 002897          852 VKLCAAREA  860 (869)
Q Consensus       852 ~~L~~~~~~  860 (869)
                      +.|+++..-
T Consensus       291 ~~l~~~~~~  299 (304)
T cd05101         291 EDLDRILTL  299 (304)
T ss_pred             HHHHHHHHh
Confidence            999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-36  Score=322.93  Aligned_cols=238  Identities=27%  Similarity=0.323  Sum_probs=186.9

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECE-ALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||.||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++++.+     .+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence            47999999999999999899999999986432   222344555554 5788899999999988654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|..++....      .+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999999887643      378899999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......|++.|+|||++.+..++.++|||||||++|||++|+.||....     .............
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~  213 (321)
T cd05603         147 VEPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPL  213 (321)
T ss_pred             CCCC--------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCC
Confidence            2211        12234568999999999998899999999999999999999999996431     1111111111100


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                       .                       .+......+.+++.+|++.||++||++.
T Consensus       214 -~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 -Q-----------------------LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -C-----------------------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             0                       0012234577999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-36  Score=328.57  Aligned_cols=279  Identities=19%  Similarity=0.235  Sum_probs=200.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  628 (869)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|+++++.++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999999899999999986432  2234567789999999999999999998754321 223


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...+++++++ +++|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence            4578999988 77999888643       289999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+++.....           .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+.
T Consensus       162 fg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~  229 (343)
T cd07878         162 FGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIM  229 (343)
T ss_pred             CccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence            9999765332           123468999999999876 46899999999999999999999999642211 1111111


Q ss_pred             hhhc--ccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVL--PEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~--~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....  .......+.......+... ................+.+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         230 EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1100  0000000000000000000 0000000000001123457799999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.7e-36  Score=313.12  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..+|++.+.||+|+||.||+|++..++   ..+|+|.++... ....+.+.+|+.++++++||||+++++++..     .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----S   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            357889999999999999999885443   479999886432 3345678999999999999999999998654     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++++|.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence            678999999999999999986543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+..........     .......++..|+|||++.+..++.++|||||||++||+++ |+.||......     +..
T Consensus       150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~  219 (267)
T cd05066         150 FGLSRVLEDDPEAA-----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVI  219 (267)
T ss_pred             CCccccccccccee-----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHH
Confidence            99998765432100     11112233568999999998889999999999999999887 99998643211     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ...... . .                     .+....++..+.+++.+|++.+|++||++.++++.|.++
T Consensus       220 ~~~~~~-~-~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         220 KAIEEG-Y-R---------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHhCC-C-c---------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111000 0 0                     000112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-36  Score=330.36  Aligned_cols=208  Identities=25%  Similarity=0.336  Sum_probs=175.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+..|+.++..++||+|+++++++.+     .+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence            36889999999999999999999999999999996432   3345678889999999999999999998654     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999997654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc---------------------------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHH
Q 002897          711 LAKFLPARPLDTVV---------------------------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL  763 (869)
Q Consensus       711 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il  763 (869)
                      ++............                           ..........||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98755322110000                           000011235799999999999999999999999999999


Q ss_pred             HHHHcCCCCCCc
Q 002897          764 LEMFSRRRPTDS  775 (869)
Q Consensus       764 ~el~tg~~pf~~  775 (869)
                      |||++|+.||..
T Consensus       227 yel~tG~~Pf~~  238 (360)
T cd05627         227 YEMLIGYPPFCS  238 (360)
T ss_pred             eecccCCCCCCC
Confidence            999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.2e-36  Score=318.00  Aligned_cols=267  Identities=23%  Similarity=0.373  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ..++|++.++||+|+||.||+|..+     ..+..||+|.+.... ......+.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence            4678999999999999999999764     235689999886433 22335678899999999999999999986543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                         ...++||||+++|+|.+++........    ....++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence               678999999999999999976432111    12357788999999999999999999   99999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~  780 (869)
                      +.++|+|||+++........      .......++..|+|||.+.++.++.++|||||||++|||++ |..||.....  
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--  227 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--  227 (288)
T ss_pred             CcEEECcCCccccccccccc------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999765432210      11122345678999999998889999999999999999998 7888864221  


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                         .+...........                       ..++.++..+.+++.+|++.||++|||+.|+++.+++....
T Consensus       228 ---~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         228 ---EQVLKFVMDGGYL-----------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ---HHHHHHHHcCCCC-----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence               1111111111000                       00112345788999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.6e-36  Score=318.54  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++...     ...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence            5689999999999999999999989999999999876666678889999999999999999999986543     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|..++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999988865433     389999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ......        .......++..|+|||++.     ...++.++|||||||++|||++|+.||.....    ......
T Consensus       159 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~  226 (292)
T cd06644         159 KNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLK  226 (292)
T ss_pred             eccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHH
Confidence            543221        1122345788999999874     34568899999999999999999999864221    111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       .........                     ..+..++..+.+++.+||+.+|++||+++|+++
T Consensus       227 -~~~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 -IAKSEPPTL---------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -HhcCCCccC---------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             000000000                     011133456789999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=349.56  Aligned_cols=260  Identities=19%  Similarity=0.289  Sum_probs=201.8

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ...++|.+.+.||+|+||+||+|.+..++..||+|++...  .......+..|+.+++.++||||+++++++...   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            3457899999999999999999999999999999998643  233456789999999999999999999987542   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceeecC----
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCK----PPVVHGDLKPSNVLLDH----  700 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~----  700 (869)
                      ...++||||+++|+|.+++......  ...+++..++.|+.||+.||+|||+...    .+||||||||+|||++.    
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            6789999999999999999764321  1248999999999999999999998521    25999999999999964    


Q ss_pred             -------------CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHH
Q 002897          701 -------------DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLE  765 (869)
Q Consensus       701 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~e  765 (869)
                                   .+.+||+|||++..+....         ......||+.|+|||++.+  ..++.++|||||||++||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                         2358999999997654321         1234568999999998854  458899999999999999


Q ss_pred             HHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC
Q 002897          766 MFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM  845 (869)
Q Consensus       766 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  845 (869)
                      |++|+.||....    ....+........     +                   ......+..+.++|..||+.+|.+||
T Consensus       236 LLTGk~PF~~~~----~~~qli~~lk~~p-----~-------------------lpi~~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        236 LCSGKTPFHKAN----NFSQLISELKRGP-----D-------------------LPIKGKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             HHHCCCCCCcCC----cHHHHHHHHhcCC-----C-------------------CCcCCCCHHHHHHHHHHhcCChhHCc
Confidence            999999996422    1112111110000     0                   00012345688999999999999999


Q ss_pred             CHHHHHH
Q 002897          846 QMRDVVV  852 (869)
Q Consensus       846 s~~evl~  852 (869)
                      ++.|++.
T Consensus       288 Sa~QlL~  294 (1021)
T PTZ00266        288 SALQCLG  294 (1021)
T ss_pred             CHHHHhc
Confidence            9999984

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6e-36  Score=316.58  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=199.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+.+++.++|++++++++.+.+.     +..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence            3677889999999999999999999999999986432   22235577899999999999999999986543     679


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999865432    2489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......         ......|+..|+|||++.+..++.++||||+||++|+|++|+.||....... ....... ..
T Consensus       149 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~-~~  217 (285)
T cd05630         149 AVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER-LV  217 (285)
T ss_pred             eeecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHh-hh
Confidence            87553321         1123468999999999999899999999999999999999999997532211 0011100 00


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      . ....                      .....+...+.+++.+||+.||++|||     ++|+++
T Consensus       218 ~-~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 K-EVQE----------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             h-hhhh----------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0 0000                      001123445789999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=294.39  Aligned_cols=258  Identities=22%  Similarity=0.259  Sum_probs=207.9

Q ss_pred             HhcCCCCC-CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSS-NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .+++|++. ++||-|-.|.|-.+.++.+|+.+|+|++..     ....++|++..-.. .|||||.++++|... +.+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            45677764 589999999999999999999999999843     24567888875555 699999999998765 77788


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl  706 (869)
                      ...+|||.|+||.|+..+...+..    .+++.++..|+.||+.|+.|||+.   +|.||||||+|+|....   -.+||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            899999999999999999988754    599999999999999999999999   99999999999999754   47999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|+.....         .......-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+....  .+..-
T Consensus       206 tDfGFAK~t~~~---------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispg  274 (400)
T KOG0604|consen  206 TDFGFAKETQEP---------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPG  274 (400)
T ss_pred             cccccccccCCC---------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChh
Confidence            999999865432         2233445799999999999999999999999999999999999999764332  11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+..+.....+..                   .+.....++...++|+.+++.+|++|.|++|+++
T Consensus       275 Mk~rI~~gqy~FP-------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  275 MKRRIRTGQYEFP-------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHhHhhccCccCC-------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1111111111211                   2233466778889999999999999999999986

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=321.26  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=198.8

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      |+-.+.||.|+||.||-|++..+.+.||||.+....+   +....+.+|+..|++++|||++.+-|+|...     ...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHH
Confidence            4455789999999999999999999999999975443   3456789999999999999999999987643     6679


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||| -|+..+.+.-.+.     ++.+.++..|+.+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.|
T Consensus       103 LVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             HHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence            999999 5588888876554     488999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCccc---CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG---TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ....+.            ..++|||.|||||++   ..+.|+-|+||||+|++..|+...++|...+...    ...+  
T Consensus       174 si~~PA------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM----SALY--  235 (948)
T KOG0577|consen  174 SIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY--  235 (948)
T ss_pred             hhcCch------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH----HHHH--
Confidence            876543            346899999999986   4578999999999999999999999997543211    1111  


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+...-    .|.+                 ...+....+..++..|++.-|.+|||.+++++
T Consensus       236 HIAQNe----sPtL-----------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  236 HIAQNE----SPTL-----------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHhcC----CCCC-----------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            111110    1111                 12255677889999999999999999998876

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=310.99  Aligned_cols=250  Identities=20%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch--hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..+-|...+.||+|.|++|-+|++.-+|+.||||++++..-+  ....+.+|++-|+.++|||||++|++..     ...
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQT   90 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQT   90 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccc
Confidence            346688899999999999999999999999999999765433  3456889999999999999999999854     458


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCcEEEcc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-DHDMVAHVGD  708 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~D  708 (869)
                      ..|+|+|.-.+|+|++|+.+....     +.+....+++.||+.|+.|+|+.   .+||||+||+||.+ ..-|-|||.|
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD  162 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD  162 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence            899999999999999999887653     99999999999999999999999   99999999999865 5678999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCC-ccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEAS-MTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||++-.+.++         ......+|+..|-|||++.|..|+ +++||||+|||+|.+++|++||+..... ..+..  
T Consensus       163 FGFSNkf~PG---------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETLTm--  230 (864)
T KOG4717|consen  163 FGFSNKFQPG---------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETLTM--  230 (864)
T ss_pred             ccccccCCCc---------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-hhhhh--
Confidence            9999876554         345567899999999999999885 5779999999999999999999853222 11111  


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                                +.|-..                ..+.....++.+||..|+..||++|.|.+||+.
T Consensus       231 ----------ImDCKY----------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  231 ----------IMDCKY----------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ----------hhcccc----------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                      111110                112355677889999999999999999999975

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.2e-36  Score=318.69  Aligned_cols=277  Identities=19%  Similarity=0.298  Sum_probs=198.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|++..++..||+|+++...  ....+.+.+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            5788999999999999999998899999999986432  2234678899999999999999999999754     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ ++|.+++.....   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 689998875432   12489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .......        .......+++.|+|||++.+. .++.++|||||||++|+|+||+.||........... ......
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~  219 (285)
T cd07861         149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILG  219 (285)
T ss_pred             eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhC
Confidence            7553321        112233568899999987654 478899999999999999999999975322111110 000000


Q ss_pred             ccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......-.......+... ...............+.++.+++.+||+.||++|||+.||+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000000000000 000000000011124567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-36  Score=318.34  Aligned_cols=267  Identities=23%  Similarity=0.372  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCC--------------CeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGEN--------------GMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIIT  618 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~  618 (869)
                      ++|++.++||+|+||.||+|.+...              ...||+|.++.. .......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5799999999999999999987532              235899998643 2334567899999999999999999999


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCc------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                      ++..     ....++||||+++++|.+++......      .....+++..++.++.|++.|++|||+.   +++|||||
T Consensus        85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            9754     36789999999999999999654211      0112378899999999999999999999   99999999


Q ss_pred             CCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc--CC
Q 002897          693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS--RR  770 (869)
Q Consensus       693 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t--g~  770 (869)
                      |+||+++.++.+||+|||++........      ........++..|+|||+..++.++.++|||||||++|+|++  |.
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcc------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999976543211      011223345778999999988889999999999999999998  56


Q ss_pred             CCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002897          771 RPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDV  850 (869)
Q Consensus       771 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  850 (869)
                      .||...... ...................                    ...+.++..+.+++.+||+.||++|||+++|
T Consensus       231 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         231 QPYSLLSDE-QVIENTGEFFRNQGRQIYL--------------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             CCCcccChH-HHHHHHHHhhhhccccccC--------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            677643211 1111111100000000000                    0001234578899999999999999999999


Q ss_pred             HHHHH
Q 002897          851 VVKLC  855 (869)
Q Consensus       851 l~~L~  855 (869)
                      ++.|+
T Consensus       290 ~~~l~  294 (295)
T cd05097         290 HHFLR  294 (295)
T ss_pred             HHHHh
Confidence            99886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-36  Score=316.14  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN-----GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence            35788999999999999999998643     4789999986433 23346788999999999999999999996543   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                        ...++||||+++|+|.+++.......    ....+++..++.++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence              77899999999999999997644221    122478899999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~  781 (869)
                      .+||+|||.++........      .......++..|+|||.+.+..++.++|||||||++||+++ |..||......  
T Consensus       157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--  228 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--  228 (277)
T ss_pred             CEEECCcccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--
Confidence            9999999999765443210      11223446789999999988889999999999999999998 99998642211  


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                         ...+........                       ..+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       229 ---~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         229 ---EVLKFVIDGGHL-----------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---HHHHHHhcCCCC-----------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence               111111100000                       001123557889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.8e-36  Score=319.68  Aligned_cols=267  Identities=25%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|.+.+.||+|+||.||+|.+..       ++..+|+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3679999999999999999998642       33579999997532 33446788899999999 799999999997653


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           ...++||||+++|+|.+++.......          ....+++.++..++.|++.||+|||+.   +++||||||
T Consensus        97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence                 67899999999999999998754210          122489999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||.+.........      .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchh------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999998765432110      11111234568999999988889999999999999999998 8888


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |....     .............                       ...+..++.++.+++.+||+.+|++|||+.||++
T Consensus       243 ~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         243 YPGVP-----VEELFKLLKEGHR-----------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             CCcCC-----HHHHHHHHHcCCC-----------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            85421     1111111110000                       0011134457889999999999999999999999


Q ss_pred             HHHHHHHhh
Q 002897          853 KLCAAREAF  861 (869)
Q Consensus       853 ~L~~~~~~~  861 (869)
                      .|.++.+..
T Consensus       295 ~l~~~~~~~  303 (307)
T cd05098         295 DLDRILALT  303 (307)
T ss_pred             HHHHHHHHh
Confidence            999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.6e-36  Score=312.34  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.++||+|+||.||+|.+..+++.||+|.+.....  .+.+.+|++++++++||||+++++++...     ...++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEE
Confidence            579999999999999999999988899999999865433  57899999999999999999999987643     77899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ++||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.
T Consensus        76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999976543     389999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......|+..|+|||++.+..++.++||||||+++|+|++|+.||..........     ... .
T Consensus       148 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~-~  213 (256)
T cd06612         148 QLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIP-N  213 (256)
T ss_pred             hcccCc--------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhc-c
Confidence            664432        11223457889999999988889999999999999999999999987532211000     000 0


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..    .                ............+.+++.+||+.||++|||+.||++
T Consensus       214 ~~----~----------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 KP----P----------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CC----C----------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00    0                000011234456889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.3e-36  Score=319.40  Aligned_cols=269  Identities=21%  Similarity=0.255  Sum_probs=207.7

Q ss_pred             ccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeec
Q 002897          544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSS  622 (869)
Q Consensus       544 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  622 (869)
                      +...++..+.++|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555667889999999999999999999999899999999986432 2235678899999999 89999999999876


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .+.......++||||+++|+|.++++.....  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            5333446789999999999999988643211  12489999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----CCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      .+||+|||.+.......        .......|+..|+|||.+...     .++.++|||||||++|||++|+.||....
T Consensus       166 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         166 GVKLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             CEEEeecccchhccccc--------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            99999999987654322        112234578999999987543     26889999999999999999999986532


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .. .....+.+..    .....                     ..++....+.+++.+||+.+|++||++.|+++
T Consensus       238 ~~-~~~~~~~~~~----~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         238 PV-KTLFKIPRNP----PPTLL---------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HH-HHHHHHhcCC----CCCCC---------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 1111111000    00000                     11123456889999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7e-36  Score=318.39  Aligned_cols=267  Identities=21%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC----------------CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG----------------ENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKI  616 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~  616 (869)
                      ++|++.++||+|+||.||+|.+.                .++..||+|++... .......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998643                23457999998654 23345678999999999999999999


Q ss_pred             EEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002897          617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDL  691 (869)
Q Consensus       617 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  691 (869)
                      ++++...     +..++||||+++|+|.+++.......     ....+++.++..++.|++.|++|||+.   +++||||
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            9997553     66899999999999999998754221     112478889999999999999999999   9999999


Q ss_pred             CCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc--C
Q 002897          692 KPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS--R  769 (869)
Q Consensus       692 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t--g  769 (869)
                      ||+||+++.++.++|+|||.+..+......      .......++..|+|||...++.++.++|||||||++|||++  |
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcce------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            999999999999999999999765432210      11122344678999999888889999999999999999998  7


Q ss_pred             CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                      ..||....... ................                    ..+.+..++..+.+++.+||+.||++||++.|
T Consensus       231 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         231 EQPYSQLSDEQ-VIENTGEFFRDQGRQV--------------------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             CCCccccChHH-HHHHHHHHHhhccccc--------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            78876432211 1100000000000000                    00011124467889999999999999999999


Q ss_pred             HHHHHH
Q 002897          850 VVVKLC  855 (869)
Q Consensus       850 vl~~L~  855 (869)
                      |++.|+
T Consensus       290 i~~~l~  295 (296)
T cd05095         290 IHATLL  295 (296)
T ss_pred             HHHHHh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.6e-36  Score=312.43  Aligned_cols=256  Identities=25%  Similarity=0.448  Sum_probs=195.4

Q ss_pred             CeeeeecceEEEEEEECC---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|.+..   .+..||+|.+... .....+.+.+|+.+++.++||||+++++++...    ....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998642   3467999998543 334457788999999999999999999976532    25578999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+.+|+|.+++.....     ..++..+..++.|+++|++|||+.   +++||||||+||+++.++.+||+|||.++..
T Consensus        77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999976543     267888899999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC-CCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .......    ........++..|+|||.+.+..++.++|||||||++|||++| .+||....     ............
T Consensus       149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~  219 (262)
T cd05058         149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQGR  219 (262)
T ss_pred             cCCccee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhcCC
Confidence            4321100    0111233457789999999888899999999999999999995 55554321     111111111000


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                                             ....+..++..+.+++.+||+.+|++||++.||++.|+++..
T Consensus       220 -----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 -----------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                                   000011234568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=318.60  Aligned_cols=254  Identities=22%  Similarity=0.369  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||.|+||.||+|.+..++..||+|+++.......+.+..|++++++++||||+++++++..     ....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence            3578999999999999999999988899999999976666666788999999999999999999998754     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....     .+++..++.++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.+
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence            99999999999999876543     389999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      .......        .......|+..|+|||.+.     +..++.++|||||||++|+|++|+.||...... .....+.
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~  221 (280)
T cd06611         151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKIL  221 (280)
T ss_pred             hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHh
Confidence            7543321        1223345889999999874     345778999999999999999999998753211 0111110


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .    ...     +.                ...+..++..+.+++.+||+.+|++||+++++++.
T Consensus       222 ~----~~~-----~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 K----SEP-----PT----------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             c----CCC-----CC----------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0    000     00                00111234567899999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-35  Score=319.09  Aligned_cols=267  Identities=26%  Similarity=0.403  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-------CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-------ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|.+.++||+|+||.||+|++.       .....||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467899999999999999999863       235679999986432 33456788999999999 699999999987543


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           ...++||||+++|+|.+++......          .....+++.++..++.|++.||+|||++   |++||||||
T Consensus        91 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          91 -----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence                 6789999999999999999765321          0123489999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||.++........      .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYY------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccc------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence            9999999999999999999866432210      01111224567999999988889999999999999999999 8888


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |.....     .............                       ..+..++.++.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         237 YPGIPV-----EELFKLLREGHRM-----------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCH-----HHHHHHHHcCCCC-----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            864221     1111111100000                       001123456789999999999999999999999


Q ss_pred             HHHHHHHhh
Q 002897          853 KLCAAREAF  861 (869)
Q Consensus       853 ~L~~~~~~~  861 (869)
                      .|.++....
T Consensus       289 ~l~~~~~~~  297 (314)
T cd05099         289 ALDKVLAAV  297 (314)
T ss_pred             HHHHHHHHh
Confidence            999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-36  Score=315.66  Aligned_cols=253  Identities=27%  Similarity=0.431  Sum_probs=199.5

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhh--HHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.+.||+|+||+||+|.+..+++.||+|++........  ....+|+.++++++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            5677899999999999999999999999999976544332  234569999999999999999999765     378899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++....      .+++..+..++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999999999998333      389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccC-CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .....        ........++..|+|||+.. +..++.++||||+|+++|+|++|..||.....  ............
T Consensus       147 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~  216 (260)
T PF00069_consen  147 KLSEN--------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILK  216 (260)
T ss_dssp             ESTST--------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHH
T ss_pred             ccccc--------ccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccc
Confidence            65211        12334566899999999998 78899999999999999999999999975410  011111110000


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...    .    ...            .........+.+++.+||+.||++|||+.|+++
T Consensus       217 ~~~----~----~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  217 RPL----P----SSS------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             THH----H----HHT------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccc----c----ccc------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    0    000            000011267889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.3e-39  Score=333.58  Aligned_cols=373  Identities=25%  Similarity=0.392  Sum_probs=278.1

Q ss_pred             cCcCCCEEEccCCccC-ccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchh
Q 002897           44 NLSALQVIDIRGNRLG-GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR  122 (869)
Q Consensus        44 ~l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~  122 (869)
                      -|+-.+-.|+++|.++ +..|....++++++.|.|.+.++. .+|..++.+.+|++|.+++|++. ++. +.++.|+.|+
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vh-GELs~Lp~LR   81 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVH-GELSDLPRLR   81 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhh-hhhccchhhH
Confidence            3456677788888887 477778888888888888888887 67888888888888888888886 444 4577888899


Q ss_pred             hhhccccccc-eeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcE
Q 002897          123 KFVAAKNNLT-GFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN  201 (869)
Q Consensus       123 ~L~l~~n~i~-~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~  201 (869)
                      .+.+..|++. .-+|..+..+..|++||||+|++.. .|..+...+++-.|+|++|+|.++|..      .|.+++.|-.
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~IetIPn~------lfinLtDLLf  154 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIETIPNS------LFINLTDLLF  154 (1255)
T ss_pred             HHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccccCCch------HHHhhHhHhh
Confidence            9999998885 2356777788899999999998864 566778888888888888888888754      5777788888


Q ss_pred             EEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcc-eecCCccccCCCCCCEEEccCc
Q 002897          202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL-IGTVPPEIGWLKNLQSLYLNSN  280 (869)
Q Consensus       202 L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~L~~N  280 (869)
                      ||||+|++. .+|..+..+.. |++|+|++|.+....-..+..+++|+.|.+++.+- ...+|.++..+.||..++|+.|
T Consensus       155 LDLS~NrLe-~LPPQ~RRL~~-LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N  232 (1255)
T KOG0444|consen  155 LDLSNNRLE-MLPPQIRRLSM-LQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSEN  232 (1255)
T ss_pred             hccccchhh-hcCHHHHHHhh-hhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcccccc
Confidence            888888887 66666777765 77777777776543333444555555555555432 1234555555555555555555


Q ss_pred             cccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCc
Q 002897          281 FLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP  360 (869)
Q Consensus       281 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p  360 (869)
                      .+. ..|+.+.++.+|+.|+||+|+|+ .+........+|++                         |+||.|+++ .+|
T Consensus       233 ~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEt-------------------------LNlSrNQLt-~LP  284 (1255)
T KOG0444|consen  233 NLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLET-------------------------LNLSRNQLT-VLP  284 (1255)
T ss_pred             CCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhh-------------------------hccccchhc-cch
Confidence            554 45555555555555555555554 33333444444444                         555555555 799


Q ss_pred             ccccCCccccccccccccccc-cCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCcccccccc
Q 002897          361 SEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLS  439 (869)
Q Consensus       361 ~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  439 (869)
                      +++..+++|+.|++.+|+++- -+|..++.+.+|+++..++|.+. ..|..++.+..|+.|.|+.|++- ++|+.+.-++
T Consensus       285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~  362 (1255)
T KOG0444|consen  285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLP  362 (1255)
T ss_pred             HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcC
Confidence            999999999999999999873 47899999999999999999998 99999999999999999999998 8999999999


Q ss_pred             ccCeeccccccCcccCCCC
Q 002897          440 FLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       440 ~L~~l~l~~N~l~~~~~~~  458 (869)
                      .|+.||+.+|+----+|..
T Consensus       363 ~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  363 DLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             CcceeeccCCcCccCCCCc
Confidence            9999999999866555543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.9e-36  Score=314.16  Aligned_cols=258  Identities=22%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .+|++.++||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.+++.++||||+++++++.+      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4688899999999999999987533   3579999886544 4455788999999999999999999998753      4


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            46899999999999999976543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++.......       .......++..|+|||.+....++.++|||||||++||+++ |..||........ ......
T Consensus       152 g~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~  223 (270)
T cd05056         152 GLSRYLEDESY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIEN  223 (270)
T ss_pred             ceeeecccccc-------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHc
Confidence            99976644321       11112234568999999988889999999999999999986 9999975432111 111000


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                          ..                       ....++.++..+.+++.+|+..+|++|||+.|+++.|.+++.+
T Consensus       224 ----~~-----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 ----GE-----------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----CC-----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                00                       0001123455788999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=309.79  Aligned_cols=251  Identities=32%  Similarity=0.460  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|..  .|+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+     ....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence            45789999999999999999998  589999999975543 45788999999999999999999998654     37789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999986542    1389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +......           ....++..|+|||++.++.++.++||||||+++|++++ |..||......     .......
T Consensus       150 ~~~~~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~  213 (256)
T cd05039         150 KEASQGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHVE  213 (256)
T ss_pred             ccccccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHh
Confidence            8653221           11234668999999988889999999999999999997 99998643211     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ....                       ...+..++..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus       214 ~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         214 KGYR-----------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             cCCC-----------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            0000                       000112346788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=321.78  Aligned_cols=202  Identities=26%  Similarity=0.343  Sum_probs=172.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.+     .+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence            4789999999999999999999989999999999642   22334568899999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999976433     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      .+........       .......||+.|+|||++..     ..++.++||||+||++|+|++|+.||..
T Consensus       148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            9876543221       11223468999999999863     4578899999999999999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.7e-36  Score=318.06  Aligned_cols=268  Identities=22%  Similarity=0.356  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC----------------eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG----------------MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIK  615 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  615 (869)
                      .++|++.+.||+|+||.||+|.+...+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457999999999999999999876433                568999986443 344577899999999999999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGD  690 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  690 (869)
                      +++++...     ...++||||+++++|.+++.......     ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99997643     67899999999999999997754211     112489999999999999999999999   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc--
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS--  768 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t--  768 (869)
                      |||+||+++.++.++|+|||.++........      .......++..|+|||++.+..++.++|||||||++|||++  
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcce------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence            9999999999999999999998765433211      11223446788999999988889999999999999999998  


Q ss_pred             CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       769 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |..||...... ..+..............                    ....+..++.++.+++.+||+.||++|||+.
T Consensus       230 ~~~p~~~~~~~-~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~  288 (296)
T cd05051         230 REQPYEHLTDQ-QVIENAGHFFRDDGRQI--------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFR  288 (296)
T ss_pred             CCCCCCCcChH-HHHHHHHhccccccccc--------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence            67777542211 11111100000000000                    0001112346789999999999999999999


Q ss_pred             HHHHHHH
Q 002897          849 DVVVKLC  855 (869)
Q Consensus       849 evl~~L~  855 (869)
                      ||++.|+
T Consensus       289 el~~~L~  295 (296)
T cd05051         289 EIHLFLQ  295 (296)
T ss_pred             HHHHHhc
Confidence            9998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.8e-36  Score=320.47  Aligned_cols=275  Identities=20%  Similarity=0.283  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeEE
Confidence            57999999999999999999998899999999986433 2234567889999999999999999999754     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ ++|.+++.....     .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            9999997 599999876543     388999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh-
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV-  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-  790 (869)
                      .......        .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... ......... 
T Consensus       152 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~  222 (301)
T cd07873         152 RAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILG  222 (301)
T ss_pred             hccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcC
Confidence            7543221        112234578899999987654 47889999999999999999999997532211 111111100 


Q ss_pred             --cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 --LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 --~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ....+....+............ .........+..+..+.+++.+|++.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         223 TPTEETWPGILSNEEFKSYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCChhhchhhhccccccccccCcc-ccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0000111111000000000000 000000011123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-35  Score=312.92  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..|+..++||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence            45788899999999999999998889999999987443 34557789999999999999999999997653     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++...       ++++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence            999999999999998753       278899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......++..|+|||++.+..++.++|||||||++|||++|+.||.......     ..... .
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~-~  214 (277)
T cd06640         149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFLI-P  214 (277)
T ss_pred             eeccCCc--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhhhh-h
Confidence            7654322        11223457889999999988889999999999999999999999986432110     00000 0


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .                      .........++..+.+++.+||+.+|++||++.|++..
T Consensus       215 ~----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 K----------------------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             c----------------------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0                      00011223456778899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9e-36  Score=316.40  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++.... ....+.+.+|+.++++++||||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~---   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG---   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence            467999999999999999999874     367899999986543 23346788999999999999999999987643   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL----------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGD  690 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  690 (869)
                        ...++||||+++|+|.+++.......                ....+++..++.++.|++.||+|||+.   +++|||
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence              67899999999999999997543211                123478899999999999999999999   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-C
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-R  769 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g  769 (869)
                      |||+||+++.++.++|+|||.+..+......      .......++..|+|||...+..++.++|||||||++|||++ |
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYY------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccc------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999998755332110      11122334678999999988899999999999999999998 8


Q ss_pred             CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                      ..||.....     .+............                       .++.++.++.+++.+||+.||++|||+.|
T Consensus       230 ~~p~~~~~~-----~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         230 MQPYYGMAH-----EEVIYYVRDGNVLS-----------------------CPDNCPLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             CCCCCCCCH-----HHHHHHHhcCCCCC-----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            888854321     11111111111000                       01123456889999999999999999999


Q ss_pred             HHHHHH
Q 002897          850 VVVKLC  855 (869)
Q Consensus       850 vl~~L~  855 (869)
                      +++.|+
T Consensus       282 l~~~l~  287 (288)
T cd05050         282 INRILQ  287 (288)
T ss_pred             HHHHhh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-36  Score=331.75  Aligned_cols=275  Identities=21%  Similarity=0.219  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++|+||+++++++...     ...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence            457999999999999999999999899999999642      23467899999999999999999987653     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|||++. ++|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       237 lv~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999995 699998876433     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccC---CchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE---GLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~---~~~~~~~~~~  789 (869)
                      +.......      ........||..|+|||++.+..++.++|||||||++|||++|..|+......   ........+.
T Consensus       308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~  381 (461)
T PHA03211        308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI  381 (461)
T ss_pred             eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence            86543211      01123456999999999999999999999999999999999988765332111   1111111111


Q ss_pred             hcc-----cccccccCccchhhhhhcccc--cCCCccchHH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLP-----EKVMEIVDPSLLLEVRANNSM--SRGGERVKIE---ECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~-----~~~~~~~d~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...     ..........+...+......  ..........   .....+.+++.+||+.||++|||+.|+++.
T Consensus       382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            100     001111111111111110000  0000010011   223467899999999999999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.2e-36  Score=315.31  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=198.2

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+++++.++|++|+++.+++..     .+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence            667789999999999999999999999999986432   2223457889999999999999999988654     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999988865432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......         ......|+..|+|||++.+..++.++||||+||++|+|++|+.||...... ............
T Consensus       150 ~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~  219 (285)
T cd05632         150 VKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVLE  219 (285)
T ss_pred             eecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhc
Confidence            7653321         112346899999999998888999999999999999999999999743211 111111111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVVK  853 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  853 (869)
                      ..  .                      ......+..+.+++..|++.||++||+     +.|++..
T Consensus       220 ~~--~----------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         220 TE--E----------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc--c----------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00  0                      001123445779999999999999999     6676663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9e-36  Score=321.04  Aligned_cols=204  Identities=21%  Similarity=0.296  Sum_probs=164.3

Q ss_pred             CCeeeeecceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          559 SNMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      .++||+|+||+||+|++.  .+++.||+|.++...  ....+.+|++++++++||||+++++++...   .....++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence            468999999999999975  467899999986432  235578899999999999999999987542   2356899999


Q ss_pred             cccCCCHHHHHhhCCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEccc
Q 002897          637 FMQNGSLEEWLHQNNDKL---EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDF  709 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df  709 (869)
                      |++ ++|.+++.......   ....+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            985 58988876432211   122489999999999999999999999   99999999999999    45679999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      |+|+.......     .........||+.|+|||++.+. .++.++||||+||++|+|++|++||...
T Consensus       157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCc-----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99986643321     11223346789999999998764 5899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-36  Score=315.07  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEee--cccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      ....|++.++||+||.+.||++... +.+.||+|.+.  ..+......|.+|+..|.++ .|.+||++++|-..     +
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----D  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----C
Confidence            3457999999999999999999986 55666666553  34556678899999999999 59999999999543     4


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..|+||||= ..+|..+++.....     ++...++.+..||+.|+.++|.+   ||||.||||.|+|+ -.|.+||+|
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLID  502 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLID  502 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeee
Confidence            8999999975 55999999987653     34348889999999999999999   99999999999999 567999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----------CCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----------EASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      ||+|..+..+...      -.....+||+.||+||.+...           +.+.++||||+|||+|+|+.|++||....
T Consensus       503 FGIA~aI~~DTTs------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  503 FGIANAIQPDTTS------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             echhcccCccccc------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            9999988776432      233457899999999986432           25789999999999999999999997421


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .      .|.+      +..+.||...-++..         .    ....++++++..||++||++|||+.|+++
T Consensus       577 n------~~aK------l~aI~~P~~~Iefp~---------~----~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 N------QIAK------LHAITDPNHEIEFPD---------I----PENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H------HHHH------HHhhcCCCccccccC---------C----CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1      1111      122223211111100         0    00123889999999999999999999986

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-35  Score=309.73  Aligned_cols=254  Identities=23%  Similarity=0.442  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++..      +..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence            457899999999999999999975 788999999864332 34678899999999999999999987532      5689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+++++|.+++.....    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence            99999999999999876442    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||++.+..++.++||||||+++||+++ |+.||......     .......
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~  217 (260)
T cd05067         150 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQNLE  217 (260)
T ss_pred             eecCCCCc-------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHH
Confidence            76653221       11122345678999999988889999999999999999999 99999643211     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .. .    .                  .+.+...+.++.+++.+||+.+|++|||++++...|+.
T Consensus       218 ~~-~----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 RG-Y----R------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             cC-C----C------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            00 0    0                  00011234568899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-35  Score=308.07  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....  ....+.+.+|++++++++|+|++++.+.+..    .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            5889999999999999999999889999999986432  3345678899999999999999999987532    235679


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence            99999999999999986432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......|++.|+|||+..+..++.++||||+||++|++++|+.||.....     .........
T Consensus       150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~  216 (257)
T cd08223         150 RVLENQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIE  216 (257)
T ss_pred             EEecccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHh
Confidence            7664321        122334588999999999998999999999999999999999999864211     111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....                       ......+..+.+++.+|++.+|++|||+.|+++
T Consensus       217 ~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         217 GKLP-----------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cCCC-----------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1000                       011134456889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-35  Score=313.90  Aligned_cols=268  Identities=23%  Similarity=0.351  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECC----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGE----NGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ..++|++.+.||+|+||.||+|.+..    .+..||+|++... .....+.+.+|+.++++++||||+++++++...   
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            34689999999999999999999874    2688999988643 233456788999999999999999999987542   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                       ....++++||+++|+|.+++.......  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence             367899999999999999997653210  113589999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTL  783 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~  783 (869)
                      ||+|||+++.+......      .......++..|+|||++.+..++.++|||||||++||+++ |+.||.....  ...
T Consensus       157 kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~  228 (280)
T cd05043         157 KITDNALSRDLFPMDYH------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEM  228 (280)
T ss_pred             EECCCCCcccccCCceE------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHH
Confidence            99999999866443211      11122345778999999988889999999999999999999 9999865311  111


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ..+.....        .                  ......++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       229 ~~~~~~~~--------~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKDGY--------R------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHcCC--------C------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11111100        0                  000112345688999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=312.36  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+++++.++|+|++++++++.+.     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence            36888999999999999999999899999999986543 34456788999999999999999999986543     7889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||+++++|.+++...       ++++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999999764       389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      +......        .......|+..|+|||++.+..++.++|||||||++|+|+||+.||......     ........
T Consensus       146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~  212 (274)
T cd06609         146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLIPK  212 (274)
T ss_pred             eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHhhh
Confidence            8765432        1123345788999999999888999999999999999999999999643211     00000000


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .     ..+..                 ....++..+.+++.+||..+|++|||++++++
T Consensus       213 ~-----~~~~~-----------------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 N-----NPPSL-----------------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             c-----CCCCC-----------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0     00000                 00013456789999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-35  Score=307.64  Aligned_cols=251  Identities=20%  Similarity=0.319  Sum_probs=204.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|+..+.||.|+||.||.++...+++.+++|.+...  .....+.+.+|++++++++|+||+++++++.+.     ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence            588899999999999999999999999999998643  344456788999999999999999999997543     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+++|+|.+++.....    ..+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999987532    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ........        ......|+..|+|||...+..++.++||||||+++|+|++|..||.....     .+.......
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~  215 (256)
T cd08221         149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQ  215 (256)
T ss_pred             EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc
Confidence            86644321        12334689999999999888899999999999999999999999864211     111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....                       ....++..+.+++.+||+.+|++||+++|+++.
T Consensus       216 ~~~~~-----------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 GNYTP-----------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCCC-----------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            10000                       012344568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=325.85  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=212.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeec-ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .....++||+|+||+||+|.+-..|+    +||+|++.. .......++..|+-+|.+++|||+++++++|...      
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------  770 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------  770 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence            34556899999999999999976664    688888853 3455568899999999999999999999999763      


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ...||++|++.|+|.+|++..++.     +.....+.|..|||+||.|||.+   ++|||||.++||||..-.++||.||
T Consensus       771 ~~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  771 TLQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             hHHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence            378999999999999999998764     88999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+....+...      .......-.+.|||=|.+....|+.++|||||||++||++| |..|++....++  +.+..+
T Consensus       843 gla~ll~~d~~e------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--I~dlle  914 (1177)
T KOG1025|consen  843 GLAKLLAPDEKE------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--IPDLLE  914 (1177)
T ss_pred             chhhccCccccc------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--hhHHHh
Confidence            999988766432      22222334678999999999999999999999999999999 999987643221  111110


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                                                .+.+...++-|+-+++.++.+||..|++.||+++++..++.+..+.
T Consensus       915 --------------------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  915 --------------------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --------------------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                                      1112334456778899999999999999999999999999887543

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.1e-36  Score=315.42  Aligned_cols=265  Identities=22%  Similarity=0.314  Sum_probs=206.5

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      +..++....+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++++ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            445556677899999999999999999999998999999999865432 345678899999998 799999999987543


Q ss_pred             cc-CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          624 DF-NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       624 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .. ......+++|||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            21 234678999999999999999976442    2478889999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      .++|+|||.+.......        .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....
T Consensus       159 ~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         159 EVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             CEEEeeCcchhhhhccc--------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            99999999987553221        1223356899999999875     3457889999999999999999999996432


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..    .......      ....+                 ......++..+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~----~~~~~~~------~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         231 PM----RALFLIP------RNPPP-----------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HH----hhhhhHh------hCCCC-----------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11    0000000      00000                 0011134567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=310.14  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=195.9

Q ss_pred             CeeeeecceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGM--LVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|++..++.  .+|+|.++.. .......+.+|+++++++ +||||+++++++...     ...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence            468999999999999987775  4688888643 234456788999999999 899999999997653     6689999


Q ss_pred             ecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          636 DFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      ||+++|+|.+++.......          ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            9999999999997653210          112478999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLH  784 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~  784 (869)
                      ++|||++......         ........+..|+|||++.+..++.++|||||||++|||++ |..||......     
T Consensus       153 l~dfgl~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----  218 (270)
T cd05047         153 IADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----  218 (270)
T ss_pred             ECCCCCccccchh---------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----
Confidence            9999998532211         01111223567999999988889999999999999999997 99998643211     


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      ............                       ..+..++..+.+++.+||+.+|.+|||+.|+++.|.++.
T Consensus       219 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         219 ELYEKLPQGYRL-----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHhCCCCC-----------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111111000000                       001123456789999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-35  Score=317.54  Aligned_cols=261  Identities=25%  Similarity=0.445  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      .++|+..+.||+|+||.||+|.+..+|.    .||+|.+.... ......+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            3578889999999999999999876665    57888886433 2334468899999999999999999998754     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++++||+++|+|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence             235789999999999999986543     388999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||.++........      .......++..|+|||++.+..++.++|||||||++||+++ |+.||......  ....+
T Consensus       152 Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~  223 (303)
T cd05110         152 DFGLARLLEGDEKE------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL  223 (303)
T ss_pred             cccccccccCcccc------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence            99999866432210      11223345778999999998889999999999999999997 89998643211  11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ....   ..  .                     +.+..++..+.+++..||..+|++||+++|+++.++++.+..
T Consensus       224 ~~~~---~~--~---------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         224 LEKG---ER--L---------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             HHCC---CC--C---------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            1110   00  0                     000112346789999999999999999999999999876553

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-35  Score=310.05  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|.+.+.||+|++|.||+|.+. .+..+|+|.+.... ...+.+.+|++++++++|||++++++++..      ...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence            56889999999999999999986 44569999876433 234678899999999999999999988632      45789


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999999999976432    2378999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++..|+|||...+..++.++|||||||++|+|++ |+.||....... ........ ..
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~-~~  221 (260)
T cd05069         151 LIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVERG-YR  221 (260)
T ss_pred             EccCCcc-------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcC-CC
Confidence            6643221       11112345678999999988889999999999999999999 899986532211 11111000 00


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                                                ...+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus       222 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 --------------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                                      00111345668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-35  Score=314.95  Aligned_cols=275  Identities=21%  Similarity=0.320  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|++|.||+|++..+|+.||+|++....  ....+.+.+|+++++.++|||++++++++...     ...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence            46889999999999999999999899999999986432  22335678999999999999999999987543     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++++++..+.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence            99999999988888776543      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh--
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK--  788 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~--  788 (869)
                      +........        ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ......  
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~  217 (286)
T cd07847         147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTL  217 (286)
T ss_pred             ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence            987644321        1223457889999999876 4578999999999999999999999975332111 111110  


Q ss_pred             -hhcccccccccCccch-hhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 -MVLPEKVMEIVDPSLL-LEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 -~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ...+ ...+..+.... .....................+..+.+++.+||+.+|++|||+.|++.
T Consensus       218 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         218 GDLIP-RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCCh-HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             0000 00000000000 000000000000000011233567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-35  Score=310.77  Aligned_cols=254  Identities=23%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---------hhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---------GALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      +|.+...||+|++|.||+|.+..+++.||+|.+.....         ...+.+.+|+.++++++||||+++++++...  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            47788999999999999999988899999998854321         1235678999999999999999999986543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                         ...++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          79 ---DHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             ---CccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence               67899999999999999997654      378899999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||.++..........  .........|+..|+|||.+.+..++.++||||+||++|+|++|+.||......    ..
T Consensus       147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~  220 (267)
T cd06628         147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA  220 (267)
T ss_pred             ecccCCCcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH
Confidence            999999987653221110  001122345889999999999888999999999999999999999999753211    11


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....      ....+                  ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       221 ~~~~~------~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         221 IFKIG------ENASP------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHh------ccCCC------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            10000      00000                  011134456789999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-35  Score=309.07  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|+..+.||+|+||.||+|.+..+++.||+|++....     ......+.+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            46889999999999999999998899999999986432     22345788999999999999999999986542   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++++||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||+|+||+++.++.++|+|
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            56789999999999999997654      378999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||++.........     ........++..|+|||++.+..++.++||||+||++||+++|+.||.....    ......
T Consensus       150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~  220 (266)
T cd06651         150 FGASKRLQTICMS-----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFK  220 (266)
T ss_pred             CCCcccccccccc-----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHH
Confidence            9999765432110     0112234578999999999988899999999999999999999999974311    111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....     ..+.                  .+....+.+.+++ +||..+|++||+++||++
T Consensus       221 ~~~~~-----~~~~------------------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQP-----TNPQ------------------LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcCC-----CCCC------------------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00000     0000                  1112334455666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-36  Score=326.53  Aligned_cols=194  Identities=24%  Similarity=0.353  Sum_probs=166.0

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ....+|++.+.||+|+||.||+|++..+++.||+|+...      .....|+.++++++||||+++++++...     ..
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence            345689999999999999999999998899999997532      2235699999999999999999987654     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+. ++|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            899999995 589998876443     489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCC
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                      .++.....         .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       203 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        203 AAQFPVVA---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccC---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99743221         1123356899999999999999999999999999999999865554

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=324.55  Aligned_cols=284  Identities=21%  Similarity=0.264  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +++|++.++||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++....+.+....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999899999999986432 3345667889999999999999999998876655556678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+||+++ ++.+++...       .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~~-~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            999999964 888887653       389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.........     ........|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+....
T Consensus       153 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~  226 (336)
T cd07849         153 ARIADPEHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVL  226 (336)
T ss_pred             eeeccccccc-----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHc
Confidence            9765433211     112234568999999998654 46889999999999999999999999642211 0011111100


Q ss_pred             ---cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 ---LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                         .++......+......................+.....+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               001111111111100000000000000000111235678899999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.2e-36  Score=318.39  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||+++++++.+     ....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence            4788899999999999999999999999999986432  2233567889999999999999999998543     47789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||++ ++|.+++.....     .+++..++.++.||++||+|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence            9999996 588888876433     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +......        .......++..|+|||++.+.. ++.++|||||||++|+|+||+.|+..............+...
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            7654321        1122345788999999887654 789999999999999999999986432221111111111100


Q ss_pred             ccc------cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEK------VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...      .....+........     ............+..+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYP-----ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCC-----CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000      00000000000000     000000111124567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=311.15  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ..+|++.+.||+|+||.||+|.+..+|+    .||+|...... ......+.+|+.++++++||||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3578899999999999999999876554    58999886443 3345678899999999999999999998753     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++||||+++|+|.+++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEEC
Confidence             568899999999999999987644     389999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||.++........      .......++..|+|||......++.++|||||||++||+++ |+.||.....     .++
T Consensus       152 dfg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~  220 (279)
T cd05057         152 DFGLAKLLDVDEKE------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEI  220 (279)
T ss_pred             CCcccccccCcccc------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHH
Confidence            99999876533210      11112224678999999988889999999999999999999 9999875321     111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      .........  .                     ..+..+...+.+++.+||..+|++||++.++++.|+.+.+.
T Consensus       221 ~~~~~~~~~--~---------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         221 PDLLEKGER--L---------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHhCCCC--C---------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            111110000  0                     00011234577999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-35  Score=305.26  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=194.9

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ++||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++...     ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence            47899999999999975 788999999865432 3345688999999999999999999997643     6789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++.....     .+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.+||+|||++......
T Consensus        75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999876543     378999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVME  797 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  797 (869)
                      ..       .......++..|+|||+..+..++.++||||||+++|++++ |..||......     ............ 
T Consensus       147 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~-  213 (250)
T cd05085         147 IY-------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQVEKGYRM-  213 (250)
T ss_pred             cc-------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCCCC-
Confidence            11       11112234678999999998889999999999999999998 99998643211     111111000000 


Q ss_pred             ccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       798 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                                            ..+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       214 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 ----------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                                  001123456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-35  Score=321.39  Aligned_cols=202  Identities=25%  Similarity=0.328  Sum_probs=173.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .......+.+|..++..++|++|+++++++..     .+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence            4789999999999999999999999999999998642   22334567889999999999999999998654     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            9999999999999999987433     388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      ++........       .......|++.|+|||++.+     +.++.++|||||||++|+|++|+.||..
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            9976543221       11223468999999998865     4678899999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=308.06  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=202.4

Q ss_pred             CeeeeecceEEEEEEECCC---CeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|.+...   +..||+|+++..... ..+.+.+|+++++.++|+|++++++++..     ....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4799999999999999765   899999999755433 36788999999999999999999998764     47889999


Q ss_pred             ecccCCCHHHHHhhCCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          636 DFMQNGSLEEWLHQNNDK---LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ||+++++|.+++......   .....+++.+++.++.|++.|++|||++   +++||||+|+||+++.++.++|+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999876211   0012489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........      ........++..|+|||.+.+..++.++||||+||++|+|++ |..||.....     ........
T Consensus       153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~  221 (262)
T cd00192         153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYLR  221 (262)
T ss_pred             cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH
Confidence            87654321      012234457889999999988889999999999999999999 6999875411     11111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ...                       ....+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       222 ~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 KGY-----------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             cCC-----------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            000                       00111234567889999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.5e-35  Score=309.64  Aligned_cols=257  Identities=23%  Similarity=0.379  Sum_probs=189.9

Q ss_pred             CeeeeecceEEEEEEEC--CCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|...  .++..+|+|.++.... .....+.+|+.++++++||||+++++++.+.     ...++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence            46899999999999864  3456799998865432 3345788999999999999999999987543     66899999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++...... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+....
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999764321 112367788889999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCC-------CCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-------EASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      ....      ........++..|+|||++.+.       .++.++|||||||++|||++ |+.||........    .. 
T Consensus       152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~-  220 (269)
T cd05087         152 KEDY------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LT-  220 (269)
T ss_pred             Ccce------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HH-
Confidence            3211      0112234578889999987642       35789999999999999996 9999965322211    00 


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ...........++...                  ...+..+.+++..|| .+|++|||++||++.|+
T Consensus       221 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         221 YTVREQQLKLPKPRLK------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHhhcccCCCCCCccC------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0000111111111110                  012345778999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-35  Score=319.32  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      ..+|++.+.||+|+||.||+|++..       .+..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3579999999999999999998642       23478999886432 33456789999999999 899999999997643


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           ...+++|||+++|+|.+++......          .....+++.++..++.|++.||+|||++   +++||||||
T Consensus        91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  162 (334)
T cd05100          91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA  162 (334)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence                 6789999999999999999864321          1123488999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||.++........      .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             ceEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999865432210      11122234568999999999899999999999999999998 8888


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |....     ..............                       ..+..++..+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~-----~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         237 YPGIP-----VEELFKLLKEGHRM-----------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             CCCCC-----HHHHHHHHHcCCCC-----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            86432     12222111110000                       001123456889999999999999999999999


Q ss_pred             HHHHHHHhh
Q 002897          853 KLCAAREAF  861 (869)
Q Consensus       853 ~L~~~~~~~  861 (869)
                      .|+++....
T Consensus       289 ~l~~~~~~~  297 (334)
T cd05100         289 DLDRVLTVT  297 (334)
T ss_pred             HHHHHhhhc
Confidence            999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=323.03  Aligned_cols=241  Identities=22%  Similarity=0.251  Sum_probs=185.7

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC---CCCccceEEEEeeccccCCCceEEEEe
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI---RHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ||+|+||+||+|++..+++.||||++....   .........|..++...   +||+|+++++++..     ....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence            699999999999999899999999986432   22234455677777655   69999999998654     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999987654      389999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      ....        .......||..|+|||++.+. .++.++||||+||++|+|++|+.||.....     .+.........
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~  213 (330)
T cd05586         147 LTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGK  213 (330)
T ss_pred             CCCC--------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCC
Confidence            2221        122345689999999998764 479999999999999999999999964221     11111111100


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ----MRDVVV  852 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  852 (869)
                      . ...                      .......+.+++.+||+.||++||+    +.|+++
T Consensus       214 ~-~~~----------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 V-RFP----------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C-CCC----------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0 000                      0012345678999999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=312.03  Aligned_cols=239  Identities=23%  Similarity=0.364  Sum_probs=185.7

Q ss_pred             eeeeecceEEEEEEECC------------------------CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceE
Q 002897          561 MVGQGSFGTVFKGIIGE------------------------NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI  616 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  616 (869)
                      .||+|+||.||+|....                        ....||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                        124689999876555555678899999999999999999


Q ss_pred             EEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 002897          617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV  696 (869)
Q Consensus       617 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  696 (869)
                      ++++...     ...++||||+++|+|..++.....     .+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            9998654     678999999999999999876443     388999999999999999999999   999999999999


Q ss_pred             eecCCC-------cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHH-
Q 002897          697 LLDHDM-------VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF-  767 (869)
Q Consensus       697 ll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~-  767 (869)
                      +++..+       .+|++|||.+......            ....++..|+|||.+.+ ..++.++|||||||++||++ 
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            997654       4899999988643221            12346788999998865 56899999999999999985 


Q ss_pred             cCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          768 SRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       768 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      +|+.||.......  ...+.....     .     .                  ++.....+.+++.+||+.+|++|||+
T Consensus       217 ~g~~p~~~~~~~~--~~~~~~~~~-----~-----~------------------~~~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         217 DGEVPLKERTPSE--KERFYEKKH-----R-----L------------------PEPSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             CCCCCccccChHH--HHHHHHhcc-----C-----C------------------CCCCChHHHHHHHHHcccChhhCcCH
Confidence            6999986432211  111100000     0     0                  00112357899999999999999999


Q ss_pred             HHHHHHH
Q 002897          848 RDVVVKL  854 (869)
Q Consensus       848 ~evl~~L  854 (869)
                      +||++.|
T Consensus       267 ~~il~~L  273 (274)
T cd05076         267 RTILRDL  273 (274)
T ss_pred             HHHHHhh
Confidence            9999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-35  Score=307.95  Aligned_cols=240  Identities=22%  Similarity=0.394  Sum_probs=187.1

Q ss_pred             CeeeeecceEEEEEEECC------------CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          560 NMVGQGSFGTVFKGIIGE------------NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      +.||+|+||.||+|+...            ....||+|++..........+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            468999999999998642            2336899988765555566788999999999999999999997643    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc----
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV----  703 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----  703 (869)
                       ...++||||+++|+|..++.....     .+++..++.++.||++|++|||+.   +|+||||||+||+++.++.    
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence             567899999999999999876543     389999999999999999999999   9999999999999987664    


Q ss_pred             ---EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-CCCCCccccchhhhHHHHHHH-cCCCCCCcCcc
Q 002897          704 ---AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-GSEASMTGDVYSFGILLLEMF-SRRRPTDSMFH  778 (869)
Q Consensus       704 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~el~-tg~~pf~~~~~  778 (869)
                         ++++|||.+......            ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.....
T Consensus       148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence               899999998654221            2245788999999886 456899999999999999998 58888754211


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .  ........    . ....                       ......+.+++.+||+.||++||++.|+++.+
T Consensus       216 ~--~~~~~~~~----~-~~~~-----------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         216 A--EKERFYEG----Q-CMLV-----------------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             h--HHHHHHhc----C-ccCC-----------------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1  00000000    0 0000                       01234578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=312.60  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeecccc-CCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDF-NGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~  628 (869)
                      ..+++|++.+.||+|++|.||+|.+..+++.+|+|++..... ..+.+.+|+++++++ +|+||+++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356899999999999999999999988899999999875443 346789999999999 79999999999876432 335


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++++|.+++......  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence            6789999999999999998764311  12489999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      ||.+.......        .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...... ...
T Consensus       157 ~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~  227 (275)
T cd06608         157 FGVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL  227 (275)
T ss_pred             Cccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH
Confidence            99987654321        12233458899999998753     34678999999999999999999999642211 111


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......         .+.                .......+..+.+++.+||..||++|||+.|+++
T Consensus       228 ~~~~~~~---------~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 FKIPRNP---------PPT----------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHhhccC---------CCC----------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1110000         000                0011234567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.9e-35  Score=306.79  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=199.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ------KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +|++.+.||+|+||+||+|... +|+.+|+|.++...      ......+.+|+++++.++|+||+++++++.+.     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence            5788999999999999999875 88999999886432      22345688999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++++|.+++....      ++++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence            78999999999999999997653      378999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+..........  ..........|+..|+|||++.+..++.++|||||||++|++++|+.||......    .....
T Consensus       146 fg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~  219 (265)
T cd06631         146 FGCARRLAWVGLHG--THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFY  219 (265)
T ss_pred             chhhHhhhhccccc--cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHH
Confidence            99997653221110  0111223356899999999999888999999999999999999999999643211    11100


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......    .+.                  .+..++..+.+++.+||+.+|++||++.|++.
T Consensus       220 ~~~~~~~----~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 IGAHRGL----MPR------------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhhccCC----CCC------------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000    000                  01123456789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-35  Score=319.61  Aligned_cols=256  Identities=21%  Similarity=0.234  Sum_probs=196.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.++||+|+||+||+|++..+++.||+|++...   .......+..|+.++..++|++|+++++++.+     ...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence            4788999999999999999999989999999998642   22234557889999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999987433     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      ++........       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....     ..+
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~  215 (332)
T cd05623         148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVE  215 (332)
T ss_pred             hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHH
Confidence            9875433211       1122356899999999876     3457899999999999999999999996421     111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVVK  853 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  853 (869)
                      ..............                   +.....++..+.+++.+|+..+|++  |++++|+++.
T Consensus       216 ~~~~i~~~~~~~~~-------------------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         216 TYGKIMNHKERFQF-------------------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHhCCCccccC-------------------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11111110000000                   0011133456778888888654444  7899999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-35  Score=307.43  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=198.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|++.+.||+|+||.||.|.+..+|+.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            47889999999999999999999899999999885321     22346788999999999999999999986542   12


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            56789999999999999997653      278889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+.........     ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.....    ......
T Consensus       150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~  220 (265)
T cd06652         150 FGASKRLQTICLS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFK  220 (265)
T ss_pred             Ccccccccccccc-----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHH
Confidence            9999865432110     0112334588999999999888899999999999999999999999864211    111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..... .                      ....+......+.+++.+|+. +|++||+++|+++
T Consensus       221 ~~~~~-~----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQP-T----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcCC-C----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11000 0                      001112344567788999984 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-35  Score=313.57  Aligned_cols=257  Identities=21%  Similarity=0.310  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...     ...
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence            357888999999999999999998899999999986543 33457789999999999999999999997653     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++....      ++++..+..++.+++.|+.|||+..  +++||||+|+||+++.++.++|+|||+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence            99999999999999987654      3899999999999999999999732  899999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc------hHHH
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL------TLHE  785 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~------~~~~  785 (869)
                      +......          ......|+..|+|||++.+..++.++|||||||++|++++|+.||........      ....
T Consensus       151 ~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~  220 (284)
T cd06620         151 SGELINS----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD  220 (284)
T ss_pred             ccchhhh----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence            8654221          11234689999999999888899999999999999999999999975432211      0001


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      +........                      .......+++..+.+++.+||+.||++|||+.|+++..
T Consensus       221 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         221 LLQQIVQEP----------------------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHhhcc----------------------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111110000                      00011123556788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.5e-36  Score=311.83  Aligned_cols=240  Identities=24%  Similarity=0.405  Sum_probs=187.6

Q ss_pred             CeeeeecceEEEEEEECCCCe-------EEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          560 NMVGQGSFGTVFKGIIGENGM-------LVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +.||+|+||.||+|.+...+.       .||+|.+........+.+..|+.+++.++||||+++++++...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            469999999999999865443       4888988655555567788999999999999999999997653     5689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--------E
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV--------A  704 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~  704 (869)
                      +||||+++|+|.++++....     .+++..+..++.||+.|++|||++   +|+||||||+||+++.++.        +
T Consensus        76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence            99999999999999987653     388999999999999999999999   9999999999999987765        6


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCC-CCCCcCccCCch
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR-RPTDSMFHEGLT  782 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~-~pf~~~~~~~~~  782 (869)
                      +++|||.+......            ....++..|+|||++.+. .++.++|||||||++|||++|. .||......  .
T Consensus       148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~  213 (258)
T cd05078         148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--K  213 (258)
T ss_pred             EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--H
Confidence            99999988644321            224578899999998874 5789999999999999999985 554421110  0


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ......    .. ..                       .+.....++.+++.+||+.||++|||++|+++.|
T Consensus       214 ~~~~~~----~~-~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         214 KLQFYE----DR-HQ-----------------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHH----cc-cc-----------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            000000    00 00                       0001224578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-35  Score=306.04  Aligned_cols=250  Identities=19%  Similarity=0.306  Sum_probs=201.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|+||.||.+....+|+.||+|.+...  .....+.+.+|+.++++++||||+++++++..     .+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence            588899999999999999999989999999998643  23345678999999999999999999998643     47899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999976432    1378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......|+..|+|||+..+..++.++|||||||++|++++|+.||....     ..........
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~  215 (256)
T cd08218         149 RVLNSTV--------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIR  215 (256)
T ss_pred             eecCcch--------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhc
Confidence            7654321        11223457889999999998889999999999999999999999986421     1111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...                       ...+...+..+.+++.+||+.+|++||++.||++
T Consensus       216 ~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         216 GSY-----------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCC-----------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            100                       0011133456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-35  Score=308.11  Aligned_cols=251  Identities=27%  Similarity=0.404  Sum_probs=198.8

Q ss_pred             CeeeeecceEEEEEEECC-CC--eEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGE-NG--MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999864 33  3699999976554 566789999999999999999999998643      6789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+...
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999987542    2489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .......     .......++..|+|||++.+..++.++|||||||++|||++ |+.||......     +.........
T Consensus       148 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~  217 (257)
T cd05040         148 PQNEDHY-----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEG  217 (257)
T ss_pred             cccccce-----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcC
Confidence            5432110     11123456789999999998899999999999999999999 99998643211     1111110000


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                       .                     ....+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       218 -~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 -E---------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -C---------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0                     00011134567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=318.60  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      -|.++..||.|+||.||+|..+.++-..|-|++.....+..+.+.-|++||..++||+||++++.|...     +..+|.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEEE
Confidence            356778899999999999999988888999999888888899999999999999999999999976543     779999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      .|||.||-....+-.-..     .+++.++.-+++|++.||.|||+.   .|||||+|+.|||++-+|.++|+|||.+..
T Consensus       108 iEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             EeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence            999999999988877654     499999999999999999999999   999999999999999999999999999864


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCccc-----CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYG-----TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ....        ......++||+.|||||+.     ...+|+.++||||||+++.||..+.+|-...... ..+....+.
T Consensus       180 n~~t--------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKiaKS  250 (1187)
T KOG0579|consen  180 NKST--------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS  250 (1187)
T ss_pred             chhH--------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHhhc
Confidence            3321        1344567899999999975     4568999999999999999999999995432111 011111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .         .|.                ...+......+.+++.+|+..||..||+++++++
T Consensus       251 e---------PPT----------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 E---------PPT----------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             C---------CCc----------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1         111                1122245567889999999999999999999986

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-35  Score=314.18  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .|.....||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++.+..     .+..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence            34445779999999999999988999999999876555556778999999999999999999998654     3788999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      |||+++++|.+++....       +++.++..++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        98 ~e~~~~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          98 MEFLEGGALTDIVTHTR-------MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EeCCCCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            99999999999986532       78999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .....        .......|+..|+|||...+..++.++|||||||++|||++|+.||....... ..... ....   
T Consensus       168 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~-~~~~---  234 (292)
T cd06658         168 VSKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRI-RDNL---  234 (292)
T ss_pred             ccccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhcC---
Confidence            53321        11233468899999999988889999999999999999999999986421110 00000 0000   


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                           .+..                .........+.+++.+||..||++|||++|+++.
T Consensus       235 -----~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 -----PPRV----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -----CCcc----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                 0000                0001233457789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-35  Score=313.65  Aligned_cols=248  Identities=22%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++..     ....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence            4666788999999999999998889999999986433 3445678999999999999999999998654     377899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++...       .+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.++++|||.+.
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence            99999999999998653       388999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......|+..|+|||++.+..++.++|||||||++|||++|+.||........     .... ..
T Consensus       150 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~-~~  215 (277)
T cd06642         150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFLI-PK  215 (277)
T ss_pred             cccCcc--------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hhhh-hc
Confidence            654322        111224578899999999988899999999999999999999999864321110     0000 00


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .    ..+.                  ....++..+.+++.+||+.+|++||++.|+++.
T Consensus       216 ~----~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 N----SPPT------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             C----CCCC------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0    0000                  011244568899999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-35  Score=325.76  Aligned_cols=275  Identities=21%  Similarity=0.209  Sum_probs=199.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..+|.+.+.||+|+||.||+|...  ..++.||+|.+...     +...+|++++++++||||+++++++..     ...
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence            357999999999999999999764  35678999987532     335689999999999999999998654     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|||++. ++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            899999995 68999885433      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC--chHHHhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG--LTLHEFSK  788 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~  788 (869)
                      +++.......      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+....+
T Consensus       231 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~  304 (392)
T PHA03207        231 AACKLDAHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR  304 (392)
T ss_pred             cccccCcccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence            9976544321      112234579999999999999999999999999999999999999996543221  11111111


Q ss_pred             hhccc--ccccccCccchhhhhhcccccCC-Cc-cch--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPE--KVMEIVDPSLLLEVRANNSMSRG-GE-RVK--IEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~--~~~~~~d~~~~~~~~~~~~~~~~-~~-~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....  .........+...+.......+. .. ...  ......++.+++.+|+..||++|||+.|++..
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11000  00000000011111000000000 00 000  01234567889999999999999999999874

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-35  Score=313.47  Aligned_cols=276  Identities=20%  Similarity=0.269  Sum_probs=200.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch-----hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-----ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.++.....     ....+..|++++++++|+||+++++++.+     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            478889999999999999999888999999999654322     33566789999999999999999999765     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+ +|+|.+++.....     .+++..+..++.|+++||+|||++   +|+|+||+|+||+++.++.++|+||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSI-----VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            889999999 8999999976542     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+.......        .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ........
T Consensus       147 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~  217 (298)
T cd07841         147 GLARSFGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE  217 (298)
T ss_pred             eeeeeccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH
Confidence            9998764432        11222346788999998755 45789999999999999999998887643221 11111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...........+.........................+..+.+++.+||+.||++|||++|+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            10000000000000000000000000000011112345678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.2e-35  Score=306.18  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=203.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...  .....+.+..|++++++++||||+++++++...   +....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            588899999999999999999989999999998643  234456788999999999999999999976532   345689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH-----HHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ++|||+++++|.+++......  ..++++..++.++.|++.||+|||     +.   +++|+||+|+||+++.++.+||+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            999999999999999764221  234899999999999999999999     66   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.+.......        .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....     .....
T Consensus       153 d~g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~  219 (265)
T cd08217         153 DFGLAKILGHDS--------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA  219 (265)
T ss_pred             cccccccccCCc--------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH
Confidence            999998765432        11223468999999999998889999999999999999999999997532     11111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +.......                       +..+...+..+.+++.+|++.+|++|||+.||++
T Consensus       220 ~~~~~~~~-----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         220 SKIKEGKF-----------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHhcCCC-----------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11110000                       0111234467889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-35  Score=311.19  Aligned_cols=255  Identities=19%  Similarity=0.293  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+|++++++++||||+++++++..     ....+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence            3688999999999999999999889999999988643 33345678899999999999999999998654     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999999999999876421   124899999999999999999999632  8999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC------CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE------ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      .......          .....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||....... .....
T Consensus       151 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~  219 (286)
T cd06622         151 GNLVASL----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQL  219 (286)
T ss_pred             ccccCCc----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHH
Confidence            7553221          12235788999999885543      4889999999999999999999996432111 01110


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                       .......                       ....+..++..+.+++.+||+.+|++||+++|++..
T Consensus       220 -~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         220 -SAIVDGD-----------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -HHHhhcC-----------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             0000000                       000112345667899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-35  Score=309.26  Aligned_cols=264  Identities=25%  Similarity=0.297  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|...++||.|++|.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++...   .....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            367888999999999999999988999999999874332 3456789999999999999999999987643   235689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++......  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence            999999999999987643221  22488999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......          .....++..|+|||.+.+..++.++||||+||++|+|++|+.||+..........+.......
T Consensus       153 ~~~~~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd06621         153 GELVNSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN  222 (287)
T ss_pred             ccccccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc
Confidence            7543321          112347889999999998899999999999999999999999997542211111111111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......+                 ........++.+.+++.+||+.+|++|||+.|+++
T Consensus       223 ~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         223 MPNPELKD-----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCchhhcc-----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00000000                 00000123456889999999999999999999988

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-35  Score=305.45  Aligned_cols=247  Identities=31%  Similarity=0.469  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||.||++..  +++.||+|.++...  ....+.+|+.++++++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            5689999999999999999976  78899999986432  33678899999999999999999998653      34689


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.
T Consensus        76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence            9999999999999976542    2478999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......           .....+..|+|||.+.+..++.++|||||||++|+|++ |+.||.....     .........
T Consensus       149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~  212 (254)
T cd05083         149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVEK  212 (254)
T ss_pred             eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhC
Confidence            543211           11234568999999988889999999999999999997 9999864321     111111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      . .                      .......++..+.+++.+||+.+|++||+++++++.|++
T Consensus       213 ~-~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 G-Y----------------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             C-C----------------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            0 0                      000111345667899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.9e-35  Score=306.34  Aligned_cols=256  Identities=21%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ------KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +|+..+.||+|++|.||+|.+..+++.||+|++....      ....+.+.+|+.++++++|+||+++++++.+     .
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence            4788899999999999999998899999999986432      1235678999999999999999999999654     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVG  707 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~  707 (869)
                      +..++||||+++++|.+++....      ++++..+..++.|++.||+|||++   +++|+||+|+||+++.++ .++|+
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence            78899999999999999997654      388999999999999999999999   999999999999998776 59999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.+.........    .........|+..|+|||.+.+..++.++||||+||++|++++|+.||........ .....
T Consensus       147 dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~  221 (268)
T cd06630         147 DFGAAARLAAKGTG----AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF  221 (268)
T ss_pred             cccccccccccccc----CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH
Confidence            99999876543210    11122334688999999999888899999999999999999999999864221110 11100


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ... ..                      ......++.....+.+++.+|++.+|++|||+.|+++
T Consensus       222 ~~~-~~----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 KIA-SA----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHh-cc----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000 00                      0011112234567889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-35  Score=312.26  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++|||++++++++...     +..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence            36899999999999999999999888999999998755555567789999999999999999999987543     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||+++++|.+++....       +++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        93 lv~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             EEEecCCCCcHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            9999999999999997643       78899999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......|++.|+|||.+.+..++.++|||||||++|++++|+.||......... ...   ...
T Consensus       163 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~---~~~  230 (293)
T cd06647         163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLI---ATN  230 (293)
T ss_pred             ecccccc--------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eeh---hcC
Confidence            7554322        1122345888999999998888999999999999999999999999653211100 000   000


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..                      .........+..+.+++.+||+.+|++||++.|++..
T Consensus       231 ~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GT----------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CC----------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                      0000112344568899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=307.51  Aligned_cols=255  Identities=26%  Similarity=0.459  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|.+. +++.||||.+..... ..+.+.+|+.++++++|+||+++++++..     ....+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence            468999999999999999999986 668899999864332 34678999999999999999999998654     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence            99999999999999977542    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||.+.+..++.++||||+||++|++++ |+.||...... .......... 
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~-  221 (261)
T cd05034         151 RLIEDDEY-------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGY-  221 (261)
T ss_pred             eeccchhh-------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCC-
Confidence            86653211       11112234678999999998889999999999999999998 99998643211 1111110000 


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                          .                      ...+...+..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus       222 ----~----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ----R----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----C----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                0                      00011234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.5e-35  Score=303.83  Aligned_cols=249  Identities=22%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|+..+.||+|++|.||+|....+++.+|+|.+...  .......+.+|+++++.++|||++++++++..     ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence            588899999999999999999989999999998643  23345778999999999999999999988543     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  711 (869)
                      +||||+++++|.+++.....    ..+++..+..++.|+++|++|||++   +++|+||+|+||+++.++ .+||+|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999987542    2489999999999999999999999   999999999999998654 689999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     .......
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~  214 (256)
T cd08220         149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIM  214 (256)
T ss_pred             ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHH
Confidence            98764432         122346889999999999888999999999999999999999998643211     1111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......                       .+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       215 ~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         215 SGTFAP-----------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             hcCCCC-----------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            000000                       01123456789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.9e-36  Score=337.24  Aligned_cols=267  Identities=22%  Similarity=0.352  Sum_probs=201.7

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-----
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSID-----  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  624 (869)
                      .-..+|+..+.||+||||.||+|+.+-+|+.||||++... .......+.+|+..+++++|||||+++..|.+..     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4456888899999999999999999999999999999644 3445577899999999999999999985432110     


Q ss_pred             ------------------------------------------------c-------------------------------
Q 002897          625 ------------------------------------------------F-------------------------------  625 (869)
Q Consensus       625 ------------------------------------------------~-------------------------------  625 (869)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             -CC-----------------------------CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHH
Q 002897          626 -NG-----------------------------VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI  675 (869)
Q Consensus       626 -~~-----------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L  675 (869)
                       ++                             ....||-||||+.-++.++++++.-.     -.....++++++|++||
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence             00                             02357899999998888888776521     14678899999999999


Q ss_pred             HHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCC---------CCCC-CccccCCCCCCccCcccccCCccc
Q 002897          676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA---------RPLD-TVVETPSSSSGIKGTVGYIAPEYG  745 (869)
Q Consensus       676 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---------~~~~-~~~~~~~~~~~~~gt~~y~aPE~~  745 (869)
                      +|+|++   |||||||||.||+++++..|||+|||+|.....         .... .........+..+||.-|+|||++
T Consensus       711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999999   999999999999999999999999999987320         0000 111122345678899999999998


Q ss_pred             CCCC---CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchH
Q 002897          746 TGSE---ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI  822 (869)
Q Consensus       746 ~~~~---~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~  822 (869)
                      .+..   |+.|+|+||+|+|++||+.   ||....+....+.......+|.. .+..+++.                   
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~-------------------  844 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEH-------------------  844 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccc-------------------
Confidence            7654   9999999999999999995   57654444334444443333333 22233222                   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          823 EECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       823 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                          +.-.++|++|++.||.+||||.|++.
T Consensus       845 ----~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  845 ----PEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ----hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence                22348999999999999999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-35  Score=308.90  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|+..+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence            36788899999999999999999899999999986543 34456788999999999999999999986543     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      +|+||+++++|.+++.....     .+++..+..++.|+++|++|||+ .   +++|+||||+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             EEEEecCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999987532     48999999999999999999999 8   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......          .....++..|+|||...+..++.++||||||+++|+|++|+.||..............+...
T Consensus       148 ~~~~~~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  217 (265)
T cd06605         148 SGQLVNSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV  217 (265)
T ss_pred             chhhHHHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence            87553221          11155788999999999889999999999999999999999999754322122222111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....     +.                 ......+..+.+++.+||..+|++|||+.|++..
T Consensus       218 ~~~~-----~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 NEPP-----PR-----------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cCCC-----CC-----------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1000     00                 0001145668899999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.3e-35  Score=306.23  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=201.5

Q ss_pred             CCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC-Cc
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG-VD  629 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~  629 (869)
                      |.+.+.||+|+||.||+|.+..   +++.||||++...  .....+++.+|++++++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5678899999999999998643   5789999998643  2334567889999999999999999999876532111 12


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++++||+++|+|.+++...........+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3578999999999999876443221223478999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++........      .......++..|++||...+..++.++|||||||++|+|++ |+.||......     ....
T Consensus       158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~  226 (273)
T cd05074         158 GLSKKIYSGDYY------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN  226 (273)
T ss_pred             cccccccCCcce------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHH
Confidence            999865432210      11122345678999999988889999999999999999999 88888643211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ........                       .....++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       227 ~~~~~~~~-----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 YLIKGNRL-----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHcCCcC-----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11000000                       00012345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-35  Score=302.31  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=196.3

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ++||+|+||.||+|.+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence            479999999999999976 999999998654333 456789999999999999999999986543     6789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++.....     .+++..+..++.+++.|++|||++   +++||||||+||+++.++.++|+|||.+......
T Consensus        75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999999976543     378999999999999999999999   9999999999999999999999999999765422


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVME  797 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  797 (869)
                      ...      .......++..|+|||.+.++.++.++|||||||++|+|++ |..||......  ..........     .
T Consensus       147 ~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~-----~  213 (251)
T cd05041         147 IYT------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY-----R  213 (251)
T ss_pred             cce------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC-----C
Confidence            110      11112234567999999988889999999999999999999 88888643211  1111110000     0


Q ss_pred             ccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       798 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                                           ...+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       214 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 ---------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                                 0011134557889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-35  Score=310.39  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ++|++.+.||+|+||.||+|+.+.     +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+.    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA----   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence            578899999999999999999753     3567999988654433 457789999999999999999999986543    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKL---EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                       ...++||||+++|+|.+++.......   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence             67899999999999999998655211   012489999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTL  783 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~  783 (869)
                      +++|||.+........       .......++..|+|||.+.+..++.++||||||+++|++++ |..||......    
T Consensus       157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----  225 (275)
T cd05046         157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----  225 (275)
T ss_pred             EEcccccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----
Confidence            9999999875432211       12223456788999999988888999999999999999999 78888642211    


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                       .............                      .....++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       226 -~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         226 -EVLNRLQAGKLEL----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -HHHHHHHcCCcCC----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             1111110000000                      001124457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-35  Score=304.13  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|++.+.||+|+||.||+|.+. +++.+|+|.+..... ....+.+|++++++++||+++++++++...     ...++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEE
Confidence            47888999999999999999985 578899998864322 235788999999999999999999986543     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++.....     .++++.+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+.
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence            9999999999999976543     378999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......++.+|+|||+..++.++.++||||||+++||+++ |+.||......     ........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~  216 (256)
T cd05112         149 FVLDDQY-------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINA  216 (256)
T ss_pred             ecccCcc-------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhC
Confidence            6543221       11122335678999999998889999999999999999998 99998642211     11111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      . . ....+                     ...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       217 ~-~-~~~~~---------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         217 G-F-RLYKP---------------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             C-C-CCCCC---------------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0 0 00000                     01235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.3e-35  Score=311.67  Aligned_cols=279  Identities=22%  Similarity=0.323  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++|+||+++.+++..     ...
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence            4578999999999999999999998899999999986443 2233467889999999999999999998654     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+. +++.+++.....     .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            899999995 688877765432     378888999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .++......        .......++..|+|||++.+. .++.++|||||||++|+|++|+.||+........+......
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  220 (291)
T cd07870         149 LARAKSIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV  220 (291)
T ss_pred             cccccCCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            987543221        112233568899999998754 47889999999999999999999997543221111111100


Q ss_pred             h-cccc-cc-ccc-CccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 V-LPEK-VM-EIV-DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~-~~~~-~~-~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      . .+.. .. ... -+..................+........+.+++.+|+..||++|||+.|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0 0000 00 000 00000000000000000000000012356779999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-34  Score=303.25  Aligned_cols=254  Identities=23%  Similarity=0.428  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|++++++++|+||+++.+++..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            467899999999999999999875 66779999886432 234678899999999999999999988643      4578


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            99999999999999976432    2478899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||++.+..++.++|||||||++|++++ |+.||......  ..........
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~  220 (260)
T cd05073         150 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY  220 (260)
T ss_pred             eeccCCCc-------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC
Confidence            76543211       11122345678999999998889999999999999999999 89998643211  1111110000


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                         .                       .+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 ---~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ---R-----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---C-----------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               0                       00011334568899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.1e-35  Score=307.51  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=196.6

Q ss_pred             CeeeeecceEEEEEEECCCC------eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          560 NMVGQGSFGTVFKGIIGENG------MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +.||+|+||.||+|++....      +.+|+|.+.... ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence            46899999999999986433      689999885432 23456788999999999999999999987543     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-----cEEE
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-----VAHV  706 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl  706 (869)
                      +||||+++++|.+++....... ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997643221 123478999999999999999999999   999999999999999887     8999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~  785 (869)
                      +|||++.........      .......++..|+|||++.++.++.++|||||||++|||++ |+.||......     .
T Consensus       153 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~  221 (269)
T cd05044         153 GDFGLARDIYKSDYY------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----E  221 (269)
T ss_pred             CCccccccccccccc------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----H
Confidence            999999765432210      11223345788999999999999999999999999999998 99998642211     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      .........                       ........+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         222 VLQHVTAGG-----------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHhcCC-----------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111110000                       00111234567889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-35  Score=313.00  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=198.4

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      |.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++..     .+..++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            3345689999999999999988999999999976554555778899999999999999999998654     37789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++++|.+++...       .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999999999988653       288999999999999999999999   9999999999999999999999999998755


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ....        .......|+..|+|||++.+..++.++|||||||++|||++|+.||.....    .... ....... 
T Consensus       168 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~-~~~~~~~-  233 (297)
T cd06659         168 SKDV--------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAM-KRLRDSP-  233 (297)
T ss_pred             cccc--------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH-HHHhccC-
Confidence            4321        112235688999999999888899999999999999999999999864211    1111 1110000 


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                          .+..                ......+..+.+++.+||+.+|++||+++|+++.
T Consensus       234 ----~~~~----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 ----PPKL----------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ----CCCc----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                0000                0001223457799999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-34  Score=302.51  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|+..+.||+|++|.||+|....+++.||+|.+....     ++..+.+.+|+++++.++|+||+++++++...     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence            4778899999999999999998899999999986533     23457789999999999999999999986543     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++|+||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            7899999999999999997654      378999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+.......         ......|+..|+|||.+.... ++.++|+|||||++|++++|+.||.....    ......
T Consensus       147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~  213 (258)
T cd06632         147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFK  213 (258)
T ss_pred             ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHH
Confidence            9987654322         123345889999999987766 89999999999999999999999875321    111100


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......                       ...+......+.+++.+||+.+|++||++.|++.
T Consensus       214 ~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         214 IGRSKEL-----------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHhcccC-----------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0000000                       0001123456778999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.8e-35  Score=313.16  Aligned_cols=204  Identities=21%  Similarity=0.306  Sum_probs=163.5

Q ss_pred             CCeeeeecceEEEEEEECC--CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          559 SNMVGQGSFGTVFKGIIGE--NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      ..+||+|+||+||+|+...  ++..||+|.++...  ....+.+|++++++++||||+++++++...   .....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence            3689999999999999753  56889999886432  235678899999999999999999987542   3467899999


Q ss_pred             cccCCCHHHHHhhCCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEccc
Q 002897          637 FMQNGSLEEWLHQNNDK---LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDF  709 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df  709 (869)
                      |+++ +|.+++......   .....+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9865 888887643211   1123488999999999999999999999   99999999999999    56679999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      |+++.......     .........||+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus       157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcc-----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99987644321     11222345689999999998764 5799999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-34  Score=303.95  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+.++++++|+|++++++++...     ...+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence            368889999999999999999998899999999875543 4457889999999999999999999997543     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      +||||+++++|.+++....      .+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence            9999999999999998753      38999999999999999999999 8   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......        .......++..|+|||...+..++.++||||||+++|+|++|+.||......  ...+......
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~  216 (264)
T cd06623         147 SKVLENTL--------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAIC  216 (264)
T ss_pred             ceecccCC--------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHh
Confidence            98664432        1112345788999999999888999999999999999999999999754321  1111111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEE-CLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....                       ..... ++..+.+++.+||+.+|++|||+.|+++.
T Consensus       217 ~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 DGPPP-----------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCCCC-----------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000                       00011 45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-35  Score=311.23  Aligned_cols=274  Identities=21%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|+..+.||.|++|.||+|++..+|+.||||+++...  ......+.+|++++++++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence            4788999999999999999999899999999986432  2234578899999999999999999998643     47889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+. ++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999996 689998876432    2489999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .......        .......++..|+|||+..+.. ++.++|||||||++|+|+||+.||....... ...+..+...
T Consensus       148 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~  218 (284)
T cd07860         148 RAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLG  218 (284)
T ss_pred             hhcccCc--------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhC
Confidence            7654321        1122234688999999876644 6889999999999999999999996532211 1111111110


Q ss_pred             ccccccccCccch--hhhhhcc-cccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLL--LEVRANN-SMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  .....+...  ....... ...........+.....+.+++.+||+.||++|||++|+++
T Consensus       219 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         219 TP--DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CC--ChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00  000000000  0000000 00000000001123456779999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-35  Score=314.98  Aligned_cols=276  Identities=24%  Similarity=0.324  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.++||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++..     ....
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence            36889999999999999999998889999999885432  2234668899999999999999999998643     4789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++++++.++.....      .+++..+..++.|+++|++|||+.   +++|||++|+||++++++.++|+|||.
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence            99999999999988776543      289999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh-
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM-  789 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~-  789 (869)
                      +.......        .......++..|+|||+..+. .++.++|||||||++|||++|++||...... ......... 
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~  217 (286)
T cd07846         147 ARTLAAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCL  217 (286)
T ss_pred             eeeccCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHh
Confidence            87654322        112234578999999988753 4788999999999999999999998643211 000000000 


Q ss_pred             -hcccccccccCccchhhhhhccc-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 -VLPEKVMEIVDPSLLLEVRANNS-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 -~~~~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ..........+............ ..........+..+..+.+++.+||+.+|++||++.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             00000000001000000000000 0000000111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-35  Score=319.71  Aligned_cols=287  Identities=22%  Similarity=0.260  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..+|.+.+.||+|+||+||+|++..+++.||||.++..  .......+.+|+.+++.++|+||+++++++.....+....
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999999999999998643  2333456788999999999999999999876543333356


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+. ++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            899999995 68999887653      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh--
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS--  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~--  787 (869)
                      ++.......        .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .......  
T Consensus       154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~  224 (337)
T cd07858         154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITEL  224 (337)
T ss_pred             cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHH
Confidence            998654321        11223457889999998765 46889999999999999999999999653211 0000000  


Q ss_pred             -hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 002897          788 -KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK--LCAAR  858 (869)
Q Consensus       788 -~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  858 (869)
                       ....+.......+......................+.++..+.+++.+||+.+|++|||++|+++.  ++.+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence             000111111111111111111000000001111122456778899999999999999999999986  55543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=310.86  Aligned_cols=276  Identities=20%  Similarity=0.303  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++..     .+..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeEE
Confidence            679999999999999999999988999999999864332 223456789999999999999999999654     37899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++ +|.+++.....     .+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        80 lv~e~~~~-~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence            99999975 99999876543     388999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +......        .......++..|+|||++.+ ..++.++||||+||++|+|++|+.||..............+...
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~  222 (291)
T cd07844         151 RAKSVPS--------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG  222 (291)
T ss_pred             cccCCCC--------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcC
Confidence            7543211        11122346889999998865 45789999999999999999999999653311111111111000


Q ss_pred             ---ccccccccCccchhhhhhcccccCCCccchHHHH--HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 ---PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEEC--LVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                         +.......+......... ...............  ...+.+++.+|++.+|++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         223 TPTEETWPGVSSNPEFKPYSF-PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CCChhhhhhhhhccccccccc-cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000000000000000000 000000000000011  256779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-34  Score=307.71  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=193.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHH-HHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEA-LRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++... ......+..|+.+ ++..+||||+++++++...     ...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence            46889999999999999999999899999999986542 2233455566665 5667899999999997643     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++ |+|.+++......  ...+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||.
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999996 6898888653321  135899999999999999999999853  899999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC----CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG----SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      +.......         ......|+..|+|||.+.+    ..++.++|||||||++|+|++|+.||......   .....
T Consensus       151 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~  218 (283)
T cd06617         151 SGYLVDSV---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLK  218 (283)
T ss_pred             cccccccc---------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHH
Confidence            87653321         1122457889999998765    34688999999999999999999998642211   11111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ... ..     ..+..                 ....++..+.+++.+||..+|++||++.|+++
T Consensus       219 ~~~-~~-----~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 QVV-EE-----PSPQL-----------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHH-hc-----CCCCC-----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110 00     00000                 01124456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.9e-35  Score=305.92  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=187.8

Q ss_pred             CeeeeecceEEEEEEEC--CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|...  .....+|+|.+.... ......+.+|+++++.++||||+++++++...     ...++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence            36899999999999753  244578889875432 33346678999999999999999999987543     67899999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++....... ....++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||.+....
T Consensus        76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence            999999999998764321 12256788899999999999999999   99999999999999999999999999986543


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCC-------CCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-------SEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      .....      .......++..|+|||+...       ..++.++|||||||++|||++ |..||....... .....  
T Consensus       152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~--  222 (269)
T cd05042         152 PEDYY------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQV--  222 (269)
T ss_pred             cchhe------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHH--
Confidence            22100      11123345778999998642       356889999999999999999 788886432111 11111  


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                        .........++..                  ...++..+.+++..|| .||++|||++||++.|.
T Consensus       223 --~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         223 --VREQDIKLPKPQL------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             --hhccCccCCCCcc------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence              1111111111110                  1123455677888898 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=314.06  Aligned_cols=260  Identities=27%  Similarity=0.354  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .+|+..+.||+|++|+||+|.+..+++.||+|.+.....   ...+.+..|+++++.++||||+++++++..     ...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence            368889999999999999999988899999999965432   245678899999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++.....    ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence            8999999999999999876432    2489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc---------------------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC
Q 002897          711 LAKFLPARPLDTVV---------------------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR  769 (869)
Q Consensus       711 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg  769 (869)
                      .+............                     ..........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98765432211000                     000112235689999999999988899999999999999999999


Q ss_pred             CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC---
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ---  846 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---  846 (869)
                      +.||......    ..+.... ....                      ........+..+.+++.+||+.||++|||   
T Consensus       229 ~~pf~~~~~~----~~~~~~~-~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~  281 (316)
T cd05574         229 TTPFKGSNRD----ETFSNIL-KKEV----------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR  281 (316)
T ss_pred             CCCCCCCchH----HHHHHHh-cCCc----------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence            9999643221    1111100 0000                      00000114567889999999999999999   


Q ss_pred             -HHHHHH
Q 002897          847 -MRDVVV  852 (869)
Q Consensus       847 -~~evl~  852 (869)
                       ++|+++
T Consensus       282 ~~~~ll~  288 (316)
T cd05574         282 GAAEIKQ  288 (316)
T ss_pred             hHHHHHc
Confidence             777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.9e-34  Score=302.24  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++....  ...+.+..|+++++.++|+||+++++++..     .+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence            58889999999999999999988999999999975544  356788999999999999999999998644     37789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||+++++|.+++....      .+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999998654      278899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC---CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE---ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ..........    ........++..|+|||++.+..   ++.++||||||+++|++++|+.||....... ........
T Consensus       147 ~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~  221 (264)
T cd06626         147 VKLKNNTTTM----GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA  221 (264)
T ss_pred             cccCCCCCcc----cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc
Confidence            8765433111    01022345788999999988766   8899999999999999999999996432111 11000000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                         .     ..+.                .+....+...+.+++.+||+.+|++|||+.|++.
T Consensus       222 ---~-----~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 ---G-----HKPP----------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---C-----CCCC----------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               0     0000                0001123456779999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-34  Score=305.57  Aligned_cols=255  Identities=22%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc----------hhhHHHHHHHHHHHhCCCCccceEEEEeeccc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK----------GALKSFLTECEALRSIRHRNLIKIITICSSID  624 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  624 (869)
                      +|...+.||+|++|.||+|....+|+.||+|.++....          ...+.+..|+.+++.++|||++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            47788999999999999999988999999998853211          123467889999999999999999998654  


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                         ....++||||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          80 ---EEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             ---CCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence               377899999999999999997753      388999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      +++|||.+........      ........|+..|+|||......  ++.++||||||+++|++++|..||.....    
T Consensus       148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----  217 (272)
T cd06629         148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----  217 (272)
T ss_pred             EEeecccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----
Confidence            9999999976543211      01122345789999999987654  78999999999999999999999863211    


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ........ .......++..                  ...+++..+.+++.+||..+|++|||++||++
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         218 IAAMFKLG-NKRSAPPIPPD------------------VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHHHhh-ccccCCcCCcc------------------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111100 00000001100                  01134567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=316.58  Aligned_cols=288  Identities=22%  Similarity=0.273  Sum_probs=210.3

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  633 (869)
                      +...+.||+|+||.||+++++.+|+.||||.++... ....+...+|++++++++|||||+++++-.+.. .--.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445678999999999999999999999999997533 334577789999999999999999999744321 011356789


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC--cEEEccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDM--VAHVGDF  709 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Df  709 (869)
                      |||||.+|||..++.+...   ...+++.+.+.+..+++.||.|||++   |||||||||.||++-  .+|  ..||+||
T Consensus        95 vmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            9999999999999987553   34699999999999999999999999   999999999999983  334  5899999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh-
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS-  787 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~-  787 (869)
                      |.|+.++++.         .....+||..|.+||.+.. +.|+..+|.|||||++|+++||..||..........+-.. 
T Consensus       169 G~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  169 GAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             cccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            9999887653         3455789999999999984 7889999999999999999999999976433221111111 


Q ss_pred             -hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHHh
Q 002897          788 -KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM--QMRDVVVKLCAAREA  860 (869)
Q Consensus       788 -~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~  860 (869)
                       ....+.......+++..+..........  ...........+..++..++.++|++|-  ...+..+.+..|...
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence             1111122222222222211111111111  0111122334567788889999999999  777777777766543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-34  Score=305.51  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=199.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .|...++||+|++|.||+|.+..+++.+|+|+++.......+.+.+|+.+++.++||||+++++++..     .+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            45556899999999999999988999999999876555555678899999999999999999998654     3778999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      +||+++++|.+++...       .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+..
T Consensus        95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            9999999999998773       288999999999999999999999   999999999999999999999999998875


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .....        .......|+..|+|||...+..++.++|||||||++|+|++|+.||.....    . ..........
T Consensus       165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~-~~~~~~~~~~  231 (285)
T cd06648         165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----L-QAMKRIRDNL  231 (285)
T ss_pred             hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----H-HHHHHHHhcC
Confidence            43321        112234588999999999888899999999999999999999999864211    1 1111110000


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                           .+..                .....++..+.+++.+||+.+|++|||+.|+++
T Consensus       232 -----~~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 -----PPKL----------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -----CCCC----------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                 0000                000123456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-34  Score=302.23  Aligned_cols=261  Identities=22%  Similarity=0.315  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence            47899999999999999999998899999999986432 2355788999999999999999999998654     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            99999999999999976432   11389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ..+.......    ........|+..|+|||++... .++.++|||||||++|+|++|+.||....... ......... 
T Consensus       150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-  223 (267)
T cd06610         150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-  223 (267)
T ss_pred             HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-
Confidence            8765543211    0122344688999999998776 78999999999999999999999997532211 111111100 


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                              .+...             ........+..+.+++.+||+.||++|||++|+++
T Consensus       224 --------~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 --------PPSLE-------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --------CCCcC-------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    00000             00001234567889999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-34  Score=306.24  Aligned_cols=274  Identities=20%  Similarity=0.255  Sum_probs=202.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            5888999999999999999998899999999987543  3345678999999999999999999998754     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+ +++|.+++.....     ++++.+++.++.||++||+|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 9999999876543     489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......|+..|+|||.+.+. .++.++||||+||++|||++|.+||...... ...........
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~  218 (286)
T cd07832         147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG  218 (286)
T ss_pred             ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence            86644321       112334689999999988654 4689999999999999999998887643211 11111111100


Q ss_pred             cc---ccccccCccchhhhhhcccccCCCc--cchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PE---KVMEIVDPSLLLEVRANNSMSRGGE--RVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~---~~~~~~d~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..   ...+..+..-....   ........  ....++....+.+++.+|++.+|++|||++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         219 TPNEETWPGLTSLPDYNKI---TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCChHHHhhccCcchhhcc---cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00   00000000000000   00000000  00111334778899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-34  Score=303.63  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      -|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...     ...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence            4778899999999999999998899999999986432 33456788999999999999999999987543     77899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            99999999999998653       388999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......        .......++..|+|||...+..++.++|||||||++|+|++|..||......     .........
T Consensus       150 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~  216 (277)
T cd06641         150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKN  216 (277)
T ss_pred             ecccch--------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcC
Confidence            654321        1122345788999999998888899999999999999999999998642211     111111000


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .. .                      .....++..+.+++.+||+.+|++||++.|+++.
T Consensus       217 ~~-~----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NP-P----------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CC-C----------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00 0                      0011234567899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-34  Score=307.95  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..     ...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence            36889999999999999999999999999999986543   2334677899999999999999999998654     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence            899999999999999997654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc-------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          711 LAKFLPARPLDTVV-------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       711 ~a~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      .++...........       ..........|+..|+|||.+.+..++.++|||||||++||+++|+.||.....     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----  221 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----  221 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            98742211100000       000111234578899999999888899999999999999999999999864221     


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .++.........   ..+.                  .....+..+.+++.+||+.||++||++.++.+.++.
T Consensus       222 ~~~~~~~~~~~~---~~~~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         222 EELFGQVISDDI---EWPE------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHHhccc---CCCC------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111110000   0000                  001234567899999999999999996555555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=343.47  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=206.6

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..+-+++...+||.|.||.||.|....+|...|+|.+....  ....+...+|..++..++|||+|+++|+-.+.     
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR----- 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR----- 1306 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----
Confidence            34457788899999999999999999999999999886433  33456778999999999999999999985543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..+|.||||++|+|.+.+...+.      .++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence            778999999999999999988763      56667778899999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC---CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE---ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      ||.|..+.....    ..+.......||+.|||||++.+..   ...++||||+|||+.||+||+.||.....+....-.
T Consensus      1378 FGsa~ki~~~~~----~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQ----TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred             ccceeEecCchh----cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence            999998876521    1123345678999999999987754   466899999999999999999999764433222211


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......                           +..++....+-.+++..|+..||++|.++.|+++
T Consensus      1454 V~~gh~---------------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAGHK---------------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HhccCC---------------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            111111                           1122234556678999999999999999988765

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-34  Score=300.46  Aligned_cols=252  Identities=30%  Similarity=0.516  Sum_probs=200.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCCC----eEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +++.+.||+|+||.||+|.+...+    ..||+|++...... ..+.+..|+++++.++|+||+++++++...     +.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            457789999999999999998665    89999999654433 567889999999999999999999987653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++|||+++++|.+++......    .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            89999999999999999865421    289999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.........       ......++..|+|||...+..++.++||||+|+++|+|++ |..||....     .......
T Consensus       149 ~~~~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~  216 (258)
T smart00219      149 LSRDLYDDDYY-------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEY  216 (258)
T ss_pred             Cceeccccccc-------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH
Confidence            99876544211       1112236789999999988889999999999999999998 788876421     1111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ......                       ......++.++.+++.+|++.+|++|||+.|+++.|
T Consensus       217 ~~~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 LKKGYR-----------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HhcCCC-----------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            110000                       001112456788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-34  Score=300.06  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=186.6

Q ss_pred             CeeeeecceEEEEEEECCC--CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGEN--GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.||+|+||.||+|....+  ...+++|.+.... ....+.+.+|+.+++.++||||+++++++...     ...++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence            3699999999999976422  3356677765433 33457889999999999999999999987643     67899999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      |+++|+|.+++......  ....++..+..++.||++||+|||+.   +++||||||+||+++.++.++|+|||.+....
T Consensus        76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence            99999999999865322  12367778889999999999999999   99999999999999999999999999986432


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCC-------CCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-------SEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      ...      .........++..|+|||+...       ..++.++|||||||++|||++ |..||.....     .+...
T Consensus       151 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~  219 (268)
T cd05086         151 KED------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLN  219 (268)
T ss_pred             cch------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            211      0011233457889999998743       245789999999999999997 5667754221     11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ....+......++.+..                  .....+.+++..|| .+|++||+++||++.|.
T Consensus       220 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         220 HVIKDQQVKLFKPQLEL------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHhhcccccCCCccCC------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111111222222111                  12345778899999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=308.00  Aligned_cols=272  Identities=22%  Similarity=0.338  Sum_probs=198.0

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.+.||.|++|.||+|.+..+|..||+|++....  ....+.+.+|+++++.++|||++++++++.+     .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence            678899999999999999998899999999986433  2334668899999999999999999999654     378999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      +|||++ ++|.+++.....    ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||.+.
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999995 699999876552    2389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh-c
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV-L  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~  791 (869)
                      ......        .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .....+.. .
T Consensus       148 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~  218 (283)
T cd07835         148 AFGVPV--------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGT  218 (283)
T ss_pred             ccCCCc--------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence            553321        111223468899999987664 578899999999999999999999865322111 11111110 0


Q ss_pred             ccc-cc-c-ccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEK-VM-E-IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~-~~-~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +.. .. . ...+.....+..   ..........+..+..+.+++.+|++.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFPK---WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CChHHhhhhhhchhhhhhccc---ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000 00 0 000000000000   0000000111123457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-34  Score=315.94  Aligned_cols=280  Identities=19%  Similarity=0.213  Sum_probs=203.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.++++++||||+++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998532  2334466788999999999999999999875432 2334


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+. ++|.+++...        +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            56899999995 4888887542        78889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.++......         ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........
T Consensus       162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~  231 (353)
T cd07850         162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE  231 (353)
T ss_pred             CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            99998654321         122345788999999999989999999999999999999999999643211 01111110


Q ss_pred             hhc--ccccccccCccchhhhhhcccc-------------cCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVL--PEKVMEIVDPSLLLEVRANNSM-------------SRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~--~~~~~~~~d~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...  +..+.+..++............             ............+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000  0001111111000000000000             0000000011345667899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-34  Score=302.14  Aligned_cols=238  Identities=25%  Similarity=0.448  Sum_probs=188.6

Q ss_pred             CeeeeecceEEEEEEECCCC----------eEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          560 NMVGQGSFGTVFKGIIGENG----------MLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +.||+|+||.||+|.+..++          ..|++|++...... ...+.+|+.++++++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999997666          35888887644433 5788999999999999999999998754      3


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-------
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-------  702 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------  702 (869)
                      ..++||||+++|+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence            46899999999999999987653     389999999999999999999999   999999999999999888       


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHc-CCCCCCcCccC
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFS-RRRPTDSMFHE  779 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~t-g~~pf~~~~~~  779 (869)
                      .+||+|||.+......            ....++..|+|||++.+.  .++.++|||||||++|++++ |..||......
T Consensus       146 ~~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~  213 (259)
T cd05037         146 FIKLSDPGIPITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS  213 (259)
T ss_pred             eEEeCCCCcccccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence            7999999999764331            123467789999998876  78999999999999999999 57777543211


Q ss_pred             CchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          780 GLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                        ....+..   ...  ....                       .....+.+++.+||..+|++|||+.||++.|
T Consensus       214 --~~~~~~~---~~~--~~~~-----------------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         214 --EKERFYQ---DQH--RLPM-----------------------PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --hHHHHHh---cCC--CCCC-----------------------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              1111100   000  0000                       0014678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=305.31  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCC---CCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIR---HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++.. .....+.+.+|+.+++.++   |||++++++++..     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            477889999999999999999889999999998643 3344567889999999996   9999999998654     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++...       .+++..++.++.|+++|++|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            89999999999999998654       389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.......        .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||......     .....
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~  213 (277)
T cd06917         147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML  213 (277)
T ss_pred             ceeecCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc
Confidence            998765432        112234588999999988654 4689999999999999999999999643211     11000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...     ...+.+                 .....+.++.+++.+||+.||++||++.|++..
T Consensus       214 ~~~-----~~~~~~-----------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         214 IPK-----SKPPRL-----------------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ccc-----CCCCCC-----------------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000     000000                 000134568899999999999999999999873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.5e-35  Score=314.98  Aligned_cols=284  Identities=23%  Similarity=0.291  Sum_probs=205.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|++|.||+|.+..+|+.||+|++....  ....+.+.+|+.++++++||||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            478999999999999999999999999999999986432  234567788999999999999999998765432 33467


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||++ |+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            899999995 69999987543      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.........    .........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .... ....
T Consensus       153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~-~~~~  226 (334)
T cd07855         153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLK-LILS  226 (334)
T ss_pred             cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHH-HHHH
Confidence            99765443211    1112234568899999998765 45899999999999999999999999653211 0111 1111


Q ss_pred             hccccccccc----CccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIV----DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~----d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......+..    +......................+..+..+.+++.+||+.+|++|||++|++..
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000000000    000000000000000000001112346778999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-34  Score=307.08  Aligned_cols=282  Identities=19%  Similarity=0.258  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+.+++.+. ||||+++++++...+..+...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36889999999999999999999899999999986432  223467888999999995 699999999877653333445


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDF  709 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  709 (869)
                      .++||||+++ ++.+++...... ....+++..++.++.||++||+|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence            8999999985 899888764321 123489999999999999999999999   9999999999999998 889999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+.......        .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ......
T Consensus       156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~  226 (295)
T cd07837         156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFK  226 (295)
T ss_pred             ccceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH
Confidence            9987653321        11122346888999998765 4578999999999999999999999865321111 111111


Q ss_pred             hhc-cc--ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVL-PE--KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~-~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ... +.  ......+........   ...........+..+..+.+++.+||+.||++||++.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         227 LLGTPTEQVWPGVSKLRDWHEFP---QWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HhCCCChhhCcchhhccchhhcC---cccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000 00  000000000000000   00000000111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-34  Score=307.39  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..|+..+.||+|+||+||+|....+|+.||+|++....   ....+.+.+|+++++.++||||+++.+++...     +.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            46889999999999999999998899999999986432   23346788999999999999999999997653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||++ |++.+++.....     .+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            899999996 588777765433     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      .+......            ....++..|+|||++.   ...++.++||||||+++|||++|+.||......    ....
T Consensus       161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~  224 (307)
T cd06607         161 SASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY  224 (307)
T ss_pred             cceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHH
Confidence            98754322            2245788999999874   456889999999999999999999998643211    0000


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                       ......     .+                 ......++..+.+++.+||+.+|++||++.+++..
T Consensus       225 -~~~~~~-----~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         225 -HIAQND-----SP-----------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -HHhcCC-----CC-----------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             000000     00                 00112345678899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=312.47  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             CCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ....+.||+|.||+|++|.|...   ...||||.++..... ....|.+|+.+|.+|+|+|++++||+..+      ...
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~  185 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA  185 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence            34557999999999999999632   246899999755443 67899999999999999999999999654      457


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      .+|||.++.|+|.+.+++...    ..+.......++.|||.||.||.++   ++||||+..+|+++-....|||+|||+
T Consensus       186 mMV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence            899999999999999998332    2488889999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.++.......+     .....-...|+|||.+....++.++|||+|||++|||+| |+.||-+....     ++    
T Consensus       259 mRaLg~ned~Yvm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----qI----  324 (1039)
T KOG0199|consen  259 MRALGENEDMYVM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----QI----  324 (1039)
T ss_pred             eeccCCCCcceEe-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----HH----
Confidence            9998876644322     222334678999999999999999999999999999999 88898653211     11    


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                           .+.+|.              +...+.++.|++++++++..||...|++|||+..+.+.+-.
T Consensus       325 -----L~~iD~--------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  325 -----LKNIDA--------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -----HHhccc--------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                 111121              11223445789999999999999999999999999865543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-34  Score=306.33  Aligned_cols=269  Identities=18%  Similarity=0.264  Sum_probs=190.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecccchhh-----------HHHHHHHHHHHhCCCCccceEEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQKGAL-----------KSFLTECEALRSIRHRNLIKIIT  618 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~  618 (869)
                      .++|.+.++||+|+||+||+|.+..+   +..+|+|+.........           .....+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999999766   66778886543222110           11123334455678999999998


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      ++.... ......++++|++.. ++.+.+....      ..++..+..++.|+++||+|||+.   +|+||||||+||++
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             eeeEec-CCceEEEEEEehhcc-CHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            765431 122355788888744 6777665543      257888999999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      +.++.++|+|||+|+.......... ..........||+.|+|||+..+..++.++|||||||++|||++|+.||.....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999987643221110 001122334699999999999999999999999999999999999999976432


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ............. .   ......                 .....++..+.+++..|++.+|++||+++++.+.+
T Consensus       239 ~~~~~~~~~~~~~-~---~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        239 NGNLIHAAKCDFI-K---RLHEGK-----------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             chHHHHHhHHHHH-H---Hhhhhh-----------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            2211111110000 0   000000                 01113456788999999999999999999998875

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-34  Score=306.83  Aligned_cols=245  Identities=27%  Similarity=0.309  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++..     ...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence            46889999999999999999999899999999986432   2345678899999999999999999998654     377


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            899999999999999998764      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......           .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.....     .......
T Consensus       147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~  210 (290)
T cd05580         147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKI  210 (290)
T ss_pred             CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            98765432           1234588999999999888889999999999999999999999864321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .....                        ..+......+.+++.+||+.||++||     +++|+++
T Consensus       211 ~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         211 LEGKV------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             hcCCc------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            00000                        00011234677999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=283.04  Aligned_cols=268  Identities=19%  Similarity=0.286  Sum_probs=209.1

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccc
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSID  624 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  624 (869)
                      +.++.+-++     +.||+|+|+.|-.+....+|..||||++++.......+..+|++++... .|+||+.+++|+    
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF----  145 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF----  145 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh----
Confidence            455555554     5899999999999999999999999999888777788999999999998 699999999994    


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC--
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM--  702 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--  702 (869)
                       +++...|+|||-|.||+|...+.+..-      +++.++.++..+|+.||.|||.+   ||.|||+||+|||.....  
T Consensus       146 -Edd~~FYLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  146 -EDDTRFYLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             -cccceEEEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence             556889999999999999999988763      89999999999999999999999   999999999999997655  


Q ss_pred             -cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          703 -VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       703 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                       -+|||||.++.-+.....-. ..........+|+..|||||+..     ...|+.++|.||+|||+|-|+.|.+||.+.
T Consensus       216 sPvKiCDfDLgSg~k~~~~~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             CceeeeccccccccccCCCCC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence             58999999887654332211 12223445678999999999742     235899999999999999999999999875


Q ss_pred             ccCCchHHH------hhhhh---cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          777 FHEGLTLHE------FSKMV---LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       777 ~~~~~~~~~------~~~~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      -.++..+.+      .-+..   +.+...+..|                   .....++.+..+++...+..||.+|.++
T Consensus       295 Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd-------------------kdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  295 CGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD-------------------KDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             cCCcCCccCCCccHHHHHHHHHHHhccCCcCCh-------------------hhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence            443222111      00000   1111111111                   1223456677889999999999999999


Q ss_pred             HHHHH
Q 002897          848 RDVVV  852 (869)
Q Consensus       848 ~evl~  852 (869)
                      .+++.
T Consensus       356 ~~vln  360 (463)
T KOG0607|consen  356 AQVLN  360 (463)
T ss_pred             hhccC
Confidence            99887

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-34  Score=304.36  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++.|+..+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|+++++.++|+|++++++++...     ...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence            45678888999999999999999988899999999976544 457788999999999999999999987653     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+||+++++|.+++.....     .+++..+..++.|++.||+|||+.   |++|+|++|+||+++.++.++|+|||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFV-----RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence            999999999999999987641     389999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......        .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......    ..... ..
T Consensus       163 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~-~~  229 (286)
T cd06614         163 AAQLTKEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFL-IT  229 (286)
T ss_pred             hhhhccch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HH
Confidence            87554321        1122345788999999998888999999999999999999999998642111    11000 00


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......                     ......++..+.+++.+||+.+|.+|||+.|+++.
T Consensus       230 ~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         230 TKGIPP---------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             hcCCCC---------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            000000                     00111245678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.5e-34  Score=298.43  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=196.1

Q ss_pred             HHHHHHHhcCCCCCCee--eeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeec
Q 002897          546 YAKLSKATSEFSSSNMV--GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSS  622 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  622 (869)
                      ..+.....++|++.+.+  |+|+||.||++....+++.+|+|++.......     .|+.....+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455556788888877  99999999999999999999999986432211     123333223 79999999998765


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .     +..++||||+++|+|.+++....      ++++.++..++.|+++|++|||+.   +++||||||+||+++.++
T Consensus        81 ~-----~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         81 L-----KGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             C-----CeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence            3     68999999999999999998764      389999999999999999999999   999999999999999998


Q ss_pred             -cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 -VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                       .++|+|||.+......            ....|+..|+|||++.+..++.++||||+||++|+|++|+.||.....+..
T Consensus       147 ~~~~l~dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  214 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL  214 (267)
T ss_pred             CeEEEecCccceecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence             9999999998765332            123578999999999988899999999999999999999999975433322


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-MRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  852 (869)
                      ....+.... ..                        ........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus       215 ~~~~~~~~~-~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        215 DLESLLKRQ-QK------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hHHHHHHhh-cc------------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            222222211 00                        00011134556889999999999999996 588874

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-35  Score=308.74  Aligned_cols=277  Identities=23%  Similarity=0.344  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|++|.||+|.+..+++.||+|+++..  .....+.+.+|++++++++|+||+++++++..     .+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            3688999999999999999999989999999998643  23345778999999999999999999999765     3678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++++.+..+.....      .+++.++..++.|++.|++|||+.   +++|||++|+||++++++.+||+|||.
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence            99999999877766654432      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........       .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .........
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~  218 (288)
T cd07833         147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCL  218 (288)
T ss_pred             ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            987654321       122334678899999999888 78999999999999999999999987432211 000000000


Q ss_pred             --ccccccccc--CccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 --LPEKVMEIV--DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 --~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        .+.......  ++....................+..++..+.+++.+||+.+|++|||++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              000000000  00000000000000000000011123677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.5e-34  Score=308.81  Aligned_cols=280  Identities=19%  Similarity=0.241  Sum_probs=195.5

Q ss_pred             Ceeeee--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQG--SFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ..||+|  +||+||+|.+..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...     +..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence            356666  89999999999899999999986432  33457789999999999999999999997653     6789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+.++++.+++.....    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+...
T Consensus        79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999999999887542    1388999999999999999999999   9999999999999999999999999866433


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ......... .........++..|+|||++.+.  .++.++||||+||++|+|++|+.||....................
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd08226         152 VRNGQKAKV-VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP  230 (328)
T ss_pred             hccCccccc-cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence            221110000 00111122356779999998764  478999999999999999999999975432211111111000000


Q ss_pred             c--------cccccCcc------chhhhhhc----ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 K--------VMEIVDPS------LLLEVRAN----NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~--------~~~~~d~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .        .....+..      ........    ..............+...+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0        00000000      00000000    000000111223456778999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-34  Score=300.51  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+....  ....+.+.+|+++++.++|+||+++++++..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence            4788899999999999999999999999999986532  2334677899999999999999999998654     37889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  711 (869)
                      +|+||+++++|.+++.....    ..+++..+..++.|+++|++|||+.   +++|+||||+||++++++ .+|++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999976442    2378999999999999999999999   999999999999999886 569999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......        .......|+..|+|||+..+..++.++||||||+++|++++|+.||....     ..+......
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~  215 (257)
T cd08225         149 ARQLNDSM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKIC  215 (257)
T ss_pred             chhccCCc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHh
Confidence            97664322        11123458899999999988889999999999999999999999986422     111111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...... .                      ....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       216 ~~~~~~-~----------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         216 QGYFAP-I----------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             cccCCC-C----------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            111100 0                      01233467899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.1e-34  Score=299.83  Aligned_cols=255  Identities=23%  Similarity=0.369  Sum_probs=198.7

Q ss_pred             CCCCCCeeeeecceEEEEEEECC-CCeEEEEEEeecc----------cchhhHHHHHHHHHHHh-CCCCccceEEEEeec
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGE-NGMLVAVKVLNLM----------QKGALKSFLTECEALRS-IRHRNLIKIITICSS  622 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  622 (869)
                      +|++.+.||+|+||.||+|.+.. .++.+|+|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999986 6789999988532          22234567788888875 699999999998654


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~  701 (869)
                           .+..++||||+++++|.+++......  ...+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.+
T Consensus        81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~  150 (269)
T cd08528          81 -----NDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED  150 (269)
T ss_pred             -----CCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence                 37899999999999999988542211  1248999999999999999999996 5   89999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      +.++|+|||.+.......         ......|+..|+|||...+..++.++||||||+++|+|++|+.||.....   
T Consensus       151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---  218 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---  218 (269)
T ss_pred             CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---
Confidence            999999999997654331         12334588999999999988899999999999999999999999864211   


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                        ...............                      .....+..+.+++.+||+.||++||++.||.++++
T Consensus       219 --~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         219 --LSLATKIVEAVYEPL----------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --HHHHHHHhhccCCcC----------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              111111110000000                      00123456789999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-34  Score=302.05  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++.     +....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence            4788899999999999999998899999999996432   234678899999999999999999998854     34789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+||+++++|.+++....      ++++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999997753      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......         ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||......  ..........
T Consensus       147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~  215 (258)
T cd05578         147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE  215 (258)
T ss_pred             ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc
Confidence            87654331         122345788999999998888999999999999999999999999754321  1111111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM--RDVV  851 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  851 (869)
                      .                        .....++..+..+.+++.+||+.||.+||++  +|++
T Consensus       216 ~------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         216 T------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             c------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0                        0001112334678899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=306.71  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ....|.+.+.||+|.|+.|.+|++..++..||+|.+++..-  .....+.+|+++|+.++|||||+++.+...     ..
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence            35679999999999999999999999999999999976542  233558999999999999999999999654     48


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+||||+.+|.+++|+.....      ..+..+..++.|+.+|++|+|++   .|||||||++||+++.+..+||+||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence            89999999999999999998764      56688999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |++..+...         .......|++.|.|||++.+.+| ++++|+||+|+++|.|+.|..||++..-.     ....
T Consensus       200 gfS~~~~~~---------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----~Lr~  265 (596)
T KOG0586|consen  200 GFSTFFDYG---------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----ELRP  265 (596)
T ss_pred             ccceeeccc---------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----cccc
Confidence            999887644         34456789999999999999876 78999999999999999999999853211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .+......-                        +.-...++.+++++++-.+|.+|++++++++.-
T Consensus       266 rvl~gk~rI------------------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  266 RVLRGKYRI------------------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             hheeeeecc------------------------cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            111111100                        001223466899999999999999999998743

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=277.10  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++.+...-||.|.-|+||+++.+.+|...|||.+... .+++.+++...++++.+- ++|+||+.+|||...     ...
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV  166 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV  166 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence            3445667899999999999999999999999999654 456678888888887666 599999999998653     567


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++.||.|.. -+...+++-..     ++++.-+-++...+++||.||.++.  +|+|||+||+|||+|+.|++|+||||+
T Consensus       167 ~IcMelMs~-C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            889998843 45556655443     4888888899999999999999876  999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC---CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS---EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      +..+-+..         ..+...|.+.|||||.+.-.   .|+-++||||||+.++|+.||+.||.....+-..+.....
T Consensus       239 sGrlvdSk---------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  239 SGRLVDSK---------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             cceeeccc---------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence            98765542         23455799999999987654   5889999999999999999999999864433333322222


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..         .|.+.+.                ...+..+.+++..|++.|+.+||...++++
T Consensus       310 ~e---------PP~L~~~----------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 EE---------PPLLPGH----------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cC---------CCCCCcc----------------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11         1111111                124567889999999999999999998876

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-34  Score=306.98  Aligned_cols=279  Identities=22%  Similarity=0.300  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++....  .....+.+|+.++++++|+|++++++++...   ..+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            4689999999999999999999998999999999864332  2234567899999999999999999987542   2256


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++ +|.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPT-----PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            7999999964 89888876542     489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.......        .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus       154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~  224 (309)
T cd07845         154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQL  224 (309)
T ss_pred             eeeecCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence            998664421        11122345788999998865 45789999999999999999999999753221 111111111


Q ss_pred             hcc--cccc-cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLP--EKVM-EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~--~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...  .... ...+......+....... ...........+.+.+++.+|++.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         225 LGTPNESIWPGFSDLPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cCCCChhhchhhhcccccccccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000  0000 000000000000000000 00000011235667899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-35  Score=284.39  Aligned_cols=210  Identities=23%  Similarity=0.339  Sum_probs=175.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC----eEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ...|+.+..||+|.||.||+|..+.+.    ..+|+|.++...  .+......+|+..++.++|||++.+..++...   
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence            346899999999999999999665332    378999996542  23456778999999999999999999987543   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----C
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD----M  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~  702 (869)
                       +...++++||.+. +|.+.++-.+.... ..++...+..|+.||+.|+.|||++   =|+|||+||.||||..+    |
T Consensus       100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen  100 -DKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             -CceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence             4789999999987 99999987665433 4689999999999999999999999   69999999999999888    8


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      .|||+|||+|+.+...-.     .-.....++-|.+|+|||.+.|. .||++.||||.|||+.||+|-++.|.+.
T Consensus       174 ~VKIaDlGlaR~~~~plk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eeEeecccHHHHhhcccc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            999999999998865431     11234567789999999998876 5899999999999999999999988653

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.1e-34  Score=304.15  Aligned_cols=274  Identities=20%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +|++.++||.|++|.||+|++..+|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.     +..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            58889999999999999999998999999999875432 2346678899999999999999999997653     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++ +|.+++.....   ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++|||.+.
T Consensus        76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            9999975 89998876542   12489999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc-
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL-  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-  791 (869)
                      ......        .......++..|+|||++.+. .++.++|||||||++|++++|+.||......+ .......... 
T Consensus       149 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~  219 (284)
T cd07836         149 AFGIPV--------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGT  219 (284)
T ss_pred             hhcCCc--------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence            553321        111233568899999987664 46889999999999999999999997543221 1111111100 


Q ss_pred             --ccccccccCcc-chhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 --PEKVMEIVDPS-LLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 --~~~~~~~~d~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ...+....+.. ......   ...........+..+..+.+++.+|++.||++||+++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         220 PTESTWPGISQLPEYKPTFP---RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CChhhHHHHhcCchhccccc---CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              00000000000 000000   00000000111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6e-34  Score=300.25  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=186.3

Q ss_pred             eeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHh---CCCCccceEEEEeeccccCCCceEEEE
Q 002897          561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRS---IRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .||+|+||.||+|.+..+++.||+|.+....   ......+.+|..+++.   .+||+|+.+.+++...     +..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            4899999999999998899999999986432   1122334455544443   4799999999886543     678999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      |||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++..
T Consensus        76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999987654      389999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .....          .....|+..|+|||...+ ..++.++||||+||++|+|++|..||.......  .......... 
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~-  213 (279)
T cd05633         147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT-  213 (279)
T ss_pred             ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhhc-
Confidence            43221          122458999999998864 558999999999999999999999997532211  1111111100 


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVK  853 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  853 (869)
                           .+                  ...++..+..+.+++.+||+.||++||     |++|+++.
T Consensus       214 -----~~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 -----VN------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -----CC------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                 00                  001123455688999999999999999     59988774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=300.46  Aligned_cols=277  Identities=21%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhC---CCCccceEEEEeeccccCCCce
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSI---RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      |++.+.||+|+||.||+|++..+++.||+|+++...  ......+.+|+.+++++   +|||++++++++...+..+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999998889999999996432  22234566788877666   6999999999987754334445


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++|||+.+ +|.+++.....    ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            8999999974 89998876542    1489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.......         ......++..|+|||++.+..++.++|||||||++|+|++|++||...... .....+....
T Consensus       153 ~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~  222 (287)
T cd07838         153 LARIYSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVI  222 (287)
T ss_pred             cceeccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHc
Confidence            997764331         112234788999999999889999999999999999999999998753221 1122221111


Q ss_pred             cc-cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LP-EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .. .................  ............+....+.+++.+||+.||++||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCChHhcCCCcccchhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00 00000000000000000  00000001112345577889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=297.86  Aligned_cols=254  Identities=19%  Similarity=0.290  Sum_probs=199.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-----QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...     .......+.+|++++++++|+||+++++++.+.   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            4789999999999999999999989999999987532     233456788999999999999999999987543   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++|+||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            56789999999999999997643      278899999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.++.......     .........|+..|+|||++.+..++.++|||||||++|++++|+.||.....    ......
T Consensus       150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~  220 (264)
T cd06653         150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFK  220 (264)
T ss_pred             cccccccccccc-----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHH
Confidence            999986533211     00112234688999999999888899999999999999999999999864311    111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .. .....                      ...+....+.+.+++.+|++ +|..||++.+++.
T Consensus       221 ~~-~~~~~----------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IA-TQPTK----------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HH-cCCCC----------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            10 00000                      01112344568899999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.7e-34  Score=305.31  Aligned_cols=286  Identities=20%  Similarity=0.306  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC---
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN---  626 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  626 (869)
                      ..++|++.++||+|+||.||+|.+..+++.||||.+....  ......+.+|++++++++||||+++++++......   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999899999999986432  22234567899999999999999999998654221   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      .....++||||+++ ++.+++.....     .+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence            23456999999964 88888866532     389999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      +|||.+..........    ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......  ....
T Consensus       161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~  234 (310)
T cd07865         161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLT  234 (310)
T ss_pred             CcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence            9999998664432110    1122334578899999987664 4788999999999999999999998653221  1111


Q ss_pred             hhhhh---cccc-cccccCccchhhhhhccccc-CCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          786 FSKMV---LPEK-VMEIVDPSLLLEVRANNSMS-RGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~---~~~~-~~~~~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....   .+.. .....+.............. ..............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            11111   0000 00000000000000000000 00000000001245678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.5e-34  Score=306.11  Aligned_cols=275  Identities=20%  Similarity=0.268  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.++....  .....+.+|+.++++++||||+++++++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            578999999999999999999998999999999964432  2234567899999999999999999987543   23679


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++ +|.+++.....     .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence            999999974 99999876543     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.......        .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... .........
T Consensus       153 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~  223 (293)
T cd07843         153 AREYGSPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLL  223 (293)
T ss_pred             eeeccCCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            98665432        112234578899999988764 46899999999999999999999997532211 111111100


Q ss_pred             cc---cccccccCccchhhhhhcccccCCC--ccchHHH--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LP---EKVMEIVDPSLLLEVRANNSMSRGG--ERVKIEE--CLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~---~~~~~~~d~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..   ..+....+-.....   ........  .......  ....+.+++.+||+.+|++|||+.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         224 GTPTEKIWPGFSELPGAKK---KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCCchHHHHHhhccchhcc---cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00   00000000000000   00000000  0000011  2556789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.8e-34  Score=296.44  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=203.7

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      +|+..+.||+|++|.||+|.+..+++.+++|++........+.+.+|+++++.++|++++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            478889999999999999999888999999999766555667899999999999999999999986543     778999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      +||+++++|.+++.....     .+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            999999999999987632     389999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      ......         .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......    ..
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~  213 (253)
T cd05122         148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-ALFKIAT----NG  213 (253)
T ss_pred             cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----cC
Confidence            654321         234568899999999988889999999999999999999999987432110 0000000    00


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....+                     ...++..+.+++.+||+.||++|||+.|+++
T Consensus       214 ~~~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 PPGLRN---------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCcCc---------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000                     0112456889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-34  Score=303.12  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ..+||+|+||.||+|....+|+.||+|++..........+.+|+.+++.++|+|++++++++...     +..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecC
Confidence            36899999999999999889999999998655555567789999999999999999999987643     7899999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++....       +++..+..++.|++.|++|||+.   |++||||+|+||+++.++.++|+|||.+......
T Consensus       100 ~~~~L~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657         100 EGGALTDIVTHTR-------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             CCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            9999999886432       78999999999999999999999   9999999999999999999999999998755432


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .        .......|+..|+|||...+..++.++||||+||++|+|++|+.||......  ..........+....  
T Consensus       170 ~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~--  237 (292)
T cd06657         170 V--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK--  237 (292)
T ss_pred             c--------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC--
Confidence            1        1122345789999999998888899999999999999999999998642111  111111111110000  


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                                            .....+..+.+++.+||+.+|.+||++.|+++
T Consensus       238 ----------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 ----------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ----------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                                  00123445778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-34  Score=310.82  Aligned_cols=288  Identities=20%  Similarity=0.246  Sum_probs=209.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|+++++.++||||+++.+++......+....+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999998889999999986543  34457789999999999999999999987664323335789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ ++|.+++....      .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999997 48999987654      389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh-
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV-  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-  790 (869)
                      .........     ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ......... 
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~  224 (330)
T cd07834         151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLG  224 (330)
T ss_pred             Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcC
Confidence            876554210     0122334678899999999887 78999999999999999999999997543211 011111100 


Q ss_pred             --cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 002897          791 --LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK--LCAAR  858 (869)
Q Consensus       791 --~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  858 (869)
                        .+.................................+..+.+++.+||+.+|++|||++|+++.  ++...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence              000000000000000000000000000000112245678899999999999999999999984  44443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.4e-34  Score=303.74  Aligned_cols=274  Identities=20%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|++|+||+|.+..+|+.||+|.+....  ....+.+.+|++++++++||||+++++++..     ....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence            47889999999999999999998899999999986432  2334678899999999999999999999754     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  710 (869)
                      ++||||++ +++.+++.....    ..+++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+||+|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999996 588888765432    1367888999999999999999999   9999999999999985 4579999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.......        .......++..|+|||++.+. .++.++||||+||++|+|+||+.||......+.. ......
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~-~~~~~~  219 (294)
T PLN00009        149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL-FKIFRI  219 (294)
T ss_pred             cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHH
Confidence            997554321        112234578899999987664 5789999999999999999999999753221111 110000


Q ss_pred             h---cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 V---LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~---~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .   ....+....+   ....... ............+..+..+.+++.+|++.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        220 LGTPNEETWPGVTS---LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hCCCChhhcccccc---chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   0000000000   0000000 000000000011123456789999999999999999999986

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-34  Score=313.13  Aligned_cols=282  Identities=22%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc--------
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID--------  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  624 (869)
                      .++|.+.+.||.|+||.||+|.+..+|+.||+|.+........+.+.+|++++++++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999999999999997666566678899999999999999999998765431        


Q ss_pred             -cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CC
Q 002897          625 -FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DM  702 (869)
Q Consensus       625 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~  702 (869)
                       +......++||||++ ++|.+++...       .+++..++.++.||++||.|||+.   +|+||||||+||+++. ++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence             112246789999997 5998888643       288999999999999999999999   9999999999999974 55


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      .+|++|||.++.......     .........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus       153 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  227 (342)
T cd07854         153 VLKIGDFGLARIVDPHYS-----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ  227 (342)
T ss_pred             eEEECCcccceecCCccc-----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            789999999976533211     0111223457889999997654 4678899999999999999999999965322111


Q ss_pred             hHHHhhhhhccc---ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMVLPE---KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ...........   ....... .............+.......+....++.+++.+|++.||++|||+.|++.
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         228 -MQLILESVPVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             -HHHHHHhcCCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             11111000000   0000000 000000000000000000111124466889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-36  Score=280.92  Aligned_cols=285  Identities=22%  Similarity=0.337  Sum_probs=211.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEe--ecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc---cCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID---FNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~  628 (869)
                      +.|....++|+|.||.||+|+.+.+|+.||+|++  .....+......+|++++..++|+|++.++++|....   ..+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4566778999999999999999999999999876  3334445567789999999999999999999887643   2234


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...|+||.+|+. +|...+.....     .++..++.+++.++..||.|+|+.   .|+|||+||.|+||+.+|.+||+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence            458999999987 99999887654     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCc--hHHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL--TLHE  785 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~--~~~~  785 (869)
                      ||+|+.+.....    ........++-|.+|++||.+.|. .|+++.|||+.|||+.||+||.+-+.+..+...  .+..
T Consensus       168 FGlar~fs~~~n----~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  168 FGLARAFSTSKN----VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             cccccceecccc----cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            999987654432    112334566779999999987765 699999999999999999999999876543311  1222


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHH------HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECL------VAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......++.+.++..-.+..........+  +.....++..      ....+++..++..||.+|+++.|++..
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~--~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPK--GQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCc--chhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            22223333333333222322221111000  0001111111      256789999999999999999999864

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-33  Score=304.02  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      |...+.||+|+||.||+|++..++..||+|++....   ......+.+|++++++++|||++++++++...     ...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEE
Confidence            677889999999999999998899999999986432   23345788999999999999999999997653     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ |++.+++.....     ++++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+
T Consensus       102 lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence            9999996 488887765433     389999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ......            ....|+..|+|||++.   .+.++.++|||||||++|+|++|+.||...... .....+...
T Consensus       173 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~  239 (317)
T cd06635         173 SIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN  239 (317)
T ss_pred             cccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhc
Confidence            654321            2235788999999873   456899999999999999999999998642111 001111100


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ..                          ........+..+.+++.+||+.+|++||++.|+++...
T Consensus       240 ~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         240 ES--------------------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             cC--------------------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            00                          00011134456889999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=304.28  Aligned_cols=210  Identities=21%  Similarity=0.354  Sum_probs=172.5

Q ss_pred             CCCCCCeeeeecceEEEEEEECC--CCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGE--NGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|++.++||+|++|.||+|.+..  +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            47888999999999999999987  79999999997532   34456778999999999999999999997643   236


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----CCcEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH----DMVAH  705 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k  705 (869)
                      ..++||||+++ ++.+++....... ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.    ++.+|
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            78999999975 7777765433211 12489999999999999999999999   9999999999999999    89999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      |+|||++.........     ........++..|+|||++.+. .++.++|||||||++|+|++|++||....
T Consensus       153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ECCCccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            9999999866443210     1223345678999999987664 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.7e-34  Score=304.12  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            5666789999999999999999999999999986433 234567889999999995 9999999998654     36788


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      ++|||+.. ++.++....... ....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999864 655543211000 0124899999999999999999999742  8999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC---CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS---EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .......         ......|+..|+|||++.+.   .++.++||||+||++|+|++|+.||....   .......+ 
T Consensus       156 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~-  222 (288)
T cd06616         156 GQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQ-  222 (288)
T ss_pred             HHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhh-
Confidence            7654321         11223578899999998776   68999999999999999999999986432   11111111 


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....     .+.+.              ......++..+.+++.+||+.+|++|||++||++.
T Consensus       223 ~~~~~-----~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         223 VVKGD-----PPILS--------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hcCCC-----CCcCC--------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10000     00000              00001345678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.4e-34  Score=303.69  Aligned_cols=284  Identities=20%  Similarity=0.299  Sum_probs=202.8

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccc----
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSID----  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  624 (869)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|+++...  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999999899999999996533  223356778999999999999999999876542    


Q ss_pred             -cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          625 -FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       625 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                       ..+....++|+||+++ ++.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence             1223478999999976 77777765432     389999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      +||+|||.+........       .......++..|+|||.+.+. .++.++|||||||++|+|++|++||..... ...
T Consensus       155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~  226 (302)
T cd07864         155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ  226 (302)
T ss_pred             EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence            99999999986644321       111223467889999987654 578899999999999999999999974221 111


Q ss_pred             HHHhhhhh---cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMV---LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ........   .+....+................. ..........+..+.+++.+||+.||++|||++|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR-RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHHhCCCChhhcccccccccccccccccccc-cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111   000011110000000000000000 0000111124567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.4e-34  Score=300.53  Aligned_cols=272  Identities=18%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.++||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |+|++++++++.+.   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            677889999999999999999899999999986432 222234457889999885 99999999997643   2257899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||++ |++.+++.....     .+++.+++.++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.+.
T Consensus        78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999996 588888876432     389999999999999999999999   9999999999999999 999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......         ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......+ .... ......
T Consensus       148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~-~~~~~~  216 (282)
T cd07831         148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAK-IHDVLG  216 (282)
T ss_pred             ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHH-HHHHcC
Confidence            654321         1122457889999997644 557889999999999999999999996532211 1111 111100


Q ss_pred             cccc---cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVM---EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~---~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....   ............. ...............+..+.+++.+||+.+|++|||++|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         217 TPDAEVLKKFRKSRHMNYNF-PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCHHHHHhhcccccccccC-cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000   0000000000000 000000000111245678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-33  Score=293.96  Aligned_cols=252  Identities=22%  Similarity=0.384  Sum_probs=204.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|.+..++..||+|++.....  ...+.+.+|+++++.++|||++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            57888999999999999999988899999999975432  4567789999999999999999999986543     7889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||+++++|.+++......  ...+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence            999999999999999875311  12489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......|++.|+|||...+..++.++||||+|+++|+|++|+.||....     ..........
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~  217 (258)
T cd08215         151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILK  217 (258)
T ss_pred             eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhc
Confidence            7654432        11223468889999999988889999999999999999999999986432     1111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....                       .+...+..+.+++.+||..+|++|||+.|+++
T Consensus       218 ~~~~~-----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 GQYPP-----------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            10000                       00123456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-33  Score=303.50  Aligned_cols=270  Identities=19%  Similarity=0.210  Sum_probs=191.7

Q ss_pred             cceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCH
Q 002897          566 SFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSL  643 (869)
Q Consensus       566 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL  643 (869)
                      ++|.||.++...+++.||||++...  .....+.+.+|+++++.++||||+++++++..     .+..+++|||+++|+|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence            4455666666668999999998654  34456789999999999999999999998654     3678999999999999


Q ss_pred             HHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCc
Q 002897          644 EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV  723 (869)
Q Consensus       644 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  723 (869)
                      .+++......    .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.+...........
T Consensus        87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999865321    388999999999999999999999   999999999999999999999999999876543221110


Q ss_pred             cccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCc
Q 002897          724 VETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDP  801 (869)
Q Consensus       724 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  801 (869)
                       ..........++..|+|||++.+.  .++.++|||||||++|||++|+.||............. ....+    ...+.
T Consensus       160 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~----~~~~~  233 (314)
T cd08216         160 -VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVP----CLLDK  233 (314)
T ss_pred             -ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCc----ccccc
Confidence             011122344578899999998763  57899999999999999999999997532221111111 10000    00000


Q ss_pred             cchhhhh----------hcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          802 SLLLEVR----------ANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       802 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......          ...................++.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000000          000000001111223345678899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.1e-34  Score=309.87  Aligned_cols=284  Identities=20%  Similarity=0.280  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++++ +||||+++++++...   +.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence            456899999999999999999999888999999988532  223345677899999999 999999999987542   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||++ ++|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            56899999997 5999998764       278899999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+..........   .........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus       151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~  226 (337)
T cd07852         151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKII  226 (337)
T ss_pred             ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence            99998765432110   0012234568999999998755 457889999999999999999999996532211 111110


Q ss_pred             hhhc--ccccccccCccchhhhhh-cccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVL--PEKVMEIVDPSLLLEVRA-NNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~--~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....  .................. ...............++..+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000  000000000000000000 00000000001111245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-34  Score=301.85  Aligned_cols=276  Identities=20%  Similarity=0.305  Sum_probs=200.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.+.||+|++|.||+|.+..+++.+|+|++....  ......+.+|+++++.++|||++++++++...+   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            677899999999999999999889999999997653  334467889999999999999999999976431   367899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++ +|.+++.....     .+++..++.++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        78 v~e~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eeccccc-cHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999975 89988876532     389999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc-
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL-  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-  791 (869)
                      .......       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......+... 
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~  220 (287)
T cd07840         149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS  220 (287)
T ss_pred             eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            6654321       11223456788999997765 35789999999999999999999999753321 11111111110 


Q ss_pred             --ccccccccCccchhhhhhcccccCCCccchHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 --PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEE-CLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ........+............. .......... ++..+.+++.+||+.+|++||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         221 PTDENWPGVSKLPWFENLKPKKPY-KRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             Cchhhccccccchhhhhccccccc-hhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              0000000000000000000000 0000011112 2667899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.6e-34  Score=308.02  Aligned_cols=277  Identities=22%  Similarity=0.268  Sum_probs=200.7

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+++++.++||||+++.+++...    
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence            45678999999999999999999999999999999987532  223346778999999999999999999987542    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++|+||+ +++|.++++...       +++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.++|+
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence            25688999998 569998886532       78888999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |||.+......           .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+
T Consensus       151 dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~  218 (328)
T cd07856         151 DFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSII  218 (328)
T ss_pred             ccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99998754321           123357889999998765 56899999999999999999999999653211 000001


Q ss_pred             hhhh--cccc-cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMV--LPEK-VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~--~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .+..  .++. .....+......................+..+..+.+++.+|++.+|++|||++|++..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1000  0000 11111111000000000000000000111234678899999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-33  Score=297.60  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=192.4

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||+||+|.+..+|+.||+|++....   ......+..|+++++.++||||+++++++..     .+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence            689999999999999899999999986432   2234566789999999999999999988654     37789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++.....    ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999976542    2489999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                               .......++..|+|||+..+..++.++||||+||++|+|++|+.||...... .............     
T Consensus       149 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-----  213 (277)
T cd05577         149 ---------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM-----  213 (277)
T ss_pred             ---------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc-----
Confidence                     1122345788999999998888999999999999999999999999653221 1111111111000     


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                                         ....+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       214 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 -------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             -------------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                               0001112345678999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=294.03  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=202.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence            57889999999999999999988899999999975543  4567889999999999999999999986543     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++....      .+++..+..++.|++.|+.|||+.   |++||||+|+||+++.++.++|+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence            9999999999999997653      389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ........        ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ........ .
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~  213 (254)
T cd06627         147 TKLNDVSK--------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-Q  213 (254)
T ss_pred             eecCCCcc--------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-c
Confidence            87654321        12334578899999998888889999999999999999999999864321    11111100 0


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ... .                      ..+...+..+.+++.+||..+|++|||+.|++.
T Consensus       214 ~~~-~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 DDH-P----------------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             cCC-C----------------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            000 0                      001123456789999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=331.48  Aligned_cols=441  Identities=27%  Similarity=0.330  Sum_probs=322.5

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++.+++ -||..++. -..++.|++++|-+-...-+.+...-+|+.|||++|++. ..|..+..+.+|+.|+++.|.
T Consensus         3 vd~s~~~l~-~ip~~i~~-~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILN-NEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             cccccccCc-ccchhhcc-HHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            456666666 66666653 233555555555554211122233334555555555555 555555555555555555555


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCC-----------------
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASN-----------------  144 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~-----------------  144 (869)
                      |. ..|.+..++.+|++|.|.+|++. .+|. .+..+.+|+.|+++.|++. ..|..+..++.                 
T Consensus        80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~-~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~  155 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPA-SISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ  155 (1081)
T ss_pred             Hh-hCchhhhhhhcchhheeccchhh-cCch-hHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc
Confidence            55 44555555555555555555554 4552 3455555555555555555 23444444444                 


Q ss_pred             --CcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccc
Q 002897          145 --LELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN  222 (869)
Q Consensus       145 --L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  222 (869)
                        ++.+++..|.+.+....+...++.  .|+|.+|.+...         .+..+.+|+.|.+..|++....   +.+  .
T Consensus       156 ~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~---------dls~~~~l~~l~c~rn~ls~l~---~~g--~  219 (1081)
T KOG0618|consen  156 TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL---------DLSNLANLEVLHCERNQLSELE---ISG--P  219 (1081)
T ss_pred             ccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh---------hhhhccchhhhhhhhcccceEE---ecC--c
Confidence              455555555555555555555555  699999998732         3778899999999999987321   111  2


Q ss_pred             cceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecc
Q 002897          223 TMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE  302 (869)
Q Consensus       223 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  302 (869)
                      +++.|+.++|.+....+  -..-.+|++++++.|+++ .+|++++.+.+|+.|+..+|+++ .+|..+...++|+.|++.
T Consensus       220 ~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~  295 (1081)
T KOG0618|consen  220 SLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA  295 (1081)
T ss_pred             chheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence            49999999999983333  223458999999999998 66799999999999999999996 888899999999999999


Q ss_pred             cccccccCCcCccCccccceeeccCcccCCCCCccccccccc-cceecccCCcccCCCcccccCCccccccccccccccc
Q 002897          303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL-SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG  381 (869)
Q Consensus       303 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  381 (869)
                      .|.+. .+|....++++|+.|+|..|+|. .+|+.++..... +..|+.+.|++.......=.....|+.|++.+|.|++
T Consensus       296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd  373 (1081)
T KOG0618|consen  296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD  373 (1081)
T ss_pred             hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence            99999 78888899999999999999998 788877776665 7788999999984332222345679999999999998


Q ss_pred             cCCccccCCCCCcEEEeeCccccCCCCc-cccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCc
Q 002897          382 DIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGV  460 (869)
Q Consensus       382 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~  460 (869)
                      ..-..+.++..|+.|+|++|+|. ++|+ .+.+++.|+.|+||+|+|+ .+|..+.++..|++|...+|++... |....
T Consensus       374 ~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-Pe~~~  450 (1081)
T KOG0618|consen  374 SCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-PELAQ  450 (1081)
T ss_pred             cchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-hhhhh
Confidence            77778999999999999999998 6664 6789999999999999998 8999999999999999999999865 47788


Q ss_pred             cCCCccccccCCcc
Q 002897          461 FSNKTRFSLSGNGK  474 (869)
Q Consensus       461 ~~~~~~~~~~~n~~  474 (869)
                      ++.++.++++.|.-
T Consensus       451 l~qL~~lDlS~N~L  464 (1081)
T KOG0618|consen  451 LPQLKVLDLSCNNL  464 (1081)
T ss_pred             cCcceEEecccchh
Confidence            89999999998853

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.7e-33  Score=291.70  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=204.9

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|+..+.||+|++|.||+|.+..+++.|++|++.....  ...+.+.+|++++++++||||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47788999999999999999988999999999865442  45678899999999999999999999865431   26789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+||+++++|.+++....      .+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999999998764      389999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .........      .......++..|+|||...+..++.++||||||+++|+|++|..||.....   ...........
T Consensus       149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~  219 (260)
T cd06606         149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSS  219 (260)
T ss_pred             Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhcccc
Confidence            876554310      012335688999999999888899999999999999999999999975331   11111000000


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...                       ...+...+..+.+++.+|++.+|++||++.|++.
T Consensus       220 ~~~-----------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 GEP-----------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCC-----------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            000                       0111123567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=307.03  Aligned_cols=282  Identities=20%  Similarity=0.255  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  630 (869)
                      .+|.+.+.||+|+||.||+|++..+|+.||+|++...  .......+.+|+++++.++||||+++++++.... ......
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            6899999999999999999999889999999998643  2223456789999999999999999999876432 122345


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|+||+.. ++.++...        .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        95 ~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             EEEEeccccc-CHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            7899999964 77776531        288999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +++.....           .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus       163 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~  230 (342)
T cd07879         163 LARHADAE-----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV  230 (342)
T ss_pred             CCcCCCCC-----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            98754321           123457889999998876 468899999999999999999999997532111 11111100


Q ss_pred             h--cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 002897          790 V--LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK--LCAARE  859 (869)
Q Consensus       790 ~--~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  859 (869)
                      .  ......+..+.......... ....+.......+.....+.+++.+||+.||++||+++|++..  ++..++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0  00000000000000000000 0000000000011234567899999999999999999999854  555543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-33  Score=304.40  Aligned_cols=290  Identities=20%  Similarity=0.271  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeecccc---CC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDF---NG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  627 (869)
                      .++|++.++||+|+||.||+|++..+++.||+|++.....  .....+.+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999998999999999864322  223467889999999999999999987654321   22


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||+++ ++.+.+.....     .+++..+..++.|+++||+|||+.   +|+|+||||+||++++++.++|+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            3467999999965 77777765432     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccc---cCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          708 DFGLAKFLPARPLDTVVE---TPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      |||++.............   .........++..|+|||.+.+. .++.++|||||||++|||++|++||....... ..
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~  236 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL  236 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence            999998665432211100   11122345678899999987654 57899999999999999999999986532211 11


Q ss_pred             HHhhhhhcccccccccCccchhhhhhccccc--CCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMS--RGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ................+..............  ..............+.+++.+|++.||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111100000000000000000000000000  00000011123356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-33  Score=293.57  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=202.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|++.++||+|++|.||+|.+..+++.+|+|.+....  ......+.+|+++++.++|+||+++.+++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            5788999999999999999999899999999986432  3345677889999999999999999988654     37899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++......  ...+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence            999999999999998773221  23489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......          .....++..|+|||...+..++.++|+||+|+++|++++|+.||......     ........
T Consensus       151 ~~~~~~~----------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~  215 (256)
T cd08530         151 KVLKKNM----------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKVQR  215 (256)
T ss_pred             hhhccCC----------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc
Confidence            8765431          11235788999999999888999999999999999999999999643211     11111100


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...                       .......+.++.+++.+|++.+|++|||+.|+++
T Consensus       216 ~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 GKY-----------------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCC-----------------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000                       0111234566889999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=297.96  Aligned_cols=273  Identities=21%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.+.||+|++|.||+|.+..+++.+|+|++.....  .....+.+|++++++++|+||+++++++..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            6778899999999999999988999999999864432  345678899999999999999999998654     378899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++ ++.+++.....     .+++..+..++.|+++|++|||+.   +|+|+||||+||+++.++.++|+|||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999975 89888876532     389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc-
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL-  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-  791 (869)
                      ......        .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .......... 
T Consensus       147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~  217 (283)
T cd05118         147 SFGSPV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGT  217 (283)
T ss_pred             ecCCCc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC
Confidence            765432        111234578899999998776 78999999999999999999999986532211 1111111100 


Q ss_pred             --ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 --PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        +.......+......... ............+..+..+.+++.+||+.||.+||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         218 PDPEVWPKFTSLARNYKFSF-PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CchHhcccchhhhhhhhhhh-ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000001000000000000 000000001122345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.4e-33  Score=292.28  Aligned_cols=243  Identities=24%  Similarity=0.312  Sum_probs=194.2

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||.|++|.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+     ....++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence            689999999999998889999999986432   2345678999999999999999999998654     37789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999998754      288999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .         ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+.   ...........    
T Consensus       147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~----  210 (262)
T cd05572         147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGN----  210 (262)
T ss_pred             c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccC----
Confidence            1         1122357889999999988889999999999999999999999997543211   11111111000    


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                                        .....+...+..+.+++.+||+.+|++||+     ++|+++
T Consensus       211 ------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 ------------------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ------------------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                              000011122456889999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-33  Score=306.19  Aligned_cols=284  Identities=19%  Similarity=0.256  Sum_probs=203.4

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccc
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSID  624 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  624 (869)
                      .++....++|++.+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|++++++++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            455667789999999999999999999998899999999986432  223466788999999999999999999876432


Q ss_pred             -cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          625 -FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       625 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                       +......+++++++ +++|.+++....       +++..+..++.|+++|++|||+.   +|+||||||+||++++++.
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence             22334578888887 789998886532       89999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      +||+|||.+......           .....++..|+|||...+ ..++.++|||||||++|+|++|+.||...... ..
T Consensus       159 ~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~  226 (345)
T cd07877         159 LKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ  226 (345)
T ss_pred             EEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            999999998754321           223457889999998766 46788999999999999999999998642211 11


Q ss_pred             HHHhhhhh--cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          783 LHEFSKMV--LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       783 ~~~~~~~~--~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ........  .+......+.......+... ..................+.+++.+|++.||.+||++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11111110  00111111111000000000 0000000000000134567899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-33  Score=304.94  Aligned_cols=281  Identities=19%  Similarity=0.301  Sum_probs=197.4

Q ss_pred             hcCCCC-CCeeeeecceEEEEEEECCCCeEEEEEEeecccchh--------------hHHHHHHHHHHHhCCCCccceEE
Q 002897          553 TSEFSS-SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--------------LKSFLTECEALRSIRHRNLIKII  617 (869)
Q Consensus       553 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~  617 (869)
                      .++|.. .+.||+|+||+||+|.+..+++.||||++.......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 577999999999999998899999999986432211              12567899999999999999999


Q ss_pred             EEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      +++..     .+..++||||++ |+|.+++....      .+++..+..++.|++.||+|||+.   +++||||+|+||+
T Consensus        87 ~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nil  151 (335)
T PTZ00024         87 DVYVE-----GDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIF  151 (335)
T ss_pred             EEEec-----CCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeE
Confidence            99754     378899999996 69999987643      389999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCcc------ccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVV------ETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR  770 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~  770 (869)
                      ++.++.++|+|||.+............      ..........++..|+|||.+.+. .++.++||||+||++|+|++|+
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999876522111000      000112233468899999998764 4689999999999999999999


Q ss_pred             CCCCcCccCCchHHHhhhhhc---ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          771 RPTDSMFHEGLTLHEFSKMVL---PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       771 ~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .||......+ ..........   ...+....+-.......   ..............+..+.+++.+|++.+|++|||+
T Consensus       232 ~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        232 PLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFT---PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             CCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhcccccccC---cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            9997532211 1111111100   00000000000000000   000000000111234568899999999999999999


Q ss_pred             HHHHH
Q 002897          848 RDVVV  852 (869)
Q Consensus       848 ~evl~  852 (869)
                      +|++.
T Consensus       308 ~~~l~  312 (335)
T PTZ00024        308 KEALK  312 (335)
T ss_pred             HHHhc
Confidence            99986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.8e-33  Score=292.22  Aligned_cols=242  Identities=22%  Similarity=0.298  Sum_probs=185.2

Q ss_pred             eeeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHH---HHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEA---LRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .||+|+||.||+|.+..+++.||+|.+.....   .....+..|..+   ++...||+|+++.+++..     .+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence            48999999999999988999999999864321   112233444443   444579999999988654     3788999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      |||+++|+|.+++....      .+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999987543      389999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .....          .....|+..|+|||++.++ .++.++||||+||++|+|++|+.||........  ......... 
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~-  213 (278)
T cd05606         147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT-  213 (278)
T ss_pred             cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc-
Confidence            43221          1234689999999998754 589999999999999999999999975322111  111000000 


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                           .++.                  .+...+..+.+++.+|+..+|++||     ++.|+++
T Consensus       214 -----~~~~------------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 -----MAVE------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -----cCCC------------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                 0000                  0112245678999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-33  Score=304.53  Aligned_cols=282  Identities=20%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             CCCCCCeeeeecceEEEEEEECCC--CeEEEEEEeecc--cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGEN--GMLVAVKVLNLM--QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|++.+.||+|+||.||+|++..+  +..||+|++...  .....+.+.+|+++++++ +||||+++++++... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            477889999999999999999877  889999998642  222346778899999999 599999999875432 12335


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++++||++ ++|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            6788999985 69999987544      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++........    .........|+..|+|||+..+ ..++.++||||+||++|++++|+.||...... ........
T Consensus       150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~  224 (332)
T cd07857         150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ  224 (332)
T ss_pred             CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence            999866543211    0112234568999999998765 46899999999999999999999998653211 01111111


Q ss_pred             hhc--c-cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVL--P-EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~--~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...  + +......++.....................+.....+.+++.+|++.||++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000  0 000111111000000000000000000000112457889999999999999999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=292.16  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      -+.|+..++||+||||.||-++.+.+|+-+|.|.+.+..   +....-..+|-.|+++++.+.||.+-..|     +..+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence            356888899999999999999999999999999885322   23345678999999999999998886664     4568


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+|+..|.||+|.-++-....    ..+++..++.++.+|+.||++||+.   +||.||+||+|||+|+.|+++|+|.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            99999999999999887766553    2499999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|..++...         .....+||.+|||||++..+.|+...|-||+||++|||+.|+.||..... ....++    
T Consensus       332 GLAvei~~g~---------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-Kvk~eE----  397 (591)
T KOG0986|consen  332 GLAVEIPEGK---------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-KVKREE----  397 (591)
T ss_pred             ceEEecCCCC---------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-hhhHHH----
Confidence            9999887653         23445899999999999999999999999999999999999999964211 111111    


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                               +|.....+           ....++..+++..++.+..+..||++|.-
T Consensus       398 ---------vdrr~~~~-----------~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  398 ---------VDRRTLED-----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ---------HHHHHhcc-----------hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence                     11111111           11122345566778899999999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=291.60  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--c-----chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--Q-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .++|-..+.||+|||+.||+|.+-...++||||+-...  .     ....+...+|.+|.+.++||.||++++|+.-.  
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec--
Confidence            45788889999999999999999989999999986421  1     12245678999999999999999999998643  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCC
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDM  702 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~  702 (869)
                        .+..|-|+|||+|-+|.-|++..+.      +++++++.|+.||+.||.||.+. +|+|||-|+||.|||+.   .-|
T Consensus       540 --tdsFCTVLEYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  540 --TDSFCTVLEYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             --cccceeeeeecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence              3778999999999999999998774      89999999999999999999997 78999999999999994   457


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----CCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----EASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      .+||+|||+++.++.+....... -..++...||.+|.+||.+.-+    +.+.|+||||+|||+|.++.|+.||.....
T Consensus       611 eIKITDFGLSKIMdddSy~~vdG-meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDG-MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             eeEeeecchhhhccCCccCcccc-eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            89999999999998765432221 1345667899999999976533    468899999999999999999999975322


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....+.. . .++..  .++                   ..+.-+....+...+|++|+++.-++|....|+..
T Consensus       690 QQdILqe-N-TIlkA--tEV-------------------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  690 QQDILQE-N-TILKA--TEV-------------------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHHHhh-h-chhcc--eec-------------------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            2111111 0 00000  000                   00011123445678999999999999998887754

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=293.48  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=188.3

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHH-hCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALR-SIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|.+..+|+.||+|+++...   ......+..|..++. ..+|+|++++++++..     .+..++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence            57999999999999998899999999986432   122234455555544 4489999999998754     37899999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+...
T Consensus        77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999997654      388999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV  795 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  795 (869)
                      ..            .....|+..|+|||...+..++.++||||+|+++|+|++|..||......     ...........
T Consensus       148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~  210 (260)
T cd05611         148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNILSRRI  210 (260)
T ss_pred             cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhccc
Confidence            32            12235788999999998888899999999999999999999999643211     11111100000


Q ss_pred             ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       796 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .                    ........++..+.+++.+||+.+|++||++.++.+.+
T Consensus       211 ~--------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         211 N--------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             C--------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0                    00001113456788999999999999999876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=252.14  Aligned_cols=270  Identities=21%  Similarity=0.293  Sum_probs=198.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +|...++||+|.||+||+|+..++++.||+|.++..  +++......+|+-+++.++|.|||+++++...     +...-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            466678999999999999999999999999999754  34456788999999999999999999998543     47889


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +|+|||.. +|..|...-.+.     ++.+.++.++.|+++|+.|+|++   ++.|||+||.|.+|+.+|+.|++|||+|
T Consensus        78 lvfe~cdq-dlkkyfdslng~-----~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   78 LVFEFCDQ-DLKKYFDSLNGD-----LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             EeHHHhhH-HHHHHHHhcCCc-----CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence            99999955 999998876653     89999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.++-.-        ...+..+-|.+|++|.++.+.+ |+...|+||.|||+.|+.. |++.|.+..-. ..+....+..
T Consensus       149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~l  219 (292)
T KOG0662|consen  149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLL  219 (292)
T ss_pred             hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHh
Confidence            8765432        2344456799999999998876 7888999999999999998 55555542221 1122211111


Q ss_pred             c---cc---ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 L---PE---KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~---~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      -   .+   .+....|-.....+.+.     ..-....+.....=.++++..+.-+|.+|.+|++.++
T Consensus       220 g~p~ed~wps~t~lpdyk~yp~ypat-----tswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  220 GTPTEDQWPSMTKLPDYKPYPIYPAT-----TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCccccCCccccCCCCcccCCcccc-----chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            0   01   11122221111111000     0000000111122357788888899999999998765

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3e-33  Score=299.51  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..|+..+.||+|+||.||+|++..++..||+|.+...   ......++.+|+++++.++|+|++++.+++...     ..
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence            3477788999999999999999989999999998642   223345678899999999999999999987653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+. |++.+++.....     ++++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            899999996 588887765432     388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      .+......            ....|+..|+|||.+.   ...++.++|||||||++|+|++|+.||....... ....+.
T Consensus       161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~  227 (308)
T cd06634         161 SASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA  227 (308)
T ss_pred             cceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHh
Confidence            98754322            1235788999999874   3567889999999999999999999986421110 001111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ....         +                 .......+..+.+++.+||+.+|++||++++++..-.
T Consensus       228 ~~~~---------~-----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         228 QNES---------P-----------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             hcCC---------C-----------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0000         0                 0001134456789999999999999999999987544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-33  Score=318.53  Aligned_cols=284  Identities=21%  Similarity=0.179  Sum_probs=189.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCC-eEEEEEE--------------ee---cccchhhHHHHHHHHHHHhCCCCcc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKV--------------LN---LMQKGALKSFLTECEALRSIRHRNL  613 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni  613 (869)
                      ..++|++.+.||+|+||+||+|..+... ..+++|.              +.   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998764322 2222221              10   0112234567899999999999999


Q ss_pred             ceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       614 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                      +++++++...     +..++|++++. +++.+++........ .......+..++.|++.||+|||++   +|+||||||
T Consensus       226 v~l~~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        226 LKIEEILRSE-----ANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcEeEEEEEC-----CeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            9999997654     67899999985 588888765432111 1234667889999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCC-
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p-  772 (869)
                      +|||++.++.+||+|||+++.+.....       .......||..|+|||++.+..++.++|||||||++|||++|..+ 
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999987643221       122345799999999999999999999999999999999998764 


Q ss_pred             CCcCccC-CchHHHhhhhhcccccccccCc--cchhhhhhcccccCC-Cccc--hHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          773 TDSMFHE-GLTLHEFSKMVLPEKVMEIVDP--SLLLEVRANNSMSRG-GERV--KIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       773 f~~~~~~-~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                      +...... ...+.+...... ....+..++  .+............. ....  .....+..+.+++.+|+++||++|||
T Consensus       369 ~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps  447 (501)
T PHA03210        369 IGDGGGKPGKQLLKIIDSLS-VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG  447 (501)
T ss_pred             ccCCCCCHHHHHHHHHHhcc-cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence            4322111 111111111110 000011110  000000000000000 0000  00112345778899999999999999


Q ss_pred             HHHHHHH
Q 002897          847 MRDVVVK  853 (869)
Q Consensus       847 ~~evl~~  853 (869)
                      +.|+++.
T Consensus       448 a~elL~h  454 (501)
T PHA03210        448 AAELLAL  454 (501)
T ss_pred             HHHHhhC
Confidence            9999863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=305.22  Aligned_cols=278  Identities=20%  Similarity=0.265  Sum_probs=199.6

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|++++++++||||+++++++.... ....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457899999999999999999999989999999998542  2223456789999999999999999999875432 1122


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+ +++|.+++...       .+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            3568999998 77999888643       389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+......           .....++..|+|||.+.+ ..++.++||||+||++|++++|+.||....... ......
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~  229 (343)
T cd07880         162 FGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIM  229 (343)
T ss_pred             cccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence            9999754322           123357889999998876 458899999999999999999999997532110 111111


Q ss_pred             hhhc--ccccccccCccchhhhhhccc-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVL--PEKVMEIVDPSLLLEVRANNS-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~--~~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....  +..+...+.......+..... ..........+.+...+.+++.+|++.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000  000000000000000000000 0000000011234456889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-33  Score=294.24  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||.||+|++..+|+.||+|++.....   ...+.+.+|++++++++||||+++++.+..     ....++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence            6899999999999988899999999864432   445678999999999999999999887543     47889999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++....      .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999998754      389999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      ................++..|+|||......++.++||||||+++|++++|+.||......     ...........   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~---  218 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGKI---  218 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCc---
Confidence            2110000011223455788999999998888999999999999999999999999643211     11111100000   


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                       .                  .+.....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       219 -~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 -E------------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -C------------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             0                  0000012466789999999999999999955554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.4e-33  Score=296.83  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=194.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|++|.||+|.+..+++.||||+++... ......+..|+.++.+. .||||+++++++.+.     ..
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----Ce
Confidence            467899999999999999999998889999999996543 23345667788777666 599999999997653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||++ +++.+++.....     .+++..+..++.|++.|++|||+..  +|+||||+|+||+++.++.+||+|||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            899999985 478777765432     4899999999999999999999732  89999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC----CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE----ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      .+.......         ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......   . +.
T Consensus       161 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~-~~  227 (296)
T cd06618         161 ISGRLVDSK---------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---F-EV  227 (296)
T ss_pred             cchhccCCC---------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---H-HH
Confidence            987654321         112234788999999987553    788999999999999999999998642111   1 11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      .............                     ....++.++.+++.+||+.||++||+++++++.-
T Consensus       228 ~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         228 LTKILQEEPPSLP---------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             HHHHhcCCCCCCC---------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            1111110000000                     0002345688999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-32  Score=295.65  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      |...+.||+|+||.||+|++..+|+.||+|++....   ......+.+|+++++.++|||++++++++.+.     ...+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            666788999999999999998899999999986432   23345678999999999999999999997653     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+. |++.+++.....     ++++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999995 588888765443     389999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .....            .....|+..|+|||++.   ...++.++|||||||++|+|++|..||......    ......
T Consensus       169 ~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~  232 (313)
T cd06633         169 SKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHI  232 (313)
T ss_pred             cccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH
Confidence            64321            12345888999999874   456888999999999999999999998643111    111000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      . .......                      ..+..+..+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~-~~~~~~~----------------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         233 A-QNDSPTL----------------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             H-hcCCCCC----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 0000000                      001233457889999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=277.80  Aligned_cols=201  Identities=29%  Similarity=0.386  Sum_probs=178.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      -++|...++||+|.||.|.+++.+.+|+.+|+|++++.   .+++...-..|-++|+..+||.+..+-..     |+..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence            46788899999999999999999999999999999743   45556667889999999999998877654     56669


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+||||..||.|.-++.+.+.      +++...+.+...|+.||.|||++   +||.||+|.+|.|+|.+|++||+||
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~------FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERV------FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhc------ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence            99999999999999988887653      88889999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      |+++.--        ......+..+||+.|.|||++....|+.++|-|.+|||+|||++|+.||..
T Consensus       313 GLCKE~I--------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  313 GLCKEEI--------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             ccchhcc--------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            9997422        122556778999999999999999999999999999999999999999975

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=294.63  Aligned_cols=271  Identities=21%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |+..+.||+|++|.||+|+...+++.||+|++....  ....+.+..|++++++++|+|++++.+++..     ....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            567789999999999999999889999999997543  3344677899999999999999999998654     378999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||++ ++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++|+|||.+.
T Consensus        76 v~e~~~-~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 599999987632     389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc-
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL-  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-  791 (869)
                      ......        .......++..|+|||.+.+. .++.++|||||||++||+++|+.||....... .......... 
T Consensus       147 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~  217 (282)
T cd07829         147 AFGIPL--------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGT  217 (282)
T ss_pred             ccCCCc--------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCC
Confidence            654322        112223457789999998776 78999999999999999999999986532110 0111110000 


Q ss_pred             --ccccccccCcc-chhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 --PEKVMEIVDPS-LLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 --~~~~~~~~d~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        +..+....+-. ....+..   ..........+.....+.+++.+||+.||++||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         218 PTEESWPGVTKLPDYKPTFPK---FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CcHHHHHhhcccccccccccc---cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              00000000000 0000000   0000000111123567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=281.83  Aligned_cols=273  Identities=22%  Similarity=0.288  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-C-C----ccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-H-R----NLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~  626 (869)
                      +.+|.+...+|+|.||.|-++.+.+++..||||+++...+ ..+...-|+++++++. + |    -+|.+.++     |+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            6799999999999999999999999999999999975443 3456688999999993 2 2    35666665     34


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC------
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH------  700 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------  700 (869)
                      -.++.|||+|.+ |-|+.+++..+..    .+++...++.+++|++++++|||+.   +++|-|+||+||++..      
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            458899999988 6699999998764    3689999999999999999999999   9999999999999931      


Q ss_pred             --------------CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHH
Q 002897          701 --------------DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM  766 (869)
Q Consensus       701 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  766 (869)
                                    ...++++|||.|....+.           .+..+.|..|+|||++.+-.++.++||||+||||+|+
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccC-----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                          235899999999864432           2456789999999999999999999999999999999


Q ss_pred             HcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhh--------hhccc---ccCCCc--------cchHHHHHH
Q 002897          767 FSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEV--------RANNS---MSRGGE--------RVKIEECLV  827 (869)
Q Consensus       767 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~--------~~~~~---~~~~~~--------~~~~~~~~~  827 (869)
                      .||...|+...  +...-.+++.+..+-...++...-...+        .....   ++...+        .........
T Consensus       303 ytG~~LFqtHe--n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~  380 (415)
T KOG0671|consen  303 YTGETLFQTHE--NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV  380 (415)
T ss_pred             eccceecccCC--cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence            99999997533  2221133333322211111111100000        00000   000000        011123446


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          828 AVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       828 ~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ++++|+++|+.+||.+|+|+.|++.
T Consensus       381 ~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  381 QLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHHHccCccccccHHHHhc
Confidence            7999999999999999999999975

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.1e-33  Score=295.94  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|.+.+.||+|++|.||+|....+|+.||+|++...   .....+.+.+|++++++++ ||||+++++++.     +.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence            4788999999999999999999989999999998642   2233467889999999998 999999998754     347


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence            8999999999999999998764      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCcc------------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          710 GLAKFLPARPLDTVV------------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       710 g~a~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      |.+............            ..........++..|+|||...+..++.++||||+|++++++++|+.||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            999876543321000            00122334567899999999988889999999999999999999999997532


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM----RDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  852 (869)
                      .. .......    ..      .                  ...+...++.+.+++.+||+.+|++|||+    +|+++
T Consensus       227 ~~-~~~~~~~----~~------~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 EY-LTFQKIL----KL------E------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HH-HHHHHHH----hc------C------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11 0111100    00      0                  00011234567899999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=293.70  Aligned_cols=271  Identities=22%  Similarity=0.296  Sum_probs=195.7

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |++.+.||+|++|+||+|+...+++.||+|.+..... .......+|+..+++++ |||++++++++..     .+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            6778999999999999999988899999999864322 22234567999999998 9999999998654     478899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+ +|+|.+++.....    ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 8899999877541    2389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh--
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV--  790 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~--  790 (869)
                      ......         ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... .........  
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~  217 (283)
T cd07830         148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGT  217 (283)
T ss_pred             eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCC
Confidence            654321         1223457889999998754 457899999999999999999999986532211 111000000  


Q ss_pred             -cccccccc--cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 -LPEKVMEI--VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 -~~~~~~~~--~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ......+.  .+.........   ..........+..+..+.+++.+||+.+|++|||++|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         218 PTKQDWPEGYKLASKLGFRFPQ---FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CChhhhhhHhhhhccccccccc---cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             00000000  00000000000   0000000011122467889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-32  Score=291.83  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             CCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      +|++.+.||+|+||.||.|...   .+|+.||+|++....    ....+.+.+|+.+++++ +|++|+++.+++..    
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence            4788899999999999999984   478999999986432    22346678899999999 69999999988543    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                       ....++||||+++++|.+++....      ++++..+..++.|+++||+|||+.   +++||||+|+||+++.++.+||
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          77 -DTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence             367899999999999999997654      378999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      +|||.+........       .......|+..|+|||...+.  .++.++||||||+++|+|++|+.||...... ....
T Consensus       147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~  218 (290)
T cd05613         147 TDFGLSKEFHEDEV-------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA  218 (290)
T ss_pred             eeCccceecccccc-------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH
Confidence            99999976543221       112234588999999998753  4678999999999999999999998632111 1112


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .+........                        .+.+..+...+.+++.+||+.||++||     ++++++.
T Consensus       219 ~~~~~~~~~~------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         219 EISRRILKSE------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHhhccC------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            2211111000                        001112345678999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-33  Score=304.21  Aligned_cols=278  Identities=20%  Similarity=0.277  Sum_probs=199.5

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  628 (869)
                      ..++|++.+.||+|++|.||+|++..+++.||+|++...  .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999989999999998642  23334667889999999999999999887654321 223


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++|+||+ +++|.+++...       .+++..+..++.|+++|++|||+.   ||+||||||+||+++.++.++|+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence            4589999998 66999998753       389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.+......           .....++..|+|||...+ ..++.++||||+||++|++++|+.||...... .......
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~  229 (343)
T cd07851         162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM  229 (343)
T ss_pred             cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            9999765332           123357889999998765 36789999999999999999999999643211 0111111


Q ss_pred             hhh--cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMV--LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~--~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...  .++.....+.......+... ....+..........+..+.+++.+|++.||++|||+.||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            100  00000000000000000000 000000000001123567889999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.1e-33  Score=293.72  Aligned_cols=257  Identities=22%  Similarity=0.268  Sum_probs=197.6

Q ss_pred             CCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      +|++.+.||+|++|.||+|+..   .+++.||||+++...    ....+.+.+|+++++++ +||+|+++.+.+..    
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~----   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT----   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence            4778899999999999999864   467899999986432    22345678999999999 69999999988543    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                       ....++||||+++|+|.+++....      .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|
T Consensus        77 -~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          77 -DTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence             367899999999999999987643      388999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      +|||+++.......       .......|+..|+|||...+..  .+.++||||||+++|+|++|..||...... ....
T Consensus       147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~  218 (288)
T cd05583         147 TDFGLSKEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS  218 (288)
T ss_pred             EECccccccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence            99999876543221       1112345789999999987665  788999999999999999999998632111 1111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ...+......                        ...+......+.+++.+||+.||++|||+.++.+.|...
T Consensus       219 ~~~~~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         219 EISRRILKSK------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHHHccC------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            1111111000                        001112345678999999999999999998887766543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.2e-33  Score=289.06  Aligned_cols=251  Identities=20%  Similarity=0.260  Sum_probs=195.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-----QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      +|.+.+.||+|+||.||+|.+...+..+++|+++..     .......+..|+.++++++||||+++++++.+     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            588899999999999999999877777777776532     12233457789999999999999999988644     36


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++......  ...+++..++.++.|+++|++|||+.   +++|+||+|+||+++. +.++|+||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence            789999999999999998753221  22489999999999999999999999   9999999999999975 57999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+.......        .......|+..|+|||...+..++.++|+||||+++|+|++|..||....     .......
T Consensus       150 g~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~  216 (260)
T cd08222         150 GVSRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLR  216 (260)
T ss_pred             CceeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH
Confidence            9987654322        11223457889999999888888999999999999999999999986321     1111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....     .                  ...+..++..+.+++.+||+.+|++||++.|+++
T Consensus       217 ~~~~~-----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         217 IVEGP-----T------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHcCC-----C------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            10000     0                  0011244567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=317.26  Aligned_cols=209  Identities=26%  Similarity=0.357  Sum_probs=184.0

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec---ccchhhHHHHHHHHHHHhCCCCccceEEEEeec
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKIITICSS  622 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  622 (869)
                      ..+++...++|.+.++||+|+||.|..++++.+++.||.|++.+   .......-|..|-++|..-+.+-|+.+...   
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---  143 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---  143 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence            35566677899999999999999999999999999999999965   234455678899999998899999988765   


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                        |++..+.|+|||||+||+|-..+.+..      ++++..++.++..|+-||.-+|+.   |+|||||||+|||+|..|
T Consensus       144 --FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  144 --FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             --hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence              567799999999999999999998875      389999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC----C-CCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT----G-SEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      ++||+|||.+-.+..+..       ..+...+|||.|++||++.    + +.|++.+|-||+||++|||+.|..||..
T Consensus       213 HikLADFGsClkm~~dG~-------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGT-------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             cEeeccchhHHhcCCCCc-------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999999999988875431       3445678999999999864    3 5699999999999999999999999964

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=296.48  Aligned_cols=242  Identities=22%  Similarity=0.240  Sum_probs=197.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .+..|.....+|.|+|+.|-.+.+..+++..+||++...    .....+|+.++... +||||+++.+.+.+     ..+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYED-----GKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecC-----Cce
Confidence            356788888899999999999999999999999999654    23345678777666 79999999999654     488


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCcEEEccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-DHDMVAHVGDF  709 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Df  709 (869)
                      .|+|||.+.++-+.+.+...+.      .. ..+..|+.+|+.|+.|||++   ||||||+||+|||+ +..++++|+||
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKPE------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             eeeeehhccccHHHHHHHhcch------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence            9999999999998888877652      23 67788999999999999999   99999999999999 58999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.++......           ...+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+    .+....
T Consensus       461 G~a~~~~~~~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~  525 (612)
T KOG0603|consen  461 GFWSELERSC-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTR  525 (612)
T ss_pred             chhhhCchhh-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHh
Confidence            9998765541           1223488999999999999999999999999999999999999864433    222222


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      +......                          +..+....+|+.+||+.||.+||+|.|+...
T Consensus       526 i~~~~~s--------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 IQMPKFS--------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hcCCccc--------------------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            2111111                          2345567899999999999999999999764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-32  Score=319.98  Aligned_cols=147  Identities=28%  Similarity=0.457  Sum_probs=131.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|.+.++||+|+||.||+|.+..+++.||||+++...   ......+..|+.+++.++||||+++++++...     ..
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CE
Confidence            57999999999999999999999899999999996432   33346788999999999999999999886543     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            999999999999999997654      378899999999999999999999   99999999999999999999999999


Q ss_pred             cccc
Q 002897          711 LAKF  714 (869)
Q Consensus       711 ~a~~  714 (869)
                      +++.
T Consensus       150 ls~~  153 (669)
T cd05610         150 LSKV  153 (669)
T ss_pred             CCcc
Confidence            9863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=289.51  Aligned_cols=245  Identities=22%  Similarity=0.308  Sum_probs=196.3

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEee
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      .++||+|.||+||-|+++.+|+.||||++++..  ......+++|+.||+.++||.||.+...|..     .+..+.|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceEEEEeh
Confidence            479999999999999999999999999996432  3334789999999999999999999888544     588999999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEccccccc
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVGDFGLAK  713 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~  713 (869)
                      -+. |+..+++-....    .++++.....++.||+.||.|||.+   +|+|+|+||+|||+...   .++||||||+|+
T Consensus       644 Kl~-GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KLH-GDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hhc-chHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            995 466666554332    2489988899999999999999999   99999999999999654   389999999999


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .+++..         .....+||+.|.|||++..+.|...-|+||.|||+|--++|..||...    ..+.+.++..   
T Consensus       716 iIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNA---  779 (888)
T KOG4236|consen  716 IIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNA---  779 (888)
T ss_pred             ecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhcc---
Confidence            988763         345578999999999999999999999999999999999999999742    1221111110   


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        .                  -........++....+++|...++..=++|-|.++-+.
T Consensus       780 --a------------------FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  780 --A------------------FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             --c------------------cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence              0                  01122233455667788999999999999998876654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-32  Score=314.51  Aligned_cols=267  Identities=25%  Similarity=0.413  Sum_probs=211.4

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEEC---C----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEee
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIG---E----NGMLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICS  621 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  621 (869)
                      ...++..+.+.+|+|.||.||+|...   .    ....||||..+.. ...+.+.+..|+++|+.+ .|+||+.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            34445567779999999999999853   1    2567999998643 334568899999999999 6999999999987


Q ss_pred             ccccCCCceEEEEeecccCCCHHHHHhhCC--Ccccc--------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002897          622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNN--DKLEV--------CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDL  691 (869)
Q Consensus       622 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  691 (869)
                      .     ....++|+||++.|+|.++++..+  ...+.        ..++..+.+.++.|||.|++||++.   ++||||+
T Consensus       373 ~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDL  444 (609)
T KOG0200|consen  373 Q-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDL  444 (609)
T ss_pred             c-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhh
Confidence            6     378899999999999999999887  11111        2389999999999999999999999   9999999


Q ss_pred             CCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCcc--CcccccCCcccCCCCCCccccchhhhHHHHHHHc-
Q 002897          692 KPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK--GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-  768 (869)
Q Consensus       692 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-  768 (869)
                      .++|||+.++..+||+|||+|+.........       .....  -...|||||.+....|+.+|||||||+++||++| 
T Consensus       445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~-------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  445 AARNVLITKNKVIKIADFGLARDHYNKDYYR-------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             hhhhEEecCCCEEEEccccceeccCCCCceE-------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence            9999999999999999999998665543211       11111  2456999999999999999999999999999999 


Q ss_pred             CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       769 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |..||.+....    ....+..                       +.+.+...++.|..+++++++.||+.+|++||++.
T Consensus       518 G~~PYp~~~~~----~~l~~~l-----------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  518 GGTPYPGIPPT----EELLEFL-----------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             CCCCCCCCCcH----HHHHHHH-----------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            88998652111    1111111                       12233345567788999999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 002897          849 DVVVKLCAARE  859 (869)
Q Consensus       849 evl~~L~~~~~  859 (869)
                      |+.+.+.....
T Consensus       571 ~~~~~~~~~l~  581 (609)
T KOG0200|consen  571 ECVEFFEKHLQ  581 (609)
T ss_pred             HHHHHHHHHHH
Confidence            99999998543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-32  Score=298.08  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=217.5

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++.+...++.|++...||.|.+|.||+++...+|+.+|+|+..... +..+++..|++|++.. .|||++.++|++.-.
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34445556678999999999999999999999999999999986543 3346778899999988 799999999998877


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                      +-..++..|+|||||.+||..+.++...+    ..+.|+.+.-|++.++.|+.+||..   .++|||||-.|||++.++.
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            66778999999999999999999988763    3599999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----CCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      ||++|||.+..+....        ......+||+.|||||++...     .|+.++|+||+|++..||.-|.+|+.++..
T Consensus       162 VKLvDFGvSaQldsT~--------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTV--------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EEEeeeeeeeeeeccc--------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            9999999997665432        445667899999999987543     477889999999999999999999876543


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....+      .++..    ..|.                ...++....++.++|..|+..|-++||++.++++
T Consensus       234 mraLF------~IpRN----PPPk----------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 MRALF------LIPRN----PPPK----------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhhhc------cCCCC----CCcc----------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            21110      01100    0111                1123456678999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=8.9e-32  Score=279.52  Aligned_cols=237  Identities=29%  Similarity=0.361  Sum_probs=191.2

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      ||+|+||.||+|.+..+++.||+|++....   ......+..|++++++++||||+++++.+.     +....++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence            689999999999998889999999986432   224567899999999999999999998754     347899999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR  718 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  718 (869)
                      ++++|.+++....      .+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999998764      389999999999999999999998   9999999999999999999999999999765443


Q ss_pred             CCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       719 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .        .......++..|+|||...+...+.++|+||||+++|++++|+.||.....     ............   
T Consensus       147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---  210 (250)
T cd05123         147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPL---  210 (250)
T ss_pred             C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCC---
Confidence            1        122345578899999999888889999999999999999999999964321     111111111000   


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                                           ..+...+..+.+++.+||..||++||++.+
T Consensus       211 ---------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 ---------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                                 000112456789999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=4.9e-34  Score=269.45  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=191.2

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHh-CCCCccceEEEEeeccccCCCceEEEEee
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRS-IRHRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      ...||.|+||+|++..++++|+..|||+++.... .+.+++..|.+...+ -+.||||+++|.+...     +..||.||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeHH
Confidence            4579999999999999999999999999976543 456788899886544 4899999999986542     66799999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      .|.- |+..+-+.-... ....+++.-+-.|+...+.||.||-...  .|+|||+||+|||++..|.+||||||++..+.
T Consensus       144 LMd~-SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHhh-hHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9944 766543322111 1124888888999999999999998775  89999999999999999999999999997654


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      +..         ..+.-.|...|||||.+...  .|+-+|||||+|+++||+.||+.||..-..   .+++....+..+.
T Consensus       220 ~Si---------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdp  287 (361)
T KOG1006|consen  220 DSI---------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDP  287 (361)
T ss_pred             HHH---------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCC
Confidence            331         22334689999999987653  488999999999999999999999864211   2333333222211


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..-..+.                   ..-+....+.+++..|+..|-++||...++.+
T Consensus       288 p~l~~~~-------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  288 PILLFDK-------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CeecCcc-------------------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1111111                   11134567889999999999999999998865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=5.5e-32  Score=278.01  Aligned_cols=222  Identities=19%  Similarity=0.134  Sum_probs=175.8

Q ss_pred             ecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCHH
Q 002897          565 GSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLE  644 (869)
Q Consensus       565 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  644 (869)
                      |.+|.||+|++..+++.||+|++....     ....|...+....||||+++++++..     .+..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence            899999999999999999999986532     23345555556679999999998654     37889999999999999


Q ss_pred             HHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCcc
Q 002897          645 EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV  724 (869)
Q Consensus       645 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  724 (869)
                      +++....      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++|||.+.......     
T Consensus        74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----  139 (237)
T cd05576          74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----  139 (237)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence            9987654      389999999999999999999999   99999999999999999999999999876543321     


Q ss_pred             ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccch
Q 002897          725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLL  804 (869)
Q Consensus       725 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  804 (869)
                            ....++..|+|||...+..++.++||||+||++|||++|+.|+.......               ......   
T Consensus       140 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~---  195 (237)
T cd05576         140 ------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTL---  195 (237)
T ss_pred             ------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cccccc---
Confidence                  12345678999999988889999999999999999999998875321100               000000   


Q ss_pred             hhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          805 LEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       805 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                                     ..+...+..+.+++.+|++.||++||++.+
T Consensus       196 ---------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         196 ---------------NIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence                           000123456789999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.3e-32  Score=275.67  Aligned_cols=137  Identities=25%  Similarity=0.422  Sum_probs=119.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-----C---CccceEEEEeeccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-----H---RNLIKIITICSSID  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~  624 (869)
                      .++|.+.++||-|.|++||+|.+..+.+.||+|+.+.. ....+....|+.+|++++     |   .+||++++.|....
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36899999999999999999999999999999998643 334467789999999982     3   47999999988763


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                       ....++|+|+|++ |-+|..+|+...-    ..++...+.+|++||+.||.|||..|  ||||-||||+|||+
T Consensus       156 -pNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 -PNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             -CCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             4458999999999 6699999987653    35999999999999999999999999  99999999999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.6e-31  Score=302.06  Aligned_cols=274  Identities=17%  Similarity=0.169  Sum_probs=173.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCC----CeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeec-cccC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGEN----GMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSS-IDFN  626 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  626 (869)
                      ..++|++.++||+|+||.||+|++..+    +..||+|++......  +....|  .++...+.++..++..+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999888    899999987532221  111111  1222223333322222111 1013


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc--------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL--------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                      .....++||||+++++|.+++.......              .........+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            4567899999999999999987543110              001122345678999999999999999   99999999


Q ss_pred             CCceeecC-CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----------------------C
Q 002897          693 PSNVLLDH-DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----------------------E  749 (869)
Q Consensus       693 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~  749 (869)
                      |+|||++. ++.+||+|||+|+.+.....       .......+++.|+|||.+...                      .
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999986 57999999999976543211       223345789999999965322                      2


Q ss_pred             CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc-----ccccccCccchhhhhhcccccCCCccchHHH
Q 002897          750 ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE-----KVMEIVDPSLLLEVRANNSMSRGGERVKIEE  824 (869)
Q Consensus       750 ~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~  824 (869)
                      ++.++||||+||++|||+++..|++..      ...+.+.....     .+....++....+...        .......
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~d~  421 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR--------GFEVLDL  421 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhh--------hhhhccc
Confidence            345679999999999999977765421      11111111000     0000001100000000        0000001


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          825 CLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       825 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......+|+.+|++.||++|||++|+++.
T Consensus       422 ~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        422 DGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             cchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            12345689999999999999999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=296.30  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=190.7

Q ss_pred             CCCCCeeeeecce-EEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEE
Q 002897          556 FSSSNMVGQGSFG-TVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       556 y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      |...+++|.|+.| .||+|..  .|+.||||++-   .+..+...+|+..++.- +|||||++++.-     .+..+.||
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEE
Confidence            3444678999987 5799999  79999999873   23345678999999988 699999999873     44589999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---C--CcEEEcc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---D--MVAHVGD  708 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~D  708 (869)
                      +.|.|.. +|.+++......  .........+.+..|+++||++||+.   +|||||+||.||||+.   +  ..++|+|
T Consensus       581 alELC~~-sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EehHhhh-hHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence            9999966 999999885211  11122255678899999999999998   9999999999999976   3  4799999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC-CCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg-~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+++..+.+...     -....+..||.+|+|||++....-+.++||||+||++|+.++| .+||+.....+..+..-.
T Consensus       655 fglsKkl~~~~sS-----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~  729 (903)
T KOG1027|consen  655 FGLSKKLAGGKSS-----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN  729 (903)
T ss_pred             cccccccCCCcch-----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc
Confidence            9999998776532     1335677899999999999998888899999999999999995 999986544332221110


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..     ...+                     ...+++  +..+||.+|+.++|..||+|.+|+.
T Consensus       730 ~~-----L~~L---------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YT-----LVHL---------------------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cc-----eeee---------------------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00     0000                     001122  5679999999999999999999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=272.53  Aligned_cols=205  Identities=25%  Similarity=0.342  Sum_probs=174.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  627 (869)
                      ...+|....+||+|+||.|.+|..+.+.+.+|||++++.   ..+..+--..|-++|+.- +.|.++++..++     +.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QT  421 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QT  421 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hh
Confidence            345899999999999999999999999999999999642   233444556677777766 577788887774     44


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      .+..|.||||+.||+|--.+++...      +.+..+..+|..||-||-+||++   ||+.||+|.+|||+|.+|++||+
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            5889999999999999998887664      77778899999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      |||+++.--..        ...+....||+.|+|||++...+|+..+|-||+||++|||+.|++||++..+
T Consensus       493 DFGmcKEni~~--------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  493 DFGMCKENIFD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ecccccccccC--------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            99999743221        2445678899999999999999999999999999999999999999987433

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-32  Score=245.95  Aligned_cols=209  Identities=25%  Similarity=0.331  Sum_probs=168.8

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      ...++......||+|+||.|-+.++..+|...|+|.++.. ..+..++..+|+.+..+. .+|.+|+++|.+..     .
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----e  117 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----E  117 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----c
Confidence            3445556678899999999999999999999999999643 344557788898876554 79999999997433     4


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...+|.||.|.. ||..+-++.-..  ...+++..+-+|+..+.+||.|||++-  .++|||+||+|||++.+|++|+||
T Consensus       118 gdvwIcME~M~t-Sldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  118 GDVWICMELMDT-SLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             ccEEEeHHHhhh-hHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence            778999999955 887665442221  224899999999999999999999986  899999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC----CCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----EASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      ||.+..+.+.-         ..+...|...|||||.+..+    .|+-|+||||+|+.+.||.+++.||+.-..
T Consensus       193 FGIsG~L~dSi---------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  193 FGISGYLVDSI---------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             cccceeehhhh---------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            99998765432         11224588899999986543    689999999999999999999999976443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.7e-32  Score=251.00  Aligned_cols=281  Identities=19%  Similarity=0.279  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+++|+|.|+.||.|....+.+.++||+++...   .+.+.+|+.|++.+. ||||++++++..++.   ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCc
Confidence            468999999999999999999988899999999997544   377899999999996 999999999987652   3567


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  710 (869)
                      .+++||+.+.+....-..         ++..+++..+.+++.||.|+|+.   ||.|||+||.|++||... .++|+|+|
T Consensus       111 aLiFE~v~n~Dfk~ly~t---------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT---------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             hhHhhhhccccHHHHhhh---------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence            899999998777666533         77788999999999999999999   999999999999998764 79999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|.++.+...         ..-++.+..|.-||.+..- .|+..-|+|||||++..|+..+.||-........+...++.
T Consensus       179 LAEFYHp~~e---------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  179 LAEFYHPGKE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             hHhhcCCCce---------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            9998866532         2334567888999987664 47888899999999999999999986544443344443333


Q ss_pred             hccccc-------ccccCccchhhhhh---cccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHH
Q 002897          790 VLPEKV-------MEIVDPSLLLEVRA---NNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV--KLCAA  857 (869)
Q Consensus       790 ~~~~~~-------~~~~d~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  857 (869)
                      .-...+       .-.+||........   ..|..- ...+...-..++..+++.+.+.+|-.+||||+|.++  .+..+
T Consensus       250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~F-i~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRF-INSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             hChHHHHHHHHHHccCCChhHhhHhhccccccHHHh-CCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            221111       11234433221111   111000 000111112356789999999999999999999986  34444


Q ss_pred             HHhh
Q 002897          858 REAF  861 (869)
Q Consensus       858 ~~~~  861 (869)
                      +++.
T Consensus       329 ~~~~  332 (338)
T KOG0668|consen  329 REAE  332 (338)
T ss_pred             HHHh
Confidence            4443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=261.31  Aligned_cols=274  Identities=21%  Similarity=0.317  Sum_probs=212.5

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCC-----eEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEE
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENG-----MLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITI  619 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~  619 (869)
                      .+++.....+++....+-+|.||.||.|.+.+..     +.|-+|.++.. .+-....+..|.-.+....|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3445555567788889999999999999886433     34566766432 33345678888888999999999999999


Q ss_pred             eeccccCCCceEEEEeecccCCCHHHHHhhCCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK--LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       620 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      +.+    +....+.++.++.-|+|..++...+..  .....++..+...++.|++.|++|||++   +|||.||.++|.+
T Consensus       356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV  428 (563)
T ss_pred             Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence            865    347788999999999999999833211  1223477888899999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      ||+..++||+|=.+++.+-+.+..      .-.........||+||.+....|+.++|||||||++|||+| |+.|+...
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             ehhheeEEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            999999999999999877655321      22223345678999999999999999999999999999999 99998653


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ...+  ...+.                          +.+.+..++-.||++++.++.-||+.+|++||+++|++.-|.+
T Consensus       503 DPfE--m~~yl--------------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  503 DPFE--MEHYL--------------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             CHHH--HHHHH--------------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            2211  11111                          1122333445789999999999999999999999999999887


Q ss_pred             HHHh
Q 002897          857 AREA  860 (869)
Q Consensus       857 ~~~~  860 (869)
                      ....
T Consensus       555 F~~q  558 (563)
T KOG1024|consen  555 FHTQ  558 (563)
T ss_pred             HHHH
Confidence            6554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6.6e-30  Score=264.18  Aligned_cols=239  Identities=27%  Similarity=0.374  Sum_probs=192.5

Q ss_pred             cceEEEEEEECCCCeEEEEEEeecccchh-hHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCHH
Q 002897          566 SFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLE  644 (869)
Q Consensus       566 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  644 (869)
                      +||.||+|.+..+|+.+|+|++....... .+.+.+|++.+++++|+|++++++++...     ...++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            58999999998889999999997654433 68899999999999999999999987653     6789999999999999


Q ss_pred             HHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCcc
Q 002897          645 EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV  724 (869)
Q Consensus       645 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  724 (869)
                      +++.....      +++..++.++.+++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----  141 (244)
T smart00220       76 DLLKKRGR------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----  141 (244)
T ss_pred             HHHHhccC------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence            99976542      78999999999999999999999   99999999999999999999999999998765432     


Q ss_pred             ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccch
Q 002897          725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLL  804 (869)
Q Consensus       725 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  804 (869)
                          ......++..|+|||...+..++.++||||+|+++|++++|..||......    ............ ..      
T Consensus       142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~~~-~~------  206 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKPKP-PF------  206 (244)
T ss_pred             ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCC-CC------
Confidence                223345788999999998888999999999999999999999998642111    111111100000 00      


Q ss_pred             hhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          805 LEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       805 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                                    ......++..+.+++.+|+..+|++||++.|+++
T Consensus       207 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 --------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             --------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence                          0000014457889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.3e-30  Score=281.95  Aligned_cols=268  Identities=18%  Similarity=0.187  Sum_probs=183.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC----------------CCCeEEEEEEeecccchhhHH--------------HHHH
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG----------------ENGMLVAVKVLNLMQKGALKS--------------FLTE  601 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  601 (869)
                      ..++|++.++||+|+||+||+|...                ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                345789999986543332222              3346


Q ss_pred             HHHHHhCCCCc-----cceEEEEeecccc---CCCceEEEEeecccCCCHHHHHhhCCCcc------------------c
Q 002897          602 CEALRSIRHRN-----LIKIITICSSIDF---NGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------------E  655 (869)
Q Consensus       602 ~~~l~~l~h~n-----iv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~  655 (869)
                      +.++.+++|.+     +++++++|.....   ......++||||+++|+|.++++......                  .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            67777776654     4677777654211   12356899999999999999997532110                  1


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccC
Q 002897          656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG  735 (869)
Q Consensus       656 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g  735 (869)
                      ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++........       .......+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccCC
Confidence            12357788999999999999999999   999999999999999999999999999975533211       11112235


Q ss_pred             cccccCCcccCCCC--------------------C--CccccchhhhHHHHHHHcCCC-CCCcCccCCch-------HHH
Q 002897          736 TVGYIAPEYGTGSE--------------------A--SMTGDVYSFGILLLEMFSRRR-PTDSMFHEGLT-------LHE  785 (869)
Q Consensus       736 t~~y~aPE~~~~~~--------------------~--~~~sDvwslG~il~el~tg~~-pf~~~~~~~~~-------~~~  785 (869)
                      ++.|+|||.+....                    +  ..+.||||+||++|+|++|.. ||.....-...       ...
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~  452 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR  452 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence            78999999875432                    1  134799999999999999875 66432111111       111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESP---TDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  852 (869)
                      |.... .    ...+                  ............+++.+|+..+|   .+|+|++|+++
T Consensus       453 ~r~~~-~----~~~~------------------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        453 WRMYK-G----QKYD------------------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHhhc-c----cCCC------------------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11000 0    0000                  00112334567789999999766   78999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-31  Score=254.36  Aligned_cols=204  Identities=24%  Similarity=0.370  Sum_probs=178.0

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ...++|...++||+|+|+.|..++.+++.+.+|+|++++.   +.+..+-.+.|-.+..+- +||.+|.+..+     |+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fq  321 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQ  321 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hc
Confidence            3457899999999999999999999999999999999743   344556677787777766 79999998887     44


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      .....++|.||++||+|--.+++.+.      ++++.++.+...|.-||.|||++   ||+.||+|.+|||+|..|++|+
T Consensus       322 tesrlffvieyv~ggdlmfhmqrqrk------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhhhc------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceee
Confidence            55889999999999999877776653      99999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +|+|+++.--.        ....++...||+.|+|||.+.+..|+..+|-|++||+++||+.|+.||+-.
T Consensus       393 tdygmcke~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  393 TDYGMCKEGLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             cccchhhcCCC--------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            99999974322        224567789999999999999999999999999999999999999999753

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=257.16  Aligned_cols=204  Identities=23%  Similarity=0.360  Sum_probs=168.7

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      +.+..+.||.|+||+||.+++..+|+.||+|.+...  .-...+++.+|+.++..++|.|++..+++......+--.+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445668999999999999999999999999988532  223457889999999999999999998876543333335567


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      .++|.|.. +|...+-...      +++...+.-+.+||++||+|||+.   +|.||||||.|.+++.+...||||||+|
T Consensus       134 V~TELmQS-DLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHh-hhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence            88888854 8887776543      488999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      +.-..+..       ......+-|..|+|||.+.|. .|+.+.||||.|||+.|++..+..|..
T Consensus       204 Rvee~d~~-------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  204 RTWDQRDR-------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             cccchhhh-------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            87654321       222334568899999999886 589999999999999999999988865

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=273.88  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=197.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec---ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++.++..||-|+||.|-++........+|+|++++   .+....+....|-.||...+.|.||++|..|.     +..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-----d~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-----DSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-----cchh
Confidence            456677899999999999999865555689888853   33445567889999999999999999998754     4588


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+.||-|-||.++..++.+..      ++......++..+++|++|||++   +||.||+||+|.+++.+|.+||.|||
T Consensus       495 vYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence            9999999999999999988764      88889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+...         ..+..++||+.|.|||++.....+.++|.||+|+++||+++|.+||.+...- ..+....+.+
T Consensus       566 FAKki~~g---------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkGi  635 (732)
T KOG0614|consen  566 FAKKIGSG---------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKGI  635 (732)
T ss_pred             hHHHhccC---------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhhh
Confidence            99988654         4566788999999999999999999999999999999999999999864321 1111111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                         +.                       ...+..+.+...+++.+..+.+|.+|.-
T Consensus       636 ---d~-----------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 ---DK-----------------------IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hh-----------------------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence               00                       0011234455678899999999999975

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-32  Score=270.15  Aligned_cols=305  Identities=19%  Similarity=0.237  Sum_probs=196.5

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcC-c
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR-N   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~-n   80 (869)
                      .|.++.+++ +||.++.   .....++|..|+|+.+.|.+|+.+++|++||||+|.|+.+-|++|.+|++|.+|-+-+ |
T Consensus        51 VdCr~~GL~-eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   51 VDCRGKGLT-EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             EEccCCCcc-cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            467889999 9999998   5788999999999988889999999999999999999999999999999988887766 9


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +|+.+..+.|.+|.+|+-|.+.-|++. .++.++|+.|++|..|.+.+|.+..+.-..|..+.+++.+.+..|.+..   
T Consensus       127 kI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic---  202 (498)
T KOG4237|consen  127 KITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC---  202 (498)
T ss_pred             chhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc---
Confidence            999777778888999999999888887 7888888999999999999988886666688888888888888887321   


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccce-EEEecCCcccccCC
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMT-TIDIGGNYFSGTIP  239 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~-~L~l~~n~l~~~~~  239 (869)
                        ..+++.+.. ++.-|.            ..+++..-..-..+.++++..+.+..|......+. .+....+... +-|
T Consensus       203 --dCnL~wla~-~~a~~~------------ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP  266 (498)
T KOG4237|consen  203 --DCNLPWLAD-DLAMNP------------IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICP  266 (498)
T ss_pred             --ccccchhhh-HHhhch------------hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cCh
Confidence              111111111 011111            11223333333334444443333333322211010 1111111111 222


Q ss_pred             -ccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcc
Q 002897          240 -PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT  318 (869)
Q Consensus       240 -~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  318 (869)
                       ..|..+++|+.|+|++|+++.+-+.+|.++..+++|+|..|+|..+-...|.++..|+.|+|.+|+|+...|.+|..+.
T Consensus       267 ~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~  346 (498)
T KOG4237|consen  267 AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF  346 (498)
T ss_pred             HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence             2355555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             ccceeeccCccc
Q 002897          319 SLIMLTLSKNKL  330 (869)
Q Consensus       319 ~L~~L~l~~N~l  330 (869)
                      +|.+|+|-.|.+
T Consensus       347 ~l~~l~l~~Np~  358 (498)
T KOG4237|consen  347 SLSTLNLLSNPF  358 (498)
T ss_pred             eeeeeehccCcc
Confidence            555555555544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=268.97  Aligned_cols=206  Identities=25%  Similarity=0.398  Sum_probs=176.7

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCC---CCcc
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIR---HRNL  613 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~ni  613 (869)
                      .++...+...+|+..+.+|.|+||.|+.|.++++...|+||.+.+..        .......-.|+.||..++   |+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            33444455568999999999999999999999999999999985432        112234567999999996   9999


Q ss_pred             ceEEEEeeccccCCCceEEEEeecc-cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          614 IKIITICSSIDFNGVDFKAIVYDFM-QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       614 v~~~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                      +++++++     ++++++|++||-. ++.+|++++.....      +++.+...|++|++.|+++||+.   ||||||||
T Consensus       632 lKlLdfF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdik  697 (772)
T KOG1152|consen  632 LKLLDFF-----EDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIK  697 (772)
T ss_pred             hhhhhee-----ecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccccc---Cceecccc
Confidence            9999995     5568999999975 45689999988764      89999999999999999999999   99999999


Q ss_pred             CCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCC
Q 002897          693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRR  771 (869)
Q Consensus       693 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~  771 (869)
                      -+||.++.+|-+||+|||.|.....++.          ..++||..|.|||++.|.+| +..-||||+|+++|.++....
T Consensus       698 denvivd~~g~~klidfgsaa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken  767 (772)
T KOG1152|consen  698 DENVIVDSNGFVKLIDFGSAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN  767 (772)
T ss_pred             cccEEEecCCeEEEeeccchhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence            9999999999999999999987766543          34679999999999999987 566899999999999999999


Q ss_pred             CCC
Q 002897          772 PTD  774 (869)
Q Consensus       772 pf~  774 (869)
                      ||.
T Consensus       768 pyy  770 (772)
T KOG1152|consen  768 PYY  770 (772)
T ss_pred             CCc
Confidence            975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.9e-29  Score=264.31  Aligned_cols=212  Identities=24%  Similarity=0.305  Sum_probs=175.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +-|..++.||-|+||.|.+|+..++...||.|.+++.+   +........|-+||..-+.+-||+++..     |++.+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            35778899999999999999998899999999987544   3344567889999999999999999887     456699


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+||+|++||++-..+-+..-      +.+..++.++.++..|+++.|..   |+|||||||+|||||.+|++||+|||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            9999999999999999887653      78888899999999999999999   99999999999999999999999999


Q ss_pred             ccccCCC---------CCC--CCcccc-----------------------CCCCCCccCcccccCCcccCCCCCCccccc
Q 002897          711 LAKFLPA---------RPL--DTVVET-----------------------PSSSSGIKGTVGYIAPEYGTGSEASMTGDV  756 (869)
Q Consensus       711 ~a~~~~~---------~~~--~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv  756 (869)
                      ++.-+.-         +..  .+.++.                       .......+||+.|+|||++....|+.-+|-
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            9865421         000  000000                       001123569999999999999999999999


Q ss_pred             hhhhHHHHHHHcCCCCCCcCccC
Q 002897          757 YSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       757 wslG~il~el~tg~~pf~~~~~~  779 (869)
                      ||.|||||||+.|++||-.....
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCC
Confidence            99999999999999999765444

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=5e-30  Score=263.32  Aligned_cols=205  Identities=22%  Similarity=0.306  Sum_probs=174.1

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC------CCccceEEEEeeccc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR------HRNLIKIITICSSID  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~  624 (869)
                      ....+|.+....|+|-|++|..|.+...|..||||++.... ...+.=..|++||+++.      --|+++++..|.   
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~---  504 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK---  504 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh---
Confidence            44578999999999999999999999899999999996533 34466689999999994      347888877644   


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-c
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-V  703 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~  703 (869)
                        ..++.|+|||-+ ..+|.+++++.+..   ..+....+..++.|+.-||..|-..   +|+|.||||+||||++.- .
T Consensus       505 --hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  505 --HKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             --hcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence              458999999988 55999999987753   4588999999999999999999998   999999999999998764 7


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      +||||||.|....+...+.          +.-+..|+|||++.|-+|+...|+||.||+|||+.||+..|.+...
T Consensus       576 LKLCDfGSA~~~~eneitP----------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITP----------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             eeeccCccccccccccccH----------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            8999999998877654322          2346789999999999999999999999999999999999976433

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=243.97  Aligned_cols=271  Identities=19%  Similarity=0.239  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  629 (869)
                      ..+|.-.+.+|.|.- .|..|.+.-.++.||+|.+..  ......++..+|...+..+.|+||++++.++.... .....
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357778889999998 788888888999999998742  23445688899999999999999999999886532 22345


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+|||+|. ++|.+.+...        ++-+.+..|..|++.|++|||+.   ||+|||+||+||++..+..+||.||
T Consensus        95 e~y~v~e~m~-~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILME--------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence            6799999994 5999998843        67788999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+.....         -..+..+.|..|+|||++.+..+.+.+||||+||++.||++|+.-|.+    ...+.+|.+.
T Consensus       163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki  229 (369)
T KOG0665|consen  163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKI  229 (369)
T ss_pred             hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHH
Confidence            999865443         123456789999999999998899999999999999999999998863    3334444333


Q ss_pred             hcccccccccCccchhhhhhc-----------------ccccCC---CccchHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRAN-----------------NSMSRG---GERVKIEECLVAVIRIGVVCSMESPTDRMQMRD  849 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~-----------------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  849 (869)
                      .-   .....|++...+....                 ...+..   ...+...-......+++.+|+-.+|++|.|+++
T Consensus       230 ~~---~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d  306 (369)
T KOG0665|consen  230 IE---QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD  306 (369)
T ss_pred             HH---HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence            21   0111111111110000                 000000   000001112345678999999999999999999


Q ss_pred             HHH
Q 002897          850 VVV  852 (869)
Q Consensus       850 vl~  852 (869)
                      +++
T Consensus       307 aL~  309 (369)
T KOG0665|consen  307 ALR  309 (369)
T ss_pred             Hhc
Confidence            986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.9e-29  Score=235.32  Aligned_cols=255  Identities=19%  Similarity=0.270  Sum_probs=194.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+.|.+.+.+|+|.||.+-+|+++.+.+.+|+|.++... ...++|.+|...--.+ .|.||+.-+++.    |+..+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence            356899999999999999999999999999999986543 2457888888765556 589999887763    5566889


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCcEEEccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDMVAHVGDF  709 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df  709 (869)
                      .+++||++.|+|.+-+...+       +.+....+++.|+++|+.|||++   ++||||||.+||||-  +..++|+|||
T Consensus        98 vF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             EEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            99999999999999887754       78888999999999999999999   999999999999993  2348999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      |.++..+..           .....-+..|.|||.....     ...+.+|||.||+++|.++||+.||+.....+..+.
T Consensus       168 G~t~k~g~t-----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~  236 (378)
T KOG1345|consen  168 GLTRKVGTT-----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW  236 (378)
T ss_pred             ccccccCce-----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence            999755432           1222346779999975432     357789999999999999999999986655555555


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      +|....-....      .+               +.......+.+.++.++-+..+|++|=-..++.++-
T Consensus       237 ~~~~w~~rk~~------~~---------------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  237 EWEQWLKRKNP------AL---------------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHHhcccCc------cC---------------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            55443321111      11               111123345677888899999999995555554443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=8e-30  Score=269.85  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|....++|.|.||.||+|+++.+++..|+|+++....+..+-.+.|+-+++..+||||+.+++-+...     +..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cCcE
Confidence            35799999999999999999999999999999999988888888899999999999999999999986543     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      |+||||.+|+|.+.-+-..      ++++.++..+++...+|++|||+.   |-+|||||-.||++++.|.+|++|||.+
T Consensus        89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence            9999999999999877655      489999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCccc---CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG---TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ..+...        ..+.....||+.|||||+.   ..+.|..++|||++|+...|+---++|-.......... -..+.
T Consensus       160 aqitat--------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-LmTkS  230 (829)
T KOG0576|consen  160 AQITAT--------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LMTKS  230 (829)
T ss_pred             hhhhhh--------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-Hhhcc
Confidence            655432        2455668899999999974   45679999999999999999998888843221111100 00010


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+.  ....-|+.                     ...+.+-++++.|+..+|++|||++.++.
T Consensus       231 ~~q--pp~lkDk~---------------------kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQ--PPTLKDKT---------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCC--CCcccCCc---------------------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            000  00011111                     23455778999999999999999988765

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=6.8e-31  Score=261.82  Aligned_cols=398  Identities=19%  Similarity=0.237  Sum_probs=238.2

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccC-CccCccCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRG-NRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      ++|+.|+|+ +||.+.|..+++|++|||++|+|+.+-|++|.++..|..|-+-+ |+|+.+..++|++|..|+.|.+.-|
T Consensus        72 irLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan  150 (498)
T KOG4237|consen   72 IRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNAN  150 (498)
T ss_pred             EEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChh
Confidence            689999999 99999999999999999999999999999999999998876666 9999877889999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccc------------eeccccccCCCCCcEE
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT------------GFLPISLSNASNLELL  148 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~------------~~~~~~l~~l~~L~~L  148 (869)
                      ++.-+..++|..+++|..|.+-.|.+. .++.+.|..+..++.+.+..|.+.            ...|..++...-..-.
T Consensus       151 ~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~  229 (498)
T KOG4237|consen  151 HINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY  229 (498)
T ss_pred             hhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence            999888999999999999999999998 999999999999999999998732            2233344444444444


Q ss_pred             EccCCccccccCcCccCC-CCCCEEEccCc-cCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceE
Q 002897          149 ELRDNQFIGKMSINFNSL-KNLSVLILGNN-HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTT  226 (869)
Q Consensus       149 ~L~~N~i~~~~~~~~~~l-~~L~~L~l~~n-~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~  226 (869)
                      .+.++++..+.+..|.-- ..+.+=..+.+ .....|      ...|..+++|+.|+|++|+|+.+-+.+|.++.. +++
T Consensus       230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP------~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~-l~e  302 (498)
T KOG4237|consen  230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP------AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAE-LQE  302 (498)
T ss_pred             HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh------HHHHhhcccceEeccCCCccchhhhhhhcchhh-hhh
Confidence            444444444444333221 11111111111 111111      124555555555555555555555555555543 555


Q ss_pred             EEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccce--ecccc
Q 002897          227 IDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL--ALEIN  304 (869)
Q Consensus       227 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~l~~n  304 (869)
                      |.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+..       ++ .|..|  .|..+
T Consensus       303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C-------nC-~l~wl~~Wlr~~  374 (498)
T KOG4237|consen  303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC-------NC-RLAWLGEWLRKK  374 (498)
T ss_pred             hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC-------cc-chHHHHHHHhhC
Confidence            5555555554444455555555555555555555555555555555555555443320       00 00000  00000


Q ss_pred             cccccCCcCccCccccceeeccCcccCCC---CCcccc---------ccccccceecccCCcccCCCcccccCCcccccc
Q 002897          305 NLQGKIPSSLGNCTSLIMLTLSKNKLDGV---LPPQIL---------SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL  372 (869)
Q Consensus       305 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~~~---------~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L  372 (869)
                      .-. ..|. -+.-..++.+.++.+.+...   .|+...         .....-+-..-|+..++ .+|..+.  ..-..|
T Consensus       375 ~~~-~~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~tel  449 (498)
T KOG4237|consen  375 SVV-GNPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTEL  449 (498)
T ss_pred             CCC-CCCC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHH
Confidence            000 0000 01112344455544433211   111000         00001111223333343 4444332  235567


Q ss_pred             ccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCC
Q 002897          373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN  425 (869)
Q Consensus       373 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N  425 (869)
                      ++.+|.++ .+|..  .+..| .+++++|++...---.|.++.+|.+|-||.|
T Consensus       450 yl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  450 YLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            77777777 55655  55666 7777777776444456777777777777765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=3.8e-28  Score=245.99  Aligned_cols=283  Identities=25%  Similarity=0.326  Sum_probs=202.7

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ...+.|..+++||.|.|++||+|.+..   ..+.||+|.+....  ...++.+|+++|..+ .+.||+++.+++     .
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r  105 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF-----R  105 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence            345678999999999999999999986   78899999886543  336789999999999 599999999984     4


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAH  705 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k  705 (869)
                      ..+..++|+||++..+..++...         ++..++..+++.+..||+++|..   |||||||||+|++.+.. +.-.
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence            56899999999999998888765         67889999999999999999999   99999999999999754 6789


Q ss_pred             EccccccccCCCCC------C----------C----------------Cc----cccCCCCCCccCcccccCCcccCCCC
Q 002897          706 VGDFGLAKFLPARP------L----------D----------------TV----VETPSSSSGIKGTVGYIAPEYGTGSE  749 (869)
Q Consensus       706 l~Dfg~a~~~~~~~------~----------~----------------~~----~~~~~~~~~~~gt~~y~aPE~~~~~~  749 (869)
                      |+|||+|.......      .          .                ..    .........+.||++|+|||++...+
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999997321100      0          0                00    00011123466999999999987654


Q ss_pred             -CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh----------cccc--cccc----cCccchhhhhhc--
Q 002897          750 -ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV----------LPEK--VMEI----VDPSLLLEVRAN--  810 (869)
Q Consensus       750 -~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~----------~~~~--~~~~----~d~~~~~~~~~~--  810 (869)
                       -++++||||.|||+.-+++++.||-....+-..+.+.+...          ..+.  +.+.    ..+.....+..-  
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence             68899999999999999999999976555433333322111          1111  1110    001111111100  


Q ss_pred             --ccc-cC-CCccchH-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          811 --NSM-SR-GGERVKI-EECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       811 --~~~-~~-~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ... .. ...+... +..+..+++++.+|+..||.+|.||+|.++
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              000 00 0111111 223457899999999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=7.8e-27  Score=235.52  Aligned_cols=211  Identities=30%  Similarity=0.522  Sum_probs=182.2

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccC
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQN  640 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  640 (869)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.+.|++++++++++...     ...++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            68999999999999877999999999755432 357789999999999999999999997643     678999999999


Q ss_pred             CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEccccccccCCCCC
Q 002897          641 GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDFGLAKFLPARP  719 (869)
Q Consensus       641 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~  719 (869)
                      ++|.+++.....     .+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        76 ~~l~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          76 GSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999999987531     388999999999999999999999   9999999999999999 8999999999998665432


Q ss_pred             CCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccc
Q 002897          720 LDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI  798 (869)
Q Consensus       720 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  798 (869)
                      .        ......+...|++||..... .++.++|+|++|++++++                                
T Consensus       148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------  187 (215)
T cd00180         148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------  187 (215)
T ss_pred             c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence            1        12234578899999998877 788999999999999999                                


Q ss_pred             cCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          799 VDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       799 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                                                  ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                        135689999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=4.9e-26  Score=232.17  Aligned_cols=200  Identities=31%  Similarity=0.506  Sum_probs=173.0

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      |.+.+.||.|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            56778999999999999999877999999999765544 567889999999999999999999986543     678999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      +||+++++|.+++......     +++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            9999999999999875431     78899999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCccc-CCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      ......       .......++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDLA-------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCccc-------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            654320       122334578889999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=6.4e-25  Score=214.31  Aligned_cols=170  Identities=21%  Similarity=0.265  Sum_probs=129.8

Q ss_pred             CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCC
Q 002897          641 GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL  720 (869)
Q Consensus       641 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  720 (869)
                      |+|.++++....     ++++.+++.++.|+++||+|||+.   +      ||+||+++.++.+|+  ||.+....... 
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence            689999986443     399999999999999999999999   6      999999999999999  99987654321 


Q ss_pred             CCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccC
Q 002897          721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVD  800 (869)
Q Consensus       721 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  800 (869)
                                  ..|++.|+|||++.+..++.++|||||||++|||+||+.||............+.....+..      
T Consensus        64 ------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  125 (176)
T smart00750       64 ------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------  125 (176)
T ss_pred             ------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------
Confidence                        25789999999999999999999999999999999999998653322222222211111000      


Q ss_pred             ccchhhhhhcccccCCCccchHHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          801 PSLLLEVRANNSMSRGGERVKIEECLV--AVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      +               ..+........  .+.+++.+||+.+|++||++.|+++.+..+...
T Consensus       126 ~---------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      126 P---------------RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             c---------------cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            0               00011122333  688999999999999999999999998877544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.92  E-value=2.5e-24  Score=266.13  Aligned_cols=337  Identities=20%  Similarity=0.253  Sum_probs=203.2

Q ss_pred             CcccccCcCCCEEEccCCc------cCccCCccccCCC-CCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCC
Q 002897           39 PVSIGNLSALQVIDIRGNR------LGGKIPDTLGQLR-KLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLP  111 (869)
Q Consensus        39 ~~~~~~l~~L~~L~L~~n~------i~~~~p~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  111 (869)
                      +.+|.++.+|+.|.+..++      +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            3445555555555554432      2223444444443 4556666555555 344444 3455566666666554 444


Q ss_pred             chhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCc-cCCCCCCCCcchh
Q 002897          112 FDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN-HLGNRAANDLDFV  190 (869)
Q Consensus       112 ~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~  190 (869)
                      .+ +..+++|+.|+|++|.....+| .++.+++|++|+|++|......|..+..+++|+.|++++| .++.++..     
T Consensus       628 ~~-~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~-----  700 (1153)
T PLN03210        628 DG-VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG-----  700 (1153)
T ss_pred             cc-cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc-----
Confidence            32 3455566666665544333333 3555666666666666544455556666666666666654 34444432     


Q ss_pred             hhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcce-------ecCC
Q 002897          191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI-------GTVP  263 (869)
Q Consensus       191 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------~~~~  263 (869)
                         .++++|+.|++++|.....+|..    ..+|+.|+|++|.++ .+|..+ .+++|++|.+.++...       ...+
T Consensus       701 ---i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~  771 (1153)
T PLN03210        701 ---INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTP  771 (1153)
T ss_pred             ---CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccch
Confidence               15667777777776544444432    223777777777776 455544 5677777777664321       1122


Q ss_pred             ccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccccc
Q 002897          264 PEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT  343 (869)
Q Consensus       264 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  343 (869)
                      ..+...++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.       
T Consensus       772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~-------  843 (1153)
T PLN03210        772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD-------  843 (1153)
T ss_pred             hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc-------
Confidence            223345789999999998777889999999999999999886544777766 788999999998754322222       


Q ss_pred             ccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeC-ccccCCCCccccccccccEEEc
Q 002897          344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD-NSFSGSIPPSLNFLKSIKVLDL  422 (869)
Q Consensus       344 ~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~L  422 (869)
                                        .   .++|+.|+|++|.++ .+|.++..+++|+.|++++ |+++ .+|..+..+++|+.|++
T Consensus       844 ------------------~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l  900 (1153)
T PLN03210        844 ------------------I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDF  900 (1153)
T ss_pred             ------------------c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeec
Confidence                              1   235666666666666 5666666667777777766 3344 46666666677777777


Q ss_pred             cCC
Q 002897          423 SSN  425 (869)
Q Consensus       423 ~~N  425 (869)
                      ++|
T Consensus       901 ~~C  903 (1153)
T PLN03210        901 SDC  903 (1153)
T ss_pred             CCC
Confidence            666

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.92  E-value=3.3e-24  Score=265.12  Aligned_cols=340  Identities=19%  Similarity=0.273  Sum_probs=220.8

Q ss_pred             cCCccccCCCCCCEEeCcCcc------cCccCCcccccCC-CCcEEECcCCcCcccCCchhhcCCcchhhhhccccccce
Q 002897           61 KIPDTLGQLRKLIYLNIGRNQ------FSGFIPPSIYNIS-SFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTG  133 (869)
Q Consensus        61 ~~p~~~~~l~~L~~L~L~~n~------i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~  133 (869)
                      ..+.+|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|.. | ...+|+.|++.+|++..
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~-f-~~~~L~~L~L~~s~l~~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSN-F-RPENLVKLQMQGSKLEK  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCc-C-CccCCcEEECcCccccc
Confidence            345667778888888776553      2234566666654 5788888887776 77754 2 46777888888887773


Q ss_pred             eccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc-CCCCCCCCcchhhhccCCCCCcEEEccCCCCCCC
Q 002897          134 FLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH-LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL  212 (869)
Q Consensus       134 ~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~  212 (869)
                       ++..+..+++|+.|+|++|......| .+..+++|++|+|++|. +..++       ..+..+++|+.|++++|...+.
T Consensus       626 -L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp-------~si~~L~~L~~L~L~~c~~L~~  696 (1153)
T PLN03210        626 -LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELP-------SSIQYLNKLEDLDMSRCENLEI  696 (1153)
T ss_pred             -cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccc-------hhhhccCCCCEEeCCCCCCcCc
Confidence             56667777888888887765333333 46777788888887764 33333       3467777888888877654445


Q ss_pred             CChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcccc-------Cc
Q 002897          213 LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH-------GY  285 (869)
Q Consensus       213 ~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------~~  285 (869)
                      +|..+ ++.+ |+.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|++|++.++...       ..
T Consensus       697 Lp~~i-~l~s-L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l  769 (1153)
T PLN03210        697 LPTGI-NLKS-LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPL  769 (1153)
T ss_pred             cCCcC-CCCC-CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcccccccc
Confidence            56544 4443 778888877654444432   356777788888776 455544 4677777777664322       11


Q ss_pred             CCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccC
Q 002897          286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN  365 (869)
Q Consensus       286 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~  365 (869)
                      .+..+...++|+.|++++|.....+|.+++++++|+.|++++|...+                         .+|..+ +
T Consensus       770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~-------------------------~LP~~~-~  823 (1153)
T PLN03210        770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE-------------------------TLPTGI-N  823 (1153)
T ss_pred             chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC-------------------------eeCCCC-C
Confidence            12222334577788888777666777778888888888877764321                         233333 4


Q ss_pred             CccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccC-CcccCCCccccccccccCee
Q 002897          366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS-NKLSGQIPKYLENLSFLEYL  444 (869)
Q Consensus       366 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~l  444 (869)
                      +++|+.|+|++|..-..+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.+
T Consensus       824 L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L  898 (1153)
T PLN03210        824 LESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETV  898 (1153)
T ss_pred             ccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCee
Confidence            567777777776543344442   356777888888877 6777777788888888877 4554 566677777778888


Q ss_pred             cccccc
Q 002897          445 NLSYNH  450 (869)
Q Consensus       445 ~l~~N~  450 (869)
                      ++++|.
T Consensus       899 ~l~~C~  904 (1153)
T PLN03210        899 DFSDCG  904 (1153)
T ss_pred             ecCCCc
Confidence            877764

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=5.1e-25  Score=264.67  Aligned_cols=207  Identities=16%  Similarity=0.235  Sum_probs=139.1

Q ss_pred             hCCC-CccceEEEEeeccccC--CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002897          607 SIRH-RNLIKIITICSSIDFN--GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCK  683 (869)
Q Consensus       607 ~l~h-~niv~~~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  683 (869)
                      .++| +||+++++++.....+  .....+.++||+ +++|.+++.....     .+++.+++.++.||++||+|||++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR-----SVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc-----cccHHHHHHHHHHHHHHHHHHHhC--
Confidence            3455 5788888876332211  124567788887 6699999975432     389999999999999999999999  


Q ss_pred             CCeEecCCCCCceeecCCCc-------------------EEEccccccccCCCCCCC------Ccc--ccCCCCCCccCc
Q 002897          684 PPVVHGDLKPSNVLLDHDMV-------------------AHVGDFGLAKFLPARPLD------TVV--ETPSSSSGIKGT  736 (869)
Q Consensus       684 ~~ivH~Dlkp~NIll~~~~~-------------------~kl~Dfg~a~~~~~~~~~------~~~--~~~~~~~~~~gt  736 (869)
                       ||+||||||+|||++..+.                   +|++|||+++........      ...  ..........||
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             9999999999999965444                   555555555432110000      000  000011224588


Q ss_pred             ccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCC
Q 002897          737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRG  816 (869)
Q Consensus       737 ~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  816 (869)
                      +.|||||++.+..++.++|||||||++|||++|.+|+....   ..........        .++..             
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~--------~~~~~-------------  234 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRV--------LPPQI-------------  234 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhh--------cChhh-------------
Confidence            99999999999999999999999999999999988864211   1111111110        00000             


Q ss_pred             CccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          817 GERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       817 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                            .........++.+||+.+|.+||+|.|+++
T Consensus       235 ------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 ------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                  011223457888999999999999999986

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=1.3e-24  Score=247.99  Aligned_cols=265  Identities=25%  Similarity=0.290  Sum_probs=179.3

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .+-..|+|++|.|+ .+|+.+.  .+|+.|++++|+|+ .+|..   +++|++|+|++|+|+. +|..   .++|+.|+|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            44556666666666 4555554  35666666666666 34432   4566667777766663 3432   346666677


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|.+. .+|.    ..++|+.|++++|+++.+ |.   ..++|+.|+|++|+|+++.. .   ..+|+.|++++|+++.
T Consensus       270 s~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~  336 (788)
T PRK15387        270 FSNPLT-HLPA----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS  336 (788)
T ss_pred             cCCchh-hhhh----chhhcCEEECcCCccccc-cc---cccccceeECCCCccccCCC-C---cccccccccccCcccc
Confidence            777665 4552    124566666777776643 32   23578888888888776432 2   2457777888888876


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++.-          ..+|++|+|++|+|++ +|..    +..|+.|++++|.|+ .+|..   ..+|+.|++++|++.+ 
T Consensus       337 LP~l----------p~~Lq~LdLS~N~Ls~-LP~l----p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-  396 (788)
T PRK15387        337 LPTL----------PSGLQELSVSDNQLAS-LPTL----PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-  396 (788)
T ss_pred             cccc----------ccccceEecCCCccCC-CCCC----Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-
Confidence            6521          1468888888888874 4432    234778888888888 35543   2468889999998884 


Q ss_pred             CCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI  338 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  338 (869)
                      +|..   .++|+.|++++|+|++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..+
T Consensus       397 LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        397 LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            5543   3679999999999985 5543   346888999999998 789999999999999999999997766544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.9e-24  Score=225.72  Aligned_cols=175  Identities=21%  Similarity=0.177  Sum_probs=134.1

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECC-CCeEEEEEEeecc-----cchhhHHHHHHHHHHHhCCCCccceEEEEeecc
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGE-NGMLVAVKVLNLM-----QKGALKSFLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      ....++|++.+.||+|+||+||+|.+.. +++.||||++...     .....+.+.+|++++++++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4456789999999999999999999875 6788899987532     222356789999999999999998533221   


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDL-KPSNVLLDHDM  702 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~  702 (869)
                           ...++||||+++++|... ..         ..   ...++.|+++||+|||+.   ||+|||| ||+|||++.++
T Consensus        91 -----~~~~LVmE~~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             -----CCcEEEEEccCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence                 346999999999999632 11         11   146788999999999999   9999999 99999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS  748 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  748 (869)
                      .+||+|||+|+.+...................+++.|+|||.+...
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999999987654322211111222456788899999987654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-23  Score=201.22  Aligned_cols=276  Identities=19%  Similarity=0.229  Sum_probs=213.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      -.|.+.++||+|+||+++.|+.--+++.||||.-...  ....++..|.+.++.+ ..++|..++-|-     +..-+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhh
Confidence            4799999999999999999999999999999975432  2346788999999988 578888887763     2335667


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-----cEEEc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-----VAHVG  707 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~  707 (869)
                      +|+|.+ |.+|.+.+.-....     ++.+++..+|.|+..-++|+|++   ..|.|||||+|+||...+     .+.++
T Consensus       101 LVidLL-GPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence            999988 77999988876553     99999999999999999999999   999999999999997654     58999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|+.+.+......... .......||.+||+-....+.+-+.+.|+-|+|-|+++.+.|..||.+....  ...+-.
T Consensus       172 DFGmAK~YrDp~TkqHIPY-rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~--tnK~kY  248 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPY-REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD--TNKEKY  248 (449)
T ss_pred             eccchhhhcCccccccCcc-ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc--chHHHH
Confidence            9999999887766555443 4455677999999999999999999999999999999999999999874332  111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcccCC
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDG  867 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  867 (869)
                      +.+-     +.-..              .......+..|.++..-+.-.-+.+-.+-|..+-+...+..+.+......|+
T Consensus       249 eKIG-----e~Kr~--------------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg  309 (449)
T KOG1165|consen  249 EKIG-----ETKRS--------------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG  309 (449)
T ss_pred             HHhc-----ccccc--------------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence            1110     00000              0111122345666777776666778888899888888888887777666554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.4e-23  Score=239.63  Aligned_cols=265  Identities=25%  Similarity=0.327  Sum_probs=157.7

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhh
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV  125 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  125 (869)
                      ..-..|+|++|.++ .+|..+.  ++|+.|+|++|+|+. +|.   ..++|++|+|++|+|+ .+|.    ..++|+.|+
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~----lp~sL~~L~  268 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELS  268 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC----cccccceee
Confidence            34556777777776 5666554  367777777777763 443   2466777777777776 5653    235667777


Q ss_pred             ccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEcc
Q 002897          126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY  205 (869)
Q Consensus       126 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~  205 (869)
                      +++|.++.+ |..   .++|+.|++++|+++.+..    .+++|+.|+|++|+++.++..          ..+|+.|+++
T Consensus       269 Ls~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~l----------p~~L~~L~Ls  330 (788)
T PRK15387        269 IFSNPLTHL-PAL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPAL----------PSELCKLWAY  330 (788)
T ss_pred             ccCCchhhh-hhc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCCC----------cccccccccc
Confidence            777776632 322   2456677777777665432    235677777777777665421          1346666777


Q ss_pred             CCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCc
Q 002897          206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY  285 (869)
Q Consensus       206 ~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  285 (869)
                      +|++++ +|.    ++..|+.|+|++|+|+ .+|...   .+|+.|++++|++.. +|..   ..+|+.|+|++|+|++ 
T Consensus       331 ~N~L~~-LP~----lp~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-  396 (788)
T PRK15387        331 NNQLTS-LPT----LPSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-  396 (788)
T ss_pred             cCcccc-ccc----cccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCcccC-
Confidence            777763 332    2234677777777776 344322   356666777777663 4432   2456777777777763 


Q ss_pred             CCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccc
Q 002897          286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI  363 (869)
Q Consensus       286 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~  363 (869)
                      +|..   .++|+.|++++|+|+ .+|..   ..+|+.|++++|+|+ .+|..+..+. .+..|+|++|.|++..|..+
T Consensus       397 LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~-~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        397 LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLS-SETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhcc-CCCeEECCCCCCCchHHHHH
Confidence            3332   245667777777776 34543   235666777777776 5666555433 34567777777776555544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.3e-22  Score=213.02  Aligned_cols=271  Identities=20%  Similarity=0.205  Sum_probs=198.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCC-eEEEEEEeecccchhhHHHHHHHHHHHhCCC----CccceEEEEeeccccCCCc
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLMQKGALKSFLTECEALRSIRH----RNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  629 (869)
                      +|.+.++||+|+||.||.|.+..++ ..+|+|............+..|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999997554 6789998765433333378889999888863    58888888742    2346


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----CcE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-----MVA  704 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~  704 (869)
                      +.++||+.+ |.+|.++......    ..++..++..|+.|++.+|+++|+.   |++||||||+|+.+...     ..+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            789999988 7799998866652    2499999999999999999999999   99999999999999765     369


Q ss_pred             EEccccccc--cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          705 HVGDFGLAK--FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       705 kl~Dfg~a~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      +|.|||+|+  .+...................||..|+++....+...+.+.|+||++.++.|+..|..||........ 
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-  245 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-  245 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence            999999998  33222211111111113456799999999999999999999999999999999999999865332111 


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...............                       .....+..+.++...+-..+..++|....+...++.+....
T Consensus       246 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            111111110000000                       00112344556666666689999999999999988876654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=7.5e-23  Score=191.22  Aligned_cols=209  Identities=24%  Similarity=0.345  Sum_probs=172.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCC-CccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH-RNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..+.|.++++||.|+||.+|.|....+|..||||+-....  ....+..|..+.+.+++ ..|..+..|..+     ..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-----~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTE-----KDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccc-----ccc
Confidence            3468999999999999999999999999999999864332  23567889999999964 556666655433     367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~  707 (869)
                      -.+||+.. |.+|.+.+.-...     .++.++++-++-|++.-++|+|.+   +++||||||+|+|..-+   ..+.++
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence            78999988 7899998876544     389999999999999999999999   99999999999999543   478999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      |||+|+.+.+......... .......||.+|.+-....+..-+.+.|+-|+|.++.++-.|..||++..
T Consensus       157 DFGLaKky~d~~t~~HIpy-re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPY-REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             eccchhhhccccccccCcc-ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            9999998877655444332 34456779999999888888778889999999999999999999998753

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.6e-24  Score=201.83  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=187.7

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      ....+|.+...|..|+|++  .|..+++|++...  .....+.|..|.-.++.+.||||..+++.|..+     ....++
T Consensus       193 nl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i  265 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII  265 (448)
T ss_pred             hhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence            3456889999999999999  5677778877532  233346789999999999999999999998765     678899


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc--ccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLA  712 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfg~a  712 (869)
                      ..||+.|+|+..+++....    -.+..++.+++.+||+|++|||+. +|-|----+....|+||++.+++|+  |--++
T Consensus       266 sq~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             eeeccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee
Confidence            9999999999999987643    367778999999999999999997 3334444689999999999987763  43333


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC---CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      ..               ..+..-.+.||+||.++..+-   -.++|+|||++++||+.|...||.....-+....-..+.
T Consensus       341 fq---------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg  405 (448)
T KOG0195|consen  341 FQ---------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG  405 (448)
T ss_pred             ee---------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence            21               112234789999999887653   357899999999999999999998644332222111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                           +.                      ...++.....+.+++.-|+..||.+||.+..|+-.|+++.
T Consensus       406 -----lr----------------------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 -----LR----------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----cc----------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 11                      1112244566789999999999999999999999888764

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=1.1e-22  Score=234.40  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=111.0

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      +...|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            3444444444444 3333332  24444444444444 2333222  24444444444444 2233222  234444444


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR  182 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~  182 (869)
                      +|.+. .+|....   .+|+.|++++|+|+. +|..+.  ++|+.|+|++|+++.+.. .+.  ++|+.|++++|.++.+
T Consensus       250 ~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~-~lp--~sL~~L~Ls~N~Lt~L  319 (754)
T PRK15370        250 INRIT-ELPERLP---SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPA-HLP--SGITHLNVQSNSLTAL  319 (754)
T ss_pred             CCccC-cCChhHh---CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCcc-cch--hhHHHHHhcCCccccC
Confidence            44444 4443221   234444444444442 233222  245555555555543321 111  2455555555555544


Q ss_pred             CCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecC
Q 002897          183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTV  262 (869)
Q Consensus       183 ~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  262 (869)
                      +..       +  .++|+.|++++|.+++ +|..+.   .+|+.|++++|+|+ .+|..+.  +.|+.|++++|++. .+
T Consensus       320 P~~-------l--~~sL~~L~Ls~N~Lt~-LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L  382 (754)
T PRK15370        320 PET-------L--PPGLKTLEAGENALTS-LPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL  382 (754)
T ss_pred             Ccc-------c--cccceeccccCCcccc-CChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence            321       1  1345555555555553 343332   23555666665555 3444332  35566666666655 33


Q ss_pred             CccccCCCCCCEEEccCccccCcCCCCC----CCCccccceeccccccc
Q 002897          263 PPEIGWLKNLQSLYLNSNFLHGYIPSSL----GNLTMLTLLALEINNLQ  307 (869)
Q Consensus       263 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~n~l~  307 (869)
                      |..+.  .+|+.|++++|++. .+|..+    ..++.+..|++.+|.++
T Consensus       383 P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        383 PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            43332  24566666666665 333322    23355666666666655

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.2e-22  Score=229.84  Aligned_cols=258  Identities=21%  Similarity=0.232  Sum_probs=190.8

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeec----c-cc-hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL----M-QK-GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~-~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ...+++|.|++|.|+.+........++.|.+..    . .. .....+..|+.+-..+.|||++..+..+.+.     ..
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence            356789999999998888876666666665531    1 11 1112256677778888999998776664432     22


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      ..-+||||++ +|...+....      .++..++..++.|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            3333999999 9999998863      278889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCcc-ccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT-GDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.........    ......+.+|+..|+|||.+.+..|.+. .||||.|+++..|.+|+.||......+...   ...
T Consensus       466 ~~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~  538 (601)
T KOG0590|consen  466 AASVFRYPWEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTN  538 (601)
T ss_pred             cceeeccCcch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhh
Confidence            99776544321    1144567889999999999999999765 699999999999999999997654443322   000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....+....                 .+........+.+...++.+|++.||.+|.|+++|++.
T Consensus       539 ~~~~~~~~~-----------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  539 NYSDQRNIF-----------------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccccc-----------------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000000000                 01112223456677899999999999999999999863

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.2e-21  Score=223.59  Aligned_cols=224  Identities=23%  Similarity=0.363  Sum_probs=135.0

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhh
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV  125 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  125 (869)
                      .+...|+++++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|++|+|++|+++ .+|....   ++|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEE
Confidence            46789999999999 6787664  58999999999999 5666554  58999999999998 7875322   3567777


Q ss_pred             ccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEcc
Q 002897          126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY  205 (869)
Q Consensus       126 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~  205 (869)
                      |++|++.. +|..+.  ++|+.|++++|+|+.+ |..+.  ++|+.|++++|+++.++..       +  .++|++|+++
T Consensus       248 Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~~-------l--p~sL~~L~Ls  312 (754)
T PRK15370        248 LSINRITE-LPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTLPAH-------L--PSGITHLNVQ  312 (754)
T ss_pred             CcCCccCc-CChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccCccc-------c--hhhHHHHHhc
Confidence            77777763 344442  3566666666666543 33222  3566666666665554421       1  1244555555


Q ss_pred             CCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCc
Q 002897          206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY  285 (869)
Q Consensus       206 ~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  285 (869)
                      +|+++.                          +|..+.  ++|+.|++++|.+.+ +|..+.  ++|+.|+|++|+|+ .
T Consensus       313 ~N~Lt~--------------------------LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~  360 (754)
T PRK15370        313 SNSLTA--------------------------LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-V  360 (754)
T ss_pred             CCcccc--------------------------CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-c
Confidence            555542                          222221  345555555555542 333332  45666666666665 3


Q ss_pred             CCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccC
Q 002897          286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD  331 (869)
Q Consensus       286 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (869)
                      +|..+.  ++|+.|++++|+|+ .+|..+.  .+|+.|++++|+|+
T Consensus       361 LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        361 LPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             CChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            444332  45666666666666 3444433  25666666666665

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.4e-21  Score=192.76  Aligned_cols=206  Identities=21%  Similarity=0.218  Sum_probs=147.0

Q ss_pred             CCCccceEEEEeeccc----------------------cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHH
Q 002897          609 RHRNLIKIITICSSID----------------------FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN  666 (869)
Q Consensus       609 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~  666 (869)
                      +|||||++.++|.+.-                      .......|+||..++. +|.+|+-...       .+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence            5999999988764420                      1224567899999866 9999997654       67778888


Q ss_pred             HHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC--cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCC
Q 002897          667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDM--VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAP  742 (869)
Q Consensus       667 i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  742 (869)
                      ++.|+++|+.|||.+   ||.|||+|.+|||+.  +|+  ...++|||++-.-+...  -............|...-|||
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--lqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--LQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--cccccccccccCCCcceecch
Confidence            999999999999999   999999999999994  333  67899999885433211  111222334445688889999


Q ss_pred             cccCCCC------CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCC
Q 002897          743 EYGTGSE------ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRG  816 (869)
Q Consensus       743 E~~~~~~------~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  816 (869)
                      |+....+      ...|+|.|+.|.+.||+++..-||..-.+.......+.+..                          
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--------------------------  474 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--------------------------  474 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--------------------------
Confidence            9876432      24689999999999999999999975221111111111111                          


Q ss_pred             CccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          817 GERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       817 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                       .+..++.++..+.+++...++.||++|+++.-....|
T Consensus       475 -LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  475 -LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence             1122335667788999999999999999976655544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=4.4e-21  Score=188.06  Aligned_cols=175  Identities=14%  Similarity=0.130  Sum_probs=134.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhh---HH------HHHHHHHHHhCCCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL---KS------FLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      .++|...+++|.|+||.||++..  ++..+|+|+++.......   ..      +.+|+..+.++.||+|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999766  577899999964432222   22      67999999999999999998885543


Q ss_pred             cc---CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 002897          624 DF---NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH  700 (869)
Q Consensus       624 ~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  700 (869)
                      ..   ......++||||++|.+|.++..          ++.    ....+++.++..+|+.   |++|||+||+||+++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            21   11346899999999999988732          332    2456999999999999   9999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      +| ++++|||..........                    ...+.....++.++|+||||+++....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            98 99999998865432210                    011333445677999999999887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.3e-19  Score=197.78  Aligned_cols=264  Identities=30%  Similarity=0.418  Sum_probs=195.9

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch---hhHHHHHHHHHHHhCCCC-ccceEEEEeeccccCCCceE
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG---ALKSFLTECEALRSIRHR-NLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  631 (869)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+++...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            677889999999999999996   88999998644332   367889999999999988 799999987432     447


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  710 (869)
                      +++++|+.++++.+++......   ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999999999777765421   2388999999999999999999999   999999999999999998 79999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcCccC--CchHHH
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSMFHE--GLTLHE  785 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~~~~--~~~~~~  785 (869)
                      .++............  .......|+..|+|||...+   ..++...|+||+|++++++++|..||......  ......
T Consensus       148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            998554432111000  12456779999999999987   57888999999999999999999997653321  011111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..................                  .......+.+++..|+..+|..|.++.+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTPSLASPLSPSN------------------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCcccccccCccc------------------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111110000000000000                  01223467789999999999999999887764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=6e-21  Score=192.89  Aligned_cols=239  Identities=21%  Similarity=0.270  Sum_probs=150.3

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCC----------CccceEEEEeec
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRH----------RNLIKIITICSS  622 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~  622 (869)
                      +...+.||.|+++.||.|++.++|+.+|||++....   ....+.+.+|.-....+.+          -.++-.++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999999999999999985332   3345666666655444322          122222222110


Q ss_pred             c---c----cCCCc-----eEEEEeecccCCCHHHHHhh---CCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002897          623 I---D----FNGVD-----FKAIVYDFMQNGSLEEWLHQ---NNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVV  687 (869)
Q Consensus       623 ~---~----~~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  687 (869)
                      .   .    -.+..     ..+++|+-+ .+||.+++..   ....  ...+....+..+..|+++.+++||+.   |+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV  167 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GLV  167 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence            0   0    00011     236788877 4588887653   2211  11244556677889999999999999   999


Q ss_pred             ecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--------CCCCccccchhh
Q 002897          688 HGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--------SEASMTGDVYSF  759 (869)
Q Consensus       688 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwsl  759 (869)
                      |+||+|+|++++.+|.++|+||+.....+....           ....+..|.+||....        -.++.+.|.|++
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceee-----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence            999999999999999999999998876543210           0234578999996533        247889999999


Q ss_pred             hHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCC
Q 002897          760 GILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSME  839 (869)
Q Consensus       760 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  839 (869)
                      |+++|.|++|..||+....+.....                     .+.            ...+.++.+..||..++++
T Consensus       237 G~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~------------~C~~~Pe~v~~LI~~lL~~  283 (288)
T PF14531_consen  237 GITLYSLWCGRLPFGLSSPEADPEW---------------------DFS------------RCRDMPEPVQFLIRGLLQR  283 (288)
T ss_dssp             HHHHHHHHHSS-STCCCGGGSTSGG---------------------GGT------------TSS---HHHHHHHHHHT-S
T ss_pred             HHHHHHHHHccCCCCCCCccccccc---------------------cch------------hcCCcCHHHHHHHHHHccC
Confidence            9999999999999985433211111                     000            0014677889999999999


Q ss_pred             CCCCC
Q 002897          840 SPTDR  844 (869)
Q Consensus       840 dP~~R  844 (869)
                      +|.+|
T Consensus       284 ~~~~R  288 (288)
T PF14531_consen  284 NPEDR  288 (288)
T ss_dssp             SGGGS
T ss_pred             CcccC
Confidence            99988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.6e-20  Score=183.20  Aligned_cols=139  Identities=17%  Similarity=0.144  Sum_probs=108.3

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccch--h-------h-----------------HHHHHHHHHHHhCCCCc
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--A-------L-----------------KSFLTECEALRSIRHRN  612 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n  612 (869)
                      ...||+|++|.||+|.+. +|+.||||+++.....  .       .                 .....|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999653211  0       1                 12245999999998877


Q ss_pred             cceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 002897          613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDL  691 (869)
Q Consensus       613 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dl  691 (869)
                      +.....+..       ...++||||++++++........      ++++.++..++.|++.+|+|+ |+.   ||+||||
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            644333211       22389999999887765533222      388999999999999999999 688   9999999


Q ss_pred             CCCceeecCCCcEEEccccccccC
Q 002897          692 KPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       692 kp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+||+++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-21  Score=218.13  Aligned_cols=254  Identities=23%  Similarity=0.256  Sum_probs=177.4

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHH---HHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSF---LTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +|...+.||++.|=.|.+|++. .|. |+||++-+.++ -..+.+   ..|++ ...++|||++++.-+.     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            6777899999999999999995 555 99999854432 223333   44444 4556899999987652     23366


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+|-+|+.+ +|+|.+..+.-      +...+...|+.|++.|+.-+|..   ||+|||||.+||||+.-.-+.|+||.
T Consensus        96 AylvRqyvkh-nLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   96 AYLVRQYVKH-NLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHHHHHHHhh-hhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            7888888866 99999877653      77888999999999999999999   99999999999999999999999997


Q ss_pred             ccccC--CCCCCCCccccCCCCCCccCcccccCCcccCCC----------C-CCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          711 LAKFL--PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS----------E-ASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       711 ~a~~~--~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      .=+..  +++...+   ..........-..|.|||.+...          . .+++.||||+||+++|+++ |++||.-.
T Consensus       166 sFKPtYLPeDNPad---f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS  242 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPAD---FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS  242 (1431)
T ss_pred             ccCCccCCCCCccc---ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence            65432  2221111   11112223344679999965331          2 5788999999999999998 78888521


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                           .+-.+...       ...|++...+.              .+  ...+..++..|++.||++|.+|++.++.-++
T Consensus       243 -----QL~aYr~~-------~~~~~e~~Le~--------------Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  243 -----QLLAYRSG-------NADDPEQLLEK--------------IE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -----HHHhHhcc-------CccCHHHHHHh--------------Cc--CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                 11111111       01111110000              00  1246789999999999999999999987554


Q ss_pred             H
Q 002897          857 A  857 (869)
Q Consensus       857 ~  857 (869)
                      .
T Consensus       295 ~  295 (1431)
T KOG1240|consen  295 L  295 (1431)
T ss_pred             c
Confidence            3

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.9e-19  Score=176.88  Aligned_cols=140  Identities=19%  Similarity=0.198  Sum_probs=111.1

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccch--------------------------hhHHHHHHHHHHHhCCCCc
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--------------------------ALKSFLTECEALRSIRHRN  612 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n  612 (869)
                      ...||+|++|.||+|.+. +|+.||||+++.....                          ....+..|++.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 8999999998753211                          0123467899999999998


Q ss_pred             cceEEEEeeccccCCCceEEEEeecccCCCHHHH-HhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecC
Q 002897          613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEW-LHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGD  690 (869)
Q Consensus       613 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~D  690 (869)
                      +.....+..       ...++||||++++++... +...       +++..+...++.|++.++.++|+ .   ||+|||
T Consensus        81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD  143 (190)
T cd05145          81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD  143 (190)
T ss_pred             CCCceEEEe-------cCCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            754444322       124899999998865433 3322       37788999999999999999999 8   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccCCC
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~~~  717 (869)
                      |||+||+++ ++.++|+|||+|.....
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999998 88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.2e-19  Score=173.58  Aligned_cols=192  Identities=16%  Similarity=0.072  Sum_probs=140.0

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc----hhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK----GALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+...|++|+||+||.+..  .+.+++.+.+.....    -....+.+|+++|+++. |+++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            4568999999999998776  788888777753322    11235789999999995 5889999886         346


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCcEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDL-KPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg  710 (869)
                      +++|||++|.+|.+....             ....++.|++++++++|+.   ||+|||| ||+||+++.++.++|+|||
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            899999999998654321             1135778999999999999   9999999 7999999999999999999


Q ss_pred             ccccCCCCCCC------CccccCCCCCCccCcccccCCcccCCC-CCC-ccccchhhhHHHHHHHcCCCCCCcC
Q 002897          711 LAKFLPARPLD------TVVETPSSSSGIKGTVGYIAPEYGTGS-EAS-MTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       711 ~a~~~~~~~~~------~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +|.........      ..... -.......++.|++|+...-- ..+ .+.+-++-|+-+|.++||..|+.+.
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~-llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRH-LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHH-HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            99855433210      00000 000112256777777753221 222 4568899999999999999987543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-21  Score=173.54  Aligned_cols=166  Identities=30%  Similarity=0.530  Sum_probs=117.7

Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL  320 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  320 (869)
                      .+.++.+.+.|.|++|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3455666777777777777 56666777777777777777776 66777777777777777777776 677777777777


Q ss_pred             ceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeC
Q 002897          321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD  400 (869)
Q Consensus       321 ~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  400 (869)
                      +.|||.+|++..                        ..+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.+
T Consensus       105 evldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd  159 (264)
T KOG0617|consen  105 EVLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD  159 (264)
T ss_pred             hhhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence            777777777652                        145666666777777777777777 6666777777777777777


Q ss_pred             ccccCCCCccccccccccEEEccCCcccCCCccccc
Q 002897          401 NSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE  436 (869)
Q Consensus       401 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  436 (869)
                      |.+- .+|..++.+.+|+.|++.+|+++ .+|..++
T Consensus       160 ndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~  193 (264)
T KOG0617|consen  160 NDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA  193 (264)
T ss_pred             Cchh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence            7766 66677777777777777777766 5555544

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=3.9e-21  Score=170.31  Aligned_cols=181  Identities=27%  Similarity=0.449  Sum_probs=160.0

Q ss_pred             ccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccccccc
Q 002897          266 IGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS  345 (869)
Q Consensus       266 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l  345 (869)
                      +..+.+++.|.|++|+++ ..|..+..+.+|+.|++++|+|. .+|.+++++++|+.|+++-|++.              
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~--------------   92 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN--------------   92 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--------------
Confidence            345678889999999998 77778999999999999999998 78999999999999999998887              


Q ss_pred             ceecccCCcccCCCcccccCCccccccccccccccc-cCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccC
Q 002897          346 LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS  424 (869)
Q Consensus       346 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~  424 (869)
                                  .+|..|+.++.|+.|||++|.++. .+|+.|..++.|+.|+|++|.+. .+|..++.+++|+.|.+.+
T Consensus        93 ------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd  159 (264)
T KOG0617|consen   93 ------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD  159 (264)
T ss_pred             ------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence                        678889999999999999999864 68999999999999999999998 8999999999999999999


Q ss_pred             CcccCCCccccccccccCeeccccccCcccCCCCCcc---CCCccccccCCcccC
Q 002897          425 NKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVF---SNKTRFSLSGNGKLC  476 (869)
Q Consensus       425 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~---~~~~~~~~~~n~~~c  476 (869)
                      |.+- .+|..+..++.|++|.+.+|+++-.+|+.+.+   .+...+.+..|||.-
T Consensus       160 ndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  160 NDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             Cchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence            9998 89999999999999999999999888886544   334556678888853

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=5e-19  Score=190.40  Aligned_cols=219  Identities=27%  Similarity=0.411  Sum_probs=164.3

Q ss_pred             HHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002897          605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKP  684 (869)
Q Consensus       605 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  684 (869)
                      |+.+.|.|+.+++|.+.+.     ...++|.+||..|+|.+.+.....     .+++.....+.++|+.||+|+|+.   
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s---   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNS---   67 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcC---
Confidence            3567899999999998764     778999999999999999988544     389999999999999999999998   


Q ss_pred             Ce-EecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-------CCccccc
Q 002897          685 PV-VHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-------ASMTGDV  756 (869)
Q Consensus       685 ~i-vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv  756 (869)
                      +| .|+.+++.|.+++..+.+|++|||+.........      ........-..-|.|||.+.+..       .+.++||
T Consensus        68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi  141 (484)
T KOG1023|consen   68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI  141 (484)
T ss_pred             cceeeeeeccccceeeeeEEEEechhhhccccccccc------ccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence            55 9999999999999999999999999987653110      01111222456799999887641       4667999


Q ss_pred             hhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhc
Q 002897          757 YSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVC  836 (869)
Q Consensus       757 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  836 (869)
                      ||||++++|+++.+.||+........ .+.+..+.. .....+-|.+.                ...+.++.+..++..|
T Consensus       142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~----------------~~~e~~~~l~~l~~~c  203 (484)
T KOG1023|consen  142 YSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIE----------------LLNELPPELLLLVARC  203 (484)
T ss_pred             ehHHHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCcchh----------------hhhhcchHHHHHHHHh
Confidence            99999999999999999864433222 222211111 11111111111                1114455788999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          837 SMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       837 l~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      |..+|++||++++|-..++.+...
T Consensus       204 w~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  204 WEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccChhhCccHHHHHhhhhhhccc
Confidence            999999999999999988877664

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.1e-18  Score=169.37  Aligned_cols=140  Identities=17%  Similarity=0.222  Sum_probs=108.9

Q ss_pred             CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-----CCCccceEEEEeeccccCCCce
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-----RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +.-.+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     +||||++++|++.+.  .+...
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeE
Confidence            34567999999999995  6556665 69988765444567899999999999     579999999998764  12233


Q ss_pred             -EEEEeec--ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeecCC----C
Q 002897          631 -KAIVYDF--MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI-EYLHHHCKPPVVHGDLKPSNVLLDHD----M  702 (869)
Q Consensus       631 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~~----~  702 (869)
                       ..+|+||  +.+|+|.+++++..       +++.  ..++.|++.++ +|||++   +|+||||||+||+++..    +
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence             4478999  55799999997642       4444  35677888777 999999   99999999999999743    3


Q ss_pred             cEEEcccccc
Q 002897          703 VAHVGDFGLA  712 (869)
Q Consensus       703 ~~kl~Dfg~a  712 (869)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            8999995443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=1.5e-20  Score=202.68  Aligned_cols=207  Identities=24%  Similarity=0.256  Sum_probs=136.6

Q ss_pred             cccCCCccc-ccCChhhhhccCCcCEEeccCCcCcc----ccCcccccCcCCCEEEccCCccCc------cCCccccCCC
Q 002897            2 FDAQNNKLV-GDIPVEIGCYLFKLENLSLAENHLTG----QLPVSIGNLSALQVIDIRGNRLGG------KIPDTLGQLR   70 (869)
Q Consensus         2 l~l~~~~~~-~~ip~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~------~~p~~~~~l~   70 (869)
                      |||++++++ +..+ .++..+.+|++|+++++.++.    .++..+...++|++|+++++.+.+      .++..+..++
T Consensus         3 l~L~~~~l~~~~~~-~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           3 LSLKGELLKTERAT-ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             cccccCcccccchH-HHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            788888887 3444 344578889999999999853    356667788889999999988772      3345677888


Q ss_pred             CCCEEeCcCcccCccCCcccccCCC---CcEEECcCCcCccc-CC--chhhcCC-cchhhhhccccccce----eccccc
Q 002897           71 KLIYLNIGRNQFSGFIPPSIYNISS---FEFIFLQSNRFHGS-LP--FDMVANL-PNLRKFVAAKNNLTG----FLPISL  139 (869)
Q Consensus        71 ~L~~L~L~~n~i~~~~p~~~~~l~~---L~~L~Ls~N~l~~~-~~--~~~~~~l-~~L~~L~l~~n~i~~----~~~~~l  139 (869)
                      +|++|+|++|.+....+..+..+.+   |++|++++|++.+. .+  ...+..+ ++|+.|++++|.+++    ..+..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            9999999999988666777776666   99999999988621 11  1223445 667777777777662    233345


Q ss_pred             cCCCCCcEEEccCCccccc----cCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          140 SNASNLELLELRDNQFIGK----MSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       140 ~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      ..+++|++|++++|.+++.    .+..+..+++|++|++++|.++.....  .+...+..+++|++|++++|.+++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--HHHHHhcccCCCCEEecCCCcCch
Confidence            5666677777777766531    122234445667777776666543322  223345556666666666666654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=6.8e-20  Score=192.35  Aligned_cols=253  Identities=24%  Similarity=0.289  Sum_probs=163.0

Q ss_pred             CCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEE-------Eeeccc
Q 002897          556 FSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIIT-------ICSSID  624 (869)
Q Consensus       556 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-------~~~~~~  624 (869)
                      +.+.+..+..+++.++..+...+   ...++.|..+...-.......+++-.+.-. .|+..+. .+       ......
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKRNK  324 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhccccc
Confidence            44455566666666655444322   233444443332212223334444444333 3443322 22       111111


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                      .....+.+|.|++|+..+|.+|+...+..   ...++.....++.|++.|++|   +   +.+|+|+||.||++..+.++
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence            11234578999999999999999865542   347888899999999999999   6   89999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTL  783 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~  783 (869)
                      ||+|||+.........  ............||..||+||++.+..|+.|+||||||++++|+++ -..+|+    .....
T Consensus       396 kIgDFgl~ts~~~~~~--~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~  469 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDET--VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATL  469 (516)
T ss_pred             hhhhhhheeecccCCc--ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhh
Confidence            9999999987765541  1112234566789999999999999999999999999999999997 333322    22222


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      .+.....+++        ..+.                  +. +.-+.++.+++...|.+||++.++.
T Consensus       470 ~d~r~g~ip~--------~~~~------------------d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  470 TDIRDGIIPP--------EFLQ------------------DY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             hhhhcCCCCh--------HHhh------------------cC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence            2222222221        1111                  11 1224788899999999999655543

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=5.8e-18  Score=171.02  Aligned_cols=144  Identities=17%  Similarity=0.155  Sum_probs=113.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEE-ECCCCeEEEEEEeecccch------------------------hhHHHHHHHHHHHh
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQKG------------------------ALKSFLTECEALRS  607 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  607 (869)
                      ...|++.+.||+|++|.||+|. +..+|+.||+|+++.....                        ....+.+|++.+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458889999999999999999 6568999999998643210                        11235789999999


Q ss_pred             CCCC--ccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002897          608 IRHR--NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP  685 (869)
Q Consensus       608 l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  685 (869)
                      +.+.  .+.+++++         ...++||||++++++..+.....      .....++..++.|++.++++||+.   +
T Consensus       107 L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g  168 (237)
T smart00090      107 LYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---G  168 (237)
T ss_pred             HHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---C
Confidence            9753  34445543         23479999999988876653322      255667789999999999999999   8


Q ss_pred             -eEecCCCCCceeecCCCcEEEccccccccC
Q 002897          686 -VVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       686 -ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                       ++|||+||+||+++ ++.++|+|||.|...
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             99999999999999 889999999998744

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=5e-20  Score=198.70  Aligned_cols=277  Identities=20%  Similarity=0.236  Sum_probs=161.2

Q ss_pred             EEeccCCcCc-cccCcccccCcCCCEEEccCCccCc----cCCccccCCCCCCEEeCcCcccCc------cCCcccccCC
Q 002897           26 NLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGG----KIPDTLGQLRKLIYLNIGRNQFSG------FIPPSIYNIS   94 (869)
Q Consensus        26 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~i~~------~~p~~~~~l~   94 (869)
                      .|+|..+.++ ......|..+.+|++|++++|.++.    .++..+...++|++|+++++.+.+      .++..+.+++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            5778888887 4556667888889999999998853    245566778889999999988762      2345566777


Q ss_pred             CCcEEECcCCcCcccCCchhhcCCcc---hhhhhccccccce----eccccccCC-CCCcEEEccCCccccccCcCccCC
Q 002897           95 SFEFIFLQSNRFHGSLPFDMVANLPN---LRKFVAAKNNLTG----FLPISLSNA-SNLELLELRDNQFIGKMSINFNSL  166 (869)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~---L~~L~l~~n~i~~----~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~~~~l  166 (869)
                      +|+.|++++|.+.+..+ ..+..+.+   |++|++++|+++.    .+...+..+ ++|+.|++++|.+           
T Consensus        82 ~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l-----------  149 (319)
T cd00116          82 GLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRL-----------  149 (319)
T ss_pred             ceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcC-----------
Confidence            88888888888763222 23333333   5555555555541    112233333 4455555555544           


Q ss_pred             CCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCC----ChhhhhccccceEEEecCCccccc----C
Q 002897          167 KNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLL----PHSLANLSNTMTTIDIGGNYFSGT----I  238 (869)
Q Consensus       167 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~~L~~L~l~~n~l~~~----~  238 (869)
                                   +.....  .+...+..+++|++|++++|.+++..    +..+.... .|+.|++++|.+++.    +
T Consensus       150 -------------~~~~~~--~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~-~L~~L~L~~n~i~~~~~~~l  213 (319)
T cd00116         150 -------------EGASCE--ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANC-NLEVLDLNNNGLTDEGASAL  213 (319)
T ss_pred             -------------CchHHH--HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCC-CCCEEeccCCccChHHHHHH
Confidence                         421111  12223444455555555555554321    11122222 255555555555422    2


Q ss_pred             CccccCCCCCCeeecccCcceecCCcccc-----CCCCCCEEEccCccccC----cCCCCCCCCccccceeccccccccc
Q 002897          239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIG-----WLKNLQSLYLNSNFLHG----YIPSSLGNLTMLTLLALEINNLQGK  309 (869)
Q Consensus       239 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~  309 (869)
                      +..+..+++|++|++++|.+.+.....+.     ..+.|++|++++|.++.    .+...+..+++|+++++++|.++..
T Consensus       214 ~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             HHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence            23455667777777777776642222221     23678888888887762    2223445567788888888888743


Q ss_pred             ----CCcCccCc-cccceeeccCccc
Q 002897          310 ----IPSSLGNC-TSLIMLTLSKNKL  330 (869)
Q Consensus       310 ----~~~~~~~l-~~L~~L~l~~N~l  330 (869)
                          ....+... +.|++|++.+|.+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         294 GAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHHHHhhcCCchhhcccCCCCC
Confidence                34444455 6788888887753

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=5.3e-18  Score=195.13  Aligned_cols=201  Identities=20%  Similarity=0.276  Sum_probs=154.8

Q ss_pred             HHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC---CCccceEEEEeeccc
Q 002897          548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR---HRNLIKIITICSSID  624 (869)
Q Consensus       548 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  624 (869)
                      +.......|.+.+.+|+|+||+||+|... +|+.||+|+-+....   -+|.--.+++.+++   -+.|+++...+..  
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~--  765 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF--  765 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc--
Confidence            34455678999999999999999999997 499999998754332   11222223344443   2333333333221  


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH----  700 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----  700 (869)
                         .+.-++|+||.+.|+|.+++...+      .++|.-++.++.|++..+++||..   +||||||||+|+|+..    
T Consensus       766 ---~~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  766 ---QNASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             ---CCcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence               255689999999999999999544      389999999999999999999999   9999999999999943    


Q ss_pred             ---CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCC
Q 002897          701 ---DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP  772 (869)
Q Consensus       701 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p  772 (869)
                         ..-++|+|||.|..+.--..      .......++|-.+-.+|...|.+++..+|-|.++.+++-|+.|+..
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPD------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCcccceEEEecccceeeeEcCC------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence               23689999999976543221      1234567789999999999999999999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.4e-18  Score=186.05  Aligned_cols=226  Identities=25%  Similarity=0.259  Sum_probs=174.5

Q ss_pred             eeeeecceEEEEEEE---CCCCeEEEEEEeecccch--hhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEEEE
Q 002897          561 MVGQGSFGTVFKGII---GENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .+|+|.||.|++++.   .+.|..+|.|+.......  .......|..++..++ ||.++++...+     +.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            378999999987654   346778999988543211  1125567888888886 99999987764     345788999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      ++|..+|.+...+.....      +.+.........++-|++++|+.   +++|||+|++||+++.+|++++.|||.++.
T Consensus        76 ld~~rgg~lft~l~~~~~------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVM------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccCCc------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            999999999998887654      67888888899999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .-...            ..+||..|||||++.  ....++|-||||++++||+||..||..         +....+..  
T Consensus       147 ~v~~~------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~--  201 (612)
T KOG0603|consen  147 AVKEK------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILK--  201 (612)
T ss_pred             hHhhh------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhh--
Confidence            54322            116899999999988  467789999999999999999999975         11111110  


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                                            .+...+.+......+++..++..+|.+|.-.
T Consensus       202 ----------------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 ----------------------AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----------------------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                                  0111223445566788888888999888754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.7e-16  Score=156.00  Aligned_cols=144  Identities=22%  Similarity=0.211  Sum_probs=111.7

Q ss_pred             HHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch----------------------hhHHHHHHHHHH
Q 002897          548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG----------------------ALKSFLTECEAL  605 (869)
Q Consensus       548 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  605 (869)
                      ++.....-|.+.+.||+|+||.||+|... +|+.||||+++.....                      .......|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            33344445888899999999999999985 8999999987532210                      112357788899


Q ss_pred             HhCCCC--ccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002897          606 RSIRHR--NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCK  683 (869)
Q Consensus       606 ~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  683 (869)
                      .++.|+  .+...++.         ...++||||+++++|.+....            .....++.+++.++.++|+.  
T Consensus        88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~--  144 (198)
T cd05144          88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH--  144 (198)
T ss_pred             HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC--
Confidence            988777  44444442         345899999999998765321            23467889999999999999  


Q ss_pred             CCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          684 PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       684 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                       +|+||||||+||++++++.++|+|||.+....
T Consensus       145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             -CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence             99999999999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.8e-16  Score=179.90  Aligned_cols=144  Identities=22%  Similarity=0.289  Sum_probs=112.6

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec--cc------chhhHHHHHHHHHHHhCCCCccceEE
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQ------KGALKSFLTECEALRSIRHRNLIKII  617 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~------~~~~~~~~~E~~~l~~l~h~niv~~~  617 (869)
                      +.........|...+.||+|+||+||+|.+.  +..+++|+...  ..      ....+++.+|+++++.++|++++...
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3333444456677899999999999999984  44455544311  11      11235688999999999999998877


Q ss_pred             EEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      .++...     ...++||||+++++|.+++.              ....++.|++++++|||+.   +++|||+||+||+
T Consensus       403 ~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NIL  460 (535)
T PRK09605        403 IYDVDP-----EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFI  460 (535)
T ss_pred             EEEEeC-----CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEE
Confidence            665432     45689999999999999875              2467899999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccccccc
Q 002897          698 LDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~  714 (869)
                      + .++.++|+|||+++.
T Consensus       461 l-~~~~~~liDFGla~~  476 (535)
T PRK09605        461 V-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             E-ECCcEEEEeCccccc
Confidence            9 678999999999964

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=5.1e-16  Score=156.20  Aligned_cols=133  Identities=19%  Similarity=0.302  Sum_probs=110.2

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccc--------hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--------GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +.||+|++|.||+|.+  .|..|++|+......        .....+.+|++++..+.|+++.....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5799999999999998  788899998643211        1124578899999999999887666654432     557


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++|++|.+++....         + .+..++.+++.+++++|+.   +++|||++|+||+++ ++.++++|||.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999986432         2 7889999999999999999   999999999999999 78999999998


Q ss_pred             cc
Q 002897          712 AK  713 (869)
Q Consensus       712 a~  713 (869)
                      +.
T Consensus       141 a~  142 (211)
T PRK14879        141 AE  142 (211)
T ss_pred             cc
Confidence            85

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=3.6e-17  Score=183.84  Aligned_cols=216  Identities=25%  Similarity=0.294  Sum_probs=146.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|..++.+..|+||.||.++++.+.+.+|+|+=+. .           .|++     ||..+.+           ..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilR-----nilt~a~-----------npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILR-----NILTFAG-----------NPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhh-----ccccccC-----------Ccc
Confidence            4689999999999999999999998999999964321 1           1111     1222111           112


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      .|      |+-...++..+.      ++.        +++.+++|+|+.   ||+|||+||+|.+|+.-|++|++|||++
T Consensus       134 vv------gDc~tllk~~g~------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIGP------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ee------chhhhhcccCCC------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence            22      444455544332      332        237899999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCc------ccc-CCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          713 KFLPARPLDTV------VET-PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       713 ~~~~~~~~~~~------~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      +..........      ... .-.....+||+.|+|||++....|+..+|-|++|+|+||.+.|+.||.+...++. +..
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~  269 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQ  269 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhh
Confidence            75432211100      001 1123456899999999999999999999999999999999999999986543311 111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM  845 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  845 (869)
                      ++...+  .+.+                       ..+..+.+..+++.+.++.+|..|-
T Consensus       270 visd~i--~wpE-----------------------~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDI--EWPE-----------------------EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhc--cccc-----------------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence            111110  0000                       1123345677899999999999995

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=1.2e-15  Score=151.81  Aligned_cols=130  Identities=22%  Similarity=0.345  Sum_probs=103.4

Q ss_pred             eeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .||+|++|.||+|.+  +|..|++|+.....        .....++.+|+++++.+.|+++.....++..     ....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence            479999999999996  78899999864221        1123567889999999988765444333322     24468


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++|++|.+++....       .      .++.+++.+++++|+.   +++|||++|+||+++ ++.++++|||.+
T Consensus        74 lv~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999999999999875421       1      7899999999999999   999999999999999 889999999998


Q ss_pred             cc
Q 002897          713 KF  714 (869)
Q Consensus       713 ~~  714 (869)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            63

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7.5e-15  Score=144.58  Aligned_cols=136  Identities=22%  Similarity=0.264  Sum_probs=98.6

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccch--hhHH----------------------HHHHHHHHHhCCCC--c
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKS----------------------FLTECEALRSIRHR--N  612 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--n  612 (869)
                      .+.||+|+||+||+|.+. +|+.||||+++.....  ....                      ...|.+.+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 8999999998643211  1111                      13556666666433  3


Q ss_pred             cceEEEEeeccccCCCceEEEEeecccCCCHHHH-HhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecC
Q 002897          613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEW-LHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGD  690 (869)
Q Consensus       613 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~D  690 (869)
                      +.+.+++         ...++||||++++++... +....       .. .+...++.+++.++.++|+ .   +|+|||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            4444443         335899999999554221 11110       11 5678899999999999999 7   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccCC
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      +||+||+++ ++.++++|||.+....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CChhhEEEE-CCcEEEEECccccccc
Confidence            999999999 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.3e-14  Score=145.20  Aligned_cols=139  Identities=19%  Similarity=0.149  Sum_probs=107.0

Q ss_pred             CCeee-eecceEEEEEEECCCCeEEEEEEeeccc-------------chhhHHHHHHHHHHHhCCCCcc--ceEEEEeec
Q 002897          559 SNMVG-QGSFGTVFKGIIGENGMLVAVKVLNLMQ-------------KGALKSFLTECEALRSIRHRNL--IKIITICSS  622 (869)
Q Consensus       559 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~  622 (869)
                      ...|| .||.|+||.+..  .+..+|||.+....             .....++.+|++++.++.|+++  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 899999999988  58889999885311             1223567899999999988775  667766433


Q ss_pred             cccCCCceEEEEeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          623 IDFNGVDFKAIVYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                      . .......++||||+++ .+|.+++....       ++..    .+.+++.++++||+.   ||+||||||.|||++.+
T Consensus       114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 R-HGLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             e-cCcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            2 1111234699999997 69999886532       4443    356899999999999   99999999999999999


Q ss_pred             CcEEEcccccccc
Q 002897          702 MVAHVGDFGLAKF  714 (869)
Q Consensus       702 ~~~kl~Dfg~a~~  714 (869)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.8e-16  Score=176.42  Aligned_cols=258  Identities=22%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-CCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-ENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  628 (869)
                      ...|...+.||+|+|+.|-.+... .....+|+|.+....  ....+....|..+-+.+. |+|++++++....     .
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----P   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----C
Confidence            346788888999999999888774 234556777765433  333455667888888886 9999999998554     4


Q ss_pred             ceEEEEeecccCCCHHHHH-hhCCCcccccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceeecCCC-cEE
Q 002897          629 DFKAIVYDFMQNGSLEEWL-HQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDM-VAH  705 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~k  705 (869)
                      +..+++++|..++++.+-+ +....     ..+......++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~  165 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK  165 (601)
T ss_pred             cccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence            7889999999999999888 43321     2566677888999999999999 77   999999999999999999 999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccC-cccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKG-TVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      ++|||+|..+....     ..........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.........
T Consensus       166 ~~df~~At~~~~~~-----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~  240 (601)
T KOG0590|consen  166 IADFGLATAYRNKN-----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY  240 (601)
T ss_pred             CCCchhhccccccC-----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence            99999998876621     11233445567 9999999998885 45778899999999999999999998655544333


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..|......      ..                  ............+++.+++..+|+.|.+.+++..
T Consensus       241 ~~~~~~~~~------~~------------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  241 SSWKSNKGR------FT------------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eeecccccc------cc------------------cCccccCChhhhhcccccccCCchhccccccccc
Confidence            333222100      00                  0011122334568888999999999999888743

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=4.8e-14  Score=133.86  Aligned_cols=135  Identities=20%  Similarity=0.232  Sum_probs=111.1

Q ss_pred             CCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCC--CccceEEEEeeccccCCCceEEEEe
Q 002897          558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH--RNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       558 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.+.+|+|.++.||++...  +..+++|.......  ...+.+|+.+++.++|  ..+++++++...     .+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEE
Confidence            4578999999999999984  47899999865433  4678899999999976  588888887543     26789999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      ||++++.+..+             +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99988766543             3456678899999999999996444799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=2.4e-14  Score=165.44  Aligned_cols=119  Identities=35%  Similarity=0.604  Sum_probs=103.3

Q ss_pred             cccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccc
Q 002897          368 NLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS  447 (869)
Q Consensus       368 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  447 (869)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcccCCCC--CccCCCccccccCCcccCCCCCCCCCCCCCC
Q 002897          448 YNHFEGEVPKK--GVFSNKTRFSLSGNGKLCGGLDEFHLPSCPS  489 (869)
Q Consensus       448 ~N~l~~~~~~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~  489 (869)
                      +|+++|.+|..  .....+..+.+.+|+.+|+.+.   .+.|..
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~~  539 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACGP  539 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCcc
Confidence            99999988864  2234556788999999998543   356754

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=7.2e-16  Score=162.03  Aligned_cols=189  Identities=30%  Similarity=0.452  Sum_probs=114.5

Q ss_pred             eecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCccc
Q 002897          251 IAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL  330 (869)
Q Consensus       251 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l  330 (869)
                      .+|+.|++. .+|..+..+..|..+.|++|.+. .+|..++++..|++|+|+.|+++ .+|..++.|+ |+.|-+++|++
T Consensus        80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl  155 (722)
T KOG0532|consen   80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL  155 (722)
T ss_pred             hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence            344444443 44444444444555555555554 44555555555555555555555 4555555544 55555555555


Q ss_pred             CCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCcc
Q 002897          331 DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS  410 (869)
Q Consensus       331 ~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  410 (869)
                      + .+|+.+. ....+..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..++ .-.|..||+|.|+++ .+|-+
T Consensus       156 ~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~  229 (722)
T KOG0532|consen  156 T-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVD  229 (722)
T ss_pred             c-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchh
Confidence            4 4455544 3333344555555554 56777788888888888888887 6777777 445778888888887 77888


Q ss_pred             ccccccccEEEccCCcccCCCccccccccc---cCeecccccc
Q 002897          411 LNFLKSIKVLDLSSNKLSGQIPKYLENLSF---LEYLNLSYNH  450 (869)
Q Consensus       411 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~l~l~~N~  450 (869)
                      |..|+.|++|-|.+|.|+ ..|..++..-.   .++|+..-++
T Consensus       230 fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  230 FRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             hhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            888888888888888887 66666653332   3556665553

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=1.2e-15  Score=160.33  Aligned_cols=178  Identities=31%  Similarity=0.423  Sum_probs=161.7

Q ss_pred             CCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccce
Q 002897          268 WLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF  347 (869)
Q Consensus       268 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~  347 (869)
                      .+..-...+|+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++.+..|+.|||+.|++. .+|..++.+.  ++-
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp--Lkv  147 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP--LKV  147 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc--cee
Confidence            3555667899999998 88999999999999999999998 89999999999999999999998 7888877665  345


Q ss_pred             ecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcc
Q 002897          348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL  427 (869)
Q Consensus       348 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (869)
                      |-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..++.| .|..||+|.|++
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki  223 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI  223 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence            889999998 89999999999999999999998 78999999999999999999998 788888866 588999999999


Q ss_pred             cCCCccccccccccCeeccccccCcccC
Q 002897          428 SGQIPKYLENLSFLEYLNLSYNHFEGEV  455 (869)
Q Consensus       428 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~  455 (869)
                      + .+|-.|.+|..|++|-|.+|+|...+
T Consensus       224 s-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  224 S-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             e-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            8 89999999999999999999998543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=1.3e-14  Score=142.65  Aligned_cols=161  Identities=24%  Similarity=0.402  Sum_probs=125.0

Q ss_pred             HHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002897          605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKP  684 (869)
Q Consensus       605 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  684 (869)
                      +-.+.|.|+|++..|+.+....+.....++.|||+.|++.+++++....  ...+......+|+-||..||.|||+. .|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            4455799999999999887776777888999999999999999886543  23478888999999999999999995 89


Q ss_pred             CeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHH
Q 002897          685 PVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL  764 (869)
Q Consensus       685 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~  764 (869)
                      +|+|+++..+-|++..+|-+|++--........-...    .......-.+-++|.|||.-.....+.++|||+||....
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~----~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNST----REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhh----hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            9999999999999999998888532221111100000    001122334678999999877777888999999999999


Q ss_pred             HHHcCCCC
Q 002897          765 EMFSRRRP  772 (869)
Q Consensus       765 el~tg~~p  772 (869)
                      ||..|..-
T Consensus       274 emailEiq  281 (458)
T KOG1266|consen  274 EMAILEIQ  281 (458)
T ss_pred             HHHHheec
Confidence            99988754

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.45  E-value=1.5e-13  Score=152.38  Aligned_cols=175  Identities=30%  Similarity=0.448  Sum_probs=78.1

Q ss_pred             cCCcCEEeccCCcCccccCcccccCc-CCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGNLS-ALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      ++.++.|++.+|.++ .++.....+. +|++|++++|.+. .+|..++.+++|+.|++++|++. .+|...+.+++|+.|
T Consensus       115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            344555555555555 3333344442 5555555555554 33344445555555555555554 333333344555555


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL  179 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l  179 (869)
                      ++++|++. .+|.. ...+..|++|.+++|.+. ..+..+.++.++..|.+.+|++... +..+..+++++.|++++|.+
T Consensus       192 ~ls~N~i~-~l~~~-~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i  267 (394)
T COG4886         192 DLSGNKIS-DLPPE-IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQI  267 (394)
T ss_pred             eccCCccc-cCchh-hhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceeccccccc
Confidence            55555554 44421 122233455555555322 2233444444444444444444321 23344444444444444444


Q ss_pred             CCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          180 GNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      +.++.        +..+.+|++|++++|.+.
T Consensus       268 ~~i~~--------~~~~~~l~~L~~s~n~~~  290 (394)
T COG4886         268 SSISS--------LGSLTNLRELDLSGNSLS  290 (394)
T ss_pred             ccccc--------ccccCccCEEeccCcccc
Confidence            44331        334444444444444444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1.1e-12  Score=144.90  Aligned_cols=162  Identities=17%  Similarity=0.249  Sum_probs=110.0

Q ss_pred             cCCCcccHHHHHHHhc------------CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhh-----------
Q 002897          539 QQFPMISYAKLSKATS------------EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-----------  595 (869)
Q Consensus       539 ~~~~~~~~~~~~~~~~------------~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------  595 (869)
                      ...|.++++++.....            .|. .+.||.|++|.||+|+.. +|+.||||+.+..-....           
T Consensus        91 d~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~  168 (437)
T TIGR01982        91 DRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLA  168 (437)
T ss_pred             cCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHH
Confidence            4556666655544332            233 368999999999999986 899999999854311100           


Q ss_pred             -----------------------------HHHHHHHHHHHhC----CCCccceEEEEeeccccCCCceEEEEeecccCCC
Q 002897          596 -----------------------------KSFLTECEALRSI----RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGS  642 (869)
Q Consensus       596 -----------------------------~~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs  642 (869)
                                                   -.+.+|+..+.++    +|..-+.+-.++.+.    ....++||||++|++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~  244 (437)
T TIGR01982       169 RIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIP  244 (437)
T ss_pred             HHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcc
Confidence                                         0244566655555    233333333333221    244689999999999


Q ss_pred             HHHHHhhCCCcccccCCCHHHHHHHHHHHHH-HHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCC
Q 002897          643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS-AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       643 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  717 (869)
                      |.++.......     .   ....++.+++. .+..+|..   |++|+|+||.||+++.++.++++|||++..+++
T Consensus       245 L~~~~~~~~~~-----~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       245 LSDIAALDEAG-----L---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             cccHHHHHhcC-----C---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            98876543211     2   23456666666 47888998   999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.3e-13  Score=145.61  Aligned_cols=253  Identities=24%  Similarity=0.279  Sum_probs=184.4

Q ss_pred             cCCCCCCeeee--ecceEEEEEEE--CCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          554 SEFSSSNMVGQ--GSFGTVFKGII--GENGMLVAVKVLNL--MQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       554 ~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ..|.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.  .......+-.+|+...+++ .|++.++....     ++
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence            34667788999  99999999998  88999999998532  2223334456777777777 59999985555     45


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeecCC-
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS----AIEYLHHHCKPPVVHGDLKPSNVLLDHD-  701 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-  701 (869)
                      +.+..++-+|++. .++.++.+.....     ++....+....+..+    |+.++|+.   +++|-|+||.||+...+ 
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~-----~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNF-----LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhccccc-----CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence            5688899999985 6899888876543     777888888888888    99999999   99999999999999999 


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      ...+++|||+...+.........   .......|...|++||...+ -++.++||||+|.++.+..+|..+.......  
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~---~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--  333 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVF---KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--  333 (524)
T ss_pred             ceeecCCcceeEEccCCccccce---eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--
Confidence            78999999999888776532211   12233367889999998765 6788999999999999999988775432111  


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+.+.....++.+                          ..+....++...+..|++.+|..|++++++.+
T Consensus       334 ~W~~~r~~~ip~e--------------------------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 SWSQLRQGYIPLE--------------------------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CccccccccCchh--------------------------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111111111110                          11112234445888999999999999877654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=3.9e-13  Score=149.16  Aligned_cols=178  Identities=39%  Similarity=0.603  Sum_probs=82.8

Q ss_pred             CCCCeeecccCcceecCCccccCCC-CCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceee
Q 002897          246 VHLNSIAMEGNQLIGTVPPEIGWLK-NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLT  324 (869)
Q Consensus       246 ~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  324 (869)
                      +.++.|++.+|.+. .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            44444444444444 3333333342 5555555555554 33344455555555555555555 3444344555555555


Q ss_pred             ccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCcccc
Q 002897          325 LSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS  404 (869)
Q Consensus       325 l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  404 (869)
                      +++|++. .+|... .....+..|.+++|.+. ..+..+.++.++..|.+++|++. .++..+..+++|+.|++++|+++
T Consensus       193 ls~N~i~-~l~~~~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~  268 (394)
T COG4886         193 LSGNKIS-DLPPEI-ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS  268 (394)
T ss_pred             ccCCccc-cCchhh-hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence            5555554 222211 11111222333333211 23444555555555555555554 33445555555555555555555


Q ss_pred             CCCCccccccccccEEEccCCcccCCCc
Q 002897          405 GSIPPSLNFLKSIKVLDLSSNKLSGQIP  432 (869)
Q Consensus       405 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p  432 (869)
                       .++. ++.+.+++.|++++|.+...+|
T Consensus       269 -~i~~-~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         269 -SISS-LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             -cccc-ccccCccCEEeccCccccccch
Confidence             2222 5555555555555555554333

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.35  E-value=4e-13  Score=126.54  Aligned_cols=142  Identities=25%  Similarity=0.358  Sum_probs=44.1

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccc-cCcCCCEEEccCCccCccCCccccCCCCCCEEeCcC
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIG-NLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~   79 (869)
                      |..|..+.|. .+|...  +..+++.|+|++|.|+. +. .++ .+.+|+.|+|++|.|+. ++ .+..+++|++|+|++
T Consensus         1 ~~~lt~~~i~-~~~~~~--n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~   73 (175)
T PF14580_consen    1 MVRLTANMIE-QIAQYN--NPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSN   73 (175)
T ss_dssp             ----------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--S
T ss_pred             Cccccccccc-cccccc--ccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCC
Confidence            5567778888 788766  35688999999999984 32 455 57889999999999984 33 478889999999999


Q ss_pred             cccCccCCccc-ccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccc
Q 002897           80 NQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGK  158 (869)
Q Consensus        80 n~i~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~  158 (869)
                      |+|+.+ +..+ ..+++|++|+|++|+|. .+..                       -..+..+++|+.|+|.+|.+...
T Consensus        74 N~I~~i-~~~l~~~lp~L~~L~L~~N~I~-~l~~-----------------------l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   74 NRISSI-SEGLDKNLPNLQELYLSNNKIS-DLNE-----------------------LEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             S---S--CHHHHHH-TT--EEE-TTS----SCCC-----------------------CGGGGG-TT--EEE-TT-GGGGS
T ss_pred             CCCCcc-ccchHHhCCcCCEEECcCCcCC-ChHH-----------------------hHHHHcCCCcceeeccCCcccch
Confidence            999854 4444 46888999999999886 3221                       12344556666666666666432


Q ss_pred             cC---cCccCCCCCCEEEc
Q 002897          159 MS---INFNSLKNLSVLIL  174 (869)
Q Consensus       159 ~~---~~~~~l~~L~~L~l  174 (869)
                      ..   ..+..+++|+.||-
T Consensus       129 ~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen  129 KNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             TTHHHHHHHH-TT-SEETT
T ss_pred             hhHHHHHHHHcChhheeCC
Confidence            11   12455677777653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1.9e-11  Score=117.76  Aligned_cols=138  Identities=18%  Similarity=0.176  Sum_probs=101.7

Q ss_pred             CCeeeeecceEEEEEEECC------CCeEEEEEEeeccc----------------------chhhHHH----HHHHHHHH
Q 002897          559 SNMVGQGSFGTVFKGIIGE------NGMLVAVKVLNLMQ----------------------KGALKSF----LTECEALR  606 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  606 (869)
                      ...||.|--+.||.|....      .+..+|||+++...                      ....+.+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998753      35899999985211                      0112223    48999999


Q ss_pred             hCC--CCccceEEEEeeccccCCCceEEEEeecccCCCHHH-HHhhCCCcccccCCCHHHHHHHHHHHHHHHHHH-HhcC
Q 002897          607 SIR--HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEE-WLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL-HHHC  682 (869)
Q Consensus       607 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~  682 (869)
                      ++.  .-++..++++         ...++||||+.+..+.. .++..       .++..+...+..+++.+|..+ |+. 
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~-  144 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC-  144 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence            984  3567777765         44689999997654422 22221       245566778889999999999 787 


Q ss_pred             CCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          683 KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       683 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                        ++||||+++.||+++ ++.++++|||.|....
T Consensus       145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             --CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence              999999999999996 5689999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=4.9e-12  Score=140.73  Aligned_cols=150  Identities=17%  Similarity=0.176  Sum_probs=97.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch----------------------------------hhH---
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG----------------------------------ALK---  596 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~---  596 (869)
                      .+|+. +.||+|++|+||+|+.+.+|+.||||+.+..-..                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35776 7999999999999999867999999999643110                                  011   


Q ss_pred             ---HHHHHHHHHHhC----CCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHH
Q 002897          597 ---SFLTECEALRSI----RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI  669 (869)
Q Consensus       597 ---~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~  669 (869)
                         ++.+|+..+.++    .+...+.+-.++.+.    ....++||||++|+.+.++-.-.....+...+....+..++.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence               134444444444    243334433333221    245789999999999987532111110011133333334444


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----cEEEccccccccCCCC
Q 002897          670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----VAHVGDFGLAKFLPAR  718 (869)
Q Consensus       670 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~~  718 (869)
                      |+       +..   |++|+|+||.||+++.++    +++++|||++..++..
T Consensus       275 Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        275 QV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            44       345   999999999999999988    9999999999877543

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.31  E-value=3.2e-14  Score=141.71  Aligned_cols=141  Identities=21%  Similarity=0.291  Sum_probs=105.7

Q ss_pred             CCCccccceeccccccccc----CCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCC
Q 002897          291 GNLTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL  366 (869)
Q Consensus       291 ~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l  366 (869)
                      ..-+.|+++....|++...    +...|...+.|+.+.++.|.+.   |++.                  ..+...+..+
T Consensus       154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~---~eG~------------------~al~eal~~~  212 (382)
T KOG1909|consen  154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIR---PEGV------------------TALAEALEHC  212 (382)
T ss_pred             CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEeccccc---Cchh------------------HHHHHHHHhC
Confidence            3446688888888887632    3346677788888888888875   2222                  0234578899


Q ss_pred             ccccccccccccccc----cCCccccCCCCCcEEEeeCccccCCCCcccc-----ccccccEEEccCCcccC----CCcc
Q 002897          367 KNLVQLDISGNRFSG----DIPGTLSACTSLEYVKMQDNSFSGSIPPSLN-----FLKSIKVLDLSSNKLSG----QIPK  433 (869)
Q Consensus       367 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~  433 (869)
                      ++|+.|||.+|-|+.    .+..+++.++.|++|++++|.+......+|.     ..++|++|.|.+|.++.    .+..
T Consensus       213 ~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~  292 (382)
T KOG1909|consen  213 PHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAA  292 (382)
T ss_pred             CcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHH
Confidence            999999999999873    3455678899999999999999876554442     36899999999999983    3444


Q ss_pred             ccccccccCeeccccccCc
Q 002897          434 YLENLSFLEYLNLSYNHFE  452 (869)
Q Consensus       434 ~~~~l~~L~~l~l~~N~l~  452 (869)
                      .+...+.|..|+|++|++.
T Consensus       293 ~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  293 CMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHhcchhhHHhcCCccccc
Confidence            5666889999999999984

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.28  E-value=4.3e-13  Score=133.77  Aligned_cols=256  Identities=20%  Similarity=0.235  Sum_probs=128.3

Q ss_pred             ccCCcCEEeccCCcCc----cccCcccccCcCCCEEEccCC---ccCccCCcc-------ccCCCCCCEEeCcCcccCcc
Q 002897           20 YLFKLENLSLAENHLT----GQLPVSIGNLSALQVIDIRGN---RLGGKIPDT-------LGQLRKLIYLNIGRNQFSGF   85 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n---~i~~~~p~~-------~~~l~~L~~L~L~~n~i~~~   85 (869)
                      ....++.|+|++|.+.    ..+.+.+.+.++|+..++|+-   ++...+|.+       +...++|++||||+|.+...
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~  107 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK  107 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence            3456777777777775    234455666667777777653   233333332       33445666666666665532


Q ss_pred             CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccC
Q 002897           86 IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNS  165 (869)
Q Consensus        86 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~  165 (869)
                      -+..|.                     +.+....+|++|.|.+|.+...-...++.  .|..|.  .|+       ..++
T Consensus       108 g~~~l~---------------------~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~  155 (382)
T KOG1909|consen  108 GIRGLE---------------------ELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAAS  155 (382)
T ss_pred             chHHHH---------------------HHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCC
Confidence            222221                     23445566666666666665222222211  122222  111       1223


Q ss_pred             CCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCC
Q 002897          166 LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL  245 (869)
Q Consensus       166 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l  245 (869)
                      -++|+++..++|++.+.+..  .++..|...+.|+.+.++.|.|....-.                     .+..+|..+
T Consensus       156 ~~~Lrv~i~~rNrlen~ga~--~~A~~~~~~~~leevr~~qN~I~~eG~~---------------------al~eal~~~  212 (382)
T KOG1909|consen  156 KPKLRVFICGRNRLENGGAT--ALAEAFQSHPTLEEVRLSQNGIRPEGVT---------------------ALAEALEHC  212 (382)
T ss_pred             CcceEEEEeeccccccccHH--HHHHHHHhccccceEEEecccccCchhH---------------------HHHHHHHhC
Confidence            35667777777777666554  4455677777777777777777522110                     111233344


Q ss_pred             CCCCeeecccCcceec----CCccccCCCCCCEEEccCccccCcCCCCC-----CCCccccceecccccccc----cCCc
Q 002897          246 VHLNSIAMEGNQLIGT----VPPEIGWLKNLQSLYLNSNFLHGYIPSSL-----GNLTMLTLLALEINNLQG----KIPS  312 (869)
Q Consensus       246 ~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~----~~~~  312 (869)
                      ++|+.|+|.+|.++..    +...++.+++|++|++++|.+.......|     ...++|+.|.|.+|.|+.    .+..
T Consensus       213 ~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~  292 (382)
T KOG1909|consen  213 PHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAA  292 (382)
T ss_pred             CcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHH
Confidence            4444444444444321    12233444555555555555543322222     124556666666665551    1223


Q ss_pred             CccCccccceeeccCccc
Q 002897          313 SLGNCTSLIMLTLSKNKL  330 (869)
Q Consensus       313 ~~~~l~~L~~L~l~~N~l  330 (869)
                      .+...+.|..|+|++|.+
T Consensus       293 ~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  293 CMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHhcchhhHHhcCCcccc
Confidence            344466666777777766

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.27  E-value=3.2e-11  Score=131.25  Aligned_cols=170  Identities=19%  Similarity=0.257  Sum_probs=131.4

Q ss_pred             EEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCC
Q 002897          572 KGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN  651 (869)
Q Consensus       572 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  651 (869)
                      .|..+.++.+|.|..++...........+-++.++.++||||+++++.+..     ....|+|+|.+.  .|..++++  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk~--  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLKE--  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHHH--
Confidence            456667899999999876666555667888899999999999999998543     468999999873  57778776  


Q ss_pred             CcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCC
Q 002897          652 DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS  731 (869)
Q Consensus       652 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  731 (869)
                             +....+...+.||+.||.|||+.|  +++|++|.-+.|+|++.|+.||++|..+........        ...
T Consensus       101 -------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------~~~  163 (690)
T KOG1243|consen  101 -------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------PAK  163 (690)
T ss_pred             -------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------ccc
Confidence                   445677888999999999999876  999999999999999999999999998865433211        111


Q ss_pred             CccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC
Q 002897          732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR  769 (869)
Q Consensus       732 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg  769 (869)
                      ...--..|..|+.+....  -..|.|-|||+++|++.|
T Consensus       164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            122233466676554332  346999999999999999

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.27  E-value=4e-13  Score=137.54  Aligned_cols=162  Identities=23%  Similarity=0.257  Sum_probs=100.0

Q ss_pred             ccCcCCCEEEccCCccCccCC--ccccCCCCCCEEeCcCcccCccCC--cccccCCCCcEEECcCCcCcccCCchhhcCC
Q 002897           43 GNLSALQVIDIRGNRLGGKIP--DTLGQLRKLIYLNIGRNQFSGFIP--PSIYNISSFEFIFLQSNRFHGSLPFDMVANL  118 (869)
Q Consensus        43 ~~l~~L~~L~L~~n~i~~~~p--~~~~~l~~L~~L~L~~n~i~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  118 (869)
                      +++++|+...|.++.+. ..+  .....|++++.||||+|-+....|  .....|++|+.|+|+.|++........-..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            45666777777776665 333  245567777777777776653322  2344567777777777776522222222345


Q ss_pred             cchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCC
Q 002897          119 PNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCS  197 (869)
Q Consensus       119 ~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~  197 (869)
                      +.|+.|.|+.|.++.. +...+..+++|+.|+|+.|....+......-+..|++|+|++|++-+.+.     ......++
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~-----~~~~~~l~  271 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ-----GYKVGTLP  271 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc-----cccccccc
Confidence            6777777777777632 22345566778888888775444555556667777777777777765442     23566777


Q ss_pred             CCcEEEccCCCCC
Q 002897          198 KLENLGLYDNQFG  210 (869)
Q Consensus       198 ~L~~L~L~~n~l~  210 (869)
                      .|+.|+++.+.+.
T Consensus       272 ~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  272 GLNQLNLSSTGIA  284 (505)
T ss_pred             chhhhhccccCcc
Confidence            7777777777766

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.26  E-value=1.3e-12  Score=133.90  Aligned_cols=191  Identities=21%  Similarity=0.229  Sum_probs=144.4

Q ss_pred             hccCCcCEEeccCCcCccccC--cccccCcCCCEEEccCCccCcc--CCccccCCCCCCEEeCcCcccCccCCcc-cccC
Q 002897           19 CYLFKLENLSLAENHLTGQLP--VSIGNLSALQVIDIRGNRLGGK--IPDTLGQLRKLIYLNIGRNQFSGFIPPS-IYNI   93 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~i~~~--~p~~~~~l~~L~~L~L~~n~i~~~~p~~-~~~l   93 (869)
                      +++.+|+...|.+..+. ..+  .....|++++.|||+.|-+..-  +-....+|++|+.|+|+.|++....... -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            46788999999999988 454  3678899999999999988742  2244678999999999999998433222 2357


Q ss_pred             CCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC-cCccCCCCCCEE
Q 002897           94 SSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS-INFNSLKNLSVL  172 (869)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L  172 (869)
                      +.|+.|.|+.|.++..--......+|+|+.|+|..|...........-+..|+.|||++|++..... ...+.++.|+.|
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence            8899999999999732222346678999999999996544555566778899999999999865432 346778999999


Q ss_pred             EccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          173 ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       173 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      +++.+.|.++..-+.+.......+++|++|+++.|++.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            99999998876543322333566778888888888875

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.24  E-value=8.1e-13  Score=146.49  Aligned_cols=246  Identities=26%  Similarity=0.334  Sum_probs=134.3

Q ss_pred             ccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchh
Q 002897           43 GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR  122 (869)
Q Consensus        43 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~  122 (869)
                      ..+..++.+++..|.|+. +-..++.+++|+.|++.+|+|..+ ...+..+.+|++|+|++|.|. .+.  .+..++.|+
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~-~i~--~l~~l~~L~  143 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKIT-KLE--GLSTLTLLK  143 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccc-ccc--chhhccchh
Confidence            345556666666666663 233456666666666666666632 233555666666666666665 332  244555566


Q ss_pred             hhhccccccceeccccccCCCCCcEEEccCCccccccC-cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcE
Q 002897          123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS-INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN  201 (869)
Q Consensus       123 ~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~  201 (869)
                      .|++.+|.|+.+  ..+..+++|+.+++++|++..+.+ . ...+.+++.+++++|.+..+..        +..+..+..
T Consensus       144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--------~~~~~~l~~  212 (414)
T KOG0531|consen  144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--------LDLLKKLVL  212 (414)
T ss_pred             hheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--------hHHHHHHHH
Confidence            666666666533  344445566666666666554433 1 3445555555555555544331        222233333


Q ss_pred             EEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCC--CCCeeecccCcceecCCccccCCCCCCEEEccC
Q 002897          202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV--HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNS  279 (869)
Q Consensus       202 L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  279 (869)
                      +++..|.++                         ...+  +..+.  +|+.+++++|.+. ..+..+..+.++..|++.+
T Consensus       213 ~~l~~n~i~-------------------------~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~  264 (414)
T KOG0531|consen  213 LSLLDNKIS-------------------------KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSS  264 (414)
T ss_pred             hhcccccce-------------------------eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhh
Confidence            344444443                         2211  11112  3666777777765 3334556667777777777


Q ss_pred             ccccCcCCCCCCCCccccceeccccccccc---CCc-CccCccccceeeccCcccCCCC
Q 002897          280 NFLHGYIPSSLGNLTMLTLLALEINNLQGK---IPS-SLGNCTSLIMLTLSKNKLDGVL  334 (869)
Q Consensus       280 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~-~~~~l~~L~~L~l~~N~l~~~~  334 (869)
                      |++...  ..+.....+..+.+..|.+...   ... .....+.++.+.+..|.+....
T Consensus       265 n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  265 NRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             cccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            777632  2345556667777777776521   111 1555677888888888776443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=2.1e-11  Score=117.94  Aligned_cols=130  Identities=17%  Similarity=0.159  Sum_probs=96.0

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccc-eEEEEeeccccCCCceEEEEeec
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI-KIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      ++.++.|.++.||+++.  .++.|++|+...... ....+.+|+.+++.+.+.+++ +++.+..       ...++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence            46789999999999997  588999999754332 223567899999988654444 4554421       234799999


Q ss_pred             ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC--KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       638 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      +++.++.+.    .       .   ....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        73 i~G~~l~~~----~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE----D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc----c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999887543    0       1   11245678999999999982  12359999999999998 6789999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.23  E-value=3.7e-12  Score=120.04  Aligned_cols=132  Identities=27%  Similarity=0.347  Sum_probs=49.7

Q ss_pred             cccCcCCCEEEccCCccCccCCcccc-CCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcc
Q 002897           42 IGNLSALQVIDIRGNRLGGKIPDTLG-QLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN  120 (869)
Q Consensus        42 ~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  120 (869)
                      +.+..++++|+|++|.|+.+  +.++ .+.+|+.|||++|.|+.+  ..+..++.|++|++++|+|+ .++         
T Consensus        15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~---------   80 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SIS---------   80 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-C---------
T ss_pred             cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccc---------
Confidence            44555677777777777733  2344 466777777777777643  23555666666666666665 332         


Q ss_pred             hhhhhccccccceeccccc-cCCCCCcEEEccCCccccccC-cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCC
Q 002897          121 LRKFVAAKNNLTGFLPISL-SNASNLELLELRDNQFIGKMS-INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK  198 (869)
Q Consensus       121 L~~L~l~~n~i~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~  198 (869)
                                      ..+ ..+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++....   .-...+..+++
T Consensus        81 ----------------~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~---YR~~vi~~lP~  141 (175)
T PF14580_consen   81 ----------------EGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN---YRLFVIYKLPS  141 (175)
T ss_dssp             ----------------HHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT---HHHHHHHH-TT
T ss_pred             ----------------cchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh---HHHHHHHHcCh
Confidence                            223 346788888888888865433 457789999999999999986542   23447888999


Q ss_pred             CcEEEccC
Q 002897          199 LENLGLYD  206 (869)
Q Consensus       199 L~~L~L~~  206 (869)
                      |+.||-..
T Consensus       142 Lk~LD~~~  149 (175)
T PF14580_consen  142 LKVLDGQD  149 (175)
T ss_dssp             -SEETTEE
T ss_pred             hheeCCEE
Confidence            99997543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.23  E-value=1.1e-12  Score=145.43  Aligned_cols=218  Identities=24%  Similarity=0.342  Sum_probs=155.2

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+..++.+++..|.|.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|+|+.+  ..+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            46788888899999983 44558889999999999999994 444488899999999999999965  456777889999


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceecc-ccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      ++++|.|. .++  .+..+++|+.+++++|.+..+.+ . ...+.+|+.+++.+|.+..+  ..+..+..+..+++..|.
T Consensus       146 ~l~~N~i~-~~~--~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  146 NLSGNLIS-DIS--GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             eeccCcch-hcc--CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence            99999998 555  36679999999999999986644 2 58889999999999998644  345566677777899999


Q ss_pred             CCCCCCCCcchhhhccCCCC--CcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccC
Q 002897          179 LGNRAANDLDFVTVLANCSK--LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN  256 (869)
Q Consensus       179 l~~~~~~~~~~~~~l~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  256 (869)
                      ++.+..        +..+..  |+.+++++|++.. .+..+..+.. +..|++.+|.+...  ..+.....+..+.+..|
T Consensus       220 i~~~~~--------l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~-l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~  287 (414)
T KOG0531|consen  220 ISKLEG--------LNELVMLHLRELYLSGNRISR-SPEGLENLKN-LPVLDLSSNRISNL--EGLERLPKLSELWLNDN  287 (414)
T ss_pred             ceeccC--------cccchhHHHHHHhcccCcccc-cccccccccc-ccccchhhcccccc--ccccccchHHHhccCcc
Confidence            876653        223333  6777777777763 2222333332 55566666655422  12333444444444444


Q ss_pred             cce
Q 002897          257 QLI  259 (869)
Q Consensus       257 ~l~  259 (869)
                      .+.
T Consensus       288 ~~~  290 (414)
T KOG0531|consen  288 KLA  290 (414)
T ss_pred             hhc
Confidence            443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=7.5e-10  Score=113.45  Aligned_cols=276  Identities=15%  Similarity=0.110  Sum_probs=173.0

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccc---cCCCceEE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSID---FNGVDFKA  632 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~---~~~~~~~~  632 (869)
                      ...+.||+|+.+.+|..-.   -+..+-|+++........+   .++.|.+. .||-+-.-+.+ ....   -+......
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaW-Pqa~L~G~~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAW-PQATLHGGRRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcc-cHHHhhCCCccceeE
Confidence            3567899999999996432   2334568886544432222   23344444 56644331221 1100   11223366


Q ss_pred             EEeecccCCC-HHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          633 IVYDFMQNGS-LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      +.|+.+++.- ...+..............|...+.+++.+|.+.+.||+.   |.+-||+.++|+||.+++.+.|.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            7888876642 233333222222334578999999999999999999999   999999999999999999999998654


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcC-CCCCCcCccCCc---h
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGL---T  782 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg-~~pf~~~~~~~~---~  782 (869)
                      -.....+         ......+|...|.+||.-.     +...+...|-|.+||++++++.| ++||.+......   .
T Consensus       164 fqi~~ng---------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         164 FQINANG---------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             eeeccCC---------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            4332221         2233457899999999644     34567789999999999999886 999987533211   0


Q ss_pred             HH-HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHHH
Q 002897          783 LH-EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES--PTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       783 ~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~  859 (869)
                      .+ .+....    +...-|        .....+.....+..+-.++.+..+..+|+...  |.-|||++-.+..|..+.+
T Consensus       235 ~E~~Ia~g~----f~ya~~--------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         235 LETDIAHGR----FAYASD--------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             chhhhhcce----eeechh--------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            11 111111    000000        11111122223344455677888999998764  5689999999999998887


Q ss_pred             hhhc
Q 002897          860 AFVS  863 (869)
Q Consensus       860 ~~~~  863 (869)
                      ....
T Consensus       303 ~L~~  306 (637)
T COG4248         303 QLKK  306 (637)
T ss_pred             hhhh
Confidence            7643

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=3.2e-12  Score=124.22  Aligned_cols=134  Identities=28%  Similarity=0.308  Sum_probs=91.0

Q ss_pred             CccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcE
Q 002897          316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEY  395 (869)
Q Consensus       316 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  395 (869)
                      .+..|+++|||+|.|+ .+.++ ..+.+.++.|++|+|.|+. + +.+..+.+|+.||||+|.++ .+.++-..+.+.+.
T Consensus       282 TWq~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             hHhhhhhccccccchh-hhhhh-hhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            3445555555555554 22221 2233334455555555542 2 34777888999999999988 56666677888899


Q ss_pred             EEeeCccccCCCCccccccccccEEEccCCcccCCC-ccccccccccCeeccccccCcccCC
Q 002897          396 VKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI-PKYLENLSFLEYLNLSYNHFEGEVP  456 (869)
Q Consensus       396 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~  456 (869)
                      |.|+.|.|..  -..++.+-+|..||+++|+|.... -..+++++.|+.+.|.+|++.+.+.
T Consensus       357 L~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  357 LKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             eehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999998852  245677778889999999887321 2568888999999999999887654

>PLN03150 hypothetical protein; Provisional

Probab=99.17  E-value=2.6e-11  Score=140.44  Aligned_cols=113  Identities=36%  Similarity=0.553  Sum_probs=104.4

Q ss_pred             cceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccC
Q 002897          345 SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS  424 (869)
Q Consensus       345 l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~  424 (869)
                      +..|+|++|.++|.+|..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            56799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCccccccc-cccCeeccccccCcccCCC
Q 002897          425 NKLSGQIPKYLENL-SFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       425 N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~~~  457 (869)
                      |+++|.+|..+..+ .++..+++++|...+..|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            99999999998764 4678899999987665443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=3.2e-11  Score=130.43  Aligned_cols=250  Identities=18%  Similarity=0.140  Sum_probs=174.5

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEEC-CCCeEEEEEEeecccchhh--HHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIG-ENGMLVAVKVLNLMQKGAL--KSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ....+|..+..||.|.|+.|+.+... .++..|++|..........  ..-..|+.+...+ .|.+++++...|...   
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence            34567889999999999999998866 6788999998754332222  2235666666666 588888877665443   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAH  705 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k  705 (869)
                        ...++--|||++++......-..      .+++..++.+..|++.++.++|+.   .++|+|+||+||++..+ +..+
T Consensus       339 --r~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  339 --RQGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             --ccccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence              55678899999999877663322      267788899999999999999999   99999999999999886 7889


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCccccc--CCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI--APEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      ++|||.+..+....           ....+..+++  +|+......+..++|+||||.-+.+..+|.+--... ..   .
T Consensus       408 ~~~~~~~t~~~~~~-----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~---~  472 (524)
T KOG0601|consen  408 LGDFGCWTRLAFSS-----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ---S  472 (524)
T ss_pred             ccccccccccceec-----------ccccccccccccchhhccccccccccccccccccccccccCcccCccc-cc---c
Confidence            99999986432211           1112233344  566666677889999999999999999987653211 00   0


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ......                            ..+........+..+...+...++..||.+.+......-.
T Consensus       473 ~~i~~~----------------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  473 LTIRSG----------------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             eeeecc----------------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            000000                            0000111224566778889999999999998876554433

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=1.1e-11  Score=120.65  Aligned_cols=125  Identities=27%  Similarity=0.305  Sum_probs=107.2

Q ss_pred             ccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEcc
Q 002897          344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS  423 (869)
Q Consensus       344 ~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~  423 (869)
                      -++.+|||+|.|+ .+.+++.-++.++.|++|+|.+. .+. .++.+.+|+.|+||+|.++ .+-.+-..+-+++.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            3567999999998 77888889999999999999998 443 4899999999999999998 667777788999999999


Q ss_pred             CCcccCCCccccccccccCeeccccccCcc--cCCCCCccCCCccccccCCcc
Q 002897          424 SNKLSGQIPKYLENLSFLEYLNLSYNHFEG--EVPKKGVFSNKTRFSLSGNGK  474 (869)
Q Consensus       424 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~~~~~~~~~~~~n~~  474 (869)
                      .|.|.. + ..+.++-+|..||+++|+|..  .+...|.++.+..+.+.+||-
T Consensus       361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  361 QNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             hhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            999973 2 467888999999999999974  344568889999999999975

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.07  E-value=3e-11  Score=142.42  Aligned_cols=271  Identities=20%  Similarity=0.179  Sum_probs=130.5

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCc--cCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNR--LGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      ...++..+-+|.+. .++.+..+ ++|+.|-+.+|.  +..+.++.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            45566666666665 33333322 356666666664  443444446666666666666665555666666666666666


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCc--cccccCcCccCCCCCCEEEccCc
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ--FIGKMSINFNSLKNLSVLILGNN  177 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~L~l~~n  177 (869)
                      +|++..++ .+|.+ +.+|+.|.+|++..+.-...+|..+..+++|++|.+..-.  ........+..+.+|+.+.....
T Consensus       601 ~L~~t~I~-~LP~~-l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~  678 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSG-LGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS  678 (889)
T ss_pred             cccCCCcc-ccchH-HHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence            66666665 66643 5666666666666665544455555666666666665443  11111222333333333333222


Q ss_pred             cCCCCCCCCcchhhhccCCCCCc----EEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccC------CCC
Q 002897          178 HLGNRAANDLDFVTVLANCSKLE----NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN------LVH  247 (869)
Q Consensus       178 ~l~~~~~~~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~------l~~  247 (869)
                      .. .+.       ..+..+++|.    .+.+.++... ..+..+..+.. |+.|.+.++.+.......+..      +++
T Consensus       679 s~-~~~-------e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~-L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~  748 (889)
T KOG4658|consen  679 SV-LLL-------EDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGN-LEELSILDCGISEIVIEWEESLIVLLCFPN  748 (889)
T ss_pred             hh-HhH-------hhhhhhHHHHHHhHhhhhcccccc-eeecccccccC-cceEEEEcCCCchhhcccccccchhhhHHH
Confidence            11 000       0111222222    2222222222 22333344433 555555555554222222111      222


Q ss_pred             CCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccccccc
Q 002897          248 LNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ  307 (869)
Q Consensus       248 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  307 (869)
                      +..+...++... ..+.+.--.++|+.|++..+.....+.+....+..+..+.+..+.+.
T Consensus       749 l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~  807 (889)
T KOG4658|consen  749 LSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLE  807 (889)
T ss_pred             HHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccc
Confidence            333333333222 22333334577777777777666555555555555555445555544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.2e-09  Score=99.03  Aligned_cols=129  Identities=23%  Similarity=0.312  Sum_probs=95.5

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc--------cchhhHHHHHHHHHHHhCCC--CccceEEEEeeccccCCCc
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--------QKGALKSFLTECEALRSIRH--RNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~  629 (869)
                      ..+++|+-+.+|.+.+  -|..+++|.=...        .+-...+..+|+.++.++.-  -++..++++.       .+
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD   72 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence            4678999999999977  5666777753111        01123566889999998853  3344445542       25


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ...|+|||++|..|.+++....             ..++..+-.-+.-||..   ||||+|+.++||++..+. +.++||
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            5689999999999998887642             34566677778889999   999999999999997665 999999


Q ss_pred             ccccc
Q 002897          710 GLAKF  714 (869)
Q Consensus       710 g~a~~  714 (869)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=6.8e-11  Score=134.19  Aligned_cols=215  Identities=22%  Similarity=0.285  Sum_probs=153.1

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ...+.+.+.+-+-+|+++.++.+.-...|...+.|+.....   ....+....+-.+.-...+|-++....-     +..
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence            45567888889999999999999887778666666553211   1112222222222222334544433322     233


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++|++|+.++++..-++....      .+.+-.+.....+..+.+|||..   .+.|+|++|.|.++..+++.++.
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence            4668899999999999999987663      55556667777888999999998   79999999999999999999999


Q ss_pred             cccccccCCCCCCCC---------------------ccc--cCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHH
Q 002897          708 DFGLAKFLPARPLDT---------------------VVE--TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL  764 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~---------------------~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~  764 (869)
                      |||............                     ...  .........||+.|.+||...+......+|.|+.|++++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence            998544332110000                     000  001234567999999999999999999999999999999


Q ss_pred             HHHcCCCCCCcCccC
Q 002897          765 EMFSRRRPTDSMFHE  779 (869)
Q Consensus       765 el~tg~~pf~~~~~~  779 (869)
                      |.++|.+||.....+
T Consensus      1027 e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             hhhcCCCCCCCcchh
Confidence            999999999865443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.02  E-value=2.7e-09  Score=97.63  Aligned_cols=142  Identities=23%  Similarity=0.263  Sum_probs=103.1

Q ss_pred             CCCeeeeecceEEEEEEECCCCeEEEEEEee-c-------ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-L-------MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       558 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ....+-+|+-+.|+++.+  .|+.++||.=. +       ..+-..++..+|++.+.++.--.|.-..-++.+.     .
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            567899999999999999  78888887531 1       1112346678999999988543433322232221     4


Q ss_pred             eEEEEeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEE
Q 002897          630 FKAIVYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAH  705 (869)
Q Consensus       630 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  705 (869)
                      .-.|+|||+++ .++.+++...-..    ....+....++.+|-+.+.-||..   +|+|||+..+||++..++   .+.
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence            45799999977 4788888765432    123333378899999999999999   999999999999997665   468


Q ss_pred             Eccccccc
Q 002897          706 VGDFGLAK  713 (869)
Q Consensus       706 l~Dfg~a~  713 (869)
                      ++|||++.
T Consensus       157 lIdfgls~  164 (229)
T KOG3087|consen  157 LIDFGLSS  164 (229)
T ss_pred             EEeecchh
Confidence            99999985

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=7.1e-09  Score=109.43  Aligned_cols=178  Identities=17%  Similarity=0.196  Sum_probs=136.1

Q ss_pred             cceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecccC-CCHH
Q 002897          566 SFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQN-GSLE  644 (869)
Q Consensus       566 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  644 (869)
                      ...+.|+|....+|..|++|+++............-+++++++.|+|+|++.+++....| ++...++||+|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence            346889999999999999999954333322334556889999999999999998875434 34778999999987 6777


Q ss_pred             HHHhhCCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          645 EWLHQNNDKL---------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       645 ~~l~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ++--......         +....+++.+|.++.|+..||.++|+.   |..-+-+.|.+|+++.+.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            7644332221         233478899999999999999999999   9999999999999999999999988887665


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCC
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP  772 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p  772 (869)
                      ..++.                      |-+.+   -.+-|.=.||.+++.|.||..-
T Consensus       444 ~~d~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPT----------------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCC----------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            54321                      11111   1246888999999999999654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.01  E-value=2e-09  Score=109.23  Aligned_cols=144  Identities=21%  Similarity=0.259  Sum_probs=109.3

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCC--CccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRH--RNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.++.|.++.||+++.. +|+.+++|....... .....+..|+++++.+.+  ..+.+++.+.....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            57899999999999985 468999999754332 134678999999999965  34677777754321  1135689999


Q ss_pred             cccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 002897          637 FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC----------------------------------  682 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  682 (869)
                      |++|.++.+.+...       .++..+...++.++++++++||+..                                  
T Consensus        81 ~i~G~~l~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLRP-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCCC-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99998887765321       2677788888888888888888531                                  


Q ss_pred             -------------------CCCeEecCCCCCceeecC--CCcEEEccccccc
Q 002897          683 -------------------KPPVVHGDLKPSNVLLDH--DMVAHVGDFGLAK  713 (869)
Q Consensus       683 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~  713 (869)
                                         ...++|+|++|.||+++.  ++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                               246799999999999998  6678999999885

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=2.6e-09  Score=102.74  Aligned_cols=126  Identities=23%  Similarity=0.262  Sum_probs=84.2

Q ss_pred             EEEEEEECCCCeEEEEEEeeccc--------------c------------hhhHHHHHHHHHHHhCCCC--ccceEEEEe
Q 002897          569 TVFKGIIGENGMLVAVKVLNLMQ--------------K------------GALKSFLTECEALRSIRHR--NLIKIITIC  620 (869)
Q Consensus       569 ~V~~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~  620 (869)
                      .||.|... +|..+|||+.+...              .            .......+|++.|.++..-  ++.+++++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48999985 89999999985211              0            0124568899999999654  56777766 


Q ss_pred             eccccCCCceEEEEeeccc--CCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcee
Q 002897          621 SSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       621 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIl  697 (869)
                              ...++||||++  |..+..+....        ++......++.+++..+..+ |..   |++|||+.+.||+
T Consensus        79 --------~~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   79 --------NRNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             --------ETTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             --------eCCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                    34579999998  55554433322        12334566778888866664 677   9999999999999


Q ss_pred             ecCCCcEEEccccccccCC
Q 002897          698 LDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~  716 (869)
                      ++++ .+.++|||.|....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9887 99999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.98  E-value=4.4e-10  Score=132.72  Aligned_cols=132  Identities=20%  Similarity=0.244  Sum_probs=111.5

Q ss_pred             ccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc--cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcc
Q 002897           43 GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ--FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN  120 (869)
Q Consensus        43 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~--i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  120 (869)
                      .+....+...+-+|.+. .++..... ++|++|-+..|.  +..+.+..|..++.|+.|||++|.--+.+|. .++.|-+
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~-~I~~Li~  596 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPS-SIGELVH  596 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCCh-HHhhhhh
Confidence            44478899999999998 55555443 489999999996  6656666788999999999999876568984 5899999


Q ss_pred             hhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc
Q 002897          121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus       121 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      ||.|++++..+. .+|.++.++++|.+||+..+.-....+.....|.+|++|.+-.-.
T Consensus       597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            999999999999 689999999999999999998766667788889999999987765

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=4.3e-10  Score=87.10  Aligned_cols=59  Identities=37%  Similarity=0.590  Sum_probs=31.5

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|++|++++|+|+.+.+.+|.++++|++|++++|+|+.+.|++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45555555555554444455555555555555555555545555555555555555554

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=4.6e-09  Score=102.94  Aligned_cols=137  Identities=23%  Similarity=0.210  Sum_probs=102.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc----------------------chhhHHHHHHHHHHHhCCCC-
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ----------------------KGALKSFLTECEALRSIRHR-  611 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~-  611 (869)
                      =+.+...||.|--|.||.|.+. .|.++|||.-+...                      .-.....++|.++|.++... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3556789999999999999996 89999999753111                      01124568999999999644 


Q ss_pred             -ccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002897          612 -NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGD  690 (869)
Q Consensus       612 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  690 (869)
                       .+.+.+++         +..++||||++|-.|...-           ++.+..-.++..|++-+.-+-..   ||||||
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGD  227 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGD  227 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence             78888776         6778999999886554332           22334445555566655555566   999999


Q ss_pred             CCCCceeecCCCcEEEccccccccC
Q 002897          691 LKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       691 lkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      +++-||+++++|.+.++||-.+...
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             CchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999877543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.94  E-value=5e-10  Score=86.74  Aligned_cols=61  Identities=23%  Similarity=0.481  Sum_probs=51.8

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcC
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRF  106 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l  106 (869)
                      ++|++|++++|+|+.+.+++|.++++|++|+|++|+|+.+.|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4788888888888877778888888888888888888888788888888888888888875

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=3.8e-08  Score=100.75  Aligned_cols=145  Identities=14%  Similarity=0.039  Sum_probs=101.4

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccch-hh----------HHHHHHHHHHHhCC--CCccceEEEEeeccccC
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-AL----------KSFLTECEALRSIR--HRNLIKIITICSSIDFN  626 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~  626 (869)
                      +.+-......|+++..  .|+.|.||........ ..          ..+.+|...+.++.  .-.++.++++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4444444455667766  7889999977432211 11          14778999888883  22334455554322111


Q ss_pred             CCceEEEEeecccCC-CHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----
Q 002897          627 GVDFKAIVYDFMQNG-SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-----  700 (869)
Q Consensus       627 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----  700 (869)
                      .....++|||++++. +|.+++.....    .+.+......++.+++..++-||..   ||+|+|++++|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            134578999999886 89999864221    1256677889999999999999999   9999999999999975     


Q ss_pred             --CCcEEEccccccc
Q 002897          701 --DMVAHVGDFGLAK  713 (869)
Q Consensus       701 --~~~~kl~Dfg~a~  713 (869)
                        ++.+.++||+.+.
T Consensus       179 ~~~~~~~LIDl~r~~  193 (268)
T PRK15123        179 EEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCCceEEEEECCccc
Confidence              4689999999885

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=2.6e-07  Score=89.07  Aligned_cols=143  Identities=16%  Similarity=0.105  Sum_probs=105.9

Q ss_pred             eeeecceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCceEEE
Q 002897          562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ------KGALKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       562 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      -|+||.+.|+....  .|..+-+|.-...-      +-....|.+|...+..+.  .-.+.+++ ++...........+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            36789999999887  55678888764110      223478899999998884  22355555 332222233456789


Q ss_pred             EeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--EEEcccc
Q 002897          634 VYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV--AHVGDFG  710 (869)
Q Consensus       634 v~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg  710 (869)
                      |+|-+++ .+|.+++.....    .+.+......+..+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            9997764 589998866432    1367788889999999999999999   9999999999999986676  9999998


Q ss_pred             cccc
Q 002897          711 LAKF  714 (869)
Q Consensus       711 ~a~~  714 (869)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            7753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=1.2e-08  Score=111.95  Aligned_cols=158  Identities=17%  Similarity=0.236  Sum_probs=104.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccC-CCCCCccCcccccCCcccC
Q 002897          668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKGTVGYIAPEYGT  746 (869)
Q Consensus       668 ~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~  746 (869)
                      +.+++.|+.|+|...  ++||++|.|++|.+++.+..||+.|+++............... ....-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345569999999885  9999999999999999999999999998766543221111110 1111223456899999999


Q ss_pred             CCCCCccccchhhhHHHHHHH-cCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHH
Q 002897          747 GSEASMTGDVYSFGILLLEMF-SRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEEC  825 (869)
Q Consensus       747 ~~~~~~~sDvwslG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~  825 (869)
                      +...+.++|+||+||.+|.+. .|+.-+.....  ...........        +.               ...-.....
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~--~~~~~~~~~~~--------~~---------------~~~~~s~~~  237 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG--LLSYSFSRNLL--------NA---------------GAFGYSNNL  237 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCC--cchhhhhhccc--------cc---------------ccccccccC
Confidence            988899999999999999999 45555543211  11111111100        00               000011245


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          826 LVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       826 ~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +.++.+=+.+++..++..||++.++..
T Consensus       238 p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  238 PSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             cHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            566777788899999999997777654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.65  E-value=2.9e-07  Score=89.65  Aligned_cols=155  Identities=21%  Similarity=0.242  Sum_probs=108.1

Q ss_pred             CcccHHHHHHHhcCCCCCCeee---eecceEEEEEEECCCCeEEEEEEeecccch------------------------h
Q 002897          542 PMISYAKLSKATSEFSSSNMVG---QGSFGTVFKGIIGENGMLVAVKVLNLMQKG------------------------A  594 (869)
Q Consensus       542 ~~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------~  594 (869)
                      -..++..+....++..+....|   .|--+.||+|... ++..+|||+++.....                        .
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            3445566666666666666555   5666789999874 7999999998632210                        0


Q ss_pred             hHHHHHHHHHHHhC--CCCccceEEEEeeccccCCCceEEEEeecccCC-CHHHHHhhCCCcccccCCCHHHHHHHHHHH
Q 002897          595 LKSFLTECEALRSI--RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNG-SLEEWLHQNNDKLEVCNLSLIQTLNIAIDV  671 (869)
Q Consensus       595 ~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i  671 (869)
                      ..-..+|+.-|+++  .+-.+.+.+++         ..-.+||||+... .-.-.++.       .++..++...+..++
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~LkD-------v~~e~~e~~~~~~~~  175 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLKD-------VPLELEEAEGLYEDV  175 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCccc-------CCcCchhHHHHHHHH
Confidence            11246777778877  35666677776         3457999998653 11111221       124444677888899


Q ss_pred             HHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCC
Q 002897          672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       672 ~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  716 (869)
                      ++.+.-|-..+  ++||+|++.-|||+. ++.+.|+|||.|....
T Consensus       176 v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         176 VEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999998843  999999999999998 8899999999997654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.63  E-value=1.2e-09  Score=118.80  Aligned_cols=198  Identities=24%  Similarity=0.239  Sum_probs=113.3

Q ss_pred             CCCCEEEccCccccCcC-CCCCCCCccccceecccccccccCCcCccCcc-ccceeeccCcccCC---CCCccccc----
Q 002897          270 KNLQSLYLNSNFLHGYI-PSSLGNLTMLTLLALEINNLQGKIPSSLGNCT-SLIMLTLSKNKLDG---VLPPQILS----  340 (869)
Q Consensus       270 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~---~~~~~~~~----  340 (869)
                      ++++.|.+-.-.=.+.. |-.+....+|+.|.+.++.|..  ...+..+. .|+.| +.+|.++.   ++....+.    
T Consensus        84 qkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns  160 (1096)
T KOG1859|consen   84 QKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISNS  160 (1096)
T ss_pred             hhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhh-hhhccHHHHHHHHHHhccccccc
Confidence            44444544433322222 6677888999999999999873  22222221 23332 12222210   00000000    


Q ss_pred             -cccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCc-ccccccccc
Q 002897          341 -VTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIK  418 (869)
Q Consensus       341 -~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~  418 (869)
                       ....+...+.+.|.++ ....++.-++.|+.|+|++|+++...  .+..|+.|+.|||++|.|+ .+|. ...++ .|+
T Consensus       161 ~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~  235 (1096)
T KOG1859|consen  161 PVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQ  235 (1096)
T ss_pred             hhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hhe
Confidence             0112334566777776 55566777777777777777776332  6677777777777777777 4443 22333 377


Q ss_pred             EEEccCCcccCCCccccccccccCeeccccccCcccC--CCCCccCCCccccccCCcccCC
Q 002897          419 VLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEV--PKKGVFSNKTRFSLSGNGKLCG  477 (869)
Q Consensus       419 ~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--~~~~~~~~~~~~~~~~n~~~c~  477 (869)
                      .|.|+||.++..  ..+.+|.+|+.||+++|-|++-.  ...+.+..+..+.+.|||--|.
T Consensus       236 ~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  236 LLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             eeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            777777777632  35667777777777777776532  2234556666777777776664

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.61  E-value=6.7e-09  Score=101.55  Aligned_cols=109  Identities=20%  Similarity=0.297  Sum_probs=61.1

Q ss_pred             CcCEEeccCCcCcccc-Cccc-ccCcCCCEEEccCCccCc--cCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           23 KLENLSLAENHLTGQL-PVSI-GNLSALQVIDIRGNRLGG--KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~-~~~~-~~l~~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      -++.|.+.++.|...= -..| ...+.++.|||.+|.|+.  .+-..+.+++.|++|+|+.|++...+...-..+.+|+.
T Consensus        46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~  125 (418)
T KOG2982|consen   46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV  125 (418)
T ss_pred             chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence            3445556666554211 1122 234667777777777773  22233556777777777777776433222245567777


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhcccccc
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNL  131 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i  131 (869)
                      |-|.+..+.-.-....+..+|.++.|.++.|++
T Consensus       126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL  158 (418)
T ss_pred             EEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence            777776654222233455666667776666644

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.61  E-value=2.6e-09  Score=104.38  Aligned_cols=216  Identities=19%  Similarity=0.237  Sum_probs=125.4

Q ss_pred             cccCcCCCEEEccCCccCccCC-cccc-CCCCCCEEeCcCcccCc--cCCcccccCCCCcEEECcCCcCcccCCchhhcC
Q 002897           42 IGNLSALQVIDIRGNRLGGKIP-DTLG-QLRKLIYLNIGRNQFSG--FIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN  117 (869)
Q Consensus        42 ~~~l~~L~~L~L~~n~i~~~~p-~~~~-~l~~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  117 (869)
                      +.....++.|-+.++.|..+-. ..|+ ..+.++.|||.+|+|+.  .+..-+.+++.|+.|+|++|.+...|... -..
T Consensus        41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~l-p~p  119 (418)
T KOG2982|consen   41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSL-PLP  119 (418)
T ss_pred             eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccC-ccc
Confidence            3344455667777777763211 1232 46788888999998883  33445667888888888888886333211 134


Q ss_pred             Ccchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCC
Q 002897          118 LPNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC  196 (869)
Q Consensus       118 l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l  196 (869)
                      +.+|+.|.|.+..+... ....+..++.++.|+++.|.+              +.+++..|-++.....    ...+..+
T Consensus       120 ~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~--------------rq~n~Dd~c~e~~s~~----v~tlh~~  181 (418)
T KOG2982|consen  120 LKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL--------------RQLNLDDNCIEDWSTE----VLTLHQL  181 (418)
T ss_pred             ccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh--------------hhhccccccccccchh----hhhhhcC
Confidence            56777777777777532 234556667777777777642              3334444444433321    1233444


Q ss_pred             CCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccC-CccccCCCCCCeeecccCcceecC-CccccCCCCCCE
Q 002897          197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI-PPGLGNLVHLNSIAMEGNQLIGTV-PPEIGWLKNLQS  274 (869)
Q Consensus       197 ~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~  274 (869)
                      +.+..++++-|++...+|        ++..+-+..|.++... ...+..++.+..|+|+.|+|.+-. -+++..+++|+.
T Consensus       182 ~c~~~~w~~~~~l~r~Fp--------nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~d  253 (418)
T KOG2982|consen  182 PCLEQLWLNKNKLSRIFP--------NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVD  253 (418)
T ss_pred             CcHHHHHHHHHhHHhhcc--------cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhhe
Confidence            455555556666654444        2555666666665322 334555666667777777765321 234566777777


Q ss_pred             EEccCccccC
Q 002897          275 LYLNSNFLHG  284 (869)
Q Consensus       275 L~L~~N~l~~  284 (869)
                      |.+++|.+..
T Consensus       254 lRv~~~Pl~d  263 (418)
T KOG2982|consen  254 LRVSENPLSD  263 (418)
T ss_pred             eeccCCcccc
Confidence            7777776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=4.7e-07  Score=89.91  Aligned_cols=110  Identities=23%  Similarity=0.234  Sum_probs=85.9

Q ss_pred             hHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCceEEEEeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHH
Q 002897          595 LKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVDFKAIVYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV  671 (869)
Q Consensus       595 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i  671 (869)
                      ..+..+|...+..+.  .-.+.+.+++...... .....++|+|++++ .+|.+++.....      .+......++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l  127 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRAL  127 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHH
Confidence            356788888887773  3345566666544322 22456899999988 479999886432      4566788999999


Q ss_pred             HHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEcccccccc
Q 002897          672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKF  714 (869)
Q Consensus       672 ~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  714 (869)
                      ++.++-||+.   ||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999   999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.60  E-value=8.1e-10  Score=120.08  Aligned_cols=175  Identities=25%  Similarity=0.286  Sum_probs=86.3

Q ss_pred             cCCcCEEeccCCcCcccc-CcccccCcCCCEEEccCCccCccCCccccCC-CCCCEEeCcCcccCc---cCCc---cccc
Q 002897           21 LFKLENLSLAENHLTGQL-PVSIGNLSALQVIDIRGNRLGGKIPDTLGQL-RKLIYLNIGRNQFSG---FIPP---SIYN   92 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l-~~L~~L~L~~n~i~~---~~p~---~~~~   92 (869)
                      +++++.|.+-.-.=.+-. |-++..+..|++|.|.++.|.. .-+ +..+ ..|++| +-+|.+..   ++..   .|++
T Consensus        83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~-~~G-L~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~n  159 (1096)
T KOG1859|consen   83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST-AKG-LQELRHQLEKL-ICHNSLDALRHVFASCGGDISN  159 (1096)
T ss_pred             HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh-hhh-hHHHHHhhhhh-hhhccHHHHHHHHHHhcccccc
Confidence            444555544433322222 5566677778888888777763 111 1111 133333 22222220   0000   0111


Q ss_pred             ---CCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCC
Q 002897           93 ---ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNL  169 (869)
Q Consensus        93 ---l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  169 (869)
                         ...|...+.++|++. .+. ..+.-++.|+.|+|++|+++..  ..+..+++|++|||++|.+..+.--...++. |
T Consensus       160 s~~Wn~L~~a~fsyN~L~-~mD-~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L  234 (1096)
T KOG1859|consen  160 SPVWNKLATASFSYNRLV-LMD-ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-L  234 (1096)
T ss_pred             chhhhhHhhhhcchhhHH-hHH-HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-h
Confidence               113455556666664 333 3355556666666666666543  2555666666666666666554444444444 6


Q ss_pred             CEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          170 SVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       170 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      +.|++.+|.++.+-        .+.++.+|+.||+++|-|.+
T Consensus       235 ~~L~lrnN~l~tL~--------gie~LksL~~LDlsyNll~~  268 (1096)
T KOG1859|consen  235 QLLNLRNNALTTLR--------GIENLKSLYGLDLSYNLLSE  268 (1096)
T ss_pred             eeeeecccHHHhhh--------hHHhhhhhhccchhHhhhhc
Confidence            66666666655433        24555666666666665543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	869
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-40
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-40
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-34
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-25
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		9e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-07
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-07
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		3e-07
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		3e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		4e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		5e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		1e-05
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		2e-05
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-05
3soa_A	444	Full-Length Human Camkii Length = 444		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		5e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		1e-04
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-04
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		7e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  163 bits (413), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 133/433 (30%), Positives = 203/433 (46%), Gaps = 42/433 (9%)
Query: 7   NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
           NK+ GD+ V        LE L ++ N+ +  +P  +G+ SALQ +DI GN+L G     +
Sbjct: 185 NKISGDVDVS---RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 240
Query: 67  GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
               +L  LNI  NQF G IPP    + S +++ L  N+F G +P  +      L     
Sbjct: 241 STCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 298
Query: 127 AKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAAN 185
           + N+  G +P                N F G++ ++    ++ L VL L  N        
Sbjct: 299 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 358
Query: 186 DLDFVTVLANCSKLENLGLYDNQFGG-LLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN 244
            L  ++     + L  L L  N F G +LP+   N  NT+  + +  N F+G IPP L N
Sbjct: 359 SLTNLS-----ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 413
Query: 245 LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXEIN 304
              L S+ +  N L GT+P  +G L  L+ L L  N L G IP              + N
Sbjct: 414 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 473
Query: 305 NLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXEIG 364
           +L G+IPS L NCT+L  ++LS N+L G +P                           IG
Sbjct: 474 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-------------------------IG 508
Query: 365 NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
            L+NL  L +S N FSG+IP  L  C SL ++ +  N F+G+IP ++ F +S K+   ++
Sbjct: 509 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM-FKQSGKI---AA 564
Query: 425 NKLSGQIPKYLEN 437
           N ++G+   Y++N
Sbjct: 565 NFIAGKRYVYIKN 577

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  163 bits (412), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 133/433 (30%), Positives = 203/433 (46%), Gaps = 42/433 (9%)
Query: 7   NKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL 66
           NK+ GD+ V        LE L ++ N+ +  +P  +G+ SALQ +DI GN+L G     +
Sbjct: 188 NKISGDVDVS---RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 243
Query: 67  GQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA 126
               +L  LNI  NQF G IPP    + S +++ L  N+F G +P  +      L     
Sbjct: 244 STCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 127 AKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAAN 185
           + N+  G +P                N F G++ ++    ++ L VL L  N        
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
Query: 186 DLDFVTVLANCSKLENLGLYDNQFGG-LLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN 244
            L  ++     + L  L L  N F G +LP+   N  NT+  + +  N F+G IPP L N
Sbjct: 362 SLTNLS-----ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 245 LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXXXXXXXEIN 304
              L S+ +  N L GT+P  +G L  L+ L L  N L G IP              + N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 305 NLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXXXXXXXEIG 364
           +L G+IPS L NCT+L  ++LS N+L G +P                           IG
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-------------------------IG 511
Query: 365 NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
            L+NL  L +S N FSG+IP  L  C SL ++ +  N F+G+IP ++ F +S K+   ++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM-FKQSGKI---AA 567
Query: 425 NKLSGQIPKYLEN 437
           N ++G+   Y++N
Sbjct: 568 NFIAGKRYVYIKN 580

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/318 (32%), Positives = 171/318 (53%), Gaps = 36/318 (11%)
Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKS 597
           Q    S  +L  A+  FS+ N++G+G FG V+KG +  +G LVAVK L     Q G L+ 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERXQGGELQ- 81
Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           F TE E +    HRNL+++   C +        + +VY +M NGS+   L +  +     
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           +    Q   IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +  
Sbjct: 137 DWPKRQ--RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF 777
           +  D  V        ++GT+G+IAPEY +  ++S   DV+ +G++LLE+ + +R  D   
Sbjct: 195 K--DXHV-----XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247
Query: 778 ---HEGLTLHEFSKMVLPEKVME-IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIG 833
               + + L ++ K +L EK +E +VD    ++++ N            +E +  +I++ 
Sbjct: 248 LANDDDVMLLDWVKGLLKEKKLEALVD----VDLQGNYK----------DEEVEQLIQVA 293
Query: 834 VVCSMESPTDRMQMRDVV 851
           ++C+  SP +R +M +VV
Sbjct: 294 LLCTQSSPMERPKMSEVV 311

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 99/318 (31%), Positives = 167/318 (52%), Gaps = 36/318 (11%)
Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKS 597
           Q    S  +L  A+  F + N++G+G FG V+KG +  +G LVAVK L     Q G L+ 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLA-DGXLVAVKRLKEERTQGGELQ- 73
Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           F TE E +    HRNL+++   C +        + +VY +M NGS+   L +  +     
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           +    Q   IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +  
Sbjct: 129 DWPKRQ--RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF 777
           +              ++G +G+IAPEY +  ++S   DV+ +G++LLE+ + +R  D   
Sbjct: 187 KDXHV-------XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 778 ---HEGLTLHEFSKMVLPEKVME-IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIG 833
               + + L ++ K +L EK +E +VD    ++++ N            +E +  +I++ 
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVD----VDLQGNYK----------DEEVEQLIQVA 285
Query: 834 VVCSMESPTDRMQMRDVV 851
           ++C+  SP +R +M +VV
Sbjct: 286 LLCTQSSPMERPKMSEVV 303

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 99/322 (30%), Positives = 153/322 (47%), Gaps = 37/322 (11%)
Query: 542 PMISY----AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           P  SY      L +AT+ F    ++G G FG V+KG++  +G  VA+K         ++ 
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEE 81
Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           F TE E L   RH +L+ +I  C     +  +   ++Y +M+NG+L+  L+ ++  L   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           ++S  Q L I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---- 187
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSM 776
               T ++       +KGT+GYI PEY      +   DVYSFG++L E+   R     S+
Sbjct: 188 --KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 777 FHEGLTLHEFSKMVLPEKVME-IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVV 835
             E + L E++        +E IVDP+L  ++R  +    G   VK              
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK-------------- 291
Query: 836 CSMESPTDRMQMRDVVVKLCAA 857
           C   S  DR  M DV+ KL  A
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYA 313

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 99/322 (30%), Positives = 152/322 (47%), Gaps = 37/322 (11%)
Query: 542 PMISY----AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           P  SY      L +AT+ F    ++G G FG V+KG++  +G  VA+K         ++ 
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEE 81
Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
           F TE E L   RH +L+ +I  C     +  +   ++Y +M+NG+L+  L+ ++  L   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           ++S  Q L I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---- 187
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSM 776
               T +        +KGT+GYI PEY      +   DVYSFG++L E+   R     S+
Sbjct: 188 --KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 777 FHEGLTLHEFSKMVLPEKVME-IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVV 835
             E + L E++        +E IVDP+L  ++R  +    G   VK              
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK-------------- 291
Query: 836 CSMESPTDRMQMRDVVVKLCAA 857
           C   S  DR  M DV+ KL  A
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYA 313

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 144/302 (47%), Gaps = 32/302 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C S     +    ++ +F+  GSL E+L ++ ++++      I+ L     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEFLPYGSLREYLQKHKERID-----HIKLLQYTSQICKGMEY 132
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        +H DL   N+L++++    +GDFGL K LP       V+ P  S      +
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-----I 184
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVME 797
            + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K  +
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQGQ 238
Query: 798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA 857
           ++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++   
Sbjct: 239 MIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 858 RE 859
           R+
Sbjct: 293 RD 294

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 144/302 (47%), Gaps = 32/302 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 147
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        +H DL   N+L++++    +GDFGL K LP       V+ P  S      +
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-----I 199
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVME 797
            + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K  +
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQGQ 253
Query: 798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA 857
           ++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++   
Sbjct: 254 MIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307
Query: 858 RE 859
           R+
Sbjct: 308 RD 309

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 127
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 180
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 181 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 233
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 856 AARE 859
             R+
Sbjct: 288 QIRD 291

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 81  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 132
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 133 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 185
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 186 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 238
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 239 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 292
Query: 856 AARE 859
             R+
Sbjct: 293 QIRD 296

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 83  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 135 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 187
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 188 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 240
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 241 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 294
Query: 856 AARE 859
             R+
Sbjct: 295 QIRD 298

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 144/302 (47%), Gaps = 32/302 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEY 147
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        +H DL   N+L++++    +GDFGL K LP       V+ P  S      +
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP-----I 199
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVME 797
            + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K  +
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQGQ 253
Query: 798 IVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA 857
           ++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++   
Sbjct: 254 MIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307
Query: 858 RE 859
           R+
Sbjct: 308 RD 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 144/307 (46%), Gaps = 32/307 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 107 YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 158
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 211
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 212 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 264
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 265 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 856 AAREAFV 862
             R+   
Sbjct: 319 QIRDQMA 325

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 75  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 126
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 127 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 179
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 180 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 232
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 233 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 286
Query: 856 AARE 859
             R+
Sbjct: 287 QIRD 290

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 144/307 (46%), Gaps = 32/307 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 74  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 125
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 126 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 178
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 179 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 231
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 232 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 285
Query: 856 AAREAFV 862
             R+   
Sbjct: 286 QIRDQMA 292

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 79  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 130
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 183
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 184 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 236
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 237 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 856 AARE 859
             R+
Sbjct: 291 QIRD 294

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 127
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 180
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 181 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 233
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 856 AARE 859
             R+
Sbjct: 288 QIRD 291

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 82  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 133
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 134 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 186
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 187 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 239
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 240 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 293
Query: 856 AARE 859
             R+
Sbjct: 294 QIRD 297

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 80  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 131
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 132 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 184
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 185 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 237
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 238 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 291
Query: 856 AARE 859
             R+
Sbjct: 292 QIRD 295

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 144/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L ++ ++++      I+ L     +   +
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGM 127
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP---- 180
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 181 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 233
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 856 AARE 859
             R+
Sbjct: 288 QIRD 291

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 143/304 (47%), Gaps = 32/304 (10%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
             +G+G+FG+V    +  +    G +VAVK L    +  L+ F  E E L+S++H N++K
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C S     +    ++ +++  GSL ++L  + ++++      I+ L     +   +
Sbjct: 79  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQAHAERID-----HIKLLQYTSQICKGM 130
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           EYL        +H DL   N+L++++    +GDFGL K LP       V+ P  S     
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP---- 183
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            + + APE  T S+ S+  DV+SFG++L E+F+    + S         EF +M+  +K 
Sbjct: 184 -IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQ 236
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC 855
            +++   L+  ++ N  + R       + C   +  I   C   +   R   RD+ +++ 
Sbjct: 237 GQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 856 AARE 859
             R+
Sbjct: 291 QIRD 294

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 151/319 (47%), Gaps = 37/319 (11%)
Query: 550 SKATSEFSSSNM-----VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLT 600
           S+  ++F   ++     +G+G+FG+V    +  +    G +VAVK L    +  L+ F  
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E E L+S++H N++K   +C S     +    ++ +++  GSL ++L ++ ++++     
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID----- 113
Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL 720
            I+ L     +   +EYL        +H +L   N+L++++    +GDFGL K LP    
Sbjct: 114 HIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170
Query: 721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
              V+ P  S      + + APE  T S+ S+  DV+SFG++L E+F+    + S     
Sbjct: 171 YYKVKEPGESP-----IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS----- 220
Query: 781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES 840
               EF +M+  +K  +++   L+  ++ N  + R       + C   +  I   C   +
Sbjct: 221 -PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNN 273
Query: 841 PTDRMQMRDVVVKLCAARE 859
              R   RD+ +++   R+
Sbjct: 274 VNQRPSFRDLALRVDQIRD 292

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 120/225 (53%), Gaps = 24/225 (10%)
Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTE 601
           +S  K     ++ +  + +G G FG V++G+  +  + VAVK L  + M+   ++ FL E
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKE 57
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     +S 
Sbjct: 58  AAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSA 108
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 109 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 161
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 162 ---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 119/223 (53%), Gaps = 24/223 (10%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECE 603
           Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E  
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAA 66
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     +S + 
Sbjct: 67  VMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVV 117
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +        
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------ 168
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 169 -DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 117/222 (52%), Gaps = 20/222 (9%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA 604
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L       ++ FL E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 75
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     ++ +  
Sbjct: 76  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 126
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +         
Sbjct: 127 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 176
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 177 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 116/221 (52%), Gaps = 20/221 (9%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL 605
           Y K     ++ +  + +G G +G V++G+  +  + VAVK L       ++ FL E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 68
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           + I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     ++ +  L
Sbjct: 69  KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVLL 119
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
            +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +         +
Sbjct: 120 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------D 169
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/247 (32%), Positives = 119/247 (48%), Gaps = 42/247 (17%)
Query: 538 EQQFPMISYAKLSKATSEFSSS------NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM- 590
           + +F   S+ +L   T+ F         N +G+G FG V+KG +  N   VAVK L  M 
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 591 ---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL 647
               +   + F  E + +   +H NL++++   S    +G D   +VY +M NGSL    
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLL--- 118
Query: 648 HQNNDKLEVCN----LSLIQTLNIAIDVASAIEYLH--HHCKPPVVHGDLKPSNVLLDHD 701
               D+L   +    LS      IA   A+ I +LH  HH     +H D+K +N+LLD  
Sbjct: 119 ----DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEA 169
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
             A + DFGL     AR  +   +T   S  I GT  Y+APE   G E +   D+YSFG+
Sbjct: 170 FTAKISDFGL-----ARASEKFAQTVMXSR-IVGTTAYMAPEALRG-EITPKSDIYSFGV 222
Query: 762 LLLEMFS 768
           +LLE+ +
Sbjct: 223 VLLEIIT 229

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV +     +G  VAVK+L         +  FL E   ++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          +IV +++  GSL   LH++  + +   L   + L++A DVA  + YLH
Sbjct: 103 VTQ-----PPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLH 154
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
           +   PP+VH +LK  N+L+D      V DFGL++            T  SS    GT  +
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--------KASTFLSSKSAAGTPEW 205
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE      ++   DVYSFG++L E+ + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Composition-based stats.
 Identities = 62/228 (27%), Positives = 121/228 (53%), Gaps = 26/228 (11%)
Query: 542 PMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFL 599
           P  +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 58
Query: 600 TECEALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
            E   ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----E 108
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           ++ +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +   
Sbjct: 109 VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG- 164
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                 +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 165 ------DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 120/225 (53%), Gaps = 24/225 (10%)
Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTE 601
           +S  K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKE 57
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     +S 
Sbjct: 58  AAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSA 108
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 109 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 161
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 162 ---DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV +     +G  VAVK+L         +  FL E   ++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          +IV +++  GSL   LH++  + +   L   + L++A DVA  + YLH
Sbjct: 103 VTQ-----PPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLH 154
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
           +   PP+VH DLK  N+L+D      V DFGL++   +  L         S    GT  +
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL--------XSKXAAGTPEW 205
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE      ++   DVYSFG++L E+ + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     +S 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     +S 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     +S 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     +S 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 62/228 (27%), Positives = 121/228 (53%), Gaps = 26/228 (11%)
Query: 542 PMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFL 599
           P  +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL 61
Query: 600 TECEALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
            E   ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----E 111
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           ++ +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +   
Sbjct: 112 VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG- 167
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                 +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 168 ------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 119/223 (53%), Gaps = 24/223 (10%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECE 603
           Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E  
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAA 268
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     +S + 
Sbjct: 269 VMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVV 319
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L +A  ++SA+EYL    K   +H +L   N L+  + +  V DFGL++ +        
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG------ 370
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 371 -DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 65
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 115
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 116 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 168
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 169 ---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 118/247 (47%), Gaps = 42/247 (17%)
Query: 538 EQQFPMISYAKLSKATSEFSSS------NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM- 590
           + +F   S+ +L   T+ F         N +G+G FG V+KG +  N   VAVK L  M 
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 591 ---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL 647
               +   + F  E + +   +H NL++++   S    +G D   +VY +M NGSL    
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLL--- 118
Query: 648 HQNNDKLEVCN----LSLIQTLNIAIDVASAIEYLH--HHCKPPVVHGDLKPSNVLLDHD 701
               D+L   +    LS      IA   A+ I +LH  HH     +H D+K +N+LLD  
Sbjct: 119 ----DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEA 169
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
             A + DFGL     AR  +   +T      I GT  Y+APE   G E +   D+YSFG+
Sbjct: 170 FTAKISDFGL-----ARASEKFAQTVMXXR-IVGTTAYMAPEALRG-EITPKSDIYSFGV 222
Query: 762 LLLEMFS 768
           +LLE+ +
Sbjct: 223 VLLEIIT 229

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 119/225 (52%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           S  K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 58
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     +S 
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSA 108
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 109 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 161
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 162 ---DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 65
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVNA 115
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 116 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 168
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 169 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 61
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 111
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 112 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 164
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 165 ---DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 62
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 112
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 113 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 165
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 166 ---DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 65
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 115
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 116 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 168
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 169 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 60
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 110
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 163
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 164 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 62
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 112
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 113 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 165
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 166 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 61/225 (27%), Positives = 120/225 (53%), Gaps = 26/225 (11%)
Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTEC 602
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEA 62
Query: 603 EALRSIRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
             ++ I+H NL++++ +C+    F       I+ +FM  G+L ++L + N +     ++ 
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVNA 112
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
           +  L +A  ++SA+EYL    K   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 113 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---- 165
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 166 ---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRH 610
            SE   S  +G GSFGTV+KG    +   VAVK+L ++       ++F  E   LR  RH
Sbjct: 35  ASEVMLSTRIGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++  +   +       D  AIV  + +  SL + LH    K +     + Q ++IA  
Sbjct: 92  VNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQ-----MFQLIDIARQ 140
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
            A  ++YLH      ++H D+K +N+ L   +   +GDFGLA           VE P+  
Sbjct: 141 TAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-- 195
Query: 731 SGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               G+V ++APE       +  S   DVYS+GI+L E+ +   P
Sbjct: 196 ----GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 119/223 (53%), Gaps = 24/223 (10%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECE 603
           Y K     ++ +  + +G G +G V++G+  +  + VAVK L  + M+   ++ FL E  
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAA 307
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            ++ I+H NL++++ +C+        F  I+ +FM  G+L ++L + N +     ++ + 
Sbjct: 308 VMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVV 358
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L +A  ++SA+EYL    K   +H +L   N L+  + +  V DFGL++ +        
Sbjct: 359 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG------ 409
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+
Sbjct: 410 -DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 114/254 (44%), Gaps = 13/254 (5%)
Query: 238 IPPGLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSXXXXXXX 296
           IP  L NL +LN + + G N L+G +PP I  L  L  LY+    + G IP         
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 297 XXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTXXXXXXXXXXXXX 356
                  N L G +P S+ +  +L+ +T   N++ G +P    S +              
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 357 XXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKS 416
                   NL NL  +D+S N   GD      +  + + + +  NS +  +   +   K+
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKN 245
Query: 417 IKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSG---NG 473
           +  LDL +N++ G +P+ L  L FL  LN+S+N+  GE+P+ G   N  RF +S    N 
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG---NLQRFDVSAYANNK 302
Query: 474 KLCGGLDEFHLPSC 487
            LCG      LP+C
Sbjct: 303 CLCGS----PLPAC 312

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S           IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 247 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 296
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 297 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 346
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S           IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 247 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 296
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 297 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 346
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS 607
           K     ++ +  + +G G +G V+ G+  +  + VAVK L       ++ FL E   ++ 
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 84
Query: 608 IRHRNLIKIITICS-SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           I+H NL++++ +C+    F       IV ++M  G+L ++L + N +     ++ +  L 
Sbjct: 85  IKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDYLRECNRE----EVTAVVLLY 134
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           +A  ++SA+EYL    K   +H DL   N L+  + V  V DFGL++ +         +T
Sbjct: 135 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG-------DT 184
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            ++ +G K  + + APE    +  S+  DV++FG+LL E+
Sbjct: 185 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 109/226 (48%), Gaps = 34/226 (15%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   ++         AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 66  ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 114
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS-- 730
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA         TV    S S  
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQ 162
Query: 731 -SGIKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
              + G++ ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 275 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S           IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 330 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 379
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 380 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 429
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 117/247 (47%), Gaps = 42/247 (17%)
Query: 538 EQQFPMISYAKLSKATSEFSSS------NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM- 590
           + +F   S+ +L   T+ F         N +G+G FG V+KG +  N   VAVK L  M 
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 60
Query: 591 ---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL 647
               +   + F  E + +   +H NL++++   S    +G D   +VY +M NGSL    
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLL--- 112
Query: 648 HQNNDKLEVCN----LSLIQTLNIAIDVASAIEYLH--HHCKPPVVHGDLKPSNVLLDHD 701
               D+L   +    LS      IA   A+ I +LH  HH     +H D+K +N+LLD  
Sbjct: 113 ----DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEA 163
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
             A + DFGL     AR  +   +       I GT  Y+APE   G E +   D+YSFG+
Sbjct: 164 FTAKISDFGL-----ARASEKFAQXVMXXR-IVGTTAYMAPEALRG-EITPKSDIYSFGV 216
Query: 762 LLLEMFS 768
           +LLE+ +
Sbjct: 217 VLLEIIT 223

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S           IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 247 VVSEEPI------YIVGEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 296
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 297 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 346
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          AIV  + +  SL   LH    K E     +I+ ++IA   A  ++YLH
Sbjct: 75  STKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTAQGMDYLH 123
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS---SGIKGT 736
                 ++H DLK +N+ L  D+   +GDFGLA         TV    S S     + G+
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQFEQLSGS 171
Query: 737 VGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
           + ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 92
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 93  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 141
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS-- 730
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA         TV    S S  
Sbjct: 142 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQ 189
Query: 731 -SGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              + G++ ++APE       +  S   DVY+FGI+L E+ + + P
Sbjct: 190 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          AIV  + +  SL   LH    K E     +I+ ++IA   A  ++YLH
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTAQGMDYLH 126
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS---SGIKGT 736
                 ++H DLK +N+ L  D+   +GDFGLA         TV    S S     + G+
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQFEQLSGS 174
Query: 737 VGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
           + ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 93
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 94  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 142
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS-- 730
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA         TV    S S  
Sbjct: 143 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQ 190
Query: 731 -SGIKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
              + G++ ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 191 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 114
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS-- 730
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA         TV    S S  
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQ 162
Query: 731 -SGIKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
              + G++ ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 119
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS-- 730
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA         TV    S S  
Sbjct: 120 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRWSGSHQ 167
Query: 731 -SGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              + G++ ++APE       +  S   DVY+FGI+L E+ + + P
Sbjct: 168 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          AIV  + +  SL   LH +  K E+  L     ++IA   A  ++YLH
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 125
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS---SGIKGT 736
                 ++H DLK +N+ L  D    +GDFGLA         TV    S S     + G+
Sbjct: 126 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA---------TVKSRWSGSHQFEQLSGS 173
Query: 737 VGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
           + ++APE     ++   S   DVY+FGI+L E+ + + P
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 16  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 71  VVSE------EPIXIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 120
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 121 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-------NEXTARQGAKFPIK 170
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ IRH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++GA+  + F+ E E +  + H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 60
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V++FM++G L ++L           L     L + +DV
Sbjct: 61  KLVQLYGVC--LEQAPI---CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 110
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL   C   V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 111 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 160
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS 
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 198

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++GA+  + F+ E E +  + H 
Sbjct: 10  SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 65
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V++FM++G L ++L           L     L + +DV
Sbjct: 66  KLVQLYGVC--LEQAPI---CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 115
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL   C   V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 116 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 165
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS
Sbjct: 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++GA+  + F+ E E +  + H 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V++FM++G L ++L           L     L + +DV
Sbjct: 63  KLVQLYGVC--LEQAPI---CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 112
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL   C   V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 113 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 162
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS 
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 200

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 19  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 74  VVSE------EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYV 123
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 124 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 173
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 114
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA               S  SG
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT------------EKSRWSG 159
Query: 733 ------IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 + G++ ++APE       +  S   DVY+FGI+L E+ + + P
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRN 612
           + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 85
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++  +   +          AIV  + +  SL   LH    K E     +I+ ++IA   A
Sbjct: 86  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTA 134
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA               S  SG
Sbjct: 135 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------------TEKSRWSG 179
Query: 733 ------IKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
                 + G++ ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 180 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            ++         AIV  + +  SL   LH +  K E+  L     ++IA   A  ++YLH
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG------I 733
                 ++H DLK +N+ L  D    +GDFGLA               S  SG      +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT------------EKSRWSGSHQFEQL 182
Query: 734 KGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
            G++ ++APE     ++   S   DVY+FGI+L E+ + + P
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKIIT 618
             +G+G+FG VF G +  +  LVAVK         LK+ FL E   L+   H N++++I 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C+           IV + +Q G    +L     +L V  L     L +  D A+ +EYL
Sbjct: 180 VCTQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEYL 229
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT-V 737
              C    +H DL   N L+    V  + DFG+++       D V    ++S G++   V
Sbjct: 230 ESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVX---AASGGLRQVPV 279
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE       S   DV+SFGILL E FS
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          AIV  + +  SL   LH    K E     +I+ ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFE-----MIKLIDIARQTAQGMDYLH 149
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG------I 733
                 ++H DLK +N+ L  D+   +GDFGLA               S  SG      +
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------------TEKSRWSGSHQFEQL 194
Query: 734 KGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
            G++ ++APE     +    S   DVY+FGI+L E+ + + P
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKIIT 618
             +G+G+FG VF G +  +  LVAVK         LK+ FL E   L+   H N++++I 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C+           IV + +Q G    +L     +L V  L     L +  D A+ +EYL
Sbjct: 180 VCTQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEYL 229
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT-V 737
              C    +H DL   N L+    V  + DFG+++       D V    ++S G++   V
Sbjct: 230 ESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVY---AASGGLRQVPV 279
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE       S   DV+SFGILL E FS
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 113/245 (46%), Gaps = 42/245 (17%)
Query: 540 QFPMISYAKLSKATSEFSSS------NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--- 590
           +F   S+ +L   T+ F         N  G+G FG V+KG +  N   VAVK L  M   
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI 59
Query: 591 -QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ 649
             +   + F  E +     +H NL++++   S    +G D   +VY +  NGSL      
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSS----DGDDL-CLVYVYXPNGSLL----- 109
Query: 650 NNDKLEVCN----LSLIQTLNIAIDVASAIEYLH--HHCKPPVVHGDLKPSNVLLDHDMV 703
             D+L   +    LS      IA   A+ I +LH  HH     +H D+K +N+LLD    
Sbjct: 110 --DRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFT 162
Query: 704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           A + DFGL     AR  +   +    S  I GT  Y APE   G E +   D+YSFG++L
Sbjct: 163 AKISDFGL-----ARASEKFAQXVXXSR-IVGTTAYXAPEALRG-EITPKSDIYSFGVVL 215
Query: 764 LEMFS 768
           LE+ +
Sbjct: 216 LEIIT 220

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 193 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S           IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 248 VVSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 297
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGL + +            ++  G K  + 
Sbjct: 298 E---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-------TARQGAKFPIK 347
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-------NEXTARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITI 619
           +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +          AIV  + +  SL   LH +  K E+  L     ++IA   A  ++YLH
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                 ++H DLK +N+ L  D    +GDFGLA            E       + G++ +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGSILW 188
Query: 740 IAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRP 772
           +APE     ++   S   DVY+FGI+L E+ + + P
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 15  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 70  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 119
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 120 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 169
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 170 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 17  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 72  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 121
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 122 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 171
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G  VAVK L     G  +     E E LR++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             IC+    NG+    ++ +F+ +GSL+E+L +N +K+     +L Q L  A+ +   ++
Sbjct: 89  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKI-----NLKQQLKYAVQICKGMD 140
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YL        VH DL   NVL++ +    +GDFGL K      ++T  E  +        
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEXXTVKDDRDSP 192
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE    S+  +  DV+SFG+ L E+ +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G  VAVK L     G  +     E E LR++ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             IC+    NG+    ++ +F+ +GSL+E+L +N +K+     +L Q L  A+ +   ++
Sbjct: 77  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKI-----NLKQQLKYAVQICKGMD 128
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YL        VH DL   NVL++ +    +GDFGL K      ++T  E  +        
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEXXTVKDDRDSP 180
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE    S+  +  DV+SFG+ L E+ +
Sbjct: 181 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q ++++  +AS + Y+
Sbjct: 78  VVSE------EPIYIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYV 127
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 128 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 177
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVCEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 27/231 (11%)
Query: 559 SNMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLI 614
             ++G G FG V  G   + G+  + VA+K L     +   + FL+E   +    H N+I
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 615 K---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
               ++T  + +         I+ +FM+NGSL+ +L QN+ +  V     IQ + +   +
Sbjct: 98  HLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGI 144
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A+ ++YL        VH DL   N+L++ ++V  V DFGL++FL     DT   T +S+ 
Sbjct: 145 AAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSAL 198
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGL 781
           G K  + + APE     + +   DV+S+GI++ E+ S   RP   M ++ +
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 249

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q ++++  +AS + Y+
Sbjct: 78  VVSE------EPIYIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYV 127
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 128 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-------TARQGAKFPIK 177
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++GA+  + F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 63
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V +FM++G L ++L           L     L + +DV
Sbjct: 64  KLVQLYGVC--LEQAPI---CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 113
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL   C   V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 114 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++G++    F+ E E +  + H 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---KEGSMSEDDFIEEAEVMMKLSHP 82
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V++FM++G L ++L           L     L + +DV
Sbjct: 83  KLVQLYGVC--LEQAPI---CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 132
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL   C   V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 133 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 182
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS 
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 220

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  GSL ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL  +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  G L ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVMEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V  G     G  VAVK +        ++FL E   +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            ++  G  +  IV ++M  GSL ++L      +    L     L  ++DV  A+EYL  +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 121
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
                VH DL   NVL+  D VA V DFGL K           E  S+    K  V + A
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 167
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE     + S   DV+SFGILL E++S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIIT 618
           +GQG FG V+ G    NG   VA+K L   + G +  ++FL E + ++ +RH  L+++  
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + S       +   IV ++M  G L ++L     K     L L Q +++A  +AS + Y+
Sbjct: 81  VVSE------EPIYIVTEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G K  + 
Sbjct: 131 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 180
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           + APE       ++  DV+SFGILL E+ ++ R
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 123/242 (50%), Gaps = 33/242 (13%)
Query: 557 SSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHR 611
           +   ++G G FG V+KG++    G+  + VA+K L     +     FL E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 612 NLIKIITICSSIDFNGVDFKA--IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           N+I++  + S        +K   I+ ++M+NG+L+++L + + +      S++Q + +  
Sbjct: 107 NIIRLEGVISK-------YKPMMIITEYMENGALDKFLREKDGEF-----SVLQLVGMLR 154
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +A+ ++YL +      VH DL   N+L++ ++V  V DFGL++ L   P     E   +
Sbjct: 155 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYT 206
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSK 788
           +SG K  + + APE  +  + +   DV+SFGI++ E+ +   RP     +  L+ HE  K
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-----YWELSNHEVMK 261
Query: 789 MV 790
            +
Sbjct: 262 AI 263

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V  G     G  VAVK +        ++FL E   +  +RH NL++++ +  
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            ++  G  +  IV ++M  GSL ++L      +    L     L  ++DV  A+EYL  +
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 308
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
                VH DL   NVL+  D VA V DFGL K           E  S+    K  V + A
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 354
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE     + S   DV+SFGILL E++S
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V  G     G  VAVK +        ++FL E   +  +RH NL++++ +  
Sbjct: 29  IGKGEFGDVMLGDY--RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            ++  G  +  IV ++M  GSL ++L      +    L     L  ++DV  A+EYL  +
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 136
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
                VH DL   NVL+  D VA V DFGL K           E  S+    K  V + A
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 182
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE     + S   DV+SFGILL E++S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V  G     G  VAVK +        ++FL E   +  +RH NL++++ +  
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
            ++  G  +  IV ++M  GSL ++L      +    L     L  ++DV  A+EYL  +
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 127
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
                VH DL   NVL+  D VA V DFGL K           E  S+    K  V + A
Sbjct: 128 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 173
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           PE    +  S   DV+SFGILL E++S  R
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +   ++GA+  + F+ E E +  + H 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  +C  ++   +    +V++FM++G L ++L           L     L + +DV
Sbjct: 63  KLVQLYGVC--LEQAPI---CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 112
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + YL    +  V+H DL   N L+  + V  V DFG+ +F+    LD   +  +SS+
Sbjct: 113 CEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFV----LD---DQYTSST 162
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
           G K  V + +PE  + S  S   DV+SFG+L+ E+FS 
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 200

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 93  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 143
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 196
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 29/229 (12%)
Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFL 599
           +SY K+ +         ++G G FG V +G +   G+    VA+K L     +   + FL
Sbjct: 15  VSYVKIEE---------VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 65
Query: 600 TECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
           +E   +    H N+I++  + +    N +    I+ +FM+NG+L+ +L  N+ +  V   
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVT----NSMPV-MILTEFMENGALDSFLRLNDGQFTV--- 117
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
             IQ + +   +AS + YL        VH DL   N+L++ ++V  V DFGL++FL    
Sbjct: 118 --IQLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS 172
Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            D    T +SS G K  + + APE     + +   D +S+GI++ E+ S
Sbjct: 173 SDP---TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 96  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 146
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 199
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 559 SNMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLI 614
             ++G G FG V  G   + G+  + VA+K L         + FL+E   +    H N+I
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 615 K---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
               ++T C  +         I+ ++M+NGSL+ +L +N+ +  V     IQ + +   +
Sbjct: 94  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGI 140
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            S ++YL        VH DL   N+L++ ++V  V DFG+++ L   P     E   ++ 
Sbjct: 141 GSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP-----EAAYTTR 192
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           G K  + + APE     + +   DV+S+GI++ E+ S
Sbjct: 193 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 198
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 198
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 100 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 150
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 203
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 154 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 204
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 257
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 29/231 (12%)
Query: 560 NMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK 615
            ++G G FG V  G   + G+  + VA+K L     +   + FL+E   +    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 616 IITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           +          GV  K+    I+ +FM+NGSL+ +L QN+ +  V     IQ + +   +
Sbjct: 73  L---------EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGI 118
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A+ ++YL        VH  L   N+L++ ++V  V DFGL++FL     DT   T +S+ 
Sbjct: 119 AAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSAL 172
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGL 781
           G K  + + APE     + +   DV+S+GI++ E+ S   RP   M ++ +
Sbjct: 173 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 96  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 146
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +++L        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV----HNKTGAK 199
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           E     +VG+G+FG V K         VA+K   +  +   K+F+ E   L  + H N++
Sbjct: 9   EIEVEEVVGRGAFGVVCKA--KWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           K+   C     N V    +V ++ + GSL   LH       +   +    ++  +  +  
Sbjct: 65  KLYGAC----LNPV---CLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 114
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + YLH      ++H DLKP N+LL     V  + DFG           T  +  +  +  
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNN 163
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
           KG+  ++APE   GS  S   DV+S+GI+L E+ +RR+P D +
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 559 SNMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLI 614
             ++G G FG V  G   + G+  + VA+K L         + FL+E   +    H N+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 615 K---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
               ++T C  +         I+ ++M+NGSL+ +L +N+ +  V     IQ + +   +
Sbjct: 73  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGI 119
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            S ++YL        VH DL   N+L++ ++V  V DFG+++ L   P     E   ++ 
Sbjct: 120 GSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP-----EAAYTTR 171
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
           G K  + + APE     + +   DV+S+GI++ E+ S   RP   M
Sbjct: 172 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 29/231 (12%)
Query: 559 SNMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLI 614
             ++G G FG V  G   + G+  + VA+K L         + FL+E   +    H N+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 615 K---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
               ++T C  +         I+ ++M+NGSL+ +L +N+ +  V     IQ + +   +
Sbjct: 79  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGI 125
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            S ++YL        VH DL   N+L++ ++V  V DFG+++ L   P     E   ++ 
Sbjct: 126 GSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP-----EAAYTTR 177
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGL 781
           G K  + + APE     + +   DV+S+GI++ E+ S   RP   M ++ +
Sbjct: 178 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           E     +VG+G+FG V K         VA+K   +  +   K+F+ E   L  + H N++
Sbjct: 10  EIEVEEVVGRGAFGVVCKA--KWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 65
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           K+   C     N V    +V ++ + GSL   LH       +   +    ++  +  +  
Sbjct: 66  KLYGAC----LNPV---CLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 115
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + YLH      ++H DLKP N+LL     V  + DFG           T  +  +  +  
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNN 164
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
           KG+  ++APE   GS  S   DV+S+GI+L E+ +RR+P D +
Sbjct: 165 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 37/233 (15%)
Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNLMQKGAL----- 595
           +SY K+ +         ++G G FG V +G +   G+    VA+K L    KG       
Sbjct: 13  VSYVKIEE---------VIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQR 59
Query: 596 KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           + FL+E   +    H N+I++  + +    N +    I+ +FM+NG+L+ +L  N+ +  
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVT----NSMPV-MILTEFMENGALDSFLRLNDGQFT 114
Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
           V     IQ + +   +AS + YL        VH DL   N+L++ ++V  V DFGL++FL
Sbjct: 115 V-----IQLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 166
Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                D    T +SS G K  + + APE     + +   D +S+GI++ E+ S
Sbjct: 167 EENSSDP---TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGLA+ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLARVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 94  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 144
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +  +   +V     + +G K
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSV----HNKTGAK 197
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+ G    N   VA+K L   + G +  +SFL E + ++ ++H  L+++  +
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-VAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            S           IV ++M  GSL ++L     +     L L   +++A  VA+ + Y+ 
Sbjct: 73  VSEEPI------YIVTEYMNKGSLLDFLKDGEGRA----LKLPNLVDMAAQVAAGMAYIE 122
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL+ +N+L+ + ++  + DFGLA+ +            ++  G K  + +
Sbjct: 123 RMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX-------TARQGAKFPIKW 172
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL E+ ++ R
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 198
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 198
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 113 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 163
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 164 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 216
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 87  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 137
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 138 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 190
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 114 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 164
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 165 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 217
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 94  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 144
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 197
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 90  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 140
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 193
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 93  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 143
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 144 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 196
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + + +    +V  +M++G L  ++       E  N ++   +   + VA  
Sbjct: 92  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++YL        VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 143 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 195
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             V ++A E     + +   DV+SFG+LL E+ +R  P
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL + L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLGRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 119/243 (48%), Gaps = 32/243 (13%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTE 601
           +AK   AT+  S   +VG G FG V  G +    +  + VA+K L +   +   + FL E
Sbjct: 26  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVC 657
              +    H N+I++          GV  K+    IV ++M+NGSL+ +L +++      
Sbjct: 85  ASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----A 130
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
             ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L  
Sbjct: 131 QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            P     E   ++ G K  + + +PE     + +   DV+S+GI+L E+ S   RP   M
Sbjct: 188 DP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 242
Query: 777 FHE 779
            ++
Sbjct: 243 SNQ 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 120/245 (48%), Gaps = 32/245 (13%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTE 601
           +AK   AT+  S   +VG G FG V  G +    +  + VA+K L +   +   + FL E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVC 657
              +    H N+I++          GV  K+    IV ++M+NGSL+ +L +++      
Sbjct: 68  ASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----A 113
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
             ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L  
Sbjct: 114 QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            P     E   ++ G K  + + +PE     + +   DV+S+GI+L E+ S   RP   M
Sbjct: 171 DP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225
Query: 777 FHEGL 781
            ++ +
Sbjct: 226 SNQDV 230

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           ++E  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 25  TYEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 78
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 79  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 129
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 130 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 181
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 182 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 236
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 237 VLWEVMSYGERPYWEM 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           ++E  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TYEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV ++M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 117/240 (48%), Gaps = 32/240 (13%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTE 601
           +AK   AT+  S   +VG G FG V  G +    +  + VA+K L +   +   + FL E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVC 657
              +    H N+I++          GV  K+    IV ++M+NGSL+ +L +++      
Sbjct: 97  ASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----A 142
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
             ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L  
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            P     E   ++ G K  + + +PE     + +   DV+S+GI+L E+ S   RP   M
Sbjct: 200 DP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 43/291 (14%)
Query: 560 NMVGQGSFGTVFKG-IIGENG--MLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLI 614
            ++G+G FG+V +G +  E+G  + VAVK + L    +  ++ FL+E   ++   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +++ +C  +   G+    ++  FM+ G L  +L  +  +    ++ L   L   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +EYL +      +H DL   N +L  DM   V DFGL+K + +       +        K
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG------DYYRQGRIAK 210
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
             V +IA E       +   DV++FG+ + E+ +R        + G+  HE    +L   
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPGVQNHEMYDYLL--- 263
Query: 795 VMEIVDPSLLLEVRANNSMSRGGERVKI-EECLVAVIRIGVVCSMESPTDR 844
                                 G R+K  E+CL  +  I   C    P DR
Sbjct: 264 ---------------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           +FE  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TFEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV + M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---AVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRN 612
           ++F     +G+G FG VF+     +    A+K + L  +  A +  + E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 613 LIKIITIC----SSIDFNGVDFKAIVYDFMQ---NGSLEEWLHQNNDKLEVCNLSLIQTL 665
           +++         ++        K  +Y  MQ     +L++W+   N +  +        L
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCL 121
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           +I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +     +  V 
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 726 TP----SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           TP    +  +G  GT  Y++PE   G+  S   D++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS--IRHRNLIKIITIC 620
            +G FG V+K  +  +   VAVK+  L  K   +S+ +E E   +  ++H NL++ I   
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFI--- 75
Query: 621 SSIDFNGVDFKA---IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +  G + +    ++  F   GSL ++L  N        ++  +  ++A  ++  + Y
Sbjct: 76  -AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-------ITWNELCHVAETMSRGLSY 127
Query: 678 LHHHC--------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPS 728
           LH           KP + H D K  NVLL  D+ A + DFGLA +F P +P       P 
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKP-------PG 180
Query: 729 SSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTD 774
            + G  GT  Y+APE   G+     +A +  D+Y+ G++L E+ SR +  D
Sbjct: 181 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 121/255 (47%), Gaps = 40/255 (15%)
Query: 545 SYAKLSKATSEFSSS---------NMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQ 591
           +Y   ++A  EF+            ++G G FG V  G +   G+  + VA+K L +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 592 KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWL 647
           +   + FL E   +    H N+I +          GV  K+    IV ++M+NGSL+ +L
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHL---------EGVVTKSKPVMIVTEYMENGSLDTFL 114
Query: 648 HQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG 707
            +N+ +  V     IQ + +   +++ ++YL        VH DL   N+L++ ++V  V 
Sbjct: 115 KKNDGQFTV-----IQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 166
Query: 708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           DFGL++ L   P     E   ++ G K  + + APE     + +   DV+S+GI++ E+ 
Sbjct: 167 DFGLSRVLEDDP-----EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221
Query: 768 SR-RRPTDSMFHEGL 781
           S   RP   M ++ +
Sbjct: 222 SYGERPYWEMTNQDV 236

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 29/226 (12%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS--IRHRNLIKII 617
            ++G+G +G V+KG + E    VAVKV +   +   ++F+ E    R   + H N+ + I
Sbjct: 19  ELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFI 73
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                +  +G     +V ++  NGSL ++L    +D +  C L        A  V   + 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL--------AHSVTRGLA 125
Query: 677 YLH------HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           YLH       H KP + H DL   NVL+ +D    + DFGL+  L    L    E  +++
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 731 SGIKGTVGYIAPEYGTGS------EASMTG-DVYSFGILLLEMFSR 769
               GT+ Y+APE   G+      E+++   D+Y+ G++  E+F R
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 119/245 (48%), Gaps = 32/245 (13%)
Query: 546 YAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQKGALKSFLTE 601
           +AK   AT+  S   +VG G FG V  G +    +  + VA+K L +   +   + FL E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVC 657
              +    H N+I++          GV  K+    IV + M+NGSL+ +L +++      
Sbjct: 68  ASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLRKHD-----A 113
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
             ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L  
Sbjct: 114 QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            P     E   ++ G K  + + +PE     + +   DV+S+GI+L E+ S   RP   M
Sbjct: 171 DP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225
Query: 777 FHEGL 781
            ++ +
Sbjct: 226 SNQDV 230

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 31/230 (13%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRH 610
           +S+F   +++G+G++G V        G +VA+K +    K   AL++ L E + L+  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ-------NNDKLEVCNLSLIQ 663
            N+I I  I     F   +   I+ + MQ       LH+       ++D ++     + Q
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQ 120
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           TL        A++ LH      V+H DLKPSN+L++ +    V DFGLA+ +     D  
Sbjct: 121 TLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 724 VETPSSSSGIK--GTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             T   S  ++   T  Y APE   T ++ S   DV+S G +L E+F RR
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLN-LMQKGALKSFLTECEALRSI 608
           +E     ++G G+FGTV+KGI    G    + VA+K+LN      A   F+ E   + S+
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H +L++++ +C S          +V   M +G L E++H++ D     N+     LN  
Sbjct: 98  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD-----NIGSQLLLNWC 146
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L         E   
Sbjct: 147 VQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEY 197
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           ++ G K  + ++A E     + +   DV+S+G+ + E+ +
Sbjct: 198 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 37/256 (14%)
Query: 530 SFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGII---GENGMLVAVKV 586
           ++E  T    +F     AK   AT+  S   +VG G FG V  G +    +  + VA+K 
Sbjct: 27  TYEDPTQTVHEF-----AKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 587 LNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNG 641
           L +   +   + FL E   +    H N+I++          GV  K+    IV + M+NG
Sbjct: 81  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENG 131
Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL+ +L +++        ++IQ + +   +AS ++YL        VH DL   N+L++ +
Sbjct: 132 SLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           +V  V DFGL++ L   P     E   ++ G K  + + +PE     + +   DV+S+GI
Sbjct: 184 LVCKVSDFGLSRVLEDDP-----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 762 LLLEMFSR-RRPTDSM 776
           +L E+ S   RP   M
Sbjct: 239 VLWEVMSYGERPYWEM 254

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQ-KGALKSFLTECEALRSI 608
           +E     ++G G+FGTV+KGI    G    + VA+K+LN      A   F+ E   + S+
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H +L++++ +C S          +V   M +G L E++H++ D     N+     LN  
Sbjct: 75  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD-----NIGSQLLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L         E   
Sbjct: 124 VQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           ++ G K  + ++A E     + +   DV+S+G+ + E+ +
Sbjct: 175 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           + +G+G+FG+V    +  +    G LVAVK L        + F  E + L+++ H + I 
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 70
Query: 616 IITICSSIDFNGVDFKA------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
                  + + GV +        +V +++ +G L ++L ++  +L+   L L  +     
Sbjct: 71  -------VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS----- 118
Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK LP      VV  P 
Sbjct: 119 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            S      + + APE  + +  S   DV+SFG++L E+F+
Sbjct: 175 QS-----PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRH 610
           +S+F   +++G+G++G V        G +VA+K +    K   AL++ L E + L+  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ-------NNDKLEVCNLSLIQ 663
            N+I I  I     F   +   I+ + MQ       LH+       ++D ++     + Q
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQ 120
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           TL        A++ LH      V+H DLKPSN+L++ +    V DFGLA+ +     D  
Sbjct: 121 TLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 724 VETPSSSSGIK--GTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             T   S   +   T  Y APE   T ++ S   DV+S G +L E+F RR
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRH 610
           +S+F   +++G+G++G V        G +VA+K +    K   AL++ L E + L+  +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ-------NNDKLEVCNLSLIQ 663
            N+I I  I     F   +   I+ + MQ       LH+       ++D ++     + Q
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQ 120
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           TL        A++ LH      V+H DLKPSN+L++ +    V DFGLA+ +     D  
Sbjct: 121 TLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 724 VETPSSSSGIK--GTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
             T   S   +   T  Y APE   T ++ S   DV+S G +L E+F RR
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 30  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 85  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 134
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 135 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 184
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 185 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 229
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 230 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 29  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 84  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 133
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 134 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 183
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 184 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 228
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 229 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 27  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 82  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 131
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 181
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 182 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 226
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 227 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 260

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 21  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 175
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 176 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 220
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 221 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 23  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 78  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 127
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 128 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 177
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 178 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 222
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 223 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 21  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 175
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 176 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 220
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 221 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 27  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 82  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 131
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 181
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 182 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 226
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 227 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 260

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 22  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 77  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 126
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 127 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEXTAREGAKFPIK 176
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 177 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 221
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 222 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 255

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 31  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 86  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 135
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 136 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 185
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 186 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 230
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 231 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 264

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 21  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 175
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 176 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 220
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 221 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 16  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 71  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 120
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 121 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 170
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 171 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 215
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 216 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 249

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 26  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 81  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 131 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 180
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 181 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 225
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 226 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 259

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 545 SYAKLSKATSEFSSS---------NMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQ 591
           +Y   ++A  +F+            ++G G FG V  G +   G+  + VA+K L +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 592 KGALKSFLTECEALRSIRHRNLIK---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH 648
           +   + FL E   +    H N++    ++T    +         IV +FM+NG+L+ +L 
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPV--------MIVIEFMENGALDAFLR 136
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
           +++ +      ++IQ + +   +A+ + YL        VH DL   N+L++ ++V  V D
Sbjct: 137 KHDGQF-----TVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSD 188
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           FGL++ +   P     E   +++G K  V + APE     + +   DV+S+GI++ E+ S
Sbjct: 189 FGLSRVIEDDP-----EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
Query: 769 R-RRPTDSM 776
              RP   M
Sbjct: 244 YGERPYWDM 252

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 134/315 (42%), Gaps = 59/315 (18%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF       +  ++ MLVAVK L    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWL--HQNNDKLEVCN-------LSLIQTLNI 667
             +C+     G     +V+++M++G L  +L  H  + KL           L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++         +  T 
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTD 212
Query: 728 SSSSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
               G +    + ++ PE     + +   DV+SFG++L E+F+                 
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------------- 255
Query: 786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM 845
           + K    +          L    A + +++G E  +   C   V  I   C    P  R 
Sbjct: 256 YGKQPWYQ----------LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRH 305
Query: 846 QMRDVVVKLCAAREA 860
            ++DV  +L A  +A
Sbjct: 306 SIKDVHARLQALAQA 320

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           + +G+G+FG+V    +  +    G LVAVK L        + F  E + L+++ H + I 
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 73
Query: 616 IITICSSIDFNGVDFKA------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
                  + + GV +        +V +++ +G L ++L ++  +L+   L L  +     
Sbjct: 74  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS----- 121
Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK LP      VV  P 
Sbjct: 122 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            S      + + APE  + +  S   DV+SFG++L E+F+
Sbjct: 178 QS-----PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 33/224 (14%)
Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF          ++ MLVAVK L      A K F  E E L +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC----------NLSLIQTLN 666
             +C     +G D   +V+++M++G L ++L  +     +            L L Q L+
Sbjct: 83  YGVCG----DG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           IA  +AS + YL        VH DL   N L+  +++  +GDFG+++         V  T
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--------DVYST 186
Query: 727 PSSSSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                G      + ++ PE     + +   DV+SFG++L E+F+
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           + +G+G+FG+V    +  +    G LVAVK L        + F  E + L+++ H + I 
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 74
Query: 616 IITICSSIDFNGVDFKA------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
                  + + GV +        +V +++ +G L ++L ++  +L+   L L  +     
Sbjct: 75  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS----- 122
Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK LP      VV  P 
Sbjct: 123 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 178
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            S      + + APE  + +  S   DV+SFG++L E+F+
Sbjct: 179 QS-----PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 134/315 (42%), Gaps = 59/315 (18%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF       +  ++ MLVAVK L    + A + F  E E L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWL--HQNNDKLEVCN-------LSLIQTLNI 667
             +C+     G     +V+++M++G L  +L  H  + KL           L L Q L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++         +  T 
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTD 183
Query: 728 SSSSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
               G +    + ++ PE     + +   DV+SFG++L E+F+                 
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------------- 226
Query: 786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM 845
           + K    +          L    A + +++G E  +   C   V  I   C    P  R 
Sbjct: 227 YGKQPWYQ----------LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRH 276
Query: 846 QMRDVVVKLCAAREA 860
            ++DV  +L A  +A
Sbjct: 277 SIKDVHARLQALAQA 291

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G   +    VAVK   ++++G++    F  E + +  + H  L+K   +
Sbjct: 16  LGSGQFGVVKLGK-WKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 620 CSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           CS       ++   IV +++ NG L  +L  +   LE       Q L +  DV   + +L
Sbjct: 72  CSK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPS-----QLLEMCYDVCEGMAFL 120
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
             H     +H DL   N L+D D+   V DFG+ +++    LD   +   SS G K  V 
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LD---DQYVSSVGTKFPVK 170
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           + APE     + S   DV++FGIL+ E+FS
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 560 NMVGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           + +G+G+FG+V    +  +    G LVAVK L        + F  E + L+++ H + I 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI- 86
Query: 616 IITICSSIDFNGVDFKA------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
                  + + GV +        +V +++ +G L ++L ++  +L+   L L  +     
Sbjct: 87  -------VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS----- 134
Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK LP      VV  P 
Sbjct: 135 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            S      + + APE  + +  S   DV+SFG++L E+F+
Sbjct: 191 QS-----PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 134/315 (42%), Gaps = 59/315 (18%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF       +  ++ MLVAVK L    + A + F  E E L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWL--HQNNDKLEVCN-------LSLIQTLNI 667
             +C+     G     +V+++M++G L  +L  H  + KL           L L Q L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++         +  T 
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTD 189
Query: 728 SSSSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
               G +    + ++ PE     + +   DV+SFG++L E+F+                 
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------------- 232
Query: 786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM 845
           + K    +          L    A + +++G E  +   C   V  I   C    P  R 
Sbjct: 233 YGKQPWYQ----------LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRH 282
Query: 846 QMRDVVVKLCAAREA 860
            ++DV  +L A  +A
Sbjct: 283 SIKDVHARLQALAQA 297

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 560 NMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK 615
            ++G G  G V  G   + G+  + VA+K L     +   + FL+E   +    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  + +           IV ++M+NGSL+ +L  ++ +      +++Q + +   V + +
Sbjct: 115 LEGVVTR-----GRLAMIVTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRGVGAGM 164
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        VH DL   NVL+D ++V  V DFGL++ L   P     +   +++G K 
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAXTTTGGKI 216
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + + APE       S   DV+SFG+++ E+ +
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 42/240 (17%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---------NLMQKGALKSFLTEC 602
           A +E      +G+G FG V KG + ++  +VA+K L          +++K   + F  E 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREV 74
Query: 603 EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
             + ++ H N++K+  +  +          +V +F+  G L    H+  DK      S+ 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDL---YHRLLDKAHPIKWSV- 123
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLPA 717
             L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFGL++    
Sbjct: 124 -KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT--GDVYSFGILLLEMFSRRRPTDS 775
                  ++  S SG+ G   ++APE     E S T   D YSF ++L  + +   P D 
Sbjct: 178 -------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALR--- 606
           ATS +     +G G++GTV+K     +G  VA+K + +   ++G   S + E   LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +  H N+++++ +C++   +      +V++ + +  L  +L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR-PLDTVVE 725
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+    +  LD VV 
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                     T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 174 ----------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 560 NMVGQGSFGTVFKG---IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIK 615
            ++G G  G V  G   + G+  + VA+K L     +   + FL+E   +    H N+I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  + +           IV ++M+NGSL+ +L  ++ +      +++Q + +   V + +
Sbjct: 115 LEGVVTR-----GRLAMIVTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRGVGAGM 164
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        VH DL   NVL+D ++V  V DFGL++ L   P     +   +++G K 
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGKI 216
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + + APE       S   DV+SFG+++ E+ +
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 69/289 (23%), Positives = 132/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G FG V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 17  LGAGQFGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 72  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 121
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H +L+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 122 EER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIK 171
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 172 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 216
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 217 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 250

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 186
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 186
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLT-ECEALRSIRHRNLIKIIT 618
           +G+GSFG V        G  VA+K++N  ++ K  ++  +  E   LR +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  S D      + I+        L +++ Q +   E       Q       + SA+EY 
Sbjct: 72  VIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 119
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H H    +VH DLKP N+LLD  +   + DFGL+  +            +  + +K + G
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM------------TDGNFLKTSCG 164
Query: 739 ---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
              Y APE  +G   A    DV+S G++L  M  RR P D 
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 80  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIXETDXX 183
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLT-ECEALRSIRHRNLIKIIT 618
           +G+GSFG V        G  VA+K++N  ++ K  ++  +  E   LR +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  S D      + I+        L +++ Q +   E       Q       + SA+EY 
Sbjct: 76  VIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 123
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H H    +VH DLKP N+LLD  +   + DFGL+  +            +  + +K + G
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM------------TDGNFLKTSCG 168
Query: 739 ---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
              Y APE  +G   A    DV+S G++L  M  RR P D 
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLT-ECEALRSIRHRNLIKIIT 618
           +G+GSFG V        G  VA+K++N  ++ K  ++  +  E   LR +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  S D      + I+        L +++ Q +   E       Q       + SA+EY 
Sbjct: 82  VIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 129
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H H    +VH DLKP N+LLD  +   + DFGL+  +            +  + +K + G
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM------------TDGNFLKTSCG 174
Query: 739 ---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
              Y APE  +G   A    DV+S G++L  M  RR P D 
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L        +S +  E + LR++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C      G     +V +++  GSL ++L +++       + L Q L  A  +   + 
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH       +H DL   NVLLD+D +  +GDFGLAK +P       V     S      
Sbjct: 149 YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP----- 200
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE     +     DV+SFG+ L E+ +
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLT-ECEALRSIRHRNLIKIIT 618
           +G+GSFG V        G  VA+K++N  ++ K  ++  +  E   LR +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +  S D      + I+        L +++ Q +   E       Q       + SA+EY 
Sbjct: 81  VIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 128
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H H    +VH DLKP N+LLD  +   + DFGL+  +            +  + +K + G
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM------------TDGNFLKTSCG 173
Query: 739 ---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
              Y APE  +G   A    DV+S G++L  M  RR P D 
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL 605
           + +   +F   N++G+GSF  V++      G+ VA+K+++   + + G ++    E +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
             ++H +++++        F   ++  +V +   NG +  +L     K  V   S  +  
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEAR 115
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           +    + + + YLH H    ++H DL  SN+LL  +M   + DFGLA         T ++
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA---------TQLK 163
Query: 726 TPSSSS-GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
            P      + GT  YI+PE  T S   +  DV+S G +   +   R P D+
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETAYY 186
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 26/241 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK---VLNLMQKGALKSFLTECEALRSIRH 610
           + F     +G+G F  V++     +G+ VA+K   + +LM   A    + E + L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL-HQNNDKLEVCNLSLIQTLNIAI 669
            N+IK     S I+ N ++   IV +    G L   + H    K  +   ++ +     +
Sbjct: 92  PNVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF---V 143
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            + SA+E++H      V+H D+KP+NV +    V  +GD GL +F  ++         ++
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TTA 192
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM 789
           +  + GT  Y++PE    +  +   D++S G LL EM + + P    + + + L+   K 
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 249
Query: 790 V 790
           +
Sbjct: 250 I 250

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 82  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 185
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+     ++   VAVK    M+ G++  ++FL E   +++++H  L+K+  +
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +           I+ +FM  GSL ++L  +    E     L + ++ +  +A  + ++ 
Sbjct: 252 VTKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL+ +N+L+   +V  + DFGLA+ +            ++  G K  + +
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKW 351
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL+E+ +  R
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 28/233 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           +  S+F    ++GQG+FG V K     +    A+K +   ++  L + L+E   L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 611 RNLIKIITIC-SSIDF----NGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           + +++         +F      V  K+ ++   ++ +NG+L + +H  N      N    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRD 116
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           +   +   +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK +  R LD 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV-HRSLDI 172
Query: 723 V----VETPSSSSGIKGTVG---YIAPEY--GTGSEASMTGDVYSFGILLLEM 766
           +       P SS  +   +G   Y+A E   GTG       D+YS GI+  EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEM 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +         + ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 186
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALR--- 606
           ATS +     +G G++GTV+K     +G  VA+K + +   ++G   S + E   LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +  H N+++++ +C++   +      +V++ + +  L  +L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+         +   
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---------IYSY 164
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             + + +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L       L+S +  E E LR++ H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C      G     +V +++  GSL ++L ++        + L Q L  A  +   + 
Sbjct: 77  KGCCED---QGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 126
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH       +H  L   NVLLD+D +  +GDFGLAK +P       V     S      
Sbjct: 127 YLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----- 178
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE     +     DV+SFG+ L E+ +
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L       L+S +  E E LR++ H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C      G     +V +++  GSL ++L ++        + L Q L  A  +   + 
Sbjct: 76  KGCCED---QGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 125
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH       +H  L   NVLLD+D +  +GDFGLAK +P       V     S      
Sbjct: 126 YLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----- 177
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE     +     DV+SFG+ L E+ +
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 560 NMVGQGSFGTVFKGIIGENGML---VAVKVLNL---MQKGALKSFLTECEALRSIRHRNL 613
           + +G G   TV+   + E+ +L   VA+K + +    ++  LK F  E      + H+N+
Sbjct: 17  DKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           + +I +         D   +V ++++  +L E++  +        LS+   +N    +  
Sbjct: 74  VSMIDVDEE-----DDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILD 122
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            I++ H      +VH D+KP N+L+D +    + DFG+AK L    L       + ++ +
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------TQTNHV 172
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GTV Y +PE   G       D+YS GI+L EM     P
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 42/240 (17%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---------NLMQKGALKSFLTEC 602
           A +E      +G+G FG V KG + ++  +VA+K L          +++K   + F  E 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREV 74
Query: 603 EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
             + ++ H N++K+  +  +          +V +F+  G L    H+  DK      S+ 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDL---YHRLLDKAHPIKWSV- 123
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLPA 717
             L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFG       
Sbjct: 124 -KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG------- 174
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT--GDVYSFGILLLEMFSRRRPTDS 775
               T  ++  S SG+ G   ++APE     E S T   D YSF ++L  + +   P D 
Sbjct: 175 ----TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 69/289 (23%), Positives = 131/289 (45%), Gaps = 61/289 (21%)
Query: 562 VGQGSFGTVFKGIIGENGML-VAVKVLNLMQKGALK--SFLTECEALRSIRHRNLIKIIT 618
           +G G  G V+ G    NG   VAVK L   ++G++   +FL E   ++ ++H+ L+++  
Sbjct: 21  LGAGQAGEVWMGYY--NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++
Sbjct: 76  VVTQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFI 125
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + 
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-------AEXTAREGAKFPIK 175
Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
           + APE   YGT    ++  DV+SFGILL E+ +  R              +  M  PE +
Sbjct: 176 WTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVI 220
Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
                           ++ RG   V+ + C   + ++  +C  E P DR
Sbjct: 221 ---------------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKI 616
           + +G G+FG V  G     G  VAVK+LN  +  +L        E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             + S+      DF  +V +++  G L +++ ++    E+    L Q       + SA++
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------ILSAVD 125
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y H H    VVH DLKP NVLLD  M A + DFGL+  +            S    ++ +
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------------SDGEFLRDS 170
Query: 737 VG---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
            G   Y APE  +G   A    D++S G++L  +     P D 
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKI 616
           + +G G+FG V  G     G  VAVK+LN  +  +L        E + L+  RH ++IK+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             + S+      DF  +V +++  G L +++ ++    E+    L Q       + SA++
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQ------QILSAVD 125
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP-ARPLDTVVETPSSSSGIKG 735
           Y H H    VVH DLKP NVLLD  M A + DFGL+  +     L T   +P+       
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------- 175
Query: 736 TVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
              Y APE  +G   A    D++S G++L  +     P D 
Sbjct: 176 ---YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/342 (22%), Positives = 142/342 (41%), Gaps = 58/342 (16%)
Query: 523 RRRSTDRSFERTTMVEQ-----QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGE 577
           R+R+  R  +   +VE      + P  +  ++ K T EF    ++G G+FGTV+KG+   
Sbjct: 14  RKRTLRRLLQERELVEPLTPSGEAPNQALLRILKET-EFKKIKVLGSGAFGTVYKGLWIP 72
Query: 578 NGMLVAVKVLNLMQKGAL-----KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA 632
            G  V + V  +  + A      K  L E   + S+ + ++ +++ IC +          
Sbjct: 73  EGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------ 126
Query: 633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK 692
           ++   M  G L +++ ++ D     N+     LN  + +A  + YL       +VH DL 
Sbjct: 127 LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLA 178
Query: 693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASM 752
             NVL+       + DFGLAK L A       E    + G K  + ++A E       + 
Sbjct: 179 ARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVPIKWMALESILHRIYTH 232
Query: 753 TGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNS 812
             DV+S+G+ + E+ +      S  ++G+   E S ++  EK   +  P +         
Sbjct: 233 QSDVWSYGVTVWELMT----FGSKPYDGIPASEISSIL--EKGERLPQPPI--------- 277
Query: 813 MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
                       C + V  I V C M     R + R+++++ 
Sbjct: 278 ------------CTIDVYMIMVKCWMIDADSRPKFRELIIEF 307

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 42/240 (17%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---------NLMQKGALKSFLTEC 602
           A +E      +G+G FG V KG + ++  +VA+K L          +++K   + F  E 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK--FQEFQREV 74
Query: 603 EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
             + ++ H N++K+  +  +          +V +F+  G L    H+  DK      S+ 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDL---YHRLLDKAHPIKWSV- 123
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLPA 717
             L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DF L++    
Sbjct: 124 -KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT--GDVYSFGILLLEMFSRRRPTDS 775
                  ++  S SG+ G   ++APE     E S T   D YSF ++L  + +   P D 
Sbjct: 178 -------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-----MQKGALKSFLTECEALRS 607
              +   + +G+G F TV+K        +VA+K + L      + G  ++ L E + L+ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + H N+I ++       F      ++V+DFM+   LE  +  N+  L   ++     + +
Sbjct: 69  LSHPNIIGLLDA-----FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVE 725
                  +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK    P R     V 
Sbjct: 123 -----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSR 769
                     T  Y APE   G+     G D+++ G +L E+  R
Sbjct: 175 ----------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 37/228 (16%)
Query: 563 GQGSFGTVFKG-IIGENGMLVAVKVLNLMQKGALKSFLTECE--ALRSIRHRNLIKIITI 619
            +G FG V+K  ++ E    VAVK+  +  K   +S+  E E  +L  ++H N+++ I  
Sbjct: 33  ARGRFGCVWKAQLLNE---YVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGA 86
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                   VD   ++  F + GSL ++L  N        +S  +  +IA  +A  + YLH
Sbjct: 87  EKRGTSVDVDL-WLITAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLH 138
Query: 680 HHC-------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSS 731
                     KP + H D+K  NVLL +++ A + DFGLA KF   +       +   + 
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK-------SAGDTH 191
Query: 732 GIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTD 774
           G  GT  Y+APE   G+     +A +  D+Y+ G++L E+ SR    D
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 128/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 65
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 121 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 171
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 172 --DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 225
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +LLE+
Sbjct: 226 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLEL 257

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +     +G G FG V + I  + G  VA+K     +     + +  E + ++ + H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 615 KIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
               +   +      D   +  ++ + G L ++L+Q  +    C L       +  D++S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISS 133
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           A+ YLH +    ++H DLKP N++L      ++  + D G AK L    L T        
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-------- 182
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               GT+ Y+APE     + ++T D +SFG L  E  +  RP
Sbjct: 183 -EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +     +G G FG V + I  + G  VA+K     +     + +  E + ++ + H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 615 KIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
               +   +      D   +  ++ + G L ++L+Q  +    C L       +  D++S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISS 132
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           A+ YLH +    ++H DLKP N++L      ++  + D G AK L    L T        
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-------- 181
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               GT+ Y+APE     + ++T D +SFG L  E  +  RP
Sbjct: 182 -EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 122/265 (46%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   AS + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 190 RANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 250 EYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 43/234 (18%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           S+     ++G+G FG   K    E G ++ +K L    +   ++FL E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 614 IKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           +K I         GV +K      + ++++ G+L   +   + +         Q ++ A 
Sbjct: 70  LKFI---------GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAK 115
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           D+AS + YLH      ++H DL   N L+  +    V DFGLA+ +        V+  + 
Sbjct: 116 DIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLM--------VDEKTQ 164
Query: 730 SSGIK--------------GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
             G++              G   ++APE   G       DV+SFGI+L E+  R
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +       Q L +  DV  A+EYL 
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT-----QQLLEMCKDVCEAMEYLE 122
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 123 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSRGSKFPVRW 172
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 53/212 (25%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+     ++   VAVK    M+ G++  ++FL E   +++++H  L+K+  +
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +       +   I+ +FM  GSL ++L  +    E     L + ++ +  +A  + ++ 
Sbjct: 79  VTK------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL+ +N+L+   +V  + DFGLA+ +            ++  G K  + +
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKW 178
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL+E+ +  R
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 23/226 (10%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALR--- 606
           ATS +     +G G++GTV+K     +G  VA+K + +   ++G   S + E   LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +  H N+++++ +C++   +      +V++ + +  L  +L    DK     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIKD 116
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+         +   
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---------IYSY 164
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             +   +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L        +S +  E + LR++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C      G     +V +++  GSL ++L +++       + L Q L  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH       +H +L   NVLLD+D +  +GDFGLAK +P       V     S      
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----- 183
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE     +     DV+SFG+ L E+ +
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 562 VGQGSFGTV----FKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIKI 616
           +G+G FG V    +       G +VAVK L        +S +  E + LR++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C      G     +V +++  GSL ++L +++       + L Q L  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH       +H +L   NVLLD+D +  +GDFGLAK +P       V     S      
Sbjct: 132 YLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----- 183
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           V + APE     +     DV+SFG+ L E+ +
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +   L     L +  DV  A+EYL 
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 137
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEETSSVGSKFPVRW 187
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +       Q L +  DV  A+EYL 
Sbjct: 68  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT-----QQLLEMCKDVCEAMEYLE 117
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSVGSKFPVRW 167
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G+G+FG VF          ++ +LVAVK L      A K F  E E L +++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV-------CNLSLIQTLNIAI 669
             +C        D   +V+++M++G L ++L  +     +         L+  Q L+IA 
Sbjct: 81  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +A+ + YL        VH DL   N L+  +++  +GDFG+++         V  T   
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--------DVYSTDYY 184
Query: 730 SSGIKGT--VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G      + ++ PE     + +   DV+S G++L E+F+
Sbjct: 185 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH +L   N ++ HD    +GDFG+ +         + ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 186
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +       Q L +  DV  A+EYL 
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT-----QQLLEMCKDVCEAMEYLE 122
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 123 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSVGSKFPVRW 172
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           ++FS   ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIM 242
Query: 614 IKIIT-------ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           + +++       +C S  F+  D  + + D M  G L   L Q+         S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRF 296
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            A ++   +E++H+     VV+ DLKP+N+LLD      + D GLA        D   + 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           P +S    GT GY+APE    G     + D +S G +L ++     P     H+    HE
Sbjct: 347 PHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHE 401
Query: 786 FSKMVL 791
             +M L
Sbjct: 402 IDRMTL 407

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS---FLTECEALRSIRHRNL 613
           +GQGSFG V++G     I GE    VAVK +N  +  +L+    FL E   ++     ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 83
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQTLNIAI 669
           ++++ + S           +V + M +G L+ +L     + E        +L + + +A 
Sbjct: 84  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++A  + YL+       VH +L   N ++ HD    +GDFG+ +         + ET   
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 187
Query: 730 SSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             G KG   V ++APE       + + D++SFG++L E+ S
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           ++FS   ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIM 242
Query: 614 IKIIT-------ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           + +++       +C S  F+  D  + + D M  G L   L Q+         S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRF 296
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            A ++   +E++H+     VV+ DLKP+N+LLD      + D GLA        D   + 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           P +S    GT GY+APE    G     + D +S G +L ++     P     H+    HE
Sbjct: 347 PHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHE 401
Query: 786 FSKMVL 791
             +M L
Sbjct: 402 IDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           ++FS   ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIM 242
Query: 614 IKIIT-------ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           + +++       +C S  F+  D  + + D M  G L   L Q+         S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRF 296
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            A ++   +E++H+     VV+ DLKP+N+LLD      + D GLA        D   + 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           P +S    GT GY+APE    G     + D +S G +L ++     P     H+    HE
Sbjct: 347 PHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHE 401
Query: 786 FSKMVL 791
             +M L
Sbjct: 402 IDRMTL 407

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           ++FS   ++G+G FG V+     + G + A+K L+   K  +K  + + E L ++  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIK--MKQGETL-ALNERIM 241
Query: 614 IKIIT-------ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           + +++       +C S  F+  D  + + D M  G L   L Q+         S      
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRF 295
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            A ++   +E++H+     VV+ DLKP+N+LLD      + D GLA        D   + 
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 345
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
           P +S    GT GY+APE    G     + D +S G +L ++     P     H+    HE
Sbjct: 346 PHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHE 400
Query: 786 FSKMVL 791
             +M L
Sbjct: 401 IDRMTL 406

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +   L     L +  DV  A+EYL 
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 137
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSVGSKFPVRW 187
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           +G G FG V+     ++   VAVK    M+ G++  ++FL E   +++++H  L+K+  +
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +           I+ +FM  GSL ++L  +    E     L + ++ +  +A  + ++ 
Sbjct: 246 VTKEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL+ +N+L+   +V  + DFGLA+                  G K  + +
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARV-----------------GAKFPIKW 335
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
            APE       ++  DV+SFGILL+E+ +  R
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIR 609
           S+F    ++G+GSFG V         +  AVKVL    +++K   K  ++E   L ++++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H  L+ +        F   D    V D++  G L   L +     E C L   +    A 
Sbjct: 98  HPFLVGL-----HFSFQTADKLYFVLDYINGGELFYHLQR-----ERCFLE-PRARFYAA 146
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++ASA+ YLH      +V+ DLKP N+LLD      + DFGL K          +E  S+
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNST 195
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           +S   GT  Y+APE         T D +  G +L EM
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 23  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +   L     L +  DV  A+EYL 
Sbjct: 79  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 128
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 129 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSVGSKFPVRW 178
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+GSF TV+KG+  E  + VA   L    + K   + F  E E L+ ++H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S    G     +V +   +G+L+ +L     + +V  + ++++      +   +++LH
Sbjct: 94  WEST-VKGKKCIVLVTELXTSGTLKTYLK----RFKVXKIKVLRSW--CRQILKGLQFLH 146
Query: 680 HHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               PP++H DLK  N+ +        +GD GLA    A          S +  + GT  
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----------SFAKAVIGTPE 195
Query: 739 YIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRPTDS---------MFHEGLTLHEFSK 788
           + APE Y    + S+  DVY+FG   LE  +   P                G+    F K
Sbjct: 196 FXAPEXYEEKYDESV--DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 789 MVLPEKVMEIVD 800
           + +PE V EI++
Sbjct: 254 VAIPE-VKEIIE 264

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRH 610
           ++S+F     +G G++ TV+KG+    G+ VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA-- 668
            N++++  +  +      +   +V++FM N      L +  D   V N      LN+   
Sbjct: 63  ENIVRLYDVIHT-----ENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKY 112
Query: 669 --IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   + + H +    ++H DLKP N+L++      +GDFGLA+     P++T    
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF--- 165
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFS 768
             SS  +  T+ Y AP+   GS    T  D++S G +L EM +
Sbjct: 166 --SSEVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 136
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 137 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 187
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 188 RANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 248 EYDFPEKFFP-KARDLVEKLLVLDA 271

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL------NLMQKGALKSFLTECEA 604
           ++  ++ +  +VG+GS+G V K    + G +VA+K         +++K A++    E + 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEW-LHQNNDKLEVCNLSLIQ 663
           L+ +RH NL+ ++ +C            +V++F+ +  L++  L  N    +V    L Q
Sbjct: 78  LKQLRHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLD 721
            +N        I + H H    ++H D+KP N+L+    V  + DFG A+ L  P    D
Sbjct: 133 IIN-------GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMF 767
             V           T  Y APE   G  +     DV++ G L+ EMF
Sbjct: 183 DEV----------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK---SFLTECEALRSIRHRNLIKI 616
           + +G G+FG V  G     G  VAVK+LN  +  +L        E + L+  RH ++IK+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             + S+      D   +V +++  G L +++ +N    E  +  L Q       + S ++
Sbjct: 82  YQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ------ILSGVD 130
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y H H    VVH DLKP NVLLD  M A + DFGL+  +            S    ++ +
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------------SDGEFLRXS 175
Query: 737 VG---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDS 775
            G   Y APE  +G   A    D++S G++L  +     P D 
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----SFLTECEA 604
           S ATS +     +G G++GTV+K     +G  VA+K + +   G        S + E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 605 LR---SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
           LR   +  H N+++++ +C++   +      +V++ + +  L  +L    DK     L  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPA 119
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
               ++       +++LH +C   +VH DLKP N+L+       + DFGLA+        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-------- 168
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +     + + +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 169 -IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 217

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 135
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 136 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 186
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 187 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 246
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 247 EYDFPEKFFP-KARDLVEKLLVLDA 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           +  S+F    ++GQG+FG V K     +    A+K +   ++  L + L+E   L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 611 RNLIKIITIC-SSIDF----NGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           + +++         +F      V  K+ ++   ++ +N +L + +H  N      N    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN-----LNQQRD 116
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           +   +   +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK +  R LD 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV-HRSLDI 172
Query: 723 V----VETPSSSSGIKGTVG---YIAPEY--GTGSEASMTGDVYSFGILLLEM 766
           +       P SS  +   +G   Y+A E   GTG       D+YS GI+  EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEM 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 74
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 180
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 181 --DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 234
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 235 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 266

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 139
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 140 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 190
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 191 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 250
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 251 EYDFPEKFFP-KARDLVEKLLVLDA 274

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 558 SSNMVGQGSFGTVFKGII---GENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNL 613
           S  ++G+G FG V+ G      +N +  A+K L+ + +   +++FL E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           + +I I    +        ++  +M +G L +++        V +L     ++  + VA 
Sbjct: 85  LALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            +EYL    +   VH DL   N +LD      V DFGLA+ +  R   +V +   +   +
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           K T    A E       +   DV+SFG+LL E+ +R  P
Sbjct: 193 KWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIG-ENGMLV--AVKVL--NLMQKGALKSFLTECEALRSI 608
            +F+   M+G+G FG+V +  +  E+G  V  AVK+L  +++    ++ FL E   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 609 RHRNLIKIITICSSIDFNG-VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
            H ++ K++ +       G +    ++  FM++G L  +L  +       NL L   +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
            +D+A  +EYL        +H DL   N +L  DM   V DFGL++ + +       +  
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG------DYY 193
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
                 K  V ++A E    +  ++  DV++FG+ + E+ +R
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 139
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 140 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 190
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 191 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 250
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 251 EYDFPEKFFP-KARDLVEKLLVLDA 274

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 250 EYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 250 EYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/267 (23%), Positives = 122/267 (45%), Gaps = 34/267 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRS 607
           K   +F    ++G+GSF TV            A+K+L   +++++  +     E + +  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           + H   +K+        F   D + + +   + +NG L +++ +     E C      T 
Sbjct: 64  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TR 110
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
               ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L          
Sbjct: 111 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------S 161
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEG 780
             + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + 
Sbjct: 162 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 221
Query: 781 LTL-HEFSKMVLPEKVMEIVDPSLLLE 806
           + L ++F +   P K  ++V+  L+L+
Sbjct: 222 IKLEYDFPEKFFP-KARDLVEKLLVLD 247

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 136
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 137 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 187
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 248 EYDFPEKFFP-KARDLVEKLLVLDA 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/267 (23%), Positives = 122/267 (45%), Gaps = 34/267 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRS 607
           K   +F    ++G+GSF TV            A+K+L   +++++  +     E + +  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           + H   +K+        F   D + + +   + +NG L +++ +     E C      T 
Sbjct: 66  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TR 112
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
               ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L          
Sbjct: 113 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------S 163
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEG 780
             + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + 
Sbjct: 164 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 223
Query: 781 LTL-HEFSKMVLPEKVMEIVDPSLLLE 806
           + L ++F +   P K  ++V+  L+L+
Sbjct: 224 IKLEYDFPEKFFP-KARDLVEKLLVLD 249

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/267 (23%), Positives = 122/267 (45%), Gaps = 34/267 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRS 607
           K   +F    ++G+GSF TV            A+K+L   +++++  +     E + +  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           + H   +K+        F   D + + +   + +NG L +++ +     E C      T 
Sbjct: 67  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TR 113
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
               ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L          
Sbjct: 114 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------S 164
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEG 780
             + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + 
Sbjct: 165 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 224
Query: 781 LTL-HEFSKMVLPEKVMEIVDPSLLLE 806
           + L ++F +   P K  ++V+  L+L+
Sbjct: 225 IKLEYDFPEKFFP-KARDLVEKLLVLD 250

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 62/267 (23%), Positives = 122/267 (45%), Gaps = 34/267 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRS 607
           K   +F    ++G+GSF TV            A+K+L   +++++  +     E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           + H   +K+        F   D + + +   + +NG L +++ +     E C      T 
Sbjct: 65  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TR 111
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
               ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L          
Sbjct: 112 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------S 162
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEG 780
             + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + 
Sbjct: 163 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222
Query: 781 LTL-HEFSKMVLPEKVMEIVDPSLLLE 806
           + L ++F +   P K  ++V+  L+L+
Sbjct: 223 IKLEYDFPEKFFP-KARDLVEKLLVLD 248

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 74  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 120
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 121 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 171
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 172 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 231
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 232 EYDFPEKFFP-KARDLVEKLLVLDA 255

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 44/237 (18%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F    ++G G FG VFK     +G    ++ +    + A +    E +AL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 615 KIITICSSIDFN---------GVDFKA---------------IVYDFMQNGSLEEWLHQN 650
                    D++           D+                 I  +F   G+LE+W+ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 651 NDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
             +     L  +  L +   +   ++Y+H      ++H DLKPSN+ L       +GDFG
Sbjct: 129 RGE----KLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           L          T ++     +  KGT+ Y++PE  +  +     D+Y+ G++L E+ 
Sbjct: 182 LV---------TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 102
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 158 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 208
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 209 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 262
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 263 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 135
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 136 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 186
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 187 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 246
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 247 EYDFPEKFFP-KARDLVEKLLVLDA 270

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 127
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 178
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 234
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 235 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 271
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 272 ELIIEF 277

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 249
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 250 EYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 136
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 137 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 187
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 248 EYDFPEKFFP-KARDLVEKLLVLDA 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKGIIGE---NGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR-----KV 186
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 239
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 240 --------------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 852 VK 853
           ++
Sbjct: 280 LE 281

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 120/266 (45%), Gaps = 36/266 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL----- 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +  +EGL       
Sbjct: 190 RANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIK 248
Query: 784 --HEFSKMVLPEKVMEIVDPSLLLEV 807
             ++F +   P K  ++V+  L+L+ 
Sbjct: 249 LEYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 232
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 233 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 269
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 270 ELIIEF 275

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 73
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 179
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 180 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 233
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 234 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 265

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALK---SFLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 67
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N  +  D    +GDFG+ +      
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR------ 173
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 174 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 227
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +LLE+
Sbjct: 228 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLEL 259

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 67
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 173
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 174 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 227
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 228 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 259

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 120/266 (45%), Gaps = 36/266 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 138
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 139 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 189
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL----- 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +  +EGL       
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIK 248
Query: 784 --HEFSKMVLPEKVMEIVDPSLLLEV 807
             ++F +   P K  ++V+  L+L+ 
Sbjct: 249 LEYDFPEKFFP-KARDLVEKLLVLDA 273

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 74
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 180
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 181 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 234
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 235 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 266

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G FG V+ G    N   VAVK L      ++++FL E   +++++H  L+++  + +
Sbjct: 21  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
                  +   I+ ++M  GSL ++L  +    E   + L + ++ +  +A  + Y+   
Sbjct: 79  R-----EEPIYIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 127
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
            +   +H DL+ +NVL+   ++  + DFGLA+ +            ++  G K  + + A
Sbjct: 128 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 179
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE       ++  DV+SFGILL E+ +
Sbjct: 180 PEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  +       +   D   +V +++  GSL + +       E C +   Q   +  +   
Sbjct: 80  VNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQ 127
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSG 732
           A+E+LH +    V+H D+K  N+LL  D    + DFG  A+  P +         S  S 
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRSX 175
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 124
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 175
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 231
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 232 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 268
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 269 ELIIEF 274

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 73
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 179
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 180 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 233
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 234 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 265

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 232
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 233 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 269
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 270 ELIIEF 275

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 71
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 127 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 177
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 178 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 231
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 232 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 263

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKD-----NIGSQYLLNWC 124
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 175
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 231
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 232 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 268
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 269 ELIIEF 274

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 126
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 177
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 233
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 234 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 270
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 271 ELIIEF 276

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKGIIGE---NGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KV 180
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 233
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 234 --------------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 273
Query: 852 VK 853
           ++
Sbjct: 274 LE 275

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKGIIGE---NGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KV 186
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 239
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 240 --------------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 852 VK 853
           ++
Sbjct: 280 LE 281

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 127/273 (46%), Gaps = 40/273 (14%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 80
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNL 659
            ++     ++++++ + S           ++ + M  G L+ +L     ++E    +   
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +      
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------ 186
Query: 720 LDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM 776
              + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P    
Sbjct: 187 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---- 240
Query: 777 FHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
            ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 241 -YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  +       +   D   +V +++  GSL + +       E C +   Q   +  +   
Sbjct: 80  VNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQ 127
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSG 732
           A+E+LH +    V+H D+K  N+LL  D    + DFG  A+  P +         S  S 
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRSE 175
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLM--QKGALKSFLTECEAL 605
           L +A  ++     +G+G++G VFK    +NG   VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 606 R---SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           R   +  H N++++  +C+    +      +V++ + +  L  +L    DK+    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
              ++   +   +++LH H    VVH DLKP N+L+       + DFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--------- 168
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +     + + +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 126
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 177
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 233
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 234 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 270
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 271 ELIIEF 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
             +       +   D   +V +++  GSL + +       E C +   Q   +  +   A
Sbjct: 81  NYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQA 128
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSGI 733
           +E+LH +    V+H D+K  N+LL  D    + DFG  A+  P +         S  S +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRSTM 176
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 230
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 231 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 267
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 268 ELIIEF 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 100 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 148
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 149 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 199
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 200 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 255
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 256 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 292
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 293 ELIIEF 298

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 126
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 177
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 233
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 234 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 270
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 271 ELIIEF 276

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 230
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 231 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 267
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 268 ELIIEF 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  +       +   D   +V +++  GSL + +       E C +   Q   +  +   
Sbjct: 81  VNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQ 128
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSG 732
           A+E+LH +    V+H D+K  N+LL  D    + DFG  A+  P +         S  S 
Sbjct: 129 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRSX 176
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 130
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 181
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 237
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 238 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 274
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 275 ELIIEF 280

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 230
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 231 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 267
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 268 ELIIEF 273

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 95  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 141
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 142 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 192
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 193 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 252
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F     P K  ++V+  L+L+ 
Sbjct: 253 EYDFPAAFFP-KARDLVEKLLVLDA 276

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G FG V+ G    N   VAVK L      ++++FL E   +++++H  L+++  + +
Sbjct: 20  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
                  +   I+ +FM  GSL ++L  +    E   + L + ++ +  +A  + Y+   
Sbjct: 78  K-----EEPIYIITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 126
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
            +   +H DL+ +NVL+   ++  + DFGLA+ +            ++  G K  + + A
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 178
Query: 742 PEYGTGSEASMTGDVYSFGILLLEMFS 768
           PE       ++  +V+SFGILL E+ +
Sbjct: 179 PEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 81  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 129
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 130 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 180
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 181 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 236
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 237 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 273
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 274 ELIIEF 279

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G+GSFG V      +   + A+K +N    +++  +++   E + ++ + H  L+ +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN------NDKLEVCNLSLIQTLNIAIDVA 672
                 F   +   +V D +  G L   L QN        KL +C L +           
Sbjct: 82  ----YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM----------- 126
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            A++YL +     ++H D+KP N+LLD     H+ DF +A  LP           +  + 
Sbjct: 127 -ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---------TQITT 173
Query: 733 IKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  Y+APE  +   G+  S   D +S G+   E+   RRP
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 72  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 120
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 121 VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 171
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 227
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 228 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 264
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 265 ELIIEF 270

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 121/266 (45%), Gaps = 36/266 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF TV            A+K+L   +++++  +     E + +  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 611 RNLIKIITICSSID---FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
              +K+   C   D   + G+ +        +NG L +++ +     E C      T   
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSY-------AKNGELLKYIRKIGSFDETC------TRFY 142
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
             ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            
Sbjct: 143 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQ 193
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLT 782
           + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + 
Sbjct: 194 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 253
Query: 783 L-HEFSKMVLPEKVMEIVDPSLLLEV 807
           L ++F +   P K  ++V+  L+L+ 
Sbjct: 254 LEYDFPEKFFP-KARDLVEKLLVLDA 278

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 117
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 168
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 224
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 225 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 261
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 262 ELIIEF 267

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLM--QKGALKSFLTECEAL 605
           L +A  ++     +G+G++G VFK    +NG   VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 606 R---SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           R   +  H N++++  +C+    +      +V++ + +  L  +L    DK+    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
              ++   +   +++LH H    VVH DLKP N+L+       + DFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--------- 168
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +     + + +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITI 619
           +G G FG V  G        VA+K   ++++G++    F+ E + + ++ H  L+++  +
Sbjct: 16  LGTGQFGVVKYGK-WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C+        F  I+ ++M NG L  +L +   + +       Q L +  DV  A+EYL 
Sbjct: 72  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT-----QQLLEMCKDVCEAMEYLE 121
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD   +  +SS G K  V +
Sbjct: 122 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD---DEYTSSVGSKFPVRW 171
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             PE    S+ S   D+++FG+L+ E++S
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLM--QKGALKSFLTECEAL 605
           L +A  ++     +G+G++G VFK    +NG   VA+K + +   ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 606 R---SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           R   +  H N++++  +C+    +      +V++ + +  L  +L    DK+    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVPEPGVPTE 120
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
              ++   +   +++LH H    VVH DLKP N+L+       + DFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--------- 168
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +     + + +  T+ Y APE    S  +   D++S G +  EMF RR+P
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 37  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 143
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 202
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
               Y+APE    S      E+    D+Y+ G++  E+  R
Sbjct: 203 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L +                   +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----------EDEIEDIQQEIT 57
Query: 616 IITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D LE   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A          + +T  
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQI 159
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ +R  P  S  H
Sbjct: 160 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSELH 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 110/245 (44%), Gaps = 38/245 (15%)
Query: 538 EQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           E + P   +A   +   ++   +++G+G    V + +    G   AVK++ +  +     
Sbjct: 80  EDELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 598 FLTEC-EALRSIRH--RNLIKIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDK 653
            L E  EA R   H  R +     I + ID +    F  +V+D M+ G L ++L      
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL------ 191
Query: 654 LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
            E   LS  +T +I   +  A+ +LH +    +VH DLKP N+LLD +M   + DFG + 
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEY----------GTGSEASMTGDVYSFGILL 763
            L   P + + E       + GT GY+APE           G G E     D+++ G++L
Sbjct: 249 HL--EPGEKLRE-------LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVIL 295
Query: 764 LEMFS 768
             + +
Sbjct: 296 FTLLA 300

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 17  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 72  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 123
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 182
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
               Y+APE    S      E+    D+Y+ G++  E+  R
Sbjct: 183 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRH 610
            +F    ++G+GSF T             A+K+L   +++++  +     E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 611 RNLIKIITICSSIDFNGVDFKAIVY--DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
              +K+        F   D + + +   + +NG L +++ +     E C      T    
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYT 136
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            +
Sbjct: 137 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQA 187
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS-----MFHEGLTL 783
            ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P  +     +F + + L
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
Query: 784 -HEFSKMVLPEKVMEIVDPSLLLEV 807
            ++F +   P K  ++V+  L+L+ 
Sbjct: 248 EYDFPEKFFP-KARDLVEKLLVLDA 271

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 12  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 67  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 118
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 177
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
               Y+APE    S      E+    D+Y+ G++  E+  R
Sbjct: 178 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 69/278 (24%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSI 608
           S+  ++F     +G+G FG VF+     +    A+K + L  +  A +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 609 RHRNLIKIITIC-----------------------------SSIDFNGVDFKAI------ 633
            H  +++                                  S +D   V  + +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 634 ------------VYDFMQ-----NGSLEEWLHQNNDKLEVCNLSLIQ---TLNIAIDVAS 673
                       VY ++Q       +L++W+++       C+L   +    L+I I +A 
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR------CSLEDREHGVCLHIFIQIAE 175
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP----SS 729
           A+E+LH      ++H DLKPSN+    D V  VGDFGL   +     +  V TP    ++
Sbjct: 176 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             G  GT  Y++PE   G+  S   D++S G++L E+ 
Sbjct: 233 HXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 50  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 156
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 215
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
               Y+APE    S      E+    D+Y+ G++  E+  R
Sbjct: 216 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L +                   +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----------EDEIEDIQQEIT 57
Query: 616 IITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D LE   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A          + +T  
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQI 159
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ +R  P  S  H
Sbjct: 160 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSELH 208

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE C          LS  
Sbjct: 81  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGL     AR +  
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL-----ARDIHH 187
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+LL E+F+
Sbjct: 188 IDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 11  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 117
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 176
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
               Y+APE    S      E+    D+Y+ G++  E+  R
Sbjct: 177 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLI 614
            +++G+G+FG V K  I ++G+ +   +  + +   K   + F  E E L  +  H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 615 KIITICSSIDFNGVDFKAIVY-------DFMQNGSLEEWLHQNNDKLEVCN-----LSLI 662
            ++  C   +  G  + AI Y       DF++   + E     +    + N     LS  
Sbjct: 90  NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLE----TDPAFAIANSTASTLSSQ 142
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           Q L+ A DVA  ++YL    +   +H DL   N+L+  + VA + DFGL++        T
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +   P         V ++A E    S  +   DV+S+G+LL E+ S
Sbjct: 200 MGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L +                   +  I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----------EDEIEDIQQEIT 77
Query: 616 IITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D LE   L   Q   I 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 130
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 131 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--------TDTQI 179
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ +R  P  S  H
Sbjct: 180 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSELH 228

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 32/235 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E  +++  RH N++  I  
Sbjct: 14  IGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++    +E         + +A+  AS + +LH
Sbjct: 69  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 120
Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA        DT+   P+   G K
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 179
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
               Y+APE    S      E+    D+Y+ G++  E+   RR +    HE   L
Sbjct: 180 ---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQL 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN- 612
            +F     +G GSFG V       NG   A+KVL        K  +     L+ + H N 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVR---LKQVEHTND 55
Query: 613 ---LIKIITICSSIDFNGV--DFKAI--VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
              ++ I+T    I   G   D + I  + D+++ G L   L ++               
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAK 109
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
             A +V  A+EYLH      +++ DLKP N+LLD +    + DFG AK++          
Sbjct: 110 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV---------- 156
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
            P  +  + GT  YIAPE  +    + + D +SFGIL+ EM +   P    F++  T+  
Sbjct: 157 -PDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKT 211
Query: 786 FSKMV 790
           + K++
Sbjct: 212 YEKIL 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 37/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L                     +  I 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEIT 72
Query: 616 IITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D LE   L   Q   I 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 126 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--------TDTQI 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ +R  P  S  H
Sbjct: 175 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSELH 223

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           +G+G +G V+ G     G  VAVKV    ++    S+  E E  +++  RH N++  I  
Sbjct: 45  IGKGRYGEVWMG--KWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI-- 97
Query: 620 CSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             + D  G      +Y   D+ +NGSL        D L+   L     L +A    S + 
Sbjct: 98  --AADIKGTGSWTQLYLITDYHENGSL-------YDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 677 YLHHHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDT-VVETPSS 729
           +LH        KP + H DLK  N+L+  +    + D GLA KF+     DT  V+ P +
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS----DTNEVDIPPN 204
Query: 730 SSGIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
           +    GT  Y+ PE    S      ++ +  D+YSFG++L E+  R
Sbjct: 205 TR--VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLI 614
            +++G+G+FG V K  I ++G+ +   +  + +   K   + F  E E L  +  H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 615 KIITICSSIDFNGVDFKAIVY-------DFMQNGSLEEWLHQNNDKLEVCN-----LSLI 662
            ++  C   +  G  + AI Y       DF++   + E     +    + N     LS  
Sbjct: 80  NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLE----TDPAFAIANSTASTLSSQ 132
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           Q L+ A DVA  ++YL    +   +H DL   N+L+  + VA + DFGL++        T
Sbjct: 133 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 189
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +   P         V ++A E    S  +   DV+S+G+LL E+ S
Sbjct: 190 MGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE C          LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGL     AR +  
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL-----ARDIHH 202
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+LL E+F+
Sbjct: 203 IDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 554 SEFSSSNMVGQGSFGTVF--KGIIGENG-MLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           S+F    ++GQGSFG VF  K I G +   L A+KVL        K+ L   + +R+   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 611 RNLIK------IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           R+++       I+ +  +    G  +  ++ DF++ G L   L +     EV        
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVK 129
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
             +A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K          +
Sbjct: 130 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--------ESI 177
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +    +    GTV Y+APE       + + D +SFG+L+ EM +
Sbjct: 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 85  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 133
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 184
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 185 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 554 SEFSSSNMVGQGSFGTVF--KGIIGENG-MLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           S+F    ++GQGSFG VF  K I G +   L A+KVL        K+ L   + +R+   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 611 RNLIK------IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           R+++       I+ +  +    G  +  ++ DF++ G L   L +     EV        
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVK 129
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
             +A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K          +
Sbjct: 130 FYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESI 177
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +    +    GTV Y+APE       + + D +SFG+L+ EM +
Sbjct: 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 126
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 177
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 554 SEFSSSNMVGQGSFGTVF--KGIIGENG-MLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           S+F    ++GQGSFG VF  K I G +   L A+KVL        K+ L   + +R+   
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 77
Query: 611 RNLIK------IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           R+++       I+ +  +    G  +  ++ DF++ G L   L +     EV        
Sbjct: 78  RDILVEVNHPFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVK 130
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
             +A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K          +
Sbjct: 131 FYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESI 178
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +    +    GTV Y+APE       + + D +SFG+L+ EM +
Sbjct: 179 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 127/275 (46%), Gaps = 44/275 (16%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 80
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ------NNDKLEVC 657
            ++     ++++++ + S           ++ + M  G L+ +L        NN  L   
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           +LS  + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +    
Sbjct: 136 SLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 186
Query: 718 RPLDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTD 774
                + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P  
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-- 240
Query: 775 SMFHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
              ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 241 ---YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 272

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 127/275 (46%), Gaps = 44/275 (16%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKS---FLTECE 603
           A  + + S  +GQGSFG V++G+       E    VA+K +N  +  +++    FL E  
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 70
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ------NNDKLEVC 657
            ++     ++++++ + S           ++ + M  G L+ +L        NN  L   
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           +LS  + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +    
Sbjct: 126 SLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 176
Query: 718 RPLDTVVETPSSSSGIKG--TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTD 774
                + ET     G KG   V +++PE       +   DV+SFG++L E+ +   +P  
Sbjct: 177 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-- 230
Query: 775 SMFHEGLTLHEFSKMVLPEKVMEIVD--PSLLLEV 807
              ++GL+  +  + V+   +++  D  P +L E+
Sbjct: 231 ---YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 262

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 127
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 178
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 234
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 235 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 271
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 272 ELIIEF 277

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 232
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 233 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 269
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 270 ELIIEF 275

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++  G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 130
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 181
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 237
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 238 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 274
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 275 ELIIEF 280

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  +       +   D   +V +++  GSL + +       E C +   Q   +  +   
Sbjct: 81  VNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQIAAVCRECLQ 128
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSG 732
           A+E+LH +    V+H ++K  N+LL  D    + DFG  A+  P +         S  S 
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------SKRST 176
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + GT  ++APE  T        D++S GI+ +EM     P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR-----KV 176
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------ 230
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 231 ---------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 852 VK 853
           ++
Sbjct: 270 LE 271

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++  G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 130
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 181
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 237
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 238 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 274
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 275 ELIIEF 280

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 230
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 231 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 267
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 268 ELIIEF 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F    ++G G FG VFK     +G    +K +    + A +    E +AL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 615 KIITICSSIDF-------NGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
                    D+       N    K     I  +F   G+LE+W+ +   +     L  + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVL 123
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL          T 
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV---------TS 171
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           ++        KGT+ Y++PE  +  +     D+Y+ G++L E+ 
Sbjct: 172 LKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           +  S+F    ++GQG+FG V K     +    A+K +   ++  L + L+E   L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 611 RNLIKIITIC-SSIDF----NGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           + +++         +F      V  K+ ++   ++ +N +L + +H  N      N    
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN-----LNQQRD 116
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           +   +   +  A+ Y+H      ++H +LKP N+ +D      +GDFGLAK +  R LD 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNV-HRSLDI 172
Query: 723 V----VETPSSSSGIK---GTVGYIAPEY--GTGSEASMTGDVYSFGILLLE 765
           +       P SS  +    GT  Y+A E   GTG       D YS GI+  E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKI-DXYSLGIIFFE 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 130
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 181
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 237
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 238 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 274
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 275 ELIIEF 280

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++  G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 123
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 174
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +      S  ++G+   E S 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISS 230
Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++  EK   +  P +                     C + V  I V C M     R + R
Sbjct: 231 IL--EKGERLPQPPI---------------------CTIDVYMIMVKCWMIDADSRPKFR 267
Query: 849 DVVVKL 854
           +++++ 
Sbjct: 268 ELIIEF 273

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KV 180
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------ 234
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 235 ---------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 273
Query: 852 VK 853
           ++
Sbjct: 274 LE 275

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KV 176
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------ 230
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 231 ---------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 852 VK 853
           ++
Sbjct: 270 LE 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++     +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP      V++        K 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KV 176
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +      +    LH+  K       
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------ 230
Query: 796 MEIVDPSLLLEVRANNSMSRGGERV-KIEECLVAVIRIGVVCSMESPTDR---MQMRDVV 851
                                GER+ + E+C   +  + V C    P DR   + +RD +
Sbjct: 231 ---------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 852 VK 853
           ++
Sbjct: 270 LE 271

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 44/281 (15%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRN 612
           F    ++G+GSFG V    + E G L AVKVL    ++Q   ++  +TE   L   R+  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            +  +  C    F   D    V +F+  G L   + ++            +    A ++ 
Sbjct: 85  FLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEII 134
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           SA+ +LH      +++ DLK  NVLLDH+    + DFG+ K          +    +++ 
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGICNGVTTAT 183
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFHEGLT----- 782
             GT  YIAPE           D ++ G+LL EM     P      D +F   L      
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 243
Query: 783 ---LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV 820
              LHE +  +L  K     +P++ L      S+++GGE  
Sbjct: 244 PTWLHEDATGIL--KSFMTKNPTMRL-----GSLTQGGEHA 277

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +K++ +  +        +F  +D K    DFM   +L          L +    L Q L 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLK----DFMDASAL------TGIPLPLIKSYLFQLLQ 117
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVV 724
                   + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V
Sbjct: 118 -------GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                      T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 168 V----------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 43/215 (20%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 213
Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +N     D   +V +F++ G+L + +     N +++    L+++Q L++        
Sbjct: 214 ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-------- 262
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSS 731
             LH      V+H D+K  ++LL HD    + DFG    ++K +P R             
Sbjct: 263 --LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------K 305
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            + GT  ++APE  +        D++S GI+++EM
Sbjct: 306 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 614 IKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +K++ +  +        +F  +D K    DFM   +L          L +    L Q L 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLK----DFMDASAL------TGIPLPLIKSYLFQLLQ 116
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVV 724
                   + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V
Sbjct: 117 -------GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 166
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                      T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 167 V----------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           +EF    ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     S  +      +
Sbjct: 70  PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 118
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA++YLH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++ 
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 168
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
               GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 43/221 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 93
Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +N     D   +V +F++ G+L + +     N +++    L+++Q L++        
Sbjct: 94  ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-------- 142
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSS 731
             LH      V+H D+K  ++LL HD    + DFG    ++K +P R             
Sbjct: 143 --LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------K 185
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            + GT  ++APE  +        D++S GI+++EM     P
Sbjct: 186 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           +EF    ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     S  +      +
Sbjct: 68  PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 116
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA++YLH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++ 
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 166
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
               GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 167 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 217

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           +EF    ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     S  +      +
Sbjct: 69  PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 117
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA++YLH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++ 
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 167
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
               GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           +EF    ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     S  +      +
Sbjct: 208 PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 256
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA++YLH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++ 
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 306
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
               GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-- 597
           Q+  +    ++K T  F    ++G+G FG V    +   G + A K L   +    K   
Sbjct: 172 QWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA 229
Query: 598 -FLTECEALRSIRHRNLIKIITICSSID--------FNGVDFKAIVYDFMQNGSLEEWLH 648
             L E + L  +  R ++ +     + D         NG D K  +Y   Q G  E    
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE---- 285
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
                         + +  A ++   +E LH   +  +V+ DLKP N+LLD      + D
Sbjct: 286 -------------ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISD 329
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            GLA  +P            +  G  GTVGY+APE       + + D ++ G LL EM +
Sbjct: 330 LGLAVHVP---------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 769 RRRPTDSMFHEGLTLHEFSKMV--LPEKVMEIVDP-------SLLLEVRANNSMSRGGER 819
            + P      + +   E  ++V  +PE+  E   P        LL +  A     RGG  
Sbjct: 381 GQSPFQQR-KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSA 439
Query: 820 VKIEE 824
            +++E
Sbjct: 440 REVKE 444

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 43/221 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 91
Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +N     D   +V +F++ G+L + +     N +++    L+++Q L++        
Sbjct: 92  ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-------- 140
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSS 731
             LH      V+H D+K  ++LL HD    + DFG    ++K +P R             
Sbjct: 141 --LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------K 183
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            + GT  ++APE  +        D++S GI+++EM     P
Sbjct: 184 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           +EF    ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     S  +      +
Sbjct: 211 PFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAE 259
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA++YLH   +  VV+ DLK  N++LD D    + DFGL K          ++  ++ 
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 309
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
               GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 310 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 360

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLI 614
            +++G+G+FG V K  I ++G+ +   +  + +   K   + F  E E L  +  H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 615 KIITICSSIDFNGVDFKAIVY-------DFMQNGSLEEWLHQNNDKLEVCN-----LSLI 662
            ++  C   +  G  + AI Y       DF++   + E     +    + N     LS  
Sbjct: 87  NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLE----TDPAFAIANSTASTLSSQ 139
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           Q L+ A DVA  ++YL    +   +H +L   N+L+  + VA + DFGL++        T
Sbjct: 140 QLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKT 196
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +   P         V ++A E    S  +   DV+S+G+LL E+ S
Sbjct: 197 MGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-- 597
           Q+  +    ++K T  F    ++G+G FG V    +   G + A K L   +    K   
Sbjct: 172 QWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA 229
Query: 598 -FLTECEALRSIRHRNLIKIITICSSID--------FNGVDFKAIVYDFMQNGSLEEWLH 648
             L E + L  +  R ++ +     + D         NG D K  +Y   Q G  E    
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE---- 285
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
                         + +  A ++   +E LH   +  +V+ DLKP N+LLD      + D
Sbjct: 286 -------------ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISD 329
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            GLA  +P            +  G  GTVGY+APE       + + D ++ G LL EM +
Sbjct: 330 LGLAVHVP---------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 769 RRRPTDSMFHEGLTLHEFSKMV--LPEKVMEIVDP-------SLLLEVRANNSMSRGGER 819
            + P      + +   E  ++V  +PE+  E   P        LL +  A     RGG  
Sbjct: 381 GQSPFQQR-KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSA 439
Query: 820 VKIEE 824
            +++E
Sbjct: 440 REVKE 444

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 43/221 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 82
Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +N     D   +V +F++ G+L + +     N +++    L+++Q L++        
Sbjct: 83  ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-------- 131
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSS 731
             LH      V+H D+K  ++LL HD    + DFG    ++K +P R             
Sbjct: 132 --LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------K 174
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            + GT  ++APE  +        D++S GI+++EM     P
Sbjct: 175 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 138
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +   D   +V +F++ G+L + +     N +++    L+++Q L++          L
Sbjct: 139 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV----------L 186
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSSGIK 734
           H      V+H D+K  ++LL HD    + DFG    ++K +P R              + 
Sbjct: 187 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------KXLV 231
Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           GT  ++APE  +        D++S GI+++EM
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  M VA+K   N       + FL E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 78  GV---ITENPV---WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STXXKASKGKLPI 176
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 43/221 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V    +  +G LVAVK ++L ++   +    E   +R  +H N++++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 86
Query: 622 SIDFNGV---DFKAIVYDFMQNGSLEEWL---HQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +N     D   +V +F++ G+L + +     N +++    L+++Q L++        
Sbjct: 87  ---YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-------- 135
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSS 731
             LH      V+H D+K  ++LL HD    + DFG    ++K +P R             
Sbjct: 136 --LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------------K 178
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            + GT  ++APE  +        D++S GI+++EM     P
Sbjct: 179 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 554 SEFSSSNMVGQGSFGTVF---KGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           S F    ++GQGSFG VF   K    ++G L A+KVL        K+ L   + +R+   
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-------KATLKVRDRVRTKME 80
Query: 611 RNLIK------IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           R+++       ++ +  +    G  +  ++ DF++ G L   L +     EV        
Sbjct: 81  RDILADVNHPFVVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVK 133
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
             +A ++A  +++LH      +++ DLKP N+LLD +    + DFGL+K          +
Sbjct: 134 FYLA-ELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--------EAI 181
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +    +    GTV Y+APE       S + D +S+G+L+ EM +
Sbjct: 182 DHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVL-NLMQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFG AK L A       E   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE------EKEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  M VA+K   N       + FL E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 78  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 176
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 40/231 (17%)
Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLT 600
           M  Y KL K          VG+G++G V+K      G +VA+K + L    +G   + + 
Sbjct: 20  MEKYQKLEK----------VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   L+ + H N++ +I +  S          +V++FM+   L++ L +N   L+   + 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK 122
Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPAR 718
           +         +   + + H H    ++H DLKP N+L++ D    + DFGLA+   +P R
Sbjct: 123 IY-----LYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFS 768
                     S +    T+ Y AP+   GS+   T  D++S G +  EM +
Sbjct: 175 ----------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 38/242 (15%)
Query: 539 QQFPMISYAKLSKATSE-FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           +Q   +    L+K   E F     +G+GS+G+V+K I  E G +VA+K + +  +  L+ 
Sbjct: 13  RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQE 70
Query: 598 FLTECEALRSIRHRNLIKIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQN 650
            + E            I I+  C S   + + G  FK     IV ++   GS+ + +   
Sbjct: 71  IIKE------------ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 651 NDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
           N  L    ++ I    +       +EYLH   K   +H D+K  N+LL+ +  A + DFG
Sbjct: 119 NKTLTEDEIATILQSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFG 170
Query: 711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           +A  L         +  +  + + GT  ++APE       +   D++S GI  +EM   +
Sbjct: 171 VAGQL--------TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 771 RP 772
            P
Sbjct: 223 PP 224

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 40/231 (17%)
Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLT 600
           M  Y KL K          VG+G++G V+K      G +VA+K + L    +G   + + 
Sbjct: 20  MEKYQKLEK----------VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   L+ + H N++ +I +  S          +V++FM+   L++ L +N   L+   + 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK 122
Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPAR 718
           +         +   + + H H    ++H DLKP N+L++ D    + DFGLA+   +P R
Sbjct: 123 IY-----LYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFS 768
                     S +    T+ Y AP+   GS+   T  D++S G +  EM +
Sbjct: 175 ----------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +K++ +  +        +F   D K    DFM   +L          L +    L Q L 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLK----DFMDASAL------TGIPLPLIKSYLFQLLQ 114
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVV 724
                   + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V
Sbjct: 115 -------GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                      T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ----------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 31/241 (12%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECE 603
           A+     ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE  
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            L++ RH  L  +        F   D    V ++   G L  + H + +++     +  +
Sbjct: 61  VLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEER 109
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
                 ++ SA+EYLH      VV+ D+K  N++LD D    + DFGL K          
Sbjct: 110 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---------- 156
Query: 724 VETPSSSSGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
            E  S  + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE 
Sbjct: 157 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 215
Query: 781 L 781
           L
Sbjct: 216 L 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 554 SEFSSSNMVGQGSFGTVFKGII---GENGML-VAVKVLNL-MQKGALKSFLTECEALRSI 608
           +E     ++G G+FGTV+KGI    GEN  + VA+KVL       A K  L E   +  +
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
               + +++ IC +          +V   M  G L + + +N  +L   +L     LN  
Sbjct: 77  GSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNWC 125
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L       + ET  
Sbjct: 126 MQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEY 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + G K  + ++A E       +   DV+S+G+ + E+ +
Sbjct: 177 HADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 203
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 246
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 247 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 217
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 260
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 261 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 304

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 72  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------ 172
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 173 ----TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 72  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------ 172
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 173 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGL     AR +  
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL-----ARDIHH 202
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+LL E+F+
Sbjct: 203 IDXXKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E  +L A KV++   +  L+ ++ E + L S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLH 679
              F   +   I+ +F   G+++  + +    L    + ++  QTL+       A+ YLH
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------ALNYLH 152
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
            +    ++H DLK  N+L   D    + DFG++    A+   T+           GT  +
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTI----QRRDSFIGTPYW 201
Query: 740 IAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE                DV+S GI L+EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 63  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 111
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+   DT+ 
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC 168
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                     GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 169 ----------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 160 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 209
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 252
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 253 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 65  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 159
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 68  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 168
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------ 165
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 217
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 260
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 261 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 304

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 66  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 116 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 165
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 166 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 69  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 119 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 169
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 170 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 67  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 117 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 167
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 66  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------ 166
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 67  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 117 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 166
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 167 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIR 609
           +  +    ++G+GSFG V        G   AVKV++   + QK   +S L E + L+ + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N++K+        F    +  +V +    G L       ++ +     S +    I  
Sbjct: 91  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAARIIR 139
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S I Y+H   K  +VH DLKP N+LL+    D    + DFGL+         T  E 
Sbjct: 140 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEA 187
Query: 727 PSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
                   GT  YIAPE  +GT  E     DV+S G++L  + S
Sbjct: 188 SKKMKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLS 228

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 65  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 159
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 69  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 119 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 168
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 169 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 68  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 168
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 67  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 117 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 167
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 65  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 159
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 66  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 166
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 65  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 159
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-------SFLTECEALRSI 608
           F+  + +G+GSFG V+KGI      +VA+K+++L +            + L++C++    
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 609 RH-RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           R+  + +K   +   +++ G        D ++ G LEE              + I T  I
Sbjct: 81  RYFGSYLKSTKLWIIMEYLG---GGSALDLLKPGPLEE--------------TYIAT--I 121
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
             ++   ++YLH   K   +H D+K +NVLL       + DFG+A          + +T 
Sbjct: 122 LREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--------GQLTDTQ 170
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
              +   GT  ++APE    S      D++S GI  +E+ ++  P +S  H
Sbjct: 171 IKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL-AKGEPPNSDLH 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 203
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 246
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 247 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 217
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 260
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 261 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 304

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 180 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 229
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 272
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 273 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 316

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 170 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 219
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 262
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 263 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 306

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 145 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 194
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 237
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 238 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 281

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  M VA+K   N       + FL E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +    N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 458 GVITE---NPV---WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 506
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 556
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 85  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGL     AR +  
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL-----ARDIHH 191
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+LL E+F+
Sbjct: 192 IDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GS+G   K     +G ++  K L+   M +   +  ++E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              ID        IV ++ + G L   + +   + +  +   +  L +   +  A++  H
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKECH 128
Query: 680 HHCK--PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                   V+H DLKP+NV LD      +GDFGLA+ L     DT     S +    GT 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DT-----SFAKAFVGTP 180
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            Y++PE       +   D++S G LL E+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 65  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 159
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  M VA+K   N       + FL E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 78  GV---ITENPV---WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+       +GDFGL++++          T   +S  K  +
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-------STYYKASKGKLPI 176
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 89  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGL     AR +  
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL-----ARDIHH 195
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+LL E+F+
Sbjct: 196 IDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 88  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +    +D 
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 197
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 198 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 66  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 166
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 202
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 245
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 246 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +    +D 
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 246
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 247 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +        F   D    V ++   G L  + H + +++     +  +      +
Sbjct: 70  PFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAE 118
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           + SA+EYLH      VV+ D+K  N++LD D    + DFGL K           E  S  
Sbjct: 119 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDG 164
Query: 731 SGIK---GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
           + +K   GT  Y+APE    ++     D +  G+++ EM   R P  +  HE L
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 218

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +K++ +  +        +F  +D K     FM   +L          L +    L Q L 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKK----FMDASAL------TGIPLPLIKSYLFQLLQ 117
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVV 724
                   + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V
Sbjct: 118 -------GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                      T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 168 V----------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKG 202
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 245
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 246 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +    +D 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 205
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 206 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 614 IKIITICSS-------IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +K++ +  +        +F  +D K     FM   +L          L +    L Q L 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKK----FMDASAL------TGIPLPLIKSYLFQLLQ 115
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVV 724
                   + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V
Sbjct: 116 -------GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                      T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 166 V----------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 562 VGQGSFG-TVFKGIIGENG------MLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG  V    IG +         VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---------NLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L       LE            LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +    +D 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 205
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +T +    +K    ++APE       +   DV+SFG+LL E+F+
Sbjct: 206 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D    +     
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-------DIYRASYYRKG 203
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 246
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 247 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 78  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 176
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 106 GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 154
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 204
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 205 KWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G + + L +      +      +T
Sbjct: 67  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQK------LSKFDEQRT 115
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 116 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 165
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 166 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F    ++G+G FG VF   +   G L A K LN  +    K +   + E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++ +     +  F       +V   M  G +    H  N   +       + +     + 
Sbjct: 247 IVSL-----AYAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           S +E+LH      +++ DLKP NVLLD D    + D GLA  L A          + + G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTKTKG 348
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT G++APE   G E   + D ++ G+ L EM + R P
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIR 609
           +  +    ++G+GSFG V        G   AVKV++   + QK   +S L E + L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N++K+        F    +  +V +    G L       ++ +     S +    I  
Sbjct: 85  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAARIIR 133
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S I Y+H   K  +VH DLKP N+LL+    D    + DFGL+         T  E 
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEA 181
Query: 727 PSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
                   GT  YIAPE  +GT  E     DV+S G++L  + S
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLS 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F    ++G+G FG VF   +   G L A K LN  +    K +   + E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++ +     +  F       +V   M  G +    H  N   +       + +     + 
Sbjct: 247 IVSL-----AYAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           S +E+LH      +++ DLKP NVLLD D    + D GLA  L A          + + G
Sbjct: 300 SGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTKTKG 348
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT G++APE   G E   + D ++ G+ L EM + R P
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L    D   +  + L    +    +  
Sbjct: 68  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------ 168
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F    ++G+G FG VF   +   G L A K LN  +    K +   + E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++ +     +  F       +V   M  G +    H  N   +       + +     + 
Sbjct: 247 IVSL-----AYAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           S +E+LH      +++ DLKP NVLLD D    + D GLA  L A          + + G
Sbjct: 300 SGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTKTKG 348
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT G++APE   G E   + D ++ G+ L EM + R P
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDXXKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDXXKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 75  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 123
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 173
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRHRN 612
           F    ++G+G FG VF   +   G L A K LN  +    K +   + E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           ++ +     +  F       +V   M  G +    H  N   +       + +     + 
Sbjct: 247 IVSL-----AYAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           S +E+LH      +++ DLKP NVLLD D    + D GLA  L A          + + G
Sbjct: 300 SGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA--------GQTKTKG 348
Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT G++APE   G E   + D ++ G+ L EM + R P
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F+    +G+GSFG VFKGI      +VA+K+++L                     +  I 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-----------EAEDEIEDIQQEIT 73
Query: 616 IITICSS---IDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +++ C S     + G   K     I+ +++  GS         D L        Q   + 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSAL-------DLLRAGPFDEFQIATML 126
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L         +T  
Sbjct: 127 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--------TDTQI 175
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             +   GT  ++APE    S      D++S GI  +E+ ++  P +S  H
Sbjct: 176 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL-AKGEPPNSDMH 224

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 83  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 131
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 181
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L + RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 137
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 138 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 184
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 614 IKIITICSSIDFNGVDFKAIVYD---FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
           +K++ +  + +   + F+ +  D   FM   +L          L +    L Q L     
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASAL------TGIPLPLIKSYLFQLLQ---- 117
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPS 728
               + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V    
Sbjct: 118 ---GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 168
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                  T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 169 -------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYD---FMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
           +K++ +  + +   + F+ +  D   FM   +L          L +    L Q L     
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASAL------TGIPLPLIKSYLFQLLQ---- 113
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPS 728
               + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V    
Sbjct: 114 ---GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---- 163
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
                  T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D          
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKG 243
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 286
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 287 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 81  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 129
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 179
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GS+G   K     +G ++  K L+   M +   +  ++E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              ID        IV ++ + G L   + +   + +  +   +  L +   +  A++  H
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKECH 128
Query: 680 HHCK--PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                   V+H DLKP+NV LD      +GDFGLA+ L     DT     S +    GT 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DT-----SFAKTFVGTP 180
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            Y++PE       +   D++S G LL E+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQKGALKSFLTEC 602
           A++ K T E     ++G G FGTV KG+    G    + V +KV+    K   +SF    
Sbjct: 7   ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVT 63
Query: 603 E---ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
           +   A+ S+ H ++++++ +C            +V  ++  GSL + + Q+   L    L
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL 117
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
                LN  + +A  + YL  H    +VH +L   NVLL       V DFG+A  LP  P
Sbjct: 118 -----LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP--P 167
Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            D  +    + + IK    ++A E     + +   DV+S+G+ + E+ +
Sbjct: 168 DDKQLLYSEAKTPIK----WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  + VA+K   N       + FL E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +   I  N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 80  GV---ITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILY-----AYQLSTALAY 128
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+  +    +GDFGL++++          T   +S  K  +
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPI 178
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 179 KWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 39/233 (16%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTECEALRSIRH 610
            S++     +GQG+FG VFK    + G  VA+K  ++   ++G   + L E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 611 RNLIKIITICSSIDFNGVDFKA---IVYDFMQN---GSLEEWLHQNNDKLEVCNLSLIQT 664
            N++ +I IC +        KA   +V+DF ++   G L   L            +L + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---------VKFTLSEI 127
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-------PA 717
             +   + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+         P 
Sbjct: 128 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSR 769
           R  + VV           T+ Y  PE   G  +     D++  G ++ EM++R
Sbjct: 185 RYXNRVV-----------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 63  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 111
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS------- 161
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 162 ---SRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 562 VGQGSFGTVFKGII--GEN-GMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           +G+G FG V +GI    EN  M VA+K   N       + FL E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +    N V    I+ +    G L  +L      L++ +L L      A  +++A+ Y
Sbjct: 458 GVITE---NPV---WIIMELCTLGELRSFLQVRKFSLDLASLILY-----AYQLSTALAY 506
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH D+   NVL+       +GDFGL++++          T   +S  K  +
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-------STYYKASKGKLPI 556
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
            ++APE       +   DV+ FG+ + E+ 
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 62  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 110
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 111 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 160
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 161 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 41/249 (16%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIRHRNLIK 615
           +G+G+FG VF+      +  E   +VAVK+L       +++ F  E   +    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS--------------- 660
           ++ +C+     G     +++++M  G L E+L   +    VC+LS               
Sbjct: 115 LLGVCAV----GKPM-CLLFEYMAYGDLNEFLRSMSPHT-VCSLSHSDLSTRARVSSPGP 168
Query: 661 ----LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP 716
                 + L IA  VA+ + YL        VH DL   N L+  +MV  + DFGL++ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI- 224
Query: 717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDS 775
                   +   +       + ++ PE    +  +   DV+++G++L E+FS   +P   
Sbjct: 225 -----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 776 MFHEGLTLH 784
           M HE +  +
Sbjct: 280 MAHEEVIYY 288

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 562 VGQGSFGTVFKGIIG-----ENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIK 615
           +G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
               C  +    +  + I+ + M  G L+ +L +   +  +  +L+++  L++A D+A  
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            +YL  +     +H D+   N LL       VA +GDFG+A+       D          
Sbjct: 171 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKG 220
Query: 732 GIKG-TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV 790
           G     V ++ PE       +   D +SFG+LL E+FS                    M 
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMP 263
Query: 791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
            P K  + V     LE      ++ GG     + C   V RI   C    P DR
Sbjct: 264 YPSKSNQEV-----LEF-----VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 307

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+GSFG        E+G    +K +N+  M     +    E   L +++H N   I+  
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN---IVQY 88
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S + NG  +  IV D+ + G L + ++     L        Q L+  + +  A++++H
Sbjct: 89  RESFEENGSLY--IVMDYCEGGDLFKRINAQKGVL----FQEDQILDWFVQICLALKHVH 142
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                 ++H D+K  N+ L  D    +GDFG+     AR L++ VE    +    GT  Y
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGI-----ARVLNSTVEL---ARACIGTPYY 191
Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEM 766
           ++PE       +   D+++ G +L E+
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIR 609
           +  +    ++G+GSFG V        G   AVKV++   + QK   +S L E + L+ + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N++K+        F    +  +V +    G L       ++ +     S +    I  
Sbjct: 109 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAARIIR 157
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S I Y+H   K  +VH DLKP N+LL+    D    + DFGL+         T  E 
Sbjct: 158 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEA 205
Query: 727 PSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
                   GT  YIAPE  +GT  E     DV+S G++L  + S
Sbjct: 206 SKKMKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLS 246

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 554 SEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVL------NLMQKGALKSFLTECEALR 606
           +E +   ++G G FG V++   IG+    VAVK        ++ Q   +++   E +   
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQ--TIENVRQEAKLFA 61
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
            ++H N+I +  +C   + N      +V +F + G L   L       ++        +N
Sbjct: 62  MLKHPNIIALRGVCLK-EPN----LCLVMEFARGGPLNRVLSGKRIPPDIL-------VN 109
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM--------VAHVGDFGLAKFLPAR 718
            A+ +A  + YLH     P++H DLK SN+L+   +        +  + DFGLA+     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----- 164
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             +    T  S++   G   ++APE    S  S   DV+S+G+LL E+ +   P
Sbjct: 165 --EWHRTTKMSAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 88  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 136
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 137 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 186
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 187 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIR 609
           +  +    ++G+GSFG V        G   AVKV++   + QK   +S L E + L+ + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N++K+        F    +  +V +    G L       ++ +     S +    I  
Sbjct: 108 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAARIIR 156
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S I Y+H   K  +VH DLKP N+LL+    D    + DFGL+         T  E 
Sbjct: 157 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEA 204
Query: 727 PSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
                   GT  YIAPE  +GT  E     DV+S G++L  + S
Sbjct: 205 SKKMKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLS 245

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L + RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 137
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 138 -GLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR---------VADPDHDHTG 184
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++  +     +  L E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 135
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR---------VADPDHDHTG 182
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 135
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 182
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQKGALKSFLTEC 602
           A++ K T E     ++G G FGTV KG+    G    + V +KV+    K   +SF    
Sbjct: 25  ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVT 81
Query: 603 E---ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
           +   A+ S+ H ++++++ +C            +V  ++  GSL + + Q+   L    L
Sbjct: 82  DHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL 135
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
                LN  + +A  + YL  H    +VH +L   NVLL       V DFG+A  LP  P
Sbjct: 136 -----LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP--P 185
Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            D  +    + + IK    ++A E     + +   DV+S+G+ + E+ +
Sbjct: 186 DDKQLLYSEAKTPIK----WMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 63  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 111
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 161
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 135
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR---------VADPDHDHTG 182
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 135
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR---------VADPDHDHTG 182
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 137
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 138 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 184
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 88  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 136
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+   D + 
Sbjct: 137 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC 193
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                     GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 194 ----------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 79  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 127
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 128 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 177
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 178 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVK----VLNLMQKGALKSFLTECEALRSIRH 610
           E+     +G G++G V        G  VA+K      +++     K  L E + L+  +H
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKH 112
Query: 611 RNLIKIITICSSIDFNGVDFKAI--VYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNI 667
            N+I I  I       G +FK++  V D M++  L + +H +    LE     L Q L  
Sbjct: 113 DNIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR- 169
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
                  ++Y+H      V+H DLKPSN+L++ +    +GDFG+A+ L   P     E  
Sbjct: 170 ------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP----AEHQ 216
Query: 728 SSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRR 771
              +    T  Y APE      E +   D++S G +  EM +RR+
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 155
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 156 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 202
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 203 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 562 VGQGSFGTVFKG-IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIIT 618
           VG+G +G V++G   GEN   VAVK+ +   +   KS+  E E   ++  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +   +      I + + + GSL        D L++  L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 679 H-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
           H        KP + H DLK  N+L+  +    + D GLA         LD V   P    
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD-VGNNPRV-- 178
Query: 732 GIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
              GT  Y+APE    +      ++    D+++FG++L E+  R
Sbjct: 179 ---GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +    ++++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKNTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 140
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 141 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 187
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 188 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 141
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 142 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 188
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 189 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 132
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 133 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 179
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 180 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 67  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 115
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 116 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 165
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 166 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 133
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 134 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 180
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 27/227 (11%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 117
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+          S
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----------S 164
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 165 RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 562 VGQGSFGTVFKG-IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIIT 618
           VG+G +G V++G   GEN   VAVK+ +   +   KS+  E E   ++  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +   +      I + + + GSL        D L++  L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 679 H-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
           H        KP + H DLK  N+L+  +    + D GLA         LD V   P    
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD-VGNNPRV-- 178
Query: 732 GIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
              GT  Y+APE    +      ++    D+++FG++L E+  R
Sbjct: 179 ---GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 562 VGQGSFGTVFKGII-GENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIIT 618
           VG+G +G V++G   GEN   VAVK+ +   +   KS+  E E   ++  RH N++  I 
Sbjct: 45  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 98
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
              +   +      I + + + GSL        D L++  L  +  L I + +AS + +L
Sbjct: 99  SDMTSRHSSTQLWLITH-YHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 150
Query: 679 H-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
           H        KP + H DLK  N+L+  +    + D GLA         LD V   P    
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD-VGNNPRV-- 207
Query: 732 GIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
              GT  Y+APE    +      ++    D+++FG++L E+  R
Sbjct: 208 ---GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 133
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 134 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 180
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 140
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 141 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 187
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 188 FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 143
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 144 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 190
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 191 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+I
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 135
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 182
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 109/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 254
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 255 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 65  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 113
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 114 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 163
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 164 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E  +L A KV++   +  L+ ++ E + L S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLH 679
              F   +   I+ +F   G+++  + +    L    + ++  QTL+       A+ YLH
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------ALNYLH 152
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
            +    ++H DLK  N+L   D    + DFG++    A+    +           GT  +
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXI----QRRDSFIGTPYW 201
Query: 740 IAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE                DV+S GI L+EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 67  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 115
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+       
Sbjct: 116 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 165
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 166 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+  + L    +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 164
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 165 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+  + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      +   +V++F+        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSS 731
            + + H H    V+H DLKP N+L++ +    + DFGLA+   +P R     V       
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV------- 163
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRR--PTDS 775
               T+ Y APE   G +   T  D++S G +  EM +RR   P DS
Sbjct: 164 ---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 103 IIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 27/227 (11%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 114
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+          S
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----------S 161
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 162 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 27/227 (11%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 114
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+          S
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----------S 161
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 162 RRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG---ALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG      ++  V V  L  +    ALK   L E   ++ + +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 85  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 132
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 184
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + APE     + S   DV+SFG+L+ E FS  ++P   M
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 93  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 140
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 141 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 192
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + APE     + S   DV+SFG+L+ E FS  ++P   M
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLT-ECEALRSIRHRNLIKIIT 618
           +G+GSFG V      +    VA+K ++  L++K  +   +  E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           + ++      D   ++      G L +++ +     E       Q       +  AIEY 
Sbjct: 77  VITT----PTDIVMVIE--YAGGELFDYIVEKKRMTEDEGRRFFQQ------IICAIEYC 124
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H H    +VH DLKP N+LLD ++   + DFGL+  +            +  + +K + G
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM------------TDGNFLKTSCG 169
Query: 739 ---YIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMF 777
              Y APE   G   A    DV+S GI+L  M   R P D  F
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVK----VLNLMQKGALKSFLTECEALRSIRH 610
           E+     +G G++G V        G  VA+K      +++     K  L E + L+  +H
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKH 113
Query: 611 RNLIKIITICSSIDFNGVDFKAI--VYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNI 667
            N+I I  I       G +FK++  V D M++  L + +H +    LE     L Q L  
Sbjct: 114 DNIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR- 170
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
                  ++Y+H      V+H DLKPSN+L++ +    +GDFG+A+ L   P     E  
Sbjct: 171 ------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP----AEHQ 217
Query: 728 SSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRR 771
              +    T  Y APE      E +   D++S G +  EM +RR+
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 142
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + APE     + S   DV+SFG+L+ E FS  ++P   M
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 142
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + APE     + S   DV+SFG+L+ E FS  ++P   M
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++    +A  +EYL        +H DL   NVL+  + V  + DFGL     AR ++ 
Sbjct: 145 DLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGL-----ARDINN 196
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 197 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIR 609
           +  +    ++G+GSFG V        G   AVKV++   + QK   +S L E + L+ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N+ K+        F    +  +V +    G L + +      +     S +    I  
Sbjct: 85  HPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 133
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S I Y H   K  +VH DLKP N+LL+    D    + DFGL+         T  E 
Sbjct: 134 QVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEA 181
Query: 727 PSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
                   GT  YIAPE  +GT  E     DV+S G++L  + S
Sbjct: 182 SKKXKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLS 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAVK+++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD DM   + DFG + +F     LDT   +P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAVK+++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD DM   + DFG + +F     LDT   +P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++    +A  +EYL        +H DL   NVL+  + V  + DFGL     AR ++ 
Sbjct: 150 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGL-----ARDINN 201
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 202 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTECEALRSIRHR 611
           S++     +GQG+FG VFK    + G  VA+K  ++   ++G   + L E + L+ ++H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 612 NLIKIITICSSIDFNGVDFKA---IVYDFMQN---GSLEEWLHQNNDKLEVCNLSLIQTL 665
           N++ +I IC +        K    +V+DF ++   G L   L            +L +  
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---------VKFTLSEIK 128
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-------PAR 718
            +   + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+         P R
Sbjct: 129 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSR 769
             + VV           T+ Y  PE   G  +     D++  G ++ EM++R
Sbjct: 186 YXNRVV-----------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L              +++    ++  
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++    +A  +EYL        +H DL   NVL+  + V  + DFGL     AR ++ 
Sbjct: 147 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGL-----ARDINN 198
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 199 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 51/243 (20%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAVK+++  Q    +L+    E   ++ + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--- 71
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEE---------WLHQNNDKLEVCNLSLIQTLNIAID 670
                F  ++ +  +Y  M+  S  E         W+ +   + +               
Sbjct: 72  -----FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------------ 114
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSS 729
           + SA++Y H      +VH DLK  N+LLD DM   + DFG + +F     LDT   +P  
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP- 170
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
                    Y APE   G +      DV+S G++L  + S   P D     G  L E  +
Sbjct: 171 ---------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRE 216
Query: 789 MVL 791
            VL
Sbjct: 217 RVL 219

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E  +L A KV++   +  L+ ++ E + L S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLH 679
              F   +   I+ +F   G+++  + +    L    + ++  QTL+       A+ YLH
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD-------ALNYLH 152
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
            +    ++H DLK  N+L   D    + DFG++    A+    +           GT  +
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXI----QRRDXFIGTPYW 201
Query: 740 IAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE                DV+S GI L+EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 39/218 (17%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----SFLTECEALRSIRHRNLIK 615
           M+G+GSFG V K          AVKV+N   K + K     + L E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  I      +   F  IV +    G L + +      ++    S      I   V S I
Sbjct: 86  LFEILE----DSSSF-YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGI 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +    
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKD 182
Query: 733 IKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFS 768
             GT  YIAPE   GT  E     DV+S G++L  + S
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKC---DVWSAGVILYILLS 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAV-KVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +++ + +G+G++G V       N + VA+ K+     +   +  L E + L   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I  I  +     +    IV D M+     L +  H +ND   +C   L Q L       
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF-LYQILR------ 139
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +G
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTG 186
Query: 733 I----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
                  T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 29/232 (12%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 64  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 112
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V
Sbjct: 113 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------V 158
Query: 725 ETPSSSS-GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             PSS    + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 159 HAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 39/233 (16%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTECEALRSIRH 610
            S++     +GQG+FG VFK    + G  VA+K  ++   ++G   + L E + L+ ++H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 611 RNLIKIITICSSIDFNGVDFKA---IVYDFMQN---GSLEEWLHQNNDKLEVCNLSLIQT 664
            N++ +I IC +        K    +V+DF ++   G L   L            +L + 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---------VKFTLSEI 126
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-------PA 717
             +   + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+         P 
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSR 769
           R  + VV           T+ Y  PE   G  +     D++  G ++ EM++R
Sbjct: 184 RYXNRVV-----------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 437 GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 484
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 485 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 536
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 438 GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 485
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 486 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 537
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 39/233 (16%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLTECEALRSIRH 610
            S++     +GQG+FG VFK    + G  VA+K  ++   ++G   + L E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 611 RNLIKIITICSSIDFNGVDFKA---IVYDFMQN---GSLEEWLHQNNDKLEVCNLSLIQT 664
            N++ +I IC +        K    +V+DF ++   G L   L            +L + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---------VKFTLSEI 127
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-------PA 717
             +   + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+         P 
Sbjct: 128 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSR 769
           R  + VV           T+ Y  PE   G  +     D++  G ++ EM++R
Sbjct: 185 RYXNRVV-----------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 106/253 (41%), Gaps = 39/253 (15%)
Query: 549 LSKATSE------FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLT 600
           ++ AT E      +     +G+G+F  V        G  VAVK+++  Q    +L+    
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   ++ + H N++K+  +  +          +V ++   G + ++L  +    E    +
Sbjct: 64  EVRIMKILNHPNIVKLFEVIET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARP 719
             +       + SA++Y H      +VH DLK  N+LLD DM   + DFG + +F     
Sbjct: 119 KFRQ------IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK 169
Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFH 778
           LDT   +P           Y APE   G +      DV+S G++L  + S   P D    
Sbjct: 170 LDTFCGSPP----------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---- 215
Query: 779 EGLTLHEFSKMVL 791
            G  L E  + VL
Sbjct: 216 -GQNLKELRERVL 227

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 112/226 (49%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 117
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 118 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 170
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L    +D++   
Sbjct: 171 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSM--- 221
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
              ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 222 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----SFLTECEALRSIRHRNLIK 615
           M+G+GSFG V K          AVKV+N   K + K     + L E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  I      +   F  IV +    G L       ++ ++    S      I   V S I
Sbjct: 86  LFEILE----DSSSF-YIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +    
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKD 182
Query: 733 IKGTVGYIAPEY--GTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT  YIAPE   GT  E     DV+S G++L  + S   P
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKC---DVWSAGVILYILLSGTPP 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V       +G  VAVK+++L ++   +    E   +R  +H N++++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK--- 109
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              +   +   ++ +F+Q G+L + + Q         L+  Q   +   V  A+ YLH  
Sbjct: 110 --SYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSSGIKGTV 737
               V+H D+K  ++LL  D    + DFG    ++K +P R              + GT 
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------------KXLVGTP 205
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            ++APE  + S  +   D++S GI+++EM     P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GS+G   K     +G ++  K L+   M +   +  ++E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              ID        IV ++ + G L   + +   + +  +   +  L +   +  A++  H
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKECH 128
Query: 680 HHCK--PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                   V+H DLKP+NV LD      +GDFGLA+ L              +    GT 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--------HDEDFAKEFVGTP 180
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            Y++PE       +   D++S G LL E+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----SFLTECEALRSIRHRNLIK 615
           M+G+GSFG V K          AVKV+N   K + K     + L E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  I      +   F  IV +    G L       ++ ++    S      I   V S I
Sbjct: 86  LFEILE----DSSSF-YIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +    
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKD 182
Query: 733 IKGTVGYIAPEY--GTGSEASMTGDVYSFGILLLEMFSRRRP 772
             GT  YIAPE   GT  E     DV+S G++L  + S   P
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKC---DVWSAGVILYILLSGTPP 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 108/227 (47%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  + Y     G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLYVIVAY--ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F    M+G+GSFG VF     +     A+K L    ++    ++  + E   L S+  
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL-SLAW 76
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN-LSLIQTLNIAI 669
            +       C+   F   +    V +++  G L          ++ C+   L +    A 
Sbjct: 77  EHPFLTHMFCT---FQTKENLFFVMEYLNGGDLMY-------HIQSCHKFDLSRATFYAA 126
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++   +++LH      +V+ DLK  N+LLD D    + DFG+ K          +   + 
Sbjct: 127 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAK 175
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFH 778
           ++   GT  YIAPE   G + + + D +SFG+LL EM   + P      + +FH
Sbjct: 176 TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 109/227 (48%), Gaps = 35/227 (15%)
Query: 562 VGQGSFGTVFKG-IIG------ENGMLVAVKVL-NLMQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V     +G      +  + VAVK+L +   +  L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----------DKLEVCNLSLI 662
           +I ++  C+    +G  +  ++  +   G+L E+L              +++    ++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGL     AR ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-----ARDIN 208
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            +     +++G +  V ++APE       +   DV+SFG+L+ E+F+
Sbjct: 209 NIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS G V        G  VAVK ++L ++   +    E   +R   H N++ + +   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS--- 109
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              +   D   +V +F++ G+L        D +    ++  Q   + + V  A+ YLH+ 
Sbjct: 110 --SYLVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSSGIKGTV 737
               V+H D+K  ++LL  D    + DFG    ++K +P R              + GT 
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR------------KXLVGTP 205
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            ++APE  +        D++S GI+++EM     P
Sbjct: 206 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 74
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 75  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 127
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 128 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 175
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P  S
Sbjct: 176 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAV++++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR------QIVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD DM   + DFG + +F     LDT   +P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 562 VGQGSFGTVFKGI---IGENGML----VAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +GQG+F  +FKG+   +G+ G L    V +KVL+   +   +SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
               +C   D N      +V +F++ GSL+ +L +N +    C ++++  L +A  +A+A
Sbjct: 76  LNYGVCVCGDEN-----ILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAAA 125
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           + +L  +    ++HG++   N+LL  +     G+    K   + P  ++   P     ++
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL--SDPGISITVLPKDI--LQ 178
Query: 735 GTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFS 768
             + ++ PE        ++  D +SFG  L E+ S
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F     +G+G FG V+     +N  ++A+KVL    L ++G       E E    +RH 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++        F+      ++ +F   G L + L ++    E  + + ++ L      
Sbjct: 76  NILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ 124
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS-SS 730
           A A+ Y H      V+H D+KP N+L+ +     + DFG +           V  PS   
Sbjct: 125 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-----------VHAPSLRR 170
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             + GT+ Y+ PE   G       D++  G+L  E      P DS  H
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 82
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 135
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 55
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 108
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 156
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 55
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 108
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 156
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECE 603
           AK   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
               +RH N++++        F+      ++ ++   G++   L +      +      +
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQR 109
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           T     ++A+A+ Y H      V+H D+KP N+LL       + DFG +           
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----------- 155
Query: 724 VETPSS-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           V  PSS  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 156 VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 55
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 108
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 156
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 55
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 108
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 156
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 55
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 108
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L           
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 156
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            S ++   GT  Y++PE   G+  S+  D++S G+ L+EM   R P
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 65  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 113
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + +FG +   P+       
Sbjct: 114 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS------- 163
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 164 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VA+K+++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          ++ ++   G + ++L  +    E    S  +       + SA++Y H
Sbjct: 80  IET-----EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQYCH 128
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
              +  +VH DLK  N+LLD DM   + DFG + +F     LDT   +P           
Sbjct: 129 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP---------- 175
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 224

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F     +G+G FG V+     ++  +VA+KVL    + ++G       E E    + H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++        F       ++ ++   G L + L ++      C     +T  I  ++
Sbjct: 84  NILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKS------CTFDEQRTATIMEEL 132
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A A+ Y H      V+H D+KP N+LL       + DFG +   P+    T+        
Sbjct: 133 ADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC------- 182
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
              GT+ Y+ PE   G   +   D++  G+L  E+     P +S  H
Sbjct: 183 ---GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRN 612
           FS    +G GSFG V+      N  +VA+K ++   K +    +  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                    +I + G   +      +    +E  L   +D LEV    L Q + IA    
Sbjct: 116 ---------TIQYRGCYLREHTAWLV----MEYCLGSASDLLEVHKKPL-QEVEIAAVTH 161
Query: 673 SAIE---YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            A++   YLH H    ++H D+K  N+LL    +  +GDFG A  +   P +  V TP  
Sbjct: 162 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA--PANXFVGTPY- 215
Query: 730 SSGIKGTVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
                    ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 216 ---------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 112/249 (44%), Gaps = 34/249 (13%)
Query: 540 QFPMISYAKLSK----ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLM 590
           + P+I+  K +K    + S       +G+  FG V+KG +     GE    VA+K L   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK 67
Query: 591 QKGALKSFLTECEALRS-IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL-- 647
            +G L+        LR+ ++H N++ ++ + +          ++++ +  +G L E+L  
Sbjct: 68  AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVM 122
Query: 648 --------HQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD 699
                     ++D+     L     +++   +A+ +EYL  H    VVH DL   NVL+ 
Sbjct: 123 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179
Query: 700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSF 759
             +   + D GL  F      D      +S   I+    ++APE     + S+  D++S+
Sbjct: 180 DKLNVKISDLGL--FREVYAADYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSY 233
Query: 760 GILLLEMFS 768
           G++L E+FS
Sbjct: 234 GVVLWEVFS 242

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEA 604
           K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E 
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
              +RH N++++        F+      ++ ++   G++   L +      +      +T
Sbjct: 64  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 112
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
                ++A+A+ Y H      V+H D+KP N+LL       + +FG +   P+       
Sbjct: 113 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS------- 162
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 163 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F     +G+G FG V+     +N  ++A+KVL    L ++G       E E    +RH 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++        F+      ++ +F   G L + L ++    E  + + ++ L      
Sbjct: 75  NILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ 123
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS-SS 730
           A A+ Y H      V+H D+KP N+L+ +     + DFG +           V  PS   
Sbjct: 124 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-----------VHAPSLRR 169
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFH 778
             + GT+ Y+ PE   G       D++  G+L  E      P DS  H
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 31/234 (13%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F    M+G+GSFG VF     +     A+K L    ++    ++  + E   L S+  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL-SLAW 75
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN-LSLIQTLNIAI 669
            +       C+   F   +    V +++  G L          ++ C+   L +    A 
Sbjct: 76  EHPFLTHMFCT---FQTKENLFFVMEYLNGGDLMY-------HIQSCHKFDLSRATFYAA 125
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
           ++   +++LH      +V+ DLK  N+LLD D    + DFG+ K          +   + 
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAK 174
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFH 778
           ++   GT  YIAPE   G + + + D +SFG+LL EM   + P      + +FH
Sbjct: 175 TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 38/230 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G VFK     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE---L 58
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-N 666
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E       Q L  
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGK 111
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++I V   + YL    K  ++H D+KPSN+L++      + DFG++  L     +  V  
Sbjct: 112 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV-- 167
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
                   GT  Y++PE   G+  S+  D++S G+ L+EM   R P   M
Sbjct: 168 --------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-----KWPV 178
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQKGAL---KSFLTECEALRS 607
           A  +   + ++G+G FG V++G+     G  + V V    +   L   + F++E   +++
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + H +++K+I I         +   I+ +    G L  +L +N + L+V  L L      
Sbjct: 66  LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY----- 114
Query: 668 AIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++         E 
Sbjct: 115 SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-------ED 163
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
              +S  +  + +++PE       +   DV+ F + + E+ S
Sbjct: 164 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQKGAL---KSFLTECEALRS 607
           A  +   + ++G+G FG V++G+     G  + V V    +   L   + F++E   +++
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + H +++K+I I         +   I+ +    G L  +L +N + L+V  L L      
Sbjct: 82  LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY----- 130
Query: 668 AIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++         E 
Sbjct: 131 SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-------ED 179
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
              +S  +  + +++PE       +   DV+ F + + E+ S
Sbjct: 180 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIRHRN 612
           FS    +G GSFG V+      N  +VA+K ++   K +    +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                    +I + G   +      +    +E  L   +D LEV    L Q + IA    
Sbjct: 77  ---------TIQYRGCYLREHTAWLV----MEYCLGSASDLLEVHKKPL-QEVEIAAVTH 122
Query: 673 SAIE---YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            A++   YLH H    ++H D+K  N+LL    +  +GDFG A  +   P +  V TP  
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA--PANXFVGTPY- 176
Query: 730 SSGIKGTVGYIAPEYGTG-SEASMTG--DVYSFGILLLEMFSRRRPTDSM 776
                    ++APE      E    G  DV+S GI  +E+  R+ P  +M
Sbjct: 177 ---------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLT 600
           M  Y KL K          +G+G++GTVFK    E   +VA+K + L    +G   S L 
Sbjct: 1   MQKYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR 50
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFK-AIVYDFMQNGSLEEWLHQNNDKL--EVC 657
           E   L+ ++H+N++++  +  S      D K  +V++F  +  L+++    N  L  E+ 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIV 103
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--L 715
              L Q L         + + H      V+H DLKP N+L++ +    + DFGLA+   +
Sbjct: 104 KSFLFQLL-------KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153
Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRP 772
           P R            S    T+ Y  P+   G++   T  D++S G +  E+ +  RP
Sbjct: 154 PVR----------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G + + L +      +      +T    
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQK------LSKFDEQRTATYI 119
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 165
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S    + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 166 SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +   V +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQKGAL---KSFLTECEALRS 607
           A  +   + ++G+G FG V++G+     G  + V V    +   L   + F++E   +++
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + H +++K+I I         +   I+ +    G L  +L +N + L+V  L L      
Sbjct: 70  LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY----- 118
Query: 668 AIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++         E 
Sbjct: 119 SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-------ED 167
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
              +S  +  + +++PE       +   DV+ F + + E+ S
Sbjct: 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 562 VGQGSFGTVFKGI---IGENGML----VAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +GQG+F  +FKG+   +G+ G L    V +KVL+   +   +SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
               +C   D N      +V +F++ GSL+ +L +N +    C ++++  L +A  +A A
Sbjct: 76  LNYGVCFCGDEN-----ILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAWA 125
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           + +L  +    ++HG++   N+LL  +     G+    K   + P  ++   P     ++
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL--SDPGISITVLPKDI--LQ 178
Query: 735 GTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFS 768
             + ++ PE        ++  D +SFG  L E+ S
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGI--IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR 611
            ++     +G+G++G V+K     GE   L  ++ L    +G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCN--LSLIQTLNIA 668
           N++K+  +  +        K +V  F       E L Q+  KL +VC   L  +   +  
Sbjct: 61  NIVKLYDVIHTK-------KRLVLVF-------EHLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVET 726
           + + + I Y H      V+H DLKP N+L++ +    + DFGLA+   +P R     V  
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-- 161
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEM 766
                    T+ Y AP+   GS+  S T D++S G +  EM
Sbjct: 162 --------VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 29/233 (12%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECE 603
           AK   A  +F     +G+G FG V+      +  ++A+KVL    L + G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
               +RH N++++        F+      ++ ++   G++   L +      +      +
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQK------LSKFDEQR 109
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           T     ++A+A+ Y H      V+H D+KP N+LL       + DFG +           
Sbjct: 110 TATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS----------- 155
Query: 724 VETPSS-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           V  PSS  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 156 VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAVK+++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD DM   + DFG + +F     LD     P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 554 SEFSSSNMVGQGSFGTVFKGI--IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR 611
            ++     +G+G++G V+K     GE   L  ++ L    +G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCN--LSLIQTLNIA 668
           N++K+  +  +        K +V  F       E L Q+  KL +VC   L  +   +  
Sbjct: 61  NIVKLYDVIHTK-------KRLVLVF-------EHLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVET 726
           + + + I Y H      V+H DLKP N+L++ +    + DFGLA+   +P R     V  
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-- 161
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEM 766
                    T+ Y AP+   GS+  S T D++S G +  EM
Sbjct: 162 --------VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 73  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 120
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 121 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 172
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL---------KSFLTECEALR 606
           +    ++G+G    V + I        AVK++++   G+          ++ L E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 607 SIR-HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
            +  H N+I++        +    F  +V+D M+ G L ++L       E   LS  +T 
Sbjct: 79  KVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETR 127
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVV 724
            I   +   I  LH   K  +VH DLKP N+LLD DM   + DFG + +  P   L +V 
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC 184
Query: 725 ETPSSSSGIKGTVGYIAPEY----------GTGSEASMTGDVYSFGILLLEMFSRRRP 772
            TPS          Y+APE           G G E     D++S G+++  + +   P
Sbjct: 185 GTPS----------YLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVL-NLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   + +    VAVK+L N     ALK   L E   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 126
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 178
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLNLMQKGALK-SFLTECEALRSIRHRNLIKII 617
           +G G+FGTV KG   +      +    + N     ALK   L E   ++ + +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC +  +       +V +  + G L ++L QN     V + ++I+ ++    V+  ++Y
Sbjct: 75  GICEAESW------MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVH---QVSMGMKY 122
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L    +   VH DL   NVLL     A + DFGL+K L A       +T       K  V
Sbjct: 123 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 174
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
            + APE     + S   DV+SFG+L+ E FS
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F+   ++G+GSFG V          L A+K+L    ++Q   ++  + E   L  +  
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
              +  +  C    F  VD    V +++  G L   + Q      V      Q +  A +
Sbjct: 79  PPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAE 128
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           ++  + +LH   K  +++ DLK  NV+LD +    + DFG+ K      +D V     ++
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGV-----TT 177
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
               GT  YIAPE         + D +++G+LL EM + + P D
Sbjct: 178 REFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 119
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 165
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 166 SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL-IKIITIC 620
           +G+G++G V K     +G ++AVK         +++ +   E  R +   ++ ++ +   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVK--------RIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 621 SSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            ++ F G  F+     I  + M + SL+++  Q  DK +     ++    IA+ +  A+E
Sbjct: 111 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALE 167
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           +LH   K  V+H D+KPSNVL++      + DFG++ +L    +D+V +T  +     G 
Sbjct: 168 HLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDA-----GC 216
Query: 737 VGYIAPEYG----TGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             Y+APE           S+  D++S GI ++E+   R P DS
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 259

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAV++++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD DM   + DFG + +F     LD    +P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G++G V+K     GE   L  ++ L    +G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCN--LSLIQTLNIAIDVASAIE 676
             +        K +V  F       E L Q+  KL +VC   L  +   +  + + + I 
Sbjct: 69  IHTK-------KRLVLVF-------EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPARPLDTVVETPSSSSGIK 734
           Y H      V+H DLKP N+L++ +    + DFGLA+   +P R     +          
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---------- 161
Query: 735 GTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEM 766
            T+ Y AP+   GS+  S T D++S G +  EM
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 49/238 (20%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL---------KSFLTECEALR 606
           +    ++G+G    V + I        AVK++++   G+          ++ L E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 607 SIR-HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
            +  H N+I++        +    F  +V+D M+ G L ++L       E   LS  +T 
Sbjct: 66  KVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETR 114
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVV 724
            I   +   I  LH   K  +VH DLKP N+LLD DM   + DFG + +  P   L  V 
Sbjct: 115 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 171
Query: 725 ETPSSSSGIKGTVGYIAPEY----------GTGSEASMTGDVYSFGILLLEMFSRRRP 772
            TPS          Y+APE           G G E     D++S G+++  + +   P
Sbjct: 172 GTPS----------YLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 35/239 (14%)
Query: 555 EFSSSNM-----VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKG---ALKSFLTECE 603
           EF   N+     +G G+FG V       I + G+ + V V  L +K      ++ ++E +
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNG--------SLEEWLHQNNDKL 654
            +  +  H N++ ++  C+      + F+   Y  + N         S +E  ++N  +L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 655 EVCN----LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
           E       L+    L  A  VA  +E+L        VH DL   NVL+ H  V  + DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 711 LAKFLPARPLDTVVETPSSSSG-IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           LA+       D + ++     G  +  V ++APE       ++  DV+S+GILL E+FS
Sbjct: 218 LAR-------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 111/247 (44%), Gaps = 36/247 (14%)
Query: 535 TMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM 590
           TM  ++ P     +L+K   E    + + + VG G++G+V      ++G+ +AVK L+  
Sbjct: 28  TMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP 87
Query: 591 QKGALKSFLT--ECEALRSIRHRN---LIKIITICSSID-FNGVDFKAIVYDFMQNGSLE 644
            +  + +  T  E   L+ ++H N   L+ + T  +S++ FN V     +   +    L 
Sbjct: 88  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDV----YLVTHLMGADL- 142
Query: 645 EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA 704
                 N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 143 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 193
Query: 705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILL 763
            + DFGLA+            T    +G   T  Y APE        +MT D++S G ++
Sbjct: 194 KILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIM 242
Query: 764 LEMFSRR 770
            E+ + R
Sbjct: 243 AELLTGR 249

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/233 (23%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECE 603
           +K   A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
               +RH N++++        F+      ++ ++   G++   L +      +      +
Sbjct: 65  IQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQR 113
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           T     ++A+A+ Y H      V+H D+KP N+LL       + DFG +           
Sbjct: 114 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----------- 159
Query: 724 VETPSS-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           V  PSS  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 160 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 114
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 160
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++        F+      ++ ++   G++   L +      +      +T     ++
Sbjct: 73  NILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSRFDEQRTATYITEL 121
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A+A+ Y H      V+H D+KP N+LL  +    + DFG +   P+   DT+        
Sbjct: 122 ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC------- 171
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
              GT+ Y+ PE   G       D++S G+L  E      P ++
Sbjct: 172 ---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 49/238 (20%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL---------KSFLTECEALR 606
           +    ++G+G    V + I        AVK++++   G+          ++ L E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 607 SIR-HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
            +  H N+I++        +    F  +V+D M+ G L ++L       E   LS  +T 
Sbjct: 79  KVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETR 127
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVV 724
            I   +   I  LH   K  +VH DLKP N+LLD DM   + DFG + +  P   L  V 
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 725 ETPSSSSGIKGTVGYIAPEY----------GTGSEASMTGDVYSFGILLLEMFSRRRP 772
            TPS          Y+APE           G G E     D++S G+++  + +   P
Sbjct: 185 GTPS----------YLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 113
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 114 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 159
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 160 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 117
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 163
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 114
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 160
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 161 SRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR----------HR 611
           +G+G++G V+K I    G +VAVK +         +F    +A R+ R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++ ++ +  + +   V    +V+D+M+       LH     +    L  +    +   +
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYMETD-----LHA---VIRANILEPVHKQYVVYQL 118
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLPAR------PLDTVV 724
              I+YLH      ++H D+KPSN+LL+ +    V DFGL++ F+  R      PL    
Sbjct: 119 IKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 725 ETPSSS------SGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMF 767
            T +        +    T  Y APE   GS     G D++S G +L E+ 
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/219 (25%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+FG+V +G+  + +  + VA+KVL    +K   +  + E + +  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C +      +   +V +    G L ++L    +++ V N++      +   V+  ++YL
Sbjct: 78  VCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               +   VH DL   NVLL +   A + DFGL+K L A   D    T  S+   K  + 
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG--KWPLK 178
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
           + APE     + S   DV+S+G+ + E  S  ++P   M
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VA+K+++  Q    +L+    E   ++ + H N++K+  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          ++ ++   G + ++L  +    E    S  +       + SA++Y H
Sbjct: 83  IET-----EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQYCH 131
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
              +  +VH DLK  N+LLD DM   + DFG + +F     LD     P           
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---------- 178
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRS-IRHRNLIK 615
           +G+  FG V+KG +     GE    VA+K L    +G L+        LR+ ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID----- 670
           ++ + +          ++++ +  +G L E+L   +   +V +    +T+  A++     
Sbjct: 77  LLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 671 -----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
                +A+ +EYL  H    VVH DL   NVL+   +   + D GL  F      D    
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKL 186
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             +S   I+    ++APE     + S+  D++S+G++L E+FS
Sbjct: 187 LGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     +   ++A+KVL    L + G       E E    +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 111
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 112 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 157
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S  + + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 158 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 117
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +   P+   D +     
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---- 170
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                 GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 171 ------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTE 601
           M +Y KL K          +G+G++ TV+KG       LVA+K + L  ++GA  + + E
Sbjct: 1   METYIKLDK----------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE 50
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              L+ ++H N++ +  I  +          +V++++ +  L+++L    + + + N+ L
Sbjct: 51  VSLLKDLKHANIVTLHDIIHT-----EKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL 104
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL--AKFLPARP 719
                    +   + Y H   +  V+H DLKP N+L++      + DFGL  AK +P + 
Sbjct: 105 F-----LFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156
Query: 720 LDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
            D  V           T+ Y  P+   GS + S   D++  G +  EM + R
Sbjct: 157 YDNEV----------VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 562 VGQGSFGTVFKGI--IGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+FG+V +G+  + +  + VA+KVL    +K   +  + E + +  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C +      +   +V +    G L ++L    +++ V N++      +   V+  ++YL
Sbjct: 404 VCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 452
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   VH +L   NVLL +   A + DFGL+K L A   D    T  S+   K  + 
Sbjct: 453 EEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG--KWPLK 504
Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
           + APE     + S   DV+S+G+ + E  S  ++P   M
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 38/234 (16%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----DKLEVCN 658
            +  + +H N++ ++  C+     G     ++ ++   G L  +L +      DK +   
Sbjct: 102 IMSHLGQHENIVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L L   L+ +  VA  + +L        +H D+   NVLL +  VA +GDFGLA+ +   
Sbjct: 157 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--- 210
Query: 719 PLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     S+  +KG     V ++APE       ++  DV+S+GILL E+FS
Sbjct: 211 -------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 38/234 (16%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----DKLEVCN 658
            +  + +H N++ ++  C+     G     ++ ++   G L  +L +      DK +   
Sbjct: 94  IMSHLGQHENIVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L L   L+ +  VA  + +L        +H D+   NVLL +  VA +GDFGLA+ +   
Sbjct: 149 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--- 202
Query: 719 PLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     S+  +KG     V ++APE       ++  DV+S+GILL E+FS
Sbjct: 203 -------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHR 611
            ++     +G+GS+G VFK    + G +VA+K     +   +  K  L E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL--NIAI 669
           NL+ ++ +     F       +V+++  +  L E        L+     + + L  +I  
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITW 109
Query: 670 DVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVET 726
               A+ + H H+C    +H D+KP N+L+    V  + DFG A+ L  P+   D  V  
Sbjct: 110 QTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-- 163
Query: 727 PSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFS 768
                    T  Y +PE   G ++     DV++ G +  E+ S
Sbjct: 164 --------ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 39/238 (16%)
Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTE 601
           +S A  + +   +     +G+G++G V+K I       VA+K + L   ++G   + + E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLS 660
              L+ ++HRN+I++ ++   I  N      +++++ +N  L++++ +N D  + V    
Sbjct: 84  VSLLKELQHRNIIELKSV---IHHN--HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 661 LIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKF 714
           L Q +N        + + H   C    +H DLKP N+LL         V  +GDFGLA+ 
Sbjct: 138 LYQLIN-------GVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 715 --LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSR 769
             +P R     +           T+ Y  PE   GS   S + D++S   +  EM  +
Sbjct: 187 FGIPIRQFTHEI----------ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 36/248 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E G L A KV+    +  L+ ++ E E L +  H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---G 83
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           +   +G  +  I+ +F   G+++  + + +       L+  Q   +   +  A+ +LH  
Sbjct: 84  AYYHDGKLW--IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK 136
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
               ++H DLK  NVL+  +    + DFG++    A+ L T+           GT  ++A
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTL----QKRDSFIGTPYWMA 185
Query: 742 PEYGTGSEASMT-----GDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
           PE         T      D++S GI L+EM     P           HE + M +  K+ 
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNPMRVLLKIA 235
Query: 797 EIVDPSLL 804
           +   P+LL
Sbjct: 236 KSDPPTLL 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 36/249 (14%)
Query: 533 RTTMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
           R + + Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+
Sbjct: 16  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 75
Query: 589 LMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGS 642
              +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGAD 131
Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L       N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 132 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 181
Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGI 761
              + DFGLA+            T    +G   T  Y APE        + T D++S G 
Sbjct: 182 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 230
Query: 762 LLLEMFSRR 770
           ++ E+ + R
Sbjct: 231 IMAELLTGR 239

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 36/248 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E G L A KV+    +  L+ ++ E E L +  H  ++K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---G 75
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           +   +G  +  I+ +F   G+++  + + +       L+  Q   +   +  A+ +LH  
Sbjct: 76  AYYHDGKLW--IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK 128
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
               ++H DLK  NVL+  +    + DFG++    A+ L T+           GT  ++A
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTL----QKRDSFIGTPYWMA 177
Query: 742 PEYGTGSEASMT-----GDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
           PE         T      D++S GI L+EM     P           HE + M +  K+ 
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNPMRVLLKIA 227
Query: 797 EIVDPSLL 804
           +   P+LL
Sbjct: 228 KSDPPTLL 235

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 114
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 160
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S    + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 161 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSI 608
           A  +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           RH N++++        F+      ++ ++   G++   L +      +      +T    
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYI 117
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++A+A+ Y H      V+H D+KP N+LL       + DFG +           V  PS
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----------VHAPS 163
Query: 729 S-SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           S    + GT+ Y+ PE   G       D++S G+L  E    + P ++
Sbjct: 164 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 36/249 (14%)
Query: 533 RTTMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
           R + + Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+
Sbjct: 17  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 76
Query: 589 LMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGS 642
              +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGAD 132
Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L       N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 133 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 182
Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGI 761
              + DFGLA+            T    +G   T  Y APE        + T D++S G 
Sbjct: 183 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 762 LLLEMFSRR 770
           ++ E+ + R
Sbjct: 232 IMAELLTGR 240

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLI 614
           ++    +G+G++G V           VA+K ++  + +   +  L E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            I  I  +     +    IV D M+    +    Q      +C   L Q L         
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF-LYQILR-------G 156
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           ++Y+H      V+H DLKPSN+L++      + DFGLA+       D   +     +   
Sbjct: 157 LKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARI-----ADPEHDHTGFLTEXV 208
Query: 735 GTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
            T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 42/238 (17%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV------ 656
            +  + +H N++ ++  C+     G     ++ ++   G L  +L + +  LE       
Sbjct: 102 IMSHLGQHENIVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 657 --CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
               LS    L+ +  VA  + +L        +H D+   NVLL +  VA +GDFGLA+ 
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 715 LPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +             S+  +KG     V ++APE       ++  DV+S+GILL E+FS
Sbjct: 214 I----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLT 600
           M  Y KL K          +G+G++GTVFK    E   +VA+K + L    +G   S L 
Sbjct: 1   MQKYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR 50
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFK-AIVYDFMQNGSLEEWLHQNNDKL--EVC 657
           E   L+ ++H+N++++  +  S      D K  +V++F  +  L+++    N  L  E+ 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIV 103
Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--L 715
              L Q L         + + H      V+H DLKP N+L++ +    + +FGLA+   +
Sbjct: 104 KSFLFQLL-------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRP 772
           P R            S    T+ Y  P+   G++   T  D++S G +  E+ +  RP
Sbjct: 154 PVR----------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 78
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 135
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 136 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 184
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 185 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 109/253 (43%), Gaps = 56/253 (22%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND 652
           + +  T  E   L+ ++H N+I ++ +                 F    SLEE+    ND
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDV-----------------FTPARSLEEF----ND 101
Query: 653 KLEVCNL------SLIQTLNIAID--------VASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              V +L      ++++   +  D        +   ++Y+H      ++H DLKPSN+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 158
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVY 757
           + D    + DFGLA+            T    +G   T  Y APE    +   + T D++
Sbjct: 159 NEDCELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207
Query: 758 SFGILLLEMFSRR 770
           S G ++ E+ + R
Sbjct: 208 SVGCIMAELLTGR 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 20/141 (14%)
Query: 633 IVYDFMQNGSL---EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG 689
           I+Y++M+N S+   +E+     DK   C + +     I   V ++  Y+H+     + H 
Sbjct: 120 IIYEYMENDSILKFDEYFFVL-DKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHR 176
Query: 690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE 749
           D+KPSN+L+D +    + DFG ++++  + +           G +GT  ++ PE+ +  E
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKI----------KGSRGTYEFMPPEFFSN-E 225
Query: 750 ASMTG---DVYSFGILLLEMF 767
           +S  G   D++S GI L  MF
Sbjct: 226 SSYNGAKVDIWSLGICLYVMF 246

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEAL 605
           E+  S  +G G+ G V      +    VA+K+++  +K A+ S           TE E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQT 664
           + + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q 
Sbjct: 70  KKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLD 721
           L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 124 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 722 TVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                      + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 173 --------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEAL 605
           E+  S  +G G+ G V      +    VA+K+++  +K A+ S           TE E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQT 664
           + + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q 
Sbjct: 70  KKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLD 721
           L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 124 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 722 TVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                      + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 173 --------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEAL 605
           E+  S  +G G+ G V      +    VA+K+++  +K A+ S           TE E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQT 664
           + + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q 
Sbjct: 70  KKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLD 721
           L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 124 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 722 TVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                      + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 173 --------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +++ A+ YLH      +++ DLK  NVLLD +    + D+G+ K    RP DT     
Sbjct: 127 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT----- 177
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 178 --TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEAL 605
           E+  S  +G G+ G V      +    VA+K+++  +K A+ S           TE E L
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 68
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQT 664
           + + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q 
Sbjct: 69  KKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLD 721
           L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 123 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 171
Query: 722 TVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                      + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 172 --------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 568 GTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIRHRNLIKIITICSSIDF 625
           G ++KG    N   + VKVL +      KS  F  EC  LR   H N++ ++  C S   
Sbjct: 24  GELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS--- 78
Query: 626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP 685
                  ++  +M  GSL   LH+  + +    +   Q +  A+D+A  + +L H  +P 
Sbjct: 79  PPAPHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDMARGMAFL-HTLEPL 133
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           +    L   +V++D DM A +      KF               S G      ++APE  
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS-MADVKF------------SFQSPGRMYAPAWVAPEAL 180
Query: 746 TGSEASM---TGDVYSFGILLLEMFSRRRP 772
                     + D++SF +LL E+ +R  P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 81
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 138
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 139 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 187
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 188 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 183
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR 611
           +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++++        F+      ++ ++   G++   L +      +      +T     ++
Sbjct: 73  NILRLYGY-----FHDATRVYLILEYAPLGTVYRELQK------LSRFDEQRTATYITEL 121
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS-S 730
           A+A+ Y H      V+H D+KP N+LL  +    + DFG +           V  PSS  
Sbjct: 122 ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS-----------VHAPSSRR 167
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           + + GT+ Y+ PE   G       D++S G+L  E      P ++
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 146
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 195
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 118
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 173
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 174 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 768 SRR 770
           + R
Sbjct: 223 TGR 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 96
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 153
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 154 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 202
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 203 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 85
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 142
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 143 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 191
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 192 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 146
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 195
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 33/234 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G+F  V        G  VAVK+++  Q    +L+    E    + + H N++K+  +
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +          +V ++   G + ++L  +    E    +  +       + SA++Y H
Sbjct: 82  IET-----EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ------IVSAVQYCH 130
Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLPARPLDTVVETPSSSSGIKGTVG 738
                 +VH DLK  N+LLD D    + DFG + +F     LD     P           
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPP---------- 177
Query: 739 YIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
           Y APE   G +      DV+S G++L  + S   P D     G  L E  + VL
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNLKELRERVL 226

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +++ A+ YLH      +++ DLK  NVLLD +    + D+G+ K    RP DT     
Sbjct: 159 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT----- 209
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 210 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 108/253 (42%), Gaps = 56/253 (22%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND 652
           + +  T  E   L+ ++H N+I ++ +                 F    SLEE+    ND
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDV-----------------FTPARSLEEF----ND 101
Query: 653 KLEVCNL------SLIQTLNIAID--------VASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              V +L      ++++   +  D        +   ++Y+H      ++H DLKPSN+ +
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 158
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVY 757
           + D    + DFGLA+            T    +G   T  Y APE        + T D++
Sbjct: 159 NEDXELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 758 SFGILLLEMFSRR 770
           S G ++ E+ + R
Sbjct: 208 SVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEAL 605
           E+  S  +G G+ G V      +    VA+K+++  +K A+ S           TE E L
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 75
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQT 664
           + + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q 
Sbjct: 76  KKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLD 721
           L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 130 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 178
Query: 722 TVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                      + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 179 --------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 108/249 (43%), Gaps = 36/249 (14%)
Query: 533 RTTMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
           R + + Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+
Sbjct: 17  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS 76
Query: 589 LMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGS 642
              +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGAD 132
Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L       N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 133 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 182
Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGI 761
              + DFGLA+            T    +G   T  Y APE        + T D++S G 
Sbjct: 183 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 762 LLLEMFSRR 770
           ++ E+ + R
Sbjct: 232 IMAELLTGR 240

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 124
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 125 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 179
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 180 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 768 SRR 770
           + R
Sbjct: 229 TGR 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNL 613
           ++    ++G G+   V           VA+K +NL + + ++   L E +A+    H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGS----LEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           +   T      F   D   +V   +  GS    ++  + +   K  V + S I T  I  
Sbjct: 71  VSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT--ILR 123
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA-------RPLDT 722
           +V   +EYLH + +   +H D+K  N+LL  D    + DFG++ FL         +   T
Sbjct: 124 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
            V TP           ++APE            D++SFGI  +E+ +   P
Sbjct: 181 FVGTPC----------WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 118
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 173
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 174 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 768 SRR 770
           + R
Sbjct: 223 TGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 112
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 113 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 167
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 168 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 216
Query: 768 SRR 770
           + R
Sbjct: 217 TGR 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 119
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 175 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 768 SRR 770
           + R
Sbjct: 224 TGR 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 120
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 176 FGLAR-----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 768 SRR 770
           + R
Sbjct: 225 TGR 227

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 90
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 147
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 148 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 196
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 197 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 30/224 (13%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNL 613
            +++ + +G+G++G V       N + VA+K ++    +   +  L E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNG--SLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           I I  I  +     +    +V   M      L +  H +ND   +C   L Q L      
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYF-LYQILR----- 155
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              ++Y+H      V+H DLKPSN+LL+      + DFGLA+         V +     +
Sbjct: 156 --GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR---------VADPDHDHT 201
Query: 732 GI----KGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRR 770
           G       T  Y APE    S+  + + D++S G +L EM S R
Sbjct: 202 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 108/249 (43%), Gaps = 36/249 (14%)
Query: 533 RTTMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
           R + + Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+
Sbjct: 16  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS 75
Query: 589 LMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGS 642
              +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGAD 131
Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L       N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 132 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 181
Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGI 761
              + DFGLA+            T    +G   T  Y APE        + T D++S G 
Sbjct: 182 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 230
Query: 762 LLLEMFSRR 770
           ++ E+ + R
Sbjct: 231 IMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 118
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 173
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 174 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 768 SRR 770
           + R
Sbjct: 223 TGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 107/253 (42%), Gaps = 56/253 (22%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 L--KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND 652
           +  K    E   L+ ++H N+I ++ +                 F    SLEE+    ND
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDV-----------------FTPARSLEEF----ND 101
Query: 653 KLEVCNL------SLIQTLNIAID--------VASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              V +L      ++++   +  D        +   ++Y+H      ++H DLKPSN+ +
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 158
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVY 757
           + D    + DFGLA+            T    +G   T  Y APE        + T D++
Sbjct: 159 NEDCELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 758 SFGILLLEMFSRR 770
           S G ++ E+ + R
Sbjct: 208 SVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 120
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 176 FGLAR-----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 768 SRR 770
           + R
Sbjct: 225 TGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITI 619
           VG+G +G V++G+   +G  VAVK+ +   +   +S+  E E   ++  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGLW--HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA- 69
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                 N      ++  + ++GSL ++L +         L     L +A+  A  + +LH
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT-------LEPHLALRLAVSAACGLAHLH 122
Query: 680 -----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H D K  NVL+  ++   + D GLA  + ++  D +      ++   
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYL---DIGNNPRV 178
Query: 735 GTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR 769
           GT  Y+APE           E+    D+++FG++L E+  R
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 136
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 137 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 191
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 192 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 768 SRR 770
           + R
Sbjct: 241 TGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 115
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 171 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 768 SRR 770
           + R
Sbjct: 220 TGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN------LMQKGALKSFLTECEALRSIR 609
           + S   VG G++G+V   I   +G  VA+K L+      +  K A +  L     L+ ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL----LKHMQ 81
Query: 610 HRN---LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           H N   L+ + T  SS+  N  DF  +V  FMQ          +  K+     S  +   
Sbjct: 82  HENVIGLLDVFTPASSLR-NFYDF-YLVMPFMQT---------DLQKIMGLKFSEEKIQY 130
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           +   +   ++Y+H      VVH DLKP N+ ++ D    + DFGLA+   A     VV  
Sbjct: 131 LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 185
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFS 768
                    T  Y APE   +    + T D++S G ++ EM +
Sbjct: 186 ---------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 120
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 176 FGLAR-----------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 768 SRR 770
           + R
Sbjct: 225 TGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 57/273 (20%)
Query: 554 SEFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVL----NLMQKGALKSFLTECEA 604
           +  S    +G G+FG V +      I  +  M VAVK+L    +L ++ AL S L     
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS---- 660
           L +  H N++ ++  C+     G     ++ ++   G L  +L +  D   +C+ +    
Sbjct: 106 LGN--HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAI 157
Query: 661 ---------LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
                    L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFG
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFG 213
Query: 711 LAKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           LA+ +             S+  +KG     V ++APE       +   DV+S+GI L E+
Sbjct: 214 LARHIKN----------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 767 FSRRR------PTDSMFHEGLTLHEFSKMVLPE 793
           FS         P DS F++   + E  +M+ PE
Sbjct: 264 FSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPE 294

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 119
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 175 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 768 SRR 770
           + R
Sbjct: 224 TGR 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +++ A+ YLH      +++ DLK  NVLLD +    + D+G+ K    RP DT     
Sbjct: 112 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT----- 162
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 163 --TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNL 613
           ++    ++G G+   V           VA+K +NL + + ++   L E +A+    H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGS----LEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           +   T      F   D   +V   +  GS    ++  + +   K  V + S I T  I  
Sbjct: 76  VSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT--ILR 128
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA-------RPLDT 722
           +V   +EYLH + +   +H D+K  N+LL  D    + DFG++ FL         +   T
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
            V TP           ++APE            D++SFGI  +E+ +   P
Sbjct: 186 FVGTPC----------WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + +G G++G+V      + G+ VAVK L+   +  
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 118
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 173
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 174 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 768 SRR 770
           + R
Sbjct: 223 TGR 225

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 168
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 217
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 120
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 176 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 768 SRR 770
           + R
Sbjct: 225 TGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 125
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 181 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 768 SRR 770
           + R
Sbjct: 230 TGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 115
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 171 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 768 SRR 770
           + R
Sbjct: 220 TGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 125
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 181 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 768 SRR 770
           + R
Sbjct: 230 TGR 232

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 124
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 125 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 179
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 180 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 768 SRR 770
           + R
Sbjct: 229 TGR 231

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 36/225 (16%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F   + +G G+ G V K     +G+++A K+++L  K A+++ +        IR    +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI--------IRE---L 65
Query: 615 KIITICSS---IDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           +++  C+S   + F G  +     +I  + M  GSL++ L +     E     ++  ++I
Sbjct: 66  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSI 121
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A  V   + YL    K  ++H D+KPSN+L++      + DFG++  L            
Sbjct: 122 A--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------ID 167
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           S ++   GT  Y+APE   G+  S+  D++S G+ L+E+   R P
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAG-PLPYIVMEYV 98
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN------LMQKGALKSFLTECEALRSIR 609
           + S   VG G++G+V   I   +G  VA+K L+      +  K A +  L     L+ ++
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL----LKHMQ 99
Query: 610 HRN---LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           H N   L+ + T  SS+  N  DF  +V  FMQ          +  K+     S  +   
Sbjct: 100 HENVIGLLDVFTPASSLR-NFYDF-YLVMPFMQT---------DLQKIMGMEFSEEKIQY 148
Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           +   +   ++Y+H      VVH DLKP N+ ++ D    + DFGLA+   A     VV  
Sbjct: 149 LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 203
Query: 727 PSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFS 768
                    T  Y APE   +    + T D++S G ++ EM +
Sbjct: 204 ---------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 115
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 171 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 768 SRR 770
           + R
Sbjct: 220 TGR 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +++ A+ YLH      +++ DLK  NVLLD +    + D+G+ K    RP DT     
Sbjct: 116 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT----- 166
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
             +S   GT  YIAPE   G +   + D ++ G+L+ EM + R P D
Sbjct: 167 --TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 119
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILD 174
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 175 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 768 SRR 770
           + R
Sbjct: 224 TGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 125
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 181 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 768 SRR 770
           + R
Sbjct: 230 TGR 232

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 103/403 (25%), Positives = 170/403 (42%), Gaps = 69/403 (17%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 99
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 100 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 143
Query: 169 LSVLI-LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
           +S L  L +    N ++N +  +  LAN + LE L +  N+   +    LA L+N + ++
Sbjct: 144 ISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTN-LESL 200
Query: 228 DIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGY 285
               N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +   
Sbjct: 201 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNL 254
Query: 286 IP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTX 344
            P S             +I+N+     S L   T+L  L L++N+L+ + P         
Sbjct: 255 APLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP--------- 300
Query: 345 XXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
                             I NLKNL  L +  N  S   P  +S+ T L+ +   +N  S
Sbjct: 301 ------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 340
Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
                SL  L +I  L    N++S   P  L NL+ +  L L+
Sbjct: 341 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 379

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 115
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILD 170
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 171 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 768 SRR 770
           + R
Sbjct: 220 TGR 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK------LEVCNLSLIQTLNI 667
           + ++  C+     G     IV +F + G+L  +L    ++      L    L+L   +  
Sbjct: 94  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V    
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDP-DYV---- 201
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                 +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 202 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 82
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 139
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 140 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 188
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 189 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEA 604
            E+  S  +G G+ G V      +    VA+++++  +K A+ S           TE E 
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 207
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQ 663
           L+ + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q
Sbjct: 208 LKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPL 720
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 262 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 721 DTVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                       + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 312 ---------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 349

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYV 98
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+L+
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILI 149
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 150 SATNAVKVVDFGIARAI-ADSGNSVXQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYV 98
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS---------FLTECEA 604
            E+  S  +G G+ G V      +    VA+++++  +K A+ S           TE E 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 193
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQ 663
           L+ + H  +IKI        F+  D+  IV + M+ G L + +  N   K   C L   Q
Sbjct: 194 LKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPL 720
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 248 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 721 DTVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLL 764
                       + GT  Y+APE     GT    +   D +S G++L 
Sbjct: 298 ---------MRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILF 335

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 168
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 217
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 57/273 (20%)
Query: 554 SEFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVL----NLMQKGALKSFLTECEA 604
           +  S    +G G+FG V +      I  +  M VAVK+L    +L ++ AL S L     
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS---- 660
           L +  H N++ ++  C+     G     ++ ++   G L  +L +  D   +C+ +    
Sbjct: 99  LGN--HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAI 150
Query: 661 ---------LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
                    L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFG
Sbjct: 151 MEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFG 206
Query: 711 LAKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           LA+ +             S+  +KG     V ++APE       +   DV+S+GI L E+
Sbjct: 207 LARDIKN----------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256
Query: 767 FSRRR------PTDSMFHEGLTLHEFSKMVLPE 793
           FS         P DS F++   + E  +M+ PE
Sbjct: 257 FSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPE 287

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYV 98
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 105
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 162
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 211
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 212 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 115
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 172
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 221
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 222 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 113
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 170
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 219
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 220 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYV 98
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 117/272 (43%), Gaps = 57/272 (20%)
Query: 555 EFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVL----NLMQKGALKSFLTECEAL 605
             S    +G G+FG V +      I  +  M VAVK+L    +L ++ AL S L     L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS----- 660
            +  H N++ ++  C+     G     ++ ++   G L  +L +  D   +C+ +     
Sbjct: 84  GN--HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIM 135
Query: 661 --------LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
                   L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 712 AKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           A+ +             S+  +KG     V ++APE       +   DV+S+GI L E+F
Sbjct: 192 ARDIKN----------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 768 SRRR------PTDSMFHEGLTLHEFSKMVLPE 793
           S         P DS F++   + E  +M+ PE
Sbjct: 242 SLGSSPYPGMPVDSKFYK--MIKEGFRMLSPE 271

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 36/249 (14%)
Query: 533 RTTMVEQQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN 588
           R + + Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+
Sbjct: 17  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS 76
Query: 589 LMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGS 642
              +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGAD 132
Query: 643 LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM 702
           L       N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 133 L-------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 182
Query: 703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGI 761
              + DFGLA+            T     G   T  Y APE        + T D++S G 
Sbjct: 183 ELKILDFGLAR-----------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 762 LLLEMFSRR 770
           ++ E+ + R
Sbjct: 232 IMAELLTGR 240

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 57/273 (20%)
Query: 554 SEFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVL----NLMQKGALKSFLTECEA 604
           +  S    +G G+FG V +      I  +  M VAVK+L    +L ++ AL S L     
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS---- 660
           L +  H N++ ++  C+     G     ++ ++   G L  +L +  D   +C+ +    
Sbjct: 106 LGN--HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAI 157
Query: 661 ---------LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
                    L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFG
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFG 213
Query: 711 LAKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           LA+ +             S+  +KG     V ++APE       +   DV+S+GI L E+
Sbjct: 214 LARDIKN----------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 767 FSRRR------PTDSMFHEGLTLHEFSKMVLPE 793
           FS         P DS F++   + E  +M+ PE
Sbjct: 264 FSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPE 294

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++M  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 136
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 137 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 191
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T     G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 192 FGLAR-----------HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 768 SRR 770
           + R
Sbjct: 241 TGR 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 47/255 (18%)
Query: 545 SYAKLSKATSEFSSSNMV-----GQGSFGTVFKG----IIGENGML-VAVKVLNL-MQKG 593
           ++  L     EF   N+V     G+G FG V K     + G  G   VAVK+L       
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 594 ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-- 651
            L+  L+E   L+ + H ++IK+   CS    +G     ++ ++ + GSL  +L ++   
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKV 123
Query: 652 ----------------DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN 695
                           D  +   L++   ++ A  ++  ++YL    +  +VH DL   N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARN 180
Query: 696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT--VGYIAPEYGTGSEASMT 753
           +L+       + DFGL++         V E  S     +G   V ++A E       +  
Sbjct: 181 ILVAEGRKMKISDFGLSR--------DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 754 GDVYSFGILLLEMFS 768
            DV+SFG+LL E+ +
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 42/238 (17%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV------ 656
            +  + +H N++ ++  C+     G     ++ ++   G L  +L + +  LE       
Sbjct: 102 IMSHLGQHENIVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 657 --CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
                S    L+ +  VA  + +L        +H D+   NVLL +  VA +GDFGLA+ 
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 715 LPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           +             S+  +KG     V ++APE       ++  DV+S+GILL E+FS
Sbjct: 214 I----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITI 619
           VG G++G V   + G  G  VA+K L    +  L  K    E   L+ +RH N+I ++ +
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 620 CS---SIDFNGVDFKAIVYDFMQN--GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +   ++D +  DF  +V  FM    G L +      D+++     +++ L         
Sbjct: 93  FTPDETLD-DFTDF-YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR-------- 142
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
             Y+H      ++H DLKP N+ ++ D    + DFGLA+           +  S   G  
Sbjct: 143 --YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----------QADSEMXGXV 186
Query: 735 GTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFS 768
            T  Y APE        + T D++S G ++ EM +
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K   ++Q    K+   E + +R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 156
Query: 616 I-ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 213
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L        V    + S I
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYI 262
Query: 734 KGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMF 767
                Y APE   G ++ + + DV+S G +L E+ 
Sbjct: 263 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 31/168 (18%)
Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   L+S+ H N+IK+  +     F    +  +V +F + G L E +  N  K + C+ +
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAA 149
Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLPA 717
                NI   + S I YLH H    +VH D+KP N+LL++    +   + DFGL+ F   
Sbjct: 150 -----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 718 --RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
             +  D +           GT  YIAPE     + +   DV+S G+++
Sbjct: 202 DYKLRDRL-----------GTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++M  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 57/265 (21%)
Query: 562 VGQGSFGTVFKG-----IIGENGMLVAVKVL----NLMQKGALKSFLTECEALRSIRHRN 612
           +G G+FG V +      I  +  M VAVK+L    +L ++ AL S L     L +  H N
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMN 106
Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS------------ 660
           ++ ++  C+     G     ++ ++   G L  +L +  D   +C+ +            
Sbjct: 107 IVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIMEDDELAL 160
Query: 661 -LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
            L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFGLA+ +   
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN- 215
Query: 719 PLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR--- 771
                     S+  +KG     V ++APE       +   DV+S+GI L E+FS      
Sbjct: 216 ---------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266
Query: 772 ---PTDSMFHEGLTLHEFSKMVLPE 793
              P DS F++   + E  +M+ PE
Sbjct: 267 PGMPVDSKFYK--MIKEGFRMLSPE 289

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 36/246 (14%)
Query: 532 ERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ 591
           ER T   Q+     +    +    + + + VG G++G+V      + G+ VAVK L+   
Sbjct: 1   ERPTFYRQELNKTIW----EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 56
Query: 592 KGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEE 645
           +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L  
Sbjct: 57  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL-- 110
Query: 646 WLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH 705
                N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    
Sbjct: 111 -----NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 162
Query: 706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLL 764
           + DFGLA+            T    +G   T  Y APE        + T D++S G ++ 
Sbjct: 163 ILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 765 EMFSRR 770
           E+ + R
Sbjct: 212 ELLTGR 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 94
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL---------HQNNDKLEVCNLSLIQT 664
           + ++  C+     G     IV +F + G+L  +L         ++  + L    L+L   
Sbjct: 95  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V 
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP-DXV- 205
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                    +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 206 ----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 47/255 (18%)
Query: 545 SYAKLSKATSEFSSSNMV-----GQGSFGTVFKG----IIGENGML-VAVKVLNL-MQKG 593
           ++  L     EF   N+V     G+G FG V K     + G  G   VAVK+L       
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 594 ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-- 651
            L+  L+E   L+ + H ++IK+   CS    +G     ++ ++ + GSL  +L ++   
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKV 123
Query: 652 ----------------DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN 695
                           D  +   L++   ++ A  ++  ++YL       +VH DL   N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARN 180
Query: 696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT--VGYIAPEYGTGSEASMT 753
           +L+       + DFGL++         V E  S     +G   V ++A E       +  
Sbjct: 181 ILVAEGRKMKISDFGLSR--------DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 754 GDVYSFGILLLEMFS 768
            DV+SFG+LL E+ +
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 36/246 (14%)
Query: 532 ERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ 591
           ER T   Q+     +    +    + + + VG G++G+V      + G+ VAVK L+   
Sbjct: 1   ERPTFYRQELNKTIW----EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 56
Query: 592 KGALKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEE 645
           +  + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L  
Sbjct: 57  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL-- 110
Query: 646 WLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH 705
                N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    
Sbjct: 111 -----NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 162
Query: 706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLL 764
           + DFGLA+            T    +G   T  Y APE        + T D++S G ++ 
Sbjct: 163 ILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 765 EMFSRR 770
           E+ + R
Sbjct: 212 ELLTGR 217

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 47/255 (18%)
Query: 545 SYAKLSKATSEFSSSNMV-----GQGSFGTVFKG----IIGENGML-VAVKVLNL-MQKG 593
           ++  L     EF   N+V     G+G FG V K     + G  G   VAVK+L       
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 594 ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN-- 651
            L+  L+E   L+ + H ++IK+   CS    +G     ++ ++ + GSL  +L ++   
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKV 123
Query: 652 ----------------DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN 695
                           D  +   L++   ++ A  ++  ++YL    +  +VH DL   N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARN 180
Query: 696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT--VGYIAPEYGTGSEASMT 753
           +L+       + DFGL++         V E  S     +G   V ++A E       +  
Sbjct: 181 ILVAEGRKMKISDFGLSR--------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 754 GDVYSFGILLLEMFS 768
            DV+SFG+LL E+ +
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           +GLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 YGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 582 VAVKVL--NLMQKGALK-SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM 638
           VAVKVL  +L +  +    F  E +   ++ H  ++ +     +    G     IV +++
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYV 115
Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              +L + +H          ++  + + +  D   A+ + H +    ++H D+KP+N+++
Sbjct: 116 DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 166
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  V DFG+A+ + A   ++V +T    + + GT  Y++PE   G       DVYS
Sbjct: 167 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYS 221
Query: 759 FGILLLEMFSRRRP 772
            G +L E+ +   P
Sbjct: 222 LGCVLYEVLTGEPP 235

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL-IKIITIC 620
           +G+G++G V K     +G ++AVK         +++ +   E  R +   ++ ++ +   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVK--------RIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 621 SSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            ++ F G  F+     I  + M + SL+++  Q  DK +     ++    IA+ +  A+E
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALE 123
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           +LH   K  V+H D+KPSNVL++      + DFG++ +L    +D V +   +     G 
Sbjct: 124 HLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDA-----GC 172
Query: 737 VGYIAPEYG----TGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             Y+APE           S+  D++S GI ++E+   R P DS
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 119
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 175 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 768 SRR 770
           + R
Sbjct: 224 TGR 226

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK--------LEVCNLSLIQTL 665
           + ++  C+     G     IV +F + G+L  +L    ++        L    L+L   +
Sbjct: 96  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
             +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V  
Sbjct: 152 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDP-DXV-- 205
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                   +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 206 ---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 103/406 (25%), Positives = 169/406 (41%), Gaps = 76/406 (18%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 99
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 100 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 143
Query: 169 LSVL----ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           +S L     L   + GN+  +    +  LAN + LE L +  N+   +    LA L+N +
Sbjct: 144 ISALSGLTSLQQLNFGNQVTD----LKPLANLTTLERLDISSNKVSDI--SVLAKLTN-L 196
Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFL 282
            ++    N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +
Sbjct: 197 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQI 250
Query: 283 HGYIP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV 341
               P S             +I+N+     S L   T+L  L L++N+L+ + P      
Sbjct: 251 SNLAPLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP------ 299
Query: 342 TTXXXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
                                I NLKNL  L +  N  S   P  +S+ T L+ +   +N
Sbjct: 300 ---------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNN 336
Query: 402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
             S     SL  L +I  L    N++S   P  L NL+ +  L L+
Sbjct: 337 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 378

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 56/253 (22%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND 652
           + +  T  E   L+ ++H N+I ++ +                 F    SLEE+    ND
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDV-----------------FTPARSLEEF----ND 101
Query: 653 KLEVCNL------SLIQTLNIAID--------VASAIEYLHHHCKPPVVHGDLKPSNVLL 698
              V +L      +++++  +  D        +   ++Y+H      ++H DLKPSN+ +
Sbjct: 102 VYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 158
Query: 699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVY 757
           + D    + DFGL +            T    +G   T  Y APE        + T D++
Sbjct: 159 NEDSELKILDFGLCR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 758 SFGILLLEMFSRR 770
           S G ++ E+ + R
Sbjct: 208 SVGCIMAELLTGR 220

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK------LEVCNLSLIQTLNI 667
           + ++  C+     G     IV +F + G+L  +L    ++      L    L+L   +  
Sbjct: 94  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V    
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV---- 201
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                 +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 202 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 27/211 (12%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLI 614
           F     +G G+F  V        G L AVK +     KG   S   E   LR I+H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +  I     +   +   +V   +  G L + + +     E    +LI+       V  A
Sbjct: 84  ALEDI-----YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDA 132
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           + YLH   +  +VH DLKP N+L    D +    + DFGL+K         V+ T     
Sbjct: 133 VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTAC--- 183
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
              GT GY+APE       S   D +S G++
Sbjct: 184 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--LKSFLTECEALRS 607
           +K +  +     +G+G+F  V + +    G+  A K++N  +  A   +    E    R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N++++             F  +V+D +  G L E +       E      IQ    
Sbjct: 85  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 135
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVV 724
              +  +I Y H +    +VH +LKP N+LL          + DFGLA           V
Sbjct: 136 --QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 181
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
               +  G  GT GY++PE       S   D+++ G++L
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 52/226 (23%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G+ VAVK L+   +  + +  T  E   L+ ++H N+I ++ +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL------SLIQTLNIAID--- 670
                            F    SLEE+    ND   V +L      ++++   +  D   
Sbjct: 86  -----------------FTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 671 -----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
                +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+            
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------H 170
Query: 726 TPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
           T    +G   T  Y APE        + T D++S G ++ E+ + R
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 103/240 (42%), Gaps = 36/240 (15%)
Query: 542 PMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS 597
           P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  + +
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 598 FLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLHQNN 651
             T  E   L+ ++H N+I ++ + +      +FN V     +   +    L       N
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL-------N 110
Query: 652 DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
           + ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGL
Sbjct: 111 NIVKCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
           A+            T    +G   T  Y APE        + T D++S G ++ E+ + R
Sbjct: 168 AR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G+ VAVK L+   +  + +  T  E   L+ ++H N+I ++ +
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 620 CSSI----DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            +      +FN V     +   +    L       N+ ++   L+      +   +   +
Sbjct: 88  FTPARSLEEFNDV----YLVTHLMGADL-------NNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +Y+H      ++H DLKPSN+ ++ D    + DFGLA+            T    +G   
Sbjct: 137 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTDDEMTGYVA 182
Query: 736 TVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
           T  Y APE        + T D++S G ++ E+ + R
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRH 610
           T E+     +G+G+F  V + +    G   A K++N  +  A      E EA   R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++++     SI   G  F  +V+D +  G L E +       E      IQ +  A+ 
Sbjct: 63  SNIVRLH---DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV- 116
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLPARPLDTVVETP 727
                  LH H +  VVH DLKP N+LL          + DFGLA          V    
Sbjct: 117 -------LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAI--------EVQGDQ 160
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
            +  G  GT GY++PE           D+++ G++L
Sbjct: 161 QAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + +   VG G++G+V      + G  VAVK L+   +  
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 73  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 123
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 124 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 178
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 179 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 227
Query: 768 SRR 770
           + R
Sbjct: 228 TGR 230

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 103/406 (25%), Positives = 169/406 (41%), Gaps = 76/406 (18%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 99
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 100 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 143
Query: 169 LSVL----ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           +S L     L   + GN+  +    +  LAN + LE L +  N+   +    LA L+N +
Sbjct: 144 ISALSGLTSLQQLNFGNQVTD----LKPLANLTTLERLDISSNKVSDI--SVLAKLTN-L 196
Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFL 282
            ++    N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +
Sbjct: 197 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQI 250
Query: 283 HGYIP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV 341
               P S             +I+N+     S L   T+L  L L++N+L+ + P      
Sbjct: 251 SNLAPLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP------ 299
Query: 342 TTXXXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
                                I NLKNL  L +  N  S   P  +S+ T L+ +   +N
Sbjct: 300 ---------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 336
Query: 402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
             S     SL  L +I  L    N++S   P  L NL+ +  L L+
Sbjct: 337 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 378

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 103/406 (25%), Positives = 168/406 (41%), Gaps = 76/406 (18%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 46  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 103
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 104 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 147
Query: 169 LSVL----ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           +S L     L     GN+  +    +  LAN + LE L +  N+   +    LA L+N +
Sbjct: 148 ISALSGLTSLQQLSFGNQVTD----LKPLANLTTLERLDISSNKVSDI--SVLAKLTN-L 200
Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFL 282
            ++    N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +
Sbjct: 201 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQI 254
Query: 283 HGYIP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV 341
               P S             +I+N+     S L   T+L  L L++N+L+ + P      
Sbjct: 255 SNLAPLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP------ 303
Query: 342 TTXXXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
                                I NLKNL  L +  N  S   P  +S+ T L+ +   +N
Sbjct: 304 ---------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 340
Query: 402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
             S     SL  L +I  L    N++S   P  L NL+ +  L L+
Sbjct: 341 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 382

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++          L    L+L  
Sbjct: 94  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP-DXV 205
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 206 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 49/246 (19%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 604 ALRSI-RHRNLIKIITICSS----------------IDFNGVDFKAIVYDFMQNGSLEEW 646
            +  + +H N++ ++  C+                 ++F     +A++   +  G   E 
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 647 LHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV 706
           L    DK +   L L   L+ +  VA  + +L        +H D+   NVLL +  VA +
Sbjct: 147 L----DKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 199
Query: 707 GDFGLAKFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGIL 762
           GDFGLA+ +             S+  +KG     V ++APE       ++  DV+S+GIL
Sbjct: 200 GDFGLARDI----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 249
Query: 763 LLEMFS 768
           L E+FS
Sbjct: 250 LWEIFS 255

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTE---CEALRSIRHRNLIKIIT 618
           +G+GSF    K +  ++    AVK+++   +   +  +T    CE      H N++K+  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +     F+      +V + +  G L E + +        + S  +   I   + SA+ ++
Sbjct: 74  V-----FHDQLHTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHM 122
Query: 679 HHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           H      VVH DLKP N+L    + ++   + DFG A+  P  P +  ++TP        
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCF------ 171
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           T+ Y APE    +    + D++S G++L  M S + P  S
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 102/402 (25%), Positives = 169/402 (42%), Gaps = 69/402 (17%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 99
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 100 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 143
Query: 169 LSVLI-LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
           +S L  L +    + ++N +  +  LAN + LE L +  N+   +    LA L+N + ++
Sbjct: 144 ISALSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTN-LESL 200
Query: 228 DIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGY 285
               N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +   
Sbjct: 201 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNL 254
Query: 286 IP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTX 344
            P S             +I+N+     S L   T+L  L L++N+L+ + P         
Sbjct: 255 APLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP--------- 300
Query: 345 XXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
                             I NLKNL  L +  N  S   P  +S+ T L+ +   +N  S
Sbjct: 301 ------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVS 340
Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNL 446
                SL  L +I  L    N++S   P  L NL+ +  L L
Sbjct: 341 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 378

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++          L    L+L  
Sbjct: 85  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP-DXV 196
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 197 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 106 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 154
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI-KGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE       +  GT
Sbjct: 155 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGT 202
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA-- 604
           A  ++ T ++     +G+G+F  V + +        A K++N  +  A      E EA  
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
            R ++H N++++     SI   G  F  +V+D +  G L E      D +     S    
Sbjct: 84  CRLLKHPNIVRLH---DSISEEG--FHYLVFDLVTGGELFE------DIVAREYYSEADA 132
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLPARPLD 721
            +    +  ++ ++H H    +VH DLKP N+LL          + DFGLA         
Sbjct: 133 SHCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAI-------- 181
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
            V     +  G  GT GY++PE           D+++ G++L
Sbjct: 182 EVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 156
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI-KGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE       +  GT
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGT 204
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 103/406 (25%), Positives = 168/406 (41%), Gaps = 76/406 (18%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 47  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 104
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 105 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 148
Query: 169 LSVL----ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           +S L     L     GN+  +    +  LAN + LE L +  N+   +    LA L+N +
Sbjct: 149 ISALSGLTSLQQLSFGNQVTD----LKPLANLTTLERLDISSNKVSDI--SVLAKLTN-L 201
Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFL 282
            ++    N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQI 255
Query: 283 HGYIP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV 341
               P S             +I+N+     S L   T+L  L L++N+L+ + P      
Sbjct: 256 SNLAPLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP------ 304
Query: 342 TTXXXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
                                I NLKNL  L +  N  S   P  +S+ T L+ +   +N
Sbjct: 305 ---------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
             S     SL  L +I  L    N++S   P  L NL+ +  L L+
Sbjct: 342 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 88  PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 136
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 137 IVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----------T 182
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 84  GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 132
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE        + GT
Sbjct: 133 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGT 180
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 84  GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 132
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE        + GT
Sbjct: 133 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGT 180
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 130
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI-KGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE       +  GT
Sbjct: 131 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGT 178
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++          L    L+L  
Sbjct: 94  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DXV 205
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 206 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G  VAVK L+   +  + +  T  E   L+ ++H N+I ++ +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 620 CSSI----DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            +      +FN V     +   +    L       N+ ++   L+      +   +   +
Sbjct: 86  FTPARSLEEFNDV----YLVTHLMGADL-------NNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +Y+H      ++H DLKPSN+ ++ D    + DFGLA+            T    +G   
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTDDEMAGFVA 180
Query: 736 TVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
           T  Y APE        + T D++S G ++ E+ + R
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F   F+    +   + A K++    L++    +    E    RS+ H++++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                  F   DF  +V +  +  SL E LH+    L     +  +       +    +Y
Sbjct: 88  GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKAL-----TEPEARYYLRQIVLGCQY 136
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKGT 736
           LH +    V+H DLK  N+ L+ D+   +GDFGLA         T VE        + GT
Sbjct: 137 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGT 184
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
             YIAPE  +    S   DV+S G ++  +   + P ++
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 94  PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 142
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 188
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++          L    L+L  
Sbjct: 94  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV 205
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 206 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 102/402 (25%), Positives = 169/402 (42%), Gaps = 69/402 (17%)
Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           QV  ++ +RLG K  D +  L  L  +N   NQ +   P  + N++    I + +N+   
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 99
Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPIXXXXXXXXXXXXXRDNQFIGKMSINFNSLKN 168
             P    ANL NL       N +T   P+             ++   + ++ ++ N++ +
Sbjct: 100 ITPL---ANLTNLTGLTLFNNQITDIDPL-------------KNLTNLNRLELSSNTISD 143
Query: 169 LSVLI-LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
           +S L  L +    + ++N +  +  LAN + LE L +  N+   +    LA L+N + ++
Sbjct: 144 ISALSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTN-LESL 200
Query: 228 DIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGY 285
               N  S   P  LG L +L+ +++ GNQL  IGT    +  L NL  L L +N +   
Sbjct: 201 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNL 254
Query: 286 IP-SSXXXXXXXXXXXXEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTX 344
            P S             +I+N+     S L   T+L  L L++N+L+ + P         
Sbjct: 255 APLSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQLEDISP--------- 300
Query: 345 XXXXXXXXXXXXXXXXXEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
                             I NLKNL  L +  N  S   P  +S+ T L+ +   +N  S
Sbjct: 301 ------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 340
Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNL 446
                SL  L +I  L    N++S   P  L NL+ +  L L
Sbjct: 341 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 378

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 130
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN----------LSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++               L+L  
Sbjct: 131 VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 187 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV 242
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 243 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--LKSFLTECEALRS 607
           +K +  +     +G+G+F  V + +    G+  A K++N  +  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N++++             F  +V+D +  G L E +       E      IQ    
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVV 724
              +  +I Y H +    +VH +LKP N+LL          + DFGLA           +
Sbjct: 113 --QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-----------I 156
Query: 725 ETPSSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           E   S +  G  GT GY++PE       S   D+++ G++L
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--LKSFLTECEALRS 607
           +K +  +     +G+G+F  V + +    G+  A K++N  +  A   +    E    R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N++++             F  +V+D +  G L E +       E      IQ    
Sbjct: 61  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 111
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVV 724
              +  +I Y H +    +VH +LKP N+LL          + DFGLA           +
Sbjct: 112 --QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-----------I 155
Query: 725 ETPSSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           E   S +  G  GT GY++PE       S   D+++ G++L
Sbjct: 156 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--LKSFLTECEALRS 607
           +K +  +     +G+G+F  V + +    G+  A K++N  +  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N++++             F  +V+D +  G L E +       E      IQ    
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVV 724
              +  +I Y H +    +VH +LKP N+LL          + DFGLA           +
Sbjct: 113 --QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA-----------I 156
Query: 725 ETPSSSS--GIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           E   S +  G  GT GY++PE       S   D+++ G++L
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G  VAVK L+   +  + +  T  E   L+ ++H N+I ++ +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 620 CSSI----DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            +      +FN V     +   +    L       N+ ++   L+      +   +   +
Sbjct: 86  FTPARSLEEFNDV----YLVTHLMGADL-------NNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +Y+H      ++H DLKPSN+ ++ D    + DFGLA+            T    +G   
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTDDEMTGYVA 180
Query: 736 TVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRR 770
           T  Y APE        + T D++S G ++ E+ + R
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F     +G GSFG V      E G   A+K+L+  +   LK         R ++  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             ++ +  S   N   +  +V +++  G +   L +      +   S       A  +  
Sbjct: 101 PFLVKLEYSFKDNSNLY--MVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQIVL 152
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
             EYLH      +++ DLKP N+L+D      V DFG AK +  R           +  +
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------TWXL 198
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           S +     +G G  G VF  +  +    VA+K + L    ++K  L E + +R + H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 614 IKIITIC------------SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
           +K+  I             S  + N V    IV ++M+   L   L Q     E   L +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSV---YIVQEYMET-DLANVLEQGPLLEEHARLFM 126
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFL 715
            Q L         ++Y+H      V+H DLKP+N+ ++  D+V  +GDFGLA+ +
Sbjct: 127 YQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+     G     IV +F + G+L  +L    ++          L    L+L  
Sbjct: 96  VNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 152 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV 207
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 208 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F     +G GSFG V      E G   A+K+L+  +   LK         R ++  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             ++ +  S   N   +  +V +++  G +   L +      +   S       A  +  
Sbjct: 101 PFLVKLEYSFKDNSNLY--MVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQIVL 152
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
             EYLH      +++ DLKP N+L+D      V DFG AK +  R           +  +
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------TWXL 198
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F     +G GSFG V      E G   A+K+L+  +   LK         R ++  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             ++ +  S   N   +  +V +++  G +   L +      +   S       A  +  
Sbjct: 101 PFLVKLEYSFKDNSNLY--MVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQIVL 152
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
             EYLH      +++ DLKP N+L+D      V DFG AK +  R           +  +
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------TWXL 198
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 170
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 216
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 87  PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 135
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 136 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 181
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 217

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 556 FSSSNMVGQGSFGTVF--KGIIGEN-GMLVAVKVLN---LMQKGALKSFL-TECEALRSI 608
           F    ++G G++G VF  + I G + G L A+KVL    ++QK        TE + L  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           R    +  +T+  +  F       ++ D++  G L   L Q     E         + I 
Sbjct: 116 RQSPFL--VTLHYA--FQTETKLHLILDYINGGELFTHLSQRERFTE-------HEVQIY 164
Query: 669 I-DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + ++  A+E+LH   K  +++ D+K  N+LLD +    + DFGL+K       + V +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------EFVADET 214
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTG--DVYSFGILLLEMFSRRRP 772
             +    GT+ Y+AP+   G ++      D +S G+L+ E+ +   P
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEM 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           ++G+G++G V+ G    N + +A+K +        +    E    + ++H+N+++ +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI-DVASAIEYLH 679
            S   NG  F  I  + +  GSL   L      L+       QT+      +   ++YLH
Sbjct: 86  GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIGFYTKQILEGLKYLH 139
Query: 680 HHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
            +    +VH D+K  NVL++ +  V  + DFG +K L    ++   ET        GT+ 
Sbjct: 140 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTET------FTGTLQ 188
Query: 739 YIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           Y+APE       G G  A    D++S G  ++EM + + P
Sbjct: 189 YMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    +  
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILG 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           FGLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 102/242 (42%), Gaps = 56/242 (23%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN------------------------- 588
           ++++  + +G+GS+G V       +    A+KVL+                         
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 589 -LMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL 647
            +  +G ++    E   L+ + H N++K++ +   +D    D   +V++ +  G +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPV---- 125
Query: 648 HQNNDKLEVCNLSLI---QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA 704
                 +EV  L  +   Q      D+   IEYLH+     ++H D+KPSN+L+  D   
Sbjct: 126 ------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHI 176
Query: 705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG---DVYSFGI 761
            + DFG++        D ++      S   GT  ++APE  + +    +G   DV++ G+
Sbjct: 177 KIADFGVSNEFKGS--DALL------SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 762 LL 763
            L
Sbjct: 229 TL 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
            GLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 AGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
            GLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 RGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 560 NMVGQGSFGTVFKGII-GENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKI 616
            ++G+G FG V+ G   GE    VA++++++ +  +  LK+F  E  A R  RH N++  
Sbjct: 39  ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           +  C S         AI+    +  +L   +      L+V      +T  IA ++   + 
Sbjct: 95  MGACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVLDVN-----KTRQIAQEIVKGMG 144
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK-- 734
           YLH      ++H DLK  NV  D+  V  + DFGL        +  V++       ++  
Sbjct: 145 YLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGLFS------ISGVLQAGRREDKLRIQ 194
Query: 735 -GTVGYIAPE----YGTGSEA-----SMTGDVYSFGILLLEMFSRRRP 772
            G + ++APE        +E      S   DV++ G +  E+ +R  P
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G++G V K     +G + AVK         +++ +   E  R +   ++      C 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVK--------RIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 622 -SIDFNGVDFK---AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            ++ F G  F+     +   + + SL+++  Q  DK +     ++    IA+ +  A+E+
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALEH 151
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH   K  V+H D+KPSNVL++        DFG++ +L    +D V +   +        
Sbjct: 152 LH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL----VDDVAKDIDAGCKPYXAP 205
Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
             I PE       S+  D++S GI  +E+   R P DS 
Sbjct: 206 ERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSW 243

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLI 614
           F    +VG G++G V+KG   + G L A+KV+++      +    E   L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 615 KIITICSSIDFNGVDFK-AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
                    +  G+D +  +V +F   GS+ + +   N K        I    I  ++  
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 140
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + +LH H    V+H D+K  NVLL  +    + DFG++       LD  V      +  
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTV---GRRNTF 189
Query: 734 KGTVGYIAPEYGTGSE-----ASMTGDVYSFGILLLEM 766
            GT  ++APE     E          D++S GI  +EM
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   +       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFAEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
            ++G G+F  VF       G L A+K +         S   E   L+ I+H N++ +  I
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                +       +V   +  G L + + +     E     +IQ       V SA++YLH
Sbjct: 75  -----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ------QVLSAVKYLH 123
Query: 680 HHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
            +    +VH DLKP N+L    + +    + DFGL+K          +E     S   GT
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----------MEQNGIMSTACGT 170
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGIL 762
            GY+APE       S   D +S G++
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN----------LSLIQ 663
           + ++  C+      +    ++ +F + G+L  +L    ++               L+L  
Sbjct: 85  VNLLGACTKPGGPLM----VITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP-DXV 196
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 197 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 522 GRRRSTDRSFERTTMVEQQFPMISYAKLSKATSE--------FSSSNMVGQGSFGTVFKG 573
           G + +    FER  M           K S + +E        +S    +G G    VF+ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ- 74
Query: 574 IIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK 631
           ++ E   + A+K +NL +     L S+  E   L  ++  +  KII +    D+   D  
Sbjct: 75  VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITD-- 128
Query: 632 AIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG 689
             +Y  M+ G+++   WL +        ++   +  +   ++  A+  +H H    +VH 
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK----GTVGYIAPEYG 745
           DLKP+N L+   M+  + DFG+A  +           P ++S +K    GTV Y+ PE  
Sbjct: 180 DLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 746 TGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSMFHEGLTLH 784
               +S              DV+S G +L  M   + P   + ++   LH
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRNLIKIITIC 620
           +G G+FG V       +G+   +K +N  +    ++    E E L+S+ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
              D++ +    IV +  + G L E +     + +  +   +  L     + +A+ Y H 
Sbjct: 90  E--DYHNM---YIVMETCEGGELLERIVSAQARGKALSEGYVAEL--MKQMMNALAYFHS 142
Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAH----VGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
                VVH DLKP N+L   D   H    + DFGLA+           ++   S+   GT
Sbjct: 143 Q---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELF---------KSDEHSTNAAGT 189
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILL 763
             Y+APE     + +   D++S G+++
Sbjct: 190 ALYMAPEV-FKRDVTFKCDIWSAGVVM 215

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFGLAK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           ++G+G++G V+ G    N + +A+K +        +    E    + ++H+N+++ +   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 71
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI-DVASAIEYLH 679
            S   NG  F  I  + +  GSL   L      L+       QT+      +   ++YLH
Sbjct: 72  GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIGFYTKQILEGLKYLH 125
Query: 680 HHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
            +    +VH D+K  NVL++ +  V  + DFG +K L    ++   ET        GT+ 
Sbjct: 126 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTET------FTGTLQ 174
Query: 739 YIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           Y+APE       G G  A    D++S G  ++EM + + P
Sbjct: 175 YMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 210

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +   +++G G+F  V          LVA+K +     +G   S   E   L  I+H N++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +  I  S    G  +  ++   +  G L + + +     E     LI        V  A
Sbjct: 80  ALDDIYES---GGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDA 128
Query: 675 IEYLHHHCKPPVVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS- 730
           ++YLH      +VH DLKP N+L   LD D    + DFGL+K          +E P S  
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----------MEDPGSVL 175
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
           S   GT GY+APE       S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G+ VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
            GLA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 GGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F    ++G+G+FG V    +     + A+K+LN  +   LK   T C      R    
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE--MLKRAETAC-----FREERD 126
Query: 614 IKIITICSSID-----FNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNI 667
           + +   C  I      F   +   +V D+   G L   L +  DKL E      I  + +
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           AID   +I  LH+      VH D+KP NVLLD +    + DFG    L      TV    
Sbjct: 187 AID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTV---- 231
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASM-----TGDVYSFGILLLEMFSRRRP 772
             SS   GT  YI+PE     E  M       D +S G+ + EM     P
Sbjct: 232 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ +M
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQM 231

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F    ++G+G+FG V    +     + A+K+LN  +   LK   T C      R    
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE--MLKRAETAC-----FREERD 142
Query: 614 IKIITICSSID-----FNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNI 667
           + +   C  I      F   +   +V D+   G L   L +  DKL E      I  + +
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           AID   +I  LH+      VH D+KP NVLLD +    + DFG    L      TV    
Sbjct: 203 AID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTV---- 247
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASM-----TGDVYSFGILLLEMFSRRRP 772
             SS   GT  YI+PE     E  M       D +S G+ + EM     P
Sbjct: 248 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +   +++G G+F  V          LVA+K +     +G   S   E   L  I+H N++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +  I  S    G  +  ++   +  G L + + +     E     LI        V  A
Sbjct: 80  ALDDIYES---GGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDA 128
Query: 675 IEYLHHHCKPPVVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS- 730
           ++YLH      +VH DLKP N+L   LD D    + DFGL+K          +E P S  
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----------MEDPGSVL 175
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
           S   GT GY+APE       S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 96  PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFXEPHARFYAAQ 144
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 145 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 190
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 226

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKI 616
           +S ++G+G++  V   +  +NG   AVK++      +      E E L   + ++N++++
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           I       F       +V++ +Q GS+   + +        + +  +   +  DVA+A++
Sbjct: 77  IEF-----FEDDTRFYLVFEKLQGGSILAHIQKQK------HFNEREASRVVRDVAAALD 125
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVG--DFGLAKFLPARPLDTVVETPSSSSGI 733
           +LH      + H DLKP N+L +  + V+ V   DF L   +      T + TP  ++  
Sbjct: 126 FLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 734 KGTVGYIAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
            G+  Y+APE         +      D++S G++L  M S   P
Sbjct: 183 -GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 170
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK               ++
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----------RVKGAT 216
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 217 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 522 GRRRSTDRSFERTTMVEQQFPMISYAKLSKATSE--------FSSSNMVGQGSFGTVFKG 573
           G + +    FER  M           K S + +E        +S    +G G    VF+ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ- 74
Query: 574 IIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK 631
           ++ E   + A+K +NL +     L S+  E   L  ++  +  KII +    D+   D  
Sbjct: 75  VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITD-- 128
Query: 632 AIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG 689
             +Y  M+ G+++   WL +        ++   +  +   ++  A+  +H H    +VH 
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK----GTVGYIAPEYG 745
           DLKP+N L+   M+  + DFG+A  +           P ++S +K    GTV Y+ PE  
Sbjct: 180 DLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 746 TGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSMFHEGLTLH 784
               +S              DV+S G +L  M   + P   + ++   LH
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +   +++G G+F  V          LVA+K +     +G   S   E   L  I+H N++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +  I  S    G  +  ++   +  G L + + +     E     LI        V  A
Sbjct: 80  ALDDIYES---GGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDA 128
Query: 675 IEYLHHHCKPPVVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS- 730
           ++YLH      +VH DLKP N+L   LD D    + DFGL+K          +E P S  
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----------MEDPGSVL 175
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
           S   GT GY+APE       S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFGLAK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+      +    ++ +F + G+L  +L    ++          L    L+L  
Sbjct: 85  VNLLGACTKPGGPLM----VITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV 196
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 197 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +   +++G G+F  V          LVA+K +     +G   S   E   L  I+H N++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            +  I  S    G  +  ++   +  G L + + +     E     LI        V  A
Sbjct: 80  ALDDIYES---GGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDA 128
Query: 675 IEYLHHHCKPPVVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS- 730
           ++YLH      +VH DLKP N+L   LD D    + DFGL+K          +E P S  
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----------MEDPGSVL 175
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
           S   GT GY+APE       S   D +S G++
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 556 FSSSNMVGQGSFGTVF--KGIIGEN-GMLVAVKVLN--LMQKGALKSFLTECEA--LRSI 608
           F    ++G+G +G VF  + + G N G + A+KVL   ++ + A  +  T+ E   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +H  ++ +I       F       ++ +++  G L   L +    +E      +  +++A
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           +         H H K  +++ DLKP N++L+H     + DFGL K          +   +
Sbjct: 134 LG--------HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCK--------ESIHDGT 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +    GT+ Y+APE    S  +   D +S G L+ +M +   P
Sbjct: 177 VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 555 EFSSSNM-----VGQGSFGTVFK----GIIGENGML-VAVKVLNLMQKGALK-SFLTECE 603
           EF  +N+     +G G+FG V +    G+  E+ +L VAVK+L        K + ++E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 604 ALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVC---- 657
            +  + +H N++ ++  C+     G     ++ ++   G L  +L +     LE      
Sbjct: 102 IMSHLGQHENIVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 658 -----NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
                 LS    L+ +  VA  + +L        +H D+   NVLL +  VA +GDFGLA
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 713 KFLPARPLDTVVETPSSSSGIKGT----VGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           + +             S+  +KG     V ++APE       ++  DV+S+GILL E+FS
Sbjct: 214 RDI----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 562 VGQGSFGTVFKGI---IGENGMLVAVKVLNLMQKGAL----KSFLTECEALRSI-RHRNL 613
           +G+G+FG V +     I +      V V  ++++GA     ++ ++E + L  I  H N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQ 663
           + ++  C+      +    ++ +F + G+L  +L    ++          L    L+L  
Sbjct: 85  VNLLGACTKPGGPLM----VITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   P D V
Sbjct: 141 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYV 196
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                     +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 197 -----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 94  PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFXEPHARFYAAQ 142
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 188
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 539 QQFPMISYAKLSKATSE----FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA 594
           Q+ P     +L+K   E    + + + VG G++G+V      + G  VAVK L+   +  
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 595 LKSFLT--ECEALRSIRHRNLIKIITICSSI----DFNGVDFKAIVYDFMQNGSLEEWLH 648
           + +  T  E   L+ ++H N+I ++ + +      +FN V     +   +    L     
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV----YLVTHLMGADL----- 113
Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD 708
             N+ ++   L+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMF 767
           F LA+            T    +G   T  Y APE        + T D++S G ++ E+ 
Sbjct: 169 FYLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 768 SRR 770
           + R
Sbjct: 218 TGR 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 47/250 (18%)
Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFL-------TECEALRSIRHR 611
           S+++GQG+   VF+G   + G L A+KV N +      SFL        E E L+ + H+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNI------SFLRPVDVQMREFEVLKKLNHK 67
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++K+  I           K ++ +F   GSL   L + ++      L   + L +  DV
Sbjct: 68  NIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDV 121
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLPARPLDTVVETP 727
              + +L  +    +VH ++KP N++     D   V  + DFG A+ L         E  
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDD 169
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
                + GT  Y+ P            D+Y   +L  +   +   T  ++  G+T +  +
Sbjct: 170 EQFVXLYGTEEYLHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 788 KMVLPEKVME 797
              LP +  E
Sbjct: 218 TGSLPFRPFE 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 556 FSSSNMVGQGSFGTVF--KGIIGEN-GMLVAVKVLN--LMQKGALKSFLTECEA--LRSI 608
           F    ++G+G +G VF  + + G N G + A+KVL   ++ + A  +  T+ E   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +H  ++ +I       F       ++ +++  G L   L +    +E      +  +++A
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           +         H H K  +++ DLKP N++L+H     + DFGL K          +   +
Sbjct: 134 LG--------HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCK--------ESIHDGT 176
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +    GT+ Y+APE    S  +   D +S G L+ +M +   P
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G++G+V K +   +G ++AVK         ++S + E E  + +   +++   + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVK--------RIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL-------NIAIDVASA 674
            I    V F   ++         E +  + DK      S++  +        I +    A
Sbjct: 82  YI----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           + +L  + K  ++H D+KPSN+LLD      + DFG++  L    +D++ +T  +     
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDA----- 186
Query: 735 GTVGYIAPEYGTGSEASMTG-----DVYSFGILLLEMFSRRRP 772
           G   Y+APE    S AS  G     DV+S GI L E+ + R P
Sbjct: 187 GCRPYMAPERIDPS-ASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRH 610
           T E+     +G+G+F  V + +    G   A K++N  +  A      E EA   R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++++     SI   G  F  +V+D +  G L E         ++         + +  
Sbjct: 63  PNIVRLH---DSISEEG--FHYLVFDLVTGGELFE---------DIVAREYYSEADASHC 108
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +   +E ++H     +VH DLKP N+LL          + DFGLA          V    
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAI--------EVQGDQ 160
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
            +  G  GT GY++PE           D+++ G++L
Sbjct: 161 QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 122 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFXEPHARFYAAQ 170
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 216
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 47/250 (18%)
Query: 559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFL-------TECEALRSIRHR 611
           S+++GQG+   VF+G   + G L A+KV N +      SFL        E E L+ + H+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNI------SFLRPVDVQMREFEVLKKLNHK 67
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++K+  I           K ++ +F   GSL   L + ++      L   + L +  DV
Sbjct: 68  NIVKLFAIEEE---TTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDV 121
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLPARPLDTVVETP 727
              + +L  +    +VH ++KP N++     D   V  + DFG A+ L         E  
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---------EDD 169
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
                + GT  Y+ P            D+Y   +L  +   +   T  ++  G+T +  +
Sbjct: 170 EQFVSLYGTEEYLHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 788 KMVLPEKVME 797
              LP +  E
Sbjct: 218 TGSLPFRPFE 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRH 610
           T E+     +G+G+F  V + +    G   A K++N  +  A      E EA   R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++++     SI   G  F  +V+D +  G L E         ++         + +  
Sbjct: 63  PNIVRLH---DSISEEG--FHYLVFDLVTGGELFE---------DIVAREYYSEADASHC 108
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +   +E ++H     +VH DLKP N+LL          + DFGLA          V    
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAI--------EVQGDQ 160
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
            +  G  GT GY++PE           D+++ G++L
Sbjct: 161 QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNL 613
           +S    +G G    VF+ ++ E   + A+K +NL +     L S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            KII +    D+   D    +Y  M+ G+++   WL +        ++   +  +   ++
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 120
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +           P ++S
Sbjct: 121 LEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTS 166
Query: 732 GIK----GTVGYIAPEYGTGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSM 776
            +K    GTV Y+ PE      +S              DV+S G +L  M   + P   +
Sbjct: 167 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 226
Query: 777 FHEGLTLH 784
            ++   LH
Sbjct: 227 INQISKLH 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHR 611
           T  +     +G GS+    + I     M  AVK+++  ++   +    E E L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N+I +  +     ++   +  +V + M+ G L + +      L     S  +   +   +
Sbjct: 77  NIITLKDV-----YDDGKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTI 125
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHD----MVAHVGDFGLAKFLPARPLDTVVETP 727
              +EYLH      VVH DLKPSN+L   +        + DFG AK L  R  + ++ TP
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTP 180
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                   T  ++APE           D++S G+LL  M +   P
Sbjct: 181 CY------TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+AP        +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEM 231

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 97/245 (39%), Gaps = 29/245 (11%)
Query: 537 VEQQFPMISYAKLSKATSE-FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
           +E   P  S  K  +   E F    ++G+G+FG V    +     + A+K+LN  +   L
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--ML 113
Query: 596 KSFLTEC-EALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL 654
           K   T C    R +      K IT      F   +   +V D+   G L   L +  D+L
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLHYA-FQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 655 --EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
             E+    L + + IAID    + Y         VH D+KP N+L+D +    + DFG  
Sbjct: 173 PEEMARFYLAEMV-IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASM-----TGDVYSFGILLLEMF 767
                  L  + +    SS   GT  YI+PE     E          D +S G+ + EM 
Sbjct: 223 -------LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 768 SRRRP 772
               P
Sbjct: 276 YGETP 280

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNL 613
           +S    +G G    VF+ ++ E   + A+K +NL +     L S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            KII +    D+   D    +Y  M+ G+++   WL +        ++   +  +   ++
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 116
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +           P ++S
Sbjct: 117 LEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTS 162
Query: 732 GIK----GTVGYIAPEYGTGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSM 776
            +K    GTV Y+ PE      +S              DV+S G +L  M   + P   +
Sbjct: 163 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 222
Query: 777 FHEGLTLH 784
            ++   LH
Sbjct: 223 INQISKLH 230

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 24/229 (10%)
Query: 536 MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
           + +Q +P     K       +     +G G+FG V +      G   A K +    +   
Sbjct: 33  IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 92
Query: 596 KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           ++   E + +  +RH  L+ +        F   +   ++Y+FM  G L E +   ++K+ 
Sbjct: 93  ETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKM- 146
Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLAK 713
               S  + +     V   + ++H +     VH DLKP N++        +   DFGL  
Sbjct: 147 ----SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
            L  +          S     GT  + APE   G       D++S G+L
Sbjct: 200 HLDPK---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 102 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFXEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 24/229 (10%)
Query: 536 MVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL 595
           + +Q +P     K       +     +G G+FG V +      G   A K +    +   
Sbjct: 139 IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 596 KSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           ++   E + +  +RH  L+ +        F   +   ++Y+FM  G L E +   ++K+ 
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKM- 252
Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLAK 713
               S  + +     V   + ++H +     VH DLKP N++        +   DFGL  
Sbjct: 253 ----SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
            L  +          S     GT  + APE   G       D++S G+L
Sbjct: 306 HLDPK---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNL 613
           +S    +G G    VF+ ++ E   + A+K +NL +     L S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            KII +    D+   D    +Y  M+ G+++   WL +        ++   +  +   ++
Sbjct: 69  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 117
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +           P ++S
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTS 163
Query: 732 GIK----GTVGYIAPEYGTGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSM 776
            +K    GTV Y+ PE      +S              DV+S G +L  M   + P   +
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 777 FHEGLTLH 784
            ++   LH
Sbjct: 224 INQISKLH 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 22/213 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            +F     +G GSFG V      E G   A+K+L+  +   LK         R  +  N 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             ++ +  S   N   +  +V ++   G +   L +      +   S       A  +  
Sbjct: 102 PFLVKLEFSFKDNSNLY--MVLEYAPGGEMFSHLRR------IGRFSEPHARFYAAQIVL 153
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
             EYLH      +++ DLKP N+L+D      V DFG AK +  R           +  +
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----------TWXL 199
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 46/248 (18%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNL 613
           +S    +G G    VF+ ++ E   + A+K +NL +     L S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            KII +    D+   D    +Y  M+ G+++   WL +        ++   +  +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +           P ++S
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTS 182
Query: 732 GIK----GTVGYIAPEYGTGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSM 776
            +K    GTV Y+ PE      +S              DV+S G +L  M   + P   +
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 777 FHEGLTLH 784
            ++   LH
Sbjct: 243 INQISKLH 250

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
           +    +     +G+G F   ++    +   + A KV+    L++    +   TE    +S
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + +++          F   DF  +V +  +  SL E LH+    +            I
Sbjct: 83  LDNPHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI 136
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE-T 726
                  ++YLH++    V+H DLK  N+ L+ DM   +GDFGLA         T +E  
Sbjct: 137 -----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA---------TKIEFD 179
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                 + GT  YIAPE       S   D++S G +L  +   + P ++
Sbjct: 180 GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 522 GRRRSTDRSFERTTMVEQQFPMISYAKLSKATSE--------FSSSNMVGQGSFGTVFKG 573
           G + +    FER  M           K S + +E        +S    +G G    VF+ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ- 74
Query: 574 IIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK 631
           ++ E   + A+K +NL +     L S+  E   L  ++  +  KII +    D+   D  
Sbjct: 75  VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITD-- 128
Query: 632 AIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG 689
             +Y  M+ G+++   WL +        ++   +  +   ++  A+  +H H    +VH 
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK----GTVGYIAPEYG 745
           DLKP+N L+   M+  + DFG+A  +           P ++S +K    G V Y+ PE  
Sbjct: 180 DLKPANFLIVDGMLKLI-DFGIANQM----------QPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 746 TGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSMFHEGLTLH 784
               +S              DV+S G +L  M   + P   + ++   LH
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIR-HRNLIK 615
             +++G+G+   V   I        AVK++   Q G ++S    E E L   + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +I       F   D   +V++ M+ GS+   +H+        + + ++   +  DVASA+
Sbjct: 76  LIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASAL 124
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVG--DFGLAKFLPARPLDTVVETPSSSSG 732
           ++LH+     + H DLKP N+L +H + V+ V   DFGL   +      + + TP   + 
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP 181
Query: 733 IKGTVGYIAPEY--GTGSEASMTG---DVYSFGILLLEMFSRRRP 772
             G+  Y+APE       EAS+     D++S G++L  + S   P
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
           +    +     +G+G F   ++    +   + A KV+    L++    +   TE    +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + +++          F   DF  +V +  +  SL E LH+    +            I
Sbjct: 99  LDNPHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI 152
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE-T 726
                  ++YLH++    V+H DLK  N+ L+ DM   +GDFGLA         T +E  
Sbjct: 153 -----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA---------TKIEFD 195
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                 + GT  YIAPE       S   D++S G +L  +   + P ++
Sbjct: 196 GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 24/222 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F+   ++G+GSFG V          L AVK+L    ++Q   ++  + E   L     
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
              +  +  C    F  +D    V +++  G L   + Q      V        +  A +
Sbjct: 80  PPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAE 129
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +A  + +L       +++ DLK  NV+LD +    + DFG+ K       D V     ++
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV-----TT 178
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               GT  YIAPE         + D ++FG+LL EM + + P
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V +++  G +   L +      +   S       A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+L+D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT   +APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
           +    +     +G+G F   ++    +   + A KV+    L++    +   TE    +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + +++          F   DF  +V +  +  SL E LH+    +            I
Sbjct: 99  LDNPHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI 152
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE-T 726
                  ++YLH++    V+H DLK  N+ L+ DM   +GDFGLA         T +E  
Sbjct: 153 -----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA---------TKIEFD 195
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                 + GT  YIAPE       S   D++S G +L  +   + P ++
Sbjct: 196 GERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
           +    +     +G+G F   ++    +   + A KV+    L++    +   TE    +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + +++          F   DF  +V +  +  SL E LH+    +            I
Sbjct: 99  LDNPHVVGFHGF-----FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI 152
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE-T 726
                  ++YLH++    V+H DLK  N+ L+ DM   +GDFGLA         T +E  
Sbjct: 153 -----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA---------TKIEFD 195
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
                 + GT  YIAPE       S   D++S G +L  +   + P ++
Sbjct: 196 GERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 35/272 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            ++     +G+G +  VF+ I   N   V VK+L  ++K  +K  +   E LR       
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRG-----G 91
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             IIT+   +        A+V++ + N   ++ L+Q         L+         ++  
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQ--------TLTDYDIRFYMYEILK 142
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA-HVGDFGLAKFL-PARPLDTVVETPSSSS 731
           A++Y H      ++H D+KP NV++DH+     + D+GLA+F  P +  +  V    +S 
Sbjct: 143 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASR 195
Query: 732 GIKGT---VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
             KG    V Y   +Y          D++S G +L  M  R+ P          L   +K
Sbjct: 196 YFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 247
Query: 789 MVLPEKVMEIVDP-SLLLEVRANNSMSRGGER 819
           ++  E + + +D  ++ L+ R N+ + R   +
Sbjct: 248 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 279

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 102 PFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L K+        F       +V ++   G +   L +      +   S       A  
Sbjct: 102 PFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFSEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKI 616
           S + ++G G FG V K      G+ +A K++        +    E   +  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIAIDVASA 674
                   F   +   +V +++  G L        D++  E  NL+ + T+     +   
Sbjct: 152 YDA-----FESKNDIVLVMEYVDGGEL-------FDRIIDESYNLTELDTILFMKQICEG 199
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLA-KFLPARPLDTVVETPSSSS 731
           I ++H      ++H DLKP N+L  +     +   DFGLA ++ P   L     TP    
Sbjct: 200 IRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE--- 253
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                  ++APE       S   D++S G++   + S   P
Sbjct: 254 -------FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           F   + +G GS+G VFK    E+G L AVK          +        L  +     + 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
               C  ++    +   I+Y  +Q       L Q+ +     +L   Q      D   A+
Sbjct: 115 QHPCCVRLE-QAWEEGGILY--LQTELCGPSLQQHCEAWGA-SLPEAQVWGYLRDTLLAL 170
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG--I 733
            +LH      +VH D+KP+N+ L       +GDFGL           +VE  ++ +G   
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL-----------LVELGTAGAGEVQ 216
Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           +G   Y+APE   GS  +   DV+S G+ +LE+
Sbjct: 217 EGDPRYMAPELLQGSYGT-AADVFSLGLTILEV 248

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 33/225 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT------E 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +  ++      E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHHNVITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
                 +E       I GT  ++APE        +  D++S G++
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT------E 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +  ++      E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHHNVITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 +E       I GT  ++APE        +  D++S G++   + S   P
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT------E 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +  ++      E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHHNVITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 +E       I GT  ++APE        +  D++S G++   + S   P
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT------E 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +  ++      E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHHNVITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IKQ------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 +E       I GT  ++APE        +  D++S G++   + S   P
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++  N +G+GS+G V   +     +  A K +       +  F  E E ++S+ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 616 II-TICSSIDFNGVDFKAIVYDFMQNGSL-EEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  T   + D        +V +    G L E  +H+      V   S      I  DV S
Sbjct: 88  LYETFEDNTDI------YLVMELCTGGELFERVVHKR-----VFRES--DAARIMKDVLS 134
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGL-AKFLPARPLDTVVETPS- 728
           A+ Y H   K  V H DLKP N L      D    + DFGL A+F P + + T V TP  
Sbjct: 135 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 191
Query: 729 -SSSGIKGTVGYIAPEYGTG 747
            S   ++G  G    E+  G
Sbjct: 192 VSPQVLEGLYGPECDEWSAG 211

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 24/222 (10%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++F+   ++G+GSFG V          L AVK+L    ++Q   ++  + E   L     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
              +  +  C    F  +D    V +++  G L   + Q      V        +  A +
Sbjct: 401 PPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAE 450
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +A  + +L       +++ DLK  NV+LD +    + DFG+ K       D V     ++
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV-----TT 499
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               GT  YIAPE         + D ++FG+LL EM + + P
Sbjct: 500 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-----FLTECEALRSIRH 610
           +     +G G++G V   ++  + +    + + +++K ++ +      L E   L+ + H
Sbjct: 39  YQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSL-EEWLHQNNDKLEVCNLSLIQTLNIAI 669
            N++K+        F       +V +  + G L +E +H+          + +    I  
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHR-------MKFNEVDAAVIIK 143
Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVET 726
            V S + YLH H    +VH DLKP N+LL   + D +  + DFGL+          V E 
Sbjct: 144 QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS---------AVFEN 191
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL 764
                   GT  YIAPE     +     DV+S G++L 
Sbjct: 192 QKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT------E 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +  ++      E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHHNVITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 +E       I GT  ++APE        +  D++S G++   + S   P
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 556 FSSSNMVGQGSFGT-VFKGIIGENGMLVAVKVLNLMQKGALKSFLTEC--------EALR 606
           F   +++G G+ GT V++G+     +             A+K  L EC        + LR
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDV-------------AVKRILPECFSFADREVQLLR 72
Query: 607 -SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
            S  H N+I+    C+  D     F+ I  +     +L+E++ Q +      +L L + +
Sbjct: 73  ESDEHPNVIRYF--CTEKDRQ---FQYIAIELCA-ATLQEYVEQKD----FAHLGL-EPI 121
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD----HDMV-AHVGDFGLAKFLPARPL 720
            +     S + +LH      +VH DLKP N+L+     H  + A + DFGL K      L
Sbjct: 122 TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK-----KL 173
Query: 721 DTVVETPSSSSGIKGTVGYIAPEY---GTGSEASMTGDVYSFGILLLEMFS 768
                + S  SG+ GT G+IAPE          + T D++S G +   + S
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 26/238 (10%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GSFG V +    + G   AVK + L    A +  L  C  L S R      I+ +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPR------IVPLYG 152
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           ++      +  I  + ++ GSL + + +       C L   + L         +EYLH  
Sbjct: 153 AVREG--PWVNIFMELLEGGSLGQLVKEQG-----C-LPEDRALYYLGQALEGLEYLHSR 204
Query: 682 CKPPVVHGDLKPSNVLLDHDMV-AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
               ++HGD+K  NVLL  D   A + DFG A  L  +P D + ++  +   I GT  ++
Sbjct: 205 ---RILHGDVKADNVLLSSDGSHAALCDFGHAVCL--QP-DGLGKSLLTGDYIPGTETHM 258
Query: 741 APEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI 798
           APE   G       DV+S   ++L M +   P    F   L L   S+   P  V EI
Sbjct: 259 APEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASE---PPPVREI 313

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 552 ATSEFSSSNMVGQGSFGTVF------KGIIGENGMLVAVKV-----------LNLMQKGA 594
           A  E+     +GQG FG ++         +G +   V VKV           L   Q+ A
Sbjct: 33  AKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCV-VKVEPSDNGPLFTELKFYQRAA 91
Query: 595 LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL 654
               + +    R +++  + K        D NG  ++ ++ D    GS  + +++ N K 
Sbjct: 92  KPEQIQKWIRTRKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK- 147
Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGL 711
                S    L +++ +   +EY+H H     VHGD+K SN+LL++   D V  V D+GL
Sbjct: 148 ---RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLV-DYGL 200
Query: 712 A-KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           A ++ P        E P       GT+ + + +   G   S  GD+   G  +++  +  
Sbjct: 201 AYRYCPEGVHKEYKEDPKRCHD--GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 771 RPTDSMFHEGLTLHEFSKMVLPEKVMEIVD 800
            P +    +   + + SK+   E +  ++D
Sbjct: 259 LPWEDNLKDPKYVRD-SKIRYRENIASLMD 287

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 552 ATSEFSSSNMVGQGSFGTVF------KGIIGENGMLVAVKV-----------LNLMQKGA 594
           A  E+     +GQG FG ++         +G +   V VKV           L   Q+ A
Sbjct: 33  AKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCV-VKVEPSDNGPLFTELKFYQRAA 91
Query: 595 LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL 654
               + +    R +++  + K        D NG  ++ ++ D    GS  + +++ N K 
Sbjct: 92  KPEQIQKWIRTRKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK- 147
Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGL 711
                S    L +++ +   +EY+H H     VHGD+K SN+LL++   D V ++ D+GL
Sbjct: 148 ---RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQV-YLVDYGL 200
Query: 712 A-KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           A ++ P        E P       GT+ + + +   G   S  GD+   G  +++  +  
Sbjct: 201 AYRYCPEGVHKEYKEDPKRCHD--GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 771 RPTDSMFHEGLTLHEFSKMVLPEKVMEIVD 800
            P +    +   + + SK+   E +  ++D
Sbjct: 259 LPWEDNLKDPKYVRD-SKIRYRENIASLMD 287

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L+K+        F       +V ++   G +   L +      +           A  
Sbjct: 101 PFLVKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFXEPHARFYAAQ 149
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 195
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRN---LIKI 616
           VG G++G+V           VAVK L+   +  + +  T  E   L+ ++H N   L+ +
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            T  +SI+    DF  +       G+        N+ ++   LS      +   +   ++
Sbjct: 88  FTPATSIE----DFSEVYLVTTLMGA------DLNNIVKCQALSDEHVQFLVYQLLRGLK 137
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y+H      ++H DLKPSNV ++ D    + DFGLA+           +     +G   T
Sbjct: 138 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QADEEMTGYVAT 183
Query: 737 VGYIAPEYG-TGSEASMTGDVYSFGILLLEMFS 768
             Y APE        + T D++S G ++ E+  
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 216

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++  N +G+GS+G V   +     +  A K +       +  F  E E ++S+ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 616 II-TICSSIDFNGVDFKAIVYDFMQNGSL-EEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +  T   + D        +V +    G L E  +H+      V   S      I  DV S
Sbjct: 71  LYETFEDNTDI------YLVMELCTGGELFERVVHKR-----VFRES--DAARIMKDVLS 117
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGL-AKFLPARPLDTVVETPS- 728
           A+ Y H   K  V H DLKP N L      D    + DFGL A+F P + + T V TP  
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 174
Query: 729 -SSSGIKGTVGYIAPEYGTG 747
            S   ++G  G    E+  G
Sbjct: 175 VSPQVLEGLYGPECDEWSAG 194

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P D V          +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 247 P-DYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG--ALKSFLTECEALRSIRHRNL 613
           +S    +G G    VF+ ++ E   + A+K +NL +     L S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLE--EWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            KII +    D+   D    +Y  M+ G+++   WL +        ++   +  +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +       V ++     
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQV--- 189
Query: 732 GIKGTVGYIAPEYGTGSEASMTG-----------DVYSFGILLLEMFSRRRPTDSMFHEG 780
              GTV Y+ PE      +S              DV+S G +L  M   + P   + ++ 
Sbjct: 190 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 781 LTLH 784
             LH
Sbjct: 247 SKLH 250

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P D V          +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 245 P-DYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTE----CEALRSIRHRNLIKII 617
           VG+GSFG V +    + G   AVK + L      + F  E    C  L S R      I+
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR------IV 113
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +  ++      +  I  + ++ GSL + + Q         L   + L         +EY
Sbjct: 114 PLYGAVREG--PWVNIFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEY 165
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           LH      ++HGD+K  NVLL  D   A + DFG A  L  +P D + ++  +   I GT
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL--QP-DGLGKSLLTGDYIPGT 219
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
             ++APE   G       D++S   ++L M +   P    F   L L
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 1/87 (1%)
Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSS 424
           L+NL+ LDIS         G  +  +SLE +KM  NSF  +  P +   L+++  LDLS 
Sbjct: 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 503
Query: 425 NKLSGQIPKYLENLSFLEYLNLSYNHF 451
            +L    P    +LS L+ LN+S+N+F
Sbjct: 504 CQLEQLSPTAFNSLSSLQVLNMSHNNF 530

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 1/87 (1%)
Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSS 424
           L+NL+ LDIS         G  +  +SLE +KM  NSF  +  P +   L+++  LDLS 
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 425 NKLSGQIPKYLENLSFLEYLNLSYNHF 451
            +L    P    +LS L+ LN+S+N+F
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNF 506

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKIITI 619
           +G+G+F  V + +    G   A K++N  +  A      E EA   R ++H N++++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH-- 87
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             SI   G  +  +++D +  G L E +       E      IQ +  A+        LH
Sbjct: 88  -DSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--------LH 136
Query: 680 HHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVVETPSSSS-GIKG 735
            H +  VVH DLKP N+LL   +      + DFGLA           VE    +  G  G
Sbjct: 137 CH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA---------IEVEGEQQAWFGFAG 186
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILL 763
           T GY++PE           D+++ G++L
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVIL 214

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 365 NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLS 423
           +L+NL+ LDIS         G  +  +SLE +KM  NSF  +  P +   L+++  LDLS
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHF 451
             +L    P    +LS L+ LN+S+N+F
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNF 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P D V          +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 252 P-DYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +   
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P D V          +  + ++APE       ++  DV+SFG+LL E+FS
Sbjct: 254 P-DYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRN---LIKI 616
           VG G++G+V           VAVK L+   +  + +  T  E   L+ ++H N   L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            T  +SI+    DF  +       G+        N+ ++   LS      +   +   ++
Sbjct: 96  FTPATSIE----DFSEVYLVTTLMGA------DLNNIVKCQALSDEHVQFLVYQLLRGLK 145
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y+H      ++H DLKPSNV ++ D    + DFGLA+           +     +G   T
Sbjct: 146 YIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----------QADEEMTGYVAT 191
Query: 737 VGYIAPEYG-TGSEASMTGDVYSFGILLLEMFS 768
             Y APE        + T D++S G ++ E+  
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTE----CEALRSIRHRNLIKII 617
           VG+GSFG V +    + G   AVK + L      + F  E    C  L S R      I+
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR------IV 129
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +  ++      +  I  + ++ GSL + + Q         L   + L         +EY
Sbjct: 130 PLYGAVREG--PWVNIFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEY 181
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           LH      ++HGD+K  NVLL  D   A + DFG A  L  +P D + ++  +   I GT
Sbjct: 182 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL--QP-DGLGKSLLTGDYIPGT 235
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
             ++APE   G       D++S   ++L M +   P    F   L L
Sbjct: 236 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS------FLTECEALR 606
           +  +     +G G++G V   ++ ++ +  A + + +++K ++ +       L E   L+
Sbjct: 20  SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSL--EEWLHQNNDKLEVCNLSLIQT 664
            + H N++K+        F       +V +  + G L  E  L Q          S +  
Sbjct: 77  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQK--------FSEVDA 123
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLD 721
             I   V S   YLH H    +VH DLKP N+LL+    D +  + DFGL+         
Sbjct: 124 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF------ 174
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
              E         GT  YIAPE     +     DV+S G++L
Sbjct: 175 ---EVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 637 FMQNGSL---EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP 693
           F ++ SL   EE   +++D      +++   ++ +  VA  +E+L        +H DL  
Sbjct: 173 FQEDKSLSDVEE--EEDSDGFYKEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAA 227
Query: 694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT 753
            N+LL  + V  + DFGLA+ +   P D V          +  + ++APE       S  
Sbjct: 228 RNILLSENNVVKICDFGLARDIYKNP-DYV-----RKGDTRLPLKWMAPESIFDKIYSTK 281
Query: 754 GDVYSFGILLLEMFS 768
            DV+S+G+LL E+FS
Sbjct: 282 SDVWSYGVLLWEIFS 296

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 33/225 (14%)
Query: 548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK------SFLTE 601
           K  K    +     +G G F  V K      G+  A K +   Q  A +          E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 602 CEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              LR + H N+I +  +      N  D   ++ + +  G L ++L Q     E    S 
Sbjct: 66  VSILRQVLHPNIITLHDVYE----NRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLPA 717
           I+       +   + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     
Sbjct: 121 IK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---- 167
Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL 762
                 +E       I GT  ++APE        +  D++S G++
Sbjct: 168 -----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GSFG V +    + G   AVK + L    A +  L  C  L S R      I+ +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPR------IVPLYG 133
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           ++      +  I  + ++ GSL + + +       C L   + L         +EYLH  
Sbjct: 134 AVREG--PWVNIFMELLEGGSLGQLVKEQG-----C-LPEDRALYYLGQALEGLEYLHSR 185
Query: 682 CKPPVVHGDLKPSNVLLDHDMV-AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
               ++HGD+K  NVLL  D   A + DFG A  L  +P D + +   +   I GT  ++
Sbjct: 186 ---RILHGDVKADNVLLSSDGSHAALCDFGHAVCL--QP-DGLGKDLLTGDYIPGTETHM 239
Query: 741 APEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI 798
           APE   G       DV+S   ++L M +   P    F   L L   S+   P  V EI
Sbjct: 240 APEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASE---PPPVREI 294

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 105/249 (42%), Gaps = 38/249 (15%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F    ++G+G+F  V    + + G + A+K++N   ++++G +  F  E + L +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--EVCNLSLIQTLNIA 668
           R + ++        F   ++  +V ++   G L   L +  +++  E+    L + + +A
Sbjct: 121 RWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV-MA 174
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           ID    + Y         VH D+KP N+LLD      + DFG    L A   D  V +  
Sbjct: 175 IDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRA---DGTVRSLV 222
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTG-------DVYSFGILLLEMFSRRRPTDSMFHEGL 781
           +     GT  Y++PE                  D ++ G+   EMF  + P    F+   
Sbjct: 223 AV----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYADS 274
Query: 782 TLHEFSKMV 790
           T   + K+V
Sbjct: 275 TAETYGKIV 283

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 28/216 (12%)
Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSF---LTECEALRSIRH 610
            +F     +G GSFG V      E G   A+K+L+  +   LK     L E   L+++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L K+        F       +V ++   G +   L +      +           A  
Sbjct: 102 PFLTKL-----EFSFKDNSNLYMVMEYAPGGEMFSHLRR------IGRFXEPHARFYAAQ 150
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +    EYLH      +++ DLKP N+++D      V DFG AK +  R           +
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----------T 196
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             + GT  Y+APE       +   D ++ G+L+ EM
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS-FLTECEALRSIR-HRNLIK 615
             +++G+G+   V   I        AVK++   Q G ++S    E E L   + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +I       F   D   +V++ M+ GS+   +H+        + + ++   +  DVASA+
Sbjct: 76  LIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASAL 124
Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVG--DFGLAKFLPARPLDTVVETPSSSSG 732
           ++LH+     + H DLKP N+L +H + V+ V   DF L   +      + + TP   + 
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 733 IKGTVGYIAPEY--GTGSEASMTG---DVYSFGILLLEMFSRRRP 772
             G+  Y+APE       EAS+     D++S G++L  + S   P
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRN---LIKI 616
           VG G++G+V           VAVK L+   +  + +  T  E   L+ ++H N   L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            T  +SI+    DF  +       G+        N+ ++   LS      +   +   ++
Sbjct: 96  FTPATSIE----DFSEVYLVTTLMGA------DLNNIVKSQALSDEHVQFLVYQLLRGLK 145
Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y+H      ++H DLKPSNV ++ D    + DFGLA+           +     +G   T
Sbjct: 146 YIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----------QADEEMTGYVAT 191
Query: 737 VGYIAPEYG-TGSEASMTGDVYSFGILLLEMFS 768
             Y APE        + T D++S G ++ E+  
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 224

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +F     +G GSFG ++ G   +    VA+K+ N+  K      L E +  R      ++
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYR------IL 59
Query: 615 KIITICSSIDFNGV--DFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIAID 670
           +  T   ++ + GV  D+  +V D +   SLE       D    C+  LSL   L +A  
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE-------DLFNFCSRKLSLKTVLMLADQ 111
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA---HVGDFGLAKFLPARPLDTVVETP 727
           + + +E++H       +H D+KP N L+     A   ++ DFGLAK    R   T    P
Sbjct: 112 MINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQHIP 166
Query: 728 -SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL 764
              +  + GT  Y +     G E S   D+ S G +L+
Sbjct: 167 YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT-----ECEALRSIRH 610
           +    ++G+G+F  V + I  E G   AVK++++ +  +     T     E      ++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            ++++++   SS   +G+ +  +V++FM    L   + +  D   V + ++    +    
Sbjct: 86  PHIVELLETYSS---DGMLY--MVFEFMDGADLCFEIVKRADAGFVYSEAVAS--HYMRQ 138
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +  A+ Y H +    ++H D+KP NVLL   ++     +GDFG+A  L         E+ 
Sbjct: 139 ILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--------ESG 187
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
             + G  GT  ++APE           DV+  G++L  + S
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 16/112 (14%)
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
            + + +  A+ YL    K  V+H D+KPSN+LLD      + DFG++     R +D   +
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAK 181
Query: 726 TPSSSSGIKGTVGYIAPEY-----GTGSEASMTGDVYSFGILLLEMFSRRRP 772
             S+     G   Y+APE       T  +  +  DV+S GI L+E+ + + P
Sbjct: 182 DRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTE----CEALRSIRHRNLIKII 617
           +G+GSFG V +    + G   AVK + L      + F  E    C  L S R      I+
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPR------IV 127
Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +  ++      +  I  + ++ GSL + + Q         L   + L         +EY
Sbjct: 128 PLYGAVREG--PWVNIFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEY 179
Query: 678 LHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           LH      ++HGD+K  NVLL  D   A + DFG A  L  +P D + ++  +   I GT
Sbjct: 180 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL--QP-DGLGKSLLTGDYIPGT 233
Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
             ++APE   G       D++S   ++L M +   P    F   L L
Sbjct: 234 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS------FLTECEALR 606
           +  +     +G G++G V   ++ ++ +  A + + +++K ++ +       L E   L+
Sbjct: 3   SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSL--EEWLHQNNDKLEVCNLSLIQT 664
            + H N++K+        F       +V +  + G L  E  L Q          S +  
Sbjct: 60  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQK--------FSEVDA 106
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLD 721
             I   V S   YLH H    +VH DLKP N+LL+    D +  + DFGL+         
Sbjct: 107 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF------ 157
Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
              E         GT  YIAPE     +     DV+S G++L
Sbjct: 158 ---EVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRS 607
           ++ T E+     +G+G+F  V + +    G   A  ++N  +  A      E EA   R 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N++++     SI   G  +  +++D +  G L E +       E      IQ +  
Sbjct: 67  LKHPNIVRL---HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKFLPARPLDTVV 724
           A+        LH H +  VVH +LKP N+LL   +      + DFGLA          V 
Sbjct: 122 AV--------LHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--------EVE 164
Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
               +  G  GT GY++PE           D+++ G++L
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 36/233 (15%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFL-TECEALRSIRHRNLI 614
           F   + +G+G+   V++          A+KVL   +K   K  + TE   L  + H N+I
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           K+  I     F      ++V + +  G L + +      +E    S     +    +  A
Sbjct: 112 KLKEI-----FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEA 160
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           + YLH +    +VH DLKP N+L      D    + DFGL+K         +VE      
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK---------IVEHQVLMK 208
Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILL------LEMFSRRRPTDSMFH 778
            + GT GY APE   G       D++S GI+        E F   R    MF 
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR 261

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 41/274 (14%)
Query: 45  LSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN 104
           L+ L+ +++ GN++    P  L  L KL  L IG N+ +     ++ N+++   ++L  +
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNED 120
Query: 105 RFHGSLPFDMVANLPNLRKF-VAAKNNLTGFLPIXXXX---XXXXXXXXXRDNQFIGKM- 159
                 P    ANL       + A +NL+   P+                +D   I  + 
Sbjct: 121 NISDISPL---ANLTKXYSLNLGANHNLSDLSPLSNXTGLNYLTVTESKVKDVTPIANLT 177
Query: 160 -----SINFNSLKNLSVLI-LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLL 213
                S+N+N ++++S L  L + H      N +  +T +AN ++L +L + +N+   L 
Sbjct: 178 DLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANXTRLNSLKIGNNKITDLS 237
Query: 214 PHSLANLSNTMTTIDIGGNYFSG-----------TIPPG---------LGNLVHLNSIAM 253
           P  LANLS  +T ++IG N  S             +  G         L NL  LNS+ +
Sbjct: 238 P--LANLSQ-LTWLEIGTNQISDINAVKDLTKLKXLNVGSNQISDISVLNNLSQLNSLFL 294
Query: 254 EGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIP 287
             NQL       IG L NL +L+L+ N +    P
Sbjct: 295 NNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRP 328

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITIC 620
           +G GS+    + +     M  AVKV++  ++   +    E E L R  +H N+I +  + 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDV- 89
Query: 621 SSIDFNGVDFKAIVYDFMQNGSL-EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               ++      +V + M+ G L ++ L Q          S  +   +   +   +EYLH
Sbjct: 90  ----YDDGKHVYLVTELMRGGELLDKILRQKF-------FSEREASFVLHTIGKTVEYLH 138
Query: 680 HHCKPPVVHGDLKPSNVLLDHDM----VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
                 VVH DLKPSN+L   +        + DFG AK L  R  + ++ TP        
Sbjct: 139 SQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL--RAENGLLMTPCY------ 187
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  ++APE           D++S GILL  M +   P
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITIC 620
           +G GS+    + +     M  AVKV++  ++   +    E E L R  +H N+I +  + 
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE----EIEILLRYGQHPNIITLKDV- 89
Query: 621 SSIDFNGVDFKAIVYDFMQNGSL-EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               ++      +V + M+ G L ++ L Q          S  +   +   +   +EYLH
Sbjct: 90  ----YDDGKHVYLVTELMRGGELLDKILRQKF-------FSEREASFVLHTIGKTVEYLH 138
Query: 680 HHCKPPVVHGDLKPSNVLLDHD----MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
                 VVH DLKPSN+L   +        + DFG AK L  R  + ++ TP        
Sbjct: 139 SQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL--RAENGLLMTPCY------ 187
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  ++APE           D++S GILL  M +   P
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI- 608
           S+ T+EF     +G G FG+VFK +   +G + A+K      K  L   + E  ALR + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 609 ------RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
                 +H ++++  +  +       D   I  ++   GSL + + +N   +     + +
Sbjct: 63  AHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
           + L   + V   + Y+H      +VH D+KPSN+ +
Sbjct: 118 KDL--LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 21/159 (13%)
Query: 547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALR 606
           A  S+ T+EF     +G G FG+VFK +   +G + A+K      K  L   + E  ALR
Sbjct: 2   AMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALR 57
Query: 607 SI-------RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
            +       +H ++++  +  +       D   I  ++   GSL + + +N   +     
Sbjct: 58  EVYAHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKE 112
Query: 660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
           + ++ L   + V   + Y+H      +VH D+KPSN+ +
Sbjct: 113 AELKDL--LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 98/235 (41%), Gaps = 32/235 (13%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQK-GALKSFLTECEALRSIRHRNL 613
           +   +++G GS+G V +        +VA+K +L + +     K  L E   L  + H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ I    D    D   +V + + +   ++             L+ +    +  ++  
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRT------PVYLTELHIKTLLYNLLV 167
Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF----------LPARPLD-- 721
            ++Y+H      ++H DLKP+N L++ D    V DFGLA+           LP  P +  
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 722 -TVVETPSSSSGIKGTVGYIAPEYGTGSE-------ASMTGDVYSFGILLLEMFS 768
             +V  P + +  +   G++   +    E        +   DV+S G +  E+ +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI- 608
           S+ T+EF     +G G FG+VFK +   +G + A+K      K  L   + E  ALR + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 609 ------RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
                 +H ++++  +  +       D   I  ++   GSL + + +N   +     + +
Sbjct: 59  AHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
           + L   + V   + Y+H      +VH D+KPSN+ +
Sbjct: 114 KDL--LLQVGRGLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI- 608
           S+ T+EF     +G G FG+VFK +   +G + A+K      K  L   + E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 609 ------RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
                 +H ++++  +  +       D   I  ++   GSL + + +N   +     + +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
           + L   + V   + Y+H      +VH D+KPSN+ +
Sbjct: 116 KDL--LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 3/102 (2%)
Query: 365 NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLS 423
           +L+NL+ LDIS         G  +  +SLE +KM  NSF  +  P +   L+++  LDLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKT 465
             +L    P    +LS L+ LN++ N  +  VP  G+F   T
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VP-DGIFDRLT 518

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 36/260 (13%)
Query: 562 VGQGSFGTVF------KGIIGENGMLVAVKV-----------LNLMQKGALKSFLTECEA 604
           +GQG FG ++         +G +   V VKV           L   Q+ A    + +   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCV-VKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
            R +++  + K        D NG  ++ ++ D    GS  + +++ N K      S    
Sbjct: 102 TRKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK----RFSRKTV 154
Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGLA-KFLPARPL 720
           L +++ +   +EY+H H     VHGD+K SN+LL++   D V ++ D+GLA ++ P    
Sbjct: 155 LQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVH 210
Query: 721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
                 P       GT+ + + +   G   S  GD+   G  +++  +   P +    + 
Sbjct: 211 KAYAADPKRCH--DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268
Query: 781 LTLHEFSKMVLPEKVMEIVD 800
             + + SK+   E +  ++D
Sbjct: 269 KYVRD-SKIRYRENIASLMD 287

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+ G V   +  I+  N   VA+K L+       + F  +  A R+ R   L+K++ 
Sbjct: 32  IGSGAQGIVVAAYDAILERN---VAIKKLS-------RPFQNQTHAKRAYRELVLMKVVN 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID-------- 670
             + I    V        F    SLEE        +E+ + +L Q + + +D        
Sbjct: 82  HKNIIGLLNV--------FTPQKSLEE-FQDVYIVMELMDANLSQVIQMELDHERMSYLL 132
Query: 671 --VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP 
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT----SFMMTPY 185
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                  T  Y APE   G       D++S G+++ EM
Sbjct: 186 VV-----TRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 42/217 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G G+ G V        G+ VAVK L+     +   K    E   L+ + H+N+I ++ +
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID--------- 670
                            F    +LEE        +E+ + +L Q +++ +D         
Sbjct: 92  -----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIHMELDHERMSYLLY 133
Query: 671 -VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +   I++LH      ++H DLKPSN+++  D    + DFGLA+          + TP  
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYV 186
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                 T  Y APE   G   +   D++S G ++ E+
Sbjct: 187 V-----TRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+ G V   +  I+  N   VA+K L+       + F  +  A R+ R   L+K++ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLS-------RPFQNQTHAKRAYRELVLMKVVN 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID-------- 670
             + I    V        F    SLEE        +E+ + +L Q + + +D        
Sbjct: 82  HKNIIGLLNV--------FTPQKSLEE-FQDVYIVMELMDANLSQVIQMELDHERMSYLL 132
Query: 671 --VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP 
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT----SFMMTPY 185
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                  T  Y APE   G       D++S G+++ EM
Sbjct: 186 VV-----TRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P        T  Y APE   G       D++S G ++ EM  
Sbjct: 184 PEVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 31/225 (13%)
Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHR 611
           T  +     +G GS+    + I        AVK+++  ++   +    E E L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N+I +  +     ++   +  +V +  + G L + +      L     S  +   +   +
Sbjct: 77  NIITLKDV-----YDDGKYVYVVTELXKGGELLDKI------LRQKFFSEREASAVLFTI 125
Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHD----MVAHVGDFGLAKFLPARPLDTVVETP 727
              +EYLH      VVH DLKPSN+L   +        + DFG AK L  R  + ++ TP
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLXTP 180
Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                   T  ++APE           D++S G+LL    +   P
Sbjct: 181 CY------TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 85/214 (39%), Gaps = 37/214 (17%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG        ++  LVAVK +   +K A  +   E    RS+RH N+++   +  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIA-ANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN---LSLIQTLNIAIDVASAIEYL 678
           +         AIV ++   G L E          +CN    S  +       + S + Y 
Sbjct: 86  T-----PTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAH--VGDFGLAK--FLPARPLDTVVETPSSSSGIK 734
           H      V H DLK  N LLD        + DFG +K   L ++P  TV           
Sbjct: 132 H---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----------- 177
Query: 735 GTVGYIAPEYGTGSEAS-MTGDVYSFGILLLEMF 767
           GT  YIAPE     E      DV+S G+ L  M 
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 42/217 (19%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G G+ G V        G+ VAVK L+     +   K    E   L+ + H+N+I ++ +
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID--------- 670
                            F    +LEE        +E+ + +L Q +++ +D         
Sbjct: 90  -----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIHMELDHERMSYLLY 131
Query: 671 -VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +   I++LH      ++H DLKPSN+++  D    + DFGLA+            T   
Sbjct: 132 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TASTNFM 179
Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            +    T  Y APE   G       D++S G ++ E+
Sbjct: 180 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 24/203 (11%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V + +    G +   K +N        +   E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              F       ++ +F+  G L + +   + K+     S  + +N        ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKM-----SEAEVINYMRQACEGLKHMHEH 168
Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVG--DFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
               +VH D+KP N++ +    + V   DFGLA  L     D +V+  ++      T  +
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTA------TAEF 216
Query: 740 IAPEYGTGSEASMTGDVYSFGIL 762
            APE           D+++ G+L
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVL 239

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G GSFG ++ G     G  VA+K+  +  K        E +  + ++    I  I  C 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIAIDVASAIEYLH 679
           +      D+  +V + +   SLE       D    C+   SL   L +A  + S IEY+H
Sbjct: 73  AEG----DYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 680 HHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKG 735
                  +H D+KP N L+       + ++ DFGLAK    R   T    P   +  + G
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQHIPYRENKNLTG 175
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLL 764
           T  Y +     G E S   D+ S G +L+
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLM 204

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G GSFG ++ G     G  VA+K+  +  K        E +  + ++    I  I  C 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIAIDVASAIEYLH 679
           +      D+  +V + +   SLE       D    C+   SL   L +A  + S IEY+H
Sbjct: 75  AEG----DYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 680 HHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETP-SSSSGIKG 735
                  +H D+KP N L+       + ++ DFGLAK    R   T    P   +  + G
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQHIPYRENKNLTG 177
Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLL 764
           T  Y +     G E S   D+ S G +L+
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  I+  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 36  AQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV- 91
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    SLEE        +E+ + +L Q + + +D          
Sbjct: 92  ----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+            T  +S
Sbjct: 135 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTS 179
Query: 731 SGIKGTV---GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
             ++  V    Y APE   G       D++S G ++ EM   +
Sbjct: 180 FMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL----KSFLTECEAL 605
           +K   ++   +++G+GS+G V + +  E     AVK+L   +   +     +   E + L
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTL 665
           R +RH+N+I+++ +  + +   +    +V ++   G  E        +  VC     Q  
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCGMQEMLDSVPEKRFPVC-----QAH 112
Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
                +   +EYLH      +VH D+KP N+LL       +   G+A+ L     D    
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 726 TPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILL 763
           T       +G+  +  PE   G +  +    D++S G+ L
Sbjct: 170 TS------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 562 VGQGSFGTV--FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G F  V   +G+   +G   A+K +   ++   +    E +  R   H N+++++  
Sbjct: 37  LGEGGFSYVDLVEGL--HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 620 CSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           C  +   G   +A ++  F + G+L   + +  DK     L+  Q L + + +   +E +
Sbjct: 95  C--LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLEAI 150
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV---VE------TPSS 729
           H        H DLKP+N+LL        GD G    +    ++     VE      T   
Sbjct: 151 H---AKGYAHRDLKPTNILL--------GDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 730 SSGIKGTVGYIAPE-YGTGSEASM--TGDVYSFGILLLEMFSRRRPTDSMFHEG 780
            +  + T+ Y APE +   S   +    DV+S G +L  M     P D +F +G
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+ G V   +  I+  N   VA+K L+       + F  +  A R+ R   L+K++ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLS-------RPFQNQTHAKRAYRELVLMKVVN 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID-------- 670
             + I    V        F    SLEE        +E+ + +L Q + + +D        
Sbjct: 82  HKNIIGLLNV--------FTPQKSLEE-FQDVYIVMELMDANLSQVIQMELDHERMSYLL 132
Query: 671 --VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP 
Sbjct: 133 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT----SFMMTPY 185
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                  T  Y APE   G       D++S G ++ EM
Sbjct: 186 VV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 56/281 (19%)
Query: 562 VGQGSFGTVFKGIIGENGM-LVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI-KIITI 619
           +G+G+FG V + +    G   VA+K++  + K    + L E   L+ I+ ++   K + +
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLCV 85
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S  FN      I ++ +   + E +L +NN +       L    ++A  +  A+ +LH
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQ----PYPLPHVRHMAYQLCHALRFLH 140
Query: 680 HHCKPPVVHGDLKPSNVLL----------DHDMVAH---------VGDFGLAKFLPARPL 720
              +  + H DLKP N+L           +H              V DFG A F      
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF------ 191
Query: 721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
                     + I  T  Y  PE       +   DV+S G +L E           ++ G
Sbjct: 192 -----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE-----------YYRG 235
Query: 781 LTL---HE-FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGG 817
            TL   HE    +V+ EK++  +   ++   R      +GG
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 276

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           +++  ++G GSFG VF+  + E+  +   KVL   Q    K+   E + +R ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMRIVKHPNVVD 96
Query: 616 IIT-ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     S+ D     F  +V +++         H    K +   + LI+       +  +
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLY--MYQLLRS 153
Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           + Y+H      + H D+KP N+LLD    V  + DFG AK L       +   P+ S   
Sbjct: 154 LAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-------IAGEPNVSXIC 203
Query: 734 KGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFS 768
             +  Y APE   G+    T  D++S G ++ E+  
Sbjct: 204 --SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P        T  Y APE   G       D++S G ++ EM  
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH 610
           +  +++     +G GSFG ++ G    +G  VA+K+  +  K        E +  + ++ 
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHP--QLHIESKFYKMMQG 63
Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--LSLIQTLNIA 668
              I  I  C +      D+  +V + +   SLE       D    C+   SL   L +A
Sbjct: 64  GVGIPSIKWCGAEG----DYNVMVMELL-GPSLE-------DLFNFCSRKFSLKTVLLLA 111
Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVE 725
             + S IEY+H       +H D+KP N L+       + ++ DFGLAK    R   T   
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQH 166
Query: 726 TP-SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLL 764
            P   +  + GT  Y +     G E S   D+ S G +L+
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 206

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G+ G V   +  I+  N   VA+K L+       + F  +  A R+ R   L+K++ 
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLS-------RPFQNQTHAKRAYRELVLMKVVN 81
Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID-------- 670
             + I    V        F    SLEE        +E+ + +L Q + + +D        
Sbjct: 82  HKNIIGLLNV--------FTPQKSLEE-FQDVYIVMELMDANLSQVIQMELDHERMSYLL 132
Query: 671 --VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP 
Sbjct: 133 YQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT----SFMMTPY 185
Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
                  T  Y APE   G       D++S G ++ EM
Sbjct: 186 VV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLXQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 48/220 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           P        T  Y APE   G       D++S G ++ EM
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLXQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 33  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 90  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 131
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 132 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 184
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
           P        T  Y APE   G       D++S G ++ EM  
Sbjct: 185 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 56/281 (19%)
Query: 562 VGQGSFGTVFKGIIGENGM-LVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI-KIITI 619
           +G+G+FG V + +    G   VA+K++  + K    + L E   L+ I+ ++   K + +
Sbjct: 36  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLCV 94
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S  FN      I ++ +   + E +L +NN +       L    ++A  +  A+ +LH
Sbjct: 95  LMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQ----PYPLPHVRHMAYQLCHALRFLH 149
Query: 680 HHCKPPVVHGDLKPSNVLL----------DHDMVAH---------VGDFGLAKFLPARPL 720
              +  + H DLKP N+L           +H              V DFG A F      
Sbjct: 150 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF------ 200
Query: 721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
                     + I  T  Y  PE       +   DV+S G +L E           ++ G
Sbjct: 201 -----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE-----------YYRG 244
Query: 781 LTL---HE-FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGG 817
            TL   HE    +V+ EK++  +   ++   R      +GG
Sbjct: 245 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 285

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 90  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSY 131
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 132 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 184
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 185 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 30  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 85
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 86  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+            T    
Sbjct: 129 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMM 176
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           +    T  Y APE   G       D++S G ++ EM   +
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 37  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 92
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 93  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP   
Sbjct: 136 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV 188
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                T  Y APE   G       D++S G ++ EM   +
Sbjct: 189 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 37  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 94  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 135
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 136 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 188
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 189 PYVV-----TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 30  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 85
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 86  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP   
Sbjct: 129 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV 181
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                T  Y APE   G       D++S G ++ EM   +
Sbjct: 182 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 54/227 (23%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  I+  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    SLEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+            T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------T 175
Query: 727 PSSSSGIKGTV---GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
             +S  ++  V    Y APE   G       D++S G ++ EM   +
Sbjct: 176 AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 29  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 84
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 85  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+            T    
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMM 175
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           +    T  Y APE   G       D++S G ++ EM   +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 687 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT 746
            H D+KP N+L+  D  A++ DFG+A         T  E  +      GT+ Y APE  +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASA-------TTDEKLTQLGNTVGTLYYXAPERFS 208
Query: 747 GSEASMTGDVYSFGILLLEMFS 768
            S A+   D+Y+   +L E  +
Sbjct: 209 ESHATYRADIYALTCVLYECLT 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE+       +E+ + +L Q + + +D      
Sbjct: 127 LNV-----------------FTPQKTLEEF-QDVYLVMELMDANLCQVIQMELDHERMSY 168
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 221
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 222 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 127 LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSY 168
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMT 221
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 222 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  I+  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 30  AQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV- 85
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    SLEE        +E+ + +L Q + + +D          
Sbjct: 86  ----------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP   
Sbjct: 129 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV 181
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                T  Y APE   G       D++S G ++ EM   +
Sbjct: 182 -----TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + + YLH      + H D+KP N+LLD      + DFGLA        + ++      + 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 165
Query: 733 IKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTD 774
           + GT+ Y+APE     E  +   DV+S GI+L  M +   P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + + YLH      + H D+KP N+LLD      + DFGLA        + ++      + 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 165
Query: 733 IKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTD 774
           + GT+ Y+APE     E  +   DV+S GI+L  M +   P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + + YLH      + H D+KP N+LLD      + DFGLA        + ++      + 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 165
Query: 733 IKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTD 774
           + GT+ Y+APE     E  +   DV+S GI+L  M +   P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + + YLH      + H D+KP N+LLD      + DFGLA        + ++      + 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 166
Query: 733 IKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTD 774
           + GT+ Y+APE     E  +   DV+S GI+L  M +   P D
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 35  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 90
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 91  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 133
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP   
Sbjct: 134 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV 186
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                T  Y APE   G       D++S G ++ EM   +
Sbjct: 187 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 89  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLXQVIQMELDHERMSY 130
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 131 LLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT----SFMMT 183
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 562 VGQGSFGTV---FKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKI 616
           +G G+ G V   +  ++  N   VA+K L+     +   K    E   ++ + H+N+I +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID------ 670
           + +                 F    +LEE        +E+ + +L Q + + +D      
Sbjct: 82  LNV-----------------FTPQKTLEE-FQDVYLVMELMDANLXQVIQMELDHERMSY 123
Query: 671 ----VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
               +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + T
Sbjct: 124 LLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT----SFMMT 176
Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
           P        T  Y APE   G       D++S G ++ EM   +
Sbjct: 177 PYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           + + YLH      + H D+KP N+LLD      + DFGLA        + ++      + 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 165
Query: 733 IKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTD 774
           + GT+ Y+APE     E  +   DV+S GI+L  M +   P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            QG     +  ++  N   VA+K L+     +   K    E   ++ + H+N+I ++ + 
Sbjct: 36  AQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV- 91
Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID---------- 670
                           F    +LEE        +E+ + +L Q + + +D          
Sbjct: 92  ----------------FTPQKTLEE-FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   I++LH      ++H DLKPSN+++  D    + DFGLA+        + + TP   
Sbjct: 135 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV 187
Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                T  Y APE   G       D++S G ++ EM   +
Sbjct: 188 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 56/281 (19%)
Query: 562 VGQGSFGTVFKGIIGENGM-LVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI-KIITI 619
           +G+G+FG V + +    G   VA+K++  + K    + L E   L+ I+ ++   K + +
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLCV 117
Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S  FN      I ++ +   + E +L +NN +       L    ++A  +  A+ +LH
Sbjct: 118 LMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQ----PYPLPHVRHMAYQLCHALRFLH 172
Query: 680 HHCKPPVVHGDLKPSNVLL----------DHDMVAH---------VGDFGLAKFLPARPL 720
              +  + H DLKP N+L           +H              V DFG A F      
Sbjct: 173 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF------ 223
Query: 721 DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
                     + I  T  Y  PE       +   DV+S G +L E           ++ G
Sbjct: 224 -----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE-----------YYRG 267
Query: 781 LTL---HE-FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGG 817
            TL   HE    +V+ EK++  +   ++   R      +GG
Sbjct: 268 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 308

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           + H D+KP N+LLD      + DFGLA        + ++      + + GT+ Y+APE  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NKMCGTLPYVAPELL 179
Query: 746 TGSE-ASMTGDVYSFGILLLEMFSRRRPTDS 775
              E  +   DV+S GI+L  M +   P D 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           + H D+KP N+LLD      + DFGLA        + ++      + + GT+ Y+APE  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NKMCGTLPYVAPELL 179
Query: 746 TGSE-ASMTGDVYSFGILLLEMFSRRRPTDS 775
              E  +   DV+S GI+L  M +   P D 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           + H D+KP N+LLD      + DFGLA        + ++      + + GT+ Y+APE  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NKMCGTLPYVAPELL 179
Query: 746 TGSE-ASMTGDVYSFGILLLEMFSRRRPTDS 775
              E  +   DV+S GI+L  M +   P D 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 10/134 (7%)
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           + H D+KP N+LLD      + DFGLA        + ++      + + GT+ Y+APE  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NKMCGTLPYVAPELL 178
Query: 746 TGSE-ASMTGDVYSFGILLLEMFSRRRPTDS---MFHEGLTLHEFSKMVLPEKVMEIVDP 801
              E  +   DV+S GI+L  M +   P D       E     E    + P K ++    
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 802 SLLLEVRANNSMSR 815
           +LL ++   N  +R
Sbjct: 239 ALLHKILVENPSAR 252

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 562 VGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G FG ++        E      VKV    + G L    +E +  + +  ++ IK   
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKV-EYQENGPL---FSELKFYQRVAKKDCIKKWI 100
Query: 619 ICSSIDFNGV---------DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT--LNI 667
               +D+ G+         +FK   Y FM    + E L  +  K+   N +  ++  L +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGLA-KFLPARPLDTV 723
            I +   +EY+H +     VHGD+K +N+LL +   D V ++ D+GL+ ++ P       
Sbjct: 157 GIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQY 212
Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
            E P    G  GT+ + + +   G   S   DV   G  +L     + P + 
Sbjct: 213 QENP--RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 686 VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG 745
           + H D+KP N+LLD      + DFGLA        + ++      + + GT+ Y+APE  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NKMCGTLPYVAPELL 179
Query: 746 TGSE-ASMTGDVYSFGILLLEMFSRRRPTDS 775
              E  +   DV+S GI+L  M +   P D 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 85/214 (39%), Gaps = 37/214 (17%)
Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG        ++  LVAVK +   +K   ++   E    RS+RH N+++   +  
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN---LSLIQTLNIAIDVASAIEYL 678
           +         AIV ++   G L E          +CN    S  +       + S + Y 
Sbjct: 85  T-----PTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAH--VGDFGLAK--FLPARPLDTVVETPSSSSGIK 734
           H      V H DLK  N LLD        + DFG +K   L ++P  TV           
Sbjct: 131 H---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----------- 176
Query: 735 GTVGYIAPEYGTGSEAS-MTGDVYSFGILLLEMF 767
           GT  YIAPE     E      DV+S G+ L  M 
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	869
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-123
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-118
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-113
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-101
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-78
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-51
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-37
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-103
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-50
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-82
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-74
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-71
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-75
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-74
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-71
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-49
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-72
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-70
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-20
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-67
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-66
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-61
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-07
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-12
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-49
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-17
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-47
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-47
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-12
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-38
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-08
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-33
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-33
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-05
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-07
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-04
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-10
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-10
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	8e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  441 bits (1137), Expect = e-143
 Identities = 145/499 (29%), Positives = 230/499 (46%), Gaps = 23/499 (4%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
                NK  G+IP  +      L  L L+ NH  G +P   G+ S L+ + +  N   G+
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 62  IP-DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSF-EFIFLQSNRFHGSLPFDM-VANL 118
           +P DTL ++R L  L++  N+FSG +P S+ N+S+    + L SN F G +  ++     
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH 178
             L++     N  TG +P +LSN S L  L L  N   G +  +  SL  L  L L  N 
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 179 L-GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT 237
           L G            L     LE L L  N   G +P  L+N +N +  I +  N  +G 
Sbjct: 454 LEGE-------IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGE 505

Query: 238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLT 297
           IP  +G L +L  + +  N   G +P E+G  ++L  L LN+N  +G IP+++   +   
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS--- 562

Query: 298 LLALEINNLQGKIPSSLGNCTSLIMLTLSKN--KLDGVLPPQILSVTTLSLFLNLSDNLL 355
              +  N + GK    + N         + N  +  G+   Q+  ++T +   N++  + 
Sbjct: 563 -GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVY 620

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
            G       N  +++ LD+S N  SG IP  + +   L  + +  N  SGSIP  +  L+
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKL 475
            + +LDLSSNKL G+IP+ +  L+ L  ++LS N+  G +P+ G F          N  L
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740

Query: 476 CGGLDEFHLPSCPSKRSRK 494
           CG    + LP C    +  
Sbjct: 741 CG----YPLPRCDPSNADG 755

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  388 bits (998), Expect = e-123
 Identities = 141/520 (27%), Positives = 238/520 (45%), Gaps = 36/520 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLP--VSIGNLSALQVIDIRGNRLGG 60
              N+ + G +     C    L +L L+ N L+G +    S+G+ S L+ +++  N L  
Sbjct: 83  FLSNSHINGSVS-GFKC-SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 61  KIPDTLG-QLRKLIYLNIGRNQFSGFIPPSIY---NISSFEFIFLQSNRFHGSLPFDMVA 116
               + G +L  L  L++  N  SG               + + +  N+  G +     +
Sbjct: 141 PGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---S 197

Query: 117 NLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGN 176
              NL     + NN +  +P  L + S L+ L++  N+  G  S   ++   L +L + +
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256

Query: 177 NHL-GNRAANDLDFVTV-LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF 234
           N   G           +       L+ L L +N+F G +P  L+   +T+T +D+ GN+F
Sbjct: 257 NQFVG----------PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 306

Query: 235 SGTIPPGLGNLVHLNSIAMEGNQLIGTVPPE-IGWLKNLQSLYLNSNFLHGYIPSSLGNL 293
            G +PP  G+   L S+A+  N   G +P + +  ++ L+ L L+ N   G +P SL NL
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366

Query: 294 TM-LTLLALEINNLQGKIPSSLGNC--TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNL 350
           +  L  L L  NN  G I  +L      +L  L L  N   G +PP + + + L   L+L
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV-SLHL 425

Query: 351 SDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS 410
           S N LSG++PS +G+L  L  L +  N   G+IP  L    +LE + +  N  +G IP  
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485

Query: 411 LNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSL 469
           L+   ++  + LS+N+L+G+IPK++  L  L  L LS N F G +P + G   +     L
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545

Query: 470 SGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVS 509
           + N    G      +P+   K+S K+ A  +       + 
Sbjct: 546 NTN-LFNG-----TIPAAMFKQSGKIAANFIAGKRYVYIK 579

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  376 bits (967), Expect = e-118
 Identities = 143/519 (27%), Positives = 229/519 (44%), Gaps = 27/519 (5%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI---GNLSALQVIDIRGNRL 58
            +  +N L     V  G  L  LE L L+ N ++G   V          L+ + I GN++
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 59  GGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANL 118
            G +   + +   L +L++  N FS  I P + + S+ + + +  N+  G     + +  
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAI-STC 246

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNN 177
             L+    + N   G  PI      +L+ L L +N+F G++      +   L+ L L  N
Sbjct: 247 TELKLLNISSNQFVG--PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP-HSLANLSNTMTTIDIGGNYFSG 236
           H                +CS LE+L L  N F G LP  +L  +   +  +D+  N FSG
Sbjct: 305 HFYGA------VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG-LKVLDLSFNEFSG 357

Query: 237 TIPPGLGNL-VHLNSIAMEGNQLIGTVPPEIG--WLKNLQSLYLNSNFLHGYIPSSLGNL 293
            +P  L NL   L ++ +  N   G + P +       LQ LYL +N   G IP +L N 
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           + L  L L  N L G IPSSLG+ + L  L L  N L+G +P +++ V TL   L L  N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE-TLILDFN 476

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF 413
            L+G +PS + N  NL  + +S NR +G+IP  +    +L  +K+ +NSFSG+IP  L  
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536

Query: 414 LKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGN 472
            +S+  LDL++N  +G IP  +   S      ++ N   G+          K     +GN
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGN 592

Query: 473 GKLCGGLDEFHLPSCPSKRSRKLIATILKVVIPTIVSCL 511
                G+    L    ++    + + +            
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  363 bits (935), Expect = e-113
 Identities = 123/470 (26%), Positives = 213/470 (45%), Gaps = 28/470 (5%)

Query: 17  IGCYLFKLENLSLAENHLT---GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLI 73
           + C   K+ ++ L+   L      +  S+ +L+ L+ + +  + + G +         L 
Sbjct: 45  VTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLT 103

Query: 74  YLNIGRNQFSGFIPP--SIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNL 131
            L++ RN  SG +    S+ + S  +F+ + SN             L +L     + N++
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163

Query: 132 TGFLPISL---SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL-GNRAANDL 187
           +G   +          L+ L +  N+  G   ++ +   NL  L + +N+          
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDVSSNNFSTG------ 215

Query: 188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH 247
             +  L +CS L++L +  N+  G    +++  +  +  ++I  N F G IPP    L  
Sbjct: 216 --IPFLGDCSALQHLDISGNKLSGDFSRAISTCTE-LKLLNISSNQFVGPIPP--LPLKS 270

Query: 248 LNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           L  +++  N+  G +P  + G    L  L L+ N  +G +P   G+ ++L  LAL  NN 
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 307 QGKIP-SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
            G++P  +L     L +L LS N+  G LP  + +++   L L+LS N  SG +   +  
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390

Query: 366 --LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
                L +L +  N F+G IP TLS C+ L  + +  N  SG+IP SL  L  ++ L L 
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450

Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGN 472
            N L G+IP+ L  +  LE L L +N   GE+P      +N    SLS N
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  332 bits (853), Expect = e-101
 Identities = 128/448 (28%), Positives = 193/448 (43%), Gaps = 26/448 (5%)

Query: 43  GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ 102
             ++++ +     N     +  +L  L  L  L +  +  +G +       +S   + L 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLS 108

Query: 103 SNRFHGSLPFDM-VANLPNLRKFVAAKNNLTGFLPIS-LSNASNLELLELRDNQFIGKMS 160
            N   G +     + +   L+    + N L     +S     ++LE+L+L  N   G   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 161 INF---NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSL 217
           + +   +    L  L +  N +             ++ C  LE L +  N F   +P  L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGD--------VDVSRCVNLEFLDVSSNNFSTGIP-FL 219

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYL 277
            + S  +  +DI GN  SG     +     L  + +  NQ +G +PP    LK+LQ L L
Sbjct: 220 GDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSL 276

Query: 278 NSNFLHGYIPSSL-GNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPP 336
             N   G IP  L G    LT L L  N+  G +P   G+C+ L  L LS N   G LP 
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 337 QILS-VTTLSLFLNLSDNLLSGSLPSEIGNLK-NLVQLDISGNRFSGDIPGTLSAC--TS 392
             L  +  L   L+LS N  SG LP  + NL  +L+ LD+S N FSG I   L      +
Sbjct: 337 DTLLKMRGLK-VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 393 LEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
           L+ + +Q+N F+G IPP+L+    +  L LS N LSG IP  L +LS L  L L  N  E
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

Query: 453 GEVPKK-GVFSNKTRFSLSGNGKLCGGL 479
           GE+P++           L  N  L G +
Sbjct: 456 GEIPQELMYVKTLETLILDFN-DLTGEI 482

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  267 bits (686), Expect = 7e-78
 Identities = 98/337 (29%), Positives = 151/337 (44%), Gaps = 15/337 (4%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
               QNN   G IP  +     +L +L L+ N+L+G +P S+G+LS L+ + +  N L G
Sbjct: 398 ELYLQNNGFTGKIPPTL-SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
           +IP  L  ++ L  L +  N  +G IP  + N ++  +I L +NR  G +P  +   L N
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI-GRLEN 515

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG 180
           L     + N+ +G +P  L +  +L  L+L  N F G +     ++   S  I  N   G
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP---AAMFKQSGKIAANFIAG 572

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDN--QFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
                       + N    +      N  +F G+    L  LS      +I    + G  
Sbjct: 573 K-------RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST-RNPCNITSRVYGGHT 624

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTL 298
            P   N   +  + M  N L G +P EIG +  L  L L  N + G IP  +G+L  L +
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684

Query: 299 LALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLP 335
           L L  N L G+IP ++   T L  + LS N L G +P
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  193 bits (492), Expect = 1e-51
 Identities = 75/253 (29%), Positives = 123/253 (48%), Gaps = 13/253 (5%)

Query: 243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
             +  ++  +   N     V   +  L  L+SL+L+++ ++G +         LT L L 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 303 INNLQGKIPS--SLGNCTSLIMLTLSKNKLDGVLP-PQILSVTTLSLFLNLSDNLLSGSL 359
            N+L G + +  SLG+C+ L  L +S N LD        L + +L   L+LS N +SG+ 
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE-VLDLSANSISGAN 167

Query: 360 PSEI---GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKS 416
                       L  L ISGN+ SGD+   +S C +LE++ +  N+FS  I P L    +
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSA 224

Query: 417 IKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLC 476
           ++ LD+S NKLSG   + +   + L+ LN+S N F G +P      +    SL+ N K  
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP-PLPLKSLQYLSLAEN-KFT 282

Query: 477 GGLDEFHLPSCPS 489
           G + +F   +C +
Sbjct: 283 GEIPDFLSGACDT 295

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  149 bits (378), Expect = 3e-37
 Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 10/191 (5%)

Query: 289 SLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFL 348
               +T + L +  +N     + SSL + T L  L LS + ++G +        +L+  L
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLT-SL 105

Query: 349 NLSDNLLSGSLPS--EIGNLKNLVQLDISGNRFSGDIP-GTLSACTSLEYVKMQDNSFSG 405
           +LS N LSG + +   +G+   L  L++S N               SLE + +  NS SG
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 406 SIPPSL---NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFS 462
           +        +    +K L +S NK+SG +   +     LE+L++S N+F   +P  G  S
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCS 223

Query: 463 NKTRFSLSGNG 473
                 +SGN 
Sbjct: 224 ALQHLDISGNK 234

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  320 bits (823), Expect = e-103
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 14/308 (4%)

Query: 187 LDFVTVLANCSKL----ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT--IPP 240
           L     L N + L          +  + G+L  +       +  +D+ G        IP 
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPS 70

Query: 241 GLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
            L NL +LN + + G N L+G +PP I  L  L  LY+    + G IP  L  +  L  L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL 359
               N L G +P S+ +  +L+ +T   N++ G +P    S + L   + +S N L+G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 360 PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV 419
           P    NL NL  +D+S N   GD      +  + + + +  NS +  +   +   K++  
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNG 248

Query: 420 LDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGL 479
           LDL +N++ G +P+ L  L FL  LN+S+N+  GE+P+ G        + + N  LCG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307

Query: 480 DEFHLPSC 487
               LP+C
Sbjct: 308 ---PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  208 bits (532), Expect = 5e-61
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 39/317 (12%)

Query: 25  ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG--KIPDTLGQLRKLIYLNI-GRNQ 81
                      G L  +      +  +D+ G  L     IP +L  L  L +L I G N 
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 82  FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN 141
             G IPP+I  ++   ++++      G++P  + + +  L     + N L+G LP S+S+
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISS 147

Query: 142 ASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
             NL  +    N+  G +  ++ S   L                               +
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------------FTS 178

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT 261
           + +  N+  G +P + ANL+  +  +D+  N   G      G+  +   I +  N L   
Sbjct: 179 MTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           +  ++G  KNL  L L +N ++G +P  L  L  L  L +  NNL G+IP   GN     
Sbjct: 237 L-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFD 294

Query: 322 MLTLSKNKL--DGVLPP 336
           +   + NK      LP 
Sbjct: 295 VSAYANNKCLCGSPLPA 311

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  178 bits (453), Expect = 4e-50
 Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 18/257 (7%)

Query: 5   QNNKLVG--DIPVEIGCYLFKLENLSLA-ENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
               L     IP  +   L  L  L +   N+L G +P +I  L+ L  + I    + G 
Sbjct: 58  SGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           IPD L Q++ L+ L+   N  SG +PPSI ++ +   I    NR  G++P     +   L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS-YGSFSKL 175

Query: 122 RKFVA-AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL- 179
              +  ++N LTG +P + +N  NL  ++L  N   G  S+ F S KN   + L  N L 
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
            +        +  +     L  L L +N+  G LP  L  L   + ++++  N   G IP
Sbjct: 235 FD--------LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-LHSLNVSFNNLCGEIP 285

Query: 240 PGLGNLVHLNSIAMEGN 256
            G GNL   +  A   N
Sbjct: 286 QG-GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  145 bits (369), Expect = 1e-38
 Identities = 57/180 (31%), Positives = 84/180 (46%), Gaps = 5/180 (2%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
                +  + G IP  +   +  L  L  + N L+G LP SI +L  L  I   GNR+ G
Sbjct: 105 YLYITHTNVSGAIPDFLS-QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 61  KIPDTLGQLRKLI-YLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP 119
            IPD+ G   KL   + I RN+ +G IPP+  N+ +  F+ L  N   G        +  
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF-GSDK 221

Query: 120 NLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
           N +K   AKN+L   L   +  + NL  L+LR+N+  G +      LK L  L +  N+L
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  143 bits (364), Expect = 4e-38
 Identities = 48/182 (26%), Positives = 68/182 (37%), Gaps = 9/182 (4%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSAL-QVIDIRGNRLGG 60
            D   N L G +P  I   L  L  ++   N ++G +P S G+ S L   + I  NRL G
Sbjct: 130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
           KIP T   L  L ++++ RN   G       +  + + I L  N     L    V    N
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--KVGLSKN 245

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGK--MSINFNSLKNLSVLILGNNH 178
           L       N + G LP  L+    L  L +  N   G+     N       +     N  
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA--YANNKC 303

Query: 179 LG 180
           L 
Sbjct: 304 LC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 34/110 (30%), Positives = 48/110 (43%), Gaps = 3/110 (2%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
            D   N L GD  V  G      + + LA+N L   L   +G    L  +D+R NR+ G 
Sbjct: 202 VDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLP 111
           +P  L QL+ L  LN+  N   G IP    N+  F+     +N+     P
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSP 308

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  265 bits (680), Expect = 6e-82
 Identities = 103/315 (32%), Positives = 166/315 (52%), Gaps = 34/315 (10%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECE 603
           S  +L  A+  FS+ N++G+G FG V+KG +  +G LVAVK L     +G    F TE E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            +    HRNL+++   C +        + +VY +M NGS+   L +  +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPK 132

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
              IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +  +  DT 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTH 190

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF---HEG 780
           V T      ++GT+G+IAPEY +  ++S   DV+ +G++LLE+ + +R  D       + 
Sbjct: 191 VTT-----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 781 LTLHEFSKMVLPE-KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSME 839
           + L ++ K +L E K+  +VD  L             G     E  +  +I++ ++C+  
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDL------------QGNYKDEE--VEQLIQVALLCTQS 291

Query: 840 SPTDRMQMRDVVVKL 854
           SP +R +M +VV  L
Sbjct: 292 SPMERPKMSEVVRML 306

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  265 bits (679), Expect = 2e-78
 Identities = 82/482 (17%), Positives = 163/482 (33%), Gaps = 26/482 (5%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRL-GGKIP 63
             N +           L  L+ L   E +L       IG+L  L+ +++  N +   K+P
Sbjct: 84  TGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIF----LQSNRFHGSLPFDMVANLP 119
           +    L  L +L++  N+        +  +     +     L  N  +   P        
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG--AFKEI 200

Query: 120 NLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDNQFIGKMSI---NFNSLKNLSVLILG 175
            L K     N  +  +    +   + LE+  L   +F  + ++   + ++L+ L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
              L        D + +    + + +  L       +     +        +++    F 
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFG-WQHLELVNCKFG 317

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH--GYIPSSLGNL 293
                 L +L  L           G        L +L+ L L+ N L   G    S    
Sbjct: 318 QFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           T L  L L  N +   + S+      L  L    + L  +    +       ++L++S  
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDI-PGTLSACTSLEYVKMQDNSFSGSIPPSLN 412
               +       L +L  L ++GN F  +  P   +   +L ++ +         P + N
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 413 FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPK--KGVFSNKTRFSLS 470
            L S++VL++S N          + L+ L+ L+ S NH      +  +   S+    +L+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 471 GN 472
            N
Sbjct: 552 QN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  254 bits (651), Expect = 2e-74
 Identities = 99/470 (21%), Positives = 179/470 (38%), Gaps = 37/470 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTG-QLPVSIGNLSALQVIDIRGNRLGGK 61
            A    L       IG +L  L+ L++A N +   +LP    NL+ L+ +D+  N++   
Sbjct: 106 VAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 62  IPDTLGQLRKL----IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN 117
               L  L ++    + L++  N  +  I P  +       + L++N    ++    +  
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223

Query: 118 LPNLRKF------VAAKNNLTGFLPISLSNASNLELLELRDNQ---FIGKMSINFNSLKN 168
           L  L            + NL  F   +L    NL + E R      ++  +   FN L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 169 LSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTID 228
           +S   L +  +          V   +     ++L L + +FG      L +L        
Sbjct: 284 VSSFSLVSVTIE--------RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR------ 329

Query: 229 IGGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGYI 286
           +      G       +L  L  + +  N L   G          +L+ L L+ N +   +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388

Query: 287 PSSLGNLTMLTLLALEINNLQGKIPSS-LGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS 345
            S+   L  L  L  + +NL+     S   +  +LI L +S              +++L 
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448

Query: 346 LFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
             L ++ N    +   +I   L+NL  LD+S  +     P   ++ +SL+ + M  N+F 
Sbjct: 449 -VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507

Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL-SFLEYLNLSYNHFEG 453
                    L S++VLD S N +     + L++  S L +LNL+ N F  
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  245 bits (628), Expect = 3e-71
 Identities = 103/508 (20%), Positives = 165/508 (32%), Gaps = 51/508 (10%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D   N L             +L+ L L+   +      +  +LS L  + + GN +    
Sbjct: 34  DLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
                 L  L  L       +      I ++ + + + +  N        +  +NL NL 
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 123 KFVAAKNNLTGFLPISLSNASNLEL---------------------------LELRDNQF 155
               + N +       L     + L                           L LR+N  
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD 212

Query: 156 IGKMSIN-FNSLKNLSVLILGNNHL---GNRAANDLDFVTVLANCSKLENLGLYDNQFGG 211
              +       L  L V  L        GN    D   +  L N +  E    Y + +  
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272

Query: 212 LLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKN 271
            +      L+N +++  +                     + +   +  G  P     LK+
Sbjct: 273 DIIDLFNCLTN-VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF-GQFPT--LKLKS 326

Query: 272 LQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ--GKIPSSLGNCTSLIMLTLSKNK 329
           L+ L   SN   G    S  +L  L  L L  N L   G    S    TSL  L LS N 
Sbjct: 327 LKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 330 LDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLS 388
           +   +    L +  L   L+   + L       +  +L+NL+ LDIS         G  +
Sbjct: 385 VIT-MSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 389 ACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
             +SLE +KM  NSF  +  P     L+++  LDLS  +L    P    +LS L+ LN+S
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502

Query: 448 YNHFEGEVPKKGVFSNK---TRFSLSGN 472
           +N+F         +           S N
Sbjct: 503 HNNFFSLDT--FPYKCLNSLQVLDYSLN 528

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  225 bits (575), Expect = 5e-64
 Identities = 88/485 (18%), Positives = 151/485 (31%), Gaps = 68/485 (14%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
            +NL L+ N L      S  +   LQV+D+    +          L  L  L +  N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNA 142
                +   +SS + +          L    + +L  L++   A N +  F LP   SN 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           +NLE L+L  N+       +   L  + +L L                          +L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL--------------------------SL 182

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP----GLGNLVHLNSIAMEGNQL 258
            L  N    + P +   +   +  + +  N+ S  +      GL  L     +  E    
Sbjct: 183 DLSLNPMNFIQPGAFKEIR--LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 259 IGTVPPEIGWLKNLQSLYLNSN------FLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
                 +   L+ L +L +         +    I      LT ++  +L    ++     
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VK 298

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL------------------FLNLSDNL 354
                     L L   K       ++ S+  L+                   FL+LS N 
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 355 LS--GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS-L 411
           LS  G          +L  LD+S N     +         LE++  Q ++       S  
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 412 NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FS 468
             L+++  LD+S              LS LE L ++ N F+       +F+         
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTFLD 476

Query: 469 LSGNG 473
           LS   
Sbjct: 477 LSQCQ 481

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (473), Expect = 3e-50
 Identities = 77/401 (19%), Positives = 136/401 (33%), Gaps = 31/401 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPV------SIGNLSALQVIDIRGN 56
             +NN    ++       L  LE   L       +  +      ++  L  L + + R  
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 57  RL---GGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFD 113
            L      I D    L  +   ++           S      ++ + L + +F G  P  
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKF-GQFPTL 322

Query: 114 MVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ--FIGKMSINFNSLKNLSV 171
            + +L  L        +  G    S  +  +LE L+L  N   F G  S +     +L  
Sbjct: 323 KLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 172 LILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHS-LANLSNTMTTIDIG 230
           L L  N +   ++N            +LE+L    +    +   S   +L N +  +DI 
Sbjct: 378 LDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDIS 429

Query: 231 GNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSS 289
             +           L  L  + M GN       P+I   L+NL  L L+   L    P++
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 290 LGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLN 349
             +L+ L +L +  NN             SL +L  S N +      ++    +   FLN
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549

Query: 350 LSDNLLSGSLPSE--IGNLKNLVQLDISGNRFSGDIPGTLS 388
           L+ N  + +   +  +  +K+  QL +   R     P    
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  148 bits (376), Expect = 1e-37
 Identities = 48/269 (17%), Positives = 93/269 (34%), Gaps = 16/269 (5%)

Query: 219 NLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLN 278
           NL  +   +D+  N           +   L  + +   ++          L +L +L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 279 SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
            N +      +   L+ L  L     NL       +G+  +L  L ++ N +     P+ 
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 339 LSVTTLSLFLNLSDNLLSGSLPSEIGNLKNL----VQLDISGNRFSGDIPGTLSACTSLE 394
            S  T    L+LS N +     +++  L  +    + LD+S N  +   PG       L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLH 203

Query: 395 YVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQ------IPKYLENLSFLEYLNLS 447
            + +++N  S ++    +  L  ++V  L   +   +          LE L  L      
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 448 YNHFEGEVPK-KGVFSNKTR---FSLSGN 472
             + +  +     +F+  T    FSL   
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (307), Expect = 6e-29
 Identities = 52/299 (17%), Positives = 97/299 (32%), Gaps = 57/299 (19%)

Query: 3   DAQNNKL--VGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
           D   N L   G            L+ L L+ N +   +  +   L  L+ +D + + L  
Sbjct: 353 DLSRNGLSFKGCCSQSDFG-TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 61  KIP-DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP 119
                    LR LIYL+I               +SS E + +  N F  +   D+   L 
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 120 NLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
           NL     ++  L    P + ++ S+L++L +  N F    +  +  L +L VL    NH+
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
                                                L +  +++  +++  N F+ T  
Sbjct: 531 ------------------------------MTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

Query: 240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTL 298
                                     + W+K+ + L +    +    PS    + +L+L
Sbjct: 561 ----------------------HQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  106 bits (267), Expect = 6e-24
 Identities = 23/129 (17%), Positives = 45/129 (34%), Gaps = 4/129 (3%)

Query: 325 LSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP 384
             +     + P  +   T     L+LS N L         +   L  LD+S         
Sbjct: 14  CMELNFYKI-PDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 385 GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYL 444
           G   + + L  + +  N        + + L S++ L      L+      + +L  L+ L
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 445 NLSYNHFEG 453
           N+++N  + 
Sbjct: 130 NVAHNLIQS 138

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  263 bits (674), Expect = 2e-77
 Identities = 82/480 (17%), Positives = 160/480 (33%), Gaps = 50/480 (10%)

Query: 26  NLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSG- 84
           N +   +    Q  VS+ +   +  + + G    G++PD +GQL +L  L +G +     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 85  ---FIPPSIYNISSFEFIFLQSNRFHGS-LPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
              F P  I    S E        +  + + +D   +  +L K     +     +  S  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
                  +    N  I  +S     L  L    +GN+                  C   E
Sbjct: 181 ITLKDTQIGQLSNN-ITFVSKAVMRLTKLRQFYMGNSPF-----------VAENICEAWE 228

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI- 259
           N      Q          NL + +T +++        +P  L  L  +  I +  N+ I 
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKD-LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

Query: 260 -------GTVPPEIGWLKNLQSLYLNSN-FLHGYIPSSLGNLTMLTLLALEINNLQGKIP 311
                       +    + +Q +Y+  N      + +SL  +  L +L    N L+GK+P
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS--EIGNLKNL 369
            + G+   L  L L+ N++   +P      T     L+ + N L   +P+  +  ++  +
Sbjct: 348 -AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVM 404

Query: 370 VQLDISGNRFSG-------DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
             +D S N            +  T     ++  + + +N  S       +    +  ++L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

Query: 423 SSNKLSG-------QIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKT---RFSLSGN 472
             N L+           +  +N   L  ++L +N     +      +         LS N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYN 523

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  260 bits (667), Expect = 2e-76
 Identities = 69/498 (13%), Positives = 151/498 (30%), Gaps = 67/498 (13%)

Query: 3   DAQNNKLVGDIPVEIG-CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
                                 L    +  +     +  S         I    N +   
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           +   + +L KL    +G + F        +   +      +  + + +       NL +L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKW-DNLKDL 251

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI--------NFNSLKNLSVLI 173
                        LP  L     ++L+ +  N+ I    +        +    + + ++ 
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311

Query: 174 LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY 233
           +G N+L           T L    KL  L    NQ  G LP +  +    + ++++  N 
Sbjct: 312 IGYNNL-----KTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIK-LASLNLAYNQ 364

Query: 234 FSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPP--EIGWLKNLQSLYLNSNFLHGY----- 285
            +  IP    G    + +++   N+L   +P   +   +  + ++  + N +        
Sbjct: 365 ITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422

Query: 286 --IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGV-------LPP 336
             +  +      ++ + L  N +           + L  + L  N L  +          
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 337 QILSVTTLSLFLNLSDNLLSGSLPSEI--GNLKNLVQLDISGNRFSGDIPGTLSACTSLE 394
              +   L+  ++L  N L+  L  +     L  LV +D+S N FS   P      ++L+
Sbjct: 483 NFKNTYLLT-SIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539

Query: 395 YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE 454
              +++                    D   N+   + P+ +     L  L +  N     
Sbjct: 540 GFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580

Query: 455 VPKKGVFSNKTRFSLSGN 472
           V  + +  N +   +  N
Sbjct: 581 VN-EKITPNISVLDIKDN 597

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  257 bits (658), Expect = 3e-75
 Identities = 90/493 (18%), Positives = 153/493 (31%), Gaps = 57/493 (11%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGNRL 58
             +     G +P  IG  L +LE L+L  +          P  I    + +         
Sbjct: 87  SLEGFGASGRVPDAIGQ-LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 59  GGKIPDTLG--QLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVA 116
                D         LI   I  +     I  S         I   SN     +    V 
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVS-KAVM 203

Query: 117 NLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGN 176
            L  LR+F    +              N E       Q      + +++LK+L+ + + N
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYN 258

Query: 177 NHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL--LPHSLANLSNT-----MTTIDI 229
                +        T L    +++ + +  N+      L      L++      +  I I
Sbjct: 259 CPNLTK------LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312

Query: 230 GGNYF-SGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPS 288
           G N   +  +   L  +  L  +    NQL G   P  G    L SL L  N +     +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPAN 371

Query: 289 SLGNLTMLTLLALEINNLQGKIPSSL--GNCTSLIMLTLSKNKLDGV-------LPPQIL 339
             G    +  L+   N L+  IP+     + + +  +  S N++  V       L P   
Sbjct: 372 FCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430

Query: 340 SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-------DIPGTLSACTS 392
               +S  +NLS+N +S            L  +++ GN  +        D          
Sbjct: 431 KGINVS-SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489

Query: 393 LEYVKMQDNSFSGSIPPSLNF--LKSIKVLDLSSNKLSGQIPKYLENLSFLEYL------ 444
           L  + ++ N  +  +        L  +  +DLS N  S   P    N S L+        
Sbjct: 490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547

Query: 445 NLSYNHFEGEVPK 457
           +   N    E P+
Sbjct: 548 DAQGNRTLREWPE 560

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  248 bits (635), Expect = 5e-72
 Identities = 88/466 (18%), Positives = 145/466 (31%), Gaps = 69/466 (14%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
            F   N+  V +   E        EN +           +   NL  L  +++       
Sbjct: 210 QFYMGNSPFVAENICEA------WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
           K+P  L  L ++  +N+  N+          +  +                         
Sbjct: 264 KLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAP----------------VGEK 306

Query: 121 LRKFVAAKNNL-TGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
           ++      NNL T  +  SL     L +LE   NQ  GK+   F S   L+ L L  N +
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPH-SLANLSNTMTTIDIGGNYFSGTI 238
               AN            ++ENL    N+   +       ++S  M+ ID   N      
Sbjct: 366 TEIPAN------FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV-MSAIDFSYNEIGSVD 418

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTL 298
                 L                  P      N+ S+ L++N +  +        + L+ 
Sbjct: 419 GKNFDPL-----------------DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461

Query: 299 LALEINNLQG-------KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNL 350
           + L  N L             +  N   L  + L  NKL   L     + T   L  ++L
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDL 520

Query: 351 SDNLLSGSLPSEIGNLKNLVQLDI------SGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
           S N  S   P++  N   L    I       GNR   + P  ++ C SL  +++  N   
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579

Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
             +   +    +I VLD+  N        Y+          L Y+ 
Sbjct: 580 -KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  258 bits (660), Expect = 4e-75
 Identities = 91/489 (18%), Positives = 164/489 (33%), Gaps = 48/489 (9%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D   N +   +  E+   L  L+ L+L  N L+     +    + L  + +  N +    
Sbjct: 55  DVGFNTISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
            +   + + LI L++  N  S     +   + + + + L +N+       +         
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE--------- 164

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
                         + +   S+L+ LEL  NQ        F+++  L  L L N  LG  
Sbjct: 165 --------------LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS 210

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNT-MTTIDIGGNYFSGTIPPG 241
               L    +    + + NL L ++Q       +   L  T +T +D+  N  +      
Sbjct: 211 LTEKL---CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNF---------LHGYIPSSLGN 292
              L  L    +E N +       +  L N++ L L  +F         L      S   
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

Query: 293 LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGV-LPPQILSVTTLSL--FLN 349
           L  L  L +E N++ G   +      +L  L+LS +      L  +       S    LN
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387

Query: 350 LSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPG-TLSACTSLEYVKMQDNSFSGSIP 408
           L+ N +S         L +L  LD+  N    ++ G       ++  + +  N +     
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447

Query: 409 PSLNFLKSIKVLDLSSNKLSG--QIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKT- 465
            S   + S++ L L    L      P   + L  L  L+LS N+         +      
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND--DMLEGLEK 505

Query: 466 --RFSLSGN 472
                L  N
Sbjct: 506 LEILDLQHN 514

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (652), Expect = 6e-74
 Identities = 93/469 (19%), Positives = 161/469 (34%), Gaps = 44/469 (9%)

Query: 3   DAQNNKLVGDIPVEI--GCYLFKLENLSLAENHLTGQLPVSIGNL--SALQVIDIRGNRL 58
              N +L   +  ++        + NLSL+ + L+     +   L  + L ++D+  N L
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260

Query: 59  GGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANL 118
                D+   L +L Y  +  N        S++ + +  ++ L+ +    S+        
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL------ 314

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH 178
                      +L      S      LE L + DN   G  S  F  L NL  L L N+ 
Sbjct: 315 ----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
              R   +  FV++    S L  L L  N+   +   + + L + +  +D+G N     +
Sbjct: 365 TSLRTLTNETFVSL--AHSPLHILNLTKNKISKIESDAFSWLGH-LEVLDLGLNEIGQEL 421

Query: 239 PPG-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG--YIPSSLGNLTM 295
                  L ++  I +  N+ +         + +LQ L L    L      PS    L  
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           LT+L L  NN+       L     L +L L  N L                   L  +  
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-----------------RLWKHAN 524

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
            G     +  L +L  L++  N F             L+ + +  N+ +       N   
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584

Query: 416 SIKVLDLSSNKLSGQIPKYLE-NLSFLEYLNLSYNHFEGEVPKKGVFSN 463
           S+K L+L  N ++    K        L  L++ +N F+        F N
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  247 bits (634), Expect = 2e-71
 Identities = 91/467 (19%), Positives = 155/467 (33%), Gaps = 60/467 (12%)

Query: 6   NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDT 65
           + KL   +P ++      +  L+L  N L      +    S L  +D+  N +    P+ 
Sbjct: 13  HLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
             +L  L  LN+  N+ S     +                          A   NL +  
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTF-------------------------AFCTNLTELH 103

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
              N++            NL  L+L  N            L+NL  L+L NN +    + 
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLG-- 243
           +LD        S L+ L L  NQ     P     +   +  + +       ++   L   
Sbjct: 164 ELDIF----ANSSLKKLELSSNQIKEFSPGCFHAIGR-LFGLFLNNVQLGPSLTEKLCLE 218

Query: 244 -NLVHLNSIAMEGNQLIGTVPPEIGWLK--NLQSLYLNSNFLHGYIPSSLGNLTMLTLLA 300
                + ++++  +QL  T       LK  NL  L L+ N L+     S   L  L    
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP 360
           LE NN+Q     SL    ++  L L ++                    ++S   L     
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK----------------QSISLASLPKIDD 322

Query: 361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF----LKS 416
                LK L  L++  N   G      +   +L+Y+ + ++  S     +  F       
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

Query: 417 IKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
           + +L+L+ NK+S         L  LE L+L  N    E+     +  
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-GQEWRG 428

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  184 bits (470), Expect = 3e-49
 Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 12/285 (4%)

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
           + +  L L  NQ   L   +    S  +T++D+G N  S   P     L  L  + ++ N
Sbjct: 25  TNITVLNLTHNQLRRLPAANFTRYSQ-LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
           +L         +  NL  L+L SN +     +       L  L L  N L      +   
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGNLKNLVQLDIS 375
             +L  L LS NK+  +   ++      SL  L LS N +    P     +  L  L ++
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 376 GNRFSGDIPGTLS---ACTSLEYVKMQDNSFSGSIPPSLNFLK--SIKVLDLSSNKLSGQ 430
             +    +   L    A TS+  + + ++  S +   +   LK  ++ +LDLS N L+  
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 431 IPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFS---LSGN 472
                  L  LEY  L YN+ +                   L  +
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFS--HSLHGLFNVRYLNLKRS 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  138 bits (351), Expect = 4e-34
 Identities = 66/340 (19%), Positives = 126/340 (37%), Gaps = 20/340 (5%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIG----NLSALQVIDIRGNR 57
            + ++N + G I   +   L  L+ LSL+ +  + +   +        S L ++++  N+
Sbjct: 334 LNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392

Query: 58  LGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPS-IYNISSFEFIFLQSNRFHGSLPFDMVA 116
           +     D    L  L  L++G N+    +       + +   I+L  N++   L  +  A
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ-LTRNSFA 451

Query: 117 NLPNLRKFVAAKNNLTGF--LPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLIL 174
            +P+L++ +  +  L      P       NL +L+L +N            L+ L +L L
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511

Query: 175 GNNHLGN--RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN 232
            +N+L    + AN    +  L   S L  L L  N F  +      +L   +  ID+G N
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE-LKIIDLGLN 570

Query: 233 YFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEI--GWLKNLQSLYLNSNFLHGYIPSSL 290
             +        N V L S+ ++ N +  +V  ++     +NL  L +  N       S  
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLI-TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629

Query: 291 GNLTMLTLLALEINNLQGKI----PSSLGNCTSLIMLTLS 326
             +  +      I  L        P        + +   S
Sbjct: 630 WFVNWINETHTNIPELSSHYLCNTPPHYHG-FPVRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (276), Expect = 6e-25
 Identities = 39/183 (21%), Positives = 62/183 (33%), Gaps = 28/183 (15%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
           + +    +   L   +P  L   T +T+L L  N L+    ++    + L          
Sbjct: 5   SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLT--------- 52

Query: 331 DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSAC 390
                            L++  N +S   P     L  L  L++  N  S     T + C
Sbjct: 53  ----------------SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96

Query: 391 TSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
           T+L  + +  NS            K++  LDLS N LS         L  L+ L LS N 
Sbjct: 97  TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156

Query: 451 FEG 453
            + 
Sbjct: 157 IQA 159

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (270), Expect = 3e-24
 Identities = 38/160 (23%), Positives = 53/160 (33%), Gaps = 10/160 (6%)

Query: 317 CT-SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDIS 375
           CT S  +   S  KL  V P  + +  T    LNL+ N L     +       L  LD+ 
Sbjct: 2   CTVSHEVADCSHLKLTQV-PDDLPTNIT---VLNLTHNQLRRLPAANFTRYSQLTSLDVG 57

Query: 376 GNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYL 435
            N  S   P        L+ + +Q N  S     +  F  ++  L L SN +        
Sbjct: 58  FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 436 ENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
                L  L+LS+N         G            LS N
Sbjct: 118 VKQKNLITLDLSHNGLSSTKL--GTQVQLENLQELLLSNN 155

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  238 bits (609), Expect = 9e-72
 Identities = 96/351 (27%), Positives = 155/351 (44%), Gaps = 49/351 (13%)

Query: 524 RRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVA 583
             S + +   + +V  +   +    L +AT+ F    ++G G FG V+KG++  +G  VA
Sbjct: 9   TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVA 67

Query: 584 VKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSL 643
           +K         ++ F TE E L   RH +L+ +I  C        +   ++Y +M+NG+L
Sbjct: 68  LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNL 122

Query: 644 EEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV 703
           +  L+     L   ++S  Q L I I  A  + YLH      ++H D+K  N+LLD + V
Sbjct: 123 KRHLY--GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177

Query: 704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG------DVY 757
             + DFG++K        T +     S+ +KGT+GYI PEY       + G      DVY
Sbjct: 178 PKITDFGISKKGTELD-QTHL-----STVVKGTLGYIDPEY------FIKGRLTEKSDVY 225

Query: 758 SFGILLLEMFSRRRPTDSMFHEGLT--LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSR 815
           SFG++L E+   R          +        +     ++ +IVDP+L  ++R       
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR------- 278

Query: 816 GGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQD 866
                   E L       V C   S  DR  M DV+ KL    E  + +Q+
Sbjct: 279 -------PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL----EYALRLQE 318

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  242 bits (619), Expect = 4e-70
 Identities = 83/481 (17%), Positives = 168/481 (34%), Gaps = 21/481 (4%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D    ++   I  +      +L+ L L  N L      ++    AL+ +      +    
Sbjct: 63  DLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
              L   + L  L +G N  S    P  +     + +  Q+N  H  L  + +++L    
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQAT 180

Query: 123 K-FVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM--SINFNSLKNLSVLILGNNHL 179
              +    N    +     +++  + L     Q +  +   +  +++++L +    +   
Sbjct: 181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240

Query: 180 GNRAANDLDFVTVLANC-SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
                 D+        C   +E++ L  + F  +  ++    S  +  +D+   + S  +
Sbjct: 241 -----EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG-LQELDLTATHLS-EL 293

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPS-SLGNLTMLT 297
           P GL  L  L  + +  N+             +L  L +  N     + +  L NL  L 
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353

Query: 298 LLALEINNLQ--GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
            L L  ++++        L N + L  L LS N+   +          L   L+L+   L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRL 412

Query: 356 SGSLP-SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI---PPSL 411
                 S   NL  L  L++S +              +L+++ +Q N F         SL
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 412 NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSG 471
             L  +++L LS   LS        +L  + +++LS+N       +          +L+ 
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS 532

Query: 472 N 472
           N
Sbjct: 533 N 533

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  230 bits (589), Expect = 7e-66
 Identities = 89/463 (19%), Positives = 156/463 (33%), Gaps = 23/463 (4%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
            E L  + N L      +   L  L  +D+   ++     DT     +L  L +  N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                ++    + + +F        S+ F  + N   L       N+++           
Sbjct: 95  FMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSV--LILGNNHLGNRAANDLDFVTVLANCSKLEN 201
            L++L+ ++N        + +SL+  +   L L  N +               + +  ++
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG-------AFDSAVFQS 206

Query: 202 LGLYDNQFGGLLPHSLANLS-NTMTTIDIGGN---YFSGTIPPGLGNLVHLNSIAMEGNQ 257
           L     Q   ++   L N +  ++             S  +  GL  +  + SI ++ + 
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHY 265

Query: 258 LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC 317
                         LQ L L +  L   +PS L  L+ L  L L  N  +     S  N 
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324

Query: 318 TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL--SGSLPSEIGNLKNLVQLDIS 375
            SL  L++  N     L    L        L+LS + +  S     ++ NL +L  L++S
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 376 GNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSNKLSGQIPKY 434
            N            C  LE + +           S    L  +KVL+LS + L     + 
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444

Query: 435 LENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTR---FSLSGNG 473
            + L  L++LNL  NHF     +K        R     LS   
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  221 bits (564), Expect = 2e-62
 Identities = 99/463 (21%), Positives = 173/463 (37%), Gaps = 24/463 (5%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
                 +     + +      LE+L L  NH++            L+V+D + N +    
Sbjct: 111 FFIQTGISSIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169

Query: 63  PDTLGQLRKL--IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMV-ANLP 119
            + +  L++   + LN+  N  +G I P  ++ + F+ +     +    +   +  + + 
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228

Query: 120 NLRKFVAAKNNLTGFLPISLSN--ASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN 177
           +L        +     P         ++E + L+ + F    S  F+    L  L L   
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

Query: 178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT 237
           HL           + L   S L+ L L  N+F  L   S +N  + +T + I GN     
Sbjct: 289 HLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNTKRLE 340

Query: 238 IPPG-LGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLT 294
           +  G L NL +L  + +  + +        ++  L +LQSL L+ N        +     
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400

Query: 295 MLTLLALEINNLQGKIP-SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
            L LL L    L+ K   S   N   L +L LS + LD     Q+         LNL  N
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGN 459

Query: 354 LLSG---SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS 410
                     + +  L  L  L +S    S       ++   + +V +  N  + S   +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519

Query: 411 LNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
           L+ LK I  L+L+SN +S  +P  L  LS    +NL  N  + 
Sbjct: 520 LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  180 bits (458), Expect = 4e-48
 Identities = 80/438 (18%), Positives = 150/438 (34%), Gaps = 30/438 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGN--LSALQVIDIRGNRLGG 60
           +   N +   I           ++L+         +   + N  + +L +          
Sbjct: 185 NLNGNDI-AGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 61  KIPDTLGQLRK--LIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANL 118
             P     L +  +  +N+ ++ F      + +  S  + + L +      LP   +  L
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP-SGLVGL 300

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNN 177
             L+K V + N       IS SN  +L  L ++ N    ++      +L+NL  L L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT 237
            +      +L       N S L++L L  N+   L   +       +  +D+        
Sbjct: 361 DIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKECPQ-LELLDLAFTRLKVK 415

Query: 238 IPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYI---PSSLGNL 293
                  NL  L  + +  + L  +       L  LQ L L  N          +SL  L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
             L +L L   +L      +  +   +  + LS N+L      + LS     ++LNL+ N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLK-GIYLNLASN 533

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTS---LEYVKMQDNSFSGSIPPS 410
            +S  LPS +  L     +++  N            C++   LE+ K        +    
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCT-------CSNIYFLEWYKENMQKLEDTEDTL 586

Query: 411 LNFLKSIKVLDLSSNKLS 428
                 ++ + LS   LS
Sbjct: 587 CENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (322), Expect = 8e-31
 Identities = 42/264 (15%), Positives = 83/264 (31%), Gaps = 13/264 (4%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYL 277
             L N+   ++   N            L++L  + +   Q+             L +L L
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88

Query: 278 NSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQ 337
            +N L     ++L     L  L      +       L N  +L  L L  N +  +  P+
Sbjct: 89  TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

Query: 338 ILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNL--VQLDISGNRFSGDIPGTLSACTSLEY 395
                 L   L+  +N +      ++ +L+    + L+++GN  +G I          + 
Sbjct: 149 GFPTEKLK-VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQS 206

Query: 396 VKMQDNSFSGSIPPSLNF--LKSIKVLDLSSNKLSGQIPKYLENLSF--LEYLNLSYNHF 451
           +          I   L    ++S+ +            P   E L    +E +NL  ++F
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266

Query: 452 EGEVPKKGVFSNKTR---FSLSGN 472
                    F   +      L+  
Sbjct: 267 FNISS--NTFHCFSGLQELDLTAT 288

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 97.0 bits (242), Expect = 7e-21
 Identities = 30/154 (19%), Positives = 49/154 (31%), Gaps = 9/154 (5%)

Query: 322 MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG 381
                   L+ + P  + + T     L  S N+L     +    L NL  LD++  +   
Sbjct: 16  TYNCENLGLNEI-PGTLPNSTE---CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 382 DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFL 441
               T  +   L+ + +  N        +L+  K++K L      +S      L N   L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 442 EYLNLSYNHFEGEVPKKGVFSNKTRF---SLSGN 472
           E L L  NH      K        +        N
Sbjct: 132 ESLYLGSNHISS--IKLPKGFPTEKLKVLDFQNN 163

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 95.1 bits (237), Expect = 3e-20
 Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 4/150 (2%)

Query: 304 NNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI 363
             L  +IP +L N  S   L  S N L  +       +  L+ FL+L+   +        
Sbjct: 22  LGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLT-FLDLTRCQIYWIHEDTF 77

Query: 364 GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
            +   L  L ++ N         LS   +L+++       S      L+  K+++ L L 
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137

Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
           SN +S            L+ L+   N    
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  224 bits (574), Expect = 5e-67
 Identities = 88/337 (26%), Positives = 143/337 (42%), Gaps = 52/337 (15%)

Query: 532 ERTTMVEQQFPMISYAKLSKATSEFSS------SNMVGQGSFGTVFKGIIGENGMLVAVK 585
           +   + + +F   S+ +L   T+ F         N +G+G FG V+KG +  N   VAVK
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVK 60

Query: 586 VLNLMQKGA----LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNG 641
            L  M         + F  E + +   +H NL++++   S       D   +VY +M NG
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNG 115

Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
           SL + L   +       LS      IA   A+ I +LH +     +H D+K +N+LLD  
Sbjct: 116 SLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSF 759
             A + DFGLA+        TV+     +S I GT  Y+APE   G  +  S   D+YSF
Sbjct: 170 FTAKISDFGLARASEKF-AQTVM-----TSRIVGTTAYMAPEALRGEITPKS---DIYSF 220

Query: 760 GILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK--VMEIVDPSLLLEVRANNSMSRGG 817
           G++LLE+ +     D        L +  + +  E+  + + +D  +      N++ S   
Sbjct: 221 GVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM------NDADSTSV 273

Query: 818 ERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
           E          +  +   C  E    R  ++ V   L
Sbjct: 274 EA---------MYSVASQCLHEKKNKRPDIKKVQQLL 301

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  237 bits (606), Expect = 2e-66
 Identities = 75/479 (15%), Positives = 155/479 (32%), Gaps = 50/479 (10%)

Query: 26  NLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGF 85
           N +   +    Q  V + N   +  + + G    G++PD +GQL +L  L+ G +  +  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTG---FLPISLSNA 142
                    + +    + +R         +     L      ++ +       PI   + 
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 143 SNLELLELRD-NQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
            +L+  ++ +    I  +S     L  L ++   N+             T        E+
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF-----------TYDNIAVDWED 471

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG- 260
                 +       S +NL + +T +++        +P  L +L  L S+ +  N+ I  
Sbjct: 472 ANSDYAKQYENEELSWSNLKD-LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 261 --------TVPPEIGWLKNLQSLYLNSNFLHGYIPSS--LGNLTMLTLLALEINNLQGKI 310
                    +  +      +Q  Y+  N L    P+S  L  +  L LL    N +  + 
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RH 587

Query: 311 PSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS--EIGNLKN 368
             + G    L  L L  N+++  +P    + T     L  S N L   +P+     ++  
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645

Query: 369 LVQLDISGNRFSGDIPGTLSA-----CTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
           +  +D S N+   +      +       +   V +  N               I  + LS
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705

Query: 424 SNKLS-------GQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
           +N ++              +N   L  ++L +N     +      +         +S N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYN 763

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  222 bits (568), Expect = 3e-61
 Identities = 72/499 (14%), Positives = 138/499 (27%), Gaps = 102/499 (20%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
           +    N+    D            E+ +           +S  NL  L  +++       
Sbjct: 452 IIYFANSPFTYDNIAVD------WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
           ++PD L  L +L  LNI  N+          + +                          
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTR------------------------- 539

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIG-KMSINFNSLKNLSVLILGNNHL 179
                         L         +++  +  N       S +   +  L +L   +N +
Sbjct: 540 --------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV 585

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
                     +       KL +L L  NQ    +P      ++ +  +    N     IP
Sbjct: 586 R--------HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIP 635

Query: 240 P--GLGNLVHLNSIAMEGNQLIGTVPPEIGW------LKNLQSLYLNSNFLHGYIPSSLG 291
                 ++  + S+    N+ IG+    I          N  ++ L+ N +  +      
Sbjct: 636 NIFNAKSVYVMGSVDFSYNK-IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694

Query: 292 NLTMLTLLALEINNLQ-------GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
             + ++ + L  N +             +  N   L  + L  NKL   L     + T  
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLP 753

Query: 345 SL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
            L  +++S N  S S P++  N   L    I   R                    + N  
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD------------------AEGNRI 794

Query: 404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
               P  +    S+  L + SN +   + + L     L  L+++ N     +    V   
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI-SIDVTSVCPY 850

Query: 464 KT----RFSLSGNGKLCGG 478
                          + G 
Sbjct: 851 IEAGMYVLLYDKTQDIRGC 869

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 14/119 (11%), Positives = 32/119 (26%), Gaps = 1/119 (0%)

Query: 371 QLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQ 430
            LD    R+            +      + + +       L+    +  L L+     G+
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338

Query: 431 IPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPS 489
           +P  +  L+ L+ L+   +         G        S     ++     +  L     
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  211 bits (539), Expect = 5e-62
 Identities = 71/334 (21%), Positives = 128/334 (38%), Gaps = 57/334 (17%)

Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
           +    L   +       +  +G FG V+K  +      VAVK+   +Q         E  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP-IQDKQSWQNEYEVY 70

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
           +L  ++H N+++ I        +      ++  F + GSL ++L  N        +S  +
Sbjct: 71  SLPGMKHENILQFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNE 122

Query: 664 TLNIAIDVASAIEYLHHH-------CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP 716
             +IA  +A  + YLH          KP + H D+K  NVLL +++ A + DFGLA    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRR 771
           A       ++   + G  GT  Y+APE   G+     +A +  D+Y+ G++L E+ SR  
Sbjct: 183 A------GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 772 PTDSMFHEGL-----------TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV 820
             D    E +           +L +  ++V+ +K      P L              +  
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK----KRPVL-------------RDYW 279

Query: 821 KIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
           +    +  +      C       R+    V  ++
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  212 bits (543), Expect = 1e-59
 Identities = 87/466 (18%), Positives = 159/466 (34%), Gaps = 35/466 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTG-QLPVSIGNLSALQVIDIRGNRLGGK 61
            A   KL   +       L  L+ L++A N +   +LP    NL+ L  +D+  N +   
Sbjct: 110 VAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168

Query: 62  IPDTLGQLRKL----IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN 117
             + L  LR+     + L++  N    FI    +       + L+ N    ++    + N
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227

Query: 118 LPNLRKFVAAKNNLTGFLPISLSNASNLE--------LLELRDNQFIGKMSINFNSLKNL 169
           L  L               + +   S +E           L          + F+ L N+
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287

Query: 170 SVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDI 229
           S + L    +         ++  +    K ++L +   Q        L  L     ++ +
Sbjct: 288 SAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL----KSLTL 335

Query: 230 GGNYFSGTIPPGLGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFLHGYIP 287
             N   G+I      L  L+ + +  N L   G          +L+ L L+ N     + 
Sbjct: 336 TMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS 392

Query: 288 SSLGNLTMLTLLALEINNLQGKIP-SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL 346
           ++   L  L  L  + + L+     S+  +   L+ L +S            L +T+L+ 
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN- 451

Query: 347 FLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG 405
            L ++ N    +  S +  N  NL  LD+S  +      G       L+ + M  N+   
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511

Query: 406 SIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
                 N L S+  LD S N++             L + NL+ N  
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  203 bits (518), Expect = 3e-56
 Identities = 85/469 (18%), Positives = 146/469 (31%), Gaps = 33/469 (7%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
             +L+ L L+   +      +   L  L  + + GN +    P +   L  L  L     
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           + +      I  + + + + +  N  H        +NL NL     + N +       L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 141 NASNLEL----LELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
                      L++  N  I  +         L  L L  N       +     T L N 
Sbjct: 175 FLRENPQVNLSLDMSLNP-IDFIQDQAFQGIKLHELTLRGNFN-----SSNIMKTCLQNL 228

Query: 197 SKLENLGLYDNQFGG------LLPHSLANLSN-TMTTIDIGGNYFSGTIPPGLGNLVHLN 249
           + L    L   +F          P  +  L + T+    +               L +++
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288

Query: 250 SIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGK 309
           ++++ G  +      ++      QSL +    L  +    L  L  LTL        +G 
Sbjct: 289 AMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL-----TMNKGS 341

Query: 310 IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGNLKN 368
           I        SL  L LS+N L          + T SL  L+LS N     + +    L+ 
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE 400

Query: 369 LVQLDISGNRFSGDIP-GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL 427
           L  LD   +            +   L Y+ +   +           L S+  L ++ N  
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460

Query: 428 SGQIPKY-LENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
                     N + L +L+LS    E      GVF    R    ++S N
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFDTLHRLQLLNMSHN 507

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (478), Expect = 8e-51
 Identities = 82/465 (17%), Positives = 155/465 (33%), Gaps = 56/465 (12%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
            +N+ L+ N L      S  N S LQ +D+    +          L  L  L +  N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
            F P S                          + L +L   VA +  L       +    
Sbjct: 94  SFSPGSF-------------------------SGLTSLENLVAVETKLASLESFPIGQLI 128

Query: 144 NLELLELRDNQFIG-KMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
            L+ L +  N     K+   F++L NL  + L  N++     NDL F+          +L
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN--PQVNLSL 186

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN------LVHLNSIAMEGN 256
            +  N    +   +   +   +  + + GN+ S  I            +  L     +  
Sbjct: 187 DMSLNPIDFIQDQAFQGIK--LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

Query: 257 QLIGTVPPEI-GWLKNLQ--SLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSS 313
           + +    P I   L ++      L               L  ++ ++L   ++  K    
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLED 302

Query: 314 LGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLD 373
           +        L++ + +L       +  + +    L L+ N    S+  +   L +L  LD
Sbjct: 303 VPKHFKWQSLSIIRCQLKQFPTLDLPFLKS----LTLTMNKG--SISFKKVALPSLSYLD 356

Query: 374 ISGNRFSGDIPGTLS--ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI 431
           +S N  S     + S     SL ++ +  N     +  +   L+ ++ LD   + L    
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT 415

Query: 432 PKY-LENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
                 +L  L YL++SY + + +    G+F   T      ++GN
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFD--GIFLGLTSLNTLKMAGN 458

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  123 bits (312), Expect = 2e-29
 Identities = 48/269 (17%), Positives = 87/269 (32%), Gaps = 15/269 (5%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYL 277
            ++ ++   ID+  N           N   L  + +   ++          L +L +L L
Sbjct: 28  DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87

Query: 278 NSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQ 337
             N +  + P S   LT L  L      L       +G   +L  L ++ N +     P 
Sbjct: 88  TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147

Query: 338 ILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNL----VQLDISGNRFSGDIPGTLSACTSL 393
             S  T  + ++LS N +     +++  L+      + LD+S N     I         L
Sbjct: 148 YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKL 206

Query: 394 EYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQI------PKYLENLSFLEYLNL 446
             + ++ N  S +I    L  L  + V  L   +   +       P  +E L  +     
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266

Query: 447 SYNHFEGEVPKKGVFSNKTR---FSLSGN 472
              +          F         SL+G 
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGV 295

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 99.3 bits (248), Expect = 1e-21
 Identities = 38/168 (22%), Positives = 56/168 (33%), Gaps = 9/168 (5%)

Query: 308 GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK 367
           G +   +    ++        KL  V P  I S T     ++LS N L         N  
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKV-PDDIPSSTK---NIDLSFNPLKILKSYSFSNFS 56

Query: 368 NLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL 427
            L  LD+S                 L  + +  N      P S + L S++ L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 428 SGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRF---SLSGN 472
           +      +  L  L+ LN+++N           FSN T      LS N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTNLVHVDLSYN 163

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.3 bits (170), Expect = 3e-12
 Identities = 19/105 (18%), Positives = 31/105 (29%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
               N    +    +      L  L L++  L          L  LQ++++  N L    
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFH 107
                QL  L  L+   N+         +   S  F  L +N   
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  198 bits (506), Expect = 4e-57
 Identities = 70/333 (21%), Positives = 132/333 (39%), Gaps = 44/333 (13%)

Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
            + ++ S          ++G+G +G V+KG +  +   VAVKV +   +   ++F+ E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKN 57

Query: 604 --ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
              +  + H N+ + I     +  +G     +V ++  NGSL ++L  +           
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDW 110

Query: 662 IQTLNIAIDVASAIEYLH------HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
           + +  +A  V   + YLH       H KP + H DL   NVL+ +D    + DFGL+  L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-------EASMTGDVYSFGILLLEMFS 768
               L    E  +++    GT+ Y+APE   G+        A    D+Y+ G++  E+F 
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI------ 822
           R   TD    E +      +  +  +      P+          +SR  +R K       
Sbjct: 231 RC--TDLFPGESVP-----EYQMAFQTEVGNHPTFEDMQVL---VSREKQRPKFPEAWKE 280

Query: 823 -EECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
               + ++      C  +    R+  +    ++
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  192 bits (490), Expect = 2e-53
 Identities = 112/445 (25%), Positives = 178/445 (40%), Gaps = 45/445 (10%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L +     L + ++T    VS  +L  +  +      +  K  D +  L  L  +N   N
Sbjct: 23  LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           Q +   P  + N++    I + +N+     P    ANL NL       N +T      L 
Sbjct: 79  QLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITD--IDPLK 131

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
           N +NL  LEL  N          + L +L  L  GN             +  LAN + LE
Sbjct: 132 NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---------LKPLANLTTLE 180

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG 260
            L +  N+   +    LA L+N + ++    N  S   P  LG L +L+ +++ GNQL  
Sbjct: 181 RLDISSNKVSDISV--LAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNGNQL-- 233

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
                +  L NL  L L +N +    P  L  LT LT L L  N +     S L   T+L
Sbjct: 234 KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 289

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS 380
             L L++N+L+ + P  I ++  L+ +L L  N +S    S + +L  L +L    N+ S
Sbjct: 290 TNLELNENQLEDISP--ISNLKNLT-YLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVS 344

Query: 381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF 440
            D+   L+  T++ ++    N  S   P  L  L  I  L L+    +     Y  N+S 
Sbjct: 345 -DVSS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS- 399

Query: 441 LEYLNLSYNHFEGEVPKKGVFSNKT 465
               N   N     +    +    +
Sbjct: 400 --IPNTVKNVTGALIAPATISDGGS 422

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  192 bits (489), Expect = 2e-53
 Identities = 110/452 (24%), Positives = 178/452 (39%), Gaps = 43/452 (9%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
           L + ++ ++    Q+  +   L+      +    +   +      L ++  L   R    
Sbjct: 3   LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                 +  +++   I   +N+     P     NL  L   +   N +       L+N +
Sbjct: 60  --SIDGVEYLNNLTQINFSNNQLTDITPL---KNLTKLVDILMNNNQIADI--TPLANLT 112

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG 203
           NL  L L +NQ          +L NL+ L L +N + +        ++ L+  + L+ L 
Sbjct: 113 NLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--------ISALSGLTSLQQLS 162

Query: 204 LYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP 263
              NQ   L P  LANL+  +  +DI  N  S      L  L +L S+    NQ+  +  
Sbjct: 163 F-GNQVTDLKP--LANLTT-LERLDISSNKVSD--ISVLAKLTNLESLIATNNQI--SDI 214

Query: 264 PEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIML 323
             +G L NL  L LN N L      +L +LT LT L L  N +    P  L   T L  L
Sbjct: 215 TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 324 TLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI 383
            L  N++  + P  +  +T L+  L L++N L     S I NLKNL  L +  N  S   
Sbjct: 271 KLGANQISNISP--LAGLTALT-NLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS 325

Query: 384 PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEY 443
           P  +S+ T L+ +   +N  S     SL  L +I  L    N++S   P  L NL+ +  
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379

Query: 444 LNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKL 475
           L L+   +           +      +  G L
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  181 bits (461), Expect = 1e-49
 Identities = 105/437 (24%), Positives = 183/437 (41%), Gaps = 41/437 (9%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  L  ++ + N LT   P  + NL+ L  I +  N++    P  L  L  L  L +  
Sbjct: 66  YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           NQ +   P  + N+++   + L SN          ++ L +L++ ++  N +T   P  L
Sbjct: 122 NQITDIDP--LKNLTNLNRLELSSNTISD---ISALSGLTSLQQ-LSFGNQVTDLKP--L 173

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           +N + LE L++  N+ +  +S     L NL  LI  NN + +        +T L   + L
Sbjct: 174 ANLTTLERLDISSNK-VSDIS-VLAKLTNLESLIATNNQISD--------ITPLGILTNL 223

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
           + L L  NQ   +   +LA+L+N +T +D+  N  S   P  L  L  L  + +  NQ+ 
Sbjct: 224 DELSLNGNQLKDI--GTLASLTN-LTDLDLANNQISNLAP--LSGLTKLTELKLGANQI- 277

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
            +    +  L  L +L LN N L    P  + NL  LT L L  NN+    P  + + T 
Sbjct: 278 -SNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRF 379
           L  L    NK+       + ++T ++ +L+   N +S    + + NL  + QL ++   +
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNIN-WLSAGHNQISD--LTPLANLTRITQLGLNDQAW 387

Query: 380 SGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLS 439
           +       +  +    VK    +     P +++   S    D++ N  S    +     S
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFS 444

Query: 440 FLEYLNLSYNHFEGEVP 456
               +      F G V 
Sbjct: 445 QPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  142 bits (361), Expect = 2e-36
 Identities = 72/382 (18%), Positives = 131/382 (34%), Gaps = 60/382 (15%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           +  +N +     +     L  L+ LS   N +T   P  + NL+ L+ +DI  N++    
Sbjct: 140 ELSSNTISDISALS---GLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SD 191

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
              L +L  L  L    NQ S   P  +  +++ + + L  N+          A+L NL 
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL---ASLTNLT 246

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
               A N ++      LS  + L  L+L  NQ           L  L+ L L  N L + 
Sbjct: 247 DLDLANNQISNL--APLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED- 301

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
                  ++ ++N   L  L LY N    + P  +++L+  +  +    N  S      L
Sbjct: 302 -------ISPISNLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFFYNNKVSD--VSSL 349

Query: 243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
            NL ++N ++   NQ+  +    +  L  +  L LN         +   N+++   +   
Sbjct: 350 ANLTNINWLSAGHNQI--SDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNV 407

Query: 303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE 362
              L    P+++ +  S     ++ N                                  
Sbjct: 408 TGALI--APATISDGGSYTEPDITWNLPS--------------------------YTNEV 439

Query: 363 IGNLKNLVQLDISGNRFSGDIP 384
                  V +      FSG + 
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  185 bits (473), Expect = 6e-53
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHR 611
            + +    +G GSFGTV +     +G  VAVK+L         +  FL E   ++ +RH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++  +   +          +IV +++  GSL   LH++  + +   L   + L++A DV
Sbjct: 95  NIVLFMGAVTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDV 146

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  + YLH+   PP+VH +LK  N+L+D      V DFGL++            T  SS 
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--------STFLSSK 197

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
              GT  ++APE      ++   DVYSFG++L E+ + ++P  ++
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  182 bits (464), Expect = 1e-51
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            E     +VG+G+FG V K         VA+K +    +   K+F+ E   L  + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNI 63

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K+   C +          +V ++ + GSL   LH           +    ++  +  + 
Sbjct: 64  VKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQCSQ 113

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            + YLH      ++H DLKP N+LL     V  + DFG A  +            +  + 
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----------QTHMTN 162

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
            KG+  ++APE   GS  S   DV+S+GI+L E+ +RR+P D +
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  179 bits (457), Expect = 3e-51
 Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 34/231 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA--LKSFLTECEALRSIRHR 611
            + +    + +   G ++KG     G  + VKVL +        + F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++ ++  C S          ++  +M  GSL   LH+  +      +   Q +  A+D+
Sbjct: 68  NVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDM 120

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  + +LH   +P +    L   +V++D DM A +    +                  S 
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------------QSP 166

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
           G      ++APE        T   ++   D++SF +LL E+ +R  P   +
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  179 bits (456), Expect = 7e-51
 Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 38/237 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL-------NLMQKGALKSFLTECEALR 606
           +E      +G+G FG V KG + ++  +VA+K L               + F  E   + 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           ++ H N++K+  +  +          +V +F+  G L   L           +     L 
Sbjct: 79  NLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLR 126

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-----HDMVAHVGDFGLAKFLPARPLD 721
           + +D+A  IEY+  +  PP+VH DL+  N+ L        + A V DFGL++        
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------- 177

Query: 722 TVVETPSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
              ++  S SG+ G   ++APE         +   D YSF ++L  + +   P D  
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  173 bits (440), Expect = 7e-48
 Identities = 82/403 (20%), Positives = 156/403 (38%), Gaps = 60/403 (14%)

Query: 48  LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFH 107
              +      +    P     L + I   + +   +  +                     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE------------------ 41

Query: 108 GSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLK 167
                     L ++ K V A   +     I     +NLE L L  NQ         ++L 
Sbjct: 42  ---------ELESITKLVVAGEKVASIQGI--EYLTNLEYLNLNGNQI--TDISPLSNLV 88

Query: 168 NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
            L+ L +G N + +        ++ L N + L  L L ++    + P  LANL+  M ++
Sbjct: 89  KLTNLYIGTNKITD--------ISALQNLTNLRELYLNEDNISDISP--LANLTK-MYSL 137

Query: 228 DIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIP 287
           ++G N+   +    L N+  LN + +  +++       I  L +L SL LN N +    P
Sbjct: 138 NLGANHNL-SDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIEDISP 194

Query: 288 SSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF 347
             L +LT L      +N +    P  + N T L  L +  NK+  + P  + +++ L+ +
Sbjct: 195 --LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT-W 247

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
           L +  N +S    + + +L  L  L++  N+ S DI   L+  + L  + + +N      
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNED 303

Query: 408 PPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
              +  L ++  L LS N ++   P  L +LS ++  + +   
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (428), Expect = 2e-46
 Identities = 81/357 (22%), Positives = 148/357 (41%), Gaps = 32/357 (8%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
           A+L    + V  K ++T    ++     ++  L +   + +  +      L NL  L L 
Sbjct: 19  ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK-VASIQ-GIEYLTNLEYLNLN 74

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
            N + +        ++ L+N  KL NL +  N+   +    L NL+N +  + +  +  S
Sbjct: 75  GNQITD--------ISPLSNLVKLTNLYIGTNKITDISA--LQNLTN-LRELYLNEDNIS 123

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
                 L NL  + S+ +  N  + +    +  +  L  L +  + +    P  + NLT 
Sbjct: 124 D--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           L  L+L  N ++    S L + TSL   T   N++  + P  + ++T L+  L + +N +
Sbjct: 179 LYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNS-LKIGNNKI 233

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
           +    S + NL  L  L+I  N+ S DI   +   T L+ + +  N  S      LN L 
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLS 287

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
            +  L L++N+L  +  + +  L+ L  L LS NH     P     S       +  
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS-LSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (428), Expect = 2e-46
 Identities = 74/405 (18%), Positives = 151/405 (37%), Gaps = 60/405 (14%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L+     +    P +  +L+      ++   +   +     +L  +  L +   + +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                 I  +++ E++ L  N+     P    +NL  L       N +T     +L N +
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISPL---SNLVKLTNLYIGTNKITD--ISALQNLT 110

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG 203
           NL  L L ++           +L  +  L LG NH        L  ++ L+N + L  L 
Sbjct: 111 NLRELYLNEDNI--SDISPLANLTKMYSLNLGANHN-------LSDLSPLSNMTGLNYLT 161

Query: 204 LYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP 263
           + +++   + P  +ANL++ + ++ +  N      P  L +L  L+      NQ+  T  
Sbjct: 162 VTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI--TDI 214

Query: 264 PEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIML 323
             +  +  L SL + +N +    P  L NL+ LT L +  N +     +++ + T L ML
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 324 TLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI 383
            +  N++  +                           S + NL  L  L ++ N+   + 
Sbjct: 271 NVGSNQISDI---------------------------SVLNNLSQLNSLFLNNNQLGNED 303

Query: 384 PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS 428
              +   T+L  + +  N  +   P  L  L  +   D ++  + 
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  167 bits (426), Expect = 5e-46
 Identities = 78/360 (21%), Positives = 153/360 (42%), Gaps = 34/360 (9%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L +     L +  +T    V+   L ++  + + G ++   I   +  L  L YLN+  N
Sbjct: 21  LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN 76

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           Q +   P  + N+     +++ +N+           NL NLR+    ++N++      L+
Sbjct: 77  QITDISP--LSNLVKLTNLYIGTNKITDISAL---QNLTNLRELYLNEDNISDI--SPLA 129

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
           N + +  L L  N  +  +S   +++  L+ L +  + + +        VT +AN + L 
Sbjct: 130 NLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD--------VTPIANLTDLY 180

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG 260
           +L L  NQ   + P  LA+L++ +       N  +   P  + N+  LNS+ +  N++  
Sbjct: 181 SLSLNYNQIEDISP--LASLTS-LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI-- 233

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
           T    +  L  L  L + +N +     +++ +LT L +L +  N +     S L N + L
Sbjct: 234 TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS 380
             L L+ N+L       I  +T L+  L LS N ++      + +L  +   D +     
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLT-TLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  152 bits (387), Expect = 9e-41
 Identities = 78/311 (25%), Positives = 131/311 (42%), Gaps = 29/311 (9%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  LE L+L  N +T   P  + NL  L  + I  N++       L  L  L  L +  
Sbjct: 64  YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNE 119

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           +  S   P  + N++    + L +N     L    ++N+  L      ++ +    PI  
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVKDVTPI-- 173

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           +N ++L  L L  NQ          SL +L       N + +        +T +AN ++L
Sbjct: 174 ANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--------ITPVANMTRL 223

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
            +L + +N+   L P  LANLS  +T ++IG N  S      + +L  L  + +  NQ+ 
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQ-LTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI- 277

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
            +    +  L  L SL+LN+N L       +G LT LT L L  N++    P  L + + 
Sbjct: 278 -SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 320 LIMLTLSKNKL 330
           +     +   +
Sbjct: 335 MDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 90.3 bits (225), Expect = 1e-19
 Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 18/181 (9%)

Query: 293 LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLS 351
              L  L   IN +         +    I   L K  +  V+  + L S+T     L ++
Sbjct: 2   AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVTQEELESITK----LVVA 52

Query: 352 DNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL 411
              ++      I  L NL  L+++GN+ +   P  LS    L  + +  N    +   +L
Sbjct: 53  GEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISAL 106

Query: 412 NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSG 471
             L +++ L L+ + +S   P  L NL+ +  LNL  NH   ++      +     +++ 
Sbjct: 107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTE 164

Query: 472 N 472
           +
Sbjct: 165 S 165

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 81.8 bits (203), Expect = 9e-17
 Identities = 35/177 (19%), Positives = 61/177 (34%), Gaps = 14/177 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
               N++    P+     L  L   +   N +T      + N++ L  + I  N++    
Sbjct: 183 SLNYNQIEDISPL---ASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLS 237

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           P  L  L +L +L IG NQ S     ++ +++  + + + SN+           NL  L 
Sbjct: 238 P--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVL---NNLSQLN 290

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
                 N L       +   +NL  L L  N           SL  +      N  +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVI 345

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (431), Expect = 3e-47
 Identities = 65/314 (20%), Positives = 120/314 (38%), Gaps = 49/314 (15%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE--ALRSIRHRNLIKII 617
             VG+G +G V++G     G  VAVK+ +       KS+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
               +   +      ++  + + GSL ++L           L  +  L I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 120

Query: 678 LH-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           LH        KP + H DLK  N+L+  +    + D GLA         +  +    ++ 
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS----QSTNQLDVGNNP 176

Query: 733 IKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF 786
             GT  Y+APE           ++    D+++FG++L E+  R                 
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----------IV 226

Query: 787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI------EECLVAVIRIGVVCSMES 840
                P   +   DPS     +    +    +R  I      +  L ++ ++   C  ++
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKV---VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283

Query: 841 PTDRMQMRDVVVKL 854
           P+ R+    +   L
Sbjct: 284 PSARLTALRIKKTL 297

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  180 bits (459), Expect = 3e-47
 Identities = 96/500 (19%), Positives = 178/500 (35%), Gaps = 47/500 (9%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           +  +      I  E    L  L  L L  + +    P +   L  L  + +    L   +
Sbjct: 54  ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 63  --PDTLGQLRKLIYLNIGRNQFSGF-IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANL- 118
                   L+ L  L++ +NQ     + PS   ++S + I   SN+    +    +  L 
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQ 172

Query: 119 -PNLRKFVAAKNNLTGFLPISLSNASN------LELLELRDNQFIGKMSINFNS------ 165
              L  F  A N+L   + +      N      LE+L++  N +   ++ NF++      
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232

Query: 166 ------LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN 219
                   ++     G +++ +   N    +      S + +L L       L       
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA----RSSVRHLDLSHGFVFSLNSRVFET 288

Query: 220 LSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLN 278
           L + +  +++  N  +         L +L  + +  N  +G +       L  +  + L 
Sbjct: 289 LKD-LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL-LGELYSSNFYGLPKVAYIDLQ 346

Query: 279 SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
            N +      +   L  L  L L  N L     +++    S+  + LS NKL   LP   
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL-VTLPKIN 400

Query: 339 LSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVK 397
           L+   + L  N  +NL           + +L  L ++ NRFS      T S   SLE + 
Sbjct: 401 LTANLIHLSENRLENLDILYFLL---RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 398 MQDNSFSGSIPPSLN-----FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
           + +N    +    L       L  ++VL L+ N L+   P    +L+ L  L+L+ N   
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 453 GEVPKKGVFSNKTRFSLSGN 472
             +    + +N     +S N
Sbjct: 518 -VLSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  162 bits (411), Expect = 3e-41
 Identities = 99/564 (17%), Positives = 193/564 (34%), Gaps = 62/564 (10%)

Query: 3   DAQNNKL-VGDIPVEIGCYLFKLENLSLAENHLTG-QLPVSIGNLSALQVIDIRGNRLGG 60
                 L    +       L  L  L L++N +    L  S G L++L+ ID   N++  
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162

Query: 61  KIPDTLGQLR--KLIYLNIGRNQFSGFIPPSIYN-ISSFEFIFLQSNRFHG--------- 108
                L  L+   L + ++  N     +       ++ F  + L+     G         
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

Query: 109 -------SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN--ASNLELLELRDNQFIGKM 159
                        +    ++       +N+      + +    S++  L+L         
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN 219
           S  F +LK+L VL L  N +     N +           L+ L L  N  G L   +   
Sbjct: 283 SRVFETLKDLKVLNLAYNKI-----NKIADEA-FYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 220 LSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLN 278
           L   +  ID+  N+ +  I       L  L ++ +  N L       I ++ ++  ++L+
Sbjct: 337 LPK-VAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLS 389

Query: 279 SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
            N L   +P       ++ L    + NL   I   L     L +L L++N+       Q 
Sbjct: 390 GNKLV-TLPKINLTANLIHLSENRLENL--DILYFLLRVPHLQILILNQNRFSSCSGDQT 446

Query: 339 LSVTTLSLFLNLSDNLLSGSLPSEI-----GNLKNLVQLDISGNRFSGDIPGTLSACTSL 393
            S       L L +N+L  +  +E+       L +L  L ++ N  +   PG  S  T+L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506

Query: 394 EYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
             + +  N  +  +  +     ++++LD+S N+L    P    +LS    L++++N F  
Sbjct: 507 RGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFIC 561

Query: 454 EVPKKG----VFSNKTRFSLSGNGKLCGG--------LDEFHLPSCPSKRSRKLIATILK 501
           E         +       +       C          L       C  +   K +   L 
Sbjct: 562 ECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLF 621

Query: 502 VVIPTIVSCLILSACFIVIYGRRR 525
           +V    ++  +++   +  +    
Sbjct: 622 IVCTVTLTLFLMTILTVTKFRGFC 645

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  158 bits (402), Expect = 4e-40
 Identities = 85/464 (18%), Positives = 154/464 (33%), Gaps = 37/464 (7%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI-PDTLGQLRKLIYLNIGR 79
           L   E L L+ N++      S   L  LQ++++        I  +    L  L  L++G 
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRF-HGSLPFDMVANLPNLRKFVAAKNNLTGF-LPI 137
           ++     P +   +     + L         L      NL  L +   +KN +    L  
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142

Query: 138 SLSNASNLELLELRDNQF--IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLAN 195
           S    ++L+ ++   NQ   + +  +     K LS   L  N L +R + D         
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202

Query: 196 CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG 255
              LE L +  N +   +  + +N               S +    L    H+       
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNA-------------ISKSQAFSLILAHHIMGAGFGF 249

Query: 256 NQLIGTVPPEI---GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
           +  I              +++ L L+  F+          L  L +L L  N +      
Sbjct: 250 HN-IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL 372
           +     +L +L LS N L   L            +++L  N ++         L+ L  L
Sbjct: 309 AFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367

Query: 373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG-QI 431
           D+  N  +     T+    S+  + +  N       P +N   +  ++ LS N+L    I
Sbjct: 368 DLRDNALT-----TIHFIPSIPDIFLSGNKLVTL--PKINL--TANLIHLSENRLENLDI 418

Query: 432 PKYLENLSFLEYLNLSYNHFEGEVPKKGVFS---NKTRFSLSGN 472
             +L  +  L+ L L+ N F          S   +  +  L  N
Sbjct: 419 LYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGEN 461

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  156 bits (396), Expect = 2e-39
 Identities = 63/409 (15%), Positives = 126/409 (30%), Gaps = 45/409 (11%)

Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
           ++   R   L  ++P  L        L +  N        S   +   + + L S     
Sbjct: 7   RIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN---FNS 165
           ++  +   NLPNLR      + +    P +     +L  L L     +    +    F +
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYFRN 121

Query: 166 LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN-TM 224
           LK L+ L L  N +       L         + L+++    NQ   +  H L  L   T+
Sbjct: 122 LKALTRLDLSKNQI-----RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
           +   +  N     +    G  ++                        L+ L ++ N    
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFR------------------NMVLEILDVSGNGWTV 218

Query: 285 YIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
            I  +              N +      SL     ++      + +          +   
Sbjct: 219 DITGNF------------SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266

Query: 345 SL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           S+  L+LS   +          LK+L  L+++ N+ +           +L+ + +  N  
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
                 +   L  +  +DL  N ++    +  + L  L+ L+L  N   
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  103 bits (259), Expect = 7e-23
 Identities = 60/305 (19%), Positives = 118/305 (38%), Gaps = 27/305 (8%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
            D  +  +   +   +   L  L+ L+LA N +      +   L  LQV+++  N LG  
Sbjct: 271 LDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
                  L K+ Y+++ +N  +     +   +   + + L+ N          +  +P++
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT------TIHFIPSI 383

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIG-KMSINFNSLKNLSVLILGNNHLG 180
                + N L     I+L+      L+ L +N+     +      + +L +LIL  N   
Sbjct: 384 PDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQF-----GGLLPHSLANLSNTMTTIDIGGNYFS 235
           +            +    LE L L +N         L       LS+ +  + +  NY +
Sbjct: 440 S-----CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH-LQVLYLNHNYLN 493

Query: 236 GTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLT 294
            ++PPG   +L  L  +++  N+L  TV        NL+ L ++ N L    P    +L+
Sbjct: 494 -SLPPGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDISRNQLLAPNPDVFVSLS 550

Query: 295 MLTLL 299
           +L + 
Sbjct: 551 VLDIT 555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.7 bits (168), Expect = 5e-12
 Identities = 27/129 (20%), Positives = 46/129 (35%), Gaps = 8/129 (6%)

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
                  L+  +P     L    +L +S N        +      L+ +++       +I
Sbjct: 9   AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64

Query: 408 PP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR 466
              +   L ++++LDL S+K+    P   + L  L  L L +      V K G F N   
Sbjct: 65  DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124

Query: 467 ---FSLSGN 472
                LS N
Sbjct: 125 LTRLDLSKN 133

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  168 bits (428), Expect = 4e-47
 Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 36/235 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL----MQKGALKSFLTECEALRSIR 609
           +E +   ++G G FG V++      G  VAVK             +++   E +    ++
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N+I +  +C            +V +F + G L   L           +     +N A+
Sbjct: 65  HPNIIALRGVCLKEPNL-----CLVMEFARGGPLNRVLSGKR-------IPPDILVNWAV 112

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLD--------HDMVAHVGDFGLAKFLPARPLD 721
            +A  + YLH     P++H DLK SN+L+          + +  + DFGLA+        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------- 164

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
                 ++     G   ++APE    S  S   DV+S+G+LL E+ +   P   +
Sbjct: 165 --EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (429), Expect = 4e-47
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 36/232 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRH 610
            + +    +G GSFGTV+KG   G+    VAVK+LN+       L++F  E   LR  RH
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++  +   ++         AIV  + +  SL   LH +  K       + + ++IA  
Sbjct: 80  VNILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKF-----EMKKLIDIARQ 128

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
            A  ++YLH      ++H DLK +N+ L  D    +GDFGLA         +        
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT------EKSRWSGSHQF 179

Query: 731 SGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
             + G++ ++APE          S  S   DVY+FGI+L E+ + + P  ++
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQS---DVYAFGIVLYELMTGQLPYSNI 228

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (433), Expect = 4e-47
 Identities = 58/258 (22%), Positives = 111/258 (43%), Gaps = 40/258 (15%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE--ALRSIRHRNLIKII 617
             +G+G FG V++G     G  VAVK+ +  ++   +S+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              +  +        +V D+ ++GSL ++L++         +++   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAH 154

Query: 678 LH-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           LH        KP + H DLK  N+L+  +    + D GLA    +      +    + + 
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNH 210

Query: 733 IKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSR----------RRPTDSM 776
             GT  Y+APE           E+    D+Y+ G++  E+  R          + P   +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 777 FHEGLTLHEFSKMVLPEK 794
                ++ E  K+V  +K
Sbjct: 271 VPSDPSVEEMRKVVCEQK 288

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  174 bits (444), Expect = 1e-46
 Identities = 88/467 (18%), Positives = 175/467 (37%), Gaps = 29/467 (6%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
           +++L L+ N +T      +   + LQV+ ++ +R+     D    L  L +L++  N  S
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRK-FVAAKNNLTGFLPISLSNA 142
                    +SS +++ L  N +       +  NL NL+   +      +    I  +  
Sbjct: 88  SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           ++L  LE++        S +  S++++  L L  +          D ++ +    +L + 
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV-RYLELRDT 206

Query: 203 GLYDNQFGGL----LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
            L   QF  L    +   +  L+   + +          +   +  L  +       N L
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266

Query: 259 IGTVPPEIGWLK--------NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI 310
               P E   +          ++ L++   +L   + +    L  +  + +E + +    
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326

Query: 311 PSSLGNCTSLIMLTLSKNKL-DGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIG---N 365
            S   +  SL  L LS+N + +  L          SL  L LS N L  S+         
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT 385

Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN 425
           LKNL  LDIS N F   +P +      + ++ +        +   +   ++++VLD+S+N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441

Query: 426 KLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
            L      +L     L+ L +S N  +  +P   +F       +S N
Sbjct: 442 NLD-SFSLFLPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRN 483

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  171 bits (436), Expect = 1e-45
 Identities = 84/467 (17%), Positives = 165/467 (35%), Gaps = 31/467 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-K 61
             +++++   I  +    L  LE+L L++NHL+       G LS+L+ +++ GN      
Sbjct: 56  ILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPP-SIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
           +      L  L  L IG  +    I       ++S   + +++     +     + ++ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRD 173

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG 180
           +       +     L I     S++  LELRD              +  S +        
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233

Query: 181 NRAANDLDFVTVLANC-SKLENLGLYDNQFGGLLPHSLANLSN----------TMTTIDI 229
                  + +  L     +L  +   D    GL   + +              T+  + I
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 230 GGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFL---HGYI 286
              Y    +      L  +  I +E +++          LK+L+ L L+ N +   +   
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353

Query: 287 PSSLGNLTMLTLLALEINNLQ--GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
            +  G    L  L L  N+L+   K    L    +L  L +S+N     +P        +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKM 412

Query: 345 SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS 404
             FLNLS   +   + + I   + L  LD+S N         L     L+ + +  N   
Sbjct: 413 -RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK 464

Query: 405 GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
            ++P +      + V+ +S N+L        + L+ L+ + L  N +
Sbjct: 465 -TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  171 bits (434), Expect = 2e-45
 Identities = 92/490 (18%), Positives = 170/490 (34%), Gaps = 34/490 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D   NK+   I          L+ L L  + +      +  +L +L+ +D+  N L    
Sbjct: 32  DLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPS-IYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
               G L  L YLN+  N +      S   N+++ + + + +      +     A L +L
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
            +      +L  +   SL +  ++  L L  ++    + I  + L ++  L L + +L  
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

Query: 182 RAANDLDFVTVLANCSKLEN--LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
              + L    V +   KL      L D  F  LL      L  +    D       G   
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270

Query: 240 PGLGN---------LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSL 290
           P   +          V +  + +    L   +      L+ ++ + + ++ +     S  
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330

Query: 291 GNLTMLTLLALEINNLQGKI---PSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS-- 345
            +L  L  L L  N +  +     +  G   SL  L LS+N L   +      + TL   
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNL 389

Query: 346 LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG 405
             L++S N     +P      + +  L++S                +LE + + +N+   
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP---QTLEVLDVSNNNLD- 444

Query: 406 SIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKT 465
           S      FL  ++ L +S NKL   +P        L  + +S N    +    G+F   T
Sbjct: 445 SFSL---FLPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQL--KSVPDGIFDRLT 497

Query: 466 R---FSLSGN 472
                 L  N
Sbjct: 498 SLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  125 bits (317), Expect = 2e-30
 Identities = 63/418 (15%), Positives = 138/418 (33%), Gaps = 47/418 (11%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPV-SIGNLSALQVIDIRGNRLGGK 61
           +   N         +   L  L+ L +       ++       L++L  ++I+   L   
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG--SLPFDMVANLP 119
              +L  +R + +L +  ++ +  +      +SS  ++ L+          P  +     
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223

Query: 120 NLRKFVAAKNNLT----GFLPISLSNASNLELLELRDNQFIGKMSIN------FNSLKNL 169
            ++K     + LT      L   L     L  +E  D    G    N       + L  +
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283

Query: 170 SVLILGNNHLGNRAANDLDFV--TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI 227
             + +   H+       L +   TV +   K++ + + +++   +      +L + +  +
Sbjct: 284 ETVTIRRLHIPQ---FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS-LEFL 339

Query: 228 DIGGNYFSGTIPPG---LGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQSLYLNSNFL 282
           D+  N             G    L ++ +  N L  +      +  LKNL SL ++ N  
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 283 HGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVT 342
           H  +P S      +  L L    ++  + +      +L +L +S N LD      +  + 
Sbjct: 400 H-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPRLQ 454

Query: 343 TLSL------------------FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGD 382
            L +                   + +S N L          L +L ++ +  N +   
Sbjct: 455 ELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 32/132 (24%), Positives = 57/132 (43%), Gaps = 7/132 (5%)

Query: 347 FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
             +      + S+PS +     +  LD+S N+ +    G L AC +L+ + ++ +  +  
Sbjct: 9   VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65

Query: 407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR 466
              +   L S++ LDLS N LS     +   LS L+YLNL  N ++  +    +F N T 
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124

Query: 467 ---FSLSGNGKL 475
                +      
Sbjct: 125 LQTLRIGNVETF 136

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  174 bits (443), Expect = 2e-46
 Identities = 92/480 (19%), Positives = 164/480 (34%), Gaps = 38/480 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D    ++   I       L  L  L L  N +      +   LS+LQ +      L    
Sbjct: 58  DLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 63  PDTLGQLRKLIYLNIGRNQFSGF-IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
              +G L+ L  LN+  N    F +P    N+++ E + L SN+   S+    +  L  +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175

Query: 122 RKFVA----AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGN 176
                    + N +    P +      L  L LR+N     +       L  L V  L  
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 177 NHL---GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY 233
                 GN    D   +  L N +  E    Y + +   +      L+N +++  +    
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVT 293

Query: 234 FSGTIP-PGLGNLVHLNSIAMEGNQL-----------------IGTVPPEIGWLKNLQSL 275
                         HL  +  +  Q                   G    E+  L +L+ L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFL 352

Query: 276 YLNSNFLH--GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGV 333
            L+ N L   G    S    T L  L L  N +   + S+      L  L    + L  +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 334 LPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI-PGTLSACTS 392
               +       ++L++S      +       L +L  L ++GN F  +  P   +   +
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471

Query: 393 LEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
           L ++ +        + P+  N L S++VL+++SN+L        + L+ L+ + L  N +
Sbjct: 472 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  170 bits (432), Expect = 5e-45
 Identities = 84/483 (17%), Positives = 158/483 (32%), Gaps = 25/483 (5%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D   N L   +         +L+ L L+   +      +  +LS L  + + GN +    
Sbjct: 34  DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
                 L  L  L       +      I ++ + + + +  N        +  +NL NL 
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 123 KFVAAKNNLTGFLPISLSNASNLEL----LELRDNQFIGKMSINFNSLKNLSVLILGNNH 178
               + N +       L     + L    L+L  N  +  +         L  L L NN 
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLHKLTLRNNF 211

Query: 179 LG-NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN-TMTTIDIGGNYFSG 236
              N     +  +  L     +      +         +L  L N T+    +    +  
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 237 TIPPGL-GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
                L   L +++S ++    +      +  +    Q L L +     +    L +L  
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNL 354
           LT  + +  N       S  +  SL  L LS+N L            T SL +L+LS N 
Sbjct: 330 LTFTSNKGGNA-----FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 355 LSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF 413
           +  ++ S    L+ L  LD   +            +  +L Y+ +       +     N 
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 414 LKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSL 469
           L S++VL ++ N             L  L +L+LS    E ++     F++ +     ++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAFNSLSSLQVLNM 501

Query: 470 SGN 472
           + N
Sbjct: 502 ASN 504

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (397), Expect = 2e-40
 Identities = 88/466 (18%), Positives = 164/466 (35%), Gaps = 57/466 (12%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
            +NL L+ N L      S  +   LQV+D+    +          L  L  L +  N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                                    SL     + L +L+K VA + NL       + +  
Sbjct: 90  -------------------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124

Query: 144 NLELLELRDNQF-IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
            L+ L +  N     K+   F++L NL  L L +N + +    DL  +  +       +L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSL 182

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGT 261
            L  N    + P +   +   +  + +  N+ S  +    +  L  L    +   +    
Sbjct: 183 DLSLNPMNFIQPGAFKEIR--LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 262 ---VPPEIGWLKNLQSLYLNSN------FLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
                 +   L+ L +L +         +    I      LT ++  +L    ++ ++  
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL 372
              N      L L   K       ++ S+      L  + N    +  SE+ +L +L  L
Sbjct: 300 FSYN-FGWQHLELVNCKFGQFPTLKLKSLKR----LTFTSNKGG-NAFSEV-DLPSLEFL 352

Query: 373 DISGNR--FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQ 430
           D+S N   F G    +    TSL+Y+ +  N    ++  +   L+ ++ LD   + L   
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 431 IPKY-LENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
                  +L  L YL++S+ H    V   G+F+  +      ++GN
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHT--RVAFNGIFNGLSSLEVLKMAGN 455

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (395), Expect = 4e-40
 Identities = 86/448 (19%), Positives = 160/448 (35%), Gaps = 49/448 (10%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGGK 61
            A    L   +      +L  L+ L++A N +   +LP    NL+ L+ +D+  N++   
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 62  IPDTLGQLRKL----IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN 117
               L  L ++    + L++  N  + FI P  +       + L++N    ++    +  
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223

Query: 118 LPNLR------KFVAAKNNLTGFLPISLSNASNLELLELRDNQ---FIGKMSINFNSLKN 168
           L  L            + NL  F   +L    NL + E R      ++  +   FN L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 169 LSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM---- 224
           +S   L +  +        + V   +     ++L L + +FG      L +L        
Sbjct: 284 VSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335

Query: 225 --------------TTIDIGGN--YFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGW 268
                           +D+  N   F G           L  + +  N +I T+      
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394

Query: 269 LKNLQSLYLNSNFLHGYIPSS-LGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSK 327
           L+ L+ L    + L      S   +L  L  L +   + +          +SL +L ++ 
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 328 NKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGT 386
           N       P I +      FL+LS   L   L      +L +L  L+++ N+      G 
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513

Query: 387 LSACTSLEYVKMQDNSFSGSIPPSLNFL 414
               TSL+ + +  N +  S  P +++L
Sbjct: 514 FDRLTSLQKIWLHTNPWDCS-CPRIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (256), Expect = 1e-22
 Identities = 46/242 (19%), Positives = 77/242 (31%), Gaps = 32/242 (13%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPE-IGWLKNLQSLY 276
            NL  +   +D+  N           +   L  + +   + I T+       L +L +L 
Sbjct: 24  DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLI 82

Query: 277 LNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPP 336
           L  N +      +   L+ L  L     NL       +G+  +L  L ++ N +      
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ----- 137

Query: 337 QILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYV 396
                              S  LP    NL NL  LD+S N+        L     +  +
Sbjct: 138 -------------------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 397 K----MQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPK-YLENLSFLEYLNLSYNHF 451
                +  N  +  I P       +  L L +N  S  + K  ++ L+ LE   L    F
Sbjct: 179 NLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 452 EG 453
             
Sbjct: 238 RN 239

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 3e-16
 Identities = 30/151 (19%), Positives = 52/151 (34%), Gaps = 8/151 (5%)

Query: 325 LSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP 384
             +     + P  +   T     L+LS N L         +   L  LD+S         
Sbjct: 14  CMELNFYKI-PDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 385 GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYL 444
           G   + + L  + +  N        + + L S++ L      L+      + +L  L+ L
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 445 NLSYNHFEGEVPKKGVFSNKTRF---SLSGN 472
           N+++N  +        FSN T      LS N
Sbjct: 130 NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 5e-46
 Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 40/258 (15%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE--ALRSIRHRNLIKII 617
             +G+G +G V+ G     G  VAVKV    ++    S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
                   +      ++ D+ +NGSL ++L           L     L +A    S + +
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCH 149

Query: 678 LH-----HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
           LH        KP + H DLK  N+L+  +    + D GLA            E     + 
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI----SDTNEVDIPPNT 205

Query: 733 IKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSR----------RRPTDSM 776
             GT  Y+ PE           ++ +  D+YSFG++L E+  R          + P   +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 777 FHEGLTLHEFSKMVLPEK 794
                +  +  ++V  +K
Sbjct: 266 VPSDPSYEDMREIVCIKK 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  164 bits (418), Expect = 2e-45
 Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 29/253 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           S+     ++G+G FG   K    E G ++ +K L    +   ++FL E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K I +              + ++++ G+L   +   + +         Q ++ A D+AS
Sbjct: 70  LKFIGVLYK-----DKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIAS 119

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT------VVETP 727
            + YLH      ++H DL   N L+  +    V DFGLA+ +                  
Sbjct: 120 GMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 728 SSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE----G 780
                + G   ++APE     +  E     DV+SFGI+L E+  R              G
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKV---DVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233

Query: 781 LTLHEFSKMVLPE 793
           L +  F     P 
Sbjct: 234 LNVRGFLDRYCPP 246

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  162 bits (411), Expect = 2e-44
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 33/235 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRH 610
            +     ++G+G FG V+ G   GE    VA++++++    +  LK+F  E  A R  RH
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++  +  C S         AI+    +  +L   +      L      + +T  IA +
Sbjct: 89  ENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVL-----DVNKTRQIAQE 138

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   + YLH      ++H DLK  NV  D+  V  + DFGL        +          
Sbjct: 139 IVKGMGYLHAK---GILHKDLKSKNVFYDNGKV-VITDFGLFSI---SGVLQAGRREDKL 191

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG---------DVYSFGILLLEMFSRRRPTDSM 776
               G + ++APE                    DV++ G +  E+ +R  P  + 
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (420), Expect = 3e-44
 Identities = 95/475 (20%), Positives = 160/475 (33%), Gaps = 95/475 (20%)

Query: 6   NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG----- 60
           ++ L  ++PVE    +        A +      P   G    + V  +R           
Sbjct: 20  SSNL-TEMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELE 77

Query: 61  -------KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFD 113
                   +P+    L  L       N  +  +P    ++ S              LP  
Sbjct: 78  LNNLGLSSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLP-- 130

Query: 114 MVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLI 173
                P L     + N L   LP  L N+S L+++++ +N          +   +L  + 
Sbjct: 131 -----PLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL----KKLPDLPPSLEFIA 179

Query: 174 LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY 233
            GNN L        + +  L N   L  +   +N    L P    +L     +I  G N 
Sbjct: 180 AGNNQL--------EELPELQNLPFLTAIYADNNSLKKL-PDLPLSL----ESIVAGNNI 226

Query: 234 FSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNL 293
                 P L NL  L +I  + N L  T+P       +L++L +  N+L   +P    +L
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLTD-LPELPQSL 279

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           T L +     + L    P+       L  L  S N++   L     S+  L    N+S+N
Sbjct: 280 TFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEEL----NVSNN 327

Query: 354 LLSGSLPSEIGNLK-----------------NLVQLDISGNRFSGDIPGTLSACTSLEYV 396
            L   LP+    L+                 NL QL +  N    + P    +   L   
Sbjct: 328 KLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM- 384

Query: 397 KMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
               NS    +P      +++K L + +N L  + P   E++   E L ++    
Sbjct: 385 ----NSHLAEVP---ELPQNLKQLHVETNPLR-EFPDIPESV---EDLRMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  149 bits (378), Expect = 1e-38
 Identities = 91/442 (20%), Positives = 147/442 (33%), Gaps = 81/442 (18%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           +  N  L   +P         LE+L  + N LT +LP    +L +L V +     L    
Sbjct: 77  ELNNLGLS-SLPELPP----HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           P        L YL +  NQ      P + N S  + I + +N     LP       P+L 
Sbjct: 131 P-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLP----DLPPSLE 176

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
              A  N L   LP  L N   L  +   +N          +   +L  ++ GNN L   
Sbjct: 177 FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL----KKLPDLPLSLESIVAGNNILEE- 229

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN----------------TMTT 226
                  +  L N   L  +   +N    L P    +L                  ++T 
Sbjct: 230 -------LPELQNLPFLTTIYADNNLLKTL-PDLPPSLEALNVRDNYLTDLPELPQSLTF 281

Query: 227 IDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYI 286
           +D+  N FS  +     NL +LN      N+ I ++        +L+ L +++N L   +
Sbjct: 282 LDVSENIFS-GLSELPPNLYYLN---ASSNE-IRSLCDL---PPSLEELNVSNNKLI-EL 332

Query: 287 PSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL 346
           P+    L  L        N   ++P    N   L    +  N L    P    SV  L +
Sbjct: 333 PALPPRLERLIAS----FNHLAEVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRM 384

Query: 347 FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
             +L+       +P    NLK   QL +  N    + P       S+E ++M        
Sbjct: 385 NSHLA------EVPELPQNLK---QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDP 431

Query: 407 IPPSLNFLKSIKVLDLSSNKLS 428
              +      ++      +   
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  103 bits (259), Expect = 2e-23
 Identities = 46/235 (19%), Positives = 79/235 (33%), Gaps = 32/235 (13%)

Query: 238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLT 297
           I P   +   L       + L   +P E   +K+    Y   +      P   G    + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 298 LLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG 357
           +  L                     L L+   L   LP     + +    L  S N L+ 
Sbjct: 62  VSRLRDC-----------LDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT- 104

Query: 358 SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSI 417
            LP    +LK+L+  + +    S   P        LEY+ + +N     + P L     +
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KL-PELQNSSFL 155

Query: 418 KVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           K++D+ +N L  ++P    +   LE++    N  E E+P+       T      N
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNN 205

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  161 bits (409), Expect = 6e-44
 Identities = 54/322 (16%), Positives = 113/322 (35%), Gaps = 27/322 (8%)

Query: 138 SLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCS 197
              ++S  E L  + +  +       + L         +        N        AN +
Sbjct: 7   HHHHSSGRENLYFQGSTALRPY---HDVLSQWQRHYNADR-------NRWHSAWRQANSN 56

Query: 198 KLENLGLYDNQFGGLLPHSLANLSNT-MTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
             +                L + +      +++         P     L HL  + ++  
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
            L+  +P  +     L++L L  N L   +P+S+ +L  L  L++       ++P  L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 317 C---------TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK 367
                      +L  L L    +   LP  I ++  L   L + ++ LS +L   I +L 
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-ALGPAIHHLP 229

Query: 368 NLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL 427
            L +LD+ G     + P        L+ + ++D S   ++P  ++ L  ++ LDL     
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289

Query: 428 SGQIPKYLENLSFLEYLNLSYN 449
             ++P  +  L     + +  +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  150 bits (382), Expect = 2e-40
 Identities = 51/330 (15%), Positives = 102/330 (30%), Gaps = 30/330 (9%)

Query: 117 NLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGN 176
           +           +         LS        +        +      +  N  +     
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTG 65

Query: 177 NHLGNRAANDLDFVTVLANCS--KLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF 234
             L            +L + +      L L         P     LS+ +  + I     
Sbjct: 66  RALK-------ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSH-LQHMTIDAAGL 116

Query: 235 SGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGN-- 292
              +P  +     L ++ +  N L   +P  I  L  L+ L + +      +P  L +  
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174

Query: 293 -------LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS 345
                  L  L  L LE   ++  +P+S+ N  +L  L +  + L   L P I  +  L 
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232

Query: 346 LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG 405
             L+L       + P   G    L +L +        +P  +   T LE + ++      
Sbjct: 233 -ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 406 SIPPSLNFLKSIKVLDLSSNKLSGQIPKYL 435
            +P  +  L +  ++ +  + L  Q+ ++ 
Sbjct: 292 RLPSLIAQLPANCIILVPPH-LQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (346), Expect = 2e-35
 Identities = 62/345 (17%), Positives = 113/345 (32%), Gaps = 52/345 (15%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLR--KLIYLNIG 78
           L + +    A+ +          N +  Q+    G  L     D L        + L + 
Sbjct: 32  LSQWQRHYNADRNRW-HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELR 89

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS 138
                   P   + +S  + + + +      LP D +     L     A+N L   LP S
Sbjct: 90  SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP-DTMQQFAGLETLTLARNPLRA-LPAS 145

Query: 139 LSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK 198
           +++ + L  L +R              L  L         L +      D          
Sbjct: 146 IASLNRLRELSIRAC----------PELTELP------EPLAS-----TDASGEHQGLVN 184

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
           L++L L       L P S+ANL N + ++ I  +  S  + P + +L  L  + + G   
Sbjct: 185 LQSLRLEWTGIRSL-PASIANLQN-LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241

Query: 259 IGTVPPEIGWLKNLQSLYL-NSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC 317
           +   PP  G    L+ L L + + L   +P  +  LT L  L L       ++PS +   
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300

Query: 318 TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE 362
            +  ++ +  +                     L  +    + P+E
Sbjct: 301 PANCIILVPPHLQA-----------------QLDQHRPV-ARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  126 bits (319), Expect = 5e-32
 Identities = 58/303 (19%), Positives = 97/303 (32%), Gaps = 54/303 (17%)

Query: 13  IPVEIG-CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRK 71
               +          L L    L  Q P     LS LQ + I    L  ++PDT+ Q   
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAG 128

Query: 72  LIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNL 131
           L  L + RN     +P SI                         A+L  LR+        
Sbjct: 129 LETLTLARNPLRA-LPASI-------------------------ASLNRLRELSIRACPE 162

Query: 132 TGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVT 191
              LP  L++                        L NL  L L    +            
Sbjct: 163 LTELPEPLASTDASG---------------EHQGLVNLQSLRLEWTGI-------RSLPA 200

Query: 192 VLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
            +AN   L++L + ++     L  ++ +L   +  +D+ G       PP  G    L  +
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPK-LEELDLRGCTALRNYPPIFGGRAPLKRL 258

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIP 311
            ++    + T+P +I  L  L+ L L        +PS +  L    ++ +   +LQ ++ 
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLD 317

Query: 312 SSL 314
              
Sbjct: 318 QHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  123 bits (310), Expect = 8e-31
 Identities = 52/276 (18%), Positives = 92/276 (33%), Gaps = 22/276 (7%)

Query: 211 GLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLK 270
           G   H   + S     +   G+         L       +                    
Sbjct: 2   GSSHHHHHHSSG-RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ-GKIPSSLGNCTSLIMLTLSKNK 329
           N Q        L       L + T    +ALE+ ++   + P      + L  +T+    
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAG 115

Query: 330 LDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP----- 384
           L   LP  +     L   L L+ N L  +LP+ I +L  L +L I       ++P     
Sbjct: 116 LM-ELPDTMQQFAGLE-TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 385 ----GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF 440
               G      +L+ ++++      S+P S+  L+++K L + ++ LS  +   + +L  
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230

Query: 441 LEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGNGKL 475
           LE L+L         P   G  +   R  L     L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 43/229 (18%), Positives = 85/229 (37%), Gaps = 23/229 (10%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
                  L+ ++P  +      LE L+LA N L   LP SI +L+ L+ + IR      +
Sbjct: 109 MTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165

Query: 62  IPDTLGQ---------LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPF 112
           +P+ L           L  L  L +        +P SI N+ + + + ++++    +L  
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG- 222

Query: 113 DMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVL 172
             + +LP L +            P      + L+ L L+D   +  + ++ + L  L  L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282

Query: 173 ILGNNHLGNRAANDLDFV-TVLANCSKLENLGLYDNQFGGLLPHSLANL 220
            L           +L  + +++A       + +  +    L  H     
Sbjct: 283 DLRGC-------VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 24/219 (10%), Positives = 47/219 (21%), Gaps = 58/219 (26%)

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
           +G+           ++LY   +         L              +          N  
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGN 377
           +  + T +   L       +   T      L L    L    P +   L +L  + I   
Sbjct: 57  NPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 378 RFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLEN 437
                                                               ++P  ++ 
Sbjct: 115 GLM-------------------------------------------------ELPDTMQQ 125

Query: 438 LSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGNGKL 475
            + LE L L+ N     +P      +     S+    +L
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 2/104 (1%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
               +N+ L   +   I   L KLE L L         P   G  + L+ + ++      
Sbjct: 210 SLKIRNSPLSA-LGPAIHH-LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN 104
            +P  + +L +L  L++        +P  I  + +   I +  +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (413), Expect = 4e-43
 Identities = 64/441 (14%), Positives = 145/441 (32%), Gaps = 28/441 (6%)

Query: 16  EIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYL 75
           EI     + +   + ++ L   L     +   ++ +D+ GN L       L    KL  L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 76  NIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFL 135
           N+  N         + ++S+   + L +N     L        P++    AA NN++   
Sbjct: 64  NLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR-- 113

Query: 136 PISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLAN 195
            +S S     + + L +N+      ++      +  L L  N +     + ++F  + A+
Sbjct: 114 -VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAAS 167

Query: 196 CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG 255
              LE+L L  N    +        +  + T+D+  N  +  + P   +   +  I++  
Sbjct: 168 SDTLEHLNLQYNFIYDV--KGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 256 NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLG 315
           N+L+  +   + + +NL+   L  N  H              +  +    ++     +  
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEE 281

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSL----FLNLSDNLLSGSLPSEIGNLKNLVQ 371
            CT   +        + +  P    +  L       L+   +     L  E  N     +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQRE 340

Query: 372 LDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI 431
           +D    ++   I        +   ++ +  +    +         +      +     ++
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IEL 399

Query: 432 PKYLENLSFLEYLNLSYNHFE 452
               E  S L+ L      +E
Sbjct: 400 QHATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  151 bits (382), Expect = 4e-39
 Identities = 59/479 (12%), Positives = 132/479 (27%), Gaps = 35/479 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
              ++ L       +    + ++ L L+ N L+      +   + L+++++  N L    
Sbjct: 16  KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-T 73

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
            D L  L  L  L++  N         +    S E +   +N     +         N+ 
Sbjct: 74  LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIY 126

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN--FNSLKNLSVLILGNNHLG 180
               A N +T    +     S ++ L+L+ N+ I  ++      S   L  L L  N + 
Sbjct: 127 ---LANNKITMLRDLDEGCRSRVQYLDLKLNE-IDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP 240
           +        V      +KL+ L L  N+    +     + +  +T I +  N     I  
Sbjct: 183 D--------VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAG-VTWISLRNNKLV-LIEK 231

Query: 241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLA 300
            L    +L    + GN           + KN +   +    +      +    T+ TL  
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDG----VLPPQILSVTTLSLFLNLSDNLLS 356
                 +           +L     +     G     L  +  +       ++       
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR-EIDALKEQYR 349

Query: 357 GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYV---KMQDNSFSGSIPPSLNF 413
             +       +  + L+         +     A   L+      +       +       
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPL 409

Query: 414 LKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
                ++         Q       +   +           E  +    + +   +L+  
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASA 468

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (355), Expect = 1e-35
 Identities = 51/397 (12%), Positives = 110/397 (27%), Gaps = 31/397 (7%)

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           I +      +     +  +     +     +  + + + L  N     +    +A    L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                + N L   L +   + S L  L+L +N              ++  L   NN++  
Sbjct: 61  ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
            + +              +N+ L +N+   L        S  +  +D+  N    T+   
Sbjct: 114 VSCSRG---------QGKKNIYLANNKITMLRDLDEGCRSR-VQYLDLKLNEID-TVNFA 162

Query: 242 --LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
               +   L  + ++ N +   V  ++     L++L L+SN L  ++     +   +T +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL 359
           +L  N L   I  +L    +L    L  N           S         ++   +    
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS--KNQRVQTVAKQTVKKLT 276

Query: 360 PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF----LK 415
                                           +L+  +    S  GS    L        
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
             + +D    +    I +          L       +
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  123 bits (309), Expect = 1e-29
 Identities = 52/275 (18%), Positives = 103/275 (37%), Gaps = 20/275 (7%)

Query: 213 LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNL 272
           +     N +       +  +     +     +  ++  + + GN L      ++     L
Sbjct: 2   IHEIKQNGNRY-KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDG 332
           + L L+SN L+      L +L+ L  L L  N +       L    S+  L  + N +  
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112

Query: 333 VLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSAC 390
            +              + L++N ++     + G    +  LD+  N     +     ++ 
Sbjct: 113 RVSCSRGQ----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 391 TSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
            +LE++ +Q N     +   +     +K LDLSSNKL+  +    ++ + + +++L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 451 FEGEVPKK-GVFSNKTRFSLSGNGKLCGGLDEFHL 484
               + K      N   F L GNG  CG L +F  
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 18/95 (18%), Positives = 40/95 (42%), Gaps = 2/95 (2%)

Query: 358 SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSI 417
           ++     N        ++ +     +     +  +++ + +  N  S      L     +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 418 KVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
           ++L+LSSN L   +   LE+LS L  L+L+ N+ +
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  143 bits (363), Expect = 3e-37
 Identities = 60/366 (16%), Positives = 123/366 (33%), Gaps = 31/366 (8%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
            L   + ++   + +       + +   ++++++   ++             +  L +G 
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           N      P    N+     + L+ N    SLP  +  N P L     + NNL      + 
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
              ++L+ L+L  N+      ++ + + +L    +  N L           + LA    +
Sbjct: 162 QATTSLQNLQLSSNRL---THVDLSLIPSLFHANVSYNLL-----------STLAIPIAV 207

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
           E L    N    +       L    T + +  N    T    L N   L  + +  N+ +
Sbjct: 208 EELDASHNSINVVRGPVNVEL----TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNE-L 260

Query: 260 GTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
             +       ++ L+ LY+++N L   +      +  L +L L  N+L   +  +     
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
            L  L L  N +   L        TL   L LS N    +    +   +N+ +  +    
Sbjct: 319 RLENLYLDHNSI-VTLKLSTHH--TLK-NLTLSHNDWDCNSLRAL--FRNVARPAVDDAD 372

Query: 379 FSGDIP 384
               I 
Sbjct: 373 QHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  140 bits (356), Expect = 2e-36
 Identities = 68/419 (16%), Positives = 129/419 (30%), Gaps = 55/419 (13%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           Y     ++ +               L+  +++  + + +       L   R++  LN+  
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
            Q                            +     A    ++K     N +    P   
Sbjct: 79  LQIE-------------------------EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 113

Query: 140 SNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK 198
            N   L +L L  N  +  +    F++   L+ L + NN+L     +           + 
Sbjct: 114 QNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDD------TFQATTS 166

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
           L+NL L  N+   +    + +L       ++  N  S      L   + +  +    N  
Sbjct: 167 LQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLLS-----TLAIPIAVEELDASHNS- 216

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
           I  V   +     L  L L  N L     + L N   L  + L  N L+  +        
Sbjct: 217 INVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
            L  L +S N+L   L      + TL   L+LS N L   +         L  L +  N 
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLEN 437
               +   LS   +L+ + +  N +  +        +++    +       +I   LE+
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  140 bits (355), Expect = 3e-36
 Identities = 60/369 (16%), Positives = 130/369 (35%), Gaps = 31/369 (8%)

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           I   L        ++I       +       +++ + +  +++     LP  ++ +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLG 180
                    +      + + A  ++ L +  N  I  +  + F ++  L+VL+L  N L 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP 240
           +          +  N  KL  L + +N    +   +    ++ +  + +  N  +  +  
Sbjct: 131 SLPRG------IFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRLT-HVDL 182

Query: 241 G-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
             + +L H N   +  N L       +     ++ L  + N ++         LT+L L 
Sbjct: 183 SLIPSLFHAN---VSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 234

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL 359
              + +      + L N   L+ + LS N+L+  +             L +S+N L  +L
Sbjct: 235 HNNLTDT-----AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 287

Query: 360 PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV 419
                 +  L  LD+S N     +         LE + +  NS   ++  S     ++K 
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKN 343

Query: 420 LDLSSNKLS 428
           L LS N   
Sbjct: 344 LTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (340), Expect = 3e-34
 Identities = 71/359 (19%), Positives = 130/359 (36%), Gaps = 41/359 (11%)

Query: 134 FLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVL 193
            +  +L        + +              +L N  ++   N+ +    A  LD    +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 194 ------------------ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
                             A    ++ L +  N    L PH   N+   +T + +  N  S
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDLS 130

Query: 236 GTIPPGL-GNLVHLNSIAMEGNQLIGTVPPEIGW-LKNLQSLYLNSNFLHGYIPSSLGNL 293
            ++P G+  N   L +++M  N  +  +  +      +LQ+L L+SN L  ++   L  +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
             L    +  N L     S+L    ++  L  S N ++ V  P  + +T     L L  N
Sbjct: 186 PSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTI----LKLQHN 236

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF 413
            L+      + N   LV++D+S N     +         LE + + +N    ++      
Sbjct: 237 NLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293

Query: 414 LKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           + ++KVLDLS N L   + +       LE L L +N     +            +LS N
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (314), Expect = 7e-31
 Identities = 60/340 (17%), Positives = 111/340 (32%), Gaps = 33/340 (9%)

Query: 153 NQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL 212
           N    +              +  + H+ +    D+ F       +  + +   ++    L
Sbjct: 2   NVKPRQPEYKCIDSNLQYDCVFYDVHI-DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60

Query: 213 LPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGW-LK 270
               L +    +  +++        I          +  + M  N  I  +PP +   + 
Sbjct: 61  PAALLDSFRQ-VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVP 117

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
            L  L L  N L         N   LT L++  NNL+     +    TSL  L LS N+L
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177

Query: 331 DGVLPPQILSVTTLSL---------------FLNLSDNLLSGSLPSEIGNLKNLVQLDIS 375
             V    I S+   ++                L+ S N ++  +   +     L  L + 
Sbjct: 178 THVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQ 234

Query: 376 GNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKY 434
            N  +      L     L  V +  N     I       ++ ++ L +S+N+L   +  Y
Sbjct: 235 HNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 435 LENLSFLEYLNLSYNHFEGEVPKKGVFSNK--TRFSLSGN 472
            + +  L+ L+LS+NH    V  +            L  N
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVE-RNQPQFDRLENLYLDHN 328

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  122 bits (309), Expect = 3e-30
 Identities = 56/331 (16%), Positives = 113/331 (34%), Gaps = 36/331 (10%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGK 61
           +  + ++  +I      Y   ++ L +  N +   LP  +  N+  L V+ +  N L   
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL 132

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
                    KL  L++  N        +    +S + + L SNR    +       +P+L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSL 188

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                + N L+     +L+    +E L+   N       +       L++L L +N+L +
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSI---NVVRGPVNVELTILKLQHNNLTD 240

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
                      L N   L  + L  N+   ++ H    +   +  + I  N     +   
Sbjct: 241 --------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLY 290

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
              +  L  + +  N  +  V         L++LYL+ N +   +   L     L  L L
Sbjct: 291 GQPIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTL 346

Query: 302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDG 332
             N+          N    +   +++  +D 
Sbjct: 347 SHNDWD-------CNSLRALFRNVARPAVDD 370

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 51/314 (16%), Positives = 102/314 (32%), Gaps = 57/314 (18%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP 63
           + N L   +P  I     KL  LS++ N+L  ++        ++LQ + +  NRL   + 
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD 181

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRK 123
             L  +  L + N+  N  S                                A    + +
Sbjct: 182 --LSLIPSLFHANVSYNLLSTL------------------------------AIPIAVEE 209

Query: 124 FVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI-NFNSLKNLSVLILGNNHLGNR 182
             A+ N++     +       L +L+L+ N            +   L  + L  N L   
Sbjct: 210 LDASHNSINV---VRGPVNVELTILKLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKI 263

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
             +            +LE L + +N+    L      +   +  +D+  N+    +    
Sbjct: 264 MYH------PFVKMQRLERLYISNNRLVA-LNLYGQPIPT-LKVLDLSHNHLL-HVERNQ 314

Query: 243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
                L ++ ++ N  I T+         L++L L+ N        +L     +   A++
Sbjct: 315 PQFDRLENLYLDHNS-IVTLKLST--HHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVD 369

Query: 303 INNLQGKIPSSLGN 316
             +   KI   L +
Sbjct: 370 DADQHCKIDYQLEH 383

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  144 bits (365), Expect = 3e-36
 Identities = 68/346 (19%), Positives = 132/346 (38%), Gaps = 29/346 (8%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
                +        +N +++  +++      +   +S + + +L L +  +         
Sbjct: 37  QTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY--- 93

Query: 189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVH 247
                A    ++ L +  N    L PH   N+   +T + +  N  S ++P G+  N   
Sbjct: 94  ---AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDLS-SLPRGIFHNTPK 148

Query: 248 LNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           L +++M  N  +  +  +      +LQ+L L+SN L  ++   L  +  L    +  N L
Sbjct: 149 LTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 204

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL 366
                S+L    ++  L  S N ++ V  P  + +T L     L  N L+      + N 
Sbjct: 205 -----STLAIPIAVEELDASHNSINVVRGPVNVELTIL----KLQHNNLT-DTAW-LLNY 253

Query: 367 KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNK 426
             LV++D+S N     +         LE + + +N    ++      + ++KVLDLS N 
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312

Query: 427 LSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           L   + +       LE L L +N     +            +LS N
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  142 bits (359), Expect = 1e-35
 Identities = 76/442 (17%), Positives = 147/442 (33%), Gaps = 32/442 (7%)

Query: 71  KLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNN 130
           +  Y    R      I  ++     F  + +          F+ +  L N +      + 
Sbjct: 4   QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNST 62

Query: 131 LTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFV 190
           +       L +   +ELL L D Q     +  F     +  L +G N +     +     
Sbjct: 63  MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH----- 117

Query: 191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLN 249
            V  N   L  L L  N    L      N    +TT+ +  N     I          L 
Sbjct: 118 -VFQNVPLLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLE-RIEDDTFQATTSLQ 174

Query: 250 SIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGK 309
           ++ +  N+ +  V      + +L    ++ N L     S+L     +  L    N++   
Sbjct: 175 NLQLSSNR-LTHVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-V 225

Query: 310 IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKN 368
           +   +     L +L L  N L       +L+   L   ++LS N L   +       ++ 
Sbjct: 226 VRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLV-EVDLSYNELE-KIMYHPFVKMQR 279

Query: 369 LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS 428
           L +L IS NR    +        +L+ + +  N     +  +      ++ L L  N + 
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

Query: 429 GQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCP 488
             +   L     L+ L LS+N ++     + +F N  R ++    + C    +     C 
Sbjct: 338 -TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393

Query: 489 SKRSRKLIATILKVVIPTIVSC 510
            +  +  +  +L+ +  T V  
Sbjct: 394 KESDKPYLDRLLQYIALTSVVE 415

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  140 bits (353), Expect = 1e-34
 Identities = 61/391 (15%), Positives = 136/391 (34%), Gaps = 32/391 (8%)

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
           I   L        ++I       +       +++ + +  +++     LP  ++ +   +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLG 180
                    +      + + A  ++ L +  N  I  +  + F ++  L+VL+L  N L 
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP 240
           +          +  N  KL  L + +N    +   +    ++ +  + +  N  +  +  
Sbjct: 137 SLPRG------IFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRLT-HVDL 188

Query: 241 G-LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
             + +L H N   +  N L       +     ++ L  + N ++         LT+L L 
Sbjct: 189 SLIPSLFHAN---VSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 240

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL 359
              + +      + L N   L+ + LS N+L+  +             L +S+N L  +L
Sbjct: 241 HNNLTDT-----AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 293

Query: 360 PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV 419
                 +  L  LD+S N     +         LE + +  NS   ++  S     ++K 
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKN 349

Query: 420 LDLSSNKLSG-QIPKYLENLSFLEYLNLSYN 449
           L LS N      +     N++     +   +
Sbjct: 350 LTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  137 bits (346), Expect = 6e-34
 Identities = 65/428 (15%), Positives = 132/428 (30%), Gaps = 56/428 (13%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
            L   + ++   + +       + +   ++++++   ++             +  L +G 
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           N      P    N+     + L+ N    SLP  +  N P L     + NNL      + 
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
              ++L+ L+L  N+      ++ + + +L    +  N L           + LA    +
Sbjct: 168 QATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL-----------STLAIPIAV 213

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
           E L    N    +       L+                          L    ++ N L 
Sbjct: 214 EELDASHNSINVVRGPVNVELT-------------------------ILK---LQHNNL- 244

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
            T    +     L  + L+ N L   +      +  L  L +  N L   +        +
Sbjct: 245 -TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRF 379
           L +L LS N L   +         L   L L  N +  +L   +     L  L +S N +
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357

Query: 380 SGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLS 439
             +    L    ++    + D      I      L+       S      ++ +Y+   S
Sbjct: 358 DCNSLRALF--RNVARPAVDDADQHCKIDYQ---LEHGLCCKESDKPYLDRLLQYIALTS 412

Query: 440 FLEYLNLS 447
            +E +  +
Sbjct: 413 VVEKVQRA 420

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  127 bits (320), Expect = 1e-30
 Identities = 68/452 (15%), Positives = 146/452 (32%), Gaps = 50/452 (11%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGK 61
           +  + ++  +I      Y   ++ L +  N +   LP  +  N+  L V+ +  N L   
Sbjct: 81  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL 138

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
                    KL  L++  N        +    +S + + L SNR    +       +P+L
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSL 194

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                + N L+     +L+    +E L+   N       +       L++L L +N+L +
Sbjct: 195 FHANVSYNLLS-----TLAIPIAVEELDASHNSI---NVVRGPVNVELTILKLQHNNLTD 246

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
            A         L N   L  + L  N+   ++ H    +   +  + I  N     +   
Sbjct: 247 TAW--------LLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLY 296

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
              +  L  + +  N L+  V         L++LYL+ N +   +   L     L  L L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTL 352

Query: 302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS 361
             N+          N    +   +++  +D              +   L   L       
Sbjct: 353 SHNDWD-------CNSLRALFRNVARPAVDDADQ-------HCKIDYQLEHGLCCKESDK 398

Query: 362 EIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLD 421
              +        I+       +      C++ + +    +            L+  + L+
Sbjct: 399 PYLDRLL---QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLE 455

Query: 422 LSSNKLSGQIPKY----LENLSFLEYLNLSYN 449
              N+L  ++ +     ++    L+ L+   +
Sbjct: 456 AEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  140 bits (356), Expect = 7e-36
 Identities = 59/425 (13%), Positives = 130/425 (30%), Gaps = 50/425 (11%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
             +   A   +     +S   L+ L  +D   + +       + +L  L  L    N  +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT 77

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                 +   ++  ++   SN+   +L       L  L       N LT    + +S   
Sbjct: 78  TL---DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT---KLDVSQNP 127

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG 203
            L  L    N       I+ +    L+ L    N               +   ++L  L 
Sbjct: 128 LLTYLNCARNTL---TEIDVSHNTQLTELDCHLNKKIT--------KLDVTPQTQLTTLD 176

Query: 204 LYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP 263
              N+   L    ++     +  ++   N  +  +   L   + L  +    N+L   + 
Sbjct: 177 CSFNKITEL---DVSQNKL-LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID 228

Query: 264 PEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIML 323
             +  L  L     + N L     S+L  LT L  +  ++  +       L + T LI  
Sbjct: 229 --VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEI------DLTHNTQLIYF 280

Query: 324 TLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI 383
                +    +    ++  T    L+     ++  L   +     LV L ++    + ++
Sbjct: 281 QAEGCRK---IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333

Query: 384 PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEY 443
              +S  T L+ +   +          +  + ++     +  +      + L N S    
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389

Query: 444 LNLSY 448
           ++   
Sbjct: 390 VSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  125 bits (316), Expect = 9e-31
 Identities = 64/404 (15%), Positives = 128/404 (31%), Gaps = 52/404 (12%)

Query: 69  LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK 128
               +               S   +++   +   ++     +    +  L  L K +   
Sbjct: 20  FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTS 73

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
           NN+T    + LS  +NL  L    N+     +++   L  L+ L    N L       LD
Sbjct: 74  NNITT---LDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKL-----TKLD 122

Query: 189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHL 248
                +    L  L    N    +       L    T +D   N         +     L
Sbjct: 123 V----SQNPLLTYLNCARNTLTEIDVSHNTQL----TELDCHLN--KKITKLDVTPQTQL 172

Query: 249 NSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG 308
            ++    N++      ++   K L  L  ++N +   +   L     LT L    N L  
Sbjct: 173 TTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT- 225

Query: 309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKN 368
           +I   +   T L     S N L   L    L  + L+  L+     L   +   + +   
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLT-ELDVSTL--SKLT-TLHCIQTDLL-EID--LTHNTQ 276

Query: 369 LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS 428
           L+     G R   ++   ++  T L  +  Q    +  +   L+    +  L L++ +L+
Sbjct: 277 LIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331

Query: 429 GQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
            ++   + + + L+ L+    H + +    G          +  
Sbjct: 332 -ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  122 bits (308), Expect = 1e-29
 Identities = 66/354 (18%), Positives = 118/354 (33%), Gaps = 62/354 (17%)

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQF-----IGKM-------------- 159
            N    VAA   +     IS    + L  L+  ++       I K+              
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT 77

Query: 160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN 219
           +++ +   NL+ L   +N L      +LD        +KL  L    N+   L       
Sbjct: 78  TLDLSQNTNLTYLACDSNKL-----TNLDV----TPLTKLTYLNCDTNKLTKLDVSQNPL 128

Query: 220 LSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNS 279
           L    T ++   N  +  I   + +   L  +    N+ I     ++     L +L  + 
Sbjct: 129 L----TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSF 179

Query: 280 NFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQIL 339
           N +       +    +L  L  + NN+  K+   L     L  L  S NKL        +
Sbjct: 180 NKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL------TEI 227

Query: 340 SVTTLSL--FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVK 397
            VT L+   + + S N L+  L   +  L  L  L         +I   L+  T L Y +
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQ 281

Query: 398 MQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
            +       +   +     + +LD  +  ++ ++   L     L YL L+    
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (299), Expect = 2e-28
 Identities = 63/382 (16%), Positives = 116/382 (30%), Gaps = 56/382 (14%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK 61
               +N +   + +        L  L+   N LT    + +  L+ L  ++   N+L   
Sbjct: 69  LICTSNNIT-TLDL---SQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL--- 118

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
               + Q   L YLN  RN  +      + + +    +    N+    L          L
Sbjct: 119 TKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDV---TPQTQL 172

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                + N +T    + +S    L  L    N       ++ N    L+ L   +N L  
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL-- 224

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
               ++D        ++L       N    L   +L+ L    TT+          I   
Sbjct: 225 ---TEIDV----TPLTQLTYFDCSVNPLTELDVSTLSKL----TTLHCIQTDLL-EID-- 270

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
           L +   L     EG + I     ++     L  L   +  +       L     L  L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKE--LDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYL 325

Query: 302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS 361
               L  ++   + + T L  L+     +       +  +  L+     ++     ++P 
Sbjct: 326 NNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNN-NFEAEGQTI-TMPK 378

Query: 362 EIGNLKNLV------QLDISGN 377
           E     +L        LD  GN
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGN 400

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (255), Expect = 7e-23
 Identities = 47/349 (13%), Positives = 106/349 (30%), Gaps = 50/349 (14%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
              L  L+ A N LT    + + + + L  +D   N+        +    +L  L+   N
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFN 180

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           + +      +        +   +N     L          L     + N LT    I ++
Sbjct: 181 KITEL---DVSQNKLLNRLNCDTNNIT-KLDL---NQNIQLTFLDCSSNKLTE---IDVT 230

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
             + L   +   N       ++ ++L  L+ L      L      ++D    L + ++L 
Sbjct: 231 PLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL-----LEID----LTHNTQLI 278

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG 260
                  +   +    + + +  +  +D      +  +   L     L  + +   +L  
Sbjct: 279 YFQAEGCRK--IKELDVTHNTQ-LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT- 331

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            +   +     L+SL   +  +      S+G +  L                      ++
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHI-QDFS-SVGKIPALNNNFEAEGQT-----------ITM 376

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNL 369
              TL+ N L   + P +L      + +   D  +     +     +NL
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVY-DQATNTITWENL 424

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 95.1 bits (237), Expect = 1e-20
 Identities = 54/276 (19%), Positives = 96/276 (34%), Gaps = 29/276 (10%)

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
               +      +       S   L+  +T++D   +  +     G+  L  L  +    N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLAT-LTSLDCHNSSITDM--TGIEKLTGLTKLICTSN 74

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
            +      ++    NL  L  +SN L   +   +  LT LT L  + N L       +  
Sbjct: 75  NITT---LDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQ 125

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG 376
              L  L  ++N L        + V+  +    L  +L       ++     L  LD S 
Sbjct: 126 NPLLTYLNCARNTL------TEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSF 179

Query: 377 NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE 436
           N+ + ++   +S    L  +    N+ +  +   LN    +  LD SSNKL+ +I   + 
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VT 230

Query: 437 NLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
            L+ L Y + S N    E+      S  T       
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVST-LSKLTTLHCIQT 264

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (344), Expect = 1e-35
 Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 61/302 (20%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI---IGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
            +      +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + HRNLI++  +  +          +V +    GSL + L ++     +  L        
Sbjct: 78  LDHRNLIRLYGVVLTPPM------KMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRY 126

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A+ VA  + YL        +H DL   N+LL    +  +GDFGL + LP        +  
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHY 178

Query: 728 SSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTL 783
                 K    + APE     T S AS   D + FG+ L EMF+  + P       GL  
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP-----WIGLNG 230

Query: 784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKI-EECLVAVIRIGVVCSMESPT 842
            +         ++  +D              + GER+   E+C   +  + V C    P 
Sbjct: 231 SQ---------ILHKID--------------KEGERLPRPEDCPQDIYNVMVQCWAHKPE 267

Query: 843 DR 844
           DR
Sbjct: 268 DR 269

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (344), Expect = 2e-35
 Identities = 51/282 (18%), Positives = 104/282 (36%), Gaps = 17/282 (6%)

Query: 192 VLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
           +  N ++ +   + D+     L     +  N +  +D+ GN  S      L     L  +
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIP 311
            +  N L      ++  L  L++L LN+N++       L     +  L    NN+  ++ 
Sbjct: 64  NLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG-SLPSEIGNLKNLV 370
            S G       + L+ NK+  +        + +  +L+L  N +   +      +   L 
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLE 172

Query: 371 QLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQ 430
            L++  N    D+ G +     L+ + +  N  +  + P       +  + L +NKL   
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 431 IPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           I K L     LE+ +L  N F     +     N+   +++  
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  132 bits (333), Expect = 5e-34
 Identities = 53/330 (16%), Positives = 116/330 (35%), Gaps = 22/330 (6%)

Query: 16  EIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYL 75
           EI     + +   + ++ L   L     +   ++ +D+ GN L       L    KL  L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 76  NIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFL 135
           N+  N         + ++S+   + L +N     L        P++    AA NN++   
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISR-- 113

Query: 136 PISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLAN 195
            +S S     + + L +N+      ++      +  L L  N +     + ++F  + A+
Sbjct: 114 -VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAAS 167

Query: 196 CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG 255
              LE+L L  N    +        +  + T+D+  N  +  + P   +   +  I++  
Sbjct: 168 SDTLEHLNLQYNFIYDV--KGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 256 NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLG 315
           N+L+  +   + + +NL+   L  N  H              +  +    ++     +  
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLS 345
            CT   +        + +  P    +  L 
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALG 311

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  128 bits (324), Expect = 9e-33
 Identities = 55/342 (16%), Positives = 109/342 (31%), Gaps = 31/342 (9%)

Query: 113 DMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVL 172
           ++  N    +      ++L   L     +A N++ L+L  N      + +      L +L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 173 ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN 232
            L +N L             L + S L  L L +N         L    + + T+    N
Sbjct: 64  NLSSNVLYETLD--------LESLSTLRTLDLNNNYV-----QELLVGPS-IETLHAANN 109

Query: 233 YFSGTIPPGLG-NLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG-YIPSSL 290
             S  +    G    ++    +  N++      + G    +Q L L  N +         
Sbjct: 110 NIS-RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 291 GNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNL 350
            +   L  L L+ N +   +   +     L  L LS NKL   + P+  S   ++ +++L
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISL 221

Query: 351 SDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS 410
            +N L   +   +   +NL   D+ GN F         +  +     +   +       +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQN 279

Query: 411 LNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
                   +    +          L        + L ++H  
Sbjct: 280 EEECTVPTLGHYGAYCCED-----LPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 15/190 (7%)

Query: 286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS 345
           I     N     +  +  ++L+  + S   +  ++  L LS N L  +    +   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL- 60

Query: 346 LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG 405
             LNLS N+L      ++ +L  L  LD++ N         L    S+E +   +N+ S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 406 SIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKT 465
            +  S    +  K + L++NK++          S ++YL+L  N  +  V    + ++  
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

Query: 466 R---FSLSGN 472
                +L  N
Sbjct: 170 TLEHLNLQYN 179

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 18/95 (18%), Positives = 40/95 (42%), Gaps = 2/95 (2%)

Query: 358 SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSI 417
           ++     N        ++ +     +     +  +++ + +  N  S      L     +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 418 KVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE 452
           ++L+LSSN L  +    LE+LS L  L+L+ N+ +
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  142 bits (359), Expect = 2e-35
 Identities = 80/386 (20%), Positives = 131/386 (33%), Gaps = 59/386 (15%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
           C       L++ E+ LT  LP  +     +  + I  N L   +P    +LR    L + 
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPALPPELRT---LEVS 89

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS 138
            NQ +  +P     +                LP    A    L K     N LT  LP+ 
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLT----HLP----ALPSGLCKLWIFGNQLT-SLPVL 139

Query: 139 LSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK 198
                 L+ L + DNQ     S+       L  L   NN L           ++    S 
Sbjct: 140 P---PGLQELSVSDNQL---ASLP-ALPSELCKLWAYNNQL----------TSLPMLPSG 182

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
           L+ L + DNQ    LP   + L      +    N  + ++P     L  L    + GN+L
Sbjct: 183 LQELSVSDNQLAS-LPTLPSEL----YKLWAYNNRLT-SLPALPSGLKELI---VSGNRL 233

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
             ++P        L+ L ++ N L   +P     L  L+   +  N L  ++P SL + +
Sbjct: 234 -TSLPVLPS---ELKELMVSGNRL-TSLPMLPSGLLSLS---VYRNQLT-RLPESLIHLS 284

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLN--LSDNLLSGSLPSEIGNLKNLVQLDISG 376
           S   + L  N L       +  +T+   +    +  ++   S P E   L       +  
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344

Query: 377 NRFSGDIPGTLSACTSLEYVKMQDNS 402
            R      G  +          +DN+
Sbjct: 345 AR-----EGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (356), Expect = 4e-35
 Identities = 69/341 (20%), Positives = 111/341 (32%), Gaps = 55/341 (16%)

Query: 69  LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK 128
                 LN+G +  +  +P  +        + +  N    SLP    A  P LR    + 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLP----ALPPELRTLEVSG 90

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
           N LT  LP+       L +                     L  L +  N L         
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQL--------- 133

Query: 189 FVTVL-ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH 247
             T L      L+ L + DNQ   L P   + L      +    N  + ++P     L  
Sbjct: 134 --TSLPVLPPGLQELSVSDNQLASL-PALPSEL----CKLWAYNNQLT-SLPMLPSGLQE 185

Query: 248 LNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
           L+   +  NQL  ++P        L  L+  +N L   +P+    L  L +      N  
Sbjct: 186 LS---VSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLKELIVS----GNRL 233

Query: 308 GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK 367
             +P        L  L +S N+L   LP     + +L    ++  N L+  LP  + +L 
Sbjct: 234 TSLPVLPSE---LKELMVSGNRLTS-LPMLPSGLLSL----SVYRNQLT-RLPESLIHLS 284

Query: 368 NLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIP 408
           +   +++ GN  S      L   TS          F  +  
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (330), Expect = 8e-32
 Identities = 67/327 (20%), Positives = 127/327 (38%), Gaps = 52/327 (15%)

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
            ++        +     +   +L + ++      ++      +++ L++ +N+L      
Sbjct: 23  ESRGRAAVVQKMRACLNNGNAVLNVGESGLT---TLPDCLPAHITTLVIPDNNL------ 73

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
                ++ A   +L  L +  NQ   L P     L   ++            +P     L
Sbjct: 74  ----TSLPALPPELRTLEVSGNQLTSL-PVLPPGLLE-LSIFSNPLT----HLPALPSGL 123

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
             L    + GNQL  ++P        LQ L ++ N L   +P+    L  L     ++ +
Sbjct: 124 CKLW---IFGNQLT-SLPVLPP---GLQELSVSDNQL-ASLPALPSELCKLWAYNNQLTS 175

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
           L    P        L  L++S N+L   LP     +  L       +N L+ SLP+    
Sbjct: 176 L----PMLPSG---LQELSVSDNQL-ASLPTLPSELYKL----WAYNNRLT-SLPALPSG 222

Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN 425
           LK   +L +SGNR +  +P      + L+ + +  N  + S+P   + L S   L +  N
Sbjct: 223 LK---ELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLPSGLLS---LSVYRN 271

Query: 426 KLSGQIPKYLENLSFLEYLNLSYNHFE 452
           +L+ ++P+ L +LS    +NL  N   
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  129 bits (326), Expect = 3e-31
 Identities = 76/368 (20%), Positives = 124/368 (33%), Gaps = 55/368 (14%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
              +N L   +P        +L  L ++ N LT  LPV    L  L +       L    
Sbjct: 67  VIPDNNLT-SLPALPP----ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL---- 116

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           P     L K   L I  NQ +  +P     +   + + +  N+   SLP    A    L 
Sbjct: 117 PALPSGLCK---LWIFGNQLT-SLPVLPPGL---QELSVSDNQL-ASLP----ALPSELC 164

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
           K  A  N LT  LP+     S L+ L + DNQ +  +    + L  L      NN L   
Sbjct: 165 KLWAYNNQLT-SLPMLP---SGLQELSVSDNQ-LASLPTLPSELYKLWAY---NNRL--- 213

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL 242
               L      A  S L+ L +  N+    LP   + L      + + GN  + ++P   
Sbjct: 214 --TSLP-----ALPSGLKELIVSGNRLTS-LPVLPSEL----KELMVSGNRLT-SLPMLP 260

Query: 243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALE 302
             L+ L+   +  NQL   +P  +  L +  ++ L  N L      +L  +T     +  
Sbjct: 261 SGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316

Query: 303 INNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE 362
           I        S+     +L          D ++P +         +        + +    
Sbjct: 317 IIRFDMAGASAPRETRALH-----LAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLF 371

Query: 363 IGNLKNLV 370
           +  L    
Sbjct: 372 LDRLSETE 379

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 55.3 bits (133), Expect = 7e-08
 Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 38/125 (30%)

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
           LN+ ++ L+ +LP  +    ++  L I  N  +                         S+
Sbjct: 45  LNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-------------------------SL 76

Query: 408 PPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRF 467
           P     L++   L++S N+L+  +P     L  L   +    H    +P     S   + 
Sbjct: 77  PALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALP-----SGLCKL 126

Query: 468 SLSGN 472
            + GN
Sbjct: 127 WIFGN 131

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 3e-35
 Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 33/254 (12%)

Query: 523 RRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
           R +  D   E  T          + K             +G+GSF TV+KG+  E  + V
Sbjct: 4   RNQQQDDIEELETKAVGMSNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTVEV 54

Query: 583 AVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY-DFMQ 639
           A   L   +  K   + F  E E L+ ++H N+++     S           ++  + M 
Sbjct: 55  AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD--SWESTVKGKKCIVLVTELMT 112

Query: 640 NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD 699
           +G+L+ +L +         + +    +    +   +++LH    PP++H DLK  N+ + 
Sbjct: 113 SGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFIT 165

Query: 700 H-DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYS 758
                  +GD GLA    A     V+          GT  ++APE     +   + DVY+
Sbjct: 166 GPTGSVKIGDLGLATLKRASFAKAVI----------GTPEFMAPEMYE-EKYDESVDVYA 214

Query: 759 FGILLLEMFSRRRP 772
           FG+ +LEM +   P
Sbjct: 215 FGMCMLEMATSEYP 228

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  139 bits (351), Expect = 4e-35
 Identities = 69/327 (21%), Positives = 123/327 (37%), Gaps = 19/327 (5%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
                 +P  +   +   LL+L  N+        F S  +L  L L  N +         
Sbjct: 21  KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG--- 74

Query: 189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVH 247
                 N   L  LGL  N+   +       LSN +T +DI  N     +   +  +L +
Sbjct: 75  ---AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKIV-ILLDYMFQDLYN 129

Query: 248 LNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           L S+ +  N  +  +       L +L+ L L    L      +L +L  L +L L   N+
Sbjct: 130 LKSLEVGDND-LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE-IGN 365
                 S      L +L +S       + P  L    L+  L+++   L+ ++P   + +
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRH 246

Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSS 424
           L  L  L++S N  S      L     L+ +++     +  + P +   L  ++VL++S 
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSG 305

Query: 425 NKLSGQIPKYLENLSFLEYLNLSYNHF 451
           N+L+        ++  LE L L  N  
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  134 bits (339), Expect = 1e-33
 Identities = 67/319 (21%), Positives = 125/319 (39%), Gaps = 19/319 (5%)

Query: 116 ANLP-NLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLI 173
             +P   R     KN +        ++  +LE LEL +N  +  +    FN+L NL  L 
Sbjct: 28  EGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLG 86

Query: 174 LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY 233
           L +N L            V    S L  L + +N+   LL +   +L N + ++++G N 
Sbjct: 87  LRSNRLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDND 139

Query: 234 FSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLG 291
               I       L  L  + +E    + ++P E    L  L  L L    ++     S  
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197

Query: 292 NLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS 351
            L  L +L +        +  +     +L  L+++   L   +P   +       FLNLS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256

Query: 352 DNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS 410
            N +S ++   +   L  L ++ + G + +   P        L  + +  N  + ++  S
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEES 314

Query: 411 L-NFLKSIKVLDLSSNKLS 428
           + + + +++ L L SN L+
Sbjct: 315 VFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  129 bits (326), Expect = 6e-32
 Identities = 71/356 (19%), Positives = 123/356 (34%), Gaps = 40/356 (11%)

Query: 27  LSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFI 86
           +          +P  I   +  +++D+  NR+     D       L  L +  N  S  +
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71

Query: 87  PPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
            P    N+ +   + L+SNR    +P  +   L NL K   ++N +   L     +  NL
Sbjct: 72  EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
           + LE+ DN  +      F+ L +L  L L   +L +           L++   L  L L 
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE------ALSHLHGLIVLRLR 184

Query: 206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPE 265
                 +  +S   L                           L  + +     + T+ P 
Sbjct: 185 HLNINAIRDYSFKRLYR-------------------------LKVLEISHWPYLDTMTPN 219

Query: 266 IGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTL 325
             +  NL SL +    L      ++ +L  L  L L  N +     S L     L  + L
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279

Query: 326 SKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFS 380
              +L  V+ P           LN+S N L+ +L   +  ++ NL  L +  N  +
Sbjct: 280 VGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  118 bits (298), Expect = 2e-28
 Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 15/308 (4%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           D   N++   +  +       LE L L EN ++   P +  NL  L+ + +R NRL    
Sbjct: 38  DLGKNRI-KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIP 96

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
                 L  L  L+I  N+    +     ++ + + + +  N     +     + L +L 
Sbjct: 97  LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
           +    K NLT     +LS+   L +L LR          +F  L  L VL + +      
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW----- 210

Query: 183 AANDLDFVTVLA-NCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
               LD +T        L +L +       +   ++ +L   +  +++  N  S TI   
Sbjct: 211 --PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY-LRFLNLSYNPIS-TIEGS 266

Query: 242 -LGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
            L  L+ L  I + G Q +  V P     L  L+ L ++ N L     S   ++  L  L
Sbjct: 267 MLHELLRLQEIQLVGGQ-LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325

Query: 300 ALEINNLQ 307
            L+ N L 
Sbjct: 326 ILDSNPLA 333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (341), Expect = 6e-35
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 41/248 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI----IGENGMLVAVKVL--NLMQKGALKSFLTECEALRS 607
           +EF    ++G G+FGTV+KG+      +  + VA+K L      K A K  L E   + S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + ++ +++ IC +          ++   M  G L +++ ++ D +    L     LN 
Sbjct: 74  VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 122

Query: 668 AIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            + +A  + YL         VH DL   NVL+       + DFGLAK L A       E 
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EK 172

Query: 727 PSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLT 782
              + G K  + ++A E   +   +  S   DV+S+G+ + E+ +   +P     ++G+ 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP-----YDGIP 224

Query: 783 LHEFSKMV 790
             E S ++
Sbjct: 225 ASEISSIL 232

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (339), Expect = 9e-35
 Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 28/222 (12%)

Query: 560 NMVGQGSFGTVFKGI---IGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLI 614
            ++G+G FG+V +G         + VAVK + L    +  ++ FL+E   ++   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +++ +C  +   G+    ++  FM+ G L  +L  +  +    ++ L   L   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 675 IEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG- 732
           +EYL + +     +H DL   N +L  DM   V DFGL     ++ + +           
Sbjct: 160 MEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGL-----SKKIYSGDYYRQGRIAK 210

Query: 733 --IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR 769
             +K      A E       +  S   DV++FG+ + E+ +R
Sbjct: 211 MPVKWI----AIESLADRVYTSKS---DVWAFGVTMWEIATR 245

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (339), Expect = 1e-34
 Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)

Query: 563 GQGSFGTVFKGII----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           G+G+FG+V            G LVAVK L        + F  E + L+++    ++K   
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +        +    +V +++ +G L ++L ++  +L+   L     L  +  +   +EYL
Sbjct: 92  VSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYL 143

Query: 679 H-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
               C    VH DL   N+L++ +    + DFGLAK LP    D  V      S I    
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWY- 197

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRP-TDSMFHEGLTLHEFSKMVLP 792
              APE       S  S   DV+SFG++L E+F+   +  + S     +   E     L 
Sbjct: 198 ---APESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 793 EKVMEIVD 800
             ++E+++
Sbjct: 252 R-LLELLE 258

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (335), Expect = 2e-34
 Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 28/229 (12%)

Query: 563 GQGSFGTVFKG----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           G+G+FG+V       +    G +VAVK L    +  L+ F  E E L+S++H N++K   
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C S     +    ++ +++  GSL ++L ++ ++++   L     L     +   +EYL
Sbjct: 79  VCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130

Query: 679 H-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                    +H DL   N+L++++    +GDFGL K LP       V+ P  S  I    
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP-IFWY- 184

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
              APE       S AS   DV+SFG++L E+F+    + S   E + +
Sbjct: 185 ---APESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  132 bits (335), Expect = 3e-34
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 563 GQGSFGTVFKG----IIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           G+G+FG+V       +    G +VAVK L    +  L+ F  E E L+S++H N++K   
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +C S     +    ++ +++  GSL ++L ++ ++++   L     L     +   +EYL
Sbjct: 110 VCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 161

Query: 679 H-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                    +H DL   N+L++++    +GDFGL K LP       V+ P  S  I    
Sbjct: 162 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP-IFWY- 215

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
              APE       S AS   DV+SFG++L E+F+
Sbjct: 216 ---APESLTESKFSVAS---DVWSFGVVLYELFT 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (338), Expect = 4e-34
 Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 42/238 (17%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           G+G+FG VF G +  +  LVAVK     +       FL E   L+   H N++++I +C+
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182

Query: 622 SID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                +       IV + +Q G    +L     +     L +   L +  D A+ +EYL 
Sbjct: 183 QKQPIY-------IVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLE 230

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG---IKGT 736
                  +H DL   N L+    V  + DFG+     +R     V   S       +K T
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGM-----SREEADGVYAASGGLRQVPVKWT 282

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
               APE   YG  S  S   DV+SFGILL E FS    P     +  L+  +  + V
Sbjct: 283 ----APEALNYGRYSSES---DVWSFGILLWETFSLGASP-----YPNLSNQQTREFV 328

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (333), Expect = 4e-34
 Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 32/249 (12%)

Query: 563 GQGSFGTVFKGI----IGENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G FG V            G  VAVK L        +     E E LR++ H N++K  
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            IC+    NG+    ++ +F+ +GSL+E+L +N +K+ +        L  A+ +   ++Y
Sbjct: 90  GICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDY 141

Query: 678 LH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           L         VH DL   NVL++ +    +GDFGL K +        V+    S  +   
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP-VFWY 196

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS--RRRPTDSMFHEGLTLHEFSKMVL 791
               APE         AS   DV+SFG+ L E+ +      +       +      +M +
Sbjct: 197 ----APECLMQSKFYIAS---DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 792 PEKVMEIVD 800
              ++  + 
Sbjct: 250 TR-LVNTLK 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (329), Expect = 9e-34
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 38/237 (16%)

Query: 563 GQGSFGTVFKGII-GENGML-VAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           G G+FGTV KG    +  +  VAVK+L             L E   ++ + +  ++++I 
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           IC +      +   +V +  + G L ++L QN       ++     + +   V+  ++YL
Sbjct: 86  ICEA------ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYL 133

Query: 679 -HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
              +     VH DL   NVLL     A + DFGL+K L A           + +  K  V
Sbjct: 134 EESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPV 184

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
            + APE   Y   S  S   DV+SFG+L+ E FS  ++P     + G+   E + M+
Sbjct: 185 KWYAPECINYYKFSSKS---DVWSFGVLMWEAFSYGQKP-----YRGMKGSEVTAML 233

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  131 bits (331), Expect = 1e-33
 Identities = 53/223 (23%), Positives = 97/223 (43%), Gaps = 29/223 (13%)

Query: 560 NMVGQGSFGTVFKGI---IGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLI 614
            M+G+G FG+V +        + + VAVK+L  +++    ++ FL E   ++   H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 615 KIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           K++ +       G      ++  FM++G L  +L  +       NL L   +   +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 674 AIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
            +EYL   +     +H DL   N +L  DM   V DFGL     +R + +        + 
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGL-----SRKIYSGDYYRQGCAS 199

Query: 733 ---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR 769
              +K      A E       +  S   DV++FG+ + E+ +R
Sbjct: 200 KLPVKWL----ALESLADNLYTVHS---DVWAFGVTMWEIMTR 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (331), Expect = 1e-33
 Identities = 64/225 (28%), Positives = 115/225 (51%), Gaps = 34/225 (15%)

Query: 563 GQGSFGTVFKGI----IGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKI 616
           G G FG V+KG+     G+  + VA+K L     +K  +  FL E   +    H N+I++
Sbjct: 53  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRL 111

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             + S           I+ ++M+NG+L+++L + + +      S++Q + +   +A+ ++
Sbjct: 112 EGVISKYKPM-----MIITEYMENGALDKFLREKDGEF-----SVLQLVGMLRGIAAGMK 161

Query: 677 YL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           YL + +     VH DL   N+L++ ++V  V DFGL     +R L+   E   ++SG K 
Sbjct: 162 YLANMNY----VHRDLAARNILVNSNLVCKVSDFGL-----SRVLEDDPEATYTTSGGKI 212

Query: 736 TVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + + APE   Y   + AS   DV+SFGI++ E+ +   RP   +
Sbjct: 213 PIRWTAPEAISYRKFTSAS---DVWSFGIVMWEVMTYGERPYWEL 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  129 bits (327), Expect = 2e-33
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 36/238 (15%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR 609
            +  S+F    ++GQG+FG V K     +    A+K +    +  L + L+E   L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60

Query: 610 HRNLIKIITICSSIDFNGVDFKA--------IVYDFMQNGSLEEWLHQNNDKLEVCNLSL 661
           H+ +++                A        I  ++ +NG+L + +H  N   +      
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR----- 115

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
            +   +   +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK +      
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 722 TVVETPSSSSGIK------GTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEM 766
             +++ +            GT  Y+A E       Y          D+YS GI+  EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI------DMYSLGIIFFEM 224

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  131 bits (332), Expect = 2e-33
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 31/223 (13%)

Query: 563 GQGSFGTVFKGII---GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G G FG V  G +    +  + VA+K L     +K     FL E   +    H N+I++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLE 112

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +           IV ++M+NGSL+ +L +++ +      ++IQ + +   +AS ++Y
Sbjct: 113 GVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKY 162

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH DL   N+L++ ++V  V DFGL      R L+   E   ++ G K  +
Sbjct: 163 LSDMG---YVHRDLAARNILINSNLVCKVSDFGL-----GRVLEDDPEAAYTTRGGKIPI 214

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + +PE   Y   + AS   DV+S+GI+L E+ S   RP   M
Sbjct: 215 RWTSPEAIAYRKFTSAS---DVWSYGIVLWEVMSYGERPYWEM 254

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (328), Expect = 3e-33
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)

Query: 563 GQGSFGTVFKGII---GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G G  G V  G +   G+  + VA+K L     ++     FL+E   +    H N+I++ 
Sbjct: 58  GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRLE 116

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +           IV ++M+NGSL+ +L  ++ +      +++Q + +   V + + Y
Sbjct: 117 GVVTRGRLA-----MIVTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRGVGAGMRY 166

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L        VH DL   NVL+D ++V  V DFGL     +R L+   +   +++G K  +
Sbjct: 167 LSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL-----SRVLEDDPDAAYTTTGGKIPI 218

Query: 738 GYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
            + APE   + T S AS   DV+SFG+++ E+ +   RP  +M
Sbjct: 219 RWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERPYWNM 258

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (328), Expect = 3e-33
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 34/249 (13%)

Query: 563 GQGSFGTVFKGII----GENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKII 617
           G+G FG V            G +VAVK L           +  E + LR++ H ++IK  
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
             C       +    +V +++  GSL ++L +++       + L Q L  A  +   + Y
Sbjct: 100 GCCEDAGAASL---QLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAY 149

Query: 678 LH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           LH  H     +H DL   NVLLD+D +  +GDFGLAK +P       V     S  +   
Sbjct: 150 LHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-VFWY 204

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS--RRRPTDSMFHEGLTLHEFSKMVL 791
               APE         AS   DV+SFG+ L E+ +      +       L      +M +
Sbjct: 205 ----APECLKEYKFYYAS---DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257

Query: 792 PEKVMEIVD 800
              + E+++
Sbjct: 258 LR-LTELLE 265

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (335), Expect = 6e-33
 Identities = 62/245 (25%), Positives = 124/245 (50%), Gaps = 40/245 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
           ++ +  + +G G +G V++G+  +  + VAVK L  + M+    + FL E   ++ I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 276

Query: 612 NLIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           NL++++ +C+     +       I+ +FM  G+L ++L + N +     +S +  L +A 
Sbjct: 277 NLVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 325

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            ++SA+EYL        +H +L   N L+  + +  V DFGL++ +         +T ++
Sbjct: 326 QISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTA 375

Query: 730 SSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHE 785
            +G K  + + APE   Y   S  S   DV++FG+LL E+ +    P     + G+ L +
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP-----YPGIDLSQ 427

Query: 786 FSKMV 790
             +++
Sbjct: 428 VYELL 432

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  133 bits (335), Expect = 7e-33
 Identities = 91/458 (19%), Positives = 175/458 (38%), Gaps = 32/458 (6%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L++++N+++      I +LS L+++ I  NR+           ++L YL++  N+  
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMV-ANLPNLRKFVAAKNNLTGFLPISLSNA 142
                S +   + + + L  N F  +LP      N+  L+    +  +L     + +++ 
Sbjct: 83  KI---SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           +  ++L +    +  K   +   L++ +   L      N+  + +  V+V    + LE  
Sbjct: 139 NISKVLLVLGETYGEK--EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK-TVANLELS 195

Query: 203 GLYDNQFGGLLPHSLANLSN-----TMTTIDIGGNYFSGTIPPGLGNLVHLNSI---AME 254
            +          + L+ L+       ++ + +     +      +  LV   ++   ++ 
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255

Query: 255 GNQLIGTVPPEIGW-----LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGK 309
             +L G +           LK L    + S+             + + +    ++  +  
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 310 IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIG---NL 366
                   +  + L  S N L   +      +T L   L L  N L   L         +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQMNQLK-ELSKIAEMTTQM 373

Query: 367 KNLVQLDISGNRFSGDIP-GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN 425
           K+L QLDIS N  S D   G  S   SL  + M  N  + +I   L     IKVLDL SN
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431

Query: 426 KLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
           K+   IPK +  L  L+ LN++ N  +  VP  G+F  
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDR 466

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  132 bits (333), Expect = 1e-32
 Identities = 76/436 (17%), Positives = 157/436 (36%), Gaps = 21/436 (4%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-K 61
              +N++   + + +  +  +LE L L+ N L     +S      L+ +D+  N      
Sbjct: 51  IISHNRI-QYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALP 106

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP-- 119
           I    G + +L +L +            I +++  + + +    +      + + +    
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166

Query: 120 NLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
           +L             L +S+   +NLEL  ++      K S   + L  L      +N  
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226

Query: 180 GNRA---ANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNT----MTTIDIGGN 232
            N      N    +  L   + +    + + +  G L     + S T    ++   +  +
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286

Query: 233 YFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGN 292
            F            ++N      +            +     L  ++N L   +  + G+
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346

Query: 293 LTMLTLLALEINNLQ--GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNL 350
           LT L  L L++N L+   KI        SL  L +S+N +         S T   L LN+
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406

Query: 351 SDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP- 409
           S N+L+ ++   +     +  LD+  N+    IP  +    +L+ + +  N    S+P  
Sbjct: 407 SSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462

Query: 410 SLNFLKSIKVLDLSSN 425
             + L S++ + L +N
Sbjct: 463 IFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  103 bits (258), Expect = 4e-23
 Identities = 57/366 (15%), Positives = 126/366 (34%), Gaps = 34/366 (9%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
           N ++      + + S L +L +  N+        F   + L  L L +N L   + +   
Sbjct: 31  NYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPT- 89

Query: 189 FVTVLANCSKLENLGLYDNQFGGL-LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH 247
                     L++L L  N F  L +     N+S  +  + +   +   +    + +L  
Sbjct: 90  --------VNLKHLDLSFNAFDALPICKEFGNMSQ-LKFLGLSTTHLEKSSVLPIAHLNI 140

Query: 248 LNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
              + + G         +   L++  +  L+  F        + ++++ T+  LE++N++
Sbjct: 141 SKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198

Query: 308 G-----------KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS--LFLNLSDNL 354
                        I + L     L  LTL+  +       +IL +   +   + ++S+  
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 355 LSGSLPSEIG-----NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP 409
           L G L          +LK L    +  + F           +++       +        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 410 SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVF---SNKTR 466
             + +     LD S+N L+  + +   +L+ LE L L  N  +       +     +  +
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378

Query: 467 FSLSGN 472
             +S N
Sbjct: 379 LDISQN 384

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  101 bits (252), Expect = 2e-22
 Identities = 66/380 (17%), Positives = 139/380 (36%), Gaps = 34/380 (8%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI-PDTLGQLR--KLIYLNI 77
           + +L+ L L+  HL     + I +L+  +V+ + G   G K  P+ L       L  +  
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

Query: 78  GRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDM-----VANLPNLRKFVAAKNNLT 132
              +F   +  S+  +++ E   ++         + +     +   P L          T
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 133 G---FLPISLSNASNLELLELRDNQFIGKM-----SINFNSLKNLSVLILGNNHLGNRAA 184
                  + L   + +    + + +  G++       +  SLK LS+  + ++       
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF----- 288

Query: 185 NDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN 244
                  +    S +       +    +     + +S     +D   N  + T+    G+
Sbjct: 289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF-LHLDFSNNLLTDTVFENCGH 346

Query: 245 LVHLNSIAMEGNQLIGTVPPEIGW---LKNLQSLYLNSNFL-HGYIPSSLGNLTMLTLLA 300
           L  L ++ ++ NQL   +         +K+LQ L ++ N + +            L  L 
Sbjct: 347 LTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP 360
           +  N L   I   L     + +L L  NK+   +P Q++ +  L   LN++ N L  S+P
Sbjct: 406 MSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ-ELNVASNQLK-SVP 460

Query: 361 SEI-GNLKNLVQLDISGNRF 379
             I   L +L ++ +  N +
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 80.3 bits (198), Expect = 8e-16
 Identities = 54/272 (19%), Positives = 97/272 (35%), Gaps = 16/272 (5%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           VP ++   +    L ++ N++     S + +L+ L +L +  N +Q    S       L 
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 322 MLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP--SEIGNLKNLVQLDISGNRF 379
            L LS NKL   +         L   L+LS N    +LP   E GN+  L  L +S    
Sbjct: 73  YLDLSHNKLVK-ISCHPT--VNLK-HLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127

Query: 380 SGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLS 439
                  ++     + + +   ++     P    L+      L     + +   ++ ++S
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVS 185

Query: 440 FLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIATI 499
                NL  ++      K  +  NK  + LS   KL       +L     + +      I
Sbjct: 186 VKTVANLELSNI-----KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240

Query: 500 LKVVIPTIVSCLILSACFIVIYGRRRSTDRSF 531
           L++V  T V    +S   +      R  D S 
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 75.7 bits (186), Expect = 3e-14
 Identities = 53/302 (17%), Positives = 102/302 (33%), Gaps = 34/302 (11%)

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG----LGNLVHLNSIA 252
            K   L +  N    L    + +LS  +  + I  N     +          L +L+   
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSK-LRILIISHNRIQ-YLDISVFKFNQELEYLD--- 75

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY-IPSSLGNLTMLTLLALEINNLQGKIP 311
           +  N+L   +        NL+ L L+ N      I    GN++ L  L L   +L+    
Sbjct: 76  LSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSV 132

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQILS-VTTLSLFLNLSDNLLSGSLPS--------- 361
             + +     +L +          P+ L    T SL +    N     +           
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192

Query: 362 EIGNLKNLVQLDISGNRFSGDIPGTLSACT---SLEYVKMQDNSFSGSIPPSLNFLKSIK 418
           E+ N+K +++ +      S       +      +L  ++   NSF       L +  ++ 
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVW 250

Query: 419 VLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEV---PKKGVF---SNKTRFSLSGN 472
              +S+ KL GQ+     + S      LS +    +V   P+  ++   SN    + + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310

Query: 473 GK 474
           G 
Sbjct: 311 GT 312

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 52/296 (17%), Positives = 94/296 (31%), Gaps = 42/296 (14%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNL---SALQVIDIRGNRLGG-----KIPDTLGQLRKL 72
             KL NL+L     T    + I  L   + +    I   +L G         +   L+ L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278

Query: 73  IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT 132
               +  + F                 F QS  +             N+       +   
Sbjct: 279 SIHQVVSDVFG----------------FPQSYIYE---------IFSNMNIKNFTVSGTR 313

Query: 133 GFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVT- 191
               +  S  S    L+  +N     +  N   L  L  LIL  N L      +L  +  
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-----KELSKIAE 368

Query: 192 VLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
           +      L+ L +  N           + + ++ ++++  N  + TI   L     +  +
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
            +  N++  ++P ++  L+ LQ L + SN L          LT L  + L  N   
Sbjct: 427 DLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  127 bits (322), Expect = 1e-32
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 18/226 (7%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRN 612
           ++F     +G+G FG VF+     +    A+K + L  ++ A +  + E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 613 LIK----IITICSSIDFNGVDFKAIVYDFMQ---NGSLEEWLHQNNDKLEVCNLSLIQTL 665
           +++     +   ++        K  +Y  MQ     +L++W++      E         L
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE---RERSVCL 121

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL----PARPLD 721
           +I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +      + + 
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
           T +   +  +G  GT  Y++PE   G+  S   D++S G++L E+ 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  128 bits (323), Expect = 1e-32
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 41/248 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI----IGENGMLVAVKVL--NLMQKGALKSFLTECEALRS 607
           +EF    ++G G+FGTV+KG+      +  + VA+K L      K A K  L E   + S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + + ++ +++ IC +          ++   M  G L +++ ++ D +    L     LN 
Sbjct: 74  VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 122

Query: 668 AIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
            + +A  + YL         VH DL   NVL+       + DFGLAK L A       E 
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EK 172

Query: 727 PSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLT 782
              + G K  + ++A E   +   +  S   DV+S+G+ + E+ +   +P     ++G+ 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP-----YDGIP 224

Query: 783 LHEFSKMV 790
             E S ++
Sbjct: 225 ASEISSIL 232

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (329), Expect = 2e-32
 Identities = 73/243 (30%), Positives = 103/243 (42%), Gaps = 42/243 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
            E      +G+G FG V  G     G  VAVK +  +   +    +FL E   +  +RH 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHS 246

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           NL++++ +             IV ++M  GSL ++L           L     L  ++DV
Sbjct: 247 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDV 298

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             A+EYL  +     VH DL   NVL+  D VA V DFGL K           E  S+  
Sbjct: 299 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQD 344

Query: 732 GIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFS 787
             K  V + APE       S  S   DV+SFGILL E++S  R P     +  + L +  
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKS---DVWSFGILLWEIYSFGRVP-----YPRIPLKDVV 396

Query: 788 KMV 790
             V
Sbjct: 397 PRV 399

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (319), Expect = 2e-32
 Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 42/239 (17%)

Query: 563 GQGSFGTVFKGI--IGENGMLVAVKVL----NLMQKGALKSFLTECEALRSIRHRNLIKI 616
           G G+FG+V +G+  + +  + VA+KVL            +  + E + +  + +  ++++
Sbjct: 19  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVRL 75

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           I +C +          +V +    G L ++L    +++ V N+       +   V+  ++
Sbjct: 76  IGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNV-----AELLHQVSMGMK 124

Query: 677 YL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           YL   +     VH DL   NVLL +   A + DFGL+K L A          ++ S  K 
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKW 175

Query: 736 TVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
            + + APE   +   S  S   DV+S+G+ + E  S  ++P     ++ +   E    +
Sbjct: 176 PLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKP-----YKKMKGPEVMAFI 226

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  126 bits (318), Expect = 2e-32
 Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 31/234 (13%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR 609
            +   +F    ++G G FG VFK     +G    +K +    + A +    E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 610 HRNLIKIITICSSIDFNGVDFKA-----------IVYDFMQNGSLEEWLHQNNDKLEVCN 658
           H N++         D++                 I  +F   G+LE+W+ +   +     
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---- 118

Query: 659 LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPAR 718
           L  +  L +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL   L   
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL--- 172

Query: 719 PLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                 +     +  KGT+ Y++PE  +  +     D+Y+ G++L E+      
Sbjct: 173 ------KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (318), Expect = 3e-32
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 29/222 (13%)

Query: 560 NMVGQGSFGTVFKGI---IGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLIK 615
            ++G+G FG V+ G         +  AVK LN +   G +  FLTE   ++   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           ++ IC   + + +    +V  +M++G L  ++          N ++   +   + VA  +
Sbjct: 91  LLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGM 141

Query: 676 EYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +YL         VH DL   N +LD      V DFGLA+ +     D    +  + +G K
Sbjct: 142 KYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAK 193

Query: 735 GTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRP 772
             V ++A E       +  S   DV+SFG+LL E+ +R   P
Sbjct: 194 LPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (320), Expect = 3e-32
 Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 39/247 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGI---IGENGML-VAVKVLN-LMQKGALKSFLTECEALRSI 608
           +E     ++G G FGTV KG+    GE+  + V +KV+     + + ++      A+ S+
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H ++++++ +C            +V  ++  GSL + + Q+   L    L     LN  
Sbjct: 73  DHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWG 121

Query: 669 IDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           + +A  + YL  H      VH +L   NVLL       V DFG+A  LP        +  
Sbjct: 122 VQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPD------DKQ 171

Query: 728 SSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTL 783
              S  K  + ++A E   +G  +  S   DV+S+G+ + E+ +    P     + GL L
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEP-----YAGLRL 223

Query: 784 HEFSKMV 790
            E   ++
Sbjct: 224 AEVPDLL 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (317), Expect = 4e-32
 Identities = 63/236 (26%), Positives = 119/236 (50%), Gaps = 40/236 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G G +G V++G+  +  + VAVK L  + M+    + FL E   ++ I+H NL++++ +C
Sbjct: 22  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 621 SSID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +     +       I+ +FM  G+L ++L + N +     +S +  L +A  ++SA+EYL
Sbjct: 79  TREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYL 127

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
                   +H DL   N L+  + +  V DFGL++ +         +T ++ +G K  + 
Sbjct: 128 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIK 177

Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           + APE   Y   S  S   DV++FG+LL E+ +    P     + G+ L +  +++
Sbjct: 178 WTAPESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELL 225

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (316), Expect = 4e-32
 Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 41/238 (17%)

Query: 563 GQGSFGTVFKGI---IGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G FG V +GI        + VA+K            + FL E   +R   H +++K+I
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKLI 82

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            + +       +   I+ +    G L  +L      L      L   +  A  +++A+ Y
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQVRKYSL-----DLASLILYAYQLSTALAY 131

Query: 678 L-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           L         VH D+   NVL+  +    +GDFGL++++     D+       +S  K  
Sbjct: 132 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYK---ASKGKLP 180

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           + ++APE   +   + AS   DV+ FG+ + E+     +P      +G+  ++    +
Sbjct: 181 IKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRI 230

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (317), Expect = 4e-32
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 29/222 (13%)

Query: 560 NMVGQGSFGTVFKGI---IGENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLIK 615
            ++G+G FG V+ G      +N +  A+K L+ + +   +++FL E   +R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +I I       G+    ++  +M +G L +++          N ++   ++  + VA  +
Sbjct: 87  LIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGM 137

Query: 676 EYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           EYL         VH DL   N +LD      V DFGLA+ +    LD    +       +
Sbjct: 138 EYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHAR 189

Query: 735 GTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRP 772
             V + A E       +  S   DV+SFG+LL E+ +R   P
Sbjct: 190 LPVKWTALESLQTYRFTTKS---DVWSFGVLLWELLTRGAPP 228

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (315), Expect = 6e-32
 Identities = 73/234 (31%), Positives = 102/234 (43%), Gaps = 42/234 (17%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRNLIKIITICS 621
           G+G FG V  G     G  VAVK +      A  ++FL E   +  +RH NL++++ +  
Sbjct: 30  GKGEFGDVMLGDY--RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL-HH 680
                      IV ++M  GSL ++L           L     L  ++DV  A+EYL  +
Sbjct: 85  E----EKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
           +     VH DL   NVL+  D VA V DFGL K           E  S+    K  V + 
Sbjct: 137 NF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 181

Query: 741 APE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           APE       S  S   DV+SFGILL E++S  R P     +  + L +    V
Sbjct: 182 APEALREKKFSTKS---DVWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRV 227

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  126 bits (318), Expect = 2e-31
 Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 41/305 (13%)

Query: 489 SKRSRKLIATILKVVIPTIVSCL----ILSACFIVIYGRRRSTDRSFERTTMVEQQFPMI 544
               R+  +    +++P     L     +      +Y +  S +  F+    V      +
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 545 S---YAKLSKATSEFSSSN-----MVGQGSFGTVFKGI---IGENGMLVAVKVLN-LMQK 592
           +      +       SS       ++G+G FG V+ G         +  AVK LN +   
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131

Query: 593 GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND 652
           G +  FLTE   ++   H N++ ++ IC   + + +    +V  +M++G L  ++     
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETH 187

Query: 653 KLEVCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
                N ++   +   + VA  +++L         VH DL   N +LD      V DFGL
Sbjct: 188 -----NPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGL 238

Query: 712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
           A+ +     D   ++  + +G K  V ++A E       +  S   DV+SFG+LL E+ +
Sbjct: 239 ARDM----YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMT 291

Query: 769 R-RRP 772
           R   P
Sbjct: 292 RGAPP 296

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (311), Expect = 2e-31
 Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 38/234 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G G FG V+ G        VAVK L    M      +FL E   ++ ++H+ L+++  + 
Sbjct: 22  GAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
           +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEE 127

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYI 740
                 +H DL+ +N+L+   +   + DFGLA+ +     D       +  G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYT---AREGAKFPIKWT 177

Query: 741 APE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
           APE   YGT +  S   DV+SFGILL E+ +  R P     + G+T  E  + +
Sbjct: 178 APEAINYGTFTIKS---DVWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNL 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (311), Expect = 2e-31
 Identities = 48/220 (21%), Positives = 100/220 (45%), Gaps = 36/220 (16%)

Query: 563 GQGSFGTVFKGI---IGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G FG V++G+        + VAVK            + F++E   ++++ H +++K+I
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            I         +   I+ +    G L  +L +N + L      ++  +  ++ +  A+ Y
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYLERNKNSL-----KVLTLVLYSLQICKAMAY 128

Query: 678 L-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           L   +C    VH D+   N+L+       +GDFGL++++     D        +S  +  
Sbjct: 129 LESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI----EDEDYYK---ASVTRLP 177

Query: 737 VGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRP 772
           + +++PE   +   + AS   DV+ F + + E+ S  ++P
Sbjct: 178 IKWMSPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (309), Expect = 3e-31
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 44/246 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
           SE +    +G G FG V  G    N   VA+K +    M +   + F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHP 63

Query: 612 NLIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
            L+++  +C              +V +FM++G L ++L            +    L + +
Sbjct: 64  KLVQLYGVCLEQAPIC-------LVTEFMEHGCLSDYLRTQRGLF-----AAETLLGMCL 111

Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           DV   + YL         +H DL   N L+  + V  V DFG+ +F+         +  +
Sbjct: 112 DVCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYT 160

Query: 729 SSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLH 784
           SS+G K  V + +PE   +   S  S   DV+SFG+L+ E+FS  + P     +E  +  
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRYSSKS---DVWSFGVLMWEVFSEGKIP-----YENRSNS 212

Query: 785 EFSKMV 790
           E  + +
Sbjct: 213 EVVEDI 218

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  126 bits (318), Expect = 5e-31
 Identities = 75/390 (19%), Positives = 138/390 (35%), Gaps = 24/390 (6%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIP-DTLGQLRKLIYLNIGRNQF 82
           +  + L+ N +      S   L  LQ + +     G  I  +T   L  LI L +  NQF
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 83  SGFIPPSIY-NISSFEFIFLQSNRFHGS-LPFDMVANLPNLRKFVAAKNNLTGFLPISL- 139
              +    +  +++ E + L      G+ L  +    L +L   V   NN+    P S  
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 140 SNASNLELLELRDNQFIGKMSINFNSL--KNLSVLILGNNHLGNRAANDLDFVT--VLAN 195
            N     +L+L  N+       +  +   K+ ++L L +  L +     L +        
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 196 CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG 255
            + +  L L  N F   +     +         +  +           +  H N    + 
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG----SSFGHTNFKDPDN 266

Query: 256 NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SL 314
               G           +++  L+ + +   + S   + T L  L L  N +  KI   + 
Sbjct: 267 FTFKGLEAS------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF 319

Query: 315 GNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLD 373
              T L+ L LS+N L G +  ++         L+LS N +  +L  +    L NL +L 
Sbjct: 320 WGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELA 377

Query: 374 ISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           +  N+      G     TSL+ + +  N +
Sbjct: 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (303), Expect = 4e-29
 Identities = 64/397 (16%), Positives = 140/397 (35%), Gaps = 42/397 (10%)

Query: 74  YLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTG 133
           Y+++  N  +     S   +   +F+ ++       +  +    L +L       N    
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93

Query: 134 FLPISLSNASNLELLELRDNQFIGKMSIN---FNSLKNLSVLILGNNHLGNRAANDLDFV 190
               + +  +NLE+L L     +    ++   F  L +L +L+L +N++       +   
Sbjct: 94  LETGAFNGLANLEVLTLTQCN-LDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKIQPA 147

Query: 191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI---------DIGGNYFSGTIPPG 241
           +   N  +   L L  N+   +    L N      T+         D+   +        
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEI---GWLKNLQSLYLNSNFLH--GYIPSSLGNLTML 296
                 + ++ + GN    ++            +QSL L++++     +  ++  +    
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

Query: 297 TLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLS 356
           T   LE + ++                 LSK+K+   L   + S  T    L L+ N ++
Sbjct: 268 TFKGLEASGVK--------------TCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN 312

Query: 357 GSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFL 414
             +       L +L++L++S N               LE + +  N    ++   S   L
Sbjct: 313 -KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL 370

Query: 415 KSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
            ++K L L +N+L        + L+ L+ + L  N +
Sbjct: 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  112 bits (283), Expect = 2e-26
 Identities = 73/363 (20%), Positives = 124/363 (34%), Gaps = 44/363 (12%)

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           +++  ++L  N        +F+ L++L  L +     G    N+          S L  L
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN-----TFRGLSSLIIL 84

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF-SGTIPPGL-GNLVHLNSIAMEGNQLIG 260
            L  NQF  L   +   L+N +  + +         +       L  L  + +  N  I 
Sbjct: 85  KLDYNQFLQLETGAFNGLAN-LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN-IK 142

Query: 261 TVPPEIGW--LKNLQSLYLNSN-----------FLHGYIPSSLGNLTMLTLLALEINNLQ 307
            + P   +  ++    L L  N              G   + L  L+ +TL  +    L 
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL-RLSSITLQDMNEYWLG 201

Query: 308 GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL----SLFLNLSDNLLSGSLPSEI 363
            +   +    TS+  L LS N     +  +           SL L+ S N+ S    +  
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261

Query: 364 GNLKN----------LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLN 412
            +  N          +   D+S ++    +    S  T LE + +  N  +  I   +  
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFW 320

Query: 413 FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSL 469
            L  +  L+LS N L     +  ENL  LE L+LSYNH    +     F         +L
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG-DQSFLGLPNLKELAL 378

Query: 470 SGN 472
             N
Sbjct: 379 DTN 381

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.8 bits (197), Expect = 9e-16
 Identities = 47/295 (15%), Positives = 89/295 (30%), Gaps = 51/295 (17%)

Query: 219 NLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLY 276
            L   +  +D+  N  +  +       L  L  + +E       +       L +L  L 
Sbjct: 27  ELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85

Query: 277 LNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI--PSSLGNCTSLIMLTLSKNKLDGVL 334
           L+ N        +   L  L +L L   NL G +   +     TSL ML L  N +  + 
Sbjct: 86  LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145

Query: 335 PPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE 394
           P                             N++    LD++ N+        L       
Sbjct: 146 PASFFL------------------------NMRRFHVLDLTFNKVKSICEEDLLNFQGKH 181

Query: 395 YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE 454
           +  ++              L SI + D++   L  +        + +  L+LS N F+  
Sbjct: 182 FTLLR--------------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227

Query: 455 VPKKGVFSNKTRFS------LSGNGKLCGGLDEFHLPSCPSKRSRKLIATILKVV 503
           +     F +    +      LS +  +       +     +   + L A+ +K  
Sbjct: 228 MA--KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC 280

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  122 bits (308), Expect = 6e-31
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 40/235 (17%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G G FG V  G        VA+K++    M +     F+ E + + ++ H  L+++  +C
Sbjct: 33  GTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL-H 679
           +           I+ ++M NG L  +L +   +         Q L +  DV  A+EYL  
Sbjct: 89  TKQRPI-----FIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLES 138

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N L++   V  V DFGL++++    LD       SS G K  V +
Sbjct: 139 KQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYT---SSVGSKFPVRW 187

Query: 740 IAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMV 790
             PE   Y   S  S   D+++FG+L+ E++S  + P     +E  T  E ++ +
Sbjct: 188 SPPEVLMYSKFSSKS---DIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHI 234

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  126 bits (318), Expect = 6e-31
 Identities = 57/243 (23%), Positives = 109/243 (44%), Gaps = 38/243 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
                   +G G FG V+          VAVK +    M     ++FL E   +++++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHD 243

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+K+  + +       +   I+ +FM  GSL ++L  +          L + ++ +  +
Sbjct: 244 KLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQI 293

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  + ++        +H DL+ +N+L+   +V  + DFGLA+ +     D       +  
Sbjct: 294 AEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYT---ARE 343

Query: 732 GIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFS 787
           G K  + + APE   +G+ +  S   DV+SFGILL+E+ +  R P     + G++  E  
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKS---DVWSFGILLMEIVTYGRIP-----YPGMSNPEVI 395

Query: 788 KMV 790
           + +
Sbjct: 396 RAL 398

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  121 bits (306), Expect = 6e-31
 Identities = 69/246 (28%), Positives = 103/246 (41%), Gaps = 44/246 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
            E +    +G G FG V  G        VAVK++    M +     F  E + +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHP 63

Query: 612 NLIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
            L+K   +CS     +       IV +++ NG L  +L  +   L        Q L +  
Sbjct: 64  KLVKFYGVCSKEYPIY-------IVTEYISNGCLLNYLRSHGKGL-----EPSQLLEMCY 111

Query: 670 DVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           DV   + +L  H      +H DL   N L+D D+   V DFG+ +++    LD       
Sbjct: 112 DVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYV--- 160

Query: 729 SSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLH 784
           SS G K  V + APE   Y   S  S   DV++FGIL+ E+FS  + P     ++  T  
Sbjct: 161 SSVGTKFPVKWSAPEVFHYFKYSSKS---DVWAFGILMWEVFSLGKMP-----YDLYTNS 212

Query: 785 EFSKMV 790
           E    V
Sbjct: 213 EVVLKV 218

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (322), Expect = 7e-31
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 563 GQGSFGTVFKGI-IGENG-MLVAVKVL-NLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G G+FG+V +G+       + VA+KVL    +K   +  + E + +  + +  ++++I +
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL- 678
           C +      +   +V +    G L ++L    +++ V N+       +   V+  ++YL 
Sbjct: 405 CQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNV-----AELLHQVSMGMKYLE 453

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
             +     VH +L   NVLL +   A + DFGL+K L A          ++ S  K  + 
Sbjct: 454 EKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLK 504

Query: 739 YIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSM 776
           + APE   +   S  S   DV+S+G+ + E  S  ++P   M
Sbjct: 505 WYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKM 543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  127 bits (320), Expect = 9e-31
 Identities = 62/307 (20%), Positives = 106/307 (34%), Gaps = 44/307 (14%)

Query: 110 LPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS-INFNSLKN 168
           LP +   +L     +    N ++G      S     E   L        +S +    +  
Sbjct: 5   LPINNNFSLSQNSFY----NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 169 LSVLILGNNHLGNRAANDLDFVTVL--ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTT 226
            S L L   +L           + L      ++  L +  N    L P   A+L      
Sbjct: 61  FSELQLNRLNL-----------SSLPDNLPPQITVLEITQNALISL-PELPASL----EY 104

Query: 227 IDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYI 286
           +D   N  S T+P    +L HL+   ++ NQL   +P        L+ +  ++N L   +
Sbjct: 105 LDACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-ML 155

Query: 287 PSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI---LSVTT 343
           P    +L +L++     NN    +P    +   L  L +S N L+  LP           
Sbjct: 156 PELPTSLEVLSVR----NNQLTFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEE 207

Query: 344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
             +F    +N ++  +P  I +L     + +  N  S  I  +LS  T+          F
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

Query: 404 SGSIPPS 410
           S S    
Sbjct: 267 SMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  115 bits (288), Expect = 1e-26
 Identities = 62/325 (19%), Positives = 111/325 (34%), Gaps = 65/325 (20%)

Query: 135 LPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVL 193
           + I L   +N  L +      I     + F++        L   +           V++L
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNE-------AVSLL 53

Query: 194 ANC--SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
             C  ++   L L       L P    NL   +T ++I  N    ++P    +L +L+  
Sbjct: 54  KECLINQFSELQLNRLNLSSL-P---DNLPPQITVLEITQNALI-SLPELPASLEYLD-- 106

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIP 311
               N+L  T+P       +L+ L +++N L   +P     L  +       NN    +P
Sbjct: 107 -ACDNRLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLEYINAD----NNQLTMLP 156

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNL-- 369
               +   L +L++  N+L   LP    S+  L    ++S NLL  SLP+      +   
Sbjct: 157 ELPTS---LEVLSVRNNQL-TFLPELPESLEAL----DVSTNLLE-SLPAVPVRNHHSEE 207

Query: 370 --VQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL 427
             +      NR +                          IP ++  L     + L  N L
Sbjct: 208 TEIFFRCRENRIT-------------------------HIPENILSLDPTCTIILEDNPL 242

Query: 428 SGQIPKYLENLSFLEYLNLSYNHFE 452
           S +I + L   +     +    +F 
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  102 bits (256), Expect = 9e-23
 Identities = 67/384 (17%), Positives = 119/384 (30%), Gaps = 64/384 (16%)

Query: 101 LQSNRFHGSL---PFDMVANLPNLRKFVAA---KNNLTGFLPISLSNASNLELLELRDNQ 154
           L  N F+ ++     D  +      K       +N     L   L N      L+L    
Sbjct: 13  LSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQLNRLN 70

Query: 155 FIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP 214
                S+  N    ++VL +  N L          +++    + LE L   DN+   L P
Sbjct: 71  L---SSLPDNLPPQITVLEITQNAL----------ISLPELPASLEYLDACDNRLSTL-P 116

Query: 215 HSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQS 274
              A+L      +D+  N  +  +P     L ++N    + NQL   +P       +L+ 
Sbjct: 117 ELPASL----KHLDVDNNQLT-MLPELPALLEYIN---ADNNQL-TMLPELPT---SLEV 164

Query: 275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL----IMLTLSKNKL 330
           L + +N L  ++P    +L  L +      NL   +P+            I     +N++
Sbjct: 165 LSVRNNQL-TFLPELPESLEALDVS----TNLLESLPAVPVRNHHSEETEIFFRCRENRI 219

Query: 331 DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSAC 390
              +P  ILS+      + L DN LS S   E  + +           +     G  +  
Sbjct: 220 T-HIPENILSLDPTC-TIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276

Query: 391 TSLEYVKMQDN-------------SFSGSIPPSLNFLKSIKVLDLSSN-----KLSGQIP 432
                  +                        +  F   +  L  + +         Q+ 
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVA 336

Query: 433 KYLENLSFLEYLNLSYNHFEGEVP 456
            +LE LS    L         +  
Sbjct: 337 AWLEKLSASAELRQQSFAVAADAT 360

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 96.6 bits (240), Expect = 7e-21
 Identities = 67/401 (16%), Positives = 115/401 (28%), Gaps = 72/401 (17%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
             N+ V  +     C + +   L L   +L+  LP ++     + V++I  N L   +P+
Sbjct: 45  NRNEAVSLLK---ECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPE 97

Query: 65  TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF 124
               L    YL+   N+ S                         +LP        +L+  
Sbjct: 98  LPASLE---YLDACDNRLS-------------------------TLP----ELPASLKHL 125

Query: 125 VAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAA 184
               N LT  LP      + LE +   +NQ      +      +L VL + NN L     
Sbjct: 126 DVDNNQLT-MLPELP---ALLEYINADNNQLT---MLP-ELPTSLEVLSVRNNQL----- 172

Query: 185 NDLDFVTVLANC-SKLENLGLYDNQFGGL--LPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
                 T L      LE L +  N    L  +P    +   T        N  +  IP  
Sbjct: 173 ------TFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPEN 225

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
           + +L    +I +E N L  +   E    +  Q  Y               N     L   
Sbjct: 226 ILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQ-NTLHRPLADA 283

Query: 302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN-LLSGSLP 360
                     S +             N     L         LS  ++  +       + 
Sbjct: 284 VTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-------DRLSDTVSARNTSGFREQVA 336

Query: 361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
           + +  L    +L       + D   +     +L +  ++  
Sbjct: 337 AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKT 377

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 20/91 (21%), Positives = 30/91 (32%), Gaps = 7/91 (7%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLEN----LSLAENHLTGQLPVSIGNLSALQVIDIRGNRL 58
           D   N L   +P          E         EN +T  +P +I +L     I +  N L
Sbjct: 186 DVSTNLLE-SLPAVPVR-NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242

Query: 59  GGKIPDTLGQLRKLIYLNIGRNQFSGFIPPS 89
             +I ++L Q       +  R  FS      
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 2e-30
 Identities = 49/231 (21%), Positives = 94/231 (40%), Gaps = 20/231 (8%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G F  V       +G   A+K +   ++   +    E +  R   H N+++++    
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94

Query: 622 SIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
            +   G   +A ++  F + G+L   + +  DK     L+  Q L + + +   +E +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK--GTVG 738
                  H DLKP+N+LL  +    + D G         ++   +  +         T+ 
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN-QACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 739 YIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
           Y APE      +    E +   DV+S G +L  M     P D +F +G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  124 bits (313), Expect = 2e-30
 Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 38/243 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
                   +GQG FG V+ G        VA+K L    M     ++FL E + ++ +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHE 239

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  + S           IV ++M  GSL ++L     K     L L Q +++A  +
Sbjct: 240 KLVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQI 289

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           AS + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +            ++  
Sbjct: 290 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQ 339

Query: 732 GIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFS 787
           G K  + + APE   YG  +  S   DV+SFGILL E+ ++ R P     + G+   E  
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKS---DVWSFGILLTELTTKGRVP-----YPGMVNREVL 391

Query: 788 KMV 790
             V
Sbjct: 392 DQV 394

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (308), Expect = 2e-30
 Identities = 34/277 (12%), Positives = 69/277 (24%), Gaps = 42/277 (15%)

Query: 523 RRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
           +  +        T+  Q       + LS+   +      +  G    VF     E     
Sbjct: 31  KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDF 90

Query: 583 AVKVLN---LMQKGALKSFLTECEALRSIRHRNLI---------------------KIIT 618
           A+KV        +  L+       A   +   +                           
Sbjct: 91  ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV-CNLSLIQTLNIAIDVASAIEY 677
           +    D   V    ++        LE      +       +  ++    +   +      
Sbjct: 151 LSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           L       +VHG   P N+ +  D    +GD                +  +        V
Sbjct: 210 LQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL-----------WKVGTRGPASSVPV 255

Query: 738 GYIAPEYGTGSEASMTG--DVYSFGILLLEMFSRRRP 772
            Y   E+   S A+ T   + +  G+ +  ++    P
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 3e-30
 Identities = 49/238 (20%), Positives = 97/238 (40%), Gaps = 30/238 (12%)

Query: 545 SYAKLSKATSEFSSSNM--------VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGA 594
             + +   T      +M        +G+GSFG        E+G    +K +N+  M    
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 595 LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL 654
            +    E   L +++H N+++     S  +   +    IV D+ + G L + ++     L
Sbjct: 67  REESRREVAVLANMKHPNIVQYRE--SFEENGSL---YIVMDYCEGGDLFKRINAQKGVL 121

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
                   Q L+  + +  A++++H      ++H D+K  N+ L  D    +GDFG+A+ 
Sbjct: 122 ----FQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           L          T   +    GT  Y++PE       +   D+++ G +L E+ + +  
Sbjct: 175 LN--------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (301), Expect = 4e-30
 Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 33/224 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIIT 618
            +G GS+G   K     +G ++  K L+   M +   +  ++E   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
               I         IV ++ + G L   +       E   L     L +   +  A++  
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 679 HHHCKPP--VVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP--LDTVVETPSSSSGIK 734
           H        V+H DLKP+NV LD      +GDFGLA+ L        T V TP       
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY------ 181

Query: 735 GTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
               Y++PE      Y   S      D++S G LL E+ +   P
Sbjct: 182 ----YMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 6e-30
 Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 31/216 (14%)

Query: 561 MVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIIT 618
            +  G  G ++  +    NG  V +K L       A    + E + L  + H ++++I  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
                D +G     IV +++   SL+    Q         L + + +   +++  A+ YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLEILPALSYL 198

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +V+ DLKP N++L  + +  + D G         ++       S   + GT G
Sbjct: 199 HSI---GLVYNDLKPENIMLTEEQLK-LIDLGA-----VSRIN-------SFGYLYGTPG 242

Query: 739 YIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRP 772
           + APE      + A+   D+Y+ G  L  +      
Sbjct: 243 FQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPT 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (311), Expect = 9e-30
 Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 38/243 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHR 611
                   +GQG FG V+ G        VA+K L    M     ++FL E + ++ +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHE 322

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L+++  + S           IV ++M  GSL ++L     K     L L Q +++A  +
Sbjct: 323 KLVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQI 372

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           AS + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +            ++  
Sbjct: 373 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQ 422

Query: 732 GIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFS 787
           G K  + + APE   YG  +  S   DV+SFGILL E+ ++ R P     + G+   E  
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKS---DVWSFGILLTELTTKGRVP-----YPGMVNREVL 474

Query: 788 KMV 790
             V
Sbjct: 475 DQV 477

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  118 bits (297), Expect = 3e-29
 Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITI 619
           ++GQG+   VF+G   + G L A+KV N +     +   + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               +      K ++ +F   GSL   L + +       L   + L +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 680 HHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIK 734
            +    +VH ++KP N++     D   V  + DFG A+ L       ++           
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---------- 176

Query: 735 GTVGYIAPEYGTGSEASMTG--------DVYSFGILLLEMFSRRRP 772
           GT  Y+ P+    +              D++S G+      +   P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  117 bits (295), Expect = 3e-29
 Identities = 49/249 (19%), Positives = 101/249 (40%), Gaps = 55/249 (22%)

Query: 563 GQGSFGTVFKGI-------IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           GQG+F  +FKG+          +   V +KVL+   +   +SF      +  + H++L+ 
Sbjct: 17  GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
              +C   D N      +V +F++ GSL+ +L +N +      ++++  L +A  +A+A+
Sbjct: 77  NYGVCVCGDEN-----ILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAAM 126

Query: 676 EYL-HHHCKPPVVHGDLKPSNVLLDHD--------MVAHVGDFGLAKFLPARPLDTVVET 726
            +L  +      +HG++   N+LL  +            + D G++  +           
Sbjct: 127 HFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV----------- 171

Query: 727 PSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGL 781
                 ++  + ++ PE        + A+   D +SFG  L E+ S   +P        L
Sbjct: 172 -LPKDILQERIPWVPPECIENPKNLNLAT---DKWSFGTTLWEICSGGDKP-----LSAL 222

Query: 782 TLHEFSKMV 790
                 +  
Sbjct: 223 DSQRKLQFY 231

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (292), Expect = 1e-28
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 53/260 (20%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G+FG VF          ++ MLVAVK L      A K F  E E L +++H +++K  
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 618 TICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQN----------NDKLEVCNLSLIQTL 665
            +C   D          +V+++M++G L ++L  +            +     L L Q L
Sbjct: 84  GVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 666 NIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           +IA  +AS + YL   H     VH DL   N L+  +++  +GDFG+     +R + +  
Sbjct: 137 HIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGM-----SRDVYSTD 187

Query: 725 ETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMF 777
                      I+       PE   Y   +  S   DV+SFG++L E+F+  ++P     
Sbjct: 188 YYRVGGHTMLPIRWM----PPESIMYRKFTTES---DVWSFGVILWEIFTYGKQP----- 235

Query: 778 HEGLTLHEFSKMVLPEKVME 797
              L+  E  + +   +V+E
Sbjct: 236 WFQLSNTEVIECITQGRVLE 255

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  121 bits (305), Expect = 1e-28
 Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 46/261 (17%)

Query: 545 SYAKLSKATSEFSSSNMV-----GQGSFGTVFKGI---IGENGMLVAVKVL--NLMQKGA 594
           +Y   S    E     +      G+G FG V +GI        M VA+K           
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-V 434

Query: 595 LKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL 654
            + FL E   +R   H +++K+I + +       +   I+ +    G L  +L      L
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSL 488

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK 713
           ++ +L     +  A  +++A+ YL         VH D+   NVL+  +    +GDFGL++
Sbjct: 489 DLASL-----ILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSR 539

Query: 714 FLPARPLDTVVETPSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR- 769
           ++     D+       +S  K  + ++APE   +   + AS   DV+ FG+ + E+    
Sbjct: 540 YM----EDSTYYK---ASKGKLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHG 589

Query: 770 RRPTDSMFHEGLTLHEFSKMV 790
            +P      +G+  ++    +
Sbjct: 590 VKP-----FQGVKNNDVIGRI 605

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 1e-28
 Identities = 59/253 (23%), Positives = 95/253 (37%), Gaps = 41/253 (16%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRS 607
           S     F   + +G GS+G VFK    E+G L AVK               L E  +   
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 608 I-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           + +H   +++     + +  G+ +  +  +     SL++        L        Q   
Sbjct: 113 VGQHPCCVRLE---QAWEEGGILY--LQTELCG-PSLQQHCEAWGASL-----PEAQVWG 161

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
              D   A+ +LH      +VH D+KP+N+ L       +GDFGL   L          T
Sbjct: 162 YLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---------GT 209

Query: 727 PSSSSGIKGTVGYIAPE-----YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL 781
             +    +G   Y+APE     YGT +      DV+S G+ +LE+           H G 
Sbjct: 210 AGAGEVQEGDPRYMAPELLQGSYGTAA------DVFSLGLTILEVACNMEL----PHGGE 259

Query: 782 TLHEFSKMVLPEK 794
              +  +  LP +
Sbjct: 260 GWQQLRQGYLPPE 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  116 bits (291), Expect = 2e-28
 Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 63/275 (22%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSI 608
           S+  ++F     +G+G FG VF+     +    A+K + L  +  A +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 609 RHRNLIKIITICSSIDFNGVDFKA------------------------------------ 632
            H  +++               +                                     
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 633 ----------------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                           I     +  +L++W+++     +         L+I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED---REHGVCLHIFIQIAEAVE 178

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL----PARPLDTVVETPSSSSG 732
           +LH      ++H DLKPSN+    D V  VGDFGL   +      + + T +   ++ +G
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF 767
             GT  Y++PE   G+  S   D++S G++L E+ 
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  115 bits (290), Expect = 3e-28
 Identities = 55/258 (21%), Positives = 109/258 (42%), Gaps = 54/258 (20%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGA----LKSFLTECEALRSIRHRNL 613
           GQGSFG V++G+       E    VA+K +N   + A       FL E   ++     ++
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHHV 90

Query: 614 IKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWL----HQNNDKLEVCNLSLIQTLNI 667
           ++++ + S             ++ + M  G L+ +L        +   +   SL + + +
Sbjct: 91  VRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 668 AIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           A ++A  + YL+ +      VH DL   N ++  D    +GDFG+      R +      
Sbjct: 144 AGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYY 194

Query: 727 PSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHE 779
                G   ++      +PE    G  +  S   DV+SFG++L E+ +   +P     ++
Sbjct: 195 RKGGKGLLPVRWM----SPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQP-----YQ 242

Query: 780 GLTLHEFSKMVLPEKVME 797
           GL+  +  + V+   +++
Sbjct: 243 GLSNEQVLRFVMEGGLLD 260

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (289), Expect = 3e-28
 Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKII 617
             +G G    VF+ +  E   + A+K +NL       L S+  E   L  ++  +  KII
Sbjct: 34  KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 91

Query: 618 TICSSIDFNGVDFKAIVYDFM--QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            +    D+        +Y  M   N  L  WL +        ++   +  +   ++  A+
Sbjct: 92  RL---YDY--EITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 140

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
             +H H    +VH DLKP+N L+   M+  + DFG+A  +       V ++        G
Sbjct: 141 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 190

Query: 736 TVGYIAPE-----------YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           TV Y+ PE             + S+ S   DV+S G +L  M   + P
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  115 bits (289), Expect = 4e-28
 Identities = 62/257 (24%), Positives = 107/257 (41%), Gaps = 52/257 (20%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLIKI 616
           G G+FG V++G +       + + VAVK L  +  +     FL E   +    H+N+++ 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98

Query: 617 ITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEV-CNLSLIQTLNIAIDV 671
           I         GV  ++    I+ + M  G L+ +L +   +     +L+++  L++A D+
Sbjct: 99  I---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 672 ASAIEYL-HHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVETP 727
           A   +YL  +H     +H D+   N LL       VA +GDFG+A     R +       
Sbjct: 150 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDIYRASYYR 200

Query: 728 SSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEG 780
                   +K       PE    G  +  +   D +SFG+LL E+FS    P     +  
Sbjct: 201 KGGCAMLPVKWM----PPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP-----YPS 248

Query: 781 LTLHEFSKMVLPEKVME 797
            +  E  + V     M+
Sbjct: 249 KSNQEVLEFVTSGGRMD 265

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (289), Expect = 4e-28
 Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 52/259 (20%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G+FG VF          ++ MLVAVK L    + A + F  E E L  ++H+++++  
Sbjct: 50  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109

Query: 618 TICSSID--FNGVDFKAIVYDFMQNGSLEEWL---------HQNNDKLEVCNLSLIQTLN 666
            +C+             +V+++M++G L  +L             + +    L L Q L 
Sbjct: 110 GVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 667 IAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
           +A  VA+ + YL   H     VH DL   N L+   +V  +GDFG+     +R + +   
Sbjct: 163 VASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGM-----SRDIYSTDY 213

Query: 726 TPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFH 778
                     I+       PE   Y   +  S   DV+SFG++L E+F+  ++P      
Sbjct: 214 YRVGGRTMLPIRWM----PPESILYRKFTTES---DVWSFGVVLWEIFTYGKQP-----W 261

Query: 779 EGLTLHEFSKMVLPEKVME 797
             L+  E    +   + +E
Sbjct: 262 YQLSNTEAIDCITQGRELE 280

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 5e-28
 Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITI 619
           ++GQG+   VF+G   + G L A+KV N +     +   + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               +      K ++ +F   GSL   L + +       L   + L +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 680 HHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIK 734
            +    +VH ++KP N++     D   V  + DFG A+ L       ++           
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---------- 176

Query: 735 GTVGYIAPEYGTGSEASMTG--------DVYSFGILLLEMFSRRRP 772
           GT  Y+ P+    +              D++S G+      +   P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  119 bits (299), Expect = 7e-28
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 22/219 (10%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKII-TIC 620
           G G FG V + I  + G  VA+K     +     + +  E + ++ + H N++       
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                   D   +  ++ + G L ++L+Q  +    C L       +  D++SA+ YLH 
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHE 139

Query: 681 HCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGT 736
           +    ++H DLKP N++L      ++  + D G AK L         V          GT
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----------GT 186

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS 775
           + Y+APE     + ++T D +SFG L  E  +  RP   
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (286), Expect = 7e-28
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+G F  V++     +G+ VA+K + +   M   A    + E + L+ + H N+IK  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              S I+ N +    IV +    G L   +   + K +   +         + + SA+E+
Sbjct: 99  A--SFIEDNEL---NIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           +H      V+H D+KP+NV +    V  +GD GL +F  +          +++  + GT 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--------KTTAAHSLVGTP 200

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            Y++PE    +  +   D++S G LL EM + + P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  113 bits (284), Expect = 9e-28
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 50/232 (21%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIK 615
           G+  FG V+KG +     GE    VA+K L          + F  E      ++H N++ 
Sbjct: 18  GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-LREEFRHEAMLRARLQHPNVVC 76

Query: 616 IITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQN----------NDKLEVCNLSLIQ 663
           ++ + +             +++ +  +G L E+L             +D+     L    
Sbjct: 77  LLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 664 TLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
            +++   +A+ +EYL  HH     VH DL   NVL+   +   + D GL      R +  
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGL-----FREVYA 180

Query: 723 VVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
                   +    I+      APE   YG  S  S   D++S+G++L E+FS
Sbjct: 181 ADYYKLLGNSLLPIRWM----APEAIMYGKFSIDS---DIWSYGVVLWEVFS 225

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (286), Expect = 1e-27
 Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 23/276 (8%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQ 257
              L L +N+   +      NL N + T+ +  N  S  I PG    LV L  + +  NQ
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 258 LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ-GKIPS-SLG 315
           L   +P ++   K LQ L ++ N +     S    L  + ++ L  N L+   I + +  
Sbjct: 112 L-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEI-GNLKNLVQLD 373
               L  + ++   +  + P  +      SL  L+L  N ++  + +     L NL +L 
Sbjct: 169 GMKKLSYIRIADTNITTI-PQGLPP----SLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222

Query: 374 ISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG---- 429
           +S N  S    G+L+    L  + + +N     +P  L   K I+V+ L +N +S     
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 430 --QIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
               P Y    +    ++L  N  +    +   F  
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (277), Expect = 1e-26
 Identities = 55/266 (20%), Positives = 110/266 (41%), Gaps = 21/266 (7%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGW-LKNLQSL 275
            +L      +D+  N  +  I  G   NL +L+++ +  N+ I  + P     L  L+ L
Sbjct: 48  KDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERL 105

Query: 276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL-DGVL 334
           YL+ N L   +P  +     L  L +  N +     S       +I++ L  N L    +
Sbjct: 106 YLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162

Query: 335 PPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE 394
                       ++ ++D  ++ ++P   G   +L +L + GN+ +     +L    +L 
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 219

Query: 395 YVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE- 452
            + +  NS S ++   SL     ++ L L++NKL  ++P  L +  +++ + L  N+   
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

Query: 453 ---GEVPKKGVFSNKTRF---SLSGN 472
               +    G  + K  +   SL  N
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 6e-26
 Identities = 65/313 (20%), Positives = 109/313 (34%), Gaps = 41/313 (13%)

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
            +  LL+L++N+       +F +LKNL  LIL NN +   +          A   KLE L
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG------AFAPLVKLERL 105

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQL-IG 260
            L  NQ   L       L      + +  N  +  +       L  +  + +  N L   
Sbjct: 106 YLSKNQLKELPEKMPKTL----QELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS 160

Query: 261 TVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SLGNCT 318
            +       +K L  + +    +   IP  L     LT L L+ N +  K+ + SL    
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLN 216

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
           +L  L LS N +  V    + +   L   L+L++N L   +P  + + K +  + +  N 
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS-GQIPKYL-E 436
            S                 +  N F    P       S   + L SN +   +I      
Sbjct: 275 IS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316

Query: 437 NLSFLEYLNLSYN 449
            +     + L   
Sbjct: 317 CVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (271), Expect = 1e-25
 Identities = 61/304 (20%), Positives = 107/304 (35%), Gaps = 34/304 (11%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
           +PP          + LQ+N+    +      NL NL   +   N ++   P + +    L
Sbjct: 50  LPPDT------ALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
           E L L  NQ      +     K L  L +  N +     +      V    +++  + L 
Sbjct: 103 ERLYLSKNQLK---ELPEKMPKTLQELRVHENEITKVRKS------VFNGLNQMIVVELG 153

Query: 206 DNQF--GGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTV 262
            N     G+   +   +   ++ I I     + TIP GL  +L  L+   ++GN+ I  V
Sbjct: 154 TNPLKSSGIENGAFQGMKK-LSYIRIADTNIT-TIPQGLPPSLTELH---LDGNK-ITKV 207

Query: 263 PPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
                  L NL  L L+ N +      SL N   L  L L  N L  K+P  L +   + 
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 266

Query: 322 MLTLSKNKL----DGVLPPQILSVTTLSL-FLNLSDN-LLSGSLPSEI-GNLKNLVQLDI 374
           ++ L  N +         P   +    S   ++L  N +    +       +     + +
Sbjct: 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326

Query: 375 SGNR 378
              +
Sbjct: 327 GNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (269), Expect = 2e-25
 Identities = 65/307 (21%), Positives = 109/307 (35%), Gaps = 47/307 (15%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDL 187
           N +T        N  NL  L L +N+ I K+S   F  L  L  L L  N L        
Sbjct: 62  NKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKNQLKELPEKMP 120

Query: 188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN-YFSGTIPPG-LGNL 245
                      L+ L +++N+   +       L+  M  +++G N   S  I  G    +
Sbjct: 121 ---------KTLQELRVHENEITKVRKSVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGM 170

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
             L+ I +     I T+P   G   +L  L+L+ N +     +SL  L  L  L L  N+
Sbjct: 171 KKLSYIRIADTN-ITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG------SL 359
           +      SL N   L  L L+ NKL   +P  +     +   + L +N +S         
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-VVYLHNNNISAIGSNDFCP 285

Query: 360 PSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV 419
           P       +   + +  N               ++Y ++Q ++F          +     
Sbjct: 286 PGYNTKKASYSGVSLFSNP--------------VQYWEIQPSTFRC--------VYVRAA 323

Query: 420 LDLSSNK 426
           + L + K
Sbjct: 324 VQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (255), Expect = 1e-23
 Identities = 64/318 (20%), Positives = 108/318 (33%), Gaps = 53/318 (16%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L L  N +T        NL  L  + +  N++    P     L KL  L + +NQ  
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                                     LP  M   L  LR     +N +T       +  +
Sbjct: 114 -------------------------ELPEKMPKTLQELR---VHENEITKVRKSVFNGLN 145

Query: 144 NLELLELRDNQFIGKMSIN---FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
            + ++EL  N  +    I    F  +K LS + + + ++                   L 
Sbjct: 146 QMIVVELGTNP-LKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---------PSLT 195

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLI 259
            L L  N+   +   SL  L+N +  + +  N  S  +  G L N  HL  + +  N+L+
Sbjct: 196 ELHLDGNKITKVDAASLKGLNN-LAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLHG------YIPSSLGNLTMLTLLALEINNLQ-GKIPS 312
             VP  +   K +Q +YL++N +          P         + ++L  N +Q  +I  
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 313 SLGNC-TSLIMLTLSKNK 329
           S   C      + L   K
Sbjct: 313 STFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 23/234 (9%)

Query: 247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           HL  +      L   VP ++    +   L L +N +         NL  L  L L  N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEI-G 364
               P +      L  L LSKN+L   LP ++      +L  L + +N ++  +   +  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK----TLQELRVHENEIT-KVRKSVFN 142

Query: 365 NLKNLVQLDISGNRFSGDI--PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL 422
            L  ++ +++  N         G       L Y+++ D + + +IP  L    S+  L L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199

Query: 423 SSNKLSGQIPK-YLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
             NK++ ++    L+ L+ L  L LS+N     V   G  +N        L+ N
Sbjct: 200 DGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVD-NGSLANTPHLRELHLNNN 250

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 9e-07
 Identities = 22/109 (20%), Positives = 41/109 (37%), Gaps = 8/109 (7%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L  L  L L+ N ++     S+ N   L+ + +  N+L  K+P  L   + +  + +  N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNN 273

Query: 81  QFS-----GFIPPSIY-NISSFEFIFLQSNRF-HGSLPFDMVANLPNLR 122
             S      F PP      +S+  + L SN   +  +       +    
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  114 bits (288), Expect = 1e-27
 Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 46/274 (16%)

Query: 522 GRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSN--------MVGQGSFGTVFKG 573
           G + +    FER  M           K S + +E  S           +G G    VF+ 
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75

Query: 574 IIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK 631
           +  E   + A+K +NL       L S+  E   L  ++  +  KII +    D+      
Sbjct: 76  L-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDY--EITD 128

Query: 632 AIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG 689
             +Y  M+  N  L  WL +        ++   +  +   ++  A+  +H H    +VH 
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179

Query: 690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPE------ 743
           DLKP+N L+   M+  + DFG+A  +       V ++        G V Y+ PE      
Sbjct: 180 DLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGAVNYMPPEAIKDMS 232

Query: 744 YGTGSEASMTG-----DVYSFGILLLEMFSRRRP 772
               +  S +      DV+S G +L  M   + P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (288), Expect = 2e-27
 Identities = 36/242 (14%), Positives = 67/242 (27%), Gaps = 40/242 (16%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---GALKSFLTECEALRSIRH------- 610
           ++GQ       +    E G    V V    ++    A+K    E   LR +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 611 ---------RNLIKIITICSSIDFNGVDFKAIVYDF-----MQNGSLEEWLHQNNDKLEV 656
                     +L+K       I     +    V            +L+ +          
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 657 CN-LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
              L     L + + V   +  LHH+    +VH  L+P +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH---- 257

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-----DVYSFGILLLEMFSRR 770
                     +P             A       +   T      D ++ G+ +  ++   
Sbjct: 258 -LVRDGASAVSPIGR--GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 771 RP 772
            P
Sbjct: 315 LP 316

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (284), Expect = 2e-27
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKII 617
             +G G    VF+ +  E   + A+K +NL       L S+  E   L  ++  +  KII
Sbjct: 15  KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 72

Query: 618 TICSSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
            +    D+        +Y  M+  N  L  WL +        ++   +  +   ++  A+
Sbjct: 73  RL---YDY--EITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 121

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
             +H H    +VH DLKP+N L+   M+  + DFG+A  +       V ++        G
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 171

Query: 736 TVGYIAPE------YGTGSEASMTG-----DVYSFGILLLEMFSRRRP 772
           TV Y+ PE          +  S +      DV+S G +L  M   + P
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  112 bits (283), Expect = 3e-27
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 57/260 (21%)

Query: 563 GQGSFGTVFKGIIGENG--MLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRNLIKII 617
           G+G+FG V K  I ++G  M  A+K +     +    + F  E E L  +  H N+I ++
Sbjct: 34  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINLL 92

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN----------NDKLEVCNLSLIQTLNI 667
             C      G  +  +  ++  +G+L ++L ++                  LS  Q L+ 
Sbjct: 93  GACEH---RGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 668 AIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
           A DVA  ++YL         +H DL   N+L+  + VA + DFGL     +R  +  V  
Sbjct: 148 AADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGL-----SRGQEVYV-- 196

Query: 727 PSSSSGIKGTVGYI-----APE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMF 777
                  K T+G +     A E   Y   +  S   DV+S+G+LL E+ S    P     
Sbjct: 197 -------KKTMGRLPVRWMAIESLNYSVYTTNS---DVWSYGVLLWEIVSLGGTP----- 241

Query: 778 HEGLTLHEFSKMVLPEKVME 797
           + G+T  E  + +     +E
Sbjct: 242 YCGMTCAELYEKLPQGYRLE 261

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 4e-27
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVL--NLMQ-KGALKSFLTECEALRSIRHRNLIKIIT 618
           +G G   TV+        + VA+K +     + +  LK F  E      + H+N++ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +      +   +  +V ++++  +L E++  +        LS+   +N    +   I++ 
Sbjct: 79  VDEE---DDCYY--LVMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHA 127

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +VH D+KP N+L+D +    + DFG+AK L          + + ++ + GTV 
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-------TSLTQTNHVLGTVQ 177

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           Y +PE   G       D+YS GI+L EM     P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  112 bits (283), Expect = 4e-27
 Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 58/260 (22%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIK 615
           G G+FG V++G +       + + VAVK L     ++     FL E   +    H+N+++
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQNIVR 138

Query: 616 IITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQN-NDKLEVCNLSLIQTLNIAID 670
            I         GV  ++    I+ + M  G L+ +L +      +  +L+++  L++A D
Sbjct: 139 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 671 VASAIEYL-HHHCKPPVVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLPARPLDTVVET 726
           +A   +YL  +H     +H D+   N LL       VA +GDFG+A+           + 
Sbjct: 190 IACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DI 234

Query: 727 PSSSSGIKGTVGYI-----APE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMF 777
             +    KG    +      PE    G  +  +   D +SFG+LL E+FS    P     
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP----- 286

Query: 778 HEGLTLHEFSKMVLPEKVME 797
           +   +  E  + V     M+
Sbjct: 287 YPSKSNQEVLEFVTSGGRMD 306

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  115 bits (289), Expect = 6e-27
 Identities = 78/459 (16%), Positives = 159/459 (34%), Gaps = 45/459 (9%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-KIP 63
            +N++   +   +  +   LE L ++ N L     +S   +++L+ +D+  N      + 
Sbjct: 84  SHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVC 139

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFD--MVANLPNL 121
              G L KL +L +   +F       + ++     +    +        +   + N   L
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                  +  +  + +S++   +L+L  ++ N    +  + F S       +L N  L +
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL-NVTLQH 258

Query: 182 RAANDLDFVTVLAN--CSKLENLGLYDNQFGGLLPHSLANLSNTMTTI----DIGGNYFS 235
                   V +        +E L +Y+      +       S T         +    F 
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
            +          +N   +  +              +   L    N     +      L  
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 296 LTLLALEINNLQ--GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           L  L L+ N L+   K+     N +SL  L +S N L+     +  +     L LNLS N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF 413
           +L+GS+   +     +  LD+  NR                           SIP  +  
Sbjct: 439 MLTGSVFRCL--PPKVKVLDLHNNRIM-------------------------SIPKDVTH 471

Query: 414 LKSIKVLDLSSNKLSGQIPK-YLENLSFLEYLNLSYNHF 451
           L++++ L+++SN+L   +P    + L+ L+Y+ L  N +
Sbjct: 472 LQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  109 bits (274), Expect = 4e-25
 Identities = 85/459 (18%), Positives = 162/459 (35%), Gaps = 36/459 (7%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
            + LSL++N ++      I  LS L+V+ +  NR+           + L YL++  N+  
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMV-ANLPNLRKFVAAKNNLTGFLPISLSNA 142
             I      ++S   + L  N F   LP      NL  L     +         + L   
Sbjct: 114 N-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPV 166

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           ++L L  +  +       I     ++L +      HL     N L  V V  + + L +L
Sbjct: 167 AHLHLSCILLDL--VSYHIKGGETESLQIPNTTVLHLVFH-PNSLFSVQVNMSVNALGHL 223

Query: 203 GLYDNQ--------FGGLLPHSLANLSNTMTTIDIGGNYFSGTIP-PGLGNLVHLNSIAM 253
            L + +            L       +    T+      +  ++          +  + +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283

Query: 254 EGNQLIGTVPPEIG-----WLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG 308
               +   +  E        LK+L   ++ +        +       + +  L I++   
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343

Query: 309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIG---N 365
                  + +S   L  ++N     +     ++  L   L L  N L  +         N
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLK-NFFKVALMTKN 401

Query: 366 LKNLVQLDISGNRFSGDIPGTL-SACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
           + +L  LD+S N  +        +   S+  + +  N  +GS+   L     +KVLDL +
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHN 459

Query: 425 NKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
           N++   IPK + +L  L+ LN++ N  +  VP  GVF  
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 93.8 bits (233), Expect = 6e-20
 Identities = 57/379 (15%), Positives = 113/379 (29%), Gaps = 34/379 (8%)

Query: 101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL-SNASNLELLELRDNQFIGKM 159
           L  N     L    ++ L  LR    + N +   L   +     +LE L++  N+     
Sbjct: 59  LSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ--- 113

Query: 160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN 219
           +I+   + +L  L L  N       + L       N +KL  LGL   +F  L    +A+
Sbjct: 114 NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 220 LSNTMTTIDIGGNYFSGTIPPGLGNLVH-LNSIAMEGNQLIGTVPPEIGWLKNLQSLYLN 278
           L  +   +D+   +  G     L      +  +    N L          +  L  L L+
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF--SVQVNMSVNALGHLQLS 226

Query: 279 SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
           +  L+      L            + N+  +   +   C+  +        +        
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV-------- 278

Query: 339 LSVTTLSLFLNLSDNLLSGSLPSEIGN-----LKNLVQLDISGNRFSGDIPGTLSACTSL 393
                   +LN+ +  ++  +  E        LK+L+   +    F        S    +
Sbjct: 279 -------EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331

Query: 394 EYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
               +  +              S   L+ + N  +  + +    L  L+ L L  N  + 
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391

Query: 454 EVPKKGVFSNKTRFSLSGN 472
                 +  N +       
Sbjct: 392 FFKVALMTKNMSSLETLDV 410

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 41/274 (14%), Positives = 91/274 (33%), Gaps = 44/274 (16%)

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG----LGNLVHLNSIA 252
            + + L L  N    L    ++ LS  +  + +  N    ++         +L +L+   
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSE-LRVLRLSHNRIR-SLDFHVFLFNQDLEYLD--- 106

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
           +  N+L   +      + +L+ L L+ N         L                   +  
Sbjct: 107 VSHNRL-QNISC--CPMASLRHLDLSFNDF-----DVLP------------------VCK 140

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI--GNLKNLV 370
             GN T L  L LS  K   +    +  +    + L+L    + G     +   N   L 
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200

Query: 371 QLDISGNRFSGDIPGTLSACTSLE--YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS 428
            +    + FS  +  +++A   L+   +K+ D +    +       +   +L+++   + 
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 429 GQIPKYLENLSF-----LEYLNLSYNHFEGEVPK 457
                 ++   F     +EYLN+        + +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 49/259 (18%), Positives = 89/259 (34%), Gaps = 22/259 (8%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           VP ++      ++L L+ N +       +  L+ L +L L  N ++            L 
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103

Query: 322 MLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLP--SEIGNLKNLVQLDISGNR 378
            L +S N+L   +    ++    SL  L+LS N     LP   E GNL  L  L +S  +
Sbjct: 104 YLDVSHNRL-QNISCCPMA----SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157

Query: 379 F-SGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLEN 437
           F   D+        S   + +      G    SL    +   L L  +  S    +   +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV-LHLVFHPNSLFSVQVNMS 216

Query: 438 LSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSKRSRKLIA 497
           ++ L +L LS                  +  ++   +L  G    ++     + + K   
Sbjct: 217 VNALGHLQLSNIKLN---------DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 498 TILKVVIPTIVSCLILSAC 516
            + +   P  V  L +   
Sbjct: 268 KLFQFFWPRPVEYLNIYNL 286

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 10/156 (6%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIG---NLSALQVIDIRGNRLGGK 61
             N    D   +    L +L+ L L  N L            N+S+L+ +D+  N L   
Sbjct: 361 TQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418

Query: 62  IPDTLGQL-RKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
             D        ++ LN+  N  +G +   +      + + L +NR   S+P   V +L  
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIP-KDVTHLQA 474

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI 156
           L++   A N L           ++L+ + L DN + 
Sbjct: 475 LQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (276), Expect = 1e-26
 Identities = 47/219 (21%), Positives = 91/219 (41%), Gaps = 30/219 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           ++G+G++G V+ G    N + +A+K +        +    E    + ++H+N+++     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 621 SSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
               + G   +     I  + +  GSL   L      L+  N   I        +   ++
Sbjct: 84  ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIG--FYTKQILEGLK 136

Query: 677 YLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           YLH +    +VH D+K  NVL++ +  V  + DFG +K         +      +    G
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK--------RLAGINPCTETFTG 185

Query: 736 TVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T+ Y+APE             D++S G  ++EM + + P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (278), Expect = 1e-26
 Identities = 50/237 (21%), Positives = 96/237 (40%), Gaps = 26/237 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITI 619
           ++ +G F  V++     +G   A+K L   ++   ++ + E   ++ +  H N+++  + 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 620 CSSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            S         +A      +   G L E+L +   +     LS    L I      A+++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP---LSCDTVLKIFYQTCRAVQH 151

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK--- 734
           +H   KPP++H DLK  N+LL +     + DFG A  +   P  +      +    +   
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 735 -GTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
             T  Y  PE       +  G +     D+++ G +L  +  R+ P    F +G  L
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHP----FEDGAKL 259

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  110 bits (277), Expect = 2e-26
 Identities = 51/276 (18%), Positives = 102/276 (36%), Gaps = 24/276 (8%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQ 257
              L L +N    L       L + +  + +  N  S  I       L  L  + +  N 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 258 LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ-GKIPSSLGN 316
           L+  +PP +    +L  L ++ N +          L  +  + +  N L+         +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEI-GNLKNLVQLDI 374
              L  L +S+ KL G+ P  +      +L  L+L  N +  ++  E       L +L +
Sbjct: 171 GLKLNYLRISEAKLTGI-PKDLPE----TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224

Query: 375 SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP-- 432
             N+      G+LS   +L  + + +N  S  +P  L  LK ++V+ L +N ++ ++   
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 433 -----KYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
                 +    ++   ++L  N       +   F  
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  104 bits (262), Expect = 1e-24
 Identities = 66/311 (21%), Positives = 116/311 (37%), Gaps = 35/311 (11%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
             L   +P  +S   +  LL+L++N        +F  L++L  L+L NN +         
Sbjct: 43  LGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK--- 96

Query: 189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVH 247
                +   KL+ L +  N    + P+  ++L      + I  N     +P G    L +
Sbjct: 97  ---AFSPLRKLQKLYISKNHLVEIPPNLPSSL----VELRIHDNRIR-KVPKGVFSGLRN 148

Query: 248 LNSIAMEGNQL-IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           +N I M GN L      P       L  L ++   L   IP  L     L  L L+ N +
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI 205

Query: 307 QGKIPS-SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
           Q  I    L   + L  L L  N++  +    +  + TL   L+L +N LS  +P+ + +
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR-ELHLDNNKLS-RVPAGLPD 262

Query: 366 LKNLVQLDISGNRFSGDIP-------GTLSACTSLEYVKMQDNSFS-GSIPPSLNF--LK 415
           LK L  + +  N  +  +        G          + + +N      + P+  F  + 
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT-FRCVT 320

Query: 416 SIKVLDLSSNK 426
               +   + K
Sbjct: 321 DRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (256), Expect = 9e-24
 Identities = 56/303 (18%), Positives = 101/303 (33%), Gaps = 33/303 (10%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
           I P          + LQ+N     L  D    L +L   V   N ++     + S    L
Sbjct: 52  ISPDT------TLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
           + L +  N  +    I  N   +L  L + +N +            V +    +  + + 
Sbjct: 105 QKLYISKNHLV---EIPPNLPSSLVELRIHDNRIRKVPKG------VFSGLRNMNCIEMG 155

Query: 206 DNQ--FGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP 263
            N     G  P +   L   +  + I     +  IP  L     LN + ++ N+ I  + 
Sbjct: 156 GNPLENSGFEPGAFDGLK--LNYLRISEAKLT-GIPKDL--PETLNELHLDHNK-IQAIE 209

Query: 264 PEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIM 322
            E       L  L L  N +      SL  L  L  L L+ N L  ++P+ L +   L +
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV 268

Query: 323 LTLSKNKL----DGVLPPQILSVTTLSL-FLNLSDNLLSGSL--PSEIGNLKNLVQLDIS 375
           + L  N +         P    V       ++L +N +      P+    + + + +   
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328

Query: 376 GNR 378
             +
Sbjct: 329 NYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 54/318 (16%), Positives = 98/318 (30%), Gaps = 54/318 (16%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L L  N ++         L  L  + +  N++          LRKL  L I +N   
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                                     +P ++ ++L  LR      N +        S   
Sbjct: 116 -------------------------EIPPNLPSSLVELR---IHDNRIRKVPKGVFSGLR 147

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLS--VLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
           N+  +E+  N  +        +   L    L +    L     +             L  
Sbjct: 148 NMNCIEMGGNP-LENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---------ETLNE 197

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIG 260
           L L  N+   +    L   S  +  + +G N     I  G L  L  L  + ++ N+L  
Sbjct: 198 LHLDHNKIQAIELEDLLRYSK-LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS- 254

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSS-------LGNLTMLTLLALEINNLQ-GKIPS 312
            VP  +  LK LQ +YL++N +   +  +                ++L  N +   ++  
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 313 SLGNC-TSLIMLTLSKNK 329
           +   C T  + +     K
Sbjct: 314 ATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 15/232 (6%)

Query: 5   QNNKLVGDIPVEIGCYLFK-LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLG-GKI 62
             N LV +IP      L   L  L + +N +          L  +  I++ GN L     
Sbjct: 110 SKNHLV-EIPPN----LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
                   KL YL I   + +G IP  +    +   + L  N+   ++  + +     L 
Sbjct: 165 EPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLY 220

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR 182
           +     N +      SLS    L  L L +N+ + ++      LK L V+ L  N++   
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNK-LSRVPAGLPDLKLLQVVYLHTNNITKV 279

Query: 183 AANDLDFVTVLANCSKLENLGLYDNQ--FGGLLPHSLANLSNTMTTIDIGGN 232
             ND   V      +    + L++N   +  + P +   +++    I  G  
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD-RLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 17/208 (8%)

Query: 247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL 306
           HL  +      L   VP EI    +   L L +N +          L  L  L L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGN 365
                 +      L  L +SKN L   +PP + S    SL  L + DN +          
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS----SLVELRIHDNRIRKVPKGVFSG 145

Query: 366 LKNLVQLDISGNRFSGDI--PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
           L+N+  +++ GN        PG       L Y+++ +   +  IP  L   +++  L L 
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLD 201

Query: 424 SNKLSGQIPK-YLENLSFLEYLNLSYNH 450
            NK+   I    L   S L  L L +N 
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  109 bits (275), Expect = 2e-26
 Identities = 45/215 (20%), Positives = 91/215 (42%), Gaps = 18/215 (8%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL--NLMQ-KGALKSFLTECEALRSIRHRNLIKII 617
           ++G G    V       +   VAVKVL  +L +       F  E +   ++ H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
               + +        IV +++   +L + +H          ++  + + +  D   A+ +
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 131

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
            H +    ++H D+KP+N+++       V DFG+A     R +     + + ++ + GT 
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIA-----RAIADSGNSVTQTAAVIGTA 183

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            Y++PE   G       DVYS G +L E+ +   P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  111 bits (280), Expect = 3e-26
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 38/230 (16%)

Query: 555 EFSSSNMVGQGSFGT-VFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALR-SIRHRN 612
            F   +++G G+ GT V++G+   +   VAVK    +          E + LR S  H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKR---ILPECFSFADREVQLLRESDEHPN 79

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
           +I+         F         Y  ++    +L+E++ Q +          ++ + +   
Sbjct: 80  VIRYFCTEKDRQF--------QYIAIELCAATLQEYVEQKDF-----AHLGLEPITLLQQ 126

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLPARPLDTVVE 725
             S + +LH      +VH DLKP N+L+        + A + DFGL K      L     
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-----LAVGRH 178

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTG---DVYSFGILLLEMFSRRRP 772
           + S  SG+ GT G+IAPE  +           D++S G +   + S    
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (274), Expect = 5e-26
 Identities = 60/265 (22%), Positives = 117/265 (44%), Gaps = 59/265 (22%)

Query: 563 GQGSFGTVFKGII-------GENGMLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRN 612
           G+G+FG V             +  + VAVK+L  +  +K  L   ++E E ++ I +H+N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKN 102

Query: 613 LIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWL----------HQNNDKLEVCNLS 660
           +I ++  C+     +       ++ ++   G+L E+L            + +++    ++
Sbjct: 103 IINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 661 LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
               ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA     R 
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA-----RD 206

Query: 720 LDTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRP 772
           ++ +     +++G   +K      APE       +  S   DV+SFG+L+ E+F+    P
Sbjct: 207 INNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP 259

Query: 773 TDSMFHEGLTLHEFSKMVLPEKVME 797
                + G+ + E  K++     M+
Sbjct: 260 -----YPGIPVEELFKLLKEGHRMD 279

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  108 bits (271), Expect = 9e-26
 Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 52/234 (22%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRNLI 614
           G+G+FG V +              VAVK+L          ++ ++E + L  I  H N++
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVV 94

Query: 615 KIITICSSID---FNGVDFKAIVYDFMQNGSLEEWL----------HQNNDKLEVCNLSL 661
            ++  C+              ++ +F + G+L  +L              + L    L+L
Sbjct: 95  NLLGACTKPGGPLM-------VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 662 IQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL 720
              +  +  VA  +E+L    C    +H DL   N+LL    V  + DFGLA     R +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLA-----RDI 198

Query: 721 DTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
               +          +K      APE       +  S   DV+SFG+LL E+FS
Sbjct: 199 YKDPDYVRKGDARLPLKWM----APETIFDRVYTIQS---DVWSFGVLLWEIFS 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (270), Expect = 1e-25
 Identities = 55/259 (21%), Positives = 103/259 (39%), Gaps = 21/259 (8%)

Query: 225 TTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFL 282
           T I       + ++P G+  +   L    +E N+ + ++P  +   L  L  L L+SN L
Sbjct: 10  TEIRCNSKGLT-SVPTGIPSSATRLE---LESNK-LQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 283 H--GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILS 340
              G    S    T L  L L  N +   + S+      L  L    + L  +    +  
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 341 VTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDI-PGTLSACTSLEYVKM 398
                ++L++S         + I   L +L  L ++GN F  +  P   +   +L ++ +
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 399 QDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNLSYNHFEGEVP 456
                   + P + N L S++VL++S N     +  +  + L+ L+ L+ S NH      
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSK 239

Query: 457 K---KGVFSNKTRFSLSGN 472
           K   +   S+    +L+ N
Sbjct: 240 KQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 2e-24
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 11/241 (4%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQL--IGTVPPEIGWLKNLQS 274
             + ++ T +++  N    ++P G    L  L  +++  N L   G          +L+ 
Sbjct: 24  TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82

Query: 275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTSLIMLTLSKNKLDGV 333
           L L+ N +   + S+   L  L  L  + +NL+     S+  +  +LI L +S      V
Sbjct: 83  LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-V 140

Query: 334 LPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTS 392
               I +  +    L ++ N    +   +I   L+NL  LD+S  +     P   ++ +S
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200

Query: 393 LEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSNKLSGQIPKYLENL-SFLEYLNLSYNH 450
           L+ + M  N+F  S+       L S++VLD S N +     + L++  S L +LNL+ N 
Sbjct: 201 LQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259

Query: 451 F 451
           F
Sbjct: 260 F 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  102 bits (256), Expect = 6e-24
 Identities = 47/236 (19%), Positives = 82/236 (34%), Gaps = 10/236 (4%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN--YFSGTIPPGLGNLVHLNSIAMEGN 256
              L L  N+   L       L+  +T + +  N   F G           L  + +  N
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSL-GNLTMLTLLALEINNLQGKIPSSLG 315
            +I T+      L+ L+ L    + L      S+  +L  L  L +   + +        
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDI 374
             +SL +L ++ N       P I +      FL+LS   L   L      +L +L  L++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206

Query: 375 SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL--NFLKSIKVLDLSSNKLS 428
           S N F            SL+ +    N    +       +F  S+  L+L+ N  +
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 2e-23
 Identities = 61/265 (23%), Positives = 93/265 (35%), Gaps = 20/265 (7%)

Query: 95  SFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ 154
           S   I   S     S+P  +     +  +     N L           + L  L L  N 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 155 --FIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL 212
             F G  S +     +L  L L  N +   ++N            +LE+L    +    +
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQM 116

Query: 213 LPHSL-ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEI-GWL 269
              S+  +L N +  +DI   +       G    L  L  + M GN       P+I   L
Sbjct: 117 SEFSVFLSLRN-LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174

Query: 270 KNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNK 329
           +NL  L L+   L    P++  +L+ L +L +  NN             SL +L  S N 
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234

Query: 330 LDGVLPPQILSVTTLSL-FLNLSDN 353
           +      Q L     SL FLNL+ N
Sbjct: 235 IM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 55/287 (19%), Positives = 97/287 (33%), Gaps = 43/287 (14%)

Query: 27  LSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFI 86
           +      LT  +P  I   S+   +++  N+L         +L +L  L++  N  S   
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS--- 65

Query: 87  PPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLE 146
                      F    S    G           +L+    + N +   +  +      LE
Sbjct: 66  -----------FKGCCSQSDFG---------TTSLKYLDLSFNGVIT-MSSNFLGLEQLE 104

Query: 147 LLELRDNQF--IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGL 204
            L+ + +    + + S+ F SL+NL  L + + H             +    S LE L +
Sbjct: 105 HLDFQHSNLKQMSEFSV-FLSLRNLIYLDISHTHTRVAFNG------IFNGLSSLEVLKM 157

Query: 205 YDNQF-GGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTV 262
             N F    LP     L N +T +D+        + P    +L  L  + M  N    ++
Sbjct: 158 AGNSFQENFLPDIFTELRN-LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN-FFSL 214

Query: 263 PPEIGW-LKNLQSLYLNSNFLHGYIPSSLGNL-TMLTLLALEINNLQ 307
                  L +LQ L  + N +       L +  + L  L L  N+  
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 45/233 (19%), Positives = 93/233 (39%), Gaps = 15/233 (6%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQ--LPVSIGNLSALQVIDIRGNRLGGKI 62
           ++NKL   +P  +   L +L  LSL+ N L+ +     S    ++L+ +D+  N +   +
Sbjct: 36  ESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITM 93

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
                 L +L +L+   +        S+  ++ +  ++ +            +   L +L
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 152

Query: 122 RKFVAAKNN-LTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHL 179
                A N+    FLP   +   NL  L+L   Q + ++S   FNSL +L VL + +N+ 
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMSHNNF 211

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGN 232
            +               + L+ L    N         L +  +++  +++  N
Sbjct: 212 FSLDTF------PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 14/209 (6%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
           +   +  NS  L   +P+ +   +  T L LE N LQ          T L  L+LS N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 331 DGVLPPQILSVTTLSL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP-GTLS 388
                       T SL +L+LS N +  ++ S    L+ L  LD   +            
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 389 ACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNL 446
           +  +L Y+ +              N L S++VL ++ N             L  L +L+L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 447 SYNHFEGEVPKKGVFSNKTR---FSLSGN 472
           S    E ++     F++ +     ++S N
Sbjct: 183 SQCQLE-QLS-PTAFNSLSSLQVLNMSHN 209

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 7/89 (7%)

Query: 388 SACT-SLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNL 446
           S C+ S   ++      + S+P       S   L+L SNKL        + L+ L  L+L
Sbjct: 3   SRCSCSGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSL 59

Query: 447 SYNHFEGEVPKKGVFSNKTR---FSLSGN 472
           S N    +          T      LS N
Sbjct: 60  SSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (269), Expect = 1e-25
 Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 24/215 (11%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKII 617
           +VG+G  G V++        +VA+K+++               E      ++  +   ++
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH---VV 97

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            I    + +G  +  +    +    L   L +         L+  + + I   + SA++ 
Sbjct: 98  PIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDA 149

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
            H        H D+KP N+L+  D  A++ DFG+A       L       +      GT+
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-------TQLGNTVGTL 199

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            Y+APE  + S A+   D+Y+   +L E  +   P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  107 bits (270), Expect = 1e-25
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 55/234 (23%)

Query: 563 GQGSFGTVFKG----IIGENG-MLVAVKVLNLMQKGA----LKSFLTECEALRSI-RHRN 612
           G G+FG V +     +  E+  + VAVK+L      A     ++ ++E + +  + +H N
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHEN 111

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV--------CNLSLIQT 664
           ++ ++  C+     G     ++ ++   G L  +L + +  LE            S    
Sbjct: 112 IVNLLGACTH---GGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 665 LNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
           L+ +  VA  + +L   +C    +H D+   NVLL +  VA +GDFGLA+         +
Sbjct: 167 LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARD--------I 214

Query: 724 VETP---SSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
           +         +    +K      APE       +  S   DV+S+GILL E+FS
Sbjct: 215 MNDSNYIVKGNARLPVKWM----APESIFDCVYTVQS---DVWSYGILLWEIFS 261

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 2e-25
 Identities = 52/290 (17%), Positives = 108/290 (37%), Gaps = 33/290 (11%)

Query: 143 SNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
             ++ L+L +N+ I  +S +      NL  L+L +N +     +        ++   LE+
Sbjct: 52  EAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEED------SFSSLGSLEH 104

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG--LGNLVHLNSIAMEGNQLI 259
           L L  N    L       LS+ +T +++ GN +  T+       +L  L  + +      
Sbjct: 105 LDLSYNYLSNLSSSWFKPLSS-LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162

Query: 260 GTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
             +  +    L  L+ L ++++ L  Y P SL ++  ++ L L +      +   +   +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
           S+  L L    LD     ++ +  T SL                         + I+   
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSL-----------------IKKFTFRNVKITDES 265

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSNKL 427
               +   L+  + L  ++   N    S+P    + L S++ + L +N  
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.5 bits (243), Expect = 6e-22
 Identities = 48/273 (17%), Positives = 89/273 (32%), Gaps = 21/273 (7%)

Query: 46  SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSI-YNISSFEFIFLQSN 104
            A++ +D+  NR+       L +   L  L +  N  +  I      ++ S E + L  N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 105 RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL-SNASNLELLELRDNQFIGKMSIN- 162
               +L       L +L       N        SL S+ + L++L + +     K+    
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN 222
           F  L  L  L +  + L +           L +   + +L L+  Q   LL   +   S+
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPK------SLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223

Query: 223 TMTTIDIGGNYFSGT----IPPG----LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQS 274
            +  +++            +  G    L       ++ +    L   V   +  +  L  
Sbjct: 224 -VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281

Query: 275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
           L  + N L          LT L  + L  N   
Sbjct: 282 LEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 48/265 (18%), Positives = 93/265 (35%), Gaps = 33/265 (12%)

Query: 21  LFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
              L+ L L  N +   +      +L +L+ +D+  N L          L  L +LN+  
Sbjct: 75  CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLG 133

Query: 80  NQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS 138
           N +      S++ +++  + + + +      +     A L  L +     ++L  + P S
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193

Query: 139 LSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVT--VLANC 196
           L +  N+  L L   Q I  + I  +   ++  L L +  L     ++L       L   
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
               N+ + D                               +   L  +  L  +    N
Sbjct: 254 FTFRNVKITDESL--------------------------FQVMKLLNQISGLLELEFSRN 287

Query: 257 QLIGTVPPEI-GWLKNLQSLYLNSN 280
           QL  +VP  I   L +LQ ++L++N
Sbjct: 288 QLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 8e-19
 Identities = 44/248 (17%), Positives = 81/248 (32%), Gaps = 17/248 (6%)

Query: 237 TIPPGL-GNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLT 294
           +IP GL   +  L+   +  N+ I  +         NLQ+L L SN ++     S  +L 
Sbjct: 45  SIPSGLTEAVKSLD---LSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100

Query: 295 MLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNL 354
            L  L L  N L     S     +SL  L L  N    +    + S  T    L + +  
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 355 LSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLN 412
               +  +    L  L +L+I  +      P +L +  ++ ++ +        +    ++
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219

Query: 413 FLKSIKVLDLSSNKLSGQIPKYLENLSF--------LEYLNLSYNHFEGEVPKKGVFSNK 464
              S++ L+L    L       L                + ++       +      S  
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL 279

Query: 465 TRFSLSGN 472
                S N
Sbjct: 280 LELEFSRN 287

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (268), Expect = 2e-25
 Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 57/237 (24%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGA----LKSFLTECEALRSI-RHRN 612
           G G+FG V +         +  M VAVK+L      A     ++ ++E + L  +  H N
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMN 88

Query: 613 LIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWL------------HQNNDKLEVCN 658
           ++ ++  C+             ++ ++   G L  +L                 + +   
Sbjct: 89  IVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 659 LSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
           L L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFGLA     
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA----- 192

Query: 718 RPLDTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
           R +          +    +K      APE       +  S   DV+S+GI L E+FS
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWM----APESIFNCVYTFES---DVWSYGIFLWELFS 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (267), Expect = 2e-25
 Identities = 59/270 (21%), Positives = 99/270 (36%), Gaps = 64/270 (23%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIK 615
           G+G FG V K              VAVK+L  N      L+  L+E   L+ + H ++IK
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQVNHPHVIK 90

Query: 616 IITICSSID--FNGVDFKAIVYDFMQNGSLEEWL------------------HQNNDKLE 655
           +   CS             ++ ++ + GSL  +L                    + D  +
Sbjct: 91  LYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 656 VCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
              L++   ++ A  ++  ++YL         VH DL   N+L+       + DFGL+  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 715 LPARPLDTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
              R +         S G   +K      A E       +  S   DV+SFG+LL E+ +
Sbjct: 198 ---RDVYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQS---DVWSFGVLLWEIVT 247

Query: 769 R-RRPTDSMFHEGLTLHEFSKMVLPEKVME 797
               P     + G+       ++     ME
Sbjct: 248 LGGNP-----YPGIPPERLFNLLKTGHRME 272

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  107 bits (269), Expect = 4e-25
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 55/263 (20%)

Query: 563 GQGSFGTVFKGII-------GENGMLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRN 612
           G+G+FG V                  VAVK+L  +  +K  L   ++E E ++ I +H+N
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKN 136

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWL----------HQNNDKLEVCNLSLI 662
           +I ++  C+    +G  +  ++ ++   G+L E+L            N        LS  
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 663 QTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
             ++ A  VA  +EYL    C    +H DL   NVL+  D V  + DFGLA     R + 
Sbjct: 192 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA-----RDIH 242

Query: 722 TVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSR-RRPTD 774
            +     +++G   +K      APE       +  S   DV+SFG+LL E+F+    P  
Sbjct: 243 HIDYYKKTTNGRLPVKWM----APEALFDRIYTHQS---DVWSFGVLLWEIFTLGGSP-- 293

Query: 775 SMFHEGLTLHEFSKMVLPEKVME 797
              + G+ + E  K++     M+
Sbjct: 294 ---YPGVPVEELFKLLKEGHRMD 313

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (268), Expect = 5e-25
 Identities = 60/267 (22%), Positives = 113/267 (42%), Gaps = 63/267 (23%)

Query: 563 GQGSFGTVFKGII-------GENGMLVAVKVL--NLMQKGALKSFLTECEALRSI-RHRN 612
           G+G FG V             +  + VAVK+L  +  +K  L   ++E E ++ I +H+N
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKN 148

Query: 613 LIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWL----------HQNNDKLEVCNLS 660
           +I ++  C+     +       ++ ++   G+L E+L            + +++    ++
Sbjct: 149 IINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 661 LIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP 719
               ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+      
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR------ 251

Query: 720 LDTVVETPSSSSGIKGTVGYI-----APE---YGTGSEASMTGDVYSFGILLLEMFSR-R 770
                +  +     K T G +     APE       +  S   DV+SFG+L+ E+F+   
Sbjct: 252 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS---DVWSFGVLMWEIFTLGG 303

Query: 771 RPTDSMFHEGLTLHEFSKMVLPEKVME 797
            P     + G+ + E  K++     M+
Sbjct: 304 SP-----YPGIPVEELFKLLKEGHRMD 325

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (267), Expect = 6e-25
 Identities = 32/248 (12%), Positives = 77/248 (31%), Gaps = 51/248 (20%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA----------------LKSFLTECEA 604
           ++GQ       +    E G    V V    ++                  L+    + +A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 605 LRSIRHRNLIKIITICSS-------IDFNGVDFKAIVYDFMQ-NGSLEEWLHQNNDKLEV 656
              +R      ++            +D   +   +  + + +   +L+ +          
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 657 C-NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
             +L     L + + V   +  LHH+    +VH  L+P +++LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEY-----------GTGSEASMTGDVYSFGILLL 764
            AR + +             + G+  PE               +  + + D ++ G+++ 
Sbjct: 257 GARVVSS------------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 765 EMFSRRRP 772
            ++    P
Sbjct: 305 WIWCADLP 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (265), Expect = 7e-25
 Identities = 45/233 (19%), Positives = 88/233 (37%), Gaps = 44/233 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN-----------------LMQKGALKSFLTECEAL 605
            QG F  +      ++    A+K                    +  K     F  E + +
Sbjct: 40  NQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 606 RSIRHRNLIKIITICSSIDFNGVDFKAI--VYDFMQNGSLEEWL--HQNNDKLEVCNLSL 661
             I++   +    I +       ++  +  +Y++M+N S+ ++       DK   C + +
Sbjct: 98  TDIKNEYCLTCEGIIT-------NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 662 IQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLD 721
                I   V ++  Y+H+     + H D+KPSN+L+D +    + DFG ++++  + + 
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 722 TVVETPSSSSGIKGTVGYIAPE--YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                        GT  ++ PE      S      D++S GI L  MF    P
Sbjct: 209 GSR----------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (265), Expect = 8e-25
 Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 64/270 (23%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVL--NLMQKGALKSFLTECEALRSIRHRNLIK 615
           G+G+FG VF+         E   +VAVK+L            F  E   +    + N++K
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDNPNIVK 114

Query: 616 IITICSSID--FNGVDFKAIVYDFMQNGSLEEWLHQN------------------NDKLE 655
           ++ +C+             +++++M  G L E+L                          
Sbjct: 115 LLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 656 VCNLSLIQTLNIAIDVASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
              LS  + L IA  VA+ + YL         VH DL   N L+  +MV  + DFGL+  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLS-- 221

Query: 715 LPARPLDTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
              R + +     +  +    I+       PE   Y   +  S   DV+++G++L E+FS
Sbjct: 222 ---RNIYSADYYKADGNDAIPIRWM----PPESIFYNRYTTES---DVWAYGVVLWEIFS 271

Query: 769 R-RRPTDSMFHEGLTLHEFSKMVLPEKVME 797
              +P     + G+   E    V    ++ 
Sbjct: 272 YGLQP-----YYGMAHEEVIYYVRDGNILA 296

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  107 bits (269), Expect = 8e-25
 Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 45/242 (18%)

Query: 556 FSSSNMVGQGSFGTV-FKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALR-SIRHRNL 613
             S  ++G GS GTV F+G     G  VAVK    M        L E + L  S  H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGS--FQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLE-VCNLSLIQTLNIAID 670
           I+     ++  F        +Y  ++  N +L++ +   N   E +        +++   
Sbjct: 72  IRYYCSETTDRF--------LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDH-------------DMVAHVGDFGLAKFLPA 717
           +AS + +LH      ++H DLKP N+L+               ++   + DFGL K L  
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD- 179

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-------DVYSFGILLLEMFSRR 770
                     ++ +   GT G+ APE    S    T        D++S G +   + S+ 
Sbjct: 180 ---SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 771 RP 772
           + 
Sbjct: 237 KH 238

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (269), Expect = 9e-25
 Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 8/235 (3%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGW-LKNLQSL 275
             + +    +++  N     I      +L HL  + +  N  I  +       L +L +L
Sbjct: 71  QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTL 128

Query: 276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLP 335
            L  N+L      +   L+ L  L L  N ++     +     SL+ L L + K    + 
Sbjct: 129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188

Query: 336 PQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEY 395
                      +LNL    +   +P+ +  L  L +L++SGN F    PG+    +SL+ 
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246

Query: 396 VKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
           + + ++  S  I   + + L S+  L+L+ N LS         L +L  L+L +N
Sbjct: 247 LWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.7 bits (246), Expect = 8e-22
 Identities = 56/266 (21%), Positives = 101/266 (37%), Gaps = 21/266 (7%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
           C   +   +      L+ ++P  I   S  + +++  N +     DT   L  L  L +G
Sbjct: 52  CS-NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 79  RNQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPI 137
           RN     I       ++S   + L  N     +P      L  LR+     N +      
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSY 165

Query: 138 SLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
           + +   +L  L+L + + +  +S   F  L NL  L LG  ++ +        +  L   
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--------MPNLTPL 217

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEG 255
             LE L +  N F  + P S   LS+ +  + +  +  S  I       L  L  + +  
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSS-LKKLWVMNSQVS-LIERNAFDGLASLVELNLAH 275

Query: 256 NQLIGTVPPEI-GWLKNLQSLYLNSN 280
           N L  ++P ++   L+ L  L+L+ N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 49/228 (21%), Positives = 92/228 (40%), Gaps = 13/228 (5%)

Query: 128 KNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAAND 186
           +NN+      +  +  +LE+L+L  N  I ++ +  FN L +L+ L L +N L    +  
Sbjct: 84  ENNIQMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLTVIPSG- 141

Query: 187 LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNL 245
                     SKL  L L +N    +  ++   + + +  +D+G       I  G    L
Sbjct: 142 -----AFEYLSKLRELWLRNNPIESIPSYAFNRVPS-LMRLDLGELKKLEYISEGAFEGL 195

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
            +L  + +    +     P +  L  L+ L ++ N      P S   L+ L  L +  + 
Sbjct: 196 FNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           +     ++     SL+ L L+ N L   LP  + +     + L+L  N
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.7 bits (241), Expect = 3e-21
 Identities = 50/278 (17%), Positives = 94/278 (33%), Gaps = 40/278 (14%)

Query: 128 KNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDL 187
           +  L+  +P  +   SN   L L +N      +  F  L +L VL LG N +        
Sbjct: 63  RRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG-- 117

Query: 188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLV 246
                    + L  L L+DN    +   +   LS  +  + +  N    +IP      + 
Sbjct: 118 ----AFNGLASLNTLELFDNWLTVIPSGAFEYLSK-LRELWLRNNPIE-SIPSYAFNRVP 171

Query: 247 HLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
            L  + +   + +  +       L NL+ L L    +   +P+ L  L  L  L +  N+
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNH 229

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
                P S    +SL  L +  +++  ++                               
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFD------------------------G 264

Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           L +LV+L+++ N  S       +    L  + +  N +
Sbjct: 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 13/217 (5%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            VP  I    N + L L  N +      +  +L  L +L L  N+++     +     SL
Sbjct: 68  EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISG-NR 378
             L L  N L  V+P       +    L L +N +  S+PS     + +L++LD+    +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL 438
                 G      +L+Y+ +   +    +P +L  L  ++ L++S N      P     L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241

Query: 439 SFLEYLNLSYNHFEGEVPKKGVFSNKTRF---SLSGN 472
           S L+ L +  +     +  +  F         +L+ N
Sbjct: 242 SSLKKLWVMNSQVS-LIE-RNAFDGLASLVELNLAHN 276

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 87.1 bits (216), Expect = 4e-18
 Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 14/207 (6%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
               +      L   +P  +   +    L L  NN+Q     +  +   L +L L +N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 331 DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIPGTLSA 389
              +     +       L L DN L+  +PS     L  L +L +  N          + 
Sbjct: 112 -RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169

Query: 390 CTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSY 448
             SL  + + +      I   +   L ++K L+L    +   +P  L  L  LE L +S 
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227

Query: 449 NHFEGEVPKKGVFSNKT---RFSLSGN 472
           NHF  E+   G F   +   +  +  +
Sbjct: 228 NHFP-EIR-PGSFHGLSSLKKLWVMNS 252

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 4/127 (3%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
           +  KL   I       LF L+ L+L   ++   +P ++  L  L+ +++ GN      P 
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPG 236

Query: 65  TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF 124
           +   L  L  L +  +Q S     +   ++S   + L  N    SLP D+   L  L + 
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVEL 295

Query: 125 VAAKNNL 131
               N  
Sbjct: 296 HLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 32/153 (20%), Positives = 59/153 (38%), Gaps = 7/153 (4%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAE-NHLTGQLPVSI-GNLSALQVIDIRGNRLGGKI 62
           +NN +   IP      +  L  L L E   L   +       L  L+ +++    +   +
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DM 211

Query: 63  PDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           P  L  L  L  L +  N F    P S + +SS + +++ +++    +  +    L +L 
Sbjct: 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLV 269

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQF 155
           +   A NNL+       +    L  L L  N +
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (263), Expect = 1e-24
 Identities = 56/255 (21%), Positives = 93/255 (36%), Gaps = 32/255 (12%)

Query: 523 RRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
           +R   +       ++ ++   + Y +  +     +    VG+GSFG V +    + G   
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86

Query: 583 AVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFM 638
           AVK + L         + E  A   +    ++            G   +     I  + +
Sbjct: 87  AVKKVRLE-----VFRVEELVACAGLSSPRIVP---------LYGAVREGPWVNIFMELL 132

Query: 639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL 698
           + GSL + + Q     E                   +EYLH      ++HGD+K  NVLL
Sbjct: 133 EGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVLL 183

Query: 699 DHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVY 757
             D   A + DFG A  L    L   + T      I GT  ++APE   G       D++
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAPEVVMGKPCDAKVDIW 240

Query: 758 SFGILLLEMFSRRRP 772
           S   ++L M +   P
Sbjct: 241 SSCCMMLHMLNGCHP 255

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  103 bits (260), Expect = 1e-24
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 33/210 (15%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+G FG V+     ++  ++A+KVL    L + G       E E    +RH N++++   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 620 CSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                         VY   ++   G++   L + +           +T     ++A+A+ 
Sbjct: 78  FHD--------ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALS 123

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y H      V+H D+KP N+LL       + DFG +   P+     +           GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----------GT 170

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           + Y+ PE   G       D++S G+L  E 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (259), Expect = 2e-24
 Identities = 46/265 (17%), Positives = 97/265 (36%), Gaps = 45/265 (16%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRS 607
           S+ T+EF     +G G FG+VFK +   +G + A+K            ++ L E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 608 I-RHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           + +H ++++         +     +     I  ++   GSL + + +N   +     + +
Sbjct: 67  LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       +   A     
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 723 V-------VETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFS 768
                   V   SS    +G   ++A E       +   +      D+++  + ++    
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKA------DIFALALTVVCAAG 226

Query: 769 RRRPTDSMFHEGLTLHEFSKMVLPE 793
                      G   HE  +  LP 
Sbjct: 227 AEPL----PRNGDQWHEIRQGRLPR 247

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 62/242 (25%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLNLMQKGA----LKSFLTECEALRSI-RHRN 612
           G G+FG V              + VAVK+L    + A     ++ ++E + +  +  H N
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHEN 110

Query: 613 LIKIITICSSID--FNGVDFKAIVYDFMQNGSLEEWL-----------------HQNNDK 653
           ++ ++  C+     +       +++++   G L  +L                  +  ++
Sbjct: 111 IVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 654 LEVCNLSLIQTLNIAIDVASAIEYL-HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
            ++  L+    L  A  VA  +E+L    C    VH DL   NVL+ H  V  + DFGLA
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 713 KFLPARPLDTVVETPSSSSG---IKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEM 766
                R + +        +    +K      APE    G  +  S   DV+S+GILL E+
Sbjct: 220 -----RDIMSDSNYVVRGNARLPVKWM----APESLFEGIYTIKS---DVWSYGILLWEI 267

Query: 767 FS 768
           FS
Sbjct: 268 FS 269

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  102 bits (255), Expect = 8e-24
 Identities = 58/274 (21%), Positives = 91/274 (33%), Gaps = 19/274 (6%)

Query: 213 LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNL 272
           L     +L   +  +D   +    T      +L  L   A      I      +  +  L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ----GKIPSSLGNC--TSLIMLTLS 326
           Q L L +  + G  P  L   T   L  L + N+         + L       L +L+++
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157

Query: 327 KNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI----GNLKNLVQLDISGNRF--- 379
           +         Q+     LS  L+LSDN   G               L  L +        
Sbjct: 158 QAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 380 SGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSSNKLSGQIPKYLENL 438
           SG      +A   L+ + +  NS   +      ++   +  L+LS   L  Q+PK L   
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--P 273

Query: 439 SFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
           + L  L+LSYN  +   P           SL GN
Sbjct: 274 AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGN 306

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.2 bits (247), Expect = 8e-23
 Identities = 49/305 (16%), Positives = 86/305 (28%), Gaps = 44/305 (14%)

Query: 137 ISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
           +     S   LL+  D +       +     +L  L +    + +R          +   
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA---LRVLGI 94

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNT-MTTIDIGGNYFSG--TIPPGLGNLV--HLNSI 251
           S L+ L L + +  G  P  L   +   +  +++    ++        L   +   L  +
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFL-------HGYIPSSLGNLTMLTLLALEIN 304
           ++     +     ++     L +L L+ N             P     L +L L    + 
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214

Query: 305 NLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIG 364
              G   +       L  L LS N L            +    LNLS   L   +P  + 
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL- 272

Query: 365 NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSS 424
               L  LD+S NR                              PS + L  +  L L  
Sbjct: 273 -PAKLSVLDLSYNRLDR--------------------------NPSPDELPQVGNLSLKG 305

Query: 425 NKLSG 429
           N    
Sbjct: 306 NPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.5 bits (240), Expect = 6e-22
 Identities = 52/291 (17%), Positives = 90/291 (30%), Gaps = 23/291 (7%)

Query: 181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTT--IDIGGNYFSGTI 238
           + A N L    V           L              ++  +++   + +        I
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 239 PPG---LGNLVHLNSIAMEGNQLIGTVPPEIGWL--KNLQSLYLNSNFLHG--YIPSSLG 291
             G   +  +  L  + +E  ++ GT PP +      +L  L L +          + L 
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 292 NLTMLTLLALEI--NNLQGKIPSSLGNCTSLIMLTLSKNKL--DGVLPPQILSVTTLSL- 346
                 L  L I   +        +    +L  L LS N    +  L   +  +   +L 
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 347 FLNLSDNL---LSGSLPSEIGNLKNLVQLDISGNRFSGDIP-GTLSACTSLEYVKMQDNS 402
            L L +      SG   +       L  LD+S N         +    + L  + +    
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 403 FSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
               +P  L     + VLDLS N+L    P   + L  +  L+L  N F  
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.5 bits (201), Expect = 8e-17
 Identities = 50/286 (17%), Positives = 94/286 (32%), Gaps = 23/286 (8%)

Query: 13  IPVEIGCYLFKLENLSLAENHLTGQLP-VSIGNLSALQVIDIRGNRLGGKIPDTLGQL-- 69
             VE+      LE L    +          I    +L+ + +R  R+  +I     ++  
Sbjct: 34  ADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG 93

Query: 70  -RKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANL-----PNLRK 123
              L  L +   + +G  PP +   +  +   L       +     +A L     P L+ 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 124 FVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM----SINFNSLKNLSVLILGNNHL 179
              A+ +   F    +     L  L+L DN  +G+     ++       L VL L N  +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP 239
                       + A   +L+ L L  N           +  + + ++++        +P
Sbjct: 214 ---ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269

Query: 240 PGLG-NLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
            GL   L  L+   +  N+L     P    L  + +L L  N    
Sbjct: 270 KGLPAKLSVLD---LSYNRL--DRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 41/216 (18%), Positives = 71/216 (32%), Gaps = 14/216 (6%)

Query: 272 LQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD 331
           L+ +   ++           +L  LT+ A  I +        +   + L  LTL   ++ 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 332 GVLPPQILSVTTLSL-FLNLSDNLLSG--SLPSEIGNL--KNLVQLDISGNRFSGDIPGT 386
           G  PP +L  T   L  LNL +   +   +  +E+       L  L I+           
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 387 LSACTSLEYVKMQDNSFSGSIPPS----LNFLKSIKVLDLSSNK---LSGQIPKYLENLS 439
           +    +L  + + DN   G              +++VL L +      SG          
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 440 FLEYLNLSYNHFEGEVPKKG--VFSNKTRFSLSGNG 473
            L+ L+LS+N              S     +LS  G
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 30/192 (15%), Positives = 60/192 (31%), Gaps = 29/192 (15%)

Query: 291 GNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS--LFL 348
           G  ++  LL            + +    SL  LT+   ++   +    L V  +S    L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 349 NLSDNLLSGSLPSEIGNL--KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
            L +  ++G+ P  +      +L  L++    ++                    +++   
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR------------------DAWLAE 142

Query: 407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPK-----KGVF 461
           +   L     +KVL ++         + +     L  L+LS N   GE           F
Sbjct: 143 LQQWLK--PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF 200

Query: 462 SNKTRFSLSGNG 473
                 +L   G
Sbjct: 201 PTLQVLALRNAG 212

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 35/212 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+G F   F+    +   + A K++    L++    +    E    RS+ H++++     
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL---EVCNLSLIQTLNIAIDVASAIE 676
                F   DF  +V +  +  SL E LH+    L   E     L Q       +    +
Sbjct: 84  -----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLGCQ 129

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIK 734
           YLH +    V+H DLK  N+ L+ D+   +GDFGLA  +         +  TP+      
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 180

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
               YIAPE  +    S   DV+S G ++  +
Sbjct: 181 ----YIAPEVLSKKGHSFEVDVWSIGCIMYTL 208

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (259), Expect = 1e-23
 Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 10/236 (4%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEIGW-LKNLQSL 275
             +S     +++  N     I      +L HL  + +  N  I T+       L NL +L
Sbjct: 60  DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANLNTL 117

Query: 276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTSLIMLTLSKNKLDGVL 334
            L  N L      +   L+ L  L L  N ++  IPS       SL  L L + K    +
Sbjct: 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176

Query: 335 PPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE 394
                   +   +LNL+   L   +P+ +  L  L +LD+SGN  S   PG+      L+
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234

Query: 395 YVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
            + M  +     I   + + L+S+  ++L+ N L+         L  LE ++L +N
Sbjct: 235 KLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 40/278 (14%)

Query: 128 KNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDL 187
           + NL   +P  +S  +N  LL L +NQ       +F  L++L +L L  NH+        
Sbjct: 52  RKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG-- 106

Query: 188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLV 246
                    + L  L L+DN+   +   +   LS  +  + +  N    +IP      + 
Sbjct: 107 ----AFNGLANLNTLELFDNRLTTIPNGAFVYLSK-LKELWLRNNPIE-SIPSYAFNRIP 160

Query: 247 HLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
            L  + +   + +  +       L NL+ L L    L   IP+ L  L  L  L L  N+
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNH 218

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
           L    P S      L  L + ++++  V+                              N
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD------------------------N 253

Query: 366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           L++LV+++++ N  +       +    LE + +  N +
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 9e-21
 Identities = 47/232 (20%), Positives = 94/232 (40%), Gaps = 13/232 (5%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQ 257
              L L++NQ   +  +S  +L + +  + +  N+   TI  G    L +LN++ +  N+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRH-LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123

Query: 258 LIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SLG 315
            + T+P     +L  L+ L+L +N +      +   +  L  L L        I   +  
Sbjct: 124 -LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDI 374
             ++L  L L+   L  +  P +  +  L   L+LS N LS ++       L +L +L +
Sbjct: 183 GLSNLRYLNLAMCNLREI--PNLTPLIKLD-ELDLSGNHLS-AIRPGSFQGLMHLQKLWM 238

Query: 375 SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSN 425
             ++             SL  + +  N+ +  +P      L  ++ + L  N
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 93.7 bits (233), Expect = 3e-20
 Identities = 62/292 (21%), Positives = 104/292 (35%), Gaps = 50/292 (17%)

Query: 23  KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF 82
           +   +     +L  ++P  I   +  +++++  N++     ++   LR L  L + RN  
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH- 99

Query: 83  SGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNA 142
                     I +     ++   F+G         L NL       N LT     +    
Sbjct: 100 ----------IRT-----IEIGAFNG---------LANLNTLELFDNRLTTIPNGAFVYL 135

Query: 143 SNLELLELRDNQFIGKMSIN---FNSLKNLSVLILGNNHLGNRAANDLDFVT--VLANCS 197
           S L+ L LR+N      SI    FN + +L  L LG           L +++       S
Sbjct: 136 SKLKELWLRNNPI---ESIPSYAFNRIPSLRRLDLGEL-------KRLSYISEGAFEGLS 185

Query: 198 KLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGN 256
            L  L L       +   +L  L   +  +D+ GN+ S  I PG    L+HL  + M  +
Sbjct: 186 NLRYLNLAMCNLREI--PNLTPLIK-LDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS 241

Query: 257 QLIGTVPPE-IGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
           Q I  +       L++L  + L  N L          L  L  + L  N   
Sbjct: 242 Q-IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 13/217 (5%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            VP  I    N + L L+ N +     +S  +L  L +L L  N+++     +     +L
Sbjct: 57  EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISG-NR 378
             L L  N+L   +P       +    L L +N +  S+PS     + +L +LD+    R
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL 438
            S    G     ++L Y+ +   +    I P+L  L  +  LDLS N LS   P   + L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 439 SFLEYLNLSYNHFEGEVPKKGVFSNKT---RFSLSGN 472
             L+ L +  +  +  +  +  F N       +L+ N
Sbjct: 231 MHLQKLWMIQSQIQ-VIE-RNAFDNLQSLVEINLAHN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (253), Expect = 2e-23
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 35/212 (16%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+G F   F+    +   + A K++    L++    +    E    RS+ H++++     
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL---EVCNLSLIQTLNIAIDVASAIE 676
                F   DF  +V +  +  SL E LH+    L   E     L Q       +    +
Sbjct: 110 -----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLGCQ 155

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIK 734
           YLH +    V+H DLK  N+ L+ D+   +GDFGLA  +         +  TP+      
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 206

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
               YIAPE  +    S   DV+S G ++  +
Sbjct: 207 ----YIAPEVLSKKGHSFEVDVWSIGCIMYTL 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (254), Expect = 2e-23
 Identities = 35/229 (15%), Positives = 75/229 (32%), Gaps = 31/229 (13%)

Query: 560 NMVGQGSFGTVFKGI-----IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
           +++G+G+F  V++         +N     +KV                E L+        
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM-- 128

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
             +   S+  F   +   +V +    G+L   ++   +  E   +     ++ A+ +   
Sbjct: 129 -FMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKV-MPQGLVISFAMRMLYM 184

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG-----------DFGLAKFLPARPLDTV 723
           IE +H      ++HGD+KP N +L +  +               D G +  +   P  T+
Sbjct: 185 IEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                  +    T G+   E  +    +   D +     +  M      
Sbjct: 242 F------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 33/210 (15%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+G FG V+     +N  ++A+KVL    L ++G       E E    +RH N++++   
Sbjct: 23  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82

Query: 620 CSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                      +  +Y   +F   G L + L Q + +         ++     ++A A+ 
Sbjct: 83  FHD--------RKRIYLMLEFAPRGELYKEL-QKHGRF-----DEQRSATFMEELADALH 128

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           Y H      V+H D+KP N+L+ +     + DFG +   P+    T+           GT
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----------GT 175

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           + Y+ PE   G       D++  G+L  E 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 53/253 (20%), Positives = 106/253 (41%), Gaps = 20/253 (7%)

Query: 193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIA 252
               +    +    +     +    A+L   +TT+   G   + TI  G+  L +L  + 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVT-TIE-GVQYLNNLIGLE 69

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
           ++ NQ+  T    +  L  +  L L+ N L     S++  L  +  L L    +    P 
Sbjct: 70  LKDNQI--TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP- 124

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL 372
            L   ++L +L L  N++  + P  +  +T L  +L++ +  +S    + + NL  L  L
Sbjct: 125 -LAGLSNLQVLYLDLNQITNISP--LAGLTNLQ-YLSIGNAQVSDL--TPLANLSKLTTL 178

Query: 373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP 432
               N+ S DI   L++  +L  V +++N  S  + P L    ++ ++ L++  ++ Q  
Sbjct: 179 KADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPV 234

Query: 433 KYLENLSFLEYLN 445
            Y  NL     + 
Sbjct: 235 FYNNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 58/312 (18%), Positives = 114/312 (36%), Gaps = 53/312 (16%)

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
              L   I +  G++  +  +                             A+L  +    
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT---------------------------QADLDGITTLS 47

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
           A    +T      +   +NL  LEL+DNQ I  ++    +L  ++ L L  N L N    
Sbjct: 48  AFGTGVTTIEG--VQYLNNLIGLELKDNQ-ITDLA-PLKNLTKITELELSGNPLKN---- 99

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
               V+ +A    ++ L L   Q   + P  LA LSN +  + +  N  +      L  L
Sbjct: 100 ----VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSN-LQVLYLDLNQITNI--SPLAGL 150

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
            +L  +++   Q+  +    +  L  L +L  + N +     S L +L  L  + L+ N 
Sbjct: 151 TNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQ 206

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
           +     S L N ++L ++TL+   +         ++   ++    S   ++   P+ I +
Sbjct: 207 ISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISD 261

Query: 366 LKNLVQLDISGN 377
                  +++ N
Sbjct: 262 NGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 56/290 (19%), Positives = 125/290 (43%), Gaps = 30/290 (10%)

Query: 161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANL 220
               +L N   +  G +++ +            A+   +  L  +      +    +  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--------TVTQADLDGITTLSAFGTGVTTIEG--VQYL 62

Query: 221 SNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSN 280
           +N +  +++  N  +  + P L NL  +  + + GN L       I  L+++++L L S 
Sbjct: 63  NN-LIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTST 117

Query: 281 FLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILS 340
            +    P  L  L+ L +L L++N +   I S L   T+L  L++   ++  + P  + +
Sbjct: 118 QITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LAN 171

Query: 341 VTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD 400
           ++ L+  L   DN +S    S + +L NL+++ +  N+ S D+   L+  ++L  V + +
Sbjct: 172 LSKLT-TLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN 226

Query: 401 NSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI-PKYLENLSFLEYLNLSYN 449
            + + + P    +  ++ V ++        I P  + +       NL++N
Sbjct: 227 QTIT-NQPV--FYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 18/232 (7%)

Query: 241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLA 300
               L +   IA   + +  TV      L  + +L      +       +  L  L  L 
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP 360
           L+ N +     + L N T +  L LS N L  V     L   ++   L+L+   ++    
Sbjct: 70  LKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGL--QSIK-TLDLTSTQITD--V 122

Query: 361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL 420
           + +  L NL  L +  N+ + +I   L+  T+L+Y+ + +   S  + P L  L  +  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGN 472
               NK+S  I   L +L  L  ++L  N      P     SN    +L+  
Sbjct: 179 KADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLAN-TSNLFIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 21/232 (9%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  L  L L +N +T   P  + NL+ +  +++ GN L  K    +  L+ +  L++  
Sbjct: 61  YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTS 116

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
            Q +   P  +  +S+ + ++L  N+     P    A L NL+        ++   P  L
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQITNISPL---AGLTNLQYLSIGNAQVSDLTP--L 169

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           +N S L  L+  DN+ I  +S    SL NL  + L NN + +        V+ LAN S L
Sbjct: 170 ANLSKLTTLKADDNK-ISDIS-PLASLPNLIEVHLKNNQISD--------VSPLANTSNL 219

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
             + L +            NL          G   +       G     N  
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLT 271

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+GSF  V++      G+ VA+K+++   + + G ++    E +    ++H +++++   
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                F   ++  +V +   NG +  +L            S  +  +    + + + YLH
Sbjct: 80  -----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPF-----SENEARHFMHQIITGMLYLH 129

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIKGTV 737
            H    ++H DL  SN+LL  +M   + DFGLA  L  P     T+           GT 
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----------GTP 176

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            YI+PE  T S   +  DV+S G +   +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTL 205

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 38/255 (14%)

Query: 529 RSFERTTMVEQQ------FPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLV 582
           +  E   + EQQ      F             +F   + +G G+ G VFK     +G+++
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 583 AVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDF 637
           A K+++L ++       + E + L       ++          F G  +      I  + 
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEH 112

Query: 638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL 697
           M  GSL++ L +     E   L  +     +I V   + YL    K  ++H D+KPSN+L
Sbjct: 113 MDGGSLDQVLKKAGRIPEQI-LGKV-----SIAVIKGLTYLREKHK--IMHRDVKPSNIL 164

Query: 698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVY 757
           ++      + DFG++  L     ++ V          GT  Y++PE   G+  S+  D++
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANSFV----------GTRSYMSPERLQGTHYSVQSDIW 214

Query: 758 SFGILLLEMFSRRRP 772
           S G+ L+EM   R P
Sbjct: 215 SMGLSLVEMAVGRYP 229

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 51/257 (19%)

Query: 525 RSTDRSFERTTMVEQQFPMISYAKLSKATSE------FSSSNMVGQGSFGTVFKGIIGEN 578
            + +  F+   +  +QF     A L     +        S   +G+GS G V       +
Sbjct: 14  GTENLYFQSGVVTHEQF----KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69

Query: 579 GMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IV 634
           G  VAVK+++L ++   +    E   +R  +H N+++                     ++
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEELWVL 120

Query: 635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPS 694
            +F+Q G+L        D +    L+  Q   +   V  A+ YLH       +H D+K  
Sbjct: 121 MEFLQGGAL-------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSD 170

Query: 695 NVLLDHDMVAHVGDFG----LAKFLPARPLDTVVETPSSSSGIKGTVGY-IAPEYGTGSE 749
           ++LL  D    + DFG    ++K +P R   ++V TP           Y +APE  + S 
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTP-----------YWMAPEVISRSL 217

Query: 750 ASMTGDVYSFGILLLEM 766
            +   D++S GI+++EM
Sbjct: 218 YATEVDIWSLGIMVIEM 234

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 31/182 (17%), Positives = 65/182 (35%), Gaps = 11/182 (6%)

Query: 269 LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKN 328
            K   +  L  +       + + +LT +TL  + + +L G     +    ++  LT++  
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI 76

Query: 329 KLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS 388
                 P  I  ++ L   L +    ++      +  L +L  LDIS +     I   ++
Sbjct: 77  HATNYNP--ISGLSNLE-RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSY 448
               +  + +  N     I P L  L  +K L++  + +       +E+   L  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 449 NH 450
             
Sbjct: 191 QT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 32/188 (17%), Positives = 62/188 (32%), Gaps = 12/188 (6%)

Query: 194 ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAM 253
           +      N  L  +    +    + +L    T I +     +     G+    ++  + +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSL----TYITLANINVTDL--TGIEYAHNIKDLTI 73

Query: 254 EGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSS 313
                  T    I  L NL+ L +    +      +L  LT LTLL +  +     I + 
Sbjct: 74  NNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 314 LGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLD 373
           +     +  + LS N     + P + ++  L   LN+  + +       I +   L QL 
Sbjct: 132 INTLPKVNSIDLSYNGAITDIMP-LKTLPELK-SLNIQFDGVHDY--RGIEDFPKLNQLY 187

Query: 374 ISGNRFSG 381
                  G
Sbjct: 188 AFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 24/161 (14%), Positives = 60/161 (37%), Gaps = 8/161 (4%)

Query: 269 LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKN 328
           + +L  + L +  +     + +     +  L +   +      + +   ++L  L +   
Sbjct: 43  MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGK 98

Query: 329 KLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS 388
            +     P +  +T+L+  L++S +    S+ ++I  L  +  +D+S N    DI   L 
Sbjct: 99  DVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LK 156

Query: 389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG 429
               L+ + +Q +         +     +  L   S  + G
Sbjct: 157 TLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 27/196 (13%), Positives = 62/196 (31%), Gaps = 21/196 (10%)

Query: 22  FKLENLSLAENHLTGQL---PVSIGNLSALQVIDIRGNRLGGKIPDT--LGQLRKLIYLN 76
                     N L GQ     ++   +++L  I +        + D   +     +  L 
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLT 72

Query: 77  IGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP 136
           I     + + P  I  +S+ E + +       S     ++ L +L     + +     + 
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDV-TSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 137 ISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
             ++    +  ++L  N  I  +     +L  L  L +  + + +           + + 
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD--------YRGIEDF 180

Query: 197 SKLENLGLYDNQFGGL 212
            KL  L  +    GG 
Sbjct: 181 PKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 26/134 (19%), Positives = 60/134 (44%), Gaps = 8/134 (5%)

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDIS 375
              + +   L ++    +   Q+ S+T +     L++  ++  L + I    N+  L I+
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYI----TLANINVT-DL-TGIEYAHNIKDLTIN 74

Query: 376 GNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYL 435
               + +    +S  ++LE +++     +    P+L+ L S+ +LD+S +     I   +
Sbjct: 75  NIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 436 ENLSFLEYLNLSYN 449
             L  +  ++LSYN
Sbjct: 133 NTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.9 bits (164), Expect = 8e-13
 Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 6/135 (4%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           Y   +++L++   H T   P  I  LS L+ + I G  +       L  L  L  L+I  
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           +     I   I  +     I L  N     +    +  LP L+      + +  +    +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--I 177

Query: 140 SNASNLELLELRDNQ 154
            +   L  L      
Sbjct: 178 EDFPKLNQLYAFSQT 192

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 99.8 bits (248), Expect = 7e-22
 Identities = 63/334 (18%), Positives = 109/334 (32%), Gaps = 79/334 (23%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
                  K    K ++T    ++ +  ++++ +   ++  I  +      L N++ L L 
Sbjct: 18  DAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKLFLN 73

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
            N L +        +  L N   L  L L +N+               +  +        
Sbjct: 74  GNKLTD--------IKPLTNLKNLGWLFLDENK---------------IKDLS------- 103

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
                 L +L  L S+++E N  I  +   +  L  L+SLYL +N +     + L  LT 
Sbjct: 104 -----SLKDLKKLKSLSLEHNG-ISDING-LVHLPQLESLYLGNNKIT--DITVLSRLTK 154

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           L  L+LE N +   I   L   T L  L LSKN +  +                      
Sbjct: 155 LDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL---------------------- 190

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
                  +  LKNL  L++             S       VK  D S       S     
Sbjct: 191 -----RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS----- 240

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
                D     +   +P++   +SF+ Y  ++  
Sbjct: 241 --DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.3 bits (244), Expect = 2e-21
 Identities = 52/291 (17%), Positives = 104/291 (35%), Gaps = 51/291 (17%)

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
                + I  N+ +   +  +                               L ++ + +
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT---------------------------QNELNSIDQII 49

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
           A  +++       +    N+  L L  N+ +  +     +LKNL  L L  N + +    
Sbjct: 50  ANNSDIKSVQG--IQYLPNVTKLFLNGNK-LTDIK-PLTNLKNLGWLFLDENKIKD---- 101

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
               ++ L +  KL++L L  N    +    L +L   + ++ +G N  +  I   L  L
Sbjct: 102 ----LSSLKDLKKLKSLSLEHNGISDING--LVHLPQ-LESLYLGNNKIT-DITV-LSRL 152

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
             L+++++E NQ+  +    +  L  LQ+LYL+ N +      +L  L  L +L L    
Sbjct: 153 TKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE 208

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLS 356
              K  +   N      +  +   L     P+I+S        N+  +L  
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLV---TPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.2 bits (218), Expect = 4e-18
 Identities = 56/252 (22%), Positives = 90/252 (35%), Gaps = 44/252 (17%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
           +            + P      +      ++     +  +      L  ++ I    +  
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAE-TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD- 54

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
           I +V   I +L N+  L+LN N L       L NL  L  L L+ N ++  + SSL +  
Sbjct: 55  IKSVQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLK 109

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
            L  L+L  N         I  +  L                    +L  L  L +  N+
Sbjct: 110 KLKSLSLEHN--------GISDINGLV-------------------HLPQLESLYLGNNK 142

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL 438
            + DI   LS  T L+ + ++DN  S  I P L  L  ++ L LS N +S    + L  L
Sbjct: 143 IT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGL 196

Query: 439 SFLEYLNLSYNH 450
             L+ L L    
Sbjct: 197 KNLDVLELFSQE 208

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.8 bits (178), Expect = 2e-13
 Identities = 49/216 (22%), Positives = 78/216 (36%), Gaps = 43/216 (19%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  +  L L  N LT   P  + NL  L  + +  N++   +  +L  L+KL  L++  
Sbjct: 63  YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEH 118

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           N         I +I+                      +LP L       N +T      L
Sbjct: 119 NG--------ISDINGLV-------------------HLPQLESLYLGNNKITDITV--L 149

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           S  + L+ L L DNQ I  +      L  L  L L  NH+ +        +  LA    L
Sbjct: 150 SRLTKLDTLSLEDNQ-ISDIV-PLAGLTKLQNLYLSKNHISD--------LRALAGLKNL 199

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
           + L L+  +      +  +NL    T  +  G+  +
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 29/153 (18%), Positives = 57/153 (37%), Gaps = 10/153 (6%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L KL++LSL  N ++  +   + +L  L+ + +  N++       L +L KL  L++  N
Sbjct: 108 LKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDN 163

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           Q S      +  ++  + ++L  N          +A L NL                  S
Sbjct: 164 QISDI--VPLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLELFSQECLNKPINHQS 218

Query: 141 NASNLELLELRDNQFIGKMSI-NFNSLKNLSVL 172
           N      ++  D   +    I +    +  +V 
Sbjct: 219 NLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVK 251

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 47/239 (19%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLT 600
           M  Y KL K          +G+G++GTVFK    E   +VA+K + L     G   S L 
Sbjct: 1   MQKYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR 50

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   L+ ++H+N++++  +      +      +V++F     L+++    N  L+   + 
Sbjct: 51  EICLLKELKHKNIVRLHDV-----LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK 104

Query: 661 --LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LP 716
             L Q L         + + H      V+H DLKP N+L++ +    + +FGLA+   +P
Sbjct: 105 SFLFQLL-------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

Query: 717 ARPLDT--VVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRRRP 772
            R   +  VV           T+ Y  P+   G++   T  D++S G +  E+ +  RP
Sbjct: 155 VRCY-SAEVV-----------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 55/208 (26%), Positives = 82/208 (39%), Gaps = 31/208 (14%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSS 622
           G G+F  VF       G L A+K +         S   E   L+ I+H N++ +  I   
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI--- 74

Query: 623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC 682
             +       +V   +  G L + +      LE    +      +   V SA++YLH + 
Sbjct: 75  --YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 683 KPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
              +VH DLKP N+L    + +    + DFGL+K      + T            GT GY
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTPGY 173

Query: 740 IAPEYGTGSEASMTGDVYSFG----ILL 763
           +APE       S   D +S G    ILL
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILL 201

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 61/216 (28%), Positives = 84/216 (38%), Gaps = 45/216 (20%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+GSFG V K          AVKV+N    +     + L E E L+ + H N++K+  I 
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI- 89

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                       IV +    G L + + +          S      I   V S I Y+H 
Sbjct: 90  ----LEDSSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHK 139

Query: 681 HCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGT 736
           H    +VH DLKP N+LL   + D    + DFGL+        +   +          GT
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----------GT 186

Query: 737 VGYIAPE-----YGTGSEASMTGDVYSFG----ILL 763
             YIAPE     Y    +     DV+S G    ILL
Sbjct: 187 AYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 7e-21
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--------LMQKGALKSFLTECEALRSIRHRNLI 614
           G G+ G V      +    VA+++++          +     +  TE E L+ + H  +I
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           KI     + D+       IV + M+ G L + +  N        L           +  A
Sbjct: 204 KIKNFFDAEDYY------IVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLA 251

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSS 730
           ++YLH +    ++H DLKP NVLL   + D +  + DFG +K L     + T+       
Sbjct: 252 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC------ 302

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG---DVYSFGILL 763
               GT  Y+APE       +      D +S G++L
Sbjct: 303 ----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 39/209 (18%)

Query: 550 SKATSEFSS----SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---------KGALK 596
           S +T  F        ++G+G    V + I        AVK++++           +   +
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 597 SFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE 655
           + L E + LR +  H N+I++        +    F  +V+D M+ G L ++L       E
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TE 117

Query: 656 VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
              LS  +T  I   +   I  LH      +VH DLKP N+LLD DM   + DFG +  L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 716 -PARPLDTVVETPSSSSGIKGTVGYIAPE 743
            P   L  V           GT  Y+APE
Sbjct: 175 DPGEKLREVC----------GTPSYLAPE 193

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 41/230 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECEALRSIRHRN 612
            ++    ++G G+   V           VA+K +NL +    +   L E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 613 LIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI-- 669
           ++      S +    V  +  +V   +  GS+ + +     K E  +  L ++  IA   
Sbjct: 75  IVSY--YTSFV----VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATIL 127

Query: 670 -DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL-------D 721
            +V   +EYLH + +   +H D+K  N+LL  D    + DFG++ FL             
Sbjct: 128 REVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 722 TVVETPSSSSGIKGTVGYIAPE-----YGTGSEASMTGDVYSFGILLLEM 766
           T V TP           ++APE      G   +A    D++SFGI  +E+
Sbjct: 185 TFVGTPC----------WMAPEVMEQVRGYDFKA----DIWSFGITAIEL 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 37/221 (16%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
             +++    +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 613 LIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           ++          +           +V +++  GSL        D +    +   Q   + 
Sbjct: 79  IVN---------YLDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVC 122

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVET 726
            +   A+E+LH +     +H D+K  N+LL  D    + DFG    +        T+V T
Sbjct: 123 RECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 727 PSSSSGIKGTVGY-IAPEYGTGSEASMTGDVYSFGILLLEM 766
           P           Y +APE  T        D++S GI+ +EM
Sbjct: 180 P-----------YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--------LMQKGALKSFLTECEALRSIRHRNLI 614
           G G+ G V      +    VA+K+++          +     +  TE E L+ + H  +I
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           KI     + D+       IV + M+ G L + +  N        L           +  A
Sbjct: 79  KIKNFFDAEDYY------IVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLA 126

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSS 730
           ++YLH +    ++H DLKP NVLL   + D +  + DFG +K L     + T+       
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC------ 177

Query: 731 SGIKGTVGYIAPEYGTGSEASMTG---DVYSFGILL 763
               GT  Y+APE       +      D +S G++L
Sbjct: 178 ----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 1e-20
 Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 38/236 (16%)

Query: 522 GRRRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSS----SNMVGQGSFGTVFKGIIGE 577
            ++ +  +      +  Q            A  EF       +++G+G    V + +   
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 578 NGMLVAVKVLNL--------MQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGV 628
            G   AVK++ +          +   ++   E   LR +  H ++I +I       +   
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESS 172

Query: 629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVH 688
            F  +V+D M+ G L ++L       E   LS  +T +I   +  A+ +LH +    +VH
Sbjct: 173 SFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223

Query: 689 GDLKPSNVLLDHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTVGYIAPE 743
            DLKP N+LLD +M   + DFG +  L P   L  +           GT GY+APE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----------GTPGYLAPE 269

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 52/245 (21%), Positives = 95/245 (38%), Gaps = 43/245 (17%)

Query: 534 TTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LM 590
              ++   P     K      +F    ++G+GSF TV            A+K+L    ++
Sbjct: 12  AGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 69

Query: 591 QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQN 650
           ++  +     E + +  + H   +K+    +   F   +       + +NG L       
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLY--FT---FQDDEKLYFGLSYAKNGEL------- 117

Query: 651 NDKLEVCNLSLIQTLNI---------AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD 701
                   L  I+ +             ++ SA+EYLH      ++H DLKP N+LL+ D
Sbjct: 118 --------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED 166

Query: 702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGI 761
           M   + DFG AK L          +        GT  Y++PE  T   A  + D+++ G 
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANS------FVGTAQYVSPELLTEKSACKSSDLWALGC 220

Query: 762 LLLEM 766
           ++ ++
Sbjct: 221 IIYQL 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.0 bits (234), Expect = 3e-20
 Identities = 54/260 (20%), Positives = 96/260 (36%), Gaps = 41/260 (15%)

Query: 524 RRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVA 583
             S   +      ++    M   +K    +  +     +G G++G V         +  A
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66

Query: 584 VKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNG 641
           +K++    +   +    L E   L+ + H N++K+       D        +V +  + G
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNY---YLVMECYKGG 121

Query: 642 SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL--- 698
            L + +            + +    I   V S + YLH H    +VH DLKP N+LL   
Sbjct: 122 ELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESK 172

Query: 699 DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTVGYIAPE-----YGTGSEASM 752
           + D +  + DFGL+      + +   +          GT  YIAPE     Y        
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERL----------GTAYYIAPEVLRKKYDEKC---- 218

Query: 753 TGDVYSFGILLLEMFSRRRP 772
             DV+S G++L  + +   P
Sbjct: 219 --DVWSIGVILFILLAGYPP 236

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 36/212 (16%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITIC 620
           +G G+FG V       +G+   +K +N  + +  ++    E E L+S+ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
               F       IV +  + G L E +     + +   LS      +   + +A+ Y H 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142

Query: 681 HCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGT 736
                VVH DLKP N+L           + DFGLA+                      GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA----------GT 189

Query: 737 VGYIAPE-----YGTGSEASMTGDVYSFGILL 763
             Y+APE          +     D++S G+++
Sbjct: 190 ALYMAPEVFKRDVTF--KC----DIWSAGVVM 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 94.0 bits (234), Expect = 3e-20
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 42/222 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+GSFG V        G   AVKV++   + QK   +S L E + L+ + H N++K+   
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
               D        +V +    G L + +            S +    I   V S I Y+H
Sbjct: 95  FE--DKGYF---YLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMH 143

Query: 680 HHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKG 735
            +    +VH DLKP N+LL     D    + DFGL+     ++ +   +          G
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----------G 190

Query: 736 TVGYIAPE-----YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  YIAPE     Y          DV+S G++L  + S   P
Sbjct: 191 TAYYIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 52/239 (21%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTE 601
           M +Y KL K          +G+G++ TV+KG       LVA+K + L  + GA  + + E
Sbjct: 1   METYIKLDK----------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE 50

Query: 602 CEALRSIRHRN---LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
              L+ ++H N   L  II    S+         +V++++    L+++L    + + + N
Sbjct: 51  VSLLKDLKHANIVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHN 101

Query: 659 LS--LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF-- 714
           +   L Q L         + Y H      V+H DLKP N+L++      + DFGLA+   
Sbjct: 102 VKLFLFQLL-------RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151

Query: 715 LPARPLDT--VVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
           +P +      VV           T+ Y  P+   GS    T  D++  G +  EM + R
Sbjct: 152 IPTKTY-DNEVV-----------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 48/218 (22%), Positives = 75/218 (34%), Gaps = 13/218 (5%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            VP  I      Q ++L+ N +     +S      LT+L L  N L     ++      L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRF 379
             L LS N     + P           L+L    L   L   +   L  L  L +  N  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 380 SGDIP-GTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLEN 437
              +P  T     +L ++ +  N  S S+P  +   L S+  L L  N+++   P    +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

Query: 438 LSFLEYLNLSYNHFEGEVPKKGVF---SNKTRFSLSGN 472
           L  L  L L  N+    +P               L+ N
Sbjct: 200 LGRLMTLYLFANNLS-ALP-TEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 55/225 (24%), Positives = 83/225 (36%), Gaps = 19/225 (8%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
           IP +       + IFL  NR    +P        NL       N L      + +  + L
Sbjct: 30  IPAAS------QRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 146 ELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGL 204
           E L+L DN  +  +    F+ L  L  L L    L            +    + L+ L L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG------LFRGLAALQYLYL 136

Query: 205 YDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVP 263
            DN    L   +  +L N +T + + GN  S ++P      L  L+ + +  N+ +  V 
Sbjct: 137 QDNALQALPDDTFRDLGN-LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNR-VAHVH 193

Query: 264 PEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ 307
           P     L  L +LYL +N L      +L  L  L  L L  N   
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 16/228 (7%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD 188
             L   +P+ +   +  + + L  N+     + +F + +NL++L L +N L    A    
Sbjct: 21  QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA--- 74

Query: 189 FVTVLANCSKLENLGLYDN-QFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLV 246
                   + LE L L DN Q   + P +   L   + T+ +        + PG    L 
Sbjct: 75  ---AFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLDRCGLQ-ELGPGLFRGLA 129

Query: 247 HLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
            L  + ++ N  +  +P +    L NL  L+L+ N +      +   L  L  L L  N 
Sbjct: 130 ALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           +    P +  +   L+ L L  N L   LP + L+      +L L+DN
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 16/243 (6%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
           CY       S  +  L   +PV I   +A Q I + GNR+      +    R L  L + 
Sbjct: 8   CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 79  RNQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPI 137
            N  +  I  +    ++  E + L  N    S+       L  L      +  L    P 
Sbjct: 65  SNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123

Query: 138 SLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
                + L+ L L+DN  +  +  + F  L NL+ L L  N + +               
Sbjct: 124 LFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRISSVPER------AFRGL 176

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEG 255
             L+ L L+ N+   + PH+  +L   + T+ +  N  S  +P   L  L  L  + +  
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGR-LMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234

Query: 256 NQL 258
           N  
Sbjct: 235 NPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 31/152 (20%), Positives = 55/152 (36%), Gaps = 12/152 (7%)

Query: 326 SKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPG 385
            +  L  V  P  +   +  +   L  N +S    +     +NL  L +  N  +     
Sbjct: 19  PQQGLQAV--PVGIPAASQRI--FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 386 TLSACTSLEYVKMQDNSFSGSIPPS-LNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEY 443
             +    LE + + DN+   S+ P+  + L  +  L L    L  ++       L+ L+Y
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133

Query: 444 LNLSYNHFEGEVPKKGVFSNKTR---FSLSGN 472
           L L  N  +  +P    F +        L GN
Sbjct: 134 LYLQDNALQ-ALP-DDTFRDLGNLTHLFLHGN 163

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 5/153 (3%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP 63
            +N  +  +       L +L  L L    L  +L   +   L+ALQ + ++ N L   +P
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALP 145

Query: 64  D-TLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
           D T   L  L +L +  N+ S     +   + S + + L  NR    +      +L  L 
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLM 204

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQF 155
                 NNL+     +L+    L+ L L DN +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 92.7 bits (230), Expect = 4e-20
 Identities = 43/222 (19%), Positives = 75/222 (33%), Gaps = 45/222 (20%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G     TV        G  V V+ +NL       +     E    +   H N++      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY--RA 93

Query: 621 SSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN---IAI---DVAS 673
           + I     D +  +V  FM  GS            ++     +  +N   IA     V  
Sbjct: 94  TFI----ADNELWVVTSFMAYGSA----------KDLICTHFMDGMNELAIAYILQGVLK 139

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A++Y+HH      VH  +K S++L+  D   ++             +             
Sbjct: 140 ALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSN----LSMISHGQRQRVVHDFP 192

Query: 734 KGTVG---YIAPE------YGTGSEASMTGDVYSFGILLLEM 766
           K +V    +++PE       G  +++    D+YS GI   E+
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACEL 230

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 44/228 (19%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
              +     +G G+FG V+K    E G L A KV+    +  L+ ++ E E L +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 613 LIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--QTLN 666
           ++K           G  +      I+ +F   G+++  + + +  L    + ++  Q L 
Sbjct: 78  IVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA--RPLDTVV 724
                  A+ +LH       +H DLK  NVL+  +    + DFG++       +  D+ +
Sbjct: 129 -------ALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 725 ETPSSSSGIKGTVGY-IAPEYGTGSEASMTG-----DVYSFGILLLEM 766
            TP           Y +APE         T      D++S GI L+EM
Sbjct: 179 GTP-----------YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.6 bits (225), Expect = 8e-20
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 63/226 (27%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--------LMQKGALKSFLTECEALRSIRHRNLI 614
           G G+FG V+  +  E    V VK +          ++   L     E   L  + H N+I
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 615 KIITICSSIDF---------NGVDFKAIVYDF-MQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           K++ I  +  F         +G+D    ++ F  ++  L+E          + +    Q 
Sbjct: 93  KVLDIFENQGFFQLVMEKHGSGLD----LFAFIDRHPRLDE---------PLASYIFRQ- 138

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTV 723
                 + SA+ YL       ++H D+K  N+++  D    + DFG  A     +   T 
Sbjct: 139 ------LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189

Query: 724 VETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
                      GT+ Y APE      Y  G E     +++S G+ L
Sbjct: 190 C----------GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTL 220

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHR 611
              F+    +G+GSFG VFKGI      +VA+K+++L + +  ++    E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 612 NLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
            + K         + G   K     I+ +++  GS         D LE   L   Q   I
Sbjct: 81  YVTK---------YYGSYLKDTKLWIIMEYLGGGSA-------LDLLEPGPLDETQIATI 124

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVE 725
             ++   ++YLH   K   +H D+K +NVLL       + DFG+A  L    +  +T V 
Sbjct: 125 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           TP           ++APE    S      D++S GI  +E+
Sbjct: 182 TPF----------WMAPEVIKQSAYDSKADIWSLGITAIEL 212

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 44/213 (20%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+G+F  V        G  VA+K+++   +   +L+    E   ++ + H N++K+  + 
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83

Query: 621 SSIDFNGVDFKAIVYDFM---QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +        +  +Y  M     G + ++L  +        +   +  +    + SA++Y
Sbjct: 84  ET--------EKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQY 129

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSGIKGT 736
            H      +VH DLK  N+LLD DM   + DFG   +F     LD     P         
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP-------- 178

Query: 737 VGYIAPE------YGTGSEASMTGDVYSFGILL 763
             Y APE      Y  G E     DV+S G++L
Sbjct: 179 --YAAPELFQGKKY-DGPEV----DVWSLGVIL 204

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 53/241 (21%), Positives = 104/241 (43%), Gaps = 51/241 (21%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTE 601
              + +L K          +G G++ TV+KG+    G+ VA+K + L  + G   + + E
Sbjct: 4   SSQFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE 53

Query: 602 CEALRSIRHRNLIKIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
              ++ ++H N++++  +  + +         +V++FM N  L++++           L 
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLT------LVFEFMDN-DLKKYMDSRTVGNTPRGLE 106

Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--LPAR 718
           L         +   + + H +    ++H DLKP N+L++      +GDFGLA+   +P  
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163

Query: 719 PLDT--VVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSR 769
              +  VV           T+ Y AP+       Y T        D++S G +L EM + 
Sbjct: 164 TF-SSEVV-----------TLWYRAPDVLMGSRTYSTSI------DIWSCGCILAEMITG 205

Query: 770 R 770
           +
Sbjct: 206 K 206

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 41/224 (18%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKII 617
            M+G+GSFG V K          AVKV+N    +     + L E E L+ + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            I    D +      IV +    G L + + +          S      I   V S I Y
Sbjct: 88  EILE--DSSSF---YIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITY 136

Query: 678 LHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGI 733
           +H H    +VH DLKP N+LL   + D    + DFGL+        +   +         
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--------- 184

Query: 734 KGTVGYIAPE-----YGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            GT  YIAPE     Y          DV+S G++L  + S   P
Sbjct: 185 -GTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGTPP 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 33/226 (14%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHR 611
              F    +VG G++G V+KG   + G L A+KV+++      +    E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81

Query: 612 NLIKIITICSSIDFNGVDFKA-IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI- 669
           N+          +  G+D +  +V +F   GS+        D ++    + ++   IA  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAYI 134

Query: 670 --DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL--DTVVE 725
             ++   + +LH H     +H D+K  NVLL  +    + DFG++  L       +T + 
Sbjct: 135 CREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 191

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTG-----DVYSFGILLLEM 766
           TP           ++APE     E          D++S GI  +EM
Sbjct: 192 TPY----------WMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECE-ALRSIRHRNLIKIITI 619
           +G+G++G V K     +G ++AVK +   +     K  L + + ++R++     +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 620 CSSIDFNGVDFK----AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
                F G  F+     I  + M + SL+++  Q  DK +     ++    IA+ +  A+
Sbjct: 71  -----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           E+LH      V+H D+KPSNVL++      + DFG++ +L        V+  +      G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--------VDDVAKDIDA-G 171

Query: 736 TVGYIAPE----YGTGSEASMTGDVYSFGILLLEM 766
              Y+APE           S+  D++S GI ++E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 55/215 (25%), Positives = 80/215 (37%), Gaps = 43/215 (20%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GS+G V   +     +  A K +       +  F  E E ++S+ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              F       +V +    G L E +                   I  DV SA+ Y H  
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL 125

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTV 737
               V H DLKP N L      D    + DFGLA    P + + T V          GT 
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----------GTP 172

Query: 738 GYIAPE-----YGTGSEASMTGDVYSFG----ILL 763
            Y++P+     YG   E     D +S G    +LL
Sbjct: 173 YYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 67/256 (26%), Positives = 112/256 (43%), Gaps = 49/256 (19%)

Query: 524 RRSTDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVA 583
                 S  R  +  Q   M  Y KL K          VG+G++G V+K      G +VA
Sbjct: 2   HHHHHHSSGRENLYFQGL-MEKYQKLEK----------VGEGTYGVVYKAK-DSQGRIVA 49

Query: 584 VKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNG 641
           +K + L  +  G   + + E   L+ + H N++ +I +      +      +V++FM+  
Sbjct: 50  LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV-----IHSERCLTLVFEFMEK- 103

Query: 642 SLEEWLHQNNDKLEVCNLS--LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD 699
            L++ L +N   L+   +   L Q L         + + H H    ++H DLKP N+L++
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLL-------RGVAHCHQHR---ILHRDLKPQNLLIN 153

Query: 700 HDMVAHVGDFGLAKF--LPARPLDT--VVETPSSSSGIKGTVGYIAPEYGTGSEASMTG- 754
            D    + DFGLA+   +P R   T  VV           T+ Y AP+   GS+   T  
Sbjct: 154 SDGALKLADFGLARAFGIPVRSY-THEVV-----------TLWYRAPDVLMGSKKYSTSV 201

Query: 755 DVYSFGILLLEMFSRR 770
           D++S G +  EM + +
Sbjct: 202 DIWSIGCIFAEMITGK 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 46/217 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+G+F  V + +    G+  A K++N   +     +    E    R ++H N++++    
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS- 73

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                    F  +V+D +  G L E +      +     S     +    +  +I Y H 
Sbjct: 74  ----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCHS 123

Query: 681 HCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGT 736
           +    +VH +LKP N+LL          + DFGLA  +  +                 GT
Sbjct: 124 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----------GT 170

Query: 737 VGYIAPE------YGTGSEASMTGDVYSFG----ILL 763
            GY++PE      Y          D+++ G    ILL
Sbjct: 171 PGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 50/267 (18%), Positives = 86/267 (32%), Gaps = 45/267 (16%)

Query: 544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKV-----LNLMQKGALKSF 598
                L +   ++     +GQGS+G V   I  +   + A+K+     +  +    ++  
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 599 LTECEALRSIRHRNLIKII-----------------------TICSSIDFNGVDFKAIVY 635
            TE   ++ + H N+ ++                         +   ID +       V 
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN------IAIDVASAIEYLHHHCKPPVVHG 689
                   E      N  +     SL           I   + SA+ YLH+     + H 
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192

Query: 690 DLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPE--YG 745
           D+KP N L   +    +   DFGL+K                 +   GT  ++APE    
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM----TTKAGTPYFVAPEVLNT 248

Query: 746 TGSEASMTGDVYSFGILLLEMFSRRRP 772
           T        D +S G+LL  +     P
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVP 275

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 37/216 (17%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEAL-RSIRHRNLIKIITI 619
           +G G+ G V+K    + G ++AVK +     K   K  L + + + +S     +++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 620 CSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
                  G         I  + M     E+   +    +    L       + + +  A+
Sbjct: 89  -----CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL       V+H D+KPSN+LLD      + DFG++  L        V+  +      G
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--------VDDKAKDRSA-G 186

Query: 736 TVGYIAPE-----YGTGSEASMTGDVYSFGILLLEM 766
              Y+APE       T  +  +  DV+S GI L+E+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 57/242 (23%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLT 600
           M  Y  L            VG+GS+G V K    + G +VA+K        K   K  + 
Sbjct: 24  MEKYENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E + L+ +RH NL+ ++ +C         +  +V++F+ + ++ + L    + L+   + 
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQ 127

Query: 661 --LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--P 716
             L Q +N        I + H H    ++H D+KP N+L+    V  + DFG A+ L  P
Sbjct: 128 KYLFQIIN-------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177

Query: 717 ARPL-DTVVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFS 768
                D V            T  Y APE       YG         DV++ G L+ EMF 
Sbjct: 178 GEVYDDEVA-----------TRWYRAPELLVGDVKYGKAV------DVWAIGCLVTEMFM 220

Query: 769 RR 770
             
Sbjct: 221 GE 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 45/243 (18%)

Query: 538 EQQFPMISYAKLSKATSE------FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ 591
            +  P     KL + +        F     +G+GS+G+V+K I  E G +VA+K + +  
Sbjct: 7   LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES 66

Query: 592 KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWL 647
              L+  + E   ++     +++K         + G  FK     IV ++   GS+ + +
Sbjct: 67  D--LQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCGAGSVSDII 115

Query: 648 HQNNDKLEVCNLSLI--QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH 705
              N  L    ++ I   TL         +EYLH   K   +H D+K  N+LL+ +  A 
Sbjct: 116 RLRNKTLTEDEIATILQSTLK-------GLEYLHFMRK---IHRDIKAGNILLNTEGHAK 165

Query: 706 VGDFGLAKFLPARPL--DTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILL 763
           + DFG+A  L       +TV+ TP           ++APE       +   D++S GI  
Sbjct: 166 LADFGVAGQLTDTMAKRNTVIGTPF----------WMAPEVIQEIGYNCVADIWSLGITA 215

Query: 764 LEM 766
           +EM
Sbjct: 216 IEM 218

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 62/333 (18%), Positives = 113/333 (33%), Gaps = 79/333 (23%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
                  K    K ++T    ++ +  ++++ +   ++  I  +      L N++ L L 
Sbjct: 21  DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKLFLN 76

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
            N L +        +  LAN   L  L L +N+               +  +        
Sbjct: 77  GNKLTD--------IKPLANLKNLGWLFLDENK---------------VKDLS------- 106

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
                 L +L  L S+++E N +  +    +  L  L+SLYL +N +     + L  LT 
Sbjct: 107 -----SLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTK 157

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           L  L+LE N +   I   L   T L  L LSKN +  +                      
Sbjct: 158 LDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL---------------------- 193

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
                  +  LKNL  L++             S       VK  D S     P  ++   
Sbjct: 194 -----RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDG 246

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSY 448
             +  ++  +      P++   +SF+ Y  ++ 
Sbjct: 247 DYEKPNVKWHL-----PEFTNEVSFIFYQPVTI 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 53/322 (16%), Positives = 110/322 (34%), Gaps = 60/322 (18%)

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
                + I  N+ +   +  +                               L ++ + +
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT---------------------------QNELNSIDQII 52

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
           A  +++       +    N+  L L  N+ +  +     +LKNL  L L  N + +    
Sbjct: 53  ANNSDIKSVQG--IQYLPNVTKLFLNGNK-LTDIK-PLANLKNLGWLFLDENKVKD---- 104

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
               ++ L +  KL++L L  N    +    L +L   + ++ +G N    T    L  L
Sbjct: 105 ----LSSLKDLKKLKSLSLEHNGISDING--LVHLPQ-LESLYLGNNKI--TDITVLSRL 155

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
             L+++++E NQ+  +    +  L  LQ+LYL+ N +      +L  L  L +L L    
Sbjct: 156 TKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE 211

Query: 306 LQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN 365
              K  +   N      +  +           +++   +S   +     +   LP     
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGS--------LVTPEIISDDGDYEKPNVKWHLPEFTNE 263

Query: 366 L----KNLVQLDISGNRFSGDI 383
           +       V +  +  RF G +
Sbjct: 264 VSFIFYQPVTIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 35/157 (22%), Positives = 58/157 (36%), Gaps = 27/157 (17%)

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQIL-SVTTLSL------------------FLNLSD 352
            S       I   L K  +   +    L S+  +                     L L+ 
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNG 77

Query: 353 NLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLN 412
           N L+  +   + NLKNL  L +  N+   D+   L     L+ + ++ N  S  I   L 
Sbjct: 78  NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LV 131

Query: 413 FLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
            L  ++ L L +NK++      L  L+ L+ L+L  N
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDN 166

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 51/264 (19%), Positives = 88/264 (33%), Gaps = 70/264 (26%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  +  L L  N LT                DI+           L  L+ L +L +  
Sbjct: 66  YLPNVTKLFLNGNKLT----------------DIKP----------LANLKNLGWLFLDE 99

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           N+        + ++SS +                   +L  L+      N ++      L
Sbjct: 100 NK--------VKDLSSLK-------------------DLKKLKSLSLEHNGISDING--L 130

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
            +   LE L L +N+ I  ++   + L  L  L L +N + +        +  LA  +KL
Sbjct: 131 VHLPQLESLYLGNNK-ITDIT-VLSRLTKLDTLSLEDNQISD--------IVPLAGLTKL 180

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
           +NL L  N    L    LA L N +  +++              NLV  N++      L+
Sbjct: 181 QNLYLSKNHISDLRA--LAGLKN-LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLH 283
              P  I    + +   +  +   
Sbjct: 238 --TPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 27/221 (12%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L  L  L L EN +   L  S+ +L  L+ + +  N +     + L  L +L  L +G N
Sbjct: 89  LKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNN 144

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           + +      +  ++  + + L+ N+    +    +A L  L+    +KN+++      L+
Sbjct: 145 KITDITV--LSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHISDLRA--LA 197

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
              NL++LEL   + +   +   N   NL V     N + N   + +    ++++    E
Sbjct: 198 GLKNLDVLELFSQECL---NKPINHQSNLVVP----NTVKNTDGSLVT-PEIISDDGDYE 249

Query: 201 NLGLYDNQFGGLLPHSLANLS---NTMTTIDIGGNYFSGTI 238
              +  +     LP     +S       TI      F G +
Sbjct: 250 KPNVKWH-----LPEFTNEVSFIFYQPVTIGKAKARFHGRV 285

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 89.8 bits (223), Expect = 7e-19
 Identities = 59/251 (23%), Positives = 90/251 (35%), Gaps = 57/251 (22%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN-------------LMQKGALKSFLTECEALRSIR 609
           G G++G V            A+KV+                 +   +    E   L+S+ 
Sbjct: 45  GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N+IK+  +    D        +V +F + G L E +   +              NI  
Sbjct: 105 HPNIIKLFDVFE--DKKYF---YLVTEFYEGGELFEQIINRH------KFDECDAANIMK 153

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVE 725
            + S I YLH H    +VH D+KP N+LL   +  +   + DFGL+ F      L   + 
Sbjct: 154 QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL- 209

Query: 726 TPSSSSGIKGTVGYIAPE-----YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG 780
                    GT  YIAPE     Y          DV+S G+++  +     P    F  G
Sbjct: 210 ---------GTAYYIAPEVLKKKYNEKC------DVWSCGVIMYILLCGYPP----FG-G 249

Query: 781 LTLHEFSKMVL 791
               +  K V 
Sbjct: 250 QNDQDIIKKVE 260

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 30/216 (13%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLI 614
             S + ++G G FG V K      G+ +A K++        +    E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           ++        F   +   +V +++  G L + +   +      NL+ + T+     +   
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFL-PARPLDTVVETPSSSS 731
           I ++H      ++H DLKP N+L  +     +   DFGLA+   P   L           
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF------- 249

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFG----ILL 763
              GT  ++APE       S   D++S G    +LL
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.2 bits (224), Expect = 8e-19
 Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 37/264 (14%)

Query: 540 QFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALK 596
           Q+  +    ++K T  F    ++G+G FG V    +   G + A K L    + ++    
Sbjct: 172 QWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA 229

Query: 597 SFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV 656
             L E + L  +  R    ++++  +  +   D   +V   M  G L+  ++        
Sbjct: 230 MALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFHIYHMGQAG-- 282

Query: 657 CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKF 714
                 + +  A ++   +E LH      +V+ DLKP N+LLD     H+   D GLA  
Sbjct: 283 --FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAVH 335

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           +P            +  G  GTVGY+APE       + + D ++ G LL EM + + P  
Sbjct: 336 VP---------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-- 384

Query: 775 SMFH---EGLTLHEFSKMVLPEKV 795
             F    + +   E  ++V     
Sbjct: 385 --FQQRKKKIKREEVERLVKEVPE 406

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.6 bits (218), Expect = 9e-19
 Identities = 70/246 (28%), Positives = 106/246 (43%), Gaps = 62/246 (25%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALK-----S 597
              Y KL            +G+G F TV+K        +VA+K + L  +   K     +
Sbjct: 9   AKRYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT 58

Query: 598 FLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVC 657
            L E + L+ + H N+I ++       F      ++V+DFM+   LE  +  N+  L   
Sbjct: 59  ALREIKLLQELSHPNIIGLLDA-----FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS 112

Query: 658 NLS--LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF- 714
           ++   ++ TL         +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK  
Sbjct: 113 HIKAYMLMTL-------QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

Query: 715 -LPARPLDT--VVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLL 764
             P R   T  VV           T  Y APE       YG G       D+++ G +L 
Sbjct: 163 GSPNRAY-THQVV-----------TRWYRAPELLFGARMYGVGV------DMWAVGCILA 204

Query: 765 EMFSRR 770
           E+  R 
Sbjct: 205 ELLLRV 210

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.5 bits (220), Expect = 9e-19
 Identities = 58/248 (23%), Positives = 98/248 (39%), Gaps = 45/248 (18%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
            +G+GSFG V      +   + A+K +N    +++  +++   E + ++ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND------KLEVCNLSLIQTLNIAIDV 671
              S   F   +   +V D +  G L   L QN        KL +C L +          
Sbjct: 82  --YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM---------- 126

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLPARPLDTVVETPSSS 730
             A++YL +     ++H D+KP N+LLD     H+ DF +A        + T+       
Sbjct: 127 --ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA------ 175

Query: 731 SGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
               GT  Y+APE      G+  S   D +S G+   E+   RRP         +  E  
Sbjct: 176 ----GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIV 229

Query: 788 KMVLPEKV 795
                  V
Sbjct: 230 HTFETTVV 237

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 43/238 (18%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSF-LTECEALRS 607
           S ATS +     +G G++GTV+K     +G  VA+K + +    G      ++    +R 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS---TVRE 61

Query: 608 I---------RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL---- 654
           +          H N+++++ +C++   +      +V++ +    L  +L +         
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
            + +L + Q L         +++LH +C   +VH DLKP N+L+       + DFGLA+ 
Sbjct: 121 TIKDL-MRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

Query: 715 --LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                     VV           T+ Y APE    S  +   D++S G +  EMF R+
Sbjct: 170 YSYQMALTPVVV-----------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 41/205 (20%), Positives = 78/205 (38%), Gaps = 28/205 (13%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSS 622
           G G+FG V + +    G +   K +N        +   E   +  + H  LI +      
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA--- 116

Query: 623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHH 681
             F       ++ +F+  G L + +   + K+ E   ++ ++           ++++H H
Sbjct: 117 --FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEGLKHMHEH 168

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFL-PARPLDTVVETPSSSSGIKGTVG 738
               +VH D+KP N++ +    + V   DFGLA  L P   +               T  
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----------ATAE 215

Query: 739 YIAPEYGTGSEASMTGDVYSFGILL 763
           + APE           D+++ G+L 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 48/254 (18%)

Query: 537 VEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGAL 595
           + +Q+  +      +  S++     +GQG+FG VFK    + G  VA+K + +  +K   
Sbjct: 1   MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 596 KSF-LTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY---DFMQNGSLEEWLHQNN 651
               L E + L+ ++H N++ +I IC +        K  +Y   DF ++  L   L    
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118

Query: 652 DKLEVCNL-SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG 710
            K  +  +  ++Q L       + + Y+H +    ++H D+K +NVL+  D V  + DFG
Sbjct: 119 VKFTLSEIKRVMQMLL------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169

Query: 711 LAKF--LPARPLDT-----VVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDV 756
           LA+   L            VV           T+ Y  PE       YG         D+
Sbjct: 170 LARAFSLAKNSQPNRYTNRVV-----------TLWYRPPELLLGERDYGPPI------DL 212

Query: 757 YSFGILLLEMFSRR 770
           +  G ++ EM++R 
Sbjct: 213 WGAGCIMAEMWTRS 226

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 33/272 (12%)

Query: 533 RTTMVEQQFPMISYAKLSKATSE-FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN--- 588
             ++   +F    + +      + F    ++G+G FG VF   +   G L A K LN   
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222

Query: 589 LMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH 648
           L ++   +  + E + L  +  R ++ +    +   F       +V   M  G +   ++
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA--YA---FETKTDLCLVMTIMNGGDIRYHIY 277

Query: 649 QNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV-- 706
             ++          + +     + S +E+LH      +++ DLKP NVLLD D   +V  
Sbjct: 278 NVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRI 330

Query: 707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            D GLA          +    + + G  GT G++APE   G E   + D ++ G+ L EM
Sbjct: 331 SDLGLAV--------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

Query: 767 FSRRRPTDSMFH---EGLTLHEFSKMVLPEKV 795
            + R P    F    E +   E  + VL + V
Sbjct: 383 IAARGP----FRARGEKVENKELKQRVLEQAV 410

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 57/242 (23%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK--VLNLMQKGALKSFLT 600
           M  Y K+ K          +G+GS+G VFK    + G +VA+K  + +       K  L 
Sbjct: 2   MEKYEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR 51

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS 660
           E   L+ ++H NL+ ++ +             +V+++  + ++   L +    +    + 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRR---KRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVK 105

Query: 661 --LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--P 716
               QTL        A+ + H H     +H D+KP N+L+    V  + DFG A+ L  P
Sbjct: 106 SITWQTLQ-------AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155

Query: 717 ARPL-DTVVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFS 768
           +    D V            T  Y +PE       YG         DV++ G +  E+ S
Sbjct: 156 SDYYDDEVA-----------TRWYRSPELLVGDTQYGPPV------DVWAIGCVFAELLS 198

Query: 769 RR 770
             
Sbjct: 199 GV 200

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 39/211 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITICS 621
           G G  G V +      G   A+K+L             E +   ++    +++ I+ +  
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALKLLY---D--SPKARQEVDHHWQASGGPHIVCILDVYE 92

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           +   +G     I+ + M+ G L   + +  D+      +  +   I  D+ +AI++LH H
Sbjct: 93  N-MHHGKRCLLIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSH 147

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               + H D+KP N+L    + D V  + DFG AK      L T             T  
Sbjct: 148 N---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----------YTPY 194

Query: 739 YIAPE------YGTGSEASMTGDVYSFGILL 763
           Y+APE      Y          D++S G+++
Sbjct: 195 YVAPEVLGPEKYDKSC------DMWSLGVIM 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 89.1 bits (221), Expect = 2e-18
 Identities = 49/248 (19%), Positives = 92/248 (37%), Gaps = 40/248 (16%)

Query: 526 STDRSFERTTMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK 585
           S++       + +Q +P     K       +     +G G+FG V +      G   A K
Sbjct: 129 SSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 188

Query: 586 VLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEE 645
            +    +   ++   E + +  +RH  L+ +        F   +   ++Y+FM  G L E
Sbjct: 189 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFE 243

Query: 646 WLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA 704
            +   ++K+ E   +  ++       V   + ++H +     VH DLKP N++       
Sbjct: 244 KVADEHNKMSEDEAVEYMRQ------VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSN 294

Query: 705 HV--GDFGLAKFL-PARPLDTVVETPSSSSGIKGTVGYIAPE------YGTGSEASMTGD 755
            +   DFGL   L P + +     T            + APE       G  +      D
Sbjct: 295 ELKLIDFGLTAHLDPKQSVKVTTGTA----------EFAAPEVAEGKPVGYYT------D 338

Query: 756 VYSFGILL 763
           ++S G+L 
Sbjct: 339 MWSVGVLS 346

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 46/217 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+G+F  V + +    G+  A K++N   +     +    E    R ++H N++++    
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS- 96

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                    F  +V+D +  G L E +      +     S     +    +  +I Y H 
Sbjct: 97  ----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCHS 146

Query: 681 HCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGT 736
           +    +VH +LKP N+LL          + DFGLA  +  +                 GT
Sbjct: 147 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----------GT 193

Query: 737 VGYIAPE------YGTGSEASMTGDVYSFG----ILL 763
            GY++PE      Y          D+++ G    ILL
Sbjct: 194 PGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 224

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 55/228 (24%), Positives = 82/228 (35%), Gaps = 65/228 (28%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLT---ECEALRSIR----HRN 612
           G+G FGTVF G    + + VA+KV+    ++    L   +T   E   L  +     H  
Sbjct: 40  GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99

Query: 613 LIKIITICSSID---------FNGVDFKAIVYDF-MQNGSLEEWLHQNNDKLEVCNLSLI 662
           +I+++    + +             D    ++D+  + G L E                 
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQD----LFDYITEKGPLGE---------GPSRCFFG 146

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLPARPLD 721
           Q       V +AI++ H      VVH D+K  N+L+D     A + DFG    L   P  
Sbjct: 147 Q-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT 196

Query: 722 TVVETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
                        GT  Y  PE      Y     A     V+S GILL
Sbjct: 197 DFD----------GTRVYSPPEWISRHQY-HALPA----TVWSLGILL 229

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-LKSFLTECE-ALRSIRHRNLIKIITI 619
           +G+G++G+V K +   +G ++AVK +         K  L + +  +RS     +++    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 620 CSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASA 674
                F G  F+     I  + M + S +++       L +V    ++    I +    A
Sbjct: 86  -----FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKA 137

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           + +L  + K  ++H D+KPSN+LLD      + DFG++  L    +D++ +T  +     
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDA----- 186

Query: 735 GTVGYIAPE----YGTGSEASMTGDVYSFGILLLEM 766
           G   Y+APE      +     +  DV+S GI L E+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 12/210 (5%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQ 257
            +NL L  N    L  +S  +    +  +D+       TI  G   +L HL+++ + GN 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 258 LIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG-KIPSSLG 315
           +  ++       L +LQ L      L       +G+L  L  L +  N +Q  K+P    
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSV----TTLSLFLNLSDNLLSGSLPSEIGNLKNLVQ 371
           N T+L  L LS NK+   +    L V      L+L L+LS N ++  +         L +
Sbjct: 147 NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204

Query: 372 LDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
           L +  N+      G     TSL+ + +  N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 23/210 (10%)

Query: 129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDL 187
           N L      S  +   L++L+L   + I  +    + SL +LS LIL  N + + A    
Sbjct: 38  NPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALG-- 94

Query: 188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG----LG 243
                 +  S L+ L   +     L    + +L      +++  N       P     L 
Sbjct: 95  ----AFSGLSSLQKLVAVETNLASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLT 149

Query: 244 NLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQ----SLYLNSNFLHGYIPSSLGNLTMLTL 298
           NL HL+   +  N+ I ++       L  +     SL L+ N ++ +I         L  
Sbjct: 150 NLEHLD---LSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204

Query: 299 LALEINNLQGKIPSSLGNCTSLIMLTLSKN 328
           LAL+ N L+          TSL  + L  N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 20/222 (9%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTSL 320
           +P  +    + ++L L+ N L      S  +   L +L L    +Q  I      + + L
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRF 379
             L L+ N +   L     S  +    L   +  L+ SL +   G+LK L +L+++ N  
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 380 -SGDIPGTLSACTSLEYVKMQDNSFSGSIPP----SLNFLKSIKV-LDLSSNKLSGQIPK 433
            S  +P   S  T+LE++ +  N    SI       L+ +  + + LDLS N ++   P 
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 434 YLENLSFLEYLNLSYNHFEGEVPKKGVF---SNKTRFSLSGN 472
             + +  L+ L L  N  +  VP  G+F   ++  +  L  N
Sbjct: 196 AFKEIR-LKELALDTNQLK-SVP-DGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 44/237 (18%), Positives = 86/237 (36%), Gaps = 36/237 (15%)

Query: 48  LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFH 107
            + +D+  N L      +     +L  L++ R +    I                     
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA----------------- 71

Query: 108 GSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLK 167
               +    +L +L   +   N +      + S  S+L+ L   +       +     LK
Sbjct: 72  ----YQ---SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124

Query: 168 NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP---HSLANLSNTM 224
            L  L + +N + +            +N + LE+L L  N+   +       L  +    
Sbjct: 125 TLKELNVAHNLIQS-----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSN 280
            ++D+  N  +  I PG    + L  +A++ NQL  +VP  I   L +LQ ++L++N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 39/179 (21%), Positives = 64/179 (35%), Gaps = 10/179 (5%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP 63
              ++   I       L  L  L L  N +   L +     LS+LQ +      L     
Sbjct: 60  SRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
             +G L+ L  LN+  N    F  P  + N+++ E + L SN+   S+    +  L  + 
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMP 176

Query: 123 KFVA----AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN 177
                   + N +  F+         L+ L L  NQ        F+ L +L  + L  N
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 24/210 (11%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICS 621
           G+G+   V   I        AVK++             E E L   + HRN++++I    
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF-- 79

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              F   D   +V++ M+ GS+   +H+        + + ++   +  DVASA+++LH+ 
Sbjct: 80  ---FEEEDRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK 130

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               + H DLKP N+L    +      + DF L   +      + + TP   +   G+  
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186

Query: 739 YIAPEYGTGSEASMTG-----DVYSFGILL 763
           Y+APE         +      D++S G++L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 45/213 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICS 621
           G+GSF    K +  ++    AVK+++   K    +   E  AL+    H N++K+  +  
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV-- 74

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              F+      +V + +  G L E + +        + S  +   I   + SA+ ++H  
Sbjct: 75  ---FHDQLHTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV 125

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPA--RPLDTVVETPSSSSGIKGT 736
               VVH DLKP N+L    + ++   + DFG A+  P   +PL T             T
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC----------FT 172

Query: 737 VGYIAPE------YGTGSEASMTGDVYSFGILL 763
           + Y APE      Y          D++S G++L
Sbjct: 173 LHYAAPELLNQNGYDESC------DLWSLGVIL 199

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.7 bits (210), Expect = 8e-18
 Identities = 52/237 (21%), Positives = 85/237 (35%), Gaps = 63/237 (26%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLT---ECEALRSIRHR--NLI 614
           G G FG+V+ GI   + + VA+K +    +   G L +      E   L+ +      +I
Sbjct: 52  GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111

Query: 615 KIITICSSIDF---------NGVDFKAIVYDFM-QNGSLEEWLHQNNDKLEVCNLSLIQT 664
           +++      D             D    ++DF+ + G+L+E                   
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQD----LFDFITERGALQE----------------ELA 151

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTV 723
            +    V  A+ + H+     V+H D+K  N+L+D +     + DFG    L        
Sbjct: 152 RSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 208

Query: 724 VETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
                      GT  Y  PE      Y  G  A     V+S GILL +M     P +
Sbjct: 209 D----------GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIPFE 250

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.6 bits (210), Expect = 9e-18
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 548 KLSKATSEFSS----SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECE 603
           +L + + +F+        +G GS+    + I     M  AVK+++   K        E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPT-EEIE 67

Query: 604 AL-RSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
            L R  +H N+I +  +     ++   +  +V + M+ G L + + +          S  
Sbjct: 68  ILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQK------FFSER 116

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLPA- 717
           +   +   +   +EYLH      VVH DLKPSN+L      +     + DFG AK L A 
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 718 -RPLDTVVETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
              L T             T  ++APE      Y          D++S G+LL
Sbjct: 174 NGLLMTPC----------YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 47/218 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
           G+G+F  V + +    G   A  ++N   +     +    E    R ++H N++++    
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS- 78

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                +      +++D +  G L E +      +     S     +    +  A+ + H 
Sbjct: 79  ----ISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCHQ 128

Query: 681 HCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIKG 735
                VVH +LKP N+LL          + DFGLA  +    +                G
Sbjct: 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA----------G 175

Query: 736 TVGYIAPE------YGTGSEASMTGDVYSFG----ILL 763
           T GY++PE      YG         D+++ G    ILL
Sbjct: 176 TPGYLSPEVLRKDPYGKPV------DLWACGVILYILL 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 41/212 (19%), Positives = 83/212 (39%), Gaps = 41/212 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V + +   +      K + + +         E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES-- 69

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHH 680
              F  ++   ++++F+    + E ++ +  +L E   +S +        V  A+++LH 
Sbjct: 70  ---FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ------VCEALQFLHS 120

Query: 681 HCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFL-PARPLDTVVETPSSSSGIKGTV 737
           H    + H D++P N++      + +   +FG A+ L P      +              
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF----------TAP 167

Query: 738 GYIAPE------YGTGSEASMTGDVYSFGILL 763
            Y APE        T +      D++S G L+
Sbjct: 168 EYYAPEVHQHDVVSTAT------DMWSLGTLV 193

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 44/226 (19%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA---LKSFLTECEALRSIR 609
              FS    +G GSFG V+      N  +VA+K ++   K +    +  + E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 610 HRNLIKIITICSSIDFNGVDFKA----IVYDFMQNGSLEEWLHQNNDKLEVCNLSLI--Q 663
           H N I+         + G   +     +V ++   GS  + L  +   L+   ++ +   
Sbjct: 113 HPNTIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            L         + YLH H     +H D+K  N+LL    +  +GDFG A  +     ++ 
Sbjct: 163 ALQ-------GLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSF 210

Query: 724 VETPSSSSGIKGTVGYIAPE---YGTGSEASMTGDVYSFGILLLEM 766
           V TP           ++APE        +     DV+S GI  +E+
Sbjct: 211 VGTPY----------WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 52/275 (18%), Positives = 109/275 (39%), Gaps = 57/275 (20%)

Query: 513 LSACFIVIYGRRRSTDRSFERTTMVEQQF--PMISYAKLSKATSEFSSSNMVGQGSFGTV 570
           ++       G   +  +     ++        +  Y +++K          +G+G++G V
Sbjct: 1   MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITK----------LGEGTYGEV 50

Query: 571 FKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSID--FN 626
           +K I       VA+K + L  +  G   + + E   L+ ++HRN+I++ ++         
Sbjct: 51  YKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH- 109

Query: 627 GVDFKAIVYDFMQNGSLEEWLHQNN--DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKP 684
                 +++++ +N  L++++ +N       + +  L Q +       + + + H     
Sbjct: 110 ------LIFEYAEN-DLKKYMDKNPDVSMRVIKSF-LYQLI-------NGVNFCHSRR-- 152

Query: 685 PVVHGDLKPSNVLLDHDMVAHVG-----DFGLAKF--LPARPL-DTVVETPSSSSGIKGT 736
             +H DLKP N+LL     +        DFGLA+   +P R     ++           T
Sbjct: 153 -CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-----------T 200

Query: 737 VGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
           + Y  PE   GS    T  D++S   +  EM  + 
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 1e-17
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 50/238 (21%)

Query: 543 MISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLT 600
           M  Y  L K          +G+G++G V+K      G   A+K + L ++  G   + + 
Sbjct: 1   MEKYHGLEK----------IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIR 49

Query: 601 ECEALRSIRHRNLIKIITICSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL 659
           E   L+ ++H N++K+  +  +           +V++ +    L++ L      LE    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLV------LVFEHLDQ-DLKKLLDVCEGGLESVTA 102

Query: 660 S--LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--L 715
              L+Q L       + I Y H      V+H DLKP N+L++ +    + DFGLA+   +
Sbjct: 103 KSFLLQLL-------NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

Query: 716 PARPLDT--VVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-DVYSFGILLLEMFSRR 770
           P R   T  +V           T+ Y AP+   GS+   T  D++S G +  EM +  
Sbjct: 153 PVRKY-THEIV-----------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 50/237 (21%), Positives = 83/237 (35%), Gaps = 68/237 (28%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT-ECEALRSIRHRNLIKIITICS 621
           G+G++G V   +       VAVK++++ +       +  E    + + H N++K      
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75

Query: 622 SIDFNGVDFKAIVYDFM-------------QNGSLEEW-----LHQNNDKLEVCNLSLIQ 663
                      I Y F+              +  + E       HQ           L+ 
Sbjct: 76  E--------GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-----------LM- 115

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
                    + + YLH      + H D+KP N+LLD      + DFGLA        + +
Sbjct: 116 ---------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 724 VETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           +          GT+ Y+APE      +          DV+S GI+L  M +   P D
Sbjct: 164 LNKMC------GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 62/262 (23%), Positives = 95/262 (36%), Gaps = 62/262 (23%)

Query: 535 TMVEQQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKG 593
           +M+       +  +  K    F    M GQG+FGTV  G     GM VA+K V+   Q  
Sbjct: 4   SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QD- 59

Query: 594 ALKSF----LTECEALRSIRHRNLIK---IITICSSIDFNGVDFKAIVYDFMQNGSLEEW 646
               F    L   + L  + H N+++           D   + +  +V +++      + 
Sbjct: 60  --PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI-YLNVVMEYV-----PDT 111

Query: 647 LHQ-------NNDKLEV--CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL 697
           LH+                  + L Q +        +I  LH      V H D+KP NVL
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLI-------RSIGCLHLPSV-NVCHRDIKPHNVL 163

Query: 698 LD-HDMVAHVGDFGLAK-FLPARPLDTVVETPSSSSGIKGTVGYI------APEYGTGSE 749
           ++  D    + DFG AK   P+ P                 V YI      APE   G++
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPN----------------VAYICSRYYRAPELIFGNQ 207

Query: 750 ASMTG-DVYSFGILLLEMFSRR 770
              T  D++S G +  EM    
Sbjct: 208 HYTTAVDIWSVGCIFAEMMLGE 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 50/230 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLT------------------- 600
           G+GS+G V       +    A+KVL+   L+++                           
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 601 ----ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV 656
               E   L+ + H N++K++ +   +D    D   +V++ +  G +        +   +
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVM-------EVPTL 131

Query: 657 CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLP 716
             LS  Q      D+   IEYLH+     ++H D+KPSN+L+  D    + DFG++    
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187

Query: 717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG---DVYSFGILL 763
            +  D ++          GT  ++APE  + +    +G   DV++ G+ L
Sbjct: 188 -KGSDALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 39/235 (16%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNLMQKG------ALK--SFLT 600
            +A  ++     +G+G++G VFK   +   G  VA+K + +           ++  + L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 601 ECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQN---GSLEEWLHQNNDKLEVC 657
               L +  H N++++  +C+    +      +V++ +       L++          + 
Sbjct: 67  H---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123

Query: 658 NLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF--L 715
           ++ + Q L         +++LH H    VVH DLKP N+L+       + DFGLA+    
Sbjct: 124 DM-MFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

Query: 716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                  VV           T+ Y APE    S  +   D++S G +  EMF R+
Sbjct: 173 QMALTSVVV-----------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN----LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           G+GS+G V + +  E     AVK+L             +   E + LR +RH+N+I+++ 
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73

Query: 619 ICSSIDFNGVDFKAIVYDFMQ--NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           +  +      + K  +Y  M+     ++E L    D +      + Q       +   +E
Sbjct: 74  VLYN------EEKQKMYMVMEYCVCGMQEML----DSVPEKRFPVCQAHGYFCQLIDGLE 123

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
           YLH      +VH D+KP N+LL       +   G+A+ L     D    T        G+
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------GS 174

Query: 737 VGYIAPE-------YGTGSEASMTGDVYSFGILL 763
             +  PE       + +G +     D++S G+ L
Sbjct: 175 PAFQPPEIANGLDTF-SGFKV----DIWSAGVTL 203

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.7 bits (212), Expect = 2e-17
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 35/250 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
           ++FS   ++G+G FG V+     + G + A+K L+   +  K      L E   L  +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            +   I+ +  +  F+  D  + + D M  G L   L Q+         S       A +
Sbjct: 249 GDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAE 300

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPS 728
           +   +E++H+     VV+ DLKP+N+LLD     HV   D GLA     +     V    
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV---- 351

Query: 729 SSSGIKGTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF--HEGLTLHE 785
                 GT GY+APE    G     + D +S G +L ++     P    F  H+    HE
Sbjct: 352 ------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHE 401

Query: 786 FSKMVLPEKV 795
             +M L   V
Sbjct: 402 IDRMTLTMAV 411

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 34/213 (15%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKV-----LNLMQKGALKSFLTECEALRSIRHRNLIKII 617
           G+G F  V + I  E G   AVK+            + +    E      ++H ++++++
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              SS          +V++FM    L   + +  D   V   S     +    +  A+ Y
Sbjct: 93  ETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFV--YSEAVASHYMRQILEALRY 145

Query: 678 LHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
            H +    ++H D+KP  VLL   ++     +G FG+A  L         E+   + G  
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ESGLVAGGRV 194

Query: 735 GTVGYIAPE----YGTGSEASMTGDVYSFGILL 763
           GT  ++APE       G       DV+  G++L
Sbjct: 195 GTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 45/214 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G G+FG V  G     G  VAVK+LN   +     +     E + L+  RH ++IK+  +
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79

Query: 620 CSSIDFNGVDFKAIVYDFM---QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
            S+            +  M     G L +++ ++    E+    L Q +       SA++
Sbjct: 80  IST--------PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVD 125

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVETPSSSSGIKG 735
           Y H H    VVH DLKP NVLLD  M A + DFGL         L T   +P+       
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------- 175

Query: 736 TVGYIAPE------YGTGSEASMTGDVYSFGILL 763
              Y APE      Y  G E     D++S G++L
Sbjct: 176 ---YAAPEVISGRLY-AGPEV----DIWSCGVIL 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 51/229 (22%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKII-TI 619
           +G+G +  VF+ I   N   V VK+L  ++K   K    E + L ++R   N+I +   +
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS------ 673
              +         +               Q           L QTL    D+        
Sbjct: 101 KDPVSRTPA---LVFEHVNNTD-----FKQ-----------LYQTLTDY-DIRFYMYEIL 140

Query: 674 -AIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFL-PARPLDTVVETPSSS 730
            A++Y H      ++H D+KP NV++DH+     + D+GLA+F  P +  +  V      
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV------ 191

Query: 731 SGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFH 778
                +  +  PE     +    + D++S G +L  M  R+ P    FH
Sbjct: 192 ----ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFH 233

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 50/240 (20%), Positives = 80/240 (33%), Gaps = 74/240 (30%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT----ECEALRSIRHRNLIKIIT 618
           G+G++G V   +       VAVK+++                E    + + H N++K   
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 619 ICSSIDFNGVDFKAIVYDFM-------------QNGSLEEW-----LHQNNDKLEVCNLS 660
                         I Y F+              +  + E       HQ           
Sbjct: 73  HRRE--------GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------- 113

Query: 661 LIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPL 720
           L+          + + YLH      + H D+KP N+LLD      + DFGLA        
Sbjct: 114 LM----------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160

Query: 721 DTVVETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           + ++          GT+ Y+APE      +          DV+S GI+L  M +   P D
Sbjct: 161 ERLLNKMC------GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 42/214 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G+   V++          A+KVL   +    K   TE   L  + H N+IK+  I  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-- 116

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
              F      ++V + +  G L + +      +E    S     +    +  A+ YLH +
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTV 737
               +VH DLKP N+L      D    + DFGL+K +     + TV           GT 
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC----------GTP 214

Query: 738 GYIAPE----YGTGSEASMTGDVYSFG----ILL 763
           GY APE       G E     D++S G    ILL
Sbjct: 215 GYCAPEILRGCAYGPEV----DMWSVGIITYILL 244

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 59/227 (25%), Positives = 86/227 (37%), Gaps = 51/227 (22%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL--KSFLTECEALRSIRHRNLIKIITIC 620
           G G+FG            LVAVK +    +GA   ++   E    RS+RH N+++   + 
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 621 SS---IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIE 676
            +   +        AI+ ++   G L E +  N  +  E       Q L       S + 
Sbjct: 86  LTPTHL--------AIIMEYASGGELYERI-CNAGRFSEDEARFFFQQL------LSGVS 130

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAH--VGDFGLAK-FLPARPLDTVVETPSSSSGI 733
           Y H      + H DLK  N LLD        + DFG +K  +      + V TP+     
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA----- 182

Query: 734 KGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
                YIAPE      Y  G  A    DV+S G+ L  M     P +
Sbjct: 183 -----YIAPEVLLRQEY-DGKIA----DVWSCGVTLYVMLVGAYPFE 219

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 41/251 (16%), Positives = 90/251 (35%), Gaps = 43/251 (17%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIR-------- 609
            +G G F TV+      N   VA+K++    +  + A      E + L+ +         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKED 81

Query: 610 HRNLIKIITICSSIDFNGVDFK--AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
                 I+ +    +  G +     +V++ +   +L   + +   +     L  ++   I
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQ--I 136

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH------VGDFGLAKFLPARPLD 721
           +  +   ++Y+H  C   ++H D+KP NVL++            + D G A +       
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YT 193

Query: 722 TVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR--PTDSMFHE 779
             ++T            Y +PE   G+      D++S   L+ E+ +       D     
Sbjct: 194 NSIQTRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

Query: 780 GLTLHEFSKMV 790
                  ++++
Sbjct: 244 TKDDDHIAQII 254

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 54/237 (22%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
              ++ + ++G GSFG V++  + ++G LVA+K +   ++   +    E + +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 613 LIKII-TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ-------NNDKL--EVCNLSLI 662
           ++++     SS +     +  +V D++      E +++           L      L + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAK-FLPARPL 720
           Q          ++ Y+H      + H D+KP N+LLD D  V  + DFG AK  +   P 
Sbjct: 164 QLF-------RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 721 DTVVETPSSSSGIKGTVGYI------APEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
                           V YI      APE   G+ + + + DV+S G +L E+   +
Sbjct: 214 ----------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 44/218 (20%), Positives = 78/218 (35%), Gaps = 47/218 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN------LMQKGALKSFLTECEALRSIRHRNLIKI 616
           G G F  V K      G+  A K +         +  + +    E   LR + H N+I +
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +     +       ++ + +  G L ++L Q        +LS  +  +    +   + 
Sbjct: 81  HDV-----YENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVN 129

Query: 677 YLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSS 731
           YLH      + H DLKP N++L           + DFGLA  +        +        
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------- 179

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
              GT  ++APE       G  +      D++S G++ 
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEA------DMWSIGVIT 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 64/225 (28%), Positives = 88/225 (39%), Gaps = 67/225 (29%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G G+FG V  G     G  VAVK+LN   +     +     E + L+  RH ++IK+  +
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84

Query: 620 CSSIDF---------NGVDFKAIVYDFMQNGSLEE-----WLHQNNDKLEVCNLSLIQTL 665
            S+             G  F  I     +NG L+E        Q           ++   
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQ-----------IL--- 126

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVV 724
                  S ++Y H H    VVH DLKP NVLLD  M A + DFGL         L T  
Sbjct: 127 -------SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176

Query: 725 ETPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
            +P+          Y APE      Y  G E     D++S G++L
Sbjct: 177 GSPN----------YAAPEVISGRLY-AGPEV----DIWSSGVIL 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 34/226 (15%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRH 610
              + +   +G G+ G V           VA+K +    Q     K    E   ++ + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 611 RNLIKIITI----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +N+I ++ +     S  +F  V    IV + M   +L + +    D   +  L L Q L 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDV---YIVMELMDA-NLCQVIQMELDHERMSYL-LYQMLC 138

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT--VV 724
                   I++LH      ++H DLKPSN+++  D    + DFGLA+      + T  VV
Sbjct: 139 -------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                      T  Y APE   G       D++S G ++ EM    
Sbjct: 189 -----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 81.9 bits (203), Expect = 2e-16
 Identities = 88/463 (19%), Positives = 153/463 (33%), Gaps = 81/463 (17%)

Query: 48  LQVIDIRGNRLGGK-IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRF 106
           +Q +DI+   L      + L  L++   + +     +        +ISS     L+ N  
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA----LRVN-- 55

Query: 107 HGSLPFDMVANLPNLRKFVAAKNNLT--GFLPIS---LSNASNLELLELRDNQF----IG 157
                       P L +     N L   G   +     + +  ++ L L++        G
Sbjct: 56  ------------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103

Query: 158 KMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSL 217
            +S    +L  L  L L +N LG+     L    +L    +LE L L            L
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLL-CEGLLDPQCRLEKLQLEYCSLSAASCEPL 162

Query: 218 ANL---SNTMTTIDIGGNYFSGT----IPPGLG----NLVHL----NSIAMEGNQLIGTV 262
           A++         + +  N  +      +  GL      L  L      +  +  + +  +
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222

Query: 263 PPEIGWLKNLQSLYLNSNFLHGY-----IPSSLGNLTMLTLLALEINNLQGK----IPSS 313
              +    +L+ L L SN L         P  L   + L  L +    +  K    +   
Sbjct: 223 ---VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279

Query: 314 LGNCTSLIMLTLSKNKL--DGV--LPPQILSVTTLSLFLNLSDNLLSG----SLPSEIGN 365
           L    SL  L+L+ N+L  +G   L   +L        L +     +        S +  
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 366 LKNLVQLDISGNRFSGD-----IPGTLSACTSLEYVKMQDNSFS----GSIPPSLNFLKS 416
            + L++L IS NR           G     + L  + + D   S     S+  +L    S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399

Query: 417 IKVLDLSSNKLSGQIPKYL-----ENLSFLEYLNLSYNHFEGE 454
           ++ LDLS+N L       L     +    LE L L   ++  E
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 75.0 bits (185), Expect = 3e-14
 Identities = 82/499 (16%), Positives = 156/499 (31%), Gaps = 100/499 (20%)

Query: 2   FDAQNNKLVGDIPVEIGC-YLFKLENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGN 56
            D Q  +L  D         L + + + L +  LT      +  ++    AL  +++R N
Sbjct: 8   LDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 66

Query: 57  RLGGK----IPDTLGQL-RKLIYLNIGRNQFS----GFIPPSIYNISSFEFIFLQSNRFH 107
            LG      +   L     K+  L++     +    G +  ++  + + + + L  N   
Sbjct: 67  ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126

Query: 108 GS----LPFDMVANLPNLRKFVAAKNNLT----GFLPISLSNASNLELLELRDNQFIGKM 159
            +    L   ++     L K      +L+      L   L    + + L + +N      
Sbjct: 127 DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 186

Query: 160 SINF-----NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG--- 211
                    +S   L  L L +  + +    DL    ++A+ + L  L L  N+ G    
Sbjct: 187 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL--CGIVASKASLRELALGSNKLGDVGM 244

Query: 212 -LLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLK 270
             L   L + S+ + T+ I                     I  +G   +  V   +   +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWE-----------------CGITAKGCGDLCRV---LRAKE 284

Query: 271 NLQSLYLNSNFLHGYIPSSLGNL-----TMLTLLALEINNLQGK----IPSSLGNCTSLI 321
           +L+ L L  N L       L          L  L ++  +          S L     L+
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344

Query: 322 MLTLSKNKL--DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRF 379
            L +S N+L   GV                     L   L         L  L ++    
Sbjct: 345 ELQISNNRLEDAGV-------------------RELCQGLGQ---PGSVLRVLWLADCDV 382

Query: 380 S----GDIPGTLSACTSLEYVKMQDNSFSGS----IPPSLNFLKS-IKVLDLSSNKLSGQ 430
           S      +  TL A  SL  + + +N    +    +  S+      ++ L L     S +
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

Query: 431 IPKYL----ENLSFLEYLN 445
           +   L    ++   L  ++
Sbjct: 443 MEDRLQALEKDKPSLRVIS 461

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 44/218 (20%), Positives = 77/218 (35%), Gaps = 47/218 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN------LMQKGALKSFLTECEALRSIRHRNLIKI 616
           G G F  V K      G+  A K +         +    +    E   LR + H N+I +
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +     +       ++ + +  G L ++L Q        +LS  +  +    +   + 
Sbjct: 81  HDV-----YENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVN 129

Query: 677 YLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSS 731
           YLH      + H DLKP N++L           + DFGLA  +        +        
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------- 179

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
              GT  ++APE       G  +      D++S G++ 
Sbjct: 180 ---GTPEFVAPEIVNYEPLGLEA------DMWSIGVIT 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 63/235 (26%), Positives = 90/235 (38%), Gaps = 66/235 (28%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G+GSFG V      +    VA+K ++   L +         E   L+ +RH ++IK+  +
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77

Query: 620 CSSIDF--------NGVDFKAIVYDFMQNGSLEE-----WLHQNNDKLEVCNLSLIQTLN 666
            ++            G  F  IV    +   + E     +  Q           +I    
Sbjct: 78  ITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQ-----------II---- 118

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLPARPLDTVVE 725
                  AIEY H H    +VH DLKP N+LLD ++   + DFGL         L T   
Sbjct: 119 ------CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG 169

Query: 726 TPSSSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           +P+          Y APE      Y  G E     DV+S GI+L  M   R P D
Sbjct: 170 SPN----------YAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLPFD 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 3e-16
 Identities = 53/238 (22%), Positives = 90/238 (37%), Gaps = 62/238 (26%)

Query: 562 VGQGSFGTVFKGII--GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           VG+G++G V+K     G++    A+K +     G   S   E   LR ++H N+I +  +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLS----------LIQTLNIAI 669
             S     V    +++D+ ++  L   +  +                    L Q L+   
Sbjct: 87  FLSHADRKV---WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD--- 139

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH----VGDFGLAKF--LPARPL--- 720
                I YLH +    V+H DLKP+N+L+  +        + D G A+    P +PL   
Sbjct: 140 ----GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 721 -DTVVETPSSSSGIKGTVGYIAPE-------YGTGSEASMTGDVYSFGILLLEMFSRR 770
              VV           T  Y APE       Y          D+++ G +  E+ +  
Sbjct: 193 DPVVV-----------TFWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTSE 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 49/222 (22%), Positives = 80/222 (36%), Gaps = 51/222 (22%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA------LKSFLTECEALRSIRHRNLIKI 616
           G G F  V K      G   A K +   +  +       +    E   LR IRH N+I +
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             I     F       ++ + +  G L ++L +        +L+  +       +   + 
Sbjct: 74  HDI-----FENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVH 122

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAH----VGDFGLAKFL-PARPLDTVVETPSSSS 731
           YLH      + H DLKP N++L    V +    + DFG+A  +        +        
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF------- 172

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFG----ILL 763
              GT  ++APE       G  +      D++S G    ILL
Sbjct: 173 ---GTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILL 205

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 81.7 bits (201), Expect = 4e-16
 Identities = 50/321 (15%), Positives = 97/321 (30%), Gaps = 15/321 (4%)

Query: 131 LTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFV 190
           L    P  +    ++   E   +    +     + +  L +++            D    
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295

Query: 191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNS 250
                   L    L D               +    + +                  L  
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW--CRDSATDEQLFR 353

Query: 251 IAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI 310
             +   +    +  E+   K LQ L   + +    I   +  L  L      +       
Sbjct: 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF---- 408

Query: 311 PSSLGNCTSLIMLTLSKNKLDGVLPPQILSVT-TLSLFLNLSDNLLSGSLPSEIGNLKNL 369
            S+L     +    L   +   +L   +L +       L+L+   L+  L   +  L  +
Sbjct: 409 -STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLV 465

Query: 370 VQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG 429
             LD+S NR    +P  L+A   LE ++  DN+   ++   +  L  ++ L L +N+L  
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ 522

Query: 430 -QIPKYLENLSFLEYLNLSYN 449
               + L +   L  LNL  N
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.6 bits (167), Expect = 5e-12
 Identities = 41/269 (15%), Positives = 89/269 (33%), Gaps = 28/269 (10%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
            +LP          +    +     +     LL+ R   +      +  + + L    L 
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC----RDSATDEQLFRCELS 357

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
                          + L +C +L+ L   +      +   +  L   +   +    +  
Sbjct: 358 VEKSTV-------LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF-- 408

Query: 236 GTIPPGLGNLVHLNSIAMEG--NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNL 293
                 L  +  + +  ++   ++ +           +++ L+L    L   +   L  L
Sbjct: 409 ----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQL 462

Query: 294 TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
            ++T L L  N L+  +P +L     L +L  S N L+ V    + ++  L   L L +N
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQ-ELLLCNN 518

Query: 354 LLSGSLPS--EIGNLKNLVQLDISGNRFS 380
            L     +   + +   LV L++ GN   
Sbjct: 519 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.5 bits (125), Expect = 5e-07
 Identities = 32/138 (23%), Positives = 45/138 (32%), Gaps = 31/138 (22%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
                +  L LA   LT  L   +  L  +  +D+  NRL   +P  L  LR L  L   
Sbjct: 438 MEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPI- 137
            N         + N+                       NLP L++ +   N L     I 
Sbjct: 495 DNA--------LENVDGVA-------------------NLPRLQELLLCNNRLQQSAAIQ 527

Query: 138 SLSNASNLELLELRDNQF 155
            L +   L LL L+ N  
Sbjct: 528 PLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 5/82 (6%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-K 61
           D  +N+L   +P  +   L  LE L  ++N L   +   + NL  LQ + +  NRL    
Sbjct: 469 DLSHNRLR-ALPPALA-ALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSA 524

Query: 62  IPDTLGQLRKLIYLNIGRNQFS 83
               L    +L+ LN+  N   
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.0 bits (200), Expect = 4e-16
 Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 41/246 (16%)

Query: 536 MVEQQFPMISYAKLSKAT-SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQ 591
            +E   P  S  K  +    +F    ++G+G+FG V    +     + A+K+LN   +++
Sbjct: 55  YLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK 114

Query: 592 KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN 651
           +     F  E + L +   + +  +    +   F   +   +V D+   G L   L +  
Sbjct: 115 RAETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLVMDYYVGGDLLTLLSKFE 169

Query: 652 DKLEVCNLSLIQTLNIAI----DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV- 706
           D+L            +A     ++  AI+ +H       VH D+KP N+L+D +   H+ 
Sbjct: 170 DRL---------PEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIR 215

Query: 707 -GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTG-----DVYSFG 760
             DFG    L     D  V++  +     GT  YI+PE     E          D +S G
Sbjct: 216 LADFGSCLKLME---DGTVQSSVAV----GTPDYISPEILQAMEGGKGRYGPECDWWSLG 268

Query: 761 ILLLEM 766
           + + EM
Sbjct: 269 VCMYEM 274

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 26/214 (12%), Positives = 56/214 (26%), Gaps = 54/214 (25%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRNLIKIIT 618
            G       ++ +       VA+  ++    +    L+  L+    L  I       +  
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG---VAR 95

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           +   +         +V ++++ GSL+E    +         S +  +     +A+A +  
Sbjct: 96  VLDVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAA 145

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      V      PS V +  D    +                                
Sbjct: 146 HRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------------- 174

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +       +      D+   G  L  +   R P
Sbjct: 175 TMPDA----NPQD---DIRGIGASLYALLVNRWP 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.4 bits (194), Expect = 8e-16
 Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 47/218 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS------FLTECEALRSIRHRNLIKI 616
           G G F  V K      G+  A K +   +  + +          E   L+ I+H N+I +
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
             +     +       ++ + +  G L ++L +        +L+  +       + + + 
Sbjct: 80  HEV-----YENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVY 128

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAH----VGDFGLAKFL-PARPLDTVVETPSSSS 731
           YLH      + H DLKP N++L    V      + DFGLA  +        +        
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF------- 178

Query: 732 GIKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
              GT  ++APE       G  +      D++S G++ 
Sbjct: 179 ---GTPEFVAPEIVNYEPLGLEA------DMWSIGVIT 207

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 41/235 (17%), Positives = 81/235 (34%), Gaps = 20/235 (8%)

Query: 225 TTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFL 282
                  +  +  IP  L  N + L        + +  +         +L+ + ++ N +
Sbjct: 12  RVFLCQESKVT-EIPSDLPRNAIELR---FVLTK-LRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 283 HGYIP----SSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
              I     S+L  L  + +   + NNL    P +  N  +L  L +S   +   LP   
Sbjct: 67  LEVIEADVFSNLPKLHEIRIE--KANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVH 123

Query: 339 LSVTTLSLFLNLSDNLLSGSLPSEI--GNLKNLVQLDISGNRFSGDIPGTLSACTSLEYV 396
              +   + L++ DN+   ++      G     V L ++ N          +     E  
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183

Query: 397 KMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNLSYN 449
              +N+    +P    +      +LD+S  ++   +P Y LENL  L   +    
Sbjct: 184 LSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 42/260 (16%), Positives = 81/260 (31%), Gaps = 21/260 (8%)

Query: 27  LSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFI 86
               E+ +T ++P  +        +     +L             L  + I +N     I
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 87  PPSI-YNISSFEFIFLQ-SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASN 144
              +  N+     I ++ +N     +  +   NLPNL+  + +   +     +   ++  
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 145 LELLELRDNQFIGKMSIN-FNSL-KNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
             LL+++DN  I  +  N F  L     +L L  N +     +              E  
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS------AFNGTQLDELN 183

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGT 261
              +N    L        S     +DI       ++P   L NL  L + +    + +  
Sbjct: 184 LSDNNNLEELPNDVFHGASG-PVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKL-- 239

Query: 262 VPPEIGWLKNLQSLYLNSNF 281
             P +  L  L    L    
Sbjct: 240 --PTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 29/176 (16%), Positives = 52/176 (29%), Gaps = 10/176 (5%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPD 64
           + N L+  I  E    L  L+ L ++   +     V   +     ++DI+ N     I  
Sbjct: 88  KANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 65  TL--GQLRKLIYLNIGRNQFSGFIPPSIYN-ISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
               G   + + L + +N     I  S +N     E     +N     LP D+       
Sbjct: 147 NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGP 204

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN 177
                ++  +       L N   L      + + +         L  L    L   
Sbjct: 205 VILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLP----TLEKLVALMEASLTYP 256

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 17/207 (8%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL 330
           +   +  +   L   +P  L      T+L L  N L     ++L   T L  L L + +L
Sbjct: 11  SHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 331 DGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSAC 390
             +     L V      L+LS N L  SLP     L  L  LD+S NR +    G L   
Sbjct: 68  TKLQVDGTLPVLG---TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 391 TSLEYVKMQDNSFSGSIPPSLNF--LKSIKVLDLSSNKLSGQIPKYL-ENLSFLEYLNLS 447
             L+ + ++ N    ++PP L       ++ L L++N L+ ++P  L   L  L+ L L 
Sbjct: 124 GELQELYLKGNELK-TLPPGL-LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 448 YNHFEGEVPKKGVFSNK--TRFSLSGN 472
            N     +P KG F +       L GN
Sbjct: 181 ENSLYT-IP-KGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 46/188 (24%), Positives = 66/188 (35%), Gaps = 15/188 (7%)

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
            +  +L L +N               L+ L L    L          + V      L  L
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--------LQVDGTLPVLGTL 82

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGT 261
            L  NQ   L P     L    T +D+  N  + ++P G    L  L  + ++GN+L  T
Sbjct: 83  DLSHNQLQSL-PLLGQTLPAL-TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KT 138

Query: 262 VPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
           +PP +      L+ L L +N L       L  L  L  L L+ N+L   IP        L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLL 197

Query: 321 IMLTLSKN 328
               L  N
Sbjct: 198 PFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 42/187 (22%), Positives = 69/187 (36%), Gaps = 17/187 (9%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L L+EN L      ++   + L  +++    L  K+    G L  L  L++  NQ  
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQLQ 90

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
             +P     + +   + +  NR   SLP   +  L  L++     N L    P  L+   
Sbjct: 91  S-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148

Query: 144 NLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGN--RAANDLDFVTVLANCSKLE 200
            LE L L +N  + ++     N L+NL  L+L  N L    +                L 
Sbjct: 149 KLEKLSLANNN-LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS---------HLLP 198

Query: 201 NLGLYDN 207
              L+ N
Sbjct: 199 FAFLHGN 205

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 39/225 (17%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHRNLIKIITIC 620
           +G+G++G V        G +VA+K +    K       L E + L+  +H N+I I  I 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78

Query: 621 ---SSIDFNGVDFKAIVYDFMQNGSLEEWLHQ--NNDKLEV--CNLSLIQTLNIAIDVAS 673
              S  +FN V    I+ + M     +  LH+  +   L        + QTL        
Sbjct: 79  RPDSFENFNEV---YIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLR------- 123

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A++ LH      V+H DLKPSN+L++ +    V DFGL     AR +D      S  +G 
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL-----ARIIDESAADNSEPTGQ 175

Query: 734 KG-------TVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRR 770
           +        T  Y APE   T ++ S   DV+S G +L E+F RR
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F    ++G+G+F  V    + + G + A+K++N   ++++G +  F  E + L +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI- 669
           R + ++    +   F   ++  +V ++   G L   L +  +++            +A  
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDLLTLLSKFGERI---------PAEMARF 166

Query: 670 ---DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVV 724
              ++  AI+ +H       VH D+KP N+LLD     H+   DFG    L         
Sbjct: 167 YLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKL-------RA 214

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVY-------SFGILLLEM 766
           +    S    GT  Y++PE             Y       + G+   EM
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 40/212 (18%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITICS 621
           G G  G V +          A+K+L    K        E E   R+ +  ++++I+ +  
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYE 125

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           +  + G     IV + +  G L   +    D+      +  +   I   +  AI+YLH  
Sbjct: 126 N-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI 180

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTV 737
               + H D+KP N+L      + +  + DFG AK       L T             T 
Sbjct: 181 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----------YTP 227

Query: 738 GYIAPE------YGTGSEASMTGDVYSFGILL 763
            Y+APE      Y          D++S G+++
Sbjct: 228 YYVAPEVLGPEKYDKSC------DMWSLGVIM 253

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 42/248 (16%), Positives = 91/248 (36%), Gaps = 24/248 (9%)

Query: 193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIA 252
               +      L       L+      LS  +   +   +    ++  G+    +L  + 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSG-VQNFNGDNSNIQ-SLA-GMQFFTNLKELH 69

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
           +  NQ I  + P +  L  L+ L +N N L      +L  +    L  L ++N + +   
Sbjct: 70  LSHNQ-ISDLSP-LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTD 122

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL 372
           SL +  +L +L++  NKL  ++   +  ++ L   L+L  N ++ +    +  LK +  +
Sbjct: 123 SLIHLKNLEILSIRNNKLKSIVM--LGFLSKLE-VLDLHGNEIT-NT-GGLTRLKKVNWI 177

Query: 373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP 432
           D++G +   +             VK  D  +      S                +  ++P
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGG-------SYVDGCVLWELP 230

Query: 433 KYLENLSF 440
            Y + +S+
Sbjct: 231 VYTDEVSY 238

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 46/267 (17%), Positives = 85/267 (31%), Gaps = 53/267 (19%)

Query: 66  LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV 125
              L   +  N+G+          + ++ S +                    L  ++ F 
Sbjct: 15  DPGLANAVKQNLGKQS--------VTDLVSQK-------------------ELSGVQNFN 47

Query: 126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAAN 185
              +N+       +   +NL+ L L  NQ I  +S     L  L  L +  N L N    
Sbjct: 48  GDNSNIQSLAG--MQFFTNLKELHLSHNQ-ISDLS-PLKDLTKLEELSVNRNRLKN---- 99

Query: 186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL 245
               +  + +   L  L L +N+        L +L N +  + I  N    +I   LG L
Sbjct: 100 ----LNGIPSA-CLSRLFLDNNELRDTDS--LIHLKN-LEILSIRNNKLK-SIVM-LGFL 149

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINN 305
             L  + + GN++  T    +  LK +  + L               L +   +     +
Sbjct: 150 SKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV----KD 203

Query: 306 LQGKI--PSSLGNCTSLIMLTLSKNKL 330
             G+   P  + N  S +   +     
Sbjct: 204 PDGRWISPYYISNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 39/182 (21%), Positives = 68/182 (37%), Gaps = 38/182 (20%)

Query: 269 LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKN 328
           L N     L    +      S   L+ +     + +N+Q  + + +   T+L  L LS N
Sbjct: 18  LANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73

Query: 329 KLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS 388
                   QI  ++ L                    +L  L +L ++ NR   ++ G   
Sbjct: 74  --------QISDLSPLK-------------------DLTKLEELSVNRNRLK-NLNG--I 103

Query: 389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSY 448
               L  + + +N         L  LK++++L + +NKL   +   L  LS LE L+L  
Sbjct: 104 PSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHG 159

Query: 449 NH 450
           N 
Sbjct: 160 NE 161

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 18/90 (20%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL 420
                L N V+ ++     + D+       + ++     +++   S+   + F  ++K L
Sbjct: 13  FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68

Query: 421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNH 450
            LS N++S  +   L++L+ LE L+++ N 
Sbjct: 69  HLSHNQIS-DL-SPLKDLTKLEELSVNRNR 96

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 34/222 (15%), Positives = 78/222 (35%), Gaps = 28/222 (12%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           +   L+ L L+ N ++  L   + +L+ L+ + +  NRL  K  + +     L  L +  
Sbjct: 61  FFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRL--KNLNGIPSA-CLSRLFLDN 115

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           N+       S+ ++ + E + +++N+        M+  L  L       N +T      L
Sbjct: 116 NELRDT--DSLIHLKNLEILSIRNNKLKS---IVMLGFLSKLEVLDLHGNEITNTGG--L 168

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           +    +  ++L   +           +K    L +  N + +     +     ++N    
Sbjct: 169 TRLKKVNWIDLTGQK------CVNEPVKYQPELYI-TNTVKDPDGRWISPYY-ISNGGSY 220

Query: 200 ENLGLYDNQFGGLLPHSLANLS---NTMTTIDIGGNYFSGTI 238
            +  +        LP     +S   +    +      F GT+
Sbjct: 221 VDGCVLWE-----LPVYTDEVSYKFSEYINVGETEAIFDGTV 257

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 45/230 (19%), Positives = 90/230 (39%), Gaps = 49/230 (21%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            ++    ++G+G+FG V          + A+K+L+   ++++     F  E + +     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             ++++    +   F    +  +V ++M  G L               ++L+   ++   
Sbjct: 129 PWVVQL--FYA---FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPEK 168

Query: 671 VA--------SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPL 720
            A         A++ +H       +H D+KP N+LLD     H+   DFG    +     
Sbjct: 169 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK--- 220

Query: 721 DTVVETPSSSSGIKGTVGYIAPE----YGTGSEASMTGDVYSFGILLLEM 766
           + +V   ++     GT  YI+PE     G         D +S G+ L EM
Sbjct: 221 EGMVRCDTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 34/226 (15%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRH 610
              + +   +G G+ G V           VA+K +    Q     K    E   ++ + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 611 RNLIKIITI----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
           +N+I ++ +     +  +F  V    +V + M   +L + +    D   +  L L Q L 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDV---YLVMELMDA-NLCQVIQMELDHERMSYL-LYQMLC 175

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT--VV 724
                   I++LH      ++H DLKPSN+++  D    + DFGLA+      + T  VV
Sbjct: 176 -------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR 770
                      T  Y APE   G       D++S G ++ EM   +
Sbjct: 226 -----------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 29/226 (12%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V        G   A+K+L    ++ K  +   LTE   L++ RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              S   F   D    V ++   G L   L +          S  +      ++ SA++Y
Sbjct: 215 --YS---FQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDY 263

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
           LH      VV+ DLK  N++LD D    + DFGL K          ++  ++     GT 
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTFCGTP 313

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFH 778
            Y+APE    ++     D +  G+++ EM   R P      + +F 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 42/217 (19%), Positives = 77/217 (35%), Gaps = 47/217 (21%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHR-NLIKIITI 619
           G+G F  V + I    G   A K L      +      L E   L   +    +I +  +
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                +       ++ ++   G +         +     +S    + +   +   + YLH
Sbjct: 98  -----YENTSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYLH 148

Query: 680 HHCKPPVVHGDLKPSNVLLDHD------MVAHVGDFGLAKFL-PARPLDTVVETPSSSSG 732
            +    +VH DLKP N+LL          +    DFG+++ +  A  L  ++        
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIM-------- 194

Query: 733 IKGTVGYIAPE------YGTGSEASMTGDVYSFGILL 763
             GT  Y+APE        T +      D+++ GI+ 
Sbjct: 195 --GTPEYLAPEILNYDPITTAT------DMWNIGIIA 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGAL-KSFLTECEALRSIRHR 611
              +++ + +G+G++G V       N + VA+K ++  +     +  L E + L   RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 612 NLIK---IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ--NNDKLEV--CNLSLIQT 664
           N+I    II   +      V    IV D M     E  L++      L        L Q 
Sbjct: 86  NIIGINDIIRAPTIEQMKDV---YIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQI 137

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L         ++Y+H      V+H DLKPSN+LL+      + DFGL     AR  D   
Sbjct: 138 LR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL-----ARVADPDH 182

Query: 725 ETPSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRR 770
           +     +    T  Y APE        + + D++S G +L EM S R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F     +G GSFG V      E+G   A+K+L+   +++   ++  L E   L+++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLH-QNNDKLEVCNLSLIQTLNIAI 669
             L+K+    S  D + +     V +++  G +  + H +   +              A 
Sbjct: 101 PFLVKLE--FSFKDNSNLYM---VMEYVAGGEM--FSHLRRIGRFSEP-----HARFYAA 148

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +    EYLH      +++ DLKP N+L+D      V DFG AK                
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----------RVKGR 194

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           +  + GT   +APE       +   D ++ G+L+ EM
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 51/237 (21%), Positives = 98/237 (41%), Gaps = 55/237 (23%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
              +++  ++G GSFG VF+  + E+   VA+K +   ++   +    E + +R ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPN 93

Query: 613 LIKII-TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ-------NNDKL--EVCNLSLI 662
           ++ +     S+ D     F  +V +++      E +++           +   +  L + 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLAK-FLPARPL 720
           Q L        ++ Y+H      + H D+KP N+LLD    V  + DFG AK  +   P 
Sbjct: 149 QLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 721 DTVVETPSSSSGIKGTVGYI------APEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
                           V YI      APE   G+   +   D++S G ++ E+   +
Sbjct: 199 ----------------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 65/243 (26%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR----------HR 611
           +G+G++G V+K I    G +VAVK +         +F    +A R+ R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSGHE 69

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ--NNDKLEV--CNLSLIQTLNI 667
           N++ ++ +  + +   V    +V+D+M     E  LH     + LE       + Q +  
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIK- 120

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
                  I+YLH      ++H D+KPSN+LL+ +    V DFGL++        T     
Sbjct: 121 ------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 728 SSSSGIKGTVG-------------YIAPE-------YGTGSEASMTGDVYSFGILLLEMF 767
           S +   +                 Y APE       Y  G       D++S G +L E+ 
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI------DMWSLGCILGEIL 225

Query: 768 SRR 770
             +
Sbjct: 226 CGK 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 48/228 (21%), Positives = 80/228 (35%), Gaps = 45/228 (19%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKS--FLTECEALRSIR---------H 610
           +  GS+G V  G+    G+ VA+K +                    R +R         H
Sbjct: 30  ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 611 RNLIKIITI---CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEV--CNLSLIQTL 665
            N++ +  I         + +    +V + M+   L + +H     +        +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKL---YLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 666 NIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT--V 723
                    +  LH   +  VVH DL P N+LL  +    + DF LA+   A    T  V
Sbjct: 145 L-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194

Query: 724 VETPSSSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRR 770
                          Y APE        +   D++S G ++ EMF+R+
Sbjct: 195 T-----------HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 58/366 (15%), Positives = 115/366 (31%), Gaps = 88/366 (24%)

Query: 139 LSNASNLELLELRDNQF----IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLA 194
           ++  S +E   L+ +         +        ++  ++L  N +G  AA  L     +A
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIA 57

Query: 195 NCSKLENLGLYDNQFGGLLPHSLANLS---------NTMTTIDIGGNYFSGTIPPGLGNL 245
           +   LE     D   G +       L            + T+ +  N F  T    L + 
Sbjct: 58  SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117

Query: 246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFL-------------HGYIPSSLGN 292
           +  +                      L+ LYL++N L                +     N
Sbjct: 118 LSKH--------------------TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKN 157

Query: 293 LTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTLSKNKL--DGVLPP--QILSV-TT 343
              L  +    N L+         +  +   L  + + +N +  +G+     + L+    
Sbjct: 158 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217

Query: 344 LSLFLNLSDNLLSG----SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQ 399
           L   L+L DN  +     +L   + +  NL +L ++    S    G  +   +       
Sbjct: 218 LK-VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR--GAAAVVDAF---SKL 271

Query: 400 DNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYL-----ENLSFLEYLNLSYNHF--E 452
           +N               ++ L L  N++     + L     E +  L +L L+ N F  E
Sbjct: 272 EN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318

Query: 453 GEVPKK 458
            +V  +
Sbjct: 319 DDVVDE 324

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 52/333 (15%), Positives = 97/333 (29%), Gaps = 73/333 (21%)

Query: 24  LENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGNRLGGK----IPDTLGQLRKLIYL 75
           +E  SL  + +T +    +   +    +++ I + GN +G +    + + +   + L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 76  NIGRNQ---FSGFIPPSIYNIS-------SFEFIFLQSNRF--HGSLPF-DMVANLPNLR 122
                        IP ++  +            + L  N F      P  D ++    L 
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 123 KFVAAKNNLT-------------GFLPISLSNASNLELLELRDNQF-------IGKMSIN 162
                 N L                +     NA  L  +    N+          K    
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT--- 182

Query: 163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN 222
           F S + L  + +  N +       L  +  LA C +L+ L L DN F             
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHL-LLEGLAYCQELKVLDLQDNTFT------------ 229

Query: 223 TMTTIDIGGNYFSGTIPPGLGNLVHL----NSIAMEGNQLIGTVPPEIGWLKNLQSLYLN 278
                 +G +  +  +     NL  L      ++  G   +            LQ+L L 
Sbjct: 230 -----HLGSSALAIAL-KSWPNLRELGLNDCLLSARGAAAVVDA-FSKLENIGLQTLRLQ 282

Query: 279 SNFLHG----YIPSSLG-NLTMLTLLALEINNL 306
            N +       + + +   +  L  L L  N  
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI-- 619
           +G G  G VF  +  +    VA+K + L    ++K  L E + +R + H N++K+  I  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 620 -----CSSIDFNGVDFKAI--VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
                 +    +  +  ++  V ++M+   L   L Q     E   L + Q L       
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR------ 131

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
             ++Y+H      V+H DLKP+N+ ++  D+V  +GDFGL     AR +D         S
Sbjct: 132 -GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL-----ARIMDPHYSHKGHLS 182

Query: 732 GIKGTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRR 770
               T  Y +P    + +  +   D+++ G +  EM + +
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 19/195 (9%)

Query: 143 SNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN 201
           ++ + L+L+ N+ +  +    F+ L  L +L L +N L    A       +      LE 
Sbjct: 37  ADTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG------IFKELKNLET 89

Query: 202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG----LGNLVHLNSIAMEGNQ 257
           L + DN+   L       L N    + +  N    ++PP     L  L +L+   +  N+
Sbjct: 90  LWVTDNKLQALPIGVFDQLVNL-AELRLDRNQLK-SLPPRVFDSLTKLTYLS---LGYNE 144

Query: 258 LIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
           L  ++P  +   L +L+ L L +N L      +   LT L  L L+ N L+     +  +
Sbjct: 145 L-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203

Query: 317 CTSLIMLTLSKNKLD 331
              L ML L +N  D
Sbjct: 204 LEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 11/193 (5%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTS 319
            +P  I    + + L L SN L      +   LT L LL L  N LQ  +P+ +     +
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNR 378
           L  L ++ NKL   LP  +         L L  N L  SLP  +  +L  L  L +  N 
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144

Query: 379 FSGDIP-GTLSACTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSSNKLSGQIPKYLE 436
               +P G     TSL+ +++ +N     +P    + L  +K L L +N+L        +
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 437 NLSFLEYLNLSYN 449
           +L  L+ L L  N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 6/175 (3%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP 63
           Q+NKL   +P +    L KL  L L +N L   LP  I   L  L+ + +  N+L     
Sbjct: 45  QSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPI 102

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVANLPNLR 122
               QL  L  L + RNQ    +PP ++ +++   ++ L  N    SLP  +   L +L+
Sbjct: 103 GVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160

Query: 123 KFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN 177
           +     N L      +    + L+ L+L +NQ        F+SL+ L +L L  N
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 40/188 (21%), Positives = 78/188 (41%), Gaps = 14/188 (7%)

Query: 48  LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYN-ISSFEFIFLQSNRF 106
            + +D++ N+L         +L KL  L +  N+    +P  I+  + + E +++  N+ 
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 107 HGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL-SNASNLELLELRDNQFIGKMSIN-FN 164
             +LP  +   L NL +    +N L   LP  +  + + L  L L  N+ +  +    F+
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE-LQSLPKGVFD 154

Query: 165 SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
            L +L  L L NN L                 ++L+ L L +NQ   +   +  +L   +
Sbjct: 155 KLTSLKELRLYNNQLKRVPEG------AFDKLTELKTLKLDNNQLKRVPEGAFDSLEK-L 207

Query: 225 TTIDIGGN 232
             + +  N
Sbjct: 208 KMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 10/128 (7%)

Query: 349 NLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIP 408
           + S   L+ ++PS I    +  +LD+  N+ S          T L  + + DN    ++P
Sbjct: 22  DCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77

Query: 409 PSL-NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVF---SNK 464
             +   LK+++ L ++ NKL        + L  L  L L  N  +  +P   VF   +  
Sbjct: 78  AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLP-PRVFDSLTKL 135

Query: 465 TRFSLSGN 472
           T  SL  N
Sbjct: 136 TYLSLGYN 143

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 27/228 (11%)

Query: 562 VGQGSFGTVFKGII-----GENGMLVAVKVLN-----LMQKGALKSFLTECEALRSIRHR 611
           +GQG FG ++   +       +     VKV       L  +        + E ++     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFM----QNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
             +K + +         D     Y FM        L++    N  +      S    L +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF-----SRKTVLQL 157

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDMVAHVGDFGLAKFLPARPLDTVVE 725
           ++ +   +EY+H H     VHGD+K SN+LL+  +    ++ D+GLA      P      
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY--CPEGVHKA 212

Query: 726 TP-SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                     GT+ + + +   G   S  GD+   G  +++  +   P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F     +G GSFG V       NG   A+KVL    +++   ++    E   L  + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             +I++    +   F       ++ D+++ G L   L + + +              A +
Sbjct: 66  PFIIRMW--GT---FQDAQQIFMIMDYIEGGELF-SLLRKSQRF-----PNPVAKFYAAE 114

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPS 728
           V  A+EYLH      +++ DLKP N+LLD +   H+   DFG AK             P 
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK-----------YVPD 158

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            +  + GT  YIAPE  +    + + D +SFGIL+ EM
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 196

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 33/214 (15%)

Query: 561 MVGQGSFGTVF---KGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLI 614
           ++GQGSFG VF   K    +   L A+KVL    L  +  +++   E + L  + H  ++
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           K+    +   F       ++ DF++ G L   L +     EV   +         ++A A
Sbjct: 90  KLH--YA---FQTEGKLYLILDFLRGGDLFTRLSK-----EVM-FTEEDVKFYLAELALA 138

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSG 732
           +++LH      +++ DLKP N+LLD +   H+   DFGL+K       +++     + S 
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK-------ESIDHEKKAYS- 185

Query: 733 IKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
             GTV Y+APE       + + D +SFG+L+ EM
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 33/225 (14%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRH 610
              + S   VG G++G+V   I   +G  VA+K +    Q     K    E   L+ ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 611 RNLIKIITI----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
            N+I ++ +     S  +F       +V  FMQ   L++ +     + E     + Q L 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDF---YLVMPFMQT-DLQKIMGLKFSE-EKIQYLVYQMLK 137

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
                   ++Y+H      VVH DLKP N+ ++ D    + DFGLA+   A     VV  
Sbjct: 138 -------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 185

Query: 727 PSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
                    T  Y APE        + T D++S G ++ EM + +
Sbjct: 186 ---------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 48/257 (18%), Positives = 94/257 (36%), Gaps = 62/257 (24%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN 612
           + ++S    +G GSFG V +    E+G   A+K +    +   +    E + ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 613 LIKIITI--CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN---LSLIQ---- 663
           +IK++     +  +          ++ +   +     H  +  +       L++I     
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 664 -TLNIAIDVAS--------------------AIEYLHHHCKPPVVHGDLKPSNVLLD-HD 701
            TL+  +                        A+ ++H      + H D+KP N+L++  D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKD 178

Query: 702 MVAHVGDFGLAK-FLPARPLDTVVETPSSSSGIKGTVGYI------APEYGTGSEASMTG 754
               + DFG AK  +P+ P                 V YI      APE   G+      
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS----------------VAYICSRFYRAPELMLGATEYTPS 222

Query: 755 -DVYSFGILLLEMFSRR 770
            D++S G +  E+   +
Sbjct: 223 IDLWSIGCVFGELILGK 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 51/258 (19%), Positives = 86/258 (33%), Gaps = 60/258 (23%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G GS+G V +        +VA+K +  +       K  L E   L  + H +++K++ I
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 620 CSSIDFNGVDFKAI--VYDFMQNGSLEEWLHQ---NNDKLE---VCNLSLIQTLNIAIDV 671
               D     F  +  V +   +        +       L    +  L L   L      
Sbjct: 121 VIPKDVE--KFDELYVVLEIADSD-----FKKLFRTPVYLTELHIKTL-LYNLLV----- 167

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              ++Y+H      ++H DLKP+N L++ D    V DFGLA+ +            S   
Sbjct: 168 --GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 732 GIKGTVG-------------------YIAPE-------YGTGSEASMTGDVYSFGILLLE 765
                V                    Y APE       Y          DV+S G +  E
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI------DVWSIGCIFAE 276

Query: 766 MFSRRRPTDSMFHEGLTL 783
           + +  +   +   +   L
Sbjct: 277 LLNMIKENVAYHADRGPL 294

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 40/205 (19%), Positives = 74/205 (36%), Gaps = 36/205 (17%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRHRNLIKIITI 619
           +G+GS+G V+          VA+K V  + +     K  L E   L  ++   +I++  +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 620 C---SSIDFNGVDFKAIVYDFMQNGSLEEWLHQ---NNDKLEV--CNLSLIQTLNIAIDV 671
                 + F+ +    IV +       +  L +       L        L   L      
Sbjct: 94  IIPDDLLKFDEL---YIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLL----- 140

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
                ++H   +  ++H DLKP+N LL+ D    V DFGL     AR +++      ++ 
Sbjct: 141 --GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL-----ARTINS---EKDTNI 187

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDV 756
                       +    +  +T  V
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHV 212

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 29/211 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
              +   F   D    V ++   G L   L +          +  +      ++ SA+EY
Sbjct: 72  --YA---FQTHDRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEY 120

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           LH      VV+ D+K  N++LD D   H+   DFGL K          +   ++     G
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--------EGISDGATMKTFCG 167

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
           T  Y+APE    ++     D +  G+++ EM
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL-NLMQKGALKSFLTECEALRSIRHR---NLIKI 616
           ++G+GSFG V K    +    VA+K++ N  +K   +    E   L  +R +   N + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           I +  +  F       + ++ +   +L E + +N  +      SL      A  +   ++
Sbjct: 162 IHMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ----GFSLPLVRKFAHSILQCLD 214

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAH--VGDFGLAKFLPARPLDTVVETPSSSSGIK 734
            LH +    ++H DLKP N+LL     +   V DFG + +   + + T +++        
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTYIQSRF------ 264

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
               Y APE   G+   M  D++S G +L E+ +
Sbjct: 265 ----YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 40/220 (18%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRHRNLIKIITI 619
           VG G++G V   + G  G  VA+K +    Q     K    E   L+ +RH N+I ++ +
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 620 ----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ--NNDKL--EVCNLSLIQTLNIAIDV 671
                +  DF       +V  FM        L +   ++KL  +     + Q L      
Sbjct: 93  FTPDETLDDFTDF---YLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLK----- 139

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
              + Y+H      ++H DLKP N+ ++ D    + DFGLA+   +     VV       
Sbjct: 140 --GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV------- 187

Query: 732 GIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRR 770
               T  Y APE        + T D++S G ++ EM + +
Sbjct: 188 ----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.6 bits (174), Expect = 3e-13
 Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 33/215 (15%)

Query: 561 MVGQGSFGTVF---KGIIGENGMLVAVKVL---NLMQKG-ALKSFLTECEALRSIRHRNL 613
           ++G+G +G VF   K      G + A+KVL    +++          E   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           + +I   +   F       ++ +++  G L   L +                    +++ 
Sbjct: 84  VDLI--YA---FQTGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISM 132

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSS 731
           A+ +LH      +++ DLKP N++L+H    HV   DFGL K       +++ +   + +
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK-------ESIHDGTVTHT 180

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
              GT+ Y+APE    S  +   D +S G L+ +M
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 4e-13
 Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 33/227 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GSFG V          L AVK+L    ++Q   ++  + E   L        +  +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
             C    F  +D    V +++  G L   + Q               +  A ++A  + +
Sbjct: 408 HSC----FQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFF 457

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           L       +++ DLK  NV+LD +   H+   DFG+ K          +    ++    G
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--------ENIWDGVTTKTFCG 504

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMF 777
           T  YIAPE         + D ++FG+LL EM + + P      D +F
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 33/167 (19%), Positives = 66/167 (39%), Gaps = 25/167 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKS------FLTECEALRSIRHRNL 613
           +G G FG ++           A  V+ +   + G L S       + + + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 614 IKIITI-----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +  + I         +F G  ++ +V +      L++   QN              L + 
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQKISGQNG------TFKKSTVLQLG 157

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDMVAHVGDFGLAK 713
           I +   +EY+H +     VHGD+K +N+LL   +    ++ D+GL+ 
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 43/218 (19%), Positives = 76/218 (34%), Gaps = 14/218 (6%)

Query: 237 TIPPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPS-SLGNLT 294
            IP    +   L    +     + T+P      L N+  +Y++ +     + S S  NL+
Sbjct: 25  RIPSLPPSTQTLK---LIETH-LRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 295 MLTLLALEINNLQGKIPSS-LGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
            +T + +        I    L     L  L +    L        +  T +   L ++DN
Sbjct: 81  KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDN 140

Query: 354 LLSGSLPSEI-GNLKN-LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL 411
               S+P      L N  + L +  N F+       +  T L+ V +  N +   I    
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDA 199

Query: 412 --NFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNL 446
                    +LD+S   ++  +P   LE+L  L   N 
Sbjct: 200 FGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 36/216 (16%), Positives = 81/216 (37%), Gaps = 21/216 (9%)

Query: 118 LPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-FNSLKNLSVLILGN 176
            P+ +     + +L      + SN  N+  + +  +  + ++  + F +L  ++ + + N
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 177 NHLGNRAANDLDFV--TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF 234
                    +L ++    L     L+ LG+++         +    ++    ++I  N +
Sbjct: 90  T-------RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPY 142

Query: 235 SGTIPP----GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSL 290
             +IP     GL N     ++ +  N    +V         L ++YLN N     I    
Sbjct: 143 MTSIPVNAFQGLCNE--TLTLKLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199

Query: 291 --GNLTMLTLLALEINNLQGKIPS-SLGNCTSLIML 323
             G  +  +LL +   ++   +PS  L +   LI  
Sbjct: 200 FGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 39/238 (16%), Positives = 89/238 (37%), Gaps = 18/238 (7%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
           C   + E+  +    +  ++P       + Q + +    L          L  +  + + 
Sbjct: 8   CECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63

Query: 79  RNQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPI 137
            +     +     YN+S    I +++ R    +  D +  LP L+        L  F  +
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDL 123

Query: 138 S-LSNASNLELLELRDNQFIGKMSIN-FNSLKNLSV-LILGNNHLGNRAANDLDFVTVLA 194
           + + +     +LE+ DN ++  + +N F  L N ++ L L NN   +             
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF------- 176

Query: 195 NCSKLENLGLYDNQF-GGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNS 250
           N +KL+ + L  N++   +   +   + +  + +D+     +  +P   L +L  L +
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 34/186 (18%), Positives = 69/186 (37%), Gaps = 9/186 (4%)

Query: 271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SLGNCTSLIMLTLSKNK 329
           + Q+L L    L      +  NL  ++ + + I+    ++ S S  N + +  + +   +
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 330 LDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE--IGNLKNLVQLDISGNRFSGDIP-GT 386
               + P  L    L  FL + +  L    P    + +      L+I+ N +   IP   
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 387 LSACTS-LEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY-LENL-SFLEY 443
                +    +K+ +N F+ S+         +  + L+ NK    I K     + S    
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 444 LNLSYN 449
           L++S  
Sbjct: 210 LDVSQT 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 36/186 (19%), Positives = 64/186 (34%), Gaps = 30/186 (16%)

Query: 21  LFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP-DTLGQLRKLIYLNIG 78
           L  +  + ++ +    QL      NLS +  I+IR  R    I  D L +L  L +L I 
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 79  RNQFSGFIPP--SIYNISSFEFIFLQSNRFHGSLPFDMVANLPN-LRKFVAAKNNLTGFL 135
                   P    +Y+   F  + +  N +  S+P +    L N         N  T  +
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SV 171

Query: 136 PISLSNASNLELLELRDNQFIGKM-----------------------SINFNSLKNLSVL 172
                N + L+ + L  N+++  +                       ++    L++L  L
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231

Query: 173 ILGNNH 178
           I  N  
Sbjct: 232 IARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 22/164 (13%), Positives = 52/164 (31%), Gaps = 35/164 (21%)

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDIS 375
           C       ++   +  +  P +   T     L L +  L  ++PS    NL N+ ++ +S
Sbjct: 10  CHQEEDFRVTCKDIQRI--PSLPPSTQ---TLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 376 GNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPK-Y 434
            +     +                 +SF          L  +  +++ + +    I    
Sbjct: 64  IDVTLQQLE---------------SHSFYN--------LSKVTHIEIRNTRNLTYIDPDA 100

Query: 435 LENLSFLEYLNLSYNHFEGEVPKKGVFSN---KTRFSLSGNGKL 475
           L+ L  L++L +     +   P      +        ++ N  +
Sbjct: 101 LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 28/173 (16%), Positives = 60/173 (34%), Gaps = 34/173 (19%)

Query: 562 VGQGSFGTVFKGI--------IGENGMLVAVKV----------LNLMQKGALKSFLTECE 603
             + + G +++           G      ++K+           N  Q+ A    + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 604 ALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQ 663
            L S     +   +        +   ++ +V       SL+  L  +   +    LS   
Sbjct: 110 KLYSTPLLAIPTCM----GFGVHQDKYRFLVLP-SLGRSLQSALDVSPKHV----LSERS 160

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAK 713
            L +A  +  A+E+LH +     VHG++   N+ +   D   V  +  +G A 
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.4 bits (173), Expect = 6e-13
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 32/225 (14%)

Query: 553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVK-VLNLMQKGAL-KSFLTECEALRSIRH 610
              + + + VG G++G+V      + G+ VAVK +    Q     K    E   L+ ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 611 RNLIKIITI----CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLN 666
            N+I ++ +     S  +FN V    +V   M    L   +       +     + Q L 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR 143

Query: 667 IAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVET 726
                   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+         V   
Sbjct: 144 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-- 191

Query: 727 PSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRR 770
                    T  Y APE        + T D++S G ++ E+ + R
Sbjct: 192 ---------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 53/257 (20%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-----HRNLIK 615
            +G G F TV+     +    VA+KV+   +    ++ L E   L+S+R       N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 616 IITICSSIDFNGVDFK--AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           ++ +      +GV+     +V++ + +  L +W+ ++N +     L L     I   V  
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG----LPLPCVKKIIQQVLQ 157

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS--- 730
            ++YLH  C+  ++H D+KP N+LL  +          A             +  S+   
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 731 -----------------------------------SGIKGTVGYIAPEYGTGSEASMTGD 755
                                              +    T  Y + E   GS  +   D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 756 VYSFGILLLEMFSRRRP 772
           ++S   +  E+ +    
Sbjct: 276 IWSTACMAFELATGDYL 292

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           M+G+GSFG VF     +     A+K L    ++    ++  + E   L  +  H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
              C+   F   +    V +++  G L   +   +         L +    A ++   ++
Sbjct: 84  F--CT---FQTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQ 132

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +LH      +V+ DLK  N+LLD D   H+   DFG+ K          +   + ++   
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK--------ENMLGDAKTNTFC 179

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMF 777
           GT  YIAPE   G + + + D +SFG+LL EM   + P      + +F
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 44/197 (22%), Positives = 64/197 (32%), Gaps = 37/197 (18%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPS--SLGNLTMLTLLALEINNLQGKIPS-SLGNC 317
            VP  +        L L+ N L   + +  +   LT L  L L  N+L   I S +    
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 318 TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGN 377
            +L  L LS N L   L   + S                        +L+ L  L +  N
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFS------------------------DLQALEVLLLYNN 122

Query: 378 RFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP----SLNFLKSIKVLDLSSNKLSGQIPK 433
                          L+ + +  N  S   P       N L  + +LDLSSNKL      
Sbjct: 123 HIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181

Query: 434 YLENLSFLEYLNLSYNH 450
            L+ L       L  ++
Sbjct: 182 DLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)

Query: 310 IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKN 368
           +P SL + T+  +L LS N L  +      +  T    L LS N L+  + SE    + N
Sbjct: 33  VPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89

Query: 369 LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKL 427
           L  LD+S N          S   +LE + + +N     +   +   +  ++ L LS N++
Sbjct: 90  LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148

Query: 428 SGQIP----KYLENLSFLEYLNLSYNHFE 452
           S + P    K    L  L  L+LS N  +
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 32/163 (19%), Positives = 62/163 (38%), Gaps = 12/163 (7%)

Query: 199 LENLGLYDNQFGGLLPH-SLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGN 256
              L L  N    L    +   L+N + ++ +  N+ +  I       + +L  + +  N
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTN-LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 257 QLIGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIP---- 311
            L  T+   +   L+ L+ L L +N +     ++  ++  L  L L  N +  + P    
Sbjct: 99  HL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156

Query: 312 SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS-LFLNLSDN 353
                   L++L LS NKL  +    +  +       L L +N
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 34/187 (18%), Positives = 56/187 (29%), Gaps = 30/187 (16%)

Query: 48  LQVIDIRGNRLGGKIPDT-LGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRF 106
             ++D+  N L     +    +L  L  L +  N  +                       
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN----------------------- 77

Query: 107 HGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSL 166
              +  +    +PNLR    + N+L        S+   LE+L L +N  +      F  +
Sbjct: 78  --FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135

Query: 167 KNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN-TMT 225
             L  L L  N +       +     L    KL  L L  N+   L    L  L      
Sbjct: 136 AQLQKLYLSQNQISRFPVELIKDGNKL---PKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192

Query: 226 TIDIGGN 232
            + +  N
Sbjct: 193 GLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 27/142 (19%), Positives = 47/142 (33%), Gaps = 10/142 (7%)

Query: 21  LFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           L  L +L L+ NHL   +       +  L+ +D+  N L          L+ L  L +  
Sbjct: 63  LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121

Query: 80  NQFSGFIPPSI-YNISSFEFIFLQSNRFHGSLP---FDMVANLPNLRKFVAAKNNLTGFL 135
           N     +  +   +++  + ++L  N+     P         LP L     + N L    
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179

Query: 136 PISLSNASNLEL--LELRDNQF 155
              L          L L +N  
Sbjct: 180 LTDLQKLPAWVKNGLYLHNNPL 201

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 35/229 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           ++G+GSFG V         +  AVKVL    +++K   K  ++E   L ++++H  L+ +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
               S   F   D    V D++  G L   L +     E C     +    A ++ASA+ 
Sbjct: 105 H--FS---FQTADKLYFVLDYINGGELFYHLQR-----ERC-FLEPRARFYAAEIASALG 153

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIK 734
           YLH      +V+ DLKP N+LLD     H+   DFGL K          +E  S++S   
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK--------ENIEHNSTTSTFC 200

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMFH 778
           GT  Y+APE         T D +  G +L EM     P     T  M+ 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 32/134 (23%), Positives = 58/134 (43%), Gaps = 5/134 (3%)

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQL 258
             + L  N    + P + +     +  ID+  N  S  + P     L  LNS+ + GN++
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKK-LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92

Query: 259 IGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC 317
              +P  +   L +LQ L LN+N ++     +  +L  L LL+L  N LQ     +    
Sbjct: 93  -TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 318 TSLIMLTLSKNKLD 331
            ++  + L++N   
Sbjct: 152 RAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 9/138 (6%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSL 275
            NL  T+T I +  N     IPPG       L  I +  NQ+   + P+    L++L SL
Sbjct: 28  TNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSL 85

Query: 276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLP 335
            L  N +     S    L  L LL L  N +      +  +  +L +L+L  NKL  +  
Sbjct: 86  VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI-A 144

Query: 336 PQIL----SVTTLSLFLN 349
                   ++ T+ L  N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 32/145 (22%), Positives = 58/145 (40%), Gaps = 7/145 (4%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            +P  +   + +  + L  N +    P +      L  + L  N +    P +     SL
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 321 IMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNR 378
             L L  NK+   LP  +   + +L L L L+ N ++  L  +   +L NL  L +  N+
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQL-LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSF 403
                 GT S   +++ + +  N F
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 31/133 (23%), Positives = 55/133 (41%), Gaps = 3/133 (2%)

Query: 25  ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSG 84
             + L +N +    P +      L+ ID+  N++    PD    LR L  L +  N+ + 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 85  FIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
            +P S+   + S + + L +N+ +  L  D   +L NL       N L      + S   
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 144 NLELLELRDNQFI 156
            ++ + L  N FI
Sbjct: 153 AIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 5/132 (3%)

Query: 323 LTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSG 381
           + L +N +  V+PP   S       ++LS+N +S  L  +    L++L  L + GN+ + 
Sbjct: 37  IRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 382 DIPGTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSNKLSGQIPKYLENLSF 440
                     SL+ + +  N  +  +   +   L ++ +L L  NKL          L  
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 441 LEYLNLSYNHFE 452
           ++ ++L+ N F 
Sbjct: 154 IQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 31/164 (18%), Positives = 50/164 (30%), Gaps = 37/164 (22%)

Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG 108
             I +  N +    P      +KL  +++  NQ                   +       
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ-------------------ISE----- 70

Query: 109 SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI---NFNS 165
            L  D    L +L   V   N +T           +L+LL L  N+      +    F  
Sbjct: 71  -LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI---NCLRVDAFQD 126

Query: 166 LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQF 209
           L NL++L L +N L   A               ++ + L  N F
Sbjct: 127 LHNLNLLSLYDNKLQTIAKGTFS------PLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 29/150 (19%), Positives = 55/150 (36%), Gaps = 20/150 (13%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
           +P +I        I L+ N     +P    +    LR+   + N ++   P +     +L
Sbjct: 30  LPETI------TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 146 ELLELRDNQFIGKMSIN---FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
             L L  N+      +    F  L +L +L+L  N +     +         +   L  L
Sbjct: 83  NSLVLYGNKI---TELPKSLFEGLFSLQLLLLNANKINCLRVD------AFQDLHNLNLL 133

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGN 232
            LYDN+   +   + + L   + T+ +  N
Sbjct: 134 SLYDNKLQTIAKGTFSPLRA-IQTMHLAQN 162

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 54/272 (19%), Positives = 87/272 (31%), Gaps = 78/272 (28%)

Query: 563 GQGSFGTVFKGII-----GENGMLVAVKVLN----------------------------- 588
           G+G+FG V +              VAVK+L                              
Sbjct: 31  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90

Query: 589 -----------------LMQKGALKSFL-----------TECEALRSIRHRNLIKIITIC 620
                              + G L ++L           T+    R  +       + + 
Sbjct: 91  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLE-EWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             +D       +    F++  SL      +  + L    L+L   +  +  VA  +E+L 
Sbjct: 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  +H DL   N+LL    V  + DFGLA+ +        V    +   +K     
Sbjct: 211 SR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWM--- 262

Query: 740 IAPE---YGTGSEASMTGDVYSFGILLLEMFS 768
            APE       +  S   DV+SFG+LL E+FS
Sbjct: 263 -APETIFDRVYTIQS---DVWSFGVLLWEIFS 290

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 24/159 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG +  G        VA+K+  +  +        E    +      L     I  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQ-----LGSGDGIPQ 69

Query: 622 SIDFNGV--DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              F G    + A+V + +   SLE+     +        SL   L IAI + S +EY+H
Sbjct: 70  VYYF-GPCGKYNAMVLE-LLGPSLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122

Query: 680 HHCKPPVVHGDLKPSNVLLDHDM-----VAHVGDFGLAK 713
                 +++ D+KP N L+         V H+ DF LAK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 24/104 (23%)

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPS 728
           +  A+E+LH      +++ D+K  N+LLD +   HV   DFGL+K       + V +   
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSK-------EFVADETE 215

Query: 729 SSSGIKGTVGYIAPE------YGTGSEASMTGDVYSFGILLLEM 766
            +    GT+ Y+AP+       G         D +S G+L+ E+
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYEL 255

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 51/236 (21%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GSFG V    + E G L AVKVL    ++Q   ++  +TE         + ++ + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE---------KRILSLA 80

Query: 618 TICSSIDFNGVDFKA---------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
                +                   V +F+  G L   + ++            +    A
Sbjct: 81  RNHPFL----TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYA 130

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVET 726
            ++ SA+ +LH      +++ DLK  NVLLDH+   H    DFG+ K          +  
Sbjct: 131 AEIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK--------EGICN 177

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMF 777
             +++   GT  YIAPE           D ++ G+LL EM     P      D +F
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEAL-RSIRHRNLIKI 616
           ++G+GSFG V          L AVK+L    ++Q   ++  + E   L    +   L ++
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
                   F  +D    V +++  G L   + Q               +  A ++A  + 
Sbjct: 87  H--SC---FQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLF 135

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +L       +++ DLK  NV+LD +   H+   DFG+ K       + + +  ++ +   
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-------ENIWDGVTTKT-FC 182

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-----TDSMF 777
           GT  YIAPE         + D ++FG+LL EM + + P      D +F
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 47/217 (21%), Positives = 89/217 (41%), Gaps = 31/217 (14%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR---NL 613
           +++G+GSFG V K         VA+K++         A      E   L  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
             I+ +     F       +V++ +   +L + L   N +     +SL  T   A  + +
Sbjct: 116 YYIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFR----GVSLNLTRKFAQQMCT 168

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH--VGDFGLAKFLPARPLDTVVETPSSSS 731
           A+ +L    +  ++H DLKP N+LL +   +   + DFG +  L  + +   +++     
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQYIQSRF--- 223

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS 768
                  Y +PE   G    +  D++S G +L+EM +
Sbjct: 224 -------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 46/226 (20%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GS+  V    + +   + A+KV+    +     +    TE         +++ +  
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE---------KHVFEQA 66

Query: 618 TICSSIDFNGVDFKA---------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +    +    V   +          V +++  G L   + +         L        +
Sbjct: 67  SNHPFL----VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYS 116

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVET 726
            +++ A+ YLH      +++ DLK  NVLLD +   H+   D+G+ K          +  
Sbjct: 117 AEISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--------EGLRP 163

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             ++S   GT  YIAPE   G +   + D ++ G+L+ EM + R P
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 24/159 (15%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GSFG +F+G    N   VA+K               E    +      L     I +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL-----LAGCTGIPN 70

Query: 622 SIDFNGV--DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              F G       +V D +   SLE+ L     K      S+      A  + + ++ +H
Sbjct: 71  VYYF-GQEGLHNVLVID-LLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIH 123

Query: 680 HHCKPPVVHGDLKPSNVLL-----DHDMVAHVGDFGLAK 713
                 +V+ D+KP N L+      +  + +V DFG+ K
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 45/226 (19%), Positives = 91/226 (40%), Gaps = 46/226 (20%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G+GS+  V    + +   + A++V+    +     +    TE         +++ +  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE---------KHVFEQA 109

Query: 618 TICSSIDFNGVDFKA---------IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
           +    +    V   +          V +++  G L   + +         L        +
Sbjct: 110 SNHPFL----VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYS 159

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVET 726
            +++ A+ YLH      +++ DLK  NVLLD +   H+   D+G+ K          +  
Sbjct: 160 AEISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--------EGLRP 206

Query: 727 PSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             ++S   GT  YIAPE   G +   + D ++ G+L+ EM + R P
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 22/157 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G GSFG ++ G     G  VA+K+  +  K        E +       + +   + I +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIY-----KMMQGGVGIPT 69

Query: 622 SIDFNGV--DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                G   D+  +V + +   SLE+  +  + K      SL   L +A  + S IEY+H
Sbjct: 70  IRWC-GAEGDYNVMVME-LLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIH 122

Query: 680 HHCKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAK 713
                  +H D+KP N L+       + ++ DFGLAK
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 17/155 (10%)

Query: 563 GQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITICS 621
           G G  G V +          A+K+L    K        E E   R+ +  ++++I+ +  
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYE 81

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           +  + G     IV + +  G L   +    D+      +  +   I   +  AI+YLH  
Sbjct: 82  N-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI 136

Query: 682 CKPPVVHGDLKPSNVLL---DHDMVAHVGDFGLAK 713
               + H D+KP N+L      + +  + DFG AK
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.7 bits (154), Expect = 2e-10
 Identities = 100/639 (15%), Positives = 179/639 (28%), Gaps = 207/639 (32%)

Query: 61  KIPDTLGQLRKL--IYLNIGRNQFSGFIPPSI---YNISSFEFIFLQSNRFHGSLPFDMV 115
              D +    +L    L+        F+   +   Y        FL S       P    
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK-------FLMS-------PIKTE 101

Query: 116 ANLPNL--RKFVAAKNNLTG----FLPISLSNASNLE-----LLELRDNQFI-------- 156
              P++  R ++  ++ L      F   ++S           LLELR  + +        
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS 161

Query: 157 GKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTV---------LANCSKLENLGLYDN 207
           GK           + + L                           L NC+  E +     
Sbjct: 162 GK-----------TWVAL-------DVCLSYKVQCKMDFKIFWLNLKNCNSPETV----- 198

Query: 208 QFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIG 267
                    L  L   +  ID          P       H ++I +  + +         
Sbjct: 199 ---------LEMLQKLLYQID----------PNWTSRSDHSSNIKLRIHSI-------QA 232

Query: 268 WLKNLQSL--YLNSNFLHGYIPSSLGNLTMLTLLAL-EINNLQGKIPSSLG-NCTSLIML 323
            L+ L     Y N                   LL L  + N   K  ++   +C  L+  
Sbjct: 233 ELRRLLKSKPYENC------------------LLVLLNVQN--AKAWNAFNLSCKILL-T 271

Query: 324 TLSKNKLDGVLPPQILSVT------------TLSLFLN-LSDNLLSGSLPSEIGNLKNLV 370
           T  K   D +       ++              SL L  L  +     LP E+       
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRR 329

Query: 371 QLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFL---------KSIKVLD 421
            L I        +       T   +  +  +  +  I  SLN L           + V  
Sbjct: 330 -LSIIAESIRDGL------ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382

Query: 422 LSSNKLSGQIPKYLENLSFLEYLNLSYN---HFEGEVPKKG-VFSNKTRFSLSGNGKLCG 477
            S++     IP  L  LS + + ++  +       ++ K   V       ++S    +  
Sbjct: 383 PSAH-----IPTIL--LSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS----IPS 430

Query: 478 GLDEFHLPSCPSKRS--RKLIA--TILKVVIPTIVSCLIL---SACFIVIYGRRRSTDRS 530
              E  +    ++ +  R ++    I K      +    L       I   G        
Sbjct: 431 IYLELKVK-LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI---GHHLKNIEH 486

Query: 531 FERTTMVEQQFPMISY-------AKLSKATSEF----SSSNMVGQGSFGTVFKGIIGENG 579
            ER T+    F M+ +        K+   ++ +    S  N + Q  F   +K  I +N 
Sbjct: 487 PERMTL----FRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDND 538

Query: 580 MLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKI 616
                 V       A+  FL + E   + S ++ +L++I
Sbjct: 539 PKYERLV------NAILDFLPKIEENLICS-KYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 3e-07
 Identities = 67/501 (13%), Positives = 142/501 (28%), Gaps = 157/501 (31%)

Query: 420 LDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGL 479
                  +   +  + +   F++  N      +     K + S +              +
Sbjct: 14  HQYQYKDI---LSVFEDA--FVD--NFDCKDVQDMP--KSILSKEE-------------I 51

Query: 480 DE-FHLPSCPSKRSRKLIATIL----KVVIPTIVSCLILSACFIVIYGRRRSTDRSFERT 534
           D            + +L  T+L    ++V   +   L ++  F++   +      S    
Sbjct: 52  DHIIMSKD-AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110

Query: 535 TMVEQQFPMIS---------------YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENG 579
             +EQ+  + +               Y KL +A  E   +  V       +        G
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV------LID-------G 157

Query: 580 MLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQ 639
           +            G+ K+++   +   S +         +   +DF        ++    
Sbjct: 158 V-----------LGSGKTWVA-LDVCLSYK---------VQCKMDFK-------IF---- 185

Query: 640 NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPS----- 694
                 WL+  N       L ++Q L   ID  +      H     +    ++       
Sbjct: 186 ------WLNLKNCNSPETVLEMLQKLLYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLL 238

Query: 695 ------NVLLDHDMV---AHVGDFGL-AKFLPARPLDTVVETPSSS---SGIKGTVGYIA 741
                 N LL    V        F L  K         ++ T            T  +I+
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCK--------ILLTTRFKQVTDFLSAATTTHIS 290

Query: 742 PEYGTGSEASMTGDVYSFGILL--LEMFSRRRPTD-------------SMF----HEGLT 782
            ++      ++T D     +LL  L+     RP D             S+      +GL 
Sbjct: 291 LDH---HSMTLTPD-EVKSLLLKYLDC----RPQDLPREVLTTNPRRLSIIAESIRDGLA 342

Query: 783 LHEFSKMVLPEKVMEIVDPSL-LL---EVRAN-NSMSRGGERVKIEECLVAVIRIGVVCS 837
             +  K V  +K+  I++ SL +L   E R   + +S       I      ++ + +   
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT---ILLSL-IWFD 398

Query: 838 MESPTDRMQMRDVVVKLCAAR 858
           +      + +  +       +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEK 419

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 4/134 (2%)

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG-LGNLVHLNSIAMEGNQL 258
             L L +N+F  L    +      +  I+   N  +  I  G       +N I +  N+L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 259 IGTVPPEI-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC 317
              V  ++   L++L++L L SN +      S   L+ + LL+L  N +    P +    
Sbjct: 94  E-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152

Query: 318 TSLIMLTLSKNKLD 331
            SL  L L  N  +
Sbjct: 153 HSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 25/146 (17%), Positives = 56/146 (38%), Gaps = 8/146 (5%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSL-GNLTMLTLLALEINNLQGKIPSSLGNCTS 319
            +P  I   +    L LN+N       + +   L  L  +    N +      +    + 
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 320 LIMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGN 377
           +  + L+ N+L+  +  ++   + +L   L L  N ++  + ++    L ++  L +  N
Sbjct: 83  VNEILLTSNRLEN-VQHKMFKGLESLKT-LMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 378 RFSGDIPGTLSACTSLEYVKMQDNSF 403
           + +   PG      SL  + +  N F
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 33/147 (22%), Positives = 57/147 (38%), Gaps = 13/147 (8%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
           IP           + L +N F       +   LP LRK   + N +T     +   AS +
Sbjct: 30  IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
             + L  N+        F  L++L  L+L +N +     +           S +  L LY
Sbjct: 84  NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGND------SFIGLSSVRLLSLY 137

Query: 206 DNQFGGLLPHSLANLSNTMTTIDIGGN 232
           DNQ   + P +   L + ++T+++  N
Sbjct: 138 DNQITTVAPGAFDTLHS-LSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 4/133 (3%)

Query: 25  ENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
             L L  N  T      I   L  L+ I+   N++             +  + +  N+  
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 84  GFIPPSI-YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNA 142
             +   +   + S + + L+SNR    +  D    L ++R      N +T   P +    
Sbjct: 95  N-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152

Query: 143 SNLELLELRDNQF 155
            +L  L L  N F
Sbjct: 153 HSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 34/151 (22%)

Query: 326 SKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSGDIP 384
           S  KL+ + P  I   T     L L++N  +    + I   L  L +++ S N+      
Sbjct: 19  SNQKLNKI-PEHIPQYTAE---LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI----- 69

Query: 385 GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYL 444
                 T +E     + +F G           +  + L+SN+L     K  + L  L+ L
Sbjct: 70  ------TDIE-----EGAFEG--------ASGVNEILLTSNRLENVQHKMFKGLESLKTL 110

Query: 445 NLSYNHFEGEVPKKGVF---SNKTRFSLSGN 472
            L  N     V     F   S+    SL  N
Sbjct: 111 MLRSNRIT-CVG-NDSFIGLSSVRLLSLYDN 139

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 22/119 (18%), Positives = 42/119 (35%), Gaps = 5/119 (4%)

Query: 5   QNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSI-GNLSALQVIDIRGNRLGGKIP 63
            NN+        I   L +L  ++ + N +T  +        S +  I +  NRL     
Sbjct: 40  NNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQH 98

Query: 64  DTLGQLRKLIYLNIGRNQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
                L  L  L +  N+ +  +    +  +SS   + L  N+   ++       L +L
Sbjct: 99  KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSL 155

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 35/228 (15%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR--NLIK 615
            +G G+FG V      +N    AVKV+       + A      E + L+ I++   N   
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVCNLSLIQTLNIAIDVASA 674
           I+       +       ++++ +   SL E + +NN       ++  I+     I++  A
Sbjct: 98  IVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGF---HIEDIK--LYCIEILKA 149

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS------ 728
           + YL       + H DLKP N+LLD                  +      ++        
Sbjct: 150 LNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 729 -SSSGIKGTVGYI-------APEYGTGSEASMTGDVYSFGILLLEMFS 768
             ++      G I       APE        ++ D++SFG +L E+++
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 49/348 (14%), Positives = 106/348 (30%), Gaps = 81/348 (23%)

Query: 140 SNASNLELLELRDNQF-------IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTV 192
           +  +++  L L  N         + ++     +  N++ L L  N L  +++++L  V  
Sbjct: 48  NTPASVTSLNLSGNSLGFKNSDELVQILAAIPA--NVTSLNLSGNFLSYKSSDEL--VKT 103

Query: 193 LANC-SKLENLGLYDNQFGG----LLPHSLANLSNTMTTIDIGGN--------YFSGTIP 239
           LA     +  L L  N F          + +NL  ++T++++ GN             + 
Sbjct: 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163

Query: 240 PGLGNLVHL----NSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH----GYIPSSL- 290
               N+  L    N++A +    +      I    ++ SL L++N L       +     
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIP--ASVTSLDLSANLLGLKSYAELAYIFS 221

Query: 291 GNLTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSL 346
                +  L L +N L G     +     +   L  + L  + +                
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK--------------- 266

Query: 347 FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
             N+S      +L +   N++ ++ +D +G         ++     +             
Sbjct: 267 --NMSKEQCK-ALGAAFPNIQKIILVDKNGKEIHPS--HSIPISNLIR------------ 309

Query: 407 IPPSLNFLKSIKVLDLSSNKLS-----GQIPKYLENLSFLEYLNLSYN 449
                       V  L +  L          + L     L     +  
Sbjct: 310 -----ELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 54/344 (15%), Positives = 112/344 (32%), Gaps = 77/344 (22%)

Query: 23  KLENLSLAENHLTGQLPVSIG-----NLSALQVIDIRGNRLGGKIPDTLGQL-----RKL 72
            + +L+L+ N L  +    +        + +  +++ GN L  K  D L +        +
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111

Query: 73  IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP-NLRKFVAAKNNL 131
             L++G N FS     S                          +NLP ++       N+L
Sbjct: 112 TVLDLGWNDFS---SKSSSEFKQ------------------AFSNLPASITSLNLRGNDL 150

Query: 132 TGFLPISLSNA-----SNLELLELRDNQF-------IGKMSINFNSLKNLSVLILGNNHL 179
                  L        +N+  L LR N         + K   +     +++ L L  N L
Sbjct: 151 GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP--ASVTSLDLSANLL 208

Query: 180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANL---SNTMTTIDIGGNYFSG 236
           G ++  +L ++   +  + + +L L  N   G    +L  L      + T+ +  +    
Sbjct: 209 GLKSYAELAYI-FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD---- 263

Query: 237 TIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG----YIPSSL-- 290
                      + +++ E  + +G   P    ++ +  +  N   +H      I + +  
Sbjct: 264 ----------IVKNMSKEQCKALGAAFPN---IQKIILVDKNGKEIHPSHSIPISNLIRE 310

Query: 291 --GNLTMLTLLALEINNLQGKIPSS--LGNCTSLIMLTLSKNKL 330
             G   + +LL   +   Q    +   L     L     +   L
Sbjct: 311 LSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 34/153 (22%)

Query: 299 LALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGS 358
           L   I  ++ K+ ++L    +   L LS N         I  +++LS             
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNN--------IEKISSLS------------- 67

Query: 359 LPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIK 418
                  ++NL  L +  N     I    +   +LE + +  N  + S+   +  L +++
Sbjct: 68  ------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLR 118

Query: 419 VLDLSSNKLS--GQIPKYLENLSFLEYLNLSYN 449
           VL +S+NK++  G+I   L  L  LE L L+ N
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 20/165 (12%)

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQF--IGKMSINFNSLKNLSVLILGNNH 178
           + K    K+ +  F       A+  E +EL       I KM    ++LK    L L  N+
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNN 59

Query: 179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
           +          ++ L+    L  L L  N    +   +L  +++T+  + I  N  + ++
Sbjct: 60  IEK--------ISSLSGMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYNQIA-SL 108

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLK---NLQSLYLNSN 280
             G+  LV+L  + M  N++  T   EI  L     L+ L L  N
Sbjct: 109 -SGIEKLVNLRVLYMSNNKI--TNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 38/194 (19%), Positives = 62/194 (31%), Gaps = 62/194 (31%)

Query: 18  GCYLFKLENLSL--AENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYL 75
                + E + L      +   +  ++  L A + + +  N +  KI  +L  +  L  L
Sbjct: 19  SVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75

Query: 76  NIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFL 135
           ++GRN         I  I + +                                      
Sbjct: 76  SLGRNL--------IKKIENLD-------------------------------------- 89

Query: 136 PISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLAN 195
               + A  LE L +  NQ I  +S     L NL VL + NN +      +   +  LA 
Sbjct: 90  ----AVADTLEELWISYNQ-IASLS-GIEKLVNLRVLYMSNNKI-----TNWGEIDKLAA 138

Query: 196 CSKLENLGLYDNQF 209
             KLE+L L  N  
Sbjct: 139 LDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/151 (19%), Positives = 53/151 (35%), Gaps = 25/151 (16%)

Query: 238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLT 297
           +   L  L     +A+  N  I  +   +  ++NL+ L L  N +   I +       L 
Sbjct: 40  MDATLSTLKACKHLALSTNN-IEKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 298 LLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF-----LNLSD 352
            L +  N +   + S +    +L +L +S NK+          +  L+       L L+ 
Sbjct: 97  ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-----NWGEIDKLAALDKLEDLLLAG 149

Query: 353 NLLSGSLPSE----------IGNLKNLVQLD 373
           N L                 +  L NL +LD
Sbjct: 150 NPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 31/169 (18%)

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
           I  +   +  LK  + L L++N +   I SSL  +  L +L+L  N ++ KI +      
Sbjct: 37  IEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVAD 93

Query: 319 SLIMLTLSKN---KLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI---GNLKNLVQL 372
           +L  L +S N    L G+     L V      L +S+N ++     EI     L  L  L
Sbjct: 94  TLEELWISYNQIASLSGIEKLVNLRV------LYMSNNKITN--WGEIDKLAALDKLEDL 145

Query: 373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLD 421
            ++GN    D     +       V              +  L ++K LD
Sbjct: 146 LLAGNPLYNDYKENNATSEYRIEV--------------VKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 18/84 (21%), Positives = 36/84 (42%), Gaps = 4/84 (4%)

Query: 369 LVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS 428
            V+L          +  TLS   + +++ +  N+    I   L+ ++++++L L  N + 
Sbjct: 27  KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83

Query: 429 GQIPKYLENLSFLEYLNLSYNHFE 452
            +I         LE L +SYN   
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA 106

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 22/157 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G GSFG ++ G   +    VA+K+ N+  K      L E +       R L     I +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIY-----RILQGGTGIPN 67

Query: 622 SIDFNGV--DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
              F GV  D+  +V D +   SLE+  +  + K     LSL   L +A  + + +E++H
Sbjct: 68  VRWF-GVEGDYNVLVMD-LLGPSLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVH 120

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAH---VGDFGLAK 713
                  +H D+KP N L+     A+   + DFGLAK
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 28/211 (13%)

Query: 148 LELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN 207
             L+        ++  N L ++  +I  N+        D+  V  +     +  L L  N
Sbjct: 24  ANLKKKSV--TDAVTQNELNSIDQIIANNS--------DIKSVQGIQYLPNVRYLALGGN 73

Query: 208 QFGGL-LPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPPE 265
           +   +     L NL    T + + GN    ++P G+   L +L  + +  NQL  ++P  
Sbjct: 74  KLHDISALKELTNL----TYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDG 127

Query: 266 I-GWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTSLIML 323
           +   L NL  L L  N L          LT LT L L  N LQ  +P  +    T L  L
Sbjct: 128 VFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186

Query: 324 TLSKNKLDGVLPPQ-----ILSVTTLSLFLN 349
            L +N+L  V  P      + S+  + L  N
Sbjct: 187 RLYQNQLKSV--PDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 297 TLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLS 356
               L+  ++     +      S+  +  + + +  V    I  +  +  +L L  N L 
Sbjct: 22  IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVR-YLALGGNKLH 76

Query: 357 GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSL-NFLK 415
             + + +  L NL  L ++GN+      G     T+L+ + + +N    S+P  + + L 
Sbjct: 77  -DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVF---SNKTRFSLSGN 472
           ++  L+L+ N+L        + L+ L  L+LSYN  +  +P +GVF   +      L  N
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLP-EGVFDKLTQLKDLRLYQN 191

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 29/170 (17%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTL-GQLRKLIYLNIGR 79
           L  +  L+L  N L   +   +  L+ L  + + GN+L   +P+ +  +L  L  L +  
Sbjct: 62  LPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118

Query: 80  NQFSGFIPPSIYN-ISSFEFIFLQSNRFHGSLP---FDMVANLPNLRKFVAAKNNLTGFL 135
           NQ    +P  +++ +++  ++ L  N+   SLP   FD    L NL +   + N L    
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFD---KLTNLTELDLSYNQLQ--- 170

Query: 136 PISLSNA-----SNLELLELRDNQFIGKMSI---NFNSLKNLSVLILGNN 177
             SL        + L+ L L  NQ     S+    F+ L +L  + L +N
Sbjct: 171 --SLPEGVFDKLTQLKDLRLYQNQL---KSVPDGVFDRLTSLQYIWLHDN 215

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 11/169 (6%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC-TS 319
           +VP  I    + + L L S  L     ++   LT LT L L+ N LQ  + + + +  T 
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNR 378
           L  L L+ N+L   LP  +    T    L L  N L  SLPS +   L  L +L ++ N+
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142

Query: 379 FSGDIP-GTLSACTSLEYVKMQDNSFSGSIPP-SLNFLKSIKVLDLSSN 425
               IP G     T+L+ + +  N    S+P  + + L  ++ + L  N
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 53/189 (28%), Positives = 76/189 (40%), Gaps = 37/189 (19%)

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
           E L+L+           F  L  L+ L L  N L   +A   D +T      +L  LGL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT------ELGTLGLA 91

Query: 206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPP 264
           +NQ        LA+L                  P G+  +L  L+ + + GNQL  ++P 
Sbjct: 92  NNQ--------LASL------------------PLGVFDHLTQLDKLYLGGNQL-KSLPS 124

Query: 265 EI-GWLKNLQSLYLNSNFLHGYIPSSL-GNLTMLTLLALEINNLQGKIPSSLGNCTSLIM 322
            +   L  L+ L LN+N L   IP+     LT L  L+L  N LQ     +      L  
Sbjct: 125 GVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT 183

Query: 323 LTLSKNKLD 331
           +TL  N+ D
Sbjct: 184 ITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 10/142 (7%)

Query: 335 PPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE 394
           P  I    T  L L      L+    +    L  L  L++  N+      G     T L 
Sbjct: 30  PSGI-PADTEKLDLQ--STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 395 YVKMQDNSFSGSIPPSL-NFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
            + + +N  + S+P  + + L  +  L L  N+L        + L+ L+ L L+ N  + 
Sbjct: 87  TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ- 144

Query: 454 EVPKKGVF---SNKTRFSLSGN 472
            +P  G F   +N    SLS N
Sbjct: 145 SIP-AGAFDKLTNLQTLSLSTN 165

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 11/158 (6%)

Query: 25  ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSG 84
           E L L    L      +   L+ L  +++  N+L          L +L  L +  NQ + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 85  FIPPSIY-NISSFEFIFLQSNRFHGSLP---FDMVANLPNLRKFVAAKNNLTGFLPISLS 140
            +P  ++ +++  + ++L  N+   SLP   FD    L  L++     N L   +P    
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD---RLTKLKELRLNTNQLQS-IPAGAF 151

Query: 141 NA-SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN 177
           +  +NL+ L L  NQ        F+ L  L  + L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.8 bits (136), Expect = 1e-08
 Identities = 32/197 (16%), Positives = 56/197 (28%), Gaps = 39/197 (19%)

Query: 552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVL--------NLMQKGALKSFLTECE 603
            T +      +G+G FG VF+ I   +   VA+K++        N   +   +  L E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 604 ALR---SIRHRNLIKIITICSSIDFNGVDFKAI-----VYDFMQ--NGSLEEWLHQNNDK 653
             +    +      +          + V           +D      GS  +      D 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 654 -----LEVCN------------LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV 696
                LE                SL    +I   + +++       +    H DL   NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 697 LLDHDMVAHVGDFGLAK 713
           LL    +  +      K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 42/233 (18%), Positives = 87/233 (37%), Gaps = 49/233 (21%)

Query: 561 MVGQGSFGTVFKGI-IGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR---NL 613
            +G+G+FG V + +        VA+K++      ++ A      E   L+ I+ +   N 
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
              + +    +F+G     I ++ +   +  E+L +NN +       L    ++A  +  
Sbjct: 82  FLCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQ----PYPLPHVRHMAYQLCH 134

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV--------- 724
           A+ +LH +    + H DLKP N+L  +     + +   +        +T +         
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEK-SVKNTSIRVADFGSAT 190

Query: 725 ---ETPSSSSGIKGTVGYI------APEYGTGSEASMTGDVYSFGILLLEMFS 768
              E  ++          +       PE       +   DV+S G +L E + 
Sbjct: 191 FDHEHHTT---------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 21/127 (16%), Positives = 47/127 (37%), Gaps = 7/127 (5%)

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
           + L+  L+  +  ++  N     +LD+ G +    I    +     + +   DN     +
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 408 PPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE--GEVPKKGVFSNKT 465
                 L+ +K L +++N++        + L  L  L L+ N     G++       + T
Sbjct: 58  DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 466 RFSLSGN 472
              +  N
Sbjct: 117 YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPIS-LSNASNLELLELRDNQFIGKMSINFNSLKNLSVLIL 174
           A L        + N +     +        L+ L + +N+          +L +L+ LIL
Sbjct: 39  ATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95

Query: 175 GNNHLGNRAANDLDFVTVLANCSKLENLGLYDN 207
            NN L      +L  +  LA+   L  L +  N
Sbjct: 96  TNNSL-----VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/142 (14%), Positives = 39/142 (27%), Gaps = 16/142 (11%)

Query: 240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
               N V    + + G + I  +      L    ++  + N +          L  L  L
Sbjct: 13  AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF-----LNLSDN- 353
            +  N +             L  L L+ N L      ++  +  L+       L +  N 
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKSLTYLCILRNP 124

Query: 354 --LLSGSLPSEIGNLKNLVQLD 373
                      I  +  +  LD
Sbjct: 125 VTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 23/145 (15%), Positives = 50/145 (34%), Gaps = 20/145 (13%)

Query: 138 SLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCS 197
             +NA     L+LR  + I  +     +L     +   +N +          +       
Sbjct: 14  QYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRK--------LDGFPLLR 64

Query: 198 KLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS--GTIPPGLGNLVHLNSIAMEG 255
           +L+ L + +N+   +       L + +T + +  N     G + P L +L  L  + +  
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPD-LTELILTNNSLVELGDLDP-LASLKSLTYLCILR 122

Query: 256 NQLIGTVPPE-----IGWLKNLQSL 275
           N +  T         I  +  ++ L
Sbjct: 123 NPV--TNKKHYRLYVIYKVPQVRVL 145

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 4/96 (4%)

Query: 358 SLPSEIGNLKNLVQLDISGNRFSGDIP-GTLSACTSLEYVKMQDNSFSGSIPP-SLNFLK 415
                +   +NL +L I   +    +    L     L  + +  +     + P + +F  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
            +  L+LS N L     K ++ LS L+ L LS N  
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 21/96 (21%), Positives = 35/96 (36%), Gaps = 2/96 (2%)

Query: 237 TIPPGLGNLVHLNSIAMEGNQLIGTVPPE-IGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
                L    +L  + +E  Q +  +    +  L  L++L +  + L    P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD 331
           L+ L L  N L+  +        SL  L LS N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 3/94 (3%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPS-SLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
                +   +NL  LY+ +     ++    L  L  L  L +  + L+   P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
           L  L LS N L+  L  + +   +L   L LS N
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 17/94 (18%), Positives = 30/94 (31%), Gaps = 1/94 (1%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
               +    +   +++++ +    L    +  L  LR     K+ L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
             L L  N            L +L  L+L  N L
Sbjct: 83  SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 17/89 (19%), Positives = 27/89 (30%), Gaps = 2/89 (2%)

Query: 20  YLFKLENLSLAENHLTGQLP-VSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
               L  L +        L    +  L  L+ + I  + L    PD      +L  LN+ 
Sbjct: 29  GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSNRFH 107
            N     +        S + + L  N  H
Sbjct: 89  FNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 20/102 (19%), Positives = 33/102 (32%), Gaps = 13/102 (12%)

Query: 136 PISLSNASNLELLELRDNQFIGKMSIN---FNSLKNLSVLILGNNHLGNRAANDLDFVTV 192
              L  A NL  L + + Q +    +       L  L  L +  + L   A +       
Sbjct: 24  LHHLPGAENLTELYIENQQHLQ--HLELRDLRGLGELRNLTIVKSGLRFVAPD------A 75

Query: 193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYF 234
                +L  L L  N    L   ++  LS  +  + + GN  
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS--LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 12/71 (16%), Positives = 23/71 (32%), Gaps = 6/71 (8%)

Query: 406 SIPPSLNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNLSYNHFEGEVPKKGVFS-- 462
                L   +++  L + + +    +    L  L  L  L +  +     V     F   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-PDAFHFT 79

Query: 463 -NKTRFSLSGN 472
              +R +LS N
Sbjct: 80  PRLSRLNLSFN 90

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 41/142 (28%), Positives = 59/142 (41%), Gaps = 8/142 (5%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSL-GNCTSL 320
           VP  I    N Q LYL+ N +    P    +L  L  L L  N L   +P  +  + T L
Sbjct: 34  VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 321 IMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRF 379
            +L L  N+L  VLP  +   +  L   L +  N L+  LP  I  L +L  L +  N+ 
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRLVHLKE-LFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

Query: 380 SGDIPGTLSACTSLEYVKMQDN 401
                G     +SL +  +  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 16/142 (11%)

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           +N ++L L DNQ        F+SL NL  L LG+N LG       D +T      +L  L
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT------QLTVL 93

Query: 203 GLYDNQFGGLLP---HSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
            L  NQ   L       L +L      + +  N  +  +P G+  L HL  +A++ NQL 
Sbjct: 94  DLGTNQLTVLPSAVFDRLVHL----KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL- 147

Query: 260 GTVPPEI-GWLKNLQSLYLNSN 280
            ++P      L +L   YL  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 33/133 (24%), Positives = 57/133 (42%), Gaps = 10/133 (7%)

Query: 49  QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYN-ISSFEFIFLQSNRFH 107
           Q++ +  N++    P     L  L  L +G NQ    +P  +++ ++    + L +N+  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 108 GSLP---FDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFN 164
             LP   FD    L +L++     N LT  LP  +   ++L  L L  NQ        F+
Sbjct: 102 -VLPSAVFD---RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFD 156

Query: 165 SLKNLSVLILGNN 177
            L +L+   L  N
Sbjct: 157 RLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 4/128 (3%)

Query: 323 LTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNRFSG 381
           L L  N++   L P +         L L  N L  +LP  +  +L  L  LD+  N+ + 
Sbjct: 45  LYLHDNQITK-LEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 382 DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFL 441
                      L+ + M  N  +  +P  +  L  +  L L  N+L        + LS L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161

Query: 442 EYLNLSYN 449
            +  L  N
Sbjct: 162 THAYLFGN 169

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 43/234 (18%), Positives = 87/234 (37%), Gaps = 51/234 (21%)

Query: 561 MVGQGSFGTVFKGI-IGENGMLVAVKVL---NLMQKGALKSFLTECEALRSIRHR---NL 613
            +G+G+FG V + I     G  VAVK++   +   + A      E + L  +      + 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNST 76

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDK-LEVCNLSLIQTLNIAIDVA 672
            + + +    + +G     IV++ +   S  +++ +N         L  I+   +A  + 
Sbjct: 77  FRCVQMLEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPF---RLDHIR--KMAYQIC 128

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV-------- 724
            ++ +LH +    + H DLKP N+L          +  + +      ++  +        
Sbjct: 129 KSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDER-TLINPDIKVVDFGSA 184

Query: 725 ----ETPSSSSGIKGTVGYI------APEYGTGSEASMTGDVYSFGILLLEMFS 768
               E  S+          +      APE       S   DV+S G +L+E + 
Sbjct: 185 TYDDEHHST---------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 13/144 (9%)

Query: 289 SLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLP-PQILSVTTLSLF 347
           +   +  L L   + N   GKI        +L  L+L    L  V   P++  +  L   
Sbjct: 22  TPAAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKL--- 76

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS--GDIPGTLSACTSLEYVKMQDN---S 402
             LS+N + G L      L NL  L++SGN+      +   L     L+ + + +    +
Sbjct: 77  -ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTN 134

Query: 403 FSGSIPPSLNFLKSIKVLDLSSNK 426
            +         L  +  LD    +
Sbjct: 135 LNDYRESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 7/116 (6%)

Query: 92  NISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELR 151
             ++   + L + + +      + A   NL         L      +L     L+ LEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 152 DNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN 207
           +N+  G + +    L NL+ L L  N L      D+  +  L     L++L L++ 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 24/111 (21%), Positives = 44/111 (39%), Gaps = 5/111 (4%)

Query: 365 NLKNLVQLDISGNRFS-GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
               + +L +   + + G I G  +   +LE++ + +     S+   L  L  +K L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHFE--GEVPKKGVFSNKTRFSLSGN 472
            N++ G +    E L  L +LNLS N  +    +             L   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 9/96 (9%)

Query: 113 DMVANLPNLRKFVAAKNNLTGFLPIS-LSNASNLELLELRDNQFIGKMSINFNSLKNLSV 171
            +      L         LT    I+ L   + L+ LEL DN+  G + +      NL+ 
Sbjct: 36  GLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92

Query: 172 LILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN 207
           L L  N +      DL  +  L     L++L L++ 
Sbjct: 93  LNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 26/111 (23%), Positives = 46/111 (41%), Gaps = 5/111 (4%)

Query: 365 NLKNLVQLDISGNRFS-GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLS 423
              ++ +L +  +R + G + G       LE++   +   + SI  +L  L  +K L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 424 SNKLSGQIPKYLENLSFLEYLNLSYNHFE--GEVPKKGVFSNKTRFSLSGN 472
            N++SG +    E    L +LNLS N  +    +       N     L   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 28/137 (20%), Positives = 45/137 (32%), Gaps = 9/137 (6%)

Query: 289 SLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFL 348
           +  ++  L L     N   GK+         L  L+     L  +     L        L
Sbjct: 15  TPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI---ANLPKLNKLKKL 69

Query: 349 NLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVKMQDNSFSGSI 407
            LSDN +SG L        NL  L++SGN+         L    +L+ + + +   +   
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129

Query: 408 ---PPSLNFLKSIKVLD 421
                    L  +  LD
Sbjct: 130 DYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 29/119 (24%), Positives = 49/119 (41%), Gaps = 13/119 (10%)

Query: 141 NASNLELLELRDNQF-IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
             S+++ L L +++   GK+    +  + L  L   N          L  +  L   +KL
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV--------GLTSIANLPKLNKL 66

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS--GTIPPGLGNLVHLNSIAMEGN 256
           + L L DN+  G L        N +T +++ GN      TI P L  L +L S+ +   
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPN-LTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 2e-06
 Identities = 25/163 (15%), Positives = 63/163 (38%), Gaps = 16/163 (9%)

Query: 307 QGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLN-LSDNLLSGSLPSEIGN 365
           Q  +   L     L  L +       +      ++ +L +    L D+++   L S++ N
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220

Query: 366 LKNLVQLDISGNRFSGDI-PGTLSA------CTSLEYVKMQDNSFSGSIPPSL---NFLK 415
           L+ L  L +    +  D                +L+++ + D      +       + L 
Sbjct: 221 LEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279

Query: 416 SIKVLDLSSNKLSG----QIPKYLENLSFLEYLNLSYNHFEGE 454
            ++ +D+S+  L+      +  +++ +  L+++N+ YN+   E
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 2e-05
 Identities = 28/171 (16%), Positives = 58/171 (33%), Gaps = 20/171 (11%)

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLG---- 291
             + P L  +  LN++ ++G   +           NL+SL + S  L   +   +     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 292 -NLTMLTLLALEINNLQGKIPSSL------GNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
            NL  L L     +       +            +L  L +   +   V+    L    L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 345 S--LFLNLSDNLLSGS----LPSEIGNLKNLVQLDISGNRFSGDIPGTLSA 389
                +++S  +L+      L   +  +K+L  +++  N  S ++   L  
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 4e-04
 Identities = 19/116 (16%), Positives = 40/116 (34%), Gaps = 14/116 (12%)

Query: 116 ANLPNLRK---FVAAKNNLTGFLPISLSNA------SNLELLELRDNQF---IGKMSINF 163
           ++LPNL K   +V  ++                    NL+ L + D +    + +M +  
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 164 NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN 219
           + L  L  + +    L +  A  L  +  +     L+ + +  N     +   L  
Sbjct: 276 DILPQLETMDISAGVLTDEGARLL--LDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.9 bits (97), Expect = 7e-04
 Identities = 27/171 (15%), Positives = 60/171 (35%), Gaps = 14/171 (8%)

Query: 279 SNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLT--LSKNKLDGVLPP 336
           S      +   L  + +L  L ++  N          N  SL +++  L  + ++ +L  
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216

Query: 337 QILSVTTLSLFLNLSDNLLSGSLPS-----EIGNLKNLVQLDISGNRFSGDIPGTLSAC- 390
            + ++  L L++ + D    G +             NL  L I        +        
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276

Query: 391 --TSLEYVKMQDNSFSGS----IPPSLNFLKSIKVLDLSSNKLSGQIPKYL 435
               LE + +     +      +   ++ +K +K +++  N LS ++ K L
Sbjct: 277 ILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 48/323 (14%), Positives = 106/323 (32%), Gaps = 27/323 (8%)

Query: 139 LSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK 198
           ++   NL+ L+L     + K++        L  L  G      R          L+ C +
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT----IPPGLGNLVHLNSIAME 254
           L  L  + +     LP   +  S  +TT+++            +      L  L  +   
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSR-LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325

Query: 255 GNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEIN--NLQGKIPS 312
            +  +  +       K+L+ L +       ++      LT   L+++ +    L+    S
Sbjct: 326 EDAGLEVL---ASTCKDLRELRVFP--SEPFVMEPNVALTEQGLVSVSMGCPKLE----S 376

Query: 313 SLGNCT-----SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK 367
            L  C      +LI +  ++  +        L +        L+   L     + + + K
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRF----RLCIIEPKAPDYLTLEPLDIGFGAIVEHCK 432

Query: 368 NLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG-SIPPSLNFLKSIKVLDLSSNK 426
           +L +L +SG           +    +E + +     S   +   L+   S++ L++    
Sbjct: 433 DLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492

Query: 427 LSGQ-IPKYLENLSFLEYLNLSY 448
              + +      L  +  L +S 
Sbjct: 493 FGDKALLANASKLETMRSLWMSS 515

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 8/118 (6%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI 321
           +P  I   +++  LYL+ N     +P  L N   LTL+ L  N +      S  N T L+
Sbjct: 25  LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 322 MLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGN 377
            L LS N+L   +PP+    + +L L L+L  N +S  +P     +L  L  L I  N
Sbjct: 82  TLILSYNRL-RCIPPRTFDGLKSLRL-LSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 10/119 (8%)

Query: 334 LPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSL 393
           LP  I    T    L L  N  +  +P E+ N K+L  +D+S NR S     + S  T L
Sbjct: 25  LPKGIPRDVTE---LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 394 EYVKMQDNSFSGSIPPSLNF--LKSIKVLDLSSNKLSGQIPK-YLENLSFLEYLNLSYN 449
             + +  N     IPP   F  LKS+++L L  N +S  +P+    +LS L +L +  N
Sbjct: 81  LTLILSYNRLR-CIPPRT-FDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 34/132 (25%), Positives = 55/132 (41%), Gaps = 15/132 (11%)

Query: 103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN 162
           SN+    LP      +P     +    N    +P  LSN  +L L++L +N+ I  +S  
Sbjct: 18  SNKGLKVLP----KGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNR-ISTLSNQ 72

Query: 163 -FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPH-SLANL 220
            F+++  L  LIL  N L        D +        L  L L+ N     +P  +  +L
Sbjct: 73  SFSNMTQLLTLILSYNRLRCIPPRTFDGLK------SLRLLSLHGNDISV-VPEGAFNDL 125

Query: 221 SNTMTTIDIGGN 232
           S  ++ + IG N
Sbjct: 126 SA-LSHLAIGAN 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 36/143 (25%), Positives = 55/143 (38%), Gaps = 23/143 (16%)

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
             L+L  N      +  F+ L +L+ L LG N L +      + +T       L  L L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT------SLTYLNLS 84

Query: 206 DNQFGGLLP---HSLANLSNTMTTIDIGGNYFSGTIPPG----LGNLVHLNSIAMEGNQL 258
            NQ   L       L  L      + +  N    ++P G    L  L  L    +  NQL
Sbjct: 85  TNQLQSLPNGVFDKLTQL----KELALNTNQLQ-SLPDGVFDKLTQLKDLR---LYQNQL 136

Query: 259 IGTVPPEI-GWLKNLQSLYLNSN 280
             +VP  +   L +LQ ++L+ N
Sbjct: 137 -KSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 48/143 (33%), Positives = 62/143 (43%), Gaps = 9/143 (6%)

Query: 262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC-TSL 320
           VP  I        L L +N L          LT LT L L  N LQ  +P+ + N  TSL
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 321 IMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDISGNR 378
             L LS N+L   LP  +   +T L   L L+ N L  SLP  +   L  L  L +  N+
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLK-ELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135

Query: 379 FSGDIPGTLSACTSLEYVKMQDN 401
                 G     TSL+Y+ + DN
Sbjct: 136 LKSVPDGVFDRLTSLQYIWLHDN 158

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 53/367 (14%), Positives = 106/367 (28%), Gaps = 66/367 (17%)

Query: 115 VANLPNLRKFVAAKNNLTGFLPISL----SNASNLELLELRDNQFIGKMSINFNSLKNLS 170
             N  +L         +  F  + L      A+NLE            M   + +L    
Sbjct: 216 ARNCRSLVSV-----KVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270

Query: 171 VLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIG 230
            L      LG       +   +    +++  L                +L   +   +  
Sbjct: 271 KL----CRLGLSYMGPNEMPILFPFAAQIRKL----------------DLLYALLETEDH 310

Query: 231 GNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSL 290
                    P L  L   N I   G +++        + K L+ L +        +    
Sbjct: 311 CTLIQKC--PNLEVLETRNVIGDRGLEVLAQ------YCKQLKRLRIERGADEQGMEDEE 362

Query: 291 GNLTMLTLLALEIN--NLQ--------------GKIPSSLGNCTSLIMLTLSKNKLDGVL 334
           G ++   L+AL      L+                I + L N     ++ L + +    L
Sbjct: 363 GLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422

Query: 335 P-----PQILSVTTLSLFLNLSDN--LLSGSLPSEIG-NLKNLVQLDISGNRFSGD-IPG 385
           P       +L                 L+    S IG    N+  + +     S + +  
Sbjct: 423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482

Query: 386 TLSACTSLEYVKMQDNSFS-GSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE---NLSFL 441
               C +L+ ++M+   FS  +I  ++  L S++ L +   + S      ++       +
Sbjct: 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNI 542

Query: 442 EYLNLSY 448
           E +    
Sbjct: 543 ELIPSRR 549

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 28/116 (24%), Positives = 44/116 (37%), Gaps = 3/116 (2%)

Query: 218 ANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSL 275
            ++    T + +  N        GL G L HL  + ++ NQL   + P       ++Q L
Sbjct: 25  RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQEL 83

Query: 276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD 331
            L  N +          L  L  L L  N +   +P S  +  SL  L L+ N  +
Sbjct: 84  QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 35/140 (25%)

Query: 143 SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           S+   LEL  N+        F+ L  L+ L L  N + +      D +T      KL  L
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT------KLTIL 81

Query: 203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL-GNLVHLNSIAMEGNQLIGT 261
            L++N+                            ++P G+   L  L  +A++ NQL  +
Sbjct: 82  YLHENKL--------------------------QSLPNGVFDKLTQLKELALDTNQL-KS 114

Query: 262 VPPEI-GWLKNLQSLYLNSN 280
           VP  I   L +LQ ++L++N
Sbjct: 115 VPDGIFDRLTSLQKIWLHTN 134

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 11/46 (23%), Positives = 18/46 (39%), Gaps = 3/46 (6%)

Query: 670 DVASAIEYLHHH---CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA 712
           D     ++L       +    HGDL  SN+ +    V+   D G +
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 41/280 (14%), Positives = 74/280 (26%), Gaps = 60/280 (21%)

Query: 139 LSNASNLELLELRDNQF--IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLA-N 195
            S    L+ + L   Q    G  ++          L L  N LG  A  DL    +L  +
Sbjct: 97  GSGRHALDEVNLASCQLDPAGLRTL-LPVFLRARKLGLQLNSLGPEACKDL--RDLLLHD 153

Query: 196 CSKLENLGLYDNQFGG----LLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSI 251
             ++  L L +N        +L   LA  + ++T + +           GL  L    + 
Sbjct: 154 QCQITTLRLSNNPLTAAGVAVLMEGLAG-NTSVTHLSLLHTGLG---DEGLELL----AA 205

Query: 252 AMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG----YIPSSLGNLTMLTLLALEINNLQ 307
            ++ N             + LQ L +  N         +  +      L LL L  N L 
Sbjct: 206 QLDRN-------------RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

Query: 308 -------GKIPSSLGNCTSLIMLTLSKNKLD--------------GVLPPQILSVTTLSL 346
                    +  +      +++       +                      +      L
Sbjct: 253 SEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELL 312

Query: 347 FLNLSDNLLSGSLPSEIGNL----KNLVQLDISGNRFSGD 382
             +L D+  +   P     L      +  L          
Sbjct: 313 LRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSP 352

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	869
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.72
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.69
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.55
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.54
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.37
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.27
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.0
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.61
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.6
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.5
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.89
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.76
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.52
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.48
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.36
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.15
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.01
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.99
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.98
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.96
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.88
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.55
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.14
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.75

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9.7e-62  Score=583.47  Aligned_cols=479  Identities=32%  Similarity=0.516  Sum_probs=380.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCc---------------------
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG---------------------   60 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~---------------------   60 (869)
                      ||+++|++++.+|. + ..+++|++|+|++|.+++.+|..|.++++|++|+|++|++.+                     
T Consensus       205 L~Ls~n~l~~~~~~-l-~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~  282 (768)
T 3rgz_A          205 LDVSSNNFSTGIPF-L-GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFT  282 (768)
T ss_dssp             EECCSSCCCSCCCB-C-TTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEE
T ss_pred             EECcCCcCCCCCcc-c-ccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccC
Confidence            56667777655655 3 356677777777777766666666666666666666665554                     


Q ss_pred             -cCCccccCC-CCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceecccc
Q 002897           61 -KIPDTLGQL-RKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS  138 (869)
Q Consensus        61 -~~p~~~~~l-~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~  138 (869)
                       .+|..+..+ ++|++|+|++|++++.+|..|.++++|++|+|++|++.+.+|...+..+++|++|++++|.+++.+|..
T Consensus       283 ~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~  362 (768)
T 3rgz_A          283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES  362 (768)
T ss_dssp             ESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT
T ss_pred             CccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH
Confidence             455555543 667777777777766667777777777777777777766666666677777777777777777666766


Q ss_pred             ccCCC-CCcEEEccCCccccccCcCccC--CCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCCh
Q 002897          139 LSNAS-NLELLELRDNQFIGKMSINFNS--LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPH  215 (869)
Q Consensus       139 l~~l~-~L~~L~L~~N~i~~~~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~  215 (869)
                      +.+++ +|++|++++|++++..+..+..  +++|++|++++|.++...      +..+..+++|++|++++|++++..|.
T Consensus       363 l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~  436 (768)
T 3rgz_A          363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------PPTLSNCSELVSLHLSFNYLSGTIPS  436 (768)
T ss_dssp             HHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------CGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred             HHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------CHHHhcCCCCCEEECcCCcccCcccH
Confidence            66665 6777777777776666666555  667777777777776433      23577888888888888888888888


Q ss_pred             hhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCcc
Q 002897          216 SLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM  295 (869)
Q Consensus       216 ~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  295 (869)
                      .+..+++ |+.|++++|.+++.+|..+..+++|++|++++|++.+.+|..++.+++|++|+|++|++++.+|..++.+++
T Consensus       437 ~l~~l~~-L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  515 (768)
T 3rgz_A          437 SLGSLSK-LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN  515 (768)
T ss_dssp             GGGGCTT-CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             HHhcCCC-CCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCC
Confidence            8888876 888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccc-------------------------------
Q 002897          296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL-------------------------------  344 (869)
Q Consensus       296 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-------------------------------  344 (869)
                      |++|++++|++++.+|..+..+++|+.|++++|++++.+|..++.....                               
T Consensus       516 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (768)
T 3rgz_A          516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE  595 (768)
T ss_dssp             CCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEE
T ss_pred             CCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccc
Confidence            8888888888888888888888888888888888888888776553221                               


Q ss_pred             --------------cceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCcc
Q 002897          345 --------------SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPS  410 (869)
Q Consensus       345 --------------l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  410 (869)
                                    ...++++.|.++|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|++|+++|.+|..
T Consensus       596 ~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~  675 (768)
T 3rgz_A          596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE  675 (768)
T ss_dssp             CTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred             cccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH
Confidence                          123455667788888888999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCCCCCCCCCCCCCC
Q 002897          411 LNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFHLPSCPSK  490 (869)
Q Consensus       411 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~~  490 (869)
                      |+.+++|+.|||++|+++|.+|..+.++++|++||+++|+++|.+|..+.+..+...++.||+++||.+.    +.|+..
T Consensus       676 l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~  751 (768)
T 3rgz_A          676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPS  751 (768)
T ss_dssp             GGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSC
T ss_pred             HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999764    478765


Q ss_pred             Ccc
Q 002897          491 RSR  493 (869)
Q Consensus       491 ~~~  493 (869)
                      ...
T Consensus       752 ~~~  754 (768)
T 3rgz_A          752 NAD  754 (768)
T ss_dssp             C--
T ss_pred             ccC
Confidence            443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.3e-57  Score=545.41  Aligned_cols=460  Identities=33%  Similarity=0.514  Sum_probs=333.3

Q ss_pred             cccCCCcccccCChhh--hhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcC
Q 002897            2 FDAQNNKLVGDIPVEI--GCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~   79 (869)
                      ||+++|++++.+|...  +..+++|++|+|++|.+++..|  +..+++|++|+|++|++++.+|. |+++++|++|+|++
T Consensus       156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~  232 (768)
T 3rgz_A          156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG  232 (768)
T ss_dssp             EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred             EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence            6788888886666552  3467777777777777775544  36677777777777777765665 77777777777777


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCC-CCCcEEEccCCccccc
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNA-SNLELLELRDNQFIGK  158 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l-~~L~~L~L~~N~i~~~  158 (869)
                      |++++.+|..|.++++|++|+|++|++.+.+|..   .+++|++|++++|.+++.+|..+... ++|++|+|++|++++.
T Consensus       233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            7777667777777777777777777776555532   56666677777776666666666554 6677777777766666


Q ss_pred             cCcCccCCCCCCEEEccCccCC-CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccc---------------
Q 002897          159 MSINFNSLKNLSVLILGNNHLG-NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSN---------------  222 (869)
Q Consensus       159 ~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---------------  222 (869)
                      .+..|..+++|++|++++|.++ .++.      ..+..+++|++|++++|++++.+|..+..+..               
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~------~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~  383 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPM------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP  383 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCH------HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEE
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCH------HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCC
Confidence            6666666666666666666665 3332      13556666666666666666555555554432               


Q ss_pred             -----------cceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCC
Q 002897          223 -----------TMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLG  291 (869)
Q Consensus       223 -----------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  291 (869)
                                 .|++|++++|.+++.+|..+.++++|+.|++++|++.+..|..++.+++|+.|++++|.+++.+|..+.
T Consensus       384 ~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~  463 (768)
T 3rgz_A          384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM  463 (768)
T ss_dssp             CCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             cChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHc
Confidence                       256666666666666677777777777777777777777777777777777777777777777777777


Q ss_pred             CCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccc
Q 002897          292 NLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQ  371 (869)
Q Consensus       292 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~  371 (869)
                      .+++|++|++++|++++.+|..+..+++|++|++++|++++.+|..+... +.++.|+|++|++++.+|..++++++|+.
T Consensus       464 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  542 (768)
T 3rgz_A          464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL-ENLAILKLSNNSFSGNIPAELGDCRSLIW  542 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC-TTCCEEECCSSCCEEECCGGGGGCTTCCE
T ss_pred             CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCCCE
Confidence            77888888888888877777788888888888888888877777766554 34567888888888888888888888888


Q ss_pred             cccccccccccCCccc----------------------------------------------------------------
Q 002897          372 LDISGNRFSGDIPGTL----------------------------------------------------------------  387 (869)
Q Consensus       372 L~L~~N~l~~~~p~~~----------------------------------------------------------------  387 (869)
                      |+|++|.++|.+|..+                                                                
T Consensus       543 L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g  622 (768)
T 3rgz_A          543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG  622 (768)
T ss_dssp             EECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEE
T ss_pred             EECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecc
Confidence            8888888876666543                                                                


Q ss_pred             ------cCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCC-Cc
Q 002897          388 ------SACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GV  460 (869)
Q Consensus       388 ------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~  460 (869)
                            ..+++|+.|+|++|+++|.+|.+++.+++|+.|+|++|+++|.+|..+.++++|+.|||++|+++|.+|.. +.
T Consensus       623 ~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~  702 (768)
T 3rgz_A          623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA  702 (768)
T ss_dssp             ECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGG
T ss_pred             cCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhC
Confidence                  33567888888888888888888888888888888888888888888888888888888888888888764 56


Q ss_pred             cCCCccccccCCcc
Q 002897          461 FSNKTRFSLSGNGK  474 (869)
Q Consensus       461 ~~~~~~~~~~~n~~  474 (869)
                      +..++.+++++|+.
T Consensus       703 l~~L~~L~ls~N~l  716 (768)
T 3rgz_A          703 LTMLTEIDLSNNNL  716 (768)
T ss_dssp             CCCCSEEECCSSEE
T ss_pred             CCCCCEEECcCCcc
Confidence            77788888888754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.8e-56  Score=521.90  Aligned_cols=466  Identities=22%  Similarity=0.218  Sum_probs=354.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      ||+++|+|+ .++...+..+++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus        38 L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  116 (606)
T 3t6q_A           38 LEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG  116 (606)
T ss_dssp             EECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred             EEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence            455555555 3433333455566666666666555555556666666666666666555555555666666666666666


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCc--EEEccCCcccccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLE--LLELRDNQFIGKM  159 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~--~L~L~~N~i~~~~  159 (869)
                      +++..|..|.++++|++|+|++|++. .++...+..+++|++|++++|.+++..+..|..+++|+  .|++++|.+.++.
T Consensus       117 i~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~  195 (606)
T 3t6q_A          117 ISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE  195 (606)
T ss_dssp             CSCGGGSCCTTCTTCCEEECCSSCCC-CCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEEC
T ss_pred             cccCCcchhccCCcccEEECCCCccc-ccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccC
Confidence            55544555555666666666666555 33222233455666666666666555555555555555  5566666555555


Q ss_pred             CcCccCC---------------------------------------------------CCCCEEEccCccCCCCCCCCcc
Q 002897          160 SINFNSL---------------------------------------------------KNLSVLILGNNHLGNRAANDLD  188 (869)
Q Consensus       160 ~~~~~~l---------------------------------------------------~~L~~L~l~~n~l~~~~~~~~~  188 (869)
                      +..|...                                                   .+|+.|++++|.++.++..   
T Consensus       196 ~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~---  272 (606)
T 3t6q_A          196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN---  272 (606)
T ss_dssp             TTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT---
T ss_pred             hhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH---
Confidence            4443321                                                   0345555555555555433   


Q ss_pred             hhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCc-ccc
Q 002897          189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPP-EIG  267 (869)
Q Consensus       189 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~  267 (869)
                         .|..+++|++|++++|+++ .+|..+..+++ |++|++++|.+++..|..+..+++|++|++++|.+.+.+|. .+.
T Consensus       273 ---~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  347 (606)
T 3t6q_A          273 ---TFHCFSGLQELDLTATHLS-ELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE  347 (606)
T ss_dssp             ---TTTTCTTCSEEECTTSCCS-CCCSSCCSCTT-CCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTT
T ss_pred             ---HhccccCCCEEeccCCccC-CCChhhccccc-CCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhh
Confidence               4788899999999999998 67777888776 99999999999988888899999999999999988755554 588


Q ss_pred             CCCCCCEEEccCccccCcC--CCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccccccc
Q 002897          268 WLKNLQSLYLNSNFLHGYI--PSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLS  345 (869)
Q Consensus       268 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l  345 (869)
                      .+++|++|++++|.+++..  +..+.++++|+.|++++|++.+..|..|..+++|+.|++++|++++..|...+...+.+
T Consensus       348 ~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  427 (606)
T 3t6q_A          348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL  427 (606)
T ss_dssp             TCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTC
T ss_pred             ccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccC
Confidence            9999999999999998766  78899999999999999999988899999999999999999999988777767777888


Q ss_pred             ceecccCCcccCCCcccccCCcccccccccccccccc---CCccccCCCCCcEEEeeCccccCCCCccccccccccEEEc
Q 002897          346 LFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGD---IPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL  422 (869)
Q Consensus       346 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L  422 (869)
                      +.|++++|.+++..|..+.++++|++|+|++|.+++.   .+..+..+++|+.|++++|++++..|..|+.+++|+.|+|
T Consensus       428 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  507 (606)
T 3t6q_A          428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL  507 (606)
T ss_dssp             CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEEC
Confidence            9999999999998999999999999999999999862   3467999999999999999999888999999999999999


Q ss_pred             cCCcccCCCccccccccccCeeccccccCcccCCCC-CccCCCccccccCCcccCCC
Q 002897          423 SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       423 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~  478 (869)
                      ++|++++..|..+.+++.| .|++++|++++.+|.. ..++.++.+++++||+.|.+
T Consensus       508 s~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          508 SHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             CSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             CCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            9999999999999999999 9999999999887753 55788899999999999964

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.2e-54  Score=503.17  Aligned_cols=464  Identities=20%  Similarity=0.194  Sum_probs=368.7

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ +||..++   +++++|+|++|+++++.+.+|.++++|++|+|++|+|+++.|.+|+++++|++|+|++|+
T Consensus        16 ~~c~~~~l~-~ip~~~~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           16 YQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EECTTSCCS-SCCTTSC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEccCCCcc-cCCCCCC---CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            567777888 7887765   677888888888887777778888888888888888887777778888888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccce-eccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTG-FLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +++..|.+|+++++|++|+|++|++. .++...++++++|++|++++|.+++ .+|..|+++++|++|++++|+++++.+
T Consensus        92 l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A           92 IQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             CCCCCTTSSTTCTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             ccccChhhcCCcccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            88777778888888888888888876 5665567788888888888888775 457778888888888888888777777


Q ss_pred             cCccCCCCCC----EEEccCccCCCCCCCCcc------------------------------------------------
Q 002897          161 INFNSLKNLS----VLILGNNHLGNRAANDLD------------------------------------------------  188 (869)
Q Consensus       161 ~~~~~l~~L~----~L~l~~n~l~~~~~~~~~------------------------------------------------  188 (869)
                      ..|..+++|+    +|++++|.++.++...+.                                                
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~  250 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF  250 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence            7666655544    566666666655443110                                                


Q ss_pred             --------------------------hhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccc
Q 002897          189 --------------------------FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL  242 (869)
Q Consensus       189 --------------------------~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~  242 (869)
                                                ....+..+++|+.|++++|.+. .+| .+..+.+ |+.|++++|.+ +.+| .+
T Consensus       251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~-L~~L~l~~n~l-~~lp-~~  325 (606)
T 3vq2_A          251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFK-WQSLSIIRCQL-KQFP-TL  325 (606)
T ss_dssp             CGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTTCC-CSEEEEESCCC-SSCC-CC
T ss_pred             ChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccch-hhh-hcccccc-CCEEEcccccC-cccc-cC
Confidence                                      0011344556666666666665 333 4555554 77788888877 3666 44


Q ss_pred             cCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCc--CCCCCCCCccccceecccccccccCCcCccCcccc
Q 002897          243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY--IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL  320 (869)
Q Consensus       243 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  320 (869)
                       .+++|+.|++++|...+..  .+..+++|++|++++|.+++.  .+..+..+++|++|++++|.++ .+|..+..+++|
T Consensus       326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L  401 (606)
T 3vq2_A          326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL  401 (606)
T ss_dssp             -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTC
T ss_pred             -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCC
Confidence             7788888888888554333  567889999999999998866  3777889999999999999998 467899999999


Q ss_pred             ceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccc-cCCccccCCCCCcEEEee
Q 002897          321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSG-DIPGTLSACTSLEYVKMQ  399 (869)
Q Consensus       321 ~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~  399 (869)
                      +.|++++|++.+..|...+.....++.|++++|.+++..|..+.++++|++|++++|.+++ .+|..+..+++|+.|+++
T Consensus       402 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls  481 (606)
T 3vq2_A          402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS  481 (606)
T ss_dssp             CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECC
Confidence            9999999999977775666667788899999999999999999999999999999999997 479999999999999999


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccC-CCccccccCCcccCCC
Q 002897          400 DNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFS-NKTRFSLSGNGKLCGG  478 (869)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~~~~~~~~~n~~~c~~  478 (869)
                      +|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|+++..++....+. .++.+++.+|++.|++
T Consensus       482 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACIC  561 (606)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred             CCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCC
Confidence            999998889999999999999999999999889999999999999999999997665555554 5899999999999975


Q ss_pred             C
Q 002897          479 L  479 (869)
Q Consensus       479 ~  479 (869)
                      .
T Consensus       562 ~  562 (606)
T 3vq2_A          562 E  562 (606)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=8.1e-53  Score=501.94  Aligned_cols=468  Identities=23%  Similarity=0.249  Sum_probs=248.0

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      ||+++|+++ .+|...+..+++|++|+|++|.+++..|.+|+++++|++|+|++|+++.+.+.+|+++++|++|+|++|+
T Consensus        30 L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~  108 (680)
T 1ziw_A           30 LNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS  108 (680)
T ss_dssp             EECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred             EECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCc
Confidence            455555555 4444444455555555555555555555555555555555555555554333445555555555555555


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceecccccc--CCCCCcEEEccCCcccccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS--NASNLELLELRDNQFIGKM  159 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~--~l~~L~~L~L~~N~i~~~~  159 (869)
                      ++++.|..|+++++|++|+|++|.+. .++...+.++++|++|++++|.+++..+..+.  .+++|++|++++|+++++.
T Consensus       109 l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~  187 (680)
T 1ziw_A          109 IQKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS  187 (680)
T ss_dssp             CCCCCSCTTTTCTTCCEEECCSSCCS-CCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBC
T ss_pred             cCccChhHccccCCCCEEECCCCccc-ccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccC
Confidence            55444455555555555555555554 23333445555555555555555544433322  2344444444444444433


Q ss_pred             CcCccC---------------------------------------------------CC--CCCEEEccCccCCCCCCCC
Q 002897          160 SINFNS---------------------------------------------------LK--NLSVLILGNNHLGNRAAND  186 (869)
Q Consensus       160 ~~~~~~---------------------------------------------------l~--~L~~L~l~~n~l~~~~~~~  186 (869)
                      +..|..                                                   ++  +|++|++++|.++.++.. 
T Consensus       188 ~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~-  266 (680)
T 1ziw_A          188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND-  266 (680)
T ss_dssp             TTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTT-
T ss_pred             hhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcc-
Confidence            332222                                                   21  133333333333332221 


Q ss_pred             cchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccc-----cCC----ccccCCCCCCeeecccCc
Q 002897          187 LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSG-----TIP----PGLGNLVHLNSIAMEGNQ  257 (869)
Q Consensus       187 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~-----~~~----~~~~~l~~L~~L~l~~n~  257 (869)
                           .|..+++|++|++++|++++..|..+..+.+ |+.|++++|...+     .+|    ..|..+++|++|++++|+
T Consensus       267 -----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~  340 (680)
T 1ziw_A          267 -----SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN-VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND  340 (680)
T ss_dssp             -----TTTTCTTCCEEECCSCCBSEECTTTTTTCTT-CCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCC
T ss_pred             -----cccCcccccEeeCCCCccCccChhhhcCCCC-ccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCc
Confidence                 2344444444444444444333333322221 2222222111110     000    022333334444444444


Q ss_pred             ceecCCccccCCCCCCEEEcc----------------------------CccccCcCCCCCCCCccccceeccccccccc
Q 002897          258 LIGTVPPEIGWLKNLQSLYLN----------------------------SNFLHGYIPSSLGNLTMLTLLALEINNLQGK  309 (869)
Q Consensus       258 l~~~~~~~~~~l~~L~~L~L~----------------------------~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  309 (869)
                      +.+..+..|..+++|++|+++                            +|++++..|..|..+++|+.|++++|++++.
T Consensus       341 l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  420 (680)
T 1ziw_A          341 IPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE  420 (680)
T ss_dssp             BCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEE
T ss_pred             cCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccc
Confidence            444333334433333333332                            2333333344444455555555555554433


Q ss_pred             CC-cCccCccccceeeccCcccCCC--------------------------CCccccccccccceecccCCcccCCCccc
Q 002897          310 IP-SSLGNCTSLIMLTLSKNKLDGV--------------------------LPPQILSVTTLSLFLNLSDNLLSGSLPSE  362 (869)
Q Consensus       310 ~~-~~~~~l~~L~~L~l~~N~l~~~--------------------------~~~~~~~~~~~l~~L~l~~N~l~~~~p~~  362 (869)
                      +| ..|.++++|++|++++|++++.                          .|..+ .....++.|++++|++++..+..
T Consensus       421 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~i~~~~  499 (680)
T 1ziw_A          421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF-QPLRNLTILDLSNNNIANINDDM  499 (680)
T ss_dssp             CCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT-TTCTTCCEEECCSSCCCCCCTTT
T ss_pred             cCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc-ccCCCCCEEECCCCCCCcCChhh
Confidence            32 3444444444444444443321                          22222 22344567777777777766667


Q ss_pred             ccCCccccccccccccccccCC--------ccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccc
Q 002897          363 IGNLKNLVQLDISGNRFSGDIP--------GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY  434 (869)
Q Consensus       363 ~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  434 (869)
                      |.++++|++|+|++|.+++..+        ..|.++++|+.|++++|+++...+..|..+++|+.|+|++|++++..+..
T Consensus       500 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~  579 (680)
T 1ziw_A          500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV  579 (680)
T ss_dssp             TTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             hccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhH
Confidence            7777888888888887775321        23677788888888888887444456888888888888888888766677


Q ss_pred             cccccccCeeccccccCcccCCCC-C-ccCCCccccccCCcccCCCC
Q 002897          435 LENLSFLEYLNLSYNHFEGEVPKK-G-VFSNKTRFSLSGNGKLCGGL  479 (869)
Q Consensus       435 ~~~l~~L~~l~l~~N~l~~~~~~~-~-~~~~~~~~~~~~n~~~c~~~  479 (869)
                      |..+++|+.|++++|++++.++.. + .+++++.+++++|||.|++.
T Consensus       580 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             TTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             hCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            788888899999999888776543 2 46788999999999999764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-53  Score=513.73  Aligned_cols=463  Identities=20%  Similarity=0.210  Sum_probs=347.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccC-ccCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLG-GKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      .|+++++++ .||. +   .++|++|+|++|.|+++.|.+|.++++|++|+|++|.+. .+.|.+|+++++|++|+|++|
T Consensus         9 ~dcs~~~L~-~vP~-l---p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            9 AFYRFCNLT-QVPQ-V---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEESCCCSS-CCCS-S---CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEccCCCCC-CCCC-C---CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            577888899 8887 3   478999999999998888888999999999999998544 344888999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCc-hhhcCCcchhhhhccccccceecc-ccccCCCCCcEEEccCCccccc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPF-DMVANLPNLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDNQFIGK  158 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~N~i~~~  158 (869)
                      .|.+..|.+|.++++|++|+|++|.+.+.+|. ..|.++++|++|++++|.+++..+ ..|+++++|++|+|++|.+.++
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~  163 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV  163 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence            99888888999999999999999998865543 358889999999999999887654 5788999999999999998888


Q ss_pred             cCcCccCC--CCCCEEEccCccCCCCCCCCcchhhhccCCC------CCcEEEccCCCCCCCCChhhhhc----------
Q 002897          159 MSINFNSL--KNLSVLILGNNHLGNRAANDLDFVTVLANCS------KLENLGLYDNQFGGLLPHSLANL----------  220 (869)
Q Consensus       159 ~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~------~L~~L~L~~n~l~~~~~~~~~~l----------  220 (869)
                      .+..|..+  ++|+.|++++|.+......      .+..++      +|++|++++|++++..+..+...          
T Consensus       164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~------~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~  237 (844)
T 3j0a_A          164 CEHELEPLQGKTLSFFSLAANSLYSRVSV------DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI  237 (844)
T ss_dssp             CSGGGHHHHHCSSCCCEECCSBSCCCCCC------CCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEE
T ss_pred             CHHHcccccCCccceEECCCCcccccccc------chhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccccee
Confidence            88887777  7788888888877664332      122222      37777777776665555444322          


Q ss_pred             ---------------------------cccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCC
Q 002897          221 ---------------------------SNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQ  273 (869)
Q Consensus       221 ---------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  273 (869)
                                                 ...|+.|++++|.+.+..+..|..+++|+.|+|++|++.+..|..|..+++|+
T Consensus       238 l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~  317 (844)
T 3j0a_A          238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ  317 (844)
T ss_dssp             CCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred             cccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence                                       12477777777777766677777777777777777777777777777777777


Q ss_pred             EEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCC------------------CC
Q 002897          274 SLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGV------------------LP  335 (869)
Q Consensus       274 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~------------------~~  335 (869)
                      +|+|++|.+++..|..|.++++|+.|++++|++....+..|..+++|+.|++++|.+++.                  +|
T Consensus       318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~  397 (844)
T 3j0a_A          318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLP  397 (844)
T ss_dssp             EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCC
T ss_pred             EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCccccc
Confidence            777777777766677777777777777777777766666677777777777777776532                  11


Q ss_pred             cc---------------------ccccccccceecccCCcccCCCcc-cccCCcccccccccccccc-----ccCCcccc
Q 002897          336 PQ---------------------ILSVTTLSLFLNLSDNLLSGSLPS-EIGNLKNLVQLDISGNRFS-----GDIPGTLS  388 (869)
Q Consensus       336 ~~---------------------~~~~~~~l~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~  388 (869)
                      ..                     .....+.++.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|.
T Consensus       398 ~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~  477 (844)
T 3j0a_A          398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE  477 (844)
T ss_dssp             CCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSS
T ss_pred             ccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhc
Confidence            11                     011234455666777776643332 3455677777777777775     33445678


Q ss_pred             CCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCcccc
Q 002897          389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFS  468 (869)
Q Consensus       389 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~  468 (869)
                      ++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|++++.+|..  +..+..++
T Consensus       478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~  553 (844)
T 3j0a_A          478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLD  553 (844)
T ss_dssp             CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEE
T ss_pred             CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEE
Confidence            888899999999999888888888999999999999999877666665  78999999999999887754  66889999


Q ss_pred             ccCCcccCCCC
Q 002897          469 LSGNGKLCGGL  479 (869)
Q Consensus       469 ~~~n~~~c~~~  479 (869)
                      +++||+.|++.
T Consensus       554 l~~Np~~C~c~  564 (844)
T 3j0a_A          554 ITHNKFICECE  564 (844)
T ss_dssp             EEEECCCCSSS
T ss_pred             ecCCCcccccc
Confidence            99999999764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.2e-52  Score=490.08  Aligned_cols=446  Identities=23%  Similarity=0.233  Sum_probs=401.2

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +||+++|++++ ++...+..+++|++|+|++|++++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus        61 ~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n  139 (606)
T 3t6q_A           61 FLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN  139 (606)
T ss_dssp             EEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSS
T ss_pred             EEECCCCccce-eChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCC
Confidence            47999999994 54444568999999999999999889999999999999999999999877889999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchh--hhhccccccceeccccccCC----------------
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR--KFVAAKNNLTGFLPISLSNA----------------  142 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~--~L~l~~n~i~~~~~~~l~~l----------------  142 (869)
                      ++.+..+..+.++++|++|+|++|++. .++...|..+++|+  .|++++|.+++..|..|...                
T Consensus       140 ~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~  218 (606)
T 3t6q_A          140 HISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVI  218 (606)
T ss_dssp             CCCCCCCCTTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHH
T ss_pred             cccccCcccccCCcccCEEEcccCccc-ccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHH
Confidence            999766566667999999999999998 67667899999999  89999999998877665432                


Q ss_pred             -----------------------------------CCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCc
Q 002897          143 -----------------------------------SNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDL  187 (869)
Q Consensus       143 -----------------------------------~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  187 (869)
                                                         .+|+.|++++|.++++.+..|..+++|++|++++|.++.++.   
T Consensus       219 ~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~---  295 (606)
T 3t6q_A          219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS---  295 (606)
T ss_dssp             HHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS---
T ss_pred             hhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh---
Confidence                                               178899999999999999999999999999999999998765   


Q ss_pred             chhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc-cccCCCCCCeeecccCcceecC--Cc
Q 002897          188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP-GLGNLVHLNSIAMEGNQLIGTV--PP  264 (869)
Q Consensus       188 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~--~~  264 (869)
                          .+..+++|++|++++|++++..|..+..+++ |++|++++|.+.+.+|. .+..+++|++|++++|.+.+..  +.
T Consensus       296 ----~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  370 (606)
T 3t6q_A          296 ----GLVGLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL  370 (606)
T ss_dssp             ----SCCSCTTCCEEECTTCCCSBGGGGCGGGCTT-CSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTT
T ss_pred             ----hhcccccCCEEECccCCcCcCchhhhhccCc-CCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcch
Confidence                4889999999999999999888889999986 99999999999866655 4999999999999999998776  78


Q ss_pred             cccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCc-CccCccccceeeccCcccCCCCCcccccccc
Q 002897          265 EIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SLGNCTSLIMLTLSKNKLDGVLPPQILSVTT  343 (869)
Q Consensus       265 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  343 (869)
                      .+..+++|++|++++|.+.+..|..|.++++|+.|++++|++.+..+. .+..+++|+.|++++|++++..|..+ ...+
T Consensus       371 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~  449 (606)
T 3t6q_A          371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF-DGLP  449 (606)
T ss_dssp             TTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT-TTCT
T ss_pred             hcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH-hCCC
Confidence            899999999999999999999999999999999999999999976654 49999999999999999986655544 4456


Q ss_pred             ccceecccCCcccC---CCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEE
Q 002897          344 LSLFLNLSDNLLSG---SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL  420 (869)
Q Consensus       344 ~l~~L~l~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  420 (869)
                      .++.|++++|++++   ..+..+..+++|++|+|++|.+++..|..|.++++|+.|++++|++++..|..+..++.| .|
T Consensus       450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L  528 (606)
T 3t6q_A          450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL  528 (606)
T ss_dssp             TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred             CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence            67899999999986   234679999999999999999998889999999999999999999999999999999999 99


Q ss_pred             EccCCcccCCCccccccccccCeeccccccCcccCCCC
Q 002897          421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       421 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~  458 (869)
                      +|++|++++.+|..+..+++|+.|++++|++.+.++..
T Consensus       529 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            99999999999999999999999999999999987643

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.9e-51  Score=490.12  Aligned_cols=469  Identities=20%  Similarity=0.203  Sum_probs=367.1

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ +||.++.   +++++|+|++|.++++.+..|.++++|++|+|++|++++..|++|+++++|++|+|++|+
T Consensus         9 ~~cs~~~L~-~ip~~~~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            9 ADCSHLKLT-QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EECCSSCCS-SCCSCSC---TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eECCCCCcc-ccccccC---CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            689999999 8998875   799999999999998888889999999999999999999999999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      ++++.+.+|.++++|++|+|++|++. .++...|.++++|++|++++|.+++..+..+.++++|++|++++|.++++.+.
T Consensus        85 l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           85 LSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             cCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            99776678999999999999999998 77778899999999999999999999999999999999999999999988777


Q ss_pred             Ccc--CCCCCCEEEccCccCCCCCCCCcchhhhcc---------------------CCCCCcEEEccCCCCCCCCChhhh
Q 002897          162 NFN--SLKNLSVLILGNNHLGNRAANDLDFVTVLA---------------------NCSKLENLGLYDNQFGGLLPHSLA  218 (869)
Q Consensus       162 ~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~---------------------~l~~L~~L~L~~n~l~~~~~~~~~  218 (869)
                      .|.  .+++|++|++++|.++.++...+.....+.                     ..++|++|++++|++++..|..+.
T Consensus       164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~  243 (680)
T 1ziw_A          164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL  243 (680)
T ss_dssp             HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred             HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence            654  568999999999999887765322111110                     125667777777777766666666


Q ss_pred             hccc-cceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCcc--------------------------------
Q 002897          219 NLSN-TMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPE--------------------------------  265 (869)
Q Consensus       219 ~l~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--------------------------------  265 (869)
                      .+.. .|+.|++++|.+++..|..|..+++|++|++++|++.+..|..                                
T Consensus       244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~  323 (680)
T 1ziw_A          244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF  323 (680)
T ss_dssp             GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred             ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence            6542 3777777777777666677777777777777777776655543                                


Q ss_pred             -ccCCCCCCEEEccCccccCcCCCCCCCCccccceecccc----------------------------cccccCCcCccC
Q 002897          266 -IGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEIN----------------------------NLQGKIPSSLGN  316 (869)
Q Consensus       266 -~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n----------------------------~l~~~~~~~~~~  316 (869)
                       |..+++|++|++++|.+++..+..|.++++|++|++++|                            ++++..|.+|..
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~  403 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW  403 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred             hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence             445666777777777777777777777666666655443                            444455667777


Q ss_pred             ccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccccccc--ccCCccccCCCCCc
Q 002897          317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS--GDIPGTLSACTSLE  394 (869)
Q Consensus       317 l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~  394 (869)
                      +++|+.|++++|++++.+|...+.....++.|++++|++++..+..|..+++|+.|++++|.++  +..|..|..+++|+
T Consensus       404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~  483 (680)
T 1ziw_A          404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT  483 (680)
T ss_dssp             CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred             CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence            7777777777777776666555555666677777777777666667777777777777777765  45778888888999


Q ss_pred             EEEeeCccccCCCCccccccccccEEEccCCcccCCCc--------cccccccccCeeccccccCcccCCC-CCccCCCc
Q 002897          395 YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP--------KYLENLSFLEYLNLSYNHFEGEVPK-KGVFSNKT  465 (869)
Q Consensus       395 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~  465 (869)
                      .|++++|++++..+..|..+++|+.|+|++|++++..+        ..+.++++|+.|++++|+++..++. ...+..++
T Consensus       484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~  563 (680)
T 1ziw_A          484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK  563 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence            99999999887777778888889999999998875422        2367888888888888888855443 35677788


Q ss_pred             cccccCCccc
Q 002897          466 RFSLSGNGKL  475 (869)
Q Consensus       466 ~~~~~~n~~~  475 (869)
                      .+++++|.-.
T Consensus       564 ~L~Ls~N~l~  573 (680)
T 1ziw_A          564 IIDLGLNNLN  573 (680)
T ss_dssp             EEECCSSCCC
T ss_pred             eeECCCCCCC
Confidence            8888887543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-52  Score=439.53  Aligned_cols=264  Identities=27%  Similarity=0.442  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|++.   ..||||+++..  .....+.|.+|++++++++|||||++++++..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            357888999999999999999874   35999998643  34456789999999999999999999998753      45


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|||||++|+|.++++....     ++++.++..|+.|||+||+|||++   +||||||||+|||+++++.+||+|||
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            7999999999999999987543     399999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      +|+.......      ........||+.|||||++.+   ++|+.++|||||||++|||+||+.||..............
T Consensus       178 la~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~  251 (307)
T 3omv_A          178 LATVKSRWSG------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG  251 (307)
T ss_dssp             SCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             CceecccCCc------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence            9987644321      122345679999999999853   4689999999999999999999999975322111111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ....        .|..               ...+.+++..+.+++.+||+.||++||||.||++.|+.++..++
T Consensus       252 ~~~~--------~p~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          252 RGYA--------SPDL---------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             TTCC--------CCCS---------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             cCCC--------CCCc---------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            1110        0100               01112456678899999999999999999999999998877654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.4e-53  Score=442.22  Aligned_cols=269  Identities=24%  Similarity=0.399  Sum_probs=216.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.     
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            46888899999999999999874     35889999999877666778899999999999999999999998653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCC-------cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNND-------KLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                      +..++|||||++|+|.++++....       ......++|.+++.|+.|||+||+|||++   +||||||||+|||++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            678999999999999999987531       11123599999999999999999999999   99999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~  780 (869)
                      +.+||+|||+|+.......      ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.....  
T Consensus       165 ~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--  236 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--  236 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGC------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred             CcEEECCcccceecCCCCc------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999986543321      112234568999999999999999999999999999999999 8999975322  


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                         .+....+.....                       .+.++.++.++.+++.+||+.||++|||++||.+.|+.+.++
T Consensus       237 ---~~~~~~i~~~~~-----------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          237 ---NEVIECITQGRV-----------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ---HHHHHHHHHTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCC-----------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence               122211111100                       011124566788999999999999999999999999998876


Q ss_pred             hhcc
Q 002897          861 FVSM  864 (869)
Q Consensus       861 ~~~~  864 (869)
                      .+..
T Consensus       291 ~p~~  294 (299)
T 4asz_A          291 SPVY  294 (299)
T ss_dssp             SCCC
T ss_pred             CCcc
Confidence            5443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-52  Score=441.97  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|.+.++||+|+||+||+|++.     .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.     
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            46777889999999999999874     36889999999877767778899999999999999999999998653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKL---------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      ...++|||||++|+|.++++......         ...+++|.+++.|+.|||+||+|||++   +||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            67899999999999999998754321         124599999999999999999999999   999999999999999


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCcc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFH  778 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~  778 (869)
                      +++.+||+|||+|+.......      ........||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             CCCcEEEcccccceeccCCCc------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999987644321      122344679999999999999999999999999999999999 8999975322


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                           .+....+....                       ..+.++.+++++.+++.+||+.||++||||+||++.|+.+.
T Consensus       267 -----~~~~~~i~~g~-----------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          267 -----TEAIDCITQGR-----------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             -----HHHHHHHHHTC-----------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHcCC-----------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                 11111111100                       01111245667889999999999999999999999999988


Q ss_pred             Hhh
Q 002897          859 EAF  861 (869)
Q Consensus       859 ~~~  861 (869)
                      ++-
T Consensus       319 ~~p  321 (329)
T 4aoj_A          319 QAP  321 (329)
T ss_dssp             HSC
T ss_pred             hCC
Confidence            764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-52  Score=438.11  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=209.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ..|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++.+.     +..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            4688999999999999999999999999999999876666667789999999999999999999997654     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |||||++|+|.+++....       +++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       149 vmEy~~gg~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EECCCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            999999999999997643       89999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .+....        ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     .+....+...
T Consensus       219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~  285 (346)
T 4fih_A          219 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDN  285 (346)
T ss_dssp             ECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS
T ss_pred             ecCCCC--------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcC
Confidence            765432        233456899999999999999999999999999999999999999975321     1111111000


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                           ..+.                ......+++++.+++.+||+.||++|||++|+++
T Consensus       286 -----~~~~----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 -----LPPR----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -----SCCC----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCC----------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0000                0011234456889999999999999999999986

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=5.1e-51  Score=479.85  Aligned_cols=439  Identities=19%  Similarity=0.150  Sum_probs=378.9

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      .||+++|+++ .+|...+..+++|++|+|++|.++++.|.+|.++++|++|+|++|++++..|++|+++++|++|+|++|
T Consensus        36 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n  114 (606)
T 3vq2_A           36 NIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET  114 (606)
T ss_dssp             EEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred             EEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence            3789999999 677766678999999999999999888999999999999999999999888999999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcc-cCCchhhcCCcchhhhhccccccceeccccccCCCCCc----EEEccCCcc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHG-SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLE----LLELRDNQF  155 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~----~L~L~~N~i  155 (869)
                      ++++..+..|+++++|++|+|++|++.+ .+| ..|+++++|++|++++|++++..+..|..+++|+    +|++++|.+
T Consensus       115 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l  193 (606)
T 3vq2_A          115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLP-AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI  193 (606)
T ss_dssp             CCCCSSSSCCTTCTTCCEEECCSSCCCCCCCC-GGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCC
T ss_pred             ccccccccccCCCCCCCEEeCCCCcccceech-HhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCc
Confidence            9998777889999999999999999974 456 5689999999999999999988887777666554    677777777


Q ss_pred             ccccCcCcc-----------------------------------------------------------------------
Q 002897          156 IGKMSINFN-----------------------------------------------------------------------  164 (869)
Q Consensus       156 ~~~~~~~~~-----------------------------------------------------------------------  164 (869)
                      +++.+..|.                                                                       
T Consensus       194 ~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~  273 (606)
T 3vq2_A          194 DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND  273 (606)
T ss_dssp             CEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTT
T ss_pred             ceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccccc
Confidence            655554443                                                                       


Q ss_pred             ---------CCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc
Q 002897          165 ---------SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       165 ---------~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~  235 (869)
                               .+++|+.|++++|.+..++        .+..+++|++|++++|++ +.+| .+ .++. |+.|++++|...
T Consensus       274 ~~~~~~~~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~-L~~L~l~~n~~~  341 (606)
T 3vq2_A          274 FSDDIVKFHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPF-LKSLTLTMNKGS  341 (606)
T ss_dssp             CCGGGGSCGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCC-CC-CCSS-CCEEEEESCSSC
T ss_pred             ccccccccccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-cccc-cC-CCCc-cceeeccCCcCc
Confidence                     3445555555555554443        478899999999999999 5777 44 6665 999999999655


Q ss_pred             ccCCccccCCCCCCeeecccCcceec--CCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCC-c
Q 002897          236 GTIPPGLGNLVHLNSIAMEGNQLIGT--VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIP-S  312 (869)
Q Consensus       236 ~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~  312 (869)
                      +..  .+..+++|++|++++|++.+.  .|..+..+++|++|++++|.+++ .|..+..+++|+.|++++|++.+..+ .
T Consensus       342 ~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~  418 (606)
T 3vq2_A          342 ISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS  418 (606)
T ss_dssp             EEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTT
T ss_pred             cch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChh
Confidence            443  678999999999999999876  48889999999999999999985 66889999999999999999998777 6


Q ss_pred             CccCccccceeeccCcccCCCCCccccccccccceecccCCcccC-CCcccccCCccccccccccccccccCCccccCCC
Q 002897          313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG-SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACT  391 (869)
Q Consensus       313 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  391 (869)
                      .+..+++|+.|++++|++++..|..+.. ...++.|++++|.+++ .+|..++.+++|+.|+|++|.+++..|..|.+++
T Consensus       419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  497 (606)
T 3vq2_A          419 AFLSLEKLLYLDISYTNTKIDFDGIFLG-LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH  497 (606)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhhccccCCEEECcCCCCCccchhhhcC-CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc
Confidence            8999999999999999999766665544 4567899999999997 4799999999999999999999998999999999


Q ss_pred             CCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCcccccccc-ccCeeccccccCcccCCCC
Q 002897          392 SLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLS-FLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       392 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~~  458 (869)
                      +|+.|++++|++++..|..|+.+++|+.|+|++|+|+ .+|..+..++ +|+.|++++|++.+.++..
T Consensus       498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            9999999999999888999999999999999999999 7788899997 5999999999999988754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-51  Score=434.61  Aligned_cols=262  Identities=24%  Similarity=0.282  Sum_probs=210.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++....     ..+|+.+++.++|||||++++++.+.     +..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-----PWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            3567788899999999999999999999999999965322     24799999999999999999997653     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  711 (869)
                      +|||||++|+|.++++...      .+++.++..++.||+.||+|||++   +||||||||+|||++.+| ++||+|||+
T Consensus       127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            9999999999999998754      399999999999999999999999   999999999999999998 699999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      |+.+........   .......+||+.|||||++.+..|+.++||||+||++|||+||+.||......... ........
T Consensus       198 a~~~~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~~  273 (336)
T 4g3f_A          198 ALCLQPDGLGKS---LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIASEPP  273 (336)
T ss_dssp             CEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHHSCC
T ss_pred             CeEccCCCcccc---eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHcCCC
Confidence            987755432111   01233467999999999999999999999999999999999999999764433221 11111100


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      +  .                       ...++.+++.+.+++.+||+.||++|||+.|+++.|..+.+...
T Consensus       274 ~--~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          274 P--I-----------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             G--G-----------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             C--c-----------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            0  0                       00112345678899999999999999999999999998877654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-51  Score=475.53  Aligned_cols=456  Identities=23%  Similarity=0.237  Sum_probs=393.1

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|.++.+++ +||..+.   .++++|+|++|+++++.+.+|.++++|++|+|++|+|+++.|++|+++++|++|+|++|+
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~   87 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (570)
T ss_dssp             EECCSSCCS-SCCSSSC---SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEeCCCCcc-ccCCCcc---ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence            467888999 8998775   689999999999998888899999999999999999998888999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +++..|.+|.++++|++|++++|++. .++...++++++|++|++++|.+++. +|..|.++++|++|++++|+++++.+
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~  166 (570)
T 2z63_A           88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (570)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred             CCccCHhhhcCccccccccccccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence            99888899999999999999999998 77766789999999999999999873 68899999999999999999998888


Q ss_pred             cCccCCCCC----CEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCC-----------------------------
Q 002897          161 INFNSLKNL----SVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN-----------------------------  207 (869)
Q Consensus       161 ~~~~~l~~L----~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n-----------------------------  207 (869)
                      ..|..+++|    +.|++++|.++.++..      .+..+ +|++|++++|                             
T Consensus       167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~------~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~  239 (570)
T 2z63_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPG------AFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN  239 (570)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTT------TTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC
T ss_pred             HHccchhccchhhhhcccCCCCceecCHH------HhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC
Confidence            888888888    8999999999887764      34433 6777777766                             


Q ss_pred             -----------------------------CCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcc
Q 002897          208 -----------------------------QFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL  258 (869)
Q Consensus       208 -----------------------------~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  258 (869)
                                                   .+.+..|..+..+++ |+.|++++|.++ .+|..+..+ +|++|++++|.+
T Consensus       240 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~-L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~  316 (570)
T 2z63_A          240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKF  316 (570)
T ss_dssp             CSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTT-CSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBC
T ss_pred             chhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCc-ccEEEecCccch-hhhhhhccC-CccEEeeccCcc
Confidence                                         334445566666665 888888888888 577888888 888889988888


Q ss_pred             eecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccC--CcCccCccccceeeccCcccCCCCCc
Q 002897          259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI--PSSLGNCTSLIMLTLSKNKLDGVLPP  336 (869)
Q Consensus       259 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~  336 (869)
                      . .+|.  ..+++|+.|++++|.+.+..+.  ..+++|+.|++++|++++..  +..+..+++|+.|++++|++++ +|+
T Consensus       317 ~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~  390 (570)
T 2z63_A          317 G-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS  390 (570)
T ss_dssp             S-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEE
T ss_pred             c-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccc
Confidence            7 4554  4678889999999988766554  78899999999999998543  6788899999999999999984 444


Q ss_pred             cccccccccceecccCCcccCCCc-ccccCCccccccccccccccccCCccccCCCCCcEEEeeCcccc-CCCCcccccc
Q 002897          337 QILSVTTLSLFLNLSDNLLSGSLP-SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFS-GSIPPSLNFL  414 (869)
Q Consensus       337 ~~~~~~~~l~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l  414 (869)
                      . +...+.++.|++++|.+++..| ..+.++++|++|++++|.+++..|..+.++++|++|++++|+++ +.+|..+..+
T Consensus       391 ~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l  469 (570)
T 2z63_A          391 N-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL  469 (570)
T ss_dssp             E-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred             c-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcc
Confidence            4 4556677899999999997766 57899999999999999999889999999999999999999998 5789999999


Q ss_pred             ccccEEEccCCcccCCCccccccccccCeeccccccCcccCCC-CCccCCCccccccCCcccCCCC
Q 002897          415 KSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPK-KGVFSNKTRFSLSGNGKLCGGL  479 (869)
Q Consensus       415 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~  479 (869)
                      ++|+.|+|++|++++..|..+..+++|++|++++|++++.++. ...++.++.+++++|++.|.++
T Consensus       470 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            9999999999999988899999999999999999999998775 3567889999999999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-52  Score=441.19  Aligned_cols=251  Identities=18%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..  .....+.+.+|++++++++|||||++++++.+.     +..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEE
Confidence            5899999999999999999999999999999999643  334567899999999999999999999997653     789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      |+|||||++|+|.+++...+.    ..+++.+++.|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence            999999999999999976543    2478999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      |+......        ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....     .+....+.
T Consensus       172 a~~~~~~~--------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~  238 (350)
T 4b9d_A          172 ARVLNSTV--------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKII  238 (350)
T ss_dssp             ESCCCHHH--------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH
T ss_pred             ceeecCCc--------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHH
Confidence            98654321        122345799999999999999999999999999999999999999975321     12221111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......                       ....++.++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          239 SGSFPP-----------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HTCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCC-----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111000                       01123456789999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-51  Score=434.06  Aligned_cols=262  Identities=23%  Similarity=0.341  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      +++++.++||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|...    
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            34566789999999999999863     367899999996443 33457899999999999999999999998653    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                       +..++|||||++|+|.+++.......          ....++|.++..|+.|||+||+|||++   +||||||||+|||
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence             67899999999999999997653211          123589999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSM  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~  776 (869)
                      +++++.+||+|||+|+......      .........||+.|||||++.++.|+.++|||||||++|||+| |+.||...
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAAD------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGG------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             ECCCCCEEECCcccceeccCCC------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999998654322      1123345679999999999999999999999999999999998 89999753


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ..     .+....+....                       ..+.+++++..+.+++.+||+.||++||||+||++.|++
T Consensus       252 ~~-----~~~~~~i~~~~-----------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          252 SN-----QDVVEMIRNRQ-----------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             CH-----HHHHHHHHTTC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CH-----HHHHHHHHcCC-----------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            22     12222211110                       111223466778999999999999999999999999975


Q ss_pred             H
Q 002897          857 A  857 (869)
Q Consensus       857 ~  857 (869)
                      .
T Consensus       304 ~  304 (308)
T 4gt4_A          304 W  304 (308)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-51  Score=424.18  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=200.3

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      ++.++||+|+||+||+|.+..+++.||+|++...  .....+.+.+|++++++++|||||++++++.+. ..+....++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence            5567899999999999999999999999999643  334457899999999999999999999997653 2334678999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDFGLAK  713 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  713 (869)
                      ||||++|+|.+++++..      .+++..+..++.||+.||+|||++ +++||||||||+|||++. +|.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999998754      389999999999999999999998 123999999999999984 7899999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      ....          ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....    ...........
T Consensus       181 ~~~~----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~  245 (290)
T 3fpq_A          181 LKRA----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSG  245 (290)
T ss_dssp             GCCT----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTT
T ss_pred             eCCC----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcC
Confidence            5432          22334679999999999875 699999999999999999999999964322    11121111111


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....                      .+..+++++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~----------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKPAS----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCGG----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCC----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000                      00112345789999999999999999999975

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-50  Score=487.34  Aligned_cols=440  Identities=20%  Similarity=0.172  Sum_probs=369.0

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCc-cCCcccccCCCCcEEECcC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSG-FIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~Ls~  103 (869)
                      +..+.++++++ .+|.   -.++|++|+|++|+|+++.|..|+++++|++|+|++|.+.+ +.|.+|.++++|++|+|++
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            57888999999 6665   46899999999999999999999999999999999995544 4488999999999999999


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceecccc--ccCCCCCcEEEccCCccccccC-cCccCCCCCCEEEccCccCC
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS--LSNASNLELLELRDNQFIGKMS-INFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~--l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~  180 (869)
                      |.+. .++.+.|.++++|++|+|++|.+++..+..  |.++++|++|+|++|.+.+..+ ..|.++++|++|+|++|.++
T Consensus        83 N~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             CCCC-EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             CcCc-ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            9998 555578999999999999999999766654  9999999999999999988765 57999999999999999998


Q ss_pred             CCCCCCcchhhhccCC--CCCcEEEccCCCCCCCCChhhhhccc-----cceEEEecCCcccccCCccccC---------
Q 002897          181 NRAANDLDFVTVLANC--SKLENLGLYDNQFGGLLPHSLANLSN-----TMTTIDIGGNYFSGTIPPGLGN---------  244 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~-----~L~~L~l~~n~l~~~~~~~~~~---------  244 (869)
                      .+...      .+..+  ++|+.|++++|.+.+..|..+..+.+     .|+.|++++|.+++..+..+..         
T Consensus       162 ~~~~~------~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~  235 (844)
T 3j0a_A          162 LVCEH------ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS  235 (844)
T ss_dssp             CCCSG------GGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSE
T ss_pred             eeCHH------HcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccc
Confidence            87654      34455  89999999999999888776554432     3899999999887666554432         


Q ss_pred             -----------------------------CCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCcc
Q 002897          245 -----------------------------LVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM  295 (869)
Q Consensus       245 -----------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  295 (869)
                                                   .++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++
T Consensus       236 L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~  315 (844)
T 3j0a_A          236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN  315 (844)
T ss_dssp             EECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSS
T ss_pred             eecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCC
Confidence                                         268999999999999999999999999999999999999999999999999


Q ss_pred             ccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCC----------------
Q 002897          296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL----------------  359 (869)
Q Consensus       296 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~----------------  359 (869)
                      |++|++++|++++..|..|..+++|+.|++++|++.+ +++..+...+.++.|+|++|.+++..                
T Consensus       316 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI-IQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV  394 (844)
T ss_dssp             CCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCC-CCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC
T ss_pred             CCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCc-cChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc
Confidence            9999999999998889999999999999999999984 45545555666778888888876421                


Q ss_pred             --c----------------------ccccCCccccccccccccccccCCc-cccCCCCCcEEEeeCcccc-----CCCCc
Q 002897          360 --P----------------------SEIGNLKNLVQLDISGNRFSGDIPG-TLSACTSLEYVKMQDNSFS-----GSIPP  409 (869)
Q Consensus       360 --p----------------------~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~-----~~~p~  409 (869)
                        |                      ..+.++++|+.|+|++|++++..+. .+..+++|+.|++++|.++     +..+.
T Consensus       395 ~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~  474 (844)
T 3j0a_A          395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD  474 (844)
T ss_dssp             CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred             cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence              1                      1133677788888888888754433 3556788888888888886     34456


Q ss_pred             cccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCC
Q 002897          410 SLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCG  477 (869)
Q Consensus       410 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~  477 (869)
                      .|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.... .+++.+++++|.....
T Consensus       475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~  541 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAP  541 (844)
T ss_dssp             CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCC
T ss_pred             hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCC
Confidence            788999999999999999999999999999999999999999987665433 7888999998865443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-51  Score=428.51  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=208.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|++++++++|||||++++++.+     .+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            5799999999999999999999999999999999743   23446789999999999999999999999654     478


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+|||||+||+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            999999999999999998754      399999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+.....      .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....     .+....+
T Consensus       178 la~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i  246 (311)
T 4aw0_A          178 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKI  246 (311)
T ss_dssp             TCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             CceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            9998754321      1233456899999999999999999999999999999999999999975321     1222111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....      .+                  ++..++++.+++.+||+.||++|||++|++.
T Consensus       247 ~~~~~------~~------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          247 IKLEY------DF------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHTCC------CC------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HcCCC------CC------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            11110      00                  0122345789999999999999999998743

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=439.64  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +.|++.++||+|+||+||+|++..+|+.||||+++.......+.+.+|+.+|+.++|||||++++++.+.     +..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence            5699999999999999999999999999999999876666667789999999999999999999997654     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      |||||+||+|.++++..+       +++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       226 VmEy~~gG~L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEECCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            999999999999997653       89999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .+....        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     .+....+...
T Consensus       296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~  362 (423)
T 4fie_A          296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDN  362 (423)
T ss_dssp             ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS
T ss_pred             ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcC
Confidence            765432        233456899999999999999999999999999999999999999975321     1111111000


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                           ..+.+                .....++.++.+|+.+||+.||++|||++|+++
T Consensus       363 -----~~~~~----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 -----LPPRL----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -----CCCCC----------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCC----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 00000                001123456789999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.4e-50  Score=424.65  Aligned_cols=275  Identities=24%  Similarity=0.332  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++..... ...+..|+..+.+++|||||+++++|...+ ......++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            4677889999999999999998  6999999999654321 122344566667889999999999987642 22246899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCcEEEcc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-----KPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      |||||++|+|.++++...       +++..+.+++.|+++||+|||+++     .++||||||||+|||++.++++||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCcHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999998653       899999999999999999999762     45899999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC------CCCccccchhhhHHHHHHHcCCCCCCcCccCCc-
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL-  781 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~-  781 (869)
                      ||+|+........    .........||+.|||||++.+.      .++.++|||||||++|||+||++||........ 
T Consensus       152 FGla~~~~~~~~~----~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          152 LGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             CTTCEEEETTTTE----ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             CCCCccccCCCCc----eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            9999876543211    11123346799999999998764      367899999999999999999988754322211 


Q ss_pred             ---------hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 ---------TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ---------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                               .............    .+|.+             .......+++..+.+++.+||+.||++||||.||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~----~rp~~-------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQK----LRPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC----CCCCC-------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             chhcccccchHHHHHHHHhccc----CCCCC-------------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                     1111111111111    11111             111222356778999999999999999999999999


Q ss_pred             HHHHHHHh
Q 002897          853 KLCAAREA  860 (869)
Q Consensus       853 ~L~~~~~~  860 (869)
                      .|+++.+.
T Consensus       291 ~L~~l~~~  298 (303)
T 3hmm_A          291 TLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHHH
Confidence            99998764

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=469.73  Aligned_cols=447  Identities=18%  Similarity=0.191  Sum_probs=395.5

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      .||+++|+++ .++...+..+++|++|+|++|+++++.|.+|.++++|++|+|++|+++...|++|+++++|++|+|++|
T Consensus        32 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  110 (570)
T 2z63_A           32 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  110 (570)
T ss_dssp             EEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             EEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccc
Confidence            3799999999 677766778999999999999999888899999999999999999999888899999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcc-cCCchhhcCCcchhhhhccccccceeccccccCCCCC----cEEEccCCcc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHG-SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL----ELLELRDNQF  155 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L----~~L~L~~N~i  155 (869)
                      ++++..+..|+++++|++|+|++|.+.+ .+| ..|.++++|++|++++|.+++..+..+..+++|    +.|++++|.+
T Consensus       111 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l  189 (570)
T 2z63_A          111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM  189 (570)
T ss_dssp             CCCCSTTCSCTTCTTCCEEECCSSCCCCCCCC-GGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCC
T ss_pred             ccccCCCccccccccccEEecCCCccceecCh-hhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCc
Confidence            9997766689999999999999999984 356 568999999999999999999989999999999    8999999999


Q ss_pred             ccccCcCccCCCCCCEEEccCccCCC-------------------------------CCCCC------------------
Q 002897          156 IGKMSINFNSLKNLSVLILGNNHLGN-------------------------------RAAND------------------  186 (869)
Q Consensus       156 ~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------------~~~~~------------------  186 (869)
                      .++.+..|..+ +|+.|++++|....                               ++...                  
T Consensus       190 ~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~  268 (570)
T 2z63_A          190 NFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD  268 (570)
T ss_dssp             CEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred             eecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence            99999888876 79999998873221                               00000                  


Q ss_pred             ---cchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCC
Q 002897          187 ---LDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP  263 (869)
Q Consensus       187 ---~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  263 (869)
                         -..+..+..+++|++|++++|.++ .+|..+..+  .|+.|++++|.+. .+|.  ..+++|+.|++++|.+.+..+
T Consensus       269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~  342 (570)
T 2z63_A          269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFS  342 (570)
T ss_dssp             EEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCC
T ss_pred             hhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccccc
Confidence               011235677899999999999998 578778777  4999999999998 5565  578999999999999886665


Q ss_pred             ccccCCCCCCEEEccCccccCcC--CCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccc
Q 002897          264 PEIGWLKNLQSLYLNSNFLHGYI--PSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV  341 (869)
Q Consensus       264 ~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  341 (869)
                      .  ..+++|++|++++|.+++..  +..+.++++|++|++++|++.+. +..+..+++|+.|++++|++.+..|...+..
T Consensus       343 ~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  419 (570)
T 2z63_A          343 E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS  419 (570)
T ss_dssp             C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTT
T ss_pred             c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhc
Confidence            5  78999999999999998654  67788999999999999999954 4449999999999999999997777666777


Q ss_pred             ccccceecccCCcccCCCcccccCCcccccccccccccc-ccCCccccCCCCCcEEEeeCccccCCCCccccccccccEE
Q 002897          342 TTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS-GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL  420 (869)
Q Consensus       342 ~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  420 (869)
                      .+.++.|++++|.+++..|..+.++++|++|+|++|.++ +.+|..+..+++|+.|++++|++++..|.+|+.+++|+.|
T Consensus       420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  499 (570)
T 2z63_A          420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  499 (570)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence            778899999999999999999999999999999999998 5789999999999999999999998889999999999999


Q ss_pred             EccCCcccCCCccccccccccCeeccccccCcccCCCCC
Q 002897          421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKG  459 (869)
Q Consensus       421 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~  459 (869)
                      +|++|++++..|..+.++++|+.|++++|+++|.+|...
T Consensus       500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            999999998888889999999999999999999988754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-50  Score=414.76  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=191.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|++++++++|||||++++++.+     .+
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence            36899999999999999999999999999999999643   23345678999999999999999999999654     47


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+||||+ +|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            899999999 679999998765      399999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+.....         ......+||+.|||||++.+..+ +.++||||+||++|+|+||+.||....     .....+
T Consensus       157 Gla~~~~~~---------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~  222 (275)
T 3hyh_A          157 GLSNIMTDG---------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFK  222 (275)
T ss_dssp             SCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred             CCCeecCCC---------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHH
Confidence            999865432         22234679999999999998876 579999999999999999999997532     122222


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......      .                  .+...++++.+++.+||+.||++|||++|+++
T Consensus       223 ~i~~~~~------~------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          223 NISNGVY------T------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHTCC------C------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHcCCC------C------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111100      0                  00123456789999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-50  Score=432.32  Aligned_cols=275  Identities=22%  Similarity=0.311  Sum_probs=217.8

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCC-CccceEEEE
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGEN-----GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRH-RNLIKIITI  619 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~~~  619 (869)
                      .+++...++|++.+.||+|+||+||+|++...     ++.||||+++... ....+.+.+|++++++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34445567899999999999999999997543     4689999996543 3345779999999999965 899999999


Q ss_pred             eeccccCCCceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 002897          620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG  689 (869)
Q Consensus       620 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  689 (869)
                      |...    ....++|||||++|+|.++++......          ....+++.++..++.|||+||+|||++   +||||
T Consensus       137 ~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          137 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             ECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            8643    356899999999999999998654211          123489999999999999999999999   99999


Q ss_pred             CCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-
Q 002897          690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-  768 (869)
Q Consensus       690 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-  768 (869)
                      ||||+|||+++++.+||+|||+|+.+......      .......||+.|||||++.+..|+.++|||||||++|||+| 
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~  283 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  283 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCc------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence            99999999999999999999999876543211      12344678999999999999999999999999999999998 


Q ss_pred             CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       769 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |+.||.................                           ....++.+++++.+++.+||+.||++|||++
T Consensus       284 G~~Pf~~~~~~~~~~~~i~~g~---------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~  336 (353)
T 4ase_A          284 GASPYPGVKIDEEFCRRLKEGT---------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  336 (353)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCC---------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence            9999975432211111111100                           0011123456788999999999999999999


Q ss_pred             HHHHHHHHHHHhh
Q 002897          849 DVVVKLCAAREAF  861 (869)
Q Consensus       849 evl~~L~~~~~~~  861 (869)
                      ||++.|+.+.++.
T Consensus       337 eil~~L~~llq~~  349 (353)
T 4ase_A          337 ELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999988753

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=7.6e-50  Score=464.14  Aligned_cols=456  Identities=19%  Similarity=0.247  Sum_probs=368.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      .|+++++++ +||.+++   ++|++|+|++|+++++.|.+|.++++|++|+|++|+|++..|++|+++++|++|+|++|+
T Consensus        10 c~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   85 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH   85 (549)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence            478899999 9999876   799999999999998889999999999999999999998888999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccc-cceeccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNN-LTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +++..|..|+++++|++|+|++|++.+.-....+.++++|++|++++|. +....+..|.++++|++|++++|.+.+..+
T Consensus        86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  165 (549)
T 2z81_A           86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS  165 (549)
T ss_dssp             CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence            9988778899999999999999999732122468999999999999998 555556789999999999999999999999


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCC--ChhhhhccccceEEEecCCcccccC
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLL--PHSLANLSNTMTTIDIGGNYFSGTI  238 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~~L~~L~l~~n~l~~~~  238 (869)
                      ..|..+++|++|++++|.+..++..      .+..+++|++|++++|++++..  |..+......|+.|++++|.+++..
T Consensus       166 ~~l~~l~~L~~L~l~~n~~~~~~~~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  239 (549)
T 2z81_A          166 QSLKSIRDIHHLTLHLSESAFLLEI------FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES  239 (549)
T ss_dssp             TTTTTCSEEEEEEEECSBSTTHHHH------HHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred             hhhhccccCceEecccCcccccchh------hHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence            9999999999999999998765432      3456899999999999998642  2222222334777777777776543


Q ss_pred             Cc----cccCCCCCCeeecccCcceecC-----------------------------------CccccCCCCCCEEEccC
Q 002897          239 PP----GLGNLVHLNSIAMEGNQLIGTV-----------------------------------PPEIGWLKNLQSLYLNS  279 (869)
Q Consensus       239 ~~----~~~~l~~L~~L~l~~n~l~~~~-----------------------------------~~~~~~l~~L~~L~L~~  279 (869)
                      +.    .+..+++|+.|++++|.+.+..                                   +..+...++|+.|++++
T Consensus       240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~  319 (549)
T 2z81_A          240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN  319 (549)
T ss_dssp             HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred             HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence            32    2344556666666666654321                                   11112235788888888


Q ss_pred             ccccCcCCCCC-CCCccccceecccccccccCC---cCccCccccceeeccCcccCCCCC-ccccccccccceecccCCc
Q 002897          280 NFLHGYIPSSL-GNLTMLTLLALEINNLQGKIP---SSLGNCTSLIMLTLSKNKLDGVLP-PQILSVTTLSLFLNLSDNL  354 (869)
Q Consensus       280 N~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~~~l~~L~l~~N~  354 (869)
                      |.++ .+|..+ .++++|++|++++|++++..|   ..++.+++|++|++++|++++..+ ...+.....++.|++++|+
T Consensus       320 n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~  398 (549)
T 2z81_A          320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT  398 (549)
T ss_dssp             SCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCC
T ss_pred             Cccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCC
Confidence            8887 455544 579999999999999987653   457889999999999999984322 1345556678899999999


Q ss_pred             ccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccc
Q 002897          355 LSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY  434 (869)
Q Consensus       355 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  434 (869)
                      ++ .+|..+..+++|++|++++|.++ .+|..+.  ++|++|++++|+|++.+    ..+++|++|+|++|+|+ .+|. 
T Consensus       399 l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-  468 (549)
T 2z81_A          399 FH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-  468 (549)
T ss_dssp             CC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-
T ss_pred             Cc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-
Confidence            98 68888999999999999999998 4555442  68999999999998642    57899999999999998 6776 


Q ss_pred             cccccccCeeccccccCcccCCC-CCccCCCccccccCCcccCCC
Q 002897          435 LENLSFLEYLNLSYNHFEGEVPK-KGVFSNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       435 ~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~  478 (869)
                      ...+++|+.|++++|++++.+|. ...+..++.+++++|++.|.+
T Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  513 (549)
T 2z81_A          469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  513 (549)
T ss_dssp             GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred             cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence            56899999999999999998876 467888999999999999864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-50  Score=473.41  Aligned_cols=416  Identities=19%  Similarity=0.265  Sum_probs=307.8

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccC---------------------------------ccCCcccc-
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLG---------------------------------GKIPDTLG-   67 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~---------------------------------~~~p~~~~-   67 (869)
                      .+++.|+|++|+++|.+|.+|+++++|++|+|++|.+.                                 +..|..++ 
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~  160 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD  160 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence            47888889988888888888888999999999888762                                 11111111 


Q ss_pred             ------------------CCCCCCEEeCc--CcccCccCCcccccCCCCcEEECcCCcCccc-----------------C
Q 002897           68 ------------------QLRKLIYLNIG--RNQFSGFIPPSIYNISSFEFIFLQSNRFHGS-----------------L  110 (869)
Q Consensus        68 ------------------~l~~L~~L~L~--~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~  110 (869)
                                        ....++.+++.  .|++++ +|..|+++++|++|+|++|++++.                 +
T Consensus       161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i  239 (636)
T 4eco_A          161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK  239 (636)
T ss_dssp             HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence                              11223333333  578887 788888888888888888888753                 6


Q ss_pred             Cchhhc--CCcchhhhhccccccceeccccccCCCCCcEEEccCCc-ccc-ccCcCccCC------CCCCEEEccCccCC
Q 002897          111 PFDMVA--NLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ-FIG-KMSINFNSL------KNLSVLILGNNHLG  180 (869)
Q Consensus       111 ~~~~~~--~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~l~~n~l~  180 (869)
                      |. .+.  ++++|++|++++|++.+.+|..|+++++|++|+|++|+ +++ ..|..+..+      ++|++|++++|+++
T Consensus       240 p~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          240 TE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             ch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            64 355  78888888888888887888888888888888888887 776 566666665      78888888888887


Q ss_pred             CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCC-CCeeecccCcce
Q 002897          181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH-LNSIAMEGNQLI  259 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~  259 (869)
                      .++..     ..+..+++|++|++++|++++.+| .+..+++ |+.|++++|.++ .+|..+..+++ |+.|++++|++.
T Consensus       319 ~ip~~-----~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~-L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          319 TFPVE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIK-LASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             SCCCH-----HHHTTCTTCCEEECCSCCCEEECC-CCEEEEE-ESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred             ccCch-----hhhccCCCCCEEeCcCCcCccchh-hhCCCCC-CCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc
Confidence            65530     147778888888888888887777 7777765 888888888887 77777888887 888888888877


Q ss_pred             ecCCccccCCC--CCCEEEccCccccCcCCCCCC-------CCccccceecccccccccCCcCccCccccceeeccCccc
Q 002897          260 GTVPPEIGWLK--NLQSLYLNSNFLHGYIPSSLG-------NLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKL  330 (869)
Q Consensus       260 ~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l  330 (869)
                       .+|..+..++  +|++|++++|.+++..|..+.       .+++|+.|++++|+++...+..+..+++|++|+|++|++
T Consensus       391 -~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l  469 (636)
T 4eco_A          391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML  469 (636)
T ss_dssp             -SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCC
T ss_pred             -ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCC
Confidence             6677776654  788888888888877777777       777888888888888743333445578888888888888


Q ss_pred             CCCCCcccccccc-------ccceecccCCcccCCCccccc--CCccccccccccccccccCCccccCCCCCcEEEe---
Q 002897          331 DGVLPPQILSVTT-------LSLFLNLSDNLLSGSLPSEIG--NLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKM---  398 (869)
Q Consensus       331 ~~~~~~~~~~~~~-------~l~~L~l~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l---  398 (869)
                      + .+|...+....       .++.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|   
T Consensus       470 ~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          470 T-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             S-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             C-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence            7 66666655443       6677888888887 5677776  77888888888888875 7777778888888888   


Q ss_pred             ---eCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCccc
Q 002897          399 ---QDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE  454 (869)
Q Consensus       399 ---~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  454 (869)
                         ++|++.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|+.||+++|++...
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISI  602 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEE
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccc
Confidence               45667777788888888888888888888 46776655  6788888888877653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.3e-50  Score=418.56  Aligned_cols=248  Identities=25%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  .....++.+|++++++++|||||++++++.+.     
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence            57999999999999999999874   468899999996432  22345688999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..|+|||||+||+|.+++.+..      .+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence            78999999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+|+......        ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....     .+...
T Consensus       170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~  236 (304)
T 3ubd_A          170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMT  236 (304)
T ss_dssp             SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             cccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHH
Confidence            99998654322        223456799999999999999999999999999999999999999975321     11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM-----RDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  852 (869)
                      .......                        ..+..+++++.+++.+||+.||++|||+     +|+++
T Consensus       237 ~i~~~~~------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          237 MILKAKL------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHCCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHcCCC------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1111100                        0011234567899999999999999985     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.4e-49  Score=412.32  Aligned_cols=263  Identities=22%  Similarity=0.343  Sum_probs=194.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEEEEeecccc-------
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKIITICSSIDF-------  625 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  625 (869)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            468999999999999999999999999999999975443 345678999999999999999999999865421       


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      ......|+|||||++|+|.+++......   ...++..++.++.||++||+|||++   +|+||||||+|||++.++.+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence            1234579999999999999999876532   2356778899999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCcc----ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          706 VGDFGLAKFLPARPLDTVV----ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      |+|||+|+...........    .........+||+.|||||++.+..|+.++|||||||++|||++   ||......  
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence            9999999887654321111    01122344679999999999999999999999999999999996   77532111  


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ..........                       ..++...+..+.+.+++.+||+.||++|||+.|+++
T Consensus       234 --~~~~~~~~~~-----------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 --VRTLTDVRNL-----------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHHHHHHHTT-----------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHhcC-----------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0101100000                       001122334455678999999999999999999986

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=451.40  Aligned_cols=452  Identities=19%  Similarity=0.178  Sum_probs=352.5

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      ++|+++|+++ .||..++   ++|++|+|++|.|++..|.+|.++++|++|+|++|+|++..|++|+++++|++|+|++|
T Consensus         4 ~l~ls~n~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC---TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             eEecCCCCcc-ccccccc---ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            4799999999 8999886   89999999999999888899999999999999999999888999999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcc-cCCchhhcCCcchhhhhccccccceeccccccCCCCC--cEEEccCCcc--
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHG-SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL--ELLELRDNQF--  155 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L--~~L~L~~N~i--  155 (869)
                      +|++ +|..  .+++|++|+|++|++.+ .+| ..|+++++|++|++++|.+++   ..+..+++|  ++|++++|.+  
T Consensus        80 ~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           80 KLVK-ISCH--PTVNLKHLDLSFNAFDALPIC-KEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             CCCE-EECC--CCCCCSEEECCSSCCSSCCCC-GGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             ceee-cCcc--ccCCccEEeccCCccccccch-hhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            9994 5655  89999999999999984 244 579999999999999999986   467778888  9999999999  


Q ss_pred             ccccCcCccCCC-CCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCC-------CCCCCChhhhhccccceEE
Q 002897          156 IGKMSINFNSLK-NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQ-------FGGLLPHSLANLSNTMTTI  227 (869)
Q Consensus       156 ~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~~L~~L  227 (869)
                      .+..+..|..+. +...+++++|.+......     ..+..+++|+.|++++|.       +.+.+| .+..+.+ |+.|
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~-----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~-L~~L  225 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILD-----VSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPK-LSNL  225 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCC-----CCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTT-CCEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhh-----hhhhcccceeeccccccccccccceeecchh-hhccccc-hhhc
Confidence            777777777765 344567777776543322     256778888888888887       544444 5666665 8888


Q ss_pred             EecCCcccccCCcccc---CCCCCCeeecccCcceecCCccc-----cCCCCCCEEEccCccccCcCC-CCCCCC---cc
Q 002897          228 DIGGNYFSGTIPPGLG---NLVHLNSIAMEGNQLIGTVPPEI-----GWLKNLQSLYLNSNFLHGYIP-SSLGNL---TM  295 (869)
Q Consensus       228 ~l~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~  295 (869)
                      ++++|.+++..+..+.   ..++|++|++++|++.+.+|..+     +.+++|+.+++++|.+  .+| ..+..+   ++
T Consensus       226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~  303 (520)
T 2z7x_B          226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMN  303 (520)
T ss_dssp             EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCC
T ss_pred             cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCc
Confidence            8888877653322221   13578888888888887778777     7788888888888887  333 333333   56


Q ss_pred             ccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccC--CCcccccCCccccccc
Q 002897          296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG--SLPSEIGNLKNLVQLD  373 (869)
Q Consensus       296 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~--~~p~~~~~l~~L~~L~  373 (869)
                      |+.|++++|.+....  .+..+++|++|++++|++++..|..+.. .+.++.|++++|++++  .+|..++.+++|++|+
T Consensus       304 L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~  380 (520)
T 2z7x_B          304 IKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGH-LTELETLILQMNQLKELSKIAEMTTQMKSLQQLD  380 (520)
T ss_dssp             CSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCC-CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred             eeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhcc-CCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence            888888888876321  1267788888888888888766665543 4456778888888875  4556788888888888


Q ss_pred             cccccccccCCc-cccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCc
Q 002897          374 ISGNRFSGDIPG-TLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFE  452 (869)
Q Consensus       374 L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  452 (869)
                      |++|.+++.+|. .+..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|++++|+++
T Consensus       381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  457 (520)
T 2z7x_B          381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK  457 (520)
T ss_dssp             CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence            888888864554 477888888888888888877666654  68888888888888 77777778888888888888888


Q ss_pred             ccCCC-CCccCCCccccccCCcccCCC
Q 002897          453 GEVPK-KGVFSNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       453 ~~~~~-~~~~~~~~~~~~~~n~~~c~~  478 (869)
                      +.++. ...+.+++.+++++|++.|.+
T Consensus       458 ~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          458 SVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCHHHhccCCcccEEECcCCCCcccC
Confidence            65544 455677888888888888853

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.8e-48  Score=457.33  Aligned_cols=419  Identities=18%  Similarity=0.282  Sum_probs=358.8

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccC------c---------------------------cCCcccc-
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS------G---------------------------FIPPSIY-   91 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~------~---------------------------~~p~~~~-   91 (869)
                      .+++.|+|++|.+.+.+|.+|++|++|++|+|++|.+.      +                           .+|..+. 
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~  160 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD  160 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence            58999999999999999999999999999999999762      1                           0111111 


Q ss_pred             ------------------cCCCCcEEECc--CCcCcccCCchhhcCCcchhhhhcccccccee-----------------
Q 002897           92 ------------------NISSFEFIFLQ--SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-----------------  134 (869)
Q Consensus        92 ------------------~l~~L~~L~Ls--~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-----------------  134 (869)
                                        ....++.+.+.  +|++++ +|. .++++++|++|+|++|.+++.                 
T Consensus       161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~  238 (636)
T 4eco_A          161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY  238 (636)
T ss_dssp             HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence                              11122333332  678886 885 599999999999999999985                 


Q ss_pred             cccccc--CCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc-CCC--CCCCCcchhhhccCCCCCcEEEccCCCC
Q 002897          135 LPISLS--NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH-LGN--RAANDLDFVTVLANCSKLENLGLYDNQF  209 (869)
Q Consensus       135 ~~~~l~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~--~~~~~~~~~~~l~~l~~L~~L~L~~n~l  209 (869)
                      +|..++  ++++|++|+|++|.+.+..|..|.++++|++|++++|+ ++.  ++.. +.....+..+++|++|++++|++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~-~~~L~~~~~l~~L~~L~L~~n~l  317 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD-WQALADAPVGEKIQIIYIGYNNL  317 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHH-HHHHHHSGGGGTCCEEECCSSCC
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHH-HHhhhccccCCCCCEEECCCCcC
Confidence            899999  99999999999999999999999999999999999998 864  3321 11111123449999999999999


Q ss_pred             CCCCCh--hhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCC-CCEEEccCccccCcC
Q 002897          210 GGLLPH--SLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKN-LQSLYLNSNFLHGYI  286 (869)
Q Consensus       210 ~~~~~~--~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~  286 (869)
                      + .+|.  .+..+++ |+.|++++|.+++.+| .|..+++|+.|++++|++. .+|..++.+++ |++|++++|.++ .+
T Consensus       318 ~-~ip~~~~l~~l~~-L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          318 K-TFPVETSLQKMKK-LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             S-SCCCHHHHTTCTT-CCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred             C-ccCchhhhccCCC-CCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc
Confidence            9 7888  8999986 9999999999998999 9999999999999999999 88888999999 999999999999 77


Q ss_pred             CCCCCCCc--cccceecccccccccCCcCcc-------CccccceeeccCcccCCCCCccccccccccceecccCCcccC
Q 002897          287 PSSLGNLT--MLTLLALEINNLQGKIPSSLG-------NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG  357 (869)
Q Consensus       287 ~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~  357 (869)
                      |..+..++  +|+.|++++|++++..|..|.       .+++|+.|++++|+++ .+|..++...+.++.|+|++|+++ 
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-  470 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-  470 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-
Confidence            88887765  899999999999999999998       8899999999999999 788888887788899999999999 


Q ss_pred             CCccc-ccCC-------ccccccccccccccccCCcccc--CCCCCcEEEeeCccccCCCCccccccccccEEEc-----
Q 002897          358 SLPSE-IGNL-------KNLVQLDISGNRFSGDIPGTLS--ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDL-----  422 (869)
Q Consensus       358 ~~p~~-~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L-----  422 (869)
                      .+|.. +..+       ++|+.|+|++|.++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|     
T Consensus       471 ~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~  548 (636)
T 4eco_A          471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD  548 (636)
T ss_dssp             BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBC
T ss_pred             CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcc
Confidence            55544 3333       39999999999999 7888887  99999999999999996 8999999999999999     


Q ss_pred             -cCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCC
Q 002897          423 -SSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       423 -~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~  478 (869)
                       ++|++.+.+|..+.++++|++|++++|++ +.+|.. ..+.++.+++++|+..|-.
T Consensus       549 ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID  603 (636)
T ss_dssp             TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred             cccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence             56888999999999999999999999999 556654 3488999999999988743

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.1e-48  Score=458.13  Aligned_cols=442  Identities=19%  Similarity=0.224  Sum_probs=358.8

Q ss_pred             hhhhc-cCCcCEEeccCCcCccccCcccccCcCCCEEEc-cCCccCccCCcc----------------------------
Q 002897           16 EIGCY-LFKLENLSLAENHLTGQLPVSIGNLSALQVIDI-RGNRLGGKIPDT----------------------------   65 (869)
Q Consensus        16 ~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-~~n~i~~~~p~~----------------------------   65 (869)
                      ++.|. -.+++.|+|++|+++|.+|.+|++|++|++|+| ++|.+.+..|-.                            
T Consensus       316 GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~  395 (876)
T 4ecn_A          316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD  395 (876)
T ss_dssp             TEEECTTSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCC
T ss_pred             ceEecCCCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccC
Confidence            34443 257999999999999999999999999999999 888876553211                            


Q ss_pred             -----------------------ccCCCCCCEEeCcC--cccCccCCcccccCCCCcEEECcCCcCcc------------
Q 002897           66 -----------------------LGQLRKLIYLNIGR--NQFSGFIPPSIYNISSFEFIFLQSNRFHG------------  108 (869)
Q Consensus        66 -----------------------~~~l~~L~~L~L~~--n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~------------  108 (869)
                                             ......++.+.++.  |++++ +|..|.++++|++|+|++|++++            
T Consensus       396 ~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~  474 (876)
T 4ecn_A          396 QRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS  474 (876)
T ss_dssp             GGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred             cchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccc
Confidence                                   01223455555554  88987 89999999999999999999996            


Q ss_pred             -----cCCchh-hcCCcchhhhhccccccceeccccccCCCCCcEEEccCCc-ccc-ccCcCcc-------CCCCCCEEE
Q 002897          109 -----SLPFDM-VANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ-FIG-KMSINFN-------SLKNLSVLI  173 (869)
Q Consensus       109 -----~~~~~~-~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~-i~~-~~~~~~~-------~l~~L~~L~  173 (869)
                           .+|... |.++++|+.|+|++|++.+.+|..|.++++|++|+|++|+ +++ ..|..|.       .+++|+.|+
T Consensus       475 n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~  554 (876)
T 4ecn_A          475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY  554 (876)
T ss_dssp             HHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred             ccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence                 278653 4499999999999999999999999999999999999998 876 5665444       445999999


Q ss_pred             ccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCC-CCeee
Q 002897          174 LGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH-LNSIA  252 (869)
Q Consensus       174 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~  252 (869)
                      |++|.++.++.     ...+.++++|++|+|++|+++ .+| .+..+++ |+.|+|++|.++ .+|..+..+++ |+.|+
T Consensus       555 Ls~N~L~~ip~-----~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~-L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~  625 (876)
T 4ecn_A          555 MGYNNLEEFPA-----SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK-LTDLKLDYNQIE-EIPEDFCAFTDQVEGLG  625 (876)
T ss_dssp             CCSSCCCBCCC-----HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE-ESEEECCSSCCS-CCCTTSCEECTTCCEEE
T ss_pred             eeCCcCCccCC-----hhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc-ceEEECcCCccc-cchHHHhhccccCCEEE
Confidence            99999986654     015889999999999999998 777 7888876 999999999999 88888999998 99999


Q ss_pred             cccCcceecCCccccCCCC--CCEEEccCccccCcCCCCC---C--CCccccceecccccccccCCcCc-cCccccceee
Q 002897          253 MEGNQLIGTVPPEIGWLKN--LQSLYLNSNFLHGYIPSSL---G--NLTMLTLLALEINNLQGKIPSSL-GNCTSLIMLT  324 (869)
Q Consensus       253 l~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~  324 (869)
                      |++|++. .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|++++|+++ .+|..+ ..+++|+.|+
T Consensus       626 Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~  703 (876)
T 4ecn_A          626 FSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTII  703 (876)
T ss_dssp             CCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEE
T ss_pred             CcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEE
Confidence            9999998 77888877654  9999999999987666432   2  3458999999999999 556554 4889999999


Q ss_pred             ccCcccCCCCCcccccccc-------ccceecccCCcccCCCccccc--CCccccccccccccccccCCccccCCCCCcE
Q 002897          325 LSKNKLDGVLPPQILSVTT-------LSLFLNLSDNLLSGSLPSEIG--NLKNLVQLDISGNRFSGDIPGTLSACTSLEY  395 (869)
Q Consensus       325 l~~N~l~~~~~~~~~~~~~-------~l~~L~l~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  395 (869)
                      |++|+++ .+|..++....       .++.|+|++|+++ .+|..+.  .+++|+.|+|++|.+++ +|..+..+++|+.
T Consensus       704 Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~  780 (876)
T 4ecn_A          704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA  780 (876)
T ss_dssp             CCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCE
T ss_pred             CCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCE
Confidence            9999998 77877776543       7788999999999 7888887  89999999999999996 7888999999999


Q ss_pred             EEeeC------ccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCC-CccCCCcccc
Q 002897          396 VKMQD------NSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFS  468 (869)
Q Consensus       396 L~l~~------N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~  468 (869)
                      |+|++      |++.+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|||++|++....+.. ........+.
T Consensus       781 L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~  857 (876)
T 4ecn_A          781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYV  857 (876)
T ss_dssp             EECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCE
T ss_pred             EECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchhee
Confidence            99976      888889999999999999999999999 58888776  68999999999987654321 1112234455


Q ss_pred             ccCCccc
Q 002897          469 LSGNGKL  475 (869)
Q Consensus       469 ~~~n~~~  475 (869)
                      +.+|+..
T Consensus       858 L~~n~~~  864 (876)
T 4ecn_A          858 LLYDKTQ  864 (876)
T ss_dssp             EECCTTS
T ss_pred             ecCCCcc
Confidence            6666544

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5.3e-48  Score=448.62  Aligned_cols=440  Identities=19%  Similarity=0.220  Sum_probs=365.2

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +||+++|++++ ++...+..+++|++|+|++|++++..|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus        30 ~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n  108 (549)
T 2z81_A           30 SLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN  108 (549)
T ss_dssp             EEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTC
T ss_pred             EEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCC
Confidence            47999999994 54444568999999999999999888899999999999999999999887788999999999999999


Q ss_pred             ccCcc-CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccccc
Q 002897           81 QFSGF-IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        81 ~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      ++++. .|..|.++++|++|++++|.+.+.+|...|.++++|++|++++|.+++..|..+..+++|++|++++|.+..+.
T Consensus       109 ~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~  188 (549)
T 2z81_A          109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL  188 (549)
T ss_dssp             CCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHH
T ss_pred             cccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccc
Confidence            99963 57889999999999999999656888888999999999999999999999999999999999999999987665


Q ss_pred             CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhh----hccccceEEEecCCccc
Q 002897          160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLA----NLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       160 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~~L~~L~l~~n~l~  235 (869)
                      ...+..+++|++|++++|+++..+....   .....+++|+.|++++|++++..+..+.    .+. .|+.|++++|.+.
T Consensus       189 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~-~L~~l~l~~~~~~  264 (549)
T 2z81_A          189 EIFADILSSVRYLELRDTNLARFQFSPL---PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL-ELSEVEFDDCTLN  264 (549)
T ss_dssp             HHHHHSTTTBSEEEEESCBCTTCCCCCC---SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCT-TCCEEEEESCEEE
T ss_pred             hhhHhhcccccEEEccCCcccccccccc---chhhhhhcccceeccccccchhHHHHHHHHhhhhc-ccccccccccccc
Confidence            5556779999999999999987642211   1244577888888888877654443332    222 3677777777665


Q ss_pred             ccC-----------------------------------CccccCCCCCCeeecccCcceecCCccc-cCCCCCCEEEccC
Q 002897          236 GTI-----------------------------------PPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNS  279 (869)
Q Consensus       236 ~~~-----------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~  279 (869)
                      +..                                   +..+..+.+|+.|++++|.+. .+|..+ ..+++|++|+|++
T Consensus       265 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~  343 (549)
T 2z81_A          265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSE  343 (549)
T ss_dssp             CCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCS
T ss_pred             ccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccC
Confidence            421                                   001122457899999999987 666665 5799999999999


Q ss_pred             ccccCcC---CCCCCCCccccceecccccccccCC--cCccCccccceeeccCcccCCCCCccccccccccceecccCCc
Q 002897          280 NFLHGYI---PSSLGNLTMLTLLALEINNLQGKIP--SSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNL  354 (869)
Q Consensus       280 N~l~~~~---~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~  354 (869)
                      |++++..   +..++.+++|+.|++++|++++..+  ..+..+++|++|++++|+++ .+|..+.. ...++.|++++|+
T Consensus       344 N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~-~~~L~~L~Ls~N~  421 (549)
T 2z81_A          344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW-PEKMRFLNLSSTG  421 (549)
T ss_dssp             SCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCC-CTTCCEEECTTSC
T ss_pred             CccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcc-cccccEEECCCCC
Confidence            9999765   3458899999999999999985432  46899999999999999998 67766544 4567899999999


Q ss_pred             ccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccc
Q 002897          355 LSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY  434 (869)
Q Consensus       355 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  434 (869)
                      ++ .+|..+  .++|++|+|++|++++.+    ..+++|++|++++|+|+ .+|. ...+++|++|+|++|++++.+|..
T Consensus       422 l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~  492 (549)
T 2z81_A          422 IR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGI  492 (549)
T ss_dssp             CS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTG
T ss_pred             cc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHH
Confidence            98 455444  268999999999999642    57899999999999998 6776 567999999999999999998889


Q ss_pred             cccccccCeeccccccCcccCCC
Q 002897          435 LENLSFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       435 ~~~l~~L~~l~l~~N~l~~~~~~  457 (869)
                      +..+++|+.|++++|++.|.+|.
T Consensus       493 ~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          493 FDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             GGGCTTCCEEECCSSCBCCCHHH
T ss_pred             HhcCcccCEEEecCCCccCCCcc
Confidence            99999999999999999998874

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.3e-46  Score=445.56  Aligned_cols=468  Identities=19%  Similarity=0.209  Sum_probs=361.8

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      .|.++.+++ +||.++.   +++++|||++|+|+++.+.+|.++++|++|+|++|+|+++.|++|+++++|++|+|++|+
T Consensus        36 ~~c~~~~l~-~vP~~lp---~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~  111 (635)
T 4g8a_A           36 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP  111 (635)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EECCCCCcC-ccCCCCC---cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence            367788999 9999886   589999999999998888899999999999999999998889999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      |++..+.+|.++++|++|+|++|+++ .+|...|+++++|++|++++|.++.. .|..+..+++|++|+|++|+|+++.+
T Consensus       112 l~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  190 (635)
T 4g8a_A          112 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  190 (635)
T ss_dssp             CCEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             CCCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence            99888889999999999999999998 78888899999999999999999864 57889999999999999999999988


Q ss_pred             cCccCCCCCC----EEEccCccCCCCCCCCcch------------------hhhccCCCCCcEEEccCCCC------CCC
Q 002897          161 INFNSLKNLS----VLILGNNHLGNRAANDLDF------------------VTVLANCSKLENLGLYDNQF------GGL  212 (869)
Q Consensus       161 ~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~------------------~~~l~~l~~L~~L~L~~n~l------~~~  212 (869)
                      ..|..+.+++    .++++.|.++.++...+..                  ...+..+..++...+..+..      ...
T Consensus       191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  270 (635)
T 4g8a_A          191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  270 (635)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             ccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence            8887765544    6888888887665432110                  01122223333222211110      000


Q ss_pred             CC---------------------------hhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecC---
Q 002897          213 LP---------------------------HSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTV---  262 (869)
Q Consensus       213 ~~---------------------------~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---  262 (869)
                      ..                           ..+.... .++.+++.+|.+...  ..+.....|+.|++.+|.+....   
T Consensus       271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~-~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~  347 (635)
T 4g8a_A          271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLT-NVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLK  347 (635)
T ss_dssp             CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGT-TCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCB
T ss_pred             cccccccccchhhhhhhhhhhcccccchhhhhhhhc-ccccccccccccccc--cccccchhhhhhhcccccccCcCccc
Confidence            00                           0111111 133333333333321  12233334444444444433221   


Q ss_pred             ----------------CccccCCCCCCEEEccCccccC--cCCCCCCCCccccceecccccccccCCcCccCccccceee
Q 002897          263 ----------------PPEIGWLKNLQSLYLNSNFLHG--YIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLT  324 (869)
Q Consensus       263 ----------------~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  324 (869)
                                      +.....+++|+.|++++|.+..  ..+..+..+.+|+.+++..|.+. ..+..+..+++|+.++
T Consensus       348 l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~  426 (635)
T 4g8a_A          348 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLD  426 (635)
T ss_dssp             CTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEE
T ss_pred             chhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchh
Confidence                            1223356777777777777653  23444556677777777777776 4566788899999999


Q ss_pred             ccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccc-cccCCccccCCCCCcEEEeeCccc
Q 002897          325 LSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRF-SGDIPGTLSACTSLEYVKMQDNSF  403 (869)
Q Consensus       325 l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~l~~N~l  403 (869)
                      ++.|+.....+...+.....+..+++++|.+++..+..+..+++|+.|+|++|.+ .+..|..|..+++|++|+|++|+|
T Consensus       427 l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L  506 (635)
T 4g8a_A          427 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  506 (635)
T ss_dssp             CTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             hhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCcc
Confidence            9999888777777777788889999999999999999999999999999999985 446788999999999999999999


Q ss_pred             cCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCC-Ccc-CCCccccccCCcccCCC
Q 002897          404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVF-SNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       404 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~~  478 (869)
                      ++..|..|.++++|++|+|++|+|++..|..|..+++|+.|||++|+|++.+|.. ..+ .+++.+++++|||.|++
T Consensus       507 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          507 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             CCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            9989999999999999999999999988999999999999999999999988764 333 67899999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=415.21  Aligned_cols=284  Identities=22%  Similarity=0.271  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeecc-ccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSI-DFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++... .+.+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999996432  33456788999999999999999999997653 2445578


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+|||||+ |+|.+++....      ++++.++..++.||+.||+|||++   |||||||||+|||++.++.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            999999996 68999998754      399999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+.+.....    .........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+......
T Consensus       204 la~~~~~~~~----~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~  278 (398)
T 4b99_A          204 MARGLCTSPA----EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV  278 (398)
T ss_dssp             TCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH
T ss_pred             eeeecccCcc----ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence            9987644321    111234457899999999998875 4699999999999999999999999753221 111111111


Q ss_pred             hc--ccccccccCc-cchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VL--PEKVMEIVDP-SLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~--~~~~~~~~d~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  +......... .....................+....++.+|+.+||..||++||||+|+++
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11  1111111100 000000000000000000001123456789999999999999999999986

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=9.9e-47  Score=448.33  Aligned_cols=432  Identities=18%  Similarity=0.216  Sum_probs=330.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEec-cCCcCccccCccc--------------------------------------
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSL-AENHLTGQLPVSI--------------------------------------   42 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L-~~n~l~~~~~~~~--------------------------------------   42 (869)
                      |||++++++|.||..++ .|++|+.|+| ++|.+++..|..-                                      
T Consensus       328 L~Ls~~~L~G~ip~~l~-~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~  406 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIG-QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD  406 (876)
T ss_dssp             EECTTTCCEEEECGGGG-GCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred             EECccCCCCCcCchHHh-ccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHH
Confidence            78999999999999886 8999999999 8888765522110                                      


Q ss_pred             -------------ccCcCCCEEEccC--CccCccCCccccCCCCCCEEeCcCcccCc-----------------cCCccc
Q 002897           43 -------------GNLSALQVIDIRG--NRLGGKIPDTLGQLRKLIYLNIGRNQFSG-----------------FIPPSI   90 (869)
Q Consensus        43 -------------~~l~~L~~L~L~~--n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-----------------~~p~~~   90 (869)
                                   .....++.+.+..  |++++ +|..|+++++|++|+|++|+|++                 .+|..+
T Consensus       407 ~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l  485 (876)
T 4ecn_A          407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL  485 (876)
T ss_dssp             HHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred             HhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhh
Confidence                         1112233334433  77776 67788888888888888888886                 277776


Q ss_pred             c--cCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccc-cce-eccccccCCC-------CCcEEEccCCcccccc
Q 002897           91 Y--NISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNN-LTG-FLPISLSNAS-------NLELLELRDNQFIGKM  159 (869)
Q Consensus        91 ~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~~~~l~~l~-------~L~~L~L~~N~i~~~~  159 (869)
                      +  ++++|++|+|++|.+.+.+| ..|.++++|+.|+|++|+ +++ .+|..+.+++       +|++|+|++|+++ ..
T Consensus       486 ~f~~L~~L~~L~Ls~N~l~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~i  563 (876)
T 4ecn_A          486 SWSNLKDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EF  563 (876)
T ss_dssp             CGGGCTTCCEEEEESCTTCCSCC-GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BC
T ss_pred             hhccCCCCCEEECcCCCCCccCh-HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-cc
Confidence            6  88888888888888777777 557788888888888887 776 6666555544       8888888888887 45


Q ss_pred             Cc--CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccccc
Q 002897          160 SI--NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT  237 (869)
Q Consensus       160 ~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~  237 (869)
                      |.  .|..+++|+.|+|++|.++.++        .|..+++|++|+|++|+++ .+|..+..+++.|+.|+|++|.++ .
T Consensus       564 p~~~~l~~L~~L~~L~Ls~N~l~~lp--------~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~  633 (876)
T 4ecn_A          564 PASASLQKMVKLGLLDCVHNKVRHLE--------AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y  633 (876)
T ss_dssp             CCHHHHTTCTTCCEEECTTSCCCBCC--------CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-S
T ss_pred             CChhhhhcCCCCCEEECCCCCcccch--------hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-c
Confidence            55  7888888888888888887554        3777888888888888887 677777777655888888888887 6


Q ss_pred             CCccccCCCC--CCeeecccCcceecCCccc---c--CCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccC
Q 002897          238 IPPGLGNLVH--LNSIAMEGNQLIGTVPPEI---G--WLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI  310 (869)
Q Consensus       238 ~~~~~~~l~~--L~~L~l~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  310 (869)
                      +|..+..++.  |+.|++++|++.+.+|...   .  .+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+ .+
T Consensus       634 lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~i  712 (876)
T 4ecn_A          634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI  712 (876)
T ss_dssp             CCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred             CchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-cc
Confidence            7777766654  8888888888876555322   2  3347888888888888433333447788888888888888 55


Q ss_pred             CcCccC--------ccccceeeccCcccCCCCCcccc-ccccccceecccCCcccCCCcccccCCcccccccccc-----
Q 002897          311 PSSLGN--------CTSLIMLTLSKNKLDGVLPPQIL-SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG-----  376 (869)
Q Consensus       311 ~~~~~~--------l~~L~~L~l~~N~l~~~~~~~~~-~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-----  376 (869)
                      |..+..        +++|+.|+|++|+++ .+|..++ ...+.++.|+|++|++++ +|..+.++++|+.|+|++     
T Consensus       713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls  790 (876)
T 4ecn_A          713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE  790 (876)
T ss_dssp             CTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTT
T ss_pred             ChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcc
Confidence            554333        338888888888888 6777665 455667788888888886 788899999999999976     


Q ss_pred             -ccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcc
Q 002897          377 -NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG  453 (869)
Q Consensus       377 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  453 (869)
                       |.+.+.+|..|.++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++....+..+.....+..+.|++|++..
T Consensus       791 ~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          791 GNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             cccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence             888889999999999999999999999 58898876  699999999999997777788777778888898888764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=428.46  Aligned_cols=439  Identities=18%  Similarity=0.194  Sum_probs=367.0

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +||+++|+++ .+|...+..+++|++|+|++|+|++..|.+|.++++|++|+|++|+|+ .+|..  .+++|++|+|++|
T Consensus        25 ~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N  100 (520)
T 2z7x_B           25 ILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFN  100 (520)
T ss_dssp             EEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSS
T ss_pred             EEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCC
Confidence            4799999999 677666678999999999999999888999999999999999999999 56665  8999999999999


Q ss_pred             ccCc-cCCcccccCCCCcEEECcCCcCcccCCchhhcCCcch--hhhhcccccc--ceeccccccCCC-CCcEEEccCCc
Q 002897           81 QFSG-FIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL--RKFVAAKNNL--TGFLPISLSNAS-NLELLELRDNQ  154 (869)
Q Consensus        81 ~i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L--~~L~l~~n~i--~~~~~~~l~~l~-~L~~L~L~~N~  154 (869)
                      ++++ .+|..|+++++|++|+|++|++.+    ..+..+++|  +.|++++|.+  .+..|..+..+. +...+++++|.
T Consensus       101 ~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~  176 (520)
T 2z7x_B          101 AFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK  176 (520)
T ss_dssp             CCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSS
T ss_pred             ccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCc
Confidence            9997 478999999999999999999974    357778888  9999999999  778888888776 45567889998


Q ss_pred             ccccc-CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhh---ccccceEEEec
Q 002897          155 FIGKM-SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN---LSNTMTTIDIG  230 (869)
Q Consensus       155 i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~---l~~~L~~L~l~  230 (869)
                      +.+.. ...+..+++|+.|++++|........-......+..+++|+.|++++|.+++..+..+..   .. .|+.|+++
T Consensus       177 ~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~-~L~~L~l~  255 (520)
T 2z7x_B          177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT-TVWYFSIS  255 (520)
T ss_dssp             CCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTS-SCSEEEEE
T ss_pred             chhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhC-cccEEEee
Confidence            76544 446889999999999999611000000012236889999999999999987543332221   22 49999999


Q ss_pred             CCcccccCCccc-----cCCCCCCeeecccCcceecCC-ccccCC---CCCCEEEccCccccCcCCCCCCCCccccceec
Q 002897          231 GNYFSGTIPPGL-----GNLVHLNSIAMEGNQLIGTVP-PEIGWL---KNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL  301 (869)
Q Consensus       231 ~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  301 (869)
                      +|.+++.+|..+     .++++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+..+++|++|++
T Consensus       256 ~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~L  331 (520)
T 2z7x_B          256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDF  331 (520)
T ss_dssp             EEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEEC
T ss_pred             cccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEe
Confidence            999999999998     9999999999999998  445 555544   68999999999987432  2378999999999


Q ss_pred             ccccccccCCcCccCccccceeeccCcccCC--CCCccccccccccceecccCCcccCCCcc-cccCCcccccccccccc
Q 002897          302 EINNLQGKIPSSLGNCTSLIMLTLSKNKLDG--VLPPQILSVTTLSLFLNLSDNLLSGSLPS-EIGNLKNLVQLDISGNR  378 (869)
Q Consensus       302 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~~~~l~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~  378 (869)
                      ++|++++..|..+..+++|++|++++|++++  .+|.. +.....++.|++++|++++.+|. .+..+++|++|++++|.
T Consensus       332 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~  410 (520)
T 2z7x_B          332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM-TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI  410 (520)
T ss_dssp             CSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHH-HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred             ECCccChhhhhhhccCCCCCEEEccCCccCccccchHH-HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence            9999998899999999999999999999984  22233 44456778999999999985665 48899999999999999


Q ss_pred             ccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccc-cccccccCeeccccccCcccCCC
Q 002897          379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY-LENLSFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       379 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~  457 (869)
                      +++..|..+.  ++|+.|++++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|++|++++|++++.++.
T Consensus       411 l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             CCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            9988877665  79999999999999 88988889999999999999999 45654 89999999999999999987764

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.3e-45  Score=428.71  Aligned_cols=431  Identities=19%  Similarity=0.232  Sum_probs=259.4

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      ++|+++|+++ .||.+++   ++|++|+|++|.|+++.|.+|.++++|++|+|++|+|++..|++|+++++|++|+|++|
T Consensus        35 ~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           35 MVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             EEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             EEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            3789999999 7998875   79999999999999888889999999999999999999888999999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCC-chhhcCCcchhhhhccccccceeccccccCCCCC--cEEEccCCcc--
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLP-FDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL--ELLELRDNQF--  155 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L--~~L~L~~N~i--  155 (869)
                      +|+. +|..  .+++|++|+|++|++. .+| ...|+++++|++|++++|.++..   .+..+++|  ++|++++|.+  
T Consensus       111 ~l~~-lp~~--~l~~L~~L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQN-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCCE-ECSC--CCTTCSEEECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             cCCc-cCcc--ccccCCEEECCCCCcc-ccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            9994 5555  8999999999999998 554 26799999999999999999863   45555666  9999999998  


Q ss_pred             ccccCcCccCCC--CCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC----CCChhhhhccc-------
Q 002897          156 IGKMSINFNSLK--NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG----LLPHSLANLSN-------  222 (869)
Q Consensus       156 ~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~-------  222 (869)
                      .+..+..|..+.  .+ .++++.|.+......     ..+..+++|+.|++++|+...    .....+..+..       
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~-----~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~  257 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVN-----MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ  257 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCE-----EEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEE
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhh-----hcccccceEEEecccccccccchHHHHHHHHhccCcceEEEec
Confidence            777777777654  22 345566655442211     134555666666666654110    00112222222       


Q ss_pred             -------------------cceEEEecCCcccccCCccc-----cCCCCCCeeecccCcceecCC-ccccC---CCCCCE
Q 002897          223 -------------------TMTTIDIGGNYFSGTIPPGL-----GNLVHLNSIAMEGNQLIGTVP-PEIGW---LKNLQS  274 (869)
Q Consensus       223 -------------------~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~-~~~~~---l~~L~~  274 (869)
                                         .|++|++++|.+++.+|..+     .+++.|+.+++..|.+  .+| ..+..   ..+|++
T Consensus       258 ~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~  335 (562)
T 3a79_B          258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKM  335 (562)
T ss_dssp             EEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred             CCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceE
Confidence                               25555555555555555544     4444444444444443  222 11111   134555


Q ss_pred             EEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCC-ccccccccccceecccCC
Q 002897          275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLP-PQILSVTTLSLFLNLSDN  353 (869)
Q Consensus       275 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~~~l~~L~l~~N  353 (869)
                      |++++|.+....  ....+++|++|++++|++++..|..+..+++|++|++++|++++..+ +..+.....++.|++++|
T Consensus       336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N  413 (562)
T 3a79_B          336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN  413 (562)
T ss_dssp             EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTS
T ss_pred             EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCC
Confidence            566555554221  11455556666666666655555555566666666666665552111 111222333444555555


Q ss_pred             cccCCCcc-cccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCc
Q 002897          354 LLSGSLPS-EIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP  432 (869)
Q Consensus       354 ~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  432 (869)
                      ++++.+|. .+..+++|++|+|++|.+++..|..+.  ++|+.|++++|+|+ .+|..+..+++|++|+|++|+|+ .+|
T Consensus       414 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~  489 (562)
T 3a79_B          414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP  489 (562)
T ss_dssp             CCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCC
T ss_pred             cCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCC
Confidence            55442222 344445555555555555443333332  34555555555554 34444444555555555555554 233


Q ss_pred             cc-cccccccCeeccccccCcccCC
Q 002897          433 KY-LENLSFLEYLNLSYNHFEGEVP  456 (869)
Q Consensus       433 ~~-~~~l~~L~~l~l~~N~l~~~~~  456 (869)
                      .. +..+++|+.|++++|++.|.++
T Consensus       490 ~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          490 DGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCcCCCcc
Confidence            22 4444555555555555544433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-45  Score=397.49  Aligned_cols=207  Identities=22%  Similarity=0.331  Sum_probs=171.5

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  626 (869)
                      ...++|++.++||+|+||+||+|+++   .+++.||+|++....  ...++.+|+++++.+ +||||+++++++.+    
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK----   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE----
Confidence            34578999999999999999999874   467899999986543  336788999999998 69999999998765    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAH  705 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k  705 (869)
                       .+..++||||+++|+|.++++.         +++.++..++.|++.||+|||++   ||+||||||+|||++.+ +.+|
T Consensus        92 -~~~~~lvmE~~~g~~L~~~~~~---------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           92 -NDHVVIAMPYLEHESFLDILNS---------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             -TTEEEEEEECCCCCCHHHHHTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             -CCEEEEEEeCCCcccHHHHHcC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence             3789999999999999999842         88999999999999999999999   99999999999999877 7999


Q ss_pred             EccccccccCCCCCCCCcc--------------------ccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHH
Q 002897          706 VGDFGLAKFLPARPLDTVV--------------------ETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLL  764 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~  764 (869)
                      |+|||+|+...........                    .........+||+.|+|||++.+. .|+.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999876543211100                    001123346799999999998776 4899999999999999


Q ss_pred             HHHcCCCCCCcC
Q 002897          765 EMFSRRRPTDSM  776 (869)
Q Consensus       765 el~tg~~pf~~~  776 (869)
                      ||++|+.||...
T Consensus       239 ell~G~~Pf~~~  250 (361)
T 4f9c_A          239 SLLSGRYPFYKA  250 (361)
T ss_dssp             HHHHTCSSSSCC
T ss_pred             HHHHCCCCCCCC
Confidence            999999999653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.1e-44  Score=426.69  Aligned_cols=447  Identities=20%  Similarity=0.172  Sum_probs=360.3

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +|||++|+|+ .||...|..+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+++|+++++|++|+|++|
T Consensus        56 ~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N  134 (635)
T 4g8a_A           56 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  134 (635)
T ss_dssp             EEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTS
T ss_pred             EEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCC
Confidence            4899999999 899888889999999999999999888889999999999999999999887889999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCC----cEEEccCCccc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL----ELLELRDNQFI  156 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L----~~L~L~~N~i~  156 (869)
                      +|+++.+..|+++++|++|+|++|++.+.-....+..+++|++|++++|++++..+..|..+.++    ..++++.|.+.
T Consensus       135 ~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~  214 (635)
T 4g8a_A          135 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN  214 (635)
T ss_dssp             CCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred             cCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc
Confidence            99988888999999999999999999732223678899999999999999999888888766554    36888888887


Q ss_pred             cccCcCccCCCCCCEEEccCccCC-------------------------------CCCCCCc------------------
Q 002897          157 GKMSINFNSLKNLSVLILGNNHLG-------------------------------NRAANDL------------------  187 (869)
Q Consensus       157 ~~~~~~~~~l~~L~~L~l~~n~l~-------------------------------~~~~~~~------------------  187 (869)
                      .+.+..+..+ .++.|++.+|...                               ......+                  
T Consensus       215 ~i~~~~~~~~-~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~  293 (635)
T 4g8a_A          215 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY  293 (635)
T ss_dssp             EECTTTTTTC-EEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCS
T ss_pred             ccCcccccch-hhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcc
Confidence            6655544332 2334444433211                               0000000                  


Q ss_pred             -------------------------chhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccc
Q 002897          188 -------------------------DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL  242 (869)
Q Consensus       188 -------------------------~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~  242 (869)
                                               .....+.....|+.|++.+|.+....+..+   . .++.+++.+|.+...  ...
T Consensus       294 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l---~-~L~~l~l~~n~~~~~--~~~  367 (635)
T 4g8a_A          294 YLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL---K-SLKRLTFTSNKGGNA--FSE  367 (635)
T ss_dssp             CEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBC---T-TCCEEEEESCCSCCB--CCC
T ss_pred             cccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccc---h-hhhhcccccccCCCC--ccc
Confidence                                     000123344556666666666654433322   2 266667777665532  234


Q ss_pred             cCCCCCCeeecccCccee--cCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccC-CcCccCccc
Q 002897          243 GNLVHLNSIAMEGNQLIG--TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI-PSSLGNCTS  319 (869)
Q Consensus       243 ~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~  319 (869)
                      ..+++|+.|++++|.+..  ..+..+..+.+|+.|++..|.+. ..+..+..+++|+.+++..|+..... +..|..+++
T Consensus       368 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~  446 (635)
T 4g8a_A          368 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN  446 (635)
T ss_dssp             CBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTT
T ss_pred             ccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccc
Confidence            568899999999998853  45667778899999999999987 45667889999999999988876544 457889999


Q ss_pred             cceeeccCcccCCCCCccccccccccceecccCCcc-cCCCcccccCCccccccccccccccccCCccccCCCCCcEEEe
Q 002897          320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL-SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKM  398 (869)
Q Consensus       320 L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  398 (869)
                      ++.++++.|++.+. ++..+.....++.|++++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus       447 l~~l~ls~n~l~~~-~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L  525 (635)
T 4g8a_A          447 LIYLDISHTHTRVA-FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  525 (635)
T ss_dssp             CCEEECTTSCCEEC-CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccccccccccccc-cccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence            99999999999854 445556667778999999985 4467889999999999999999999999999999999999999


Q ss_pred             eCccccCCCCccccccccccEEEccCCcccCCCccccccc-cccCeeccccccCcccCCC
Q 002897          399 QDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL-SFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       399 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~~~  457 (869)
                      ++|+|++..|..|..+++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|.+.+..
T Consensus       526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            9999998888999999999999999999999999999988 6899999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-44  Score=408.42  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=199.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHH---HHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSF---LTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.++||+|+||+||+|+++.+|+.||||+++...   .......   ..++.+++.++|||||++++++.+    
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----  263 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----  263 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence            367999999999999999999999999999999996432   1222233   344666777899999999999654    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                       .+..|+|||||+||+|.+++....      .+++..++.++.||+.||+|||++   |||||||||+|||++.+|++||
T Consensus       264 -~~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          264 -PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             -CCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence             488999999999999999998754      399999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      +|||+|+.+....          ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.......  ...
T Consensus       334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~  401 (689)
T 3v5w_A          334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE  401 (689)
T ss_dssp             CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHH
T ss_pred             cccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHH
Confidence            9999998765432          234679999999999865 579999999999999999999999997533221  111


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      ..........                        ..+...++++.+|+.+||+.||++|++     ++||++
T Consensus       402 i~~~i~~~~~------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          402 IDRMTLTMAV------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHCCC------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHhhcCCCC------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1111111100                        001123456789999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-44  Score=414.24  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=209.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||++++++.+     ....+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence            3689999999999999999999999999999999977666666788999999999999999999999754     48899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD--MVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg  710 (869)
                      +|||||+||+|.+++.....     .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||
T Consensus       231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999999999976543     389999999999999999999999   99999999999999854  899999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+....         .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......     +....+
T Consensus       303 ~a~~~~~~~---------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i  368 (573)
T 3uto_A          303 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNV  368 (573)
T ss_dssp             SCEECCTTS---------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHH
T ss_pred             ceeEccCCC---------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHH
Confidence            998775432         223457999999999999999999999999999999999999999753221     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..... . ++.                  .....++..+.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~~~~-~-~~~------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          369 KSCDW-N-MDD------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HTTCC-C-CCS------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCC-C-CCc------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11000 0 000                  011123456789999999999999999999986

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7e-44  Score=414.09  Aligned_cols=434  Identities=16%  Similarity=0.170  Sum_probs=335.0

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .....+++++++|+++ .+|..+.  ++|++|+|++|+|++..|.+|+++++|++|+|++|+|++..|.+|.++++|++|
T Consensus        29 ~~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  105 (562)
T 3a79_B           29 SNELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL  105 (562)
T ss_dssp             ----CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred             ccCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence            3455689999999999 5777664  899999999999998888999999999999999999999989999999999999


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccCcCccCCCCC--CEEEccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMSINFNSLKNL--SVLILGN  176 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~l~~  176 (869)
                      +|++|++. .+|..   .+++|++|++++|++++. .|..|+++++|++|++++|++...   .|..+++|  ++|++++
T Consensus       106 ~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~  178 (562)
T 3a79_B          106 DVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDL  178 (562)
T ss_dssp             ECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEE
T ss_pred             ECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeec
Confidence            99999998 88865   899999999999999974 468999999999999999998763   45666666  9999999


Q ss_pred             ccC--CCCCCCCcchhhhccCCC-CCcEEEccCCCCCCCCChh-hhhccccceEEEecCCc-----ccccCCccccCCCC
Q 002897          177 NHL--GNRAANDLDFVTVLANCS-KLENLGLYDNQFGGLLPHS-LANLSNTMTTIDIGGNY-----FSGTIPPGLGNLVH  247 (869)
Q Consensus       177 n~l--~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~-~~~l~~~L~~L~l~~n~-----l~~~~~~~~~~l~~  247 (869)
                      |.+  +.....      .+..+. +.-.+++++|.+.+..+.. +..+. .|+.|++++|.     +.+ ....+..+++
T Consensus       179 n~l~~~~~~~~------~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~  250 (562)
T 3a79_B          179 VSYHIKGGETE------SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG-HLQLSNIKLNDENCQRLMT-FLSELTRGPT  250 (562)
T ss_dssp             SSCCCCSSSCC------EEEECCEEEEEEEECSSSCCCCCCEEEESSEE-EEEEEEEECCSTTHHHHHH-HHHHHHSCSS
T ss_pred             ccccccccCcc------cccccCcceEEEEecCccchhhhhhhcccccc-eEEEecccccccccchHHH-HHHHHhccCc
Confidence            999  655443      344443 1226688999988766653 34444 49999999985     221 1223455555


Q ss_pred             CCeeecccCcceecC----CccccCCCCCCEEEccCccccCcCCCCC-----CCC-------------------------
Q 002897          248 LNSIAMEGNQLIGTV----PPEIGWLKNLQSLYLNSNFLHGYIPSSL-----GNL-------------------------  293 (869)
Q Consensus       248 L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l-------------------------  293 (869)
                      |+.|+++++.+.+..    +..+ ..++|++|++++|.+++.+|..+     .++                         
T Consensus       251 L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~  329 (562)
T 3a79_B          251 LLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA  329 (562)
T ss_dssp             CEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHH
T ss_pred             ceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhc
Confidence            555555555443211    1111 12355566666666555555444     333                         


Q ss_pred             -ccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCC--CcccccCCcccc
Q 002897          294 -TMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGS--LPSEIGNLKNLV  370 (869)
Q Consensus       294 -~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~--~p~~~~~l~~L~  370 (869)
                       .+|+.|++++|.+....  ....+++|++|++++|++++..|..+.. .+.++.|+|++|++++.  +|..+.++++|+
T Consensus       330 ~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~  406 (562)
T 3a79_B          330 EMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCST-LKRLQTLILQRNGLKNFFKVALMTKNMSSLE  406 (562)
T ss_dssp             TCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCS-CSSCCEEECCSSCCCBTTHHHHTTTTCTTCC
T ss_pred             cCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcc-cCCCCEEECCCCCcCCcccchhhhcCCCCCC
Confidence             34666777777665211  1278899999999999999877766644 45678899999999963  356799999999


Q ss_pred             ccccccccccccCCc-cccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccc
Q 002897          371 QLDISGNRFSGDIPG-TLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN  449 (869)
Q Consensus       371 ~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  449 (869)
                      +|+|++|.+++.+|. .+..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|++++|
T Consensus       407 ~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N  483 (562)
T 3a79_B          407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN  483 (562)
T ss_dssp             EEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred             EEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence            999999999974554 588999999999999999877776654  79999999999998 78888889999999999999


Q ss_pred             cCcccCCC-CCccCCCccccccCCcccCCC
Q 002897          450 HFEGEVPK-KGVFSNKTRFSLSGNGKLCGG  478 (869)
Q Consensus       450 ~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~  478 (869)
                      ++++.++. ...++.++.+++++|++.|++
T Consensus       484 ~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          484 QLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             CCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred             CCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence            99976655 567788999999999999964

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.7e-43  Score=396.25  Aligned_cols=388  Identities=18%  Similarity=0.222  Sum_probs=257.0

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCc-cCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-KIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n   80 (869)
                      ++.++++++ .+|. +.   ++|++|+|++|.|+++.|.+|.++++|++|+|++|.+.+ +.|.+|+++++|++|+|++|
T Consensus        15 ~~c~~~~l~-~lp~-l~---~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           15 AICINRGLH-QVPE-LP---AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EECCSSCCS-SCCC-CC---TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             cCcCCCCcc-cCCC-CC---CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            567888999 8997 43   789999999999998889999999999999999999874 45778999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCC-chhhcCCcchhhhhccccccceecccc-ccCCCCCcEEEccCCccccc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLP-FDMVANLPNLRKFVAAKNNLTGFLPIS-LSNASNLELLELRDNQFIGK  158 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~~-l~~l~~L~~L~L~~N~i~~~  158 (869)
                      ++++..|..|.++++|++|+|++|++.+.++ ...|..+++|++|++++|.+++..|.. +.++++|++|++++|++.++
T Consensus        90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~  169 (455)
T 3v47_A           90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI  169 (455)
T ss_dssp             TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred             ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence            9998889999999999999999999975333 345788888888888888888776765 78888888888888888888


Q ss_pred             cCcCccCC--CCCCEEEccCccCCCCCCCCcch--hhhccCCCCCcEEEccCCCCCCCCChhhhhcc--ccceEEEecCC
Q 002897          159 MSINFNSL--KNLSVLILGNNHLGNRAANDLDF--VTVLANCSKLENLGLYDNQFGGLLPHSLANLS--NTMTTIDIGGN  232 (869)
Q Consensus       159 ~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~~L~~L~l~~n  232 (869)
                      .+..+..+  .+|+.|++++|.+..++...+..  ...+..+++|++|++++|++++..|..+....  ..++.|++++|
T Consensus       170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~  249 (455)
T 3v47_A          170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS  249 (455)
T ss_dssp             CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred             ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence            88777766  67888888888887766542211  11234556777777777777766666665541  23666666666


Q ss_pred             cccccCCccccCCCCCCeeecccCcceecCCccccC--CCCCCEEEccCccccCcCCCCCCCCccccceecccccccccC
Q 002897          233 YFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGW--LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKI  310 (869)
Q Consensus       233 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  310 (869)
                      .+.+..              +..+.+....+..+..  .++|++|++++|.+++..|..+.++++|+.|++++|++++..
T Consensus       250 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  315 (455)
T 3v47_A          250 YNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID  315 (455)
T ss_dssp             TTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred             cccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccC
Confidence            544211              0111111111111211  234555555555554444444444444444444444444333


Q ss_pred             CcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCC
Q 002897          311 PSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSAC  390 (869)
Q Consensus       311 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  390 (869)
                      |..                                                 |.++++|++|+|++|.+++..|..|.++
T Consensus       316 ~~~-------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  346 (455)
T 3v47_A          316 DNA-------------------------------------------------FWGLTHLLKLNLSQNFLGSIDSRMFENL  346 (455)
T ss_dssp             TTT-------------------------------------------------TTTCTTCCEEECCSSCCCEECGGGGTTC
T ss_pred             hhH-------------------------------------------------hcCcccCCEEECCCCccCCcChhHhcCc
Confidence            444                                                 4444555555555555554445555555


Q ss_pred             CCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCC
Q 002897          391 TSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPK  457 (869)
Q Consensus       391 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  457 (869)
                      ++|++|++++|++++..|.+|..+++|++|+|++|++++..+..+..+++|++|++++|++++.+|.
T Consensus       347 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          347 DKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            5555555555555555555555566666666666666554444555666666666666666666554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.2e-43  Score=370.07  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=209.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++...     +..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            46899999999999999999999989999999999876666667889999999999999999999997654     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++....       +++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        94 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999998753       89999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......        .......||+.|+|||++.+..++.++||||+||++|||++|+.||......    ....... .
T Consensus       164 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~-~  230 (297)
T 3fxz_A          164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-T  230 (297)
T ss_dssp             EECCSTT--------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHH-H
T ss_pred             eecCCcc--------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-h
Confidence            8765432        2234457999999999999999999999999999999999999999653211    1111000 0


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....                     ...++.++..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 NGTPE---------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HCSCC---------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCC---------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00000                     0011234456889999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.2e-42  Score=393.63  Aligned_cols=383  Identities=18%  Similarity=0.196  Sum_probs=262.2

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCc-cCCcccccCCCCcEEECc
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSG-FIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~Ls  102 (869)
                      -+.++.++++++ .+|. +  .++|++|+|++|+|++..|..|+++++|++|+|++|.+.+ +.+..|.++++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            345667777776 4554 2  2667777777777776667777777777777777776653 334556666666666666


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC--cCccCCCCCCEEEccCccCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS--INFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~l~~n~l~  180 (869)
                      +|++.                         +..|..|.++++|++|+|++|++++..+  ..|..+++|++|+|++|.++
T Consensus        88 ~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~  142 (455)
T 3v47_A           88 YNQFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK  142 (455)
T ss_dssp             TCTTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred             CCccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence            66665                         3344455555555555555555544222  22555555555555555555


Q ss_pred             CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhcc-ccceEEEecCCcccccCCcc--------ccCCCCCCee
Q 002897          181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLS-NTMTTIDIGGNYFSGTIPPG--------LGNLVHLNSI  251 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~~L~~L~l~~n~l~~~~~~~--------~~~l~~L~~L  251 (869)
                      .+.+.     ..+.++++|++|++++|++++..+..+..+. ..++.|++++|.+.+..+..        +..+++|++|
T Consensus       143 ~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L  217 (455)
T 3v47_A          143 KIQPA-----SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL  217 (455)
T ss_dssp             SCCCC-----GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEE
T ss_pred             ccCcc-----cccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeE
Confidence            54322     1245566666666666666655555555442 13666666666666444333        2355677777


Q ss_pred             ecccCcceecCCccccCC---CCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCc--cccceeecc
Q 002897          252 AMEGNQLIGTVPPEIGWL---KNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC--TSLIMLTLS  326 (869)
Q Consensus       252 ~l~~n~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~  326 (869)
                      ++++|++.+..|..+...   ++|+.|++++|.+.+..              +..+.+....+..+..+  ++|+.|+++
T Consensus       218 ~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~  283 (455)
T 3v47_A          218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLS  283 (455)
T ss_dssp             ECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECC
T ss_pred             ecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEec
Confidence            777777776666655433   67778888777665321              11222222222233332  456666666


Q ss_pred             CcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCC
Q 002897          327 KNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS  406 (869)
Q Consensus       327 ~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  406 (869)
                      +|+++                         +..|..++.+++|++|+|++|.+++..|..|.++++|++|++++|++++.
T Consensus       284 ~n~l~-------------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  338 (455)
T 3v47_A          284 KSKIF-------------------------ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI  338 (455)
T ss_dssp             SSCCC-------------------------EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             Ccccc-------------------------ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc
Confidence            66655                         46677889999999999999999988899999999999999999999988


Q ss_pred             CCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCC-CccCCCccccccCCcccCCCC
Q 002897          407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGNGKLCGGL  479 (869)
Q Consensus       407 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~  479 (869)
                      .|..|+.+++|++|+|++|++++..|..+..+++|++|++++|++++.++.. ..+++++.+++++|++.|.++
T Consensus       339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            8899999999999999999999888999999999999999999999876654 567899999999999999754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=371.84  Aligned_cols=272  Identities=23%  Similarity=0.369  Sum_probs=217.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.+.     ...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            36788999999999999999999999999999998776667778899999999999999999999997654     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.++++....     .+++.++..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999987543     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCcc------ccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          713 KFLPARPLDTVV------ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       713 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +...........      ..........||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            877544321100      00011224679999999999999999999999999999999999999986533221111000


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                      ....        .+.                  ..+..++..+.+++.+||+.||++|||++|+++.|+++++....
T Consensus       236 ~~~~--------~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          236 VRGF--------LDR------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HHHH--------HHH------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhcc--------ccc------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            0000        000                  00012344578999999999999999999999999999887654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.5e-43  Score=377.18  Aligned_cols=286  Identities=32%  Similarity=0.492  Sum_probs=228.9

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID  624 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  624 (869)
                      ++.++...+++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++++.++||||+++++++..  
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--  106 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--  106 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence            34455567889999999999999999999975 799999999877666667889999999999999999999999654  


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                         .+..++||||+++|+|.+++......  ...+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+
T Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          107 ---RNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             ---TTCCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCE
T ss_pred             ---CCeEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCE
Confidence               36789999999999999998765421  23489999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC-chH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG-LTL  783 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~-~~~  783 (869)
                      ||+|||.++.......      ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus       179 kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~  252 (321)
T 2qkw_B          179 KITDFGISKKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL  252 (321)
T ss_dssp             EECCCTTCEECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred             EEeecccccccccccc------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence            9999999986543221      122234568999999999988899999999999999999999999997644322 222


Q ss_pred             HHhhhh-hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          784 HEFSKM-VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       784 ~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ..+... ..........++...              .....+++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          253 AEWAVESHNNGQLEQIVDPNLA--------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHHTHHHHTTTCCCSSSSSSCT--------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHhhhccccccHHHhcChhhc--------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            222211 111222333333221              1223467888999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.5e-43  Score=377.62  Aligned_cols=290  Identities=34%  Similarity=0.593  Sum_probs=232.2

Q ss_pred             cCCCcccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhCCCCccceEE
Q 002897          539 QQFPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKII  617 (869)
Q Consensus       539 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~  617 (869)
                      .....+++.++....++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            44567889999999999999999999999999999875 799999999965432 2234689999999999999999999


Q ss_pred             EEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      +++...     ...++||||+++|+|.+++......  ..++++..+..++.|++.||+|||+.+.++|+||||||+||+
T Consensus        94 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  166 (326)
T 3uim_A           94 GFCMTP-----TERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL  166 (326)
T ss_dssp             EEECCS-----SCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred             EEEecC-----CceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence            997643     6779999999999999999876532  234899999999999999999999987778999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC-
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM-  776 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~-  776 (869)
                      ++.++.+||+|||.++.......       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+.. 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             ECCCCCEEeccCccccccCcccc-------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence            99999999999999987654321       2233456999999999998888999999999999999999999999632 


Q ss_pred             --ccCCchHHHhhhhhccc-ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          777 --FHEGLTLHEFSKMVLPE-KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       777 --~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                        .........+....... ......+....              .....+.+..+.+++.+||+.||++|||+.||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  305 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQ--------------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM  305 (326)
T ss_dssp             HTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT--------------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cccccchhHHHHHHHHhhchhhhhhcChhhc--------------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence              12223333343333222 22333332221              12234677889999999999999999999999999


Q ss_pred             HHHH
Q 002897          854 LCAA  857 (869)
Q Consensus       854 L~~~  857 (869)
                      |++.
T Consensus       306 L~~~  309 (326)
T 3uim_A          306 LEGD  309 (326)
T ss_dssp             HHTS
T ss_pred             hcCc
Confidence            9753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.5e-42  Score=366.19  Aligned_cols=268  Identities=23%  Similarity=0.382  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--CCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS--IRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||+||+|++  +|+.||||++...   ....+..|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            46899999999999999999998  7999999998643   33556667777766  7999999999987653 334467


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceeecCCC
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH--------HHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .++||||+++|+|.++++..       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred             eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence            89999999999999999654       3899999999999999999999        77   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC------CCCccccchhhhHHHHHHHcC-------
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS------EASMTGDVYSFGILLLEMFSR-------  769 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~el~tg-------  769 (869)
                      .+||+|||+|+.........    ........||+.|+|||++.+.      .+++++|||||||++|||++|       
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQL----DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEE----ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CEEEeeCCCeeecccccccc----cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            99999999997665432111    1122345799999999998876      455799999999999999999       


Q ss_pred             ---CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          770 ---RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       770 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                         +.||...........................                 .......++..+.+++.+||+.||++|||
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps  289 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP-----------------NRWFSDPTLTSLAKLMKECWYQNPSARLT  289 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-----------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCCCCCC-----------------hhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence               7787655444444333333222111111111                 11122356788999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 002897          847 MRDVVVKLCAA  857 (869)
Q Consensus       847 ~~evl~~L~~~  857 (869)
                      +.||++.|+++
T Consensus       290 ~~~i~~~L~~i  300 (301)
T 3q4u_A          290 ALRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHhcc
Confidence            99999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-43  Score=371.71  Aligned_cols=282  Identities=26%  Similarity=0.428  Sum_probs=214.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEE----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGI----IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||+||+|+    +..+++.||||++........+.+.+|++++++++||||+++++++...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            4689999999999999999999    4568999999999877666678899999999999999999999997543   22


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence            457999999999999999987653     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||++.........     ........++..|+|||++.+..++.++|||||||++|||++|..||......      +..
T Consensus       158 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~  226 (295)
T 3ugc_A          158 FGLTKVLPQDKEF-----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMR  226 (295)
T ss_dssp             CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHH
T ss_pred             CcccccccCCcce-----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHh
Confidence            9999876543211     12223345788899999999889999999999999999999999998643211      111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      .....................      ....+.+..++..+.+++.+||+.||++|||++|+++.|+++++...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          227 MIGNDKQGQMIVFHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHCTTCCTHHHHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hhcCccccchhHHHHHHHHhc------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            110000000000000001100      11111223456778999999999999999999999999999988753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-42  Score=370.35  Aligned_cols=285  Identities=24%  Similarity=0.299  Sum_probs=213.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||+||+|++  .++.||||++..... .......|+.++++++||||+++++++.... ......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            46899999999999999999998  589999999965433 3345567899999999999999999987642 2235679


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCceeecCCCcEE
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-------KPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      +||||+++|+|.++++...       +++..++.++.|+++||+|||+.+       .++|+||||||+||+++.++.+|
T Consensus        99 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            9999999999999997753       899999999999999999999851       33799999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----CCCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----EASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      |+|||.|+.......      ........||+.|+|||++.+.     .++.++|||||||++|||+||+.||.......
T Consensus       172 L~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  245 (322)
T 3soc_A          172 IADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY  245 (322)
T ss_dssp             ECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred             EccCCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence            999999987654321      1223345799999999998863     45678899999999999999999997643321


Q ss_pred             ch-HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          781 LT-LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       781 ~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      .. ........  ....+     +.....................++..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       246 ~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          246 MLPFEEEIGQH--PSLED-----MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CCTTHHHHCSS--CCHHH-----HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchhhhhccC--Cchhh-----hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11 00000000  00000     000000000000001111223566779999999999999999999999999999987


Q ss_pred             hh
Q 002897          860 AF  861 (869)
Q Consensus       860 ~~  861 (869)
                      ..
T Consensus       319 ~~  320 (322)
T 3soc_A          319 LT  320 (322)
T ss_dssp             HC
T ss_pred             Hh
Confidence            53

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-41  Score=364.75  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=214.0

Q ss_pred             CcccHHHHHHHhcC----------CCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCC
Q 002897          542 PMISYAKLSKATSE----------FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR  611 (869)
Q Consensus       542 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  611 (869)
                      +.++++++..+++.          |...++||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            55777777777754          66678999999999999999889999999999876666667899999999999999


Q ss_pred             ccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002897          612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDL  691 (869)
Q Consensus       612 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  691 (869)
                      ||+++++++...     ...++||||+++|+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||
T Consensus       103 niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A          103 NVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             TBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             CcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            999999997654     6789999999999999998754       389999999999999999999999   9999999


Q ss_pred             CCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCC
Q 002897          692 KPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR  771 (869)
Q Consensus       692 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~  771 (869)
                      ||+||+++.++.+||+|||++.......        .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDV--------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCc--------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999998765432        12234579999999999999999999999999999999999999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||......     .........     ..+..                ......+..+.+++.+||+.||++|||++|++
T Consensus       240 pf~~~~~~-----~~~~~~~~~-----~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  293 (321)
T 2c30_A          240 PYFSDSPV-----QAMKRLRDS-----PPPKL----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELL  293 (321)
T ss_dssp             TTTTSCHH-----HHHHHHHHS-----SCCCC----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCCHH-----HHHHHHhcC-----CCCCc----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            99643211     111111000     00000                00112345678999999999999999999998


Q ss_pred             HH
Q 002897          852 VK  853 (869)
Q Consensus       852 ~~  853 (869)
                      +.
T Consensus       294 ~h  295 (321)
T 2c30_A          294 DH  295 (321)
T ss_dssp             TS
T ss_pred             cC
Confidence            73

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.2e-42  Score=368.07  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++...  .....+++.+|+++++.++||||+++++++..     ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            346899999999999999999999989999999999654  33455778899999999999999999999764     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             EEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence            8999999999999999997754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCC-ccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEAS-MTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |++......         .......||+.|+|||++.+..++ .++||||+||++|+|++|+.||....     ......
T Consensus       159 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~  224 (328)
T 3fe3_A          159 GFSNEFTVG---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRE  224 (328)
T ss_dssp             TCCGGGSSS---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred             cCceecCCC---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence            999765432         223445799999999999888764 79999999999999999999997532     112221


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ........                        .+...+..+.+++.+||+.||++|||++|+++.
T Consensus       225 ~i~~~~~~------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          225 RVLRGKYR------------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHCCCC------------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHhCCCC------------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111000                        001123457799999999999999999999863

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.7e-41  Score=380.30  Aligned_cols=398  Identities=22%  Similarity=0.295  Sum_probs=158.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCC-------------CEEEccCCccCccCCccccC
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSAL-------------QVIDIRGNRLGGKIPDTLGQ   68 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~p~~~~~   68 (869)
                      |++++|++ |+||..++ .+++|++|++++|.+++.+|.+++++.+|             ++|++++|.+++ +|..   
T Consensus        16 L~l~~n~l-~~iP~~i~-~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---   89 (454)
T 1jl5_A           16 PLRHSSNL-TEMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---   89 (454)
T ss_dssp             --------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---
T ss_pred             hhcccCch-hhCChhHh-cccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---
Confidence            45555555 35555553 45555555555555555555555555543             555555555552 3331   


Q ss_pred             CCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEE
Q 002897           69 LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELL  148 (869)
Q Consensus        69 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L  148 (869)
                      .++|++|+|++|++++ +|..   +++|++|++++|++. .+|..    .++|++|++++|++++ +| .|+++++|++|
T Consensus        90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L  158 (454)
T 1jl5_A           90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKII  158 (454)
T ss_dssp             CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred             cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEE
Confidence            2455555555555553 3332   245555555555554 33310    1455555555555554 33 35555555555


Q ss_pred             EccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEE
Q 002897          149 ELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTID  228 (869)
Q Consensus       149 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~  228 (869)
                      ++++|+++++. ..   ..+|++|++++|+++.++        .+.++++|++|++++|++++ +|...    ..|+.|+
T Consensus       159 ~l~~N~l~~lp-~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~  221 (454)
T 1jl5_A          159 DVDNNSLKKLP-DL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK-LPDLP----LSLESIV  221 (454)
T ss_dssp             ECCSSCCSCCC-CC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCCCC----TTCCEEE
T ss_pred             ECCCCcCcccC-CC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-CCCCc----CcccEEE
Confidence            55555554422 11   235555555555555433        14455555555555555553 22211    1255555


Q ss_pred             ecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccc
Q 002897          229 IGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG  308 (869)
Q Consensus       229 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  308 (869)
                      +++|.++ .+| .+..+++|++|++++|++.+ +|..   +++|+.|++++|++++ +|..   .++|+.|++++|++++
T Consensus       222 l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          222 AGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG  291 (454)
T ss_dssp             CCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred             CcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence            5555555 334 25555555555555555542 2221   2455555555555553 2222   2445555555555543


Q ss_pred             cCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCcccc
Q 002897          309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS  388 (869)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  388 (869)
                       +|..   .++|+.|++++|++++ ++    .....++.|++++|++++ +|..   +++|++|++++|.++ .+|.   
T Consensus       292 -l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---  354 (454)
T 1jl5_A          292 -LSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---  354 (454)
T ss_dssp             -ESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---
T ss_pred             -ccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---
Confidence             1110   1345555555555542 11    111234445555555543 3322   244555555555554 2333   


Q ss_pred             CCCCCcEEEeeCccccC--CCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcc--cCCCCCccCCC
Q 002897          389 ACTSLEYVKMQDNSFSG--SIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG--EVPKKGVFSNK  464 (869)
Q Consensus       389 ~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~~~~~  464 (869)
                      .+++|++|++++|++++  .+|.+++.        |+.|.+.+.+|..   +++|+.|++++|++++  .+|.     .+
T Consensus       355 ~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-----sl  418 (454)
T 1jl5_A          355 LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE-----SV  418 (454)
T ss_dssp             CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC----------------------------------------
T ss_pred             hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh-----hH
Confidence            24455555555555554  33333322        1223333344432   2789999999999987  4443     34


Q ss_pred             ccccccCCcccC
Q 002897          465 TRFSLSGNGKLC  476 (869)
Q Consensus       465 ~~~~~~~n~~~c  476 (869)
                      ..+.+.+|...|
T Consensus       419 ~~L~~~~~~~~~  430 (454)
T 1jl5_A          419 EDLRMNSERVVD  430 (454)
T ss_dssp             ------------
T ss_pred             hheeCcCcccCC
Confidence            556666665444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.1e-42  Score=367.52  Aligned_cols=263  Identities=27%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++....  ....+.+.+|++++++++||||+++++++...     .
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----P  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----T
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence            456899999999999999999988  78999999986443  34456789999999999999999999997543     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEEc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ..++||||+++|+|.+++......   ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence            789999999999999999875421   2389999999999999999999999   8  9999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+++......        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ...
T Consensus       182 Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~~  248 (309)
T 3p86_A          182 DFGLSRLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVV  248 (309)
T ss_dssp             CCC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHH
T ss_pred             CCCCCccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            999997544321        2233456899999999999999999999999999999999999999753221     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ........                      ....+..++..+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus       249 ~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          249 AAVGFKCK----------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHSCC----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHhcCC----------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            11000000                      000011234568899999999999999999999999999877543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=369.12  Aligned_cols=266  Identities=26%  Similarity=0.407  Sum_probs=210.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC---eEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||+||+|.+..++   ..||||+++.. .....+.+.+|+.++++++||||+++++++...     
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            357889999999999999999997544   45999999754 334457789999999999999999999997553     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.++++....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence            678999999999999999976543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+++.........     .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......     ...
T Consensus       195 fg~a~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~  264 (325)
T 3kul_A          195 FGLSRVLEDDPDAA-----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVI  264 (325)
T ss_dssp             CSSCEECC----CC-----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH
T ss_pred             CCcccccccCccce-----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHH
Confidence            99998775543211     12233456788999999988889999999999999999999 99999653221     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      .......                       ..+.+..++..+.+++.+||+.||++|||+.||++.|+++.+...+.
T Consensus       265 ~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          265 SSVEEGY-----------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             HHHHTTC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             HHHHcCC-----------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence            1111000                       00011134567889999999999999999999999999998775544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.4e-42  Score=363.41  Aligned_cols=268  Identities=22%  Similarity=0.382  Sum_probs=210.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.++++++||||+++++++..     .+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence            36799999999999999999999999999999998543   23445788999999999999999999999754     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      ++++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence            8899999999999999998754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+........       .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........    ....
T Consensus       156 g~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~~  224 (294)
T 4eqm_A          156 GIAKALSETSL-------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIKH  224 (294)
T ss_dssp             SSSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHHH
T ss_pred             CCccccccccc-------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHH
Confidence            99986644321       222345689999999999999999999999999999999999999975322111    1111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhhhccc
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-QMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~~~  865 (869)
                      . ....     +....              ....+++..+.+++.+||+.||++|| +++++.+.|..+........
T Consensus       225 ~-~~~~-----~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~  281 (294)
T 4eqm_A          225 I-QDSV-----PNVTT--------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE  281 (294)
T ss_dssp             H-SSCC-----CCHHH--------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred             h-hccC-----CCcch--------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence            1 0000     00000              00113456788999999999999998 89999999988766544433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-41  Score=371.34  Aligned_cols=268  Identities=23%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-------CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-------ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999873       356789999997543 34457889999999999 899999999997543


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           +..++||||+++|+|.+++......          .....+++.+++.++.||+.||+|||++   +|+||||||
T Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          160 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             -----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence                 6789999999999999999876421          1123489999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||+|+........      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999876543211      12233457889999999999999999999999999999999 9999


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |......     +.........                       ....+..++..+.+++.+||+.||++|||+.|+++
T Consensus       306 ~~~~~~~-----~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          306 YPGIPVE-----ELFKLLKEGH-----------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             STTCCGG-----GHHHHHHTTC-----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHH-----HHHHHHhcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9753221     1111110000                       00011134456889999999999999999999999


Q ss_pred             HHHHHHHhhh
Q 002897          853 KLCAAREAFV  862 (869)
Q Consensus       853 ~L~~~~~~~~  862 (869)
                      .|+++.....
T Consensus       358 ~L~~il~~~~  367 (370)
T 2psq_A          358 DLDRILTLTT  367 (370)
T ss_dssp             HHHHHHHHHC
T ss_pred             HHHHHHHHhc
Confidence            9999887643

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.3e-41  Score=377.94  Aligned_cols=390  Identities=25%  Similarity=0.316  Sum_probs=257.7

Q ss_pred             ChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCC-------------CEEeCcCc
Q 002897           14 PVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKL-------------IYLNIGRN   80 (869)
Q Consensus        14 p~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L-------------~~L~L~~n   80 (869)
                      |.++  ..++|++|++++|.+ +.+|.+|+++++|++|++++|++.+.+|..++++++|             ++|++++|
T Consensus         5 p~~~--~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~   81 (454)
T 1jl5_A            5 PRNV--SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL   81 (454)
T ss_dssp             --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS
T ss_pred             cccc--ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCC
Confidence            4555  468999999999999 5999999999999999999999999999999999875             99999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      .+++ +|..   .++|++|++++|.+. .+|.    .+++|++|++++|++++. +..   .++|++|++++|+++++ |
T Consensus        82 ~l~~-lp~~---~~~L~~L~l~~n~l~-~lp~----~~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~l-p  147 (454)
T 1jl5_A           82 GLSS-LPEL---PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEKL-P  147 (454)
T ss_dssp             CCSC-CCSC---CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSSC-C
T ss_pred             cccc-CCCC---cCCCCEEEccCCcCC-cccc----ccCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCCC-c
Confidence            9885 3442   368999999999998 4773    247888999999988853 221   26899999999998874 4


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                       .|..+++|++|++++|+++.++..          ..+|++|++++|++++ +| .+..+++ |+.|++++|.+++ +|.
T Consensus       148 -~~~~l~~L~~L~l~~N~l~~lp~~----------~~~L~~L~L~~n~l~~-l~-~~~~l~~-L~~L~l~~N~l~~-l~~  212 (454)
T 1jl5_A          148 -ELQNSSFLKIIDVDNNSLKKLPDL----------PPSLEFIAAGNNQLEE-LP-ELQNLPF-LTAIYADNNSLKK-LPD  212 (454)
T ss_dssp             -CCTTCTTCCEEECCSSCCSCCCCC----------CTTCCEEECCSSCCSS-CC-CCTTCTT-CCEEECCSSCCSS-CCC
T ss_pred             -ccCCCCCCCEEECCCCcCcccCCC----------cccccEEECcCCcCCc-Cc-cccCCCC-CCEEECCCCcCCc-CCC
Confidence             588899999999999988876532          2488999999998886 45 5777775 8899999998884 444


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL  320 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  320 (869)
                      ..   ++|++|++++|.+. .+| .++.+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   .++|
T Consensus       213 ~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L  279 (454)
T 1jl5_A          213 LP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSL  279 (454)
T ss_dssp             CC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred             Cc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcC
Confidence            32   57888899998887 566 48888889999999998885 4432   3778888999888884 5543   3788


Q ss_pred             ceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCC-ccccccccccccccccCCccccCCCCCcEEEee
Q 002897          321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNL-KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQ  399 (869)
Q Consensus       321 ~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  399 (869)
                      +.|++++|++++ +|.    ....++.|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|+.|+++
T Consensus       280 ~~L~ls~N~l~~-l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~  345 (454)
T 1jl5_A          280 TFLDVSENIFSG-LSE----LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIAS  345 (454)
T ss_dssp             CEEECCSSCCSE-ESC----CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CEEECcCCccCc-ccC----cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECC
Confidence            888999888875 221    22456788888888874 22    23 478888888888885 5553   5788888888


Q ss_pred             CccccCCCCccccccccccEEEccCCcccC--CCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccC
Q 002897          400 DNSFSGSIPPSLNFLKSIKVLDLSSNKLSG--QIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLC  476 (869)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  476 (869)
                      +|+++ .+|.   .+++|++|++++|++++  .+|..+..        ++.|.+.+.+|..  +.+++.+++++|+...
T Consensus       346 ~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~--~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          346 FNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL--PQNLKQLHVETNPLRE  410 (454)
T ss_dssp             SSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------
T ss_pred             CCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc--cCcCCEEECCCCcCCc
Confidence            88888 5666   46888888888888887  56665543        3456777777663  5788999999997654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.6e-41  Score=356.87  Aligned_cols=284  Identities=30%  Similarity=0.455  Sum_probs=225.0

Q ss_pred             CCCcccHHHHHHHhcCCCCC------CeeeeecceEEEEEEECCCCeEEEEEEeecc----cchhhHHHHHHHHHHHhCC
Q 002897          540 QFPMISYAKLSKATSEFSSS------NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM----QKGALKSFLTECEALRSIR  609 (869)
Q Consensus       540 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  609 (869)
                      ..+.+++.++..++++|...      ++||+|+||.||+|.+  +++.||||++...    .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45678899999999998877      9999999999999997  7899999998642    2344578899999999999


Q ss_pred             CCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 002897          610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG  689 (869)
Q Consensus       610 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  689 (869)
                      ||||+++++++...     +..++||||+++|+|.+++.....   ..++++..++.++.|++.||+|||+.   +|+||
T Consensus        89 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~  157 (307)
T 2nru_A           89 HENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHR  157 (307)
T ss_dssp             CTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence            99999999997543     678999999999999999975432   23489999999999999999999999   99999


Q ss_pred             CCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC
Q 002897          690 DLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR  769 (869)
Q Consensus       690 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg  769 (869)
                      ||||+||+++.++.+||+|||.+.........      .......||+.|+|||.+.+ .++.++|||||||++|+|++|
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g  230 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG  230 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred             CCCHHHEEEcCCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence            99999999999999999999999876543211      12234568999999998865 588999999999999999999


Q ss_pred             CCCCCcCccCCchHHHhhhhhc--ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          770 RRPTDSMFHEGLTLHEFSKMVL--PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       770 ~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      +.||........ ...+.....  ...+.+.+++.+               ......++..+.+++.+||+.||++|||+
T Consensus       231 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~  294 (307)
T 2nru_A          231 LPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKM---------------NDADSTSVEAMYSVASQCLHEKKNKRPDI  294 (307)
T ss_dssp             CCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSC---------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCcccCcchHH-HHHHHHHhhhhhhhhhhhccccc---------------cccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence            999976433321 112211111  111122222111               11234567789999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 002897          848 RDVVVKLCAARE  859 (869)
Q Consensus       848 ~evl~~L~~~~~  859 (869)
                      .||++.|+++.+
T Consensus       295 ~~l~~~L~~l~~  306 (307)
T 2nru_A          295 KKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHC-
T ss_pred             HHHHHHHHHHhc
Confidence            999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=361.34  Aligned_cols=285  Identities=19%  Similarity=0.238  Sum_probs=216.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++...   +....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            367999999999999999999999899999999997533 33457788999999999999999999987643   23578


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVG  707 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  707 (869)
                      ++||||+++|+|.+++......   ..+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             EEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence            9999999999999999875431   2389999999999999999999999   99999999999999    788889999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccC--------CCCCCccccchhhhHHHHHHHcCCCCCCcCccC
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT--------GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~  779 (869)
                      |||.|+......         ......||+.|+|||++.        +..++.++|||||||++|||++|+.||......
T Consensus       159 Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  229 (319)
T 4euu_A          159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (319)
T ss_dssp             CCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred             cCCCceecCCCC---------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            999998765432         223456899999999875        567899999999999999999999999753332


Q ss_pred             CchHHHh---hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          780 GLTLHEF---SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       780 ~~~~~~~---~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .......   .....+.......... ........  ............+..+.+++.+||+.||++|||++|+++....
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          230 RRNKEVMYKIITGKPSGAISGVQKAE-NGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             GGCHHHHHHHHHHCCTTCCEEEECST-TCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             chhHHHHHHHhcCCCcccchhhhccc-CCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            2221111   1111111111111000 00000000  0001112335677889999999999999999999999998876


Q ss_pred             HH
Q 002897          857 AR  858 (869)
Q Consensus       857 ~~  858 (869)
                      ..
T Consensus       307 ~~  308 (319)
T 4euu_A          307 IL  308 (319)
T ss_dssp             HT
T ss_pred             Hh
Confidence            54

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-41  Score=367.08  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch------hhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG------ALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++.+    
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN----   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence            46799999999999999999999999999999999754321      34678999999999999999999999754    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  702 (869)
                       ....++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++    
T Consensus        87 -~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           87 -RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence             378999999999999999997654      389999999999999999999999   999999999999998877    


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      .+||+|||++.......         ......||+.|+|||++.+..++.++||||+||++|+|++|..||......   
T Consensus       157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---  224 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---  224 (361)
T ss_dssp             CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---
T ss_pred             CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            79999999998765432         223456999999999999989999999999999999999999999753211   


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ...........  ..++                  ......+..+.+++.+||..||++|||+.|+++
T Consensus       225 --~~~~~i~~~~~--~~~~------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 --ETLANITAVSY--DFDE------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --HHHHHHHTTCC--CCCH------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHhcCC--CCCc------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              11111110000  0000                  111133456889999999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-41  Score=364.75  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|+++..   .......+.+|+.+++.++||||+++++++...     +
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence            36799999999999999999999999999999999753   234457789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.+|.+||+||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            8999999999999999998654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~  216 (337)
T 1o6l_A          150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFEL  216 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             cchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHH
Confidence            9997543221        223456799999999999999999999999999999999999999964321     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .......                        .+...+..+.+++.+||+.||++||     +++|+++
T Consensus       217 i~~~~~~------------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          217 ILMEEIR------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHCCCC------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHcCCCC------------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1111000                        0012345678999999999999999     8999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=363.14  Aligned_cols=253  Identities=17%  Similarity=0.274  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.     +..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence            468999999999999999999999999999999986443 3446788999999999999999999997654     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH--DMVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg  710 (869)
                      +||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+|||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999976543     389999999999999999999999   9999999999999987  7899999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .+.......         ......||+.|+|||++.+..++.++||||+||++|+|++|..||......     ......
T Consensus       150 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i  215 (321)
T 1tki_A          150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENI  215 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH
T ss_pred             CCeECCCCC---------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHH
Confidence            998765432         223456899999999999888999999999999999999999999753221     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......  .                  .......++.++.+++.+||+.||++|||+.|+++.
T Consensus       216 ~~~~~~--~------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          216 MNAEYT--F------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTCCC--C------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HcCCCC--C------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            100000  0                  001112345678899999999999999999999884

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.9e-42  Score=375.25  Aligned_cols=263  Identities=27%  Similarity=0.395  Sum_probs=211.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++...     ..
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence            3467889999999999999999998899999999986442 23345688999999999999999999997543     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            8999999999999999986543     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+.......      ........++..|+|||++.++.++.++|||||||++|||++ |..||......     .....
T Consensus       259 ~s~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~~~  327 (377)
T 3cbl_A          259 MSREEADGVY------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTREF  327 (377)
T ss_dssp             GCEECTTSEE------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHHHH
T ss_pred             CceecCCCce------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence            9986543210      011122345778999999988889999999999999999998 99998753221     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      .....                       ..+.++.++..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       328 ~~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          328 VEKGG-----------------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             HHTTC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            10000                       00111234567889999999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-41  Score=363.43  Aligned_cols=255  Identities=20%  Similarity=0.290  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence            468999999999999999999999999999999996433 22346688999999999999999999997653     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            99999999999999997654      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........      ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+....
T Consensus       152 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  225 (323)
T 3tki_A          152 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  225 (323)
T ss_dssp             CEECEETTE------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred             cceeccCCc------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence            986543221      122334679999999999987775 7789999999999999999999976443323222222211


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...                          .....++..+.+++.+||+.||++|||++|+++.
T Consensus       226 ~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccC--------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000                          0011234567799999999999999999999763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-41  Score=369.98  Aligned_cols=263  Identities=26%  Similarity=0.429  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|++.   .++..||||+++.. .....+.+.+|+.++++++||||+++++++...     
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-----  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----
Confidence            358999999999999999999986   46778999999754 334457899999999999999999999997543     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.++++....     .+++.+++.++.||++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence            678999999999999999987543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+++.........     .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....     ....
T Consensus       191 fg~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~  260 (373)
T 2qol_A          191 FGLGRVLEDDPEAA-----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVI  260 (373)
T ss_dssp             C---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHH
T ss_pred             CccccccccCCccc-----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            99998765432110     11222345778999999998899999999999999999998 9999965321     1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ....... .                      .+.+..++..+.+++.+||+.||++||++.||++.|+++.+..
T Consensus       261 ~~i~~~~-~----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          261 KAVDEGY-R----------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHTTE-E----------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHcCC-C----------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            1111000 0                      0001134456889999999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.4e-41  Score=355.82  Aligned_cols=277  Identities=19%  Similarity=0.272  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...  ......+.+|+.++++++||||+++++++.+.     ...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence            57899999999999999999999999999999996433  33457788999999999999999999997653     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++ ++.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999976 66666655433     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......        .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||..............+..
T Consensus       148 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~  219 (292)
T 3o0g_A          148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             ceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            98764332        2234457899999999987766 79999999999999999999888643222222222222211


Q ss_pred             cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .................... ...............+..+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            11100000000000000000 000000001111234567889999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.9e-41  Score=356.44  Aligned_cols=274  Identities=16%  Similarity=0.197  Sum_probs=217.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....  ..+.+.+|+.+++.+ +|++++++++++...     ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----cee
Confidence            467999999999999999999998899999999986433  235678899999999 799999999997543     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----EEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV-----AHV  706 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl  706 (869)
                      ++||||+ +++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.     +||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            9999999 9999999987543     389999999999999999999999   9999999999999987776     999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch--HH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT--LH  784 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~--~~  784 (869)
                      +|||.++............ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  231 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIP-YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  231 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EECcccccccccccccccc-ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence            9999998776543221111 12234567999999999999999999999999999999999999999764322111  01


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ...........                       ......++..+.+++.+||+.||++|||++||++.|+++.+.....
T Consensus       232 ~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          232 RIGEKKQSTPL-----------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHhhccCccH-----------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            11000000000                       0001134567889999999999999999999999999998876554


Q ss_pred             cC
Q 002897          865 QD  866 (869)
Q Consensus       865 ~~  866 (869)
                      .+
T Consensus       289 ~~  290 (298)
T 1csn_A          289 ED  290 (298)
T ss_dssp             SC
T ss_pred             CC
Confidence            33

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.6e-41  Score=362.90  Aligned_cols=274  Identities=19%  Similarity=0.214  Sum_probs=215.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+++++++ +||||+++++++...     ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence            3679999999999999999999988999999999865432  34688999999999 999999999997653     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----EEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV-----AHV  706 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl  706 (869)
                      ++||||+ +++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence            9999999 9999999987533     389999999999999999999999   9999999999999999887     999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|+........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.
T Consensus       152 ~DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~  228 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKER  228 (330)
T ss_dssp             CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHH
T ss_pred             EEcccceeeecCCCCccc-cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHH
Confidence            999999876544321111 0112345679999999999999999999999999999999999999998643221  1111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  865 (869)
                      ..........  ...                 ......++ .+.+++..||+.||.+||++++|.+.|+.+.+......
T Consensus       229 ~~~i~~~~~~--~~~-----------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~  287 (330)
T 2izr_A          229 YQKIGDTKRA--TPI-----------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF  287 (330)
T ss_dssp             HHHHHHHHHH--SCH-----------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHhhhcc--CCH-----------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence            1111000000  000                 00001133 78899999999999999999999999999987765443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.6e-41  Score=362.99  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....   ......+.+|+.+++.++||||+++++++...     .
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            468999999999999999999999999999999996432   23346789999999999999999999997654     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+ +|+|.+++....      .+++.+++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            789999999 789999987654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |++......         .......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........     ..
T Consensus       153 G~s~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~  218 (336)
T 3h4j_B          153 GLSNIMTDG---------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----FK  218 (336)
T ss_dssp             SCTBTTTTS---------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----BC
T ss_pred             ccceeccCC---------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----HH
Confidence            999865443         22234569999999999988776 7899999999999999999999975322110     00


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....                        ....+...+..+.+++.+||+.||++|||++|+++.
T Consensus       219 ~i~~~------------------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          219 KVNSC------------------------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCSS------------------------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHcC------------------------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00000                        000011234567899999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=372.16  Aligned_cols=255  Identities=19%  Similarity=0.268  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+     .
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----E   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----S
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----C
Confidence            34578999999999999999999999999999999996543  3345678999999999999999999999764     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEE
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAH  705 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k  705 (869)
                      ...++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++   .++.+|
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            78899999999999999998764      389999999999999999999999   999999999999998   467899


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||+|.......        .......||+.|+|||++.+..++.++||||+||++|+|++|..||......     .
T Consensus       154 L~DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-----~  220 (444)
T 3soa_A          154 LADFGLAIEVEGEQ--------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-----R  220 (444)
T ss_dssp             ECCCSSCBCCCTTC--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----H
T ss_pred             EccCceeEEecCCC--------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-----H
Confidence            99999998665432        2223467999999999999999999999999999999999999999653211     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......... ....                   +....+++.+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~i~~~~~-~~~~-------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          221 LYQQIKAGAY-DFPS-------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHTCC-CCCT-------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhCCC-CCCc-------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111110000 0000                   001123456889999999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.1e-41  Score=356.88  Aligned_cols=275  Identities=22%  Similarity=0.330  Sum_probs=203.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|++. +|+.||+|++....  ......+.+|++++++++||||+++++++.+     ...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----SSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----CCE
Confidence            468999999999999999999996 69999999996432  2335678899999999999999999999754     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++ +|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            8999999975 88888876553     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .++......        .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ........
T Consensus       165 ~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~  235 (311)
T 3niz_A          165 LARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI  235 (311)
T ss_dssp             TCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred             CceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            998764332        22234568999999999876 468999999999999999999999997644332 22222221


Q ss_pred             hcc---cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLP---EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~---~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...   .......+......... ............+.+..++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          236 LGTPNPREWPQVQELPLWKQRTF-QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HCCCCTTTSGGGTTSHHHHSCCC-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HCCCChHHhhhhhccchhhhccc-ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111   11111111000000000 000000000111223457889999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-41  Score=351.74  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+     ....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            357889999999999999999997 688899999975433 23678999999999999999999999754     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....     .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence            99999999999999977554     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......     .......
T Consensus       154 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~  221 (269)
T 4hcu_A          154 RFVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIS  221 (269)
T ss_dssp             GGBCCHHH-------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH
T ss_pred             cccccccc-------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHh
Confidence            86644211       12233457889999999998899999999999999999999 99998753221     1111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      .. . ...                     .+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       222 ~~-~-~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          222 TG-F-RLY---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             TT-C-CCC---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cC-c-cCC---------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            00 0 000                     0012245678999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-41  Score=369.81  Aligned_cols=286  Identities=18%  Similarity=0.251  Sum_probs=214.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCC-----CeEEEEEEeecccchh-----------hHHHHHHHHHHHhCCCCccce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGEN-----GMLVAVKVLNLMQKGA-----------LKSFLTECEALRSIRHRNLIK  615 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  615 (869)
                      ..++|++.+.||+|+||+||+|.+..+     ++.||||++.......           ......|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999999754     5889999986543211           122345566677788999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN  695 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  695 (869)
                      +++++... ..+....++||||+ +++|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+|
T Consensus       113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            99998764 23346789999999 9999999987543     399999999999999999999999   99999999999


Q ss_pred             eeec--CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCC
Q 002897          696 VLLD--HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       696 Ill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                      ||++  .++.+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999  8899999999999876543221111 112224456999999999999999999999999999999999999999


Q ss_pred             CcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          774 DSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       774 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....... ...............+..++.+                 ....++..+.+++..||+.||++||++.++++.
T Consensus       262 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          262 EDNLKDP-KYVRDSKIRYRENIASLMDKCF-----------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             GGGTTCH-HHHHHHHHHHHHCHHHHHHHHS-----------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccccCH-HHHHHHHHHhhhhHHHHHHHhc-----------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            7533221 1111111111111111111100                 001235678899999999999999999999999


Q ss_pred             HHHHHHhhhcccC
Q 002897          854 LCAAREAFVSMQD  866 (869)
Q Consensus       854 L~~~~~~~~~~~~  866 (869)
                      |+.+.+......+
T Consensus       324 l~~~~~~~~~~~~  336 (364)
T 3op5_A          324 LLQGLKAIGSKDD  336 (364)
T ss_dssp             HHHHHHHTTCCCC
T ss_pred             HHHHHHHcCCCcC
Confidence            9999887655443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=360.13  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=205.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch------hhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG------ALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++......      ..+.+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK---   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence            35689999999999999999999999999999999654321      357789999999999999999999997653   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  702 (869)
                        ...++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++    
T Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           87 --TDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             --SEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence              78999999999999999997654      389999999999999999999999   999999999999999887    


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      .+||+|||+++......         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .
T Consensus       156 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~  225 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T  225 (326)
T ss_dssp             CEEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred             CEEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-H
Confidence            89999999998765332         2234569999999999999899999999999999999999999996532110 1


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .........          ..              ........+..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~----------~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          226 LANVSAVNY----------EF--------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHTCC----------CC--------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCC----------Cc--------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111100000          00              00111133456889999999999999999999987

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-41  Score=367.89  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.++||+|+||.||+|+++.+++.||+|+++...   ....+.+..|..+++++ +||||+++++++.+     .
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence            468999999999999999999999999999999997542   23345678999999887 89999999999764     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence            78999999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc----hHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL----TLH  784 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~----~~~  784 (869)
                      ||+|+......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...
T Consensus       197 FGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~  268 (396)
T 4dc2_A          197 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  268 (396)
T ss_dssp             CTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred             cceeeecccCC--------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence            99997532221        233456799999999999999999999999999999999999999964322110    111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      ...........                        ..+...+..+.+++.+||+.||++||++
T Consensus       269 ~~~~~i~~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          269 YLFQVILEKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHHCCC------------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHHhcccc------------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11111110000                        0011234567899999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-41  Score=371.95  Aligned_cols=277  Identities=22%  Similarity=0.315  Sum_probs=217.8

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEE-----ECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEE
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGI-----IGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKII  617 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~  617 (869)
                      ...+.....++|++.+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            344555567899999999999999999998     45577999999997543 33456789999999999 799999999


Q ss_pred             EEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcc-------------------------------------------
Q 002897          618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-------------------------------------------  654 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------  654 (869)
                      +++...    ....++||||+++|+|.+++.......                                           
T Consensus        93 ~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            997653    355899999999999999998764310                                           


Q ss_pred             -----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCC
Q 002897          655 -----------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       655 -----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  717 (869)
                                       ....+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                             011289999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       718 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      ....      .......||+.|+|||++.+..++.++|||||||++|||++ |+.||................. ..   
T Consensus       246 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~---  315 (359)
T 3vhe_A          246 DPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RM---  315 (359)
T ss_dssp             CTTC------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-CC---
T ss_pred             cccc------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-CC---
Confidence            3211      22334568899999999998899999999999999999998 9999975432211111111100 00   


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                                             ..+..++..+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus       316 -----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          316 -----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                                   000123456889999999999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=363.96  Aligned_cols=296  Identities=22%  Similarity=0.312  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHH--HHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||+||+|++  +++.||||++.....   ..+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999988  789999999965432   344445444  44589999999998776655566677


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceeecCCCcE
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC------KPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                      .++||||+++|+|.+++....       .++..++.++.||++||+|||+..      .++|+||||||+||+++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            899999999999999997654       688999999999999999999862      3389999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-------CCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-------SEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      ||+|||+|+.+...................||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987754432111111123345579999999999887       356778999999999999999987764322


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhccc-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNS-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ........+..........+.    .......... ............++..+.+++.+||+.||++|||++|+++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFED----MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHH----HHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHH----HHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            211100000000000000000    0000000000 00000011122466789999999999999999999999999999


Q ss_pred             HHHhhhcc
Q 002897          857 AREAFVSM  864 (869)
Q Consensus       857 ~~~~~~~~  864 (869)
                      +...+..-
T Consensus       316 ll~~~~~~  323 (336)
T 3g2f_A          316 LMMIWERN  323 (336)
T ss_dssp             HHHCCCC-
T ss_pred             HHHHHHhc
Confidence            99877543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-40  Score=363.40  Aligned_cols=254  Identities=20%  Similarity=0.316  Sum_probs=205.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.     .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            3568999999999999999999999999999999996432  33456789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  706 (869)
                      ..++||||+++|+|.+++....      .+++..+..++.||++||+|||++   +|+||||||+||+++.++   .+||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            8899999999999999997654      389999999999999999999999   999999999999998654   5999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||++.......         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ...
T Consensus       173 ~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~  238 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRL  238 (362)
T ss_dssp             CCCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred             eecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            9999998665332         22345799999999999998999999999999999999999999975321     111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......... ...                   ......++..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~i~~~~~-~~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          239 YAQIKAGAY-DYP-------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHTCC-CCC-------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhCCC-CCC-------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111110000 000                   00111334568899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-41  Score=363.87  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...     ....+.+.+|+.+++.++||||+++++++...    
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----   98 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD----   98 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence            357999999999999999999999999999999996432     11357789999999999999999999997653    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---E
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV---A  704 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~  704 (869)
                       ...++||||+++|+|.+++......  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +
T Consensus        99 -~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           99 -GMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             -TEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             -CEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence             7899999999999999888654211  12489999999999999999999999   9999999999999987654   9


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      ||+|||++.......        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....      
T Consensus       173 kl~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------  238 (351)
T 3c0i_A          173 KLGGFGVAIQLGESG--------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------  238 (351)
T ss_dssp             EECCCTTCEECCTTS--------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------
T ss_pred             EEecCcceeEecCCC--------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------
Confidence            999999998765432        123345799999999999999999999999999999999999999975211      


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...........  ..+                  ......++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~i~~~~~--~~~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          239 RLFEGIIKGKY--KMN------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHTCC--CCC------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCC--CCC------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111110000  000                  0011123467889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-40  Score=357.72  Aligned_cols=280  Identities=21%  Similarity=0.321  Sum_probs=192.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|++++++++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence            468999999999999999999999899999999997543 2344778899999999999999999999654     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++ |+|.+++...........+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||.
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999998 59999987653222223489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......        .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus       155 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~  225 (317)
T 2pmi_A          155 ARAFGIPV--------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIM  225 (317)
T ss_dssp             CEETTSCC--------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred             ceecCCCc--------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            98764322        122345689999999998764 6899999999999999999999999754321 1111111111


Q ss_pred             c--ccccccccCccchhhhhhcccccCC-C-----ccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 L--PEKVMEIVDPSLLLEVRANNSMSRG-G-----ERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~--~~~~~~~~d~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .  +.........  ...+......... .     .....+..+..+.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          226 GTPNESLWPSVTK--LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CSCCTTTCGGGGG--CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhHhhhhhh--hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0  0000000000  0000000000000 0     00001123457889999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=360.47  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.     .
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            36799999999999999999999999999999999643   233457789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   ||+||||||+||+++.+|.+||+||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence            8999999999999999998754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |+|......         .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||......  .....
T Consensus       160 G~a~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~  228 (384)
T 4fr4_A          160 NIAAMLPRE---------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEI  228 (384)
T ss_dssp             TTCEECCTT---------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHH
T ss_pred             ceeeeccCC---------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHH
Confidence            999876543         22344679999999999864   45899999999999999999999999743222  11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-MRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  852 (869)
                      .........                        ..+..++..+.+++.+||+.||++||+ ++++.+
T Consensus       229 ~~~~~~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          229 VHTFETTVV------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHCCC------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHhhccc------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111100000                        001123456889999999999999998 666653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-40  Score=354.84  Aligned_cols=278  Identities=25%  Similarity=0.374  Sum_probs=209.5

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC--CCCccceEEEEeeccccCC
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI--RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~  627 (869)
                      ....++|++.+.||+|+||.||+|++  .|+.||||++....   ......|.+++...  +||||+++++++... ...
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-TGS  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCC
Confidence            34457899999999999999999998  59999999986432   24455666666555  899999999997654 222


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCC
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-----KPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~  702 (869)
                      ....++||||+++|+|.++++...       +++..++.++.|++.||+|||+.+     .++|+||||||+||+++.++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCceEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence            367899999999999999997653       899999999999999999999752     34899999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCcc------ccchhhhHHHHHHHcC-------
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT------GDVYSFGILLLEMFSR-------  769 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~il~el~tg-------  769 (869)
                      .+||+|||+|..........    ........||+.|+|||++.+..++.+      +|||||||++|||+||       
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEV----DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CEEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CEEEEeCCCceeeccccccc----cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            99999999998765433211    111234579999999999988776665      9999999999999999       


Q ss_pred             ---CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          770 ---RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       770 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                         +.||.........................                 ........+++..+.+++.+||+.||++|||
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  318 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS-----------------FPNRWSSDECLRQMGKLMTECWAHNPASRLT  318 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC-----------------CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             ccccccHhhhcCCCCchhhhHHHHhhhccCcc-----------------ccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence               55554433332222222222111111110                 1111223467888999999999999999999


Q ss_pred             HHHHHHHHHHHHHhh
Q 002897          847 MRDVVVKLCAAREAF  861 (869)
Q Consensus       847 ~~evl~~L~~~~~~~  861 (869)
                      +.||++.|+++.+..
T Consensus       319 ~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          319 ALRVKKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhhc
Confidence            999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=366.87  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|++.++||+|+||.||+|++..+|+.||||+++..   .....+.+.+|..+++.+ +||||+++++++.+.    
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----   96 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----   96 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Confidence            357899999999999999999999999999999999743   233456788999999988 799999999997653    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        97 -~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           97 -DRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence             78999999999999999998754      389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|+......        .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ...
T Consensus       167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~  233 (353)
T 3txo_A          167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLF  233 (353)
T ss_dssp             CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred             cccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            999997543221        2234567999999999998888999999999999999999999999753221     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM------RDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  852 (869)
                      .........                        .+...+..+.+++.+||+.||++||++      +|+++
T Consensus       234 ~~i~~~~~~------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          234 EAILNDEVV------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHCCCC------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHcCCCC------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            111111000                        001123457799999999999999998      66664

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=364.57  Aligned_cols=253  Identities=18%  Similarity=0.264  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+++++.++||||+++++++.+     ....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            4689999999999999999999999999999999976655556788999999999999999999999764     37899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH--DMVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg  710 (869)
                      +||||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.  ++.+||+|||
T Consensus       125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999976543     389999999999999999999999   9999999999999974  4789999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+......         ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus       197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~  266 (387)
T 1kob_A          197 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD  266 (387)
T ss_dssp             TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC
T ss_pred             cceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence            998765432         122346899999999999999999999999999999999999999753211 1111111100


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .      ..++.                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       267 ~------~~~~~------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 W------EFDED------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             C------CCCSS------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C------CCCcc------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0      00000                  11123456889999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=356.60  Aligned_cols=281  Identities=21%  Similarity=0.296  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhC---CCCccceEEEEeecc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-----KGALKSFLTECEALRSI---RHRNLIKIITICSSI  623 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~  623 (869)
                      ..++|++.++||+|+||+||+|++..+|+.||||+++...     ......+.+|+++++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4679999999999999999999998899999999996432     12235677888887776   499999999998775


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                      ........++||||++ |+|.+++......    .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            4444456899999997 5999999876532    389999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      +||+|||.|+.....         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..
T Consensus       159 ~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~  228 (308)
T 3g33_A          159 VKLADFGLARIYSYQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QL  228 (308)
T ss_dssp             EEECSCSCTTTSTTC---------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HH
T ss_pred             EEEeeCccccccCCC---------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence            999999999865432         22234578999999999999999999999999999999999999997533221 11


Q ss_pred             HHhhhhhccccccccc-CccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIV-DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..............+. +........  ............++.+..+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGS--CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhcccccc--CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111111000000000 000000000  000000001111234567889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-40  Score=367.36  Aligned_cols=288  Identities=16%  Similarity=0.169  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeee--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQG--SFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|++.++||+|  +||+||+|++..+|+.||||+++...  ....+.+.+|+.+++.++||||+++++++...    
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----   98 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD----   98 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC----
Confidence            35689999999999  99999999999999999999997543  34457788999999999999999999997654    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++||||+++|+|.+++.....    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B           99 -NELWVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             -TEEEEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             -CEEEEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence             789999999999999999987532    2489999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |||.+........... ..........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............
T Consensus       171 dfg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  249 (389)
T 3gni_B          171 GLRSNLSMISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK  249 (389)
T ss_dssp             CGGGCEECEETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred             ccccceeecccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999875533211110 01122334578999999999987  57899999999999999999999999764333222111


Q ss_pred             hhhhhcccccc------ccc---------Cccchhhhhh---cccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          786 FSKMVLPEKVM------EIV---------DPSLLLEVRA---NNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       786 ~~~~~~~~~~~------~~~---------d~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      .. ...+....      +..         ..........   ..........+....++..+.+++.+||+.||++|||+
T Consensus       250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          250 LN-GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             ---------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             hc-CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            11 11000000      000         0000000000   00000000111223455678999999999999999999


Q ss_pred             HHHHHH
Q 002897          848 RDVVVK  853 (869)
Q Consensus       848 ~evl~~  853 (869)
                      +|+++.
T Consensus       329 ~ell~h  334 (389)
T 3gni_B          329 STLLNH  334 (389)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999853

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-41  Score=362.22  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeE----EEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGML----VAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      .++|++.++||+|+||+||+|++..+++.    ||+|.++.. .....+.+.+|+.++++++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            35799999999999999999999777765    577777533 23445789999999999999999999999865     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++|+||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence             347899999999999999987654     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+|+........      .......||..|+|||++.+..++.++|||||||++|||++ |+.||......  .....
T Consensus       160 Dfg~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~  231 (327)
T 3poz_A          160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI  231 (327)
T ss_dssp             CTTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred             cCcceeEccCCccc------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHH
Confidence            99999876544211      22233457889999999999999999999999999999999 99999753322  11111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ......                          ...+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       232 ~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          232 LEKGER--------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTTCC--------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCC--------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            111000                          001112345688999999999999999999999999988653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.4e-41  Score=349.76  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++..     ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence            468999999999999999999986 788899999975433 33678999999999999999999999754     36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999987543     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......     .......
T Consensus       152 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~  219 (268)
T 3sxs_A          152 RYVLDDQY-------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVS  219 (268)
T ss_dssp             EECCTTCE-------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHH
T ss_pred             eecchhhh-------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHH
Confidence            87654321       12233456788999999988889999999999999999999 99998753221     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...  ...                     .+...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       220 ~~~--~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          220 QGH--RLY---------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTC--CCC---------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             cCC--CCC---------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            000  000                     0011234678999999999999999999999999988654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-40  Score=359.60  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|..+++++ +||||+++++++.+     .
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence            35799999999999999999999999999999999754   233456788999999988 89999999999754     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence            78999999999999999998654      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC----chHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG----LTLH  784 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~----~~~~  784 (869)
                      ||+|+......        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ....
T Consensus       154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  225 (345)
T 3a8x_A          154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  225 (345)
T ss_dssp             GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred             ccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence            99997543221        22345679999999999999999999999999999999999999996432111    0111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      ...........                        ..+...+..+.+++.+||+.||++||++
T Consensus       226 ~~~~~i~~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          226 YLFQVILEKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHHCCC------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHHcCCC------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11111100000                        0011234567899999999999999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.1e-41  Score=353.22  Aligned_cols=275  Identities=20%  Similarity=0.297  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|++....  ....+.+.+|++++++++||||+++++++...     +..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence            5788999999999999999999 589999999986433  23347788999999999999999999997653     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++ +|.+++.....     .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999975 99999987543     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++......        .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ......+..
T Consensus       147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~  217 (288)
T 1ob3_A          147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL  217 (288)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHH
Confidence            98664321        122334689999999998764 58999999999999999999999997543211 111111111


Q ss_pred             cccccccccCccchhhhhhccc-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNS-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ................+..... .............+..+.+++.+||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000000000000000000 0000000111234566889999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=368.49  Aligned_cols=269  Identities=24%  Similarity=0.367  Sum_probs=210.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.. .......+.+|+.++++++||||+++++++...   
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS---  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            35789999999999999999994     457789999999643 334456788999999999999999999997543   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  702 (869)
                        ...++||||+++|+|.+++....... ....+++.+++.++.||++||+|||++   +|+||||||+|||++.++   
T Consensus       147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          147 --LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             --CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence              66799999999999999998754321 123489999999999999999999999   999999999999999655   


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~  781 (869)
                      .+||+|||+|+.......      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.....   
T Consensus       222 ~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---  292 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---  292 (367)
T ss_dssp             CEEECCCHHHHHHHHHSS------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eEEECCCccccccccccc------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            599999999975432210      122234567899999999988899999999999999999998 9999975321   


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                        ............                       ...+..++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       293 --~~~~~~i~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          293 --QEVLEFVTSGGR-----------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             --HHHHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --HHHHHHHHcCCC-----------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence              111111111100                       0011133456889999999999999999999999999987765


Q ss_pred             hc
Q 002897          862 VS  863 (869)
Q Consensus       862 ~~  863 (869)
                      ..
T Consensus       348 ~~  349 (367)
T 3l9p_A          348 DV  349 (367)
T ss_dssp             HH
T ss_pred             hh
Confidence            43

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=353.46  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--------------------------hhhHHHHHHHHHHH
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--------------------------GALKSFLTECEALR  606 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  606 (869)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999864321                          12356889999999


Q ss_pred             hCCCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002897          607 SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPV  686 (869)
Q Consensus       607 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  686 (869)
                      +++||||+++++++.+.   .....++||||+++++|.+++...       ++++.+++.++.|+++||+|||+.   +|
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            99999999999997652   246789999999999998765432       489999999999999999999999   99


Q ss_pred             EecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC---CCccccchhhhHHH
Q 002897          687 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE---ASMTGDVYSFGILL  763 (869)
Q Consensus       687 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il  763 (869)
                      +||||||+||+++.++.+||+|||+++......        .......||+.|+|||++.+..   ++.++|||||||++
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccc--------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence            999999999999999999999999998765432        1223457999999999988765   47889999999999


Q ss_pred             HHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 002897          764 LEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD  843 (869)
Q Consensus       764 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  843 (869)
                      |+|++|+.||.....     ............ ..                     +....++..+.+++.+||+.||++
T Consensus       231 ~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-~~---------------------~~~~~~~~~l~~li~~~l~~dp~~  283 (298)
T 2zv2_A          231 YCFVFGQCPFMDERI-----MCLHSKIKSQAL-EF---------------------PDQPDIAEDLKDLITRMLDKNPES  283 (298)
T ss_dssp             HHHHHSSCSSCCSSH-----HHHHHHHHHCCC-CC---------------------CSSSCCCHHHHHHHHHHTCSCTTT
T ss_pred             HHHHHCCCCCCCccH-----HHHHHHHhcccC-CC---------------------CCccccCHHHHHHHHHHhhcChhh
Confidence            999999999964321     111111100000 00                     000123456889999999999999


Q ss_pred             CCCHHHHHH
Q 002897          844 RMQMRDVVV  852 (869)
Q Consensus       844 RPs~~evl~  852 (869)
                      |||+.|+++
T Consensus       284 R~s~~e~l~  292 (298)
T 2zv2_A          284 RIVVPEIKL  292 (298)
T ss_dssp             SCCHHHHTT
T ss_pred             CCCHHHHhc
Confidence            999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.2e-40  Score=350.05  Aligned_cols=274  Identities=20%  Similarity=0.251  Sum_probs=215.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+.+++.++|++++..+.++...    ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC----CCceE
Confidence            4689999999999999999999988999999999865432  35688999999999998888777766442    36789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDF  709 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  709 (869)
                      +||||+ +++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+||
T Consensus        82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999999 8999999985543     389999999999999999999999   99999999999999   48889999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC--chHHHhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG--LTLHEFS  787 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~--~~~~~~~  787 (869)
                      |.+............ .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .......
T Consensus       153 g~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          153 GLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             TTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCccccccccccccc-ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            999877654321111 0122345679999999999999999999999999999999999999997643221  1111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  865 (869)
                      ........                       ......++..+.+++.+||+.||++|||++||++.|+.+........
T Consensus       232 ~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  286 (296)
T 3uzp_A          232 EKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             ccccCCch-----------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence            11110000                       00001234678899999999999999999999999999988765543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.8e-41  Score=353.85  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch-------hhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-------ALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||+||+|++..+++.||+|++......       ..+.+.+|++++++++||||+++++++.+.  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            46899999999999999999999999999999998643221       126789999999999999999999997542  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCc
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~  703 (869)
                           .++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.
T Consensus        96 -----~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           96 -----PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             -----TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred             -----CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence                 2699999999999999876543     489999999999999999999999   8  999999999999988776


Q ss_pred             -----EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC--CCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          704 -----AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT--GSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       704 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                           +||+|||.++....           ......||+.|+|||++.  ...++.++||||+||++|+|++|+.||...
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSS-----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCceeEEeCCCCccccccc-----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence                 99999999974322           223456899999999984  455789999999999999999999999754


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      .............   .....                      ..+..++..+.+++.+||+.||++|||++|+++.|++
T Consensus       232 ~~~~~~~~~~~~~---~~~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          232 SYGKIKFINMIRE---EGLRP----------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CCCHHHHHHHHHH---SCCCC----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cccHHHHHHHHhc---cCCCC----------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            3322111111110   00000                      0111334568899999999999999999999999975


Q ss_pred             H
Q 002897          857 A  857 (869)
Q Consensus       857 ~  857 (869)
                      +
T Consensus       287 l  287 (287)
T 4f0f_A          287 L  287 (287)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-40  Score=350.86  Aligned_cols=274  Identities=20%  Similarity=0.252  Sum_probs=212.5

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+|+++++.++|++++..+.++...    ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence            45789999999999999999999988999999998754332  24578899999999998888887776442    3778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D  708 (869)
                      ++||||+ +++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            9999999 9999999986543     389999999999999999999999   99999999999999   7889999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC--chHHHh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG--LTLHEF  786 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~--~~~~~~  786 (869)
                      ||.++............ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......
T Consensus       152 fg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIP-YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CTTCEECBCTTTCCBCC-CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             CccceeccCcccCccCC-CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            99998776543221111 122345679999999999999999999999999999999999999997643221  111111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      .........                       ......++..+.+++.+||+.||++|||++|+++.|+++.+.....
T Consensus       231 ~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          231 SEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            111100000                       0000123567889999999999999999999999999998876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4e-41  Score=373.30  Aligned_cols=263  Identities=20%  Similarity=0.223  Sum_probs=207.7

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeec
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSS  622 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  622 (869)
                      +.++....++|++.++||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556789999999999999999999999899999999996432   2223458899999999999999999999765


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                      .     ...++||||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       146 ~-----~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          146 D-----NNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             S-----SEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             C-----CEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence            3     789999999999999999987433     389999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      .+||+|||+|+.......       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....
T Consensus       213 ~vkL~DFGla~~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CEEECCCTTCEECCTTSC-------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEcchhhhhhcccCCC-------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999986654321       1223457999999999986     5678999999999999999999999997532


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  852 (869)
                      .. ...............     |.                  .....+..+.+++.+|+..+|++  ||+++|+++
T Consensus       286 ~~-~~~~~i~~~~~~~~~-----p~------------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          286 LV-ETYGKIMNHKERFQF-----PT------------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HH-HHHHHHHTHHHHCCC-----CS------------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hh-HHHHhhhhccccccC-----Cc------------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            11 111111110000000     00                  00113446779999999998888  999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.7e-41  Score=354.44  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.++||+|+||+||+|++.   ..||+|+++..  .....+.+.+|++++++++||||+++++++..      .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence            3568999999999999999999874   35999998643  33445778999999999999999999997532      4


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             ccEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence            57899999999999999976543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |.+........      ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||.............
T Consensus       165 g~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  238 (289)
T 3og7_A          165 GLATEKSRWSG------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV  238 (289)
T ss_dssp             C------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred             eeccccccccc------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            99976543221      12223456899999999886   5678899999999999999999999997543221111111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      ...........                       ....++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       239 ~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          239 GRGSLSPDLSK-----------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHTSCCCCTTS-----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccccCcchhh-----------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11111110000                       011345678899999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=355.01  Aligned_cols=246  Identities=26%  Similarity=0.317  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+     ..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence            367999999999999999999999999999999997532   2345678899999999999999999999764     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            8999999999999999998754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+++.....           .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......
T Consensus       151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~  214 (318)
T 1fot_A          151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEK  214 (318)
T ss_dssp             SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred             CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            999865432           2345699999999999999999999999999999999999999965321     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .......                        .+...+..+.+++.+|++.||++||     +++|+++
T Consensus       215 i~~~~~~------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          215 ILNAELR------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHCCCC------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhCCCC------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1111000                        0012234678999999999999999     8888875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.2e-41  Score=360.55  Aligned_cols=273  Identities=22%  Similarity=0.374  Sum_probs=197.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCe---EEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGM---LVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ..++|++.+.||+|+||+||+|++..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35689999999999999999999876664   8999999654  344567899999999999999999999998654211


Q ss_pred             C-CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          627 G-VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       627 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      + ....++||||+++|+|.+++...........+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence            1 123489999999999999997654322233589999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLH  784 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~  784 (869)
                      |+|||.|+........      .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||....... ...
T Consensus       178 l~Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYN  250 (323)
T ss_dssp             ECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHH
T ss_pred             Eeeccccccccccccc------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHH
Confidence            9999999876443211      12233456889999999998899999999999999999999 999997533221 111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ....    ...                       ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       251 ~~~~----~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 YLIG----GNR-----------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHT----TCC-----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhc----CCC-----------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1110    000                       0011123456889999999999999999999999999987654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-41  Score=361.46  Aligned_cols=266  Identities=18%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+++.||||+++..   .......+.+|++++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            46899999999999999999999989999999999653   2334567899999999999999999999976542 2223


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            5699999999999999998654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.++.......     .........||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus       161 g~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~  235 (311)
T 3ork_A          161 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED  235 (311)
T ss_dssp             SCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred             cCccccccccc-----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            99987654321     1122334568999999999999999999999999999999999999997532211111100000


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV-VKLCAAR  858 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~  858 (869)
                      .        ..+                 ......++..+.+++.+||+.||++||++.+++ ..+.++.
T Consensus       236 ~--------~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          236 P--------IPP-----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             C--------CCH-----------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C--------CCc-----------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            0        000                 000112456688999999999999999766655 4555443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.5e-41  Score=360.86  Aligned_cols=281  Identities=24%  Similarity=0.342  Sum_probs=214.7

Q ss_pred             cCCCCCCeeeeecceEEEEEE----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGI----IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++...   +..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence            578999999999999999999    4568999999999877666678899999999999999999999987632   346


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred             eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence            78999999999999999987543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+..........     .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......      ....
T Consensus       172 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~  240 (327)
T 3lxl_A          172 GLAKLLPLDKDYY-----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRM  240 (327)
T ss_dssp             GGCEECCTTCSEE-----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHH
T ss_pred             ccceecccCCccc-----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hhhh
Confidence            9998775443111     1233456888999999998888999999999999999999999998642211      0000


Q ss_pred             h-cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          790 V-LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       790 ~-~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      . ........  .........      ......+..++..+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus       241 ~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          241 MGCERDVPAL--SRLLELLEE------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             CC----CCHH--HHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             cccccccccH--HHHHHHhhc------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            0 00000000  000000000      0111112245567889999999999999999999999999987765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=360.69  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=190.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++...     ...
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeE
Confidence            3567999999999999999999999899999999997543  336688999999999999999999997653     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  708 (869)
                      ++||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence            99999999999999998654      389999999999999999999999   9999999999999975   88999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+++......         ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus       195 fg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~  265 (349)
T 2w4o_A          195 FGLSKIVEHQV---------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN  265 (349)
T ss_dssp             CC-------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred             CccccccCccc---------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence            99998654321         223456899999999999999999999999999999999999999653222111111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..    . ....                   +...+.+..+.+++.+||+.||++|||+.|+++
T Consensus       266 ~~----~-~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 CE----Y-YFIS-------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TC----C-CCCT-------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC----C-ccCC-------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10    0 0000                   001123456789999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.7e-41  Score=362.39  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      ....++|++.+.||+|+||.||+|+++.+|+.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+   
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---   89 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---   89 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe---
Confidence            345678999999999999999999999999999999997532   33456788899999877 99999999999765   


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                        ....++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+|
T Consensus        90 --~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           90 --KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence              378999999999999999998754      389999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||+|+......        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..
T Consensus       159 L~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~  225 (345)
T 1xjd_A          159 IADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EE  225 (345)
T ss_dssp             ECCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred             EeEChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HH
Confidence            99999997543221        223456799999999999999999999999999999999999999975321     11


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR-DVV  851 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  851 (869)
                      .........      +.                  .+...+..+.+++.+||+.||++||++. |++
T Consensus       226 ~~~~i~~~~------~~------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          226 LFHSIRMDN------PF------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHHHCC------CC------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHHhCC------CC------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            111111000      00                  0011234678999999999999999997 654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=368.04  Aligned_cols=287  Identities=19%  Similarity=0.249  Sum_probs=217.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|.+.++||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++...   +....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            357999999999999999999999899999999997533 23456788999999999999999999997643   23478


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCcEEEc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMVAHVG  707 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  707 (869)
                      ++||||+++|+|.+++......   ..+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence            9999999999999999865421   2389999999999999999999999   99999999999999    778889999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--------CCCCccccchhhhHHHHHHHcCCCCCCcCccC
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--------SEASMTGDVYSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~il~el~tg~~pf~~~~~~  779 (869)
                      |||.|+......         ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......
T Consensus       159 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~  229 (396)
T 4eut_A          159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (396)
T ss_dssp             CGGGCEECCCGG---------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred             cCCCceEccCCC---------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            999998765432         2234569999999998764        45788999999999999999999999754332


Q ss_pred             CchHHHhhhhh---cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          780 GLTLHEFSKMV---LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       780 ~~~~~~~~~~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ...........   .+......... .........  ............+..+.+++.+||+.||++|||+.|+++.+..
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          230 RRNKEVMYKIITGKPSGAISGVQKA-ENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             TTCHHHHHHHHHSCCTTCCEEEECS-TTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cchHHHHHHHhcCCCcccchhheec-cCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            22222221111   11111111000 000000000  0001112235677889999999999999999999999999998


Q ss_pred             HHHh
Q 002897          857 AREA  860 (869)
Q Consensus       857 ~~~~  860 (869)
                      +.+.
T Consensus       307 il~~  310 (396)
T 4eut_A          307 ILHR  310 (396)
T ss_dssp             HHTC
T ss_pred             Hhhc
Confidence            8764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=362.77  Aligned_cols=270  Identities=24%  Similarity=0.380  Sum_probs=211.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|+.++++++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            4578999999999999999999996     355899999997543 3345778999999999999999999999754   


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVV  687 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  687 (869)
                        ....++||||+++|+|.+++.......                  ....+++.+++.++.||++||+|||++   +|+
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence              367899999999999999998753210                  013589999999999999999999999   999


Q ss_pred             ecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          688 HGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       688 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      ||||||+||+++.++.+||+|||.++.......      ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCcc------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence            999999999999999999999999986543221      01223456789999999998888999999999999999999


Q ss_pred             c-CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          768 S-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       768 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                      + |..||.....     .............                       ..+..++..+.+++.+||+.||++|||
T Consensus       271 t~g~~p~~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps  322 (343)
T 1luf_A          271 SYGLQPYYGMAH-----EEVIYYVRDGNIL-----------------------ACPENCPLELYNLMRLCWSKLPADRPS  322 (343)
T ss_dssp             TTTCCTTTTSCH-----HHHHHHHHTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hcCCCcCCCCCh-----HHHHHHHhCCCcC-----------------------CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            9 9999975321     1111111111000                       001123456889999999999999999


Q ss_pred             HHHHHHHHHHHHHhhhc
Q 002897          847 MRDVVVKLCAAREAFVS  863 (869)
Q Consensus       847 ~~evl~~L~~~~~~~~~  863 (869)
                      +.|+++.|+++.+....
T Consensus       323 ~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          323 FCSIHRILQRMCERAEG  339 (343)
T ss_dssp             HHHHHHHHHHTTC----
T ss_pred             HHHHHHHHHHHHhhhhh
Confidence            99999999999877654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=351.32  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||+||+|++  .++.||||++...  ...+.+.+|++++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            5788999999999999999998  5899999998643  34578899999999999999999999864       23689


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-EEEcccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV-AHVGDFGLA  712 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a  712 (869)
                      ||||+++|+|.+++.....   ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||.+
T Consensus        77 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            9999999999999987543   123789999999999999999999932129999999999999998886 799999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......           .....||+.|+|||++.+..++.++|||||||++|||++|+.||................   
T Consensus       154 ~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  219 (307)
T 2eva_A          154 CDIQTH-----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---  219 (307)
T ss_dssp             ----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---
T ss_pred             cccccc-----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---
Confidence            754322           123358999999999999999999999999999999999999997532221111110000   


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  865 (869)
                      ...                       ......++..+.+++.+||+.||++|||++|+++.|+.+.+.+....
T Consensus       220 ~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          220 GTR-----------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             TCC-----------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             CCC-----------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence            000                       00011234568899999999999999999999999999988765443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-40  Score=350.66  Aligned_cols=260  Identities=21%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+..   .+..||+|+++.. .....+.+.+|+.++++++||||+++++++.+      
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence            4689999999999999999999864   3567999998653 33445778999999999999999999998642      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence            457899999999999999987543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.++.......       .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus       160 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~  231 (281)
T 1mp8_A          160 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE  231 (281)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH
T ss_pred             cccccccCcccc-------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHH
Confidence            999987654321       11223456789999999988889999999999999999997 999997533221 111110


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...    .                       ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       232 ~~~----~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          232 NGE----R-----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             TTC----C-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC----C-----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000    0                       0011134456889999999999999999999999999987754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=363.38  Aligned_cols=270  Identities=25%  Similarity=0.357  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|.+.++||+|+||+||+|++..       .+..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4689999999999999999999742       34689999996543 34457789999999999 999999999997643


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           +..++||||+++|+|.+++......          .....+++.+++.++.||+.||+|||+.   +|+||||||
T Consensus       148 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          148 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             -----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence                 6789999999999999999876421          0123489999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||+|+.......      ........+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCT------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceEEEcCCCcEEEcccCcccccccccc------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999987654321      122334457889999999999999999999999999999999 9999


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |.....     .+...........                       ..+..++..+.+++.+||+.||++|||++||++
T Consensus       294 ~~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          294 YPGVPV-----EELFKLLKEGHRM-----------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             STTCCH-----HHHHHHHHTTCCC-----------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCH-----HHHHHHHHcCCCC-----------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            864321     1111111111000                       001123456889999999999999999999999


Q ss_pred             HHHHHHHhhhcc
Q 002897          853 KLCAAREAFVSM  864 (869)
Q Consensus       853 ~L~~~~~~~~~~  864 (869)
                      .|+++.+.....
T Consensus       346 ~L~~~~~~~~~~  357 (382)
T 3tt0_A          346 DLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHHHHSCSC
T ss_pred             HHHHHHHHHhcC
Confidence            999998765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-40  Score=349.30  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++..     ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCe
Confidence            3468999999999999999999986 788999999975433 23678999999999999999999999754     3678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            999999999999999987433     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........       .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||......     ......
T Consensus       167 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~  234 (283)
T 3gen_A          167 SRYVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHI  234 (283)
T ss_dssp             GGGBCCHHH-------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHH
T ss_pred             ccccccccc-------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHH
Confidence            986644211       12233456889999999998889999999999999999998 99999753221     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ... .. ..                     .+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       235 ~~~-~~-~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          235 AQG-LR-LY---------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HTT-CC-CC---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcc-cC-CC---------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            000 00 00                     0011234678999999999999999999999999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.2e-41  Score=350.96  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=193.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc----hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK----GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+  .|+.||||+++....    ...+.+.+|+++++.++||||+++++++...     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence            35788999999999999999998  589999999864322    2346789999999999999999999997643     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--------
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH--------  700 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------  700 (869)
                      ...++||||+++++|.+++...       .+++..++.++.|+++||+|||++...+|+||||||+||+++.        
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             CceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            6789999999999999999643       3899999999999999999999991112999999999999986        


Q ss_pred             CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      ++.+||+|||.+.......          .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  221 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA  221 (271)
T ss_dssp             SCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred             CcceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            6789999999997654322          123468999999999998889999999999999999999999997532211


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                           ............                      ..+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       222 -----~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 -----VAYGVAMNKLAL----------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -----HHHHHHTSCCCC----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -----HHHhhhcCCCCC----------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                 111110000000                      00112345688999999999999999999999999753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-40  Score=371.81  Aligned_cols=278  Identities=18%  Similarity=0.198  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  629 (869)
                      .++|++.++||+|+||+||+|.+..+|+.||||++...  .....+++.+|+.+++.++||||+++++++.... .++..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999643  3445678899999999999999999999986542 23446


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++ ++.+.+..        .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            78999999976 57666643        288999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+.....         .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+....+.
T Consensus       209 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~  278 (464)
T 3ttj_A          209 GLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ  278 (464)
T ss_dssp             CCC-----C---------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred             EeeeecCCC---------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence            999865432         2234467999999999999999999999999999999999999999753211 111111111


Q ss_pred             hccc--ccccccCccchhhhhhccc------------ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPE--KVMEIVDPSLLLEVRANNS------------MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~--~~~~~~d~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .-..  .......+...........            ................+.+++.+||+.||++|||++|+++
T Consensus       279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000  0000000000000000000            0000111122334677899999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-40  Score=373.37  Aligned_cols=207  Identities=22%  Similarity=0.346  Sum_probs=162.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||++...  .....+++.+|+++++.++||||+++++++.....+....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999999999999998643  3344578899999999999999999999987665566678


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+||||+ +|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            99999998 569999997654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc-------------------ccCCCCCCccCcccccCCccc-CCCCCCccccchhhhHHHHHHHcC
Q 002897          711 LAKFLPARPLDTVV-------------------ETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSR  769 (869)
Q Consensus       711 ~a~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~el~tg  769 (869)
                      +|+...........                   .........+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            99876543211000                   000123456789999999975 556799999999999999999993

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=5.4e-39  Score=363.68  Aligned_cols=357  Identities=25%  Similarity=0.381  Sum_probs=258.0

Q ss_pred             CCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCcc
Q 002897            6 NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGF   85 (869)
Q Consensus         6 ~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~   85 (869)
                      .+.+.+.++..   .+.+++.|++++|.++ .+| .+..+++|++|+|++|.+++. |. |+++++|++|+|++|++.+.
T Consensus        33 ~~~~~~~i~~~---~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~  105 (466)
T 1o6v_A           33 KTNVTDTVSQT---DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADI  105 (466)
T ss_dssp             CSSTTSEECHH---HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC
T ss_pred             ccccccccChh---HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccC
Confidence            34444455543   3578999999999998 455 488899999999999999854 43 89999999999999999865


Q ss_pred             CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccC
Q 002897           86 IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNS  165 (869)
Q Consensus        86 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~  165 (869)
                      .+  +.++++|++|+|++|.+. .++.  +..+++|++|++++|.+++. + .+..+++|++|+++ |.+....  .+..
T Consensus       106 ~~--~~~l~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~  175 (466)
T 1o6v_A          106 TP--LANLTNLTGLTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLAN  175 (466)
T ss_dssp             GG--GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTT
T ss_pred             hh--hcCCCCCCEEECCCCCCC-CChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhcc
Confidence            44  889999999999999987 5553  78888999999999988864 2 58888889999886 4444443  3888


Q ss_pred             CCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCC
Q 002897          166 LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL  245 (869)
Q Consensus       166 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l  245 (869)
                      +++|++|++++|.++.++        .+..+++|++|++++|++++..|  +..+++ |+.|++++|.+++.  ..+..+
T Consensus       176 l~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~-L~~L~l~~n~l~~~--~~l~~l  242 (466)
T 1o6v_A          176 LTTLERLDISSNKVSDIS--------VLAKLTNLESLIATNNQISDITP--LGILTN-LDELSLNGNQLKDI--GTLASL  242 (466)
T ss_dssp             CTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECCSSCCCCCGG--GGGCTT-CCEEECCSSCCCCC--GGGGGC
T ss_pred             CCCCCEEECcCCcCCCCh--------hhccCCCCCEEEecCCccccccc--ccccCC-CCEEECCCCCcccc--hhhhcC
Confidence            888888888888887653        36778888888888888876544  455554 88888888887743  356777


Q ss_pred             CCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeec
Q 002897          246 VHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTL  325 (869)
Q Consensus       246 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  325 (869)
                      ++|+.|++++|.+.+..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++
T Consensus       243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L  316 (466)
T 1o6v_A          243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL  316 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred             CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence            777777777777765433  6777777777777777775444  6677777777777777764332  666777777777


Q ss_pred             cCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccC
Q 002897          326 SKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG  405 (869)
Q Consensus       326 ~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  405 (869)
                      ++|++++.                         .|  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++
T Consensus       317 ~~n~l~~~-------------------------~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~  367 (466)
T 1o6v_A          317 YFNNISDI-------------------------SP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD  367 (466)
T ss_dssp             CSSCCSCC-------------------------GG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred             cCCcCCCc-------------------------hh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence            77776632                         22  45566666666666666643  356666666666666666665


Q ss_pred             CCCccccccccccEEEccCCcccC
Q 002897          406 SIPPSLNFLKSIKVLDLSSNKLSG  429 (869)
Q Consensus       406 ~~p~~~~~l~~L~~L~L~~N~l~~  429 (869)
                      ..|  +..+++|+.|++++|++++
T Consensus       368 ~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          368 LTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CGG--GTTCTTCCEEECCCEEEEC
T ss_pred             cch--hhcCCCCCEEeccCCcccC
Confidence            544  6666666666666666664

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.3e-40  Score=356.51  Aligned_cols=259  Identities=23%  Similarity=0.372  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeE----EEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGML----VAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|++.++||+|+||+||+|++..+++.    ||+|.+.... ......+.+|+.++++++||||+++++++..      
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            5788999999999999999999877765    7777764322 3334567889999999999999999998743      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence            568899999999999999987543     388999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+|+........      .......|+..|+|||++.+..++.++|||||||++|+|++ |+.||......  ......
T Consensus       159 fg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~  230 (325)
T 3kex_A          159 FGVADLLPPDDKQ------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLL  230 (325)
T ss_dssp             CSGGGGSCCCTTC------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHH
T ss_pred             CCcccccCccccc------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHH
Confidence            9999887554311      22334567889999999998899999999999999999999 99999753222  111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ........                          +..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       231 ~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 EKGERLAQ--------------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HTTCBCCC--------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HcCCCCCC--------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11100000                          001223466899999999999999999999999988654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-40  Score=355.98  Aligned_cols=275  Identities=24%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ...++|.+.+.||+|+||.||+|.+..   +++.||+|+++..  .....+.+.+|+.++++++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345789999999999999999998764   4568999998644  33445778999999999999999999999876543


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                      .+....++||||+++|+|.+++...........+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence            33346799999999999999996543322234599999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLH  784 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~  784 (869)
                      |+|||.+.........      .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... ...
T Consensus       188 l~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~  260 (313)
T 3brb_A          188 VADFGLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYD  260 (313)
T ss_dssp             ECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH
T ss_pred             EeecCcceeccccccc------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHH
Confidence            9999999866443210      12233457889999999999899999999999999999999 889986532211 111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      .......                           ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       261 ~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 YLLHGHR---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHTTCC---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHcCCC---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            1111000                           00111334568899999999999999999999999999988754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.8e-40  Score=355.89  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc------
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF------  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  625 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999999999999999997543 3355788999999999999999999998865321      


Q ss_pred             ----------------------------------------------CCCceEEEEeecccCCCHHHHHhhCCCcccccCC
Q 002897          626 ----------------------------------------------NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNL  659 (869)
Q Consensus       626 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l  659 (869)
                                                                    ......++||||+++|+|.+++......   ...
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~  161 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDR  161 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGS
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cch
Confidence                                                          1123489999999999999999876542   236


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCcc----ccCCCCCCccC
Q 002897          660 SLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV----ETPSSSSGIKG  735 (869)
Q Consensus       660 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~g  735 (869)
                      ++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...........    ..........|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            7778999999999999999999   9999999999999999999999999999887654321110    00122344579


Q ss_pred             cccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccC
Q 002897          736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSR  815 (869)
Q Consensus       736 t~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  815 (869)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+...       ..........                      
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~~~----------------------  289 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNL----------------------  289 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHHTT----------------------
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhhcc----------------------
Confidence            99999999999999999999999999999999987774311       0111100000                      


Q ss_pred             CCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          816 GGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       816 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       .........++.+.+++.+||+.||++|||++|+++
T Consensus       290 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          290 -KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             -CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             -CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence             011122345566789999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3e-40  Score=371.03  Aligned_cols=254  Identities=30%  Similarity=0.398  Sum_probs=207.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+  .|+.||||+++...  ..+.+.+|++++++++||||+++++++...    ....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            46788899999999999999998  58899999997543  457899999999999999999999997643    24689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       264 iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            99999999999999987542    1378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.....           .....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ......... 
T Consensus       337 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~~~~-  403 (450)
T 1k9a_A          337 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGY-  403 (450)
T ss_dssp             EECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHHHTTC-
T ss_pred             cccccc-----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC-
Confidence            854322           112256889999999999999999999999999999998 999997543221 111111000 


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                                                ....+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       404 --------------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 --------------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                                      0011123456788999999999999999999999999998765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-40  Score=354.08  Aligned_cols=276  Identities=26%  Similarity=0.388  Sum_probs=209.4

Q ss_pred             cCCCCCCeeeeecceEEEEEE----ECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGI----IGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .+|++.+.||+|+||.||+|+    +..+++.||+|+++... ....+.+.+|+++++.++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            468899999999999999999    45689999999997433 33457889999999999999999999998653   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            568999999999999999966543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+.........     ........||..|+|||++.+..++.++||||+||++|+|++|+.|+.....      ....
T Consensus       170 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~  238 (302)
T 4e5w_A          170 FGLTKAIETDKEY-----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLK  238 (302)
T ss_dssp             CTTCEECCTTCCE-----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHH
T ss_pred             ccccccccCCCcc-----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhh
Confidence            9999877654311     1223345688899999999888899999999999999999999998643211      1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      ...+.. ..............      ......+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          239 MIGPTH-GQMTVTRLVNTLKE------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHCSCC-GGGHHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCcc-cccCHHHHHHHHhc------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            000000 00000000000000      0011111234567889999999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-40  Score=360.82  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=195.2

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++.++||||+++++++...     ...
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-----THL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEE
Confidence            35689999999999999999999999999999999965432 336788999999999999999999997653     779


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--EEEccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV--AHVGDF  709 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df  709 (869)
                      ++||||+++|+|.+++....      .+++..++.++.|++.||+|||++   ||+||||||+||+++.++.  +||+||
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence            99999999999999997654      389999999999999999999999   9999999999999987765  999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCcc-ccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMT-GDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+.....         .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ......
T Consensus       163 g~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~  232 (361)
T 3uc3_A          163 GYSKSSVLH---------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQ  232 (361)
T ss_dssp             CCC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHH
T ss_pred             Ccccccccc---------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHH
Confidence            999743222         22234569999999999988777655 8999999999999999999976433222 122111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..........                      .....+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          233 RILSVKYSIP----------------------DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHTTCCCCC----------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhcCCCCCC----------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1111100000                      000123567899999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-40  Score=354.81  Aligned_cols=249  Identities=22%  Similarity=0.282  Sum_probs=181.5

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEEEEeec
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .+.||+|+||+||+|.+..+|+.||||++...   ....+.+|+.+++.+. ||||+++++++.+.     ...++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEEc
Confidence            47899999999999999999999999999643   3467789999999996 99999999997643     788999999


Q ss_pred             ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---cEEEcccccccc
Q 002897          638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM---VAHVGDFGLAKF  714 (869)
Q Consensus       638 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  714 (869)
                      +++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||+++.
T Consensus        88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999998764      389999999999999999999999   999999999999998766   899999999986


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccC--CchHHHhhhhhcc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE--GLTLHEFSKMVLP  792 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~  792 (869)
                      .....        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......  .....+.......
T Consensus       159 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          159 KPPDN--------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             CCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             cCCCC--------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            65432        2223456899999999999999999999999999999999999999753321  1111111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...                    .........++.++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~--------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          231 GDF--------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TCC--------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCC--------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            100                    0011112234567889999999999999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=362.40  Aligned_cols=247  Identities=20%  Similarity=0.281  Sum_probs=197.6

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeecc
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      .+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++||||+++++++...     +..++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCC
Confidence            56899999999999999989999999999876656667899999999999999999999997653     7789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--cCCCcEEEccccccccCC
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL--DHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~  716 (869)
                      ++|+|.+++.....     .+++..++.++.||++||+|||+.   +|+||||||+||++  +.++.+||+|||+++...
T Consensus       169 ~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          169 DGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             TTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999976543     389999999999999999999999   99999999999999  567899999999998765


Q ss_pred             CCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          717 ARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      ...         ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............    
T Consensus       241 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~----  306 (373)
T 2x4f_A          241 PRE---------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD----  306 (373)
T ss_dssp             TTC---------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC----
T ss_pred             Ccc---------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC----
Confidence            432         223346999999999999889999999999999999999999999753211 111111111000    


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       . .                  ......++..+.+++.+||+.||++|||++|+++
T Consensus       307 -~-~------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 -L-E------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -S-C------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -C-C------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0 0                  0011133456889999999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-40  Score=358.65  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|+++..   .....+.+..|..+++.+ +||+|+++++++.+     
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence            457899999999999999999999988999999999753   233456788999999988 89999999999754     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      .+..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   ||+||||||+||+++.+|.+||+
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence            378999999999999999998654      389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|+......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....
T Consensus       164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~  230 (353)
T 2i0e_A          164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF  230 (353)
T ss_dssp             CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred             eCCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHH
Confidence            999997543221        223456799999999999999999999999999999999999999975321     1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      .........                        .+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       231 ~~i~~~~~~------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          231 QSIMEHNVA------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHCCCC------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHhCCCC------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111111000                        00123456789999999999999995     466654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5e-40  Score=345.69  Aligned_cols=252  Identities=21%  Similarity=0.245  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++...     ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeE
Confidence            346799999999999999999999999999999999876666678899999999999999999999997643     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D  708 (869)
                      ++||||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999999987754      389999999999999999999999   99999999999999   7889999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+.......         ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... .......
T Consensus       153 fg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~  221 (277)
T 3f3z_A          153 FGLAARFKPGK---------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIRE  221 (277)
T ss_dssp             CTTCEECCTTS---------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             cccceeccCcc---------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence            99998765432         2234568999999999876 48999999999999999999999997532211 1111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....                        ........++..+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GTFT------------------------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCC------------------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCC------------------------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000                        000001123567889999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-40  Score=355.58  Aligned_cols=270  Identities=23%  Similarity=0.359  Sum_probs=214.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhC-CCCccceEEEEeeccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQK-GALKSFLTECEALRSI-RHRNLIKIITICSSID  624 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  624 (869)
                      ..++|++.+.||+|+||.||+|++     ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence            346899999999999999999985     45788999999975432 3457789999999999 999999999997543 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDK------------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLK  692 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  692 (869)
                          +..++||||+++|+|.+++......            .....+++..++.++.|+++||+|||++   +|+|||||
T Consensus       100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A          100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence                6789999999999999999876531            0122489999999999999999999999   99999999


Q ss_pred             CCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCC
Q 002897          693 PSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRR  771 (869)
Q Consensus       693 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~  771 (869)
                      |+||+++.++.+||+|||.+.........      .......|++.|+|||++.+..++.++|||||||++|+|++ |+.
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccc------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999876544211      12233457889999999988899999999999999999999 999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||........ ..........    .                      ..+..++..+.+++.+||+.||++|||+.|++
T Consensus       247 p~~~~~~~~~-~~~~~~~~~~----~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  299 (313)
T 1t46_A          247 PYPGMPVDSK-FYKMIKEGFR----M----------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV  299 (313)
T ss_dssp             SSTTCCSSHH-HHHHHHHTCC----C----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCcccchhH-HHHHhccCCC----C----------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            9975432211 1111111100    0                      00012345688999999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 002897          852 VKLCAAREAFV  862 (869)
Q Consensus       852 ~~L~~~~~~~~  862 (869)
                      +.|+++.+...
T Consensus       300 ~~L~~~~~~~~  310 (313)
T 1t46_A          300 QLIEKQISEST  310 (313)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHhh
Confidence            99999887643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=355.07  Aligned_cols=276  Identities=20%  Similarity=0.312  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++....  ....+.+.+|++++++++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            57899999999999999999999899999999985433  23356788999999999999999999997653     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            99999999999999887654      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +.......        .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ........
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~  219 (311)
T 4agu_A          149 ARLLTGPS--------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTL  219 (311)
T ss_dssp             CEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred             chhccCcc--------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence            98765332        22234568999999999876 5689999999999999999999999975432211 11111100


Q ss_pred             ---cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 ---LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                         .+................................++..+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               00000000000000000000000000000011234567889999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-40  Score=358.16  Aligned_cols=246  Identities=23%  Similarity=0.268  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+     ..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence            368999999999999999999999999999999996432   2345678899999999999999999999764     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence            8999999999999999998754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+++.....           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~  249 (350)
T 1rdq_E          186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEK  249 (350)
T ss_dssp             TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHH
Confidence            999865432           2345699999999999999999999999999999999999999975321     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      .......                        .+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       250 i~~~~~~------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          250 IVSGKVR------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHCCCC------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHcCCCC------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1111000                        00123456789999999999999998     888865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-40  Score=367.35  Aligned_cols=260  Identities=17%  Similarity=0.226  Sum_probs=206.8

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeecc
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      .++....++|++.++||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-  140 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  140 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence            445556789999999999999999999999999999999996422   2233557899999999999999999999765 


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                          ....++||||+++|+|.++++...       +++..++.++.||+.||+|||++   +|+||||||+|||++.+++
T Consensus       141 ----~~~~~lV~E~~~gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          141 ----DRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             ----SSEEEEEECCCTTEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence                378999999999999999997643       89999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC----CCccccchhhhHHHHHHHcCCCCCCcCccC
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE----ASMTGDVYSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~el~tg~~pf~~~~~~  779 (869)
                      +||+|||+|+.......       .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......
T Consensus       207 ikL~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  279 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  279 (410)
T ss_dssp             EEECCCTTCEECCTTSE-------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             EEEeccceeEeeccCCc-------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence            99999999987654321       1233567999999999987655    789999999999999999999999753211


Q ss_pred             CchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002897          780 GLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD--RMQMRDVVVK  853 (869)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  853 (869)
                       ...............                        +.....+..+.+++.+||+.+|++  ||+++||++.
T Consensus       280 -~~~~~i~~~~~~~~~------------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          280 -GTYSKIMNHKNSLTF------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -HHHHHHHTHHHHCCC------------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -hHHHHHHhccccccC------------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence             111111110000000                        000023356789999999999998  9999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=358.02  Aligned_cols=282  Identities=26%  Similarity=0.434  Sum_probs=216.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE----CCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|++    ..+|+.||||++........+.+.+|++++++++||||+++++++...   +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence            35788999999999999999994    568999999999876666778899999999999999999999987643   23


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++.+++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence            467999999999999999987653     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+..........     .......++..|+|||++.+..++.++|||||||++|+|+||..||.....      .+.+
T Consensus       189 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~  257 (326)
T 2w1i_A          189 FGLTKVLPQDKEYY-----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMR  257 (326)
T ss_dssp             CTTCEECCSSCSEE-----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHH
T ss_pred             Ccchhhcccccccc-----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHH
Confidence            99998775442110     112334578889999999888899999999999999999999999763211      1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ..............+......      ....+.+..++..+.+++.+||+.||++|||+.|+++.|+++++.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          258 MIGNDKQGQMIVFHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHCTTCCTHHHHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhccccchhhhHHHHHHHhhc------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            000000000000000000000      00111122455678899999999999999999999999999988764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-39  Score=353.36  Aligned_cols=276  Identities=23%  Similarity=0.350  Sum_probs=215.6

Q ss_pred             HHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--CCCCccceEEEEeeccccC
Q 002897          549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS--IRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       549 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~  626 (869)
                      -....++|++.+.||+|+||.||+|++  +|+.||||++...   ....+.+|+++++.  ++||||+++++++.... .
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~  110 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G  110 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence            345567899999999999999999998  6999999998643   34667889999887  68999999999976541 1


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceee
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH--------HHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll  698 (869)
                      .....++||||+++|+|.+++....       +++..++.++.|++.||+|||        +.   +|+||||||+||++
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            1237899999999999999997643       899999999999999999999        77   99999999999999


Q ss_pred             cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC------CCccccchhhhHHHHHHHcC---
Q 002897          699 DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE------ASMTGDVYSFGILLLEMFSR---  769 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~el~tg---  769 (869)
                      +.++.+||+|||++..........    ........||+.|+|||++.+..      ++.++|||||||++|||++|   
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             CCCCCEEEEECCCceecccccccc----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            999999999999998765432110    01234457999999999987753      34689999999999999999   


Q ss_pred             -------CCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCC
Q 002897          770 -------RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPT  842 (869)
Q Consensus       770 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  842 (869)
                             ..||............+............+.                 ......+++..+.+++.+||+.||+
T Consensus       257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~  319 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-----------------NRWQSCEALRVMAKIMRECWYANGA  319 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-----------------GGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred             CCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCc-----------------ccccchhHHHHHHHHHHHHhccChh
Confidence                   6777654444334444333322211111111                 1112236777899999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHhh
Q 002897          843 DRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       843 ~RPs~~evl~~L~~~~~~~  861 (869)
                      +|||++||++.|+++.+..
T Consensus       320 ~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          320 ARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             GSCCHHHHHHHHHHHHHTT
T ss_pred             hCCCHHHHHHHHHHHHHHh
Confidence            9999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.1e-40  Score=354.30  Aligned_cols=267  Identities=23%  Similarity=0.343  Sum_probs=213.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ..++|.+.+.||+|+||.||+|++     ..+++.||||+++... ....+.+.+|+++++.++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            356899999999999999999998     3456899999997533 3455788999999999999999999999754   


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVV  687 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  687 (869)
                        ....++||||+++|+|.+++.......                  ....+++.+++.++.|+++||+|||++   +|+
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv  172 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV  172 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence              367899999999999999998754310                  112489999999999999999999999   999


Q ss_pred             ecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          688 HGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       688 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      ||||||+||+++.++.+||+|||.+.........      .......+++.|+|||++.+..++.++|||||||++|||+
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  246 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV  246 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccc------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999876543211      1223345788999999998888999999999999999999


Q ss_pred             c-CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          768 S-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       768 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                      + |+.||.......  ..........                          ...+..++..+.+++.+||+.||++|||
T Consensus       247 t~g~~p~~~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps  298 (314)
T 2ivs_A          247 TLGGNPYPGIPPER--LFNLLKTGHR--------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPV  298 (314)
T ss_dssp             TTSCCSSTTCCGGG--HHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hCCCCCCCCCCHHH--HHHHhhcCCc--------------------------CCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9 999997533221  1111110000                          0001123456889999999999999999


Q ss_pred             HHHHHHHHHHHHHh
Q 002897          847 MRDVVVKLCAAREA  860 (869)
Q Consensus       847 ~~evl~~L~~~~~~  860 (869)
                      +.|+++.|+++.+.
T Consensus       299 ~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          299 FADISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999998765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.7e-40  Score=366.94  Aligned_cols=212  Identities=23%  Similarity=0.316  Sum_probs=173.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...  .....+++.+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999643  3344578899999999999999999999987665555578


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||++ |+|.+++....      .+++..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            999999986 59999998654      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCcc--------------ccCCCCCCccCcccccCCccc-CCCCCCccccchhhhHHHHHHHcCCCCCC
Q 002897          711 LAKFLPARPLDTVV--------------ETPSSSSGIKGTVGYIAPEYG-TGSEASMTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       711 ~a~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~el~tg~~pf~  774 (869)
                      +|+...........              .........+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            99877543211000              000123556799999999985 55679999999999999999999766654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-40  Score=353.08  Aligned_cols=265  Identities=27%  Similarity=0.446  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCC----CeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGEN----GMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|++.+.||+|+||+||+|.+..+    +..||||+++... ......+.+|+.++++++||||+++++++..     .
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence            4677789999999999999998644    3469999997543 3345678999999999999999999999754     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence            778999999999999999987543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.++.........     .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....     ....
T Consensus       191 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~  260 (333)
T 1mqb_A          191 FGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVM  260 (333)
T ss_dssp             CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred             CCcchhhccccccc-----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHH
Confidence            99998765432111     11223446789999999998899999999999999999999 9999964321     1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ........                       .+.+..++..+.+++.+||+.||++||++.|+++.|+++.+.....
T Consensus       261 ~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          261 KAINDGFR-----------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             HHHHTTCC-----------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             HHHHCCCc-----------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            11110000                       0001123456889999999999999999999999999988765543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.3e-40  Score=351.60  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch------hhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG------ALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++......      ..+.+.+|+.++++++||||+++++++...   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR---   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC---
Confidence            46799999999999999999999989999999999653321      357789999999999999999999997643   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  702 (869)
                        ...++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           88 --TDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence              77999999999999999998654      389999999999999999999999   999999999999999888    


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      .+||+|||.+.......         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   
T Consensus       157 ~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  224 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---  224 (321)
T ss_dssp             CEEECCCTTCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---
T ss_pred             CEEEccCccceecCccc---------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---
Confidence            79999999998765432         223456899999999999999999999999999999999999999653211   


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        ..........  ...++                  ......+..+.+++.+||+.||++|||+.|+++
T Consensus       225 --~~~~~i~~~~--~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          225 --ETLANITSVS--YDFDE------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --HHHHHHHTTC--CCCCH------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHHHhcc--cccCh------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              1111110000  00000                  011123456889999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.7e-40  Score=361.02  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=195.6

Q ss_pred             hcCCCCC-CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh-CCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSS-NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRS-IRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|.+. ++||+|+||+||+|.+..+|+.||||+++.     ...+.+|++++.+ .+||||+++++++... ..+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3567665 689999999999999999999999999853     2456788888754 5899999999987642 234577


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  707 (869)
                      .++||||+++|+|.+++.....    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            8999999999999999987542    2489999999999999999999999   9999999999999997   7899999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCc---hHH
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL---TLH  784 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~---~~~  784 (869)
                      |||+++.....         .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...
T Consensus       207 DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  277 (400)
T 1nxk_A          207 DFGFAKETTSH---------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT  277 (400)
T ss_dssp             CCTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred             ecccccccCCC---------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence            99999865432         122345689999999999999999999999999999999999999975432211   011


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......     ...                   ......++.++.+++.+||+.||++|||+.|+++.
T Consensus       278 ~i~~~~~-----~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          278 RIRMGQY-----EFP-------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHTCC-----CCC-------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHcCcc-----cCC-------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1110000     000                   00011344568899999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-39  Score=344.18  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..|.+.+.||+|+||+||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++... ..+....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence            3477788999999999999999999999999998643  344567789999999999999999999987654 3445778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeec-CCCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLD-HDMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~D  708 (869)
                      ++||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence            99999999999999998754      389999999999999999999999   7  99999999999997 789999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+......          ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.......    ....
T Consensus       176 fg~~~~~~~~----------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~  240 (290)
T 1t4h_A          176 LGLATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYR  240 (290)
T ss_dssp             TTGGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHH
T ss_pred             CCCccccccc----------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHH
Confidence            9999754332          2233568999999998874 58999999999999999999999997532221    1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..........                      .....++.+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          241 RVTSGVKPAS----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHTTTCCCGG----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCccc----------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111000000                      00112345789999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=360.55  Aligned_cols=270  Identities=21%  Similarity=0.335  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSID  624 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  624 (869)
                      ..++|++.+.||+|+||.||+|++     ..+++.||||++... .....+.+.+|+.+++++ +||||+++++++... 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            457899999999999999999997     346778999999643 234457889999999999 899999999997643 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcc-----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKL-----------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVV  687 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  687 (869)
                          +..++||||+++|+|.+++.......                 ....+++..++.++.||+.||+|||+.   ||+
T Consensus       122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                67899999999999999998764321                 012379999999999999999999999   999


Q ss_pred             ecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          688 HGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       688 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      ||||||+||+++.++.+||+|||.+.........      .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccc------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            9999999999999999999999999866433211      1223455788999999998889999999999999999999


Q ss_pred             c-CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          768 S-RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       768 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                      | |..||....... ............                          ..+..++..+.+++.+||+.||++|||
T Consensus       269 t~g~~p~~~~~~~~-~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps  321 (344)
T 1rjb_A          269 SLGVNPYPGIPVDA-NFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPS  321 (344)
T ss_dssp             TTSCCSSTTCCCSH-HHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cCCCCCcccCCcHH-HHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence            8 999997643221 111111111000                          001123456889999999999999999


Q ss_pred             HHHHHHHHHHHHHhhh
Q 002897          847 MRDVVVKLCAAREAFV  862 (869)
Q Consensus       847 ~~evl~~L~~~~~~~~  862 (869)
                      +.|+++.|+.+.+...
T Consensus       322 ~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          322 FPNLTSFLGCQLADAE  337 (344)
T ss_dssp             HHHHHHHHHHHC----
T ss_pred             HHHHHHHHHHHHHHHH
Confidence            9999999999877654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-40  Score=351.08  Aligned_cols=270  Identities=21%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||||+++..   .......+.+|+.++++++||||+++++++...     +
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            45799999999999999999999889999999999642   344557789999999999999999999997654     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++......  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence            889999999999999998753211  12489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+.......        .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......   .......
T Consensus       181 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  249 (310)
T 2wqm_A          181 GLGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK  249 (310)
T ss_dssp             --------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHH
T ss_pred             cceeeecCCC--------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHH
Confidence            9997654332        1223356899999999999999999999999999999999999999643221   1111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  865 (869)
                      .........                      ....++..+.+++.+||+.||++|||+.||++.|+++.+....+-
T Consensus       250 ~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          250 IEQCDYPPL----------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             HHTTCSCCC----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             hhcccCCCC----------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            111000000                      001234568899999999999999999999999999988776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-39  Score=343.60  Aligned_cols=253  Identities=19%  Similarity=0.311  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CE
Confidence            468999999999999999999999999999999996543  33457788999999999999999999997643     77


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV---AHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~  707 (869)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            899999999999999987654      389999999999999999999999   9999999999999987655   9999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.+.......         ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......     ...
T Consensus       151 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~  216 (284)
T 3kk8_A          151 DFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLY  216 (284)
T ss_dssp             CCTTCEECCSSC---------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred             eceeeEEcccCc---------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHH
Confidence            999997665432         223456899999999999999999999999999999999999999653211     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ........ ....                   +....++..+.+++.+||+.||++|||++|+++.
T Consensus       217 ~~~~~~~~-~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          217 AQIKAGAY-DYPS-------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHTCC-CCCT-------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHhccc-cCCc-------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11100000 0000                   0011234568899999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-40  Score=350.23  Aligned_cols=267  Identities=24%  Similarity=0.404  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..+|++.++||+|+||+||+|++..+   +..||+|.+... .....+.+.+|+.++++++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            35688899999999999999997533   346899998643 334557889999999999999999999986542    3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred             CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence            678999999999999999976543     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||.++........    .........||+.|+|||.+.+..++.++||||+|+++|+|++ |.+||...... .......
T Consensus       172 fg~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~  246 (298)
T 3f66_A          172 FGLARDMYDKEYY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL  246 (298)
T ss_dssp             CGGGCCCSCGGGC----BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHH
T ss_pred             ccccccccccchh----ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHh
Confidence            9999866543211    1122344567889999999998899999999999999999999 55555432221 1111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                      ....                           ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+.+..
T Consensus       247 ~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          247 QGRR---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             TTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             cCCC---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1100                           000112345688999999999999999999999999999887654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-40  Score=351.73  Aligned_cols=257  Identities=21%  Similarity=0.378  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC-------eEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG-------MLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||+||+|++..++       ..||+|++........+.+.+|++++++++||||+++++++...  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            357889999999999999999997666       57999999876666778899999999999999999999997653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV--  703 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--  703 (869)
                         +..++||||+++|+|.+++.....     .+++..++.++.|+++||+|||++   +|+||||||+||+++.++.  
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence               677999999999999999987653     389999999999999999999999   9999999999999998887  


Q ss_pred             ------EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          704 ------AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       704 ------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                            +||+|||.+......            ....|++.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccccceeeeccCcccccccCc------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence                  999999998654221            22457889999999887 67899999999999999999965554322


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ....... .....  ......                          ..+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       222 ~~~~~~~-~~~~~--~~~~~~--------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          222 LDSQRKL-QFYED--RHQLPA--------------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             SCHHHHH-HHHHT--TCCCCC--------------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             cchHHHH-HHhhc--cCCCCC--------------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111111 10000  000000                          012346789999999999999999999999998


Q ss_pred             HHHhhhc
Q 002897          857 AREAFVS  863 (869)
Q Consensus       857 ~~~~~~~  863 (869)
                      +...-.+
T Consensus       273 l~~p~~~  279 (289)
T 4fvq_A          273 LFTPDLV  279 (289)
T ss_dssp             CC-----
T ss_pred             hcCCCCC
Confidence            8665443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-40  Score=368.52  Aligned_cols=248  Identities=26%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....   ......+.+|+.+++.++||||+++++++...     .
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            367999999999999999999999999999999996432   23456789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            7999999999999999997654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |++.......         ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......     ....
T Consensus       161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~  226 (476)
T 2y94_A          161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFK  226 (476)
T ss_dssp             SSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHH
T ss_pred             cchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHH
Confidence            9998765432         2234569999999999988775 68999999999999999999999753211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ........                        .+...+..+.+++.+||+.||++|||++|+++
T Consensus       227 ~i~~~~~~------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          227 KICDGIFY------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHTTCCC------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcCCcC------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            11111000                        00112345789999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-40  Score=342.71  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=209.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+++++.++||||+++++++...     ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence            357889999999999999999996 788999999975433 236789999999999999999999997543     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....     .+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence            99999999999999987643     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||++.+..++.++||||+|+++|+|++ |+.||.....     ........
T Consensus       152 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~  219 (267)
T 3t9t_A          152 RFVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDIS  219 (267)
T ss_dssp             GGBCCHHH-------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHH
T ss_pred             cccccccc-------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHh
Confidence            86543210       12233457889999999988889999999999999999999 8999875321     11111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ... .. .                     .+..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       220 ~~~-~~-~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          220 TGF-RL-Y---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TTC-CC-C---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCC-cC-C---------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            000 00 0                     0012245678999999999999999999999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=348.53  Aligned_cols=245  Identities=22%  Similarity=0.259  Sum_probs=193.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.++||+|+||+||+|++..+|+.||||++....  .........|+..+.++ +||||+++++++...     ..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence            57999999999999999999999899999999985432  22334555666666555 899999999997653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+ +++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            99999999 6799999877543     399999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++.......         ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...    ..........
T Consensus       203 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~  268 (311)
T 3p1a_A          203 LLVELGTAG---------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY  268 (311)
T ss_dssp             TCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC
T ss_pred             eeeecccCC---------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC
Confidence            998764432         2233468999999999876 7899999999999999999997776431    1111111110


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .        .+                  .....++..+.+++.+||+.||++|||++|+++
T Consensus       269 ~--------~~------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 L--------PP------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             C--------CH------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--------Cc------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            0        00                  111134567889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=365.13  Aligned_cols=262  Identities=20%  Similarity=0.250  Sum_probs=206.1

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeec
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSS  622 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  622 (869)
                      +.+.....++|++.++||+|+||.||+|+++.+|+.||+|+++...   ....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3445556789999999999999999999999999999999996432   2334568899999999999999999999764


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                           ....++||||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       133 -----~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          133 -----ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence                 3789999999999999999986532     389999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-------CCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-------GSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      ++||+|||+|+.......       .......||+.|+|||++.       +..++.++|||||||++|||++|+.||..
T Consensus       200 ~vkL~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             CEEECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CEEEeechhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            999999999987654321       1223457999999999886       45689999999999999999999999975


Q ss_pred             CccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 002897          776 MFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR---MQMRDVVV  852 (869)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  852 (869)
                      .... ...........  ..   .-+                  ......+.++.+++.+||. +|++|   |+++|+++
T Consensus       273 ~~~~-~~~~~i~~~~~--~~---~~p------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          273 DSTA-ETYGKIVHYKE--HL---SLP------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             SSHH-HHHHHHHTHHH--HC---CCC----------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCHH-HHHHHHHhccc--Cc---CCC------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            3211 11111111000  00   000                  0011234567899999999 99998   58998865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=355.61  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEE----EEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLV----AVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      .++|++.++||+|+||+||+|++..+++.|    |+|.+... .....+.+.+|+.++++++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            367999999999999999999998777655    66666432 33456789999999999999999999999764     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++|+||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             -CCceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence             347899999999999999987654     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+++........      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  ....
T Consensus       160 DfG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~  231 (327)
T 3lzb_A          160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI  231 (327)
T ss_dssp             CTTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred             cCcceeEccCcccc------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH
Confidence            99999876543211      22233457889999999999999999999999999999999 999997543221  1111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ......                          ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       232 ~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          232 LEKGER--------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTTCC--------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCC--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111000                          001112345688999999999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.5e-40  Score=346.77  Aligned_cols=261  Identities=20%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|.+.+.||+|+||+||+|++..   ++..||+|+++.. .....+.+.+|+.+++.++||||+++++++..     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            35689999999999999999998753   3457999998754 33456788999999999999999999998653     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++||||+++++|.+++.....     .+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence             346899999999999999986543     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||.+........       .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.......  ....
T Consensus       156 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~  226 (281)
T 3cc6_A          156 DFGLSRYIEDEDY-------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV  226 (281)
T ss_dssp             CCCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH
T ss_pred             ccCCCcccccccc-------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH
Confidence            9999987654321       12233457889999999988889999999999999999998 999997432221  1111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ......                          ...+..+++.+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       227 ~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          227 LEKGDR--------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HhcCCC--------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            110000                          0000123456889999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=362.45  Aligned_cols=265  Identities=24%  Similarity=0.429  Sum_probs=199.6

Q ss_pred             CCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .|.+.++||+|+||+||+|++..+   +..||||.++.. .....+.+.+|+.++++++||||+++++++...    ...
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence            466778999999999999997532   346899998643 344567899999999999999999999987542    356


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++.+++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence            7899999999999999986543     388999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +++........    .........+++.|+|||++.+..++.++|||||||++|||++ |.+||........ .......
T Consensus       238 ~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~~~~~~~  312 (373)
T 3c1x_A          238 LARDMYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQG  312 (373)
T ss_dssp             ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-HHHHHTT
T ss_pred             ccccccccccc----cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-HHHHHcC
Confidence            99866443211    1112234557889999999998899999999999999999999 6777764322211 1111110


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                      .      .                     ...+..++..+.+++.+||+.||++|||+.|+++.|+++...+..
T Consensus       313 ~------~---------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          313 R------R---------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             C------C---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             C------C---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            0      0                     000112445688999999999999999999999999999887654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.7e-40  Score=357.78  Aligned_cols=283  Identities=21%  Similarity=0.239  Sum_probs=210.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999999999999999996433 3345778999999999999999999999877655556788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++ |+|.+++....       +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999997 59999997643       89999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........     .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .........
T Consensus       175 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~  248 (364)
T 3qyz_A          175 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGIL  248 (364)
T ss_dssp             CEECCGGGC-----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHH
T ss_pred             eEecCCCCC-----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHh
Confidence            987654321     1122344579999999998654 458999999999999999999999997643221 111111111


Q ss_pred             ccc---ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPE---KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...   ......+.........................+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000   00011000000000000000000000011123467889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.8e-40  Score=346.55  Aligned_cols=255  Identities=22%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||+||+|++  .++.||||+++...  ....+.+.+|+.++++++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            35799999999999999999999  59999999997543  34456789999999999999999999997643   2367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEEcc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      .++||||+++|+|.+++.....    ..+++..++.++.|+++||+|||+.   +  |+||||||+||+++.++.++++|
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            8999999999999999987543    2489999999999999999999998   7  99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCc---cccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASM---TGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      ||++.....             ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.......     
T Consensus       157 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----  218 (271)
T 3kmu_A          157 ADVKFSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----  218 (271)
T ss_dssp             GGSCCTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----
T ss_pred             ccceeeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----
Confidence            998754222             2346899999999988765544   7999999999999999999997532211     


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      ............                      ..+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       219 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          219 IGMKVALEGLRP----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHSCCCC----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHhcCCCC----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111110000000                      0011234568899999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-40  Score=347.70  Aligned_cols=267  Identities=24%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENG---MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .|...++||+|+||+||+|++..++   ..||+|++.... ....+.+.+|+.++++++||||+++++++...    ...
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence            4666789999999999999975444   379999986533 34457889999999999999999999997643    244


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+.+|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            5899999999999999987543     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .++.......    ..........+++.|+|||.+.+..++.++|||||||++|+|++|..|+....... .........
T Consensus       170 ~~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~  244 (298)
T 3pls_A          170 LARDILDREY----YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQG  244 (298)
T ss_dssp             SSCTTTTGGG----GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTT
T ss_pred             CcccccCCcc----cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcC
Confidence            9986544321    11123344568899999999999999999999999999999999666643322211 111111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ..                          ...+..++..+.+++.+||+.||++|||+.|+++.|+++.++....
T Consensus       245 ~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          245 RR--------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             CC--------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            00                          0001123456889999999999999999999999999998887543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=345.51  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=184.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----N   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----S
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----C
Confidence            467999999999999999999998899999999996432   22347789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     ++++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence            88999999999999999987543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+.......        .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .    ..
T Consensus       157 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~  223 (278)
T 3cok_A          157 GLATQLKMPH--------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L----NK  223 (278)
T ss_dssp             TTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred             cceeeccCCC--------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H----HH
Confidence            9998764322        112235689999999999988899999999999999999999999975322110 0    00


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....      +..                  .+...+..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~------~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 VVLA------DYE------------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCSS------CCC------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hhhc------ccC------------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0000      000                  00123456789999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=359.77  Aligned_cols=277  Identities=17%  Similarity=0.227  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeecccch-----------hhHHHHHHHHHHHhCCCCccceEEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLMQKG-----------ALKSFLTECEALRSIRHRNLIKIIT  618 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  618 (869)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3679999999999999999999986   7889999998654321           1234668888999999999999999


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      ++... +.+....++||||+ +++|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+||++
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            98763 34457899999999 999999998654      389999999999999999999999   99999999999999


Q ss_pred             cCCC--cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          699 DHDM--VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       699 ~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +.++  .+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             ccCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9887  9999999999876543211100 112224567999999999999989999999999999999999999999643


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ...............     ...........             ....++..+.+++.+||+.||++|||++||++.|+.
T Consensus       264 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          264 LKDPVAVQTAKTNLL-----DELPQSVLKWA-------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             TTCHHHHHHHHHHHH-----HTTTHHHHHHS-------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             ccccHHHHHHHHhhc-----ccccHHHHhhc-------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            222211111111110     00000000000             000244578899999999999999999999999987


Q ss_pred             HHH
Q 002897          857 ARE  859 (869)
Q Consensus       857 ~~~  859 (869)
                      +..
T Consensus       326 ~~~  328 (345)
T 2v62_A          326 HGI  328 (345)
T ss_dssp             TCC
T ss_pred             cCC
Confidence            654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-39  Score=341.61  Aligned_cols=254  Identities=20%  Similarity=0.296  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence            467999999999999999999999899999999997443 34457889999999999999999999997653     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence            99999999999999987643      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........      ........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||............+....
T Consensus       152 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (276)
T 2yex_A          152 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  225 (276)
T ss_dssp             CEECEETTE------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred             ccccCCCcc------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence            986543211      012334568999999999988775 7789999999999999999999976443322222222111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..      .                    ......+..+.+++.+||+.||++|||++|+++
T Consensus       226 ~~------~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 TY------L--------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TT------S--------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc------c--------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00      0                    001123456789999999999999999999976

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-40  Score=357.59  Aligned_cols=267  Identities=20%  Similarity=0.245  Sum_probs=203.5

Q ss_pred             HHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhCCCCccceEEEEeecc
Q 002897          549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-----QKGALKSFLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       549 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      +....++|++.+.||+|+||+||+|.+..+++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455678899999999999999999999999999999999643     234567899999999999999999999997653


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcc----------------------------------cccCCCHHHHHHHHH
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------------------------------EVCNLSLIQTLNIAI  669 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~  669 (869)
                           ...++||||+++|+|.+++.......                                  ....+++..++.++.
T Consensus       101 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          101 -----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             -----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             -----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence                 78999999999999999986311100                                  011246788899999


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCceeecCCC--cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC
Q 002897          670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM--VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG  747 (869)
Q Consensus       670 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  747 (869)
                      ||+.||+|||+.   +|+||||||+||+++.++  .+||+|||.+..+.......    ........||+.|+|||++.+
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhhcc
Confidence            999999999999   999999999999998776  89999999998654322111    112344569999999999865


Q ss_pred             --CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHH
Q 002897          748 --SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEEC  825 (869)
Q Consensus       748 --~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~  825 (869)
                        ..++.++|||||||++|||++|+.||....... ..........     ..                   ..+.....
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~-----~~-------------------~~~~~~~~  303 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKL-----CF-------------------ENPNYNVL  303 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-----CT-------------------TSGGGGGS
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccc-----cc-------------------CCcccccC
Confidence              678999999999999999999999997532211 1111111000     00                   00111123


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          826 LVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       826 ~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +..+.+++.+||+.||++|||+.|+++
T Consensus       304 ~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          304 SPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            456889999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.2e-40  Score=351.18  Aligned_cols=275  Identities=20%  Similarity=0.265  Sum_probs=200.1

Q ss_pred             hcCCCCC-CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSS-NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++. +.||+|+||+||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++...     +.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            3578874 7899999999999999989999999999766555667899999999985 799999999997653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV---AHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~  707 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence            999999999999999998754      389999999999999999999999   9999999999999998776   9999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----CCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      |||++............ .........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+..
T Consensus       157 Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CTTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            99999765432211100 0112234569999999999865     45889999999999999999999999764332211


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....  ..+.     ....+........   ..........++..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~--~~~~-----~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          236 WDRGE--ACPA-----CQNMLFESIQEGK---YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             C------CCHH-----HHHHHHHHHHHCC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccc--cchh-----HHHHHHHHHhccC---cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00000  0000     0000000000000   00000011134567889999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-40  Score=358.74  Aligned_cols=211  Identities=27%  Similarity=0.358  Sum_probs=182.1

Q ss_pred             CCcccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-----CCccce
Q 002897          541 FPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-----HRNLIK  615 (869)
Q Consensus       541 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  615 (869)
                      ...+++.+.....++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34455555556678999999999999999999999989999999999643 233466788999999986     999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN  695 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  695 (869)
                      +++++...     +..++||||+ +++|.+++......    .+++..+..++.||+.||+|||+.   +|+||||||+|
T Consensus       101 ~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  167 (360)
T 3llt_A          101 YHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN  167 (360)
T ss_dssp             EEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCccc
Confidence            99997654     6899999999 89999999876532    489999999999999999999999   99999999999


Q ss_pred             eeecC-------------------------CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC
Q 002897          696 VLLDH-------------------------DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA  750 (869)
Q Consensus       696 Ill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  750 (869)
                      ||++.                         ++.+||+|||+|......           .....||+.|+|||++.+..+
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~  236 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILNLGW  236 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTTCCC
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcCCCC
Confidence            99975                         789999999999864332           234568999999999999999


Q ss_pred             CccccchhhhHHHHHHHcCCCCCCcC
Q 002897          751 SMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       751 ~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +.++|||||||++|+|++|+.||...
T Consensus       237 ~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          237 DVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccchHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999999753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=344.53  Aligned_cols=264  Identities=23%  Similarity=0.356  Sum_probs=211.0

Q ss_pred             cCCCCCC-eeeeecceEEEEEEEC--CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSN-MVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||+++... ....+.+.+|+++++.++||||+++++++..      +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            4566666 9999999999999864  468899999997543 3456788999999999999999999999732      4


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            58999999999999999976543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+.........     ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||......  .......
T Consensus       155 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~  227 (287)
T 1u59_A          155 GLSKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE  227 (287)
T ss_dssp             TTCEECTTCSCE-----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred             cceeeeccCcce-----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHh
Confidence            999877543211     112233457899999999988889999999999999999998 99999753221  1111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      .   ...                       ...+..++..+.+++.+||+.||++|||+.|+++.|+++..+....
T Consensus       228 ~---~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          228 Q---GKR-----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             T---TCC-----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             c---CCc-----------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            0   000                       0011134567889999999999999999999999999998776543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-40  Score=357.73  Aligned_cols=277  Identities=20%  Similarity=0.290  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+++.+|+++++.++||||+++++++.... ..+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999999999999999998542  3334577899999999999999999999986542 22335


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+ +++|.+++....       +++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            679999999 789999998642       89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+.....           .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......
T Consensus       173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~  240 (367)
T 1cm8_A          173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK  240 (367)
T ss_dssp             TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            999865432           234568999999999877 679999999999999999999999997532211 1111111


Q ss_pred             hh--cccccccccCccchhhh-hhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MV--LPEKVMEIVDPSLLLEV-RANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~--~~~~~~~~~d~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  .+......+.......+ ..................+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            11  00001000000000000 000000000001111234567889999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-40  Score=364.28  Aligned_cols=254  Identities=22%  Similarity=0.280  Sum_probs=195.6

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCCCCccceEEEEeec
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIRHRNLIKIITICSS  622 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  622 (869)
                      ...++|.+.+.||+|+||+||+|.+..+++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999999999999999996432        1122357899999999999999999998643


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                            ...++||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus       212 ------~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          212 ------EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             ------SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             ------CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence                  45789999999999999887654      389999999999999999999999   999999999999997544


Q ss_pred             ---cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          703 ---VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       703 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                         .+||+|||+|+.....         .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...
T Consensus       277 ~~~~~kl~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CcceEEEeecccceecCCC---------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence               5999999999876432         22234579999999999853   56888999999999999999999999754


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ................                        ........++..+.+++.+||+.||++|||++|+++
T Consensus       348 ~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          348 RTQVSLKDQITSGKYN------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SSSCCHHHHHHTTCCC------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchHHHHHHHhcCCCC------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            3322222111111100                        000111234567889999999999999999999987

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=9.4e-39  Score=361.74  Aligned_cols=361  Identities=30%  Similarity=0.416  Sum_probs=276.3

Q ss_pred             ccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcc
Q 002897           29 LAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHG  108 (869)
Q Consensus        29 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  108 (869)
                      +..+.+.+.++  ...+++|+.|++++|.++ .+|. +..+++|++|+|++|.+++..|  +.++++|++|++++|.+. 
T Consensus        31 ~~~~~~~~~i~--~~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-  103 (466)
T 1o6v_A           31 LGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-  103 (466)
T ss_dssp             TTCSSTTSEEC--HHHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred             hcccccccccC--hhHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-
Confidence            44445554443  245789999999999998 5564 8899999999999999996544  999999999999999998 


Q ss_pred             cCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcc
Q 002897          109 SLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD  188 (869)
Q Consensus       109 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  188 (869)
                      .++.  +.++++|++|++++|.+++..+  +.++++|++|++++|.+.++.  .+..+++|++|+++ |.+....     
T Consensus       104 ~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~-----  171 (466)
T 1o6v_A          104 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK-----  171 (466)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG-----
T ss_pred             cChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch-----
Confidence            5553  8888999999999998886643  888899999999999887653  48888888888886 4444332     


Q ss_pred             hhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccC
Q 002897          189 FVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGW  268 (869)
Q Consensus       189 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  268 (869)
                         .+..+++|++|++++|++++.  ..+..+++ |+.|++++|.+++..|  ++.+++|+.|++++|++.+.  ..+..
T Consensus       172 ---~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~-L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~  241 (466)
T 1o6v_A          172 ---PLANLTTLERLDISSNKVSDI--SVLAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLAS  241 (466)
T ss_dssp             ---GGTTCTTCCEEECCSSCCCCC--GGGGGCTT-CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGG
T ss_pred             ---hhccCCCCCEEECcCCcCCCC--hhhccCCC-CCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhc
Confidence               377888888888888888743  23566654 7777777777765444  56677777777777776642  34666


Q ss_pred             CCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccccccccee
Q 002897          269 LKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFL  348 (869)
Q Consensus       269 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L  348 (869)
                      +++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|+++                 
T Consensus       242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~-----------------  300 (466)
T 1o6v_A          242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE-----------------  300 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS-----------------
T ss_pred             CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc-----------------
Confidence            6777777777777765444  6666667777777666664322  666666666666666655                 


Q ss_pred             cccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCccc
Q 002897          349 NLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS  428 (869)
Q Consensus       349 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  428 (869)
                              +..+  ++.+++|+.|+|++|.+++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|+++
T Consensus       301 --------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~  366 (466)
T 1o6v_A          301 --------DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS  366 (466)
T ss_dssp             --------CCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred             --------Cchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccC
Confidence                    3222  7788999999999999997655  88999999999999999864  57899999999999999999


Q ss_pred             CCCccccccccccCeeccccccCcccC
Q 002897          429 GQIPKYLENLSFLEYLNLSYNHFEGEV  455 (869)
Q Consensus       429 ~~~p~~~~~l~~L~~l~l~~N~l~~~~  455 (869)
                      +..|  +..+++|+.|++++|++++.+
T Consensus       367 ~~~~--~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          367 DLTP--LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             BCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred             ccch--hhcCCCCCEEeccCCcccCCc
Confidence            8877  889999999999999999854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.7e-40  Score=346.42  Aligned_cols=263  Identities=25%  Similarity=0.435  Sum_probs=214.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+++++.++||||+++++++..     ....
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence            4578999999999999999999999889999999996533 345788999999999999999999999754     3678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence            999999999999999987543    2489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +........       .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......  .........
T Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~  228 (288)
T 3kfa_A          158 SRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKD  228 (288)
T ss_dssp             GGTSCSSSS-------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTT
T ss_pred             ceeccCCcc-------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcc
Confidence            987654321       12233456889999999998899999999999999999999 99998753221  111111110


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ..                          ...+..++..+.+++.+||+.||++|||++|+++.|+.+.+...
T Consensus       229 ~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          229 YR--------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CC--------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            00                          00111334568899999999999999999999999999877643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.4e-40  Score=345.20  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++.+.     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence            3568999999999999999999999999999999986432   22346789999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence            77899999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+......          ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......     ....
T Consensus       153 fg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~  217 (279)
T 3fdn_A          153 FGWSVHAPSS----------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYK  217 (279)
T ss_dssp             CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH
T ss_pred             ccccccCCcc----------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHH
Confidence            9998654332          123356899999999999999999999999999999999999999743211     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......                        ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       218 ~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          218 RISRVEF------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHTCC------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHhCCC------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1100000                        0001233467899999999999999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-40  Score=356.92  Aligned_cols=280  Identities=26%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             CC-CCCCeeeeecceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          555 EF-SSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       555 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +| ++.++||+|+||+||+|.+    ..+++.||||+++... ....+.+.+|++++++++||||+++++++.+.   +.
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  107 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GA  107 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TT
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CC
Confidence            44 8899999999999988764    3578999999997543 34457789999999999999999999998753   24


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||+++|+|.+++....       +++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D  177 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD  177 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             ceEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence            67899999999999999997653       89999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+.........     ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............+..
T Consensus       178 fg~a~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  252 (318)
T 3lxp_A          178 FGLAKAVPEGHEY-----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ  252 (318)
T ss_dssp             GGGCEECCTTCSE-----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred             ccccccccccccc-----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence            9999877554211     11233455788999999999888999999999999999999999998643211000000000


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhccc
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  865 (869)
                      ..     ..  ...+.....      .......+..++..+.+++.+||+.||++|||+.|+++.|+++.+.+....
T Consensus       253 ~~-----~~--~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          253 GQ-----MT--VLRLTELLE------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HH-----HH--HHHHHHHHH------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             cc-----hh--HHHHHHHHh------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            00     00  000000000      000111122345678999999999999999999999999999998876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-39  Score=347.67  Aligned_cols=263  Identities=20%  Similarity=0.259  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...     
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence            3578999999999999999999999899999999996442   23347789999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence            68899999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+........       .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......  .......
T Consensus       178 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~  248 (309)
T 2h34_A          178 FGIASATTDEKL-------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN  248 (309)
T ss_dssp             CCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH
T ss_pred             CccCcccccccc-------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc
Confidence            999976544321       1223456899999999999999999999999999999999999999753211  1111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-QMRDVVVKLCAAREAF  861 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  861 (869)
                      ...+       .+                 ......++..+.+++.+||+.||++|| |++++++.|+++.+..
T Consensus       249 ~~~~-------~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          249 QAIP-------RP-----------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             SCCC-------CG-----------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCC-------Cc-----------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0000       00                 000112345688999999999999999 9999999999876554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=356.66  Aligned_cols=244  Identities=21%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCCCCccceEEEEeecc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...        ......+.+|++++++++||||+++++++.. 
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            4568999999999999999999999999999999997542        1133467789999999999999999999764 


Q ss_pred             ccCCCceEEEEeecccCC-CHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          624 DFNGVDFKAIVYDFMQNG-SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                          ....++||||+.+| +|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       101 ----~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A          101 ----QGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             ----SSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred             ----CCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence                37889999999777 9999998764      389999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      .+||+|||.+.......         ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......  
T Consensus       168 ~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--  236 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--  236 (335)
T ss_dssp             CEEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--
T ss_pred             cEEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--
Confidence            99999999998765432         2233568999999999988876 88999999999999999999999642110  


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                           ....        ..                    .+..++..+.+++.+||+.||++|||++|+++.
T Consensus       237 -----~~~~--------~~--------------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAA--------IH--------------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTC--------CC--------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----Hhhc--------cC--------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000        00                    000123467899999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-40  Score=352.82  Aligned_cols=249  Identities=20%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||.||+|++.   .+|+.||+|+++...    ......+.+|+.+++.++||||+++++++...  
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence            468999999999999999999985   589999999996432    23345678999999999999999999997653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                         +..++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus        94 ---~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           94 ---GKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             ---SCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence               78999999999999999998654      389999999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||+++......        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     .
T Consensus       162 l~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~  228 (327)
T 3a62_A          162 LTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----K  228 (327)
T ss_dssp             ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----H
T ss_pred             EEeCCcccccccCC--------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----H
Confidence            99999997543221        1223456999999999999989999999999999999999999999753221     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .......... .                       .+...+..+.+++.+||+.||++||     +++|+++
T Consensus       229 ~~~~i~~~~~-~-----------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          229 TIDKILKCKL-N-----------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHTCC-C-----------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHhCCC-C-----------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1111110000 0                       0012345678999999999999999     7778765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-40  Score=361.44  Aligned_cols=288  Identities=21%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNG  627 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  627 (869)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++...  ......++.+|+.+++.+. ||||+++++++...   +
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence            3457899999999999999999999999999999998532  3344567889999999997 99999999998643   3


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||++ |+|.+++....       +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRANI-------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHTC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCEEEEEecccC-cCHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            357899999997 59999998643       89999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCc-------------cccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCC
Q 002897          708 DFGLAKFLPARPLDTV-------------VETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                      |||+|+..........             ...........||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            9999987643211000             001122344679999999999876 57899999999999999999999999


Q ss_pred             CcCccCCchHHHhhhhhc-cc-c-cccccCc---cchhhhhhcccccCCCccchH-------------HHHHHHHHHHHh
Q 002897          774 DSMFHEGLTLHEFSKMVL-PE-K-VMEIVDP---SLLLEVRANNSMSRGGERVKI-------------EECLVAVIRIGV  834 (869)
Q Consensus       774 ~~~~~~~~~~~~~~~~~~-~~-~-~~~~~d~---~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~  834 (869)
                      ...... ..........- +. . +.....+   .....................             ..+++.+.+++.
T Consensus       232 ~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          232 PGSSTM-NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCSSHH-HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCHH-HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            753221 11111111110 00 0 0000000   000000000000000000000             023457889999


Q ss_pred             hccCCCCCCCCCHHHHHHH
Q 002897          835 VCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       835 ~cl~~dP~~RPs~~evl~~  853 (869)
                      +||+.||++|||++|+++.
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-40  Score=348.57  Aligned_cols=265  Identities=26%  Similarity=0.350  Sum_probs=209.5

Q ss_pred             HhcCCCCCC-eeeeecceEEEEEEE--CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          552 ATSEFSSSN-MVGQGSFGTVFKGII--GENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       552 ~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      ..++|.+.+ .||+|+||+||+|.+  ..+++.||||+++...  ....+.+.+|+++++.++||||+++++++..    
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence            346788887 999999999999954  5568999999996543  3345788999999999999999999999732    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                        +..++||||+++++|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||
T Consensus        90 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl  158 (291)
T 1xbb_A           90 --ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI  158 (291)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             --CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence              56889999999999999998754      389999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~  785 (869)
                      +|||.+..........     .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......     .
T Consensus       159 ~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~  228 (291)
T 1xbb_A          159 SDFGLSKALRADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E  228 (291)
T ss_dssp             CCCTTCEECCTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H
T ss_pred             ccCCcceeeccCCCcc-----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----H
Confidence            9999998765443111     11223346789999999988889999999999999999999 99999753221     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ..........                       ...+..++..+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus       229 ~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          229 VTAMLEKGER-----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             HHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC-----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence            1111110000                       0001134456889999999999999999999999999998776544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.6e-39  Score=359.08  Aligned_cols=354  Identities=19%  Similarity=0.217  Sum_probs=265.6

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+++|++|+|++|.+++. | .|..+++|++|+|++|+|++. |  ++.+++|++|+|++|++++. |  +.++++|++|
T Consensus        40 ~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L  111 (457)
T 3bz5_A           40 QLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL  111 (457)
T ss_dssp             HHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred             HcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence            678888888888888853 4 678888888888888888853 3  77888888888888888754 3  7788888888


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL  179 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l  179 (869)
                      +|++|++. .+|   +..+++|++|++++|++++.   .++++++|++|++++|+..+..  .+..+++|++|++++|++
T Consensus       112 ~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l  182 (457)
T 3bz5_A          112 NCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI  182 (457)
T ss_dssp             ECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred             ECCCCcCC-eec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence            88888887 455   67778888888888888764   3777788888888888543333  467777888888888877


Q ss_pred             CCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcce
Q 002897          180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI  259 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  259 (869)
                      +.++         +..+++|++|++++|++++.   .+..+++ |+.|++++|.+++ +|  +..+++|+.|++++|++.
T Consensus       183 ~~l~---------l~~l~~L~~L~l~~N~l~~~---~l~~l~~-L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~  246 (457)
T 3bz5_A          183 TELD---------VSQNKLLNRLNCDTNNITKL---DLNQNIQ-LTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT  246 (457)
T ss_dssp             CCCC---------CTTCTTCCEEECCSSCCSCC---CCTTCTT-CSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCS
T ss_pred             ceec---------cccCCCCCEEECcCCcCCee---ccccCCC-CCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCC
Confidence            7653         45677788888888877754   2555554 7777777777775 44  677777777777777777


Q ss_pred             ecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccc
Q 002897          260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQIL  339 (869)
Q Consensus       260 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (869)
                      +..   ++.+++|+.|++++|              +|+.|++++|++.+.+|  ++.+++|+.|++++|++.+.+|... 
T Consensus       247 ~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~-  306 (457)
T 3bz5_A          247 ELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA-  306 (457)
T ss_dssp             CCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT-
T ss_pred             CcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC-
Confidence            543   445667777777665              45678888888776666  5788999999999998776555321 


Q ss_pred             ccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccE
Q 002897          340 SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKV  419 (869)
Q Consensus       340 ~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  419 (869)
                         ..++.|+             ++++++|++|++++|++++ ++  ++.+++|+.|++++|+|++        ++.|..
T Consensus       307 ---~~L~~L~-------------l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~  359 (457)
T 3bz5_A          307 ---AGITELD-------------LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGK  359 (457)
T ss_dssp             ---CCCSCCC-------------CTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGG
T ss_pred             ---CcceEec-------------hhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------cccccc
Confidence               2222233             4555789999999999997 43  8999999999999999985        356777


Q ss_pred             EEccCCcccCCCccccccccccCeeccccccCcccCCCC
Q 002897          420 LDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       420 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~  458 (869)
                      |++++|.++|.     .++..|..+++++|+++|.+|..
T Consensus       360 L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          360 IPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             SSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             ccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            88999999976     35677899999999999998864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-40  Score=355.62  Aligned_cols=281  Identities=22%  Similarity=0.283  Sum_probs=199.4

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-----hhhHHHHHHHHHHHhCCCCccceEEEEeeccc
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-----GALKSFLTECEALRSIRHRNLIKIITICSSID  624 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  624 (869)
                      ....++|++.+.||+|+||.||+|++..+|+.||||++.....     ...+.+.+|+++++.++||||+++++++..  
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   83 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--   83 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence            3445789999999999999999999998999999999964322     123467899999999999999999999754  


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                         ....++||||+++ +|.+++.....     .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        84 ---~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           84 ---KSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             ---TTCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             ---CCceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence               3678999999976 89999877543     388899999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      ||+|||+++......        .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... ..
T Consensus       152 kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~  222 (346)
T 1ua2_A          152 KLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QL  222 (346)
T ss_dssp             EECCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred             EEEecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HH
Confidence            999999998764332        223345689999999998764 48999999999999999999999987532211 11


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..............+.+..-..+..................++..+.+++.+||+.||++|||++|+++.
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1111111000000000000000000000000000000112344678999999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.7e-40  Score=354.53  Aligned_cols=278  Identities=21%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ....++|++.++||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++...    
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  105 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----  105 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET----
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC----
Confidence            345678999999999999999999999999999999996443  22345678999999999999999999997654    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-----CCC
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-----HDM  702 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~  702 (869)
                       ...++||||+++ +|.+++.....      +++..++.++.||+.||+|||+.   +|+||||||+||+++     .++
T Consensus       106 -~~~~lv~e~~~~-~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          106 -HRLHLIFEYAEN-DLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             -TEEEEEEECCSE-EHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CC
T ss_pred             -CEEEEEEecCCC-CHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccc
Confidence             789999999975 99999987653      89999999999999999999999   999999999999994     555


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      .+||+|||.|+......        .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... 
T Consensus       175 ~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-  245 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-  245 (329)
T ss_dssp             EEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             eEEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-
Confidence            69999999998764332        222345689999999998875 48999999999999999999999997533221 


Q ss_pred             hHHHhhhhh-cccccccccCccchhhhhhcc-c-ccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMV-LPEKVMEIVDPSLLLEVRANN-S-MSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......... .+.. ...........+.... . ................+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          246 QLFKIFEVLGLPDD-TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHHHCCCCT-TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCch-hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            111111111 0000 0000000000000000 0 0000000011123467889999999999999999999976

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-40  Score=371.51  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.++||+|+||.||+|.+..+|+.||||+++..   .......+.+|+.+++.++||||+++++++...     +
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence            46799999999999999999999999999999999743   333456778999999999999999999997654     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ..++||||+++|+|.+++....      .+++..+..++.||+.||+|||+ .   ||+||||||+|||++.++.+||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            7899999999999999997654      38999999999999999999998 7   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+|+......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....
T Consensus       293 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~  359 (446)
T 4ejn_A          293 FGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFE  359 (446)
T ss_dssp             CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             CCCceeccCCC--------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHH
Confidence            99997543321        223446799999999999999999999999999999999999999965321     11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      ........                        .+...+..+.+++.+||+.||++||     |++|+++
T Consensus       360 ~i~~~~~~------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          360 LILMEEIR------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHCCCC------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhCCCC------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11110000                        0012335678999999999999999     9999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.2e-40  Score=357.35  Aligned_cols=251  Identities=27%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHH-HHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEA-LRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++...   ......+..|..+ ++.++||||+++++++.+     .
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence            467999999999999999999999999999999997543   2234556677776 567899999999999765     3


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.+|++||+|
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence            78999999999999999998754      389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+++......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....
T Consensus       183 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~  249 (373)
T 2r5t_A          183 FGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYD  249 (373)
T ss_dssp             CCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHH
T ss_pred             CccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHH
Confidence            99998543221        233456799999999999999999999999999999999999999975321     11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ........  +.                      ...+..+.+++.+||+.||++||++.+.++.+
T Consensus       250 ~i~~~~~~--~~----------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          250 NILNKPLQ--LK----------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             HHHHSCCC--CC----------------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             HHHhcccC--CC----------------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            11111000  00                      01234577999999999999999986544433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-39  Score=352.37  Aligned_cols=268  Identities=23%  Similarity=0.371  Sum_probs=211.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-------CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-------ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++++ +||||+++++++.. 
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence            478999999999999999999975       367889999997543 34457789999999999 89999999999754 


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                          .+..++||||+++|+|.+++.......          ....+++.+++.++.||++||+|||+.   +|+||||||
T Consensus       113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence                367899999999999999998764310          112489999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||.++........      .......+++.|+|||++.+..++.++|||||||++|+|++ |+.|
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSE------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccc------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999876543210      12233457889999999988889999999999999999999 9999


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |.....     .+...........                       ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          260 YPGIPV-----EELFKLLKEGHRM-----------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             STTCCH-----HHHHHHHHHTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCcCCH-----HHHHHHHhcCCCC-----------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            865321     1111111100000                       001123456889999999999999999999999


Q ss_pred             HHHHHHHhhh
Q 002897          853 KLCAAREAFV  862 (869)
Q Consensus       853 ~L~~~~~~~~  862 (869)
                      .|+++.....
T Consensus       312 ~L~~l~~~~~  321 (334)
T 2pvf_A          312 DLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHHC
T ss_pred             HHHHHHhccc
Confidence            9999977644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-40  Score=374.57  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=211.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+|++.++||+|+||.||+|++..++..||||+++... ...+.+.+|+.++++++||||+++++++...     ...+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence            457888999999999999999998889999999997543 2357899999999999999999999997653     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       293 lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence            99999999999999987542    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......       .......++..|+|||++.+..++.++|||||||++|||++ |..||......  ..........
T Consensus       366 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~  436 (495)
T 1opk_A          366 RLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY  436 (495)
T ss_dssp             ECCTTCCE-------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC
T ss_pred             eeccCCce-------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence            87644321       11223456789999999988889999999999999999999 99998753221  1111111000


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                                                ....+..++..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus       437 --------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 --------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                                      001112345678899999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=355.78  Aligned_cols=275  Identities=19%  Similarity=0.268  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG-ALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+++++.++||||+++++++...     ...+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence            5789999999999999999999989999999999643322 122456799999999999999999997643     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||++ |+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence            9999997 599999987654     389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +......        .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ......+...
T Consensus       148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~  218 (324)
T 3mtl_A          148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILG  218 (324)
T ss_dssp             ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            8654322        22234568999999999876 568999999999999999999999997643221 1111111110


Q ss_pred             ---ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 ---PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                         +..+....+.......... ...........+..+..+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          219 TPTEETWPGILSNEEFKTYNYP-KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCTTTSTTGGGCHHHHHTCCC-CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChHhchhhhcchhhcccccc-cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               1111111111000000000 00000001111234567889999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-39  Score=341.65  Aligned_cols=260  Identities=21%  Similarity=0.270  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK------GALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++....      ...+.+.+|+.++++++||||+++++++...    
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK----   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence            578999999999999999999998999999999864321      1357889999999999999999999997653    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----c
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----V  703 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~  703 (869)
                       ...++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           81 -TDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred             -CeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence             67899999999999999997644      389999999999999999999999   999999999999998877    8


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      +||+|||.+.......         ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......    
T Consensus       151 ~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----  217 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----  217 (283)
T ss_dssp             EEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----
T ss_pred             eEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----
Confidence            9999999998764432         123346899999999999989999999999999999999999999753211    


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHHHhh
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV--KLCAAREAF  861 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~  861 (869)
                       ..........  ...+                  .......+..+.+++.+||+.||++|||+.|+++  .++.++...
T Consensus       218 -~~~~~~~~~~--~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          218 -ETLTNISAVN--YDFD------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             -HHHHHHHTTC--CCCC------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             -HHHHHhHhcc--cCCc------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence             1111110000  0000                  0111133456889999999999999999999998  456655443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-39  Score=343.08  Aligned_cols=254  Identities=23%  Similarity=0.314  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|.+.++||+|+||+||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeE
Confidence            357999999999999999999999999999999997543 33457889999999999999999999997643     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D  708 (869)
                      ++||||+++|+|.+++......  ...+++..++.++.|+++||+|||+.   +|+||||||+||++   +.++.+||+|
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            9999999999999998654211  12489999999999999999999999   99999999999999   4567899999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||.+.......         ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......     ....
T Consensus       171 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~  235 (285)
T 3is5_A          171 FGLAELFKSDE---------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQ  235 (285)
T ss_dssp             CCCCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             eecceecCCcc---------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHh
Confidence            99997654322         223456899999999886 46899999999999999999999999753221     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..........                     ......++.+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          236 KATYKEPNYA---------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHCCCCCC---------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             hhccCCcccc---------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100000000                     000012346779999999999999999999985

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=366.33  Aligned_cols=318  Identities=18%  Similarity=0.172  Sum_probs=200.3

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++++++ +||..++   .+++.|+|++|+|+++.+..|.++++|++|+|++|.|++..|.+|+++++|++|+|++|+
T Consensus        16 v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           16 VLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            356667777 6776654   467777777777776666777777777777777777776667777777777777777777


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      ++++.+..|.++++|++|+|++|++. .++...|.++++|++|++++|.++...+..|.++++|++|+|++|+++++.+.
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             CCccCcccccCCCCCCEEECCCCccc-cCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            77655556677777777777777776 44445566666666666666666666666666666666666666666666555


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCcc
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG  241 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  241 (869)
                      .|..+++|+.|++++|.+..++..      .|..+++|++|++++|.+.+.+|.......+ |+.|++++|.++...+..
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~~~~~------~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~  243 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINAIRDY------SFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLTAVPYLA  243 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCEECTT------CSCSCTTCCEEEEECCTTCCEECTTTTTTCC-CSEEEEESSCCCSCCHHH
T ss_pred             HhcccCCCcEEeCCCCcCcEeChh------hcccCcccceeeCCCCccccccCcccccCcc-ccEEECcCCcccccCHHH
Confidence            566666666666666666655443      4556666666666666555555444444332 666666666665333344


Q ss_pred             ccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccc
Q 002897          242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLI  321 (869)
Q Consensus       242 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  321 (869)
                      |..+++|+.|+|++|.+.+..+..|..+++|++|+|++|++++..|..|.++++|+.|++++|++++..+..|..+++|+
T Consensus       244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  323 (477)
T 2id5_A          244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE  323 (477)
T ss_dssp             HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCC
T ss_pred             hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccC
Confidence            55555666666666655555555555555566666666655555555555555555555555555544444555555555


Q ss_pred             eeeccCcccC
Q 002897          322 MLTLSKNKLD  331 (869)
Q Consensus       322 ~L~l~~N~l~  331 (869)
                      .|++++|++.
T Consensus       324 ~L~l~~N~l~  333 (477)
T 2id5_A          324 TLILDSNPLA  333 (477)
T ss_dssp             EEECCSSCEE
T ss_pred             EEEccCCCcc
Confidence            5555555554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-39  Score=352.96  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..|+..+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|++++++++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            45888999999999999999998899999999996432   33446789999999999999999999997654     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||++ |++.+++.....     ++++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            899999997 688888865433     489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      ++......            ....||+.|+|||++.   ++.++.++|||||||++|||++|+.||......    ....
T Consensus       200 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~  263 (348)
T 1u5q_A          200 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY  263 (348)
T ss_dssp             TCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH
T ss_pred             CceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHH
Confidence            99765321            2346899999999874   567899999999999999999999998643211    1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ... ...     .+..                 ....++..+.+++.+||+.||++|||++|+++.
T Consensus       264 ~~~-~~~-----~~~~-----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          264 HIA-QNE-----SPAL-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHH-HSC-----CCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHH-hcC-----CCCC-----------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            100 000     0000                 001234567899999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-40  Score=356.49  Aligned_cols=275  Identities=22%  Similarity=0.320  Sum_probs=215.0

Q ss_pred             HHHHhcCCCCCCeeeeecceEEEEEEECCCCe-----EEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEee
Q 002897          549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGM-----LVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICS  621 (869)
Q Consensus       549 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  621 (869)
                      .....++|++.+.||+|+||.||+|.+..+++     .||+|++.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            33445789999999999999999999976554     79999996543 33457789999999999 8999999999975


Q ss_pred             ccccCCCceEEEEeecccCCCHHHHHhhCCCcc--------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL--------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       622 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                      ..     +..++||||+++|+|.+++.......        ....+++..++.++.|++.||+|||+.   +|+||||||
T Consensus       121 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  192 (333)
T 2i1m_A          121 HG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA  192 (333)
T ss_dssp             SS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             cC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence            43     67899999999999999997642110        012479999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +||+++.++.+||+|||++.........      .......||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  266 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNY------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP  266 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTS------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ceEEECCCCeEEECccccccccccccce------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999865433211      12233457889999999988899999999999999999999 9999


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |....... ............                          ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~-~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          267 YPGILVNS-KFYKLVKDGYQM--------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             STTCCSSH-HHHHHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccchhH-HHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            87543221 111111111000                          000112456789999999999999999999999


Q ss_pred             HHHHHHHhhhcc
Q 002897          853 KLCAAREAFVSM  864 (869)
Q Consensus       853 ~L~~~~~~~~~~  864 (869)
                      .|+++.+.....
T Consensus       320 ~L~~~~~~~~~~  331 (333)
T 2i1m_A          320 FLQEQAQEDRRE  331 (333)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHhhhcc
Confidence            999988776544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-39  Score=369.00  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.++||+|+||.||+|++..+|+.||+|++....   ......+.+|+++++.++||||+++++++.+     .+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence            467999999999999999999999999999999996432   2344678899999999999999999998754     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            89999999999999999986542    2489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+......         ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus       331 Gla~~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~  400 (576)
T 2acx_A          331 GLAVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERL  400 (576)
T ss_dssp             TTCEECCTTC---------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHH
T ss_pred             ccceecccCc---------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHH
Confidence            9998765432         1233579999999999999899999999999999999999999997643221 11111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .....      ..                  .+...+..+.+++.+||+.||++||     +++||++
T Consensus       401 i~~~~------~~------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          401 VKEVP------EE------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHCC------CC------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hhccc------cc------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            11000      00                  0012345678999999999999999     7888875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=367.14  Aligned_cols=347  Identities=20%  Similarity=0.219  Sum_probs=238.5

Q ss_pred             EEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCc
Q 002897           98 FIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN  177 (869)
Q Consensus        98 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n  177 (869)
                      .++.+++.+. .+|.+.   .++++.|+|++|+|++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            3444444444 444321   134455555555555555566666677777777777766666666777777777777777


Q ss_pred             cCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCc
Q 002897          178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQ  257 (869)
Q Consensus       178 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  257 (869)
                      .++.++..      .|.++++|++|+|++|++++..+..+..+.+ |+.|++++|.+++..+..|..+++|+.|++++|+
T Consensus        91 ~l~~~~~~------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  163 (477)
T 2id5_A           91 RLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN  163 (477)
T ss_dssp             CCCSCCTT------SSTTCTTCCEEECTTSCCCEECTTTTTTCTT-CCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred             cCCccCcc------cccCCCCCCEEECCCCccccCChhHcccccc-CCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence            76666543      4566677777777777776666666666654 6666666666666666667777777777777777


Q ss_pred             ceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcc
Q 002897          258 LIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQ  337 (869)
Q Consensus       258 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  337 (869)
                      +.+..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.++..+....+|+.|++++|+++      
T Consensus       164 l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~------  237 (477)
T 2id5_A          164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT------  237 (477)
T ss_dssp             CSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC------
T ss_pred             CcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc------
Confidence            76655556777777777777777777666666777777777777776665555555555556666666666655      


Q ss_pred             ccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccc
Q 002897          338 ILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSI  417 (869)
Q Consensus       338 ~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  417 (869)
                                         +..+..+.++++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|
T Consensus       238 -------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (477)
T 2id5_A          238 -------------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL  298 (477)
T ss_dssp             -------------------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred             -------------------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence                               2333567777888888888888887777778888888888888888887778888888888


Q ss_pred             cEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCCCC
Q 002897          418 KVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLD  480 (869)
Q Consensus       418 ~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  480 (869)
                      +.|+|++|+|++..+..|..+++|+.|++++|++.+.++..+.+.......+.++...|+.+.
T Consensus       299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            888888888887777777888888888888888887766544444445566777777776544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=348.59  Aligned_cols=278  Identities=19%  Similarity=0.207  Sum_probs=212.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence            46899999999999999999999889999999999776666678899999999999999999999998642 12346789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++......  ...+++.+++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            999999999999999863211  12489999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCcc-ccCCCCCCccCcccccCCcccCCCC---CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          713 KFLPARPLDTVV-ETPSSSSGIKGTVGYIAPEYGTGSE---ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       713 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ............ ..........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...............
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            765321100000 0000012235799999999987654   689999999999999999999999643222211111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ....                          .+....++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       262 ~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          262 NQLS--------------------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             CC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             ccCC--------------------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            1000                          00001234568899999999999999999999999998865543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-40  Score=370.75  Aligned_cols=260  Identities=23%  Similarity=0.424  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++..      ...
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~  257 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI  257 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Ccc
Confidence            3467889999999999999999996 68889999997543 345789999999999999999999998752      567


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.++++....    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999975431    2388999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+.......       .......++..|+|||++.+..++.++|||||||++|||+| |+.||......     +.....
T Consensus       331 a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i  398 (454)
T 1qcf_A          331 ARVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRAL  398 (454)
T ss_dssp             GGGBCCHHH-------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHH
T ss_pred             ceEcCCCce-------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence            987643210       11223446789999999988899999999999999999999 99999753211     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...                       ...+.+..++..+.+++.+||+.||++|||+++|++.|+.+..+.
T Consensus       399 ~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          399 ERG-----------------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHT-----------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HcC-----------------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            000                       000111234567889999999999999999999999999876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=356.27  Aligned_cols=277  Identities=14%  Similarity=0.151  Sum_probs=211.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC--------CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccce---------
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE--------NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK---------  615 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  615 (869)
                      .++|++.+.||+|+||.||+|++..        .++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999986        4889999998643     45789999999999999988         


Q ss_pred             ------EEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 002897          616 ------IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHG  689 (869)
Q Consensus       616 ------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  689 (869)
                            +++++..    .....++||||+ +++|.+++.....    ..+++.+++.++.||+.||+|||++   +|+||
T Consensus       116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~  183 (352)
T 2jii_A          116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHEN---EYVHG  183 (352)
T ss_dssp             TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred             ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence                  4555443    247889999999 9999999987521    2499999999999999999999999   99999


Q ss_pred             CCCCCceeecCCC--cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          690 DLKPSNVLLDHDM--VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       690 Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      ||||+||+++.++  .+||+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            9999999999998  9999999999876543211110 112234457999999999999999999999999999999999


Q ss_pred             cCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          768 SRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       768 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                      +|+.||.................. .......+...                 ....++..+.+++.+||+.||++|||+
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~  324 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFV-DKPGPFVGPCG-----------------HWIRPSETLQKYLKVVMALTYEEKPPY  324 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHH-HSCCCEECTTS-----------------CEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhcc-CChhhhhhhcc-----------------ccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence            999999764322222222211111 00111111000                 000224568899999999999999999


Q ss_pred             HHHHHHHHHHHHhhhccc
Q 002897          848 RDVVVKLCAAREAFVSMQ  865 (869)
Q Consensus       848 ~evl~~L~~~~~~~~~~~  865 (869)
                      +|+++.|+++.+......
T Consensus       325 ~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          325 AMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             HHHHHHHHHHHHHTTCCT
T ss_pred             HHHHHHHHHHHHhcCCCc
Confidence            999999999988876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-39  Score=343.19  Aligned_cols=260  Identities=21%  Similarity=0.362  Sum_probs=208.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc------
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF------  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  625 (869)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|+++...    +.+.+|++++++++||||+++++++...++      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999998899999999996543    346789999999999999999998754221      


Q ss_pred             -----CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 002897          626 -----NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH  700 (869)
Q Consensus       626 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  700 (869)
                           ......++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                 123568999999999999999976532    2489999999999999999999999   9999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      ++.+||+|||.+.......         ......|++.|+|||++.+..++.++||||||+++|+|++|..|+...    
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----  224 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----  224 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----
T ss_pred             CCCEEECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----
Confidence            9999999999998765432         123346899999999999889999999999999999999999986421    


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                         .............                          ..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       225 ---~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          225 ---SKFFTDLRDGIIS--------------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             ---HHHHHHHHTTCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             ---HHHHHHhhccccc--------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence               1111111000000                          01234577999999999999999999999999998776


Q ss_pred             hhcc
Q 002897          861 FVSM  864 (869)
Q Consensus       861 ~~~~  864 (869)
                      ....
T Consensus       276 ~~~~  279 (284)
T 2a19_B          276 PEKN  279 (284)
T ss_dssp             ----
T ss_pred             CCcc
Confidence            5443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.7e-40  Score=353.21  Aligned_cols=277  Identities=22%  Similarity=0.323  Sum_probs=217.1

Q ss_pred             HHHHHHHhcCCCCCCeeeeecceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEE
Q 002897          546 YAKLSKATSEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIIT  618 (869)
Q Consensus       546 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~  618 (869)
                      ..+.....++|++.+.||+|+||+||+|++     ..+++.||||+++... ....+.+.+|+.+++++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            344445568999999999999999999985     3577999999997543 33456789999999999 7999999999


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCccc----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----------VCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVH  688 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  688 (869)
                      ++...    ....++||||+++|+|.+++........          ...+++..++.++.|+++||+|||+.   +|+|
T Consensus        99 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H  171 (316)
T 2xir_A           99 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  171 (316)
T ss_dssp             EECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            97643    3568999999999999999987653210          11278999999999999999999999   9999


Q ss_pred             cCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc
Q 002897          689 GDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS  768 (869)
Q Consensus       689 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t  768 (869)
                      |||||+||+++.++.+||+|||.++........      .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccc------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence            999999999999999999999999866543211      12234557889999999988899999999999999999998


Q ss_pred             -CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          769 -RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       769 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                       |+.||................. ...                          .+..++..+.+++.+||+.||++|||+
T Consensus       246 ~g~~p~~~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~  298 (316)
T 2xir_A          246 LGASPYPGVKIDEEFCRRLKEGT-RMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTF  298 (316)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTC-CCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcccchhHHHHHHhccCc-cCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence             9999975432211111111100 000                          001233567899999999999999999


Q ss_pred             HHHHHHHHHHHHhhh
Q 002897          848 RDVVVKLCAAREAFV  862 (869)
Q Consensus       848 ~evl~~L~~~~~~~~  862 (869)
                      .|+++.|+.+.++..
T Consensus       299 ~ell~~L~~~~~~~~  313 (316)
T 2xir_A          299 SELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhhhc
Confidence            999999999987653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=8.2e-39  Score=358.79  Aligned_cols=350  Identities=18%  Similarity=0.206  Sum_probs=297.6

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +||+++|+++ .+| .+ ..+++|++|+|++|+|+++ |  ++.+++|++|+|++|+|++. |  |+++++|++|+|++|
T Consensus        46 ~L~Ls~n~l~-~~~-~l-~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N  116 (457)
T 3bz5_A           46 SLDCHNSSIT-DMT-GI-EKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTN  116 (457)
T ss_dssp             EEECCSSCCC-CCT-TG-GGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSS
T ss_pred             EEEccCCCcc-cCh-hh-cccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCC
Confidence            3799999999 688 44 5899999999999999964 4  99999999999999999964 4  999999999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      ++++. |  +.++++|++|++++|+++ .++   +..+++|++|++++|...+.+  .+..+++|++|++++|+++++. 
T Consensus       117 ~l~~l-~--~~~l~~L~~L~l~~N~l~-~l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~-  186 (457)
T 3bz5_A          117 KLTKL-D--VSQNPLLTYLNCARNTLT-EID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD-  186 (457)
T ss_dssp             CCSCC-C--CTTCTTCCEEECTTSCCS-CCC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC-
T ss_pred             cCCee-c--CCCCCcCCEEECCCCccc-eec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec-
Confidence            99964 4  899999999999999998 465   789999999999999655444  5889999999999999998853 


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                        +..+++|+.|++++|.++.++         +..+++|++|++++|++++ +|  +..+++ |+.|++++|.+++..  
T Consensus       187 --l~~l~~L~~L~l~~N~l~~~~---------l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~-L~~L~l~~N~l~~~~--  249 (457)
T 3bz5_A          187 --VSQNKLLNRLNCDTNNITKLD---------LNQNIQLTFLDCSSNKLTE-ID--VTPLTQ-LTYFDCSVNPLTELD--  249 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSCCC---------CTTCTTCSEEECCSSCCSC-CC--CTTCTT-CSEEECCSSCCSCCC--
T ss_pred             --cccCCCCCEEECcCCcCCeec---------cccCCCCCEEECcCCcccc-cC--ccccCC-CCEEEeeCCcCCCcC--
Confidence              889999999999999998763         6789999999999999997 45  677765 999999999999753  


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL  320 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  320 (869)
                       +..+++|+.|++++|              +|+.|++++|.+.+.+|  ++.+++|+.|++++|+..+.+|.   ..++|
T Consensus       250 -~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L  309 (457)
T 3bz5_A          250 -VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGI  309 (457)
T ss_dssp             -CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCC
T ss_pred             -HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcc
Confidence             566788888888775              46678889998777766  57889999999999988777764   45677


Q ss_pred             ceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeC
Q 002897          321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD  400 (869)
Q Consensus       321 ~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  400 (869)
                      +.|++++|.              .++.|++++|++++. +  ++++++|+.|++++|++++        ++.|..|++++
T Consensus       310 ~~L~l~~~~--------------~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~  364 (457)
T 3bz5_A          310 TELDLSQNP--------------KLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALN  364 (457)
T ss_dssp             SCCCCTTCT--------------TCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGG
T ss_pred             eEechhhcc--------------cCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccC
Confidence            888887772              356799999999974 3  8999999999999999985        35677788999


Q ss_pred             ccccCCCCccccccccccEEEccCCcccCCCccccc
Q 002897          401 NSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLE  436 (869)
Q Consensus       401 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  436 (869)
                      |.+.|.     +.+..|..+++++|+++|.+|..+.
T Consensus       365 n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          365 NNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             TSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             CcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence            999865     4667888999999999999997654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.8e-40  Score=352.55  Aligned_cols=254  Identities=23%  Similarity=0.294  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||+++....    ...+|++++.++ +||||+++++++.+     ...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-----GKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCE
Confidence            35679999999999999999999999999999999965432    235688888888 79999999999754     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CcEEE
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD----MVAHV  706 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl  706 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   ||+||||||+||++..+    +.+||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999999998754      389999999999999999999999   99999999999998543    35999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+++......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+.
T Consensus       162 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~  231 (342)
T 2qr7_A          162 CDFGFAKQLRAEN--------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEI  231 (342)
T ss_dssp             CCCTTCEECBCTT--------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHH
T ss_pred             EECCCcccCcCCC--------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHH
Confidence            9999998764432        1223456899999999998878899999999999999999999999753221  22222


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .......... . .                  .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~i~~~~~~-~-~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          232 LARIGSGKFS-L-S------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHHHHCCCC-C-C------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHccCCcc-c-C------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2211111100 0 0                  00011234567899999999999999999999873

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.5e-39  Score=345.23  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|+.++++++||||+++++++...     ...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEE
Confidence            46799999999999999999999989999999999765544556789999999999999999999997643     7789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDF  709 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  709 (869)
                      +||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence            9999999999999987654      389999999999999999999999   99999999999999   78889999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+......          ......|++.|+|||++.+..++.++||||+||++|+|++|+.||......     .....
T Consensus       154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~  218 (304)
T 2jam_A          154 GLSKMEQNG----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFEK  218 (304)
T ss_dssp             STTCCCCCB----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH
T ss_pred             CcceecCCC----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH
Confidence            998754321          122345899999999999999999999999999999999999999753211     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...... .. .                  .......+..+.+++.+||+.||++|||++|+++
T Consensus       219 i~~~~~-~~-~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          219 IKEGYY-EF-E------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHCCC-CC-C------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCC-CC-C------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            100000 00 0                  0011123456889999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.3e-39  Score=360.67  Aligned_cols=273  Identities=21%  Similarity=0.247  Sum_probs=210.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|++..+++.||||++.....  ...+.+|+++++.++|++.+..+.++..    .....+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            4689999999999999999999988999999998864433  2457899999999987554444444332    236789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEEccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHVGDF  709 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  709 (869)
                      +||||+ +++|.+++.....     .+++.+++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+||
T Consensus        80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence            999999 9999999986543     399999999999999999999999   99999999999999   68899999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+++.+.......... ........||..|+|||++.+..++.++|||||||++|||++|+.||........  ......
T Consensus       151 Gla~~~~~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~  227 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIP-YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEK  227 (483)
T ss_dssp             TTCEECBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHH
T ss_pred             CcceeccCCccccccc-cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHH
Confidence            9998776543221110 1223456799999999999999999999999999999999999999976433211  111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      ..........                   ......++.++.+++..||+.||++||++.+|++.|+.+.....
T Consensus       228 i~~~~~~~~~-------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          228 ISEKKVATSI-------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HHHHHHHSCH-------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HhhccccccH-------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            1000000000                   00111345678999999999999999999999999999877553

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=352.49  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=193.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCC--CccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRH--RNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.++++++|  |||+++++++...     
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----
Confidence            457999999999999999999985 7999999998643  33445778999999999976  9999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||| +.+|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++ ++.+||+|
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             CEEEEEEe-CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence            78999999 56889999998764      389999999999999999999999   999999999999997 67899999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----------CCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----------SEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      ||+|+.......      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||....
T Consensus       151 FG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          151 FGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccCcccc------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            999987654321      112234579999999998754           678999999999999999999999997532


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..   .........+..... .                      +...+..+.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~---~~~~~~~~~~~~~~~-~----------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          225 NQ---ISKLHAIIDPNHEIE-F----------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             SH---HHHHHHHHCTTSCCC-C----------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hH---HHHHHHHhcCCcccC-C----------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            21   111111110000000 0                      00112457799999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-39  Score=350.11  Aligned_cols=267  Identities=25%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEE--EEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLV--AVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.+.||+|+||.||+|++..++..+  |+|.++.. .....+.+.+|+++++++ +||||+++++++...     +
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence            67999999999999999999998888865  99988643 233456789999999999 899999999997654     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      ..++||||+++|+|.+++......          .....+++.+++.++.|+++||+|||++   +|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence            789999999999999999875410          0123589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCcc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFH  778 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~  778 (869)
                      .++.+||+|||+++.....         .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CCCeEEEcccCcCcccccc---------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            9999999999999743221         11223456889999999988889999999999999999998 9999965321


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                           ...........     .                  ...+..++..+.+++.+||+.||++|||++|+++.|.++.
T Consensus       248 -----~~~~~~~~~~~-----~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          248 -----AELYEKLPQGY-----R------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             -----HHHHHHGGGTC-----C------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHhhcCC-----C------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 11111111100     0                  0001123456889999999999999999999999999998


Q ss_pred             Hhhhccc
Q 002897          859 EAFVSMQ  865 (869)
Q Consensus       859 ~~~~~~~  865 (869)
                      +......
T Consensus       300 ~~~~~~~  306 (327)
T 1fvr_A          300 EERKTYV  306 (327)
T ss_dssp             HSSSCSB
T ss_pred             HhhcCcc
Confidence            8765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-39  Score=344.40  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...     +
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----C
Confidence            46899999999999999999999999999999998644   234457788999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++....      .+++.+++.++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            7899999999999999987654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+.......        .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......     +....
T Consensus       160 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~  226 (294)
T 2rku_A          160 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLR  226 (294)
T ss_dssp             TTCEECCSTT--------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH
T ss_pred             cCceecccCc--------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            9998764332        1223456899999999999988999999999999999999999999753211     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......                        ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus       227 ~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          227 IKKNEY------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHTTCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhhccC------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            100000                        0001223467899999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.2e-40  Score=354.46  Aligned_cols=273  Identities=21%  Similarity=0.384  Sum_probs=213.4

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEe
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITIC  620 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~  620 (869)
                      ++.....++|++.+.||+|+||.||+|++.     .+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344556788999999999999999999875     357899999996443 23446789999999999999999999997


Q ss_pred             eccccCCCceEEEEeecccCCCHHHHHhhCCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 002897          621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV  696 (869)
Q Consensus       621 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  696 (869)
                      ..     ....++||||+++|+|.+++.......    ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        98 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI  169 (322)
T 1p4o_A           98 SQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  169 (322)
T ss_dssp             CS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             cc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence            54     367899999999999999997643110    012478999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCc
Q 002897          697 LLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDS  775 (869)
Q Consensus       697 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~  775 (869)
                      +++.++.+||+|||.++.......      ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             EEcCCCeEEECcCccccccccccc------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            999999999999999976543211      011223457889999999988889999999999999999999 8999865


Q ss_pred             CccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          776 MFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ...     ..............                       .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       244 ~~~-----~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          244 LSN-----EQVLRFVMEGGLLD-----------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             SCH-----HHHHHHHHTTCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             CCH-----HHHHHHHHcCCcCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            321     11111111111000                       01123456889999999999999999999999998


Q ss_pred             HHHHhh
Q 002897          856 AAREAF  861 (869)
Q Consensus       856 ~~~~~~  861 (869)
                      ++.+..
T Consensus       296 ~~~~~~  301 (322)
T 1p4o_A          296 EEMEPG  301 (322)
T ss_dssp             GGSCTT
T ss_pred             HhhccC
Confidence            875543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.5e-39  Score=348.49  Aligned_cols=282  Identities=23%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeecccc---CC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDF---NG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  627 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||++....  ......+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999899999999985433  2334678899999999999999999999876421   11


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||+++ ++.+.+.....     .+++.+++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            3578999999975 88888776543     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |||.|+.+......    .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus       167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i  241 (351)
T 3mi9_A          167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI  241 (351)
T ss_dssp             CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred             cchhcccccccccc----cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence            99999876543221    1123345678999999998876 457999999999999999999999997633221 11111


Q ss_pred             hhh---hcccccccccCccchhhhhhcccccCCCccchHHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKM---VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEE-----CLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~---~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...   ..+................    ............     ..+.+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          242 SQLCGSITPEVWPNVDNYELYEKLE----LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHCCCCTTTSTTGGGCGGGTSSC----CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCChhhccccccchhhcccc----cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111   1111111110000000000    000000111111     1356889999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-39  Score=340.95  Aligned_cols=259  Identities=25%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++..      +..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence            467899999999999999999986 778999999865432 35778999999999999999999998653      4578


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            99999999999999975421    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ........       .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     .......
T Consensus       157 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~  224 (279)
T 1qpc_A          157 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLE  224 (279)
T ss_dssp             EECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH
T ss_pred             ccccCccc-------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHHHh
Confidence            87654321       11233456889999999988889999999999999999999 99998653211     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ... .                      ...+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       225 ~~~-~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          225 RGY-R----------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             TTC-C----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccc-C----------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            000 0                      0001123456889999999999999999999999999987764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.3e-39  Score=350.30  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=205.7

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhC-CCCccceEE
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSI-RHRNLIKII  617 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~  617 (869)
                      .......++|++.+.||+|+||.||+|++..+|+.||||+++...        ....+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999998899999999986433        12245678999999999 799999999


Q ss_pred             EEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 002897          618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVL  697 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  697 (869)
                      +++...     ...++||||+++++|.+++....      .+++..+..++.||+.||+|||+.   ||+||||||+||+
T Consensus       167 ~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          167 DSYESS-----SFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL  232 (365)
T ss_dssp             EEEEBS-----SEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             EEEeeC-----CEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            997643     78999999999999999998643      389999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC------CCCCCccccchhhhHHHHHHHcCCC
Q 002897          698 LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT------GSEASMTGDVYSFGILLLEMFSRRR  771 (869)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~el~tg~~  771 (869)
                      ++.++.+||+|||++..+....         ......||+.|+|||++.      ...++.++|||||||++|+|++|+.
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~  303 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP  303 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ECCCCCEEEEecCcccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence            9999999999999998765432         223457999999999875      3358899999999999999999999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||.....     ............ ..                   ..+.....+..+.+++.+||+.||++|||++|++
T Consensus       304 pf~~~~~-----~~~~~~i~~~~~-~~-------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell  358 (365)
T 2y7j_A          304 PFWHRRQ-----ILMLRMIMEGQY-QF-------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL  358 (365)
T ss_dssp             SSCCSSH-----HHHHHHHHHTCC-CC-------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCCH-----HHHHHHHHhCCC-CC-------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            9964211     111111100000 00                   0001112345688999999999999999999998


Q ss_pred             H
Q 002897          852 V  852 (869)
Q Consensus       852 ~  852 (869)
                      +
T Consensus       359 ~  359 (365)
T 2y7j_A          359 Q  359 (365)
T ss_dssp             H
T ss_pred             c
Confidence            6

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.6e-39  Score=339.72  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=199.2

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      +|....+||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++...     +..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEE
Confidence            455556999999999999999989999999999876666678899999999999999999999997653     678999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCcEEEccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-DMVAHVGDFGLAK  713 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  713 (869)
                      |||+++++|.+++......   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||.+.
T Consensus        98 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEeCCCCCHHHHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            9999999999999875431   2367899999999999999999999   9999999999999987 8999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      ......        .......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||................. 
T Consensus       172 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-  242 (295)
T 2clq_A          172 RLAGIN--------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-  242 (295)
T ss_dssp             ESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-
T ss_pred             ccCCCC--------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-
Confidence            764422        1223456899999999987643  78999999999999999999999964321111110000000 


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                             ..+.                  .+..++..+.+++.+||+.||++|||++|+++
T Consensus       243 -------~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 -------VHPE------------------IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -------CCCC------------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -------cccc------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   0000                  01123456789999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.9e-39  Score=342.84  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+.|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence            357899999999999999999999899999999997543 34567899999999999999999999997653     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++++|.+++...       ++++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        96 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence            9999999999999999753       389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......        .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......     .......
T Consensus       166 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~  232 (303)
T 3a7i_A          166 AGQLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLFLIP  232 (303)
T ss_dssp             CEECBTTB--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHH
T ss_pred             ceecCccc--------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHHHhh
Confidence            98765432        1223456899999999999999999999999999999999999998753211     1111100


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ...     .+..                  ...++..+.+++.+||+.||++|||+.|+++..
T Consensus       233 ~~~-----~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          233 KNN-----PPTL------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HSC-----CCCC------------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             cCC-----CCCC------------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            000     0000                  012234678999999999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-39  Score=348.92  Aligned_cols=269  Identities=17%  Similarity=0.228  Sum_probs=209.3

Q ss_pred             ccCCCcccHHHHHHHhcCCCCC-CeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhC-CCCcc
Q 002897          538 EQQFPMISYAKLSKATSEFSSS-NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSI-RHRNL  613 (869)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~ni  613 (869)
                      ....+.+.+.......++|.+. +.||+|+||+||+|.+..+|+.||+|++....  ......+.+|+.+++.+ .||||
T Consensus        12 ~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             ----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             cccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence            3445566666777778889888 89999999999999999999999999996433  33457889999999999 57999


Q ss_pred             ceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       614 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                      +++++++..     ....++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||
T Consensus        92 v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp  159 (327)
T 3lm5_A           92 INLHEVYEN-----TSEIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKP  159 (327)
T ss_dssp             CCEEEEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             EEEEEEEEe-----CCeEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCh
Confidence            999999764     3778999999999999999865432    2489999999999999999999999   999999999


Q ss_pred             CceeecC---CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCC
Q 002897          694 SNVLLDH---DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR  770 (869)
Q Consensus       694 ~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~  770 (869)
                      +||+++.   ++.+||+|||.++......         ......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       160 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          160 QNILLSSIYPLGDIKIVDFGMSRKIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             GGEEESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEecCCCCCcEEEeeCccccccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999988   7899999999998765432         223356899999999999999999999999999999999999


Q ss_pred             CCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002897          771 RPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDV  850 (869)
Q Consensus       771 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  850 (869)
                      .||....... ..........  ..                      .......++..+.+++.+||+.||++|||++|+
T Consensus       231 ~pf~~~~~~~-~~~~i~~~~~--~~----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l  285 (327)
T 3lm5_A          231 SPFVGEDNQE-TYLNISQVNV--DY----------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC  285 (327)
T ss_dssp             CSSCCSSHHH-HHHHHHHTCC--CC----------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCCCchH-HHHHHHhccc--cc----------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            9997532211 1111111000  00                      000111334568899999999999999999999


Q ss_pred             HH
Q 002897          851 VV  852 (869)
Q Consensus       851 l~  852 (869)
                      ++
T Consensus       286 l~  287 (327)
T 3lm5_A          286 LS  287 (327)
T ss_dssp             TT
T ss_pred             hC
Confidence            76

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-39  Score=342.90  Aligned_cols=255  Identities=29%  Similarity=0.380  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|.+  +|+.||||+++...  ..+.+.+|++++++++||||+++++++...    ....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence            46899999999999999999998  58999999986433  457789999999999999999999986542    35689


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            99999999999999976432    1378999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      .......           ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......     .......
T Consensus       165 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~  228 (278)
T 1byg_A          165 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE  228 (278)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHT
T ss_pred             ccccccc-----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh
Confidence            7543321           22357889999999988889999999999999999998 99999753221     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...     .                  ...+..++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       229 ~~~-----~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          229 KGY-----K------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             TTC-----C------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCC-----C------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            000     0                  0011133456889999999999999999999999999987653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-40  Score=355.11  Aligned_cols=277  Identities=23%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....  ....+.+.+|+.++++++||||+++++++...     ..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CE
Confidence            367999999999999999999999899999999986433  23346678999999999999999999997653     77


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            899999999999998876544      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .+.......        .......|++.|+|||++.+. .++.++||||+||++|+|++|+.||........ .......
T Consensus       170 ~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~  240 (331)
T 4aaa_A          170 FARTLAAPG--------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMC  240 (331)
T ss_dssp             TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred             CceeecCCc--------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHH
Confidence            997654432        222345689999999998875 689999999999999999999999975432211 1111100


Q ss_pred             hcc--cccccccCc-cchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLP--EKVMEIVDP-SLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~--~~~~~~~d~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...  ......... .....................+.++..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000  000000000 000000000000000001111234577899999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-39  Score=364.36  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|.+.++||+|+||.||+|++..+|+.||+|++....   ......+.+|++++++++||||+++++++..     ..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence            367899999999999999999999899999999996432   2335678899999999999999999998754     37


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++......  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.+|.+||+||
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence            799999999999999999765421  22489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+++......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus       334 Gla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~  404 (543)
T 3c4z_A          334 GLAVELKAGQ--------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQR  404 (543)
T ss_dssp             TTCEECCTTC--------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHH
T ss_pred             ceeeeccCCC--------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHH
Confidence            9998765432        1223457999999999999999999999999999999999999999764321 111222221


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM-----RDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  852 (869)
                      ......                        ..+...+..+.+++.+||+.||++||++     +|+++
T Consensus       405 i~~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          405 VLEQAV------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHCCC------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             Hhhccc------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            111100                        0001234567899999999999999975     56653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.8e-39  Score=341.22  Aligned_cols=247  Identities=22%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.     .
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence            467999999999999999999999899999999996432   22346789999999999999999999997643     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            8899999999999999998754      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+......          ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......     .....
T Consensus       159 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~  223 (284)
T 2vgo_A          159 GWSVHAPSL----------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRR  223 (284)
T ss_dssp             TTCEECSSS----------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH
T ss_pred             cccccCccc----------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHH
Confidence            998765432          123356899999999999999999999999999999999999999753211     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......      .                  .+...+..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~------~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 IVNVDL------K------------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHTTCC------C------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhcccc------C------------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            110000      0                  00123356789999999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.7e-39  Score=354.94  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=194.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  629 (869)
                      .+|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.++++++  ||||+++++++...     +
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence            46999999999999999999987 5999999999643  3345678899999999996  59999999997653     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||| +.+++|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            7999999 56889999998765      389999999999999999999999   999999999999995 589999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----------CCCCccccchhhhHHHHHHHcCCCCCCcCcc
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----------SEASMTGDVYSFGILLLEMFSRRRPTDSMFH  778 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~el~tg~~pf~~~~~  778 (869)
                      |+++.+.....      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....
T Consensus       199 G~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~  272 (390)
T 2zmd_A          199 GIANQMQPDTT------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  272 (390)
T ss_dssp             SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CccccccCCCc------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence            99987654321      012234579999999998764           3689999999999999999999999975322


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..........    ........                      ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       273 ~~~~~~~~~~----~~~~~~~~----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          273 QISKLHAIID----PNHEIEFP----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHHHC----TTSCCCCC----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhC----ccccCCCC----------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111111111    00000000                      0113457899999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=375.14  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=204.1

Q ss_pred             eeeeecceEEEEEEEC--CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEeec
Q 002897          561 MVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .||+|+||.||+|.+.  .++..||||+++... ....+.+.+|++++++++||||+++++++..      +..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence            7999999999999875  356789999997543 3456789999999999999999999999753      458999999


Q ss_pred             ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCC
Q 002897          638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA  717 (869)
Q Consensus       638 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  717 (869)
                      +++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       417 ~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          417 AGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             CTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999976543     389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccccc
Q 002897          718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEKVM  796 (869)
Q Consensus       718 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  796 (869)
                      .....     .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......  ........   ..  
T Consensus       489 ~~~~~-----~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~---~~--  556 (613)
T 2ozo_A          489 DDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ---GK--  556 (613)
T ss_dssp             ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHT---TC--
T ss_pred             CCcee-----eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc---CC--
Confidence            32110     11122345789999999998899999999999999999998 99999753221  11111110   00  


Q ss_pred             cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcccC
Q 002897          797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQD  866 (869)
Q Consensus       797 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~  866 (869)
                                           ....+..++..+.+++.+||+.||++|||+.||++.|+.+........+
T Consensus       557 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~  605 (613)
T 2ozo_A          557 ---------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  605 (613)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence                                 0011123556788999999999999999999999999998877655433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-39  Score=350.48  Aligned_cols=250  Identities=21%  Similarity=0.300  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.     +
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----C
Confidence            46899999999999999999999999999999998643   234457789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++....      .+++.+++.++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence            8899999999999999987654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+.......        .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......     .....
T Consensus       186 g~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~  252 (335)
T 2owb_A          186 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLR  252 (335)
T ss_dssp             TTCEECCSTT--------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH
T ss_pred             cCceecccCc--------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHH
Confidence            9998765332        1223456899999999999888999999999999999999999999753211     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ......      .                  .+..++..+.+++.+||+.||++|||++|+++.
T Consensus       253 ~~~~~~------~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          253 IKKNEY------S------------------IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHTCC------C------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhcCCC------C------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            100000      0                  001223457799999999999999999999873

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.2e-40  Score=356.81  Aligned_cols=277  Identities=19%  Similarity=0.265  Sum_probs=188.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeecc-ccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSI-DFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+++.+|+++++.++||||+++++++... ......
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999999999999999998643  234457788999999999999999999997653 123345


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++|+||+ +++|.+++...       .+++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            689999999 68999998763       389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+++.....           .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......+
T Consensus       177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~  244 (367)
T 2fst_X          177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR  244 (367)
T ss_dssp             -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             ccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            999764322           233568999999999877 67899999999999999999999999753221 11111111


Q ss_pred             hhccc--ccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPE--KVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~--~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....  .....+.......+... ...............+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            11000  00000000000000000 000000000011123467889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.3e-39  Score=347.34  Aligned_cols=273  Identities=18%  Similarity=0.206  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccc---cCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSID---FNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~~  628 (869)
                      ..+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++....   ..+.
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999999999999999999997666666778899999999995 999999999985322   1345


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCcEEE
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP--VVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      ...++||||++ |+|.+++.....   ..++++.+++.++.||+.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            66899999995 699999875321   12489999999999999999999999   8  999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccc----cCCCCCCccCcccccCCccc---CCCCCCccccchhhhHHHHHHHcCCCCCCcCccC
Q 002897          707 GDFGLAKFLPARPLDTVVE----TPSSSSGIKGTVGYIAPEYG---TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE  779 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~  779 (869)
                      +|||.++............    .........||+.|+|||++   .+..++.++|||||||++|+|++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765433211000    00112245689999999998   5667899999999999999999999999642211


Q ss_pred             CchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          780 GLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      .     ..........                          ....+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       260 ~-----~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 R-----IVNGKYSIPP--------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -----------CCCCT--------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-----hhcCcccCCc--------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0     0000000000                          00112236789999999999999999999999999987


Q ss_pred             hhhc
Q 002897          860 AFVS  863 (869)
Q Consensus       860 ~~~~  863 (869)
                      ....
T Consensus       309 ~~~~  312 (337)
T 3ll6_A          309 ARNV  312 (337)
T ss_dssp             HTTC
T ss_pred             ccCC
Confidence            6543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-39  Score=350.41  Aligned_cols=272  Identities=20%  Similarity=0.268  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||+||+|++..+++.||||+++...   .+.+.+|++++++++ ||||+++++++...   .....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence            67999999999999999999999999999999986433   467899999999997 99999999998652   246789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  711 (869)
                      +||||+++++|.+++..         +++..+..++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||.
T Consensus       110 lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EEEECCCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeccCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            99999999999999853         78899999999999999999999   999999999999999777 899999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+......         ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus       178 a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~  248 (330)
T 3nsz_A          178 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  248 (330)
T ss_dssp             CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             ceEcCCCC---------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence            98765432         2234568999999999877 6689999999999999999999999964332222222211111


Q ss_pred             ccccccc-------ccCccchhhhhhc--ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVME-------IVDPSLLLEVRAN--NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~-------~~d~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......+       ..++.........  ...............+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1100000       0111110000000  000000011112234567899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.8e-39  Score=350.01  Aligned_cols=279  Identities=18%  Similarity=0.203  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999999999999999999643  3344567889999999999999999999986542 23345


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++ +|.+++..        .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            78999999975 78888853        288999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+.....         .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ........
T Consensus       172 g~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~  241 (371)
T 2xrw_A          172 GLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ  241 (371)
T ss_dssp             CC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-
T ss_pred             ecccccccc---------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence            999865432         12234568999999999999999999999999999999999999997532211 11111110


Q ss_pred             hccc--ccccccCccchhhhhhcc------------cccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          790 VLPE--KVMEIVDPSLLLEVRANN------------SMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       790 ~~~~--~~~~~~d~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....  .......+..........            ..............+..+.+++.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0000  000000000000000000            000001112233456789999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.3e-39  Score=374.78  Aligned_cols=255  Identities=27%  Similarity=0.368  Sum_probs=201.8

Q ss_pred             CeeeeecceEEEEEEE--CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGII--GENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      +.||+|+||.||+|.+  ..+++.||||+++...  ....+.+.+|++++++++||||+++++++..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999955  4567899999997533  3345789999999999999999999999753      4578999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus       449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            9999999999998654      389999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      .......     .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......     +.........
T Consensus       520 ~~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~~  589 (635)
T 4fl3_A          520 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAMLEKGE  589 (635)
T ss_dssp             TC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTC
T ss_pred             ccCcccc-----ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCC
Confidence            5443111     12233456789999999998899999999999999999998 99999753221     1111111000


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                                             ....+..++.++.+++..||+.||++|||+++|++.|+.+.....
T Consensus       590 -----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          590 -----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence                                   000111345678899999999999999999999999999876653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.6e-39  Score=348.76  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEE-----ECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGI-----IGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||.||+|+     ...+++.||||++... .......+.+|+.++++++||||+++++++...   
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS---  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC---
Confidence            4689999999999999999999     4457889999999643 334456789999999999999999999997643   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---C
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL-EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---M  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~  702 (869)
                        ...++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+   .
T Consensus       106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence              66799999999999999998765321 123489999999999999999999999   99999999999999844   4


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~  781 (869)
                      .+||+|||.+........      ........|++.|+|||++.+..++.++|||||||++|+|++ |+.||.....   
T Consensus       181 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  251 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---  251 (327)
T ss_dssp             CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eEEECccccccccccccc------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---
Confidence            699999999976543221      012233567899999999988899999999999999999998 9999865321   


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                        .............                       ..+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       252 --~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          252 --QEVLEFVTSGGRM-----------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             --HHHHHHHHTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --HHHHHHHhcCCCC-----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence              1111111110000                       001123456889999999999999999999999999887654


Q ss_pred             h
Q 002897          862 V  862 (869)
Q Consensus       862 ~  862 (869)
                      .
T Consensus       307 ~  307 (327)
T 2yfx_A          307 D  307 (327)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-39  Score=343.15  Aligned_cols=259  Identities=21%  Similarity=0.289  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...  .....+.+.+|++++++++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            46899999999999999999999999999999999743  234457789999999999999999999987532   2367


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceeecCCCcEE
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPP-----VVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~k  705 (869)
                      .++||||+++|+|.+++......  ...+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+|
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence            89999999999999999764321  22489999999999999999999999   7     99999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||.+.......        .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....     ..
T Consensus       157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~  223 (279)
T 2w5a_A          157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KE  223 (279)
T ss_dssp             ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred             EecCchheeecccc--------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HH
Confidence            99999998764321        111234689999999999988999999999999999999999999975321     11


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLC  855 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  855 (869)
                      ............                       .+..++..+.+++.+||+.||++|||+.|+++.+.
T Consensus       224 ~~~~i~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          224 LAGKIREGKFRR-----------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHHHHTCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHHhhccccc-----------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            111111100000                       00123456889999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.1e-39  Score=364.90  Aligned_cols=253  Identities=26%  Similarity=0.315  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.++||+|+||+||+|++..+++.||||++....  ......+.+|++++++++||||+++++++...     .
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----S   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----C
Confidence            3468999999999999999999999999999999996432  33457789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl  706 (869)
                      ..++||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++   .++.+||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            8999999999999999987654      389999999999999999999999   999999999999995   4568999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|+......         ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......     ..
T Consensus       166 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~  230 (486)
T 3mwu_A          166 IDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DI  230 (486)
T ss_dssp             CSCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH
T ss_pred             EECCcCeECCCCC---------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence            9999998654432         2234569999999999876 5999999999999999999999999753211     11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..........                    ...+....++..+.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~i~~~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          231 LKRVETGKYA--------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHTCCC--------------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHhCCCC--------------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111100000                    0001112344568899999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-39  Score=365.13  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.++||+|+||.||+|.+. .+..||||+++.... ..+.+.+|++++++++||||+++++++..      ...+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            467888999999999999999996 567899999975432 34678999999999999999999999753      4579


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       255 iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence            99999999999999975321    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......       .......++..|+|||++.+..++.++|||||||++|||++ |+.||......     +......
T Consensus       328 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~  395 (452)
T 1fmk_A          328 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVE  395 (452)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH
T ss_pred             eecCCCce-------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence            87654321       11223456889999999988899999999999999999999 99998753221     1111110


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...                       ..+.+..++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus       396 ~~~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          396 RGY-----------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             TTC-----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cCC-----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            000                       0011123456788999999999999999999999999987654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=357.70  Aligned_cols=282  Identities=18%  Similarity=0.213  Sum_probs=198.7

Q ss_pred             HHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc----
Q 002897          550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF----  625 (869)
Q Consensus       550 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  625 (869)
                      ....++|++.+.||+|+||+||+|++..+|+.||||++.....    ...+|+++++.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456789999999999999999999999999999999864332    23479999999999999999999855321    


Q ss_pred             -----------------------------CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHH
Q 002897          626 -----------------------------NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE  676 (869)
Q Consensus       626 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~  676 (869)
                                                   .+....++||||++ |+|.+.+......  ...+++..+..++.||++||+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence                                         23455889999998 4887777642110  124899999999999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceeec-CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccc
Q 002897          677 YLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTG  754 (869)
Q Consensus       677 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  754 (869)
                      |||+.   ||+||||||+||+++ .++.+||+|||.|+......         ......||+.|+|||++.+. .++.++
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------PSVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------CCcCcccCCCccCHHHhcCCCCCCcch
Confidence            99999   999999999999997 68899999999998764432         22345689999999988775 489999


Q ss_pred             cchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccc--cccCccchhhhhhcccccCCCccchHHHHHHHHHHH
Q 002897          755 DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM--EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRI  832 (869)
Q Consensus       755 DvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  832 (869)
                      ||||+||++|||++|+.||......+ .........-.....  ...++.... ...............++..+..+.++
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTE-VRFPTLKAKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC---CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCccccc-ccCCccCcccHHhhCCCCCCHHHHHH
Confidence            99999999999999999997532221 111111111000000  000000000 00000000000000112245678899


Q ss_pred             HhhccCCCCCCCCCHHHHHH
Q 002897          833 GVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       833 i~~cl~~dP~~RPs~~evl~  852 (869)
                      +.+||+.||++|||+.|+++
T Consensus       302 i~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-40  Score=363.39  Aligned_cols=260  Identities=16%  Similarity=0.161  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeec---ccchhhHHHHHHHHH---HHhCCCCccceEE-------EE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEA---LRSIRHRNLIKII-------TI  619 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~---l~~l~h~niv~~~-------~~  619 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||++..   ......+.+.+|+.+   ++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4678899999999999999999988999999999973   234456788999954   5555899999998       44


Q ss_pred             eeccc-------cCCCc-----eEEEEeecccCCCHHHHHhhCCCccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002897          620 CSSID-------FNGVD-----FKAIVYDFMQNGSLEEWLHQNNDKLE-VCNLSLIQTLNIAIDVASAIEYLHHHCKPPV  686 (869)
Q Consensus       620 ~~~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  686 (869)
                      +....       +.+..     ..++||||+ +|+|.+++.......+ ...+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            43321       00111     378999999 6799999986432100 11245688899999999999999999   99


Q ss_pred             EecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-----------CCCcccc
Q 002897          687 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-----------EASMTGD  755 (869)
Q Consensus       687 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sD  755 (869)
                      +||||||+|||++.++.+||+|||+|+....           ......| +.|+|||++.+.           .++.++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            9999999999999999999999999985322           2233457 999999999877           7999999


Q ss_pred             chhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhh
Q 002897          756 VYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVV  835 (869)
Q Consensus       756 vwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  835 (869)
                      ||||||++|||++|+.||.........     ......     .                       ..++..+.+++.+
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~~-----~~~~~~-----~-----------------------~~~~~~~~~li~~  342 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGGS-----EWIFRS-----C-----------------------KNIPQPVRALLEG  342 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CCS-----GGGGSS-----C-----------------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccch-----hhhhhh-----c-----------------------cCCCHHHHHHHHH
Confidence            999999999999999999653221100     000000     0                       0223567899999


Q ss_pred             ccCCCCCCCCCHHHHHH--HHHHHHHhh
Q 002897          836 CSMESPTDRMQMRDVVV--KLCAAREAF  861 (869)
Q Consensus       836 cl~~dP~~RPs~~evl~--~L~~~~~~~  861 (869)
                      ||+.||++|||+.|+++  .++.+.+..
T Consensus       343 ~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          343 FLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            99999999999999996  555555543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.5e-39  Score=350.54  Aligned_cols=288  Identities=23%  Similarity=0.274  Sum_probs=208.1

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|++++++++||||+++++++....+......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999999899999999996433 3345678899999999999999999999876656666889


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||++ |+|.+++....       +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQM-------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999997 59999998643       89999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCcc--ccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          712 AKFLPARPLDTVV--ETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       712 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      +............  ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~  237 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFG  237 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH
Confidence            9877543221100  00012234578999999998654 678999999999999999999999997532211 1111111


Q ss_pred             hhcc---cc-cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLP---EK-VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~---~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....   .. ......+.......................++..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000   00 0000011000000000000000001111234567889999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.7e-39  Score=352.63  Aligned_cols=201  Identities=25%  Similarity=0.395  Sum_probs=175.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence            35799999999999999999999999999999999754 334457789999999999999999999997653     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||.
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCC
Confidence            99999999999999998754      3899999999999999999999832  799999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +......          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       179 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          179 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             CHHHHHH----------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             Ccccccc----------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            8754321          123346899999999999999999999999999999999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=341.55  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=199.9

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....  ..+.+.+|+.+++.++||||+++++++...     ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence            4568999999999999999999999899999999997543  347789999999999999999999997653     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999974332     389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +.......        .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......    .... ...
T Consensus       172 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~  238 (314)
T 3com_A          172 AGQLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIF-MIP  238 (314)
T ss_dssp             CEECBTTB--------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH-HHH
T ss_pred             chhhhhhc--------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHH-HHh
Confidence            98664432        1223456899999999999989999999999999999999999999743211    1100 000


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...     .+.                ...+..++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~-----~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 TNP-----PPT----------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HSC-----CCC----------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCC-----Ccc----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000     000                0001123456889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-39  Score=345.01  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++...     ...+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence            46899999999999999999999989999999999776666678899999999999999999999997653     6789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999876433     389999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCccc-----CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG-----TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      .......        .......|++.|+|||++     .+..++.++|||||||++|+|++|+.||....... ......
T Consensus       165 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~  235 (302)
T 2j7t_A          165 AKNLKTL--------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIA  235 (302)
T ss_dssp             HHHHHHH--------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH
T ss_pred             ccccccc--------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHh
Confidence            5322110        112234689999999987     46678999999999999999999999997532211 011111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...    ....                     ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~----~~~~---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          236 KSD----PPTL---------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HSC----CCCC---------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccC----Cccc---------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            100    0000                     011123456889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.9e-39  Score=356.38  Aligned_cols=199  Identities=23%  Similarity=0.315  Sum_probs=173.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC------CCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI------RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~  626 (869)
                      ..+|++.++||+|+||+||+|.+..+++.||||+++... ...+.+.+|+++++.+      .|+||+++++++...   
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            457999999999999999999999999999999996532 3346677888888877      577999999997654   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--E
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV--A  704 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~  704 (869)
                        ...++||||+. ++|.+++.....    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.  +
T Consensus       172 --~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          172 --NHICMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             --TEEEEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             --CeEEEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence              78999999996 699999987653    2489999999999999999999999   9999999999999999987  9


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      ||+|||+|+.....           .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999754332           23356899999999999999999999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-38  Score=349.37  Aligned_cols=288  Identities=20%  Similarity=0.240  Sum_probs=205.2

Q ss_pred             cHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-----------hhhHHHHHHHHHHHhCCCCcc
Q 002897          545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-----------GALKSFLTECEALRSIRHRNL  613 (869)
Q Consensus       545 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni  613 (869)
                      ...++....++|++.+.||+|+||.||+|.+. +|+.||||++.....           ...+.+.+|++++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34677788899999999999999999999986 599999999854221           223788999999999999999


Q ss_pred             ceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       614 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                      +++++++...+.......++||||++ |+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  162 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP  162 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence            99999987654445567899999997 589888876543     389999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~p  772 (869)
                      +||+++.++.+||+|||.+......         .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.|
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTAD---------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             GGEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             HHEEEcCCCCEEEEecCcccccccc---------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            9999999999999999999754332         22234568999999998877 6789999999999999999999999


Q ss_pred             CCcCccCCchHHHhhhhhcccccc---cccCccchhhhhhcc-cccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVM---EIVDPSLLLEVRANN-SMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |....... ...............   ....+.......... ..............+..+.+++.+||+.||++|||+.
T Consensus       234 f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  312 (362)
T 3pg1_A          234 FRGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE  312 (362)
T ss_dssp             CCCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence            97532211 111111111100000   000000000000000 0000000111123356788999999999999999999


Q ss_pred             HHHH
Q 002897          849 DVVV  852 (869)
Q Consensus       849 evl~  852 (869)
                      |+++
T Consensus       313 ell~  316 (362)
T 3pg1_A          313 QALR  316 (362)
T ss_dssp             HHHT
T ss_pred             HHHc
Confidence            9986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.4e-39  Score=365.22  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|++..++..||+|++....  ......+.+|+.+++.++||||+++++++...     ..
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            457999999999999999999999999999999996542  33457789999999999999999999997653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~  707 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++..   +.+||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            899999999999999887654      389999999999999999999999   99999999999999764   459999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|......         .......||+.|+|||++. +.++.++||||+||++|+|++|+.||......     ...
T Consensus       182 DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~  246 (494)
T 3lij_A          182 DFGLSAVFENQ---------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EIL  246 (494)
T ss_dssp             CCTTCEECBTT---------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred             ECCCCeECCCC---------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            99999876432         2233456999999999986 46999999999999999999999999753221     111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ........ .. +                  .+....++..+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~i~~~~~-~~-~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          247 RKVEKGKY-TF-D------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHTCC-CC-C------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHhCCC-CC-C------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            11110000 00 0                  00111234567899999999999999999999863

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.9e-39  Score=337.37  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence            468999999999999999999999899999999996432   23456789999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            7899999999999999997654      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.+.......         ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....     .....
T Consensus       156 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~  221 (276)
T 2h6d_A          156 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFK  221 (276)
T ss_dssp             CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             ccccccCCCc---------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHH
Confidence            9998664432         1223468999999999988765 6899999999999999999999975321     11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....... .                       .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       222 ~~~~~~~-~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          222 KIRGGVF-Y-----------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHCCC-C-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HhhcCcc-c-----------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1100000 0                       001223467899999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.1e-39  Score=345.11  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=198.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCCCCccceEEEEeecc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIRHRNLIKIITICSSI  623 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  623 (869)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            3468999999999999999999999999999999986432        1223457899999999999999999999754 


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                           ...++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        87 -----~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           87 -----EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             -----SSEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred             -----CceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence                 33799999999999999997654      389999999999999999999999   9999999999999987664


Q ss_pred             ---EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCccc---CCCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          704 ---AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG---TGSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       704 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                         +||+|||.+.......         ......||+.|+|||++   ....++.++|||||||++|+|++|+.||....
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             SCCEEECCCTTCEECCCCH---------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             CCeEEEccCccceeccccc---------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence               9999999998764321         11234689999999986   35678999999999999999999999997543


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...............      ..                  ......++..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~------~~------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          224 TQVSLKDQITSGKYN------FI------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CSSCHHHHHHHTCCC------CC------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHHHHhCccc------cC------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            322211111111000      00                  0011134567889999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-38  Score=364.06  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc-------------hhhHHHHHHHHHHHhCCCCccceEEE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-------------GALKSFLTECEALRSIRHRNLIKIIT  618 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~  618 (869)
                      ..++|++.++||+|+||+||+|++..+++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35789999999999999999999999999999999964321             23467899999999999999999999


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      ++.+     ....++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          114 VFED-----KKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL  179 (504)
T ss_dssp             EEEC-----SSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEEc-----CCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence            9765     378999999999999999997654      389999999999999999999999   99999999999999


Q ss_pred             cCCC---cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          699 DHDM---VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       699 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                      +.++   .+||+|||+|.......         ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            8776   69999999998765432         2234569999999999874 699999999999999999999999975


Q ss_pred             CccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          776 MFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....     ............  .                  .......++..+.+++.+||+.||++|||++|+++.
T Consensus       250 ~~~~-----~~~~~i~~~~~~--~------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          250 QNDQ-----DIIKKVEKGKYY--F------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             SSHH-----HHHHHHHHCCCC--C------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHH-----HHHHHHHcCCCC--C------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            3221     111111110000  0                  001112344678899999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=346.46  Aligned_cols=280  Identities=19%  Similarity=0.269  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc--------
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID--------  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  624 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            368999999999999999999999889999999998776667788999999999999999999999875321        


Q ss_pred             -cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCC
Q 002897          625 -FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDM  702 (869)
Q Consensus       625 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~  702 (869)
                       +......++||||++ |+|.+++...       ++++..++.++.|++.||+|||++   +|+||||||+||+++ .++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence             234477899999997 5999999753       389999999999999999999999   999999999999997 567


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      .+||+|||.++.......     .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... 
T Consensus       159 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  232 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYS-----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-  232 (320)
T ss_dssp             EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             eEEEccCccccccCCCcc-----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999999999987643321     1122334567999999998765 678999999999999999999999997543211 


Q ss_pred             hHHHhhhhhccc---ccc---cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          782 TLHEFSKMVLPE---KVM---EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       782 ~~~~~~~~~~~~---~~~---~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ............   ...   ............    ............++..+.+++.+||+.||++|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMT----EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT----SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhcCCCchhhhhhhhhcCccccccccc----CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            111111110000   000   000000000000    00000001112345678999999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=352.17  Aligned_cols=260  Identities=13%  Similarity=0.103  Sum_probs=203.2

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEE-----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC---CCccceEEEEeec
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGI-----IGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR---HRNLIKIITICSS  622 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  622 (869)
                      ...++|.+.++||+|+||+||+|.     +..+++.||||+++...   ...+..|+++++.++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345789999999999999999994     56689999999996543   356778888888886   9999999999765


Q ss_pred             cccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--
Q 002897          623 IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH--  700 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--  700 (869)
                      .     +..++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.   +|+||||||+|||++.  
T Consensus       139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          139 Q-----NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             S-----SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred             C-----CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence            4     6789999999999999999753211 112499999999999999999999999   9999999999999998  


Q ss_pred             ---------CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCC
Q 002897          701 ---------DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR  771 (869)
Q Consensus       701 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~  771 (869)
                               ++.+||+|||+|+.+.....      ........||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  283 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY  283 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence                     89999999999976532211      122344679999999999999999999999999999999999999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCC-CCHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR-MQMRDV  850 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ev  850 (869)
                      ||.........            ......                 ..    ...+.+.+++..|++.+|.+| |+++++
T Consensus       284 pf~~~~~~~~~------------~~~~~~-----------------~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          284 MKVKNEGGECK------------PEGLFR-----------------RL----PHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             CCEEEETTEEE------------ECSCCT-----------------TC----SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             ccccCCCCcee------------echhcc-----------------cc----CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            98542211000            000000                 00    013356688999999999999 678888


Q ss_pred             HHHHHHHHHhh
Q 002897          851 VVKLCAAREAF  861 (869)
Q Consensus       851 l~~L~~~~~~~  861 (869)
                      .+.|++..+..
T Consensus       331 ~~~l~~~l~~~  341 (365)
T 3e7e_A          331 RQKLKKVFQQH  341 (365)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            88888876654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.7e-39  Score=366.89  Aligned_cols=252  Identities=27%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.++++++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----G   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            457999999999999999999999999999999996432   34467889999999999999999999997653     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCcEEE
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL---DHDMVAHV  706 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl  706 (869)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||++   +.++.+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence            8999999999999999998754      389999999999999999999999   99999999999999   56789999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|.......         ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......     ..
T Consensus       171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~  235 (484)
T 3nyv_A          171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DI  235 (484)
T ss_dssp             CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH
T ss_pred             EeeeeeEEccccc---------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HH
Confidence            9999998765432         2233569999999999876 6899999999999999999999999753211     11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..........                    ...+....++..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~i~~~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          236 LKKVEKGKYT--------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHHHHHCCCC--------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHcCCCC--------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            1111100000                    0001112344568899999999999999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=346.64  Aligned_cols=266  Identities=21%  Similarity=0.315  Sum_probs=202.0

Q ss_pred             ccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeec
Q 002897          544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSS  622 (869)
Q Consensus       544 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  622 (869)
                      +.+.++....++|++.+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334444556789999999999999999999999899999999997543 3347789999999999 89999999999876


Q ss_pred             cccC-CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 002897          623 IDFN-GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD  701 (869)
Q Consensus       623 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  701 (869)
                      .... .....++||||+++|+|.+++.....    ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC
Confidence            4221 14678999999999999999987532    2489999999999999999999999   99999999999999999


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +.+||+|||.+.......        .......|++.|+|||++.     +..++.++|||||||++|+|++|+.||...
T Consensus       166 ~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             CCEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCEEEeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999997654321        1223456899999999986     556899999999999999999999999643


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...    ... ............                      ...++..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~----~~~-~~~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          238 HPM----RAL-FLIPRNPAPRLK----------------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CHH----HHH-HHHHHSCCCCCS----------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cHH----HHH-HHhhcCccccCC----------------------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            211    110 000000000000                      0122456889999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-38  Score=336.62  Aligned_cols=255  Identities=22%  Similarity=0.279  Sum_probs=186.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++...  ....+.+..+...++.++||||+++++++...     ..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence            468999999999999999999999999999999996542  22223344555567888999999999997653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++ +|.+++......  ...+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             EEEEEehhcc-chHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            8999999974 888877652111  124899999999999999999999853  89999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCccc----CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG----TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      .+.......         ......||+.|+|||++    .+..++.++||||+||++|+|++|+.||.............
T Consensus       156 ~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  226 (290)
T 3fme_A          156 ISGYLVDDV---------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV  226 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred             Ccccccccc---------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence            998664432         12234689999999995    55678999999999999999999999997432221111111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....+.                          .....++..+.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPSPQ--------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSCCCC--------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccCCCC--------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111000                          000123456889999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-38  Score=336.43  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=203.7

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---------chhhHHHHHHHHHHHhCC-CCccceEEEEe
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---------KGALKSFLTECEALRSIR-HRNLIKIITIC  620 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  620 (869)
                      ...++|++.+.||+|+||.||+|++..+|+.||||+++...         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999999999999999996442         123466789999999995 99999999997


Q ss_pred             eccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 002897          621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH  700 (869)
Q Consensus       621 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  700 (869)
                      ..     ....++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        94 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           94 ET-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  159 (298)
T ss_dssp             EC-----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             cc-----CCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence            54     378999999999999999998653      389999999999999999999999   9999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC------CCCCCccccchhhhHHHHHHHcCCCCCC
Q 002897          701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT------GSEASMTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~el~tg~~pf~  774 (869)
                      ++.+||+|||.+.......         ......|++.|+|||++.      ...++.++||||||+++|+|++|+.||.
T Consensus       160 ~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             TCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            9999999999998765432         223356899999999874      4568899999999999999999999996


Q ss_pred             cCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....     ........... ...                   .+....++..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~-----~~~~~~~~~~~-~~~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          231 HRKQM-----LMLRMIMSGNY-QFG-------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CSSHH-----HHHHHHHHTCC-CCC-------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CccHH-----HHHHHHhcCCc-ccC-------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            43211     11111110000 000                   0011134556889999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-38  Score=349.61  Aligned_cols=277  Identities=21%  Similarity=0.245  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+. ....
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            35899999999999999999999999999999999643  23345778899999999999999999999865421 1222


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||++ ++|.+++..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence            3499999997 589888743        289999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++.....           .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......
T Consensus       189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~  256 (371)
T 4exu_A          189 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK  256 (371)
T ss_dssp             TCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             CcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence            999754332           233568999999999877 678999999999999999999999997532211 1111111


Q ss_pred             hh-c-ccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MV-L-PEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~-~-~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .. . +..............+... ..............++..+.+++.+||+.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            11 0 0011111111110000000 0000000011112345678999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.8e-38  Score=333.64  Aligned_cols=248  Identities=19%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  628 (869)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...  .......+.+|+.++..+ +||||+++++++.+.     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            356899999999999999999999989999999999753  234457788999999999 999999999997654     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-------
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-------  701 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------  701 (869)
                      +..++||||+++|+|.+++......  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.+       
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence            7889999999999999999864311  12489999999999999999999999   99999999999999844       


Q ss_pred             ------------CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHc
Q 002897          702 ------------MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFS  768 (869)
Q Consensus       702 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~t  768 (869)
                                  ..+||+|||.+.......            ...||+.|+|||++.+. .+++++|||||||++|+|++
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG  226 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence                        479999999998664321            23489999999998776 56789999999999999999


Q ss_pred             CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       769 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |.+|+...    ...........+    .                       .+..++..+.+++.+||+.||++|||+.
T Consensus       227 ~~~~~~~~----~~~~~~~~~~~~----~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          227 AEPLPRNG----DQWHEIRQGRLP----R-----------------------IPQVLSQEFTELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             CCCCCSSS----HHHHHHHTTCCC----C-----------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCcch----hHHHHHHcCCCC----C-----------------------CCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence            99876431    111111111100    0                       0012345678999999999999999999


Q ss_pred             HHHH
Q 002897          849 DVVV  852 (869)
Q Consensus       849 evl~  852 (869)
                      |+++
T Consensus       276 ~ll~  279 (289)
T 1x8b_A          276 ALVK  279 (289)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-39  Score=344.09  Aligned_cols=263  Identities=27%  Similarity=0.379  Sum_probs=198.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-CC--eEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-NG--MLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||+||+|++.. ++  ..||||+++..   .....+.+.+|++++++++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            3579999999999999999998642 33  36899998643   33456788999999999999999999999764    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                        ...++||||+++|+|.+++.....     .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||
T Consensus        93 --~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  162 (291)
T 1u46_A           93 --PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI  162 (291)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             --CCceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence              237899999999999999987543     389999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHH
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~  785 (869)
                      +|||.+..........     .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......     .
T Consensus       163 ~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~  232 (291)
T 1u46_A          163 GDFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----Q  232 (291)
T ss_dssp             CCCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred             ccccccccccccccch-----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----H
Confidence            9999998775543111     12233457889999999988889999999999999999999 99999753211     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ...........                      ......++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       233 ~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          233 ILHKIDKEGER----------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             HHHHHHTSCCC----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHHHHHccCCC----------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            11111100000                      0001134456889999999999999999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-39  Score=349.19  Aligned_cols=256  Identities=23%  Similarity=0.309  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhC-CCCccceEEEEeeccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLMQ----KGALKSFLTECEALRSI-RHRNLIKIITICSSID  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  624 (869)
                      .++|++.++||+|+||.||+|++.   .+|+.||||+++...    ....+.+.+|+++++.+ +||||+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            468999999999999999999984   489999999986432    23345677899999999 699999999987653 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                          ...++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus       132 ----~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  198 (355)
T 1vzo_A          132 ----TKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  198 (355)
T ss_dssp             ----TEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             ----ceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence                67899999999999999998654      389999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      ||+|||+++.......       .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||....... .
T Consensus       199 kl~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~  270 (355)
T 1vzo_A          199 VLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-S  270 (355)
T ss_dssp             EESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-C
T ss_pred             EEeeCCCCeecccCCC-------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-h
Confidence            9999999986543211       222345699999999998863  47899999999999999999999997533221 1


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVVKL  854 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  854 (869)
                      ...+........                        ...+.+++..+.+++.+||+.||++||     |++|+++..
T Consensus       271 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          271 QAEISRRILKSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHHHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHHHHHhccC------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            122211111000                        001112345678999999999999999     999998743

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.5e-38  Score=340.21  Aligned_cols=279  Identities=22%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEEC-CCCeEEEEEEeecccc--hhhHHHHHHHHHHHhC---CCCccceEEEEeeccc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIG-ENGMLVAVKVLNLMQK--GALKSFLTECEALRSI---RHRNLIKIITICSSID  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~  624 (869)
                      .+.++|++.+.||+|+||.||+|++. .+|+.||+|+++....  .....+.+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999995 6789999999964332  2234566788777766   8999999999987443


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcE
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVA  704 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  704 (869)
                      .......++||||++ |+|.+++......    .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence            345578899999997 6999999876432    489999999999999999999999   99999999999999999999


Q ss_pred             EEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          705 HVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      ||+|||.+......         .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus       160 kl~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~  229 (326)
T 1blx_A          160 KLADFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLG  229 (326)
T ss_dssp             EECSCCSCCCCCGG---------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred             EEecCcccccccCC---------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH
Confidence            99999999765422         12234568999999999999899999999999999999999999997543211 111


Q ss_pred             Hhhhhhc-cc--ccccccC-ccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          785 EFSKMVL-PE--KVMEIVD-PSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~-~~--~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....... +.  .+..... +..  .+..   ............++..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPRQ--AFHS---KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGG--GSCC---CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCcccCccccccchh--hhcc---cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111110 00  0000000 000  0000   0000000111234567889999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.1e-39  Score=352.67  Aligned_cols=268  Identities=12%  Similarity=0.022  Sum_probs=187.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhC--CCCccceEE-------EEe
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSI--RHRNLIKII-------TIC  620 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~  620 (869)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345889999999999999999999899999999997643   23456677885554444  699988855       333


Q ss_pred             eccccC------------CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHH------HHHHHHHHHHHHHHHhcC
Q 002897          621 SSIDFN------------GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT------LNIAIDVASAIEYLHHHC  682 (869)
Q Consensus       621 ~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~  682 (869)
                      ......            .....++||||++ |+|.+++.....     .+++..+      ..++.||++||+|||++ 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK-  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence            221100            0145899999998 899999987532     2444555      77889999999999999 


Q ss_pred             CCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhh
Q 002897          683 KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFG  760 (869)
Q Consensus       683 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG  760 (869)
                        +|+||||||+|||++.++.+||+|||+|+.....           .....+|+.|+|||++.+  ..++.++||||||
T Consensus       214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  280 (371)
T 3q60_A          214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----------GPASSVPVTYAPREFLNASTATFTHALNAWQLG  280 (371)
T ss_dssp             --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred             --CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----------ccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence              9999999999999999999999999999865422           113456799999999987  6799999999999


Q ss_pred             HHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCC
Q 002897          761 ILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMES  840 (869)
Q Consensus       761 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  840 (869)
                      |++|||++|+.||.........  .+......    ......              ...+....++..+.+++.+||+.|
T Consensus       281 ~il~elltg~~Pf~~~~~~~~~--~~~~~~~~----~~~~~~--------------~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          281 LSIYRVWCLFLPFGLVTPGIKG--SWKRPSLR----VPGTDS--------------LAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             HHHHHHHHSSCSTTBCCTTCTT--CCCBCCTT----SCCCCS--------------CCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCcCccccc--chhhhhhh----hccccc--------------cchhhccCCCHHHHHHHHHHcCCC
Confidence            9999999999999764322111  00000000    000000              000011134567889999999999


Q ss_pred             CCCCCCHHHHHH--HHHHHHHh
Q 002897          841 PTDRMQMRDVVV--KLCAAREA  860 (869)
Q Consensus       841 P~~RPs~~evl~--~L~~~~~~  860 (869)
                      |++|||+.|+++  .++.+...
T Consensus       341 P~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          341 RRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             TTTCCCHHHHTTSHHHHHHHHH
T ss_pred             hhhCCCHHHHhcCHHHHHHHHH
Confidence            999999999975  44444443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.6e-39  Score=343.29  Aligned_cols=272  Identities=21%  Similarity=0.294  Sum_probs=185.4

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...     +
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence            34578999999999999999999998899999999986433 33456788999999999999999999997653     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDK--LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ..++||||+++++|.+++......  .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            789999999999999998752110  0122489999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |||.+..........   .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..
T Consensus       164 dfg~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~  239 (303)
T 2vwi_A          164 DFGVSAFLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LT  239 (303)
T ss_dssp             CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HH
T ss_pred             eccchheeccCCCcc---chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HH
Confidence            999998765432110   0112234568999999998865 468999999999999999999999997543221111 11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....+.......++.                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQNDPPSLETGVQDKE------------------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSSCCCTTC-----C------------------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCCCccccccccch------------------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0100000000000000                  01123456889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.4e-38  Score=350.41  Aligned_cols=280  Identities=18%  Similarity=0.248  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC--------CCccceEEEEeeccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR--------HRNLIKIITICSSID  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~  624 (869)
                      .++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36899999999999999999999999999999999643 334567889999999985        788999999876431


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC--
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM--  702 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--  702 (869)
                       ......++||||+ ++++.+++.....    ..+++..++.++.||+.||+|||+++  ||+||||||+|||++.++  
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence             2346889999999 5577766665432    24899999999999999999999964  799999999999999775  


Q ss_pred             -----------------------------------------------cEEEccccccccCCCCCCCCccccCCCCCCccC
Q 002897          703 -----------------------------------------------VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG  735 (869)
Q Consensus       703 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g  735 (869)
                                                                     .+||+|||.|......           .....|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~~~~~g  255 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------FTEDIQ  255 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------SCSCCS
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------CccCCC
Confidence                                                           7999999999865432           233468


Q ss_pred             cccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchH-----HHhhhhh--cccccc--cccCccchhh
Q 002897          736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL-----HEFSKMV--LPEKVM--EIVDPSLLLE  806 (869)
Q Consensus       736 t~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~-----~~~~~~~--~~~~~~--~~~d~~~~~~  806 (869)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||..........     .......  .+....  ..........
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999899999999999999999999999997644332111     0110000  000000  0000000000


Q ss_pred             hhhcccccC---C-------CccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          807 VRANNSMSR---G-------GERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       807 ~~~~~~~~~---~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .........   .       .......+.+..+.+++.+||+.||++|||++|+++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000000   0       001123456778999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=332.35  Aligned_cols=255  Identities=20%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc----chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ----KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+.+|+++++.++||||+++++++..   .+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            478999999999999999999999999999999996432    2345788999999999999999999999753   234


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++||||++++ +.+++.....    ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence            6789999999876 7777776432    2489999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC--CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE--ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      ||.+.........      .......|++.|+|||++.+..  ++.++|||||||++|+|++|+.||....     ....
T Consensus       153 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~  221 (305)
T 2wtk_C          153 LGVAEALHPFAAD------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKL  221 (305)
T ss_dssp             CTTCEECCTTCSS------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH
T ss_pred             cccccccCccccc------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHH
Confidence            9999876543211      1223456899999999987654  4789999999999999999999997522     1111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .........                        ..+..++..+.+++.+||+.||++|||++|+++.
T Consensus       222 ~~~i~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          222 FENIGKGSY------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHCCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcCCC------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111110000                        0001234567899999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-38  Score=372.74  Aligned_cols=250  Identities=23%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|++.++||+|+||.||+|++..+++.||||+++..   .....+.+..|..++..+ +||+|+++++++.     +
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence            456899999999999999999999999999999999743   234457788999999988 7999999999854     3


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      .+..++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence            478999999999999999998754      389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|+......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..
T Consensus       485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~  551 (674)
T 3pfq_A          485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF  551 (674)
T ss_dssp             CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred             ecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHH
Confidence            999998643322        223456799999999999999999999999999999999999999975321     1222


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM-----RDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  852 (869)
                      ..+......                        .+...+.++.+++.+||+.||++||++     +||++
T Consensus       552 ~~i~~~~~~------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          552 QSIMEHNVA------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHSSCCC------------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHhCCCC------------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            222111100                        001234567899999999999999997     66653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.6e-39  Score=367.41  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=207.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.++||+|+||.||+|.+. .+..||||+++.... ..+.+.+|++++++++||||+++++++..      ...
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            3467888999999999999999996 567899999975432 34679999999999999999999999753      457


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.++++....    ..+++.+++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             eEeeehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            999999999999999975321    2389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      ++.......       .......++..|+|||++.+..++.++|||||||++|||++ |+.||......     +.....
T Consensus       410 a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~i  477 (535)
T 2h8h_A          410 ARLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV  477 (535)
T ss_dssp             TTTCCCHHH-------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHHH
T ss_pred             ceecCCCce-------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence            986543210       11223456789999999988899999999999999999999 99998753221     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ....                       ....+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus       478 ~~~~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          478 ERGY-----------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HTTC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            1000                       0001123456788999999999999999999999999887543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.6e-39  Score=355.37  Aligned_cols=275  Identities=21%  Similarity=0.268  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  631 (869)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....    ....+|+++++.++||||+++++++..... .+....
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346889999999999999999999899999999986432    223479999999999999999998765322 233457


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CcEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg  710 (869)
                      ++||||+++ ++.+.+.....  ....+++..++.++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             Eeehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            799999976 67666553211  012489999999999999999999999   99999999999999965 578999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+......         ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....+.
T Consensus       203 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~  272 (420)
T 1j1b_A          203 SAKQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKV  272 (420)
T ss_dssp             TCEECCTTC---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred             hhhhcccCC---------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence            998764432         12335689999999998765 6899999999999999999999999753221 111122111


Q ss_pred             hccc---ccccccCccchhhhhhcccccCCCccc---hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPE---KVMEIVDPSLLLEVRANNSMSRGGERV---KIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .-..   .+.. .++.... +.   ........+   .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       273 lg~p~~~~~~~-~~~~~~~-~~---~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          273 LGTPTREQIRE-MNPNYTE-FK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCHHHHHH-HCSCCCC-CC---CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCCHHHHHh-hChhhhh-hc---cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1000   0000 0000000 00   000000000   01123467889999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.6e-38  Score=345.65  Aligned_cols=203  Identities=24%  Similarity=0.323  Sum_probs=171.9

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CC-----ccceEEEEeeccc
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HR-----NLIKIITICSSID  624 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~  624 (869)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.++ |+     +|+++++++... 
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence            3457899999999999999999999999999999999643 233467788999988884 55     499999987653 


Q ss_pred             cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC
Q 002897          625 FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDM  702 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~  702 (869)
                          ...++||||++ |+|.+++.....    ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++
T Consensus       129 ----~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          129 ----NHLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             ----TEEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             ----CceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence                78999999996 599999987642    2489999999999999999999952 12899999999999994  477


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      .+||+|||+|+.....           .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       199 ~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8999999999876432           22356899999999999999999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-38  Score=350.94  Aligned_cols=278  Identities=19%  Similarity=0.244  Sum_probs=193.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  631 (869)
                      ..+|++.++||+|+||+||+|++..+++ ||+|++.....    ...+|+++++.++||||+++++++..... .+....
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3579999999999999999999975555 88887753322    22479999999999999999999865432 334557


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg  710 (869)
                      ++||||++++.+.........   ...+++..++.++.||++||+|||++   +|+||||||+||+++ .++.+||+|||
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEeeccCccHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            899999987544333221110   12489999999999999999999999   999999999999999 79999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      +|+......         ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ......+.
T Consensus       188 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~  257 (394)
T 4e7w_A          188 SAKILIAGE---------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKV  257 (394)
T ss_dssp             TCEECCTTC---------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             CcccccCCC---------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence            998764432         22345689999999998765 58999999999999999999999997643211 11111111


Q ss_pred             hcccc--cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEK--VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .-...  .....++........ ...............+.++.+++.+||+.||++|||+.|+++
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hCCCCHHHHHhhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            10000  000000000000000 000000000001124567889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.7e-38  Score=335.45  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=196.3

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-------
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID-------  624 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  624 (869)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356799999999999999999999989999999999643 344577899999999999999999999876421       


Q ss_pred             -cCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          625 -FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       625 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                       .......++||||+++|+|.+++.....     .+++..++.++.|+++||+|||++   +|+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence             1235678999999999999999987543     378899999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCc------cccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          704 AHVGDFGLAKFLPARPLDTV------VETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +||+|||.+...........      ...........|++.|+|||++.+. .++.++|||||||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999987643211000      0001223445689999999998764 68999999999999999998   55421


Q ss_pred             ccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          777 FHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..    ............  ....+.                  .....+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~----~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 ME----RVNILKKLRSVS--IEFPPD------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH----HHHHHHHHHSTT--CCCCTT------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hh----HHHHHHhccccc--cccCcc------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11    111111110000  000000                  01123456789999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.8e-38  Score=329.87  Aligned_cols=253  Identities=26%  Similarity=0.317  Sum_probs=202.9

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----
Confidence            34578999999999999999999999899999999996433  23457889999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CcEE
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD---MVAH  705 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k  705 (869)
                      ...++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+|
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            77899999999999999987654      389999999999999999999999   99999999999999764   4799


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE  785 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~  785 (869)
                      |+|||.+.......         ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......     .
T Consensus       165 L~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~  229 (287)
T 2wei_A          165 IIDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----D  229 (287)
T ss_dssp             ECSTTGGGTBCCCS---------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H
T ss_pred             EeccCcceeecCCC---------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----H
Confidence            99999998654332         1223458999999999876 4899999999999999999999999753211     1


Q ss_pred             hhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          786 FSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       786 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...........  .+                  .+....++..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~--~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          230 ILKRVETGKYA--FD------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHCCCC--CC------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCC--CC------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11111100000  00                  0011123456889999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-38  Score=339.95  Aligned_cols=259  Identities=20%  Similarity=0.290  Sum_probs=177.3

Q ss_pred             HhcCCCCCC-eeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          552 ATSEFSSSN-MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       552 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..++|.+.+ +||+|+||+||+|.+..+|+.||||++....    .........++.++||||+++++++... ..+...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCce
Confidence            356888855 6999999999999999999999999986422    1222233345667999999999998653 233466


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  707 (869)
                      .++||||+++|+|.+++.....    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            8999999999999999987643    2489999999999999999999999   9999999999999976   4569999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.+.......          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ..
T Consensus       174 Dfg~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~  242 (336)
T 3fhr_A          174 DFGFAKETTQNA----------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MK  242 (336)
T ss_dssp             CCTTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             ccccceeccccc----------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HH
Confidence            999998654321          2334689999999999888899999999999999999999999975332211000 00


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ...... ....                   .......++..+.+++.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~-~~~~-------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          243 RRIRLG-QYGF-------------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---------CC-------------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Hhhhcc-cccc-------------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000000 0000                   000111345568899999999999999999999973

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-37  Score=336.76  Aligned_cols=274  Identities=19%  Similarity=0.276  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEE-CCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCC------ccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGII-GENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR------NLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|+++++.++|+      +++++++++...  
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence            36899999999999999999998 5689999999996432 3456788999999988655      599999987653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-----  700 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----  700 (869)
                         +..++||||+ +++|.+++.....    .++++..+..++.|+++||+|||++   +|+||||||+||+++.     
T Consensus        90 ---~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           90 ---GHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             ---TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             ---CcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence               6899999999 8899999987653    2489999999999999999999999   9999999999999987     


Q ss_pred             --------------CCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHH
Q 002897          701 --------------DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM  766 (869)
Q Consensus       701 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  766 (869)
                                    ++.+||+|||.+......           .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence                          668999999999864332           2345689999999999998999999999999999999


Q ss_pred             HcCCCCCCcCccCCchHHHhhhhh--cccccccc--------------cCccchhhhhhcccccCCCccchHHHHHHHHH
Q 002897          767 FSRRRPTDSMFHEGLTLHEFSKMV--LPEKVMEI--------------VDPSLLLEVRANNSMSRGGERVKIEECLVAVI  830 (869)
Q Consensus       767 ~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~--------------~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  830 (869)
                      ++|+.||....... .........  .+......              ..........................+++.+.
T Consensus       228 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  306 (339)
T 1z57_A          228 YLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF  306 (339)
T ss_dssp             HHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred             HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence            99999997532211 111111100  00000000              00000000000000000000111234567899


Q ss_pred             HHHhhccCCCCCCCCCHHHHHH
Q 002897          831 RIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       831 ~li~~cl~~dP~~RPs~~evl~  852 (869)
                      +++.+||+.||++|||++|+++
T Consensus       307 ~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          307 DLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhCcCcccccCHHHHhc
Confidence            9999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=342.53  Aligned_cols=276  Identities=21%  Similarity=0.241  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-CCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-NGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  629 (869)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35799999999999999999999999999999999643  23345678999999999999999999999765321 1123


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||++ |+|.+++..        .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence            4699999997 588877643        289999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.++.....           .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......
T Consensus       171 g~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~  238 (353)
T 3coi_A          171 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK  238 (353)
T ss_dssp             TCTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH
T ss_pred             ccccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            999754322           223468999999999877 678999999999999999999999997532211 1111111


Q ss_pred             hh--cccccccccCccchhhh-hhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MV--LPEKVMEIVDPSLLLEV-RANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~--~~~~~~~~~d~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..  .+..............+ .................++..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            10  00001111110000000 000000000001111234567889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.9e-38  Score=337.43  Aligned_cols=261  Identities=21%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             ccHHHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCC--CCccceEEEE
Q 002897          544 ISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIR--HRNLIKIITI  619 (869)
Q Consensus       544 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~  619 (869)
                      +.+..+....++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|++++++++  ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            333444445678999999999999999999996 6999999999643  3345678899999999996  5999999999


Q ss_pred             eeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       620 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      +...     ...++||| +.+++|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++
T Consensus        97 ~~~~-----~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           97 EITD-----QYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV  161 (313)
T ss_dssp             EECS-----SEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred             eecC-----CEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE
Confidence            7653     67899999 56889999998764      389999999999999999999999   999999999999996


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-----------CCCCccccchhhhHHHHHHHc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-----------SEASMTGDVYSFGILLLEMFS  768 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~el~t  768 (869)
                      + +.+||+|||.+........      ........|++.|+|||++.+           ..++.++|||||||++|+|++
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~  234 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  234 (313)
T ss_dssp             T-TEEEECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred             C-CeEEEeeccccccccCccc------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence            4 8999999999986644321      012234568999999999865           468889999999999999999


Q ss_pred             CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002897          769 RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR  848 (869)
Q Consensus       769 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  848 (869)
                      |+.||.......   ........+..... .                      +...+..+.+++.+||+.||++|||++
T Consensus       235 g~~pf~~~~~~~---~~~~~~~~~~~~~~-~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (313)
T 3cek_A          235 GKTPFQQIINQI---SKLHAIIDPNHEIE-F----------------------PDIPEKDLQDVLKCCLKRDPKQRISIP  288 (313)
T ss_dssp             SSCTTTTCCSHH---HHHHHHHCTTSCCC-C----------------------CCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCchhhHHHHH---HHHHHHHhcccccC-C----------------------cccchHHHHHHHHHHccCCcccCcCHH
Confidence            999997532221   11111110000000 0                      001234678999999999999999999


Q ss_pred             HHHHH
Q 002897          849 DVVVK  853 (869)
Q Consensus       849 evl~~  853 (869)
                      |+++.
T Consensus       289 ell~h  293 (313)
T 3cek_A          289 ELLAH  293 (313)
T ss_dssp             HHHTS
T ss_pred             HHhcC
Confidence            99874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.4e-38  Score=343.10  Aligned_cols=289  Identities=21%  Similarity=0.238  Sum_probs=194.0

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeecccc-
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDF-  625 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  625 (869)
                      .......++|++.+.||+|+||+||+|++..+|+.||||++.... .......+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445677789999999999999999999999899999999985432 233456778888899999999999999865422 


Q ss_pred             -CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCceeecC-C
Q 002897          626 -NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH--HHCKPPVVHGDLKPSNVLLDH-D  701 (869)
Q Consensus       626 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~  701 (869)
                       ......++||||+++ ++.+.+.....  ....+++..+..++.|++.||+|||  +.   +|+||||||+||+++. +
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence             223347899999976 55544432111  0124899999999999999999999  88   9999999999999997 8


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      +.+||+|||+++......         ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... 
T Consensus       169 ~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-  238 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE---------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-  238 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS---------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred             CcEEEeeCCCceecCCCC---------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-
Confidence            999999999998765432         223456899999999986654 899999999999999999999999763322 


Q ss_pred             chHHHhhhhhccc--ccccccCccchh-hhhhccccc-CCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          781 LTLHEFSKMVLPE--KVMEIVDPSLLL-EVRANNSMS-RGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       781 ~~~~~~~~~~~~~--~~~~~~d~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......+.....  ......++.... ......... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111111111000  000000100000 000000000 00000001124567899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.3e-38  Score=365.86  Aligned_cols=261  Identities=21%  Similarity=0.362  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECC---CCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGE---NGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ..++|++.+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+     
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence            44678889999999999999999853   35689999986533 3445778999999999999999999998743     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       +..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence             457899999999999999986543     389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+++.......       .......+++.|+|||++.+..++.++|||||||++|||++ |..||......     +.
T Consensus       534 DFG~a~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~  601 (656)
T 2j0j_A          534 DFGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DV  601 (656)
T ss_dssp             CCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred             ecCCCeecCCCcc-------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HH
Confidence            9999987644321       11223456789999999988899999999999999999997 99999753221     11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      .........                       ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       602 ~~~i~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          602 IGRIENGER-----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHHHHHTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCC-----------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            111100000                       0011134457889999999999999999999999999987653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.8e-38  Score=341.18  Aligned_cols=266  Identities=20%  Similarity=0.322  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchh-----------------hHHHHHHHHHHHhCCCCccce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGA-----------------LKSFLTECEALRSIRHRNLIK  615 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  615 (869)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++.......                 .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  89999999996432211                 178999999999999999999


Q ss_pred             EEEEeeccccCCCceEEEEeecccCCCHHHH------HhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 002897          616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEW------LHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVH  688 (869)
Q Consensus       616 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH  688 (869)
                      +++++...     +..++||||+++|+|.++      +....    ...+++..++.++.|++.||+|||+ .   ||+|
T Consensus       108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            99997653     788999999999999998      54421    2358999999999999999999999 8   9999


Q ss_pred             cCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCc-cccchhhhHHHHHH
Q 002897          689 GDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASM-TGDVYSFGILLLEM  766 (869)
Q Consensus       689 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~il~el  766 (869)
                      |||||+||+++.++.+||+|||.+......          ......|+..|+|||++.+. .++. ++|||||||++|+|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999999999865432          22345689999999999887 5666 99999999999999


Q ss_pred             HcCCCCCCcCccCCchHHHhhhhhcccccccccCc-cchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC
Q 002897          767 FSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDP-SLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM  845 (869)
Q Consensus       767 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  845 (869)
                      ++|+.||................    ......+. .......      ..........++..+.+++.+||+.||++||
T Consensus       246 ~~g~~pf~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  315 (348)
T 2pml_X          246 FYNVVPFSLKISLVELFNNIRTK----NIEYPLDRNHFLYPLT------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERI  315 (348)
T ss_dssp             HHSSCSSCCSSCSHHHHHHHTSC----CCCCCCSSSSSTTTTC------C--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HhCCCCCCCCCcHHHHHHHHhcc----CcCCccchhhhhcccc------ccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence            99999997643321111111111    10000000 0000000      0000011123456788999999999999999


Q ss_pred             CHHHHHH
Q 002897          846 QMRDVVV  852 (869)
Q Consensus       846 s~~evl~  852 (869)
                      |++|+++
T Consensus       316 s~~e~l~  322 (348)
T 2pml_X          316 TSEDALK  322 (348)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-37  Score=335.90  Aligned_cols=259  Identities=21%  Similarity=0.276  Sum_probs=178.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHH-HHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECE-ALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|.+..+|+.||||+++... ......+..|+. +++.++||||+++++++...     +.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence            468999999999999999999999899999999997543 233455666666 67778999999999997653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++ +|.+++...... ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            8999999975 888877641100 0124899999999999999999999953  79999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCccc----CCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG----TGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      .++......         ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||..........   
T Consensus       172 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---  239 (327)
T 3aln_A          172 ISGQLVDSI---------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL---  239 (327)
T ss_dssp             SSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred             Cceeccccc---------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH---
Confidence            997654321         12234689999999998    45678999999999999999999999997532111110   


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ........     +.+.              ......++..+.+++.+||+.||++|||+.|+++
T Consensus       240 -~~~~~~~~-----~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 -TQVVKGDP-----PQLS--------------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CCCCCSCC-----CCCC--------------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHHhcCCC-----CCCC--------------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             00000000     0000              0000123456889999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=345.83  Aligned_cols=209  Identities=21%  Similarity=0.299  Sum_probs=157.6

Q ss_pred             cCCCC-CCeeeeecceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSS-SNMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      +.|.+ .++||+|+||+||+|++.  .+++.||||++....  ....+.+|+.++++++||||+++++++...   ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCe
Confidence            34665 568999999999999975  468899999996433  235788999999999999999999997542   3467


Q ss_pred             EEEEeecccCCCHHHHHhhCCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDK---LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL----DHDMV  703 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~  703 (869)
                      .++||||+++ +|.+++......   .....+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            8999999964 888887643211   1122489999999999999999999999   99999999999999    67789


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +||+|||+|+.......     .........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       171 ~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCCCc-----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999999987654321     11223446789999999998874 5899999999999999999999999754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=339.48  Aligned_cols=264  Identities=21%  Similarity=0.286  Sum_probs=197.8

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..++|++.+.||+|+||.||+|.+..   .||+|+++...  ....+.+.+|+.++++++||||+++++++...     .
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence            45789999999999999999999853   49999986432  23345678899999999999999999997653     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++ ++.+||+||
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred             ceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence            78999999999999999987543     389999999999999999999999   999999999999998 679999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---------CCCCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---------SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      |++..........   .........|++.|+|||++.+         ..++.++|||||||++|||++|+.||...... 
T Consensus       174 g~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-  249 (319)
T 2y4i_B          174 GLFSISGVLQAGR---REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-  249 (319)
T ss_dssp             SCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-
T ss_pred             CCccccccccccc---cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            9987654322110   1122334568999999998764         45788999999999999999999999753221 


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                          ................                      ..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       250 ----~~~~~~~~~~~~~~~~----------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          250 ----AIIWQMGTGMKPNLSQ----------------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ----HHHHHHHTTCCCCCCC----------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ----HHHHHhccCCCCCCCc----------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                1111110000000000                      01233577999999999999999999999999988766


Q ss_pred             hh
Q 002897          861 FV  862 (869)
Q Consensus       861 ~~  862 (869)
                      ..
T Consensus       304 ~~  305 (319)
T 2y4i_B          304 NR  305 (319)
T ss_dssp             --
T ss_pred             hc
Confidence            43

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-37  Score=341.21  Aligned_cols=280  Identities=16%  Similarity=0.229  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-----------CCccceEEEEee
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-----------HRNLIKIITICS  621 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  621 (869)
                      .++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36899999999999999999999989999999999643 233467889999998885           899999999987


Q ss_pred             ccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--
Q 002897          622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--  699 (869)
Q Consensus       622 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--  699 (869)
                      ... .+....++||||+ +++|.+++.....    ..+++..+..++.||+.||+|||+++  +|+||||||+||+++  
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence            542 2234789999999 8899999987543    24899999999999999999999953  899999999999994  


Q ss_pred             ----CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCc
Q 002897          700 ----HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDS  775 (869)
Q Consensus       700 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~  775 (869)
                          ..+.+||+|||++......           .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCCcCcceEEEcccccccccCCC-----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                4458999999999865432           2234689999999999999999999999999999999999999975


Q ss_pred             CccCCc-----hHHHhhhhhc--ccccc-------cccCcc-chhhhhhcc-cc---cCCCccchHHHHHHHHHHHHhhc
Q 002897          776 MFHEGL-----TLHEFSKMVL--PEKVM-------EIVDPS-LLLEVRANN-SM---SRGGERVKIEECLVAVIRIGVVC  836 (869)
Q Consensus       776 ~~~~~~-----~~~~~~~~~~--~~~~~-------~~~d~~-~~~~~~~~~-~~---~~~~~~~~~~~~~~~l~~li~~c  836 (869)
                      ......     .........-  +....       ..++.. ......... +.   ........+..++..+.+++.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence            432110     1111111000  00000       000000 000000000 00   00000112246778899999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 002897          837 SMESPTDRMQMRDVVV  852 (869)
Q Consensus       837 l~~dP~~RPs~~evl~  852 (869)
                      |+.||++|||++|+++
T Consensus       318 L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             hccCccccCCHHHHhh
Confidence            9999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=336.46  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=192.0

Q ss_pred             HHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhC----CCCccceEE
Q 002897          548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK------GALKSFLTECEALRSI----RHRNLIKII  617 (869)
Q Consensus       548 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~  617 (869)
                      +.....++|++.+.||+|+||.||+|++..+++.||||+++....      .....+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            344556789999999999999999999998999999999964432      1223456799999988    899999999


Q ss_pred             EEeeccccCCCceEEEEeec-ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 002897          618 TICSSIDFNGVDFKAIVYDF-MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNV  696 (869)
Q Consensus       618 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  696 (869)
                      +++..     .+..++|||| +.+++|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||
T Consensus       105 ~~~~~-----~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          105 DWFET-----QEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             EEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             EEEec-----CCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            99654     3678999999 78999999998754      389999999999999999999999   999999999999


Q ss_pred             eec-CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCC-ccccchhhhHHHHHHHcCCCCCC
Q 002897          697 LLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEAS-MTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       697 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~el~tg~~pf~  774 (869)
                      +++ .++.+||+|||.+.......          .....|+..|+|||++.+..+. .++|||||||++|+|++|+.||.
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence            999 88999999999998765432          2334689999999998776664 58999999999999999999996


Q ss_pred             cCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...       .......          .                  ....++..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~-------~~~~~~~----------~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          241 RDQ-------EILEAEL----------H------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             SHH-------HHHHTCC----------C------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ChH-------HHhhhcc----------C------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            421       1110000          0                  00123346789999999999999999999987

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.1e-37  Score=338.30  Aligned_cols=335  Identities=18%  Similarity=0.205  Sum_probs=204.6

Q ss_pred             CCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEE
Q 002897           69 LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELL  148 (869)
Q Consensus        69 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L  148 (869)
                      +++|+.|++++|.+....+..|.++++|++|+|++|.+. .++...|..+++|++|++++|.+++..|..|.++++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            456667777777666554445566666666666666665 4443444445555555555555444444444444444444


Q ss_pred             EccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEE
Q 002897          149 ELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTID  228 (869)
Q Consensus       149 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~  228 (869)
                      +|++|+++.+.+..|..+++|++|++++|                              ++++..+..+..+++ |++|+
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n------------------------------~l~~~~~~~~~~l~~-L~~L~  171 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNN------------------------------NLERIEDDTFQATTS-LQNLQ  171 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSS------------------------------CCCBCCTTTTSSCTT-CCEEE
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCC------------------------------ccCccChhhccCCCC-CCEEE
Confidence            44444444444433444444444444444                              444433333443333 44444


Q ss_pred             ecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccc
Q 002897          229 IGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG  308 (869)
Q Consensus       229 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  308 (869)
                      +++|.+++.   .+..+++|+.|++++|.+.+     +...++|++|++++|.+... |..  ..++|+.|++++|++++
T Consensus       172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          172 LSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             CCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcc
Confidence            444444422   13344555555555555542     12234566666666666543 221  13456666666666653


Q ss_pred             cCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCcccc
Q 002897          309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS  388 (869)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  388 (869)
                      .  ..+..+++|++|++++|+++                         +..|..|.++++|++|+|++|+++ .+|..+.
T Consensus       241 ~--~~l~~l~~L~~L~Ls~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~  292 (390)
T 3o6n_A          241 T--AWLLNYPGLVEVDLSYNELE-------------------------KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ  292 (390)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCC-------------------------EEESGGGTTCSSCCEEECCSSCCC-EEECSSS
T ss_pred             c--HHHcCCCCccEEECCCCcCC-------------------------CcChhHccccccCCEEECCCCcCc-ccCcccC
Confidence            2  45666666666666666555                         345677788888888999988888 4566677


Q ss_pred             CCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCcccc
Q 002897          389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFS  468 (869)
Q Consensus       389 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~  468 (869)
                      .+++|++|++++|+++ .+|..+..+++|+.|+|++|++++ +|  +..+++|+.|++++|++++.... ..+..+....
T Consensus       293 ~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~  367 (390)
T 3o6n_A          293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPA  367 (390)
T ss_dssp             CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTT
T ss_pred             CCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhc
Confidence            8889999999999998 677788889999999999999984 44  67788999999999999875432 2355566666


Q ss_pred             ccCCcccCCCC
Q 002897          469 LSGNGKLCGGL  479 (869)
Q Consensus       469 ~~~n~~~c~~~  479 (869)
                      +.+++..|..+
T Consensus       368 ~~~~~~~c~~~  378 (390)
T 3o6n_A          368 VDDADQHCKID  378 (390)
T ss_dssp             BCCCCSCCCTT
T ss_pred             ccccCceeccc
Confidence            77888888753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-36  Score=331.21  Aligned_cols=273  Identities=20%  Similarity=0.289  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC-eEEEEEEeecccchhhHHHHHHHHHHHhCCCCc------cceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG-MLVAVKVLNLMQKGALKSFLTECEALRSIRHRN------LIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~  625 (869)
                      .++|++.+.||+|+||+||+|.+..++ +.||+|+++... ...+.+.+|+.+++.++|++      ++.+.+++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--
Confidence            468999999999999999999997666 799999996432 34467888999999987655      88888886543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-------
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL-------  698 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-------  698 (869)
                         ...++||||+ ++++.+++.....    ..+++.+++.++.||+.||+|||++   +|+||||||+||++       
T Consensus        95 ---~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           95 ---GHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             ---TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred             ---CeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence               6899999999 6677777766542    2489999999999999999999999   99999999999999       


Q ss_pred             ------------cCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHH
Q 002897          699 ------------DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM  766 (869)
Q Consensus       699 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  766 (869)
                                  +.++.+||+|||.++.....           .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence                        56789999999999864332           2335689999999999999999999999999999999


Q ss_pred             HcCCCCCCcCccCCchHHHhhhhh--ccccccc-ccCccc-------h------hh-hhhcccccCCCccchHHHHHHHH
Q 002897          767 FSRRRPTDSMFHEGLTLHEFSKMV--LPEKVME-IVDPSL-------L------LE-VRANNSMSRGGERVKIEECLVAV  829 (869)
Q Consensus       767 ~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~-~~d~~~-------~------~~-~~~~~~~~~~~~~~~~~~~~~~l  829 (869)
                      ++|+.||....... .........  .+..... ......       +      .. ...... ............+..+
T Consensus       233 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  310 (355)
T 2eu9_A          233 YRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQL  310 (355)
T ss_dssp             HHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHH
T ss_pred             HhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHH
Confidence            99999997532211 111111100  0000000 000000       0      00 000000 0000001112345678


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHH
Q 002897          830 IRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       830 ~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+++.+||+.||++|||++|+++
T Consensus       311 ~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          311 FDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-37  Score=352.18  Aligned_cols=286  Identities=21%  Similarity=0.279  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|.+..+|+.||||+++.. .....+.+.+|++++++++||||+++++++.... +.....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999989999999998653 3444577899999999999999999999875521 233577


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---EEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV---AHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~  707 (869)
                      .++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.   +||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            8999999999999999987543   12488899999999999999999999   9999999999999997764   9999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||.+.......         ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....    ....|.
T Consensus       167 DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~  233 (676)
T 3qa8_A          167 DLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWH  233 (676)
T ss_dssp             SCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSS
T ss_pred             cccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhh
Confidence            999998765432         2234578999999999999999999999999999999999999996531    111221


Q ss_pred             hhhcccccc-cccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHHHH
Q 002897          788 KMVLPEKVM-EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD-----VVVKLCAARE  859 (869)
Q Consensus       788 ~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~  859 (869)
                      ......... ........+.......  ...........+..+.+++.+||++||++|||++|     ..+.+..+..
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            111111000 0000001000000000  00011122345678899999999999999999988     4455555543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4e-38  Score=338.03  Aligned_cols=242  Identities=20%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccch------hhHHHHHHHHHHHhCC--CCccceEEEEeecc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKG------ALKSFLTECEALRSIR--HRNLIKIITICSSI  623 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~  623 (869)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++.....      ....+.+|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            457899999999999999999999999999999999654321      2345678999999996  59999999997653


Q ss_pred             ccCCCceEEEEeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CC
Q 002897          624 DFNGVDFKAIVYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HD  701 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~  701 (869)
                           +..++||||+.+ ++|.+++....      .+++..++.++.|+++||+|||+.   +|+||||||+||+++ .+
T Consensus       121 -----~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          121 -----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             -----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred             -----CcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence                 778999999976 89999998754      389999999999999999999999   999999999999999 78


Q ss_pred             CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          702 MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      +.+||+|||.++......          .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....   
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---  253 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---  253 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             CCEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence            899999999998765422          223468999999999877665 688999999999999999999996421   


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                          .......      ...                      ..++..+.+++.+||+.||++|||++|+++
T Consensus       254 ----~~~~~~~------~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ----EIIRGQV------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----HHHHCCC------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----hhhcccc------ccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1110000      000                      012346789999999999999999999986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.5e-36  Score=333.95  Aligned_cols=311  Identities=17%  Similarity=0.191  Sum_probs=198.1

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+.++++|++++|.++.+.+..|..+++|++|+|++|+|+...+..|+.+++|++|+|++|++++..|..|.++++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            46778888888888875555557778888888888888877767778888888888888888887777777788888888


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL  179 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l  179 (869)
                      +|++|++. .+|...|.++++|++|++++|.+++..+..|.++++|++|++++|+++++   .+..+++|+.|++++|.+
T Consensus       123 ~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l  198 (390)
T 3o6n_A          123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL  198 (390)
T ss_dssp             ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred             ECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence            88888776 66666666666666666666666666566666666666666666666543   244455566666666655


Q ss_pred             CCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcce
Q 002897          180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI  259 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  259 (869)
                      +.+           ...++|++|++++|+++.                         . |..  ..++|+.|++++|.+.
T Consensus       199 ~~~-----------~~~~~L~~L~l~~n~l~~-------------------------~-~~~--~~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          199 STL-----------AIPIAVEELDASHNSINV-------------------------V-RGP--VNVELTILKLQHNNLT  239 (390)
T ss_dssp             SEE-----------ECCSSCSEEECCSSCCCE-------------------------E-ECC--CCSSCCEEECCSSCCC
T ss_pred             ccc-----------CCCCcceEEECCCCeeee-------------------------c-ccc--ccccccEEECCCCCCc
Confidence            432           222345555555555542                         2 111  1245556666666555


Q ss_pred             ecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccc
Q 002897          260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQIL  339 (869)
Q Consensus       260 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (869)
                      +.  ..+..+++|++|+|++|.+++..|..|.++++|+.|++++|+++ .+|..+..+++|++|++++|+++        
T Consensus       240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~--------  308 (390)
T 3o6n_A          240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL--------  308 (390)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC--------
T ss_pred             cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce--------
Confidence            32  35556666666666666666666666666666666666666666 34555566667777777666665        


Q ss_pred             ccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccC
Q 002897          340 SVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG  405 (869)
Q Consensus       340 ~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  405 (869)
                                        .+|..+..+++|+.|+|++|.+++ ++  +..+++|+.|++++|++.+
T Consensus       309 ------------------~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          309 ------------------HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             ------------------CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEH
T ss_pred             ------------------ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccc
Confidence                              233344555566666666666663 32  5556666666666666653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=330.24  Aligned_cols=252  Identities=19%  Similarity=0.242  Sum_probs=179.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....  ...+.+..+..+++.++||||+++++++...     +.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence            4678899999999999999999998999999999975432  2223344555578888999999999997653     68


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      .++||||+ ++.+..+......     .+++..++.++.|+++||+|||+ .   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence            89999999 5566666554332     38999999999999999999998 6   8999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH  784 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~  784 (869)
                      |.+.......         ......|++.|+|||++.     ...++.++|||||||++|+|++|+.||...........
T Consensus       170 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  240 (318)
T 2dyl_A          170 GISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT  240 (318)
T ss_dssp             TTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             CCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence            9997654322         122346899999999984     45688999999999999999999999975322111111


Q ss_pred             HhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       785 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......    ... .                    ....++..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~----~~~-~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          241 KVLQEEP----PLL-P--------------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHSCC----CCC-C--------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHhccCC----CCC-C--------------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1111100    000 0                    00013456789999999999999999999987

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.8e-36  Score=353.45  Aligned_cols=343  Identities=18%  Similarity=0.211  Sum_probs=220.9

Q ss_pred             CCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEE
Q 002897           69 LRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELL  148 (869)
Q Consensus        69 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L  148 (869)
                      +++++.|++++|.+..+.+..|.++++|++|+|++|.+.                         +..+..|..+++|++|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L  104 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-------------------------EIDTYAFAYAHTIQKL  104 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-------------------------EECTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-------------------------CCChHHhcCCCCCCEE
Confidence            345555555555555444444455555555555555554                         4444455555555566


Q ss_pred             EccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEE
Q 002897          149 ELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTID  228 (869)
Q Consensus       149 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~  228 (869)
                      +|++|.++++.+..|+++++|++|+|++|.++.++..      .|.++++|++|+|++|.+++..|..+..+++ |+.|+
T Consensus       105 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~  177 (597)
T 3oja_B          105 YMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRG------IFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQ  177 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCCCBCCTTTTTTCTT-CCEEE
T ss_pred             ECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHH------HhccCCCCCEEEeeCCcCCCCChhhhhcCCc-CcEEE
Confidence            6665555555555555555555555555555555432      3455555566666665555555555555543 55555


Q ss_pred             ecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccc
Q 002897          229 IGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG  308 (869)
Q Consensus       229 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  308 (869)
                      |++|.+++.   .+..+++|+.|++++|.+.+     +...++|+.|++++|.++...+..   .++|+.|++++|.+++
T Consensus       178 L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~  246 (597)
T 3oja_B          178 LSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD  246 (597)
T ss_dssp             CTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC
T ss_pred             CcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC
Confidence            555555532   13445556666666665543     223456667777777666433222   1456666666666653


Q ss_pred             cCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCcccc
Q 002897          309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS  388 (869)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  388 (869)
                        +..+..+++|+.|+|++|.++                         +..|..|+++++|+.|+|++|.+++ +|..+.
T Consensus       247 --~~~l~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~  298 (597)
T 3oja_B          247 --TAWLLNYPGLVEVDLSYNELE-------------------------KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ  298 (597)
T ss_dssp             --CGGGGGCTTCSEEECCSSCCC-------------------------EEESGGGTTCSSCCEEECTTSCCCE-EECSSS
T ss_pred             --ChhhccCCCCCEEECCCCccC-------------------------CCCHHHhcCccCCCEEECCCCCCCC-CCcccc
Confidence              355666666666666666655                         4567788888999999999999985 677778


Q ss_pred             CCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCccCCCcccc
Q 002897          389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFS  468 (869)
Q Consensus       389 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~  468 (869)
                      .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++. |  +..+++|+.|++++|++++.... ..+..+....
T Consensus       299 ~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~  373 (597)
T 3oja_B          299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPA  373 (597)
T ss_dssp             CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTT
T ss_pred             cCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhc
Confidence            8999999999999998 7888889999999999999999854 3  67788999999999999876532 2355666667


Q ss_pred             ccCCcccCCCCCCCCCCCC
Q 002897          469 LSGNGKLCGGLDEFHLPSC  487 (869)
Q Consensus       469 ~~~n~~~c~~~~~~~~~~~  487 (869)
                      +.++...|+.+.......|
T Consensus       374 ~~~~~~~C~~~~~~~~~~c  392 (597)
T 3oja_B          374 VDDADQHCKIDYQLEHGLC  392 (597)
T ss_dssp             BCCCCCCCCTTCEEETTEE
T ss_pred             cccccccCCcchhccCCcc
Confidence            8889999987654444444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-37  Score=341.29  Aligned_cols=257  Identities=21%  Similarity=0.255  Sum_probs=184.8

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .|.+.++||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+     ....++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~l   86 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYI   86 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEE
Confidence            455568899999999987655 48999999998643   235678999999876 89999999998654     378999


Q ss_pred             EeecccCCCHHHHHhhCCCcccc-cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----------
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEV-CNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-----------  701 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----------  701 (869)
                      ||||++ |+|.+++......... ...++..++.++.||+.||+|||+.   +|+||||||+||+++.+           
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence            999995 6999999876532111 1123445678999999999999999   99999999999999754           


Q ss_pred             --CcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-------CCCCccccchhhhHHHHHHHc-CCC
Q 002897          702 --MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-------SEASMTGDVYSFGILLLEMFS-RRR  771 (869)
Q Consensus       702 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~el~t-g~~  771 (869)
                        +.+||+|||+|+.........    ........||+.|+|||++.+       ..++.++|||||||++|||++ |+.
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             CceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence              489999999998775532110    012234579999999999865       568999999999999999999 999


Q ss_pred             CCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       772 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                      ||.......   ...........  .                   .........+.++.+++.+||+.||++|||+.||+
T Consensus       239 Pf~~~~~~~---~~i~~~~~~~~--~-------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  294 (434)
T 2rio_A          239 PFGDKYSRE---SNIIRGIFSLD--E-------------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL  294 (434)
T ss_dssp             TTCSTTTHH---HHHHHTCCCCC--C-------------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhH---HHHhcCCCCcc--c-------------------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence            996532211   11111110000  0                   00111235667889999999999999999999998


Q ss_pred             H
Q 002897          852 V  852 (869)
Q Consensus       852 ~  852 (869)
                      +
T Consensus       295 ~  295 (434)
T 2rio_A          295 R  295 (434)
T ss_dssp             T
T ss_pred             h
Confidence            6

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=336.70  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=184.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..+|.+.++||+|+||+||.... .+|+.||||++.....   ..+.+|+++++.+ +||||+++++++.+.     ...
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEE
Confidence            35688889999999999664433 4899999999864332   2356899999999 799999999987653     778


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCcEEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-----DMVAHV  706 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl  706 (869)
                      ++||||++ |+|.+++......     .++..++.++.||++||+|||+.   +|+||||||+||+++.     ...+||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             EEEEECCC-CCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            99999996 5999999876532     44556789999999999999999   9999999999999953     236889


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC---CCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCch
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT---GSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLT  782 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~  782 (869)
                      +|||+|+........     ........||+.|+|||++.   ...++.++|||||||++|||++ |..||......   
T Consensus       165 ~DFG~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---  236 (432)
T 3p23_A          165 SDFGLCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---  236 (432)
T ss_dssp             CCTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---
T ss_pred             ecccceeeccCCCcc-----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---
Confidence            999999876543211     12234467999999999987   4567889999999999999999 99998542211   


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...   ............                    ........+.+++.+||+.||++|||++||++
T Consensus       237 ~~~---~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          237 QAN---ILLGACSLDCLH--------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHH---HHTTCCCCTTSC--------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHH---HHhccCCccccC--------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            101   010000000000                    01133455779999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.8e-36  Score=315.41  Aligned_cols=234  Identities=13%  Similarity=0.104  Sum_probs=185.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.++++++||||+++++++...     +.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----Cc
Confidence            67999999999999999999999889999999997542   33457889999999999999999999997653     67


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.++++..        ....++..++.|++.||+|||++   ||+||||||+||+++.++.+||+++|
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence            89999999999999999643        35567889999999999999999   99999999999999999999998544


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .                            ++       .++.++|||||||++|||+||+.||.......... ......
T Consensus       175 ~----------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~~~~  218 (286)
T 3uqc_A          175 T----------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDT  218 (286)
T ss_dssp             C----------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECCBCT
T ss_pred             c----------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHHHHh
Confidence            2                            22       36889999999999999999999997643221000 000000


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                       ..   ....+                 ......++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       219 -~~---~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          219 -AG---QPIEP-----------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             -TS---CBCCH-----------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             -cc---CCCCh-----------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence             00   00000                 00111345678899999999999999 9999999999987553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-35  Score=345.43  Aligned_cols=310  Identities=17%  Similarity=0.184  Sum_probs=192.2

Q ss_pred             cCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEE
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIF  100 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  100 (869)
                      +.+++.|++++|.++.+.+..|.++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45666666666666654445566666666666666666666666666666666666666666666666666666666666


Q ss_pred             CcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      |++|.+. .+|...|.++++|++|++++|.+++..|..|.++++|++|+|++|.++++.   +..+++|+.|++++|.++
T Consensus       130 L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             eeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence            6666665 555555555555555555555555555555555555555555555544331   333444444555444443


Q ss_pred             CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCccee
Q 002897          181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG  260 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  260 (869)
                      .+           ...++                         |+.|++++|.++...+..   .++|+.|+|++|.+.+
T Consensus       206 ~l-----------~~~~~-------------------------L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~  246 (597)
T 3oja_B          206 TL-----------AIPIA-------------------------VEELDASHNSINVVRGPV---NVELTILKLQHNNLTD  246 (597)
T ss_dssp             EE-----------ECCTT-------------------------CSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC
T ss_pred             cc-----------cCCch-------------------------hheeeccCCccccccccc---CCCCCEEECCCCCCCC
Confidence            21           12233                         555555555554322211   2456677777776654


Q ss_pred             cCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccc
Q 002897          261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILS  340 (869)
Q Consensus       261 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  340 (869)
                        +..++.+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++ +|..+..+++|+.|+|++|+++         
T Consensus       247 --~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~---------  314 (597)
T 3oja_B          247 --TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL---------  314 (597)
T ss_dssp             --CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC---------
T ss_pred             --ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC---------
Confidence              3566777777777777777777777777777777777777777774 4666667777888777777776         


Q ss_pred             cccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccC
Q 002897          341 VTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSG  405 (869)
Q Consensus       341 ~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  405 (869)
                                       .+|..+..+++|+.|+|++|.+++. |  +..+++|+.|++++|++.+
T Consensus       315 -----------------~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          315 -----------------HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             -----------------CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             -----------------ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence                             3445566667777777777777743 3  5667788888888888764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-36  Score=353.26  Aligned_cols=248  Identities=20%  Similarity=0.327  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-CCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-NGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|.+.. +|+.||||++... .......+.+|++++++++||||+++++++...+..+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999975 7899999998643 3344567899999999999999999999987754333334


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++++|.+++..        .+++.+++.++.||++||+|||++   +|+||||||+||+++.+ .+||+|||
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             eEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            7999999999999987754        289999999999999999999999   99999999999999875 89999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +++.....            ....||+.|+|||++.+. ++.++|||||||++|+|++|..||........         
T Consensus       227 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------  284 (681)
T 2pzi_A          227 AVSRINSF------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------  284 (681)
T ss_dssp             TCEETTCC------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred             cchhcccC------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence            99865432            335699999999998765 48899999999999999999988764221100         


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-QMRDVVVKLCAAREA  860 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~  860 (869)
                       +       .                  .......+..+.+++.+||+.||++|| +++++...+..+.+.
T Consensus       285 -~-------~------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          285 -P-------E------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             -C-------T------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             -c-------c------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence             0       0                  001113345688999999999999999 566777777766544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-36  Score=335.79  Aligned_cols=251  Identities=17%  Similarity=0.145  Sum_probs=182.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCC-Cccc---------eEEEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRH-RNLI---------KIITI  619 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv---------~~~~~  619 (869)
                      ...|...++||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.+++.+.| ++..         ...+.
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999999999999999987332   2336789999999999977 2211         11111


Q ss_pred             ------------eeccccCCCceEEEEeecccCCCHHHHHhhCCC-cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002897          620 ------------CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNND-KLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPV  686 (869)
Q Consensus       620 ------------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  686 (869)
                                  ............+++|+++ +++|.+++..... ......+++..++.++.||++||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                        1110000123457777766 6799999852210 00012478889999999999999999999   99


Q ss_pred             EecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCccc----------CCCCCCccccc
Q 002897          687 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYG----------TGSEASMTGDV  756 (869)
Q Consensus       687 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv  756 (869)
                      +||||||+|||++.++.+||+|||+++.....           .....| +.|+|||++          .+..++.++||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            99999999999999999999999999764332           233467 999999998          55668999999


Q ss_pred             hhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhc
Q 002897          757 YSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVC  836 (869)
Q Consensus       757 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  836 (869)
                      |||||++|||++|+.||........     .......                        .    ..++..+.+++.+|
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~-----~~~~~~~------------------------~----~~~~~~~~~li~~~  347 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGG-----SEWIFRS------------------------C----KNIPQPVRALLEGF  347 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSC-----SGGGGSS------------------------C----CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhh-----HHHHHhh------------------------c----ccCCHHHHHHHHHH
Confidence            9999999999999999975322110     0000000                        0    01235688999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 002897          837 SMESPTDRMQMRDVVV  852 (869)
Q Consensus       837 l~~dP~~RPs~~evl~  852 (869)
                      |+.||++|||+.|+++
T Consensus       348 l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          348 LRYPKEDRLLPLQAME  363 (413)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             ccCChhhCcCHHHHHh
Confidence            9999999999888754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-35  Score=313.56  Aligned_cols=237  Identities=20%  Similarity=0.294  Sum_probs=182.9

Q ss_pred             hcCCCCC-CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHH-HhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSS-NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|+++.     ...+.+|++++ +..+||||+++++++... ..+...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence            3567776 789999999999999999999999999853     24567888888 556999999999997653 233577


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  707 (869)
                      .++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            8999999999999999987643    2489999999999999999999999   9999999999999998   7899999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||++....                              +..++.++||||+||++|||++|+.||.........     
T Consensus       163 Dfg~a~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----  207 (299)
T 3m2w_A          163 DFGFAKETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----  207 (299)
T ss_dssp             CCTTCEECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------
T ss_pred             ccccccccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----
Confidence            999986432                              234678999999999999999999999653221100     


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .... .   ......            ..........++..+.+++.+||+.||++|||+.|+++.
T Consensus       208 ~~~~-~---~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          208 PGMK-T---RIRMGQ------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSC-C---SSCTTC------------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH-H---HHhhcc------------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000 0   000000            000001112345678899999999999999999999873

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.4e-34  Score=312.98  Aligned_cols=308  Identities=22%  Similarity=0.400  Sum_probs=150.7

Q ss_pred             ccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcc
Q 002897           41 SIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN  120 (869)
Q Consensus        41 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  120 (869)
                      .+..+++|++|++++|.+. .+| .++.+++|++|+|++|++++. +. +.++++|++|+|++|.+. .+|  .+.++++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKIT-DIS--ALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG--GGTTCTT
T ss_pred             cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCccc-Cch--HHcCCCc
Confidence            3566777888888888777 344 377777888888888877743 33 777777777777777776 333  2444444


Q ss_pred             hhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCc
Q 002897          121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE  200 (869)
Q Consensus       121 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~  200 (869)
                      |++|++++|.++...+  +..+++|++|++++|......+ .+.                              .+++|+
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~------------------------------~l~~L~  158 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLS------------------------------NMTGLN  158 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGT------------------------------TCTTCC
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chh------------------------------hCCCCc
Confidence            4444444444443222  4445555555555553322211 244                              444444


Q ss_pred             EEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCc
Q 002897          201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSN  280 (869)
Q Consensus       201 ~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  280 (869)
                      +|++++|.+.+..+  +..+++ |+.|++++|.+++..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|
T Consensus       159 ~L~l~~~~~~~~~~--~~~l~~-L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          159 YLTVTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             EEECCSSCCCCCGG--GGGCTT-CSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             EEEecCCCcCCchh--hccCCC-CCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence            44444444432211  222222 3333333333331111  3334444444444444432222  344444444444444


Q ss_pred             cccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCc
Q 002897          281 FLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLP  360 (869)
Q Consensus       281 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p  360 (869)
                      .+++..+                          +..+++|++|++++|++++                          + 
T Consensus       232 ~l~~~~~--------------------------~~~l~~L~~L~l~~n~l~~--------------------------~-  258 (347)
T 4fmz_A          232 KITDLSP--------------------------LANLSQLTWLEIGTNQISD--------------------------I-  258 (347)
T ss_dssp             CCCCCGG--------------------------GTTCTTCCEEECCSSCCCC--------------------------C-
T ss_pred             ccCCCcc--------------------------hhcCCCCCEEECCCCccCC--------------------------C-
Confidence            4443222                          4444444444444444431                          0 


Q ss_pred             ccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccc
Q 002897          361 SEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF  440 (869)
Q Consensus       361 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  440 (869)
                      +.+..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..|..++.+++|+.|+|++|++++..|  +..+++
T Consensus       259 ~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~  334 (347)
T 4fmz_A          259 NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK  334 (347)
T ss_dssp             GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTT
T ss_pred             hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhc
Confidence            1233344444445554444422  234455555555555555554444555555555555555555554433  555555


Q ss_pred             cCeeccccccCc
Q 002897          441 LEYLNLSYNHFE  452 (869)
Q Consensus       441 L~~l~l~~N~l~  452 (869)
                      |++|++++|+|+
T Consensus       335 L~~L~l~~N~i~  346 (347)
T 4fmz_A          335 MDSADFANQVIK  346 (347)
T ss_dssp             CSEESSSCC---
T ss_pred             cceeehhhhccc
Confidence            555555555553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.7e-34  Score=312.55  Aligned_cols=284  Identities=26%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             hccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           19 CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      ..+++|++|++++|.++ .++ .+..+++|++|++++|+++.. |. |.++++|++|+|++|.++..  +.|.++++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred             hhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCE
Confidence            36899999999999999 454 499999999999999999954 44 99999999999999999853  47999999999


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      |++++|.+. .++.  +..+++|+.|++++|.....++ .+..+++|++|++++|.+..+.+  +..+++|++|++++|.
T Consensus       115 L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          115 LYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             EECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             EECcCCccc-Cchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            999999998 6664  8899999999999996664444 59999999999999999887655  8899999999999999


Q ss_pred             CCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcc
Q 002897          179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL  258 (869)
Q Consensus       179 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  258 (869)
                      +..++        .+..+++|+.|++++|++++..+  +..+++ |++|++++|.+++..+  +..+++|++|++++|.+
T Consensus       189 l~~~~--------~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~-L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  255 (347)
T 4fmz_A          189 IEDIS--------PLASLTSLHYFTAYVNQITDITP--VANMTR-LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI  255 (347)
T ss_dssp             CCCCG--------GGGGCTTCCEEECCSSCCCCCGG--GGGCTT-CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             ccccc--------cccCCCccceeecccCCCCCCch--hhcCCc-CCEEEccCCccCCCcc--hhcCCCCCEEECCCCcc
Confidence            87654        26778888888888888875433  455543 6666666666663322  55555555555555555


Q ss_pred             eecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccC
Q 002897          259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD  331 (869)
Q Consensus       259 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (869)
                      .+.  ..+..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..+..+..+++|++|++++|+++
T Consensus       256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  324 (347)
T 4fmz_A          256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT  324 (347)
T ss_dssp             CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred             CCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccc
Confidence            432  2345555555555555555432  22344444444444444444333344444444444444444433

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.7e-35  Score=315.75  Aligned_cols=255  Identities=30%  Similarity=0.524  Sum_probs=185.4

Q ss_pred             ceEEEecCCcccc--cCCccccCCCCCCeeeccc-CcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCcccccee
Q 002897          224 MTTIDIGGNYFSG--TIPPGLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLA  300 (869)
Q Consensus       224 L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  300 (869)
                      ++.|+|++|.+++  .+|..|.++++|++|++++ |.+.+.+|..|+.+++|++|+|++|.+++..|..|.++++|++|+
T Consensus        52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  131 (313)
T 1ogq_A           52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence            4555555555554  4555555555555555553 555555555555555555555555555555555555555555555


Q ss_pred             cccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccccccc
Q 002897          301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS  380 (869)
Q Consensus       301 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  380 (869)
                      +++|++++.+|..|..+++|++|++++|++++.+|..+......++.|++++|++++.+|..+..++ |+.|+|++|.++
T Consensus       132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~  210 (313)
T 1ogq_A          132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred             CCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence            5555555555555555566666666666655555555555544555666666666667788888887 999999999999


Q ss_pred             ccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCc
Q 002897          381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGV  460 (869)
Q Consensus       381 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~  460 (869)
                      +..|..|..+++|+.|++++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+.
T Consensus       211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~  289 (313)
T 1ogq_A          211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence            88899999999999999999999866555 88889999999999999999999999999999999999999999998888


Q ss_pred             cCCCccccccCCcccCCCCC
Q 002897          461 FSNKTRFSLSGNGKLCGGLD  480 (869)
Q Consensus       461 ~~~~~~~~~~~n~~~c~~~~  480 (869)
                      +++++.+.+.+|+++||.+.
T Consensus       290 l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          290 LQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTTS
T ss_pred             ccccChHHhcCCCCccCCCC
Confidence            89999999999999999654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.3e-34  Score=310.58  Aligned_cols=305  Identities=18%  Similarity=0.241  Sum_probs=234.4

Q ss_pred             CCCcccccCChhhhhcc-----CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcC
Q 002897            5 QNNKLVGDIPVEIGCYL-----FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         5 ~~~~~~~~ip~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~   79 (869)
                      ..+.++ ++|..+....     .+++.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++
T Consensus        12 ~~~~l~-~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~   87 (332)
T 2ft3_A           12 GIPDLD-SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN   87 (332)
T ss_dssp             --------------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCCccc-cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCC
Confidence            445566 7887654322     37999999999999 6777663  7999999999999988888999999999999999


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccc--
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIG--  157 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~--  157 (869)
                      |++++..|..|.++++|++|+|++|++. .+|...+   ++|++|++++|.++...+..|.++++|++|++++|.++.  
T Consensus        88 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  163 (332)
T 2ft3_A           88 NKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG  163 (332)
T ss_dssp             SCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGG
T ss_pred             CccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCC
Confidence            9999888999999999999999999998 7886544   788889999999987777788889999999999998853  


Q ss_pred             ccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccccc
Q 002897          158 KMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT  237 (869)
Q Consensus       158 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~  237 (869)
                      ..+..|..+ +|++|++++|.++.++..       +  .++|++|++++|++++..+..+..+++ |+.|++++|.+++.
T Consensus       164 ~~~~~~~~l-~L~~L~l~~n~l~~l~~~-------~--~~~L~~L~l~~n~i~~~~~~~l~~l~~-L~~L~L~~N~l~~~  232 (332)
T 2ft3_A          164 FEPGAFDGL-KLNYLRISEAKLTGIPKD-------L--PETLNELHLDHNKIQAIELEDLLRYSK-LYRLGLGHNQIRMI  232 (332)
T ss_dssp             SCTTSSCSC-CCSCCBCCSSBCSSCCSS-------S--CSSCSCCBCCSSCCCCCCTTSSTTCTT-CSCCBCCSSCCCCC
T ss_pred             CCcccccCC-ccCEEECcCCCCCccCcc-------c--cCCCCEEECCCCcCCccCHHHhcCCCC-CCEEECCCCcCCcC
Confidence            667778877 888888888888877653       1  267888888888888777777777765 88888888888877


Q ss_pred             CCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCC------ccccceeccccccc--cc
Q 002897          238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNL------TMLTLLALEINNLQ--GK  309 (869)
Q Consensus       238 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~n~l~--~~  309 (869)
                      .+..+..+++|+.|++++|++. .+|..+..+++|++|++++|++++..+..|...      ..|+.|++++|.+.  ..
T Consensus       233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~  311 (332)
T 2ft3_A          233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV  311 (332)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGS
T ss_pred             ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccccc
Confidence            7777888888888888888887 667777788888888888888887766666553      56777888888776  45


Q ss_pred             CCcCccCccccceeeccCcc
Q 002897          310 IPSSLGNCTSLIMLTLSKNK  329 (869)
Q Consensus       310 ~~~~~~~l~~L~~L~l~~N~  329 (869)
                      .|.+|..+++|+.|++++|+
T Consensus       312 ~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          312 QPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGGTTBCCSTTEEC----
T ss_pred             Ccccccccchhhhhhccccc
Confidence            66777778888888877764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.5e-33  Score=303.99  Aligned_cols=291  Identities=20%  Similarity=0.268  Sum_probs=234.4

Q ss_pred             cCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEE
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIF  100 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  100 (869)
                      ..+++.++++++.++ .+|..+.  ++|++|+|++|+|++..+..|+++++|++|+|++|++++..|..|.++++|++|+
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            347899999999998 6776664  6899999999999988778899999999999999999988899999999999999


Q ss_pred             CcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccc--ccCcCccCCCCCCEEEccCcc
Q 002897          101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIG--KMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      |++|++. .+|...+   ++|++|++++|.+++..+..|.++++|++|++++|.+..  ..+..|..+++|++|++++|.
T Consensus       107 Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             CCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             CCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            9999998 7886544   788888999999888877888889999999999998854  667778888888888888888


Q ss_pred             CCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcc
Q 002897          179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL  258 (869)
Q Consensus       179 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  258 (869)
                      ++.++..       +  .++|++|++++|++++..|..+..+++ |+.|++++|.+++..+..+..+++|++|++++|++
T Consensus       183 l~~l~~~-------~--~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  252 (330)
T 1xku_A          183 ITTIPQG-------L--PPSLTELHLDGNKITKVDAASLKGLNN-LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  252 (330)
T ss_dssp             CCSCCSS-------C--CTTCSEEECTTSCCCEECTGGGTTCTT-CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             cccCCcc-------c--cccCCEEECCCCcCCccCHHHhcCCCC-CCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence            8877653       1  267888888888888777777877775 88888888888877777788888888888888888


Q ss_pred             eecCCccccCCCCCCEEEccCccccCcCCCCCCCC------ccccceecccccccc--cCCcCccCccccceeeccCcc
Q 002897          259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNL------TMLTLLALEINNLQG--KIPSSLGNCTSLIMLTLSKNK  329 (869)
Q Consensus       259 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~  329 (869)
                      . .+|..+..+++|++|++++|+|++..+..|...      +.|+.|++++|.+..  ..|..|..+++|+.+++++|+
T Consensus       253 ~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             c-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            7 677778888888888888888887766666543      567777888887752  455677777777777777774

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=5e-33  Score=299.98  Aligned_cols=285  Identities=18%  Similarity=0.208  Sum_probs=252.7

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++++++ .+|..++   ++++.|+|++|+|+++.+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus        36 l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (330)
T 1xku_A           36 VQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ  111 (330)
T ss_dssp             EECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             EEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence            688999999 8998775   689999999999998888899999999999999999998889999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccce--eccccccCCCCCcEEEccCCcccccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTG--FLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~--~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      ++ .+|..+.  ++|++|++++|++. .++...|.++++|+.|++++|.++.  ..+..|.++++|++|++++|.++.+.
T Consensus       112 l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~  187 (330)
T 1xku_A          112 LK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP  187 (330)
T ss_dssp             CS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred             CC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCC
Confidence            99 4565554  79999999999998 7888889999999999999999964  77889999999999999999998765


Q ss_pred             CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCC
Q 002897          160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP  239 (869)
Q Consensus       160 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~  239 (869)
                      ...+   ++|++|++++|.++.+...      .|..+++|++|++++|++++..+..+..+++ |+.|+|++|.++ .+|
T Consensus       188 ~~~~---~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~-~lp  256 (330)
T 1xku_A          188 QGLP---PSLTELHLDGNKITKVDAA------SLKGLNNLAKLGLSFNSISAVDNGSLANTPH-LRELHLNNNKLV-KVP  256 (330)
T ss_dssp             SSCC---TTCSEEECTTSCCCEECTG------GGTTCTTCCEEECCSSCCCEECTTTGGGSTT-CCEEECCSSCCS-SCC
T ss_pred             cccc---ccCCEEECCCCcCCccCHH------HhcCCCCCCEEECCCCcCceeChhhccCCCC-CCEEECCCCcCc-cCC
Confidence            4433   8999999999999987643      6889999999999999999888888988886 999999999999 788


Q ss_pred             ccccCCCCCCeeecccCcceecCCccccC------CCCCCEEEccCccccC--cCCCCCCCCccccceeccccc
Q 002897          240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGW------LKNLQSLYLNSNFLHG--YIPSSLGNLTMLTLLALEINN  305 (869)
Q Consensus       240 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~n~  305 (869)
                      .++..+++|++|++++|++.+..+..|..      .+.|+.|++++|.+..  +.|..|..+..++.+++++|+
T Consensus       257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            89999999999999999999887777754      3789999999999864  667889999999999999985

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.8e-33  Score=303.65  Aligned_cols=284  Identities=22%  Similarity=0.273  Sum_probs=253.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++++++ ++|..++   ++|++|+|++|.|+++.|.+|.++++|++|+|++|+|++..|.+|+++++|++|+|++|+
T Consensus        38 l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  113 (332)
T 2ft3_A           38 VQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH  113 (332)
T ss_dssp             EECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred             EECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence            688999999 9999875   699999999999998888899999999999999999998889999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccc--eeccccccCCCCCcEEEccCCcccccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT--GFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~--~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      ++ .+|..+.  ++|++|++++|++. .+|...|.++++|+.|++++|.++  +..+..+..+ +|++|++++|+++++.
T Consensus       114 l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~  188 (332)
T 2ft3_A          114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP  188 (332)
T ss_dssp             CC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC
T ss_pred             CC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC
Confidence            99 5565554  89999999999998 788888999999999999999996  3778888888 9999999999998765


Q ss_pred             CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCC
Q 002897          160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP  239 (869)
Q Consensus       160 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~  239 (869)
                      ...+   ++|++|++++|.++.++..      .+..+++|++|++++|++++..+..+..+++ |+.|++++|.++ .+|
T Consensus       189 ~~~~---~~L~~L~l~~n~i~~~~~~------~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~-~lp  257 (332)
T 2ft3_A          189 KDLP---ETLNELHLDHNKIQAIELE------DLLRYSKLYRLGLGHNQIRMIENGSLSFLPT-LRELHLDNNKLS-RVP  257 (332)
T ss_dssp             SSSC---SSCSCCBCCSSCCCCCCTT------SSTTCTTCSCCBCCSSCCCCCCTTGGGGCTT-CCEEECCSSCCC-BCC
T ss_pred             cccc---CCCCEEECCCCcCCccCHH------HhcCCCCCCEEECCCCcCCcCChhHhhCCCC-CCEEECCCCcCe-ecC
Confidence            4333   7899999999999988754      5889999999999999999888888998886 999999999999 788


Q ss_pred             ccccCCCCCCeeecccCcceecCCccccCC------CCCCEEEccCcccc--CcCCCCCCCCccccceeccccc
Q 002897          240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWL------KNLQSLYLNSNFLH--GYIPSSLGNLTMLTLLALEINN  305 (869)
Q Consensus       240 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~n~  305 (869)
                      ..+..+++|+.|++++|++++..+..|...      ++|+.|++++|.+.  +..|..|..+++|+.+++++|+
T Consensus       258 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             TTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             hhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            889999999999999999998877777653      67999999999988  6788889999999999999885

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-34  Score=311.41  Aligned_cols=247  Identities=18%  Similarity=0.210  Sum_probs=187.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCC---------CCccce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIR---------HRNLIK  615 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  615 (869)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++...        ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  78999999997542        223477889999998885         888888


Q ss_pred             EEEEeecc-------------------------ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHH
Q 002897          616 IITICSSI-------------------------DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID  670 (869)
Q Consensus       616 ~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~  670 (869)
                      +.+++...                         ++.+....++||||+++|++.+.+...       .+++..++.++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence            87764311                         012357899999999999777666442       3899999999999


Q ss_pred             HHHHHHHHH-hcCCCCeEecCCCCCceeecCCC--------------------cEEEccccccccCCCCCCCCccccCCC
Q 002897          671 VASAIEYLH-HHCKPPVVHGDLKPSNVLLDHDM--------------------VAHVGDFGLAKFLPARPLDTVVETPSS  729 (869)
Q Consensus       671 i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~  729 (869)
                      |+.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....           
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------  235 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------  235 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence            999999999 89   999999999999999887                    8999999999865431           


Q ss_pred             CCCccCcccccCCcccCCCCCCccccchhhhHH-HHHHHcCCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhh
Q 002897          730 SSGIKGTVGYIAPEYGTGSEASMTGDVYSFGIL-LLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVR  808 (869)
Q Consensus       730 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  808 (869)
                        ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.....    ............              
T Consensus       236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~----~~~~~~~~~~~~--------------  294 (336)
T 2vuw_A          236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW----LHYLTDKMLKQM--------------  294 (336)
T ss_dssp             --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH----HHHHHHHHHHTC--------------
T ss_pred             --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh----hhHHHHhhhhhh--------------
Confidence              246999999999998766 889999998777 7888999999843100    000000000000              


Q ss_pred             hcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002897          809 ANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVV  851 (869)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  851 (869)
                         ..............++++.+++.+||+.|     |++|++
T Consensus       295 ---~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          295 ---TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             ---CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             ---ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence               00001112234567888999999999976     999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=9.6e-34  Score=302.23  Aligned_cols=253  Identities=29%  Similarity=0.500  Sum_probs=216.9

Q ss_pred             CCCcEEEccCCCCCC--CCChhhhhccccceEEEecC-CcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCC
Q 002897          197 SKLENLGLYDNQFGG--LLPHSLANLSNTMTTIDIGG-NYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQ  273 (869)
Q Consensus       197 ~~L~~L~L~~n~l~~--~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  273 (869)
                      .++++|+|++|++++  .+|..+..++. |++|++++ |.+.+.+|..|.++++|++|++++|++.+..|..|..+++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~-L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCC-CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            467778888888877  77777877775 88888884 778777888888888888888888888878888888888888


Q ss_pred             EEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcc-ccceeeccCcccCCCCCccccccccccceecccC
Q 002897          274 SLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT-SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD  352 (869)
Q Consensus       274 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~  352 (869)
                      +|+|++|.+++..|..+.++++|++|++++|++++.+|..+..++ +|+.|++++|++++.+|..+....  ++.|++++
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--L~~L~Ls~  206 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSR  206 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC--CSEEECCS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc--ccEEECcC
Confidence            888888888878888888888888888888888877888888887 888888888888877777776664  77888888


Q ss_pred             CcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCc
Q 002897          353 NLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIP  432 (869)
Q Consensus       353 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  432 (869)
                      |.+++..|..|..+++|+.|+|++|.+++.+|. +..+++|++|++++|++++.+|..+..+++|+.|+|++|+++|.+|
T Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            888888999999999999999999999976665 8899999999999999999999999999999999999999999999


Q ss_pred             cccccccccCeecccccc-Cccc
Q 002897          433 KYLENLSFLEYLNLSYNH-FEGE  454 (869)
Q Consensus       433 ~~~~~l~~L~~l~l~~N~-l~~~  454 (869)
                      .. .++++|+.+++++|+ +.|.
T Consensus       286 ~~-~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          286 QG-GNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             CS-TTGGGSCGGGTCSSSEEEST
T ss_pred             CC-ccccccChHHhcCCCCccCC
Confidence            86 889999999999999 5553

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3.7e-37  Score=349.22  Aligned_cols=364  Identities=19%  Similarity=0.176  Sum_probs=194.2

Q ss_pred             CCcCEEeccCCcCccccCcc-cccCcCCCEEEccCCccCc----cCCccccCCCCCCEEeCcCcccCccCCcccc-cCC-
Q 002897           22 FKLENLSLAENHLTGQLPVS-IGNLSALQVIDIRGNRLGG----KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIY-NIS-   94 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~-   94 (869)
                      ++|+.|+|++|+++...... |..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+....+..+. .+. 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            56888888888887544333 7788888888888888874    3466677788888888888888754443333 344 


Q ss_pred             ---CCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCc-----cCC
Q 002897           95 ---SFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF-----NSL  166 (869)
Q Consensus        95 ---~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~-----~~l  166 (869)
                         +|++|+|++|++.. ...                    ..++..+..+++|++|+|++|.+....+..+     ...
T Consensus        83 ~~~~L~~L~L~~n~i~~-~~~--------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTG-AGC--------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             TTCCCCEEECTTSCCBG-GGH--------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             CCCceeEEEccCCCCCH-HHH--------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence               57788888777752 110                    1234455555666666666666543322221     224


Q ss_pred             CCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhc----cccceEEEecCCccccc----C
Q 002897          167 KNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANL----SNTMTTIDIGGNYFSGT----I  238 (869)
Q Consensus       167 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l----~~~L~~L~l~~n~l~~~----~  238 (869)
                      ++|++|++++|.++.....  .++..+..+++|++|++++|.++...+..+...    ...|+.|++++|.+++.    +
T Consensus       142 ~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  219 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCE--PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL  219 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred             CcceEEECCCCCCCHHHHH--HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHH
Confidence            4566666666655543321  223345556666666666666654333333221    11355555555555532    2


Q ss_pred             CccccCCCCCCeeecccCcceecC-----CccccCCCCCCEEEccCccccCc----CCCCCCCCccccceeccccccccc
Q 002897          239 PPGLGNLVHLNSIAMEGNQLIGTV-----PPEIGWLKNLQSLYLNSNFLHGY----IPSSLGNLTMLTLLALEINNLQGK  309 (869)
Q Consensus       239 ~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~  309 (869)
                      +..+..+++|++|++++|.+....     +..+..+++|++|++++|.++..    ++..+.++++|+.|++++|+++..
T Consensus       220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  299 (461)
T 1z7x_W          220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  299 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence            344445555555555555544321     11222345555555555555432    233333344444444444444322


Q ss_pred             CCcCccCc-----cccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCC
Q 002897          310 IPSSLGNC-----TSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP  384 (869)
Q Consensus       310 ~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  384 (869)
                      .+..+...     ++|++|++++|.+++...                     ..++..+..+++|++|+|++|.+++..+
T Consensus       300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  358 (461)
T 1z7x_W          300 GARLLCETLLEPGCQLESLWVKSCSFTAACC---------------------SHFSSVLAQNRFLLELQISNNRLEDAGV  358 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCBGGGH---------------------HHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred             HHHHHHHHhccCCccceeeEcCCCCCchHHH---------------------HHHHHHHhhCCCccEEEccCCccccccH
Confidence            22222211     344444444444431100                     0133445555666666666666654433


Q ss_pred             ccccC-----CCCCcEEEeeCccccC----CCCccccccccccEEEccCCcccC
Q 002897          385 GTLSA-----CTSLEYVKMQDNSFSG----SIPPSLNFLKSIKVLDLSSNKLSG  429 (869)
Q Consensus       385 ~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~  429 (869)
                      ..+..     +++|++|++++|++++    .+|..+..+++|++|+|++|++++
T Consensus       359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            33332     4566666666666654    445555556666666666666653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=7.3e-36  Score=338.57  Aligned_cols=390  Identities=18%  Similarity=0.149  Sum_probs=242.5

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCcc----ccCcccccCcCCCEEEccCCccCccCCccc-cCCC----C
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTG----QLPVSIGNLSALQVIDIRGNRLGGKIPDTL-GQLR----K   71 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~-~~l~----~   71 (869)
                      .||+++|+++..-...++..+++|++|+|++|+++.    .++..+..+++|++|+|++|++....+..+ ..++    +
T Consensus         7 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~   86 (461)
T 1z7x_W            7 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK   86 (461)
T ss_dssp             EEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCC
T ss_pred             ehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCc
Confidence            378999999844445557789999999999999984    457788899999999999999986444333 3455    7


Q ss_pred             CCEEeCcCcccCc----cCCcccccCCCCcEEECcCCcCcccCCch----hhcCCcchhhhhcccccccee----ccccc
Q 002897           72 LIYLNIGRNQFSG----FIPPSIYNISSFEFIFLQSNRFHGSLPFD----MVANLPNLRKFVAAKNNLTGF----LPISL  139 (869)
Q Consensus        72 L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~l~~n~i~~~----~~~~l  139 (869)
                      |++|+|++|+|..    .++..+.++++|++|+|++|.+.+..+..    .+...++|++|++++|+++..    ++..+
T Consensus        87 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  166 (461)
T 1z7x_W           87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL  166 (461)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHH
T ss_pred             eeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHH
Confidence            9999999999984    45888999999999999999986322211    122244566666666666542    24445


Q ss_pred             cCCCCCcEEEccCCccccccCcCcc-----CCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCC
Q 002897          140 SNASNLELLELRDNQFIGKMSINFN-----SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP  214 (869)
Q Consensus       140 ~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  214 (869)
                      ..+++|++|++++|.+.......+.     ..++|++|++++|.++..+..  .++..+..+++|++|++++|++++...
T Consensus       167 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~l~~~~~  244 (461)
T 1z7x_W          167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSNKLGDVGM  244 (461)
T ss_dssp             HHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred             hhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--HHHHHHHhCCCccEEeccCCcCChHHH
Confidence            5556666666666665443333222     234555555555555432211  122334445555555555555442211


Q ss_pred             hhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec----CCccccCCCCCCEEEccCccccCcCCCCC
Q 002897          215 HSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT----VPPEIGWLKNLQSLYLNSNFLHGYIPSSL  290 (869)
Q Consensus       215 ~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  290 (869)
                      ..+.                    +..+..+++|++|++++|.+...    ++..+..+++|++|+|++|.+++..+..+
T Consensus       245 ~~l~--------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l  304 (461)
T 1z7x_W          245 AELC--------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL  304 (461)
T ss_dssp             HHHH--------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             HHHH--------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHH
Confidence            1111                    12223456666666666666543    34555566777777777776654333222


Q ss_pred             C-----CCccccceeccccccccc----CCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcc
Q 002897          291 G-----NLTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS  361 (869)
Q Consensus       291 ~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~  361 (869)
                      .     ..++|+.|++++|.+++.    ++..+..+++|++|++++|++++..+..+.                     .
T Consensus       305 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~---------------------~  363 (461)
T 1z7x_W          305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC---------------------Q  363 (461)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH---------------------H
T ss_pred             HHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH---------------------H
Confidence            2     225677777777777643    455667778888888888887632111111                     1


Q ss_pred             ccc-CCccccccccccccccc----cCCccccCCCCCcEEEeeCccccCCCCcccc-----ccccccEEEccCCcccCCC
Q 002897          362 EIG-NLKNLVQLDISGNRFSG----DIPGTLSACTSLEYVKMQDNSFSGSIPPSLN-----FLKSIKVLDLSSNKLSGQI  431 (869)
Q Consensus       362 ~~~-~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~  431 (869)
                      .+. ..++|++|+|++|.+++    .+|..+..+++|++|++++|++++.....+.     ...+|+.|++.+|.+....
T Consensus       364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~  443 (461)
T 1z7x_W          364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM  443 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred             HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHH
Confidence            121 14578888888888875    6677777888888888888887743222221     1235666776666665433


Q ss_pred             cc
Q 002897          432 PK  433 (869)
Q Consensus       432 p~  433 (869)
                      +.
T Consensus       444 ~~  445 (461)
T 1z7x_W          444 ED  445 (461)
T ss_dssp             HH
T ss_pred             HH
Confidence            33

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.5e-31  Score=291.19  Aligned_cols=273  Identities=19%  Similarity=0.197  Sum_probs=159.9

Q ss_pred             ccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCccc
Q 002897            3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF   82 (869)
Q Consensus         3 ~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i   82 (869)
                      |+++++++ +||..++   ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|.+|+++++|++|+|++|++
T Consensus        37 ~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  112 (353)
T 2z80_A           37 KGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL  112 (353)
T ss_dssp             ECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             eCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence            55666666 6666554   3666666666666655555666666666666666666655566666666666666666666


Q ss_pred             CccCCcccccCCCCcEEECcCCcCcccCCc-hhhcCCcchhhhhcccc-ccceeccccccCCCCCcEEEccCCccccccC
Q 002897           83 SGFIPPSIYNISSFEFIFLQSNRFHGSLPF-DMVANLPNLRKFVAAKN-NLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        83 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~l~~n-~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      ++..+..|.++++|++|+|++|++. .+|. ..|..+++|++|++++| .++...+..|.++++|++|++++|.+.+..+
T Consensus       113 ~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  191 (353)
T 2z80_A          113 SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP  191 (353)
T ss_dssp             SSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             CcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence            6444444666666666666666665 5554 45555666666666665 3554445555556666666666666555555


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                      ..|..+++|++|++++|.++.++..      .+..+++|++|++++|++++..+..+..                     
T Consensus       192 ~~l~~l~~L~~L~l~~n~l~~~~~~------~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------  244 (353)
T 2z80_A          192 KSLKSIQNVSHLILHMKQHILLLEI------FVDVTSSVECLELRDTDLDTFHFSELST---------------------  244 (353)
T ss_dssp             TTTTTCSEEEEEEEECSCSTTHHHH------HHHHTTTEEEEEEESCBCTTCCCC-------------------------
T ss_pred             HHHhccccCCeecCCCCccccchhh------hhhhcccccEEECCCCcccccccccccc---------------------
Confidence            5555555555555555555443321      2333455555555555555433222211                     


Q ss_pred             cccCCCCCCeeecccCccee----cCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIG----TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG  308 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~  308 (869)
                       ......++.++++++.+.+    .+|..+..+++|++|+|++|+++...+..|.++++|++|++++|++.+
T Consensus       245 -~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          245 -GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             -ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence             1123445555555555543    356667777888888888888874444445778888888888887763

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3e-30  Score=280.93  Aligned_cols=282  Identities=17%  Similarity=0.148  Sum_probs=214.0

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      ..+.....++++|+++ .+|..+.  ++|++|+|++|+|++..+..|+++++|++|+|++|++++..|..|.++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            4566677899999999 6776654  589999999999997777789999999999999999998888889999999999


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceecc-ccccCCCCCcEEEccCC-ccccccCcCccCCCCCCEEEccCc
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDN-QFIGKMSINFNSLKNLSVLILGNN  177 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~n  177 (869)
                      +|++|+++ .+|...|.++++|++|++++|.++...+ ..|.++++|++|++++| .+..+.+..|.++++|++|++++|
T Consensus       106 ~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n  184 (353)
T 2z80_A          106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS  184 (353)
T ss_dssp             ECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred             ECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence            99999997 7787778888888888888888876544 47778888888888887 466666677777777777777777


Q ss_pred             cCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhh-hhccccceEEEecCCcccccCCccccCCCCCCeeecccC
Q 002897          178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSL-ANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN  256 (869)
Q Consensus       178 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  256 (869)
                      .++.....      .+..+++|++|++++|+++. .|..+ ..++ .|+.|++++|.+++..+..+..            
T Consensus       185 ~l~~~~~~------~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~l~~------------  244 (353)
T 2z80_A          185 DLQSYEPK------SLKSIQNVSHLILHMKQHIL-LLEIFVDVTS-SVECLELRDTDLDTFHFSELST------------  244 (353)
T ss_dssp             TCCEECTT------TTTTCSEEEEEEEECSCSTT-HHHHHHHHTT-TEEEEEEESCBCTTCCCC----------------
T ss_pred             CcCccCHH------HHhccccCCeecCCCCcccc-chhhhhhhcc-cccEEECCCCcccccccccccc------------
Confidence            77765433      46677777777777777753 33333 3333 3677777777666433222111            


Q ss_pred             cceecCCccccCCCCCCEEEccCccccC----cCCCCCCCCccccceecccccccccCCcC-ccCccccceeeccCcccC
Q 002897          257 QLIGTVPPEIGWLKNLQSLYLNSNFLHG----YIPSSLGNLTMLTLLALEINNLQGKIPSS-LGNCTSLIMLTLSKNKLD  331 (869)
Q Consensus       257 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~N~l~  331 (869)
                               ......++.++|+++.+.+    .+|..+.++++|+.|++++|+++ .+|.. |..+++|++|++++|++.
T Consensus       245 ---------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          245 ---------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             -----------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ---------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence                     1235678888888888875    35667889999999999999999 55555 689999999999999998


Q ss_pred             CCCC
Q 002897          332 GVLP  335 (869)
Q Consensus       332 ~~~~  335 (869)
                      +..|
T Consensus       315 ~~~~  318 (353)
T 2z80_A          315 CSCP  318 (353)
T ss_dssp             CCHH
T ss_pred             CcCC
Confidence            6544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.5e-30  Score=277.31  Aligned_cols=280  Identities=19%  Similarity=0.219  Sum_probs=161.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCcc--CCccccCCCCCCEEeCcC
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK--IPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~--~p~~~~~l~~L~~L~L~~   79 (869)
                      +++++++++ ++|..++   ++|++|+|++|+++.+.+..|.++++|++|+|++|+++..  .|..+..+++|++|+|++
T Consensus        12 l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~   87 (306)
T 2z66_A           12 IRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF   87 (306)
T ss_dssp             EECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred             EEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence            456666676 6776554   4667777777777644444566777777777777766622  245555667777777777


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCc-hhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccc-
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPF-DMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIG-  157 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~-  157 (869)
                      |.+. .+|..+.++++|++|++++|++. .++. ..+..+++|++|++++|.+++..+..|.++++|++|++++|.+.+ 
T Consensus        88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             CSEE-EEEEEEETCTTCCEEECTTSEEE-SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             Cccc-cChhhcCCCCCCCEEECCCCccc-ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            7766 34555666777777777777665 3332 345555555555555555555555555555555555555555543 


Q ss_pred             ccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccccc
Q 002897          158 KMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT  237 (869)
Q Consensus       158 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~  237 (869)
                      ..+..|..+++|++|++++|                              ++++..|..+..+++ |+.|++++|.+++.
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n------------------------------~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~  214 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQC------------------------------QLEQLSPTAFNSLSS-LQVLNMSHNNFFSL  214 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTS------------------------------CCCEECTTTTTTCTT-CCEEECTTSCCSBC
T ss_pred             cchhHHhhCcCCCEEECCCC------------------------------CcCCcCHHHhcCCCC-CCEEECCCCccCcc
Confidence            34444444555555555554                              444444444444443 55555555555544


Q ss_pred             CCccccCCCCCCeeecccCcceecCCccccCCC-CCCEEEccCccccCcCC--CCCCCCccccceecccccccccCCcCc
Q 002897          238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLK-NLQSLYLNSNFLHGYIP--SSLGNLTMLTLLALEINNLQGKIPSSL  314 (869)
Q Consensus       238 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~  314 (869)
                      .+..+..+++|+.|++++|++.+..|..+..++ +|++|+|++|.+++.-.  .....+...+.+....+.+....|..+
T Consensus       215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~  294 (306)
T 2z66_A          215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK  294 (306)
T ss_dssp             CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred             ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence            444566666666666666666666666666663 67777777777663211  011223344555556666665666666


Q ss_pred             cCcc
Q 002897          315 GNCT  318 (869)
Q Consensus       315 ~~l~  318 (869)
                      .+.+
T Consensus       295 ~g~~  298 (306)
T 2z66_A          295 QGMP  298 (306)
T ss_dssp             TTCB
T ss_pred             CCce
Confidence            5543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.7e-29  Score=281.78  Aligned_cols=248  Identities=20%  Similarity=0.246  Sum_probs=164.7

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      +...++.+++.++ .+|..+.  ++|++|+|++|+|+++.|+.|+++++|++|+|++|+|+++.|..|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            3566777777777 5565543  577777777777777777777777777777777777777767777777777777777


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccC-CccccccCcCccCCCCCCEEEccCccCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRD-NQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      +|++. .+|.+.|.++++|++|+|++|.++.+.+..|.++++|++|++++ |.+..+.+..|.++++|++|+|++|+++.
T Consensus       132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            77776 56656666666666666666666665556666666666666666 44444444456666666666666666554


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++        .+..+++                         |+.|+|++|.+++..|..|.++++|+.|++++|++.+.
T Consensus       211 ~~--------~~~~l~~-------------------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  257 (452)
T 3zyi_A          211 MP--------NLTPLVG-------------------------LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI  257 (452)
T ss_dssp             CC--------CCTTCTT-------------------------CCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred             cc--------ccccccc-------------------------ccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence            43        1344444                         44555555555545555666666667777777777666


Q ss_pred             CCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccccccc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ  307 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  307 (869)
                      .+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus       258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            6667777777777777777777666666777777777777777665

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=280.37  Aligned_cols=248  Identities=19%  Similarity=0.262  Sum_probs=158.4

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      ....++.++++++ .+|..+.  +++++|+|++|+|+.+.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            3456666666666 5555443  566666666666666666666666666666666666666666666666666666666


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccC-CccccccCcCccCCCCCCEEEccCccCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRD-NQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      +|+++ .+|.+.|..+++|++|++++|.++...+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+++.
T Consensus       121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            66665 55555555566666666666655555555566666666666665 33444444455555555555555555554


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++        .+..+++                         |+.|+|++|.+++..|..|..+++|+.|+|++|++.+.
T Consensus       200 ~~--------~~~~l~~-------------------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  246 (440)
T 3zyj_A          200 IP--------NLTPLIK-------------------------LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI  246 (440)
T ss_dssp             CC--------CCTTCSS-------------------------CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             cc--------ccCCCcc-------------------------cCEEECCCCccCccChhhhccCccCCEEECCCCceeEE
Confidence            33        1333444                         55555555555555566677777777777777777777


Q ss_pred             CCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccccccc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ  307 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~  307 (869)
                      .+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       247 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            7777777777788888888777777777777778888888887765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.5e-29  Score=283.15  Aligned_cols=244  Identities=19%  Similarity=0.196  Sum_probs=206.9

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++++++ +||.+++   +++++|+|++|+|+++.|.+|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+
T Consensus        59 v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           59 VVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             EECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            467889999 8998876   699999999999999889999999999999999999999989999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccc-cccceeccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK-NNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      |+...+..|.++++|++|+|++|++. .+|...|.++++|+.|++++ |.+..+.+..|.++++|++|+|++|+++++. 
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-  212 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-  212 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC-
T ss_pred             CCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc-
Confidence            99888888999999999999999998 88888999999999999999 5666666678999999999999999998763 


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                       .+..+++|++|+|++|.++.+...      .|.++++|++|+|++|++++..                         +.
T Consensus       213 -~~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~~-------------------------~~  260 (452)
T 3zyi_A          213 -NLTPLVGLEELEMSGNHFPEIRPG------SFHGLSSLKKLWVMNSQVSLIE-------------------------RN  260 (452)
T ss_dssp             -CCTTCTTCCEEECTTSCCSEECGG------GGTTCTTCCEEECTTSCCCEEC-------------------------TT
T ss_pred             -cccccccccEEECcCCcCcccCcc------cccCccCCCEEEeCCCcCceEC-------------------------HH
Confidence             588999999999999999876543      5777777777777777776444                         44


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH  283 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  283 (869)
                      .|..+++|+.|+|++|++.+..+..|..+++|+.|+|++|.+.
T Consensus       261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            4555566666666666666555566667777777777777665

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.7e-29  Score=281.90  Aligned_cols=244  Identities=20%  Similarity=0.223  Sum_probs=207.5

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      ++.++++++ +||.+++   ++++.|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.+.+|.++++|++|+|++|+
T Consensus        48 v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           48 VICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             EECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             EEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            467889999 9999886   789999999999998888999999999999999999998888999999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccc-cccceeccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK-NNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      |+.+.+..|.++++|++|+|++|++. .+|...|.++++|++|++++ |.+..+.+..|.++++|++|+|++|.++.+. 
T Consensus       124 l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-  201 (440)
T 3zyj_A          124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-  201 (440)
T ss_dssp             CSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-
T ss_pred             CCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-
Confidence            99887789999999999999999998 88888999999999999999 5666666678999999999999999998664 


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                       .+..+++|++|+|++|.++.+...      .|.++++|++|+|++|++++.                         .+.
T Consensus       202 -~~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~-------------------------~~~  249 (440)
T 3zyj_A          202 -NLTPLIKLDELDLSGNHLSAIRPG------SFQGLMHLQKLWMIQSQIQVI-------------------------ERN  249 (440)
T ss_dssp             -CCTTCSSCCEEECTTSCCCEECTT------TTTTCTTCCEEECTTCCCCEE-------------------------CTT
T ss_pred             -ccCCCcccCEEECCCCccCccChh------hhccCccCCEEECCCCceeEE-------------------------Chh
Confidence             589999999999999999887654      577777777777777777644                         344


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH  283 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  283 (869)
                      .|..+++|+.|+|++|++....+..|..+++|+.|+|++|.+.
T Consensus       250 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             SSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             hhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            5555666666666666666566666677777777777777765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=8.8e-30  Score=268.35  Aligned_cols=266  Identities=20%  Similarity=0.228  Sum_probs=136.7

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ .+|.+++   ++|++|+|++|.++++.+..|..+++|++|+|++|++++..|.+|+++++|++|+|++|.
T Consensus        16 ~~c~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~   91 (285)
T 1ozn_A           16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (285)
T ss_dssp             EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCcCCcc-cCCcCCC---CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence            455556666 5665443   456666666666665555556666666666666666665555566666666666666664


Q ss_pred             -cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           82 -FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 -i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                       +....|..|.++++|++|+|++|++. .+                        .+..|.++++|++|++++|+++.+.+
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~  146 (285)
T 1ozn_A           92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-EL------------------------GPGLFRGLAALQYLYLQDNALQALPD  146 (285)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCC-CC------------------------CTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CccccCHHHhcCCcCCCEEECCCCcCC-EE------------------------CHhHhhCCcCCCEEECCCCcccccCH
Confidence             55444555556666666666666555 33                        34444444444555555554444444


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPP  240 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  240 (869)
                      ..|..+++|++|++++|+++.++..      .|..+++|++|++++|++++..|..+..+++ |+.|++++|.+++..+.
T Consensus       147 ~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~  219 (285)
T 1ozn_A          147 DTFRDLGNLTHLFLHGNRISSVPER------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR-LMTLYLFANNLSALPTE  219 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTT------TTTTCTTCCEEECCSSCCCEECTTTTTTCTT-CCEEECCSSCCSCCCHH
T ss_pred             hHhccCCCccEEECCCCcccccCHH------HhcCccccCEEECCCCcccccCHhHccCccc-ccEeeCCCCcCCcCCHH
Confidence            4444445555555555544444332      2444455555555555555444545544443 55555555555544444


Q ss_pred             cccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCC--Cccccceecccc
Q 002897          241 GLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGN--LTMLTLLALEIN  304 (869)
Q Consensus       241 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~l~~n  304 (869)
                      .+..+++|+.|++++|.+....+.. .-...++.+..+.+.+....|..+.+  +..++..++.+|
T Consensus       220 ~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C  284 (285)
T 1ozn_A          220 ALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC  284 (285)
T ss_dssp             HHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred             HcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence            4555555666666666554322110 00112333345555555555554433  334444444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=3.3e-29  Score=266.97  Aligned_cols=251  Identities=17%  Similarity=0.196  Sum_probs=173.0

Q ss_pred             CCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCC--chhhcCCcchhhhh
Q 002897           48 LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLP--FDMVANLPNLRKFV  125 (869)
Q Consensus        48 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~l~~L~~L~  125 (869)
                      -+.++++++.++ .+|..+.  ++|++|+|++|+++.+.+..|.++++|++|+|++|++. .+.  ...+..+++|++|+
T Consensus         9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-EEEEEEHHHHSCSCCCEEE
T ss_pred             CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC-cccCcccccccccccCEEE
Confidence            357888888888 6666554  68888999998888655556788888888888888876 221  12233445555555


Q ss_pred             ccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEcc
Q 002897          126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY  205 (869)
Q Consensus       126 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~  205 (869)
                      +++|.++. +|..+..                        +++|++|++++|.++.++..     ..+..+++|++|+++
T Consensus        85 Ls~n~i~~-l~~~~~~------------------------l~~L~~L~l~~n~l~~~~~~-----~~~~~l~~L~~L~l~  134 (306)
T 2z66_A           85 LSFNGVIT-MSSNFLG------------------------LEQLEHLDFQHSNLKQMSEF-----SVFLSLRNLIYLDIS  134 (306)
T ss_dssp             CCSCSEEE-EEEEEET------------------------CTTCCEEECTTSEEESSTTT-----TTTTTCTTCCEEECT
T ss_pred             CCCCcccc-ChhhcCC------------------------CCCCCEEECCCCcccccccc-----hhhhhccCCCEEECC
Confidence            55554442 2333444                        44555555555544443320     135555666666666


Q ss_pred             CCCCCCCCChhhhhccccceEEEecCCcccc-cCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccC
Q 002897          206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSG-TIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG  284 (869)
Q Consensus       206 ~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  284 (869)
                      +|++++..+..+..+++ |++|++++|.+++ ..|..+..+++|++|++++|++.+..|..+..+++|++|+|++|.+++
T Consensus       135 ~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  213 (306)
T 2z66_A          135 HTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS  213 (306)
T ss_dssp             TSCCEECSTTTTTTCTT-CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CCcCCccchhhcccCcC-CCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence            66666555555655554 6777777777665 467778888888888888888887778888888888888888888887


Q ss_pred             cCCCCCCCCccccceecccccccccCCcCccCcc-ccceeeccCcccCCC
Q 002897          285 YIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT-SLIMLTLSKNKLDGV  333 (869)
Q Consensus       285 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~  333 (869)
                      ..+..+..+++|+.|++++|++++..|..+..++ +|++|++++|++++.
T Consensus       214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            7776788888888888888888877888888874 888888888888744

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=3.3e-29  Score=263.97  Aligned_cols=269  Identities=20%  Similarity=0.190  Sum_probs=221.5

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      -+.++.+++.++ .+|..+  .++|++|+|++|+|+...+..|+.+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            467888888888 556544  46888888888888877777888888888888888888877777888888888888888


Q ss_pred             Cc-CcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCC
Q 002897          104 NR-FHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR  182 (869)
Q Consensus       104 N~-l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~  182 (869)
                      |+ +. .                        ..+..|..+++|++|++++|.++++.+..|..+++|++|++++|.++.+
T Consensus        90 n~~l~-~------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  144 (285)
T 1ozn_A           90 NAQLR-S------------------------VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL  144 (285)
T ss_dssp             CTTCC-C------------------------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCcc-c------------------------cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccccc
Confidence            86 54 3                        3355777889999999999999999899999999999999999999988


Q ss_pred             CCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecC
Q 002897          183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTV  262 (869)
Q Consensus       183 ~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  262 (869)
                      +..      .|..+++|++|++++|++++..+..+..+.+ |+.|++++|.+++..|..|..+++|+.|++++|++.+..
T Consensus       145 ~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  217 (285)
T 1ozn_A          145 PDD------TFRDLGNLTHLFLHGNRISSVPERAFRGLHS-LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP  217 (285)
T ss_dssp             CTT------TTTTCTTCCEEECCSSCCCEECTTTTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CHh------HhccCCCccEEECCCCcccccCHHHhcCccc-cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCC
Confidence            754      5889999999999999999777778888876 999999999999999999999999999999999999877


Q ss_pred             CccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccC--ccccceeeccCc
Q 002897          263 PPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN--CTSLIMLTLSKN  328 (869)
Q Consensus       263 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--l~~L~~L~l~~N  328 (869)
                      +..+..+++|+.|+|++|.+....+ ...-...++.+..+.+.+....|..+.+  +..++..++.+|
T Consensus       218 ~~~~~~l~~L~~L~l~~N~~~c~~~-~~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C  284 (285)
T 1ozn_A          218 TEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC  284 (285)
T ss_dssp             HHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred             HHHcccCcccCEEeccCCCccCCCC-cHHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence            7789999999999999999974322 1122345777788888888788887765  445555555544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=4.3e-30  Score=274.81  Aligned_cols=264  Identities=16%  Similarity=0.217  Sum_probs=149.2

Q ss_pred             ccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCccc
Q 002897            3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF   82 (869)
Q Consensus         3 ~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i   82 (869)
                      |++++.+. +++..++..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|  |+.+++|++|+|++|++
T Consensus        16 ~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l   92 (317)
T 3o53_A           16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV   92 (317)
T ss_dssp             SCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred             eccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence            44445554 4444454445555555555555554444555555555555555555553322  55555555555555555


Q ss_pred             CccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcC
Q 002897           83 SGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN  162 (869)
Q Consensus        83 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  162 (869)
                      ++..     ..++|++|++++|++.                         +..+..   +++|++|++++|+++++.+..
T Consensus        93 ~~l~-----~~~~L~~L~l~~n~l~-------------------------~~~~~~---~~~L~~L~l~~N~l~~~~~~~  139 (317)
T 3o53_A           93 QELL-----VGPSIETLHAANNNIS-------------------------RVSCSR---GQGKKNIYLANNKITMLRDLD  139 (317)
T ss_dssp             EEEE-----ECTTCCEEECCSSCCS-------------------------EEEECC---CSSCEEEECCSSCCCSGGGBC
T ss_pred             cccc-----CCCCcCEEECCCCccC-------------------------CcCccc---cCCCCEEECCCCCCCCccchh
Confidence            4321     2245555555555554                         333222   344555555555555555555


Q ss_pred             ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccc
Q 002897          163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL  242 (869)
Q Consensus       163 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~  242 (869)
                      |..+++|++|++++|.++.+...     ..+..+++|++|+|++|++++..+.  ..++ .|++|+|++|.+++ +|..+
T Consensus       140 ~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~--~~l~-~L~~L~Ls~N~l~~-l~~~~  210 (317)
T 3o53_A          140 EGCRSRVQYLDLKLNEIDTVNFA-----ELAASSDTLEHLNLQYNFIYDVKGQ--VVFA-KLKTLDLSSNKLAF-MGPEF  210 (317)
T ss_dssp             TGGGSSEEEEECTTSCCCEEEGG-----GGGGGTTTCCEEECTTSCCCEEECC--CCCT-TCCEEECCSSCCCE-ECGGG
T ss_pred             hhccCCCCEEECCCCCCCcccHH-----HHhhccCcCCEEECCCCcCcccccc--cccc-cCCEEECCCCcCCc-chhhh
Confidence            55555555555555555544322     0123455566666666655533111  1233 26666666666663 34447


Q ss_pred             cCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcccc-CcCCCCCCCCccccceecccc-cccccCCc
Q 002897          243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLH-GYIPSSLGNLTMLTLLALEIN-NLQGKIPS  312 (869)
Q Consensus       243 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~  312 (869)
                      ..+++|+.|++++|++. .+|..+..+++|+.|+|++|.+. +..+..+..+++|+.|++++| .+++..+.
T Consensus       211 ~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             GGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             cccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            77777888888888877 45667778888888888888887 666777788888888888844 45544443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.5e-28  Score=261.82  Aligned_cols=226  Identities=20%  Similarity=0.287  Sum_probs=167.2

Q ss_pred             CCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEE
Q 002897          197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLY  276 (869)
Q Consensus       197 ~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  276 (869)
                      ++++.|+|++|+++ .+|..+..+.. |++|+|++|.++ .+|..+..+++|++|+|++|++. .+|..++.+++|++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~-L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTT-CSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCC-CCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            45566666666665 44555555554 666666666666 56666666666777777777666 5566666777777777


Q ss_pred             ccCccccCcCCCCCCC---------CccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccce
Q 002897          277 LNSNFLHGYIPSSLGN---------LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF  347 (869)
Q Consensus       277 L~~N~l~~~~~~~~~~---------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~  347 (869)
                      |++|++.+.+|..+..         +++|++|++++|+++ .+|..+..+++|++|++++|+++                
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~----------------  219 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS----------------  219 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC----------------
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC----------------
Confidence            7776666666665543         666777777777766 56666777777777766666665                


Q ss_pred             ecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcc
Q 002897          348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL  427 (869)
Q Consensus       348 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (869)
                                .+|..++.+++|++|+|++|.+.+.+|..+.++++|+.|++++|++.+.+|..++.+++|+.|+|++|++
T Consensus       220 ----------~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~  289 (328)
T 4fcg_A          220 ----------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN  289 (328)
T ss_dssp             ----------CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred             ----------cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence                      3455678888899999999888888888899999999999999888888898899999999999999988


Q ss_pred             cCCCccccccccccCeeccccccCcc
Q 002897          428 SGQIPKYLENLSFLEYLNLSYNHFEG  453 (869)
Q Consensus       428 ~~~~p~~~~~l~~L~~l~l~~N~l~~  453 (869)
                      .+.+|..+.++++|+.++++.|.+..
T Consensus       290 ~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          290 LSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             CCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             hhhccHHHhhccCceEEeCCHHHHHH
Confidence            88999999999999999988877653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.4e-32  Score=318.75  Aligned_cols=417  Identities=13%  Similarity=0.098  Sum_probs=248.8

Q ss_pred             cCChhhhhccCCcCEEeccCCcCc---cccCcccc------------cCcCCCEEEccCCccCccCCccccCC--CCCCE
Q 002897           12 DIPVEIGCYLFKLENLSLAENHLT---GQLPVSIG------------NLSALQVIDIRGNRLGGKIPDTLGQL--RKLIY   74 (869)
Q Consensus        12 ~ip~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~L~~n~i~~~~p~~~~~l--~~L~~   74 (869)
                      ..|..++..+++|+.|+|+++...   +.+|..++            .+++|++|+|++|.++...+..+..+  ++|++
T Consensus        63 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~  142 (592)
T 3ogk_B           63 ATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLET  142 (592)
T ss_dssp             SCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCE
T ss_pred             cChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcE
Confidence            455666667788888888765321   22332222            67888888888887776555556553  34888


Q ss_pred             EeCcCcc-cCc-cCCcccccCCCCcEEECcCCcCcccCC---chhhcCCcchhhhhccccccc----eeccccccCCCCC
Q 002897           75 LNIGRNQ-FSG-FIPPSIYNISSFEFIFLQSNRFHGSLP---FDMVANLPNLRKFVAAKNNLT----GFLPISLSNASNL  145 (869)
Q Consensus        75 L~L~~n~-i~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~~l~~L~~L~l~~n~i~----~~~~~~l~~l~~L  145 (869)
                      |+|++|. +.. .++..+.++++|++|+|++|.+.+.-.   ...+..+++|++|++++|.++    ..++..+.++++|
T Consensus       143 L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L  222 (592)
T 3ogk_B          143 LKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSL  222 (592)
T ss_dssp             EEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTC
T ss_pred             EECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCC
Confidence            8888876 221 122233467888888888887753311   124556778888888888776    3344556677888


Q ss_pred             cEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccce
Q 002897          146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMT  225 (869)
Q Consensus       146 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~  225 (869)
                      ++|++++|.+.+ .+..+..+++|++|+++.+.......   .....+..+++|+.|+++++... .+|..+..+++ |+
T Consensus       223 ~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~---~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~-L~  296 (592)
T 3ogk_B          223 VSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP---EKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQ-IR  296 (592)
T ss_dssp             CEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT---TSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGG-CC
T ss_pred             cEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH---HHHHHhhccccccccCccccchh-HHHHHHhhcCC-Cc
Confidence            888888887765 34567777888888887533221111   12234667777888887775433 45555555554 77


Q ss_pred             EEEecCCcccccCC-ccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccC-----------ccccCcCC-CCCCC
Q 002897          226 TIDIGGNYFSGTIP-PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNS-----------NFLHGYIP-SSLGN  292 (869)
Q Consensus       226 ~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~~-~~~~~  292 (869)
                      +|+|++|.+++... ..+..+++|+.|+++++.....++..+..+++|++|+|++           |.+++... ..+..
T Consensus       297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~  376 (592)
T 3ogk_B          297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG  376 (592)
T ss_dssp             EEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred             EEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence            78887777654333 3356777777777773322222333335567777777773           44443211 11234


Q ss_pred             CccccceecccccccccCCcCccC-ccccceeecc----CcccCCCCCccccccccccceecccCCcccCCCcccccCCc
Q 002897          293 LTMLTLLALEINNLQGKIPSSLGN-CTSLIMLTLS----KNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLK  367 (869)
Q Consensus       293 l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~  367 (869)
                      +++|++|+++.|++++..+..+.. +++|+.|+++    .|.+++...+.                    .++..+.+++
T Consensus       377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~--------------------~~~~~~~~~~  436 (592)
T 3ogk_B          377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN--------------------GVRSLLIGCK  436 (592)
T ss_dssp             CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH--------------------HHHHHHHHCT
T ss_pred             CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH--------------------HHHHHHHhCC
Confidence            666777777666666554445544 6667777774    44444211000                    1222355566


Q ss_pred             cccccccccc--cccccCCcccc-CCCCCcEEEeeCccccCC-CCccccccccccEEEccCCcccCC-CccccccccccC
Q 002897          368 NLVQLDISGN--RFSGDIPGTLS-ACTSLEYVKMQDNSFSGS-IPPSLNFLKSIKVLDLSSNKLSGQ-IPKYLENLSFLE  442 (869)
Q Consensus       368 ~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~  442 (869)
                      +|++|+|++|  .+++..+..+. .+++|+.|++++|++++. ++..+..+++|+.|+|++|.+++. ++..+..+++|+
T Consensus       437 ~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  516 (592)
T 3ogk_B          437 KLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR  516 (592)
T ss_dssp             TCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCC
T ss_pred             CCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccC
Confidence            7777777643  35544444443 367777777777777642 233445667777777777776543 333445677777


Q ss_pred             eeccccccCccc
Q 002897          443 YLNLSYNHFEGE  454 (869)
Q Consensus       443 ~l~l~~N~l~~~  454 (869)
                      +|++++|++++.
T Consensus       517 ~L~ls~n~it~~  528 (592)
T 3ogk_B          517 YLWVQGYRASMT  528 (592)
T ss_dssp             EEEEESCBCCTT
T ss_pred             eeECcCCcCCHH
Confidence            777777776643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2e-31  Score=312.16  Aligned_cols=394  Identities=13%  Similarity=0.076  Sum_probs=276.3

Q ss_pred             hccCCcCEEeccCCcCccccCcccccC--cCCCEEEccCCc-cCc-cCCccccCCCCCCEEeCcCcccCcc----CCccc
Q 002897           19 CYLFKLENLSLAENHLTGQLPVSIGNL--SALQVIDIRGNR-LGG-KIPDTLGQLRKLIYLNIGRNQFSGF----IPPSI   90 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~-i~~-~~p~~~~~l~~L~~L~L~~n~i~~~----~p~~~   90 (869)
                      ..+++|++|+|++|.+++..+..+...  .+|++|+|++|. ++. .++..+..+++|++|+|++|.+.+.    ++..+
T Consensus       109 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~  188 (592)
T 3ogk_B          109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA  188 (592)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred             hhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence            368999999999999987777777764  459999999987 321 2233345789999999999998765    33456


Q ss_pred             ccCCCCcEEECcCCcCcccCCc----hhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc---cccCcCc
Q 002897           91 YNISSFEFIFLQSNRFHGSLPF----DMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI---GKMSINF  163 (869)
Q Consensus        91 ~~l~~L~~L~Ls~N~l~~~~~~----~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~---~~~~~~~  163 (869)
                      .++++|++|+|++|.+. .+..    ..+.++++|++|++++|.+.+ ++..+.++++|+.|+++.+...   ......+
T Consensus       189 ~~~~~L~~L~L~~n~~~-~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l  266 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFA-KISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL  266 (592)
T ss_dssp             HHCCCCCEEECTTCCCS-SCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC
T ss_pred             hcCCCccEEEeeccCCC-ccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHh
Confidence            78999999999999986 2221    345678999999999999986 6788999999999999865432   2334567


Q ss_pred             cCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCC-hhhhhccccceEEEecCCcccc-cCCcc
Q 002897          164 NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP-HSLANLSNTMTTIDIGGNYFSG-TIPPG  241 (869)
Q Consensus       164 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~~L~~L~l~~n~l~~-~~~~~  241 (869)
                      ..+++|+.|+++++....++       ..+..+++|++|+|++|.+++... ..+..+++ |+.|+++ +.+.. .++..
T Consensus       267 ~~~~~L~~L~l~~~~~~~l~-------~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~-L~~L~L~-~~~~~~~l~~~  337 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPNEMP-------ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN-LEVLETR-NVIGDRGLEVL  337 (592)
T ss_dssp             CCCTTCCEEEETTCCTTTGG-------GGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT-CCEEEEE-GGGHHHHHHHH
T ss_pred             hccccccccCccccchhHHH-------HHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC-CCEEecc-CccCHHHHHHH
Confidence            88899999999886544433       457789999999999999765444 23456665 9999999 44443 33444


Q ss_pred             ccCCCCCCeeeccc-----------CcceecCC-ccccCCCCCCEEEccCccccCcCCCCCCC-Cccccceecc----cc
Q 002897          242 LGNLVHLNSIAMEG-----------NQLIGTVP-PEIGWLKNLQSLYLNSNFLHGYIPSSLGN-LTMLTLLALE----IN  304 (869)
Q Consensus       242 ~~~l~~L~~L~l~~-----------n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~l~----~n  304 (869)
                      +..+++|++|++++           |.++.... ..+..+++|++|+++.|.+++..+..+.. +++|+.|+++    .|
T Consensus       338 ~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n  417 (592)
T 3ogk_B          338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE  417 (592)
T ss_dssp             HHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCS
T ss_pred             HHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCc
Confidence            56789999999993           56654322 22456899999999999998766666655 8899999996    67


Q ss_pred             ccccc-----CCcCccCccccceeeccCcc--cCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccc
Q 002897          305 NLQGK-----IPSSLGNCTSLIMLTLSKNK--LDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGN  377 (869)
Q Consensus       305 ~l~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N  377 (869)
                      .+++.     ++..+.++++|+.|++++|.  +++..+..+.                        ..+++|++|+|++|
T Consensus       418 ~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~------------------------~~~~~L~~L~L~~n  473 (592)
T 3ogk_B          418 RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG------------------------QYSPNVRWMLLGYV  473 (592)
T ss_dssp             CCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHH------------------------HSCTTCCEEEECSC
T ss_pred             cccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHH------------------------HhCccceEeeccCC
Confidence            77742     33346778999999997543  4422111111                        23556777777777


Q ss_pred             cccc-cCCccccCCCCCcEEEeeCccccCC-CCccccccccccEEEccCCcccCCCcccc-ccccccCeeccc
Q 002897          378 RFSG-DIPGTLSACTSLEYVKMQDNSFSGS-IPPSLNFLKSIKVLDLSSNKLSGQIPKYL-ENLSFLEYLNLS  447 (869)
Q Consensus       378 ~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~l~  447 (869)
                      .+++ .++..+.++++|++|++++|++++. ++..+..+++|+.|+|++|+++..-...+ ..++.+....+.
T Consensus       474 ~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~  546 (592)
T 3ogk_B          474 GESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIP  546 (592)
T ss_dssp             CSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEEC
T ss_pred             CCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEec
Confidence            7664 2344456677777777777776543 22333556777777777777764422222 234444444333

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=3.5e-28  Score=260.69  Aligned_cols=234  Identities=23%  Similarity=0.243  Sum_probs=146.0

Q ss_pred             cCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEE
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIF  100 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  100 (869)
                      ..+++.|+|++|+++ .+|..+..+++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..|.++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            478888888888888 77778888888888888888888 78888888888888888888888 6688888888888888


Q ss_pred             CcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      |++|.+.+.+|.....            +    ..+..|.++++|++|+|++|+++ ..|..|..+++|++|+|++|.++
T Consensus       157 L~~n~~~~~~p~~~~~------------~----~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~  219 (328)
T 4fcg_A          157 IRACPELTELPEPLAS------------T----DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS  219 (328)
T ss_dssp             EEEETTCCCCCSCSEE------------E----C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred             CCCCCCccccChhHhh------------c----cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence            8888777666643211            0    11233455666666666666655 33444555555555555555555


Q ss_pred             CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCccee
Q 002897          181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG  260 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  260 (869)
                      .++.       .+..+++|++|+|++|++.+.+|                         ..+..+++|++|++++|++.+
T Consensus       220 ~l~~-------~l~~l~~L~~L~Ls~n~~~~~~p-------------------------~~~~~l~~L~~L~L~~n~~~~  267 (328)
T 4fcg_A          220 ALGP-------AIHHLPKLEELDLRGCTALRNYP-------------------------PIFGGRAPLKRLILKDCSNLL  267 (328)
T ss_dssp             CCCG-------GGGGCTTCCEEECTTCTTCCBCC-------------------------CCTTCCCCCCEEECTTCTTCC
T ss_pred             cCch-------hhccCCCCCEEECcCCcchhhhH-------------------------HHhcCCCCCCEEECCCCCchh
Confidence            4332       24455555555555555544444                         444444455555555544444


Q ss_pred             cCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccc
Q 002897          261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNL  306 (869)
Q Consensus       261 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l  306 (869)
                      .+|..++.+++|++|+|++|++.+.+|..++++++|+.+++..+.+
T Consensus       268 ~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             BCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             hcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            4555555555555555555555555555555555555555544433

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=6.9e-28  Score=277.67  Aligned_cols=277  Identities=24%  Similarity=0.281  Sum_probs=226.2

Q ss_pred             CChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCccccc
Q 002897           13 IPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYN   92 (869)
Q Consensus        13 ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~   92 (869)
                      +|....|...+++.|++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|++ +|.   .
T Consensus        31 ~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~   99 (622)
T 3g06_A           31 VQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---L   99 (622)
T ss_dssp             HHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---C
T ss_pred             CcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---C
Confidence            44444555567999999999999 7777765  79999999999998 5665   57899999999999984 555   7


Q ss_pred             CCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEE
Q 002897           93 ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVL  172 (869)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  172 (869)
                      +++|++|+|++|+++ .+|.    .+++|+.|++++|+++.+ |..   +++|++|+|++|+++++..    .+++|+.|
T Consensus       100 l~~L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L  166 (622)
T 3g06_A          100 PPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLASLPA----LPSELCKL  166 (622)
T ss_dssp             CTTCCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSCCCC----CCTTCCEE
T ss_pred             CCCCCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCCcCC----ccCCCCEE
Confidence            789999999999998 6774    678899999999999864 443   4899999999999987543    35789999


Q ss_pred             EccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeee
Q 002897          173 ILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIA  252 (869)
Q Consensus       173 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  252 (869)
                      ++++|.++.++          ..+++|+.|++++|++++ +|..+    .+|+.|++++|.++ .+|..   +++|+.|+
T Consensus       167 ~L~~N~l~~l~----------~~~~~L~~L~Ls~N~l~~-l~~~~----~~L~~L~L~~N~l~-~l~~~---~~~L~~L~  227 (622)
T 3g06_A          167 WAYNNQLTSLP----------MLPSGLQELSVSDNQLAS-LPTLP----SELYKLWAYNNRLT-SLPAL---PSGLKELI  227 (622)
T ss_dssp             ECCSSCCSCCC----------CCCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCS-SCCCC---CTTCCEEE
T ss_pred             ECCCCCCCCCc----------ccCCCCcEEECCCCCCCC-CCCcc----chhhEEECcCCccc-ccCCC---CCCCCEEE
Confidence            99999998876          236889999999999985 44322    34999999999998 45543   47899999


Q ss_pred             cccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCC
Q 002897          253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDG  332 (869)
Q Consensus       253 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~  332 (869)
                      +++|++.+ +|   ..+++|+.|+|++|.|+. +|.   .+++|+.|++++|+|+ .+|..|..+++|+.|+|++|++++
T Consensus       228 Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~  298 (622)
T 3g06_A          228 VSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE  298 (622)
T ss_dssp             CCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCH
T ss_pred             ccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCC
Confidence            99999985 55   456899999999999994 554   6788999999999999 789999999999999999999997


Q ss_pred             CCCcccccc
Q 002897          333 VLPPQILSV  341 (869)
Q Consensus       333 ~~~~~~~~~  341 (869)
                      ..|..+...
T Consensus       299 ~~~~~l~~L  307 (622)
T 3g06_A          299 RTLQALREI  307 (622)
T ss_dssp             HHHHHHHHH
T ss_pred             cCHHHHHhc
Confidence            666555443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.6e-27  Score=274.53  Aligned_cols=269  Identities=23%  Similarity=0.292  Sum_probs=212.9

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhh
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV  125 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  125 (869)
                      .++++|++++|.|+ .+|..+.  ++|++|+|++|.|+. +|.   .+++|++|+|++|+++ .+|.    .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC----CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEE
Confidence            46899999999998 7777666  799999999999984 555   5789999999999997 7775    678999999


Q ss_pred             ccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEcc
Q 002897          126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY  205 (869)
Q Consensus       126 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~  205 (869)
                      +++|+++++..    .+++|+.|++++|+|+.+..    .+++|++|+|++|+++.++.          .+++|+.|+++
T Consensus       108 Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~----------~~~~L~~L~L~  169 (622)
T 3g06_A          108 IFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----------LPSELCKLWAY  169 (622)
T ss_dssp             ECSCCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC----------CCTTCCEEECC
T ss_pred             CcCCcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCcCC----------ccCCCCEEECC
Confidence            99999986533    56889999999999887544    24889999999999987653          24688999999


Q ss_pred             CCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCc
Q 002897          206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY  285 (869)
Q Consensus       206 ~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  285 (869)
                      +|++++ +|   ..+ .+|+.|++++|.+++ +|..   +++|+.|++++|.+. .+|..   +++|+.|+|++|.|++ 
T Consensus       170 ~N~l~~-l~---~~~-~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-  235 (622)
T 3g06_A          170 NNQLTS-LP---MLP-SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-  235 (622)
T ss_dssp             SSCCSC-CC---CCC-TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-
T ss_pred             CCCCCC-Cc---ccC-CCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-
Confidence            999985 44   222 349999999999984 4443   478899999999988 44432   4789999999999985 


Q ss_pred             CCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccC
Q 002897          286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGN  365 (869)
Q Consensus       286 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~  365 (869)
                      +|   ..+++|+.|++++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.. .+.++.|+|++|.+++..|..+..
T Consensus       236 lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~-l~~L~~L~L~~N~l~~~~~~~l~~  306 (622)
T 3g06_A          236 LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIH-LSSETTVNLEGNPLSERTLQALRE  306 (622)
T ss_dssp             CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGG-SCTTCEEECCSCCCCHHHHHHHHH
T ss_pred             CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhh-ccccCEEEecCCCCCCcCHHHHHh
Confidence            44   45688999999999998 5565   5688999999999998 67776554 455678999999999877776665


Q ss_pred             Cc
Q 002897          366 LK  367 (869)
Q Consensus       366 l~  367 (869)
                      ++
T Consensus       307 L~  308 (622)
T 3g06_A          307 IT  308 (622)
T ss_dssp             HH
T ss_pred             cc
Confidence            54

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.8e-29  Score=269.97  Aligned_cols=268  Identities=18%  Similarity=0.180  Sum_probs=214.9

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      ..++.++++.+.+....+..+..+++|++|+|++|+|++..|..|+++++|++|+|++|++++..+  |.++++|++|+|
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            346666777777775555666677778888888888876666777788888888888887775443  677777777777


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|++. .++                             ..++|++|++++|+++++.+..   +++|++|++++|+++.
T Consensus        88 s~n~l~-~l~-----------------------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~  134 (317)
T 3o53_A           88 NNNYVQ-ELL-----------------------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITM  134 (317)
T ss_dssp             CSSEEE-EEE-----------------------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCS
T ss_pred             cCCccc-ccc-----------------------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCC
Confidence            777665 221                             2279999999999998877654   5789999999999998


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhh-hccccceEEEecCCcccccCCccccCCCCCCeeecccCccee
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLA-NLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG  260 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  260 (869)
                      ++..      .+..+++|++|++++|++++..+..+. .++. |++|++++|.+++.  .....+++|++|++++|++.+
T Consensus       135 ~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~-L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~  205 (317)
T 3o53_A          135 LRDL------DEGCRSRVQYLDLKLNEIDTVNFAELAASSDT-LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF  205 (317)
T ss_dssp             GGGB------CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTT-CCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCE
T ss_pred             ccch------hhhccCCCCEEECCCCCCCcccHHHHhhccCc-CCEEECCCCcCccc--ccccccccCCEEECCCCcCCc
Confidence            7653      578899999999999999988777775 4554 99999999999966  234459999999999999996


Q ss_pred             cCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccccccc-ccCCcCccCccccceeeccC-cccCCCCC
Q 002897          261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ-GKIPSSLGNCTSLIMLTLSK-NKLDGVLP  335 (869)
Q Consensus       261 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~-N~l~~~~~  335 (869)
                      . |..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|++. +..+..+..+++|+.|++++ +.+++..|
T Consensus       206 l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          206 M-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             E-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             c-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            5 445899999999999999999 56788999999999999999998 77888999999999999994 44554443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=4.7e-29  Score=285.81  Aligned_cols=187  Identities=14%  Similarity=0.032  Sum_probs=132.1

Q ss_pred             eeeeecceEEEEEEECCCCeEEEEEEeeccc----------chhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ----------KGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       561 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ..+.|+.|.+..++..-.|+.||+|++....          +...+++.+|+++|+++ .|+||+++++++.+     ..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CC
Confidence            4566777777776666678999999996431          22346799999999999 79999999999654     48


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..||||||++|++|.+++.....      ++..   +|+.||++||+|+|++   |||||||||+|||++.+|.+||+||
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            89999999999999999987653      5554   5789999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCC
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                      |+|+......        ......+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       384 GlAr~~~~~~--------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          384 GSIVTTPQDC--------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             TTEESCC-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ccCeeCCCCC--------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            9998765432        22345679999999999876 5677899999999998887765543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.6e-29  Score=268.07  Aligned_cols=202  Identities=21%  Similarity=0.253  Sum_probs=123.8

Q ss_pred             ceEEEecCCcccccCCccc--cCCCCCCeeecccCcceecCCccccCC-----CCCCEEEccCccccCcCCCCCCCCccc
Q 002897          224 MTTIDIGGNYFSGTIPPGL--GNLVHLNSIAMEGNQLIGTVPPEIGWL-----KNLQSLYLNSNFLHGYIPSSLGNLTML  296 (869)
Q Consensus       224 L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L  296 (869)
                      |++|+|++|.+++.+|..+  ..+++|++|++++|++.+. |..++.+     ++|++|+|++|++++..|..|.++++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            5555555555554444443  4455555555555555433 4444433     455555555555554444455555555


Q ss_pred             cceeccccccccc--CCcCc--cCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccc
Q 002897          297 TLLALEINNLQGK--IPSSL--GNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL  372 (869)
Q Consensus       297 ~~L~l~~n~l~~~--~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L  372 (869)
                      ++|++++|++.+.  .+..+  ..+++|++|++++|++++ ++                     ......+.++++|++|
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~---------------------~~~~~~~~~l~~L~~L  233 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET-PS---------------------GVCSALAAARVQLQGL  233 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCC-HH---------------------HHHHHHHHTTCCCSEE
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcc-hH---------------------HHHHHHHhcCCCCCEE
Confidence            5555555544322  11122  444455555554444431 00                     1112334567889999


Q ss_pred             ccccccccccCC-ccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccC
Q 002897          373 DISGNRFSGDIP-GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF  451 (869)
Q Consensus       373 ~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  451 (869)
                      +|++|.+++..| ..+..+++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|+|
T Consensus       234 ~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l  308 (312)
T 1wwl_A          234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPF  308 (312)
T ss_dssp             ECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTT
T ss_pred             ECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCC
Confidence            999999987664 45667889999999999998 7787776  8899999999999865 65 88899999999999998


Q ss_pred             cc
Q 002897          452 EG  453 (869)
Q Consensus       452 ~~  453 (869)
                      ++
T Consensus       309 ~~  310 (312)
T 1wwl_A          309 LD  310 (312)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.4e-28  Score=260.55  Aligned_cols=255  Identities=19%  Similarity=0.205  Sum_probs=203.0

Q ss_pred             hhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccC-ccCCcccc-------CCCCCCEEeCcCcccCccC
Q 002897           15 VEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLG-GKIPDTLG-------QLRKLIYLNIGRNQFSGFI   86 (869)
Q Consensus        15 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~p~~~~-------~l~~L~~L~L~~n~i~~~~   86 (869)
                      .++++..++|+.|++++|.+  .+|..+...  |++|+|++|+++ ..+|..+.       ++++|++|+|++|++++..
T Consensus        36 ~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  111 (312)
T 1wwl_A           36 VELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTA  111 (312)
T ss_dssp             EEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCC
T ss_pred             EEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchh
Confidence            34556778889999999998  567766654  888899999884 45666655       7889999999999998888


Q ss_pred             Cccc--ccCCCCcEEECcCCcCcccCCchhhcCC-----cchhhhhccccccceeccccccCCCCCcEEEccCCcccccc
Q 002897           87 PPSI--YNISSFEFIFLQSNRFHGSLPFDMVANL-----PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        87 p~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-----~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      |..+  .++++|++|+|++|++.+ +| ..+..+     ++|++|++++|++++..+..|+++++|++|+|++|++.+..
T Consensus       112 ~~~~~~~~l~~L~~L~Ls~N~l~~-~~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          112 PPPLLEATGPDLNILNLRNVSWAT-RD-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER  189 (312)
T ss_dssp             CCCSSSCCSCCCSEEEEESCBCSS-SS-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH
T ss_pred             HHHHHHhcCCCccEEEccCCCCcc-hh-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch
Confidence            8876  888999999999999884 45 556666     88999999999998888889999999999999999876531


Q ss_pred             --Cc--CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCCh-hhhhccccceEEEecCCcc
Q 002897          160 --SI--NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPH-SLANLSNTMTTIDIGGNYF  234 (869)
Q Consensus       160 --~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~~L~~L~l~~n~l  234 (869)
                        +.  .+..+++|++|+|++|+++.++..   ....+..+++|++|++++|++++..|. .+..+. .|+.|+|++|.|
T Consensus       190 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-~L~~L~Ls~N~l  265 (312)
T 1wwl_A          190 GLISALCPLKFPTLQVLALRNAGMETPSGV---CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QLNSLNLSFTGL  265 (312)
T ss_dssp             HHHHHSCTTSCTTCCEEECTTSCCCCHHHH---HHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT-TCCEEECTTSCC
T ss_pred             HHHHHHHhccCCCCCEEECCCCcCcchHHH---HHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC-CCCEEECCCCcc
Confidence              22  348889999999999998854321   112456789999999999999887753 444454 499999999999


Q ss_pred             cccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccC
Q 002897          235 SGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG  284 (869)
Q Consensus       235 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  284 (869)
                      + .+|..+.  ++|++|++++|++.+. |. +..+++|++|+|++|++++
T Consensus       266 ~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          266 K-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             S-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             C-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            8 7777776  8999999999999865 65 8899999999999999875

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=9.8e-28  Score=271.39  Aligned_cols=237  Identities=16%  Similarity=0.223  Sum_probs=164.5

Q ss_pred             CCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEE
Q 002897          196 CSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSL  275 (869)
Q Consensus       196 l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  275 (869)
                      +++|++|+|++|.+++..|..|..+++ |+.|+|++|.+++..|  |..+++|++|+|++|.+.+..+     .++|++|
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTK-LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTT-CCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCC-CCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            347788888888887766777777765 8888888888776554  7788888888888888875432     2788888


Q ss_pred             EccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcc
Q 002897          276 YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL  355 (869)
Q Consensus       276 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l  355 (869)
                      ++++|.+++..+..   +++|+.|++++|++++..|..|+.+++|+.|+|++|++++..|..+....+.++.|+|++|.|
T Consensus       105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            88888888666543   467888888888888777778888888888888888887655555554445556666666666


Q ss_pred             cCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCccc-CCCccc
Q 002897          356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLS-GQIPKY  434 (869)
Q Consensus       356 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~  434 (869)
                      ++. | .+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++. +.+|..
T Consensus       182 ~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~  257 (487)
T 3oja_A          182 YDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF  257 (487)
T ss_dssp             CEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred             ccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence            643 2 23346667777777777764 3334666677777777777776 35666666677777777777666 455666


Q ss_pred             cccccccCeeccc
Q 002897          435 LENLSFLEYLNLS  447 (869)
Q Consensus       435 ~~~l~~L~~l~l~  447 (869)
                      +..++.|+.++++
T Consensus       258 ~~~l~~L~~l~~~  270 (487)
T 3oja_A          258 FSKNQRVQTVAKQ  270 (487)
T ss_dssp             HTTCHHHHHHHHH
T ss_pred             HHhCCCCcEEecc
Confidence            6666666666665

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=1.2e-27  Score=270.64  Aligned_cols=234  Identities=18%  Similarity=0.239  Sum_probs=138.5

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      +|++|+|++|.|++..|.+|..+++|++|+|++|.|++..|  |+.+++|++|+|++|.|++..     ..++|++|+|+
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence            56666666666665555666666666666666666664433  666666666666666665332     22566666666


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCcc-CCCCCCEEEccCccCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFN-SLKNLSVLILGNNHLGN  181 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~l~~n~l~~  181 (869)
                      +|.+. .++.   ..+++|+.|++++|.+++..|..|+.+++|++|+|++|.+++..+..|. .+++|++|+|++|.++.
T Consensus       108 ~N~l~-~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          108 NNNIS-RVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             SSCCC-CEEE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             CCcCC-CCCc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            66665 3332   1234455555555555544444555555555555555555544444443 34444444444444443


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++.        +..+++                         |+.|+|++|.+++. |..+..+++|+.|+|++|.+.+ 
T Consensus       184 ~~~--------~~~l~~-------------------------L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-  228 (487)
T 3oja_A          184 VKG--------QVVFAK-------------------------LKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-  228 (487)
T ss_dssp             EEC--------CCCCTT-------------------------CCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-
T ss_pred             ccc--------cccCCC-------------------------CCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-
Confidence            321        122333                         56666666666543 3346677777777777777774 


Q ss_pred             CCccccCCCCCCEEEccCcccc-CcCCCCCCCCccccceecc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLH-GYIPSSLGNLTMLTLLALE  302 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~  302 (869)
                      +|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       229 lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            5666777888888888888887 5666777888888888886

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=2.6e-26  Score=240.51  Aligned_cols=225  Identities=21%  Similarity=0.259  Sum_probs=143.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      .+..+.+++ +||..+.   ++|++|+|++|++++..+..|.++++|++|+|++|++++..+.+|+++++|++|+|++|+
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            355667777 7887664   578888888888886666678888888888888888887767778888888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhcccccccee-ccccccCCCCCcEEEccCCccccccC
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      +++..+..|.++++|++|++++|.+. .++...+..+++|++|++++|.++.. +|..|.++++|++|+|++|+++++.+
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             cCccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            88777777788888888888888776 44433445555555555555555432 24444445555555555554444444


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCc-EEEccCCCCCCCCChhhhhccccceEEEecCCcccccCC
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE-NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP  239 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~  239 (869)
                      ..|..+++|+                           .|. +|++++|++++..+..+...  +|+.|++++|.+++..+
T Consensus       167 ~~~~~l~~L~---------------------------~l~l~L~ls~n~l~~~~~~~~~~~--~L~~L~L~~n~l~~~~~  217 (276)
T 2z62_A          167 TDLRVLHQMP---------------------------LLNLSLDLSLNPMNFIQPGAFKEI--RLKELALDTNQLKSVPD  217 (276)
T ss_dssp             GGGHHHHTCT---------------------------TCCEEEECCSSCCCEECTTSSCSC--CEEEEECCSSCCSCCCT
T ss_pred             HHhhhhhhcc---------------------------ccceeeecCCCcccccCccccCCC--cccEEECCCCceeecCH
Confidence            3333333333                           222 55666666654444333332  26677777777665555


Q ss_pred             ccccCCCCCCeeecccCccee
Q 002897          240 PGLGNLVHLNSIAMEGNQLIG  260 (869)
Q Consensus       240 ~~~~~l~~L~~L~l~~n~l~~  260 (869)
                      ..|..+++|+.|++++|++..
T Consensus       218 ~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          218 GIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             TTTTTCCSCCEEECCSSCBCC
T ss_pred             hHhcccccccEEEccCCcccc
Confidence            556777777777777777763

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.3e-25  Score=235.22  Aligned_cols=228  Identities=19%  Similarity=0.225  Sum_probs=166.1

Q ss_pred             EEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcc
Q 002897          202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNF  281 (869)
Q Consensus       202 L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  281 (869)
                      .+..+..++ .+|..+.   .++++|++++|.+++..+..|.++++|++|++++|++.+..+..|..+++|++|+|++|.
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            344444444 3343322   247777777777776666677777778888888887777777777777888888888888


Q ss_pred             ccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcc
Q 002897          282 LHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPS  361 (869)
Q Consensus       282 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~  361 (869)
                      +++..+..|.++++|++|++++|++.+..+..+..+++|++|++++|++++.                        .+|.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~  143 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPE  143 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCch
Confidence            7777777777788888888888877766665677777888777777777621                        2466


Q ss_pred             cccCCccccccccccccccccCCccccCCCCCc----EEEeeCccccCCCCccccccccccEEEccCCcccCCCcccccc
Q 002897          362 EIGNLKNLVQLDISGNRFSGDIPGTLSACTSLE----YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLEN  437 (869)
Q Consensus       362 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  437 (869)
                      .+.++++|++|+|++|++++..+..+..+.+|+    .|++++|++++..+..+. ..+|+.|+|++|++++..+..+..
T Consensus       144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~  222 (276)
T 2z62_A          144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDR  222 (276)
T ss_dssp             GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTT
T ss_pred             hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcc
Confidence            777778888888888888866666777666666    788888888855554444 347888999999988766667788


Q ss_pred             ccccCeeccccccCcccCCCC
Q 002897          438 LSFLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       438 l~~L~~l~l~~N~l~~~~~~~  458 (869)
                      +++|+.|++++|++++.++..
T Consensus       223 l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          223 LTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCSCCEEECCSSCBCCCTTTT
T ss_pred             cccccEEEccCCcccccCCch
Confidence            889999999999988877654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.1e-25  Score=232.46  Aligned_cols=203  Identities=20%  Similarity=0.332  Sum_probs=141.4

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .+.+.+++++++++ .+|..+.  ++|++|+|++|+|+...+.+|+++++|++|+|++|+++.+.+..|.++++|++|+|
T Consensus        16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            34667777777777 4555443  56777777777777555566777777777777777777555556667777777777


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|++. .+|...|..+++|++|++++|.++...+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|.++.
T Consensus        93 ~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           93 TDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            777776 5666666777777777777777776666677777777777777777777666667777777777777777776


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~  235 (869)
                      ++..      .|..+++|++|+|++|++++..+..+..+++ |+.|+|++|.+.
T Consensus       172 ~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~~~  218 (270)
T 2o6q_A          172 VPEG------AFDKLTELKTLKLDNNQLKRVPEGAFDSLEK-LKMLQLQENPWD  218 (270)
T ss_dssp             CCTT------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTT-CCEEECCSSCBC
T ss_pred             eChh------HhccCCCcCEEECCCCcCCcCCHHHhccccC-CCEEEecCCCee
Confidence            6643      4666777777777777777655555666654 777777777765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=2.4e-29  Score=294.80  Aligned_cols=312  Identities=13%  Similarity=0.100  Sum_probs=201.0

Q ss_pred             cCChhhhhccCCcCEEeccCCcCcc---ccC------------cccccCcCCCEEEccCCccCccCCcccc-CCCCCCEE
Q 002897           12 DIPVEIGCYLFKLENLSLAENHLTG---QLP------------VSIGNLSALQVIDIRGNRLGGKIPDTLG-QLRKLIYL   75 (869)
Q Consensus        12 ~ip~~~~~~l~~L~~L~L~~n~l~~---~~~------------~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L   75 (869)
                      ..|..++..+++|+.|+|+++....   ..|            ..+..+++|++|+|++|.++...+..+. .+++|++|
T Consensus        56 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L  135 (594)
T 2p1m_B           56 VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVL  135 (594)
T ss_dssp             SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEE
T ss_pred             cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEE
Confidence            4566677788999999999876321   111            2235678999999999988876666665 68899999


Q ss_pred             eCcCc-ccCcc-CCcccccCCCCcEEECcCCcCcccCCc---hhhcCCcchhhhhccccc--cce-eccccccCCCCCcE
Q 002897           76 NIGRN-QFSGF-IPPSIYNISSFEFIFLQSNRFHGSLPF---DMVANLPNLRKFVAAKNN--LTG-FLPISLSNASNLEL  147 (869)
Q Consensus        76 ~L~~n-~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~L~~L~l~~n~--i~~-~~~~~l~~l~~L~~  147 (869)
                      +|++| .+... ++..+.++++|++|+|++|.+.+..+.   .....+++|++|++++|.  ++. .++..+..+++|++
T Consensus       136 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~  215 (594)
T 2p1m_B          136 VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS  215 (594)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCE
T ss_pred             eCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcE
Confidence            99998 55532 444555889999999999987632221   223366789999998886  321 12223345789999


Q ss_pred             EEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEE-EccCCCCCCCCChhhhhccccceE
Q 002897          148 LELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL-GLYDNQFGGLLPHSLANLSNTMTT  226 (869)
Q Consensus       148 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~~L~~  226 (869)
                      |++++|.-.+..+..+..+++|++|+++.+...-....--.+...+.++++|+.| .+.+... +.++..+..+++ |+.
T Consensus       216 L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~-L~~  293 (594)
T 2p1m_B          216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSR-LTT  293 (594)
T ss_dssp             EECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTT-CCE
T ss_pred             EecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-hhHHHHHHhhCC-CCE
Confidence            9999883222356667788899999876554210000001223357888888888 4444332 234444445554 999


Q ss_pred             EEecCCcccccCC-ccccCCCCCCeeecccCcceec-CCccccCCCCCCEEEccC---------ccccCcCCCCCC-CCc
Q 002897          227 IDIGGNYFSGTIP-PGLGNLVHLNSIAMEGNQLIGT-VPPEIGWLKNLQSLYLNS---------NFLHGYIPSSLG-NLT  294 (869)
Q Consensus       227 L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~  294 (869)
                      |+|++|.+++... ..+..+++|++|++++| +... ++.....+++|++|++++         +.+++.....+. +++
T Consensus       294 L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~  372 (594)
T 2p1m_B          294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCP  372 (594)
T ss_dssp             EECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCT
T ss_pred             EEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhch
Confidence            9999988764332 23567889999999888 4322 222233578899998843         344432222222 367


Q ss_pred             cccceecccccccccCCcCcc-Cccccceeecc
Q 002897          295 MLTLLALEINNLQGKIPSSLG-NCTSLIMLTLS  326 (869)
Q Consensus       295 ~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~  326 (869)
                      +|+.|.++.|.++......+. .+++|+.|+++
T Consensus       373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~  405 (594)
T 2p1m_B          373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLC  405 (594)
T ss_dssp             TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence            788888877877755444454 47788888887

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=4.7e-29  Score=292.32  Aligned_cols=414  Identities=14%  Similarity=0.115  Sum_probs=239.7

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCc---cCCcc------------ccCCCCCCEEeCcCcccCccCCcc
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG---KIPDT------------LGQLRKLIYLNIGRNQFSGFIPPS   89 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~---~~p~~------------~~~l~~L~~L~L~~n~i~~~~p~~   89 (869)
                      +.++++..... ..+..+..+++|++|+|++|....   ..|..            +..+++|++|+|++|.+++..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            35555544433 333456788899999999875221   22211            245778888888888887666666


Q ss_pred             cc-cCCCCcEEECcCC-cCcccCCchhhcCCcchhhhhccccccceecccccc----CCCCCcEEEccCCccccccCcC-
Q 002897           90 IY-NISSFEFIFLQSN-RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS----NASNLELLELRDNQFIGKMSIN-  162 (869)
Q Consensus        90 ~~-~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~----~l~~L~~L~L~~N~i~~~~~~~-  162 (869)
                      +. .+++|++|+|++| .+........+.++++|++|++++|.+++..+..+.    .+++|++|++++|. ..+.... 
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l  203 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSAL  203 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHH
Confidence            65 6788888888888 444221223445678888888888877654433333    56678888887775 2122222 


Q ss_pred             ---ccCCCCCCEEEccCc-cCCCCCCCCcchhhhccCCCCCcEEEccCCC-------CCCCCChhhhhccccceEE-Eec
Q 002897          163 ---FNSLKNLSVLILGNN-HLGNRAANDLDFVTVLANCSKLENLGLYDNQ-------FGGLLPHSLANLSNTMTTI-DIG  230 (869)
Q Consensus       163 ---~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~~L~~L-~l~  230 (869)
                         +..+++|++|++++| .++       .++..+..+++|++|+++.+.       +.+ ++..+.++.+ |+.| .+.
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~-------~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~-L~~Ls~~~  274 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLE-------KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE-LRCLSGFW  274 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHH-------HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT-CCEEECCB
T ss_pred             HHHHHhCCCCcEEecCCCCcHH-------HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC-cccccCCc
Confidence               234577888888777 222       134456677777777755443       221 2234555554 6666 333


Q ss_pred             CCcccccCCccccCCCCCCeeecccCcceecCC-ccccCCCCCCEEEccCccccCc-CCCCCCCCccccceecc------
Q 002897          231 GNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP-PEIGWLKNLQSLYLNSNFLHGY-IPSSLGNLTMLTLLALE------  302 (869)
Q Consensus       231 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~------  302 (869)
                      +.... .++..+..+++|++|++++|.+..... ..+..+++|++|++++| ++.. .+.....+++|+.|++.      
T Consensus       275 ~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g  352 (594)
T 2p1m_B          275 DAVPA-YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV  352 (594)
T ss_dssp             TCCGG-GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC
T ss_pred             ccchh-hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc
Confidence            33222 334444466777777777777553322 22456777777777777 3321 11112246677777773      


Q ss_pred             ---cccccccCCcCcc-CccccceeeccCcccCCCCCccccccccccceeccc--C----CcccCCC-----cccccCCc
Q 002897          303 ---INNLQGKIPSSLG-NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS--D----NLLSGSL-----PSEIGNLK  367 (869)
Q Consensus       303 ---~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~--~----N~l~~~~-----p~~~~~l~  367 (869)
                         .+.++......+. .+++|+.|.++.|++++.....+....+.++.|+++  +    |.+++..     +..+.+++
T Consensus       353 ~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~  432 (594)
T 2p1m_B          353 MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK  432 (594)
T ss_dssp             SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCT
T ss_pred             cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCC
Confidence               2344432222232 367777777777777643333333334556667777  3    4554211     11255666


Q ss_pred             cccccccccccccccCCccccC-CCCCcEEEeeCccccCCCCccc-cccccccEEEccCCcccCCCcc-ccccccccCee
Q 002897          368 NLVQLDISGNRFSGDIPGTLSA-CTSLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSSNKLSGQIPK-YLENLSFLEYL  444 (869)
Q Consensus       368 ~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l  444 (869)
                      +|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|+.|
T Consensus       433 ~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L  511 (594)
T 2p1m_B          433 DLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL  511 (594)
T ss_dssp             TCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEE
T ss_pred             CccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEE
Confidence            777777766 555444444544 6777777777777764444444 4567777777777777543332 33446777777


Q ss_pred             ccccccCc
Q 002897          445 NLSYNHFE  452 (869)
Q Consensus       445 ~l~~N~l~  452 (869)
                      ++++|+++
T Consensus       512 ~l~~~~~~  519 (594)
T 2p1m_B          512 WMSSCSVS  519 (594)
T ss_dssp             EEESSCCB
T ss_pred             eeeCCCCC
Confidence            77777763

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=1.5e-24  Score=226.16  Aligned_cols=198  Identities=23%  Similarity=0.298  Sum_probs=101.3

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ .||..++   .++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+
T Consensus        21 l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~   96 (270)
T 2o6q_A           21 VDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK   96 (270)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC
T ss_pred             EEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc
Confidence            345555555 4554443   345555555555554444455555555555555555554444444555555555555555


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      +++..+..|.++++|++|+|++|++. .++...|..+++|++|++++|.++...+..|..+++|++|+|++|+++.+.+.
T Consensus        97 l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  175 (270)
T 2o6q_A           97 LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG  175 (270)
T ss_dssp             CCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             CCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence            55444444555555555555555554 44444455555555555555555544444455555555555555555555444


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      .|..+++|++|+|++|+++.++..      .|..+++|+.|+|++|.+.
T Consensus       176 ~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          176 AFDKLTELKTLKLDNNQLKRVPEG------AFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSSCBC
T ss_pred             HhccCCCcCEEECCCCcCCcCCHH------HhccccCCCEEEecCCCee
Confidence            455555555555555555544432      3444555555555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.7e-24  Score=225.79  Aligned_cols=202  Identities=22%  Similarity=0.222  Sum_probs=148.4

Q ss_pred             CCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCC
Q 002897          117 NLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC  196 (869)
Q Consensus       117 ~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l  196 (869)
                      .+..+..+.+.++.+...  ..+..+++|+.|++++|.+..+  ..+..+++|++|++++|.++.++        .+..+
T Consensus        17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~--------~l~~l   84 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDIS--------ALKEL   84 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCG--------GGTTC
T ss_pred             hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCch--------hhcCC
Confidence            345677888888888754  4566788999999999988754  35788889999999998887643        47788


Q ss_pred             CCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEE
Q 002897          197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLY  276 (869)
Q Consensus       197 ~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  276 (869)
                      ++|++|++++|++++..+..+..+++ |++|++++|.+++..+..|..+++|++|++++|++.+..+..++.+++|++|+
T Consensus        85 ~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           85 TNLTYLILTGNQLQSLPNGVFDKLTN-LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCccChhHhcCCcC-CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            88888888888888766666666665 77777777777766666677777777777777777766666667777777777


Q ss_pred             ccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccC
Q 002897          277 LNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD  331 (869)
Q Consensus       277 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (869)
                      +++|++++..+..|.++++|+.|++++|++++..+..|..+++|+.|++++|.+.
T Consensus       164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence            7777777666666677777777777777777666666667777777777766665

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.1e-24  Score=227.12  Aligned_cols=229  Identities=21%  Similarity=0.319  Sum_probs=165.5

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .++..+++..+.++...  .+..+++|++|++++|.++ .++ .++.+++|++|+|++|.+.+.  ..+.++++|++|+|
T Consensus        19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L   92 (272)
T 3rfs_A           19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL   92 (272)
T ss_dssp             HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             HHHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence            35566667776666432  3566777777777777776 333 467777777777777777642  36777777777777


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|.+. .++...|.++++|++|++++|++++..+..|..+++|++|++++|+++++.+..|..+++|++|++++|+++.
T Consensus        93 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            777776 5665667777777777777777776666677778888888888888777777777778888888888888777


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++..      .+..+++|++|++++|++++..+..+..+++ |+.|++++|.+.+       .++.|+.|++..|.+.+.
T Consensus       172 ~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~  237 (272)
T 3rfs_A          172 LPEG------VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS-LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV  237 (272)
T ss_dssp             CCTT------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTT-CCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGG
T ss_pred             cCHH------HhcCCccCCEEECCCCcCCccCHHHHhCCcC-CCEEEccCCCccc-------cCcHHHHHHHHHHhCCCc
Confidence            6643      4677788888888888888777766777765 8888888887763       345688888888888888


Q ss_pred             CCccccCCCC
Q 002897          262 VPPEIGWLKN  271 (869)
Q Consensus       262 ~~~~~~~l~~  271 (869)
                      +|.+++.++.
T Consensus       238 ip~~~~~~~~  247 (272)
T 3rfs_A          238 VRNSAGSVAP  247 (272)
T ss_dssp             BBCTTSCBCG
T ss_pred             ccCcccccCC
Confidence            8888776654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.1e-24  Score=228.91  Aligned_cols=199  Identities=24%  Similarity=0.270  Sum_probs=100.1

Q ss_pred             ceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccc
Q 002897          224 MTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEI  303 (869)
Q Consensus       224 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  303 (869)
                      ++++++++|.++ .+|..+.  ++++.|++++|.+.+..+..|..+++|++|+|++|.+++..+.  ..+++|++|++++
T Consensus        12 l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~   86 (290)
T 1p9a_G           12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSH   86 (290)
T ss_dssp             CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCS
T ss_pred             ccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCC
Confidence            555555555555 3333332  3445555555555544444455555555555555555432221  3444444444444


Q ss_pred             ccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccC
Q 002897          304 NNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI  383 (869)
Q Consensus       304 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  383 (869)
                      |+++ .+|..+..+++|++|++++|+++                         +..|..|.++++|++|+|++|++++..
T Consensus        87 N~l~-~l~~~~~~l~~L~~L~l~~N~l~-------------------------~l~~~~~~~l~~L~~L~L~~N~l~~~~  140 (290)
T 1p9a_G           87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-------------------------SLPLGALRGLGELQELYLKGNELKTLP  140 (290)
T ss_dssp             SCCS-SCCCCTTTCTTCCEEECCSSCCC-------------------------CCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred             CcCC-cCchhhccCCCCCEEECCCCcCc-------------------------ccCHHHHcCCCCCCEEECCCCCCCccC
Confidence            4444 33444444444444444444443                         233344555556666666666665544


Q ss_pred             CccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCccc
Q 002897          384 PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE  454 (869)
Q Consensus       384 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  454 (869)
                      +..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.+++++|++.+.
T Consensus       141 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             hhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            455555666666666666665433344555566666666666655 4555555555555555555555443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=2.7e-24  Score=225.95  Aligned_cols=203  Identities=21%  Similarity=0.226  Sum_probs=167.4

Q ss_pred             hhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCc
Q 002897           18 GCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFE   97 (869)
Q Consensus        18 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~   97 (869)
                      ...+++++.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            346788888888888888 5665553  6888888888888877788888888888888888888865332  7788888


Q ss_pred             EEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCc
Q 002897           98 FIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNN  177 (869)
Q Consensus        98 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n  177 (869)
                      +|+|++|++. .+|. .+..+++|++|++++|+|+...+..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|
T Consensus        81 ~L~Ls~N~l~-~l~~-~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             EEECCSSCCS-SCCC-CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCC-cCch-hhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            8888888887 7774 5778888888899999888877788889999999999999998888888888999999999999


Q ss_pred             cCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc
Q 002897          178 HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       178 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~  235 (869)
                      +++.++..      .|..+++|++|+|++|+++ .+|..+..... |+.|+|++|.+.
T Consensus       159 ~l~~l~~~------~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~-L~~l~L~~Np~~  208 (290)
T 1p9a_G          159 NLTELPAG------LLNGLENLDTLLLQENSLY-TIPKGFFGSHL-LPFAFLHGNPWL  208 (290)
T ss_dssp             CCSCCCTT------TTTTCTTCCEEECCSSCCC-CCCTTTTTTCC-CSEEECCSCCBC
T ss_pred             cCCccCHH------HhcCcCCCCEEECCCCcCC-ccChhhccccc-CCeEEeCCCCcc
Confidence            99888764      5778889999999999998 56766776664 899999999876

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=1.6e-24  Score=221.48  Aligned_cols=188  Identities=17%  Similarity=0.216  Sum_probs=112.9

Q ss_pred             cccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCc-cCccCCccccCCCCCCEEeCcC-cccCcc
Q 002897            8 KLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNR-LGGKIPDTLGQLRKLIYLNIGR-NQFSGF   85 (869)
Q Consensus         8 ~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~L~~-n~i~~~   85 (869)
                      +++ +||. +.   .+|++|+|++|+|+++.+..|.++++|++|+|++|+ ++.+.+.+|+++++|++|+|++ |+++++
T Consensus        22 ~l~-~ip~-~~---~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i   96 (239)
T 2xwt_C           22 DIQ-RIPS-LP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI   96 (239)
T ss_dssp             SCS-SCCC-CC---TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE
T ss_pred             Ccc-ccCC-CC---CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc
Confidence            366 6776 43   467777777777776666677777777777777776 7666666777777777777777 777766


Q ss_pred             CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchh---hhhcccc-ccceeccccccCCCCCc-EEEccCCccccccC
Q 002897           86 IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLR---KFVAAKN-NLTGFLPISLSNASNLE-LLELRDNQFIGKMS  160 (869)
Q Consensus        86 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~---~L~l~~n-~i~~~~~~~l~~l~~L~-~L~L~~N~i~~~~~  160 (869)
                      .+..|.++++|++|+|++|+++ .+|.  |..+++|+   .|++++| +++.+.+..|.++++|+ +|++++|+++.+.+
T Consensus        97 ~~~~f~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~  173 (239)
T 2xwt_C           97 DPDALKELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG  173 (239)
T ss_dssp             CTTSEECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECT
T ss_pred             CHHHhCCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCH
Confidence            6667777777777777777776 4553  55555554   5555555 55554444555555555 55555555554444


Q ss_pred             cCccCCCCCCEEEccCcc-CCCCCCCCcchhhhccCC-CCCcEEEccCCCCC
Q 002897          161 INFNSLKNLSVLILGNNH-LGNRAANDLDFVTVLANC-SKLENLGLYDNQFG  210 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~l~~l-~~L~~L~L~~n~l~  210 (869)
                      ..|.. ++|++|++++|+ ++.++..      .|..+ ++|++|++++|+++
T Consensus       174 ~~~~~-~~L~~L~L~~n~~l~~i~~~------~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          174 YAFNG-TKLDAVYLNKNKYLTVIDKD------AFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             TTTTT-CEEEEEECTTCTTCCEECTT------TTTTCSBCCSEEECTTCCCC
T ss_pred             hhcCC-CCCCEEEcCCCCCcccCCHH------HhhccccCCcEEECCCCccc
Confidence            44443 445555555552 4444332      23444 44444444444444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=2.2e-25  Score=243.04  Aligned_cols=260  Identities=19%  Similarity=0.220  Sum_probs=135.8

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccC----cccccCc-CCCEEEccCCccCccCCccccCC-----CC
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLP----VSIGNLS-ALQVIDIRGNRLGGKIPDTLGQL-----RK   71 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l-----~~   71 (869)
                      ++++.|+++|.+|..+. ..++|++|+|++|.|++..+    +.|..++ +|++|+|++|+|+...+..|..+     ++
T Consensus         3 ~~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             cccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            35666666665555442 34446777777776665444    5566666 66666666666665555555554     66


Q ss_pred             CCEEeCcCcccCccCCccccc----C-CCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccC-CCCC
Q 002897           72 LIYLNIGRNQFSGFIPPSIYN----I-SSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN-ASNL  145 (869)
Q Consensus        72 L~~L~L~~n~i~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~-l~~L  145 (869)
                      |++|+|++|++++..+..+..    + ++|++|+|++|++. ..+...+.                    ..+.. .++|
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~--------------------~~l~~~~~~L  140 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-SKSSSEFK--------------------QAFSNLPASI  140 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-GSCHHHHH--------------------HHHTTSCTTC
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC-cHHHHHHH--------------------HHHHhCCCce
Confidence            666666666666555443333    2 56666666666665 33322211                    11222 2355


Q ss_pred             cEEEccCCccccccCcC----ccCCC-CCCEEEccCccCCCCCCCCcchhhhccCC-CCCcEEEccCCCCCCC----CCh
Q 002897          146 ELLELRDNQFIGKMSIN----FNSLK-NLSVLILGNNHLGNRAANDLDFVTVLANC-SKLENLGLYDNQFGGL----LPH  215 (869)
Q Consensus       146 ~~L~L~~N~i~~~~~~~----~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l-~~L~~L~L~~n~l~~~----~~~  215 (869)
                      ++|+|++|.++......    +..++ +|++|+|++|+++.....  .+...+..+ ++|++|+|++|++++.    ++.
T Consensus       141 ~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~  218 (362)
T 3goz_A          141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCA--ELAKFLASIPASVTSLDLSANLLGLKSYAELAY  218 (362)
T ss_dssp             CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH--HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHH--HHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence            55555555554322221    22333 555555555555544322  222334444 3666666666666542    223


Q ss_pred             hhhhccccceEEEecCCcccccCC----ccccCCCCCCeeecccCcceec-------CCccccCCCCCCEEEccCccccC
Q 002897          216 SLANLSNTMTTIDIGGNYFSGTIP----PGLGNLVHLNSIAMEGNQLIGT-------VPPEIGWLKNLQSLYLNSNFLHG  284 (869)
Q Consensus       216 ~~~~l~~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~L~~N~l~~  284 (869)
                      .+.....+|++|+|++|.+++..+    ..+..+++|+.|++++|.+...       ++..+..+++|+.|++++|.+..
T Consensus       219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            333333235666666665554322    2234556666666666663322       22344556666666666666654


Q ss_pred             c
Q 002897          285 Y  285 (869)
Q Consensus       285 ~  285 (869)
                      .
T Consensus       299 ~  299 (362)
T 3goz_A          299 S  299 (362)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=3.2e-25  Score=252.61  Aligned_cols=193  Identities=17%  Similarity=0.159  Sum_probs=142.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--------KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .+...++||+|+||+||+|..  .++.+|+|+.....        ....+++.+|++++++++||||+++..++...   
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---  411 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL---  411 (540)
T ss_dssp             -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---
T ss_pred             cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---
Confidence            335567999999999999955  78899999864221        11235689999999999999999444443322   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                        +..++||||+++++|.+++..              +..++.|+++||+|||++   +|+||||||+|||++.  .+||
T Consensus       412 --~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          412 --DNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             --TTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred             --CccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence              456999999999999999875              458899999999999999   9999999999999998  9999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC--CCCCccccchhhhHHHHHHHcCCCCCC
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG--SEASMTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el~tg~~pf~  774 (869)
                      +|||+|+.......... ..........||+.|+|||++..  ..|+..+|+|+...-..+-+.++.+|.
T Consensus       471 ~DFGla~~~~~~~~~~~-~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAV-DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCTTCEECCCHHHHHH-HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECccCEECCCcccccc-chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99999987654210000 00001134579999999999876  457888999999998888888877763

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=3.3e-25  Score=241.57  Aligned_cols=263  Identities=19%  Similarity=0.229  Sum_probs=193.4

Q ss_pred             EEeccCCcCccccCcccccCcCCCEEEccCCccCccCC----ccccCCC-CCCEEeCcCcccCccCCcccccC-----CC
Q 002897           26 NLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIP----DTLGQLR-KLIYLNIGRNQFSGFIPPSIYNI-----SS   95 (869)
Q Consensus        26 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p----~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l-----~~   95 (869)
                      .++|++|++++.+|..+...++|++|+|++|+|+...+    .+|.+++ +|++|+|++|+|.+..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            46788899998888777777779999999999986666    6788888 89999999999987777777775     88


Q ss_pred             CcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCC-CCCcEEEccCCccccccCcCcc----C-CCCC
Q 002897           96 FEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNA-SNLELLELRDNQFIGKMSINFN----S-LKNL  169 (869)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L  169 (869)
                      |++|+|++|++.+..+ ..                    +...+..+ ++|++|+|++|+++...+..+.    . .++|
T Consensus        82 L~~L~Ls~n~l~~~~~-~~--------------------l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L  140 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSS-DE--------------------LVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI  140 (362)
T ss_dssp             CCEEECCSSCGGGSCH-HH--------------------HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTC
T ss_pred             ccEEECcCCcCChHHH-HH--------------------HHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCce
Confidence            8888888888863222 21                    11234445 7899999999998776665543    3 3699


Q ss_pred             CEEEccCccCCCCCCCCcchhhhccCCC-CCcEEEccCCCCCCCCChhhhhc----cccceEEEecCCccccc----CCc
Q 002897          170 SVLILGNNHLGNRAANDLDFVTVLANCS-KLENLGLYDNQFGGLLPHSLANL----SNTMTTIDIGGNYFSGT----IPP  240 (869)
Q Consensus       170 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l----~~~L~~L~l~~n~l~~~----~~~  240 (869)
                      ++|+|++|.++.....  .++..+..++ +|++|+|++|++++..+..+...    +.+|++|||++|.|++.    ++.
T Consensus       141 ~~L~Ls~N~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~  218 (362)
T 3goz_A          141 TSLNLRGNDLGIKSSD--ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY  218 (362)
T ss_dssp             CEEECTTSCGGGSCHH--HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             eEEEccCCcCCHHHHH--HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence            9999999999865543  3445566666 99999999999987777655543    22499999999998853    344


Q ss_pred             cccC-CCCCCeeecccCcceecCC----ccccCCCCCCEEEccCccccCc-------CCCCCCCCccccceecccccccc
Q 002897          241 GLGN-LVHLNSIAMEGNQLIGTVP----PEIGWLKNLQSLYLNSNFLHGY-------IPSSLGNLTMLTLLALEINNLQG  308 (869)
Q Consensus       241 ~~~~-l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~l~~n~l~~  308 (869)
                      .+.. .++|++|+|++|.+....+    ..+..+++|++|+|++|.+.+.       ++..+.++++|+.|++++|++..
T Consensus       219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            5554 4588888898888876544    3346678888888888885432       33466778888888888888775


Q ss_pred             cCC
Q 002897          309 KIP  311 (869)
Q Consensus       309 ~~~  311 (869)
                      ..+
T Consensus       299 ~~~  301 (362)
T 3goz_A          299 SHS  301 (362)
T ss_dssp             GGC
T ss_pred             cch
Confidence            433

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=2.1e-23  Score=214.84  Aligned_cols=181  Identities=23%  Similarity=0.328  Sum_probs=142.8

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .+.++++++++.++ .+|..+.  ++|++|+|++|+|++..+.+|+++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            45677788888777 5665554  57788888888887777777778888888888888887777777777888888888


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|++. .+|...|..+++|++|++++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+++.
T Consensus        91 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  169 (251)
T 3m19_A           91 ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS  169 (251)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence            888876 6666777778888888888888887777778888888888888888888877788888888888888888887


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCC
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGL  212 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~  212 (869)
                      ++..      .|..+++|++|+|++|.+...
T Consensus       170 ~~~~------~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          170 VPHG------AFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCTT------TTTTCTTCCEEECCSCCBCTT
T ss_pred             cCHH------HHhCCCCCCEEEeeCCceeCC
Confidence            7654      577888888999999888754

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.5e-24  Score=217.00  Aligned_cols=206  Identities=16%  Similarity=0.246  Sum_probs=127.6

Q ss_pred             cCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc-cCccCCcccccCCCCcEEECcC-CcCcccC
Q 002897           33 HLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ-FSGFIPPSIYNISSFEFIFLQS-NRFHGSL  110 (869)
Q Consensus        33 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~  110 (869)
                      .++ .+|. +.  .+|++|+|++|+|+++.+.+|+++++|++|+|++|+ ++++.+..|.++++|++|+|++ |++. .+
T Consensus        22 ~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i   96 (239)
T 2xwt_C           22 DIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YI   96 (239)
T ss_dssp             SCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EE
T ss_pred             Ccc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-Ec
Confidence            355 5555 43  378888888888887666678888888888888886 7766666777777888887777 7776 55


Q ss_pred             CchhhcCCcchhhhhccccccceeccccccCCCCCc---EEEccCC-ccccccCcCccCCCCCC-EEEccCccCCCCCCC
Q 002897          111 PFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLE---LLELRDN-QFIGKMSINFNSLKNLS-VLILGNNHLGNRAAN  185 (869)
Q Consensus       111 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~---~L~L~~N-~i~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~  185 (869)
                      |...|.++++|++|++++|.+++ +|. |..+++|+   +|++++| .++.+.+..|.++++|+ +|++++|+++.++. 
T Consensus        97 ~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~-  173 (239)
T 2xwt_C           97 DPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG-  173 (239)
T ss_dssp             CTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECT-
T ss_pred             CHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCH-
Confidence            55555666666666666666554 232 55555555   5555555 55554444455555555 55555444443332 


Q ss_pred             CcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCc-ccccCCccccCC-CCCCeeecccCcceecCC
Q 002897          186 DLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY-FSGTIPPGLGNL-VHLNSIAMEGNQLIGTVP  263 (869)
Q Consensus       186 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~  263 (869)
                                                   ..+.. . .|+.|++++|. +++..+..|..+ ++|+.|++++|++.+. |
T Consensus       174 -----------------------------~~~~~-~-~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~  221 (239)
T 2xwt_C          174 -----------------------------YAFNG-T-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-P  221 (239)
T ss_dssp             -----------------------------TTTTT-C-EEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-C
T ss_pred             -----------------------------hhcCC-C-CCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-C
Confidence                                         22222 2 36666666663 665555666666 7777777777777643 3


Q ss_pred             ccccCCCCCCEEEccCc
Q 002897          264 PEIGWLKNLQSLYLNSN  280 (869)
Q Consensus       264 ~~~~~l~~L~~L~L~~N  280 (869)
                      ..  .+++|+.|+++++
T Consensus       222 ~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          222 SK--GLEHLKELIARNT  236 (239)
T ss_dssp             CT--TCTTCSEEECTTC
T ss_pred             hh--HhccCceeeccCc
Confidence            32  4667777777765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=1.3e-23  Score=223.79  Aligned_cols=229  Identities=18%  Similarity=0.222  Sum_probs=166.0

Q ss_pred             CCCcEEEccCCCCCCCCCh---hhhhccccceEEEecCCcccccCCccc--cCCCCCCeeecccCcceecCC----cccc
Q 002897          197 SKLENLGLYDNQFGGLLPH---SLANLSNTMTTIDIGGNYFSGTIPPGL--GNLVHLNSIAMEGNQLIGTVP----PEIG  267 (869)
Q Consensus       197 ~~L~~L~L~~n~l~~~~~~---~~~~l~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~----~~~~  267 (869)
                      ..++.|.+.++.++...-.   .+..+.+ |++|++++|.+++..|..+  ..+++|++|++++|.+.+..+    ..+.
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSR-LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSC-CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCc-eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            3466777777666422111   1122333 8888888888887888777  888888999999888886544    3445


Q ss_pred             CCCCCCEEEccCccccCcCCCCCCCCccccceeccccccccc--C--CcCccCccccceeeccCcccCCCCCcccccccc
Q 002897          268 WLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGK--I--PSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT  343 (869)
Q Consensus       268 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  343 (869)
                      .+++|++|+|++|++++..+..|.++++|++|++++|++.+.  +  +..+..+++|++|++++|+++ .++..      
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~------  215 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGV------  215 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHH------
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHH------
Confidence            688899999999999888888888899999999999987632  1  233467888888888888876 11110      


Q ss_pred             ccceecccCCcccCCCcccccCCccccccccccccccccCCccccCC---CCCcEEEeeCccccCCCCccccccccccEE
Q 002897          344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSAC---TSLEYVKMQDNSFSGSIPPSLNFLKSIKVL  420 (869)
Q Consensus       344 ~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  420 (869)
                                     .+..++++++|++|+|++|.+++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|
T Consensus       216 ---------------~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L  277 (310)
T 4glp_A          216 ---------------CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL  277 (310)
T ss_dssp             ---------------HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred             ---------------HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence                           00124667788888888888887767777766   58888888888888 6677664  788888


Q ss_pred             EccCCcccCCCccccccccccCeeccccccCcc
Q 002897          421 DLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEG  453 (869)
Q Consensus       421 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  453 (869)
                      +|++|+|++. |. +..+++|+.|++++|+|+.
T Consensus       278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             ECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            8888888854 43 6778888888888888864

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=1.6e-23  Score=227.07  Aligned_cols=240  Identities=19%  Similarity=0.198  Sum_probs=131.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccC-CccccCCCCCCE-EeCcC
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI-PDTLGQLRKLIY-LNIGR   79 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~-L~L~~   79 (869)
                      ++.++++++ +||.+++   +++++|+|++|+|+.+.+.+|.++++|++|+|++|+|.+.+ +++|.++++|++ +.++.
T Consensus        14 v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           14 FLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            456667777 6776664   46777777777777555556777777777777777764433 356667766654 45556


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccccc
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      |+|+.+.|..|.++++|++|++++|++. .+|...+....++..|++.+                       .|++..+.
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~-----------------------~~~i~~l~  145 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQD-----------------------NINIHTIE  145 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEES-----------------------CTTCCEEC
T ss_pred             CcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhcc-----------------------cccccccc
Confidence            6777666666777777777777777765 44444444444444444433                       13344444


Q ss_pred             CcCccCCC-CCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccC-CCCCCCCChhhhhccccceEEEecCCccccc
Q 002897          160 SINFNSLK-NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYD-NQFGGLLPHSLANLSNTMTTIDIGGNYFSGT  237 (869)
Q Consensus       160 ~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~  237 (869)
                      +..|..+. .++.|+|++|+|+.++..       .....+|++|++++ |.++.+.+..|..+.+ |+.|||++|+|+..
T Consensus       146 ~~~f~~~~~~l~~L~L~~N~i~~i~~~-------~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~-L~~LdLs~N~l~~l  217 (350)
T 4ay9_X          146 RNSFVGLSFESVILWLNKNGIQEIHNS-------AFNGTQLDELNLSDNNNLEELPNDVFHGASG-PVILDISRTRIHSL  217 (350)
T ss_dssp             TTSSTTSBSSCEEEECCSSCCCEECTT-------SSTTEEEEEEECTTCTTCCCCCTTTTTTEEC-CSEEECTTSCCCCC
T ss_pred             ccchhhcchhhhhhccccccccCCChh-------hccccchhHHhhccCCcccCCCHHHhccCcc-cchhhcCCCCcCcc
Confidence            44444432 344455555555444432       11233455555542 3444333334445543 55666666655533


Q ss_pred             CCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcc
Q 002897          238 IPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNF  281 (869)
Q Consensus       238 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  281 (869)
                      .+..|.++++|+.+++  +.+. .+| .+..+++|+.+++.++.
T Consensus       218 p~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          218 PSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             ChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence            3333444443333332  2222 445 36677788888877653

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=9.5e-23  Score=209.89  Aligned_cols=176  Identities=22%  Similarity=0.301  Sum_probs=147.9

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ ++|..++   .+++.|+|++|++++..+.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        19 l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~   94 (251)
T 3m19_A           19 VDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ   94 (251)
T ss_dssp             EECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence            678888888 8888775   578888888888887777788888888888888888888777788888888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      |++..+..|.++++|++|+|++|++. .+|...|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+++++.+.
T Consensus        95 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  173 (251)
T 3m19_A           95 LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG  173 (251)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             ccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence            88777778888888888888888887 77777788888888888888888877777888888888888888888888887


Q ss_pred             CccCCCCCCEEEccCccCCCC
Q 002897          162 NFNSLKNLSVLILGNNHLGNR  182 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~  182 (869)
                      .|..+++|+.|+|++|.+...
T Consensus       174 ~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          174 AFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTCTTCCEEECCSCCBCTT
T ss_pred             HHhCCCCCCEEEeeCCceeCC
Confidence            888888888888888888654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=9.6e-24  Score=224.80  Aligned_cols=229  Identities=14%  Similarity=0.210  Sum_probs=170.1

Q ss_pred             CCcCEEeccCCcCcccc-C--cccccCcCCCEEEccCCccCccCCccc--cCCCCCCEEeCcCcccCccCC----ccccc
Q 002897           22 FKLENLSLAENHLTGQL-P--VSIGNLSALQVIDIRGNRLGGKIPDTL--GQLRKLIYLNIGRNQFSGFIP----PSIYN   92 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~-~--~~~~~l~~L~~L~L~~n~i~~~~p~~~--~~l~~L~~L~L~~n~i~~~~p----~~~~~   92 (869)
                      ..++.|.+.++.++... .  ..+..+++|++|+|++|++.+..|..+  +.+++|++|+|++|++.+..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            45788888888776211 1  112345678899999998888888887  888889999999998886555    44567


Q ss_pred             CCCCcEEECcCCcCcccCCchhhcCCcchhhhhcccccccee---c-cccccCCCCCcEEEccCCccccccCc---CccC
Q 002897           93 ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF---L-PISLSNASNLELLELRDNQFIGKMSI---NFNS  165 (869)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~---~-~~~l~~l~~L~~L~L~~N~i~~~~~~---~~~~  165 (869)
                      +++|++|+|++|++. .++...|..+++|++|++++|++.+.   . +..+..+++|++|+|++|+++.+...   .+..
T Consensus       144 ~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence            888899999999887 66667788888899999998887542   2 23457888899999999988643322   3567


Q ss_pred             CCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCC
Q 002897          166 LKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNL  245 (869)
Q Consensus       166 l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l  245 (869)
                      +++|++|+|++|+++...+..+   ..+..+++|++|+|++|+++ .+|..+.   ..|+.|+|++|.|++. |. +..+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~---~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l  293 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSA---PRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDEL  293 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCC---SSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSC
T ss_pred             CCCCCEEECCCCCCCccchhhH---HhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhC
Confidence            8899999999999887733211   12333478999999999998 5566554   3599999999999854 43 6788


Q ss_pred             CCCCeeecccCccee
Q 002897          246 VHLNSIAMEGNQLIG  260 (869)
Q Consensus       246 ~~L~~L~l~~n~l~~  260 (869)
                      ++|+.|++++|++..
T Consensus       294 ~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          294 PEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCSCEECSSTTTSC
T ss_pred             CCccEEECcCCCCCC
Confidence            999999999999863

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=5.2e-23  Score=223.00  Aligned_cols=243  Identities=19%  Similarity=0.183  Sum_probs=138.3

Q ss_pred             CEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhh-hhcc
Q 002897           49 QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRK-FVAA  127 (869)
Q Consensus        49 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~-L~l~  127 (869)
                      ++++.++++++ .+|..+  .++|++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|.++|.++++|++ +.+.
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            34455555555 444433  2355555555555554444455555555555555555544455555555555443 3334


Q ss_pred             ccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccC-ccCCCCCCCCcchhhhccCCCCCcEEEccC
Q 002897          128 KNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGN-NHLGNRAANDLDFVTVLANCSKLENLGLYD  206 (869)
Q Consensus       128 ~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  206 (869)
                      .|+++.+.|..|..+++|++|++++|++..+.+..+....++..|++.+ |++..++                       
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~-----------------------  145 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE-----------------------  145 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC-----------------------
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc-----------------------
Confidence            4555555566666677777777777776666555555555555555533 3444443                       


Q ss_pred             CCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeeccc-CcceecCCccccCCCCCCEEEccCccccCc
Q 002897          207 NQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLHGY  285 (869)
Q Consensus       207 n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  285 (869)
                             +..|..+...++.|+|++|.|+. +|.......+|+.|++.+ |.+..+.+..|..+++|++|+|++|+|+.+
T Consensus       146 -------~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l  217 (350)
T 4ay9_X          146 -------RNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL  217 (350)
T ss_dssp             -------TTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred             -------ccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence                   33333443335556666666653 333333445667777654 555544445677777888888888888766


Q ss_pred             CCCCCCCCccccceecccccccccCCcCccCccccceeeccCcc
Q 002897          286 IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNK  329 (869)
Q Consensus       286 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  329 (869)
                      .+..|.++++|+.+++.  .+. .+| .+..+++|+.++++++.
T Consensus       218 p~~~~~~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          218 PSYGLENLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CSSSCTTCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             ChhhhccchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCCc
Confidence            66666666666665553  333 455 37778888888876543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=7.1e-23  Score=217.42  Aligned_cols=212  Identities=23%  Similarity=0.346  Sum_probs=126.5

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .++..+.+..+.+++.+  .+..+++|++|++++|.++ .+| .++.+++|++|+|++|++.+.. . +.++++|++|+|
T Consensus        19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~-~-~~~l~~L~~L~L   92 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA-P-LKNLTKITELEL   92 (308)
T ss_dssp             HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCCSCCEEEC
T ss_pred             HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCCh-h-HccCCCCCEEEc
Confidence            34455566666666433  2556778888888888777 344 5777788888888888877543 3 777778888888


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|++. .++  .+..+++|++|++++|.+++..  .+..+++|++|++++|.++++.+  +..+++|+.|++++|.++.
T Consensus        93 ~~n~l~-~~~--~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           93 SGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             cCCcCC-Cch--hhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence            888776 443  3555566666666666655432  25666666666666666655433  5556666666666666554


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ++        .+..+++|++|++++|++++..+                           +..+++|++|++++|++.+.
T Consensus       166 ~~--------~l~~l~~L~~L~l~~n~l~~~~~---------------------------l~~l~~L~~L~L~~N~l~~~  210 (308)
T 1h6u_A          166 LT--------PLANLSKLTTLKADDNKISDISP---------------------------LASLPNLIEVHLKNNQISDV  210 (308)
T ss_dssp             CG--------GGTTCTTCCEEECCSSCCCCCGG---------------------------GGGCTTCCEEECTTSCCCBC
T ss_pred             Ch--------hhcCCCCCCEEECCCCccCcChh---------------------------hcCCCCCCEEEccCCccCcc
Confidence            33        14555555555555555553221                           34444555555555555433


Q ss_pred             CCccccCCCCCCEEEccCcccc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLH  283 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~  283 (869)
                      .  .+..+++|+.|+|++|+++
T Consensus       211 ~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          211 S--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             G--GGTTCTTCCEEEEEEEEEE
T ss_pred             c--cccCCCCCCEEEccCCeee
Confidence            2  2455555666666666555

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=1.4e-25  Score=247.21  Aligned_cols=79  Identities=13%  Similarity=0.206  Sum_probs=52.3

Q ss_pred             eccCCcCccccCcccccCcCCCEEEccCCccCccC----CccccCCCCCCEEeCcCccc---CccCCccc-------ccC
Q 002897           28 SLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI----PDTLGQLRKLIYLNIGRNQF---SGFIPPSI-------YNI   93 (869)
Q Consensus        28 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~----p~~~~~l~~L~~L~L~~n~i---~~~~p~~~-------~~l   93 (869)
                      .++...+. .++..+..+++|++|+|++|+|+...    +..|..+++|++|+|++|.+   .+.+|..+       .++
T Consensus        15 ~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~   93 (386)
T 2ca6_A           15 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC   93 (386)
T ss_dssp             SCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTC
T ss_pred             CCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhC
Confidence            33444444 56677788888888888888887543    33466788888888888543   33444444       566


Q ss_pred             CCCcEEECcCCcCc
Q 002897           94 SSFEFIFLQSNRFH  107 (869)
Q Consensus        94 ~~L~~L~Ls~N~l~  107 (869)
                      ++|++|+|++|.+.
T Consensus        94 ~~L~~L~Ls~n~l~  107 (386)
T 2ca6_A           94 PKLHTVRLSDNAFG  107 (386)
T ss_dssp             TTCCEEECCSCCCC
T ss_pred             CcccEEECCCCcCC
Confidence            67777777777665

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=2.5e-22  Score=213.20  Aligned_cols=205  Identities=22%  Similarity=0.326  Sum_probs=168.9

Q ss_pred             cCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccC
Q 002897            4 AQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS   83 (869)
Q Consensus         4 l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~   83 (869)
                      +..+++++.++.   ..+++|+.|++++|.++. +| .+..+++|++|+|++|+++.. +. +..+++|++|+|++|+++
T Consensus        26 l~~~~~~~~~~~---~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~   98 (308)
T 1h6u_A           26 AGKSNVTDTVTQ---ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLK   98 (308)
T ss_dssp             TTCSSTTSEECH---HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCS
T ss_pred             hCCCCcCceecH---HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCC
Confidence            455666633442   357899999999999994 55 699999999999999999954 44 999999999999999998


Q ss_pred             ccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCc
Q 002897           84 GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF  163 (869)
Q Consensus        84 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~  163 (869)
                      +.  ..+.++++|++|+|++|++. .++.  +..+++|++|++++|.+++..+  +..+++|++|++++|.++++.+  +
T Consensus        99 ~~--~~~~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l  169 (308)
T 1h6u_A           99 NV--SAIAGLQSIKTLDLTSTQIT-DVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L  169 (308)
T ss_dssp             CC--GGGTTCTTCCEEECTTSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred             Cc--hhhcCCCCCCEEECCCCCCC-Cchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence            54  47999999999999999998 5663  8999999999999999997654  8999999999999999987665  9


Q ss_pred             cCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc
Q 002897          164 NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       164 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~  235 (869)
                      ..+++|+.|++++|.++.++.        +..+++|++|++++|++++..+  +..+++ |+.|++++|.++
T Consensus       170 ~~l~~L~~L~l~~n~l~~~~~--------l~~l~~L~~L~L~~N~l~~~~~--l~~l~~-L~~L~l~~N~i~  230 (308)
T 1h6u_A          170 ANLSKLTTLKADDNKISDISP--------LASLPNLIEVHLKNNQISDVSP--LANTSN-LFIVTLTNQTIT  230 (308)
T ss_dssp             TTCTTCCEEECCSSCCCCCGG--------GGGCTTCCEEECTTSCCCBCGG--GTTCTT-CCEEEEEEEEEE
T ss_pred             cCCCCCCEEECCCCccCcChh--------hcCCCCCCEEEccCCccCcccc--ccCCCC-CCEEEccCCeee
Confidence            999999999999999987652        7788999999999999885432  444443 555555555554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=6.1e-25  Score=242.11  Aligned_cols=260  Identities=19%  Similarity=0.235  Sum_probs=150.0

Q ss_pred             CCcccccCChhhhhccCCcCEEeccCCcCcccc----CcccccCcCCCEEEccCCc---cCccCCccc-------cCCCC
Q 002897            6 NNKLVGDIPVEIGCYLFKLENLSLAENHLTGQL----PVSIGNLSALQVIDIRGNR---LGGKIPDTL-------GQLRK   71 (869)
Q Consensus         6 ~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~---i~~~~p~~~-------~~l~~   71 (869)
                      ...+. .++..+. .+++|+.|+|++|.|+...    +..|..+++|++|+|++|.   +++.+|..+       ..+++
T Consensus        18 ~~~~~-~l~~~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~   95 (386)
T 2ca6_A           18 TEDEK-SVFAVLL-EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPK   95 (386)
T ss_dssp             SHHHH-TTSHHHH-HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTT
T ss_pred             HHHHH-HHHHHHh-cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCc
Confidence            33455 6777765 6889999999999998653    3457789999999999964   444555554       78999


Q ss_pred             CCEEeCcCcccCc----cCCcccccCCCCcEEECcCCcCcccCCchhhcC-CcchhhhhccccccceeccccccCCCCCc
Q 002897           72 LIYLNIGRNQFSG----FIPPSIYNISSFEFIFLQSNRFHGSLPFDMVAN-LPNLRKFVAAKNNLTGFLPISLSNASNLE  146 (869)
Q Consensus        72 L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-l~~L~~L~l~~n~i~~~~~~~l~~l~~L~  146 (869)
                      |++|+|++|.+..    .+|..+.++++|++|+|++|.+.+..+ ..+.. +..+.     .|.+.+       ..++|+
T Consensus        96 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~-~~l~~~l~~l~-----~~~~~~-------~~~~L~  162 (386)
T 2ca6_A           96 LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG-AKIARALQELA-----VNKKAK-------NAPPLR  162 (386)
T ss_dssp             CCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH-HHHHHHHHHHH-----HHHHHH-------TCCCCC
T ss_pred             ccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH-HHHHHHHHHHh-----hhhhcc-------cCCCCc
Confidence            9999999999986    467788999999999999999862222 22221 11111     111111       115677


Q ss_pred             EEEccCCcccc-ccC---cCccCCCCCCEEEccCccCCCCCCCCcchhh-hccCCCCCcEEEccCCCCC----CCCChhh
Q 002897          147 LLELRDNQFIG-KMS---INFNSLKNLSVLILGNNHLGNRAANDLDFVT-VLANCSKLENLGLYDNQFG----GLLPHSL  217 (869)
Q Consensus       147 ~L~L~~N~i~~-~~~---~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~l~~l~~L~~L~L~~n~l~----~~~~~~~  217 (869)
                      +|+|++|+++. ..+   ..|..+++|++|+|++|.++.....  .+.. .+..+++|++|+|++|.++    ..+|..+
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~--~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l  240 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE--HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL  240 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH--HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHH--HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence            77777776652 222   2344556666666666665421110  0112 4555666666666666654    2333444


Q ss_pred             hhccccceEEEecCCccccc----CCccc--cCCCCCCeeecccCccee----cCCccc-cCCCCCCEEEccCcccc
Q 002897          218 ANLSNTMTTIDIGGNYFSGT----IPPGL--GNLVHLNSIAMEGNQLIG----TVPPEI-GWLKNLQSLYLNSNFLH  283 (869)
Q Consensus       218 ~~l~~~L~~L~l~~n~l~~~----~~~~~--~~l~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~L~~N~l~  283 (869)
                      ..+++ |+.|+|++|.+++.    ++..+  +.+++|++|+|++|.+..    .+|..+ .++++|++|+|++|+++
T Consensus       241 ~~~~~-L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~  316 (386)
T 2ca6_A          241 KSWPN-LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  316 (386)
T ss_dssp             GGCTT-CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             ccCCC-cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence            44433 45555555544432    22333  124445555555555443    233333 33445555555555444

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=5.3e-23  Score=214.47  Aligned_cols=153  Identities=18%  Similarity=0.165  Sum_probs=121.2

Q ss_pred             HHHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc------------------hhhHHHHHHHHHHHhC
Q 002897          547 AKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK------------------GALKSFLTECEALRSI  608 (869)
Q Consensus       547 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  608 (869)
                      ..+......|.+.+.||+|+||.||+|.+ .+|+.||+|+++....                  .....+.+|+++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34445556677789999999999999999 7899999999964321                  1345689999999999


Q ss_pred             CCCccceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002897          609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVH  688 (869)
Q Consensus       609 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  688 (869)
                      +|   +++.+++..      +..++||||+++|+|.+ +..            .....++.|+++||+|||+.   ||+|
T Consensus       162 ~~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiH  216 (282)
T 1zar_A          162 QG---LAVPKVYAW------EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVH  216 (282)
T ss_dssp             TT---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cC---CCcCeEEec------cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEe
Confidence            84   444444322      45699999999999988 422            12347999999999999999   9999


Q ss_pred             cCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC
Q 002897          689 GDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG  747 (869)
Q Consensus       689 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  747 (869)
                      |||||+|||++ ++.+||+|||+|+.                     +..|+|||++..
T Consensus       217 rDlkp~NILl~-~~~vkl~DFG~a~~---------------------~~~~~a~e~l~r  253 (282)
T 1zar_A          217 GDLSQYNVLVS-EEGIWIIDFPQSVE---------------------VGEEGWREILER  253 (282)
T ss_dssp             SCCSTTSEEEE-TTEEEECCCTTCEE---------------------TTSTTHHHHHHH
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCCeE---------------------CCCCCHHHHHHH
Confidence            99999999999 99999999999963                     445788997643

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=2.2e-23  Score=225.17  Aligned_cols=255  Identities=18%  Similarity=0.230  Sum_probs=179.6

Q ss_pred             CCCEEEccCCccCccCCccccCC--CCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCccc-CCchhhcCCcchhh
Q 002897           47 ALQVIDIRGNRLGGKIPDTLGQL--RKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGS-LPFDMVANLPNLRK  123 (869)
Q Consensus        47 ~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~~  123 (869)
                      .++.|++++|.+.   |..+..+  ++++.|++++|.+.+..+. +.++++|++|+|++|.+.+. +| ..+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~-~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH-GILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH-HHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH-HHHhhCCCCCE
Confidence            3667777777665   4556665  6777777777777755444 44677777777777776533 33 45667777777


Q ss_pred             hhccccccceeccccccCCCCCcEEEccCC-ccccc-cCcCccCCCCCCEEEccCc-cCCCCCCCCcchhhhccCCC-CC
Q 002897          124 FVAAKNNLTGFLPISLSNASNLELLELRDN-QFIGK-MSINFNSLKNLSVLILGNN-HLGNRAANDLDFVTVLANCS-KL  199 (869)
Q Consensus       124 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~l~~l~-~L  199 (869)
                      |++++|.+++..+..+..+++|++|+|++| .+++. .+..+..+++|++|++++| .++..     ..+..+..++ +|
T Consensus       123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-----~~~~~~~~l~~~L  197 (336)
T 2ast_B          123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-----HVQVAVAHVSETI  197 (336)
T ss_dssp             EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-----HHHHHHHHSCTTC
T ss_pred             EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-----HHHHHHHhcccCC
Confidence            777777777666777777888888888888 56542 4445777888888888888 77642     1234567788 88


Q ss_pred             cEEEccCC--CCC-CCCChhhhhccccceEEEecCCc-ccccCCccccCCCCCCeeecccCc-ceecCCccccCCCCCCE
Q 002897          200 ENLGLYDN--QFG-GLLPHSLANLSNTMTTIDIGGNY-FSGTIPPGLGNLVHLNSIAMEGNQ-LIGTVPPEIGWLKNLQS  274 (869)
Q Consensus       200 ~~L~L~~n--~l~-~~~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~  274 (869)
                      ++|++++|  .++ +.++..+..+++ |+.|++++|. +++..+..+..+++|++|++++|. +.......++.+++|+.
T Consensus       198 ~~L~l~~~~~~~~~~~l~~~~~~~~~-L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~  276 (336)
T 2ast_B          198 TQLNLSGYRKNLQKSDLSTLVRRCPN-LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT  276 (336)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTT-CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             CEEEeCCCcccCCHHHHHHHHhhCCC-CCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence            88888888  454 345566666665 8888888888 676777788888999999999985 32222235788999999


Q ss_pred             EEccCccccCcCCCCCCCCc-cccceecccccccccCCcCccC
Q 002897          275 LYLNSNFLHGYIPSSLGNLT-MLTLLALEINNLQGKIPSSLGN  316 (869)
Q Consensus       275 L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~  316 (869)
                      |++++| ++   ...+..+. .++.|++++|++++..|..++.
T Consensus       277 L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          277 LQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             EECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             EeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            999988 33   33455553 4888889999999888887765

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=2.5e-23  Score=224.84  Aligned_cols=256  Identities=17%  Similarity=0.171  Sum_probs=183.6

Q ss_pred             CCCEEeCcCcccCccCCcccccC--CCCcEEECcCCcCcccCCchhhcCCcchhhhhcccccccee-ccccccCCCCCcE
Q 002897           71 KLIYLNIGRNQFSGFIPPSIYNI--SSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGF-LPISLSNASNLEL  147 (869)
Q Consensus        71 ~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~  147 (869)
                      .++.|++++|.+.   |..+..+  ++++.|++++|.+.+..+ . +..+++|++|++++|.+++. ++..+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~-~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-E-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-S-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccch-h-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence            4778888888776   5667777  788888888888874444 3 45678888888888888755 6777888888888


Q ss_pred             EEccCCccccccCcCccCCCCCCEEEccCc-cCCCCCCCCcchhhhccCCCCCcEEEccCC-CCCCC-CChhhhhccccc
Q 002897          148 LELRDNQFIGKMSINFNSLKNLSVLILGNN-HLGNRAANDLDFVTVLANCSKLENLGLYDN-QFGGL-LPHSLANLSNTM  224 (869)
Q Consensus       148 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~~L  224 (869)
                      |+|++|.+++..+..|..+++|++|++++| .++..     .++..+..+++|++|++++| .+++. ++..+..++.+|
T Consensus       123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~-----~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L  197 (336)
T 2ast_B          123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-----ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  197 (336)
T ss_dssp             EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH-----HHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH-----HHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence            888888877777777788888888888888 55431     12345677888888888888 77754 455666776238


Q ss_pred             eEEEecCC--ccc-ccCCccccCCCCCCeeecccCc-ceecCCccccCCCCCCEEEccCcc-ccCcCCCCCCCCccccce
Q 002897          225 TTIDIGGN--YFS-GTIPPGLGNLVHLNSIAMEGNQ-LIGTVPPEIGWLKNLQSLYLNSNF-LHGYIPSSLGNLTMLTLL  299 (869)
Q Consensus       225 ~~L~l~~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L  299 (869)
                      ++|++++|  .++ +.++..+.++++|++|++++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|
T Consensus       198 ~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L  277 (336)
T 2ast_B          198 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL  277 (336)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence            88888888  444 3456667778888888888888 666667777888888888888884 332222356778888888


Q ss_pred             ecccccccccCCcCccCcc-ccceeeccCcccCCCCCccccc
Q 002897          300 ALEINNLQGKIPSSLGNCT-SLIMLTLSKNKLDGVLPPQILS  340 (869)
Q Consensus       300 ~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~  340 (869)
                      ++++| ++   ...+..+. +|+.|++++|++++..|+.+..
T Consensus       278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             eccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            88887 33   33455553 4777778888888777765543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=1.5e-21  Score=194.80  Aligned_cols=180  Identities=20%  Similarity=0.320  Sum_probs=100.9

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      +.++++++.++ .+|..+  .++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            34555555555 333332  235555555555555444445555555555555555555444444555555555555555


Q ss_pred             cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCC
Q 002897          105 RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAA  184 (869)
Q Consensus       105 ~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  184 (869)
                      ++. .+|...|.++++|++|++++|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|.+.    
T Consensus        87 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~----  161 (208)
T 2o6s_A           87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD----  161 (208)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC----
T ss_pred             cCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee----
Confidence            554 444444444444444444444444444455666667777777777766666656666666666666666542    


Q ss_pred             CCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhcc
Q 002897          185 NDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLS  221 (869)
Q Consensus       185 ~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~  221 (869)
                               ..+++|++|+++.|++++.+|..++.+.
T Consensus       162 ---------~~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          162 ---------CTCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             ---------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ---------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence                     2345666666666666666666555543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=9.8e-21  Score=188.82  Aligned_cols=179  Identities=20%  Similarity=0.265  Sum_probs=124.3

Q ss_pred             CCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhcc
Q 002897           48 LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAA  127 (869)
Q Consensus        48 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~  127 (869)
                      -+.++++++.++ .+|..+  .++|++|+|++|++++..+..|.++++|++|+|++|++. .+|...|..+++|++|+++
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence            467889999988 556554  468999999999999777778889999999999999997 6776667777777777777


Q ss_pred             ccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCC
Q 002897          128 KNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN  207 (869)
Q Consensus       128 ~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n  207 (869)
                      +|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|++++|.++.++..      .+..+++|++|++++|
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~l~~N  158 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG------VFDRLTSLQYIWLHDN  158 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSC
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH------HhccCCCccEEEecCC
Confidence            7777766666677777777777777777766666667777777777777776665543      3556666666666666


Q ss_pred             CCCCCCChhhhhccccceEEEecCCcccccCCccccC
Q 002897          208 QFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN  244 (869)
Q Consensus       208 ~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~  244 (869)
                      .+.+..|        .|+.|+++.|.+++.+|..++.
T Consensus       159 ~~~~~~~--------~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          159 PWDCTCP--------GIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             CBCCCTT--------TTHHHHHHHHHCTTTBBCTTSS
T ss_pred             CeecCCC--------CHHHHHHHHHhCCceeeccCcc
Confidence            5553222        1444444444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=9.2e-21  Score=215.49  Aligned_cols=168  Identities=25%  Similarity=0.356  Sum_probs=94.4

Q ss_pred             CCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeecc
Q 002897          247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLS  326 (869)
Q Consensus       247 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  326 (869)
                      +|++|+|++|++. .+|   ..+++|+.|+|++|+|++ +|. +.+  +|+.|++++|+|++ +|.   .+++|+.|+++
T Consensus        81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  148 (571)
T 3cvr_A           81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD  148 (571)
T ss_dssp             TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred             CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence            3444444444444 233   223444555555555443 333 333  45555555555543 333   34455555555


Q ss_pred             CcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCC-------cEEEee
Q 002897          327 KNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSL-------EYVKMQ  399 (869)
Q Consensus       327 ~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~l~  399 (869)
                      +|+|++ +|.    ..+.++.|+|++|+|++ +|. |.  ++|+.|+|++|.|+ .+|. |..  +|       +.|+|+
T Consensus       149 ~N~l~~-lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls  215 (571)
T 3cvr_A          149 NNQLTM-LPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR  215 (571)
T ss_dssp             SSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred             CCccCc-CCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence            555542 332    22334445555555543 444 44  67777777777777 5555 544  56       888888


Q ss_pred             CccccCCCCccccccccccEEEccCCcccCCCccccccccc
Q 002897          400 DNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF  440 (869)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  440 (869)
                      +|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus       216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            88887 67777777888888888888888888877776554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=3.2e-21  Score=209.76  Aligned_cols=178  Identities=21%  Similarity=0.222  Sum_probs=143.2

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCcccc-CCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLG-QLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      -+.+++++|+|+ .+|..+.  ..+++|+|++|+|++..+..|. ++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            367888888888 5666553  4578888888888877777777 88888888888888887777788888888888888


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCc---cCCCCCCEEEccCccC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF---NSLKNLSVLILGNNHL  179 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~---~~l~~L~~L~l~~n~l  179 (869)
                      +|++. .++...|.++++|+.|+|++|+|+...+..|.++++|++|+|++|+|+.+.+..|   ..+++|+.|+|++|+|
T Consensus        97 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l  175 (361)
T 2xot_A           97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL  175 (361)
T ss_dssp             SSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred             CCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence            88887 6777778888888888888888888888899999999999999999988777777   5689999999999999


Q ss_pred             CCCCCCCcchhhhccCCCC--CcEEEccCCCCCC
Q 002897          180 GNRAANDLDFVTVLANCSK--LENLGLYDNQFGG  211 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~--L~~L~L~~n~l~~  211 (869)
                      +.++..      .+..++.  |+.|+|++|.+..
T Consensus       176 ~~l~~~------~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          176 KKLPLT------DLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCCCHH------HHHHSCHHHHTTEECCSSCEEC
T ss_pred             CccCHH------HhhhccHhhcceEEecCCCccC
Confidence            987743      4666666  4889999999873

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=1.7e-20  Score=188.38  Aligned_cols=152  Identities=20%  Similarity=0.332  Sum_probs=111.9

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      +.+++++++++ .+|..+.  ++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            56666777766 4555443  56777777777777666666777777777777777777666677777777777777777


Q ss_pred             cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          105 RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       105 ~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      +++ .+|...|.++++|+.|+|++|.|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus        91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            776 666666777777777777777777777778888888888888888888888878888888888888888775

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=3.6e-20  Score=185.95  Aligned_cols=150  Identities=22%  Similarity=0.351  Sum_probs=102.4

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++++++ +||..++   ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+++.|++|.++++|++|+|++|+
T Consensus        16 v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           16 VDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            456667777 6776654   566777777777776555667777777777777777776666777777777777777777


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI  156 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~  156 (869)
                      |+.+.+..|.++++|++|+|++|++. .++...|.++++|+.|+|++|.|++..+..|..+++|++|+|++|.+.
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCC-EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            77555555666777777777777776 555556667777777777777777666666777777777777777654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.82  E-value=2.3e-20  Score=212.25  Aligned_cols=197  Identities=24%  Similarity=0.287  Sum_probs=162.8

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .+|+.|+|++|+|++ +|..+  +++|++|+|++|+|+ .+|   +.+++|++|+|++|+|++ +|. +.+  +|++|+|
T Consensus        59 ~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           59 NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            499999999999996 77766  389999999999999 677   567999999999999996 666 666  9999999


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|+++ .+|.    .+++|+.|++++|.|++ +|.   .+++|++|+|++|+|+++..  |.  ++|+.|+|++|+|+.
T Consensus       128 s~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~~  194 (571)
T 3cvr_A          128 DNNQLT-MLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLES  194 (571)
T ss_dssp             CSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCSS
T ss_pred             CCCcCC-CCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCCc
Confidence            999998 5885    68999999999999997 454   57899999999999998544  65  999999999999998


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCC
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVH  247 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~  247 (869)
                      ++.  +.- ..+...+.|+.|+|++|+|+ .+|..+..+++ |+.|+|++|.+++.+|..+..++.
T Consensus       195 lp~--~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          195 LPA--VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDP-TCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CCC--CC---------CCEEEECCSSCCC-CCCGGGGGSCT-TEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             hhh--HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCC-CCEEEeeCCcCCCcCHHHHHHhhc
Confidence            774  110 11122233499999999999 57888888776 999999999999988888877554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=2.5e-20  Score=187.15  Aligned_cols=153  Identities=22%  Similarity=0.275  Sum_probs=103.9

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCC-ccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIP-DTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..| ..|+.+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            46666666666 3454442  345666666666665433 3466666666666666666666556666666666666666


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      |++. .++...|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+.-
T Consensus        91 N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            6665 5555666666666666676676666667777888888888888888888778888888888888888887753

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=3.2e-20  Score=195.08  Aligned_cols=189  Identities=21%  Similarity=0.340  Sum_probs=107.9

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      +..+.+..+.+++..+  +..+++|++|++++|.++. ++ .++.+++|++|+|++|++++..+  +.++++|++|+|++
T Consensus        26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~   99 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE   99 (291)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCcccccc--hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence            3444455555543222  3455556666666666552 22 25555666666666666654322  55566666666666


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCC
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRA  183 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  183 (869)
                      |++. .+|  .+..+++|++|++++|++++.  ..+..+++|++|++++|+++++  ..+..+++|++|++++|.++.++
T Consensus       100 n~l~-~~~--~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~  172 (291)
T 1h6t_A          100 NKVK-DLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  172 (291)
T ss_dssp             SCCC-CGG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred             CcCC-CCh--hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence            6655 333  255566666666666666543  3456666666666666666654  45666666666666666666543


Q ss_pred             CCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccc
Q 002897          184 ANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSG  236 (869)
Q Consensus       184 ~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~  236 (869)
                              .+..+++|++|++++|++++. + .+..+++ |+.|++++|.++.
T Consensus       173 --------~l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~-L~~L~l~~n~i~~  214 (291)
T 1h6t_A          173 --------PLAGLTKLQNLYLSKNHISDL-R-ALAGLKN-LDVLELFSQECLN  214 (291)
T ss_dssp             --------GGTTCTTCCEEECCSSCCCBC-G-GGTTCTT-CSEEEEEEEEEEC
T ss_pred             --------hhcCCCccCEEECCCCcCCCC-h-hhccCCC-CCEEECcCCcccC
Confidence                    155666666666666666642 2 3555554 6777777776653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=5.3e-20  Score=211.82  Aligned_cols=192  Identities=21%  Similarity=0.341  Sum_probs=120.8

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .++..+.|+.+.++...+  +..+++|+.|+|++|.|. .+| .|+.+++|+.|+|++|+|.+..|  +..+++|+.|+|
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L   94 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL   94 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence            345555666666654333  456666666666666666 333 46666666666666666664433  666666666666


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|.+. .+|  .+..+++|+.|+|++|.++..  ..+..+++|+.|+|++|.|.++  ..|..+++|+.|+|++|.++.
T Consensus        95 s~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           95 DENKIK-DLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CSSCCC-CCT--TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             cCCCCC-CCh--hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence            666665 444  356666666666666666643  3466677777777777777655  456677777777777777765


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccccc
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGT  237 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~  237 (869)
                      ++.        +..+++|+.|+|++|+|++.  ..+..+++ |+.|+|++|.+.+.
T Consensus       168 ~~~--------l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~-L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          168 IVP--------LAGLTKLQNLYLSKNHISDL--RALAGLKN-LDVLELFSQECLNK  212 (605)
T ss_dssp             CGG--------GTTCTTCCEEECCSSCCCBC--GGGTTCTT-CSEEECCSEEEECC
T ss_pred             chh--------hccCCCCCEEECcCCCCCCC--hHHccCCC-CCEEEccCCcCcCC
Confidence            431        56677777777777777643  34556654 77777777776643

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=2.3e-20  Score=196.16  Aligned_cols=170  Identities=23%  Similarity=0.379  Sum_probs=96.3

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  ++++++|++|+|++|++++.  ..+.++++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence            345566666666666532 2 35556666666666666653322  55666666666666666532  235566666666


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL  179 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l  179 (869)
                      +|++|++. .++  .+..+++|+.|++++|.+++.  ..+..+++|++|++++|+++++.+  +..+++|+.|++++|.+
T Consensus       118 ~L~~n~i~-~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          118 SLEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             ECTTSCCC-CCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             ECCCCcCC-CCh--hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence            66666665 332  355566666666666666543  455566666666666666655443  55566666666666666


Q ss_pred             CCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          180 GNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      +.++        .+..+++|+.|++++|+++
T Consensus       191 ~~l~--------~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          191 SDLR--------ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CBCG--------GGTTCTTCSEEEEEEEEEE
T ss_pred             CCCh--------hhccCCCCCEEECcCCccc
Confidence            5442        2555666666666666555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=5.6e-20  Score=211.63  Aligned_cols=185  Identities=21%  Similarity=0.367  Sum_probs=120.7

Q ss_pred             ccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCccc
Q 002897            3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF   82 (869)
Q Consensus         3 ~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i   82 (869)
                      .++++.+...++   ...+.+|+.|+|++|.|+. ++ .|..+++|++|+|++|+|++..|  |+.+++|+.|+|++|+|
T Consensus        27 ~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l   99 (605)
T 1m9s_A           27 NLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI   99 (605)
T ss_dssp             HTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             hccCCCcccccc---hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCC
Confidence            345555553233   1346677777777777763 33 46777777777777777764433  66777777777777777


Q ss_pred             CccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcC
Q 002897           83 SGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN  162 (869)
Q Consensus        83 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  162 (869)
                      .+ +| .+..+++|++|+|++|++. .++  .+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|.|.++.+  
T Consensus       100 ~~-l~-~l~~l~~L~~L~Ls~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--  170 (605)
T 1m9s_A          100 KD-LS-SLKDLKKLKSLSLEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--  170 (605)
T ss_dssp             CC-CT-TSTTCTTCCEEECTTSCCC-CCG--GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred             CC-Ch-hhccCCCCCEEEecCCCCC-CCc--cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence            64 22 5667777777777777776 443  366677777777777777654  566677777777777777766555  


Q ss_pred             ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       163 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      |..+++|+.|+|++|.|+.++        .+..+++|+.|+|++|++.+
T Consensus       171 l~~l~~L~~L~Ls~N~i~~l~--------~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          171 LAGLTKLQNLYLSKNHISDLR--------ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             GTTCTTCCEEECCSSCCCBCG--------GGTTCTTCSEEECCSEEEEC
T ss_pred             hccCCCCCEEECcCCCCCCCh--------HHccCCCCCEEEccCCcCcC
Confidence            667777777777777776542        36667777777777777664

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=3.9e-20  Score=201.11  Aligned_cols=181  Identities=19%  Similarity=0.245  Sum_probs=152.8

Q ss_pred             CCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccc-cCCCCcEEECcCCcCcccCCchhhcCCcchhhhhc
Q 002897           48 LQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIY-NISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA  126 (869)
Q Consensus        48 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l  126 (869)
                      -+.+++++|+++ .+|..+.  ..++.|+|++|+|++..+..|. ++++|++|+|++|++. .++...|.++++|++|+|
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~L   95 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL   95 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEEC
Confidence            368999999998 6776655  4689999999999988888887 8999999999999998 777778999999999999


Q ss_pred             cccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccC
Q 002897          127 AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYD  206 (869)
Q Consensus       127 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  206 (869)
                      ++|+|+.+.+..|.++++|++|+|++|+|..+.+..|..+++|+.|+|++|+|+.++...   ...+..+++|+.|+|++
T Consensus        96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~---~~~~~~l~~L~~L~L~~  172 (361)
T 2xot_A           96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVEL---IKDGNKLPKLMLLDLSS  172 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGG---TC----CTTCCEEECCS
T ss_pred             CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHH---hcCcccCCcCCEEECCC
Confidence            999999888888999999999999999999998999999999999999999999887641   11126789999999999


Q ss_pred             CCCCCCCChhhhhcccc-ceEEEecCCccc
Q 002897          207 NQFGGLLPHSLANLSNT-MTTIDIGGNYFS  235 (869)
Q Consensus       207 n~l~~~~~~~~~~l~~~-L~~L~l~~n~l~  235 (869)
                      |+|+...+..+..++.. ++.|+|++|.+.
T Consensus       173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             SCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            99997666777777642 478999999887

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=1.5e-19  Score=181.34  Aligned_cols=151  Identities=19%  Similarity=0.280  Sum_probs=74.8

Q ss_pred             EEEccCCccCccCCccccCCCCCCEEeCcCcccCccCC-cccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccc
Q 002897           50 VIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIP-PSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK  128 (869)
Q Consensus        50 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~  128 (869)
                      ++++++|.++ .+|..+.  ..+++|+|++|+|++..| ..|.++++|++|+|++|+++ .++...|.++++|++|+|++
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECCC
Confidence            4555555554 3343332  234455555555554422 23455555555555555554 34444455555555555555


Q ss_pred             cccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCC
Q 002897          129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQ  208 (869)
Q Consensus       129 n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~  208 (869)
                      |.+++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+++.+...      .|..+++|++|+|++|.
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~  164 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG------AFDTLHSLSTLNLLANP  164 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT------TTTTCTTCCEEECCSCC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH------HhcCCCCCCEEEecCcC
Confidence            555544444455555555555555555555555555555555555555555544332      34445555555555555


Q ss_pred             CC
Q 002897          209 FG  210 (869)
Q Consensus       209 l~  210 (869)
                      +.
T Consensus       165 l~  166 (220)
T 2v70_A          165 FN  166 (220)
T ss_dssp             EE
T ss_pred             Cc
Confidence            54

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=2.8e-19  Score=180.76  Aligned_cols=152  Identities=21%  Similarity=0.284  Sum_probs=88.4

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      -+.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|..+.+..|.++++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            345666666665 4444332  5666666666666655566666666666666666666655455566666666666666


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      |+++ .+|...|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|..+.+..|..+++|+.|+|++|.+.
T Consensus        98 N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             CcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            6665 444444444444444444444444 33445556666666666666666555555555555555555555543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.78  E-value=1.5e-19  Score=194.09  Aligned_cols=288  Identities=12%  Similarity=0.066  Sum_probs=183.8

Q ss_pred             cCCcCEEeccCCcCccccCccccc-CcCCCEEEccCCccC--ccCCccccCCCCCCEEeCcCcccCccCCccccc-----
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGN-LSALQVIDIRGNRLG--GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYN-----   92 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~-----   92 (869)
                      +.+++.|.++++ +....-..+.. +++|++|||++|+|.  ...+..+.   .++.+.+..|.|   .+.+|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I---~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFV---PAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEE---CTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccc---cccccccccccc---CHHHhccccccc
Confidence            456777777754 22122223334 667788888887777  33332222   245555555533   3456666     


Q ss_pred             ---CCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCc----cccccCcCccC
Q 002897           93 ---ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ----FIGKMSINFNS  165 (869)
Q Consensus        93 ---l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~----i~~~~~~~~~~  165 (869)
                         +++|+.|+|.+ .++ .++..+|.++++|+.|++.+|.+..+.+.+|.++.++..+.+..+.    ...+....|.+
T Consensus        97 ~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             EEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             ccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence               77777777777 665 6666677777777777777777766666677776666666665532    23344445555


Q ss_pred             CCCCC-EEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccC
Q 002897          166 LKNLS-VLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN  244 (869)
Q Consensus       166 l~~L~-~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~  244 (869)
                      +.+|+ .+.+....  .++..   ....-....++..+.+.++-.. .....+......|+.|+|++|.++.+.+.+|.+
T Consensus       175 ~~~L~~~i~~~~~~--~l~~~---~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~  248 (329)
T 3sb4_A          175 GEPLETTIQVGAMG--KLEDE---IMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ  248 (329)
T ss_dssp             SCCCEEEEEECTTC--CHHHH---HHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred             ccccceeEEecCCC--cHHHH---HhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence            55555 33333211  11100   0001112445566666554221 112222221234889999988888777778889


Q ss_pred             CCCCCeeecccCcceecCCccccCCCCCC-EEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcccccee
Q 002897          245 LVHLNSIAMEGNQLIGTVPPEIGWLKNLQ-SLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIML  323 (869)
Q Consensus       245 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  323 (869)
                      +++|+.|++.+| +..+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.|+++.|+++...+.+|.++++|+.+
T Consensus       249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            999999999887 7778888889999998 999988 7777888889999999999998888887777889999999888


Q ss_pred             ec
Q 002897          324 TL  325 (869)
Q Consensus       324 ~l  325 (869)
                      +.
T Consensus       327 y~  328 (329)
T 3sb4_A          327 YK  328 (329)
T ss_dssp             EC
T ss_pred             cc
Confidence            64

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=2e-19  Score=185.23  Aligned_cols=139  Identities=19%  Similarity=0.177  Sum_probs=109.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeE--EEEEEeecccch------------------------hhHHHHHHHHHHHh
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGML--VAVKVLNLMQKG------------------------ALKSFLTECEALRS  607 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  607 (869)
                      .-|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+.++++
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467789999999999999999668999  999997532111                        11367899999999


Q ss_pred             CCCCcc--ceEEEEeeccccCCCceEEEEeecccC-C----CHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHH-
Q 002897          608 IRHRNL--IKIITICSSIDFNGVDFKAIVYDFMQN-G----SLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH-  679 (869)
Q Consensus       608 l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-  679 (869)
                      +.|+++  ..++++         ...++||||+.+ |    +|.++...         .++..+..++.|++.||+||| 
T Consensus       127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHH
Confidence            988754  444443         346899999943 4    77776532         224467789999999999999 


Q ss_pred             hcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       680 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      +.   ||+||||||+|||++.  .++|+|||+|...
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            88   9999999999999988  9999999999754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.3e-19  Score=187.26  Aligned_cols=171  Identities=22%  Similarity=0.285  Sum_probs=126.7

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+.++..+++++|.++++.  .+..+++|++|++++|+|+ .+| .++.+++|++|+|++|+|++..+  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3567888889999988443  6888899999999999988 455 68889999999999999986544  8889999999


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL  179 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l  179 (869)
                      +|++|++. .+|.  +.. ++|+.|++++|++++.  ..+..+++|++|+|++|+|+++.  .+..+++|+.|++++|++
T Consensus        91 ~L~~N~l~-~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           91 SVNRNRLK-NLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             ECCSSCCS-CCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCC
T ss_pred             ECCCCccC-CcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcC
Confidence            99999887 5653  222 6777777777777753  35777777777777777776652  566777777777777777


Q ss_pred             CCCCCCCcchhhhccCCCCCcEEEccCCCCCCC
Q 002897          180 GNRAANDLDFVTVLANCSKLENLGLYDNQFGGL  212 (869)
Q Consensus       180 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~  212 (869)
                      +.+.        .+..+++|+.|++++|.++..
T Consensus       163 ~~~~--------~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          163 TNTG--------GLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CBCT--------TSTTCCCCCEEEEEEEEEECC
T ss_pred             cchH--------HhccCCCCCEEeCCCCcccCC
Confidence            6651        366677777777777776643

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=4.3e-21  Score=219.66  Aligned_cols=104  Identities=21%  Similarity=0.229  Sum_probs=53.7

Q ss_pred             ccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecC-CccccCCCC
Q 002897          193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTV-PPEIGWLKN  271 (869)
Q Consensus       193 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~  271 (869)
                      +..+++|+.|+|++|+|+ .+|..+..+++ |+.|+|++|.|++ +| .++.+++|+.|+|++|++.+.. |..++.+++
T Consensus       459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~-L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~  534 (567)
T 1dce_A          459 LEQLLLVTHLDLSHNRLR-ALPPALAALRC-LEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR  534 (567)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTT-CCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred             ccccccCcEeecCccccc-ccchhhhcCCC-CCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC
Confidence            344444444444444444 34444444443 5555555555553 33 5555566666666666665544 556666666


Q ss_pred             CCEEEccCccccCcCCCC---CCCCcccccee
Q 002897          272 LQSLYLNSNFLHGYIPSS---LGNLTMLTLLA  300 (869)
Q Consensus       272 L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~  300 (869)
                      |+.|+|++|++++.+|..   +..+++|+.|+
T Consensus       535 L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          535 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             CCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            666666666665443321   11245555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=3.9e-18  Score=172.33  Aligned_cols=155  Identities=20%  Similarity=0.281  Sum_probs=129.5

Q ss_pred             CCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhc
Q 002897           47 ALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA  126 (869)
Q Consensus        47 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l  126 (869)
                      ..+.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|++. .+|...|.++++|+.|+|
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~L   95 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL   95 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEEC
Confidence            3678999999998 6776655  89999999999999988999999999999999999997 888778888888888888


Q ss_pred             cccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccC
Q 002897          127 AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYD  206 (869)
Q Consensus       127 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  206 (869)
                      ++|+|+...+..|..+++|++|+|++|+|+. .|..+..+++|++|+|++|+++.++..      .|..+++|+.|+|++
T Consensus        96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~  168 (229)
T 3e6j_A           96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHG------AFDRLSSLTHAYLFG  168 (229)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCS-CCTTGGGCTTCSEEECCSSCCCCCCTT------TTTTCTTCCEEECTT
T ss_pred             CCCcCCccChhHhCcchhhCeEeccCCcccc-cCcccccCCCCCEEECCCCcCCccCHH------HHhCCCCCCEEEeeC
Confidence            8888887777778888888888888888874 456678888888888888888877653      567788888888888


Q ss_pred             CCCCCC
Q 002897          207 NQFGGL  212 (869)
Q Consensus       207 n~l~~~  212 (869)
                      |.+...
T Consensus       169 N~~~c~  174 (229)
T 3e6j_A          169 NPWDCE  174 (229)
T ss_dssp             SCBCTT
T ss_pred             CCccCC
Confidence            887744

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=1.2e-18  Score=179.89  Aligned_cols=166  Identities=20%  Similarity=0.286  Sum_probs=145.3

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +++++++++ .+|.  +..+++|++|++++|+|+ .++ .+..+++|++|+|++|+|++..+  |+++++|++|+|++|+
T Consensus        24 l~l~~~~i~-~~~~--~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~   96 (263)
T 1xeu_A           24 QNLGKQSVT-DLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR   96 (263)
T ss_dssp             HHHTCSCTT-SEEC--HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred             HHhcCCCcc-cccc--hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc
Confidence            568899999 7872  357999999999999999 455 79999999999999999995544  9999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      +++. |.. .. ++|++|+|++|+++ .++  .+..+++|+.|++++|++++. + .+..+++|++|+|++|++.++  .
T Consensus        97 l~~l-~~~-~~-~~L~~L~L~~N~l~-~~~--~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~  166 (263)
T 1xeu_A           97 LKNL-NGI-PS-ACLSRLFLDNNELR-DTD--SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G  166 (263)
T ss_dssp             CSCC-TTC-CC-SSCCEEECCSSCCS-BSG--GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred             cCCc-Ccc-cc-CcccEEEccCCccC-CCh--hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence            9964 433 33 99999999999998 565  489999999999999999976 3 799999999999999999887  6


Q ss_pred             CccCCCCCCEEEccCccCCCCCC
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAA  184 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~  184 (869)
                      .+..+++|+.|++++|.++..+.
T Consensus       167 ~l~~l~~L~~L~l~~N~~~~~~~  189 (263)
T 1xeu_A          167 GLTRLKKVNWIDLTGQKCVNEPV  189 (263)
T ss_dssp             TSTTCCCCCEEEEEEEEEECCCE
T ss_pred             HhccCCCCCEEeCCCCcccCCcc
Confidence            79999999999999999987653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=2.9e-19  Score=191.72  Aligned_cols=264  Identities=9%  Similarity=0.047  Sum_probs=184.2

Q ss_pred             cCCcCEEeccCCcCc--cccCcccccCcCCCEEEccCCccCccCCccccC--------CCCCCEEeCcCcccCccCCccc
Q 002897           21 LFKLENLSLAENHLT--GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQ--------LRKLIYLNIGRNQFSGFIPPSI   90 (869)
Q Consensus        21 l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~--------l~~L~~L~L~~n~i~~~~p~~~   90 (869)
                      +++|++|||++|+|+  ...+..   ++.++.+.+..|.|.   +.+|.+        +++|+.|+|.+ .++.+.+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCcccc---ccccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            678999999999998  333333   333666777777444   577888        99999999999 8887888899


Q ss_pred             ccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccc----cceeccccccCCCCCc-EEEccCCcc-ccccCcCcc
Q 002897           91 YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNN----LTGFLPISLSNASNLE-LLELRDNQF-IGKMSINFN  164 (869)
Q Consensus        91 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~----i~~~~~~~l~~l~~L~-~L~L~~N~i-~~~~~~~~~  164 (869)
                      .++++|++|++++|.+. .++..+|.+..++..+.+..+.    .......+|.++.+|+ .+.+..... .........
T Consensus       121 ~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~  199 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGL  199 (329)
T ss_dssp             TTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTC
T ss_pred             hcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhccc
Confidence            99999999999999987 7888889888888777766532    2333455677777777 555554321 111111112


Q ss_pred             CCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccC
Q 002897          165 SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGN  244 (869)
Q Consensus       165 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~  244 (869)
                      ...+++.+.+.++-. ..     ++......+++|+.|+|++|+++.+.+.+|.++.+ |+.|+|.+| ++.+.+.+|.+
T Consensus       200 ~~~~~~~l~~~~~l~-~~-----~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~-L~~l~l~~n-i~~I~~~aF~~  271 (329)
T 3sb4_A          200 QPRDINFLTIEGKLD-NA-----DFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY-LLKIKLPHN-LKTIGQRVFSN  271 (329)
T ss_dssp             CGGGCSEEEEEECCC-HH-----HHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT-CCEEECCTT-CCEECTTTTTT
T ss_pred             CccccceEEEeeeec-HH-----HHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC-CCEEECCcc-cceehHHHhhC
Confidence            345566666655421 11     11111223677888888877777666667777765 888888777 66667777888


Q ss_pred             CCCCC-eeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceec
Q 002897          245 LVHLN-SIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL  301 (869)
Q Consensus       245 l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  301 (869)
                      +++|+ .+.+.+ .+..+.+.+|.++++|+.|++++|.++.+.+..|.++++|+.++.
T Consensus       272 ~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          272 CGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             ChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            88888 888877 677677788888888888888888888777778888888887753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=3.2e-21  Score=220.76  Aligned_cols=192  Identities=22%  Similarity=0.208  Sum_probs=142.3

Q ss_pred             cCCCCCCeeecccCcceecCCccccCCCCCCEEEccCcc-------------ccCcCCCCCCCCcccccee-cccccccc
Q 002897          243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNF-------------LHGYIPSSLGNLTMLTLLA-LEINNLQG  308 (869)
Q Consensus       243 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-l~~n~l~~  308 (869)
                      ..+++|+.|+|++|++. .+|..++.+++|+.|++++|.             +.+..|..++++++|+.|+ ++.|.+  
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence            45666667777777765 556666666677777665554             3334444555555555555 444432  


Q ss_pred             cCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCcccc
Q 002897          309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLS  388 (869)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  388 (869)
                               .+|..+.+++|.++. +|.      ..++.|+|++|.|++ +|. |+++++|+.|+|++|.|+ .+|..|+
T Consensus       423 ---------~~L~~l~l~~n~i~~-l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~  483 (567)
T 1dce_A          423 ---------DDLRSKFLLENSVLK-MEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA  483 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHH-HHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred             ---------chhhhhhhhcccccc-cCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence                     234444555555542 111      125678999999985 676 999999999999999999 7888999


Q ss_pred             CCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCC-ccccccccccCeeccccccCcccCCCC
Q 002897          389 ACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI-PKYLENLSFLEYLNLSYNHFEGEVPKK  458 (869)
Q Consensus       389 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~~  458 (869)
                      ++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|..
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            99999999999999985 66 8999999999999999999776 899999999999999999999887754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.75  E-value=1.8e-18  Score=170.45  Aligned_cols=181  Identities=13%  Similarity=0.161  Sum_probs=127.8

Q ss_pred             ccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCc
Q 002897            9 LVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPP   88 (869)
Q Consensus         9 ~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~   88 (869)
                      ++ .+|...+.   ......+..+...   +-+...+++|++|++++|.|+ .+| .+..+++|++|+|++|.++.  +.
T Consensus        14 ~~-~~pd~~~~---~~~~~~~~~~~~~---~i~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~   82 (197)
T 4ezg_A           14 NV-NIPDSTFK---AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YN   82 (197)
T ss_dssp             BC-CCCCHHHH---HHHHHHHTCCTTC---CCBHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CG
T ss_pred             ee-ecCcHHHH---HHHHHHhCCCccc---cCChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--ch
Confidence            44 57766553   2222333333333   223466777888888888887 555 57778888888888886652  34


Q ss_pred             ccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCc-cccccCcCccCCC
Q 002897           89 SIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ-FIGKMSINFNSLK  167 (869)
Q Consensus        89 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~-i~~~~~~~~~~l~  167 (869)
                      .+.++++|++|++++|++.+..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|. ++.+ + .+..++
T Consensus        83 ~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~  159 (197)
T 4ezg_A           83 PISGLSNLERLRIMGKDVTSDKI-PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLP  159 (197)
T ss_dssp             GGTTCTTCCEEEEECTTCBGGGS-CCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCS
T ss_pred             hhhcCCCCCEEEeECCccCcccC-hhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCC
Confidence            67778888888888888774344 347778888888888888887777888888899999999997 6554 3 688889


Q ss_pred             CCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          168 NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       168 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      +|++|++++|.++.++        .+..+++|++|++++|++.+
T Consensus       160 ~L~~L~l~~n~i~~~~--------~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          160 ELKSLNIQFDGVHDYR--------GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             SCCEEECTTBCCCCCT--------TGGGCSSCCEEEECBC----
T ss_pred             CCCEEECCCCCCcChH--------HhccCCCCCEEEeeCcccCC
Confidence            9999999999888754        37788899999999998863

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=2.5e-17  Score=180.16  Aligned_cols=268  Identities=11%  Similarity=0.123  Sum_probs=215.1

Q ss_pred             hccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           19 CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      .....++.+.+.+ .++.+-..+|.++ +|+.+.|.+| ++.+...+|.+. +|+.+.|.. .++.+.+.+|.++++|+.
T Consensus       110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~  184 (401)
T 4fdw_A          110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK  184 (401)
T ss_dssp             EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred             EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence            3457778888765 4565777788875 7888888777 666777888884 688888885 677677788888888999


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      ++|++|++. .++..+|. ..+|+.+.+.+ +++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+ .+.
T Consensus       185 l~l~~n~l~-~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~  258 (401)
T 4fdw_A          185 ADLSKTKIT-KLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG  258 (401)
T ss_dssp             EECTTSCCS-EECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred             eecCCCcce-EechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence            998888887 78888887 47888888874 477778888889999999999875 67788888888 78999988 456


Q ss_pred             CCCCCCCCcchhhhccCCCCCcEEEccCCCCC-----CCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeec
Q 002897          179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFG-----GLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAM  253 (869)
Q Consensus       179 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  253 (869)
                      ++.++..      +|.+|++|+.+++.+|.+.     .+.+..|.++.+ |+.++|. +.++.+...+|.++++|+.+.|
T Consensus       259 i~~I~~~------aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~-L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l  330 (401)
T 4fdw_A          259 VTNIASR------AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK-LARFEIP-ESIRILGQGLLGGNRKVTQLTI  330 (401)
T ss_dssp             CCEECTT------TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT-CCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred             ccEEChh------HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc-CCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence            7777655      6888999999998887765     456677888776 9999998 4577677888999999999999


Q ss_pred             ccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCc-cccceeccccccc
Q 002897          254 EGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLT-MLTLLALEINNLQ  307 (869)
Q Consensus       254 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~n~l~  307 (869)
                      ..| +..+...+|.++ +|+.+++.+|.+....+..|.+++ .++.|.+..+.+.
T Consensus       331 p~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          331 PAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             Ccc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            555 777888899999 999999999998888888888885 6888988888765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=2.7e-18  Score=169.23  Aligned_cols=152  Identities=16%  Similarity=0.219  Sum_probs=78.9

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .+++|+.|++++|.|+ .+| .+..+++|++|++++|.++ . +..++.+++|++|+|++|++++..|..|.++++|++|
T Consensus        42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            3455555555555555 333 4555555555555555444 1 2345555555555555555554455555555555555


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccc-cceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCcc
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNN-LTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH  178 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~  178 (869)
                      +|++|++.+..| ..+..+++|++|++++|. ++.. + .+..+++|++|++++|+++++.  .+..+++|++|++++|+
T Consensus       118 ~Ls~n~i~~~~~-~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          118 DISHSAHDDSIL-TKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             ECCSSBCBGGGH-HHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EecCCccCcHhH-HHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            555555552222 345555555555555555 4432 2 4555555555555555555432  45555555555555555


Q ss_pred             CC
Q 002897          179 LG  180 (869)
Q Consensus       179 l~  180 (869)
                      ++
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            43

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=5.3e-17  Score=177.58  Aligned_cols=269  Identities=12%  Similarity=0.119  Sum_probs=231.2

Q ss_pred             cccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcch
Q 002897           42 IGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL  121 (869)
Q Consensus        42 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  121 (869)
                      +..+..++.+.+.++ ++.+...+|.+. +|+.++|..| ++.+...+|.+. +|+.+.+.. .+. .++..+|.++++|
T Consensus       109 ~~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L  182 (401)
T 4fdw_A          109 TEILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNL  182 (401)
T ss_dssp             EEECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTC
T ss_pred             EEecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccC
Confidence            445688999998764 665778899985 7999999887 777888899985 799999996 666 7888999999999


Q ss_pred             hhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcE
Q 002897          122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLEN  201 (869)
Q Consensus       122 ~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~  201 (869)
                      +.+++.+|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+.+..| ++.++..      +|.+ .+|+.
T Consensus       183 ~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~------aF~~-~~L~~  252 (401)
T 4fdw_A          183 KKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQE------AFRE-SGITT  252 (401)
T ss_dssp             CEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTT------TTTT-CCCSE
T ss_pred             CeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccc------cccc-CCccE
Confidence            9999999999988888887 589999999855 88899999999999999999875 7777765      5677 78999


Q ss_pred             EEccCCCCCCCCChhhhhccccceEEEecCCccc-----ccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEE
Q 002897          202 LGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS-----GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLY  276 (869)
Q Consensus       202 L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  276 (869)
                      +.+ .+.++.+...+|.++.+ |+.+++.+|.+.     .+.+.+|.++++|+.+.+. +.+..+...+|.++++|+.+.
T Consensus       253 i~l-p~~i~~I~~~aF~~c~~-L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~  329 (401)
T 4fdw_A          253 VKL-PNGVTNIASRAFYYCPE-LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLT  329 (401)
T ss_dssp             EEE-ETTCCEECTTTTTTCTT-CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEE
T ss_pred             EEe-CCCccEEChhHhhCCCC-CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEE
Confidence            999 55677677888988886 999999998875     5677889999999999998 558878889999999999999


Q ss_pred             ccCccccCcCCCCCCCCccccceecccccccccCCcCccCcc-ccceeeccCcccC
Q 002897          277 LNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT-SLIMLTLSKNKLD  331 (869)
Q Consensus       277 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~  331 (869)
                      |.+| ++.+...+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus       330 lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          330 IPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             ECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            9665 777888999999 999999999999877788899885 7899999888765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=1.3e-18  Score=170.57  Aligned_cols=133  Identities=24%  Similarity=0.366  Sum_probs=73.3

Q ss_pred             cceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccc
Q 002897          297 TLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG  376 (869)
Q Consensus       297 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~  376 (869)
                      +.+++++|+++ .+|..+..  +|++|++++|++++..+...                        |+.+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~------------------------~~~l~~L~~L~Ls~   63 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGL------------------------FGRLPHLVKLELKR   63 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCS------------------------GGGCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccc------------------------cccCCCCCEEECCC
Confidence            45666666665 45544432  56666666666553322222                        55555555555555


Q ss_pred             ccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCC
Q 002897          377 NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVP  456 (869)
Q Consensus       377 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  456 (869)
                      |.+++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..+..+++|++|++++|+|++.++
T Consensus        64 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           64 NQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             SCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=1.5e-18  Score=205.14  Aligned_cols=163  Identities=23%  Similarity=0.281  Sum_probs=106.3

Q ss_pred             EccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccc
Q 002897          203 GLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFL  282 (869)
Q Consensus       203 ~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  282 (869)
                      +++.|++. ..+..+..+.. |+.|+|++|.+. .+|..+..+++|++|+|++|.|. .+|..|+.+++|++|+|++|.|
T Consensus       207 ~~~~n~~~-~~~~~~~~l~~-L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          207 DDIENRMV-MPKDSKYDDQL-WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             ----------------CCCC-CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             ccccccee-cChhhhccCCC-CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            34455554 45666666665 888888888877 66666778888888888888887 7778888888888888888888


Q ss_pred             cCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCccc
Q 002897          283 HGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSE  362 (869)
Q Consensus       283 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~  362 (869)
                      + .+|..|+++++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+.........++|++|.+++.+|..
T Consensus       283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            8 66888888888888888888887 677778888888888888888886666655544333334666777776666543


Q ss_pred             ccCCccccccccccc
Q 002897          363 IGNLKNLVQLDISGN  377 (869)
Q Consensus       363 ~~~l~~L~~L~L~~N  377 (869)
                            |+.|++++|
T Consensus       361 ------l~~l~l~~n  369 (727)
T 4b8c_D          361 ------RRFIEINTD  369 (727)
T ss_dssp             ---------------
T ss_pred             ------cceeEeecc
Confidence                  344555555

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.72  E-value=1.9e-17  Score=162.29  Aligned_cols=177  Identities=20%  Similarity=0.233  Sum_probs=137.9

Q ss_pred             CEEEccCccccCcCCCCCCCCccccceecccccccccCCc-CccCccccceeeccCcccCCCCCccccccccccceeccc
Q 002897          273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS-SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS  351 (869)
Q Consensus       273 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~  351 (869)
                      +.+++++|.++ .+|..+..  +|+.|++++|+|++..+. .|..+++|+.|+|++|++++                   
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------   68 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-------------------   68 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-------------------
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCC-------------------
Confidence            78999999997 56665544  899999999999966654 48999999999999998873                   


Q ss_pred             CCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCC
Q 002897          352 DNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI  431 (869)
Q Consensus       352 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  431 (869)
                            ..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..
T Consensus        69 ------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           69 ------IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             ------BCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             ------cCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence                  45677888999999999999999888888999999999999999999888999999999999999999999776


Q ss_pred             ccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCCCC
Q 002897          432 PKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLD  480 (869)
Q Consensus       432 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  480 (869)
                      +... -...++...+.++...+..|..  +....-..+..+...|.+..
T Consensus       143 ~l~~-~~~~l~~~~~~~~~~~C~~P~~--l~~~~l~~l~~~~~~C~~~~  188 (192)
T 1w8a_A          143 HLAW-FAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             GGHH-HHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             cchH-HHHHHHHcCCCCCCCCCCCChH--HcCCChhhCcHhhcCcCCCC
Confidence            5221 1112333445556555554442  44555556777777786543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=2.2e-18  Score=203.63  Aligned_cols=162  Identities=19%  Similarity=0.199  Sum_probs=110.9

Q ss_pred             CcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc
Q 002897           77 IGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI  156 (869)
Q Consensus        77 L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~  156 (869)
                      ++.|.+. ..|..|..+.+|+.|+|++|.+. .+|...+ .+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+
T Consensus       208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  283 (727)
T 4b8c_D          208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred             cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence            4445555 55677777788888888888876 7776544 7788888888888887 66778889999999999999988


Q ss_pred             cccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccc
Q 002897          157 GKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSG  236 (869)
Q Consensus       157 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~  236 (869)
                      . +|..|..+++|++|+|++|.|+.++.       .|..+++|++|+|++|.|++.+|..+......+..|+|++|.+++
T Consensus       284 ~-lp~~~~~l~~L~~L~L~~N~l~~lp~-------~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~  355 (727)
T 4b8c_D          284 S-LPAELGSCFQLKYFYFFDNMVTTLPW-------EFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI  355 (727)
T ss_dssp             S-CCSSGGGGTTCSEEECCSSCCCCCCS-------STTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             c-cChhhcCCCCCCEEECCCCCCCccCh-------hhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence            4 47788999999999999999987765       388899999999999999988888877654334456778888776


Q ss_pred             cCCccccCCCCCCeeecccC
Q 002897          237 TIPPGLGNLVHLNSIAMEGN  256 (869)
Q Consensus       237 ~~~~~~~~l~~L~~L~l~~n  256 (869)
                      .+|..      |..|+++.|
T Consensus       356 ~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          356 PLPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCCC---------------
T ss_pred             cCccc------cceeEeecc
Confidence            66653      344555555

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=2e-17  Score=161.87  Aligned_cols=125  Identities=21%  Similarity=0.321  Sum_probs=69.1

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++|+++ +||..++   .+|++|+|++|+|+ .+|..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+
T Consensus        15 l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           15 VRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            345555555 5555443   35555555555555 444555555555555555555555444555555555555555555


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI  156 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~  156 (869)
                      |+++.|..|.++++|++|+|++|++.                         ...+..|..+++|+.|+|++|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDIS-------------------------VVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCC-------------------------eeChhhhhcCccccEEEeCCCCee
Confidence            55544445555555555555555554                         444445666666777777777664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=3.5e-17  Score=156.81  Aligned_cols=137  Identities=16%  Similarity=0.151  Sum_probs=102.6

Q ss_pred             cCCcCEEeccCCcCc-cccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           21 LFKLENLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        21 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      .++|+.|+|++|+++ +.+|..|..+++|++|+|++|.|+..  ..|+.+++|++|+|++|++++.+|..+.++++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            478999999999998 67888889999999999999999855  788899999999999999997788888889999999


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC---cCccCCCCCCEEEccC
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS---INFNSLKNLSVLILGN  176 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~l~~  176 (869)
                      +|++|++. .+|.                       +..+..+++|++|++++|.++++.+   ..|..+++|++|++++
T Consensus       101 ~Ls~N~l~-~~~~-----------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~  156 (168)
T 2ell_A          101 NLSGNKLK-DIST-----------------------LEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD  156 (168)
T ss_dssp             ECBSSSCC-SSGG-----------------------GGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred             eccCCccC-cchh-----------------------HHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence            99999887 4432                       1344455555666666665554443   3455566666666666


Q ss_pred             ccCCCCC
Q 002897          177 NHLGNRA  183 (869)
Q Consensus       177 n~l~~~~  183 (869)
                      |.+..++
T Consensus       157 n~~~~~~  163 (168)
T 2ell_A          157 REDQEAP  163 (168)
T ss_dssp             TTSCBCC
T ss_pred             CChhhcc
Confidence            6655554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.69  E-value=4.5e-16  Score=171.27  Aligned_cols=336  Identities=14%  Similarity=0.095  Sum_probs=245.5

Q ss_pred             cCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCc
Q 002897           33 HLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPF  112 (869)
Q Consensus        33 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  112 (869)
                      .++.+-..+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ +. .+..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~  133 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGV  133 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecc
Confidence            355566677888888888888744 66566778888888888888755 66566778888888888777655 33 4555


Q ss_pred             hhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhh
Q 002897          113 DMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTV  192 (869)
Q Consensus       113 ~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~  192 (869)
                      .+|.+...++....  +.+..+...+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..| ++.++..      +
T Consensus       134 ~aF~~~~~~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~------~  203 (394)
T 4fs7_A          134 EAFKGCDFKEITIP--EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY------C  203 (394)
T ss_dssp             TTTTTCCCSEEECC--TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT------T
T ss_pred             eeeecccccccccC--ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch------h
Confidence            66776654433322  23333456788999999999997664 5677888999999999998776 6666654      6


Q ss_pred             ccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCC
Q 002897          193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNL  272 (869)
Q Consensus       193 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  272 (869)
                      |.++..|+.+.+..+... ... ...... .|+.+.+..+. +.+....|..+..|+.+.+..+... +....|.....+
T Consensus       204 F~~~~~L~~i~~~~~~~~-i~~-~~~~~~-~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l  278 (394)
T 4fs7_A          204 FAECILLENMEFPNSLYY-LGD-FALSKT-GVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL  278 (394)
T ss_dssp             TTTCTTCCBCCCCTTCCE-ECT-TTTTTC-CCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred             hccccccceeecCCCceE-eeh-hhcccC-CCceEEECCCc-eecccccccccccceeEEcCCCcce-eecccccccccc
Confidence            888889998888776543 222 222333 38888887543 4366678889999999999887654 777888999999


Q ss_pred             CEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccC
Q 002897          273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD  352 (869)
Q Consensus       273 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~  352 (869)
                      +.+....+.+   ....|..+.+|+.+.+..+ ++.+...+|.++++|+.+++.++ ++                     
T Consensus       279 ~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~---------------------  332 (394)
T 4fs7_A          279 KKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE---------------------  332 (394)
T ss_dssp             CEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC---------------------
T ss_pred             ceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc---------------------
Confidence            9998877653   3457888999999999765 66567788999999999988643 33                     


Q ss_pred             CcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEE
Q 002897          353 NLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVL  420 (869)
Q Consensus       353 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  420 (869)
                          ..-..+|.++++|+.+++..| ++.....+|.+|.+|+.+++..+ ++ .+..+|.+.++|+.+
T Consensus       333 ----~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          333 ----EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             ----EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ----EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence                133467888999999999877 66566778999999999999865 33 345678777777764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.68  E-value=6.8e-16  Score=169.89  Aligned_cols=336  Identities=13%  Similarity=0.089  Sum_probs=209.0

Q ss_pred             ccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceecc
Q 002897           57 RLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP  136 (869)
Q Consensus        57 ~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~  136 (869)
                      .++.+-..+|.++++|+.+.|..+ ++.+...+|.++++|+.++|..+ +. .++..+|.++.+|+.+.+..+ +..+..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecc
Confidence            466566788999999999999754 77677788999999999999766 54 677788888888888777644 555666


Q ss_pred             ccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChh
Q 002897          137 ISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHS  216 (869)
Q Consensus       137 ~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  216 (869)
                      .+|.++..+........  ..+...+|.++++|+.+.+..+ +..++..      +|.++.+|+.+.+..| ++.+....
T Consensus       134 ~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~------~F~~c~~L~~i~l~~~-~~~I~~~~  203 (394)
T 4fs7_A          134 EAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDS-METLHNG------LFSGCGKLKSIKLPRN-LKIIRDYC  203 (394)
T ss_dssp             TTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTT-CCEECTT------TTTTCTTCCBCCCCTT-CCEECTTT
T ss_pred             eeeecccccccccCccc--cccchhhhcccCCCcEEecCCc-cceeccc------cccCCCCceEEEcCCC-ceEeCchh
Confidence            77877765554444333  3456677888888888888654 3445443      5777778877777655 43344444


Q ss_pred             hhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccc
Q 002897          217 LANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTML  296 (869)
Q Consensus       217 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  296 (869)
                      |.+... |+.+.+..+...  +.+.+.....|+.+.+..+ +..+....+....+|+.+.+..+... +....|..+..+
T Consensus       204 F~~~~~-L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l  278 (394)
T 4fs7_A          204 FAECIL-LENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL  278 (394)
T ss_dssp             TTTCTT-CCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred             hccccc-cceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccccc
Confidence            444443 555554444322  1222333345555555332 22244444555555555555544332 444455555555


Q ss_pred             cceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccc
Q 002897          297 TLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG  376 (869)
Q Consensus       297 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~  376 (869)
                      +.+....+.+.   ...|..+.+|+.+.+..+                          ++..-..+|.++++|+.++|.+
T Consensus       279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~--------------------------i~~I~~~aF~~c~~L~~i~lp~  329 (394)
T 4fs7_A          279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS--------------------------VKFIGEEAFESCTSLVSIDLPY  329 (394)
T ss_dssp             CEEEECSSEEC---TTTTTTCTTCCEEEECTT--------------------------CCEECTTTTTTCTTCCEECCCT
T ss_pred             ceeccCceeec---cccccccccccccccccc--------------------------cceechhhhcCCCCCCEEEeCC
Confidence            55554443322   234455555555544332                          2223445678888888888865


Q ss_pred             ccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCee
Q 002897          377 NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYL  444 (869)
Q Consensus       377 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l  444 (869)
                      + ++.....+|.+|.+|+.+.+..| ++.....+|.++++|+.+++..| ++ .+...|.++++|+.+
T Consensus       330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            4 66455678888888888888776 66455667888888888888655 33 345667777777654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.2e-16  Score=154.55  Aligned_cols=127  Identities=24%  Similarity=0.364  Sum_probs=89.3

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            45666666666 4444332  45666666666665 45556666666666666666666555555555555555555555


Q ss_pred             cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          105 RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       105 ~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      +++                         .+.+..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        89 ~l~-------------------------~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           89 RLR-------------------------CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCC-------------------------BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ccC-------------------------EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            554                         455667888999999999999999998889999999999999999985

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=2.5e-16  Score=152.28  Aligned_cols=132  Identities=18%  Similarity=0.303  Sum_probs=74.0

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      .+.+++++|+++ .+|..+  .++|++|++++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            345555555555 333322  24555555555555544444455555555555555555544444455555555555555


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccccc
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM  159 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~  159 (869)
                      |+++ .+|...|..+++|+.|++++|.+++..+..|..+++|++|+|++|.+.+..
T Consensus        86 N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            5555 444445555555555666666555555555666777777777777765433

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.1e-16  Score=150.04  Aligned_cols=130  Identities=20%  Similarity=0.188  Sum_probs=93.6

Q ss_pred             ccCCcCEEeccCCcCc-cccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           20 YLFKLENLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      ..++|+.|++++|.++ +.+|..+..+++|++|+|++|++++.  ..|+.+++|++|+|++|++++.+|..+.++++|++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            3467889999999988 67888888889999999999988855  67888889999999999888767888888888888


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC---cCccCCCCCCEEEcc
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS---INFNSLKNLSVLILG  175 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~l~  175 (869)
                      |++++|++. .+|                       .+..+..+++|++|++++|.+++..+   ..|..+++|+.|+++
T Consensus        93 L~ls~N~i~-~~~-----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           93 LNLSGNKIK-DLS-----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EECTTSCCC-SHH-----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             EECCCCcCC-ChH-----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            888888886 332                       11344445555555555555554443   345555555555543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=1.4e-16  Score=152.69  Aligned_cols=139  Identities=20%  Similarity=0.221  Sum_probs=101.5

Q ss_pred             cCCCEEEccCCccC-ccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhh
Q 002897           46 SALQVIDIRGNRLG-GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKF  124 (869)
Q Consensus        46 ~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  124 (869)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|.|++.  ..+..+++|++|+|++|++.                 
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~-----------------   84 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIF-----------------   84 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCC-----------------
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCc-----------------
Confidence            56677777777666 45566666666666666666666643  55555666666666666554                 


Q ss_pred             hccccccceeccccccCCCCCcEEEccCCccccccC-cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEE
Q 002897          125 VAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS-INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG  203 (869)
Q Consensus       125 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~  203 (869)
                              +.+|..+.++++|++|+|++|.++++.. ..|..+++|++|++++|.++.++..   ....+..+++|++|+
T Consensus        85 --------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~  153 (168)
T 2ell_A           85 --------GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY---RESVFKLLPQLTYLD  153 (168)
T ss_dssp             --------SCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTH---HHHHHTTCSSCCEET
T ss_pred             --------hHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHH---HHHHHHhCccCcEec
Confidence                    3345566678999999999999987643 7899999999999999999887641   112688999999999


Q ss_pred             ccCCCCCCCCCh
Q 002897          204 LYDNQFGGLLPH  215 (869)
Q Consensus       204 L~~n~l~~~~~~  215 (869)
                      +++|.+.. .|.
T Consensus       154 l~~n~~~~-~~~  164 (168)
T 2ell_A          154 GYDREDQE-APD  164 (168)
T ss_dssp             TEETTSCB-CCS
T ss_pred             CCCCChhh-ccc
Confidence            99999974 443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=3e-16  Score=166.72  Aligned_cols=141  Identities=14%  Similarity=0.182  Sum_probs=103.5

Q ss_pred             HHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc--------------hh--------hHHHHHHHHHHHhC
Q 002897          551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK--------------GA--------LKSFLTECEALRSI  608 (869)
Q Consensus       551 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~--------~~~~~~E~~~l~~l  608 (869)
                      ....=|++.++||+|++|.||+|.+. +|+.||||+++....              ..        .....+|...+.++
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            33344889999999999999999986 799999999753210              00        01124577777777


Q ss_pred             CCCcc--ceEEEEeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002897          609 RHRNL--IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPV  686 (869)
Q Consensus       609 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  686 (869)
                      .+.++  ...+++         ...++||||++|++|.++...            .....++.|++.+|.|||+.   ||
T Consensus       171 ~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gI  226 (397)
T 4gyi_A          171 YEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GL  226 (397)
T ss_dssp             HHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CC
Confidence            54433  333333         234799999999888654321            13456789999999999999   99


Q ss_pred             EecCCCCCceeecCCC----------cEEEccccccccCC
Q 002897          687 VHGDLKPSNVLLDHDM----------VAHVGDFGLAKFLP  716 (869)
Q Consensus       687 vH~Dlkp~NIll~~~~----------~~kl~Dfg~a~~~~  716 (869)
                      |||||||.|||+++++          .+.|+||+.+....
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999999998876          38999999886543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=9.3e-16  Score=148.21  Aligned_cols=128  Identities=19%  Similarity=0.234  Sum_probs=64.9

Q ss_pred             CEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccc
Q 002897           49 QVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK  128 (869)
Q Consensus        49 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~  128 (869)
                      +.+++++|+++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++. .+|...|..+++|+.|++++
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECCC
Confidence            44555555555 3332222  35555555555555444444455555555555555554 44444455555555555555


Q ss_pred             cccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          129 NNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       129 n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      |++++..+..|..+++|++|++++|+++++.+..|..+++|++|++++|.+.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            5555444444555555555555555555444444555555555555555544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=3.7e-16  Score=150.80  Aligned_cols=146  Identities=16%  Similarity=0.187  Sum_probs=94.5

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCc-CCCEEEccCCccCccCCccccCCCCCCEEeCcC
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLS-ALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~   79 (869)
                      |+.+..+.+. ..|..  ....+|+.|+|++|+++. +|. +..+. +|++|+|++|+|++.  ..|+.+++|++|+|++
T Consensus         1 m~~lt~~~i~-~~~~~--~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~   73 (176)
T 1a9n_A            1 MVKLTAELIE-QAAQY--TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNN   73 (176)
T ss_dssp             -CCCCHHHHH-TSCEE--ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCS
T ss_pred             CccccHHHHH-HHHhc--CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCC
Confidence            3444555555 44443  356788888888888884 454 44444 888888888888854  5788888888888888


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCc-hhhcCCcchhhhhccccccceeccc----cccCCCCCcEEEccCCc
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPF-DMVANLPNLRKFVAAKNNLTGFLPI----SLSNASNLELLELRDNQ  154 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~----~l~~l~~L~~L~L~~N~  154 (869)
                      |+|++..+..|.++++|++|+|++|++. .+|. ..+..+++|+.|++++|.++.. |.    .+..+++|++||+++|.
T Consensus        74 N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           74 NRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             SCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECC
T ss_pred             CcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCC
Confidence            8888665566688888888888888885 5553 2344555555555555555432 22    24444555555555444


Q ss_pred             c
Q 002897          155 F  155 (869)
Q Consensus       155 i  155 (869)
                      +
T Consensus       152 ~  152 (176)
T 1a9n_A          152 L  152 (176)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=5e-16  Score=145.41  Aligned_cols=132  Identities=21%  Similarity=0.239  Sum_probs=103.5

Q ss_pred             CcCCCEEEccCCccC-ccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhh
Q 002897           45 LSALQVIDIRGNRLG-GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRK  123 (869)
Q Consensus        45 l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~  123 (869)
                      .++|++|++++|.++ +.+|..++.+++|++|+|++|.+++.  ..+.++++|++|+|++|++.+               
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~---------------   78 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSG---------------   78 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCS---------------
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccc---------------
Confidence            367888888888887 67777788888888888888888754  667777777777777777762               


Q ss_pred             hhccccccceeccccccCCCCCcEEEccCCcccccc-CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEE
Q 002897          124 FVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM-SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL  202 (869)
Q Consensus       124 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L  202 (869)
                                .+|..+..+++|++|++++|+++++. +..+..+++|++|++++|.++.++..   ....+..+++|++|
T Consensus        79 ----------~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L  145 (149)
T 2je0_A           79 ----------GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDY---RENVFKLLPQLTYL  145 (149)
T ss_dssp             ----------CTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTH---HHHHHHHCTTCCEE
T ss_pred             ----------hHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHH---HHHHHHHCCCcccc
Confidence                      24455667889999999999998753 47899999999999999999887641   01258889999999


Q ss_pred             EccC
Q 002897          203 GLYD  206 (869)
Q Consensus       203 ~L~~  206 (869)
                      ++++
T Consensus       146 ~l~d  149 (149)
T 2je0_A          146 DGYD  149 (149)
T ss_dssp             TTBC
T ss_pred             cCCC
Confidence            9874

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=2.9e-17  Score=161.99  Aligned_cols=154  Identities=23%  Similarity=0.262  Sum_probs=118.8

Q ss_pred             hccCCcCEEeccCCcCccccCc------ccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCccccc
Q 002897           19 CYLFKLENLSLAENHLTGQLPV------SIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYN   92 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~   92 (869)
                      ....+++.++++.+.+++..|.      .|..+++|++|+|++|+|++ +| .++++++|++|+|++|+|+ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3567888888888888877776      88999999999999999985 66 8888999999999999998 56778888


Q ss_pred             CCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceecc-ccccCCCCCcEEEccCCccccccCcC---------
Q 002897           93 ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDNQFIGKMSIN---------  162 (869)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~---------  162 (869)
                      +++|++|+|++|++. .+|  .+..+++|+.|++++|.++...+ ..+..+++|++|++++|.+.+..+..         
T Consensus        92 ~~~L~~L~L~~N~l~-~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           92 ADTLEELWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHCSEEEEEEEECC-CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             CCcCCEEECcCCcCC-cCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            888999999999887 455  47778888888888888875433 46778888888888888876655432         


Q ss_pred             -ccCCCCCCEEEccCccCC
Q 002897          163 -FNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       163 -~~~l~~L~~L~l~~n~l~  180 (869)
                       +..+++|+.|+  +|.++
T Consensus       169 ~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGT
T ss_pred             HHHhCCCcEEEC--CcccC
Confidence             55566666554  44443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=1.4e-15  Score=146.70  Aligned_cols=112  Identities=17%  Similarity=0.265  Sum_probs=70.4

Q ss_pred             cccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCc
Q 002897           40 VSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP  119 (869)
Q Consensus        40 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~  119 (869)
                      ..+.++.+|++|+|++|+++ .+|......++|++|+|++|+|++.  ..|.++++|++|+|++|++. .+|.+.|..++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~   88 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALP   88 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCT
T ss_pred             HhcCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCC
Confidence            34677788888888888888 4454333334888888888888754  56777778888888888776 55544445555


Q ss_pred             chhhhhccccccceeccc--cccCCCCCcEEEccCCccc
Q 002897          120 NLRKFVAAKNNLTGFLPI--SLSNASNLELLELRDNQFI  156 (869)
Q Consensus       120 ~L~~L~l~~n~i~~~~~~--~l~~l~~L~~L~L~~N~i~  156 (869)
                      +|++|++++|.|+. +|.  .+..+++|++|++++|.+.
T Consensus        89 ~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           89 DLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             TCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC
Confidence            55555555555542 222  4444455555555555444

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.55  E-value=1.1e-14  Score=139.18  Aligned_cols=102  Identities=24%  Similarity=0.345  Sum_probs=85.2

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++|+++ +||..++   ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+
T Consensus        14 l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           14 VDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            678888888 7887764   688888888888887778888888888888888888887777778888888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      |+++.+..|.++++|++|+|++|.+.
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            88776777888888888888888886

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.54  E-value=4.3e-13  Score=147.41  Aligned_cols=335  Identities=11%  Similarity=0.111  Sum_probs=171.7

Q ss_pred             ccccCcccccCc-CCCEEEccCCccCccCCccccCCCCCCEEeCcCcc---cCccCCcccccCCCCcEEECcCCcCcccC
Q 002897           35 TGQLPVSIGNLS-ALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ---FSGFIPPSIYNISSFEFIFLQSNRFHGSL  110 (869)
Q Consensus        35 ~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~---i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  110 (869)
                      +.+-..+|.+++ .|+.+.+-.+ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ +. .+
T Consensus        52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I  128 (394)
T 4gt6_A           52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EI  128 (394)
T ss_dssp             EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EE
T ss_pred             eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-ee
Confidence            334445566653 4666666543 444556666666666666666553   44445556666666666655544 32 45


Q ss_pred             CchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchh
Q 002897          111 PFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFV  190 (869)
Q Consensus       111 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  190 (869)
                      +..+|.++.+|+.+.+..+ +..+...+|..+.+|+.+.+.++ ++.+...+|.. .+|+.+.+..+- ..+...     
T Consensus       129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~~i~~~-----  199 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-TRIGTN-----  199 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-CEECTT-----
T ss_pred             hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc-cccccc-----
Confidence            5566666666666666533 34455667777777777777655 45566666654 567777775542 233322     


Q ss_pred             hhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCC
Q 002897          191 TVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLK  270 (869)
Q Consensus       191 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  270 (869)
                       +|..+.+|.......+..... ...+.........           ....+.....+..+.+. +.+..+...+|.++.
T Consensus       200 -af~~c~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~  265 (394)
T 4gt6_A          200 -AFSECFALSTITSDSESYPAI-DNVLYEKSANGDY-----------ALIRYPSQREDPAFKIP-NGVARIETHAFDSCA  265 (394)
T ss_dssp             -TTTTCTTCCEEEECCSSSCBS-SSCEEEECTTSCE-----------EEEECCTTCCCSEEECC-TTEEEECTTTTTTCS
T ss_pred             -hhhhccccceecccccccccc-cceeecccccccc-----------cccccccccccceEEcC-CcceEcccceeeecc
Confidence             567777777776665554421 1111110000000           00011122223333332 223334455566666


Q ss_pred             CCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecc
Q 002897          271 NLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNL  350 (869)
Q Consensus       271 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l  350 (869)
                      +|+.+.+.++... +....|.+++.|+.+.+. +.++.....+|.++.+|+.+++..+ ++                   
T Consensus       266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-------------------  323 (394)
T 4gt6_A          266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-------------------  323 (394)
T ss_dssp             SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-------------------
T ss_pred             cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-------------------
Confidence            6666666544332 555566666666666664 3344344556666666666665432 22                   


Q ss_pred             cCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcc
Q 002897          351 SDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL  427 (869)
Q Consensus       351 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (869)
                            ..-..+|.++.+|+.+.+..+ ++.....+|.+|++|+.+++.+|....   .++.....|+.+.+..|.+
T Consensus       324 ------~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          324 ------QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             ------EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             ------EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence                  022345566666666666443 443444566666666666666655431   3444555666666555543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=1.8e-14  Score=138.10  Aligned_cols=102  Identities=24%  Similarity=0.352  Sum_probs=84.8

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|+++|+++ +||..++   ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|+++++|++|+|++|+
T Consensus        17 l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           17 VNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            678888888 8888775   788888888888887778888888888888888888887666677888888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      |+++.+..|.++++|++|+|++|.+.
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcc
Confidence            88666666888888888888888886

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=7e-17  Score=159.22  Aligned_cols=83  Identities=20%  Similarity=0.209  Sum_probs=37.9

Q ss_pred             CccccccccccccccccCCccccCCCCCcEEEeeCccccCCCC-ccccccccccEEEccCCcccCCCcc----------c
Q 002897          366 LKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIP-PSLNFLKSIKVLDLSSNKLSGQIPK----------Y  434 (869)
Q Consensus       366 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----------~  434 (869)
                      +++|++|+|++|.+++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++++.+|.          .
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~  169 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence            3444444444444442 22 34444444444444444442111 2344455555555555555444333          2


Q ss_pred             cccccccCeeccccccCc
Q 002897          435 LENLSFLEYLNLSYNHFE  452 (869)
Q Consensus       435 ~~~l~~L~~l~l~~N~l~  452 (869)
                      +..+++|+.||  +|+++
T Consensus       170 ~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          170 VKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHCSSCSEEC--CGGGT
T ss_pred             HHhCCCcEEEC--CcccC
Confidence            55666666665  55554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.51  E-value=9.4e-13  Score=144.70  Aligned_cols=337  Identities=10%  Similarity=0.112  Sum_probs=206.9

Q ss_pred             ccCccCCccccCCC-CCCEEeCcCcccCccCCcccccCCCCcEEECcCCc---CcccCCchhhcCCcchhhhhccccccc
Q 002897           57 RLGGKIPDTLGQLR-KLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNR---FHGSLPFDMVANLPNLRKFVAAKNNLT  132 (869)
Q Consensus        57 ~i~~~~p~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~~l~~L~~L~l~~n~i~  132 (869)
                      .++.+-..+|.+++ .|+.+.|..+ ++.+-..+|.++++|+.+.++.|.   ++ .++..+|.++.+|+.+.+..+ ++
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~  126 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VT  126 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CS
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cc
Confidence            35556677888875 5999999765 776778899999999999998774   54 677778888888887777654 55


Q ss_pred             eeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCC
Q 002897          133 GFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL  212 (869)
Q Consensus       133 ~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~  212 (869)
                      .+...+|..+.+|+.+.+..+ +..+....|..+.+|+.+.+..+ +..++..      +|.. .+|+.+.+..+-.. .
T Consensus       127 ~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~------aF~~-~~l~~i~ip~~~~~-i  196 (394)
T 4gt6_A          127 EIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER------AFTG-TALTQIHIPAKVTR-I  196 (394)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT------TTTT-CCCSEEEECTTCCE-E
T ss_pred             eehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccc------cccc-cceeEEEECCcccc-c
Confidence            566677888888888888654 45666777777777777777654 5555443      3432 45666666543322 3


Q ss_pred             CChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCC
Q 002897          213 LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGN  292 (869)
Q Consensus       213 ~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  292 (869)
                      ...++..... ++......+.... ....+.          ..+.........+.....+..+.+.+ .++.+....|.+
T Consensus       197 ~~~af~~c~~-l~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~  263 (394)
T 4gt6_A          197 GTNAFSECFA-LSTITSDSESYPA-IDNVLY----------EKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDS  263 (394)
T ss_dssp             CTTTTTTCTT-CCEEEECCSSSCB-SSSCEE----------EECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTT
T ss_pred             ccchhhhccc-cceeccccccccc-ccceee----------cccccccccccccccccccceEEcCC-cceEcccceeee
Confidence            3334443332 4444433332221 111000          00000000000111223444455432 344456667888


Q ss_pred             CccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccc
Q 002897          293 LTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQL  372 (869)
Q Consensus       293 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L  372 (869)
                      ++.|+.+.+..+... ....+|.++++|+.+.+.. .++                         .....+|.++.+|+.+
T Consensus       264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~-------------------------~I~~~aF~~c~~L~~i  316 (394)
T 4gt6_A          264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RIT-------------------------ELPESVFAGCISLKSI  316 (394)
T ss_dssp             CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCC-------------------------EECTTTTTTCTTCCEE
T ss_pred             cccccEEecccccce-ecCcccccccccccccCCC-ccc-------------------------ccCceeecCCCCcCEE
Confidence            888888888765443 5667778888888777742 222                         1334578888899999


Q ss_pred             ccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccC
Q 002897          373 DISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF  451 (869)
Q Consensus       373 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  451 (869)
                      +|..+ ++.....+|.+|.+|+.+.+..+ ++.....+|.++.+|+.+++.+|...   -..+..+.+|+.+.+..|.+
T Consensus       317 ~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          317 DIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             ECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred             EeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            88765 55466778999999999999755 66455678889999999999888654   14667778888888776654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=5e-14  Score=134.61  Aligned_cols=106  Identities=21%  Similarity=0.262  Sum_probs=67.5

Q ss_pred             ecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcc
Q 002897          348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL  427 (869)
Q Consensus       348 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (869)
                      +++++|.++ .+|..+.  ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus        14 l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l   90 (170)
T 3g39_A           14 VDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL   90 (170)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence            444444444 3444332  5666677777777666666666777777777777777655555566677777777777777


Q ss_pred             cCCCccccccccccCeeccccccCcccCC
Q 002897          428 SGQIPKYLENLSFLEYLNLSYNHFEGEVP  456 (869)
Q Consensus       428 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  456 (869)
                      ++..+..|..+++|+.|+|++|++++.++
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           91 KSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            65555566677777777777777766554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=1.2e-13  Score=132.41  Aligned_cols=102  Identities=18%  Similarity=0.240  Sum_probs=63.7

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            366777777776 5555553  6777777777777766677777777777777777777765555566677777777777


Q ss_pred             CcCcccCCchhhcCCcchhhhhcccc
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKN  129 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n  129 (869)
                      |++. .+|...|..+++|+.|+|++|
T Consensus        91 N~l~-~l~~~~~~~l~~L~~L~L~~N  115 (174)
T 2r9u_A           91 NHLK-SIPRGAFDNLKSLTHIYLYNN  115 (174)
T ss_dssp             SCCC-CCCTTTTTTCTTCSEEECCSS
T ss_pred             Cccc-eeCHHHhccccCCCEEEeCCC
Confidence            7665 444333333333333333333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=7.9e-15  Score=158.75  Aligned_cols=83  Identities=20%  Similarity=0.202  Sum_probs=49.9

Q ss_pred             cccccCCCCCcEEEccCCcccccc----CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          136 PISLSNASNLELLELRDNQFIGKM----SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       136 ~~~l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      +.++..+++|++|+|++|.|+...    ...+...++|++|+|++|.|+..+..  .++.++..+++|++|+|++|.|+.
T Consensus       176 ~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~--~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          176 MEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL--ALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH--HHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH--HHHHHHHhCCCCCEEeccCCCCCH
Confidence            344556677777777777765432    33455566777777777777654332  234455566777777777777765


Q ss_pred             CCChhhhhc
Q 002897          212 LLPHSLANL  220 (869)
Q Consensus       212 ~~~~~~~~l  220 (869)
                      .....+..+
T Consensus       254 ~g~~~L~~~  262 (372)
T 3un9_A          254 EGRQVLRDL  262 (372)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHHHH
Confidence            544444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.37  E-value=9.2e-13  Score=142.30  Aligned_cols=102  Identities=19%  Similarity=0.217  Sum_probs=81.4

Q ss_pred             cccCCC-cccccCChhhhhccCCcCEEeccC-CcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcC
Q 002897            2 FDAQNN-KLVGDIPVEIGCYLFKLENLSLAE-NHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR   79 (869)
Q Consensus         2 l~l~~~-~~~~~ip~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~   79 (869)
                      +|++++ +|+ .||. +. .+++|++|+|++ |.|+++.+.+|.++++|++|+|++|+|+++.|.+|++|++|++|+|++
T Consensus        13 v~~~~~n~l~-~ip~-l~-~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             EECCSSCCCT-TTTT-SC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEcCCCCCCC-ccCC-CC-CCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            467777 788 7888 54 678888888885 888877777888888888888888888888888888888888888888


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCc
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      |+|+++.+..|..+. |+.|+|++|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            888866666666665 888888888876

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.34  E-value=1.5e-14  Score=156.55  Aligned_cols=140  Identities=16%  Similarity=0.140  Sum_probs=68.6

Q ss_pred             CCCCEEeCcCcccCccCCcccccC-----CCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccc-----
Q 002897           70 RKLIYLNIGRNQFSGFIPPSIYNI-----SSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL-----  139 (869)
Q Consensus        70 ~~L~~L~L~~n~i~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l-----  139 (869)
                      ++|++|+|++|.|+......+...     .+|++|+|++|.+...........+++|+.|+|++|.|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            455555666555553322222222     4556666666655421111222233444455555554443222222     


Q ss_pred             cCCCCCcEEEccCCccccccC----cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          140 SNASNLELLELRDNQFIGKMS----INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       140 ~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      ...++|++|+|++|.|+....    ..+..+++|++|+|++|.|+..+..  .++..+..+++|++|+|++|.|+.
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--HHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--HHHHHHhcCCCcCeEECCCCCCCH
Confidence            234567777777776654222    2234556666666666666543321  223345555666666666666653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.29  E-value=1.7e-12  Score=140.26  Aligned_cols=130  Identities=21%  Similarity=0.209  Sum_probs=89.7

Q ss_pred             ecccCC-cccCCCcccccCCcccccccccc-ccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCC
Q 002897          348 LNLSDN-LLSGSLPSEIGNLKNLVQLDISG-NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSN  425 (869)
Q Consensus       348 L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N  425 (869)
                      ++++++ .|+ .+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            455565 566 4666 78888888888885 8888776777888888888888888888777778888888888888888


Q ss_pred             cccCCCccccccccccCeeccccccCcccCCCCC--ccCCCccccccCCcccCCCCC
Q 002897          426 KLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKG--VFSNKTRFSLSGNGKLCGGLD  480 (869)
Q Consensus       426 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~  480 (869)
                      +|++..+..+..++ |+.|+|++|+|.+.+....  .+.......+..+...|..+.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            88866555565555 8888888888877654221  111112233444556665443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.27  E-value=3e-10  Score=124.05  Aligned_cols=289  Identities=12%  Similarity=0.071  Sum_probs=202.8

Q ss_pred             hccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           19 CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      ....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++.+...+|... +|+.
T Consensus        43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~  117 (379)
T 4h09_A           43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDD  117 (379)
T ss_dssp             GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSE
T ss_pred             ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cccc
Confidence            3457788888864 567677788999999999999755 666777888887 6888888654 554666677664 7999


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccc------------cCcCccCC
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGK------------MSINFNSL  166 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~------------~~~~~~~l  166 (869)
                      +.+..+..  .+...+|.+. +|+.+.+.. .++.+...+|..+.+++.+.+..+.....            ....+...
T Consensus       118 i~lp~~~~--~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (379)
T 4h09_A          118 FEFPGATT--EIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA  193 (379)
T ss_dssp             EECCTTCC--EECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred             ccCCCccc--cccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence            99987633  4555566554 455554443 35556677888888888888876543211            12234455


Q ss_pred             CCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCC
Q 002897          167 KNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLV  246 (869)
Q Consensus       167 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~  246 (869)
                      ..+..+.+..+.. .+..      .++..+.+|+.+.+..+ +..+....+.+... |+.+.+..+ ++.+...+|.++.
T Consensus       194 ~~~~~~~~~~~~~-~i~~------~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~-L~~i~lp~~-v~~I~~~aF~~~~  263 (379)
T 4h09_A          194 KTGTEFTIPSTVK-TVTA------YGFSYGKNLKKITITSG-VTTLGDGAFYGMKA-LDEIAIPKN-VTSIGSFLLQNCT  263 (379)
T ss_dssp             CCCSEEECCTTCC-EECT------TTTTTCSSCSEEECCTT-CCEECTTTTTTCSS-CCEEEECTT-CCEECTTTTTTCT
T ss_pred             cccccccccccee-EEee------cccccccccceeeeccc-eeEEccccccCCcc-ceEEEcCCC-ccEeCccccceee
Confidence            5666665544322 2221      25677788888888655 44355566666665 888888766 5556677888888


Q ss_pred             CCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeecc
Q 002897          247 HLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLS  326 (869)
Q Consensus       247 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  326 (869)
                      +|+.+.+..+ +..+....|.++++|+.+.+.++.++.+....|.++++|+.+.+..+ ++.+...+|.++++|+.+.+.
T Consensus       264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            8888888654 55566778888899999999888888777888889999999988754 665667788899999988886


Q ss_pred             Cc
Q 002897          327 KN  328 (869)
Q Consensus       327 ~N  328 (869)
                      .+
T Consensus       342 ~~  343 (379)
T 4h09_A          342 KS  343 (379)
T ss_dssp             TT
T ss_pred             Cc
Confidence            54

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.2e-11  Score=127.63  Aligned_cols=147  Identities=16%  Similarity=0.114  Sum_probs=113.5

Q ss_pred             HHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCC
Q 002897          549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNG  627 (869)
Q Consensus       549 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  627 (869)
                      +......|++...++.|+.+.||++..  .++.+++|+...........+.+|+++++.+. +..+.++++++...    
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~----   82 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD----   82 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET----
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC----
Confidence            344556788888899999999999986  47899999986532233356889999999884 67788898886542    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-------------------------  682 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------  682 (869)
                       +..++||||++|.++.+.+..           ......++.+++++++.||+..                         
T Consensus        83 -~~~~lv~e~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T 3tm0_A           83 -GWSNLLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             -TEEEEEEECCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             -CceEEEEEecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence             678999999999999876421           1123477899999999999810                         


Q ss_pred             -------------------------------CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          683 -------------------------------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       683 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                                     .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                           1369999999999999876566799999874

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.22  E-value=6.7e-10  Score=121.31  Aligned_cols=310  Identities=9%  Similarity=0.041  Sum_probs=172.3

Q ss_pred             cccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCc
Q 002897           40 VSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLP  119 (869)
Q Consensus        40 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~  119 (869)
                      .++....+|+.+.+... ++.+-..+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ +. .++..+|.+. 
T Consensus        40 ~~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~-  113 (379)
T 4h09_A           40 PWYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGT-  113 (379)
T ss_dssp             TTGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTC-
T ss_pred             cccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccC-
Confidence            34667788888888754 56566788999999999999754 666777788877 6777777654 43 5666666654 


Q ss_pred             chhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcc------hhhhc
Q 002897          120 NLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD------FVTVL  193 (869)
Q Consensus       120 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------~~~~l  193 (869)
                      +|+.+.+..+ ++.+...+|.+. +|+.+.+..+ ++.+....|....+++...+..+...........      ....+
T Consensus       114 ~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (379)
T 4h09_A          114 DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESY  190 (379)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEEC
T ss_pred             CcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccc
Confidence            6777777654 333445555554 5666655544 4556666677777777776665543322211000      00011


Q ss_pred             cCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCC
Q 002897          194 ANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQ  273 (869)
Q Consensus       194 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  273 (869)
                      ..+..                         +..+.+..+.- ......+.....|+.+.+..+ +..+....|....+|+
T Consensus       191 ~~~~~-------------------------~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~  243 (379)
T 4h09_A          191 PAAKT-------------------------GTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALD  243 (379)
T ss_dssp             CTTCC-------------------------CSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCC
T ss_pred             ccccc-------------------------cccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccce
Confidence            22222                         33333332221 133445555666666666443 3335555566666666


Q ss_pred             EEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCC
Q 002897          274 SLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN  353 (869)
Q Consensus       274 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N  353 (869)
                      .+.+..+ ++.+....|.++.+|+.+.+..+ +......+|.++++|+.+.+.++.++ .                    
T Consensus       244 ~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~--------------------  300 (379)
T 4h09_A          244 EIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-T--------------------  300 (379)
T ss_dssp             EEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-E--------------------
T ss_pred             EEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-e--------------------
Confidence            6666554 44455556666666666666533 44344556666666666666655554 1                    


Q ss_pred             cccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCcccccc
Q 002897          354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFL  414 (869)
Q Consensus       354 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  414 (869)
                          ....+|.++.+|+.+.|..+ ++.....+|.+|.+|+.+.+..+ ++.....+|.+.
T Consensus       301 ----I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          301 ----LEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             ----ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             ----ehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence                12234555555555555433 43334445556666666555443 332333444443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.00  E-value=3.6e-10  Score=116.52  Aligned_cols=137  Identities=16%  Similarity=0.112  Sum_probs=97.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCc--cceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN--LIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~  631 (869)
                      .+|.+....+.|..+.||++.. .+|+.+++|+....   ....+..|+++++.+.+.+  +.+++++...     .+..
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~   90 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRD   90 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCC
Confidence            3444433334556699999976 36788999997543   2355788999999885444  4567777543     2568


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-----------------------------  682 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------  682 (869)
                      ++||||++|.++.  ...         .+   ...++.++++.++.||+..                             
T Consensus        91 ~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             EEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             EEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence            9999999998884  211         11   2356778888888888741                             


Q ss_pred             --------------------------CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          683 --------------------------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       683 --------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                                .+.++|+|++|.||++++++.+.|+|||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                      1139999999999999877667799999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=2e-10  Score=122.93  Aligned_cols=82  Identities=10%  Similarity=0.060  Sum_probs=41.0

Q ss_pred             CcCEEeccCCcCcc-c-------cCcccccCcCCCEEEccCCccC---------ccCCccccCCCCCCEEeCcCcccCcc
Q 002897           23 KLENLSLAENHLTG-Q-------LPVSIGNLSALQVIDIRGNRLG---------GKIPDTLGQLRKLIYLNIGRNQFSGF   85 (869)
Q Consensus        23 ~L~~L~L~~n~l~~-~-------~~~~~~~l~~L~~L~L~~n~i~---------~~~p~~~~~l~~L~~L~L~~n~i~~~   85 (869)
                      .++.|.+......+ .       +..+...+++|+.|.+.++...         +.++..+..+++|+.|+|++|.-. .
T Consensus       108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~  186 (362)
T 2ra8_A          108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-S  186 (362)
T ss_dssp             GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-B
T ss_pred             hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-e
Confidence            45666666544331 1       1233455667777777554321         112233455666666666665211 1


Q ss_pred             CCcccccCCCCcEEECcCCcCc
Q 002897           86 IPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        86 ~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      ++. + .+++|++|+|..|.+.
T Consensus       187 l~~-~-~~~~L~~L~L~~~~l~  206 (362)
T 2ra8_A          187 IGK-K-PRPNLKSLEIISGGLP  206 (362)
T ss_dssp             CCS-C-BCTTCSEEEEECSBCC
T ss_pred             ecc-c-cCCCCcEEEEecCCCC
Confidence            222 2 2566666666666554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=2.9e-09  Score=115.26  Aligned_cols=145  Identities=15%  Similarity=0.196  Sum_probs=106.3

Q ss_pred             CCCeeeeecceEEEEEEECCCCeEEEEEEee--cccc-hhhHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCceEE
Q 002897          558 SSNMVGQGSFGTVFKGIIGENGMLVAVKVLN--LMQK-GALKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       558 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ..+.++.|.++.||++..  .+..+++|+..  .... .....+.+|+.+++.+.  +..+.+++.++.+..  ..+..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence            356789999999999987  35678888875  3221 12356788999999996  456788888876532  124578


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC------------------------------  682 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------  682 (869)
                      +||||++|..+.+...        ..++..++..++.+++++|+.||+..                              
T Consensus       118 ~vme~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             EEEECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            9999999977743111        12678889999999999999999831                              


Q ss_pred             -------------------------CCCeEecCCCCCceeecCCCc--EEEcccccccc
Q 002897          683 -------------------------KPPVVHGDLKPSNVLLDHDMV--AHVGDFGLAKF  714 (869)
Q Consensus       683 -------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  714 (869)
                                               .+.++|||++|.||+++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     247999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=1.7e-09  Score=113.96  Aligned_cols=196  Identities=15%  Similarity=0.122  Sum_probs=123.9

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCc--cceEEEEeeccccCCCceEEEEe
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRN--LIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      .+.++.|.+..||++.     ..+++|+....  .....+.+|+++++.+. +..  +.+++.+....  ......++||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence            4679999999999864     45889986432  34567899999998883 332  44555543221  1112457899


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC---------------------------------  682 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  682 (869)
                      ++++|.++.+....        .++..++..++.++++.++.||+..                                 
T Consensus        96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            99999888754332        2778888899999999999999611                                 


Q ss_pred             ----------------------CCCeEecCCCCCceeecC--CCcEEEccccccccCCCCCCCCccccCC--CC----CC
Q 002897          683 ----------------------KPPVVHGDLKPSNVLLDH--DMVAHVGDFGLAKFLPARPLDTVVETPS--SS----SG  732 (869)
Q Consensus       683 ----------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~~----~~  732 (869)
                                            .+.++|+|++|.||++++  ...+.++||+.+..-+....-.......  ..    ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                  245899999999999998  4568899999987543211000000000  00    00


Q ss_pred             ccCcccccC-CcccCCCCCCccccchhhhHHHHHHHcCCCCC
Q 002897          733 IKGTVGYIA-PEYGTGSEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       733 ~~gt~~y~a-PE~~~~~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                      .....++.. |+....  .....+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000001111 111110  112258999999999999998876

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.83  E-value=6.3e-10  Score=119.07  Aligned_cols=189  Identities=15%  Similarity=0.164  Sum_probs=117.6

Q ss_pred             ccCCcCEEeccCCcCc---------cccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCccc
Q 002897           20 YLFKLENLSLAENHLT---------GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSI   90 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~   90 (869)
                      .+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+.......+
T Consensus       137 ~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l  213 (362)
T 2ra8_A          137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDI  213 (362)
T ss_dssp             HHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHH
T ss_pred             hcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHH
Confidence            5789999999765432         124456678899999999998412 2333 44 8999999999998875443445


Q ss_pred             c--cCCCCcEEECcCC--cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCc---
Q 002897           91 Y--NISSFEFIFLQSN--RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF---  163 (869)
Q Consensus        91 ~--~l~~L~~L~Ls~N--~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~---  163 (869)
                      .  .+++|++|+|+.+  ...+...   +   ..|..          .+  .-..+++|++|+|++|.+.......+   
T Consensus       214 ~~~~lp~L~~L~L~~~~~~~~~~~~---~---~~l~~----------~l--~~~~~p~Lr~L~L~~~~i~~~~~~~la~a  275 (362)
T 2ra8_A          214 LGSDLPNLEKLVLYVGVEDYGFDGD---M---NVFRP----------LF--SKDRFPNLKWLGIVDAEEQNVVVEMFLES  275 (362)
T ss_dssp             HHSBCTTCCEEEEECBCGGGTCCSC---G---GGTGG----------GS--CTTTCTTCCEEEEESCTTHHHHHHHHHHC
T ss_pred             HHccCCCCcEEEEeccccccccchh---H---HHHHH----------HH--hcCCCCCcCEEeCCCCCCchHHHHHHHhC
Confidence            4  7899999998642  2211100   1   11110          00  00245777777777777653222222   


Q ss_pred             cCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCc
Q 002897          164 NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNY  233 (869)
Q Consensus       164 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~  233 (869)
                      ..+++|++|+|+.|.++.....  .++..+..+++|+.|+|++|.++......+....  ...++++.++
T Consensus       276 ~~~~~L~~LdLs~n~L~d~G~~--~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          276 DILPQLETMDISAGVLTDEGAR--LLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             SSGGGCSEEECCSSCCBHHHHH--HHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             ccCCCCCEEECCCCCCChHHHH--HHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            2467788888888877654322  1222345678888888888887755444555421  3567888876

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.60  E-value=3e-09  Score=107.65  Aligned_cols=64  Identities=20%  Similarity=0.339  Sum_probs=30.6

Q ss_pred             ccCcCCCEEEccCCccCc--cCCccccCCCCCCEEeCcCcccCccCCcccccCC--CCcEEECcCCcCcc
Q 002897           43 GNLSALQVIDIRGNRLGG--KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNIS--SFEFIFLQSNRFHG  108 (869)
Q Consensus        43 ~~l~~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~--~L~~L~Ls~N~l~~  108 (869)
                      .++++|++|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence            344555555555555554  2234444555555555555555533  2222222  55555555555543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.50  E-value=1.9e-08  Score=97.00  Aligned_cols=117  Identities=11%  Similarity=0.030  Sum_probs=56.3

Q ss_pred             cccccCcCCCEEEccCC-ccCc----cCCccccCCCCCCEEeCcCcccCcc----CCcccccCCCCcEEECcCCcCcccC
Q 002897           40 VSIGNLSALQVIDIRGN-RLGG----KIPDTLGQLRKLIYLNIGRNQFSGF----IPPSIYNISSFEFIFLQSNRFHGSL  110 (869)
Q Consensus        40 ~~~~~l~~L~~L~L~~n-~i~~----~~p~~~~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~  110 (869)
                      ..+...++|++|+|++| .|..    .+...+...++|++|+|++|.|...    +...+...++|++|+|++|.|...-
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            34444555555555555 4442    1223334445555555555555421    2233334455555555555554110


Q ss_pred             C---chhhcCCcchhhhhc--ccccccee----ccccccCCCCCcEEEccCCccc
Q 002897          111 P---FDMVANLPNLRKFVA--AKNNLTGF----LPISLSNASNLELLELRDNQFI  156 (869)
Q Consensus       111 ~---~~~~~~l~~L~~L~l--~~n~i~~~----~~~~l~~l~~L~~L~L~~N~i~  156 (869)
                      -   ...+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            0   112333344555555  44544422    2345555677778888777764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=1.4e-08  Score=97.84  Aligned_cols=124  Identities=16%  Similarity=0.120  Sum_probs=64.5

Q ss_pred             ccccCCCCCCEEeCcCc-ccCcc----CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceecccc
Q 002897           64 DTLGQLRKLIYLNIGRN-QFSGF----IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS  138 (869)
Q Consensus        64 ~~~~~l~~L~~L~L~~n-~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~  138 (869)
                      ..+...++|++|+|++| .|...    +...+...++|++|+|++|.+...-. .                    .+...
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~-~--------------------~l~~~   88 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVA-F--------------------ALAEM   88 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHH-H--------------------HHHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHH-H--------------------HHHHH
Confidence            44556677777777777 66532    23344555666667766666641100 0                    12233


Q ss_pred             ccCCCCCcEEEccCCcccccc----CcCccCCCCCCEEEc--cCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          139 LSNASNLELLELRDNQFIGKM----SINFNSLKNLSVLIL--GNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       139 l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l--~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      +...++|++|+|++|.|....    ...+...++|++|+|  ++|.|+.....  .+...+...++|++|+|++|.+.
T Consensus        89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~--~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--EIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--HHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH--HHHHHHHhCCCcCEEeccCCCCC
Confidence            444556666666666665321    233444455555555  55555443321  23334445555555555555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.48  E-value=1e-07  Score=96.42  Aligned_cols=96  Identities=18%  Similarity=0.223  Sum_probs=73.8

Q ss_pred             cccCCCcccccCChh---hhhccCCcCEEeccCCcCcc--ccCcccccCcCCCEEEccCCccCccCCccccCCC--CCCE
Q 002897            2 FDAQNNKLVGDIPVE---IGCYLFKLENLSLAENHLTG--QLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLR--KLIY   74 (869)
Q Consensus         2 l~l~~~~~~~~ip~~---~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~--~L~~   74 (869)
                      ++++.|+.. .++..   +...+++|+.|+|++|+|++  .+|..+..+++|++|+|++|+|++.  ..+..++  +|++
T Consensus       148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~  224 (267)
T 3rw6_A          148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE  224 (267)
T ss_dssp             CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred             ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence            456667555 55542   23468899999999999997  4457788999999999999999964  3455555  9999


Q ss_pred             EeCcCcccCccCCc-------ccccCCCCcEEE
Q 002897           75 LNIGRNQFSGFIPP-------SIYNISSFEFIF  100 (869)
Q Consensus        75 L~L~~n~i~~~~p~-------~~~~l~~L~~L~  100 (869)
                      |+|++|.+.+..|.       .+..+++|+.||
T Consensus       225 L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          225 LWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             EECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             EEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            99999999876652       366788888775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=1e-06  Score=90.94  Aligned_cols=135  Identities=18%  Similarity=0.099  Sum_probs=99.8

Q ss_pred             eeeeecce-EEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEEEEeecc
Q 002897          561 MVGQGSFG-TVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKAIVYDFM  638 (869)
Q Consensus       561 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~  638 (869)
                      .+..|..+ .||+......+..+++|+-...   ....+.+|+.+++.+. +--+.++++++.+.     +..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence            45556655 6999888777888999986532   3456788999998884 33466778876543     6789999999


Q ss_pred             cCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 002897          639 QNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC------------------------------------  682 (869)
Q Consensus       639 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  682 (869)
                      +|.++.+......          .....++.++++.++.||+..                                    
T Consensus       103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9998887765432          233456777778888888531                                    


Q ss_pred             -------------------CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          683 -------------------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       683 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                         .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                               1237999999999999987777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2.5e-06  Score=89.55  Aligned_cols=136  Identities=18%  Similarity=0.144  Sum_probs=95.0

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCC---ccceEEEEeeccccCCCceEEEEe
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR---NLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      .+.++.|....||+.     |..+++|+...  ......+.+|+++++.+.+.   .+.+++.+...    ..+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            356888888899987     46688888532  23456789999999999642   35566666532    235568999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH----------------------------------  681 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------  681 (869)
                      ||++|.++.+....        .++..+...++.++++.|+.||+.                                  
T Consensus        93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            99999888763221        144555556666666666666643                                  


Q ss_pred             -----------------------CCCCeEecCCCCCceeecC---CCc-EEEccccccc
Q 002897          682 -----------------------CKPPVVHGDLKPSNVLLDH---DMV-AHVGDFGLAK  713 (869)
Q Consensus       682 -----------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfg~a~  713 (869)
                                             ..+.++|+|++|.||+++.   ++. +.|+||+.+.
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                   1235799999999999987   455 4899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.03  E-value=8.9e-06  Score=87.54  Aligned_cols=83  Identities=10%  Similarity=0.005  Sum_probs=55.0

Q ss_pred             Cee-eeecceEEEEEEEC--C----CCeEEEEEEeeccc---chhhHHHHHHHHHHHhCC-C--CccceEEEEeeccccC
Q 002897          560 NMV-GQGSFGTVFKGIIG--E----NGMLVAVKVLNLMQ---KGALKSFLTECEALRSIR-H--RNLIKIITICSSIDFN  626 (869)
Q Consensus       560 ~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~  626 (869)
                      +.| +.|....+|++...  .    +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+... 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~-  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV-  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence            567 78888999998762  0    16789999875432   101245788999888883 3  357778887644311 


Q ss_pred             CCceEEEEeecccCCCHH
Q 002897          627 GVDFKAIVYDFMQNGSLE  644 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~  644 (869)
                       ....++||||++|.++.
T Consensus       105 -~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 -LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             -TSSCEEEEECCCCBCCC
T ss_pred             -cCCceEEEEecCCCChh
Confidence             13467999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=2e-05  Score=86.07  Aligned_cols=76  Identities=14%  Similarity=0.107  Sum_probs=49.3

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccc-------hhhHHHHHHHHHHHhCCC--C-ccceEEEEeeccccCCC
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-------GALKSFLTECEALRSIRH--R-NLIKIITICSSIDFNGV  628 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~  628 (869)
                      .+.+|.|.++.||++....+++.++||.......       ....++..|+++++.+..  + .+.+++.+..       
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~-------  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC-------
Confidence            4578999999999997655678999998643211       123566889999888732  3 3445655421       


Q ss_pred             ceEEEEeecccCC
Q 002897          629 DFKAIVYDFMQNG  641 (869)
Q Consensus       629 ~~~~lv~e~~~~g  641 (869)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            3357999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.89  E-value=4.3e-05  Score=79.30  Aligned_cols=78  Identities=13%  Similarity=0.135  Sum_probs=57.0

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-C--CccceEEEEeeccccCCCceE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-H--RNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +...++.+|.|..+.||+++.. +|+.|++|+...........+..|++.|+.+. .  --+.+++++         +..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence            3444578999999999999985 89999999875444433456789999998884 2  235566665         234


Q ss_pred             EEEeecccCCC
Q 002897          632 AIVYDFMQNGS  642 (869)
Q Consensus       632 ~lv~e~~~~gs  642 (869)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            78999998764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.76  E-value=6.1e-06  Score=77.09  Aligned_cols=34  Identities=12%  Similarity=-0.023  Sum_probs=14.6

Q ss_pred             CCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           71 KLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        71 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      +|+.|||++|.|+..--..+.++++|++|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            3444444444444322233344444444444444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.75  E-value=6.1e-06  Score=77.05  Aligned_cols=84  Identities=15%  Similarity=0.110  Sum_probs=61.4

Q ss_pred             ccccccccccccccccCCccccCCCCCcEEEeeCcc-ccCCCCcccccc----ccccEEEccCCc-ccCCCccccccccc
Q 002897          367 KNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNS-FSGSIPPSLNFL----KSIKVLDLSSNK-LSGQIPKYLENLSF  440 (869)
Q Consensus       367 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~  440 (869)
                      .+|+.|||+++.+++.--..+.+|++|+.|+|++|. +++..-..+..+    ++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            468888888888876656667888899999999885 654333345443    368899998874 76443456777888


Q ss_pred             cCeecccccc
Q 002897          441 LEYLNLSYNH  450 (869)
Q Consensus       441 L~~l~l~~N~  450 (869)
                      |++|++++++
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            9999988875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00022  Score=74.17  Aligned_cols=141  Identities=18%  Similarity=0.155  Sum_probs=90.7

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC---CCccceEEEEeeccccCCCceEEEEe
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR---HRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      .+.++.|....+|+...  +++.+++|+....   ....+..|++.++.+.   ...+.++++++...     +..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence            35789999999999986  5778889987542   3467889999988883   35678888875432     5689999


Q ss_pred             ecccCCCHH-----------HHHhhCCC--ccc--------------ccCCCHHHHH---HHHH----------------
Q 002897          636 DFMQNGSLE-----------EWLHQNND--KLE--------------VCNLSLIQTL---NIAI----------------  669 (869)
Q Consensus       636 e~~~~gsL~-----------~~l~~~~~--~~~--------------~~~l~~~~~~---~i~~----------------  669 (869)
                      ||+++..+.           ..++....  ...              ...-+|....   ++..                
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            999987642           12333221  000              0012454322   1111                


Q ss_pred             HHHHH-HHHHHh-cCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          670 DVASA-IEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       670 ~i~~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++. ...|.. ...+.++|+|+.+.|++++.++ +.|+|++
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11111 123321 2256899999999999999887 8899984

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.00036  Score=74.33  Aligned_cols=148  Identities=17%  Similarity=0.096  Sum_probs=79.4

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC--CCccceEEEEeeccc-cCCCceEEEEee
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR--HRNLIKIITICSSID-FNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~-~~~~~~~~lv~e  636 (869)
                      +.++.|..+.||++...  +..+++|+....    ......|+.+++.+.  .-.+.+++....... ....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34666778999999873  445899998642    133445666665552  112333333110000 011356789999


Q ss_pred             cccCCCHH--------------HHHhhCCCcc----c----ccCCCHHH-------------------------------
Q 002897          637 FMQNGSLE--------------EWLHQNNDKL----E----VCNLSLIQ-------------------------------  663 (869)
Q Consensus       637 ~~~~gsL~--------------~~l~~~~~~~----~----~~~l~~~~-------------------------------  663 (869)
                      |++|.++.              ..++......    .    ...-.|..                               
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1122111000    0    00012211                               


Q ss_pred             HHHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          664 TLNIAIDVASAIEYLHH----------HCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       664 ~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ...+..++..++++|++          ...+.++|+|+++.||+++.++.+.++||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11112234456667763          124589999999999999888899999999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.52  E-value=1.2e-05  Score=76.51  Aligned_cols=69  Identities=12%  Similarity=0.136  Sum_probs=38.9

Q ss_pred             ccccCCCCCcEEEccCCccccccCcCc----cCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCC
Q 002897          137 ISLSNASNLELLELRDNQFIGKMSINF----NSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDN  207 (869)
Q Consensus       137 ~~l~~l~~L~~L~L~~N~i~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n  207 (869)
                      .++...+.|+.|+|++|+|.......+    ..-+.|++|+|++|.|+..+..  .+..++...+.|++|+|++|
T Consensus        64 ~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~--ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           64 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA--RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--HHHHHTTTTCCCSEEECCCC
T ss_pred             HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH--HHHHHHhhCCceeEEECCCC
Confidence            455555666666666666654333332    2345666666666666554432  34445666666666666654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.48  E-value=1.6e-05  Score=75.70  Aligned_cols=78  Identities=12%  Similarity=0.158  Sum_probs=51.6

Q ss_pred             cccccCCCCCcEEEccCC-ccccc----cCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          136 PISLSNASNLELLELRDN-QFIGK----MSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       136 ~~~l~~l~~L~~L~L~~N-~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      ...+.+.+.|+.|+|++| +|...    +...+..-+.|+.|+|++|.|++....  .++.++...+.|++|+|++|+|+
T Consensus        34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~--alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR--GLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT--THHHHHHHCSSCCEEECCSSBCC
T ss_pred             HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHH--HHHHHHhcCCccCeEecCCCcCC
Confidence            345566678888888875 66432    233455667788888888888766544  45566677777788888877777


Q ss_pred             CCCCh
Q 002897          211 GLLPH  215 (869)
Q Consensus       211 ~~~~~  215 (869)
                      .....
T Consensus       112 ~~Ga~  116 (197)
T 1pgv_A          112 PELLA  116 (197)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            54333

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.36  E-value=0.00052  Score=75.34  Aligned_cols=78  Identities=17%  Similarity=0.226  Sum_probs=47.1

Q ss_pred             CCCeEecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccC--cccccCCcccCCC---CCCccccch
Q 002897          683 KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG--TVGYIAPEYGTGS---EASMTGDVY  757 (869)
Q Consensus       683 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvw  757 (869)
                      .+.++|||++|.||+++.++ ++++||+.+..-+....         .....+  ...|++|+.....   ......++.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---------la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---------IGAYLGNLILAFFAQDGHATQENDRKEYKQWIL  300 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---------HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---------HHHHHHHHHHHHHhcccccccccchHHHHHHHH
Confidence            34899999999999998876 99999998864321100         000000  1346666654311   112234556


Q ss_pred             hhhHHHHHHHcCC
Q 002897          758 SFGILLLEMFSRR  770 (869)
Q Consensus       758 slG~il~el~tg~  770 (869)
                      +....+|+.++++
T Consensus       301 ~~~~~~~~~y~~~  313 (420)
T 2pyw_A          301 RTIEQTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            7777888777653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.15  E-value=0.00032  Score=62.41  Aligned_cols=57  Identities=23%  Similarity=0.310  Sum_probs=42.0

Q ss_pred             CEEeccCCcCc-cccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccC
Q 002897           25 ENLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS   83 (869)
Q Consensus        25 ~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~   83 (869)
                      ..++.++++++ ..+|..+.  .+|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            46777888876 34554332  36888888888888777777888888888888888765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.11  E-value=0.0014  Score=68.20  Aligned_cols=71  Identities=10%  Similarity=0.080  Sum_probs=44.6

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCcc-ceEEEEeeccccCCCceEEEEeec
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL-IKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .+.|+.|....+|++      +.+++|+....... ......|+.+++.+....+ .+++++..       +..++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEee
Confidence            678999999999998      45889987543221 1223568888877732222 45665522       224689999


Q ss_pred             c-cCCCH
Q 002897          638 M-QNGSL  643 (869)
Q Consensus       638 ~-~~gsL  643 (869)
                      + ++.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 65444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.08  E-value=0.0043  Score=65.17  Aligned_cols=168  Identities=14%  Similarity=0.121  Sum_probs=89.4

Q ss_pred             CcccHHHHHHHhcCCCCC-----CeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCc--cc
Q 002897          542 PMISYAKLSKATSEFSSS-----NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN--LI  614 (869)
Q Consensus       542 ~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  614 (869)
                      +.++.+++.....+|...     +.++.|....+|++... +| .+++|+....  .....+..|+.+++.+....  +.
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            345666677666677653     34566888899999874 34 6889988642  12234567888777763212  23


Q ss_pred             eEEEEeeccc-cCCCceEEEEeecccCCCHH-----H---------HHhhCCCccccc---CC---CHHHHHH-------
Q 002897          615 KIITICSSID-FNGVDFKAIVYDFMQNGSLE-----E---------WLHQNNDKLEVC---NL---SLIQTLN-------  666 (869)
Q Consensus       615 ~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~~~~~~---~l---~~~~~~~-------  666 (869)
                      +++....... ....+..+++|+|++|..+.     .         .++.........   ..   .|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            3332110000 00124568999999886431     0         122111000000   01   1211100       


Q ss_pred             -----HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          667 -----IAIDVASAIEYLHHH----CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       667 -----i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                           +...+.+.++++++.    ...+++|+|+++.||+++.++.+.++||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 011244455666532    13479999999999999887666899999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.01  E-value=0.0018  Score=61.81  Aligned_cols=105  Identities=16%  Similarity=0.136  Sum_probs=70.0

Q ss_pred             CCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccCCCCC
Q 002897          640 NGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARP  719 (869)
Q Consensus       640 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  719 (869)
                      ..+|.+.+.....     +++++++|.++.|.+.+|.-.-.+.  .-..+=+.|..|++..+|.|...+ +.+.      
T Consensus        32 ~vSL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------   97 (229)
T ss_dssp             EEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred             cccHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------
Confidence            3489999988765     5999999999999999988763211  111233457899999999988764 2211      


Q ss_pred             CCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCC
Q 002897          720 LDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPT  773 (869)
Q Consensus       720 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf  773 (869)
                                    .....+.|||... ...+.+.=|||+|+++|..+--..|-
T Consensus        98 --------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 --------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             --------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                          0133466888764 34567888999999999999865553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.99  E-value=0.0017  Score=71.41  Aligned_cols=75  Identities=12%  Similarity=0.087  Sum_probs=48.3

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCcc-ceEEEEeeccccCCCceEEEEeec
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL-IKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .+.|+.|-...+|++.....++.+++|+........ -...+|..+++.+...++ .++++++.       +  ..||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-------~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-------N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-------T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-------C--eEEEEe
Confidence            357888889999999985435889999874332211 123689999998864444 46666642       1  259999


Q ss_pred             ccCCCH
Q 002897          638 MQNGSL  643 (869)
Q Consensus       638 ~~~gsL  643 (869)
                      ++|.++
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.98  E-value=0.0047  Score=65.11  Aligned_cols=166  Identities=15%  Similarity=0.114  Sum_probs=89.6

Q ss_pred             CCcccHHHHHHHhcCCCC-----CCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCC--cc
Q 002897          541 FPMISYAKLSKATSEFSS-----SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHR--NL  613 (869)
Q Consensus       541 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni  613 (869)
                      ++.++.+.+......|.+     ...++ |....||++... +|+.+++|+..... .....+..|..+++.+...  .+
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence            344555666655555533     23466 888899988764 57789999986321 1235667788888777321  23


Q ss_pred             ceEEEEeeccc--cCCCceEEEEeecccCCCHH-----HH---------HhhCC---CcccccCCCHHHH----HH----
Q 002897          614 IKIITICSSID--FNGVDFKAIVYDFMQNGSLE-----EW---------LHQNN---DKLEVCNLSLIQT----LN----  666 (869)
Q Consensus       614 v~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~~---~~~~~~~l~~~~~----~~----  666 (869)
                      .+++..  +..  ....+..+++|+|++|.++.     .+         ++...   ........++...    ..    
T Consensus        85 p~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (328)
T 1zyl_A           85 AAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED  162 (328)
T ss_dssp             CCCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred             cceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence            444432  110  01124567899999875431     11         11110   0000001222111    00    


Q ss_pred             -----------HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          667 -----------IAIDVASAIEYLHHH----CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       667 -----------i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                 +...+...++.+.+.    ..+.++|||+++.||+++ + .+.++||+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                       111111223333221    234689999999999998 4 89999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.96  E-value=0.0059  Score=64.47  Aligned_cols=144  Identities=11%  Similarity=0.033  Sum_probs=73.9

Q ss_pred             CeeeeecceE-EEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCceEEEEee
Q 002897          560 NMVGQGSFGT-VFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVDFKAIVYD  636 (869)
Q Consensus       560 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e  636 (869)
                      +.++.|.... +|+.... +|+.+++|.......   ..+..|+.+++.+.  .-.+.+++.+...      . .+++||
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~------~-g~ll~e   92 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA------R-GLLLIE   92 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT------T-TEEEEC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC------C-CEEEEe
Confidence            4566665554 6677642 367788886543221   23455677777663  2235566665321      1 268999


Q ss_pred             cccCCCHHHHHhhCCCc--------------------ccccCCCHHHHH-------H-------------HHHHHHHHHH
Q 002897          637 FMQNGSLEEWLHQNNDK--------------------LEVCNLSLIQTL-------N-------------IAIDVASAIE  676 (869)
Q Consensus       637 ~~~~gsL~~~l~~~~~~--------------------~~~~~l~~~~~~-------~-------------i~~~i~~~L~  676 (869)
                      ++.+.++.+++......                    .....++.....       .             ....+...++
T Consensus        93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~  172 (333)
T 3csv_A           93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA  172 (333)
T ss_dssp             CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred             eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            99877776655432110                    000011111100       0             0011112222


Q ss_pred             HHHh---cCCCCeEecCCCCCceeecCC----CcEEEcccccccc
Q 002897          677 YLHH---HCKPPVVHGDLKPSNVLLDHD----MVAHVGDFGLAKF  714 (869)
Q Consensus       677 ~LH~---~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  714 (869)
                      .+.+   ...+.++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            2211   123479999999999999875    6899999998863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.96  E-value=0.0025  Score=68.16  Aligned_cols=145  Identities=11%  Similarity=0.122  Sum_probs=83.5

Q ss_pred             CCeeeeecceEEEEEEECC-------CCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCce
Q 002897          559 SNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .+.+..|-...+|++....       +++.+++|+..... .......+|.++++.+. +.-..++++++.       + 
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-------~-  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP-------E-  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-------T-
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC-------C-
Confidence            3567778889999998742       35789999863322 22355668999998884 333356666642       1 


Q ss_pred             EEEEeecccCCCHHH--------------H---HhhCCCcccccCC-CHHHHHHHHHHHHH-------------------
Q 002897          631 KAIVYDFMQNGSLEE--------------W---LHQNNDKLEVCNL-SLIQTLNIAIDVAS-------------------  673 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~--------------~---l~~~~~~~~~~~l-~~~~~~~i~~~i~~-------------------  673 (869)
                       .+||||++|.++..              .   ++.........+. -+.++.++..++..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             28999998865431              0   1111110001111 23455555544422                   


Q ss_pred             HHHHHHh----c-CCCCeEecCCCCCceeecCC----CcEEEccccccc
Q 002897          674 AIEYLHH----H-CKPPVVHGDLKPSNVLLDHD----MVAHVGDFGLAK  713 (869)
Q Consensus       674 ~L~~LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~  713 (869)
                      .++.|.+    . ....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2333322    1 13468999999999999876    789999999885

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.88  E-value=0.0019  Score=57.39  Aligned_cols=57  Identities=14%  Similarity=0.255  Sum_probs=47.6

Q ss_pred             CEEEccCCccC-ccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCc
Q 002897           49 QVIDIRGNRLG-GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        49 ~~L~L~~n~i~-~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      ..++.+++.++ ..+|..+.  .+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47899999987 35565443  47999999999999888888999999999999999886

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.55  E-value=0.0035  Score=67.38  Aligned_cols=73  Identities=10%  Similarity=0.130  Sum_probs=43.9

Q ss_pred             CeeeeecceEEEEEEECC--------CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCc-cceEEEEeeccccCCCce
Q 002897          560 NMVGQGSFGTVFKGIIGE--------NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN-LIKIITICSSIDFNGVDF  630 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  630 (869)
                      +.++.|....+|++....        .++.+++|+....... ......|.++++.+...+ +.++++..         .
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---------~  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---------N  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---------C
Confidence            467788889999998742        1368899987543221 123467888888874323 44666542         1


Q ss_pred             EEEEeecccCCC
Q 002897          631 KAIVYDFMQNGS  642 (869)
Q Consensus       631 ~~lv~e~~~~gs  642 (869)
                      .++||||++|.+
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            268999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.52  E-value=0.011  Score=64.73  Aligned_cols=74  Identities=15%  Similarity=0.155  Sum_probs=49.1

Q ss_pred             CCeeeeecceEEEEEEECC-------CCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCc-cceEEEEeeccccCCCce
Q 002897          559 SNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN-LIKIITICSSIDFNGVDF  630 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  630 (869)
                      .+.|+.|....||++....       +++.+++|+.....  ....+..|+.+++.+...+ ..++++.+.       + 
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-------~-  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS-------G-  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-------T-
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-------C-
Confidence            3568888889999998752       25789999884321  1144557999988884333 356666532       1 


Q ss_pred             EEEEeecccCCCH
Q 002897          631 KAIVYDFMQNGSL  643 (869)
Q Consensus       631 ~~lv~e~~~~gsL  643 (869)
                       .+|+||++|.++
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             289999986443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.29  E-value=0.013  Score=61.78  Aligned_cols=31  Identities=19%  Similarity=0.305  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          684 PPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       684 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.99  E-value=0.026  Score=61.13  Aligned_cols=74  Identities=12%  Similarity=0.102  Sum_probs=48.1

Q ss_pred             CeeeeecceEEEEEEECCC-------CeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceE
Q 002897          560 NMVGQGSFGTVFKGIIGEN-------GMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +.+..|-...+|++.....       ++.+++|+...... ..-...+|..+++.+. +.-..++++.+.         -
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~---------~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP---------E  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------T
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------C
Confidence            4677788889999987521       67899998744322 2223467888888874 333455665421         2


Q ss_pred             EEEeecccCCCH
Q 002897          632 AIVYDFMQNGSL  643 (869)
Q Consensus       632 ~lv~e~~~~gsL  643 (869)
                      +.||||++|.++
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.75  E-value=0.25  Score=53.31  Aligned_cols=28  Identities=25%  Similarity=0.377  Sum_probs=24.3

Q ss_pred             eEecCCCCCceee------cCCCcEEEccccccc
Q 002897          686 VVHGDLKPSNVLL------DHDMVAHVGDFGLAK  713 (869)
Q Consensus       686 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~  713 (869)
                      ++|+|+.+.||++      +++..++++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456689999999885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	869
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-45
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-26
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-11
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	6e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	7e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-56
 Identities = 71/306 (23%), Positives = 125/306 (40%), Gaps = 51/306 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHR 611
            + +    +G GSFGTV+KG    +   VAVK+LN+       L++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
           N++  +   ++         AIV  + +  SL   LH    K       +I+ ++IA   
Sbjct: 65  NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKF-----EMIKLIDIARQT 113

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
           A  ++YLH      ++H DLK +N+ L  D+   +GDFGLA                   
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR------WSGSHQFE 164

Query: 732 GIKGTVGYIAPEYGTGSEA---SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G++ ++APE     +    S   DVY+FGI+L E+ + + P  ++ +    +    +
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
             L   + ++                          C  A+ R+   C  +   +R    
Sbjct: 225 GYLSPDLSKVRS-----------------------NCPKAMKRLMAECLKKKRDERPLFP 261

Query: 849 DVVVKL 854
            ++  +
Sbjct: 262 QILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 7e-52
 Identities = 72/323 (22%), Positives = 137/323 (42%), Gaps = 56/323 (17%)

Query: 545 SYAKLSKATSEFSSS---------NMVGQGSFGTVFKGII---GENGMLVAVKVLNL-MQ 591
           ++   ++A  EF+            ++G G FG V  G +   G+  + VA+K L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 592 KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN 651
           +   + FL+E   +    H N+I +  + +           I+ +FM+NGSL+ +L QN+
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQND 122

Query: 652 DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL 711
                   ++IQ + +   +A+ ++YL        VH DL   N+L++ ++V  V DFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR 771
           ++FL     DT   T +S+ G K  + + APE     + +   DV+S+GI++ E+ S   
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

Query: 772 PTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIR 831
                 +  +T  +    +  +  +                           +C  A+ +
Sbjct: 232 R----PYWDMTNQDVINAIEQDYRLPP-----------------------PMDCPSALHQ 264

Query: 832 IGVVCSMESPTDRMQMRDVVVKL 854
           + + C  +    R +   +V  L
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTL 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-50
 Identities = 54/242 (22%), Positives = 103/242 (42%), Gaps = 24/242 (9%)

Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRS 607
           +     +F   + +G G+ G VFK     +G+++A K+++L ++       + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
                ++       S         +I  + M  GSL++ L +         +       +
Sbjct: 61  CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
           +I V   + YL    K  ++H D+KPSN+L++      + DFG++  L     ++ V   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 164

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
                  GT  Y++PE   G+  S+  D++S G+ L+EM   R P      + L L    
Sbjct: 165 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

Query: 788 KM 789
           ++
Sbjct: 218 QV 219

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 3e-50
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 22/245 (8%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+GSF TV+KG+  E  + VA   L    + K   + F  E E L+ ++H N+++    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S    G     +V + M +G+L+ +L +         + +    +    +   +++LH
Sbjct: 77  WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129

Query: 680 HHCKPPVVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
               PP++H DLK  N+ +        +GD GLA    A     V+          GT  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------GTPE 178

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI 798
           ++APE     +   + DVY+FG+ +LEM +   P     +        +  V P    ++
Sbjct: 179 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 799 VDPSL 803
             P +
Sbjct: 238 AIPEV 242

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-50
 Identities = 62/307 (20%), Positives = 119/307 (38%), Gaps = 52/307 (16%)

Query: 563 GQGSFGTVFKGI--IGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           G G+FG+V +G+  + +  + VA+KVL    +K   +  + E + +  + +  ++++I +
Sbjct: 18  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
           C +          +V +    G L ++L    +++      +     +   V+  ++YL 
Sbjct: 78  CQAEAL------MLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYLE 126

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                  VH DL   NVLL +   A + DFGL+K L A          ++ S  K  + +
Sbjct: 127 EK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKW 178

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIV 799
            APE     + S   DV+S+G+ + E  S  +      ++ +   E    +   K ME  
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKGPEVMAFIEQGKRMEC- 233

Query: 800 DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE 859
                                   EC   +  +   C +    DR     V  ++   R 
Sbjct: 234 ----------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM---RA 268

Query: 860 AFVSMQD 866
            + S+  
Sbjct: 269 CYYSLAS 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-49
 Identities = 63/306 (20%), Positives = 120/306 (39%), Gaps = 37/306 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA--LRSIRHRNLIKIITI 619
           +G+G FG V++G     G  VAVK+ +  ++   +S+  E E      +RH N++  I  
Sbjct: 11  IGKGRFGEVWRGK--WRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +  +        +V D+ ++GSL ++L++         +++   + +A+  AS + +LH
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 117

Query: 680 HHC-----KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
                   KP + H DLK  N+L+  +    + D GLA    +      +    + +   
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRV 173

Query: 735 GTVGYIAPEYGTGSEASMTG------DVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
           GT  Y+APE    S            D+Y+ G++  E+  R                +  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYD 230

Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           +V  +  +E     +   V           R +  E L  + +I   C   +   R+   
Sbjct: 231 LVPSDPSVEE----MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286

Query: 849 DVVVKL 854
            +   L
Sbjct: 287 RIKKTL 292

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-49
 Identities = 67/309 (21%), Positives = 125/309 (40%), Gaps = 47/309 (15%)

Query: 559 SNMVGQGSFGTVFKGIIGEN---GMLVAVKVLN-LMQKGALKSFLTECEALRSIRHRNLI 614
           + ++G+G FG V+ G + +N    +  AVK LN +   G +  FLTE   ++   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++ IC   + +      +V  +M++G L  ++        V        +   + VA  
Sbjct: 92  SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKG 142

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
              +        VH DL   N +LD      V DFGLA+ +  +  D+V     + +G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----HNKTGAK 195

Query: 735 GTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
             V ++A E     + +   DV+SFG+LL E+ +R  P     +  +   + +  +L   
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL--- 248

Query: 795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
                               +G   ++ E C   +  + + C       R    ++V ++
Sbjct: 249 --------------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

Query: 855 CAAREAFVS 863
            A    F+ 
Sbjct: 289 SAIFSTFIG 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 6e-49
 Identities = 65/301 (21%), Positives = 125/301 (41%), Gaps = 49/301 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
                   +G G FG V+ G        VAVK L      +  +FL E   ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +++  + +       +   I+ ++M+NGSL ++L   +       L++ + L++A  +A 
Sbjct: 71  VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + ++        +H DL+ +N+L+   +   + DFGLA+ +            ++  G 
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEYTAREGA 170

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           K  + + APE       ++  DV+SFGILL E+ +  R      + G+T  E  + +   
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQNLE-- 224

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
                                RG   V+ + C   + ++  +C  E P DR     +   
Sbjct: 225 ---------------------RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263

Query: 854 L 854
           L
Sbjct: 264 L 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 9e-49
 Identities = 69/321 (21%), Positives = 136/321 (42%), Gaps = 54/321 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII----GENGMLVAVKVLNL-MQKGALKSFLTECEALRSI 608
           S  +   ++G G FG V+KG++    G+  + VA+K L     +     FL E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            H N+I++  + S           I+ ++M+NG+L+++L + +        S++Q + + 
Sbjct: 67  SHHNIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
             +A+ +    +      VH DL   N+L++ ++V  V DFGL++ L   P  T      
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-----Y 168

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
           ++SG K  + + APE  +  + +   DV+SFGI++ E+ +                    
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------- 218

Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
                +VM+ ++    L                  +C  A+ ++ + C  +    R +  
Sbjct: 219 ---NHEVMKAINDGFRLP--------------TPMDCPSAIYQLMMQCWQQERARRPKFA 261

Query: 849 DVVVKLCAAREAFVSMQDGLR 869
           D+V  L    +  +   D L+
Sbjct: 262 DIVSIL----DKLIRAPDSLK 278

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-48
 Identities = 57/253 (22%), Positives = 102/253 (40%), Gaps = 23/253 (9%)

Query: 550 SKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRS 607
           S+A  ++     +G GS+G   K     +G ++  K L+   M +   +  ++E   LR 
Sbjct: 1   SRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           ++H N+++            +    IV ++ + G L   + +   + +   L     L +
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRV 114

Query: 668 AIDVASAIEYLHHH--CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVE 725
              +  A++  H        V+H DLKP+NV LD      +GDFGLA+ L          
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--------H 166

Query: 726 TPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHE 785
             S +    GT  Y++PE       +   D++S G LL E+ +   P         +  E
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKE 221

Query: 786 FSKMVLPEKVMEI 798
            +  +   K   I
Sbjct: 222 LAGKIREGKFRRI 234

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (433), Expect = 3e-48
 Identities = 71/310 (22%), Positives = 141/310 (45%), Gaps = 47/310 (15%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEA 604
           +Y K     ++ +  + +G G +G V++G+  +  + VAVK L       ++ FL E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 605 LRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQT 664
           ++ I+H NL++++ +C+           I+ +FM  G+L ++L + N +     +S +  
Sbjct: 67  MKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVL 117

Query: 665 LNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVV 724
           L +A  ++SA+EYL        +H DL   N L+  + +  V DFGL++ +         
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 167

Query: 725 ETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH 784
           +T ++ +G K  + + APE    ++ S+  DV++FG+LL E+ +         + G+ L 
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLS 223

Query: 785 EFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDR 844
           +         V E+++    +E              + E C   V  +   C   +P+DR
Sbjct: 224 Q---------VYELLEKDYRME--------------RPEGCPEKVYELMRACWQWNPSDR 260

Query: 845 MQMRDVVVKL 854
               ++    
Sbjct: 261 PSFAEIHQAF 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-47
 Identities = 78/301 (25%), Positives = 113/301 (37%), Gaps = 53/301 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            E      +G+G FG V  G     G  VAVK +        ++FL E   +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 62

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           ++++ +             IV ++M  GSL ++L      +    L     L  ++DV  
Sbjct: 63  VQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A+EYL  +     VH DL   NVL+  D VA V DFGL K              S+    
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTG 160

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           K  V + APE     + S   DV+SFGILL E++S  R      +  + L +    V   
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKG 216

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
             M+  D                        C  AV  +   C       R     +  +
Sbjct: 217 YKMDAPD-----------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

Query: 854 L 854
           L
Sbjct: 254 L 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 68/301 (22%), Positives = 124/301 (41%), Gaps = 49/301 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
                   +GQG FG V+ G        VA+K L      + ++FL E + ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +++  + S       +   IV ++M  GSL ++L     K         Q +++A  +AS
Sbjct: 75  VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G 
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGA 174

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           K  + + APE       ++  DV+SFGILL E+ ++ R      + G+            
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMV---------NR 221

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
           +V++ V+    +                  EC  ++  +   C  + P +R     +   
Sbjct: 222 EVLDQVERGYRMPCP--------------PECPESLHDLMCQCWRKEPEERPTFEYLQAF 267

Query: 854 L 854
           L
Sbjct: 268 L 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-47
 Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 51/299 (17%)

Query: 560 NMVGQGSFGTVFKGII--GENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIK 615
             +G G+FGTV KG     +    VAVK+L             L E   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +I IC        +   +V +  + G L ++L QN       ++     + +   V+  +
Sbjct: 73  MIGICE------AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           +YL        VH DL   NVLL     A + DFGL+K L A           + +  K 
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
            V + APE     + S   DV+SFG+L+ E FS  +      + G+   E + M+   + 
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMKGSEVTAMLEKGER 228

Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
           M                            C   +  +  +C      +R     V ++L
Sbjct: 229 MGC-----------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-45
 Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
           SE +    +G G FG V  G    N   VA+K +      + + F+ E E +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +++  +C            +V++FM++G L ++L            +    L + +DV  
Sbjct: 63  VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCE 112

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
               + +  +  V+H DL   N L+  + V  V DFG+ +F+         +  +SS+G 
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGT 162

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           K  V + +PE  + S  S   DV+SFG+L+ E+FS  +      +E  +  E  + +   
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDIS-- 216

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
               +  P L                         V +I   C  E P DR     ++ +
Sbjct: 217 TGFRLYKPRL---------------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

Query: 854 LCAAREA 860
           L    E+
Sbjct: 256 LAEIAES 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 63/334 (18%), Positives = 119/334 (35%), Gaps = 65/334 (19%)

Query: 545 SYAKLSKATSEFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVLNL-MQKGALKSF 598
               L    +       +G+G+FG VF+      +  E   +VAVK+L           F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 599 LTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN 658
             E   +    + N++K++ +C+           +++++M  G L E+L   +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 659 ------------------LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH 700
                             LS  + L IA  VA+ + YL        VH DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 701 DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFG 760
           +MV  + DFGL++ + +       +   +       + ++ PE    +  +   DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYSA------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229

Query: 761 ILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERV 820
           ++L E+FS         + G+   E    V    ++                        
Sbjct: 230 VVLWEIFSYGLQ----PYYGMAHEEVIYYVRDGNILACP--------------------- 264

Query: 821 KIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
             E C + +  +  +C  + P DR     +   L
Sbjct: 265 --ENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-45
 Identities = 65/328 (19%), Positives = 126/328 (38%), Gaps = 65/328 (19%)

Query: 541 FPMISYAKLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKS 597
           +P++ +       ++    +++G+G+FG V K  I ++G+ +   +  +     K   + 
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 598 FLTECEALRSI-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNN----- 651
           F  E E L  +  H N+I ++  C    +       +  ++  +G+L ++L ++      
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 652 -----DKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV 706
                       LS  Q L+ A DVA     + +  +   +H DL   N+L+  + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168

Query: 707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEM 766
            DFGL++           E     +  +  V ++A E    S  +   DV+S+G+LL E+
Sbjct: 169 ADFGLSRG---------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219

Query: 767 FSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECL 826
            S         + G+T  E  + +     +E                           C 
Sbjct: 220 VSLGGT----PYCGMTCAELYEKLPQGYRLEK-----------------------PLNCD 252

Query: 827 VAVIRIGVVCSMESPTDRMQMRDVVVKL 854
             V  +   C  E P +R     ++V L
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVSL 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-45
 Identities = 52/246 (21%), Positives = 97/246 (39%), Gaps = 28/246 (11%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F     +G+G FG V+     ++  ++A+KVL    L + G       E E    +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
            N++++                ++ ++   G++   L + +           +T     +
Sbjct: 66  PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITE 114

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +A+A+ Y H      V+H D+KP N+LL       + DFG +   P+    T+       
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------ 165

Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKM 789
               GT+ Y+ PE   G       D++S G+L  E    + P   + + E        + 
Sbjct: 166 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221

Query: 790 VLPEKV 795
             P+ V
Sbjct: 222 TFPDFV 227

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-44
 Identities = 68/306 (22%), Positives = 124/306 (40%), Gaps = 52/306 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNL-MQKGALKSFLTECEALRSI 608
           +EF    ++G G+FGTV+KG+    G    + VA+K L       A K  L E   + S+
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
            + ++ +++ IC +          ++   M  G L +++ ++ D     N+     LN  
Sbjct: 69  DNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWC 117

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
           + +A  + YL       +VH DL   NVL+       + DFGLAK L A       E   
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEY 168

Query: 729 SSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK 788
            + G K  + ++A E       +   DV+S+G+ + E+ +         ++G+   E S 
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISS 224

Query: 789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR 848
           ++   + +                            C + V  I V C M     R + R
Sbjct: 225 ILEKGERLPQ-----------------------PPICTIDVYMIMVKCWMIDADSRPKFR 261

Query: 849 DVVVKL 854
           +++++ 
Sbjct: 262 ELIIEF 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 31/246 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V+K    E  +L A KV++   +  L+ ++ E + L S  H N++K++    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
                  +   I+ +F   G+++  + +         L+  Q   +      A+ YLH +
Sbjct: 80  Y-----ENNLWILIEFCAGGAVDAVMLELERP-----LTESQIQVVCKQTLDALNYLHDN 129

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIA 741
               ++H DLK  N+L   D    + DFG++             T        GT  ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------RTIQRRDSFIGTPYWMA 178

Query: 742 PEY-----GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
           PE                DV+S GI L+EM     P     H  L        +   +  
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAKSEPP 233

Query: 797 EIVDPS 802
            +  PS
Sbjct: 234 TLAQPS 239

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 8e-44
 Identities = 58/302 (19%), Positives = 105/302 (34%), Gaps = 59/302 (19%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL---MQKGALKSFLTECEALRSIRHRN 612
           FS    +G GSFG V+      N  +VA+K ++          +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
            I+                 +V ++    + +              L  ++   +     
Sbjct: 77  TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSG 732
             + YLH H    ++H D+K  N+LL    +  +GDFG A  +            + ++ 
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170

Query: 733 IKGTVGYIAPEYGTGS---EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM 789
             GT  ++APE        +     DV+S GI  +E+  R+ P          L   + M
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LFNMNAM 220

Query: 790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRD 849
                + +   P+L      +   S       ++ CL            + P DR     
Sbjct: 221 SALYHIAQNESPALQ-----SGHWSEYFRNF-VDSCLQ-----------KIPQDRPTSEV 263

Query: 850 VV 851
           ++
Sbjct: 264 LL 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-43
 Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 49/301 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNL 613
            + +    +G G FG V  G        VA+K++      +   F+ E + + ++ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +++  +C+           I+ ++M NG L  +L +   +         Q L +  DV  
Sbjct: 62  VQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCE 111

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
           A+EYL        +H DL   N L++   V  V DFGL++++            +SS G 
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGS 161

Query: 734 KGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
           K  V +  PE    S+ S   D+++FG+L+ E++S  +      +E  T  E ++ +   
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM----PYERFTNSETAEHIA-- 215

Query: 794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK 853
           + + +  P L  E                      V  I   C  E   +R   + ++  
Sbjct: 216 QGLRLYRPHLASE---------------------KVYTIMYSCWHEKADERPTFKILLSN 254

Query: 854 L 854
           +
Sbjct: 255 I 255

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITI 619
             +GQG+ GTV+  +    G  VA++ +NL Q+   +  + E   +R  ++ N++  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
                    D   +V +++  GSL + + +             Q   +  +   A+E+LH
Sbjct: 86  YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
            +    V+H D+K  N+LL  D    + DFG    +            S  S + GT  +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--------PEQSKRSTMVGTPYW 182

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +APE  T        D++S GI+ +EM     P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-43
 Identities = 57/325 (17%), Positives = 111/325 (34%), Gaps = 64/325 (19%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNL-MQKGALKSFLTECEALRS 607
                  ++G G+FG V              + VAVK+L         ++ ++E + +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 608 I-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------ 654
           +  H N++ ++  C+           +++++   G L  +L    +K             
Sbjct: 97  LGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 655 -----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF 709
                ++  L+    L  A  VA  +E+L        VH DL   NVL+ H  V  + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208

Query: 710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR 769
           GLA+ + +                +  V ++APE       ++  DV+S+GILL E+FS 
Sbjct: 209 GLARDIMSD------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 770 RRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAV 829
                           +  + +     +++     ++              +       +
Sbjct: 263 GVNP------------YPGIPVDANFYKLIQNGFKMD--------------QPFYATEEI 296

Query: 830 IRIGVVCSMESPTDRMQMRDVVVKL 854
             I   C       R    ++   L
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-43
 Identities = 48/252 (19%), Positives = 95/252 (37%), Gaps = 22/252 (8%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNL 613
           ++     +G+G++G V   +       VAVK++++       ++   E    + + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K        +      + +  ++   G L + +  +        +           + +
Sbjct: 66  VKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMA 114

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + YLH      + H D+KP N+LLD      + DFGLA                  + +
Sbjct: 115 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNKM 165

Query: 734 KGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP 792
            GT+ Y+APE     E  +   DV+S GI+L  M +   P D          ++ +    
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225

Query: 793 EKVMEIVDPSLL 804
               + +D + L
Sbjct: 226 LNPWKKIDSAPL 237

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 8e-43
 Identities = 74/304 (24%), Positives = 112/304 (36%), Gaps = 53/304 (17%)

Query: 562 VGQGSFGTVFKGII---GENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIK 615
           +G GSFG V +G         + VAVK L    L Q  A+  F+ E  A+ S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          +V +    GSL + L ++          L      A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEGM 124

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
            YL        +H DL   N+LL    +  +GDFGL + LP        +        K 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKV 176

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKV 795
              + APE       S   D + FG+ L EMF+  +        GL   +    +     
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE----PWIGLNGSQILHKID---- 228

Query: 796 MEIVDPSLLLEVRANNSMSRGGERVKI-EECLVAVIRIGVVCSMESPTDRMQMRDVVVKL 854
                              + GER+   E+C   +  + V C    P DR     +   L
Sbjct: 229 -------------------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

Query: 855 CAAR 858
             A+
Sbjct: 270 LEAQ 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 60/320 (18%), Positives = 109/320 (34%), Gaps = 59/320 (18%)

Query: 554 SEFSSSNMVGQGSFGTVFKG-----IIGENGMLVAVKVLNL-MQKGALKSFLTECEALRS 607
           +  S    +G G+FG V +      I  +  M VAVK+L         ++ ++E + L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 608 I-RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------ 654
           +  H N++ ++  C+           ++ ++   G L  +L +  D              
Sbjct: 83  LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 655 EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF 714
           +   L L   L+ +  VA  + +L        +H DL   N+LL H  +  + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD 774
           +                  +  V ++APE       +   DV+S+GI L E+FS      
Sbjct: 195 IKND------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGV 834
                              K  +++     +                 E     +  I  
Sbjct: 249 PGMPV------------DSKFYKMIKEGFRML--------------SPEHAPAEMYDIMK 282

Query: 835 VCSMESPTDRMQMRDVVVKL 854
            C    P  R   + +V  +
Sbjct: 283 TCWDADPLKRPTFKQIVQLI 302

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 56/311 (18%), Positives = 121/311 (38%), Gaps = 51/311 (16%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNL-MQKGALKSFLTECEALRS 607
            + + S  +GQGSFG V++G+       E    VA+K +N          FL E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLE----VCNLSLIQ 663
               ++++++ + S           ++ + M  G L+ +L      +     +   SL +
Sbjct: 80  FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 664 TLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTV 723
            + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ + +        
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----- 186

Query: 724 VETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL 783
            +           V +++PE       +   DV+SFG++L E+ +         ++GL+ 
Sbjct: 187 -DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241

Query: 784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTD 843
            +  + V+   +++  D                        C   +  +  +C   +P  
Sbjct: 242 EQVLRFVMEGGLLDKPD-----------------------NCPDMLFELMRMCWQYNPKM 278

Query: 844 RMQMRDVVVKL 854
           R    +++  +
Sbjct: 279 RPSFLEIISSI 289

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 551 KATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRS 607
           K   +F    ++G+GSF TV            A+K+L    ++++  +     E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNI 667
           + H   +K+            +       + +NG L +++ +        +     T   
Sbjct: 65  LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113

Query: 668 AIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETP 727
             ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK L            
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQ 164

Query: 728 SSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           + ++   GT  Y++PE  T   A  + D+++ G ++ ++ +   P
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 47/213 (22%), Positives = 82/213 (38%), Gaps = 24/213 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V +      G   A K +    +   ++   E + +  +RH  L+ +     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
                  +   ++Y+FM  G L E +   ++K     +S  + +     V   + ++H +
Sbjct: 94  DD-----NEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHEN 143

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                VH DLKP N++        +   DFGL   L         +   S     GT  +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---------DPKQSVKVTTGTAEF 191

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            APE   G       D++S G+L   + S   P
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-39
 Identities = 55/303 (18%), Positives = 111/303 (36%), Gaps = 52/303 (17%)

Query: 561 MVGQGSFGTVFKGII---GENGMLVAVKVLNLMQK-GALKSFLTECEALRSIRHRNLIKI 616
            +G+G FG V +GI        + VA+K           + FL E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 617 ITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           I + +       +   I+ +    G L  +L          +L L   +  A  +++A  
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
            L +      VH D+   NVL+  +    +GDFGL++++          T   +S  K  
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLP 172

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
           + ++APE       +   DV+ FG+ + E+            +G+  ++    +   + +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIGRIENGERL 228

Query: 797 EIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA 856
            +                           L +++     C    P+ R +  ++  +L  
Sbjct: 229 PMPP--------------------NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLST 265

Query: 857 ARE 859
             E
Sbjct: 266 ILE 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  146 bits (370), Expect = 4e-39
 Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 25/245 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G+FG V + +    G +   K +N        +   E   +  + H  LI +     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
                      ++ +F+  G L + +   + K     +S  + +N        ++++H H
Sbjct: 97  D-----KYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH 146

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
               +VH D+KP N++ +    + V   DFGLA  L                    T  +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL---------NPDEIVKVTTATAEF 194

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKMVLPEKVMEI 798
            APE           D+++ G+L   + S   P       E L   +       E     
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254

Query: 799 VDPSL 803
           V P  
Sbjct: 255 VSPEA 259

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (362), Expect = 6e-39
 Identities = 48/247 (19%), Positives = 94/247 (38%), Gaps = 19/247 (7%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKII 617
           ++G G    V           VAVKVL             F  E +   ++ H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
               + +        IV +++   +L + +H          ++  + + +  D   A+ +
Sbjct: 74  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 126

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
            H +    ++H D+KP+N+++       V DFG+A+ +          + + ++ + GT 
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NSVTQTAAVIGTA 178

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKMVLPEKVM 796
            Y++PE   G       DVYS G +L E+ +   P T          H     + P    
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 797 EIVDPSL 803
           E +   L
Sbjct: 239 EGLSADL 245

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 65/322 (20%), Positives = 121/322 (37%), Gaps = 64/322 (19%)

Query: 562 VGQGSFGTVFKGI-------IGENGMLVAVKVLNL-MQKGALKSFLTECEALRSI-RHRN 612
           +G+G+FG V                  VAVK+L     +  L   ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQ----------NNDKLEVCNLSLI 662
           +I ++  C+           ++ ++   G+L E+L            N        LS  
Sbjct: 81  IINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
             ++ A  VA     + +      +H DL   NVL+  D V  + DFGLA+ +       
Sbjct: 136 DLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----- 187

Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT 782
            ++    ++  +  V ++APE       +   DV+SFG+LL E+F+         + G+ 
Sbjct: 188 -IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVP 242

Query: 783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPT 842
           + E  K++     M+                           C   +  +   C    P+
Sbjct: 243 VEELFKLLKEGHRMDK-----------------------PSNCTNELYMMMRDCWHAVPS 279

Query: 843 DRMQMRDVVVKLCAAREAFVSM 864
            R   + +V  L    +  V++
Sbjct: 280 QRPTFKQLVEDL----DRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 59/317 (18%), Positives = 109/317 (34%), Gaps = 54/317 (17%)

Query: 554 SEFSSSNMVGQGSFGTVFKGII-----GENGMLVAVKVLNL-MQKGALKSFLTECEALRS 607
                   +G+G+FG V +              VAVK+L         ++ ++E + L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 608 IRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCN--------- 658
           I H   +  +    +     +    ++ +F + G+L  +L    ++              
Sbjct: 73  IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 659 -LSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPA 717
            L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 718 RPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMF 777
            P              +  + ++APE       ++  DV+SFG+LL E+FS        +
Sbjct: 187 DP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PY 237

Query: 778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCS 837
                  EF + +     M   D                            + +  + C 
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPD-----------------------YTTPEMYQTMLDCW 274

Query: 838 MESPTDRMQMRDVVVKL 854
              P+ R    ++V  L
Sbjct: 275 HGEPSQRPTFSELVEHL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  134 bits (339), Expect = 8e-36
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 39/229 (17%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL---------MQKGALKSFLTECEALRSIR- 609
            ++G+G    V + I        AVK++++           +   ++ L E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
           H N+I++     +  F       +V+D M+ G L ++L +         LS  +T  I  
Sbjct: 69  HPNIIQLKDTYETNTF-----FFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSS 729
            +   I  LH      +VH DLKP N+LLD DM   + DFG +  L         +    
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL---------DPGEK 165

Query: 730 SSGIKGTVGYIAPEYGTGSEASMTG------DVYSFGILLLEMFSRRRP 772
              + GT  Y+APE    S            D++S G+++  + +   P
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-35
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 26/222 (11%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEAL-RSIRH 610
           +F    M+G+GSFG VF     +     A+K L    ++    ++  + E   L  +  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             L  +     +      +    V +++  G L   +   +         L +    A +
Sbjct: 63  PFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAE 111

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           +   +++LH      +V+ DLK  N+LLD D    + DFG+ K          +   + +
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN--------MLGDAKT 160

Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           +   GT  YIAPE   G + + + D +SFG+LL EM   + P
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-35
 Identities = 41/246 (16%), Positives = 95/246 (38%), Gaps = 26/246 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+G FG V + +   +      K + + +         E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
           S     ++   ++++F+    + E ++ +  +L     +  + ++    V  A+++LH H
Sbjct: 72  S-----MEELVMIFEFISGLDIFERINTSAFEL-----NEREIVSYVHQVCEALQFLHSH 121

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
               + H D++P N++      + +   +FG A+ L         +   +   +     Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---------KPGDNFRLLFTAPEY 169

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKMVLPEKVMEI 798
            APE       S   D++S G L+  + S   P       + +     ++    E+  + 
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229

Query: 799 VDPSLL 804
           +    +
Sbjct: 230 ISIEAM 235

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  135 bits (340), Expect = 4e-35
 Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 31/256 (12%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEA---LRSI 608
           +FS   ++G+G FG V+     + G + A+K L+   +  K      L E      + + 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 609 RHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIA 668
               ++ +     +      D  + + D M  G L   L Q+    E            A
Sbjct: 65  DCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113

Query: 669 IDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPS 728
            ++   +E++H+     VV+ DLKP+N+LLD      + D GLA             +  
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----------SKK 160

Query: 729 SSSGIKGTVGYIAPEY-GTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS 787
                 GT GY+APE    G     + D +S G +L ++     P      +     +  
Sbjct: 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220

Query: 788 KMVLPEKVMEIVDPSL 803
            + +  ++ +   P L
Sbjct: 221 TLTMAVELPDSFSPEL 236

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 7e-35
 Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 19/222 (8%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITIC 620
            +G GSFG ++ G     G  VA+K+  +  K        E +  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
            +      D+  +V + +     + +   +         SL   L +A  + S IEY+H 
Sbjct: 72  GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121

Query: 681 HCKPPVVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTV 737
                 +H D+KP N L        + ++ DFGLAK          +    + + + GT 
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN-LTGTA 177

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHE 779
            Y +     G E S   D+ S G +L+       P   +   
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 62/309 (20%), Positives = 119/309 (38%), Gaps = 27/309 (8%)

Query: 549 LSKATSEFSSSNMVGQGSFGTVFKGI-IGENGMLVAVKVLNL--MQKGALKSFLTECEAL 605
           L +A  ++     +G+G++G VFK   +   G  VA+K + +   ++G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 606 R---SIRHRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLI 662
           R   +  H N++++  +C+    +      +V++ +               +        
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV-----PTE 116

Query: 663 QTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDT 722
              ++   +   +++LH H    VVH DLKP N+L+       + DFGLA+         
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY------- 166

Query: 723 VVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT 782
                 + + +  T+ Y APE    S  +   D++S G +  EMF R+            
Sbjct: 167 --SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224

Query: 783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVK-IEECLVAVIRIGVVCSMESP 841
                 + LP +     D +L  +   + S     + V  I+E    ++     C   +P
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK---CLTFNP 281

Query: 842 TDRMQMRDV 850
             R+     
Sbjct: 282 AKRISAYSA 290

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 47/219 (21%), Positives = 75/219 (34%), Gaps = 23/219 (10%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +++G G+F  V          LVA+K +     +G   S   E   L  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           I  S          ++   +  G L + + +          +      +   V  A++YL
Sbjct: 75  IYES-----GGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-PARPLDTVVETPSSSSGIKGTV 737
           H                  LD D    + DFGL+K   P   L T            GT 
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC----------GTP 173

Query: 738 GYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM 776
           GY+APE       S   D +S G++   +     P    
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 28/222 (12%)

Query: 554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRH 610
            +F     +G GSFG V       NG   A+KVL    +++   ++    E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 611 RNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAID 670
             +I++                ++ D+++ G L   L ++                 A +
Sbjct: 64  PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAE 112

Query: 671 VASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSS 730
           V      L +     +++ DLKP N+LLD +    + DFG AK++           P  +
Sbjct: 113 VC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVT 158

Query: 731 SGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
             + GT  YIAPE  +    + + D +SFGIL+ EM +   P
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-34
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIK 615
           ++ + ++G GSFG V++  + ++G LVA+K +   +    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 616 IITIC-SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
           +     SS +     +  +V D++         H +  K     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFL-PARPLDTVVETPSSSSG 732
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L    P  + + +      
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----- 186

Query: 733 IKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
                 Y APE   G+   + + DV+S G +L E+   +  
Sbjct: 187 -----YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-34
 Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 18/237 (7%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIIT 618
           + +G+G++G V       N + VA+K ++  + +   +  L E + L   RH N+I I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
           I  +     +    +V   M    L + L   +       LS          +   ++Y+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH-------LSNDHICYFLYQILRGLKYI 125

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      V+H DLKPSN+LL+      + DFGLA+       D   +     +    T  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGFLTEYVATRW 177

Query: 739 YIAPEYGTGSEASMT-GDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
           Y APE    S+      D++S G +L EM S R       +     H    +  P +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 9e-34
 Identities = 45/237 (18%), Positives = 93/237 (39%), Gaps = 26/237 (10%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEAL-RSIRHRNLIKIITI 619
           ++G G  G V +          A+K+L    K        E E   R+ +  ++++I+ +
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             ++         IV + +  G L   +    D+      +  +   I   +  AI+YLH
Sbjct: 74  YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 128

Query: 680 HHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
                 + H D+KP N+L      + +  + DFG AK   +          +S +    T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---------NSLTTPCYT 176

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE 793
             Y+APE     +   + D++S G+++  +     P  S     ++    +++ + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-33
 Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 22/298 (7%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +GQG+FG VFK    + G  VA+K + +   ++G   + L E + L+ ++H N++ +I I
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 620 CSSIDFNGVDFKA---IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           C +        K    +V+DF ++       +           +L +   +   + +   
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNG-- 129

Query: 677 YLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGT 736
            L++  +  ++H D+K +NVL+  D V  + DFGLA+             P+  +    T
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS----LAKNSQPNRYTNRVVT 184

Query: 737 VGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP-TDSMFHEGLTLHEFSKMVLPEK 794
           + Y  PE   G        D++  G ++ EM++R      +     L L       +  +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSM--ESPTDRMQMRDV 850
           V   VD   L E        +   + +++  +     + ++  +    P  R+   D 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 47/254 (18%), Positives = 88/254 (34%), Gaps = 28/254 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G+GSFG +F+G    N   VA+K     ++        E    + +     I  +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 622 SIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHH 681
               + V    +V D +  G   E L     +      S+      A  + + ++ +H  
Sbjct: 71  QEGLHNV----LVIDLL--GPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEK 120

Query: 682 CKPPVVHGDLKPSNVLLDHDMVAHVG-----DFGLAKFLPARPLDTVVETPSSSSGIKGT 736
               +V+ D+KP N L+      +       DFG+ KF         +      + + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN-LSGT 176

Query: 737 VGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVM 796
             Y++     G E S   D+ + G + +       P   +          +     E++ 
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-------KAATNKQKYERIG 229

Query: 797 EIVDPSLLLEVRAN 810
           E    + L E+ A 
Sbjct: 230 EKKQSTPLRELCAG 243

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-32
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 28/219 (12%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL-----MQKGALKSFLTECEALRSIRHRNLI 614
           + +G+G F TV+K        +VA+K + L      + G  ++ L E + L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
            ++              ++V+DFM+          +                  +     
Sbjct: 64  GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK               + +   
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------SPNRAYTHQV 161

Query: 735 GTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
            T  Y APE   G+    +  D+++ G +L E+  R   
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-32
 Identities = 42/221 (19%), Positives = 83/221 (37%), Gaps = 33/221 (14%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLM------QKGALKSFLTECEALRSIRHRNLIK 615
           +G G F  V K      G+  A K +         +  + +    E   L+ I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 616 IITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAI 675
           +  +  +          ++ + +  G L ++L +     E      ++ +         +
Sbjct: 78  LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123

Query: 676 EYLHHHCKPPVVHGDLKPSNVLLDHDMVA----HVGDFGLAKFLPARPLDTVVETPSSSS 731
             +++     + H DLKP N++L    V      + DFGLA  +         +  +   
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---------DFGNEFK 174

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            I GT  ++APE        +  D++S G++   + S   P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 9e-32
 Identities = 52/244 (21%), Positives = 94/244 (38%), Gaps = 30/244 (12%)

Query: 555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHR 611
           +F    ++G+G+FG V        G   A+K+L    ++ K  +   +TE   L++ RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 612 NLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDV 671
            L  +     +      D    V ++   G L   L +          +  +      ++
Sbjct: 66  FLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEI 114

Query: 672 ASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            SA   L +     VV+ D+K  N++LD D    + DFGL K              ++  
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--------SDGATMK 163

Query: 732 GIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL 791
              GT  Y+APE    ++     D +  G+++ EM   R P               +++L
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELIL 218

Query: 792 PEKV 795
            E++
Sbjct: 219 MEEI 222

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 5e-31
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 28/214 (13%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN---LMQKGALKSFLTECEALRSIRHRNLIKIIT 618
           +G GSFG V      E+G   A+K+L+   +++   ++  L E   L+++    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
                         +V +++  G +   L +          S       A  +    EYL
Sbjct: 109 SFKDNSN-----LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYL 157

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H      +++ DLKP N+L+D      V DFG AK +  R              + GT  
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----------WTLCGTPE 203

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
            +APE       +   D ++ G+L+ EM +   P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-30
 Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 24/298 (8%)

Query: 556 FSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNL 613
           F     +G+G++G V+K      G +VA+K + L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 614 IKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVAS 673
           +K++ +  +      + K  +     +  L++++  +        + L    +    +  
Sbjct: 64  VKLLDVIHT------ENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQ 113

Query: 674 AIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGI 733
            + + H H    V+H DLKP N+L++ +    + DFGLA+               + +  
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHE 162

Query: 734 KGTVGYIAPE-YGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP 792
             T+ Y APE        S   D++S G +  EM +RR               F  +  P
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222

Query: 793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDV 850
           ++V+     S+     +    +R      +         +        P  R+  +  
Sbjct: 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-30
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 23/213 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G+G++GTVFK    E   +VA+K + L    +G   S L E   L+ ++H+N++++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
             S          +V++F      + +   N D       S +  L         ++ L 
Sbjct: 70  LHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                 V+H DLKP N+L++ +    + +FGLA+          +     S+ +      
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-------IPVRCYSAEVVTLWYR 168

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                      S + D++S G +  E+ +  RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-29
 Identities = 42/222 (18%), Positives = 75/222 (33%), Gaps = 33/222 (14%)

Query: 561 MVGQGSFGTVFKGIIGENGMLVAVKVLNL------MQKGALKSFLTECEALRSIR--HRN 612
           ++G G FG+V+ GI   + + VA+K +         +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 613 LIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVA 672
           +I+++           D   ++ +  +                   L      +    V 
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVL 120

Query: 673 SAIEYLHHHCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSS 731
            A+ + H+     V+H D+K  N+L+D +     + DFG    L                
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------- 170

Query: 732 GIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRP 772
              GT  Y  PE+         +  V+S GILL +M     P
Sbjct: 171 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-29
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 26/215 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           VG G++G V   + G  G  VA+K L      +   K    E   L+ +RH N+I ++ +
Sbjct: 26  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 620 CSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
            +  +  +      +V  FM  G+    L ++        L   +   +   +   + Y+
Sbjct: 86  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYI 137

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H        H DLKP N+ ++ D    + DFGLA+              S  +G   T  
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----------DSEMTGYVVTRW 183

Query: 739 YIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRP 772
           Y APE        + T D++S G ++ EM + +  
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (290), Expect = 7e-29
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 30/242 (12%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITIC 620
           +G+G +  VF+ I   N   V VK+L  ++K   K    E + L ++R   N+I +  I 
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99

Query: 621 SSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH 680
                      A+V++ + N   ++             L+         ++  A++Y H 
Sbjct: 100 KDPVSRTP---ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147

Query: 681 HCKPPVVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                ++H D+KP NV++DH+     + D+GLA+F                +    +  +
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQEYNVRVASRYF 195

Query: 740 IAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEKVMEI 798
             PE     +    + D++S G +L  M  R+ P          L   +K++  E + + 
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 799 VD 800
           +D
Sbjct: 256 ID 257

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  112 bits (280), Expect = 6e-28
 Identities = 53/296 (17%), Positives = 104/296 (35%), Gaps = 30/296 (10%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL--MQKGALKSFLTECEALRSIRHRNLIKII 617
             +G+G++G V+K      G   A+K + L    +G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 618 TICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEY 677
            +  +        + ++     +  L++ L      LE               +   +  
Sbjct: 67  DVIHT------KKRLVLVFEHLDQDLKKLLDVCEGGLESVT--------AKSFLLQLLNG 112

Query: 678 LHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--PARPLDTVVETPSSSSGIKG 735
           + +     V+H DLKP N+L++ +    + DFGLA+    P R     + T         
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-------- 164

Query: 736 TVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK 794
              Y AP+   GS+  S T D++S G +  EM +       +      +  F  +  P  
Sbjct: 165 --WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDV 850
                   L                  ++    + I +        P  R+  +  
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  113 bits (284), Expect = 9e-28
 Identities = 85/394 (21%), Positives = 137/394 (34%), Gaps = 32/394 (8%)

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
             DT   L + +   +G+   +  +  +  ++     +             D V  L NL
Sbjct: 16  FTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNL 68

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
            +   + N LT   P  L N + L  + + +NQ      +   +      L        +
Sbjct: 69  TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN------LSNTMTTIDIGGNYFS 235
              N  +   +  + + + ++                       L+N  T   +  +   
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
            +    L  L +L S+    NQ+    P  I    NL  L LN N L      +L +LT 
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTN 242

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           LT L L  N +    P  L   T L  L L  N++  + P   L+  T            
Sbjct: 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED- 299

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
                S I NLKNL  L +  N  S   P  +S+ T L+ +   +N  S     SL  L 
Sbjct: 300 ----ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLT 351

Query: 416 SIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYN 449
           +I  L    N++S   P  L NL+ +  L L+  
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (263), Expect = 6e-25
 Identities = 79/385 (20%), Positives = 144/385 (37%), Gaps = 26/385 (6%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
           L +     L + ++T    VS  +L  +  +      +  K  D +  L  L  +N   N
Sbjct: 21  LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76

Query: 81  QFSGFIP-PSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
           Q +   P  ++  +        Q            +  L      +   + L     ++ 
Sbjct: 77  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGN---NHLGNRAANDLDFVTVLANC 196
              S+  + ++     +  +       +   +  L N       + ++N +  ++VLA  
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGN 256
           + LE+L   +NQ   + P     +   +  + + GN         L +L +L  + +  N
Sbjct: 197 TNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 257 QLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGN 316
           Q+    P  +  L  L  L L +N +    P  L  LT LT L L  N L+   P S  N
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--N 305

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG 376
             +L  LTL  N +  + P  + S+T L   L  ++N +S    S + NL N+  L    
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 377 NRFSGDIPGTLSACTSLEYVKMQDN 401
           N+ S   P  L+  T +  + + D 
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 84.3 bits (207), Expect = 8e-18
 Identities = 79/358 (22%), Positives = 129/358 (36%), Gaps = 38/358 (10%)

Query: 20  YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGR 79
           YL  L  ++ + N LT   P  + NL+ L  I +  N+                  N+  
Sbjct: 64  YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ----------IADITPLANLTN 111

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
                     I +I   + +   +     S     ++ L  L                 L
Sbjct: 112 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPL 171

Query: 140 SNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL 199
           +N + LE L++  N+           L NL  LI  NN + +        +T L   + L
Sbjct: 172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISD--------ITPLGILTNL 221

Query: 200 ENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLI 259
           + L L  NQ       +LA+L+N +T +D+  N  S   P  L  L  L  + +  NQ+ 
Sbjct: 222 DELSLNGNQLKD--IGTLASLTN-LTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276

Query: 260 GTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTS 319
              P           L  N       I     NL  LT L L  NN+    P  + + T 
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPIS----NLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 320 LIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGN 377
           L  L  + NK+       + ++T ++ +L+   N +S   P  + NL  + QL ++  
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.4 bits (197), Expect = 1e-16
 Identities = 77/369 (20%), Positives = 142/369 (38%), Gaps = 38/369 (10%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
             L    K V  K N+T    +S ++   +  L+      I  +      L NL+ +   
Sbjct: 19  TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLG-IKSID-GVEYLNNLTQINFS 74

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
           NN L +        +T L N +KL ++ + +NQ   + P +       +T  +       
Sbjct: 75  NNQLTD--------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126

Query: 236 GTIPPGLG--------NLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSL----YLNSNFLH 283
                            +  +++++   +    +   ++  LK L +L     L+ +   
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186

Query: 284 GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT 343
               S L  LT L  L    N +    P      T+L  L+L+ N+L       + S+T 
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTN 242

Query: 344 LSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSF 403
           L+  L+L++N +S   P  +  L  L +L +  N+ S   P  L+  T+L  +++ +N  
Sbjct: 243 LT-DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 297

Query: 404 SGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSN 463
               P   + LK++  L L  N +S   P  + +L+ L+ L  + N     V      +N
Sbjct: 298 EDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTN 352

Query: 464 KTRFSLSGN 472
               S   N
Sbjct: 353 INWLSAGHN 361

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.1 bits (139), Expect = 2e-09
 Identities = 20/86 (23%), Positives = 38/86 (44%), Gaps = 6/86 (6%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
             L  L  L+L  N+++   P  + +L+ LQ +    N++      +L  L  + +L+ G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSN 104
            NQ S   P  + N++    + L   
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 1e-07
 Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 7/80 (8%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
                 N +    PV     L KL+ L  A N ++     S+ NL+ +  +    N++  
Sbjct: 311 YLTLYFNNISDISPV---SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 61  KIPDTLGQLRKLIYLNIGRN 80
             P  L  L ++  L +   
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 40/213 (18%), Positives = 77/213 (36%), Gaps = 22/213 (10%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           VG G++G+V      + G+ VAVK L+         K    E   L+ ++H N+I ++ +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 620 CSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLH 679
            +            +   +    L   +           L+      +   +   ++Y+H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH 138

Query: 680 HHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGY 739
                   H DLKPSN+ ++ D    + DFGLA+                +  +      
Sbjct: 139 SADII---HRDLKPSNLAVNEDCELKILDFGLARHT----------DDEMTGYVATRWYR 185

Query: 740 IAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
                      + T D++S G ++ E+ + R  
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 15/217 (6%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICS 621
           +G G F TV+      N   VA+K++    K   ++   E + L+ +   +  K  ++ +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 622 S-----IDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIE 676
           +     +D         V+  M    L E L     K E   + LI    I+  +   ++
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 677 YLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKG 735
           Y+H  C   ++H D+KP NVL++  D   ++    +A    A             +    
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC------WYDEHYTNSIQ 191

Query: 736 TVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           T  Y +PE   G+      D++S   L+ E+ +    
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 4e-27
 Identities = 43/214 (20%), Positives = 80/214 (37%), Gaps = 24/214 (11%)

Query: 562 VGQGSFGTVFKGIIGENGMLVAVKVLN--LMQKGALKSFLTECEALRSIRHRNLIKIITI 619
           +G G+ G V           VA+K L+     +   K    E   ++ + H+N+I ++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 620 CSSID-FNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYL 678
            +            +V + M     +    + + +         +   +   +   I++L
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135

Query: 679 HHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVG 738
           H       +H DLKPSN+++  D    + DFGLA+            T    +    T  
Sbjct: 136 HSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART---------AGTSFMMTPYVVTRY 183

Query: 739 YIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRP 772
           Y APE   G       D++S G ++ EM   +  
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-27
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 562 VGQGSFGTVFKG---IIGENGMLVAVKVLN----LMQKGALKSFLTECEALRSIRHRNLI 614
           +G G++G VF        + G L A+KVL     + +    +   TE + L  IR    +
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 615 KIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASA 674
             +       F       ++ D++  G L   L Q     E           + I V   
Sbjct: 92  VTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138

Query: 675 IEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIK 734
           +  L H  K  +++ D+K  N+LLD +    + DFGL+K   A   +        +    
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-------AYDFC 191

Query: 735 GTVGYIAPEYGTGSEASMTG--DVYSFGILLLEMFSRRRP 772
           GT+ Y+AP+   G ++      D +S G+L+ E+ +   P
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  106 bits (265), Expect = 8e-26
 Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 9/266 (3%)

Query: 225 TTIDIGGNYFSG--TIPPGLGNLVHLNSIAMEGN-QLIGTVPPEIGWLKNLQSLYLNSNF 281
             +D+ G        IP  L NL +LN + + G   L+G +PP I  L  L  LY+    
Sbjct: 53  NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112

Query: 282 LHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV 341
           + G IP  L  +  L  L    N L G +P S+ +  +L+ +T   N++ G +P    S 
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172

Query: 342 TTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDN 401
           + L   + +S N L+G +P    NL                     S   + +    +++
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232

Query: 402 SFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVF 461
                        K++  LDL +N++ G +P+ L  L FL  LN+S+N+  GE+P+ G  
Sbjct: 233 LAFDLGKV--GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290

Query: 462 SNKTRFSLSGNGKLCGGLDEFHLPSC 487
                 + + N  LCG      LP+C
Sbjct: 291 QRFDVSAYANNKCLCG----SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.9 bits (164), Expect = 9e-13
 Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 15/269 (5%)

Query: 23  KLENLSLAENHLTG--QLPVSIGNLSALQVIDIRGN-RLGGKIPDTLGQLRKLIYLNIGR 79
           ++ NL L+  +L     +P S+ NL  L  + I G   L G IP  + +L +L YL I  
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 80  NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISL 139
              SG IP  +  I +   +    N   G+LP   +++LPNL       N ++G +P S 
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNRISGAIPDSY 169

Query: 140 SNASNLEL-LELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSK 198
            + S L   + +  N+  GK+   F +L    V +  N   G+ +               
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
             +L     + G     +  +L N         N   GT+P GL  L  L+S+ +  N L
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRN---------NRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIP 287
            G + P+ G L+        +N      P
Sbjct: 281 CGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.3 bits (134), Expect = 5e-09
 Identities = 17/62 (27%), Positives = 27/62 (43%), Gaps = 2/62 (3%)

Query: 29  LAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF-SGFIP 87
           L  N + G LP  +  L  L  +++  N L G+IP   G L++        N+   G   
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPL 309

Query: 88  PS 89
           P+
Sbjct: 310 PA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 4/64 (6%)

Query: 2   FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRL--G 59
            D +NN++ G +P  +   L  L +L+++ N+L G++P   GNL    V     N+   G
Sbjct: 249 LDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306

Query: 60  GKIP 63
             +P
Sbjct: 307 SPLP 310

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (246), Expect = 1e-23
 Identities = 47/255 (18%), Positives = 87/255 (34%), Gaps = 5/255 (1%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
            + + L+ N+   +   S     N                    G  +       +  QL
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
               P     L  L +L+L+   L    P     L  L  L L+ N LQ     +  +  
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
           +L  L L  N++  V       + +L     L  N ++   P    +L  L+ L +  N 
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENL 438
            S      L+   +L+Y+++ DN +      +      ++    SS+++   +P+ L   
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271

Query: 439 SFLEYLNLSYNHFEG 453
                  L+ N  +G
Sbjct: 272 DL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (182), Expect = 3e-15
 Identities = 41/272 (15%), Positives = 76/272 (27%), Gaps = 14/272 (5%)

Query: 13  IPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKL 72
           +PV I       + + L  N ++     S      L ++ +  N L          L  L
Sbjct: 26  VPVGIPAAS---QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 73  IYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT 132
             L++  N     + P+ ++                 L   +   L  L+      N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 133 GFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTV 192
                +  +  NL  L L  N+        F  L +L  L+L  N + +   +    +  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIA 252
           L       N              +L         + +  N +             L    
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRAL-------QYLRLNDNPWVCDCRA-RPLWAWLQKFR 254

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
              +++  ++P     L       L +N L G
Sbjct: 255 GSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (178), Expect = 1e-14
 Identities = 51/247 (20%), Positives = 81/247 (32%), Gaps = 26/247 (10%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            VP  I      Q ++L+ N +     +S      LT+L L  N L     ++      L
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD------------------------NLLS 356
             L LS N     + P           L+L                          N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 357 GSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKS 416
                   +L NL  L + GNR S           SL+ + +  N  +   P +   L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 417 IKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLC 476
           +  L L +N LS    + L  L  L+YL L+ N +  +   + +++   +F  S +   C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262

Query: 477 GGLDEFH 483
                  
Sbjct: 263 SLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 38/179 (21%), Positives = 63/179 (35%), Gaps = 2/179 (1%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG 60
             D  +N  +  +       L +L  L L    L    P     L+ALQ + ++ N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 61  KIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN 120
              DT   L  L +L +  N+ S     +   + S + + L  NR     P     +L  
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HAFRDLGR 202

Query: 121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHL 179
           L       NNL+     +L+    L+ L L DN ++            L      ++ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEV 260

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.6 bits (239), Expect = 2e-22
 Identities = 56/262 (21%), Positives = 102/262 (38%), Gaps = 17/262 (6%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
              L L +N+   +      NL N + T+ +  N  S   P     LV L  + +  NQL
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQ--GKIPSSLGN 316
              +P ++     LQ L ++ N +     S    L  + ++ L  N L+  G    +   
Sbjct: 92  -KELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148

Query: 317 CTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG 376
              L  + ++   +   +P  +    T    L+L  N ++    + +  L NL +L +S 
Sbjct: 149 MKKLSYIRIADTNIT-TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 377 NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG------Q 430
           N  S    G+L+    L  + + +N     +P  L   K I+V+ L +N +S        
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263

Query: 431 IPKYLENLSFLEYLNLSYNHFE 452
            P Y    +    ++L  N  +
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.9 bits (224), Expect = 2e-20
 Identities = 49/216 (22%), Positives = 79/216 (36%), Gaps = 7/216 (3%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            VP ++    +   L L +N +         NL  L  L L  N +    P +      L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS 380
             L LSKN+L  +      ++  L +  N    +          N   +V+L  +  + S
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQMIVVELGTNPLKSS 139

Query: 381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF 440
           G   G       L Y+++ D + + +IP  L    S+  L L  NK++      L+ L+ 
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 441 LEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLC 476
           L  L LS+N            +   R     N KL 
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.7 bits (208), Expect = 2e-18
 Identities = 56/268 (20%), Positives = 86/268 (32%), Gaps = 19/268 (7%)

Query: 119 PNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNH 178
           P+        N +T        N  NL  L L +N+        F  L  L  L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
           L          +  L    + E   +  + F GL    +  L              SG  
Sbjct: 91  LKELPEKMPKTLQEL-RVHENEITKVRKSVFNGLNQMIVVELGTNP-------LKSSGIE 142

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTL 298
                 +  L+ I +    +  T+P   G   +L  L+L+ N +     +SL  L  L  
Sbjct: 143 NGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199

Query: 299 LALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG- 357
           L L  N++      SL N   L  L L+ NKL  V P  +     +   + L +N +S  
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQ-VVYLHNNNISAI 257

Query: 358 -----SLPSEIGNLKNLVQLDISGNRFS 380
                  P       +   + +  N   
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.2 bits (186), Expect = 1e-15
 Identities = 47/286 (16%), Positives = 87/286 (30%), Gaps = 21/286 (7%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              L L  N +T        NL  L  + +  N++    P     L KL  L + +NQ  
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 84  GFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS 143
                    +        +  +   S+   +  N   + +        +G    +     
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG 203
            L  + + D       +I      +L+ L L  N +    A  L         + L  LG
Sbjct: 151 KLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLK------GLNNLAKLG 201

Query: 204 LYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG--- 260
           L  N    +   SLAN  +               +P GL +  ++  + +  N +     
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 261 ---TVPPEIGWLKNLQSLYLNSNFLHGY--IPSSLGNLTMLTLLAL 301
                P       +   + L SN +  +   PS+   + +   + L
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 34/174 (19%), Positives = 61/174 (35%), Gaps = 30/174 (17%)

Query: 334 LPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSL 393
           +P  +   T     L+L +N ++     +  NLKNL  L +  N+ S   PG  +    L
Sbjct: 25  VPKDLPPDTA---LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 394 EYVKMQDNSFSGSIPPS----------------------LNFLKSIKVLDLSS--NKLSG 429
           E + +  N     +P                         N L  + V++L +   K SG
Sbjct: 82  ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 430 QIPKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGLDEFH 483
                 + +  L Y+ ++  +    +P +G+  + T   L GN           
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIP-QGLPPSLTELHLDGNKITKVDAASLK 192

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 2e-18
 Identities = 27/166 (16%), Positives = 46/166 (27%), Gaps = 29/166 (17%)

Query: 560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNL----------MQKGALKSFLTECEALRSIR 609
            ++G+G    VF     E      VK   +           +      F           
Sbjct: 6   KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 610 HRNLIKIITICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAI 669
            R L K+  +              VY +  N  L E +                   +  
Sbjct: 65  FRALQKLQGLAV----------PKVYAWEGNAVLMELIDAKELYRVRVE----NPDEVLD 110

Query: 670 DVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 715
            +   +   +H     +VHGDL   NVL+  +    + DF  +  +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (154), Expect = 9e-12
 Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 7/191 (3%)

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            +PP++   K+   L+L+ N L+ +  ++L   T LT L L  +  +       G    L
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVL 79

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS 380
             L LS N+L  +              L++S N L+      +  L  L +L + GN   
Sbjct: 80  GTLDLSHNQLQSLPLLGQ--TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137

Query: 381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSF 440
              PG L+    LE + + +N+ +      LN L+++  L L  N L   IPK       
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196

Query: 441 LEYLNLSYNHF 451
           L +  L  N +
Sbjct: 197 LPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 48/212 (22%), Positives = 73/212 (34%), Gaps = 7/212 (3%)

Query: 265 EIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLT 324
           E+  + +   +  +   L   +P  L      T+L L  N L     ++L   T L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 325 LSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIP 384
           L + +L  +     L      L      +    SLP     L  L  LD+S NR +    
Sbjct: 62  LDRAELTKLQVDGTLP----VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 385 GTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYL 444
           G L     L+ + ++ N      P  L     ++ L L++N L+      L  L  L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 445 NLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLC 476
            L  N                   L GN  LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 38/192 (19%), Positives = 60/192 (31%), Gaps = 9/192 (4%)

Query: 237 TIPPGLG-NLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTM 295
            +PP L  +   L+   +  N L       +     L  L L+   L          L +
Sbjct: 24  ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPV 78

Query: 296 LTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLL 355
           L  L L  N LQ             ++           LP   L        L L  N L
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNEL 136

Query: 356 SGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLK 415
               P  +     L +L ++ N  +    G L+   +L+ + +Q+NS   +IP       
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195

Query: 416 SIKVLDLSSNKL 427
            +    L  N  
Sbjct: 196 LLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 7e-06
 Identities = 26/184 (14%), Positives = 46/184 (25%), Gaps = 6/184 (3%)

Query: 199 LENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL 258
              L L +N        +L   +                +   L  L  L+    +   L
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92

Query: 259 IGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCT 318
                          S    ++   G +        +         N    +P  L   T
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL-----KGNELKTLPPGLLTPT 147

Query: 319 SLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNR 378
             +      N     LP  +L+       L L +N L  ++P        L    + GN 
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206

Query: 379 FSGD 382
           +  +
Sbjct: 207 WLCN 210

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 33/198 (16%), Positives = 54/198 (27%), Gaps = 48/198 (24%)

Query: 24  LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFS 83
              ++  + +LT  LP  +       ++ +  N L      TL    +L  LN+ R + +
Sbjct: 12  HLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 84  GF--------------------------------------------IPPSIYNISSFEFI 99
                                                         +P            
Sbjct: 69  KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128

Query: 100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM 159
                    +LP  ++   P L K   A NNLT      L+   NL+ L L++N     +
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187

Query: 160 SINFNSLKNLSVLILGNN 177
              F     L    L  N
Sbjct: 188 PKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 17/76 (22%), Positives = 24/76 (31%), Gaps = 1/76 (1%)

Query: 32  NHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIY 91
           N L    P  +     L+ + +  N L       L  L  L  L +  N     IP   +
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 92  NISSFEFIFLQSNRFH 107
                 F FL  N + 
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.2 bits (140), Expect = 8e-11
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)

Query: 348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSI 407
           L+L+   L+      +  L  +  LD+S NR     P  L+A   LE ++  DN+     
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--N 57

Query: 408 PPSLNFLKSIKVLDLSSNKL-SGQIPKYLENLSFLEYLNLSYNHFEGE 454
              +  L  ++ L L +N+L      + L +   L  LNL  N    E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 7/111 (6%)

Query: 273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDG 332
           + L+L    L   +   L  L ++T L L  N L+   P+ L     L +L  S N L+ 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57

Query: 333 VLPPQILSVTTLSLFLNLSDNLL-SGSLPSEIGNLKNLVQLDISGNRFSGD 382
           V     L        L L +N L   +    + +   LV L++ GN    +
Sbjct: 58  VDGVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 29/123 (23%), Positives = 42/123 (34%), Gaps = 5/123 (4%)

Query: 27  LSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFI 86
           L LA   LT      +  L  +  +D+  NRL    P  L  LR L  L    N      
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57

Query: 87  PPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLE 146
              + N+   + + L +NR   S     + + P L       N+L     I    A  L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 147 LLE 149
            + 
Sbjct: 118 SVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 5e-06
 Identities = 27/118 (22%), Positives = 42/118 (35%), Gaps = 6/118 (5%)

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
           +    L  TV   +  L  +  L L+ N L    P +L  L  L +  L+ ++   +   
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV--LQASDNALENVD 59

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLV 370
            + N   L  L L  N+L      Q L      + LNL  N L          L  ++
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 4e-05
 Identities = 25/106 (23%), Positives = 42/106 (39%), Gaps = 6/106 (5%)

Query: 226 TIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGY 285
            + +       T+   L  L+ +  + +  N+L    PP +  L+ L+   L ++     
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLE--VLQASDNALE 56

Query: 286 IPSSLGNLTMLTLLALEINNLQG-KIPSSLGNCTSLIMLTLSKNKL 330
               + NL  L  L L  N LQ       L +C  L++L L  N L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.001
 Identities = 12/39 (30%), Positives = 21/39 (53%), Gaps = 2/39 (5%)

Query: 418 KVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVP 456
           +VL L+   L+  +  +LE L  + +L+LS+N      P
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP 37

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 42/274 (15%), Positives = 86/274 (31%), Gaps = 12/274 (4%)

Query: 49  QVIDIRGNRLGGKIPDTLGQL--RKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRF 106
           Q +D+ G  L    PD  G+L  + +I     R+     +     +    + + L ++  
Sbjct: 3   QTLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVI 58

Query: 107 HGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGK--MSINFN 164
             S    +++    L+        L+  +  +L+  SNL  L L       +  +    +
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 165 SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           S   L  L L            +    V    ++L   G   N     L   +    N +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLH 283
                               L +L  +++     +I     E+G +  L++L +      
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 284 GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNC 317
           G +      L  L    +  ++       ++GN 
Sbjct: 239 GTLQLLKEALPHLQ---INCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 46/285 (16%), Positives = 93/285 (32%), Gaps = 27/285 (9%)

Query: 134 FLPISLSNASNLELLELRDNQ-FIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTV 192
             P       +  ++  R  + F+ +      S   +  + L N+ +            +
Sbjct: 12  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVI-----EVSTLHGI 66

Query: 193 LANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIA 252
           L+ CSKL+NL L   +    + ++LA  SN +                   NL   +  +
Sbjct: 67  LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL-----------------NLSGCSGFS 109

Query: 253 MEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPS 312
               Q + +    +  L            +   +      +T L L     N  +  + +
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169

Query: 313 SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSD-NLLSGSLPSEIGNLKNLVQ 371
            +  C +L+ L LS + +      Q          L+LS    +      E+G +  L  
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

Query: 372 LDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKS 416
           L + G    G +     A   L   ++  + F+    P++   K+
Sbjct: 230 LQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNKKN 271

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 39/244 (15%), Positives = 77/244 (31%), Gaps = 14/244 (5%)

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQL-IGTVPPEIGWLKNLQSLYLNSNFLH 283
            T+D+ G       P   G L+    IA    +  +     E      +Q + L+++ + 
Sbjct: 3   QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 284 GY-IPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVT 342
              +   L   + L  L+LE   L   I ++L   ++L+ L LS          Q L  +
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 343 TLSLFLNLSDNLLSGSLPSEIGNLKNLVQLD----ISGNRFSGDIPGTLSACTSLEYVKM 398
              L           +       + ++ +      +SG R +       +       +  
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 399 QDNSF----SGSIPPSLNFLKSIKVLDLSS-NKLSGQIPKYLENLSFLEYLNLSYNHFEG 453
            D S               L  ++ L LS    +  +    L  +  L+ L +     +G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 454 EVPK 457
            +  
Sbjct: 240 TLQL 243

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 23/120 (19%), Positives = 45/120 (37%), Gaps = 4/120 (3%)

Query: 372 LDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSG-Q 430
           LD++G     D+ G L +   +   +   +     +    +  + ++ +DLS++ +    
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 431 IPKYLENLSFLEYLNLSYNHFEGEVPKK-GVFSNKTRFSLSGNGKLCGGLDEFHLPSCPS 489
           +   L   S L+ L+L        +       SN  R +LSG         +  L SC  
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 32/250 (12%), Positives = 72/250 (28%), Gaps = 15/250 (6%)

Query: 198 KLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSG-TIPPGLGNLVHLNSIAMEGN 256
            +       +     L    +     +  +D+  +     T+   L     L ++++EG 
Sbjct: 24  GVIAFRCPRSFMDQPLAEHFSPFR--VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81

Query: 257 QLIGTVPPEIGWLKNLQSL--------YLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG 308
           +L   +   +    NL  L           +        S L  L +         ++Q 
Sbjct: 82  RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 141

Query: 309 KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKN 368
            +       T L +    KN     L   +     L         +L      E   L  
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201

Query: 369 LVQLDISG-NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL 427
           L  L +S       +    L    +L+ +++      G++       +++  L ++ +  
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ---LLKEALPHLQINCSHF 258

Query: 428 SGQIPKYLEN 437
           +      + N
Sbjct: 259 TTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 5e-04
 Identities = 18/98 (18%), Positives = 40/98 (40%), Gaps = 4/98 (4%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLFKLENLSLAE-NHLTGQLPVSIGNLSALQVIDIRGNRLG 59
             D  ++ ++ +   +    L  L++LSL+    +  +  + +G +  L+ + + G    
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 60  GKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFE 97
           G +      L  L    I  + F+    P+I N  + E
Sbjct: 239 GTLQLLKEALPHL---QINCSHFTTIARPTIGNKKNQE 273

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.5 bits (137), Expect = 2e-09
 Identities = 51/331 (15%), Positives = 97/331 (29%), Gaps = 17/331 (5%)

Query: 19  CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG 78
           C   +   L L    L+  LP    +L   + +    N L  ++P+    L+ L+  N  
Sbjct: 35  CLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNN 89

Query: 79  RNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPIS 138
               S   P   Y   S   +       + S    +  +  +L+K      +L      +
Sbjct: 90  LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 139 LSNASNLELLELRDNQ--FIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANC 196
                  EL  L      +    S+       LS+  +   +       +L  +  L   
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209

Query: 197 SKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAME-G 255
               NL          L       +      ++  +     +   + + +      +   
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269

Query: 256 NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLG 315
           N     +        +L+ L +++N L   +P+    L  L        N   ++P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIAS----FNHLAEVPELPQ 324

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSL 346
           N   L  L +  N L    P    SV  L +
Sbjct: 325 N---LKQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 20/97 (20%), Positives = 39/97 (40%), Gaps = 10/97 (10%)

Query: 349 NLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIP 408
               N  S  + S      +L +L++S N+   ++P        LE +    N  +  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320

Query: 409 PSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLN 445
                 +++K L +  N L  + P   E++  L  +N
Sbjct: 321 EL---PQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 13/85 (15%)

Query: 195 NCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAME 254
               LE L + +N+   L P     L      +    N+ +  +P    NL  L+   +E
Sbjct: 282 LPPSLEELNVSNNKLIEL-PALPPRL----ERLIASFNHLA-EVPELPQNLKQLH---VE 332

Query: 255 GNQLIGTVPPEIGWLKNLQSLYLNS 279
            N L     P+I   ++++ L +NS
Sbjct: 333 YNPL--REFPDI--PESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 8e-05
 Identities = 20/74 (27%), Positives = 34/74 (45%), Gaps = 11/74 (14%)

Query: 3   DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKI 62
           +  NNKL+ ++P        +LE L  + NHL  ++P    N   L+ + +  N L  + 
Sbjct: 290 NVSNNKLI-ELPALPP----RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPL-REF 339

Query: 63  PDTLGQLRKLIYLN 76
           PD    +  L  +N
Sbjct: 340 PDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 7/78 (8%)

Query: 395 YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGE 454
                 N+ S  I    +   S++ L++S+NKL  ++P        LE L  S+NH   E
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-E 318

Query: 455 VPKKGVFSNKTRFSLSGN 472
           VP+  +  N  +  +  N
Sbjct: 319 VPE--LPQNLKQLHVEYN 334

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 1e-08
 Identities = 16/94 (17%), Positives = 31/94 (32%), Gaps = 10/94 (10%)

Query: 368 NLVQLDISGNRFS-GDIPGTLSACTSLEYVKMQDNSFSG----SIPPSLNFLKSIKVLDL 422
           ++  LDI     S       L      + V++ D   +      I  +L    ++  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 423 SSNKLSGQIPKYL-----ENLSFLEYLNLSYNHF 451
            SN+L       +          ++ L+L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 7/96 (7%)

Query: 144 NLELLELRDNQFIGK-MSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL 202
           +++ L+++  +      +     L+   V+ L +  L      D+   + L     L  L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60

Query: 203 GLYDNQFGG----LLPHSLANLSNTMTTIDIGGNYF 234
            L  N+ G      +   L   S  +  + +     
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 19/83 (22%), Positives = 31/83 (37%), Gaps = 9/83 (10%)

Query: 384 PGTLSACTSLEYVKMQDNSFSG----SIPPSLNFLKSIKVLDLSSNKLSGQIPKYL---- 435
            G     + L  + + D   S     S+  +L    S++ LDLS+N L       L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 436 -ENLSFLEYLNLSYNHFEGEVPK 457
            +    LE L L   ++  E+  
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 9/83 (10%)

Query: 365 NLKNLVQLDISGNRFSGD----IPGTLSACTSLEYVKMQDNSFSGSIPPSL-----NFLK 415
               L  L ++    S      +  TL A  SL  + + +N    +    L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 416 SIKVLDLSSNKLSGQIPKYLENL 438
            ++ L L     S ++   L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 3e-06
 Identities = 14/71 (19%), Positives = 23/71 (32%), Gaps = 5/71 (7%)

Query: 392 SLEYVKMQDNSFSGSIPPSL-NFLKSIKVLDLSSNKLSGQ----IPKYLENLSFLEYLNL 446
            ++ + +Q    S +    L   L+  +V+ L    L+      I   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 447 SYNHFEGEVPK 457
             N        
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 5/95 (5%)

Query: 139 LSNASNLELLELRDNQF----IGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLA 194
               S L +L L D          ++    +  +L  L L NN LG+     L   +V  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423

Query: 195 NCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDI 229
               LE L LYD  +   +   L  L     ++ +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 13/86 (15%)

Query: 348 LNLSDNLLSG----SLPSEIGNLKNLVQLDISGNRFSGDIPGTLSA-----CTSLEYVKM 398
           L L+D  +S     SL + +    +L +LD+S N         L          LE + +
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 399 QDNSFSGSIPPSLNFLK----SIKVL 420
            D  +S  +   L  L+    S++V+
Sbjct: 434 YDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 271 NLQSLYLNSNFL-HGYIPSSLGNLTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTL 325
           ++QSL +    L        L  L    ++ L+   L       I S+L    +L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 326 SKNKLDGVLPPQI---LSVTTLSL-FLNLSDN 353
             N+L  V    +   L   +  +  L+L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 13/87 (14%), Positives = 27/87 (31%), Gaps = 4/87 (4%)

Query: 323 LTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSG----SLPSEIGNLKNLVQLDISGNR 378
           L +   +L      ++L +      + L D  L+      + S +     L +L++  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 379 FSGDIPGTLSACTSLEYVKMQDNSFSG 405
                   +         K+Q  S   
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 14/77 (18%), Positives = 28/77 (36%), Gaps = 9/77 (11%)

Query: 23  KLENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGNRLGGKIPDTLGQ-----LRKLI 73
            L  L LA+  ++      L  ++    +L+ +D+  N LG      L +        L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 74  YLNIGRNQFSGFIPPSI 90
            L +    +S  +   +
Sbjct: 430 QLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 16/80 (20%), Positives = 30/80 (37%), Gaps = 4/80 (5%)

Query: 2  FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGNR 57
           D Q  +L      E+   L + + + L +  LT      +  ++    AL  +++R N 
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 58 LGGKIPDTLGQLRKLIYLNI 77
          LG      + Q  +     I
Sbjct: 67 LGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 20/101 (19%), Positives = 34/101 (33%), Gaps = 9/101 (8%)

Query: 283 HGYIPSSLGNLTMLTLLALEINNLQGK----IPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
                      ++L +L L   ++       + ++L    SL  L LS N L      Q+
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417

Query: 339 LSV----TTLSLFLNLSDNLLSGSLPSEIGNL-KNLVQLDI 374
           +        L   L L D   S  +   +  L K+   L +
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 12/72 (16%), Positives = 24/72 (33%), Gaps = 5/72 (6%)

Query: 24 LENLSLAENHLT-GQLPVSIGNLSALQVIDIRGNRLGGK----IPDTLGQLRKLIYLNIG 78
          +++L +    L+  +    +  L   QV+ +    L       I   L     L  LN+ 
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 79 RNQFSGFIPPSI 90
           N+        +
Sbjct: 64 SNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 11/68 (16%), Positives = 21/68 (30%), Gaps = 4/68 (5%)

Query: 395 YVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQ----IPKYLENLSFLEYLNLSYNH 450
             +++D                ++VL L+   +S      +   L     L  L+LS N 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 451 FEGEVPKK 458
                  +
Sbjct: 409 LGDAGILQ 416

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 13/91 (14%), Positives = 27/91 (29%), Gaps = 12/91 (13%)

Query: 44  NLSALQVIDIRGNRLGGK----IPDTLGQLRKLIYLNIGRNQFSGFIPPSI-----YNIS 94
             S L+V+ +    +       +  TL     L  L++  N         +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 95  SFEFIFLQSNRFHGSLPF---DMVANLPNLR 122
             E + L    +   +      +  + P+LR
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 36/218 (16%), Positives = 72/218 (33%), Gaps = 15/218 (6%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
             L N  K  A K+N+T    ++ ++   +  L       +  +      L NL  L L 
Sbjct: 16  PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG-VTTIE-GVQYLNNLIGLELK 71

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
           +N + + A             S      +        +       +       + G    
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIG-------TVPPEIGWLKNLQSLYLNSNFLHGYIPS 288
             +   L  + +++ +A   N           +    +  L  L +L  + N +    P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 289 SLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLS 326
            L +L  L  + L+ N +    P  L N ++L ++TL+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 6e-07
 Identities = 39/221 (17%), Positives = 72/221 (32%), Gaps = 24/221 (10%)

Query: 240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
           P L N + +       + +  TV      L  + +L      +       +  L  L  L
Sbjct: 16  PALANAIKIA---AGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68

Query: 300 ALEINNLQGKIPSS------LGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN 353
            L+ N +    P            +   +  +S       +    L+ T ++    L+  
Sbjct: 69  ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 354 LLSGSLPSEIGNLKNLVQLDI-------SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGS 406
                L  ++  + N+  L         S           L+  + L  +K  DN  S  
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 407 IPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
            P  L  L ++  + L +N++S   P  L N S L  + L+
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 39/241 (16%), Positives = 82/241 (34%), Gaps = 28/241 (11%)

Query: 62  IPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNL 121
            PD    L   I +  G++  +  +  +  ++     +             + V  L NL
Sbjct: 13  FPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT---IEGVQYLNNL 65

Query: 122 RKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN 181
                  N +T       +   NL  +   +       +++  +          +    +
Sbjct: 66  IGLELKDNQITDL-----APLKNLTKITELELSGNPLKNVSAIAGLQ-------SIKTLD 113

Query: 182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPG 241
             +  +  VT LA  S L+ L L  NQ       +++ L+       +       +    
Sbjct: 114 LTSTQITDVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTP 168

Query: 242 LGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLAL 301
           L NL  L ++  + N++  +    +  L NL  ++L +N +    P  L N + L ++ L
Sbjct: 169 LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 302 E 302
            
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 32/202 (15%), Positives = 60/202 (29%), Gaps = 21/202 (10%)

Query: 269 LKNLQSLYLNSNFLHGYIPSS-LGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSK 327
           L N   +    + +   +  + L  +T L+     +  ++G     +    +LI L L  
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72

Query: 328 NKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISG----------- 376
           N++  + P + L+  T           +S     +     +L    I+            
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 377 --NRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY 434
                   I              +   +   S    L  L  +  L    NK+S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 435 LENLSFLEYLNLSYNHFEGEVP 456
           L +L  L  ++L  N      P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 33/235 (14%), Positives = 65/235 (27%), Gaps = 26/235 (11%)

Query: 141 NASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLE 200
             +N   +    +      ++    L  ++ L      +          +  +   + L 
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--------IEGVQYLNNLI 66

Query: 201 NLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG 260
            L L DNQ   L P         +          S          + L S  +     + 
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
            +        +L  +   S          L                     + L N + L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS-----------DLTPLANLSKL 175

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDIS 375
             L    NK+  + P  + S+  L   ++L +N +S   P  + N  NL  + ++
Sbjct: 176 TTLKADDNKISDISP--LASLPNLI-EVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 4/86 (4%)

Query: 91  YNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLEL 150
             ++    +   S           +ANL  L    A  N ++   P  L++  NL  + L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202

Query: 151 RDNQFIGKMSINFNSLKNLSVLILGN 176
           ++NQ          +  NL ++ L N
Sbjct: 203 KNNQISD--VSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 29/236 (12%), Positives = 78/236 (33%), Gaps = 26/236 (11%)

Query: 165 SLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTM 224
           +L N   +  G +        ++      A+   +  L  +      +    +  L+N +
Sbjct: 17  ALANAIKIAAGKS--------NVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNN-L 65

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
             +++  N  +   P      +    ++    + +  +           +    ++    
Sbjct: 66  IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125

Query: 285 YIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTL 344
              S+L  L +       I+ L G       +  +  +               + +++ L
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKL 175

Query: 345 SLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQD 400
           +      DN +S    S + +L NL+++ +  N+ S   P  L+  ++L  V + +
Sbjct: 176 TTLKA-DDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 4e-07
 Identities = 41/214 (19%), Positives = 73/214 (34%), Gaps = 30/214 (14%)

Query: 255 GNQLIGTVPPEIGW------LKNLQSLYLNSNFLHGYIPSS-LGNLTMLTLLALEINNLQ 307
           G++ I TVP  I                L    +   +  + L ++  +     +I ++Q
Sbjct: 4   GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ 62

Query: 308 GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF--------------LNLSDN 353
           G     +    ++  L L+ NKL  + P   L                        L   
Sbjct: 63  G-----IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117

Query: 354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNF 413
            L  +  S+I  L +L QL+      +     T+ +  +       +++    I P L  
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAG 176

Query: 414 LKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
           L  ++ L LS N +S    + L  L  L+ L L 
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 36/203 (17%), Positives = 72/203 (35%), Gaps = 20/203 (9%)

Query: 111 PFDMVANLPNLRKFVAA---KNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLK 167
           P   + +     + +     K ++T    ++ +  ++++ +   ++       I +  L 
Sbjct: 13  PIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQY--LP 68

Query: 168 NLSVLILGNN---------HLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLA 218
           N++ L L  N         +L N     LD   V    S  +   L            + 
Sbjct: 69  NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 219 NLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLN 278
            L +      +       T    L  L  L+++++E NQ+       +  L  LQ+LYL+
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLS 186

Query: 279 SNFLHGYIPSSLGNLTMLTLLAL 301
            N +      +L  L  L +L L
Sbjct: 187 KNHISD--LRALAGLKNLDVLEL 207

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 30/179 (16%), Positives = 59/179 (32%), Gaps = 7/179 (3%)

Query: 273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDG 332
            ++      L   IP  +      T L L  N L       L      ++    K     
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 333 VLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTS 392
            + P      +    L L +N +          L  L  L++  N+ S  +PG+     S
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 393 LEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHF 451
           L  + +  N F+ +   +  F + ++   L+        P  + ++      +L ++ F
Sbjct: 128 LTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEF 182

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (108), Expect = 3e-06
 Identities = 20/144 (13%), Positives = 49/144 (34%), Gaps = 9/144 (6%)

Query: 301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS-DNLLSGSL 359
           L+   ++ ++   +          L    L          +   ++ + L+  + ++ +L
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATL 57

Query: 360 PSEIGNLKNLVQLDISGNRFSG--DIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSI 417
                N+  L+ L++S NR     D+   +    +L+ + +  N               +
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 418 KVLDLSSNKLSGQIPKYLENLSFL 441
           + L L  N LS         +S +
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAI 141

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.4 bits (108), Expect = 8e-06
 Identities = 50/346 (14%), Positives = 97/346 (28%), Gaps = 32/346 (9%)

Query: 144 NLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLG 203
           +L+L  +        +        ++  ++L  N +G  AA  L     +A+   LE   
Sbjct: 9   SLKLDAITTED-EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIASKKDLEIAE 65

Query: 204 LYDNQ---FGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG 260
             D         +P +L  L   +                G      L     +   L  
Sbjct: 66  FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 261 TVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL 320
                 G      +    +         +     + +++        G +        S 
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185

Query: 321 IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS 380
            +L   K   +G+ P  I  +    L                       +Q +   +  S
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLA-------------YCQELKVLDLQDNTFTHLGS 232

Query: 381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSL------NFLKSIKVLDLSSNKLSGQIPKY 434
             +   L +  +L  + + D   S     ++           ++ L L  N++     + 
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 435 L-----ENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKL 475
           L     E +  L +L L+ N F  E     V   +  FS  G G+L
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSEE--DDVVDEIREVFSTRGRGEL 336

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.2 bits (97), Expect = 2e-04
 Identities = 41/356 (11%), Positives = 98/356 (27%), Gaps = 45/356 (12%)

Query: 22  FKLENLSLAENHLTGQ----LPVSIGNLSALQVIDIRGNRLGGK----IPDTLGQLRKLI 73
           F +E  SL  + +T +    +   +    +++ I + GN +G +    + + +   + L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 74  YLNIGRNQ----------FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRK 123
                                 +  ++        + L  N F  +    ++  L     
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 124 FVAAKNNLTGFLPISLSNASNLELLELRDNQFIG-----KMSINFNSLKNLSVLILGNNH 178
                 +  G  P + +  +        + +         +    N L+N S+       
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 179 LGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTI 238
             +R  + +  V        +E+L L    +   L       +               + 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 239 PPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTL 298
           P      ++   ++  G   +     +      LQ+L L  N +      +L        
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSK-LENIGLQTLRLQYNEIELDAVRTLKT------ 295

Query: 299 LALEINNLQGKIPSSLGNCTSLIMLTLSKNKL--DGVLPPQILSVTTLSLFLNLSD 352
                                L+ L L+ N+   +  +  +I  V +      L +
Sbjct: 296 -------------VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 338

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.4 bits (95), Expect = 3e-04
 Identities = 39/294 (13%), Positives = 89/294 (30%), Gaps = 23/294 (7%)

Query: 112 FDMVANLPNLRKFVAAKNNLTG----FLPISLSNASNLELLELRDNQFIGKMSINFNSLK 167
           F ++    ++++ V + N +      +L  ++++  +LE+ E  D            +L+
Sbjct: 24  FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR 83

Query: 168 NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLAN---LSNTM 224
            L   +L    L     +D  F                  +   L  + L          
Sbjct: 84  LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 143

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHG 284
              ++  N  +   PP    +   N +     +           L  ++ +         
Sbjct: 144 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 203

Query: 285 YIPSSLGNLTMLTLLALEINNLQ------GKIPSSLGNCTSLIMLTLSKNKLDGVLPPQI 338
                 G      L  L++ +          +  +L +  +L  L L+   L       +
Sbjct: 204 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263

Query: 339 LSVTTLS-----LFLNLSDNLLSGSLPSEI-----GNLKNLVQLDISGNRFSGD 382
           +   +         L L  N +       +       + +L+ L+++GNRFS +
Sbjct: 264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 6e-04
 Identities = 11/83 (13%), Positives = 27/83 (32%), Gaps = 11/83 (13%)

Query: 1   MFDAQNNKLVGDIPVEIGCYLF-----KLENLSLAENHLTGQLPVSI-----GNLSALQV 50
                +  L       +           L+ L L  N +      ++       +  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 51  IDIRGNRLGGKIPDTLGQLRKLI 73
           +++ GNR   +  D + ++R++ 
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 10/70 (14%), Positives = 27/70 (38%), Gaps = 6/70 (8%)

Query: 339 LSVTTLSL-FLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGD----IPGTLSACTSL 393
            S+   SL    ++      S+ + +    ++ ++ +SGN    +    +   +++   L
Sbjct: 3   FSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61

Query: 394 EYVKMQDNSF 403
           E  +  D   
Sbjct: 62  EIAEFSDIFT 71

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (101), Expect = 2e-05
 Identities = 22/137 (16%), Positives = 36/137 (26%), Gaps = 6/137 (4%)

Query: 240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLL 299
               N V    + + G + I  +      L    ++  + N +          L  L  L
Sbjct: 12  AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 300 ALEINNLQGKIPSSLGNCTSLIMLTLSKNK---LDGVLPPQILSVTTLSLFLNLSDNLLS 356
            +  N +             L  L L+ N    L  + P   L   T    L        
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 357 GSLPSEIGNLKNLVQLD 373
                 I  +  +  LD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 23/136 (16%), Positives = 43/136 (31%), Gaps = 3/136 (2%)

Query: 21  LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN 80
             +   L L    +   +      L     ID   N +  +  D    LR+L  L +  N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73

Query: 81  QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLS 140
           +           +     + L +N        D +A+L +L      +N +T      L 
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 141 NASNLELLELRDNQFI 156
               +  + + D Q +
Sbjct: 134 VIYKVPQVRVLDFQKV 149

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 33/190 (17%), Positives = 60/190 (31%), Gaps = 21/190 (11%)

Query: 269 LKNLQSLYLNSNFLHGYIPSS-LGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSK 327
           L       L    +   +  + L  +T L    L I ++ G     +    +L  +  S 
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71

Query: 328 NKLDGVLP-------------PQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDI 374
           N+L  + P                ++  T    L     L   +      +    +    
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 375 SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKY 434
                S  I    +        ++  +S   +    L  L +++ LD+SSNK+S      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 435 LENLSFLEYL 444
           L  L+ LE L
Sbjct: 190 LAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 29/191 (15%), Positives = 57/191 (29%), Gaps = 13/191 (6%)

Query: 116 ANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILG 175
             L    K V  K N+T    +S ++   +  L+      I  +      L NL+ +   
Sbjct: 15  TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLG-IKSID-GVEYLNNLTQINFS 70

Query: 176 NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS 235
           NN L +          V    +  +   +        L       +       +      
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 236 GTIPPGLGNLVHLNSIAMEGNQLIG-------TVPPEIGWLKNLQSLYLNSNFLHGYIPS 288
             +      +  +++++   +           T    +  L  L+ L ++SN +     S
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--IS 188

Query: 289 SLGNLTMLTLL 299
            L  LT L  L
Sbjct: 189 VLAKLTNLESL 199

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 1e-04
 Identities = 39/227 (17%), Positives = 59/227 (25%), Gaps = 15/227 (6%)

Query: 197 SKLENLGLYDNQFGGLLPHSLANLS-NTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEG 255
                L     +   +   + +         I                          + 
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 256 NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLG 315
           N L+   P     L NLQ L +++  +         +     LL ++ N     I  +  
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 316 NCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEI-GNLKNLVQLDI 374
              S   + L  NK             T    LNLSDN     LP+++       V LDI
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 375 SGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLD 421
           S  R        L     L                S   LK +  L+
Sbjct: 209 SRTRIHSLPSYGLENLKKLRAR-------------STYNLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 10/58 (17%), Positives = 18/58 (31%)

Query: 390 CTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLS 447
               E     +N+         +      +LD+S  ++       LENL  L   +  
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 6e-04
 Identities = 23/146 (15%), Positives = 44/146 (30%), Gaps = 3/146 (2%)

Query: 225 TTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEI-GWLKNLQSLYLNSNFLH 283
           + +    +         L    +L  + +E  Q +  +       L  L++L +  + L 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 284 GYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTT 343
              P +      L+ L L   N    +        SL  L LS N L      + L    
Sbjct: 70  FVAPDAFHFTPRLSRLNLS-FNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 344 LSLFLNLSDNLLSGSLPSEIGNLKNL 369
                 + +  L       + ++ N 
Sbjct: 129 EEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 7e-04
 Identities = 20/138 (14%), Positives = 41/138 (29%), Gaps = 6/138 (4%)

Query: 86  IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNL 145
               +    +   +++++ +    L    +  L  LR     K+ L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 146 ELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY 205
             L L  N            L    +++ GN    + A         L    +    G+ 
Sbjct: 83  SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRW------LQRWEEEGLGGVP 136

Query: 206 DNQFGGLLPHSLANLSNT 223
           + +        LA++ N 
Sbjct: 137 EQKLQCHGQGPLAHMPNA 154

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	869
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.51
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.71
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.57
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.85
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.72
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.68
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.68
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.28
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.09
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.5
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=421.97  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|+.+   ..||||+++..  .....+.+.+|++++++++|||||++++++..      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            468999999999999999999863   35999998643  34556789999999999999999999998643      45


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++.....     .+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            7999999999999999976543     389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      +|+.......      ........||+.|||||++.+   ..++.++|||||||++|||+||+.||..............
T Consensus       150 la~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~  223 (276)
T d1uwha_         150 LATVKSRWSG------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG  223 (276)
T ss_dssp             CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ceeeccccCC------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence            9987654321      122345679999999999864   3589999999999999999999999975432211111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFV  862 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  862 (869)
                      +...+...                       ......+++.+.+++.+||+.||++||||+||++.|+.+.++.+
T Consensus       224 ~~~~~p~~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         224 RGYLSPDL-----------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HTSCCCCG-----------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cCCCCCcc-----------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11111000                       00112345678899999999999999999999999999987643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=419.07  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.     +..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence            4799999999999999999999999999999999876666667899999999999999999999997654     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++....       +++.++..++.||+.||+|||++   ||+||||||+|||++.++++||+|||+|+
T Consensus        95 vmEy~~gg~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            999999999999887643       89999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .+....        .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .........   
T Consensus       165 ~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~---  232 (293)
T d1yhwa1         165 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNG---  232 (293)
T ss_dssp             ECCSTT--------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHC---
T ss_pred             eecccc--------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCC---
Confidence            765432        22345679999999999999999999999999999999999999996532111 111111100   


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                       ...                     ...++.++..+.+++.+||+.||++|||++|+++
T Consensus       233 -~~~---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 -TPE---------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SCC---------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCC---------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000                     0011234456889999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=417.13  Aligned_cols=254  Identities=20%  Similarity=0.291  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++... .+..+.+.+|++++++++||||+++++++.+.     +..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence            357999999999999999999999999999999996543 23346789999999999999999999997654     789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++....      .+++.+++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence            99999999999999997654      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+.......      .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.................
T Consensus       150 a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~  223 (271)
T d1nvra_         150 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  223 (271)
T ss_dssp             CEECEETTE------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred             heeeccCCc------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence            987643321      122345679999999999988776 5789999999999999999999976443322222221111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..                          .......++++.+++.+||+.||++|||++|+++
T Consensus       224 ~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 TY--------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TT--------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00                          0011123456779999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=412.16  Aligned_cols=246  Identities=22%  Similarity=0.350  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++...   .....+.+.+|++++++++||||+++++++.+.     +.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence            5799999999999999999999999999999998643   233457789999999999999999999997653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence            999999999999999998754      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.....
T Consensus       152 ~a~~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i  216 (263)
T d2j4za1         152 WSVHAPSSR----------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRI  216 (263)
T ss_dssp             SCSCCCCCC----------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred             eeeecCCCc----------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHH
Confidence            997654322          2345699999999999999999999999999999999999999975321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....                        ..++.+++++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~~~------------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         217 SRVEF------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HTTCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCC------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            11100                        000123456789999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=413.91  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=199.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++||||++++|+|...     +..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence            57888999999999999999996 78899999997533 3347799999999999999999999998653     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....     .+++..+..++.|||+||+|||++   +|+||||||+||++++++.+||+|||+|+
T Consensus        78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999887654     389999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC-CCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...     ...+.......
T Consensus       150 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~  217 (263)
T d1sm2a_         150 FVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDIST  217 (263)
T ss_dssp             ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHH
T ss_pred             eccCCCc-------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHh
Confidence            7654321       222345689999999999999999999999999999999995 4444321     11122111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ..  ...                     .+..+++++.+++.+||+.||++||||+||++.|+++.++
T Consensus       218 ~~--~~~---------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         218 GF--RLY---------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             TC--CCC---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cC--CCC---------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            00  000                     1112345688999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=414.49  Aligned_cols=258  Identities=21%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..  .+...+.+.+|++++++++|||||++++++.+.   .....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            6799999999999999999999999999999999654  334456789999999999999999999987642   23568


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCcEEEccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC--KPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ++||||+++|+|.+++......  ...+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            9999999999999998753211  224999999999999999999999971  113999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+......        .......||+.|+|||++.+..+++++|||||||++|||+||+.||.....     .+....
T Consensus       159 G~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~  225 (269)
T d2java1         159 GLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGK  225 (269)
T ss_dssp             HHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH
T ss_pred             cceeecccCC--------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHH
Confidence            9998765432        223446799999999999999999999999999999999999999975322     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ........                       .+..+++++.+++.+||+.||++|||++|+++
T Consensus       226 i~~~~~~~-----------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 IREGKFRR-----------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHTCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCC-----------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11111100                       00123456889999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=406.60  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      +..++||+|+||+||+|++..+++.||+|++...  .....+.+.+|++++++++|||||++++++.+. ..+....++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            5567899999999999999999999999998643  334456789999999999999999999998653 3445678999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCcEEEccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD-HDMVAHVGDFGLAK  713 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  713 (869)
                      |||+++|+|.+++....      .+++..++.++.||++||+|||++ +++|+||||||+|||++ +++.+||+|||+|+
T Consensus        91 mE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999998754      389999999999999999999998 12299999999999996 57899999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhccc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPE  793 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  793 (869)
                      .....          ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......    ....+.....
T Consensus       164 ~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~~~  228 (270)
T d1t4ha_         164 LKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSG  228 (270)
T ss_dssp             GCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTT
T ss_pred             eccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHHcC
Confidence            54332          2334679999999999875 6999999999999999999999999643221    1111111111


Q ss_pred             ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          794 KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       794 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....                      .....++++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKPAS----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCCGG----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcc----------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            00000                      01122345789999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=417.39  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      +.|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.     +..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence            4688999999999999999999999999999999876666778899999999999999999999997654     78999


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....     ++++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999876433     389999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccC-----CCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT-----GSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ......        .......||+.|+|||++.     +..|+.++||||+||++|||+||+.||....... .......
T Consensus       159 ~~~~~~--------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~  229 (288)
T d2jfla1         159 KNTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK  229 (288)
T ss_dssp             ECHHHH--------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH
T ss_pred             ccCCCc--------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence            543211        1223467999999999874     4568999999999999999999999997543221 1111111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...    .                     ....+..++.++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~----~---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         230 SEP----P---------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SCC----C---------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC----C---------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100    0                     00111234556889999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-49  Score=414.80  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=199.4

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe---EEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM---LVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.++||+|+||+||+|+++.+++   .||||.+... .....+.+.+|++++++++|||||+++|++...     +
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            456777899999999999999976654   6899988643 344557899999999999999999999997653     6


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....     .+++.++..++.|||+||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence            78999999999999999887554     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+..........   ........||+.|+|||.+.++.++.++|||||||++|||+| |+.||......     +...
T Consensus       173 Gla~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~  244 (299)
T d1jpaa_         173 GLSRFLEDDTSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVIN  244 (299)
T ss_dssp             --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred             ccceEccCCCCcce---eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            99987755432111   112233568999999999999999999999999999999998 89998753221     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      .+...                       ...+.+.+++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       245 ~i~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         245 AIEQD-----------------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHTT-----------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcC-----------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            11110                       00111123556788999999999999999999999999988764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=410.00  Aligned_cols=267  Identities=24%  Similarity=0.364  Sum_probs=213.8

Q ss_pred             cCCCCCC-eeeeecceEEEEEEEC--CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSN-MVGQGSFGTVFKGIIG--ENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|.+.+ +||+|+||+||+|.++  .++..||||+++.. .....+++.+|++++++++|||||++++++..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            4555666 4999999999999875  34568999999644 34456789999999999999999999999753      4


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++...+.     .+++.++..++.||++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            57999999999999999876543     389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~  788 (869)
                      |+|+.+......     ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......     +...
T Consensus       154 Gla~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~  223 (285)
T d1u59a_         154 GLSKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMA  223 (285)
T ss_dssp             TTCEECTTCSCE-----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHH
T ss_pred             hhhhcccccccc-----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            999987654321     122334568999999999998899999999999999999998 99999753221     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcccCC
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSMQDG  867 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~  867 (869)
                      .+....                       ..+.++.+++++.+++.+||+.||++|||+.+|++.|+.+..+..+..++
T Consensus       224 ~i~~~~-----------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~  279 (285)
T d1u59a_         224 FIEQGK-----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  279 (285)
T ss_dssp             HHHTTC-----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHHcCC-----------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence            111000                       01111235567889999999999999999999999999888776655443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-50  Score=419.97  Aligned_cols=261  Identities=25%  Similarity=0.445  Sum_probs=212.6

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ..++|++.+.||+|+||+||+|++..+|+.||||+++... ...+++.+|++++++++|||||+++++|.+.     +..
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Cee
Confidence            4568999999999999999999999899999999986543 3457899999999999999999999997643     678


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+++|+|.+++.....    ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             EEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence            999999999999999976543    2489999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      |+.......       .......|++.|+|||++.+..++.++|||||||++|||++|..||.....    .....+...
T Consensus       162 a~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~i~  230 (287)
T d1opja_         162 SRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLE  230 (287)
T ss_dssp             TTTCCSSSS-------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHH
T ss_pred             eeecCCCCc-------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHHHh
Confidence            987654321       222345688999999999999999999999999999999998777643221    111111111


Q ss_pred             ccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          792 PEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       792 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      .. .                      ..+.++.+++.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus       231 ~~-~----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         231 KD-Y----------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TT-C----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             cC-C----------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            00 0                      001112345678899999999999999999999999988754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=409.49  Aligned_cols=258  Identities=24%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||++++++.+      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            457889999999999999999986 78899999997543 334679999999999999999999998753      4568


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|.+++.....    ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence            99999999999998765432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      +.......       .......||+.|+|||++.++.++.++|||||||++|||+||..|+.....    ..+.......
T Consensus       157 ~~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~~  225 (272)
T d1qpca_         157 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLER  225 (272)
T ss_dssp             EECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHT
T ss_pred             EEccCCcc-------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHHHh
Confidence            87754321       223345689999999999988999999999999999999997666543221    1111111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAARE  859 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  859 (869)
                      ..                       ....+..+++++.+++.+||+.||++||||+||++.|+....
T Consensus       226 ~~-----------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         226 GY-----------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC-----------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            00                       000111345568899999999999999999999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=418.10  Aligned_cols=200  Identities=26%  Similarity=0.408  Sum_probs=177.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.++||+|+||+||+|++..+|+.||+|+++.. ......++.+|+.++++++|||||++++++.+.     ...
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            57899999999999999999999999999999999754 334457789999999999999999999997654     789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      ++||||+++|+|.+++.+..      .+++..++.++.|+++||.|||+ +   +|+||||||+|||++.+|.+||+|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            99999999999999998654      38999999999999999999997 5   89999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcC
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSM  776 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~  776 (869)
                      +|+.....          .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       151 la~~~~~~----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         151 VSGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCHHHHHH----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CccccCCC----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99865332          223467999999999999999999999999999999999999999753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=406.97  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCC----eEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENG----MLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      +.|+..++||+|+||+||+|.++.++    ..||||+++... ......+.+|++++++++|||||+++|++.+.     
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            56888899999999999999986544    579999996433 33456789999999999999999999997653     


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+.+|++.+++.....     .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D  153 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  153 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence            678999999999999998877654     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+|+.+......     ........||+.|+|||++.++.++.++|||||||++|||++|..|+......    .+..+
T Consensus       154 FGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~  224 (283)
T d1mqba_         154 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMK  224 (283)
T ss_dssp             CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH
T ss_pred             cchhhcccCCCcc-----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHH
Confidence            9999876543211     12233456899999999999999999999999999999999976665432211    11111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      .....                       ...+.+.+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       225 ~i~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         225 AINDG-----------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHTT-----------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHhcc-----------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            11110                       00111123456788999999999999999999999999988765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=396.50  Aligned_cols=253  Identities=24%  Similarity=0.404  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.++||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||++++|+|.+.     +..++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEE
Confidence            68999999999999999999996 889999999976443 346899999999999999999999997653     67899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|++.+++.....     .+++..+++++.||++||+|||++   ||+||||||+||+++.++.+||+|||+|+
T Consensus        77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999999999776554     389999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .......       .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......     +....+..
T Consensus       149 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~i~~  216 (258)
T d1k2pa_         149 YVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQ  216 (258)
T ss_dssp             BCSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHT
T ss_pred             eccCCCc-------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHHHHh
Confidence            7654321       22334568999999999999999999999999999999998 89999754322     22211111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCA  856 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  856 (869)
                      ..  ..                     ..+..+++++.+++.+||+.||++|||++|+++.|..
T Consensus       217 ~~--~~---------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 GL--RL---------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TC--CC---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC--CC---------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            00  00                     0111234578899999999999999999999998854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=409.05  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|++++++++||||+++++++.+     .+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence            5799999999999999999999999999999999643   23445778999999999999999999999754     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            999999999999999988765      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+.....      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .......
T Consensus       154 ~a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i  222 (288)
T d1uu3a_         154 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKI  222 (288)
T ss_dssp             TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             cceecccCCc------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHH
Confidence            9987754321      1223345799999999999999999999999999999999999999975321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..... . +                      ++..++.+.+++.+||+.||++|||++|+++.
T Consensus       223 ~~~~~-~-~----------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         223 IKLEY-D-F----------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HTTCC-C-C----------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HcCCC-C-C----------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            11100 0 0                      01234467899999999999999999997653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=401.84  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             CeeeeecceEEEEEEEC--CCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEEe
Q 002897          560 NMVGQGSFGTVFKGIIG--ENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIVY  635 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  635 (869)
                      ++||+|+||+||+|.+.  .+++.||||+++..  +....+++.+|++++++++|||||+++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            47999999999999864  35678999999643  33445789999999999999999999999753      3468999


Q ss_pred             ecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccccC
Q 002897          636 DFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  715 (869)
Q Consensus       636 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  715 (869)
                      ||+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            9999999999998765      389999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcccc
Q 002897          716 PARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      ......     ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     .+....+....
T Consensus       158 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~~~~  227 (277)
T d1xbba_         158 RADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGE  227 (277)
T ss_dssp             CTTCSE-----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC
T ss_pred             cccccc-----cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHHcCC
Confidence            544311     122334568999999999999999999999999999999998 8999975321     11111111100


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                                             ..+.+..++.++.+++.+||+.||++|||++||++.|+......
T Consensus       228 -----------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 -----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                                   00111234567889999999999999999999999988765443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-48  Score=410.31  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=190.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++|||||++++++.+     .+..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            457999999999999999999999999999999996443 2334567899999999999999999999754     3789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCcEEEcc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD---HDMVAHVGD  708 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D  708 (869)
                      ++||||+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||++.   +++.+||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence            99999999999999998654      399999999999999999999999   999999999999994   578999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      ||+|+......         .....+||+.|+|||++.+..+++++||||+||++|||++|+.||......     ....
T Consensus       154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~  219 (307)
T d1a06a_         154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLFE  219 (307)
T ss_dssp             C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH
T ss_pred             cceeEEccCCC---------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            99998654332         223457999999999999999999999999999999999999999753221     1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ........  .                  ..+..+..++++.+++.+||+.||++|||++|+++
T Consensus       220 ~i~~~~~~--~------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         220 QILKAEYE--F------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHTTCCC--C------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhccCCC--C------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11111000  0                  00111234456889999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-48  Score=413.48  Aligned_cols=253  Identities=21%  Similarity=0.292  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++.+.     +..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            45899999999999999999999999999999999776666667889999999999999999999997653     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH--DMVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg  710 (869)
                      +|||||++|+|.+++.....     .+++..++.++.||+.||+|||++   +||||||||+|||++.  ++.+||+|||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            99999999999999965543     399999999999999999999999   9999999999999964  5789999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+....         ......||+.|||||++.+..++.++||||+||++|||++|+.||.....     .+.....
T Consensus       172 ~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i  237 (350)
T d1koaa2         172 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNV  237 (350)
T ss_dssp             TCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             hheeccccc---------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            998765432         22345799999999999999999999999999999999999999975321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ......  .+.                  .....+++.+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~--~~~------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         238 KSCDWN--MDD------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHTCCC--SCC------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HhCCCC--CCc------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110000  000                  011123456789999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-48  Score=405.18  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ..|+..+.||+|+||+||+|++..+|+.||||+++...   ....+.+.+|++++++++|||||++++++.+.     +.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence            35889999999999999999999999999999996543   33456789999999999999999999997654     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++|||||++|++..++....      ++++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence            999999999999987776554      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCC---CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG---SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      +|+....            .....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||......    ..+.
T Consensus       161 ~a~~~~~------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~  224 (309)
T d1u5ra_         161 SASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY  224 (309)
T ss_dssp             TCBSSSS------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH
T ss_pred             cccccCC------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----HHHH
Confidence            9975432            223569999999999864   45899999999999999999999999643211    1111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      . ..........                      ...+++.+.+++.+||+.||++|||++|+++
T Consensus       225 ~-i~~~~~~~~~----------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         225 H-IAQNESPALQ----------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             H-HHHSCCCCCS----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             H-HHhCCCCCCC----------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1 1111000000                      0123456889999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-47  Score=410.50  Aligned_cols=253  Identities=18%  Similarity=0.268  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+     .+..+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3579999999999999999999999999999999976655556788999999999999999999999754     47899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD--HDMVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg  710 (869)
                      +|||||++|+|.+++.....     ++++.+++.++.||+.||+|||++   ||+||||||+|||++  .++.+||+|||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999999999998876543     389999999999999999999999   999999999999997  57899999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.+....         ......||+.|+|||++.+..++.++||||+||++|||+||+.||....... .........
T Consensus       175 la~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~  244 (352)
T d1koba_         175 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCD  244 (352)
T ss_dssp             TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCC
T ss_pred             cceecCCCC---------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence            998775432         2234568999999999999999999999999999999999999997532211 111111110


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..      ..                  ......++.++.+++.+||+.||++|||++|+++
T Consensus       245 ~~------~~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 WE------FD------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CC------CC------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CC------CC------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      00                  0011123456789999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=411.16  Aligned_cols=263  Identities=22%  Similarity=0.346  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC-----eEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG-----MLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.++||+|+||+||+|++...+     ..||+|++... .......+.+|+.+++++ +|||||++++++.+.  
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            367899999999999999999986443     37999998543 344457789999999998 899999999997653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc-----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL-----------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVH  688 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  688 (869)
                         +..++||||+++|+|.++++......                 ....+++..++.++.||++||+|||++   +|||
T Consensus       114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence               67899999999999999998764321                 123489999999999999999999999   9999


Q ss_pred             cCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc
Q 002897          689 GDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS  768 (869)
Q Consensus       689 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t  768 (869)
                      |||||+||+++.++.+||+|||+|+........      .......||+.|||||++.++.++.++|||||||++|||+|
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCce------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence            999999999999999999999999865443211      12234568999999999999999999999999999999998


Q ss_pred             -CCCCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002897          769 -RRRPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQM  847 (869)
Q Consensus       769 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  847 (869)
                       |+.||...... ..+.........                          .+.+..+++++.+++.+||+.||++|||+
T Consensus       262 ~g~~Pf~~~~~~-~~~~~~~~~~~~--------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         262 LGVNPYPGIPVD-ANFYKLIQNGFK--------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             TSCCSSTTCCCS-HHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCCHH-HHHHHHHhcCCC--------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence             89999754322 112222111100                          01112345678899999999999999999


Q ss_pred             HHHHHHHHH
Q 002897          848 RDVVVKLCA  856 (869)
Q Consensus       848 ~evl~~L~~  856 (869)
                      +||++.|..
T Consensus       315 ~ei~~~L~~  323 (325)
T d1rjba_         315 PNLTSFLGC  323 (325)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhC
Confidence            999999853

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=399.89  Aligned_cols=252  Identities=20%  Similarity=0.278  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ------KGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+    
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----   84 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----   84 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence            357999999999999999999999999999999996432      1235788999999999999999999999765    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM----  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  702 (869)
                       .+..++|||||++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        85 -~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          85 -KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred             -CCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence             378999999999999999998754      399999999999999999999999   999999999999998877    


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCch
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLT  782 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~  782 (869)
                      .+|++|||+|.......         ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   
T Consensus       155 ~vkl~DfG~a~~~~~~~---------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---  222 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---  222 (293)
T ss_dssp             CEEECCCTTCEECTTSC---------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             ceEecchhhhhhcCCCc---------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---
Confidence            59999999998765432         233457899999999999999999999999999999999999999753211   


Q ss_pred             HHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          783 LHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       783 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                        +..........      .              ........++..+.+++.+||+.||++|||++|+++
T Consensus       223 --~~~~~i~~~~~------~--------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         223 --ETLANVSAVNY------E--------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --HHHHHHHTTCC------C--------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --HHHHHHHhcCC------C--------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11111110000      0              001111234566889999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-47  Score=397.73  Aligned_cols=266  Identities=18%  Similarity=0.325  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..   +....+.+.+|+++++.++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            46799999999999999999999999999999999643   2344567899999999999999999999987642 2335


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+||||+++|+|.+++....      ++++.+++.++.||++||+|||++   +|+||||||+||+++.++.++++||
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred             eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence            6899999999999999987765      389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.+........     .........||+.|+|||++.+..+++++||||+||++|||+||+.||......     +....
T Consensus       156 ~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~  225 (277)
T d1o6ya_         156 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQ  225 (277)
T ss_dssp             TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH
T ss_pred             hhhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHH
Confidence            99876644321     112344567999999999999999999999999999999999999999753221     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-QMRDVVVKLCAAR  858 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  858 (869)
                      ......   ..+                 ....+.+++++.+++.+||+.||++|| |++|+++.|.+++
T Consensus       226 ~~~~~~---~~~-----------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         226 HVREDP---IPP-----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHCCC---CCG-----------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHhcCC---CCC-----------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            110000   000                 000112445688999999999999999 8999999998875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=403.00  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      .++|++.+.||+|+||.||+|+++.+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+     .+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----cc
Confidence            36799999999999999999999999999999999743   23456788999999999999999999999765     47


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+++|+|.+++.....      +++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence            89999999999999999987653      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |+|+......        ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.....     .+..+.
T Consensus       150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~  216 (337)
T d1o6la_         150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFEL  216 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             ccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHH
Confidence            9998654322        223456799999999999999999999999999999999999999975322     111111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      ......                        ..+..++.++.+++.+||+.||++||+     ++|+++
T Consensus       217 i~~~~~------------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         217 ILMEEI------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHCCC------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhcCCC------------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            111100                        001123456789999999999999995     788876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=402.65  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCe----EEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGM----LVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      ++|++.++||+|+||+||+|++..+|+    +||+|.++.. .....+.+.+|++++++++|||||+++++|.+      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            479999999999999999999987775    5888887543 34456789999999999999999999999865      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      ...++++||+.+|+|.+++.....     .+++..++.++.|||+||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             CCeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence            346788999999999999887654     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+|+.......      ........||+.|+|||++.++.++.++|||||||++|||+| |++||+......  +....
T Consensus       155 FGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i  226 (317)
T d1xkka_         155 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL  226 (317)
T ss_dssp             CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH
T ss_pred             cccceecccccc------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH
Confidence            999987755321      122334568999999999999999999999999999999998 788887532221  11111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ....                          ..+.++.++..+.+++.+||+.||++|||+.||++.|..+.+.
T Consensus       227 ~~~~--------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         227 EKGE--------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHTC--------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HcCC--------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            1100                          0011123456788999999999999999999999999887653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=390.43  Aligned_cols=253  Identities=30%  Similarity=0.387  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.++||+|+||.||+|++  .|+.||||+++..  ...+.+.+|++++++++||||++++|+|.+.    .+..++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEE
Confidence            5688889999999999999999  5889999999653  3447899999999999999999999987542    356799


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||+++|+|.+++.....    ..+++..+++|+.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        79 v~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence            9999999999999976432    2489999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      .....           .....++..|+|||++.++.+++++|||||||++|||+| |++||......  .....   +..
T Consensus       152 ~~~~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~---i~~  215 (262)
T d1byga_         152 EASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR---VEK  215 (262)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH---HTT
T ss_pred             ecCCC-----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHH---HHc
Confidence            64332           223457899999999998999999999999999999998 67777643222  11111   111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ..                       ..+.++.+++++.+++.+||+.||++||||.|+++.|+.++..
T Consensus       216 ~~-----------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         216 GY-----------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             TC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-----------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            00                       0011113345688999999999999999999999999988653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=396.67  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++|||||++++++.+      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            367999999999999999999997 567899999965433 34789999999999999999999999743      3468


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLA  712 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  712 (869)
                      +||||+++|+|..++.....    ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEecCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence            99999999999999876432    2489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      +.......       .......||+.|+|||++.++.++.++|||||||++|||++|..|+......    .+.......
T Consensus       161 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i~~  229 (285)
T d1fmka3         161 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER  229 (285)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT
T ss_pred             hhccCCCc-------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHHh
Confidence            87654321       2233456899999999999999999999999999999999977665432221    111111110


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                      ..                       ..+.++.+++++.+++.+||+.||++||||+||++.|+...
T Consensus       230 ~~-----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 GY-----------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TC-----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             cC-----------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            00                       00111234567889999999999999999999998887654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=392.22  Aligned_cols=259  Identities=21%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN---GMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGV  628 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  628 (869)
                      .++|++.+.||+|+||+||+|++..+   +..||||.++.. .....+.+.+|++++++++||||+++++++.+      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35789999999999999999998643   457899998643 33445779999999999999999999999743      


Q ss_pred             ceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcc
Q 002897          629 DFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGD  708 (869)
Q Consensus       629 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  708 (869)
                      +..++||||+++|++.+++.....     .+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence            467999999999999999876553     389999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHhh
Q 002897          709 FGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~~  787 (869)
                      ||+|+.......       .......||+.|+|||++.+..++.++|||||||++|||+| |.+||....... ......
T Consensus       152 fG~a~~~~~~~~-------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~  223 (273)
T d1mp8a_         152 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE  223 (273)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH
T ss_pred             chhheeccCCcc-------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHH
Confidence            999987654321       22334568999999999999999999999999999999998 899987543221 111111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...    .                       .+.+..++..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       224 ~~~----~-----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         224 NGE----R-----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TTC----C-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCC----C-----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            100    0                       011123456788999999999999999999999999998765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=393.80  Aligned_cols=283  Identities=22%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHH--HHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLT--ECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .+|...++||+|+||+||+|++  +|+.||||+++....   +.+.+  |+..+..++||||+++++++.+.+ ......
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            4677888999999999999998  799999999864332   33444  444556789999999999987652 233568


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCcEEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-----KPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      ++||||+++|+|.+++++..       +++..+++++.|+|.||+|+|+..     .++|+||||||+|||++.++.+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEecccCCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            99999999999999998753       899999999999999999999731     238999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC------CCccccchhhhHHHHHHHcCCCCCCcCccCC
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE------ASMTGDVYSFGILLLEMFSRRRPTDSMFHEG  780 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~el~tg~~pf~~~~~~~  780 (869)
                      +|||+++........    .........||+.|+|||++.+..      ++.++|||||||++|||+||..||.......
T Consensus       150 ~DFGl~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         150 ADLGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CCCTTCEEEETTTTE----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             EecCccccccCCCcc----eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            999999877543311    112334567999999999987642      5778999999999999999998876433221


Q ss_pred             chHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          781 LTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...........  ..     .......................+.+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       226 ~~~~~~~~~~~--~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         226 LPYYDLVPSDP--SV-----EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CTTTTTSCSSC--CH-----HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhhcccccc--hH-----HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11111000000  00     000000000000011112223345677899999999999999999999999999998865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=393.91  Aligned_cols=262  Identities=25%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             CCeeeeecceEEEEEEECCCC---eEEEEEEeec-ccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEEE
Q 002897          559 SNMVGQGSFGTVFKGIIGENG---MLVAVKVLNL-MQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAIV  634 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  634 (869)
                      .++||+|+||+||+|++..++   ..||||+++. ......+++.+|++++++++||||++++|++...    +...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence            468999999999999986443   3699999964 3455568899999999999999999999997653    2578999


Q ss_pred             eecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccccccc
Q 002897          635 YDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAKF  714 (869)
Q Consensus       635 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  714 (869)
                      |||+++|+|.+++.....     ..++..++.++.|+++||.|+|+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus       108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence            999999999999987654     378899999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcccc
Q 002897          715 LPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLPEK  794 (869)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  794 (869)
                      ........    ........||+.|+|||.+.++.++.++||||||+++|||+||+.||.................    
T Consensus       180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~----  251 (311)
T d1r0pa_         180 MYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----  251 (311)
T ss_dssp             TTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC----
T ss_pred             cccccccc----ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----
Confidence            76543211    1233446789999999999999999999999999999999998888764322211111111110    


Q ss_pred             cccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhc
Q 002897          795 VMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVS  863 (869)
Q Consensus       795 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  863 (869)
                        ..                     ..++.+++.+.+++.+||+.||++||||.||++.|+++.+.+..
T Consensus       252 --~~---------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         252 --RL---------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             --CC---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             --CC---------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence              00                     01112345688999999999999999999999999999887654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-46  Score=396.29  Aligned_cols=245  Identities=26%  Similarity=0.323  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+++.++||||+++++++.+     .+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence            5799999999999999999999999999999999643   23445788999999999999999999999765     378


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+++|++..++.....      +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeeEeeecCCcccccccccccc------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence            9999999999999999987764      78999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.....           .....||+.|+|||++.+..++.++||||+||++|||+||+.||.....     .+.....
T Consensus       150 ~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i  213 (316)
T d1fota_         150 FAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKI  213 (316)
T ss_dssp             SCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred             cceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHH
Confidence            99876432           2345799999999999999999999999999999999999999975321     1111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .....                        ..+...++++.+++.+||+.||++||     |++|+++
T Consensus       214 ~~~~~------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         214 LNAEL------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHCCC------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HcCCC------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            11100                        00012334577999999999999996     8999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-47  Score=398.49  Aligned_cols=265  Identities=24%  Similarity=0.387  Sum_probs=209.7

Q ss_pred             HhcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeecccc
Q 002897          552 ATSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDF  625 (869)
Q Consensus       552 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  625 (869)
                      ..++|++.+.||+|+||+||+|++.     .+++.||||+++... .+..+++.+|++++++++||||++++++|...  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence            4568999999999999999999974     356899999996543 33457799999999999999999999997653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVV  687 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  687 (869)
                         ...++||||+++|+|.+++.......                  ....+++..+..++.|++.||+|||++   +||
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence               67899999999999999997643211                  123489999999999999999999999   999


Q ss_pred             ecCCCCCceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHH
Q 002897          688 HGDLKPSNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMF  767 (869)
Q Consensus       688 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~  767 (869)
                      ||||||+|||++.++.+||+|||+|+.......      ........|++.|+|||.+.+..++.++|||||||++|||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell  236 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  236 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCcc------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence            999999999999999999999999986644321      12233456889999999999999999999999999999999


Q ss_pred             cCC-CCCCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC
Q 002897          768 SRR-RPTDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ  846 (869)
Q Consensus       768 tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  846 (869)
                      +|. +||.....     .+....+......                       +.++.++.++.+++.+||+.||++|||
T Consensus       237 ~~~~~p~~~~~~-----~e~~~~v~~~~~~-----------------------~~p~~~~~~~~~li~~cl~~~P~~RPt  288 (301)
T d1lufa_         237 SYGLQPYYGMAH-----EEVIYYVRDGNIL-----------------------ACPENCPLELYNLMRLCWSKLPADRPS  288 (301)
T ss_dssp             TTTCCTTTTSCH-----HHHHHHHHTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ccCCCCCCCCCH-----HHHHHHHHcCCCC-----------------------CCCccchHHHHHHHHHHcCCChhHCcC
Confidence            986 56654321     1111111111100                       011234557889999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 002897          847 MRDVVVKLCAAR  858 (869)
Q Consensus       847 ~~evl~~L~~~~  858 (869)
                      |.||++.|+++.
T Consensus       289 ~~ev~~~L~~i~  300 (301)
T d1lufa_         289 FCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhc
Confidence            999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-46  Score=384.33  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc---------hhhHHHHHHHHHHHhCC-CCccceEEEEeecc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK---------GALKSFLTECEALRSIR-HRNLIKIITICSSI  623 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  623 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            689999999999999999999999999999999964321         22356889999999996 9999999999764 


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMV  703 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  703 (869)
                          .+..|+||||+++|+|.++++...      ++++.+++.++.||++||+|||++   +|+||||||+||+++.++.
T Consensus        82 ----~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          82 ----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             ----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             ----CcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence                488999999999999999998654      399999999999999999999999   9999999999999999999


Q ss_pred             EEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccC------CCCCCccccchhhhHHHHHHHcCCCCCCcCc
Q 002897          704 AHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGT------GSEASMTGDVYSFGILLLEMFSRRRPTDSMF  777 (869)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~el~tg~~pf~~~~  777 (869)
                      +||+|||+|+......         ......||+.|+|||.+.      ...++.++||||+||++|||++|+.||....
T Consensus       149 ~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         149 IKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             EEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eEEccchheeEccCCC---------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            9999999998775432         223457999999999874      3357889999999999999999999997532


Q ss_pred             cCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          778 HEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..     ............ .                   ..+....+++++.+++.+||+.||++|||++||++
T Consensus       220 ~~-----~~~~~i~~~~~~-~-------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         220 QM-----LMLRMIMSGNYQ-F-------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HH-----HHHHHHHHTCCC-C-------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH-----HHHHHHHhCCCC-C-------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            21     111111111100 0                   00111234567889999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.7e-46  Score=397.50  Aligned_cols=249  Identities=23%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc---chhhHHHH---HHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ---KGALKSFL---TECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.   .|+.+++.++|||||++++++.+.    
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~----   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP----   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence            57999999999999999999999999999999986322   12223333   446677778899999999997653    


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       +..|+||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus        80 -~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          80 -DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred             -CEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence             78999999999999999998754      389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |||+|+......          .....||+.|+|||++.. ..++.++||||+||++|||+||+.||.......  ....
T Consensus       150 DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~  217 (364)
T d1omwa3         150 DLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEI  217 (364)
T ss_dssp             CCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHH
T ss_pred             eeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            999998765432          234579999999999865 468999999999999999999999997543221  1111


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQ-----MRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  852 (869)
                      .+.......                        ..+..+++++.+++.+||+.||++|||     |+|+++
T Consensus       218 ~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         218 DRMTLTMAV------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHSSSCCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHhcccCCC------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            111111100                        001123456789999999999999999     688865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=395.32  Aligned_cols=257  Identities=19%  Similarity=0.262  Sum_probs=202.7

Q ss_pred             hcCCCCCC-eeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSN-MVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|.+.. .||+|+||+||+|++..+|+.||||+++.     ...+.+|++++.++ +|||||++++++.+. ......
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            46788765 69999999999999999999999999853     25577899987655 899999999987653 234477


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVG  707 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  707 (869)
                      .|+|||||++|+|.+++.....    ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.   .+.+||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            8999999999999999986532    2489999999999999999999999   9999999999999985   5679999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFS  787 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~  787 (869)
                      |||+|+......         ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||........ .....
T Consensus       157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~  226 (335)
T d2ozaa1         157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMK  226 (335)
T ss_dssp             CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred             ccceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHH
Confidence            999998765432         22345799999999999999999999999999999999999999975322111 11111


Q ss_pred             hhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          788 KMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       788 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ....... .                   ....+....+++++.+++.+||+.||++|||+.|+++
T Consensus       227 ~~i~~~~-~-------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQ-Y-------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCS-S-------------------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCC-C-------------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1000000 0                   0011122345677899999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=392.84  Aligned_cols=258  Identities=27%  Similarity=0.380  Sum_probs=198.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECC-C--CeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCC
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGE-N--GMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNG  627 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  627 (869)
                      ++|++.+.||+|+||+||+|++.. +  ...||||+++..   ..+..+++.+|+.++++++||||++++|++.+     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            578999999999999999998642 2  347899998643   34455789999999999999999999999754     


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                       ...++||||+++|++.+++.....     .+++..+..++.|||+||+|||++   +|+||||||+||+++.++.+||+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             -cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence             346899999999999998876543     399999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~pf~~~~~~~~~~~~~  786 (869)
                      |||+++.........     .......|+..|+|||++.+..++.++|||||||++|||+| |+.||......     +.
T Consensus       154 DfGl~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~  223 (273)
T d1u46a_         154 DFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI  223 (273)
T ss_dssp             CCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred             cchhhhhcccCCCcc-----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HH
Confidence            999999875543211     22334567889999999999999999999999999999998 89999743221     11


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAA  857 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  857 (869)
                      ..........                      .+.++.++..+.+++.+||+.||++||||+||.+.|+++
T Consensus       224 ~~~i~~~~~~----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         224 LHKIDKEGER----------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHTSCCC----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhCCCC----------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111111100                      011123445688999999999999999999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-46  Score=391.02  Aligned_cols=268  Identities=22%  Similarity=0.319  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECC-----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGE-----NGMLVAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.++||+|+||.||+|++..     +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++...  
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence            4689999999999999999999743     4578999999643 334456778888888777 689999999987543  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL----------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSN  695 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  695 (869)
                        ....++|||||++|+|.++++......          ....+++.++..++.||++||+|||++   +|+||||||+|
T Consensus        90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence              356899999999999999998654211          123489999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCC-CCCC
Q 002897          696 VLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR-RPTD  774 (869)
Q Consensus       696 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~-~pf~  774 (869)
                      ||++.++.+||+|||+|+.......      ........||+.|+|||++.+..++.++|||||||++|||+||. +||.
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999987654321      12334567999999999999999999999999999999999975 5675


Q ss_pred             cCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002897          775 SMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKL  854 (869)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  854 (869)
                      ..... ..+.........                          ...++.+++++.+++.+||+.||++||||+||++.|
T Consensus       239 ~~~~~-~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L  291 (299)
T d1ywna1         239 GVKID-EEFCRRLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  291 (299)
T ss_dssp             TCCCS-HHHHHHHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHH-HHHHHHHhcCCC--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            43222 111111111000                          001112345688999999999999999999999999


Q ss_pred             HHHHHh
Q 002897          855 CAAREA  860 (869)
Q Consensus       855 ~~~~~~  860 (869)
                      +.+.++
T Consensus       292 ~~ilq~  297 (299)
T d1ywna1         292 GNLLQA  297 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHhC
Confidence            998765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=393.46  Aligned_cols=252  Identities=17%  Similarity=0.278  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++.... ....+.+|+++++.++||||+++++++.+.     +..|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            3689999999999999999999999999999999976443 335688999999999999999999997653     7899


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CcEEEcccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD--MVAHVGDFG  710 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg  710 (869)
                      +|||||++|+|.+++.....     .+++.+++.++.||++||+|||++   ||+||||||+|||++.+  +.+||+|||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999987543     389999999999999999999999   99999999999999854  489999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +++......         ......||+.|+|||...+..++.++||||+||++|+|++|+.||......     ......
T Consensus       150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i  215 (321)
T d1tkia_         150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENI  215 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH
T ss_pred             hhhccccCC---------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            998764432         223456899999999999999999999999999999999999999753221     111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .....  ..+                  ......++.++.+++.+||..||++|||++|+++
T Consensus       216 ~~~~~--~~~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         216 MNAEY--TFD------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTCC--CCC------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCC--CCC------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11000  000                  0111123456789999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-46  Score=398.06  Aligned_cols=245  Identities=23%  Similarity=0.268  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+++++.++|||||++++++.+.     ..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence            5799999999999999999999999999999999643   234457789999999999999999999997653     78


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .++||||+.+|+|.+++....      .+++..++.++.||+.||.|||++   +||||||||+|||++.+|.+||+|||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            899999999999999998764      389999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      +|+.....           .....||+.|||||++.+..++.++|||||||++|||+||+.||....     ........
T Consensus       187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i  250 (350)
T d1rdqe_         187 FAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKI  250 (350)
T ss_dssp             TCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred             eeeecccc-----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHH
Confidence            99876432           234579999999999999999999999999999999999999997532     11111111


Q ss_pred             cccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                      .....                        ..+..+++++.+++.+||+.||++|+     |++|+++
T Consensus       251 ~~~~~------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         251 VSGKV------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHCCC------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCCC------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11100                        00012345678999999999999994     8999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=392.42  Aligned_cols=271  Identities=22%  Similarity=0.258  Sum_probs=195.9

Q ss_pred             CCeeeeecceEEEEEEECCCCeEEEEEEeecccc-----hhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          559 SNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK-----GALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      .++||+|+||+||+|++..+|+.||||+++....     ...+.+.+|+.++++++|||||++++++..     .+..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCceee
Confidence            4689999999999999999999999999864322     123568899999999999999999999754     377899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ||||++++++..+.....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.|+
T Consensus        78 vmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             EEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             hhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence            999999887776665443      388899999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhcc
Q 002897          714 FLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVLP  792 (869)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  792 (869)
                      ......        ......+||+.|+|||++.+. .++.++||||+||++|||+||++||......+ .+....+....
T Consensus       149 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~  219 (299)
T d1ua2a_         149 SFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGT  219 (299)
T ss_dssp             TTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred             ccCCCc--------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCC
Confidence            665432        223345799999999988654 57999999999999999999999997532211 11111111111


Q ss_pred             cccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          793 EKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       793 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .......+..-.......................+.+.+++.+||+.||++||||+|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000000000000000000000000011123467889999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=394.24  Aligned_cols=265  Identities=26%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeE--EEEEEeecc-cchhhHHHHHHHHHHHhC-CCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGML--VAVKVLNLM-QKGALKSFLTECEALRSI-RHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.++||+|+||+||+|+++.+|..  ||||+++.. ..+..+.+.+|+++++++ +|||||+++++|.+.     +
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            5788899999999999999999877764  677877533 334456799999999999 799999999998764     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLD  699 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  699 (869)
                      ..++||||+++|+|.++++.....          .....+++..+..++.|||+||.|+|+.   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            899999999999999999765210          1123599999999999999999999999   999999999999999


Q ss_pred             CCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCC-CCCcCcc
Q 002897          700 HDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRR-PTDSMFH  778 (869)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~-pf~~~~~  778 (869)
                      .++.+||+|||+|+......         ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...  
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--  230 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--  230 (309)
T ss_dssp             GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--
T ss_pred             CCCceEEccccccccccccc---------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--
Confidence            99999999999997654322         2234468999999999999999999999999999999999765 56432  


Q ss_pred             CCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002897          779 EGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAR  858 (869)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  858 (869)
                         ...+....+.....                       .+.+..+++++.+++.+||+.||++||||+||++.|+++.
T Consensus       231 ---~~~~~~~~i~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         231 ---TCAELYEKLPQGYR-----------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             ---CHHHHHHHGGGTCC-----------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHHhcCC-----------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               22222222211100                       0011134457889999999999999999999999999988


Q ss_pred             Hhhhc
Q 002897          859 EAFVS  863 (869)
Q Consensus       859 ~~~~~  863 (869)
                      +....
T Consensus       285 ~~~~~  289 (309)
T d1fvra_         285 EERKT  289 (309)
T ss_dssp             HSSSC
T ss_pred             hcCcC
Confidence            76543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=390.15  Aligned_cols=276  Identities=21%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|++++++++|||||++++++.+.     ...
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            57999999999999999999999999999999996433  23457889999999999999999999997654     789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++||||+.+ ++.+++.....    ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||.
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            999999976 44444443321    2499999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+......        .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||........ ........
T Consensus       149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~  219 (298)
T d1gz8a_         149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTL  219 (298)
T ss_dssp             HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred             ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhc
Confidence            98765432        2334567999999999877665 57899999999999999999999975322211 11111111


Q ss_pred             cccccccccCccchh--hhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKVMEIVDPSLLL--EVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ....  +...+....  ..... ..................+.+++.+||+.||++|||++|+++.
T Consensus       220 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         220 GTPD--EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCCC--TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCc--hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000  000000000  00000 0000000001111234678899999999999999999999873

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=394.50  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHH-hCCCCccceEEEEeeccccCCCc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM---QKGALKSFLTECEALR-SIRHRNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~  629 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..   .....+.+..|..++. .++|||||++++++.+.     +
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence            5799999999999999999999999999999999643   2334456777777665 68999999999997654     7


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..|+||||+++|+|.+++.....      +++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            89999999999999999987653      89999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      |.|+......        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....     +....
T Consensus       148 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~  214 (320)
T d1xjda_         148 GMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHS  214 (320)
T ss_dssp             TTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred             chhhhccccc--------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            9998654432        2234467999999999999999999999999999999999999999753221     11111


Q ss_pred             hcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 002897          790 VLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMR-DVVV  852 (869)
Q Consensus       790 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  852 (869)
                      .....      +                  ..+..+++++.+++.+||+.||++|||+. |+++
T Consensus       215 i~~~~------~------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         215 IRMDN------P------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHCC------C------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHcCC------C------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11000      0                  00112345678999999999999999995 6753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=387.81  Aligned_cols=280  Identities=21%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCC-CeEEEEEEeeccc--chhhHHHHHHHHHHHhC---CCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGEN-GMLVAVKVLNLMQ--KGALKSFLTECEALRSI---RHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.++||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++.....+
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999655 6789999986432  22334567788877766   799999999998765556


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEE
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHV  706 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  706 (869)
                      .....+++|||++++++.........     .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence            66789999999988777655544433     389999999999999999999999   9999999999999999999999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||.++.....         .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ......
T Consensus       158 ~dfg~~~~~~~~---------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i  227 (305)
T d1blxa_         158 ADFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKI  227 (305)
T ss_dssp             CSCCSCCCCCGG---------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred             cchhhhhhhccc---------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence            999998754332         2334567999999999999999999999999999999999999999753221 111111


Q ss_pred             hhhhccccccccc-CccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMVLPEKVMEIV-DPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ............. +.........  ..............++.+.+|+.+||+.||++||||+|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         228 LDVIGLPGEEDWPRDVALPRQAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSC--CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhCCCchhcccccccchhhhhc--cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111110000000 0000000000  00000001111233456789999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=385.04  Aligned_cols=267  Identities=23%  Similarity=0.364  Sum_probs=212.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhC-CCCccceEEEEeecccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLMQ-KGALKSFLTECEALRSI-RHRNLIKIITICSSIDF  625 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  625 (869)
                      .++|++.++||+|+||.||+|++.     .+++.||||+++... ......+.+|+.+++++ +|||||+++++|.+.  
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence            368899999999999999999863     467899999997543 33456789999999999 699999999997653  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcc------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKL------------EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                         ...++||||+++|+|.++++......            ....+++..+..++.||++||+|||++   +|+||||||
T Consensus       100 ---~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_         100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence               67899999999999999998765321            123589999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcC-CCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSR-RRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg-~~p  772 (869)
                      +||+++.++.+|++|||.++........      .......||+.|+|||++.++.++.++|||||||++|||+|+ .+|
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            9999999999999999999877554321      223456789999999999999999999999999999999995 454


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |... .....+..........                          ..++.++..+.+|+.+||+.||++||||+||++
T Consensus       248 ~~~~-~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         248 YPGM-PVDSKFYKMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             STTC-CSSHHHHHHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC-CHHHHHHHHHhcCCCC--------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5432 2222222222111100                          011123456889999999999999999999999


Q ss_pred             HHHHHHHh
Q 002897          853 KLCAAREA  860 (869)
Q Consensus       853 ~L~~~~~~  860 (869)
                      .|+++..+
T Consensus       301 ~L~~~i~~  308 (311)
T d1t46a_         301 LIEKQISE  308 (311)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHhhcc
Confidence            99987655

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=383.38  Aligned_cols=265  Identities=25%  Similarity=0.367  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCC-------eEEEEEEeecccc-hhhHHHHHHHHHHHhC-CCCccceEEEEeecc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENG-------MLVAVKVLNLMQK-GALKSFLTECEALRSI-RHRNLIKIITICSSI  623 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  623 (869)
                      .++|++.+.||+|+||.||+|+....+       ..||||+++.... .....+.+|...+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            368999999999999999999975433       5799999965433 3457788999999888 899999999998653


Q ss_pred             ccCCCceEEEEeecccCCCHHHHHhhCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002897          624 DFNGVDFKAIVYDFMQNGSLEEWLHQNNDK----------LEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKP  693 (869)
Q Consensus       624 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  693 (869)
                           ...++||||+++|+|.+++......          .....+++.+++.++.||+.||+|||+.   +||||||||
T Consensus        92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence                 6789999999999999999866421          1123589999999999999999999999   999999999


Q ss_pred             CceeecCCCcEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHc-CCCC
Q 002897          694 SNVLLDHDMVAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFS-RRRP  772 (869)
Q Consensus       694 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p  772 (869)
                      +|||++.++.+||+|||.++.......      ........|++.|+|||.+.++.|++++|||||||++|||++ |.+|
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCT------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cceeecCCCCeEeccchhhcccccccc------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            999999999999999999987654321      123345678999999999999999999999999999999998 6888


Q ss_pred             CCcCccCCchHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          773 TDSMFHEGLTLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       773 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      |......     ...+......                       ..+.+..++..+.+++.+||+.||++||||.||++
T Consensus       238 ~~~~~~~-----~~~~~i~~~~-----------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         238 YPGVPVE-----ELFKLLKEGH-----------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             STTCCHH-----HHHHHHHTTC-----------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHH-----HHHHHHHcCC-----------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            7643221     1111111000                       00011123456889999999999999999999999


Q ss_pred             HHHHHHH
Q 002897          853 KLCAARE  859 (869)
Q Consensus       853 ~L~~~~~  859 (869)
                      .|+++.+
T Consensus       290 ~L~~i~a  296 (299)
T d1fgka_         290 DLDRIVA  296 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhh
Confidence            9998865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-44  Score=379.01  Aligned_cols=275  Identities=19%  Similarity=0.271  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.++||+|+||+||+|+++ +|+.||||+++..  .....+++.+|+.++++++||||+++++++...     +..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            58999999999999999999996 8899999999643  233467899999999999999999999997654     789


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      +++|||+.++.+..+.....      .+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            99999998877777665443      399999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |.......        .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .........
T Consensus       147 a~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~  217 (286)
T d1ob3a_         147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL  217 (286)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             ceecccCc--------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhh
Confidence            98765432        223345689999999998765 46899999999999999999999997543221 111111111


Q ss_pred             cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .........+.......... ............+..+..+.+++.+||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110011000000000000 000000111112234457889999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=381.93  Aligned_cols=241  Identities=20%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhCC--CCccceEEEEeeccc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK------GALKSFLTECEALRSIR--HRNLIKIITICSSID  624 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  624 (869)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....      ....++.+|+.++++++  |||||++++++.+. 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            3689999999999999999999999999999999864321      12244678999999996  89999999997653 


Q ss_pred             cCCCceEEEEeecccC-CCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-C
Q 002897          625 FNGVDFKAIVYDFMQN-GSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHD-M  702 (869)
Q Consensus       625 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~  702 (869)
                          +..++||||+.+ +++.+++....      .+++.+++.++.||++||+|||++   +|+||||||+|||++.+ +
T Consensus        82 ----~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          82 ----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             ----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             ----CeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence                789999999976 68888887654      389999999999999999999999   99999999999999854 7


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCC-CccccchhhhHHHHHHHcCCCCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEA-SMTGDVYSFGILLLEMFSRRRPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~pf~~~~~~~~  781 (869)
                      .+||+|||+|+.....          ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....    
T Consensus       149 ~vkl~DFG~a~~~~~~----------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----  214 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT----------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----  214 (273)
T ss_dssp             EEEECCCTTCEECCSS----------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred             eEEECccccceecccc----------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----
Confidence            9999999999865432          2234679999999999887765 577899999999999999999996421    


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                         ...+...      ...                      ..++.++.+++.+||+.||++|||++|+++
T Consensus       215 ---~i~~~~~------~~~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 ---EIIRGQV------FFR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---HHHHCCC------CCS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHhhccc------CCC----------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               1111100      000                      012346789999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=385.29  Aligned_cols=266  Identities=21%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEEC-----CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhCCCCccceEEEEeeccccC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIG-----ENGMLVAVKVLNLM-QKGALKSFLTECEALRSIRHRNLIKIITICSSIDFN  626 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  626 (869)
                      .++|++.++||+|+||+||+|.+.     .+++.||||+++.. .......+.+|++++++++||||+++++++...   
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---   95 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG---   95 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC---
Confidence            468889999999999999999884     24678999999643 333446789999999999999999999997643   


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKL----EVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM  702 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  702 (869)
                        ...++||||+++|+|.+++.......    ....+++..+.+++.|+|+||.|||++   +|+||||||+|||+++++
T Consensus        96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence              67899999999999999987543211    112478999999999999999999999   999999999999999999


Q ss_pred             cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCC-CCCCcCccCCc
Q 002897          703 VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRR-RPTDSMFHEGL  781 (869)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~-~pf~~~~~~~~  781 (869)
                      ++||+|||+|+.......      ........||+.|+|||.+.+..++.++|||||||++|||+||. +||...     
T Consensus       171 ~~Kl~DFGla~~~~~~~~------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----  239 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----  239 (308)
T ss_dssp             CEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----
T ss_pred             eEEEeecccceeccCCcc------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----
Confidence            999999999986644321      12233456899999999999999999999999999999999985 666532     


Q ss_pred             hHHHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 002897          782 TLHEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREA  860 (869)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  860 (869)
                      ...+..........                       .+.+..++..+.+++.+||+.||++|||++||++.|++..+.
T Consensus       240 ~~~~~~~~i~~~~~-----------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         240 SNEQVLRFVMEGGL-----------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             CHHHHHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             CHHHHHHHHHhCCC-----------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            22222222211111                       001113445788999999999999999999999999876553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=383.63  Aligned_cols=284  Identities=20%  Similarity=0.224  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ-KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      +.+|++.++||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999999999999999996543 3445788999999999999999999999877655554555


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++++ |+.+|+|.+++....       +++..++.++.|++.||+|||++   |||||||||+|||++.++.+||+|||+
T Consensus        87 ~l~~-~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          87 YLVT-HLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             EEEE-ECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEE-eecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence            6655 566899999997643       89999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |........     .........||+.|+|||++... .++.++||||+||++|+|++|+.||......+. ........
T Consensus       156 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~  229 (345)
T d1pmea_         156 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGIL  229 (345)
T ss_dssp             CEECCGGGC-----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred             eeeccCCCc-----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhc
Confidence            987654321     11234456799999999998554 578899999999999999999999975432111 11111111


Q ss_pred             ccccc---ccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          791 LPEKV---MEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       791 ~~~~~---~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      .....   ................................++.+++.+||+.||++||||+|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000   0000000000000000000000000111233568899999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-43  Score=371.02  Aligned_cols=269  Identities=21%  Similarity=0.254  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceEEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFKAI  633 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  633 (869)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....  .+++..|+++++.++|++++..+..+...    .+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence            579999999999999999999998999999999865432  24578999999999888766666555432    377899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcEEEcccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH---DMVAHVGDFG  710 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  710 (869)
                      ||||+ ++++.+.+.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.   +..+|++|||
T Consensus        81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99999 5577777665443     389999999999999999999999   9999999999999864   4579999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHH--Hhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLH--EFSK  788 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~  788 (869)
                      +|+.+......... .........||+.|+|||++.+..+++++|||||||++|||+||+.||...........  ....
T Consensus       152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             cceeccccccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            99987654332211 11234556899999999999999999999999999999999999999976433221111  1111


Q ss_pred             hhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 002897          789 MVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAF  861 (869)
Q Consensus       789 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  861 (869)
                      ......                       .......+++++.+++..||+.+|++||+++++.+.|+.+....
T Consensus       231 ~~~~~~-----------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         231 KKMSTP-----------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHSC-----------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCC-----------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            000000                       00011134567889999999999999999999999998876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=371.90  Aligned_cols=285  Identities=21%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc---cCC
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID---FNG  627 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~  627 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||++...  .+...+++.+|++++++++||||+++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999999999999998543  3344577899999999999999999999886532   122


Q ss_pred             CceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEc
Q 002897          628 VDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVG  707 (869)
Q Consensus       628 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  707 (869)
                      ....++||||++++.+..+.....      .+++..++.++.|+++||.|||+.   ||+||||||+|||++.++.+|++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence            456899999998877665544433      389999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          708 DFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      |||+|+.........    ........||+.|+|||++.+. .+++++||||+||++|||++|+.||...... ......
T Consensus       160 dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i  234 (318)
T d3blha1         160 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI  234 (318)
T ss_dssp             CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred             ecceeeecccccccc----cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHH
Confidence            999998765433211    1223345799999999998765 5899999999999999999999999753221 111111


Q ss_pred             hhhh---cccccccccCccchhhhhhcccccCCCccc--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          787 SKMV---LPEKVMEIVDPSLLLEVRANNSMSRGGERV--KIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       787 ~~~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .+..   .+.................... .......  ......+.+.+|+.+||+.||++||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSS-CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCChhhccccchhhhhhhhccccc-ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1111   1111111111111111100000 0000000  01112346778999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.1e-43  Score=365.30  Aligned_cols=274  Identities=17%  Similarity=0.202  Sum_probs=213.5

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCC-CccceEEEEeeccccCCCceE
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRH-RNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  631 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||+++....  ...+.+|+++++.+.| +|++.+++++...     ...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----Ccc
Confidence            3689999999999999999999999999999999854332  3457889999999965 8999999986543     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCcEEE
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDH-----DMVAHV  706 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl  706 (869)
                      ++||||+ +++|.+++.....     .+++.++..++.|++.||+|||+.   ||+||||||+||+++.     ++.+||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence            9999999 6899999887654     389999999999999999999999   9999999999999974     578999


Q ss_pred             ccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHh
Q 002897          707 GDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEF  786 (869)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~  786 (869)
                      +|||+|+........... .........||+.|||||++.+..++.++|||||||++|||+||+.||......... .. 
T Consensus       148 ~DFG~a~~~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~-  224 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QK-  224 (293)
T ss_dssp             CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HH-
T ss_pred             cccceeEEcccCccccce-eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HH-
Confidence            999999987654322211 112344568999999999999999999999999999999999999999754332111 11 


Q ss_pred             hhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhcc
Q 002897          787 SKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVKLCAAREAFVSM  864 (869)
Q Consensus       787 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  864 (869)
                      ........  ....   .              ......+++++.+++..|++.+|++||+++.+.+.|+++.+.....
T Consensus       225 ~~~i~~~~--~~~~---~--------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         225 YERIGEKK--QSTP---L--------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             HHHHHHHH--HHSC---H--------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHhcc--CCCC---h--------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            11000000  0000   0              0001134567889999999999999999999999999887765443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=378.98  Aligned_cols=278  Identities=20%  Similarity=0.285  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCc
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVD  629 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  629 (869)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..  .....+.+.+|+++++.++|||||++++++...+ .....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999999999999999643  3344578899999999999999999999987643 23445


Q ss_pred             eEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccc
Q 002897          630 FKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDF  709 (869)
Q Consensus       630 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  709 (869)
                      ..++||||+ +++|..+.+...       +++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence            679999999 668888876543       99999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC-CCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhh
Q 002897          710 GLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS-EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSK  788 (869)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  788 (869)
                      |.|+.....           .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||....... .......
T Consensus       166 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~  233 (346)
T d1cm8a_         166 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK  233 (346)
T ss_dssp             TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             cceeccCCc-----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHh
Confidence            999865432           2345799999999988764 56899999999999999999999997532211 1111111


Q ss_pred             hh--cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002897          789 MV--LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVVK  853 (869)
Q Consensus       789 ~~--~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  853 (869)
                      ..  .+.................. ................+.+.+|+.+||..||++||||+|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            10  01111111111000000000 0000000011112234567899999999999999999999873

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=367.81  Aligned_cols=277  Identities=19%  Similarity=0.248  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCceE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDFK  631 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  631 (869)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...  .....++.+|+.+++.++||||+++++++.+.     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            57999999999999999999999999999999996433  34567889999999999999999999997654     788


Q ss_pred             EEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEccccc
Q 002897          632 AIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFGL  711 (869)
Q Consensus       632 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  711 (869)
                      ++|+|++.++++..++....      .+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            99999999999988887654      389999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+......        .......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.................
T Consensus       148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  219 (292)
T d1unla_         148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             hhcccCCC--------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence            98765432        2233445788999999887665 68999999999999999999999754222211122211111


Q ss_pred             cccccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPEKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      .................... ................+.+.+++.+||+.||++||||+|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11100000000000000000 000001111122234456789999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=380.29  Aligned_cols=276  Identities=22%  Similarity=0.272  Sum_probs=196.1

Q ss_pred             CCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCceEEE
Q 002897          555 EFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDFKAI  633 (869)
Q Consensus       555 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  633 (869)
                      +|+..++||+|+||+||+|++..+|+.||||++.....    ...+|++++++++||||+++++++.... ..+..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            68889999999999999999999999999999965432    2347999999999999999999986542 234456899


Q ss_pred             EeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEcccccc
Q 002897          634 VYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGLA  712 (869)
Q Consensus       634 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  712 (869)
                      ||||++++.+.........   ...+++.+++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            9999987644433321111   12499999999999999999999999   999999999999999775 8999999999


Q ss_pred             ccCCCCCCCCccccCCCCCCccCcccccCCcccCC-CCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhhc
Q 002897          713 KFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTG-SEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMVL  791 (869)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  791 (869)
                      +......         ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+...
T Consensus       171 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g  240 (350)
T d1q5ka_         171 KQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG  240 (350)
T ss_dssp             EECCTTS---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred             hhccCCc---------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            8765432         2234579999999998765 468999999999999999999999997532211 1111111100


Q ss_pred             cc---ccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          792 PE---KVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       792 ~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ..   .+... .+...... .................++++.+|+.+||+.||++||||+|+++
T Consensus       241 ~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         241 TPTREQIREM-NPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCHHHHHHH-CC---CCC-CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHhhhhh-ccchhhcc-ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   00000 00000000 00000000000011123456889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-42  Score=371.46  Aligned_cols=272  Identities=20%  Similarity=0.268  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCceEE
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDFKA  632 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  632 (869)
                      ++|++.++||+|+||+||+|++..+|+.||||+++..   ..+++.+|+++++++. ||||+++++++...   .....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence            5799999999999999999999999999999998643   3467889999999995 99999999997642   346789


Q ss_pred             EEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-cEEEccccc
Q 002897          633 IVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDM-VAHVGDFGL  711 (869)
Q Consensus       633 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  711 (869)
                      +||||+++++|..+.+         .+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||.
T Consensus       109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            9999999999976632         389999999999999999999999   999999999999998765 699999999


Q ss_pred             cccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          712 AKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      |+......         ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.................
T Consensus       177 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~  247 (328)
T d3bqca1         177 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  247 (328)
T ss_dssp             CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             ceeccCCC---------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence            98765432         234456899999999977654 79999999999999999999999975332211111111100


Q ss_pred             ccc---cccc----ccCccchhhhhhc--ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPE---KVME----IVDPSLLLEVRAN--NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~---~~~~----~~d~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...   ....    ..++.........  ...............++++.+|+.+||+.||++|||++|+++
T Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   0000    0000000000000  000000111112234567889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=370.11  Aligned_cols=277  Identities=18%  Similarity=0.189  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhCCCCccceEEEEeeccc-cCCCce
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLM--QKGALKSFLTECEALRSIRHRNLIKIITICSSID-FNGVDF  630 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  630 (869)
                      ++|++.++||+|+||+||+|++..+|+.||||++...  .....+++.+|+.++++++||||+++++++.... .+....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999999999999999643  3344567899999999999999999999986542 245578


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .|+||||+.++.+ +.+..        .+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchHHH-Hhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            9999999976544 44432        289999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKMV  790 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  790 (869)
                      .++.....         .......||+.|+|||++.+..+++++||||+||++|+|++|+.||...... ..........
T Consensus       165 ~~~~~~~~---------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~  234 (355)
T d2b1pa1         165 LARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL  234 (355)
T ss_dssp             C------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             hhhccccc---------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhc
Confidence            98765432         2334456899999999999999999999999999999999999999753211 1111111111


Q ss_pred             ccc--ccccccCccchhhhh------------hcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          791 LPE--KVMEIVDPSLLLEVR------------ANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       791 ~~~--~~~~~~d~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...  ...............            .................+..+.+|+.+|++.||++||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000  000000000000000            00000111222334456778999999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=366.22  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeeecceEEEEEEEC---CCCeEEEEEEeecc----cchhhHHHHHHHHHHHhCCC-CccceEEEEeecccc
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIG---ENGMLVAVKVLNLM----QKGALKSFLTECEALRSIRH-RNLIKIITICSSIDF  625 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  625 (869)
                      ++|++.++||+|+||+||+|++.   .+|+.||||+++..    +....+.+.+|++++++++| |||+++++++.+.  
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~--  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence            67999999999999999999873   46899999998532    22345678899999999966 8999999997654  


Q ss_pred             CCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEE
Q 002897          626 NGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAH  705 (869)
Q Consensus       626 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  705 (869)
                         ...++||||+.+|+|.+++.....      +++..+..++.||+.||+|+|+.   +|+||||||+||+++.++.+|
T Consensus       102 ---~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk  169 (322)
T d1vzoa_         102 ---TKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  169 (322)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             ---CceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence               789999999999999999987653      78899999999999999999999   999999999999999999999


Q ss_pred             EccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCC--CCCccccchhhhHHHHHHHcCCCCCCcCccCCchH
Q 002897          706 VGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGS--EASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTL  783 (869)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~  783 (869)
                      |+|||+|+.+.....       .......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||..........
T Consensus       170 L~DFG~a~~~~~~~~-------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~  242 (322)
T d1vzoa_         170 LTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  242 (322)
T ss_dssp             ESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             Eeeccchhhhccccc-------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999987654321       223345789999999998765  46889999999999999999999997654333222


Q ss_pred             HHhhhhhcccccccccCccchhhhhhcccccCCCccchHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002897          784 HEFSKMVLPEKVMEIVDPSLLLEVRANNSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRM-----QMRDVVV  852 (869)
Q Consensus       784 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  852 (869)
                       ..........                        ...+..++.++.+++.+||++||++||     |++|+++
T Consensus       243 -~i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         243 -EISRRILKSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -HHHHHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -HHHHhcccCC------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             1111111000                        001113456788999999999999999     4788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=373.37  Aligned_cols=278  Identities=18%  Similarity=0.234  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhCCCCccceEEEEeeccccCCCce
Q 002897          553 TSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQ--KGALKSFLTECEALRSIRHRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       553 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  630 (869)
                      .++|++.++||+|+||+||+|++..+|+.||||+++...  ....+++.+|+++++.++|||||++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999996433  334567899999999999999999999886543323344


Q ss_pred             EEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcEEEcccc
Q 002897          631 KAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLLDHDMVAHVGDFG  710 (869)
Q Consensus       631 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  710 (869)
                      .+++++|+.+|+|.+++...+       +++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~-------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhccccc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            456677788999999996543       89999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCC-CCccccchhhhHHHHHHHcCCCCCCcCccCCchHHHhhhh
Q 002897          711 LAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSE-ASMTGDVYSFGILLLEMFSRRRPTDSMFHEGLTLHEFSKM  789 (869)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  789 (869)
                      .|.....           ......|++.|+|||...+.. ++.++||||+||++|+|++|+.||....... ......+.
T Consensus       167 ~a~~~~~-----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~  234 (348)
T d2gfsa1         167 LARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL  234 (348)
T ss_dssp             ---CCTG-----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred             hhcccCc-----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            9975432           233457899999999876654 6889999999999999999999997532211 11111111


Q ss_pred             hcc--cccccccCccchhhhhhc-ccccCCCccchHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002897          790 VLP--EKVMEIVDPSLLLEVRAN-NSMSRGGERVKIEECLVAVIRIGVVCSMESPTDRMQMRDVVV  852 (869)
Q Consensus       790 ~~~--~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  852 (869)
                      ...  .................. ..................+.+|+.+||+.||++||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            100  000000000000000000 000000000001123456789999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.4e-37  Score=330.97  Aligned_cols=277  Identities=17%  Similarity=0.200  Sum_probs=189.7

Q ss_pred             cCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-----------CCccceEEEEeec
Q 002897          554 SEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-----------HRNLIKIITICSS  622 (869)
Q Consensus       554 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  622 (869)
                      ++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999999999999999996533 23467788999888774           5789999988754


Q ss_pred             cccCCCceEEEEeecccCCC-HHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecC
Q 002897          623 IDFNGVDFKAIVYDFMQNGS-LEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHH-HCKPPVVHGDLKPSNVLLDH  700 (869)
Q Consensus       623 ~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~  700 (869)
                      .   +....+++++++..+. .........    ...+++..+..++.||+.||+|||+ .   ||+||||||+|||++.
T Consensus        92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          92 K---GPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             E---ETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             c---cccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence            3   2345556666654443 333332222    2248999999999999999999998 6   9999999999999987


Q ss_pred             CC------cEEEccccccccCCCCCCCCccccCCCCCCccCcccccCCcccCCCCCCccccchhhhHHHHHHHcCCCCCC
Q 002897          701 DM------VAHVGDFGLAKFLPARPLDTVVETPSSSSGIKGTVGYIAPEYGTGSEASMTGDVYSFGILLLEMFSRRRPTD  774 (869)
Q Consensus       701 ~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~pf~  774 (869)
                      ++      .++++|||.|......           .....||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             cCcccccceeeEeecccccccccc-----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence            65      4999999999754322           234569999999999999999999999999999999999999997


Q ss_pred             cCccCCc-----hHHHhhhhhc--cccc-------ccccCcc-chhhhhhcccc----cCCCccchHHHHHHHHHHHHhh
Q 002897          775 SMFHEGL-----TLHEFSKMVL--PEKV-------MEIVDPS-LLLEVRANNSM----SRGGERVKIEECLVAVIRIGVV  835 (869)
Q Consensus       775 ~~~~~~~-----~~~~~~~~~~--~~~~-------~~~~d~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~  835 (869)
                      .......     .........-  +...       ....+.. ...........    .........+...+.+.+|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            5322110     0111111000  0000       0000000 00000000000    0000111224567789999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 002897          836 CSMESPTDRMQMRDVVV  852 (869)
Q Consensus       836 cl~~dP~~RPs~~evl~  852 (869)
                      |+++||++||||+|+++
T Consensus       311 mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GGCSSTTTCBCHHHHHT
T ss_pred             HCCCChhHCcCHHHHhc
Confidence            99999999999999976

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.4e-32  Score=291.50  Aligned_cols=259  Identities=30%  Similarity=0.532  Sum_probs=226.4

Q ss_pred             ceEEEecCCcccc--cCCccccCCCCCCeeeccc-CcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCcccccee
Q 002897          224 MTTIDIGGNYFSG--TIPPGLGNLVHLNSIAMEG-NQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLA  300 (869)
Q Consensus       224 L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  300 (869)
                      ++.|||++|.+.+  .+|..++++++|++|+|++ |++.+.+|..|+++++|++|+|++|++.+..+..+..+..|+.++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            6777777777765  4678888888888888876 788888888888888888888888888888888888888888888


Q ss_pred             cccccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccccccc
Q 002897          301 LEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFS  380 (869)
Q Consensus       301 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  380 (869)
                      +++|++.+.+|..+..++.|+.+++++|.+.+.+|..+.....+++.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            888888888888888888899999999988888888888888888888999999998888888887655 6999999999


Q ss_pred             ccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccCCCCCc
Q 002897          381 GDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEVPKKGV  460 (869)
Q Consensus       381 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~  460 (869)
                      +.+|..+..+++|+.+++++|.+++.+ ..++.+++|+.|+|++|+++|.+|..|.++++|++|||++|+|+|.+|..+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             ccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence            999999999999999999999998654 4688899999999999999999999999999999999999999999998888


Q ss_pred             cCCCccccccCCcccCCCCCCCCCCCCC
Q 002897          461 FSNKTRFSLSGNGKLCGGLDEFHLPSCP  488 (869)
Q Consensus       461 ~~~~~~~~~~~n~~~c~~~~~~~~~~~~  488 (869)
                      +.+++.+++.+|+.+||.|.    |.|.
T Consensus       290 L~~L~~l~l~~N~~l~g~pl----p~c~  313 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSPL----PACT  313 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTTS----SCCC
T ss_pred             CCCCCHHHhCCCccccCCCC----CCCC
Confidence            88999999999999999754    5663

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.4e-29  Score=276.92  Aligned_cols=356  Identities=28%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             eccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCc
Q 002897           28 SLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        28 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      .+..+.+++.+.  ...+.+|++|++++|.|+. + +.++.+++|++|+|++|+|++. | .+.++++|++|++++|++.
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~  101 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA  101 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccc
Confidence            344444443332  2344455555555555542 2 2344555555555555555532 2 2555555555555555554


Q ss_pred             ccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCc
Q 002897          108 GSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDL  187 (869)
Q Consensus       108 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  187 (869)
                       .++  .++.+++|+.|++++|.+++..  .......+..+....|.+.......................+        
T Consensus       102 -~i~--~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--------  168 (384)
T d2omza2         102 -DIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL--------  168 (384)
T ss_dssp             -CCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC--------
T ss_pred             -ccc--cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccchh--------
Confidence             232  1445555555555555554332  223344555555555555443333222222222222221111        


Q ss_pred             chhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCcccc
Q 002897          188 DFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIG  267 (869)
Q Consensus       188 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  267 (869)
                         ..+...+.........|...  ....+..++. +..+++++|.+++..|  +...++|++|++++|++.. + ..+.
T Consensus       169 ---~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~-~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~  238 (384)
T d2omza2         169 ---KPLANLTTLERLDISSNKVS--DISVLAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLA  238 (384)
T ss_dssp             ---GGGTTCTTCCEEECCSSCCC--CCGGGGGCTT-CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGG
T ss_pred             ---hhhccccccccccccccccc--cccccccccc-cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhh
Confidence               12334444444555554443  2333444443 6666666666664433  3455677777777777663 2 3566


Q ss_pred             CCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCccccccccccce
Q 002897          268 WLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLF  347 (869)
Q Consensus       268 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~  347 (869)
                      .+++|+.|++++|.+++..+  +..+++|+.|++++|++++. + .+..++.++.++++.|++++               
T Consensus       239 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~---------------  299 (384)
T d2omza2         239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED---------------  299 (384)
T ss_dssp             GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC---------------
T ss_pred             cccccchhccccCccCCCCc--ccccccCCEeeccCcccCCC-C-cccccccccccccccccccc---------------
Confidence            77788888888887775443  66777888888888887643 2 36677777777777777662               


Q ss_pred             ecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcc
Q 002897          348 LNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKL  427 (869)
Q Consensus       348 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (869)
                                 + ..+..+++++.|++++|++++. + .+..+++|++|++++|+|++ ++ .+..+++|++|+|++|+|
T Consensus       300 -----------~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l  363 (384)
T d2omza2         300 -----------I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQI  363 (384)
T ss_dssp             -----------C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCC
T ss_pred             -----------c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcC
Confidence                       1 2345566677777777777743 2 26677777777777777763 33 577777777777777777


Q ss_pred             cCCCccccccccccCeeccccc
Q 002897          428 SGQIPKYLENLSFLEYLNLSYN  449 (869)
Q Consensus       428 ~~~~p~~~~~l~~L~~l~l~~N  449 (869)
                      ++..|  +.++++|+.|+|++|
T Consensus       364 ~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         364 SDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CBCGG--GTTCTTCSEEECCCE
T ss_pred             CCChh--hccCCCCCEeeCCCC
Confidence            75543  677777777777776

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.2e-29  Score=277.41  Aligned_cols=356  Identities=22%  Similarity=0.314  Sum_probs=277.4

Q ss_pred             ccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCccc
Q 002897            3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF   82 (869)
Q Consensus         3 ~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i   82 (869)
                      ++.++++++.++..   .+.+|++|++++|+|+. + +.+..+++|++|+|++|+|+.. | .|+++++|++|+|++|+|
T Consensus        28 ~l~~~~~~~~~~~~---~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEECHH---HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccCHH---HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence            35667777666653   56899999999999984 3 4688999999999999999954 4 399999999999999999


Q ss_pred             CccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcC
Q 002897           83 SGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN  162 (869)
Q Consensus        83 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  162 (869)
                      .+..  .+.++++|+.|++++|.+. .++.  ......+..+....|.+....+..................+     ..
T Consensus       101 ~~i~--~l~~l~~L~~L~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~  170 (384)
T d2omza2         101 ADIT--PLANLTNLTGLTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KP  170 (384)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GG
T ss_pred             cccc--ccccccccccccccccccc-cccc--ccccccccccccccccccccccccccccccccccccccchh-----hh
Confidence            8643  4889999999999999987 4442  44566777777888887755444444444444433333322     34


Q ss_pred             ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccc
Q 002897          163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGL  242 (869)
Q Consensus       163 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~  242 (869)
                      +...+.........|.....        ..+..+++++.+++++|.+++..|.  .... .|+.|++++|.++.  .+.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~~~~l~l~~n~i~~~~~~--~~~~-~L~~L~l~~n~l~~--~~~l  237 (384)
T d2omza2         171 LANLTTLERLDISSNKVSDI--------SVLAKLTNLESLIATNNQISDITPL--GILT-NLDELSLNGNQLKD--IGTL  237 (384)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCCCGGG--GGCT-TCCEEECCSSCCCC--CGGG
T ss_pred             hccccccccccccccccccc--------cccccccccceeeccCCccCCCCcc--cccC-CCCEEECCCCCCCC--cchh
Confidence            55566777777777766543        2477889999999999999876543  3344 49999999999984  3468


Q ss_pred             cCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccce
Q 002897          243 GNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIM  322 (869)
Q Consensus       243 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  322 (869)
                      ..+++|+.|++++|++.+..  .++.+++|++|++++|++++..  .+..++.++.++++.|++++  ...+..+++++.
T Consensus       238 ~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~  311 (384)
T d2omza2         238 ASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTY  311 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSE
T ss_pred             hcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCe
Confidence            88999999999999998543  3788999999999999998654  37788999999999999974  345888889999


Q ss_pred             eeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCcc
Q 002897          323 LTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNS  402 (869)
Q Consensus       323 L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  402 (869)
                      |++++|++++                          ++ .+..+++|++|++++|++++ ++ .+.++++|++|++++|+
T Consensus       312 L~ls~n~l~~--------------------------l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~  362 (384)
T d2omza2         312 LTLYFNNISD--------------------------IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ  362 (384)
T ss_dssp             EECCSSCCSC--------------------------CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred             EECCCCCCCC--------------------------Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence            8888888872                          22 36778899999999999984 54 68999999999999999


Q ss_pred             ccCCCCccccccccccEEEccCC
Q 002897          403 FSGSIPPSLNFLKSIKVLDLSSN  425 (869)
Q Consensus       403 l~~~~p~~~~~l~~L~~L~L~~N  425 (869)
                      |++..|  +.++++|+.|+|++|
T Consensus       363 l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         363 ISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCChh--hccCCCCCEeeCCCC
Confidence            996544  889999999999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=7.8e-30  Score=270.06  Aligned_cols=252  Identities=29%  Similarity=0.512  Sum_probs=214.9

Q ss_pred             CCcEEEccCCCCCC--CCChhhhhccccceEEEecC-CcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCE
Q 002897          198 KLENLGLYDNQFGG--LLPHSLANLSNTMTTIDIGG-NYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQS  274 (869)
Q Consensus       198 ~L~~L~L~~n~l~~--~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  274 (869)
                      ++++|+|++|.+.+  .+|..+..++. |++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~-L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCcc-ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            56777888877776  36778888876 88888876 7788788888888888888888888888888888888888888


Q ss_pred             EEccCccccCcCCCCCCCCccccceecccccccccCCcCccCcccc-ceeeccCcccCCCCCccccccccccceecccCC
Q 002897          275 LYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSL-IMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDN  353 (869)
Q Consensus       275 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N  353 (869)
                      +++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+.....  ..+++++|
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~--~~l~l~~~  207 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRN  207 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC--SEEECCSS
T ss_pred             cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence            8888888888888888888888888888888888888888888776 78888888888777766554432  35888899


Q ss_pred             cccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCcc
Q 002897          354 LLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPK  433 (869)
Q Consensus       354 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  433 (869)
                      .+.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|+|+|.+|.+|+.+++|++|+|++|+|+|.+|.
T Consensus       208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~  286 (313)
T d1ogqa_         208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence            9999999999999999999999999997655 688999999999999999999999999999999999999999999984


Q ss_pred             ccccccccCeecccccc-Cccc
Q 002897          434 YLENLSFLEYLNLSYNH-FEGE  454 (869)
Q Consensus       434 ~~~~l~~L~~l~l~~N~-l~~~  454 (869)
                       +.++++|+.+++++|+ ++|.
T Consensus       287 -~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         287 -GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             -STTGGGSCGGGTCSSSEEEST
T ss_pred             -cccCCCCCHHHhCCCccccCC
Confidence             6889999999999998 5554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.6e-27  Score=248.43  Aligned_cols=280  Identities=20%  Similarity=0.261  Sum_probs=172.9

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      +|.++++++ +||.+++   +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.|++|.++++|++|+|++|+
T Consensus        15 ~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~   90 (305)
T d1xkua_          15 VQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ   90 (305)
T ss_dssp             EECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             EEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence            345555666 5666554   456666666666664444456666666666666666665555566666666666666666


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccc--ccc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFI--GKM  159 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~--~~~  159 (869)
                      |+. +|..+  ...|+.|++++|.+. .++                        +..+.....+..++...|...  ...
T Consensus        91 l~~-l~~~~--~~~l~~L~~~~n~l~-~l~------------------------~~~~~~~~~~~~l~~~~n~~~~~~~~  142 (305)
T d1xkua_          91 LKE-LPEKM--PKTLQELRVHENEIT-KVR------------------------KSVFNGLNQMIVVELGTNPLKSSGIE  142 (305)
T ss_dssp             CSB-CCSSC--CTTCCEEECCSSCCC-BBC------------------------HHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred             cCc-Cccch--hhhhhhhhccccchh-hhh------------------------hhhhhccccccccccccccccccCCC
Confidence            653 23221  234555555555554 344                        334444555555555555432  223


Q ss_pred             CcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCC
Q 002897          160 SINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIP  239 (869)
Q Consensus       160 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~  239 (869)
                      ...|..+++|+.+++++|.+..++..         .+++|++|++++|.++...+..+..+.. ++.|++++|.+++..+
T Consensus       143 ~~~~~~l~~L~~l~l~~n~l~~l~~~---------~~~~L~~L~l~~n~~~~~~~~~~~~~~~-l~~L~~s~n~l~~~~~  212 (305)
T d1xkua_         143 NGAFQGMKKLSYIRIADTNITTIPQG---------LPPSLTELHLDGNKITKVDAASLKGLNN-LAKLGLSFNSISAVDN  212 (305)
T ss_dssp             TTGGGGCTTCCEEECCSSCCCSCCSS---------CCTTCSEEECTTSCCCEECTGGGTTCTT-CCEEECCSSCCCEECT
T ss_pred             ccccccccccCccccccCCccccCcc---------cCCccCEEECCCCcCCCCChhHhhcccc-cccccccccccccccc
Confidence            34466666666666666666655432         2456777777777777666667766654 7777777777777777


Q ss_pred             ccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCC------CCCccccceeccccccc--ccCC
Q 002897          240 PGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSL------GNLTMLTLLALEINNLQ--GKIP  311 (869)
Q Consensus       240 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~n~l~--~~~~  311 (869)
                      ..+.++++|++|+|++|+++ .+|.+|..+++|++|+|++|+|+.+....|      ..+.+|+.|++++|+++  ...|
T Consensus       213 ~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~  291 (305)
T d1xkua_         213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP  291 (305)
T ss_dssp             TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred             ccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence            77777888888888888777 456777888888888888888875544433      35677888888888875  3455


Q ss_pred             cCccCccccceee
Q 002897          312 SSLGNCTSLIMLT  324 (869)
Q Consensus       312 ~~~~~l~~L~~L~  324 (869)
                      .+|..+.....++
T Consensus       292 ~~f~~~~~~~~~~  304 (305)
T d1xkua_         292 STFRCVYVRAAVQ  304 (305)
T ss_dssp             GGGTTCCCGGGEE
T ss_pred             hHhcccccCcccc
Confidence            5665555444443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=5e-27  Score=247.32  Aligned_cols=282  Identities=19%  Similarity=0.288  Sum_probs=232.0

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECc
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls  102 (869)
                      ..+.+|-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            6777888888888 6676664  688899999999886666688888999999999998887778888888888888888


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNR  182 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~  182 (869)
                      +|+++ .+|..                           ....|..|++++|.+..+.+..+.....+..++...|.....
T Consensus        88 ~n~l~-~l~~~---------------------------~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~  139 (305)
T d1xkua_          88 KNQLK-ELPEK---------------------------MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS  139 (305)
T ss_dssp             SSCCS-BCCSS---------------------------CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred             CCccC-cCccc---------------------------hhhhhhhhhccccchhhhhhhhhhcccccccccccccccccc
Confidence            88887 55521                           125788899999999988888899999999999999877554


Q ss_pred             CCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecC
Q 002897          183 AANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTV  262 (869)
Q Consensus       183 ~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  262 (869)
                      ...    ...+..+++|+.+++++|.+.. +|..+   ..+|+.|++++|.++...+..|.+++.++.|++++|.+.+..
T Consensus       140 ~~~----~~~~~~l~~L~~l~l~~n~l~~-l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~  211 (305)
T d1xkua_         140 GIE----NGAFQGMKKLSYIRIADTNITT-IPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD  211 (305)
T ss_dssp             GBC----TTGGGGCTTCCEEECCSSCCCS-CCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred             CCC----ccccccccccCccccccCCccc-cCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence            432    3468889999999999999984 44433   235999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcC------ccCccccceeeccCcccC-CCCC
Q 002897          263 PPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSS------LGNCTSLIMLTLSKNKLD-GVLP  335 (869)
Q Consensus       263 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L~l~~N~l~-~~~~  335 (869)
                      +..+.++++|++|+|++|+|+ .+|..|.++++|++|++++|+|+......      +..+++|+.|++++|++. ..++
T Consensus       212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~  290 (305)
T d1xkua_         212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ  290 (305)
T ss_dssp             TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred             cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence            999999999999999999998 56789999999999999999999543333      346788999999999985 3456


Q ss_pred             ccccccccc
Q 002897          336 PQILSVTTL  344 (869)
Q Consensus       336 ~~~~~~~~~  344 (869)
                      +..+.....
T Consensus       291 ~~~f~~~~~  299 (305)
T d1xkua_         291 PSTFRCVYV  299 (305)
T ss_dssp             GGGGTTCCC
T ss_pred             HhHhccccc
Confidence            655554433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.8e-27  Score=243.30  Aligned_cols=222  Identities=18%  Similarity=0.248  Sum_probs=151.8

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCc-Cc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIG-RN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~-~n   80 (869)
                      +++++++++ +||..++   +++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+..+..++.++.+ .|
T Consensus        16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            456777888 8888775   567888888888886666778888888888888888887777778888888887664 56


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      .+....|.+|.++++|++|++++|.+. .++...+..+++|+.+++++|+|+.+.+..|..+++|+.|++++|++..+.+
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            677666777888888888888888776 5555556666666666666666666555666666666666666666666666


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCccc
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFS  235 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~  235 (869)
                      ..|.++++|+.+++++|+++.+...      .|..+++|++|++++|++.+..+..|..+.+ |+.|++++|.+.
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~------~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~-L~~L~l~~N~l~  238 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPH------AFRDLGRLMTLYLFANNLSALPTEALAPLRA-LQYLRLNDNPWV  238 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTT------TTTTCTTCCEEECCSSCCSCCCHHHHTTCTT-CCEEECCSSCEE
T ss_pred             hhhccccccchhhhhhccccccChh------Hhhhhhhcccccccccccccccccccccccc-cCEEEecCCCCC
Confidence            6666666666666666666655433      4555666666666666666555555555443 555555555544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.3e-26  Score=235.93  Aligned_cols=268  Identities=20%  Similarity=0.201  Sum_probs=161.1

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      ..++.++++++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|++++|++..+.+..+.++..++.++...+
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            45677777887 6666553  56788888888888666677888888888888888888777777777788877766533


Q ss_pred             -cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCC
Q 002897          105 -RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRA  183 (869)
Q Consensus       105 -~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  183 (869)
                       .+. .++...|.++++|++|++++|.+.                        .+.+..+...++|+.+++++|+++.++
T Consensus        91 ~~~~-~l~~~~~~~l~~L~~L~l~~n~~~------------------------~~~~~~~~~~~~L~~l~l~~N~l~~i~  145 (284)
T d1ozna_          91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQ------------------------ELGPGLFRGLAALQYLYLQDNALQALP  145 (284)
T ss_dssp             TTCC-CCCTTTTTTCTTCCEEECTTSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             cccc-cccchhhcccccCCEEecCCcccc------------------------cccccccchhcccchhhhccccccccC
Confidence             443 555444555555555555544444                        444444444445555555555554444


Q ss_pred             CCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCC
Q 002897          184 ANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVP  263 (869)
Q Consensus       184 ~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  263 (869)
                      .+      +|+.+++|++|++++|+++...+..|.++++ |+.+++++|.+++..|..|..+++|++|++++|.+.+..+
T Consensus       146 ~~------~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~-L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~  218 (284)
T d1ozna_         146 DD------TFRDLGNLTHLFLHGNRISSVPERAFRGLHS-LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT  218 (284)
T ss_dssp             TT------TTTTCTTCCEEECCSSCCCEECTTTTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred             hh------HhccccchhhcccccCcccccchhhhccccc-cchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence            32      3444555555555555555444455555543 5555555555555556666666667777777777666666


Q ss_pred             ccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccC
Q 002897          264 PEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLD  331 (869)
Q Consensus       264 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (869)
                      ..|+.+++|++|+|++|.+...- +...-...++.+....+++....|..+.+   ....+++.+.|+
T Consensus       219 ~~~~~~~~L~~L~l~~N~l~C~C-~~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         219 EALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             HHHTTCTTCCEEECCSSCEECSG-GGHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             cccccccccCEEEecCCCCCCCc-cchHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            66777777777777777665321 11111223566666666666556665544   333345555544

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.4e-24  Score=222.92  Aligned_cols=194  Identities=22%  Similarity=0.255  Sum_probs=138.8

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      .|.++++++ +||.+++   +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+
T Consensus        15 v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~   88 (266)
T d1p9ag_          15 VNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQ   88 (266)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSC
T ss_pred             EEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccc
Confidence            367778888 7887765   577888888888886666778888888888888888873 33 35678888888888888


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      ++ ..+..+.++++|+.|++++|.+. .++...+..+.+++.|++++|.++...+..+..+++|+.|++++|+++++.+.
T Consensus        89 l~-~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~  166 (266)
T d1p9ag_          89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG  166 (266)
T ss_dssp             CS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred             cc-ccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence            87 45667777888888888888776 56666666777777777777777766666666677777777777777666666


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      .|..+++|++|+|++|+|+.++.+       +..+++|+.|+|++|.+.
T Consensus       167 ~~~~l~~L~~L~Ls~N~L~~lp~~-------~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         167 LLNGLENLDTLLLQENSLYTIPKG-------FFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTT-------TTTTCCCSEEECCSCCBC
T ss_pred             ccccccccceeecccCCCcccChh-------HCCCCCCCEEEecCCCCC
Confidence            666677777777777776666543       345666666666666654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=7.5e-24  Score=217.45  Aligned_cols=200  Identities=24%  Similarity=0.265  Sum_probs=143.3

Q ss_pred             ceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccc
Q 002897          224 MTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEI  303 (869)
Q Consensus       224 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  303 (869)
                      +.+.|.+++.++ .+|..+.  ++++.|+|++|+|.+..+..|.++++|++|+|++|+|+.. + .++.+++|+.|++++
T Consensus        12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccc
Confidence            556678888877 4566554  4677777777777766666777777777777777777643 2 245677777777777


Q ss_pred             ccccccCCcCccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCccccccccccccccccC
Q 002897          304 NNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDI  383 (869)
Q Consensus       304 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  383 (869)
                      |+++ ..+..+..+++|+.|++++|++.                         +..+..+..+.+++.|++++|.++...
T Consensus        87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~~~~l~~l~~L~l~~n~l~~l~  140 (266)
T d1p9ag_          87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-------------------------SLPLGALRGLGELQELYLKGNELKTLP  140 (266)
T ss_dssp             SCCS-SCCCCTTTCTTCCEEECCSSCCC-------------------------CCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred             cccc-ccccccccccccccccccccccc-------------------------eeeccccccccccccccccccccceec
Confidence            7776 44556677777777777666665                         233445666777888888888888666


Q ss_pred             CccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCCccccccccccCeeccccccCcccC
Q 002897          384 PGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQIPKYLENLSFLEYLNLSYNHFEGEV  455 (869)
Q Consensus       384 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  455 (869)
                      +..+..++.|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+.+
T Consensus       141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            667777888888888888888666677788888888888888887 67777777777777777777766543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=2.7e-20  Score=199.84  Aligned_cols=304  Identities=24%  Similarity=0.353  Sum_probs=142.7

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .++++|||++|+|+ .+|+.   .++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. ++..   .++|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            35677777777776 45543   356777777777777 556543   466777777777663 2211   124666666


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|.+. .+|.                          ++.+++|++|++++|.+....    .....+..+.+.++....
T Consensus       106 ~~n~l~-~lp~--------------------------~~~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~~  154 (353)
T d1jl5a_         106 SNNQLE-KLPE--------------------------LQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLEE  154 (353)
T ss_dssp             CSSCCS-SCCC--------------------------CTTCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS
T ss_pred             cccccc-cccc--------------------------hhhhccceeeccccccccccc----cccccccchhhccccccc
Confidence            666665 4441                          234455555555555543222    123344555554444432


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT  261 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  261 (869)
                      ..        .+..++.++.|++++|.+... +...    ...+.+..+++.+. ..+ .+..++.|+.+++++|... .
T Consensus       155 ~~--------~l~~l~~l~~L~l~~n~~~~~-~~~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~  218 (353)
T d1jl5a_         155 LP--------ELQNLPFLTAIYADNNSLKKL-PDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-T  218 (353)
T ss_dssp             CC--------CCTTCTTCCEEECCSSCCSSC-CCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-S
T ss_pred             cc--------cccccccceeccccccccccc-cccc----cccccccccccccc-ccc-ccccccccccccccccccc-c
Confidence            21        244555566666666655422 1110    11233333333332 111 2334444444444444433 1


Q ss_pred             CCccccCCCCCCEEEccCccccCcCCCCCCCCccccceecccccccccCCcCccCccccceeeccCcccCCCCCcccccc
Q 002897          262 VPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQGKIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSV  341 (869)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  341 (869)
                      .+.   ...++..+.+.+|.+..                         .+..   ...+...++..|.+.+     +...
T Consensus       219 ~~~---~~~~l~~~~~~~~~~~~-------------------------~~~~---~~~l~~~~~~~~~~~~-----l~~l  262 (353)
T d1jl5a_         219 LPD---LPPSLEALNVRDNYLTD-------------------------LPEL---PQSLTFLDVSENIFSG-----LSEL  262 (353)
T ss_dssp             CCS---CCTTCCEEECCSSCCSC-------------------------CCCC---CTTCCEEECCSSCCSE-----ESCC
T ss_pred             ccc---ccccccccccccccccc-------------------------cccc---cccccccccccccccc-----cccc
Confidence            111   12334444444444331                         1111   1223333333333221     0011


Q ss_pred             ccccceecccCCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEE
Q 002897          342 TTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLD  421 (869)
Q Consensus       342 ~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~  421 (869)
                      .......++..|.+.+    ....+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|+
T Consensus       263 ~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~  330 (353)
T d1jl5a_         263 PPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLH  330 (353)
T ss_dssp             CTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred             cchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEE
Confidence            1111223333444332    1223456667777777666 45532   456666666666666 44532   34566666


Q ss_pred             ccCCcccCCCcc
Q 002897          422 LSSNKLSGQIPK  433 (869)
Q Consensus       422 L~~N~l~~~~p~  433 (869)
                      |++|+|+ .+|+
T Consensus       331 L~~N~L~-~lp~  341 (353)
T d1jl5a_         331 VEYNPLR-EFPD  341 (353)
T ss_dssp             CCSSCCS-SCCC
T ss_pred             CcCCcCC-CCCc
Confidence            6666665 4554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.8e-23  Score=200.35  Aligned_cols=133  Identities=19%  Similarity=0.228  Sum_probs=106.2

Q ss_pred             CCCCeeeeecceEEEEEEECCCCeEEEEEEeecccc------------------hhhHHHHHHHHHHHhCCCCccceEEE
Q 002897          557 SSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQK------------------GALKSFLTECEALRSIRHRNLIKIIT  618 (869)
Q Consensus       557 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~  618 (869)
                      .+.++||+|+||+||+|++. +|+.||||+++....                  .......+|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999986 899999998752110                  11234567888999999999999887


Q ss_pred             EeeccccCCCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 002897          619 ICSSIDFNGVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHCKPPVVHGDLKPSNVLL  698 (869)
Q Consensus       619 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  698 (869)
                      +         ...+++|||++++...+             ++......++.|+++|++|||++   ||+||||||+|||+
T Consensus        82 ~---------~~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv  136 (191)
T d1zara2          82 W---------EGNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  136 (191)
T ss_dssp             E---------ETTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             e---------cCCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence            6         22379999998754422             34445678999999999999999   99999999999999


Q ss_pred             cCCCcEEEccccccccCC
Q 002897          699 DHDMVAHVGDFGLAKFLP  716 (869)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~  716 (869)
                      +++ .++|+|||.|....
T Consensus       137 ~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             ETT-EEEECCCTTCEETT
T ss_pred             eCC-CEEEEECCCcccCC
Confidence            865 58999999997654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=1.7e-20  Score=201.34  Aligned_cols=176  Identities=26%  Similarity=0.273  Sum_probs=125.8

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +|||++++++ +||+.    .++|++|+|++|+|+ .+|..   +.+|+.|++++|+++ .+++.   .++|++|+|++|
T Consensus        42 ~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n  108 (353)
T d1jl5a_          42 ELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNN  108 (353)
T ss_dssp             EEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSS
T ss_pred             EEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccccc
Confidence            4899999999 89963    478999999999999 67765   468999999999998 44432   246999999999


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      ++.. +|. +..+++|++|++++|.+. ..+.    ....+..+.+..+...  ....+..++.++.|++++|.+.....
T Consensus       109 ~l~~-lp~-~~~l~~L~~L~l~~~~~~-~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~  179 (353)
T d1jl5a_         109 QLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD  179 (353)
T ss_dssp             CCSS-CCC-CTTCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC
T ss_pred             cccc-ccc-hhhhccceeecccccccc-cccc----ccccccchhhcccccc--ccccccccccceeccccccccccccc
Confidence            9994 554 688999999999999987 4442    2344555555555443  23456677788888888877654322


Q ss_pred             cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          161 INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       161 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                          .....+.+...++.+..++        .+..++.|+.+++++|...
T Consensus       180 ----~~~~~~~l~~~~~~~~~~~--------~~~~l~~L~~l~l~~n~~~  217 (353)
T d1jl5a_         180 ----LPLSLESIVAGNNILEELP--------ELQNLPFLTTIYADNNLLK  217 (353)
T ss_dssp             ----CCTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCS
T ss_pred             ----ccccccccccccccccccc--------ccccccccccccccccccc
Confidence                2233456666666655443        2456677777777777665

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=7.2e-21  Score=192.37  Aligned_cols=199  Identities=17%  Similarity=0.192  Sum_probs=124.7

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCc-cCCccccCCCCCCEEeCcC-
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGG-KIPDTLGQLRKLIYLNIGR-   79 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~-   79 (869)
                      ++.++++++ +||.+++   +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. ..+.+|.+++++++|++.+ 
T Consensus        13 i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          13 FLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            466777888 8887775   478888888888886556678888888888888887764 3456788888888887764 


Q ss_pred             cccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCC-CCcEEEccCCccccc
Q 002897           80 NQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNAS-NLELLELRDNQFIGK  158 (869)
Q Consensus        80 n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~-~L~~L~L~~N~i~~~  158 (869)
                      |.+....+..|.++++|++|++++|.+...-+...+..+..+..+...++.+..+.+..|.+++ .++.|++++|+++.+
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence            6777677777888888888888888876222222333444555555555555555555555543 555666666666555


Q ss_pred             cCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCC
Q 002897          159 MSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFG  210 (869)
Q Consensus       159 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~  210 (869)
                      ....|.....++.+.+++|+++.++.+      .|.++++|++|+|++|+|+
T Consensus       169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~------~f~~l~~L~~L~Ls~N~l~  214 (242)
T d1xwdc1         169 HNCAFNGTQLDELNLSDNNNLEELPND------VFHGASGPVILDISRTRIH  214 (242)
T ss_dssp             CTTTTTTCCEEEEECTTCTTCCCCCTT------TTTTSCCCSEEECTTSCCC
T ss_pred             ccccccchhhhccccccccccccccHH------HhcCCCCCCEEECCCCcCC
Confidence            444443322222333455555554432      3444555555555555544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=7.4e-20  Score=184.84  Aligned_cols=203  Identities=17%  Similarity=0.094  Sum_probs=101.6

Q ss_pred             CCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccc-cccceeccccccCCCCCcEEE
Q 002897           71 KLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAK-NNLTGFLPISLSNASNLELLE  149 (869)
Q Consensus        71 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~  149 (869)
                      ++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...++...|.++++++++.+.. |++....+..|.++++|++|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            4444444444444333334444444444444444443233333333333333333321 233334444555555555555


Q ss_pred             ccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEe
Q 002897          150 LRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDI  229 (869)
Q Consensus       150 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l  229 (869)
                      +++|.+....+..                             .+..+..+..+...++++....+..+..+...++.|++
T Consensus       110 l~~~~l~~~~~~~-----------------------------~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l  160 (242)
T d1xwdc1         110 ISNTGIKHLPDVH-----------------------------KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL  160 (242)
T ss_dssp             EESCCCCSCCCCT-----------------------------TTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred             cchhhhccccccc-----------------------------ccccccccccccccccccccccccccccccccceeeec
Confidence            5555544322211                             12223333344444444443334444444434666666


Q ss_pred             cCCcccccCCccccCCCCCCe-eecccCcceecCCccccCCCCCCEEEccCccccCcCCCCCCCCccccceeccc
Q 002897          230 GGNYFSGTIPPGLGNLVHLNS-IAMEGNQLIGTVPPEIGWLKNLQSLYLNSNFLHGYIPSSLGNLTMLTLLALEI  303 (869)
Q Consensus       230 ~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  303 (869)
                      ++|+++...+..+ +..++.. +.+++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+++++.+
T Consensus       161 ~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         161 NKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            6666664433333 3333333 34566667655555677777888888888777766666677777777776643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.3e-22  Score=226.55  Aligned_cols=387  Identities=18%  Similarity=0.155  Sum_probs=174.8

Q ss_pred             CcCEEeccCCcCccc-cCcccccCcCCCEEEccCCccCc----cCCccccCCCCCCEEeCcCcccCcc----CCcccc-c
Q 002897           23 KLENLSLAENHLTGQ-LPVSIGNLSALQVIDIRGNRLGG----KIPDTLGQLRKLIYLNIGRNQFSGF----IPPSIY-N   92 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~i~~~----~p~~~~-~   92 (869)
                      +|+.||++.|+|++. +.+.+..+++|++|+|++|.|+.    .+..++..+++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            567777777777632 23345666777777777777662    2234456677777777777776521    111121 1


Q ss_pred             CCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCc-----cCCC
Q 002897           93 ISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINF-----NSLK  167 (869)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~  167 (869)
                      ..+|++|+|++|++++ ....                    .++.++..+++|++|+|++|.|.......+     ....
T Consensus        83 ~~~L~~L~L~~n~it~-~~~~--------------------~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~  141 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTG-AGCG--------------------VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  141 (460)
T ss_dssp             TCCCCEEECTTSCCBG-GGHH--------------------HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCCCEEECCCCCccc-cccc--------------------cccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence            2356666666666641 1100                    122344445555555555555432211111     1112


Q ss_pred             CCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCC----hhhhhccccceEEEecCCccccc----CC
Q 002897          168 NLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLP----HSLANLSNTMTTIDIGGNYFSGT----IP  239 (869)
Q Consensus       168 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~~L~~L~l~~n~l~~~----~~  239 (869)
                      ....+......+.....  ......+.....++.++++++.+.....    ..+.........+++..+.+...    ..
T Consensus       142 ~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~  219 (460)
T d1z7xw1         142 RLEKLQLEYCSLSAASC--EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC  219 (460)
T ss_dssp             CCCEEECTTSCCBGGGH--HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred             ccccccccccccchhhh--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccc
Confidence            22333333332221111  1122234445556666666555432111    11111112244455555544311    11


Q ss_pred             ccccCCCCCCeeecccCccee-----cCCccccCCCCCCEEEccCccccCcC----CCCCCCCccccceecccccccccC
Q 002897          240 PGLGNLVHLNSIAMEGNQLIG-----TVPPEIGWLKNLQSLYLNSNFLHGYI----PSSLGNLTMLTLLALEINNLQGKI  310 (869)
Q Consensus       240 ~~~~~l~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~  310 (869)
                      ..+...+.++.+.+++|.+..     ..+........|+.|++++|.+....    ...+...+.++.+++++|.++...
T Consensus       220 ~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~  299 (460)
T d1z7xw1         220 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG  299 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred             ccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            122334555555555555421     11222333455666666666554211    111223444555555555543211


Q ss_pred             CcCc-----cCccccceeeccCcccCCCCCccccccccccceecccCCcccCCCcccccCCcccccccccccccccc---
Q 002897          311 PSSL-----GNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSLPSEIGNLKNLVQLDISGNRFSGD---  382 (869)
Q Consensus       311 ~~~~-----~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---  382 (869)
                      ...+     .....|+.+++++|.++.....                     .+...+...++|++|+|++|.+++.   
T Consensus       300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~---------------------~l~~~~~~~~~L~~L~Ls~N~i~~~g~~  358 (460)
T d1z7xw1         300 ARLLCETLLEPGCQLESLWVKSCSFTAACCS---------------------HFSSVLAQNRFLLELQISNNRLEDAGVR  358 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---------------------HHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred             cchhhccccccccccccccccccchhhhhhh---------------------hcccccccccchhhhheeeecccCcccc
Confidence            1111     1123455555555544311000                     0111223344566666666666532   


Q ss_pred             -CCcccc-CCCCCcEEEeeCccccCC----CCccccccccccEEEccCCcccCCCccc----cc-cccccCeeccccccC
Q 002897          383 -IPGTLS-ACTSLEYVKMQDNSFSGS----IPPSLNFLKSIKVLDLSSNKLSGQIPKY----LE-NLSFLEYLNLSYNHF  451 (869)
Q Consensus       383 -~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~-~l~~L~~l~l~~N~l  451 (869)
                       ++..+. ..+.|++|+|++|+|+..    ++..+...++|++|+|++|+|+......    +. +...|+.|++++|.+
T Consensus       359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~  438 (460)
T d1z7xw1         359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW  438 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred             hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence             222222 345566666666666532    2233444566666777766665322222    21 223566666666666


Q ss_pred             cc
Q 002897          452 EG  453 (869)
Q Consensus       452 ~~  453 (869)
                      ..
T Consensus       439 ~~  440 (460)
T d1z7xw1         439 SE  440 (460)
T ss_dssp             CH
T ss_pred             CH
Confidence            53

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1.6e-19  Score=180.08  Aligned_cols=208  Identities=23%  Similarity=0.332  Sum_probs=128.4

Q ss_pred             cCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEE
Q 002897           21 LFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIF  100 (869)
Q Consensus        21 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~  100 (869)
                      +.++..++++.+++++..  .+..+.+|++|++.+|+|+. ++ .++++++|++|+|++|+|.+..  .+.++++|++++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--cccccccccccc
Confidence            455666778888887544  46778888888888888884 43 5888888888888888887543  378888888888


Q ss_pred             CcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCC
Q 002897          101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLG  180 (869)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~  180 (869)
                      +++|.++ .++  .+.++++|+.+.+++|...+.  ..+...+.++.+.++++.+...  ..+..+++|++|++++|.+.
T Consensus        92 ~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~  164 (227)
T d1h6ua2          92 LSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS  164 (227)
T ss_dssp             CCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             ccccccc-ccc--ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence            8888876 554  255566666666666655432  2344555666666666655432  22455555666666555554


Q ss_pred             CCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCccee
Q 002897          181 NRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIG  260 (869)
Q Consensus       181 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  260 (869)
                      ...        .++++++|++|+|++|++++.                           ..++++++|++|+|++|++++
T Consensus       165 ~~~--------~l~~l~~L~~L~Ls~n~l~~l---------------------------~~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         165 DLT--------PLANLSKLTTLKADDNKISDI---------------------------SPLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CCG--------GGTTCTTCCEEECCSSCCCCC---------------------------GGGGGCTTCCEEECTTSCCCB
T ss_pred             cch--------hhcccccceecccCCCccCCC---------------------------hhhcCCCCCCEEECcCCcCCC
Confidence            322        244555555555555555421                           124455555555555555553


Q ss_pred             cCCccccCCCCCCEEEcc
Q 002897          261 TVPPEIGWLKNLQSLYLN  278 (869)
Q Consensus       261 ~~~~~~~~l~~L~~L~L~  278 (869)
                      . + .++++++|+.|+++
T Consensus       210 i-~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         210 V-S-PLANTSNLFIVTLT  225 (227)
T ss_dssp             C-G-GGTTCTTCCEEEEE
T ss_pred             C-c-ccccCCCCCEEEee
Confidence            2 2 25556666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=6e-19  Score=175.85  Aligned_cols=202  Identities=21%  Similarity=0.303  Sum_probs=163.9

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQ   81 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~   81 (869)
                      ++++.+++++.++   ...+.+|+.|++.+|+|+. ++ .+..+++|++|++++|+|++..  .+..+++|++|++++|.
T Consensus        24 ~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~   96 (227)
T d1h6ua2          24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNP   96 (227)
T ss_dssp             HHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCC
T ss_pred             HHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccc
Confidence            3567778885443   2467899999999999995 43 5999999999999999999543  38999999999999999


Q ss_pred             cCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCc
Q 002897           82 FSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSI  161 (869)
Q Consensus        82 i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  161 (869)
                      ++..  ..+.++++|+.+++++|... .++  .+...+.++.+.++++.+...  ..+.++++|++|++++|.+....  
T Consensus        97 ~~~i--~~l~~l~~L~~l~l~~~~~~-~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--  167 (227)
T d1h6ua2          97 LKNV--SAIAGLQSIKTLDLTSTQIT-DVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--  167 (227)
T ss_dssp             CSCC--GGGTTCTTCCEEECTTSCCC-CCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--
T ss_pred             cccc--cccccccccccccccccccc-ccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--
Confidence            9843  46889999999999999987 333  367788999999999998754  35788999999999999987544  


Q ss_pred             CccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEec
Q 002897          162 NFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIG  230 (869)
Q Consensus       162 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~  230 (869)
                      .|.++++|++|+|++|++++++        .++++++|++|+|++|++++..  .+.++++ |+.|+++
T Consensus       168 ~l~~l~~L~~L~Ls~n~l~~l~--------~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~-L~~L~ls  225 (227)
T d1h6ua2         168 PLANLSKLTTLKADDNKISDIS--------PLASLPNLIEVHLKNNQISDVS--PLANTSN-LFIVTLT  225 (227)
T ss_dssp             GGTTCTTCCEEECCSSCCCCCG--------GGGGCTTCCEEECTTSCCCBCG--GGTTCTT-CCEEEEE
T ss_pred             hhcccccceecccCCCccCCCh--------hhcCCCCCCEEECcCCcCCCCc--ccccCCC-CCEEEee
Confidence            4889999999999999998764        3788999999999999988532  2455543 6666654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2.3e-20  Score=180.69  Aligned_cols=126  Identities=20%  Similarity=0.302  Sum_probs=75.0

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCcc-ccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTG-QLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +|+++++++ +||.+++   +++++|+|++|+|++ +.+..|.++++|++|+|++|++....++.|..+++|++|+|++|
T Consensus        13 v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          13 VDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            456666666 6666654   456666666666654 33445566666666666666666666666666666666666666


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT  132 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~  132 (869)
                      +|+.+.|.+|.++++|++|+|++|+|+ .+|.++|.++++|++|+|++|.+.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBC
T ss_pred             cccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccc
Confidence            666555556666666666666666665 455444544444444444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=5.8e-19  Score=173.20  Aligned_cols=184  Identities=21%  Similarity=0.348  Sum_probs=113.7

Q ss_pred             cCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcC
Q 002897           24 LENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQS  103 (869)
Q Consensus        24 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~  103 (869)
                      +...++..+.+++.++.  ..+.+|++|++++|+|+. ++ .++.+++|++|+|++|+|++. + .+.++++|++|++++
T Consensus        26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~   99 (210)
T d1h6ta2          26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDE   99 (210)
T ss_dssp             HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCS
T ss_pred             HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccc
Confidence            33445666666644432  345566667777776663 22 256666777777777766643 2 355666777777777


Q ss_pred             CcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCC
Q 002897          104 NRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRA  183 (869)
Q Consensus       104 N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  183 (869)
                      |+++ .+|  .+.++++|+.|++++|.+...  ..+..+++|+.+++++|.++..  ..+..+++|+++++++|+++.++
T Consensus       100 n~i~-~l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~  172 (210)
T d1h6ta2         100 NKVK-DLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  172 (210)
T ss_dssp             SCCC-CGG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred             cccc-ccc--ccccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            7665 454  356666777777776666532  3566677777777777776532  34566677777777777776543


Q ss_pred             CCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecC
Q 002897          184 ANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGG  231 (869)
Q Consensus       184 ~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~  231 (869)
                              .++++++|++|+|++|+++. ++ .+..+++ |+.|+|++
T Consensus       173 --------~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~-L~~L~Ls~  209 (210)
T d1h6ta2         173 --------PLAGLTKLQNLYLSKNHISD-LR-ALAGLKN-LDVLELFS  209 (210)
T ss_dssp             --------GGTTCTTCCEEECCSSCCCB-CG-GGTTCTT-CSEEEEEE
T ss_pred             --------cccCCCCCCEEECCCCCCCC-Ch-hhcCCCC-CCEEEccC
Confidence                    25667777777777777763 33 4666654 77777653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4e-22  Score=222.58  Aligned_cols=389  Identities=19%  Similarity=0.160  Sum_probs=213.5

Q ss_pred             CcccCCCcccccCC-hhhhhccCCcCEEeccCCcCcc----ccCcccccCcCCCEEEccCCccCcc----CCcccc-CCC
Q 002897            1 MFDAQNNKLVGDIP-VEIGCYLFKLENLSLAENHLTG----QLPVSIGNLSALQVIDIRGNRLGGK----IPDTLG-QLR   70 (869)
Q Consensus         1 ~l~l~~~~~~~~ip-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~p~~~~-~l~   70 (869)
                      +||++.|++++ .. ..+...++++++|+|++|+|+.    .++..+..+++|++|||++|+|+..    +...+. ...
T Consensus         6 ~ld~~~~~i~~-~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~   84 (460)
T d1z7xw1           6 SLDIQCEELSD-ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC   84 (460)
T ss_dssp             EEEEESCCCCH-HHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTC
T ss_pred             EEEeeCCcCCh-HHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCC
Confidence            48999999983 32 4455678999999999999983    4456678999999999999998631    223333 235


Q ss_pred             CCCEEeCcCcccCcc----CCcccccCCCCcEEECcCCcCcccCCchhhc-CC----cchhhhhccccccce----eccc
Q 002897           71 KLIYLNIGRNQFSGF----IPPSIYNISSFEFIFLQSNRFHGSLPFDMVA-NL----PNLRKFVAAKNNLTG----FLPI  137 (869)
Q Consensus        71 ~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~l----~~L~~L~l~~n~i~~----~~~~  137 (869)
                      +|++|+|++|+|+..    ++..+..+++|++|+|++|.+.. .....+. .+    ............+..    ....
T Consensus        85 ~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~-~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (460)
T d1z7xw1          85 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD-AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS  163 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCEEECCCCCccccccccccchhhccccccccccccccchh-hhhhhhhhcccccccccccccccccccchhhhccccc
Confidence            899999999999753    45677889999999999999862 2111111 00    001111111111110    0112


Q ss_pred             cccCCCCCcEEEccCCccccccCcC-----ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCC
Q 002897          138 SLSNASNLELLELRDNQFIGKMSIN-----FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGL  212 (869)
Q Consensus       138 ~l~~l~~L~~L~L~~N~i~~~~~~~-----~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~  212 (869)
                      .+.....++.++++++.+.......     .........+.+..+.+......  .....+...+.++.+++++|++...
T Consensus       164 ~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~--~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         164 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhh--cccccccccccccccchhhcccccc
Confidence            2344566777777766543211000     11223455566665554432211  2223344555666666666654321


Q ss_pred             CChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceec----CCccccCCCCCCEEEccCccccCcCCC
Q 002897          213 LPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGT----VPPEIGWLKNLQSLYLNSNFLHGYIPS  288 (869)
Q Consensus       213 ~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~  288 (869)
                      ...                    ...+........++.+++++|.+...    ....+...+.++.+++++|.++.....
T Consensus       242 ~~~--------------------~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~  301 (460)
T d1z7xw1         242 GMA--------------------ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  301 (460)
T ss_dssp             HHH--------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             ccc--------------------hhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            100                    01112222334455555555544321    112233455566666666655421111


Q ss_pred             C-----CCCCccccceecccccccccCCc----CccCccccceeeccCcccCCCCCccccccccccceecccCCcccCCC
Q 002897          289 S-----LGNLTMLTLLALEINNLQGKIPS----SLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLSDNLLSGSL  359 (869)
Q Consensus       289 ~-----~~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~~N~l~~~~  359 (869)
                      .     ......|+.+++++|.++.....    .+...++|++|+|++|+++..   ++.                  .+
T Consensus       302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~---g~~------------------~l  360 (460)
T d1z7xw1         302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA---GVR------------------EL  360 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH---HHH------------------HH
T ss_pred             hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCc---ccc------------------hh
Confidence            1     11234566777777766533222    234456788888888887521   000                  11


Q ss_pred             ccccc-CCcccccccccccccccc----CCccccCCCCCcEEEeeCccccCCCCcccc-----ccccccEEEccCCcccC
Q 002897          360 PSEIG-NLKNLVQLDISGNRFSGD----IPGTLSACTSLEYVKMQDNSFSGSIPPSLN-----FLKSIKVLDLSSNKLSG  429 (869)
Q Consensus       360 p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~  429 (869)
                      +..+. ..+.|++|+|++|.|++.    ++..+..+++|++|+|++|+|+......+.     ....|+.|++++|.+..
T Consensus       361 ~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             hhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            12222 244577777777777632    344556677788888888877643332221     22368888888888775


Q ss_pred             CCccc
Q 002897          430 QIPKY  434 (869)
Q Consensus       430 ~~p~~  434 (869)
                      .....
T Consensus       441 ~~~~~  445 (460)
T d1z7xw1         441 EMEDR  445 (460)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44433

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=3.1e-18  Score=166.48  Aligned_cols=182  Identities=24%  Similarity=0.356  Sum_probs=122.7

Q ss_pred             CCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEEC
Q 002897           22 FKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFL  101 (869)
Q Consensus        22 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L  101 (869)
                      .++..+.++.+.+++.++  ...+.+|++|++++|.|+. ++ .++.+++|++|+|++|+|++..|  +.++++|++|++
T Consensus        18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l   91 (199)
T d2omxa2          18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM   91 (199)
T ss_dssp             HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence            344556677777765443  3456777777777777773 32 46777777777777777774322  777777777777


Q ss_pred             cCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCC
Q 002897          102 QSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGN  181 (869)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~  181 (869)
                      ++|.+. .++  .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++..+  ..+..+++|+.|++++|+++.
T Consensus        92 ~~n~~~-~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          92 NNNQIA-DIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CSSCCC-CCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             cccccc-ccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC
Confidence            777775 554  366777777777777777643  3466777888888888877643  247777888888888887776


Q ss_pred             CCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEE
Q 002897          182 RAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTI  227 (869)
Q Consensus       182 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L  227 (869)
                      ++        .++++++|++|++++|++++. + .+..+++ |++|
T Consensus       165 l~--------~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~-L~~L  199 (199)
T d2omxa2         165 LK--------PLANLTTLERLDISSNKVSDI-S-VLAKLTN-LESL  199 (199)
T ss_dssp             CG--------GGTTCTTCCEEECCSSCCCCC-G-GGGGCTT-CSEE
T ss_pred             Cc--------cccCCCCCCEEECCCCCCCCC-c-cccCCCC-CCcC
Confidence            54        367778888888888887743 2 4566654 6554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.1e-18  Score=169.79  Aligned_cols=176  Identities=21%  Similarity=0.311  Sum_probs=124.7

Q ss_pred             ccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCccc
Q 002897            3 DAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQF   82 (869)
Q Consensus         3 ~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i   82 (869)
                      +++.+++++.++.   ..+.+++.|++++|+|+. + +.+..+++|++|+|++|+|++. + .|+++++|++|++++|.+
T Consensus        24 ~l~~~~~~~~~~~---~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~   96 (199)
T d2omxa2          24 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI   96 (199)
T ss_dssp             HTTCSSTTSEECH---HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccCH---HHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-c-cccCCccccccccccccc
Confidence            4556666644432   246778888888888874 3 2477788888888888888743 3 277888888888888877


Q ss_pred             CccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcC
Q 002897           83 SGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN  162 (869)
Q Consensus        83 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  162 (869)
                      ... + .+.++++|+.|++++|.+. .++  .+..+++|+.|++++|++...  ..+..+++|+.|++++|+++++.  .
T Consensus        97 ~~~-~-~l~~l~~L~~L~l~~~~~~-~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~  167 (199)
T d2omxa2          97 ADI-T-PLANLTNLTGLTLFNNQIT-DID--PLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--P  167 (199)
T ss_dssp             CCC-G-GGTTCTTCSEEECCSSCCC-CCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--G
T ss_pred             ccc-c-ccccccccccccccccccc-ccc--ccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--c
Confidence            643 3 4777888888888888776 333  367778888888888887643  35777888888888888877653  3


Q ss_pred             ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEE
Q 002897          163 FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENL  202 (869)
Q Consensus       163 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L  202 (869)
                      |.++++|++|++++|++++++        .++++++|++|
T Consensus       168 l~~l~~L~~L~ls~N~i~~i~--------~l~~L~~L~~L  199 (199)
T d2omxa2         168 LANLTTLERLDISSNKVSDIS--------VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCCCG--------GGGGCTTCSEE
T ss_pred             ccCCCCCCEEECCCCCCCCCc--------cccCCCCCCcC
Confidence            777888888888888877654        36677777765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=1.5e-18  Score=167.62  Aligned_cols=176  Identities=20%  Similarity=0.229  Sum_probs=116.8

Q ss_pred             CEEEccCccccCcCCCCCCCCccccceecccccccc-cCCcCccCccccceeeccCcccCCCCCccccccccccceeccc
Q 002897          273 QSLYLNSNFLHGYIPSSLGNLTMLTLLALEINNLQG-KIPSSLGNCTSLIMLTLSKNKLDGVLPPQILSVTTLSLFLNLS  351 (869)
Q Consensus       273 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~l~~L~l~  351 (869)
                      +.++.++++++ .+|..+.  +++++|+|++|+|+. ..+..|.++++|+.|+|++|++.                    
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~--------------------   67 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT--------------------   67 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC--------------------
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc--------------------
Confidence            35556666655 3333332  345555555555543 22344455555555555555554                    


Q ss_pred             CCcccCCCcccccCCccccccccccccccccCCccccCCCCCcEEEeeCccccCCCCccccccccccEEEccCCcccCCC
Q 002897          352 DNLLSGSLPSEIGNLKNLVQLDISGNRFSGDIPGTLSACTSLEYVKMQDNSFSGSIPPSLNFLKSIKVLDLSSNKLSGQI  431 (869)
Q Consensus       352 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  431 (869)
                           +..+..|..+++|++|+|++|+|+...|.+|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+.+..
T Consensus        68 -----~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          68 -----GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             -----CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             -----cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence                 566677788888888888888888777778888888888888888888777778888888888888888887543


Q ss_pred             ccccccccccCeeccccccCcccCCCCCccCCCccccccCCcccCCCC
Q 002897          432 PKYLENLSFLEYLNLSYNHFEGEVPKKGVFSNKTRFSLSGNGKLCGGL  479 (869)
Q Consensus       432 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  479 (869)
                      +.. .-...++.+.+..|.+++..|..  +..+...+++.|...|.+.
T Consensus       143 ~~~-~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         143 HLA-WFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             GGH-HHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC
T ss_pred             chH-HHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCCCC
Confidence            322 11234666777888887766643  5566667778887778644

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=2.9e-18  Score=168.20  Aligned_cols=185  Identities=23%  Similarity=0.333  Sum_probs=114.5

Q ss_pred             cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhh
Q 002897           46 SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFV  125 (869)
Q Consensus        46 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  125 (869)
                      .++...+++.+.+++.++.  .++.+|++|++++|.|+.. + .+..+++|++|+|++|+++ .++.  ++.+++|+.|+
T Consensus        24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~   96 (210)
T d1h6ta2          24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCcccc-Cccc--cccCccccccc
Confidence            3444557777877754432  4678999999999999854 3 4889999999999999998 4542  45666666666


Q ss_pred             ccccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEcc
Q 002897          126 AAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLY  205 (869)
Q Consensus       126 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~  205 (869)
                      +++|+|+.+ + .+.++++|+.|++++|.+..+  ..+..+++++.+++++|.++...        .+..+++|++++++
T Consensus        97 l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~--------~~~~l~~L~~l~l~  164 (210)
T d1h6ta2          97 LDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT--------VLSRLTKLDTLSLE  164 (210)
T ss_dssp             CCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECC
T ss_pred             ccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc--------cccccccccccccc
Confidence            666666642 2 455666666666666655432  23555555555555555554322        23444555555555


Q ss_pred             CCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCCeeecccCcceecCCccccCCCCCCEEEcc
Q 002897          206 DNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLNSIAMEGNQLIGTVPPEIGWLKNLQSLYLN  278 (869)
Q Consensus       206 ~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  278 (869)
                      +|+++                         +. + .++++++|+.|++++|+++. ++ .+..+++|++|+|+
T Consensus       165 ~n~l~-------------------------~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         165 DNQIS-------------------------DI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             SSCCC-------------------------CC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             ccccc-------------------------cc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            55544                         22 1 25556666666666666653 33 46666666666665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=2.2e-16  Score=146.69  Aligned_cols=127  Identities=17%  Similarity=0.136  Sum_probs=83.6

Q ss_pred             ccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEE
Q 002897           20 YLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFI   99 (869)
Q Consensus        20 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L   99 (869)
                      ...++++|+|++|+|+ .++..+..+++|++|+|++|+|+.. + .|+.+++|++|+|++|+|+...+..+.++++|++|
T Consensus        16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence            4567788888888887 4466667777888888888887743 3 47777788888888888876655666677777777


Q ss_pred             ECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccC---cCccCCCCCCEEE
Q 002897          100 FLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS---INFNSLKNLSVLI  173 (869)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~  173 (869)
                      +|++|++. .++.                       ...+..+++|++|++++|.++....   ..+..+++|+.||
T Consensus        93 ~L~~N~i~-~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          93 ILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             ECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             eecccccc-cccc-----------------------ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            77777776 3331                       1234555666666666666543321   2355566666664

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1.2e-15  Score=134.46  Aligned_cols=101  Identities=20%  Similarity=0.302  Sum_probs=78.1

Q ss_pred             CcccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            1 MFDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         1 ~l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      ||||++|+|+ .+|. + ..+++|++|++++|+|+ .+|..|+.+++|++|++++|+|+ .+| .|+++++|++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~-l-~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH-L-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC-G-GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc-c-ccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            5788888888 7774 4 47888888888888887 56777888888888888888888 344 4788888888888888


Q ss_pred             ccCccC-CcccccCCCCcEEECcCCcCc
Q 002897           81 QFSGFI-PPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        81 ~i~~~~-p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      +|+... ...+.++++|++|++++|++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            887543 256778888888888888876

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=3.1e-16  Score=145.65  Aligned_cols=134  Identities=16%  Similarity=0.182  Sum_probs=93.3

Q ss_pred             ccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcc
Q 002897           41 SIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPN  120 (869)
Q Consensus        41 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  120 (869)
                      .|.+..+|++|+|++|+|+ .+++.+..+++|++|||++|+|+..  +.|..+++|++|++++|+++             
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-------------   76 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-------------   76 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-------------
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-------------
Confidence            3556666777777777776 3455566667777777777776643  23555666666666666654             


Q ss_pred             hhhhhccccccceeccccccCCCCCcEEEccCCccccccC-cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCC
Q 002897          121 LRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMS-INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKL  199 (869)
Q Consensus       121 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L  199 (869)
                                  ...+..+..+++|+.|++++|+|..+.. ..+..+++|++|++++|.++..+..   -...++.+++|
T Consensus        77 ------------~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~---r~~~i~~lp~L  141 (162)
T d1a9na_          77 ------------RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY---RLYVIYKVPQV  141 (162)
T ss_dssp             ------------EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTH---HHHHHHHCTTC
T ss_pred             ------------CCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccch---HHHHHHHCCCc
Confidence                        3444456678899999999999876643 5688999999999999999876531   12357889999


Q ss_pred             cEEEcc
Q 002897          200 ENLGLY  205 (869)
Q Consensus       200 ~~L~L~  205 (869)
                      ++||-+
T Consensus       142 ~~LD~~  147 (162)
T d1a9na_         142 RVLDFQ  147 (162)
T ss_dssp             SEETTE
T ss_pred             CeeCCC
Confidence            998743

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=2.6e-15  Score=132.31  Aligned_cols=119  Identities=25%  Similarity=0.323  Sum_probs=80.0

Q ss_pred             CEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCC
Q 002897           25 ENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      |+|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|+.+++|++|++++|+|++. | .+.++++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            57888888887 444 3778888888888888887 5677788888888888888888743 3 4777788888888888


Q ss_pred             cCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCcccccc---CcCccCCCCCCEE
Q 002897          105 RFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKM---SINFNSLKNLSVL  172 (869)
Q Consensus       105 ~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~L  172 (869)
                      ++. .+|.                       ...+..+++|+.|++++|+++...   ...+..+++|+.|
T Consensus        76 ~i~-~~~~-----------------------~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQ-QSAA-----------------------IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCC-SSST-----------------------TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccC-CCCC-----------------------chhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            776 4431                       124555666666666666665332   2223345666554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=4.6e-16  Score=159.94  Aligned_cols=100  Identities=15%  Similarity=0.108  Sum_probs=65.7

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCcc-CCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGK-IPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~p~~~~~l~~L~~L~L~~n   80 (869)
                      +|++++.+...+...+..  ..+..+.+++..+.... .......+|++|||++|.++.. ++..+.++++|++|+|++|
T Consensus         5 lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           5 LDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             EECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             EECCCCCCCchHHHHHHh--ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            577777766555555542  34666777666665322 2333456788888888777632 3445677788888888888


Q ss_pred             ccCccCCcccccCCCCcEEECcCC
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSN  104 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N  104 (869)
                      .+....+..+.++++|++|+|++|
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c  105 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGC  105 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTC
T ss_pred             CCCcHHHHHHhcCCCCcCcccccc
Confidence            777666677777777888887775

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=3.5e-16  Score=160.89  Aligned_cols=79  Identities=11%  Similarity=0.138  Sum_probs=38.2

Q ss_pred             CEEeccCCcCccccCcccccC--cCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCcc-CCcccccCCCCcEEEC
Q 002897           25 ENLSLAENHLTGQLPVSIGNL--SALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGF-IPPSIYNISSFEFIFL  101 (869)
Q Consensus        25 ~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~-~p~~~~~l~~L~~L~L  101 (869)
                      ++|||+++.+.   |+.+..+  ..+..+.++.+.+.... .......+|++|||++|.+... ++..+.++++|++|+|
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L   78 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL   78 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence            35677766664   2222221  23445555555544222 2223345666666666665532 2233445555555555


Q ss_pred             cCCcCc
Q 002897          102 QSNRFH  107 (869)
Q Consensus       102 s~N~l~  107 (869)
                      ++|.+.
T Consensus        79 ~~~~l~   84 (284)
T d2astb2          79 EGLRLS   84 (284)
T ss_dssp             TTCBCC
T ss_pred             cccCCC
Confidence            555543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.54  E-value=2.5e-16  Score=167.47  Aligned_cols=257  Identities=18%  Similarity=0.198  Sum_probs=135.3

Q ss_pred             cCChhhhhccCCcCEEeccCCcCcc----ccCcccccCcCCCEEEccCCccCcc----------CCccccCCCCCCEEeC
Q 002897           12 DIPVEIGCYLFKLENLSLAENHLTG----QLPVSIGNLSALQVIDIRGNRLGGK----------IPDTLGQLRKLIYLNI   77 (869)
Q Consensus        12 ~ip~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~----------~p~~~~~l~~L~~L~L   77 (869)
                      .+...+ ....+|+.|+|++|.|..    .+...+...++|+.|+++++.+...          +...+..+++|++|+|
T Consensus        22 ~l~~~L-~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L  100 (344)
T d2ca6a1          22 SVFAVL-LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL  100 (344)
T ss_dssp             TTSHHH-HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred             HHHHHH-hhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccc
Confidence            344444 356788888888888863    3344566778888888887755421          1223556788888888


Q ss_pred             cCcccCcc----CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCC
Q 002897           78 GRNQFSGF----IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDN  153 (869)
Q Consensus        78 ~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N  153 (869)
                      ++|.+...    +...+...++|++|++++|.+... ....++  ..|..+...         ......+.|+.|++++|
T Consensus       101 ~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~-~~~~l~--~~l~~~~~~---------~~~~~~~~L~~l~l~~n  168 (344)
T d2ca6a1         101 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ-AGAKIA--RALQELAVN---------KKAKNAPPLRSIICGRN  168 (344)
T ss_dssp             CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH-HHHHHH--HHHHHHHHH---------HHHHTCCCCCEEECCSS
T ss_pred             cccccccccccchhhhhcccccchheeccccccccc-cccccc--ccccccccc---------cccccCcccceeecccc
Confidence            88888753    334455678888888888877411 001110  011111110         01123345555555555


Q ss_pred             ccccccC----cCccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCC----Chhhhhccccce
Q 002897          154 QFIGKMS----INFNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLL----PHSLANLSNTMT  225 (869)
Q Consensus       154 ~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~~L~  225 (869)
                      .+.....    ..+...++|++|+|++|.|+...... .....+..+++|+.|+|++|.++...    ...+...+. |+
T Consensus       169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~-~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~-L~  246 (344)
T d2ca6a1         169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH-LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN-LR  246 (344)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHH-HHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT-CC
T ss_pred             cccccccccccchhhhhhhhccccccccccccccccc-chhhhhcchhhhccccccccccccccccccccccccccc-ch
Confidence            5432111    11333455555555555554321100 01123445555555555555554221    122233332 55


Q ss_pred             EEEecCCcccccCCc----ccc--CCCCCCeeecccCcceecC----Cccc-cCCCCCCEEEccCcccc
Q 002897          226 TIDIGGNYFSGTIPP----GLG--NLVHLNSIAMEGNQLIGTV----PPEI-GWLKNLQSLYLNSNFLH  283 (869)
Q Consensus       226 ~L~l~~n~l~~~~~~----~~~--~l~~L~~L~l~~n~l~~~~----~~~~-~~l~~L~~L~L~~N~l~  283 (869)
                      +|+|++|.|++....    .+.  ..+.|++|++++|++....    ...+ .+.++|+.|+|++|++.
T Consensus       247 ~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            555555555432111    222  2356777777777765422    2223 24678888888888886

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.51  E-value=5.8e-16  Score=164.62  Aligned_cols=252  Identities=17%  Similarity=0.203  Sum_probs=140.1

Q ss_pred             ccCcccccCcCCCEEEccCCccCc----cCCccccCCCCCCEEeCcCcccCcc----------CCcccccCCCCcEEECc
Q 002897           37 QLPVSIGNLSALQVIDIRGNRLGG----KIPDTLGQLRKLIYLNIGRNQFSGF----------IPPSIYNISSFEFIFLQ  102 (869)
Q Consensus        37 ~~~~~~~~l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~i~~~----------~p~~~~~l~~L~~L~Ls  102 (869)
                      .+..++.....|++|+|++|.|..    .+...+...++|+.|+++++.+...          +...+...++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            344567778888888888888753    2234566778888888887654421          11223445666666666


Q ss_pred             CCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCccccccCcC-------------ccCCCCC
Q 002897          103 SNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQFIGKMSIN-------------FNSLKNL  169 (869)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L  169 (869)
                      +|.+.. ....                    .+...+..+++|++|++++|.+.......             ....+.|
T Consensus       102 ~n~i~~-~~~~--------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L  160 (344)
T d2ca6a1         102 DNAFGP-TAQE--------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL  160 (344)
T ss_dssp             SCCCCT-TTHH--------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             cccccc-cccc--------------------chhhhhcccccchheecccccccccccccccccccccccccccccCccc
Confidence            666641 1100                    12233445566777777776653211111             1234567


Q ss_pred             CEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCCCCChhhhhccccceEEEecCCcccccCCccccCCCCCC
Q 002897          170 SVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGGLLPHSLANLSNTMTTIDIGGNYFSGTIPPGLGNLVHLN  249 (869)
Q Consensus       170 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  249 (869)
                      +.|.+++|.++.....  .+...+..++.|++|+|++|+++......                    .+...+..+++|+
T Consensus       161 ~~l~l~~n~i~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~g~~~--------------------~l~~~l~~~~~L~  218 (344)
T d2ca6a1         161 RSIICGRNRLENGSMK--EWAKTFQSHRLLHTVKMVQNGIRPEGIEH--------------------LLLEGLAYCQELK  218 (344)
T ss_dssp             CEEECCSSCCTGGGHH--HHHHHHHHCTTCCEEECCSSCCCHHHHHH--------------------HHHTTGGGCTTCC
T ss_pred             ceeecccccccccccc--cccchhhhhhhhccccccccccccccccc--------------------chhhhhcchhhhc
Confidence            7777777766543332  23344555666666666666665211000                    1122344555666


Q ss_pred             eeecccCcceec----CCccccCCCCCCEEEccCccccCcCCCCC----C--CCccccceeccccccccc----CCcCcc
Q 002897          250 SIAMEGNQLIGT----VPPEIGWLKNLQSLYLNSNFLHGYIPSSL----G--NLTMLTLLALEINNLQGK----IPSSLG  315 (869)
Q Consensus       250 ~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~--~l~~L~~L~l~~n~l~~~----~~~~~~  315 (869)
                      .|++++|.+...    +...+...++|++|+|++|.|++.....+    .  ..+.|+.|++++|+|+..    +...+.
T Consensus       219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~  298 (344)
T d2ca6a1         219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID  298 (344)
T ss_dssp             EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHH
Confidence            666666665422    23344556677777777776664322221    1  235577777777777632    223332


Q ss_pred             -CccccceeeccCcccC
Q 002897          316 -NCTSLIMLTLSKNKLD  331 (869)
Q Consensus       316 -~l~~L~~L~l~~N~l~  331 (869)
                       ++++|+.|+|++|++.
T Consensus       299 ~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         299 EKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHCTTCCEEECTTSBSC
T ss_pred             ccCCCCCEEECCCCcCC
Confidence             4677888888888886

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.46  E-value=9e-16  Score=147.86  Aligned_cols=133  Identities=22%  Similarity=0.290  Sum_probs=96.5

Q ss_pred             cCCcCEEeccCC--cCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcE
Q 002897           21 LFKLENLSLAEN--HLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEF   98 (869)
Q Consensus        21 l~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~   98 (869)
                      ...++.++++.+  .++ .+|.+|..+++|++|+|++|+|+. ++ .|+++++|++|+|++|+|+ .+|..+..+++|++
T Consensus        22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~   97 (198)
T d1m9la_          22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE   97 (198)
T ss_dssp             CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCE
T ss_pred             ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccc
Confidence            344566677654  344 566788888999999999999884 44 4888889999999999888 45666666778888


Q ss_pred             EECcCCcCcccCCchhhcCCcchhhhhccccccceecc-ccccCCCCCcEEEccCCccccccC
Q 002897           99 IFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLP-ISLSNASNLELLELRDNQFIGKMS  160 (869)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~  160 (869)
                      |++++|+++ .++  .+..+++|+.|++++|+|+.... ..|..+++|+.|+|++|++....+
T Consensus        98 L~l~~N~i~-~l~--~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_          98 LWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             EECSEEECC-CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             ccccccccc-ccc--cccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence            888888887 453  36677777778888777765422 457777777777777777654433

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1.1e-13  Score=127.31  Aligned_cols=103  Identities=18%  Similarity=0.207  Sum_probs=62.6

Q ss_pred             cccCCCcccccCChhhhhccCCcCEEeccCC-cCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCc
Q 002897            2 FDAQNNKLVGDIPVEIGCYLFKLENLSLAEN-HLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRN   80 (869)
Q Consensus         2 l~l~~~~~~~~ip~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n   80 (869)
                      +++++++++ ++|..+. .+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|++|.++++|++|+|++|
T Consensus        13 l~c~~~~~~-~~p~~l~-~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             EECCSSCCC-TTTTTSC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEecCCCCc-cCccccc-CccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            455566666 5666654 4666666666544 366555556666666666666666666666666666666666666666


Q ss_pred             ccCccCCcccccCCCCcEEECcCCcCc
Q 002897           81 QFSGFIPPSIYNISSFEFIFLQSNRFH  107 (869)
Q Consensus        81 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~  107 (869)
                      +|+.+.+..|..+ +|+.|+|++|.+.
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCcccChhhhccc-cccccccCCCccc
Confidence            6664434444333 5666666666654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=1.6e-15  Score=146.15  Aligned_cols=134  Identities=19%  Similarity=0.297  Sum_probs=109.3

Q ss_pred             cccccCChhhhhccCCcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCC
Q 002897            8 KLVGDIPVEIGCYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIP   87 (869)
Q Consensus         8 ~~~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p   87 (869)
                      .++ .+|..+. .+++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.+  
T Consensus        36 ~i~-~l~~sl~-~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--  108 (198)
T d1m9la_          36 PIE-KMDATLS-TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--  108 (198)
T ss_dssp             TCC-CCHHHHH-HTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--
T ss_pred             chh-hhhhHHh-cccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--
Confidence            355 5666664 79999999999999994 44 5999999999999999998 6677777778999999999999954  


Q ss_pred             cccccCCCCcEEECcCCcCcccCCc-hhhcCCcchhhhhccccccceecccc----------ccCCCCCcEEE
Q 002897           88 PSIYNISSFEFIFLQSNRFHGSLPF-DMVANLPNLRKFVAAKNNLTGFLPIS----------LSNASNLELLE  149 (869)
Q Consensus        88 ~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~----------l~~l~~L~~L~  149 (869)
                      ..+.++++|+.|+|++|++. .++. ..+..+++|+.|++++|.+....+..          +..+++|+.||
T Consensus       109 ~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         109 SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             ccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            45889999999999999997 5553 56899999999999999997554432          44556666654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=1.4e-13  Score=126.43  Aligned_cols=111  Identities=19%  Similarity=0.181  Sum_probs=90.3

Q ss_pred             hccCCcCEEeccCCcCccccCcccccCcCCCEEEccCC-ccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCc
Q 002897           19 CYLFKLENLSLAENHLTGQLPVSIGNLSALQVIDIRGN-RLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFE   97 (869)
Q Consensus        19 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~   97 (869)
                      |.......++.++++++ ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|.+|.++++|+
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            34456677899999988 67788889999999999766 58877778899999999999999999988888999999999


Q ss_pred             EEECcCCcCcccCCchhhcCCcchhhhhccccccc
Q 002897           98 FIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT  132 (869)
Q Consensus        98 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~  132 (869)
                      +|+|++|+++ .+|.++|..+ +|+.|+|++|.+.
T Consensus        84 ~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          84 RLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             EEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             ceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence            9999999997 7887766544 4666666666553

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=1.8e-10  Score=106.25  Aligned_cols=104  Identities=13%  Similarity=0.096  Sum_probs=61.0

Q ss_pred             CcCEEeccCCcCccccCcccccCcCCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccC--CcccccCCCCcEEE
Q 002897           23 KLENLSLAENHLTGQLPVSIGNLSALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFI--PPSIYNISSFEFIF  100 (869)
Q Consensus        23 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~--p~~~~~l~~L~~L~  100 (869)
                      ..+.|+++++...    ..+..+..+..|+...+.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4556666655432    23445555555665555554 44555566777888888888777542  34466677777777


Q ss_pred             CcCCcCcccCCchhhcCCcchhhhhccccccc
Q 002897          101 LQSNRFHGSLPFDMVANLPNLRKFVAAKNNLT  132 (869)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~  132 (869)
                      |++|+++ .++...+....+|+.|++++|.+.
T Consensus        98 Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          98 LSGNELK-SERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             cccCccc-cchhhhhhhccccceeecCCCCcC
Confidence            7777776 554433333344555555555554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=9.4e-08  Score=95.78  Aligned_cols=148  Identities=16%  Similarity=0.132  Sum_probs=103.4

Q ss_pred             HHHHHhcCCCCCCeeeeecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccC
Q 002897          548 KLSKATSEFSSSNMVGQGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFN  626 (869)
Q Consensus       548 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  626 (869)
                      ++.+....|++.+..+.++.+.||++..  +++.+++|+...........+.+|...++.+. +--+.+++.+...    
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----   81 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----   81 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec----
Confidence            5556667777666655555678999875  67778899886555444556788888888773 3335667766443    


Q ss_pred             CCceEEEEeecccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 002897          627 GVDFKAIVYDFMQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC------------------------  682 (869)
Q Consensus       627 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------  682 (869)
                       .+..++||++++|.++.+......           ....++.++++.++.||+..                        
T Consensus        82 -~~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T d1j7la_          82 -DGWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             -TTEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             -CCceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence             267799999999988876543221           12345666777777777532                        


Q ss_pred             --------------------------------CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          683 --------------------------------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       683 --------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                                      .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                            1237999999999999987667799999875

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=1.7e-09  Score=99.40  Aligned_cols=129  Identities=21%  Similarity=0.201  Sum_probs=70.0

Q ss_pred             CCCEEEccCCccCccCCccccCCCCCCEEeCcCcccCccCCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhc
Q 002897           47 ALQVIDIRGNRLGGKIPDTLGQLRKLIYLNIGRNQFSGFIPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVA  126 (869)
Q Consensus        47 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l  126 (869)
                      ..+.|++++++..    ..+..+..+..|++..|.+. .++..+.++++|++|+|++|+|+ .++.              
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~--------------   82 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDD--------------   82 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSG--------------
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCch--------------
Confidence            4566777766533    23555566666666666554 44555667788888888888876 4431              


Q ss_pred             cccccceeccccccCCCCCcEEEccCCccccccCcCccCCCCCCEEEccCccCCCCCCCCcc-hhhhccCCCCCcEEE
Q 002897          127 AKNNLTGFLPISLSNASNLELLELRDNQFIGKMSINFNSLKNLSVLILGNNHLGNRAANDLD-FVTVLANCSKLENLG  203 (869)
Q Consensus       127 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~~l~~l~~L~~L~  203 (869)
                              ++..+..+++|+.|+|++|.|+.+.+..+....+|+.|++++|.+.....+... ....+..+++|+.||
T Consensus        83 --------~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          83 --------MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             --------GGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             --------hHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence                    122334455555555555555544443333344556666666665543322111 112355667777664

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.85  E-value=3.2e-06  Score=77.39  Aligned_cols=117  Identities=10%  Similarity=0.051  Sum_probs=74.9

Q ss_pred             ccCCcCEEeccCC-cCcc----ccCcccccCcCCCEEEccCCccCc----cCCccccCCCCCCEEeCcCcccCcc----C
Q 002897           20 YLFKLENLSLAEN-HLTG----QLPVSIGNLSALQVIDIRGNRLGG----KIPDTLGQLRKLIYLNIGRNQFSGF----I   86 (869)
Q Consensus        20 ~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~i~~~----~   86 (869)
                      ..++|+.|+|+++ .++.    .+-.++...++|++|+|++|.+..    .+...+...+.|++|+|++|.|...    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            4578888888874 5652    234456677888888888888873    2223445667888888888887743    2


Q ss_pred             CcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccCCCCCcEEEccCCc
Q 002897           87 PPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSNASNLELLELRDNQ  154 (869)
Q Consensus        87 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~  154 (869)
                      -.++...++|++|+|++|++. .+.....                 ..+...+...++|+.|+++.+.
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~-~~g~~~~-----------------~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQS-VLGNQVE-----------------MDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSC-CCCHHHH-----------------HHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHhCCcCCEEECCCCcCC-CccHHHH-----------------HHHHHHHHhCCCccEeeCcCCC
Confidence            234556677888888877664 3321110                 0233455666778888887664

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.72  E-value=2.6e-05  Score=76.86  Aligned_cols=130  Identities=16%  Similarity=0.100  Sum_probs=82.4

Q ss_pred             eeeeecc-eEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCC--CCccceEEEEeeccccCCCceEEEEeec
Q 002897          561 MVGQGSF-GTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIR--HRNLIKIITICSSIDFNGVDFKAIVYDF  637 (869)
Q Consensus       561 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~  637 (869)
                      .+..|.. +.||++... .+..+++|......   ...+..|+..++.+.  .-.+.+++++..+     .+..++||+|
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEe
Confidence            3445554 689998874 67778899865433   234677888887773  2335667776543     2567899999


Q ss_pred             ccCCCHHHHHhhCCCcccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 002897          638 MQNGSLEEWLHQNNDKLEVCNLSLIQTLNIAIDVASAIEYLHHHC-----------------------------------  682 (869)
Q Consensus       638 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  682 (869)
                      ++|.++.+..           .+.   ...+.++++.++-||+..                                   
T Consensus        88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             eecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            9886653210           111   111223333344444211                                   


Q ss_pred             --------------------CCCeEecCCCCCceeecCCCcEEEccccccc
Q 002897          683 --------------------KPPVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       683 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                                          .+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                                2347999999999999987667899999875

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.68  E-value=4.6e-06  Score=76.28  Aligned_cols=73  Identities=11%  Similarity=0.106  Sum_probs=45.6

Q ss_pred             ccccCCCCCcEEEccCCccccccCcC----ccCCCCCCEEEccCccCCCCCCCCcchhhhccCCCCCcEEEccCCCCCC
Q 002897          137 ISLSNASNLELLELRDNQFIGKMSIN----FNSLKNLSVLILGNNHLGNRAANDLDFVTVLANCSKLENLGLYDNQFGG  211 (869)
Q Consensus       137 ~~l~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  211 (869)
                      .++...++|++|+|++|.+.......    +...+.|++|+|++|.|+..+..  .+..++...++|++|++++|.+..
T Consensus        38 ~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~--~l~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          38 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA--RLLRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--HHHHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH--HHHHHHHhCCcCCEEECCCCcCCC
Confidence            34555667777777777765322222    33456777777777777654432  345567777777788777776653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.68  E-value=4.4e-05  Score=80.24  Aligned_cols=76  Identities=14%  Similarity=0.124  Sum_probs=49.6

Q ss_pred             CeeeeecceEEEEEEECCCCeEEEEEEeecc----c---chhhHHHHHHHHHHHhC-CC--CccceEEEEeeccccCCCc
Q 002897          560 NMVGQGSFGTVFKGIIGENGMLVAVKVLNLM----Q---KGALKSFLTECEALRSI-RH--RNLIKIITICSSIDFNGVD  629 (869)
Q Consensus       560 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~~  629 (869)
                      +.||.|....||++....+++.|+||.-...    .   +....+...|++.++.+ .+  ..+.+++.+..       +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence            4689999999999998777889999975321    1   11234567788888777 22  34666666532       3


Q ss_pred             eEEEEeecccCCC
Q 002897          630 FKAIVYDFMQNGS  642 (869)
Q Consensus       630 ~~~lv~e~~~~gs  642 (869)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            4578999997654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.28  E-value=1.2e-05  Score=73.48  Aligned_cols=39  Identities=8%  Similarity=-0.015  Sum_probs=16.3

Q ss_pred             CCCCCCEEeCcCcccCcc----CCcccccCCCCcEEECcCCcC
Q 002897           68 QLRKLIYLNIGRNQFSGF----IPPSIYNISSFEFIFLQSNRF  106 (869)
Q Consensus        68 ~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l  106 (869)
                      ..++|++|+|++|.+...    +-..+...++++.|++++|.+
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~   86 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI   86 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence            344444444444444321    112233344445555544444

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.09  E-value=0.00023  Score=72.58  Aligned_cols=143  Identities=13%  Similarity=0.095  Sum_probs=76.9

Q ss_pred             ceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhCCCCc--cceEEEEeeccccCCCceEEEEeecccCCCH-
Q 002897          567 FGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSIRHRN--LIKIITICSSIDFNGVDFKAIVYDFMQNGSL-  643 (869)
Q Consensus       567 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL-  643 (869)
                      .-.||+++.. +|+.|++|+.+.... ..+++..|...+..+....  ++..+.......+......+.++++++|..+ 
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            3589999985 899999999865422 3466778888887773222  2222221111112234567889999876432 


Q ss_pred             ----HHH---------Hhh---CCCcccccC-------------------CCHHHHHHHHHHHHHHHHHHHhc----CCC
Q 002897          644 ----EEW---------LHQ---NNDKLEVCN-------------------LSLIQTLNIAIDVASAIEYLHHH----CKP  684 (869)
Q Consensus       644 ----~~~---------l~~---~~~~~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~~----~~~  684 (869)
                          ..+         ++.   .........                   ++......+...+.+.++.+...    ...
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                111         111   000000001                   11111112222223333333322    245


Q ss_pred             CeEecCCCCCceeecCCCcEEEccccccc
Q 002897          685 PVVHGDLKPSNVLLDHDMVAHVGDFGLAK  713 (869)
Q Consensus       685 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  713 (869)
                      ++||+|+.+.|||++++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            78999999999999743  4589999885

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.01  E-value=7.5e-05  Score=67.85  Aligned_cols=119  Identities=16%  Similarity=0.119  Sum_probs=61.7

Q ss_pred             cCCCCCCEEeCcC-cccCcc----CCcccccCCCCcEEECcCCcCcccCCchhhcCCcchhhhhccccccceeccccccC
Q 002897           67 GQLRKLIYLNIGR-NQFSGF----IPPSIYNISSFEFIFLQSNRFHGSLPFDMVANLPNLRKFVAAKNNLTGFLPISLSN  141 (869)
Q Consensus        67 ~~l~~L~~L~L~~-n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~  141 (869)
                      .+.++|++|+|++ +.|+..    +-.++...++|++|+|++|.+.... ..                    .+...+..
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~-~~--------------------~L~~~l~~   72 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPV-AF--------------------ALAEMLKV   72 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHH-HH--------------------HHHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHH-HH--------------------HHHHHHhh
Confidence            3456666666665 344421    2234446667777777777664110 00                    12234445


Q ss_pred             CCCCcEEEccCCcccccc----CcCccCCCCCCEEEcc--CccCCCCCCCCcchhhhccCCCCCcEEEccCCC
Q 002897          142 ASNLELLELRDNQFIGKM----SINFNSLKNLSVLILG--NNHLGNRAANDLDFVTVLANCSKLENLGLYDNQ  208 (869)
Q Consensus       142 l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l~--~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~  208 (869)
                      .++|+.+++++|.+....    ...+...++|+.++|+  +|.++.....  .++..+...+.|++|+++.+.
T Consensus        73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~--~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--EIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--HHHHHHHHCSSCCEEECCCSS
T ss_pred             cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH--HHHHHHHhCCCcCEEeCcCCC
Confidence            567777777777764322    2334555666654443  4444432221  334455566666666665544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.50  E-value=0.0044  Score=62.37  Aligned_cols=61  Identities=7%  Similarity=0.040  Sum_probs=38.9

Q ss_pred             ccHHHHHHHhcCCCCCCeee-----eecceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhC
Q 002897          544 ISYAKLSKATSEFSSSNMVG-----QGSFGTVFKGIIGENGMLVAVKVLNLMQKGALKSFLTECEALRSI  608 (869)
Q Consensus       544 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  608 (869)
                      ++.+++.....+|.+.+...     .|.--+.|+++..  +..+++|+++...  ..+.+..|++++..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L   68 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHL   68 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhh
Confidence            56678888888998866544     4555778999874  3458999986432  224455667777666

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.24  E-value=0.0042  Score=64.76  Aligned_cols=74  Identities=14%  Similarity=0.128  Sum_probs=49.9

Q ss_pred             CCeeeeecceEEEEEEECC-------CCeEEEEEEeecccchhhHHHHHHHHHHHhCC-CCccceEEEEeeccccCCCce
Q 002897          559 SNMVGQGSFGTVFKGIIGE-------NGMLVAVKVLNLMQKGALKSFLTECEALRSIR-HRNLIKIITICSSIDFNGVDF  630 (869)
Q Consensus       559 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  630 (869)
                      ++.|+.|-.-.+|++....       .++.|.+++... .. ......+|..+++.+. +.-..++++++..        
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG--------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence            3578888889999998752       345677777642 22 2245568999988884 4334577777432        


Q ss_pred             EEEEeecccCCCH
Q 002897          631 KAIVYDFMQNGSL  643 (869)
Q Consensus       631 ~~lv~e~~~~gsL  643 (869)
                       .+|+||++|.++
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             588999987544